PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Golden, JW; Josleyn, M; Mucker, EM; Hung, CF; Loudon, PT; Wu, TC; Hooper, JW				Golden, Joseph W.; Josleyn, Matthew; Mucker, Eric M.; Hung, Chien-Fu; Loudon, Peter T.; Wu, T. C.; Hooper, Jay W.			Side-by-Side Comparison of Gene-Based Smallpox Vaccine with MVA in Nonhuman Primates	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; PROTECTIVE IMMUNITY; DNA VACCINATION; MUCOSAL ADJUVANTICITY; ANTIBODY-RESPONSES; POXVIRUS INFECTION; ANKARA ACAM3000; VIRUS CHALLENGE; CHOLERA-TOXIN	Orthopoxviruses remain a threat as biological weapons and zoonoses. The licensed live-virus vaccine is associated with serious health risks, making its general usage unacceptable. Attenuated vaccines are being developed as alternatives, the most advanced of which is modified-vaccinia virus Ankara (MVA). We previously developed a gene-based vaccine, termed 4pox, which targets four orthopoxvirus antigens, A33, B5, A27 and L1. This vaccine protects mice and non-human primates from lethal orthopoxvirus disease. Here, we investigated the capacity of the molecular adjuvants GM-CSF and Escherichia coli heat-labile enterotoxin (LT) to enhance the efficacy of the 4pox gene-based vaccine. Both adjuvants significantly increased protective antibody responses in mice. We directly compared the 4pox plus LT vaccine against MVA in a monkeypox virus (MPXV) nonhuman primate (NHP) challenge model. NHPs were vaccinated twice with MVA by intramuscular injection or the 4pox/LT vaccine delivered using a disposable gene gun device. As a positive control, one NHP was vaccinated with ACAM2000. NHPs vaccinated with each vaccine developed anti-orthopoxvirus antibody responses, including those against the 4pox antigens. After MPXV intravenous challenge, all control NHPs developed severe disease, while the ACAM2000 vaccinated animal was well protected. All NHPs vaccinated with MVA were protected from lethality, but three of five developed severe disease and all animals shed virus. All five NHPs vaccinated with 4pox/LT survived and only one developed severe disease. None of the 4pox/LT-vaccinated animals shed virus. Our findings show, for the first time, that a subunit orthopoxvirus vaccine delivered by the same schedule can provide a degree of protection at least as high as that of MVA.	[Golden, Joseph W.; Josleyn, Matthew; Hooper, Jay W.] USA, Med Res Inst Infect Dis, Dept Mol Virol, Div Virol, Ft Detrick, MD 21702 USA; [Mucker, Eric M.] USA, Med Res Inst Infect Dis, Dept Viral Therapeut, Div Virol, Ft Detrick, MD 21702 USA; [Hung, Chien-Fu; Wu, T. C.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Loudon, Peter T.] Pfizer Ltd, Sandwich Labs, Sandwich CT13 9NJ, Kent, England	Johns Hopkins University; Johns Hopkins Medicine; Pfizer	Golden, JW (corresponding author), USA, Med Res Inst Infect Dis, Dept Mol Virol, Div Virol, Ft Detrick, MD 21702 USA.	jay.hooper@amedd.army.mil	Hooper, Jay/K-2362-2017	Hooper, Jay/0000-0002-4475-0415; Mucker, Eric/0000-0002-4656-5379; Golden, Joseph/0000-0002-9709-313X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [IAA Y1-AI-9426-02]; NIAID [UO1 AI070346-01]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under IAA Y1-AI-9426-02, Appendix A120 B.19 and NIAID UO1 AI070346-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acambis, 2008, PACK INS ACAM2000 SM; [Anonymous], 2010, HUMAN VACCINES, V6, P368; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Arrington J, 2002, J VIROL, V76, P4536, DOI 10.1128/JVI.76.9.4536-4546.2002; Benhnia MREI, 2009, J VIROL, V83, P12355, DOI 10.1128/JVI.01593-09; Berhanu A, 2008, J VIROL, V82, P3517, DOI 10.1128/JVI.01854-07; Bhanuprakash V, 2010, ZOONOSES PUBLIC HLTH, V57, pE149, DOI 10.1111/j.1863-2378.2009.01314.x; Boudreau EF, 2012, VACCINE, V30, P1951, DOI 10.1016/j.vaccine.2012.01.024; Boulter E A, 1973, Prog Med Virol, V16, P86; Buchman GW, 2010, VACCINE, V28, P6627, DOI 10.1016/j.vaccine.2010.07.030; Davies DH, 2005, J VIROL, V79, P11724, DOI 10.1128/JVI.79.18.11724-11733.2005; Department of Health and Human Services Declaration regarding administration of smallpox countermeasures, 2003, FED REG, V68, P4212; Earl PL, 2007, VIROLOGY, V366, P84, DOI 10.1016/j.virol.2007.02.041; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Essbauer S, 2010, VET MICROBIOL, V140, P229, DOI 10.1016/j.vetmic.2009.08.026; Feltquate DM, 1997, J IMMUNOL, V158, P2278; Flo J, 2000, VACCINE, V18, P3242, DOI 10.1016/S0264-410X(00)00132-8; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Fogg CN, 2008, J VIROL, V82, P8022, DOI 10.1128/JVI.00568-08; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Giuliani MM, 1998, J EXP MED, V187, P1123, DOI 10.1084/jem.187.7.1123; Glatz M, 2010, LANCET INFECT DIS, V10, P288, DOI 10.1016/S1473-3099(10)70054-2; Golden JW, 2008, VACCINE, V26, P3507, DOI 10.1016/j.vaccine.2008.04.017; Golden JW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-441; Golden JW, 2011, EXPERT REV VACCINES, V10, P1021, DOI [10.1586/ERV.11.46, 10.1586/erv.11.46]; Golden JW, 2010, CLIN VACCINE IMMUNOL, V17, P1656, DOI 10.1128/CVI.00235-10; Haynes JR, 2006, VACCINE, V24, P5016, DOI 10.1016/j.vaccine.2006.03.046; Henderson DA, 2011, BIOSECUR BIOTERROR, V9, P163, DOI 10.1089/bsp.2011.0011; Heraud JM, 2006, J IMMUNOL, V177, P2552, DOI 10.4049/jimmunol.177.4.2552; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hooper JW, 2007, VACCINE, V25, P1814, DOI 10.1016/j.vaccine.2006.11.017; Hooper JW, 2009, VACCINE, V28, P494, DOI 10.1016/j.vaccine.2009.09.133; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Isaacs SN, 2010, NEW GENERATION VACCI, P838; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Kenner J, 2006, VACCINE, V24, P7009, DOI 10.1016/j.vaccine.2006.03.087; Kulesh DA, 2004, LAB INVEST, V84, P1200, DOI 10.1038/labinvest.3700143; Lane J Michael, 2003, Semin Pediatr Infect Dis, V14, P189, DOI 10.1016/S1045-1870(03)00032-3; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; Lewis-Jones S, 2004, CURR OPIN INFECT DIS, V17, P81, DOI 10.1097/00001432-200404000-00003; Lewis-Jones S, 2002, DERMATOL NURS, V14, P85; Lewis-Jones Susan, 2002, Dermatol Nurs, V14, P79; Melkebeek V, 2008, VET IMMUNOL IMMUNOP, V125, P354, DOI 10.1016/j.vetimm.2008.04.021; Moise L, 2011, VACCINE, V29, P501, DOI 10.1016/j.vaccine.2010.10.064; Nalca A, 2011, J GEN VIROL, V92, P31, DOI 10.1099/vir.0.026237-0; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Panchanathan V, 2008, IMMUNOL CELL BIOL, V86, P80, DOI 10.1038/sj.icb.7100118; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Rappuoli R, 1999, IMMUNOL TODAY, V20, P493, DOI 10.1016/S0167-5699(99)01523-6; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Rudraraju R, 2010, VACCINE, V28, P4997, DOI 10.1016/j.vaccine.2010.05.023; Sakhatskyy P, 2006, VIROLOGY, V355, P164, DOI 10.1016/j.virol.2006.07.017; SARKAR JK, 1975, B WORLD HEALTH ORGAN, V52, P307; Schmaljohn C, 1997, J VIROL, V71, P9563, DOI 10.1128/JVI.71.12.9563-9569.1997; Seaman MS, 2010, J INFECT DIS, V201, P1353, DOI 10.1086/651560; Snyder JT, 2004, J VIROL, V78, P7052, DOI 10.1128/JVI.78.13.7052-7060.2004; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Tovey MG, 2010, METHODS MOL BIOL, V626, P287, DOI 10.1007/978-1-60761-585-9_19; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; Wilck MB, 2010, J INFECT DIS, V201, P1361, DOI 10.1086/651561; WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378; World Health Organization, 1979, WEEKLY EPIDEMIOLOGIC, V54, P329; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8; Xu RH, 2008, J EXP MED, V205, P981, DOI 10.1084/jem.20071854; [No title captured]	73	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42353	10.1371/journal.pone.0042353	http://dx.doi.org/10.1371/journal.pone.0042353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860117	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600093
J	Irimu, GW; Gathara, D; Zurovac, D; Kihara, H; Maina, C; Mwangi, J; Mbori-Ngacha, D; Todd, J; Greene, A; English, M				Irimu, Grace W.; Gathara, David; Zurovac, Dejan; Kihara, Harrison; Maina, Christopher; Mwangi, Julius; Mbori-Ngacha, Dorothy; Todd, Jim; Greene, Alexandra; English, Mike			Performance of Health Workers in the Management of Seriously Sick Children at a Kenyan Tertiary Hospital: Before and after a Training Intervention	PLOS ONE			English	Article							SEVERELY MALNOURISHED CHILDREN; SEVERE MALNUTRITION; CARE; GUIDELINES; QUALITY; ILLNESS; COMPLEXITY; INDICATORS; MORTALITY	Background: Implementation of WHO case management guidelines for serious common childhood illnesses remains a challenge in hospitals in low-income countries. The impact of locally adapted clinical practice guidelines (CPGs) on the quality-of-care of patients in tertiary hospitals has rarely been evaluated. Methods and Findings: We conducted, in Kenyatta National Hospital, an uncontrolled before and after study with an attempt to explore intervention dose-effect relationships, as CPGs were disseminated and training was progressively implemented. The emergency triage, assessment and treatment plus admission care (ETAT+) training and locally adapted CPGs targeted common, serious childhood illnesses. We compared performance in the pre-intervention (2005) and post-intervention periods (2009) using quality indicators for three diseases: pneumonia, dehydration and severe malnutrition. The indicators spanned four domains in the continuum of care namely assessment, classification, treatment, and follow-up care in the initial 48 hours of admission. In the pre-intervention period patients' care was largely inconsistent with the guidelines, with nine of the 15 key indicators having performance of below 10%. The intervention produced a marked improvement in guideline adherence with an absolute effect size of over 20% observed in seven of the 15 key indicators; three of which had an effect size of over 50%. However, for all the five indicators that required sustained team effort performance continued to be poor, at less than 10%, in the post-intervention period. Data from the five-year period (2005-09) suggest some dose dependency though the adoption rate of the best-practices varied across diseases and over time. Conclusion: Active dissemination of locally adapted clinical guidelines for common serious childhood illnesses can achieve a significant impact on documented clinical practices, particularly for tasks that rely on competence of individual clinicians. However, more attention must be given to broader implementation strategies that also target institutional and organisational aspects of service delivery to further enhance quality-of-care.	[Irimu, Grace W.; Mbori-Ngacha, Dorothy; English, Mike] Univ Nairobi, Coll Hlth Sci, Dept Paediat & Child Hlth, Nairobi, Kenya; [Irimu, Grace W.; Gathara, David; Zurovac, Dejan; English, Mike] KEMRI Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Zurovac, Dejan] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Zurovac, Dejan] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Kihara, Harrison; Maina, Christopher; Mwangi, Julius] Kenyatta Natl Hosp, Nairobi, Kenya; [Todd, Jim] London Sch Hyg & Trop Med, London WC1, England; [Greene, Alexandra] Univ Dundee, Dundee, Scotland; [English, Mike] Univ Oxford, Dept Paediat, Oxford, England	University of Nairobi; University of Oxford; Boston University; Kenyatta National Hospital; University of London; London School of Hygiene & Tropical Medicine; University of Dundee; University of Oxford	Irimu, GW (corresponding author), Univ Nairobi, Coll Hlth Sci, Dept Paediat & Child Hlth, Nairobi, Kenya.	girimu@nairobi.kemri-wellcome.org		Gathara, David/0000-0002-0958-0713; Todd, Jim/0000-0001-5918-4914; English, Michael/0000-0002-7427-0826	University of Nairobi; Wellcome Trust [084538]; Kenyatta National Hospital (KNH)	University of Nairobi; Wellcome Trust(Wellcome TrustEuropean Commission); Kenyatta National Hospital (KNH)	GI was supported by the University of Nairobi to undertake these studies and received additional support for training from a Wellcome Trust Strategic Award (#084538). Kenyatta National Hospital (KNH) contributed funds to support some ETAT+ training courses. The funders had no role in the design, conduct, analyses or writing of this study nor in the decision to submit for publication.	Abbott A., 1988, SYSTEM PROFESSIONS E; [Anonymous], 2005, HOSP CAR CHILDR GUID; Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Bazin D., 2009, EC ANAL, V42, P7; Bradley J, 2005, INT J QUAL HEALTH C, V17, P391, DOI 10.1093/intqhc/mzi057; Burnes B, 2005, INT J MANAG REV, V7, P73, DOI 10.1111/j.1468-2370.2005.00107.x; Craig P, 2007, DEV EVALUATING COMPL; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-124; English M, 2011, ARCH DIS CHILD, V96, P285, DOI 10.1136/adc.2010.189126; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finn R, 2010, ORGAN STUD, V31, P1069, DOI 10.1177/0170840610376142; Gathara D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-307; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; Ministry of Health Kenya, 2004, GUID HIV TEST CLIN S; Ministry of Health Kenya, 2006, BAS PAED PROT; Mwakyusa Sekela, 2006, BMC Int Health Hum Rights, V6, P9, DOI 10.1186/1472-698X-6-9; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nzioki C, 2009, INT HEALTH, V1, P91, DOI 10.1016/j.inhe.2009.06.008; O'Cathain A, 2007, J MIX METHOD RES, V1, P147, DOI 10.1177/1558689806299094; Osterholt DM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-77; Paxton LA, 1996, B WORLD HEALTH ORGAN, V74, P613; Puoane T, 2008, HEALTH POLICY PLANN, V23, P428, DOI 10.1093/heapol/czn036; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rowe AK, 2000, AM J EPIDEMIOL, V151, P1029, DOI 10.1093/oxfordjournals.aje.a010131; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; STACEY RD, 1995, STRATEGIC MANAGE J, V16, P477, DOI 10.1002/smj.4250160606; Teddlie C, 2003, HDB MIXED METHOD SOC, P4; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400	35	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e39964	10.1371/journal.pone.0039964	http://dx.doi.org/10.1371/journal.pone.0039964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22859945	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600006
J	McGhee, GC; Sundin, GW				McGhee, Gayle C.; Sundin, George W.			Erwinia amylovora CRISPR Elements Provide New Tools for Evaluating Strain Diversity and for Microbial Source Tracking	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FIRE BLIGHT; GENETIC-ANALYSIS; MOLECULAR DIFFERENTIATION; STREPTOMYCIN RESISTANCE; NUCLEOTIDE-SEQUENCE; ACQUIRED-RESISTANCE; PHAGE RESISTANCE; PLASMID; BACTERIOPHAGES	Clustered regularly interspaced short palindromic repeats (CRISPRs) comprise a family of short DNA repeat sequences that are separated by non repetitive spacer sequences and, in combination with a suite of Cas proteins, are thought to function as an adaptive immune system against invading DNA. The number of CRISPR arrays in a bacterial chromosome is variable, and the content of each array can differ in both repeat number and in the presence or absence of specific spacers. We utilized a comparative sequence analysis of CRISPR arrays of the plant pathogen Erwinia amylovora to uncover previously unknown genetic diversity in this species. A total of 85 E. amylovora strains varying in geographic isolation (North America, Europe, New Zealand, and the Middle East), host range, plasmid content, and streptomycin sensitivity/resistance were evaluated for CRISPR array number and spacer variability. From these strains, 588 unique spacers were identified in the three CRISPR arrays present in E. amylovora, and these arrays could be categorized into 20, 17, and 2 patterns types, respectively. Analysis of the relatedness of spacer content differentiated most apple and pear strains isolated in the eastern U. S. from western U. S. strains. In addition, we identified North American strains that shared CRISPR genotypes with strains isolated on other continents. E. amylovora strains from Rubus and Indian hawthorn contained mostly unique spacers compared to apple and pear strains, while strains from loquat shared 79% of spacers with apple and pear strains. Approximately 23% of the spacers matched known sequences, with 16% targeting plasmids and 5% targeting bacteriophage. The plasmid pEU30, isolated in E. amylovora strains from the western U. S., was targeted by 55 spacers. Lastly, we used spacer patterns and content to determine that streptomycin-resistant strains of E. amylovora from Michigan were low in diversity and matched corresponding streptomycin-sensitive strains from the background population.	[McGhee, Gayle C.] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; Michigan State Univ, Ctr Pathogenesis, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	McGhee, GC (corresponding author), Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA.	sundin@msu.edu			United States Department of Agriculture (USDA) CSREES; USDA Specialty Crops Research Initiative; Project GREEEN; Michigan State University; Michigan AgBioResearch	United States Department of Agriculture (USDA) CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA Specialty Crops Research Initiative; Project GREEEN; Michigan State University; Michigan AgBioResearch	This work was funded in part by a grant from the United States Department of Agriculture (USDA) CSREES, USDA Specialty Crops Research Initiative, Project GREEEN, a Michigan plant agriculture initiative at Michigan State University, and Michigan AgBioResearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin JE, 2011, PHYTOPATHOLOGY, V101, P935, DOI 10.1094/PHYTO-12-10-0339; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Born Y, 2011, APPL ENVIRON MICROB, V77, P5945, DOI 10.1128/AEM.03022-10; Boule J, 2011, CAN J PLANT PATHOL, V33, P308, DOI 10.1080/07060661.2011.588250; CHIOU CS, 1993, J BACTERIOL, V175, P732, DOI 10.1128/JB.175.3.732-740.1993; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Geider K, 2006, INT J SYST EVOL MICR, V56, P2937, DOI 10.1099/ijs.0.64032-0; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jock S, 2002, ENVIRON MICROBIOL, V4, P106, DOI 10.1046/j.1462-2920.2002.00277.x; Jock S, 2004, ENVIRON MICROBIOL, V6, P480, DOI 10.1111/j.1462-2920.2004.00583.x; Kim WS, 1999, EUR J PLANT PATHOL, V105, P703, DOI 10.1023/A:1008723717211; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Kube M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-110, 10.1186/1471-2164-11-393]; LAURENT J, 1989, Molecular Plant-Microbe Interactions, V2, P160, DOI 10.1094/MPMI-2-160; Lehman SM, 2009, APPL ENVIRON MICROB, V75, P2139, DOI 10.1128/AEM.02352-08; Llop P, 2006, PHYTOPATHOLOGY, V96, P900, DOI 10.1094/PHYTO-96-0900; Llop P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028651; Maxson-Stein K, 2003, PHYTOPATHOLOGY, V93, P1393, DOI 10.1094/PHYTO.2003.93.11.1393; McGhee GC, 2008, ACTA HORTIC, V793, P271; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P182, DOI 10.1094/PHYTO-04-10-0127; McGhee GC, 2000, APPL ENVIRON MICROB, V66, P4897, DOI 10.1128/AEM.66.11.4897-4907.2000; McGhee GC, 2002, APPL ENVIRON MICROB, V68, P6182, DOI 10.1128/AEM.68.12.6182-6192.2002; MCMANUS PS, 1994, PHYTOPATHOLOGY, V84, P627, DOI 10.1094/Phyto-84-627; McManus PS, 1995, PHYTOPATHOLOGY, V85, P1547, DOI 10.1094/Phyto-85-1547; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Momol MT, 1997, J APPL MICROBIOL, V82, P389, DOI 10.1046/j.1365-2672.1997.00377.x; Muller I, 2011, J BACTERIOL, V193, P795, DOI 10.1128/JB.01293-10; Norelli JL, 2003, PLANT DIS, V87, P756, DOI 10.1094/PDIS.2003.87.7.756; Park DH, 2011, J BACTERIOL, V193, P586, DOI 10.1128/JB.01246-10; Powney R, 2011, J BACTERIOL, V193, P785, DOI 10.1128/JB.01352-10; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Rico A, 2008, PHYTOPATHOLOGY, V98, P260, DOI 10.1094/PHYTO-98-3-0260; Schnabel EL, 1998, PLANT DIS, V82, P1334, DOI 10.1094/PDIS.1998.82.12.1334; Schnabel EL, 2001, APPL ENVIRON MICROB, V67, P59, DOI 10.1128/AEM.67.1.59-64.2001; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Smits THM, 2011, J BIOTECHNOL, V155, P34, DOI 10.1016/j.jbiotec.2010.10.075; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; STEINBERGER EM, 1990, PLASMID, V24, P12, DOI 10.1016/0147-619X(90)90021-4; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Triplett LR, 2009, APPL ENVIRON MICROB, V72, P7359; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; van der Zwet T, 1979, USDA HDB, V510; van der Zwet T, 2004, ACTA HORTIC, V704, P35; Zhao YF, 2009, CAN J MICROBIOL, V55, P457, DOI [10.1139/W08-147, 10.1139/w08-147]	56	53	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41706	10.1371/journal.pone.0041706	http://dx.doi.org/10.1371/journal.pone.0041706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860008	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600038
J	Schowalter, RM; Reinhold, WC; Buck, CB				Schowalter, Rachel M.; Reinhold, William C.; Buck, Christopher B.			Entry Tropism of BK and Merkel Cell Polyomaviruses in Cell Culture	PLOS ONE			English	Article							JC-VIRUS; PAPILLOMAVIRUS CAPSIDS; HEPARAN-SULFATE; GROWTH-FACTOR; IN-VITRO; CARCINOMA; RECEPTOR; DNA; LINE; IDENTIFICATION	Merkel Cell Polyomavirus (MCV or MCPyV) was recently discovered in an aggressive form of skin cancer known as Merkel cell carcinoma (MCC). Integration of MCV DNA into the host genome likely contributes to the development of MCC in humans. MCV infection is common and many healthy people shed MCV virions from the surface of their skin. MCV DNA has also been detected in samples from a variety of other tissues. Although MCC tumors serve as a record that MCV can infect the Merkel cell lineage, the true tissue tropism and natural reservoirs of MCV infection in the host are not known. In an effort to gain insight into the tissue tropism of MCV, and to possibly identify cellular factors responsible for mediating infectious entry of the virus, the infection potential of human cells derived from a variety of tissues was evaluated. MCV gene transfer vectors (pseudoviruses) carrying reporter plasmid DNA encoding GFP or luciferase genes were used to transduce keratinocytes and melanocytes, as well as lines derived from MCC tumors and the NCI-60 panel of human tumor cell lines. MCV transduction was compared to transduction with pseudoviruses based on the better-studied human BK polyomavirus (BKV). The efficiency of MCV and BKV transduction of various cell types occasionally overlapped, but often differed greatly, and no clear tissue type preference emerged. Application of native MCV virions to a subset of highly transducible cell types suggested that the lines do not support robust replication of MCV, consistent with recent proposals that the MCV late phase may be governed by cellular differentiation in vivo. The availability of carefully curated gene expression data for the NCI-60 panel should make the MCV and BKV transduction data for these lines a useful reference for future studies aimed at elucidation of the infectious entry pathways of these viruses.	[Schowalter, Rachel M.; Buck, Christopher B.] NCI, Tumor Virus Mol Biol Sect, Cellular Oncol Lab, Bethesda, MD 20892 USA; [Reinhold, William C.] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schowalter, RM (corresponding author), NCI, Tumor Virus Mol Biol Sect, Cellular Oncol Lab, Bethesda, MD 20892 USA.	buckc@mail.nih.gov	Buck, Christopher/G-8358-2017; Reinhold, William/J-6704-2017	Buck, Christopher/0000-0003-3165-8094; Reinhold, William/0000-0001-5513-9323	Intramural Research Program of National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011090, ZIABC011460] Funding Source: NIH RePORTER	Intramural Research Program of National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Bluemn EG, 2009, J CLIN VIROL, V44, P164, DOI 10.1016/j.jcv.2008.11.008; Boldorini R, 2005, ARCH PATHOL LAB MED, V129, P69; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Broekema NM, 2012, VIROLOGY, V422, P235, DOI 10.1016/j.virol.2011.10.026; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Day PM, 2008, J VIROL, V82, P12565, DOI 10.1128/JVI.01631-08; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022468; Foulongne V, 2010, EMERG INFECT DIS, V16, P685, DOI 10.3201/eid1604.091278; GARDNER SD, 1971, LANCET, V1, P1253; Ghez D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-99; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105; HOGAN TF, 1980, J CLIN MICROBIOL, V11, P178, DOI 10.1128/JCM.11.2.178-183.1980; HOLTHOFER H, 1994, KIDNEY INT, V45, P123, DOI 10.1038/ki.1994.14; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Husseiny MI, 2010, J CLIN VIROL, V49, P137, DOI 10.1016/j.jcv.2010.06.017; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kiasari BA, 2011, J MED VIROL, V83, P2220, DOI 10.1002/jmv.22222; KNOWLES WA, 1989, J MED VIROL, V28, P118, DOI 10.1002/jmv.1890280212; Low JA, 2006, J VIROL, V80, P1361, DOI 10.1128/JVI.80.3.1361-1366.2006; Margolis L, 1998, FEBS LETT, V433, P5, DOI 10.1016/S0014-5793(98)00858-8; Mertz KD, 2010, J INVEST DERMATOL, V130, P1146, DOI 10.1038/jid.2009.392; Moll I, 2005, EUR J CELL BIOL, V84, P259, DOI 10.1016/j.ejcb.2004.12.023; Neumann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029112; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Pastrana DV, 2010, VIROLOGY, V405, P20, DOI 10.1016/j.virol.2010.06.022; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Ramos E, 2009, TRANSPLANTATION, V87, P621, DOI 10.1097/TP.0b013e318197c17d; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; ROSEN ST, 1987, LAB INVEST, V56, P302; Rubin J, 2011, ANTICANCER RES, V31, P3489; Schowalter RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002161; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Singh HK, 2006, ADV EXP MED BIOL, V577, P201; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Wang TS, 2011, SEMIN CUTAN MED SURG, V30, P48, DOI 10.1016/j.sder.2011.02.001; Weinstein JN, 2003, CR BIOL, V326, P909, DOI 10.1016/j.crvi.2003.08.005; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575; WINTERBOURNE DJ, 1981, J BIOL CHEM, V256, P4310; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030317	59	54	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42181	10.1371/journal.pone.0042181	http://dx.doi.org/10.1371/journal.pone.0042181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860078	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600069
J	Bartrons, M; Grimalt, JO; de Mendoza, G; Catalan, J				Bartrons, Mireia; Grimalt, Joan O.; de Mendoza, Guillermo; Catalan, Jordi			Pollutant Dehalogenation Capability May Depend on the Trophic Evolutionary History of the Organism: PBDEs in Freshwater Food Webs	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; RANGE ATMOSPHERIC TRANSPORT; BROMINATED FLAME RETARDANTS; HIGH-MOUNTAIN LAKES; POLYCHLORINATED-BIPHENYLS; DECABROMODIPHENYL ETHER; ORGANOCHLORINE COMPOUNDS; HERBIVORE INTERACTIONS; MARINE WORMS; BIOTRANSFORMATION	Organohalogen compounds are some of the most notorious persistent pollutants disturbing the Earth biosphere. Although human-made, these chemicals are not completely alien to living systems. A large number of natural organohalogens, part of the secondary metabolism, are involved in chemical trophic interactions. Surprisingly, the relationship between organisms' trophic position and synthetic organohalogen biotransformation capability has not been investigated. We studied the case for polybromodiphenyl ethers (PBDE), a group of flame-retardants of widespread use in the recent years, in aquatic food webs from remote mountain lakes. These relatively simple ecosystems only receive pollution by atmospheric transport. A large predominance of the PBDE congener currently in use in Europe, BDE-209, largely dominated the PBDE composition of the basal resources of the food web. In contrast, primary consumers (herbivores and detritivores) showed a low proportion of BDE-209, and dominance of several less brominated congeners (e.g. BDE-100, BDE47). Secondary consumers (predators) showed large biomagnification of BDE-209 compare to other congeners. Finally, top predator fish characterized by low total PBDE concentrations. Examination of the bromine stable isotopic composition indicates that primary consumers showed higher PBDE biotransformation capability than secondary consumers. We suggest that the evolutionary response of primary consumers to feeding deterrents would have pre-adapted them for PBDE biotransformation. The observed few exceptions, some insect taxa, can be interpreted in the light of the trophic history of the evolutionary lineage of the organisms. Bromine isotopic composition in fish indicates that low PBDE values are due to not only biotransformation but also to some other process likely related to transport. Our finding illustrates that organohalogen compounds may strongly disturb ecosystems even at low concentrations, since the species lacking or having scarce biotransformation capability may be selectively more exposed to these halogenated hydrophobic semi-volatile organic pollutants due to their high bioaccumulation potential.	[Bartrons, Mireia] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Grimalt, Joan O.] CSIC, Inst Environm Assessment & Water Res, Barcelona, Spain; [de Mendoza, Guillermo; Catalan, Jordi] CSIC, Ctr Adv Studies Blanes, Blanes, Spain; [Catalan, Jordi] Ctr Recerca Ecol & Aplicac Forestals, Cerdanyola Del Valles, Spain	University of Wisconsin System; University of Wisconsin Madison; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Bartrons, M (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	catalan@ceab.csic.es	Hernández, Tonia/J-9335-2012; Catalan, Jordi/A-5420-2008; Grimalt, Joan O/E-2073-2011; Bartrons, Mireia/D-3452-2014; de Mendoza, Guillermo/K-4298-2012	Catalan, Jordi/0000-0002-2934-4013; Grimalt, Joan O/0000-0002-7391-5768; Bartrons, Mireia/0000-0003-0617-9577; de Mendoza, Guillermo/0000-0003-1323-8686	EU [GOCE-CT-2003-505540]; Spanish government [CGL2004-0289]; Graccie [CSD2007-00067]	EU(European Commission); Spanish government(Spanish GovernmentEuropean Commission); Graccie	This work was funded by the EU project Euro-limpacs (GOCE-CT-2003-505540) and the Spanish government projects Trazas (CGL2004-0289) and Graccie (CSD2007-00067). M.B. has a postdoc fellowship from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksa K, 2012, FORENSIC SCI INT, V218, P37, DOI 10.1016/j.forsciint.2011.10.003; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Awad NE, 2004, PHYTOTHER RES, V18, P275, DOI 10.1002/ptr.1273; Bartrons M, 2011, ENVIRON POLLUT, V159, P1816, DOI 10.1016/j.envpol.2011.03.027; BOCK WJ, 1959, EVOLUTION, V13, P194, DOI 10.2307/2405873; Bohlke JK, 2005, J PHYS CHEM REF DATA, V34, P57, DOI 10.1063/1.1836764; Bradford-Grieve JM, 2002, HYDROBIOLOGIA, V485, P223, DOI 10.1023/A:1021373412738; Breivik K, 2006, ENVIRON SCI TECHNOL, V40, P4612, DOI 10.1021/es060730s; Catalan J, 2004, ENVIRON SCI TECHNOL, V38, P4269, DOI 10.1021/es040035p; Chen Y, 2008, J MAR BIOL ASSOC UK, V88, P1487, DOI 10.1017/S0025315408001951; Cowart JD, 2000, MAR BIOL, V136, P993, DOI 10.1007/s002270000271; COX P, 2003, OFF J EUR UNION, V42, P45; de Carvalho LR, 2000, QUIM NOVA, V23, P757, DOI 10.1590/S0100-40422000000600009; de Wit CA, 2006, CHEMOSPHERE, V64, P209, DOI 10.1016/j.chemosphere.2005.12.029; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; Eljarrat E, 2004, ANAL BIOANAL CHEM, V378, P610, DOI 10.1007/s00216-003-2220-7; Gallego E, 2007, ENVIRON SCI TECHNOL, V41, P2196, DOI 10.1021/es062197m; Gerecke AC, 2005, ENVIRON SCI TECHNOL, V39, P1078, DOI 10.1021/es048634j; Gouin T, 2004, ENVIRON POLLUT, V128, P139, DOI 10.1016/j.envpol.2003.08.025; Gribble GW, 1999, CHEM SOC REV, V28, P335, DOI 10.1039/a900201d; GRIBBLE GW, 2004, NATURAL ORGANOHALOGE; Grimaldi David, 2005, pi; Hakk H, 2003, ENVIRON INT, V29, P801, DOI 10.1016/S0160-4120(03)00109-0; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; HAY ME, 1988, ANNU REV ECOL SYST, V19, P111, DOI 10.1146/annurev.es.19.110188.000551; He JZ, 2006, ENVIRON SCI TECHNOL, V40, P4429, DOI 10.1021/es052508d; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P945, DOI 10.1021/es035082g; Holzenthal RW, 2007, ZOOTAXA, P639; Johnson-Restrepo B, 2005, ENVIRON SCI TECHNOL, V39, P8243, DOI 10.1021/es051551y; Kicklighter CE, 2006, ECOL MONOGR, V76, P195, DOI 10.1890/0012-9615(2006)076[0195:IPDTCO]2.0.CO;2; Kicklighter CE, 2004, LIMNOL OCEANOGR, V49, P430, DOI 10.4319/lo.2004.49.2.0430; Kicklighter CE, 2007, OECOLOGIA, V151, P161, DOI 10.1007/s00442-006-0567-0; Kierkegaard A, 2007, ENVIRON SCI TECHNOL, V41, P417, DOI 10.1021/es0619197; KUNIYOSHI M, 1985, EXPERIENTIA, V41, P523, DOI 10.1007/BF01966182; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Manzo E, 2005, TETRAHEDRON, V61, P7456, DOI 10.1016/j.tet.2005.05.051; McDonald TA, 2002, CHEMOSPHERE, V46, P745, DOI 10.1016/S0045-6535(01)00239-9; McKinney MA, 2006, AQUAT TOXICOL, V77, P87, DOI 10.1016/j.aquatox.2005.08.016; Meijer SN, 2003, ENVIRON SCI TECHNOL, V37, P667, DOI 10.1021/es025809l; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Paul NA, 2006, MAR ECOL PROG SER, V323, P1, DOI 10.3354/meps323001; Puyana M, 2003, MAR ECOL PROG SER, V246, P127, DOI 10.3354/meps246127; Qiu MD, 2012, BIODEGRADATION, V23, P351, DOI 10.1007/s10532-011-9514-9; Rayne S, 2003, J CHROMATOGR A, V1016, P235, DOI 10.1016/j.chroma.2003.07.002; Riu A, 2008, ENVIRON INT, V34, P318, DOI 10.1016/j.envint.2007.03.007; Robrock KR, 2009, ENVIRON SCI TECHNOL, V43, P5705, DOI 10.1021/es900411k; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rotander A, 2012, ENVIRON INT, V40, P102, DOI 10.1016/j.envint.2011.07.001; Saether OA, 2000, SYST ENTOMOL, V25, P223, DOI 10.1046/j.1365-3113.2000.00101.x; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Sormo EG, 2006, ENVIRON TOXICOL CHEM, V25, P2502, DOI 10.1897/05-591R.1; Stapleton HM, 2004, ENVIRON TOXICOL CHEM, V23, P1939, DOI 10.1897/03-462; Sun J, 2005, J NAT PROD, V68, P915, DOI 10.1021/np050096g; Tomy GT, 2004, ENVIRON SCI TECHNOL, V38, P1496, DOI 10.1021/es035070v; Trudel D, 2011, ENVIRON SCI TECHNOL, V45, P2391, DOI 10.1021/es1035046; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Verdel EF, 2000, COMP BIOCHEM PHYS B, V125, P179, DOI 10.1016/S0305-0491(99)00168-6; Verreault J, 2005, ENVIRON SCI TECHNOL, V39, P6021, DOI 10.1021/es050738m; Vives I, 2002, J CHROMATOGR B, V768, P247, DOI 10.1016/S1570-0232(01)00585-2; Wania F, 2003, ENVIRON TOXICOL CHEM, V22, P1252, DOI [10.1897/1551-5028(2003)022&lt;1252:ATLRTP&gt;2.0.CO;2, 10.1002/etc.5620220610]; Webster P, 2004, SCIENCE, V304, P1730; Zeng X, 2005, J CHEM ENG DATA, V50, P1548, DOI 10.1021/je050018v	63	22	22	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41829	10.1371/journal.pone.0041829	http://dx.doi.org/10.1371/journal.pone.0041829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848624	Green Published, gold			2022-12-27	WOS:000306950200112
J	Cox, R; Revie, CW; Sanchez, J				Cox, Ruth; Revie, Crawford W.; Sanchez, Javier			The Use of Expert Opinion to Assess the Risk of Emergence or Re-Emergence of Infectious Diseases in Canada Associated with Climate Change	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; PUBLIC-HEALTH; VECTOR-BORNE; ELICITATION; IMPACT; TEMPERATURE; CONSENSUS; NETWORK; MODEL	Global climate change is predicted to lead to an increase in infectious disease outbreaks. Reliable surveillance for diseases that are most likely to emerge is required, and given limited resources, policy decision makers need rational methods with which to prioritise pathogen threats. Here expert opinion was collected to determine what criteria could be used to prioritise diseases according to the likelihood of emergence in response to climate change and according to their impact. We identified a total of 40 criteria that might be used for this purpose in the Canadian context. The opinion of 64 experts from academic, government and independent backgrounds was collected to determine the importance of the criteria. A weight was calculated for each criterion based on the expert opinion. The five that were considered most influential on disease emergence or impact were: potential economic impact, severity of disease in the general human population, human case fatality rate, the type of climate that the pathogen can tolerate and the current climatic conditions in Canada. There was effective consensus about the influence of some criteria among participants, while for others there was considerable variation. The specific climate criteria that were most likely to influence disease emergence were: an annual increase in temperature, an increase in summer temperature, an increase in summer precipitation and to a lesser extent an increase in winter temperature. These climate variables were considered to be most influential on vector-borne diseases and on food and water-borne diseases. Opinion about the influence of climate on air-borne diseases and diseases spread by direct/indirect contact were more variable. The impact of emerging diseases on the human population was deemed more important than the impact on animal populations.	[Cox, Ruth; Revie, Crawford W.; Sanchez, Javier] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada	University of Prince Edward Island	Cox, R (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada.	rucox@upei.ca	sanchez, javier/AAA-4179-2022; Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340	Public Health Agency of Canada [4500217733]	Public Health Agency of Canada	Funding for this research was provided by the Public Health Agency of Canada (www.publichealth.gc.ca), grant number: 4500217733. The funders provided advice about potential study participants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMMUN DIS REP CDR S; Charron DF, 2004, J TOXICOL ENV HEAL A, V67, P1667, DOI 10.1080/15287390490492313; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P745, DOI 10.1016/j.ress.2007.03.017; Davidson VJ, 2011, FOODBORNE PATHOG DIS, V8, P983, DOI 10.1089/fpd.2010.0786; Department for Environment Food and Rural Affairs, 2010, DOC D2R2 DAT DIS BRI; Doherty J A, 2000, Can J Infect Dis, V11, P21; Eisenberg JNS, 2007, ENVIRON HEALTH PERSP, V115, P1216, DOI 10.1289/ehp.9806; Fleury M, 2006, INT J BIOMETEOROL, V50, P385, DOI 10.1007/s00484-006-0028-9; Gale P, 2010, EPIDEMIOL INFECT, V138, P214, DOI 10.1017/S0950268809990367; Giesecke J, 1999, LANCET, V353, P344, DOI 10.1016/S0140-6736(05)74946-1; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Gustafson LL, 2005, PREV VET MED, V70, P17, DOI 10.1016/j.prevetmed.2005.02.012; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Horby P, 2001, Commun Dis Public Health, V4, P8; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Hurd MD, 2002, ECON J, V112, P966, DOI 10.1111/1468-0297.00065; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003; Knol AB, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-19; Kovats RS, 2005, CAN MED ASSOC J, V172, P501, DOI 10.1503/cmaj.050020; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Krause G, 2008, Euro Surveill, V13; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lemmen D, 2007, CLIMATE CHANGE IMPAC; McKenzie J, 2007, PREV VET MED, V81, P194, DOI 10.1016/j.prevetmed.2007.04.003; Morgan D, 2009, EPIDEMIOL INFECT, V137, P1521, DOI 10.1017/S0950268809990227; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Mourits MCM, 2010, PREV VET MED, V96, P201, DOI 10.1016/j.prevetmed.2010.06.010; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Assessment Synthesis Team, 2000, CLIM CHANG IMP US PO; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Olson MJ, 1997, J BEHAV DECIS MAKING, V10, P117, DOI 10.1002/(SICI)1099-0771(199706)10:2<117::AID-BDM251>3.0.CO;2-7; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Parkinson Alan J, 2005, Int J Circumpolar Health, V64, P478; Parkinson AJ, 2008, EMERG INFECT DIS, V14, P18, DOI 10.3201/eid1401.070717; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Public Health Agency of Canada, 2008, CANADA COMMUNICABLE, V34, P25; Roberts H, 2010, ZOON CLIM CHANG C U; Seguin J., 2008, CAN ASS VULN AD CAP; Sockett P N, 1995, Can J Infect Dis, V6, P165; Soon JM, 2012, EXPERT SYST APPL, V39, P8325, DOI 10.1016/j.eswa.2012.01.189; Stark KDC, 2002, PREV VET MED, V53, P7, DOI 10.1016/S0167-5877(01)00278-1; Stephen Craig, 2004, Can J Infect Dis Med Microbiol, V15, P339; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Van der Fels-Klerx HJ, 2005, RISK ANAL, V25, P109, DOI 10.1111/j.0272-4332.2005.00571.x; Wentholt MTA, 2010, FOOD CONTROL, V21, P1731, DOI 10.1016/j.foodcont.2010.07.006; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; World Health Organization, 2008, GLOBAL BURDEN DIS; Zhang Y, 2007, J ENVIRON HEALTH, V70, P32	54	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41590	10.1371/journal.pone.0041590	http://dx.doi.org/10.1371/journal.pone.0041590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848536	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200074
J	Czaplik, M; Hubner, C; Kony, M; Kaliciak, J; Kezze, F; Leonhardt, S; Rossaint, R				Czaplik, Michael; Huebner, Christa; Koeny, Markus; Kaliciak, Julia; Kezze, Fatima; Leonhardt, Steffen; rossaint, Rolf			Acute Pain Therapy in Postanesthesia Care Unit Directed by Skin Conductance: A Randomized Controlled Trial	PLOS ONE			English	Article							POSTOPERATIVE PAIN; ASSESS EMERGENCE; SURGICAL STRESS; BISPECTRAL INDEX(R); STIMULATION; ENTROPY; TOOL	Background: After surgery, effective and well-directed acute pain therapy is a necessary and integral part of the overall treatment plan. Generally, the assessment of pain intensity depends on a patient's self-evaluation using scoring systems such as numeric rating scales (NRS, 0 to 10). Recently, a "Pain Monitor" was commercially provided which is based on measurements of fluctuations of skin conductance (NFSC). In this randomized, controlled, single-blind trial, possible benefits of this certain device were studied. Methods: Postoperative patients (n = 44) were randomly assigned to a test or a control group during their stay in the postanesthesia care unit (PACU). All patients were treated and monitored according to internal hospital standards. Whereas all patients systematically evaluated their pain each 15 min, test group patients were additionally addressed when NFSC exceeded a predefined level. In cases of NRS >= 5 during a routine elevation or in between, pain relief was achieved by standard procedures irrespective of group allocation. Results: During their stay in PACU, both test and control groups experienced a significant decrease in NRS as a consequence of pain therapy. No significant differences in mean NRS or in NFSC values were found between the test and control groups. No correlation was observed between NRS and NFSC. Conclusion: Postoperative patients experience diverse stressors, such as anxiety, disorientation, shivering, sickness and pain. Although the application of continuous pain monitoring would be meaningful in this clinical setting, the tested device failed to distinguish pain from other stressors in postoperative adult patients.	[Czaplik, Michael; Huebner, Christa; Kaliciak, Julia; Kezze, Fatima; rossaint, Rolf] Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany; [Czaplik, Michael; Koeny, Markus; Leonhardt, Steffen] Rhein Westfal TH Aachen, Philips Chair Med Informat Technol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Philips; Philips Healthcare; RWTH Aachen University	Czaplik, M (corresponding author), Univ Hosp Aachen, Dept Anesthesiol, Aachen, Germany.	mczaplik@ukaachen.de	Leonhardt, Steffen/AAO-9082-2021; Czaplik, Michael/G-1120-2012	Leonhardt, Steffen/0000-0002-6898-6887; 				ALDRETE JA, 1970, ANESTH ANAL CURR RES, V49, P924; Bosenberg A, 2003, PAEDIATR ANAESTH, V13, P708, DOI 10.1046/j.1460-9592.2003.01142.x; Choo EK, 2010, ANESTHESIOLOGY, V113, P175, DOI 10.1097/ALN.0b013e3181de6ce9; GE Healthcare, 2011, SURG PHLETH IND SPI; Gjerstad AC, 2007, ACTA ANAESTH SCAND, V51, P1, DOI 10.1111/j.1399-6576.2006.01188.x; Gjerstad AC, 2007, ACTA ANAESTH SCAND, V51, P8, DOI 10.1111/j.1399-6576.2006.01189.x; Gjerstad AC, 2008, PEDIATRICS, V122, pE848, DOI 10.1542/peds.2007-2545; GOULD TH, 1992, BRIT MED J, V305, P1187, DOI 10.1136/bmj.305.6863.1187; Guignard B, 2006, BEST PRACT RES-CLIN, V20, P161, DOI 10.1016/j.bpa.2005.09.002; Hullett B, 2009, ANESTHESIOLOGY, V111, P513, DOI 10.1097/ALN.0b013e3181b27c18; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; KEHLET H, 1989, BRIT J ANAESTH, V63, P189, DOI 10.1093/bja/63.2.189; Ledowski T, 2007, BRIT J ANAESTH, V99, P547, DOI 10.1093/bja/aem189; Ledowski T, 2007, ANAESTHESIA, V62, P989, DOI 10.1111/j.1365-2044.2007.05191.x; Ledowski T, 2006, BRIT J ANAESTH, V97, P862, DOI 10.1093/bja/ael280; Ledowski T, 2006, BRIT J ANAESTH, V97, P817, DOI 10.1093/bja/ael278; Ledowski T, 2006, BRIT J ANAESTH, V97, P187, DOI 10.1093/bja/ael119; Ledowski T, 2010, ANAESTHESIA, V65, P1001, DOI 10.1111/j.1365-2044.2010.06480.x; Ledowski T, 2009, ANAESTHESIA, V64, P727, DOI 10.1111/j.1365-2044.2008.05834.x; Ledowski T, 2009, EUR J ANAESTH, V26, P777, DOI 10.1097/EJA.0b013e32832bb678; Loggia ML, 2011, PAIN, V152, P592, DOI 10.1016/j.pain.2010.11.032; Lynch M, 2001, Adv Nurse Pract, V9, P28; NISBET HIA, 1967, BRIT J ANAESTH, V39, P798, DOI 10.1093/bja/39.10.798; Polomano Rosemary C, 2008, J Perianesth Nurs, V23, pS4, DOI 10.1016/j.jopan.2007.11.004; Rodriguez CS, 2004, CANCER NURS, V27, P425; Storm H, 2002, ACTA ANAESTH SCAND, V46, P887, DOI 10.1034/j.1399-6576.2002.460721.x; Storm H, 2005, ACTA ANAESTH SCAND, V49, P798, DOI 10.1111/j.1399-6576.2005.00665.x; Storm H, 2000, ARCH DIS CHILD-FETAL, V83, pF143, DOI 10.1136/fn.83.2.F143; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; Vaurio LE, 2006, ANESTH ANALG, V102, P1267, DOI 10.1213/01.ane.0000199156.59226.af; WALLIN BG, 1981, PSYCHOPHYSIOLOGY, V18, P470, DOI 10.1111/j.1469-8986.1981.tb02483.x	31	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41758	10.1371/journal.pone.0041758	http://dx.doi.org/10.1371/journal.pone.0041758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848592	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200101
J	de Bock, M; Derraik, JGB; Brennan, CM; Biggs, JB; Smith, GC; Cameron-Smith, D; Wall, CR; Cutfield, WS				de Bock, Martin; Derraik, Jose G. B.; Brennan, Christine M.; Biggs, Janene B.; Smith, Greg C.; Cameron-Smith, David; Wall, Clare R.; Cutfield, Wayne S.			Psyllium Supplementation in Adolescents Improves Fat Distribution & Lipid Profile: A Randomized, Participant-Blinded, Placebo-Controlled, Crossover Trial	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; INSULIN SENSITIVITY; DIETARY FIBER; CARDIOVASCULAR-DISEASE; GLUCOSE-TOLERANCE; PUBERTAL GIRLS; RISK-FACTORS; BODY-MASS; CHILDREN	Aims: We aimed to assess the effects of psyllium supplementation on insulin sensitivity and other parameters of the metabolic syndrome in an at risk adolescent population. Methods: This study encompassed a participant-blinded, randomized, placebo-controlled, crossover trial. Subjects were 47 healthy adolescent males aged 15-16 years, recruited from secondary schools in lower socio-economic areas with high rates of obesity. Participants received 6 g/day of psyllium or placebo for 6 weeks, with a two-week washout before crossing over. Fasting lipid profiles, ambulatory blood pressure, auxological data, body composition, activity levels, and three-day food records were collected at baseline and after each 6-week intervention. Insulin sensitivity was measured by the Matsuda method using glucose and insulin values from an oral glucose tolerance test. Results: 45 subjects completed the study, and compliance was very high: 87% of participants took > 80% of prescribed capsules. At baseline, 44% of subjects were overweight or obese. 28% had decreased insulin sensitivity, but none had impaired glucose tolerance. Fibre supplementation led to a 4% reduction in android fat to gynoid fat ratio (p = 0.019), as well as a 0.12 mmol/l (6%) reduction in LDL cholesterol (p = 0.042). No associated adverse events were recorded. Conclusions: Dietary supplementation with 6 g/day of psyllium over 6 weeks improves fat distribution and lipid profile (parameters of the metabolic syndrome) in an at risk population of adolescent males.	[de Bock, Martin; Derraik, Jose G. B.; Brennan, Christine M.; Biggs, Janene B.; Cameron-Smith, David; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Smith, Greg C.] Univ Auckland, Dept Mol Genet, Auckland 1, New Zealand; [Wall, Clare R.] Univ Auckland, Dept Nutr, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	de Bock, M (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Wall, Clare/0000-0003-1062-3909; Cameron-Smith, David/0000-0002-0144-5816	Paykel Trust of the Maurice & Agnes Paykel Clinical Research Unit at the Liggins Institute; Starship Foundation; Australasian Paediatric Endocrine Group; New Zealand Society for the Study of Diabetes	Paykel Trust of the Maurice & Agnes Paykel Clinical Research Unit at the Liggins Institute; Starship Foundation; Australasian Paediatric Endocrine Group; New Zealand Society for the Study of Diabetes	Starship Foundation, Australasian Paediatric Endocrine Group, and New Zealand Society for the Study of Diabetes. We also acknowledge the Paykel Trust for long-term funding of the Maurice & Agnes Paykel Clinical Research Unit at the Liggins Institute. The psyllium suppliers (Douglas Pharmaceuticals) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Anderson JW, 1999, AM J CLIN NUTR, V70, P466; ANDERSON JW, 1987, AM J CARDIOL, V60, pG17, DOI 10.1016/0002-9149(87)90587-X; [Anonymous], 2001, CEREAL FOOD WORLD, V46, P112; Australian National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N; BOURQUIN LD, 1993, SCAND J GASTROENTERO, V28, P249, DOI 10.3109/00365529309096081; Campbell JM, 1997, NUTR RES, V17, P619, DOI 10.1016/S0271-5317(97)00034-1; Carlson JJ, 2011, J AM DIET ASSOC, V111, P1688, DOI 10.1016/j.jada.2011.08.008; Chen AK, 2006, METABOLISM, V55, P871, DOI 10.1016/j.metabol.2006.03.001; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; DENNISON BA, 1993, J PEDIATR-US, V123, P24, DOI 10.1016/S0022-3476(05)81532-X; DERIDDER CM, 1991, AM J CLIN NUTR, V54, P805, DOI 10.1093/ajcn/54.5.805; Dikeman CL, 2006, CRIT REV FOOD SCI, V46, P649, DOI 10.1080/10408390500511862; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; GLASSMAN M, 1990, AM J DIS CHILD, V144, P973, DOI 10.1001/archpedi.1990.02150330033016; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guillon F, 2000, FOOD RES INT, V33, P233, DOI 10.1016/S0963-9969(00)00038-7; Isken F, 2010, J NUTR BIOCHEM, V21, P278, DOI 10.1016/j.jnutbio.2008.12.012; JENKINS DJA, 1978, BRIT MED J, V1, P1392, DOI 10.1136/bmj.1.6124.1392; Johnston KL, 2010, DIABETIC MED, V27, P391, DOI 10.1111/j.1464-5491.2010.02923.x; KANNEL WB, 1991, J CLIN EPIDEMIOL, V44, P183, DOI 10.1016/0895-4356(91)90265-B; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Lorenzo C, 2010, J CLIN ENDOCR METAB, V95, P5082, DOI 10.1210/jc.2010-1144; Maki KC, 2010, DIABETES TECHNOL THE, V12, P895, DOI 10.1089/dia.2010.0083; Maki KC, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-22; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; Parikh S, 2012, J CLIN ENDOCRINOL ME, V97; Rodriguez-Moran M, 1998, J DIABETES COMPLICAT, V12, P273, DOI 10.1016/S1056-8727(98)00003-8; Salmond C., 2007, NZDEP2006 INDEX DEPR; Schneider D, 2000, SOC SCI MED, V51, P955, DOI 10.1016/S0277-9536(00)00074-5; Sierra M, 2002, EUR J CLIN NUTR, V56, P830, DOI 10.1038/sj.ejcn.1601398; Steffen LM, 2003, AM J EPIDEMIOL, V158, P243, DOI 10.1093/aje/kwg146; TANEJA A, 1989, EUR J CLIN NUTR, V43, P197; Thomas D, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005105.PUB2; Ventura E, 2009, ARCH PEDIAT ADOL MED, V163, P320, DOI 10.1001/archpediatrics.2009.11; Weickert MO, 2008, J NUTR, V138, P439, DOI 10.1093/jn/138.3.439; Weickert MO, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-90; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; WILLIAMS CL, 1995, J AM COLL NUTR, V14, P251; Wuhl E, 2002, J HYPERTENS, V20, P1995, DOI 10.1097/00004872-200210000-00019	41	28	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41735	10.1371/journal.pone.0041735	http://dx.doi.org/10.1371/journal.pone.0041735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848584	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200098
J	Laricchiuta, D; Rojo, ML; Rodriguez-Gaztelumendi, A; Ferlazzo, F; Petrosini, L; Fowler, CJ				Laricchiuta, Daniela; Rojo, Maria Luisa; Rodriguez-Gaztelumendi, Antonio; Ferlazzo, Fabio; Petrosini, Laura; Fowler, Christopher J.			CB1 Receptor Autoradiographic Characterization of the Individual Differences in Approach and Avoidance Motivation	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; ANXIETY-LIKE BEHAVIOR; ENDOCANNABINOID SYSTEM; RAT-BRAIN; CANNABINOID RECEPTORS; NOVELTY-SEEKING; EMERGING ROLE; INHIBITION; ADOLESCENT; EXPRESSION	Typically, approach behaviour is displayed in the context of moving towards a desired goal, while avoidance behaviour is displayed in the context of moving away from threatening or novel stimuli. In the current research, we detected three sub-populations of C57BL/6J mice that spontaneously responded with avoiding, balancing or approaching behaviours in the presence of the same conflicting stimuli. While the balancing animals reacted with balanced responses between approach and avoidance, the avoiding or approaching animals exhibited inhibitory or advance responses towards one of the conflicting inputs, respectively. Individual differences in approach and avoidance motivation might be modulated by the normal variance in the level of functioning of different systems, such as endocannabinoid system (ECS). The present research was aimed at analysing the ECS involvement on approach and avoidance behavioural processes. To this aim, in the three selected sub-populations of mice that exhibited avoiding or balancing or approaching responses in an approach/avoidance Y-maze we analysed density and functionality of CB1 receptors as well as enzyme fatty acid amide hydrolase activity in different brain regions, including the networks functionally responsible for emotional and motivational control. The main finding of the present study demonstrates that in both approaching and avoiding animals higher CB1 receptor density in the amygdaloidal centro-medial nuclei and in the hypothalamic ventro-medial nucleus was found when compared with the CB1 receptor density exhibited by the balancing animals. The characterization of the individual differences to respond in a motivationally based manner is relevant to clarify how the individual differences in ECS activity are associated with differences in motivational and affective functioning.	[Laricchiuta, Daniela; Petrosini, Laura] Santa Lucia Fdn, CERC, Rome, Italy; [Rojo, Maria Luisa; Rodriguez-Gaztelumendi, Antonio; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Laricchiuta, Daniela; Ferlazzo, Fabio; Petrosini, Laura] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	IRCCS Santa Lucia; Umea University; Sapienza University Rome	Laricchiuta, D (corresponding author), Santa Lucia Fdn, CERC, Rome, Italy.	daniela.laricchiuta@uniroma1.it	Laricchiuta, Daniela/K-1080-2016; Fowler, Christopher J./M-6313-2019	Laricchiuta, Daniela/0000-0003-2237-2086; Fowler, Christopher J./0000-0002-6658-7874	Swedish Research Council [12158]; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University	The work has been supported by Swedish Research Council grant number 12158, medicine (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and by the local funds from Umea University (http://www.medforsk.org.umu.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Al-Hayani A, 2000, BRIT J PHARMACOL, V131, P663, DOI 10.1038/sj.bjp.0703642; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Brand T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031169; Breivogel CS, 2000, J PHARMACOL EXP THER, V295, P328; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Cain CK, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P17; Chambers R Andrew, 2003, J Gambl Stud, V19, P53, DOI 10.1023/A:1021275130071; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Di Nocera F, 2000, BEHAV RES METH INS C, V32, P111, DOI 10.3758/BF03200793; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P3; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerra G, 2000, PSYCHONEUROENDOCRINO, V25, P479, DOI 10.1016/S0306-4530(00)00004-4; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Good RL, 2011, PHARMACOL BIOCHEM BE, V98, P101, DOI 10.1016/j.pbb.2010.12.004; Haring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026617; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Hefner K, 2007, BEHAV BRAIN RES, V176, P210, DOI 10.1016/j.bbr.2006.10.001; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; Katona I, 1999, J NEUROSCI, V19, P4544; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lafenetre P, 2009, NEUROPHARMACOLOGY, V57, P715, DOI 10.1016/j.neuropharm.2009.07.014; Laricchiuta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033260; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Linfoot I, 2009, PROG NEURO-PSYCHOPH, V33, P1129, DOI 10.1016/j.pnpbp.2009.06.008; Lutz B, 2007, MOL NEUROBIOL, V36, P92, DOI 10.1007/s12035-007-8004-x; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Maccarrone M, 2002, VITAM HORM, V65, P225, DOI 10.1016/S0083-6729(02)65066-6; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Mato S, 2004, NEUROPHARMACOLOGY, V46, P716, DOI 10.1016/j.neuropharm.2003.11.004; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meyer B, 1999, J PSYCHOPATHOL BEHAV, V21, P275, DOI 10.1023/A:1022119414440; Mitchell JT, 2006, PERS INDIV DIFFER, V40, P749, DOI 10.1016/j.paid.2005.08.011; Moesgaard B, 2000, J LIPID RES, V41, P985; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; Muris P, 2001, BEHAV RES THER, V39, P1051, DOI 10.1016/S0005-7967(00)00081-4; Naidu PS, 2007, PSYCHOPHARMACOLOGY, V192, P61, DOI 10.1007/s00213-006-0689-4; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Pattij T, 2007, PSYCHOPHARMACOLOGY, V193, P85, DOI 10.1007/s00213-007-0773-4; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Roberts BW, 2001, J PERS SOC PSYCHOL, V81, P670, DOI 10.1037//0022-3514.81.4.670; Robson P, 2005, HANDB EXP PHARMACOL, V168, P719; Rodriguez-Gaztelumendi A, 2009, J NEUROCHEM, V108, P1423, DOI 10.1111/j.1471-4159.2009.05898.x; Royer S, 1999, J NEUROSCI, V19, P10575; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Sim LJ, 1996, J NEUROSCI, V16, P8057; Slawecki CJ, 2005, BEHAV NEUROSCI, V119, P1477, DOI 10.1037/0735-7044.119.6.1477; Spear LP, 2002, J STUD ALCOHOL, P71, DOI 10.15288/jsas.2002.s14.71; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Van Laere K, 2009, ARCH GEN PSYCHIAT, V66, P196, DOI 10.1001/archgenpsychiatry.2008.530; Wallace JM, 2003, ADDICTION, V98, P225, DOI 10.1046/j.1360-0443.2003.00282.x; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; Witkin JM, 2005, BEHAV PHARMACOL, V16, P315, DOI 10.1097/00008877-200509000-00005	78	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42111	10.1371/journal.pone.0042111	http://dx.doi.org/10.1371/journal.pone.0042111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848724	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200167
J	Mets, OM; Smit, EJ; Hoesein, FAAM; Gietema, HA; Bokkers, RPH; Attrach, M; van Amelsvoort-van de Vorst, S; Scholten, ET; Buckens, CFM; Oudkerk, M; Lammers, JWJ; Prokop, M; de Jong, PA				Mets, Onno M.; Smit, Ewoud J.; Hoesein, Firdaus A. A. Mohamed; Gietema, Hester A.; Bokkers, Reinoud P. H.; Attrach, Mohamed; van Amelsvoort-van de Vorst, Saskia; Scholten, Ernst Th; Buckens, Constantinus F. M.; Oudkerk, Matthijs; Lammers, Jan-Willem J.; Prokop, Mathias; de Jong, Pim A.			Visual versus Automated Evaluation of Chest Computed Tomography for the Presence of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SMOKING-CESSATION; LUNG-FUNCTION; MORTALITY; COPD; PROJECTIONS; POPULATION; PREVALENCE; BURDEN; RISK	Background: Incidental CT findings may provide an opportunity for early detection of chronic obstructive pulmonary disease (COPD), which may prove important in CT-based lung cancer screening setting. We aimed to determine the diagnostic performance of human observers to visually evaluate COPD presence on CT images, in comparison to automated evaluation using quantitative CT measures. Methods: This study was approved by the Dutch Ministry of Health and the institutional review board. All participants provided written informed consent. We studied 266 heavy smokers enrolled in a lung cancer screening trial. All subjects underwent volumetric inspiratory and expiratory chest computed tomography (CT). Pulmonary function testing was used as the reference standard for COPD. We evaluated the diagnostic performance of eight observers and one automated model based on quantitative CT measures. Results: The prevalence of COPD in the study population was 44% (118/266), of whom 62% (73/118) had mild disease. The diagnostic accuracy was 74.1% in the automated evaluation, and ranged between 58.3% and 74.3% for the visual evaluation of CT images. The positive predictive value was 74.3% in the automated evaluation, and ranged between 52.9% and 74.7% for the visual evaluation. Interobserver variation was substantial, even within the subgroup of experienced observers. Agreement within observers yielded kappa values between 0.28 and 0.68, regardless of the level of expertise. The agreement between the observers and the automated CT model showed kappa values of 0.12-0.35. Conclusions: Visual evaluation of COPD presence on chest CT images provides at best modest accuracy and is associated with substantial interobserver variation. Automated evaluation of COPD subjects using quantitative CT measures appears superior to visual evaluation by human observers.	[Mets, Onno M.; Smit, Ewoud J.; Hoesein, Firdaus A. A. Mohamed; Gietema, Hester A.; Bokkers, Reinoud P. H.; Attrach, Mohamed; van Amelsvoort-van de Vorst, Saskia; Scholten, Ernst Th; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Buckens, Constantinus F. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands; [Lammers, Jan-Willem J.] Univ Med Ctr Utrecht, Dept Pulmonol, Utrecht, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Mets, OM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	o.m.mets@umcutrecht.nl	de Jong, Pim A/G-7220-2014; Bokkers, Reinoud P H/ABD-2928-2020; Smit, Ewoud J/A-5272-2011; Prokop, W.M./H-8081-2014	de Jong, Pim A/0000-0003-4840-6854; Bokkers, Reinoud P H/0000-0001-6130-7311; Smit, Ewoud J/0000-0002-7090-2742; Prokop, Mathias/0000-0001-8157-8055; Buckens, Constantinus F/0000-0002-3190-258X; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund; Siemens Germany	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund; Siemens Germany(Siemens AG)	The NELSON-trial was sponsored by Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Roche Diagnostics; Siemens Germany; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer and Erasmus Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association, 2012, PROV GUID LUNG CANC; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Barnes PJ, 2007, PLOS MED, V4, P779, DOI 10.1371/journal.pmed.0040112; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cavigli E, 2009, EUR RADIOL, V19, P1686, DOI 10.1007/s00330-009-1320-y; Decramer M, 2010, THORAX, V65, P837, DOI 10.1136/thx.2009.133355; Fiore MC, 2011, NEW ENGL J MED, V365, P1222, DOI 10.1056/NEJMcp1101512; FRASER RG, 1974, AM J ROENTGENOL, V120, P737, DOI 10.2214/ajr.120.4.737; Godtfredsen NS, 2008, EUR RESPIR J, V32, P844, DOI 10.1183/09031936.00160007; Hawass NED, 1997, BRIT J RADIOL, V70, P360, DOI 10.1259/bjr.70.832.9166071; Hole DJ, 1996, BRIT MED J, V313, P711; Lee CI, 2010, RADIOLOGY, V257, P313, DOI 10.1148/radiol.10101437; Malinen A, 2002, ACTA RADIOL, V43, P54, DOI 10.1080/028418502127347448; Mascalchi M, 2012, ACTA RADIOL, V53, P53, DOI 10.1258/ar.2011.110419; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Pinsky P, 2007, THORAX, V62, P190, DOI 10.1136/thx.2006.073288; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Sekine Y, 2012, EUR RESPIR J, V39, P1230, DOI 10.1183/09031936.00126011; Shaker Saher B, 2007, COPD, V4, P143, DOI 10.1080/15412550701341277; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Takasugi JE, 1998, RADIOL CLIN N AM, V36, P29, DOI 10.1016/S0033-8389(05)70006-3; Ten Cate O, 2010, MED TEACH, V32, P669, DOI 10.3109/0142159X.2010.500897; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Washko GR, 2010, SEMIN RESP CRIT CARE, V31, P276, DOI 10.1055/s-0030-1254068; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022; WOODRING JH, 1991, J THORAC IMAG, V6, P14, DOI 10.1097/00005382-199104000-00005	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42227	10.1371/journal.pone.0042227	http://dx.doi.org/10.1371/journal.pone.0042227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848747	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200185
J	Muller-Lucks, A; Bock, S; Wu, BH; Beitz, E				Mueller-Lucks, Annika; Bock, Sinja; Wu, Binghua; Beitz, Eric			Fluorescent In Situ Folding Control for Rapid Optimization of Cell-Free Membrane Protein Synthesis	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; FREE EXPRESSION; TRANSPORTER; AQUAGLYCEROPORIN; PURIFICATION; SYSTEM; OVEREXPRESSION; WATER	Cell-free synthesis is an open and powerful tool for high-yield protein production in small reaction volumes predestined for high-throughput structural and functional analysis. Membrane proteins require addition of detergents for solubilization, liposomes, or nanodiscs. Hence, the number of parameters to be tested is significantly higher than with soluble proteins. Optimization is commonly done with respect to protein yield, yet without knowledge of the protein folding status. This approach contains a large inherent risk of ending up with non-functional protein. We show that fluorophore formation in C-terminal fusions with green fluorescent protein (GFP) indicates the folding state of a membrane protein in situ, i.e. within the cell-free reaction mixture, as confirmed by circular dichroism (CD), proteoliposome reconstitution and functional assays. Quantification of protein yield and in-gel fluorescence intensity imply suitability of the method for membrane proteins of bacterial, protozoan, plant, and mammalian origin, representing vacuolar and plasma membrane localization, as well as intra- and extracellular positioning of the C-terminus. We conclude that GFP-fusions provide an extension to cell-free protein synthesis systems eliminating the need for experimental folding control and, thus, enabling rapid optimization towards membrane protein quality.	[Mueller-Lucks, Annika; Bock, Sinja; Wu, Binghua; Beitz, Eric] Univ Kiel, Kiel, Germany	University of Kiel	Muller-Lucks, A (corresponding author), Univ Kiel, Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			Deutsche Forschungsgemeinschaft [Be2253/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft (Be2253/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikawa Y, 2011, PROTEIN SCI, V20, P1720, DOI 10.1002/pro.707; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bernard C, 2011, J EXP BOT, V62, P4627, DOI 10.1093/jxb/err183; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; Chow CC, 2003, BIOCHEMISTRY-US, V42, P7090, DOI 10.1021/bi0273056; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Hovijitra NT, 2009, BIOTECHNOL BIOENG, V104, P40, DOI 10.1002/bit.22385; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Mohlmann T, 2001, FEBS LETT, V509, P370, DOI 10.1016/S0014-5793(01)03195-7; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nozawa A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-35; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; SMITH CP, 1995, J CLIN INVEST, V96, P1556, DOI 10.1172/JCI118194; Song J, 2012, BBA-BIOMEMBRANES, V1818, P1218, DOI 10.1016/j.bbamem.2012.01.025; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Traub M, 2007, PLANT J, V49, P855, DOI 10.1111/j.1365-313X.2006.02998.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Veerappan A, 2011, BIOCHEMISTRY-US, V50, P10223, DOI 10.1021/bi201266m; Verdoucq L, 2006, BIOCHEM J, V415, P409; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Yakata K, 2007, BBA-BIOMEMBRANES, V1768, P688, DOI 10.1016/j.bbamem.2006.11.005	32	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42186	10.1371/journal.pone.0042186	http://dx.doi.org/10.1371/journal.pone.0042186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848743	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200181
J	Schmitz, A; Anselme, C; Ravallec, M; Rebuf, C; Simon, JC; Gatti, JL; Poirie, M				Schmitz, Antonin; Anselme, Caroline; Ravallec, Marc; Rebuf, Christian; Simon, Jean-Christophe; Gatti, Jean-Luc; Poirie, Marylene			The Cellular Immune Response of the Pea Aphid to Foreign Intrusion and Symbiotic Challenge	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM; ENDOSYMBIOTIC BACTERIUM; SODALIS-GLOSSINIDIUS; HOST GENOTYPE; SYSTEM; RESISTANCE; WOLBACHIA; HOMOPTERA; BUCHNERA; DEFENSE	Recent studies suggest that the pea aphid (Acyrthosiphon pisum) has low immune defenses. However, its immune components are largely undescribed, and notably, extensive characterization of circulating cells has been missing. Here, we report characterization of five cell categories in hemolymph of adults of the LL01 pea aphid clone, devoid of secondary symbionts (SS): prohemocytes, plasmatocytes, granulocytes, spherulocytes and wax cells. Circulating lipid-filed wax cells are rare; they otherwise localize at the basis of the cornicles. Spherulocytes, that are likely sub-cuticular sessile cells, are involved in the coagulation process. Prohemocytes have features of precursor cells. Plasmatocytes and granulocytes, the only adherent cells, can form a layer in vivo around inserted foreign objects and phagocytize latex beads or Escherichia coli bacteria injected into aphid hemolymph. Using digital image analysis, we estimated that the hemolymph from one LL01 aphid contains about 600 adherent cells, 35% being granulocytes. Among aphid YR2 lines differing only in their SS content, similar results to LL01 were observed for YR2-Amp (without SS) and YR2-Ss (with Serratia symbiotica), while YR2-Hd (with Hamiltonella defensa) and YR2(Ri) (with Regiella insecticola) had strikingly lower adherent hemocyte numbers and granulocyte proportions. The effect of the presence of SS on A. pisum cellular immunity is thus symbiont-dependent. Interestingly, Buchnera aphidicola (the aphid primary symbiont) and all SS, whether naturally present, released during hemolymph collection, or artificially injected, were internalized by adherent hemocytes. Inside hemocytes, SS were observed in phagocytic vesicles, most often in phagolysosomes. Our results thus raise the question whether aphid symbionts in hemolymph are taken up and destroyed by hemocytes, or actively promote their own internalization, for instance as a way of being transmitted to the next generation. Altogether, we demonstrate here a strong interaction between aphid symbionts and immune cells, depending upon the symbiont, highlighting the link between immunity and symbiosis.	[Schmitz, Antonin; Anselme, Caroline; Rebuf, Christian; Gatti, Jean-Luc; Poirie, Marylene] INRA, Unite Mixte Rech 1355, ISA, Sophia Antipolis, France; [Schmitz, Antonin; Anselme, Caroline; Rebuf, Christian; Gatti, Jean-Luc; Poirie, Marylene] CNRS, Unite Mixte Rech 7254, Sophia Antipolis, France; [Schmitz, Antonin; Anselme, Caroline; Rebuf, Christian; Gatti, Jean-Luc; Poirie, Marylene] Univ Nice Sophia Antipolis, Nice, France; [Ravallec, Marc] Univ Montpellier 2, INRA, Unite Mixte Rech Diversite Genomes & Interact Mic, Montpellier, France; [Simon, Jean-Christophe] INRA, UMR 1349, Inst Genet Environm & Protect Plantes, Le Rheu, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; INRAE; Universite de Montpellier; INRAE	Schmitz, A (corresponding author), INRA, Unite Mixte Rech 1355, ISA, Sophia Antipolis, France.	poirie@sophia.inra.fr	Gatti, jean-luc/ABB-3294-2020; Simon, Jean-Christophe/I-2700-2014	Gatti, jean-luc/0000-0001-7683-718X; 	"Jeune Equipe" funding from the National Institute for Agronomic Research (INRA); "Provence Alpes Cote d'Azur (PACA)" region; INRA "Sante des Plantes et Environnement (SPE)" department; INRA SPE department	"Jeune Equipe" funding from the National Institute for Agronomic Research (INRA); "Provence Alpes Cote d'Azur (PACA)" region(Region Provence-Alpes-Cote d'Azur); INRA "Sante des Plantes et Environnement (SPE)" department; INRA SPE department	This work was supported by a "Jeune Equipe" funding (2009-2011) from the National Institute for Agronomic Research (INRA). A. Schmitz PhD grant was co-funded by the "Provence Alpes Cote d'Azur (PACA)" region, and the INRA "Sante des Plantes et Environnement (SPE)" department. C. Anselme received post-doctoral support from the INRA SPE department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2011, J INNATE IMMUN, V3, P495, DOI 10.1159/000327714; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Behera M.K., 1999, Indian Journal of Entomology, V61, P51; Behura B.K., 1983, Pranikee, V4, P376; BEHURA B K, 1978, Journal of Entomological Research (New Delhi), V2, P199; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; Bohidar K., 1987, Journal of Aphidology, V1, P42; BOITEAU G, 1976, CAN J ZOOL, V54, P228, DOI 10.1139/z76-025; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; BREHELIN M, 1978, CELL TISSUE RES, V195, P45; Broderick Nichole A., 2009, P13; Burke GR, 2011, GENOME BIOL EVOL, V3, P195, DOI 10.1093/gbe/evr002; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; CARVER M, 1985, ENTOMOPHAGA, V30, P193, DOI 10.1007/BF02372253; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; CHEN SW, 1972, Z ZELLFORSCH MIK ANA, V130, P312, DOI 10.1007/BF00306945; Chevalier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018531; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Darby AC, 2005, APPL ENVIRON MICROB, V71, P4833, DOI 10.1128/AEM.71.8.4833-4839.2005; Degnan PH, 2010, ENVIRON MICROBIOL, V12, P2060, DOI 10.1111/j.1462-2920.2009.02085.x; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P2748, DOI 10.1128/AEM.66.7.2748-2758.2000; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; GREGOIRE C, 1951, BLOOD, V6, P1173, DOI 10.1182/blood.V6.11.1173.1173; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; Gross R, 2009, MOL MICROBIOL, V73, P751, DOI 10.1111/j.1365-2958.2009.06820.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HENTER HJ, 1995, EVOLUTION, V49, P439, DOI 10.1111/j.1558-5646.1995.tb02276.x; Hollande A, 1911, ARCH ZOOL EXP GEN, V5, P283; Howell L, 2012, IMMUNOGENETICS, V64, P155, DOI 10.1007/s00251-011-0571-3; Hurst G. D., 2009, INSECT INFECT IMMUNI, V25, P119; Hypsa V, 1997, FOLIA PARASIT, V44, P62; Kapranas A, 2009, BIOL CONTROL, V48, P1, DOI 10.1016/j.biocontrol.2008.09.015; Koga R, 2007, FEMS MICROBIOL ECOL, V60, P229, DOI 10.1111/j.1574-6941.2007.00284.x; Koga R, 2012, P NATL ACAD SCI USA, V109, pE1230, DOI 10.1073/pnas.1119212109; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Ling EJ, 2005, INSECT BIOCHEM MOLEC, V35, P1356, DOI 10.1016/j.ibmb.2005.08.007; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; MENSCHIK Z, 1953, STAIN TECHNOL, V28, P13, DOI 10.3109/10520295309112630; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Outreman Y, 2001, J INSECT PHYSIOL, V47, P339, DOI 10.1016/S0022-1910(00)00142-6; Patro B., 2005, Indian Journal of Agricultural Research, V39, P192; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Simon JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021831; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Tsuchida T, 2005, MICROB ECOL, V49, P126, DOI 10.1007/s00248-004-0216-2; Weiss BL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000619; Weiss BL, 2008, P NATL ACAD SCI USA, V105, P15088, DOI 10.1073/pnas.0805666105; Welchman David P, 2009, Cell Host Microbe, V6, P107, DOI 10.1016/j.chom.2009.07.008; WIGGLESWORTH VB, 1988, TISSUE CELL, V20, P919, DOI 10.1016/0040-8166(88)90033-X; Wilkinson TL, 2003, ARTHROPOD STRUCT DEV, V32, P241, DOI 10.1016/S1467-8039(03)00036-7; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	69	57	60	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42114	10.1371/journal.pone.0042114	http://dx.doi.org/10.1371/journal.pone.0042114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848726	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200169
J	Yu, HL; Wen, D; Ma, CL; Meng, YX; Li, SJ; Ni, ZY; Cong, B				Yu, Hailei; Wen, Di; Ma, Chunling; Meng, Yanxin; Li, Shujin; Ni, Zhiyu; Cong, Bin			Effects of Exogenous Cholecystokinin Octapeptide on Acquisition of Naloxone Precipitated Withdrawal Induced Conditioned Place Aversion in Rats	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; ANXIETY-LIKE BEHAVIOR; CCK2 RECEPTOR; MORPHINE-DEPENDENCE; B RECEPTORS; NUCLEUS-ACCUMBENS; INDUCED ANALGESIA; BRAIN; ANTAGONISTS; EXPRESSION	Cholecystokinin octapeptide (CCK-8), a gut-brain peptide, regulates a variety of physiological behavioral processes. Previously, we reported that exogenous CCK-8 attenuated morphine-induced conditioned place preference, but the possible effects of CCK-8 on aversively motivated drug seeking remained unclear. To investigate the effects of endogenous and exogenous CCK on negative components of morphine withdrawal, we evaluated the effects of CCK receptor antagonists and CCK-8 on the naloxone-precipitated withdrawal-induced conditioned place aversion (CPA). The results showed that CCK2 receptor antagonist (LY-288,513, 10 mu g, i.c.v.), but not CCK1 receptor antagonist (L-364,718, 10 mu g, i.c.v.), inhibited the acquisition of CPA when given prior to naloxone (0.3 mg/kg) administration in morphine-dependent rats. Similarly, CCK-8 (0.1-1 mu g, i.c.v.) significantly attenuated naloxone-precipitated withdrawal-induced CPA, and this inhibitory function was blocked by co-injection with L-364,718. Microinjection of L-364,718, LY-288,513 or CCK-8 to saline pretreated rats produced neither a conditioned preference nor aversion, and the induction of CPA by CCK-8 itself after morphine pretreatments was not significant. Our study identifies a different role of CCK1 and CCK2 receptors in negative affective components of morphine abstinence and an inhibitory effect of exogenous CCK-8 on naloxone-precipitated withdrawal-induced CPA via CCK1 receptor.	[Yu, Hailei; Wen, Di; Ma, Chunling; Meng, Yanxin; Li, Shujin; Ni, Zhiyu; Cong, Bin] Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang, Peoples R China	Hebei Medical University	Yu, HL (corresponding author), Hebei Med Univ, Dept Forens Med, Hebei Key Lab Forens Med, Shijiazhuang, Peoples R China.	chunlingma@126.com; hbydcongbin@126.com	Wen, Di/AAF-7316-2019		Natural Science Foundation of China [81172900, 30672355]; Applied Basic Research Key Program of Hebei Province [10966911D]; Natural Science Foundation of Hebei Province [C2007000826]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Key Program of Hebei Province; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This study was supported in part by grants from the Natural Science Foundation of China (www.nsfc.gov.cn) (No. 81172900, 30672355), the Applied Basic Research Key Program of Hebei Province (No. 10966911D) and the Natural Science Foundation of Hebei Province (www.hensf.gov.cn) (No. C2007000826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALSCHUN D, 1994, NEUROPEPTIDES, V26, P421, DOI 10.1016/0143-4179(94)90028-0; Becker C, 2000, NEUROPHARMACOLOGY, V39, P161, DOI 10.1016/S0028-3908(99)00161-6; BENOLIEL JJ, 1992, J NEUROCHEM, V58, P916, DOI 10.1111/j.1471-4159.1992.tb09344.x; Carlezon WA, 2003, METH MOLEC MED, V84, P243; Cohen H, 2004, DEPRESS ANXIETY, V20, P139, DOI 10.1002/da.20032; Crespi F, 1998, METHOD FIND EXP CLIN, V20, P679, DOI 10.1358/mf.1998.20.8.487502; Dauge V, 1998, NEUROSCI BIOBEHAV R, V22, P815, DOI 10.1016/S0149-7634(98)00011-6; Dauge V, 2001, NEUROPSYCHOPHARMACOL, V25, P690, DOI 10.1016/S0893-133X(01)00291-3; de la Mora MP, 2007, EUR J NEUROSCI, V26, P3614, DOI 10.1111/j.1460-9568.2007.05963.x; DeSantana JM, 2010, PAIN, V148, P84, DOI 10.1016/j.pain.2009.10.011; FARIS PL, 1983, SCIENCE, V219, P310, DOI 10.1126/science.6294831; Gospic K, 2008, PSYCHOPHARMACOLOGY, V197, P295, DOI 10.1007/s00213-007-1032-4; Hadjiivanova Christina, 2003, Acta Physiol Pharmacol Bulg, V27, P83; Hamilton ME, 2000, SYNAPSE, V38, P238, DOI 10.1002/1098-2396(20001201)38:3<238::AID-SYN2>3.0.CO;2-5; Hebb ALO, 2005, PROG NEURO-PSYCHOPH, V29, P1225, DOI 10.1016/j.pnpbp.2005.08.008; Heinricher MM, 2004, J NEUROPHYSIOL, V92, P1982, DOI 10.1152/jn.00411.2004; Hernandez-Gomez AM, 2002, AMINO ACIDS, V23, P283, DOI 10.1007/s00726-001-0139-x; Huang C, 2007, BRAIN RES BULL, V71, P447, DOI 10.1016/j.brainresbull.2006.11.008; ITOH S, 1982, EUR J PHARMACOL, V80, P421, DOI 10.1016/0014-2999(82)90089-9; Koks S, 2003, NEUROPEPTIDES, V37, P25, DOI 10.1016/S0143-4179(02)00137-3; Koks S, 1999, NEUROPEPTIDES, V33, P63, DOI 10.1054/npep.1999.0015; Koks S, 2001, PSYCHOPHARMACOLOGY, V158, P198, DOI 10.1007/s002130100855; Koob GF, 2012, HAND CLINIC, V106, P137, DOI 10.1016/B978-0-444-52002-9.00009-7; Lena I, 1999, NEUROPHARMACOLOGY, V38, P543, DOI 10.1016/S0028-3908(98)00223-8; Li Y, 2007, ADDICT BIOL, V12, P470, DOI 10.1111/j.1369-1600.2007.00059.x; Lo CM, 2008, AM J PHYSIOL-REG I, V294, pR803, DOI 10.1152/ajpregu.00682.2007; Lu L, 2000, NEUROREPORT, V11, P829, DOI 10.1097/00001756-200003200-00034; Lu L, 2002, BRAIN RES, V954, P132, DOI 10.1016/S0006-8993(02)03359-0; Lu L, 2001, BEHAV BRAIN RES, V120, P105, DOI 10.1016/S0166-4328(00)00361-2; Ma KT, 2006, BRAIN RES, V1121, P66, DOI 10.1016/j.brainres.2006.08.094; MANNISTO PT, 1994, N-S ARCH PHARMACOL, V349, P478; Mercer LD, 1997, NEUROSCI LETT, V225, P97, DOI 10.1016/S0304-3940(97)00197-3; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Mitchell JM, 2006, PHARMACOL BIOCHEM BE, V85, P787, DOI 10.1016/j.pbb.2006.11.014; MORAN TH, 1995, CRIT REV NEUROBIOL, V9, P1; Noble F, 2003, DRUGS TODAY, V39, P897, DOI 10.1358/dot.2003.39.11.799467; Nomoto S, 1999, PHYSIOL BEHAV, V66, P869, DOI 10.1016/S0031-9384(99)00033-5; Pommier B, 2002, J NEUROSCI, V22, P2005, DOI 10.1523/JNEUROSCI.22-05-02005.2002; Rezayat M, 1997, PHARMACOL TOXICOL, V81, P124, DOI 10.1111/j.1600-0773.1997.tb00041.x; Rothwell PE, 2009, NEUROPSYCHOPHARMACOL, V34, P2285, DOI 10.1038/npp.2009.56; Runkorg K, 2012, BEHAV BRAIN RES, V226, P335, DOI 10.1016/j.bbr.2011.09.005; Runkorg K, 2003, BEHAV BRAIN RES, V144, P125, DOI 10.1016/S0166-4328(03)00070-6; Tanganelli S, 2001, PEPTIDES, V22, P1229, DOI 10.1016/S0196-9781(01)00446-6; Valverde O, 2005, HANDB EXP PHARMACOL, V168, P117; WANG XJ, 1989, LIFE SCI, V45, P117, DOI 10.1016/0024-3205(89)90285-3; WANG XJ, 1990, J NEUROCHEM, V55, P1379, DOI 10.1111/j.1471-4159.1990.tb03149.x; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; Wen D, 2012, NEUROSCI LETT, V510, P24, DOI 10.1016/j.neulet.2011.12.063; Wen Di, 2011, Zhongguo Yaolixue Tongbao, V27, P1363, DOI 10.3969/j.issn.1001-1978.2011.10.008; WOODRUFF GN, 1991, NEUROPEPTIDES, V19, P45, DOI 10.1016/0143-4179(91)90082-T; [闫玉仙 YAN YuXian], 2007, [第四军医大学学报, Journal of the Fourth Military Medical University], V28, P1214; ZARBIN MA, 1981, LIFE SCI, V29, P697, DOI 10.1016/0024-3205(81)90022-9; Zhang Z, 2008, PHARMACOL BIOCHEM BE, V89, P392, DOI 10.1016/j.pbb.2008.01.013	53	4	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41860	10.1371/journal.pone.0041860	http://dx.doi.org/10.1371/journal.pone.0041860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848639	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200116
J	Ahmad, N; Michoux, F; Nixon, PJ				Ahmad, Niaz; Michoux, Franck; Nixon, Peter J.			Investigating the Production of Foreign Membrane Proteins in Tobacco Chloroplasts: Expression of an Algal Plastid Terminal Oxidase	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; ALTERNATIVE OXIDASE; ARABIDOPSIS; LIGHT; IMMUTANS; STRESS; PHOTOSYNTHESIS; IDENTIFICATION; PLASTOQUINONE; CHALLENGES	Chloroplast transformation provides an inexpensive, easily scalable production platform for expression of recombinant proteins in plants. However, this technology has been largely limited to the production of soluble proteins. Here we have tested the ability of tobacco chloroplasts to express a membrane protein, namely plastid terminal oxidase 1 from the green alga Chlamydomonas reinhardtii (Cr-PTOX1), which is predicted to function as a plastoquinol oxidase. A homoplastomic plant containing a codon-optimised version of the nuclear gene encoding PTOX1, driven by the 16S rRNA promoter and 5'UTR of gene 10 from phage T7, was generated using a particle delivery system. Accumulation of Cr-PTOX1 was shown by immunoblotting and expression in an enzymatically active form was confirmed by using chlorophyll fluorescence to measure changes in the redox state of the plastoquinone pool in leaves. Growth of Cr-PTOX1 expressing plants was, however, more sensitive to high light than WT. Overall our results confirm the feasibility of using plastid transformation as a means of expressing foreign membrane proteins in the chloroplast.	[Ahmad, Niaz; Michoux, Franck; Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Imperial College London	Ahmad, N (corresponding author), Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan.	niazbloch@yahoo.com		Nixon, Peter/0000-0003-1952-6937; Ahmad, Niaz/0000-0002-9391-2089	Higher Education Commission (Government of Pakistan) [1-1-/PM (OSS)/Phase-II/B-2/10%Fin/2007/626]	Higher Education Commission (Government of Pakistan)(Higher Education Commission of Pakistan)	This study was funded by the Higher Education Commission (Government of Pakistan) under the "Overseas Scholarship Scheme for MS/MPhil Leading to PhD in Selected Fields Phase-II-Batch-II'' (ref no: 1-1-/PM (OSS)/Phase-II/B-2/10%Fin/2007/626). Website address: http://www.hec.gov.pk/InsideHEC/Divisions/HRD/Scholarships/ForeignScholarships/ossphase2batch3/Pages/OverseasScholarshipsPhase-II.aspx. Please note that this scheme has now expired. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2012, PLANTA, V235, P863, DOI 10.1007/s00425-011-1584-8; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; Cho K, 2006, J PLANT BIOL, V49, P413, DOI 10.1007/BF03031120; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fu AG, 2005, J BIOL CHEM, V280, P42489, DOI 10.1074/jbc.M508940200; Heyno E, 2009, J BIOL CHEM, V284, P31174, DOI 10.1074/jbc.M109.021667; Houille-Vernes L, 2011, P NATL ACAD SCI USA, V108, P20820, DOI 10.1073/pnas.1110518109; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Joet T, 2002, J BIOL CHEM, V277, P31623, DOI 10.1074/jbc.M203538200; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kuntz M, 2004, PLANTA, V218, P896, DOI 10.1007/s00425-004-1217-6; Kuroda H, 2001, NUCLEIC ACIDS RES, V29, P970, DOI 10.1093/nar/29.4.970; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lennon AM, 2003, PLANTA, V218, P254, DOI 10.1007/s00425-003-1111-7; Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x; Mano J, 1995, PLANT CELL PHYSIOL, V36, P1589; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McDonald AE, 2003, PLANT MOL BIOL, V53, P865, DOI 10.1023/B:PLAN.0000023669.79465.d2; Michoux F, 2011, PLANT BIOTECHNOL J, V9, P575, DOI 10.1111/j.1467-7652.2010.00575.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Murashige T, 1962, PLANT PHYSIOL, V79, P197; Mussgnug JH, 2005, PLANT CELL, V17, P3409, DOI 10.1105/tpc.105.035774; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Sprenger RR, 2010, PROTEOMICS, V10, P3997, DOI 10.1002/pmic.201000312; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; UMBACH AL, 1993, PLANT PHYSIOL, V103, P845, DOI 10.1104/pp.103.3.845; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Ye GN, 2001, PLANT J, V25, P261, DOI 10.1046/j.1365-313x.2001.00958.x; Zhang Y, 2011, BBA-BIOENERGETICS, V1807, P391, DOI 10.1016/j.bbabio.2011.01.006	49	31	32	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41722	10.1371/journal.pone.0041722	http://dx.doi.org/10.1371/journal.pone.0041722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848578	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600107
J	Al Safadi, R; Abu-Ali, GS; Sloup, RE; Rudrik, JT; Waters, CM; Eaton, KA; Manning, SD				Al Safadi, Rim; Abu-Ali, Galeb S.; Sloup, Rudolph E.; Rudrik, James T.; Waters, Christopher M.; Eaton, Kathryn A.; Manning, Shannon D.			Correlation between In Vivo Biofilm Formation and Virulence Gene Expression in Escherichia coli O104:H4	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; CELLS; PATHOGENESIS; ADHERENCE; O157-H7; STRAINS; DISEASE; GROWTH; ROLES; LOCUS	The emergence of novel pathogens poses a major public health threat causing widespread epidemics in susceptible populations. The Escherichia coli O104:H4 strain implicated in a 2011 outbreak in northern Germany caused the highest frequency of hemolytic uremic syndrome (HUS) and death ever recorded in a single E. coli outbreak. Therefore, it has been suggested that this strain is more virulent than other pathogenic E. coli (e.g., E. coli O157:H7). The E. coli O104:H4 outbreak strain possesses multiple virulence factors from both Shiga toxin (Stx)-producing E. coli (STEC) and enteroaggregative E. coli (EAEC), though the mechanism of pathogenesis is not known. Here, we demonstrate that E. coli O104:H4 produces a stable biofilm in vitro and that in vivo virulence gene expression is highest when E. coli O104:H4 overexpresses genes required for aggregation and exopolysaccharide production, a characteristic of bacterial cells residing within an established biofilm. Interrupting exopolysaccharide production and biofilm formation may therefore represent effective strategies for combating future E. coli O104:H4 infections.	[Al Safadi, Rim; Sloup, Rudolph E.; Waters, Christopher M.; Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Abu-Ali, Galeb S.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Rudrik, James T.] Michigan Dept Community Hlth, Bur Labs, Lansing, MI USA; [Eaton, Kathryn A.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Michigan State University; US Food & Drug Administration (FDA); MDHHS - Michigan Department of Health & Human Services; University of Michigan System; University of Michigan	Al Safadi, R (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mannin71@msu.edu	Manning, Shannon/GXA-0622-2022; Abu-Ali, Galeb/AAE-9742-2020	Manning, Shannon/0000-0001-9581-0660; Abu-Ali, Galeb/0000-0002-2599-2937	National Institutes of Health Enterics Research Investigational Network Cooperative Research Center at Michigan State University [U19AI090872]; United States Department of Agriculture, National Institute of Food and Agriculture [2011-67005-30004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER	National Institutes of Health Enterics Research Investigational Network Cooperative Research Center at Michigan State University; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Enterics Research Investigational Network Cooperative Research Center at Michigan State University [grant number U19AI090872 (SDM)] and in part by the United States Department of Agriculture, National Institute of Food and Agriculture [grant number 2011-67005-30004 (SDM)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; FASANO A, 1995, J CLIN INVEST, V95, P2853, DOI 10.1172/JCI117991; Frank C, 2011, N ENGL J MED; Harrington SM, 2005, CELL MICROBIOL, V7, P1565, DOI 10.1111/j.1462-5822.2005.00588.x; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Leenanon B, 2003, J FOOD PROTECT, V66, P970, DOI 10.4315/0362-028X-66.6.970; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Morin N, 2010, FEMS IMMUNOL MED MIC, V58, P344, DOI [10.1111/j.1574-695X.2009.00645.x, 10.1111/j.1574-695X.2010.00645.x]; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; RILEY LW, 1987, ANNU REV MICROBIOL, V41, P383, DOI 10.1146/annurev.micro.41.1.383; Sambanthamoorthy K, 2011, ANTIMICROB AGENTS CH, V55, P4369, DOI 10.1128/AAC.00583-11; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; TZIPORI S, 1992, INFECT IMMUN, V60, P5302, DOI 10.1128/IAI.60.12.5302-5306.1992; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P3959, DOI 10.1128/IAI.58.12.3959-3965.1990	34	44	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41628	10.1371/journal.pone.0041628	http://dx.doi.org/10.1371/journal.pone.0041628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848550	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600097
J	Campanella, C; Bucchieri, F; Merendino, AM; Fucarino, A; Burgio, G; Corona, DFV; Barbieri, G; David, S; Farina, F; Zummo, G; de Macario, EC; Macario, AJL; Cappello, F				Campanella, Claudia; Bucchieri, Fabio; Merendino, Anna M.; Fucarino, Alberto; Burgio, Giosalba; Corona, Davide F. V.; Barbieri, Giovanna; David, Sabrina; Farina, Felicia; Zummo, Giovanni; de Macario, Everly Conway; Macario, Alberto J. L.; Cappello, Francesco			The Odyssey of Hsp60 from Tumor Cells to Other Destinations Includes Plasma Membrane-Associated Stages and Golgi and Exosomal Protein-Trafficking Modalities	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MITOCHONDRIAL CHAPERONES; MAMMALIAN-CELLS; STRESS-PROTEINS; CELLULAR STRESS; CANCER; HEAT-SHOCK-PROTEIN-60; IDENTIFICATION; ACTIVATION; LOCALIZATION	Background: In a previous work we showed for the first time that human tumor cells secrete Hsp60 via exosomes, which are considered immunologically active microvesicles involved in tumor progression. This finding raised questions concerning the route followed by Hsp60 to reach the exosomes, its location in them, and whether Hsp60 can be secreted also via other mechanisms, e. g., by the Golgi. We addressed these issues in the work presented here. Principal Findings: We found that Hsp60 localizes in the tumor cell plasma membrane, is associated with lipid rafts, and ends up in the exosomal membrane. We also found evidence that Hsp60 localizes in the Golgi apparatus and its secretion is prevented by an inhibitor of this organelle. Conclusions/Significance: We propose a multistage process for the translocation of Hsp60 from the inside to the outside of the cell that includes a combination of protein traffic pathways and, ultimately, presence of the chaperonin in the circulating blood. The new information presented should help in designing future strategies for research and for developing diagnostic-monitoring means useful in clinical oncology.	[Campanella, Claudia; Bucchieri, Fabio; Merendino, Anna M.; Fucarino, Alberto; David, Sabrina; Farina, Felicia; Zummo, Giovanni; Cappello, Francesco] Univ Palermo, Dipartimento BIONEC, Sez Anat Umana, Palermo, Italy; [Campanella, Claudia; Bucchieri, Fabio; Macario, Alberto J. L.; Cappello, Francesco] Ist Euro Mediterraneo Sci & Tecnol, Palermo, Italy; [Burgio, Giosalba; Corona, Davide F. V.] Univ Palermo, Dipartimento STEMBIO, Palermo, Italy; [Burgio, Giosalba; Corona, Davide F. V.] Dulbecco Telethon Inst, Palermo, Italy; [Barbieri, Giovanna] CNR, Ist Biomed & Immunol Mol, Palermo, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de Macario, Everly Conway; Macario, Alberto J. L.] IMET, Baltimore, MD USA	University of Palermo; University of Palermo; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University System of Maryland; University of Maryland Baltimore	Campanella, C (corresponding author), Univ Palermo, Dipartimento BIONEC, Sez Anat Umana, Palermo, Italy.	francapp@hotmail.com	Bucchieri, Fabio/F-8877-2012; Corona, Davide F.V./H-8467-2012; Barbieri, Giovanna/AAH-3645-2019; Cappello, Francesco/F-9153-2012	BARBIERI, GIOVANNA/0000-0002-5895-1795; fucarino, alberto/0000-0001-8958-525X; BUCCHIERI, Fabio/0000-0002-0209-8668; Cappello, Francesco/0000-0001-9288-1148; DAVID, Sabrina/0000-0003-4106-6826	University of Palermo, Italy; Istituto Euro-Mediterraneo di Scienza e Tecnologia, Palermo, Italy; Federazione Italiana Ricerca sul Cancro, Italy; Fondazione Telethon Armenise-Harvard Foundation, Italy; Associazione Italiana Ricerca sul Cancro, Italy	University of Palermo, Italy; Istituto Euro-Mediterraneo di Scienza e Tecnologia, Palermo, Italy; Federazione Italiana Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon Armenise-Harvard Foundation, Italy(Fondazione Telethon); Associazione Italiana Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was supported by funds from: University of Palermo, Italy (FB, FC, FF and GZ); Istituto Euro-Mediterraneo di Scienza e Tecnologia, Palermo, Italy (FC and AJLM); Federazione Italiana Ricerca sul Cancro, Italy (GB); Fondazione Telethon Armenise-Harvard Foundation, Italy (DFVC); Associazione Italiana Ricerca sul Cancro, Italy (DFVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barazi HO, 2002, CANCER RES, V62, P1541; BARBIERI G, 1994, EUR J BIOCHEM, V223, P427, DOI 10.1111/j.1432-1033.1994.tb19010.x; Burgio G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000089; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Cappello Francesco, 2011, Front Biosci (Schol Ed), V3, P341, DOI 10.2741/s155; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chen WL, 2006, EUR J IMMUNOL, V36, P1598, DOI 10.1002/eji.200535501; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gupta Radhey S, 2008, Novartis Found Symp, V291, P59; Hamelin C, 2011, FEBS J, V278, P4845, DOI 10.1111/j.1742-4658.2011.08385.x; Hamrita B, 2008, CLIN CHIM ACTA, V393, P95, DOI 10.1016/j.cca.2008.03.017; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hayoun D, 2012, FEBS J, V279, P2083, DOI 10.1111/j.1742-4658.2012.08594.x; IKAWA S, 1992, P NATL ACAD SCI USA, V89, P2012, DOI 10.1073/pnas.89.6.2012; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Laad AD, 1999, INT J CANCER, V80, P709, DOI 10.1002/(SICI)1097-0215(19990301)80:5<709::AID-IJC14>3.3.CO;2-I; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lv LH, 2012, J BIOL CHEM, V287, P15874, DOI 10.1074/jbc.M112.340588; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Macario AJL, 2007, ANN NY ACAD SCI, V1113, P178, DOI 10.1196/annals.1391.009; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Qian-Lin Zhu, 2010, J Surg Oncol, V102, P419, DOI 10.1002/jso.21625; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4	38	91	94	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42008	10.1371/journal.pone.0042008	http://dx.doi.org/10.1371/journal.pone.0042008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848686	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600155
J	Lavine, MD; Arrizabalaga, G				Lavine, Mark D.; Arrizabalaga, Gustavo			Analysis of Monensin Sensitivity in Toxoplasma gondii Reveals Autophagy as a Mechanism for Drug Induced Death	PLOS ONE			English	Article							LYSOSOMAL PROTEIN-DEGRADATION; CELL-CYCLE ARREST; RAT HEPATOCYTES; CROSS-TALK; 3-METHYLADENINE; IDENTIFICATION; CHEMOTHERAPY; APICOMPLEXA; PARASITES; PATHWAYS	Understanding the mechanisms by which anti-parasitic drugs alter the physiology and ultimately kill is an important area of investigation. Development of novel parasitic drugs, as well as the continued utilization of existing drugs in the face of resistant parasite populations, requires such knowledge. Here we show that the anti-coccidial drug monensin kills Toxoplasma gondii by inducing autophagy in the parasites, a novel mechanism of cell death in response to an antimicrobial drug. Monensin treatment results autophagy, as shown by translocation of ATG8 to autophagosomes, as well as causing marked morphological changes in the parasites' mitochondria. Use of the autophagy inhibitor 3-methyladenine blocks autophagy and mitochondrial alterations, and enhances parasite survival, in monensin-exposed parasites, although it does not block other monensin-induced effects on the parasites, such as late S-phase cell cycle arrest. Monensin does not induce autophagy in a parasite strain deficient in the mitochondrial DNA repair enzyme TgMSH-1 an enzyme that mediates monensin-induced late S-phase arrest. TgMSH-1 therefore either mediates cell cycle arrest and autophagy independently, or autophagy occurs downstream of cell cycle arrest in a manner analogous to apoptosis of cells arrested in G(2) of the cell cycle. Overall, our results point to autophagy as a potentially important mode of cell death of protozoan parasites in response to antimicrobial drugs and indicate that disruption of the autophagy pathway could result in drug resistance.	[Lavine, Mark D.; Arrizabalaga, Gustavo] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Lavine, MD (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	garrizab@iupui.edu			National Institutes of Health [R01 AI 89808-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI 89808-01 (http://NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Bonhomme A., 1992, Parassitologia (Rome), V34, P31; Chapman HD, 2010, POULTRY SCI, V89, P1788, DOI 10.3382/ps.2010-00931; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Francia ME, 2011, EXP CELL RES, V317, P1382, DOI 10.1016/j.yexcr.2011.03.020; Garrison EM, 2009, MOL MICROBIOL, V72, P425, DOI 10.1111/j.1365-2958.2009.06655.x; Ghosh D, 2011, CELL MICROBIOL; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; Haberkorn A, 1996, PARASITOL RES, V82, P193, DOI 10.1007/s004360050094; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Lavine MD, 2011, ANTIMICROB AGENTS CH, V55, P745, DOI 10.1128/AAC.01092-10; LAWRENCE K, 1988, VET REC, V123, P323, DOI 10.1136/vr.123.12.323-a; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Mahmoudi N, 2006, J ANTIMICROB CHEMOTH, V57, P489, DOI 10.1093/jac/dki470; Mead JR, 2002, DRUG RESIST UPDATE, V5, P47, DOI 10.1016/S1368-7646(02)00011-0; Meneceur P, 2008, ANTIMICROB AGENTS CH, V52, P1269, DOI 10.1128/AAC.01203-07; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Muller J, 2011, CURR TOP MED CHEM, V11, P2029, DOI 10.2174/156802611796575876; O'Brien V, 2006, CARCINOGENESIS, V27, P682, DOI 10.1093/carcin/bgi298; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Souza AC, 2005, J VET MED A, V52, P230, DOI 10.1111/j.1439-0442.2005.00728.x; Takatsuka C, 2004, PLANT CELL PHYSIOL, V45, P265, DOI 10.1093/pcp/pch031; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Wang YB, 2010, MOL BIOCHEM PARASIT, V173, P142, DOI 10.1016/j.molbiopara.2010.05.020; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	30	55	57	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42107	10.1371/journal.pone.0042107	http://dx.doi.org/10.1371/journal.pone.0042107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848721	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600167
J	Macri, S; Ceci, C; Canese, R; Laviola, G				Macri, Simone; Ceci, Chiara; Canese, Rossella; Laviola, Giovanni			Prenatal Stress and Peripubertal Stimulation of the Endocannabinoid System Differentially Regulate Emotional Responses and Brain Metabolism in Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; INDUCED CORTICOSTERONE SECRETION; DEPRESSION-LIKE BEHAVIOR; LONG-TERM CONSEQUENCES; MATERNAL-DEPRIVATION; CANNABIS USE; FEMALE RATS; PREFRONTAL MYOINOSITOL; PSYCHIATRIC-DISORDERS; ENRICHED ENVIRONMENT	The central endocannabinoid system (ECS) and the hypothalamic-pituitary-adrenal-axis mediate individual responses to emotionally salient stimuli. Their altered developmental adjustment may relate to the emergence of emotional disturbances. Although environmental influences regulate the individual phenotype throughout the entire lifespan, their effects may result particularly persistent during plastic developmental stages (e. g. prenatal life and adolescence). Here, we investigated whether prenatal stress - in the form of gestational exposure to corticosterone supplemented in the maternal drinking water (100 mg/l) during the last week of pregnancy - combined with a pharmacological stimulation of the ECS during adolescence (daily fatty acid amide hydrolase URB597 i.p. administration - 0.4 mg/kg - between postnatal days 2938), influenced adult mouse emotional behaviour and brain metabolism measured through in vivo quantitative magnetic resonance spectroscopy. Compared to control mice, URB597-treated subjects showed, in the short-term, reduced locomotion and, in the long term, reduced motivation to execute operant responses to obtain palatable rewards paralleled by reduced levels of inositol and taurine in the prefrontal cortex. Adult mice exposed to prenatal corticosterone showed increased behavioural anxiety and reduced locomotion in the elevated zero maze, and altered brain metabolism (increased glutamate and reduced taurine in the hippocampus; reduced inositol and N-Acetyl-Aspartate in the hypothalamus). Present data further corroborate the view that prenatal stress and pharmacological ECS stimulation during adolescence persistently regulate emotional responses in adulthood. Yet, whilst we hypothesized these factors to be interactive in nature, we observed that the consequences of prenatal corticosterone administration were independent from those of ECS drug-induced stimulation during adolescence.	[Macri, Simone; Ceci, Chiara; Canese, Rossella; Laviola, Giovanni] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Macri, S (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	simone.macri@iss.it	Canese, Rossella/B-3969-2017; Laviola, Giovanni/K-4392-2016; Laviola, Giovanni/AAA-2391-2022	Canese, Rossella/0000-0001-9093-6803; Laviola, Giovanni/0000-0003-0388-0835; Laviola, Giovanni/0000-0003-0388-0835; Macri, Simone/0000-0003-2946-4784	Department of Antidrug Policies c/o Presidency of the Council of Ministers, Italy	Department of Antidrug Policies c/o Presidency of the Council of Ministers, Italy	This work was supported by the grant "ECS-EMOTION" from the Department of Antidrug Policies c/o Presidency of the Council of Ministers, Italy to G. L. and S. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Alonso SJ, 2000, J PHYSIOL BIOCHEM, V56, P77, DOI 10.1007/BF03179902; Andersen SL, 2009, NEUROSCI BIOBEHAV R, V33, P516, DOI 10.1016/j.neubiorev.2008.09.009; ARCHER J E, 1971, Developmental Psychobiology, V4, P193, DOI 10.1002/dev.420040302; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Bambico FR, 2010, NEUROBIOL DIS, V37, P641, DOI 10.1016/j.nbd.2009.11.020; Barbazanges A, 1996, J NEUROSCI, V16, P7783; Neto JBB, 2012, NEUROPHARMACOLOGY, V62, P518, DOI 10.1016/j.neuropharm.2011.09.011; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Biscaia M, 2003, PSYCHOPHARMACOLOGY, V170, P301, DOI 10.1007/s00213-003-1550-7; Brenhouse HC, 2011, NEUROSCI BIOBEHAV R, V35, P1687, DOI 10.1016/j.neubiorev.2011.04.013; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Canese R, 2011, NMR BIOMED; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Casadio P, 2011, NEUROSCI BIOBEHAV R, V35, P1779, DOI 10.1016/j.neubiorev.2011.04.007; CATALANI A, 1993, BRAIN RES, V624, P209, DOI 10.1016/0006-8993(93)90079-3; Chen J, 2011, NEUROPSYCH DIS TREAT, V7, P241, DOI 10.2147/NDT.S10997; Coupland NJ, 2005, BIOL PSYCHIAT, V57, P1526, DOI 10.1016/j.biopsych.2005.02.027; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Darnaudery M, 2004, BEHAV NEUROSCI, V118, P590, DOI 10.1037/0735-7044.118.3.590; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P; Depke M, 2008, ENDOCRINOLOGY, V149, P2714, DOI 10.1210/en.2008-0038; Eisenstein SA, 2009, SYNAPSE, V63, P941, DOI 10.1002/syn.20679; Fernandes C, 1999, PHARMACOL BIOCHEM BE, V64, P731, DOI 10.1016/S0091-3057(99)00139-2; Fride E, 2009, VITAM HORM, V81, P139, DOI 10.1016/S0083-6729(09)81006-6; Gao PF, 2011, J NEUROSCI RES, V89, P329, DOI 10.1002/jnr.22550; GIDEON P, 1992, STROKE, V23, P1566, DOI 10.1161/01.STR.23.11.1566; Giedd JN, 2010, NEUROPSYCHOL REV, V20, P349, DOI 10.1007/s11065-010-9151-9; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Gorman JM, 2010, J NEUROPSYCH CLIN N, V22, P256, DOI 10.1176/appi.neuropsych.22.3.256; Hauser J, 2006, BEHAV BRAIN RES, V175, P51, DOI 10.1016/j.bbr.2006.07.026; Hauser J, 2009, HORM BEHAV, V56, P364, DOI 10.1016/j.yhbeh.2009.07.003; HENRY C, 1995, BRAIN RES, V685, P179, DOI 10.1016/0006-8993(95)00430-X; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Hill MN, 2009, P NATL ACAD SCI USA, V106, P4579, DOI 10.1073/pnas.0901519106; ISAACKS RE, 1994, NEUROCHEM RES, V19, P331, DOI 10.1007/BF00971582; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Jezova D, 2002, STRESS, V5, P177, DOI 10.1080/1025389021000010512; Kippin TE, 2008, NEUROPSYCHOPHARMACOL, V33, P769, DOI 10.1038/sj.npp.1301447; Knapman A, 2012, EUR J NEUROSCI, V35, P412, DOI 10.1111/j.1460-9568.2011.07968.x; Kong WX, 2006, PHARMACOL BIOCHEM BE, V83, P271, DOI 10.1016/j.pbb.2006.02.007; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Laviola G, 2004, EUR J NEUROSCI, V20, P1655, DOI 10.1111/j.1460-9568.2004.03597.x; LAVIOLA G, 1991, NEUROSCI BIOBEHAV R, V15, P501, DOI 10.1016/S0149-7634(05)80139-3; Laviola G, 2011, NEUROSCI BIOBEHAV R, V35, P1631, DOI 10.1016/j.neubiorev.2011.05.011; Lee J, 2006, NEUROPHARMACOLOGY, V51, P557, DOI 10.1016/j.neuropharm.2006.04.016; Lehmann J, 2000, BEHAV BRAIN RES, V107, P133, DOI 10.1016/S0166-4328(99)00122-9; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Maccari S, 1997, ARCH PEDIATRIE, V4, pS138, DOI 10.1016/S0929-693X(97)86481-0; MACCARI S, 1995, J NEUROSCI, V15, P110; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Macri S, 2004, BEHAV BRAIN RES, V154, P231, DOI 10.1016/j.bbr.2004.02.009; Macri S, 2011, NEUROSCI BIOBEHAV R, V35, P1534, DOI 10.1016/j.neubiorev.2010.12.014; Macri S, 2009, HORM BEHAV, V56, P391, DOI 10.1016/j.yhbeh.2009.07.006; Macri S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001015; Marco EM, 2011, NEUROTOX RES, V19, P286, DOI 10.1007/s12640-010-9205-z; Marco EM, 2007, PHARMACOL BIOCHEM BE, V86, P334, DOI 10.1016/j.pbb.2006.10.006; Marco EM, 2011, BEHAV BRAIN RES, V220, P140, DOI 10.1016/j.bbr.2011.01.044; Marco EM, 2009, BRAIN RES, V1257, P25, DOI 10.1016/j.brainres.2008.12.037; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Meaney MJ, 2002, PSYCHONEUROENDOCRINO, V27, P127, DOI 10.1016/S0306-4530(01)00040-3; Moscarello JM, 2010, NEUROSCIENCE, V170, P468, DOI 10.1016/j.neuroscience.2010.07.002; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Noorlander CW, 2006, J COMP NEUROL, V499, P924, DOI 10.1002/cne.21162; O'Regan D, 2008, J ENDOCRINOL, V196, P343, DOI 10.1677/JOE-07-0327; Parker KJ, 2011, NEUROSCI BIOBEHAV R, V35, P1466, DOI 10.1016/j.neubiorev.2010.09.003; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; PFISTER HP, 1992, INT J NEUROSCI, V62, P227; Poland RE, 1999, J PSYCHIATR RES, V33, P41, DOI 10.1016/S0022-3956(98)00043-0; Poryazova R, 2009, SLEEP, V32, P607, DOI 10.1093/sleep/32.5.607; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rademacher DJ, 2008, NEUROPHARMACOLOGY, V54, P108, DOI 10.1016/j.neuropharm.2007.06.012; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Salomon S, 2011, J NEUROENDOCRINOL, V23, P118, DOI 10.1111/j.1365-2826.2010.02097.x; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; Schmidt M, 2004, J NEUROENDOCRINOL, V16, P52, DOI 10.1111/j.1365-2826.2004.01123.x; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Smith JW, 2004, PSYCHONEUROENDOCRINO, V29, P227, DOI 10.1016/S0306-4530(03)00025-8; Suarez J, 2010, BRAIN RES, V1349, P162, DOI 10.1016/j.brainres.2010.06.042; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Sultan SE, 2003, J EXP ZOOL PART B, V296B, P1, DOI 10.1002/jez.b.00010; Thomas MB, 2009, PHYSIOL BEHAV, V97, P270, DOI 10.1016/j.physbeh.2009.02.025; Trezza V, 2009, J PHARMACOL EXP THER, V328, P343, DOI 10.1124/jpet.108.141069; TRULLAS R, 1993, PSYCHOPHARMACOLOGY, V111, P323, DOI 10.1007/BF02244948; Vallee M, 1997, J NEUROSCI, V17, P2626; van den Hove Daniel L A, 2010, Front Biosci (Elite Ed), V2, P43; Waddell BJ, 2010, J ENDOCRINOL, V205, P171, DOI 10.1677/JOE-09-0459; Ward SJ, 2005, BEHAV PHARMACOL, V16, P381, DOI 10.1097/00008877-200509000-00010; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9; Yang JL, 2006, BRAIN RES, V1125, P132, DOI 10.1016/j.brainres.2006.10.028; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199; Zheng HR, 2010, PROG NEURO-PSYCHOPH, V34, P1189, DOI 10.1016/j.pnpbp.2010.06.009; Zoratto F, 2011, PROG NEURO-PSYCHOPH, V35, P1479, DOI 10.1016/j.pnpbp.2011.02.016	104	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41821	10.1371/journal.pone.0041821	http://dx.doi.org/10.1371/journal.pone.0041821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848620	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600127
J	Penick, CA; Copple, RN; Mendez, RA; Smith, AA				Penick, Clint A.; Copple, R. Neale; Mendez, Raymond A.; Smith, Adrian A.			The Role of Anchor-Tipped Larval Hairs in the Organization of Ant Colonies	PLOS ONE			English	Article							FIRE ANT; BROOD; NEST; HYMENOPTERA; POLLEN; PREFERENCES; FORMICIDAE	The spatial organization within a social insect colony is a key component of colony life. It influences individual interaction rates, resource distribution, and division of labor within the nest. Yet studies of social insect behavior are most often carried out in artificial constructions, which may change worker behavior and colony organization. We observed how workers of the ant Pheidole rhea organized brood in nests with deep chambers and textured walls that were designed to mimic their natural constructions more closely. Instead of clumping larvae into piles on the chamber floor, workers suspended fourth-instar larvae from the vertical walls and ceiling of each chamber while young larvae and pupae were clumped at the base. Fourth-instar larvae possess five rows of anchor-tipped hairs on their dorsal side, and we predicted that these hairs functioned to attach larvae to the nest walls. We gave larvae "haircuts," where only the anchor-tipped hairs were removed, and then tested their ability to adhere to a textured surface raised to an angle of 90 degrees and then 120 degrees with respect to the horizontal plane. Larvae whose hairs had been clipped came unattached in almost all trials, while larvae whose hairs remained intact stayed attached. This confirmed that anchor-tipped hairs functioned to attach larvae to the walls of the nest. The presence of anchor-tipped hairs is widespread and has been documented in at least 22 genera from the ant subfamily Myrmicinae, including species that occur in a variety of environments and represent a broad range of nesting habits. Based on our results, it is likely that many species exhibit this larval hanging behavior, and this could impact colony characteristics such as spatial organization and the care of developing larvae by nurse workers.	[Penick, Clint A.; Copple, R. Neale; Smith, Adrian A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Mendez, Raymond A.] Work Play, Portal, AZ USA	Arizona State University; Arizona State University-Tempe	Penick, CA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Clint.Penick@asu.edu		Penick, Clint/0000-0002-5368-507X	Graduate and Professional Student Association (GPSA) of Arizona State University	Graduate and Professional Student Association (GPSA) of Arizona State University	This study was funded in part by the Graduate and Professional Student Association (GPSA) of Arizona State University. http://gpsa.asu.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Couvillon MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2411, DOI 10.1098/rspb.2009.0172; Dreller C, 1999, BEHAV ECOL SOCIOBIOL, V45, P227, DOI 10.1007/s002650050557; FRANKS NR, 1992, BEHAV ECOL SOCIOBIOL, V30, P109; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; Holldobler B., 1990, pi; Huang MH, 2011, INSECT SOC, V58, P539, DOI 10.1007/s00040-011-0176-8; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; JEANNE RL, 1975, Q REV BIOL, V50, P267, DOI 10.1086/408564; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morgan RC, 2009, INVERTEBRATES ED CON, P131; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; PASSERA L, 1979, INSECT SOC, V26, P343, DOI 10.1007/BF02223553; Penick CA, 2008, INSECT SOC, V55, P176, DOI 10.1007/s00040-008-0987-4; PORTER SD, 1993, BEHAV ECOL SOCIOBIOL, V32, P321, DOI 10.1007/BF00183787; POTTS LR, 1984, INSECT SOC, V31, P335, DOI 10.1007/BF02223616; Rajakumar R, 2012, SCIENCE, V335, P79, DOI 10.1126/science.1211451; RICHARDS OW, 1971, BIOL REV, V46, P483, DOI 10.1111/j.1469-185X.1971.tb01054.x; Ruger MH, 2008, INSECT SOC, V55, P12, DOI 10.1007/s00040-007-0965-2; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Sendova-Franks AB, 2004, ANIM BEHAV, V68, P1095, DOI 10.1016/j.anbehav.2004.02.013; TAYLOR ROBERT W., 1967, PAC INSECTS MONOGR, V13, P1; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; TSCHINKEL WR, 1988, PHYSIOL ENTOMOL, V13, P327, DOI 10.1111/j.1365-3032.1988.tb00484.x; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Wheeler DE, 1982, THESIS DUKE U DURHAM; Wheeler G.C., 1976, Memoirs ent Soc Wash, VNo. 7, P1; WHEELER GC, 1952, AM MIDL NAT, V48, P604, DOI 10.2307/2422200; WHEELER GC, 1948, AM MIDL NAT, V40, P664, DOI 10.2307/2421490; Winston M. L. L., 1991, BIOL HONEY BEE	32	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41595	10.1371/journal.pone.0041595	http://dx.doi.org/10.1371/journal.pone.0041595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848539	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600091
J	Karsai, M; Kaski, K; Kertesz, J				Karsai, Marton; Kaski, Kimmo; Kertesz, Janos			Correlated Dynamics in Egocentric Communication Networks	PLOS ONE			English	Article							HEAVY TAILS; BURSTS	We investigate the communication sequences of millions of people through two different channels and analyse the fine grained temporal structure of correlated event trains induced by single individuals. By focusing on correlations between the heterogeneous dynamics and the topology of egocentric networks we find that the bursty trains usually evolve for pairs of individuals rather than for the ego and his/her several neighbours, thus burstiness is a property of the links rather than of the nodes. We compare the directional balance of calls and short messages within bursty trains to the average on the actual link and show that for the trains of voice calls the imbalance is significantly enhanced, while for short messages the balance within the trains increases. These effects can be partly traced back to the technological constraints (for short messages) and partly to the human behavioural features (voice calls). We define a model that is able to reproduce the empirical results and may help us to understand better the mechanisms driving technology mediated human communication dynamics.	[Karsai, Marton; Kaski, Kimmo; Kertesz, Janos] Aalto Univ, Sch Sci, BECS, Espoo, Finland; [Kertesz, Janos] Budapest Univ Technol & Econ, Inst Phys, Budapest, Hungary	Aalto University; Budapest University of Technology & Economics	Karsai, M (corresponding author), Aalto Univ, Sch Sci, BECS, Espoo, Finland.	marton.karsai@aalto.fi	Kaski, Kimmo K K/G-8067-2012; Karsai, Marton/M-6684-2015; Karsai, Marton/G-3391-2011; Kaski, Kimmo/AAO-4320-2021	Karsai, Marton/0000-0001-5752-556X; Karsai, Marton/0000-0001-5752-556X; Kaski, Kimmo/0000-0002-3805-9687; Karsai, Marton/0000-0001-5382-8950	EUs FP7 FET-Open to ICTeCollective [238597]; TEKES (FiDiPro)	EUs FP7 FET-Open to ICTeCollective; TEKES (FiDiPro)(Finnish Funding Agency for Technology & Innovation (TEKES))	Financial support from EUs FP7 FET-Open to ICTeCollective Project No. 238597 and TEKES (FiDiPro) are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anteneodo C, 2010, EUR PHYS J B, V75, P389, DOI 10.1140/epjb/e2010-00139-9; Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barrett L., 2002, HUMAN EVOLUTIONARY P; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Degenne A., 1999, INTRO SOCIAL NETWORK, DOI 10.4135/9781849209373; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Engestrom Y., 1999, ACTIVITY THEORY SOCI; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Jo HH, 2011, NEW J PHYS, V14; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397; Kovanen L, 2009, THESIS AALTO U HELSI; Kovanen L, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/11/P11005; Licoppe C, 2005, SOC NETWORKS, V27, P317, DOI 10.1016/j.socnet.2004.11.001; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Onnela JP, 2007, P NATL ACAD SCI USA, V104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Palchykov V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00370; Roberts SGB, 2008, PERS INDIV DIFFER, V44, P954, DOI 10.1016/j.paid.2007.10.033; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wasserman S, 1994, SOCIAL NETWORK ANAL; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107	29	47	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2012	7	7							e40612	10.1371/journal.pone.0040612	http://dx.doi.org/10.1371/journal.pone.0040612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973NH	22866176	Green Published, Green Submitted, gold			2022-12-27	WOS:000306366400040
J	Benavente, CA; Schnell, SA; Jacobson, EL				Benavente, Claudia A.; Schnell, Stephanie A.; Jacobson, Elaine L.			Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin	PLOS ONE			English	Article							RAT BONE-MARROW; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; XERODERMA-PIGMENTOSUM; DEFICIENCY INCREASES; HUMAN KERATINOCYTES; MAMMALIAN-CELLS; NAD; APOPTOSIS	Sirtuins (SIRTs) and poly(ADP-ribose) polymerases (PARPs), NAD(+)-dependent enzymes, link cellular energy status with responses to environmental stresses. Skin is frequently exposed to the DNA damaging effects of UV irradiation, a known etiology in skin cancer. Thus, understanding the defense mechanisms in response to UV, including the role of SIRTs and PARPs, may be important in developing skin cancer prevention strategies. Here, we report expression of the seven SIRT family members in human skin. SIRTs gene expressions are progressively upregulated in A431 epidermoid carcinoma cells (SIRTs1 and 3), actinic keratoses (SIRTs 2, 3, 5, 6, and 7) and squamous cell carcinoma (SIRTs 1-7). Photodamage induces dynamic changes in SIRT expression with upregulation of both SIRT1 and SIRT4 mRNAs. Specific losses of SIRT proteins occur early after photodamage followed by accumulation later, especially for SIRT4. Niacin restriction, which decreases NAD(+), the sirtuin substrate, results in an increase in acetylated proteins, upregulation of SIRTs 2 and 4, increased inherent DNA damage, alterations in SIRT responses to photodamage, abrogation of PARP activation following photodamage, and increased sensitivity to photodamage that is completely reversed by repleting niacin. These data support the hypothesis that SIRTs and PARPs play important roles in resistance to photodamage and identify specific SIRTs that respond to photodamage and may be targets for skin cancer prevention.	[Benavente, Claudia A.] Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona; University of Arizona	Benavente, CA (corresponding author), Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA.	elaine.jacobson@pharmacy.arizona.edu		Benavente, Claudia/0000-0002-6875-3186	National Institute of Health [CA43894, CA106677, CA27502, ES06694]; NATIONAL CANCER INSTITUTE [R01CA043894, R01CA106677, P01CA027502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institute of Health grants CA43894, CA106677, CA27502 and ES06694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; BASUMODAK S, 1993, CANCER RES, V53, P4505; Benavente CA, 2008, FREE RADICAL BIO MED, V44, P527, DOI 10.1016/j.freeradbiomed.2007.10.006; BERGER NA, 1980, BIOCHEMISTRY-US, V19, P289, DOI 10.1021/bi00543a006; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyonoski AC, 1999, MOL CELL BIOCHEM, V193, P83, DOI 10.1023/A:1006964227277; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; Chang H, 2002, BIOL CHEM, V383, P703, DOI 10.1515/BC.2002.072; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Dal Farra C, 2006, J COSMET SCI, V57, P187; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Halappanavar SS, 1999, J BIOL CHEM, V274, P37097, DOI 10.1074/jbc.274.52.37097; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; JACOBSON EL, 1993, J AM COLL NUTR, V12, P412, DOI 10.1080/07315724.1993.10718330; Jacobson EL, 1997, METHOD ENZYMOL, V280, P221; JACOBSON EL, 1983, J BIOL CHEM, V258, P103; Jacobson EL, 1999, MOL CELL BIOCHEM, V193, P69, DOI 10.1023/A:1006960126369; Jacobson EL, 2001, J PHOTOCH PHOTOBIO B, V63, P141, DOI 10.1016/S1011-1344(01)00211-1; JACOBSON EL, 1979, J CELL PHYSIOL, V99, P417, DOI 10.1002/jcp.1040990316; Jacobson EL, 2007, EXP DERMATOL, V16, P490, DOI 10.1111/j.1600-0625.2007.00553.x; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Kubilus J, 1996, IN VITRO TOXICOL, V9, P157; Lee JS, 2010, EXP DERMATOL, V19, P1060, DOI 10.1111/j.1600-0625.2010.01129.x; Ming M, 2010, P NATL ACAD SCI USA, V107, P22623, DOI 10.1073/pnas.1010377108; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Ohguchi K, 2010, BRIT J DERMATOL, V163, P689, DOI 10.1111/j.1365-2133.2010.09825.x; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; SHAH GM, 2002, CANCER RES, V131, pS3150; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Spronck JC, 2003, NUTR CANCER, V45, P124, DOI 10.1207/S15327914NC4501_14; Spronck JC, 2002, MUTAT RES-FUND MOL M, V508, P83, DOI 10.1016/S0027-5107(02)00188-4; Spronck JC, 2007, NUTR CANCER, V57, P88, DOI 10.1080/01635580701268337; STEVNSNER T, 1994, NUCLEIC ACIDS RES, V22, P4620, DOI 10.1093/nar/22.22.4620; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wondrak GT, 2005, J PHARMACOL EXP THER, V312, P482, DOI 10.1124/jpet.104.075101; Wondrak GT, 2003, J INVEST DERMATOL, V121, P578, DOI 10.1046/j.1523-1747.2003.12414.x; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHANG JZ, 1993, J NUTR, V123, P1349	57	48	49	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42276	10.1371/journal.pone.0042276	http://dx.doi.org/10.1371/journal.pone.0042276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860104	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600084
J	Gladigau, G; Haselmayer, P; Scharrer, I; Munder, M; Prinz, N; Lackner, K; Schild, H; Stein, P; Radsak, MP				Gladigau, Gerd; Haselmayer, Philipp; Scharrer, Inge; Munder, Markus; Prinz, Nadine; Lackner, Karl; Schild, Hansjoerg; Stein, Pamela; Radsak, Markus P.			A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; TISSUE FACTOR; FETAL INJURY; ANTIBODIES; ACTIVATION; THROMBOSIS; C5A; MONOCYTES; RESPONSES; MICROBES	The anti-phospholipid syndrome (APS) is characterized by recurrent thrombosis and occurrence of anti-phospholipid antibodies (aPL). aPL are necessary, but not sufficient for the clinical manifestations of APS. Growing evidence suggests a role of innate immune cells, in particular polymorphonuclear neutrophils (PMN) and Toll-like receptors (TLR) to be additionally involved. aPL activate endothelial cells and monocytes through a TLR4-dependent signalling pathway. Whether this is also relevant for PMN in a similar way is currently not known. To address this issue, we used purified PMN from healthy donors and stimulated them in the presence or absence of human monoclonal aPL and the TLR4 agonist LPS monitoring neutrophil effector functions, namely the oxidative burst, phagocytosis, L-Selectin shedding and IL-8 production. aPL alone were only able to induce minor activation of PMN effector functions at high concentrations. However, in the additional presence of LPS the activation threshold was markedly lower indicating a synergistic activation pathway of aPL and TLR in PMN. In summary, our results indicate that PMN effector functions are directly activated by aPL and boosted by the additional presence of microbial products. This highlights a role for PMN as important innate immune effector cells that contribute to the pathophysiology of APS.	[Gladigau, Gerd; Haselmayer, Philipp; Schild, Hansjoerg; Stein, Pamela; Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Inst Immunol, Med Ctr, D-6500 Mainz, Germany; [Scharrer, Inge; Munder, Markus; Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med 3, Mainz, Germany; [Prinz, Nadine; Lackner, Karl] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Gladigau, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Immunol, Med Ctr, Obere Zahlbacher Str 67, D-6500 Mainz, Germany.	pamela.stein@uni-mainz.de; radsak@uni-mainz.de	Scharrer, Inge/N-2999-2013; Munder, Markus/K-6737-2013; Radsak, Markus P/L-3651-2013	Radsak, Markus P/0000-0002-3991-5721	Deutsche Forschungsgemeinschaft KFO 183 [Ra 988/4-2]; University Medical Center Mainz ("Schwerpunkt Vaskulare Pravention''); Federal Ministry of Education and Research [BMBF 01EO1003]	Deutsche Forschungsgemeinschaft KFO 183; University Medical Center Mainz ("Schwerpunkt Vaskulare Pravention''); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft KFO 183 (Ra 988/4-2 to H. S. and M. P. R.), University Medical Center Mainz ("Schwerpunkt Vaskulare Pravention'' to M. P. R.) and by the Federal Ministry of Education and Research (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherson RA, 1996, LUPUS, V5, P414, DOI 10.1177/096120339600500516; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Cervera R, 2004, ANN RHEUM DIS, V63, P1312, DOI 10.1136/ard.2003.014175; Doring Y, 2010, IMMUNOBIOLOGY, V215, P230, DOI 10.1016/j.imbio.2009.03.002; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Giron-Gonzalez JA, 2004, J RHEUMATOL, V31, P1560; Haselmayer P, 2006, IMMUNOLOGY, V119, P404, DOI 10.1111/j.1365-2567.2006.02449.x; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; Jankowski M, 2003, BLOOD, V101, P157, DOI 10.1182/blood-2002-05-1310; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lackner KJ, 2000, THROMB HAEMOSTASIS, V83, P583; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Pierangeli SS, 2000, J AUTOIMMUN, V15, P241, DOI 10.1006/jaut.2000.0420; Prinz N, 2011, BLOOD, V118, P2322, DOI 10.1182/blood-2011-01-330639; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140; Raschi E, 2003, BLOOD, V101, P3495, DOI 10.1182/blood-2002-08-2349; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shovinan O, 2007, CLIN REV ALLERG IMMU, V32, P145, DOI 10.1007/s12016-007-0001-3; Stephenson MD, 1996, FERTIL STERIL, V66, P24; Tripodi A, 2001, BRIT J HAEMATOL, V115, P672, DOI 10.1046/j.1365-2141.2001.03178.x; von Landenberg C, 1999, J AUTOIMMUN, V13, P215, DOI 10.1006/jaut.1999.0316; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yetman DL, 1996, FERTIL STERIL, V66, P540, DOI 10.1016/S0015-0282(16)58565-3	35	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42176	10.1371/journal.pone.0042176	http://dx.doi.org/10.1371/journal.pone.0042176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860075	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600066
J	Stamps, JA; Yang, LH; Morales, VM; Boundy-Mills, KL				Stamps, Judy A.; Yang, Louie H.; Morales, Vanessa M.; Boundy-Mills, Kyria L.			Drosophila Regulate Yeast Density and Increase Yeast Community Similarity in a Natural Substrate	PLOS ONE			English	Article							MELANOGASTER; BEHAVIOR; EVOLUTION; LARVAL; IDENTIFICATION; ORGANIZATION; AGRICULTURE; SELECTION; ANTS; FOOD	Drosophila melanogaster adults and larvae, but especially larvae, had profound effects on the densities and community structure of yeasts that developed in banana fruits. Pieces of fruit exposed to adult female flies previously fed fly-conditioned bananas developed higher yeast densities than pieces of the same fruits that were not exposed to flies, supporting previous suggestions that adult Drosophila vector yeasts to new substrates. However, larvae alone had dramatic effects on yeast density and species composition. When yeast densities were compared in pieces of the same fruits assigned to different treatments, fruits that developed low yeast densities in the absence of flies developed significantly higher yeast densities when exposed to larvae. Across all of the fruits, larvae regulated yeast densities within narrow limits, as compared to a much wider range of yeast densities that developed in pieces of the same fruits not exposed to flies. Larvae also affected yeast species composition, dramatically reducing species diversity across fruits, reducing variation in yeast communities from one fruit to the next (beta diversity), and encouraging the consistent development of a yeast community composed of three species of yeast (Candida californica, C. zemplinina, and Pichia kluvyeri), all of which were palatable to larvae. Larvae excreted viable cells of these three yeast species in their fecal pools, and discouraged the growth of filamentous fungi, processes which may have contributed to their effects on the yeast communities in banana fruits. These and other findings suggest that D. melanogaster adults and their larval offspring together engage in 'niche construction', facilitating a predictable microbial environment in the fruit substrates in which the larvae live and develop.	[Stamps, Judy A.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Yang, Louie H.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Morales, Vanessa M.; Boundy-Mills, Kyria L.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Stamps, JA (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	jastamps@ucdavis.edu	Stamps, Judy A/A-5142-2010	Yang, Louie/0000-0002-9237-5357				Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Anagnostou C, 2010, OIKOS, V119, P533, DOI 10.1111/j.1600-0706.2009.18001.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Begon M., 1982, Genetics and Biology of Drosophila, V3b, P345; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; BUDNIK M, 1981, REV BRAS GENET, V4, P513; Carroll G. C., 1992, The fungal community: its organization and role in the ecosystem., P327; CASTRO JA, 1986, ARCH INSECT BIOCHEM, V3, P485, DOI 10.1002/arch.940030508; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Davis JM, 2007, ANIM BEHAV, V74, P111, DOI 10.1016/j.anbehav.2006.11.014; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Ganter PF, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P303, DOI 10.1007/3-540-30985-3_14; GANTER PF, 1988, OECOLOGIA, V75, P400, DOI 10.1007/BF00376943; GILBERT DG, 1980, OECOLOGIA, V46, P135, DOI 10.1007/BF00346979; GODOYHERRERA R, 1986, HEREDITY, V56, P33, DOI 10.1038/hdy.1986.6; Gowen JW, 1919, GENETICS, V4, P205; GREEN CH, 1983, ANIM BEHAV, V31, P282, DOI 10.1016/S0003-3472(83)80198-5; Harlan JR, 1992, CROPS MAN, V2nd; Hata H, 2004, J EXP MAR BIOL ECOL, V313, P285, DOI 10.1016/j.jembe.2004.08.009; Hoffmann AA, 2006, EVOL ECOL RES, V8, P813; Janzen D.H., 1985, P40; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; LACHANCE MA, 1989, YEAST, V5, P501; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Laland KN, 2006, EVOLUTION, V60, P1751; LARUE TA, 1968, CAN J MICROBIOL, V14, P79, DOI 10.1139/m68-012; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; MORAIS PB, 1994, ANTON LEEUW INT J G, V66, P313, DOI 10.1007/BF00882766; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012668; Murakami T, 1997, J ETHOL, V15, P17, DOI 10.1007/BF02767322; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Oksanen J., 2013, R PACKAGE VERSION 2, P292; ONISHI H, 1978, J AGR CHEM SOC JPN, V52, P317, DOI 10.1271/nogeikagaku1924.52.8_317; Pearce T, 2011, BIOL PHILOS, V26, P793, DOI 10.1007/s10539-011-9282-2; Phaff H. J., 1987, YEASTS, V1, P123; Rohlfs M, 2005, MYCOLOGIA, V97, P996, DOI 10.3852/mycologia.97.5.996; Rohlfs M, 2010, J APPL ENTOMOL, V134, P667, DOI 10.1111/j.1439-0418.2009.01458.x; SEWELL D, 1974, GENET RES, V24, P163, DOI 10.1017/S0016672300015196; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Smith B. D., 1998, EMERGENCE AGR; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; Stamps JA, 2006, ANIM BEHAV, V71, P663, DOI 10.1016/j.anbehav.2005.07.015; Starmer WT, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P65, DOI 10.1016/B978-0-444-52149-1.00006-9; STARMER WT, 1986, J CHEM ECOL, V12, P1037, DOI 10.1007/BF01638995; Starmer WT, 1990, ECOLOGICAL EVOLUTION; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Wertheim B, 2002, ECOL ENTOMOL, V27, P608, DOI 10.1046/j.1365-2311.2002.00449.x	57	86	88	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42238	10.1371/journal.pone.0042238	http://dx.doi.org/10.1371/journal.pone.0042238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860093	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600079
J	Guignard, JH; Jacquet, AY; Lubart, TI				Guignard, Jacques-Henri; Jacquet, Anne-Yvonne; Lubart, Todd I.			Perfectionism and Anxiety: A Paradox in Intellectual Giftedness?	PLOS ONE			English	Article							ADOLESCENTS; DIMENSIONS; STUDENTS; CHILDREN	Numerous authors reported a prevalence of perfectionism in gifted populations. In addition, an unhealthy form of perfectionism that leads to anxiety disorder has been described. Using self-report measures (CAPS and R-CMAS) with 132 children, we hypothesized that intellectually gifted children express a higher level of perfectionism and anxiety. Our results pointed out a paradox: the gifted group obtained a higher self-oriented perfectionism score than the control group in 6th grade, but present the same level of anxiety. In contrast, the gifted group showed the same level of perfectionism than non-gifted 5th graders, but reported a higher anxiety level. Thus, the interplay between perfectionism and anxiety appears to be more complex than a simple linear relationship in giftedness.	[Guignard, Jacques-Henri] Ctr Hosp Guillaume Regnier, Ctr Natl Aide Enfant & Adolescent Haut Potentiel, Rennes, France; [Guignard, Jacques-Henri; Lubart, Todd I.] Univ Paris 05, Lab Adaptat Travail Individu, Paris, France; [Jacquet, Anne-Yvonne] Univ Paris 05, Lab Psychol Percept, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Guignard, JH (corresponding author), Ctr Hosp Guillaume Regnier, Ctr Natl Aide Enfant & Adolescent Haut Potentiel, Rennes, France.	jhguignard@free.fr	Lubart, todd/Z-4126-2019	Lubart, todd/0000-0002-8776-8797	Inkermann Fund, Fondation de France	Inkermann Fund, Fondation de France	This work was supported by the Inkermann Fund, Fondation de France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro D, 1999, ECHELLE REVISEE ANXI; Chan DW, 2003, HIGH ABIL STUD, V14, P41, DOI 10.1080/13598130304089; Clemens FW, 1981, CEG TAG NAT TOP C GI; Cook LC, 2009, PERS INDIV DIFFER, V46, P325, DOI 10.1016/j.paid.2008.10.029; Dixon FA, 2004, GIFTED CHILD QUART, V48, P95, DOI 10.1177/001698620404800203; Flett G.L., 2002, PERFECTIONISM MALADJ, DOI DOI 10.1037/10458-001; HAMACHEK DE, 1978, PSYCHOLOGY, V15, P27; HEWITT PL, 1991, J PERS SOC PSYCHOL, V60, P456, DOI 10.1037/0022-3514.60.3.456; Hewitt PL, 2002, PERS INDIV DIFFER, V32, P1049, DOI 10.1016/S0191-8869(01)00109-X; Locicero K. A., 2000, ROEPER REV, V22, P182, DOI [10.1080/02783190009554030, DOI 10.1080/02783190009554030]; Mann MP, 2004, PERS INDIV DIFFER, V36, P1797, DOI 10.1016/j.paid.2003.07.001; McCreary BT, 2004, J CLIN CHILD ADOLESC, V33, P313, DOI 10.1207/s15374424jccp3302_13; Neumeister KLS, 2004, J EDUC GIFTED, V27, P311, DOI 10.4219/jeg-2004-320; OLSZEWSKIKUBILIUS PM, 1988, GIFTED CHILD QUART, V32, P347, DOI 10.1177/001698628803200403; Parker WD, 1996, GIFTED CHILD QUART, V40, P194, DOI 10.1177/001698629604000404; Parker WD, 2000, J SECONDARY GIFTED E, V11, P173, DOI DOI 10.4219/JSGE-2000-632; Pyryt MC, 1994, 5 ANN SAGE C SEPT 30; Reynolds JR, 1997, REVISED CHILDRENS MA; ROBERTS SM, 1994, J EDUC GIFTED, V17, P241, DOI 10.1177/016235329401700304; Roome J. R., 1985, ROEPER REV, V7, P177; SCHOLWINSKI E, 1985, GIFTED CHILD QUART, V29, P125, DOI 10.1177/001698628502900305; Schuler PA., 2000, J SECONDARY GIFTED E, V11, P183, DOI [10.4219/jsge-2000-629, DOI 10.4219/JSGE-2000-629]; Sondergeld TA, 2007, ROEPER REV, V29, P19, DOI 10.1080/02783193.2007.11869220; SOUSSIGNAN R, 1988, J CHILD PSYCHOL PSYC, V29, P321, DOI 10.1111/j.1469-7610.1988.tb00720.x; Todorov C, 1996, CAN J PSYCHIAT, V41, P291, DOI 10.1177/070674379604100506	25	28	28	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41043	10.1371/journal.pone.0041043	http://dx.doi.org/10.1371/journal.pone.0041043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22859964	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900015
J	Ternan, NG; Jain, S; Srivastava, M; McMullan, G				Ternan, Nigel G.; Jain, Shailesh; Srivastava, Malay; McMullan, Geoff			Comparative Transcriptional Analysis of Clinically Relevant Heat Stress Response in Clostridium difficile Strain 630	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CHANGING EPIDEMIOLOGY; SECRETION STRESS; TOXIN-B; INFECTION; PROTEOME; DISEASE; SHOCK; EXPRESSION; BACTERIA	Clostridium difficile is considered to be one of the most important causes of health care-associated infections worldwide. In order to understand more fully the adaptive response of the organism to stressful conditions, we examined transcriptional changes resulting from a clinically relevant heat stress (41 degrees C versus 37 degrees C) in C. difficile strain 630 and identified 341 differentially expressed genes encompassing multiple cellular functional categories. While the transcriptome was relatively resilient to the applied heat stress, we noted upregulation of classical heat shock genes including the groEL and dnaK operons in addition to other stress-responsive genes. Interestingly, the flagellin gene (fliC) was downregulated, yet genes encoding the cell-wall associated flagellar components were upregulated suggesting that while motility may be reduced, adherence - to mucus or epithelial cells - could be enhanced during infection. We also observed that a number of phage associated genes were downregulated, as were genes associated with the conjugative transposon Tn5397 including a group II intron, thus highlighting a potential decrease in retromobility during heat stress. These data suggest that maintenance of lysogeny and genome wide stabilisation of mobile elements could be a global response to heat stress in this pathogen.	[Ternan, Nigel G.; Jain, Shailesh; Srivastava, Malay; McMullan, Geoff] Univ Ulster, No Ireland Ctr Food & Hlth NICHE, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Ternan, NG (corresponding author), Univ Ulster, No Ireland Ctr Food & Hlth NICHE, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	ng.ternan@ulster.ac.uk		McMullan, Geoffrey/0000-0001-6511-2925	Vice Chancellor's Research Scholarship award from the University of Ulster; Innovation Leaders award from the HSC Research and Development office	Vice Chancellor's Research Scholarship award from the University of Ulster; Innovation Leaders award from the HSC Research and Development office	SJ was supported by a Vice Chancellor's Research Scholarship award (2007-2010) from the University of Ulster. GMcM was supported by an Innovation Leaders award (2009) from the HSC Research and Development office (http://www.publichealth.hscni.net/directorate-public-health/hsc-research-and-development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen YL, 2011, MBIO, V2, DOI 10.1128/mBio.00340-10; Coros CJ, 2009, MOL CELL, V34, P250, DOI 10.1016/j.molcel.2009.03.014; Darmon E, 2002, J BACTERIOL, V184, P5661, DOI 10.1128/JB.184.20.5661-5671.2002; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Do JH, 2007, ENG LIFE SCI, V7, P26, DOI 10.1002/elsc.200620169; Donovan M, 2001, INFECT IMMUN, V69, P2542, DOI 10.1128/IAI.69.4.2542-2548.2001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Graham RLJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r110; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Health Do Agency HP, 2009, CLOSTRIDIUM DIFFICIL; Hecker M, 2001, ADV MICROB PHYSIOL, V44, P35, DOI 10.1016/S0065-2911(01)44011-2; Hecker M, 2009, RES MICROBIOL, V160, P245, DOI 10.1016/j.resmic.2009.03.008; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; Jain S, 2011, J PROTEOME RES, V10, P3880, DOI 10.1021/pr200327t; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Janvilisri T, 2009, J BACTERIOL, V191, P3881, DOI 10.1128/JB.00222-09; Jasni AS, 2010, ANTIMICROB AGENTS CH, V54, P4924, DOI 10.1128/AAC.00496-10; Karlsson S, 2003, INFECT IMMUN, V71, P1784, DOI 10.1128/IAI.71.4.1784-1793.2003; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Koskenniemi K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002741; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Lyras Dena, 2005, P631; Marsden GL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-389; McFarland LV, 2008, NAT CLIN PRACT GASTR, V5, P40, DOI 10.1038/ncpgasthep1029; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; MOSZER I, 1995, MICROBIOL-SGM, V141, P261, DOI 10.1099/13500872-141-2-261; Mullany P, 2002, CELL MOL LIFE SCI, V59, P2017, DOI 10.1007/s000180200001; Nielsen AK, 2010, J MOL MICROB BIOTECH, V18, P162, DOI 10.1159/000315457; Olivares-Hernandez R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-33; Olivares-Hernandez R, 2010, BIOTECHNOL BIOENG, V107, P865, DOI 10.1002/bit.22868; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Schumann W, 2003, CELL STRESS CHAPERON, V8, P207, DOI 10.1379/1466-1268(2003)008<0207:TBSHSS>2.0.CO;2; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Ternan NG, 1998, SYST APPL MICROBIOL, V21, P346, DOI 10.1016/S0723-2020(98)80043-X; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Versteeg S, 2003, J BACTERIOL, V185, P466, DOI 10.1128/JB.185.2.466-474.2003; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150	61	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42410	10.1371/journal.pone.0042410	http://dx.doi.org/10.1371/journal.pone.0042410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860125	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900092
J	Hoskins, JM; Ong, PS; Keku, TO; Galanko, JA; Martin, CF; Coleman, CA; Wolfe, M; Sandler, RS; McLeod, HL				Hoskins, Janelle M.; Ong, Pei-Shi; Keku, Temitope O.; Galanko, Joseph A.; Martin, Christopher F.; Coleman, Clint A.; Wolfe, Michelle; Sandler, Robert S.; McLeod, Howard L.			Association of Eleven Common, Low-Penetrance Colorectal Cancer Susceptibility Genetic Variants at Six Risk Loci with Clinical Outcome	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COLON-CANCER; ALLELIC IMBALANCE; CHROMOSOME 8Q24; MUTATIONS; PROSTATE; SURVIVAL; SHOWS; MYC	Background: Low-penetrance genetic variants have been increasingly recognized to influence the risk of tumor development. Risk variants for colorectal cancer (CRC) have been mapped to chromosome positions 8q23.3, 8q24, 9p24.1, 10p14, 11q23, 14q22.2, 15q13, 16q22.1, 18q21, 19q13.1 and 20p12.3. In particular, the 8q24 single nucleotide polymorphism (SNP), rs6983267, has reproducibly been associated with the risk of developing CRC. As the CRC risk SNPs may also influence disease outcome, thus in this study, we evaluated whether they influence patient survival. Methodology/Principal Findings: DNA samples from 583 CRC patients enrolled in the prospective, North Carolina Cancer Care Outcomes Research and Surveillance Consortium Study (NC CanCORS) were genotyped for 11 CRC susceptibility SNPs at 6 CRC risk loci. Relationships between genotypes and patient survival were examined using Cox regression analysis. In multivariate analysis, patients homozygous for the CRC risk allele of rs7013278 or rs7014346 (both at 8 q24) were only nominally significant for poorer overall survival compared to patients homozygous for the protective allele (hazard ratio = 2.20 and 1.96, respectively; P < 0.05). None of these associations, however, remained statistically significant after correction for multiple testing. The other nine susceptibility SNPs tested were not significantly associated with survival. Conclusions/Significance: We did not find evidence of association of CRC risk variants with patient survival.	[Hoskins, Janelle M.; Ong, Pei-Shi; Coleman, Clint A.; McLeod, Howard L.] Univ N Carolina, Eshelman Sch Pharm, Inst Pharmacogen & Individualized Therapy, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA; [Galanko, Joseph A.] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [McLeod, Howard L.] Univ N Carolina, Div Hematol & Oncol, Chapel Hill, NC USA; [McLeod, Howard L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hoskins, JM (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Inst Pharmacogen & Individualized Therapy, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA.	phaops@nus.edu.sg	Ong, Pei-Shi/X-8042-2019; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Institutes of Health (NIH) Pharmacogenetics Research Network [U01 GM63340]; NIH [U01 CA 093326, P50 CA 106991]; Center for Gastrointestinal Biology and Disease [P30 DK034987]; Department of Pharmacy, National University of Singapore; NATIONAL CANCER INSTITUTE [U01CA093326, P30CA016086, P50CA106991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM063340] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Pharmacogenetics Research Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Gastrointestinal Biology and Disease; Department of Pharmacy, National University of Singapore(National University of Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Pharmacogenetics Research Network (U01 GM63340). The NC CanCORS and GI SPORE were supported by NIH U01 CA 093326 and P50 CA 106991 respectively. The study also received support from the Center for Gastrointestinal Biology and Disease (P30 DK034987). PO was supported by the Department of Pharmacy, National University of Singapore. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cicek MS, 2009, CANCER EPIDEM BIOMAR, V18, P2492, DOI 10.1158/1055-9965.EPI-09-0362; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gruber SB, 2007, CANCER BIOL THER, V6, P1143, DOI 10.4161/cbt.6.7.4704; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Li L, 2008, CANCER EPIDEM BIOMAR, V17, P339, DOI 10.1158/1055-9965.EPI-07-0713; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Marsh S, 2004, J HUM GENET, V49, P579, DOI 10.1007/s10038-004-0183-y; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2010, CLIN CANCER RES, V16, P3754, DOI 10.1158/1078-0432.CCR-10-0439; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NAT GENET       0527, V41, P161; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41954	10.1371/journal.pone.0041954	http://dx.doi.org/10.1371/journal.pone.0041954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848671	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200134
J	Johansson, S; Povlsen, GK; Edvinsson, L				Johansson, Sara; Povlsen, Gro Klitgaard; Edvinsson, Lars			Expressional Changes in Cerebrovascular Receptors after Experimental Transient Forebrain Ischemia	PLOS ONE			English	Article							GLOBAL CEREBRAL-ISCHEMIA; UP-REGULATION; SUBARACHNOID HEMORRHAGE; INCOMPLETE ISCHEMIA; 2-VESSEL OCCLUSION; 5-HT1B RECEPTOR; BRAIN-INJURY; CA1 NEURONS; BLOOD-FLOW; RAT-BRAIN	Background: Global ischemic stroke is one of the most prominent consequences of cardiac arrest, since the diminished blood flow to the brain results in cell damage and sometimes permanently impaired neurological function. The post-arrest period is often characterised by cerebral hypoperfusion due to subacute hemodynamic disturbances, the pathophysiology of which are poorly understood. In two other types of stroke, focal ischemic stroke and subarachnoid hemorrhage, it has earlier been demonstrated that the expression of certain vasoconstrictor receptors is increased in cerebral arteries several days after the insult, a phenomenon that leads to increased contraction of cerebral arteries, reduced perfusion of the affected area and worsened ischemic damage. Based on these findings, the aim of the present study was to investigate if transient global cerebral ischemia is associated with upregulation of vasoconstrictive endothelin and 5-hydroxytryptamine receptors in cerebral arteries. Experimental transient forebrain ischemia of varying durations was induced in male wistar rats, followed by reperfusion for 48 hours. Neurological function was assessed daily by three different tests and cerebrovascular expression and contractile function of endothelin and 5-hydroxytryptamine receptors were evaluated by wire myography, immunohistochemistry and western blotting. Results: Transient forebrain ischemia induced neurological deficits as well as functional upregulation of vasoconstrictive ETB and 5-HT1B receptors in cerebral arteries supplying mid-and forebrain regions. No receptor upregulation was seen in arteries supplying the hindbrain. Immunohistochemical stainings and western blotting demonstrated expressional upregulation of these receptor subtypes in the mid-and forebrain arteries and confirmed that the receptors were located in the smooth muscle layer of the cerebral arteries. Conclusions: This study reveals a new pathophysiological aspect of global ischemic stroke, namely expressional upregulation of vasoconstrictor receptors in cerebral arteries two days after the insult, which might contribute to cerebral hypoperfusion and delayed neuronal damage after cardiac arrest.	[Johansson, Sara; Povlsen, Gro Klitgaard; Edvinsson, Lars] Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Edvinsson, Lars] Lund Univ, Dept Clin Sci, Div Expt Vasc Res, Lund, Sweden	University of Copenhagen; Lund University	Johansson, S (corresponding author), Glostrup Cty Hosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	saeljo01@regionh.dk		Edvinsson, Lars/0000-0002-1805-1346	Lundbeck Foundation; Danish Institute of Science and Technology; Danish National Research Council for Health and Disease; Swedish Research council; Heart and Lung Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Institute of Science and Technology; Danish National Research Council for Health and Disease; Swedish Research council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The study is financially supported by the Lundbeck Foundation, the Danish Institute of Science and Technology and the Danish National Research Council for Health and Disease, and the Swedish Research council and the Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar S, 2007, AM J PHYSIOL-HEART C, V293, pH3750, DOI 10.1152/ajpheart.00857.2007; BARONE FC, 1994, J CEREBR BLOOD F MET, V14, P337, DOI 10.1038/jcbfm.1994.41; BASS E, 1985, ANN INTERN MED, V103, P920, DOI 10.7326/0003-4819-103-6-920; Beg SAS, 2006, J CEREBR BLOOD F MET, V26, P846, DOI 10.1038/sj.jcbfm.9600236; Bendel O, 2005, BRAIN RES, V1033, P135, DOI 10.1016/j.brainres.2004.11.033; EKLOF B, 1972, ACTA PHYSIOL SCAND, V86, P155, DOI 10.1111/j.1748-1716.1972.tb05322.x; GROGAARD B, 1988, ACTA NEUROCHIR, V95, P136, DOI 10.1007/BF01790775; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Hansen-Schwartz J, 2003, J NEUROSURG, V99, P115, DOI 10.3171/jns.2003.99.1.0115; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Henriksson M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-7; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; Hoel NL, 2001, NEUROREPORT, V12, P1605, DOI 10.1097/00001756-200106130-00019; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; KAGSTROM E, 1983, J CEREBR BLOOD F MET, V3, P183, DOI 10.1038/jcbfm.1983.25; Kaundal RK, 2012, DRUG DISCOV TODAY, V17, P793, DOI 10.1016/j.drudis.2012.02.017; Larsen CC, 2011, J NEUROSURG, V114, P1143, DOI 10.3171/2010.6.JNS1018; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; McBean DE, 1998, GEN PHARMACOL-VASC S, V30, P431, DOI 10.1016/S0306-3623(97)00284-X; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; NUNN J, 1994, BEHAV BRAIN RES, V65, P1, DOI 10.1016/0166-4328(94)90069-8; PALJARVI L, 1984, ACTA NEUROPATHOL, V64, P89, DOI 10.1007/BF00695571; Popp E, 2006, NEUROL CLIN, V24, P73, DOI 10.1016/j.ncl.2005.10.008; Puttgen HA, 2009, CURR OPIN CRIT CARE, V15, P118, DOI 10.1097/MCC.0b013e328326077c; Rasmussen MNP, 2009, J CEREB BLOOD FLOW M, V29, P166; Richmond T S, 1997, AACN Clin Issues, V8, P171, DOI 10.1097/00044067-199705000-00002; Schneider A, 2009, ANESTH ANALG, V108, P971, DOI 10.1213/ane.0b013e318193ca99; SMITH ML, 1988, ACTA NEUROPATHOL, V76, P253, DOI 10.1007/BF00687772; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; Stenman E, 2002, STROKE, V33, P2311, DOI 10.1161/01.STR.0000028183.04277.32; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Zacharia BE, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/124384	36	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41852	10.1371/journal.pone.0041852	http://dx.doi.org/10.1371/journal.pone.0041852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848635	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200114
J	Ng, H; Smith, DJ; Nagley, P				Ng, Heling; Smith, Danielle J.; Nagley, Phillip			Application of Flow Cytometry to Determine Differential Redistribution of Cytochrome c and Smac/DIABLO from Mitochondria during Cell Death Signaling	PLOS ONE			English	Article							INDUCED APOPTOSIS; PROAPOPTOTIC BAX; BCL-2 FAMILY; RELEASE; PROTEINS; ACTIVATION; MECHANISM; MEMBRANE; SURVIVIN; GATEWAY	Mitochondrially mediated apoptosis is characterized by redistribution of proteins from mitochondria to cytoplasm following permeabilization of the outer mitochondrial membrane. We applied flow cytometry to quantify simultaneously the redistribution of two apoptogenic proteins, cytochrome c (cyt c) and Smac/DIABLO (Smac). Mammalian cells were treated with digitonin that selectively permeabilizes the plasma membrane. Following fixation, treated cells were infused successively with primary and secondary antibodies (the latter fluorescently tagged) enabling independent detection of cyt c and Smac. Digitonin-treated cells that retain cyt c or Smac in mitochondria generate strong fluorescence signals in flow cytometry. Cells in which cyt c or Smac have transited the outer mitochondrial membrane show greatly reduced fluorescence because the proteins are lost from the digitonin-permeabilized cells. Quantitative flow cytometry revealed that in 143B TK- cells treated with staurosporine, cyt c and Smac exit mitochondria asymmetrically, with cyt c redistribution preceding that of Smac. However, in HeLa cells likewise treated, cyt c and Smac exit mitochondria concurrently. Under other conditions of apoptotic induction, for example, 143B TK- cells treated with MT-21 (an apoptotic inducer that binds to the mitochondrial adenine nucleotide transporter), redistribution of Smac precedes that of cyt c. The various patterns of redistribution of these proteins were confirmed by immunocytochemical analysis and confocal microscopy. We conclude that flow cytometry can be employed effectively to quantify simultaneously the redistribution of cyt c and Smac from mitochondria to the cytosol. Moreover, differential redistribution of cyt c and Smac occurs under various conditions, thereby reflecting constraints on availability of these proteins to exit mitochondria after permeabilization of the outer membrane.	[Ng, Heling] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia	Monash University; Monash University	Ng, H (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	phillip.nagley@monash.edu			Australian Research Council (ARC); ARC Centre of Excellence in Structural and Functional Microbial Genomics [CE0348193]	Australian Research Council (ARC)(Australian Research Council); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council)	Funding was obtained by a grant from the Australian Research Council (ARC), www.arc.gov.au: ARC Centre of Excellence in Structural and Functional Microbial Genomics (CE0348193) to P. Nagley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Ceballos-Cancino G, 2007, ONCOGENE, V26, P7569, DOI 10.1038/sj.onc.1210560; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hardwick JM, 2002, MOL CELL, V10, P963, DOI 10.1016/S1097-2765(02)00751-7; Kim JY, 2006, BIOCHEM BIOPH RES CO, V350, P949, DOI 10.1016/j.bbrc.2006.09.143; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lim MLR, 2006, EXP CELL RES, V312, P1174, DOI 10.1016/j.yexcr.2006.01.026; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Machida K, 2002, J BIOL CHEM, V277, P31243, DOI 10.1074/jbc.M204564200; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smith DJ, 2008, IUBMB LIFE, V60, P383, DOI 10.1002/iub.44; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Watabe M, 2000, CANCER RES, V60, P5214; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhou LL, 2005, APOPTOSIS, V10, P289, DOI 10.1007/s10495-005-0803-9	29	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42298	10.1371/journal.pone.0042298	http://dx.doi.org/10.1371/journal.pone.0042298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848756	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200193
J	Prendergast, BJ; Zucker, I				Prendergast, Brian J.; Zucker, Irving			Photoperiodic Influences on Ultradian Rhythms of Male Siberian Hamsters	PLOS ONE			English	Article							VOLE MICROTUS-ARVALIS; LOMB-SCARGLE METHOD; SPACED TIME-SERIES; CIRCADIAN-RHYTHMS; PHODOPUS-SUNGORUS; COMMON VOLE; SUPRACHIASMATIC NUCLEUS; DJUNGARIAN HAMSTER; GENE-EXPRESSION; BODY-TEMPERATURE	Seasonal changes in mammalian physiology and behavior are proximately controlled by the annual variation in day length. Long summer and short winter day lengths markedly alter the amplitude of endogenous circadian rhythms and may affect ultradian oscillations, but the threshold photoperiods for inducing these changes are not known. We assessed the effects of short and intermediate day lengths and changes in reproductive physiology on circadian and ultradian rhythms of locomotor activity in Siberian hamsters. Males were maintained in a long photoperiod from birth (15 h light/day; 15 L) and transferred in adulthood to 1 of 7 experimental photoperiods ranging from 14 L to 9 L. Decreases in circadian rhythm (CR) robustness, mesor and amplitude were evident in photoperiods <= 14 L, as were delays in the timing of CR acrophase and expansion of nocturnal activity duration. Nocturnal ultradian rhythms (URs) were comparably prevalent in all day lengths, but 15 L markedly inhibited the expression of light-phase URs. The period (tau'), amplitude and complexity of URs increased in day lengths <= 13 L. Among hamsters that failed to undergo gonadal regression in short day lengths (nonresponders), tau' of the dark-phase UR was longer than in photoresponsive hamsters; in 13 L the incidence and amplitude of light-phase URs were greater in hamsters that did not undergo testicular regression. Day lengths as long as 14 L were sufficient to trigger changes in the waveform of CRs without affecting UR waveform. The transition from a long- to a short-day ultradian phenotype occurred for most UR components at day lengths of 12 L-13 L, thereby establishing different thresholds for CR and UR responses to day length. At the UR-threshold photoperiod of 13 L, differences in gonadal status were largely without effect on most UR parameters.	[Prendergast, Brian J.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Prendergast, Brian J.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Chicago; University of Chicago; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Prendergast, BJ (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	prendergast@uchicago.edu			National Institutes of Health [AI-67406]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant AI-67406, from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Carr AJF, 2003, CURR BIOL, V13, P1543, DOI 10.1016/S0960-9822(03)00619-5; DAAN S, 1978, J COMP PHYSIOL, V127, P215, DOI 10.1007/BF01350112; DUNCAN MJ, 1984, J EXP ZOOL, V230, P89, DOI 10.1002/jez.1402300112; EASTMAN CI, 1984, PHYSIOL BEHAV, V32, P357, DOI 10.1016/0031-9384(84)90248-8; ELLIOTT JA, 1994, J COMP PHYSIOL A, V174, P469; ESKES GA, 1978, P NATL ACAD SCI USA, V75, P1034, DOI 10.1073/pnas.75.2.1034; Evans JA, 2004, AM J PHYSIOL-REG I, V286, pR539, DOI 10.1152/ajpregu.00456.2003; Freeman DA, 1997, J BIOL RHYTHM, V12, P100, DOI 10.1177/074873049701200202; Fuentes-Pardo B., 2008, P147, DOI 10.1007/978-1-4020-8352-5_6; GERKEMA MP, 1993, J BIOL RHYTHM, V8, P151, DOI 10.1177/074873049300800205; GERKEMA MP, 1990, J BIOL RHYTHM, V5, P81, DOI 10.1177/074873049000500201; GORMAN MR, 1995, BIOL REPROD, V53, P116, DOI 10.1095/biolreprod53.1.116; Gorman MR, 1997, J BIOL RHYTHM, V12, P122, DOI 10.1177/074873049701200204; Halle S, 2006, FOLIA PRIMATOL, V77, P15, DOI 10.1159/000089693; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; Hoffmann K., 1982, P297; HOOGENBOOM I, 1984, OECOLOGIA, V61, P18, DOI 10.1007/BF00379084; ILLNEROVA H, 1984, NEUROENDOCRINOLOGY, V38, P226, DOI 10.1159/000123895; Jasnow AM, 2000, HORM BEHAV, V38, P102, DOI 10.1006/hbeh.2000.1604; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Knobil E, 1999, NEWS PHYSIOL SCI, V14, P1; Kriegsfeld Lance J., 2002, P33; LEE TM, 1986, AM J PHYSIOL, V250, pR831, DOI 10.1152/ajpregu.1986.250.5.R831; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Lincoln GA, 2002, REPRODUCTION, P131; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; MORIN LP, 1981, PHYSIOL BEHAV, V26, P825, DOI 10.1016/0031-9384(81)90106-2; NELSON RJ, 1987, AM NAT, V130, P350, DOI 10.1086/284715; Oklejewicz M, 2001, CHRONOBIOL INT, V18, P657, DOI 10.1081/CBI-100106079; Paul MJ, 2009, AM J PHYSIOL-REG I, V296, pR1613, DOI 10.1152/ajpregu.91047.2008; Prendergast BJ, 2000, P NATL ACAD SCI USA, V97, P5586, DOI 10.1073/pnas.100098597; Prendergast BJ, 2001, Q REV BIOL, V76, P293, DOI 10.1086/393989; Prendergast BJ, 2012, J BIOL RHYT IN PRESS; Prendergast BJ, 2012, J BIOL RHYTHM, V27, P246, DOI 10.1177/0748730412441315; Prendergast BJ, 2009, J BIOL RHYTHM, V24, P509, DOI 10.1177/0748730409349714; PUCHALSKI W, 1988, J COMP PHYSIOL A, V162, P309, DOI 10.1007/BF00606119; PUCHALSKI W, 1986, J COMP PHYSIOL A, V159, P7, DOI 10.1007/BF00612490; REFINETTI R, 1994, J THERM BIOL, V19, P269, DOI 10.1016/0306-4565(94)90050-7; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Refinetti Roberto, 1996, Animal Biology, V5, P111; RUBY NF, 1992, AM J PHYSIOL, V263, pR353, DOI 10.1152/ajpregu.1992.263.2.R353; Ruby NF, 1996, AM J PHYSIOL-REG I, V271, pR881, DOI 10.1152/ajpregu.1996.271.4.R881; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; RUSAK B, 1977, J COMP PHYSIOL, V118, P145, DOI 10.1007/BF00611819; SCHLATT S, 1995, BIOL REPROD, V53, P1169, DOI 10.1095/biolreprod53.5.1169; Schwartz WJ, 2011, P NATL ACAD SCI USA, V108, P17219, DOI 10.1073/pnas.1107848108; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; SUMOVA A, 1995, P NATL ACAD SCI USA, V92, P7754, DOI 10.1073/pnas.92.17.7754; van der Veen DR, 2006, P NATL ACAD SCI USA, V103, P3393, DOI 10.1073/pnas.0507825103; Van Dongen HPA, 2001, BIOL RHYTHM RES, V32, P347, DOI 10.1076/brhm.32.3.347.1348; van Dongen HPA, 1999, BIOL RHYTHM RES, V30, P149, DOI 10.1076/brhm.30.2.149.1424; van Oort BEH, 2007, NATURWISSENSCHAFTEN, V94, P183, DOI 10.1007/s00114-006-0174-2; Veldhuis J. D., 2008, P229, DOI 10.1007/978-1-4020-8352-5_10; WOLFE AM, 1995, BIOL REPROD, V53, P724, DOI 10.1095/biolreprod53.3.724; WOLLNIK F, 1989, AM J PHYSIOL, V256, pR1027, DOI 10.1152/ajpregu.1989.256.5.R1027; Yates F. E., 2008, P249, DOI 10.1007/978-1-4020-8352-5_11	59	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41723	10.1371/journal.pone.0041723	http://dx.doi.org/10.1371/journal.pone.0041723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848579	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200096
J	Wang, F; Li, QR; Wang, CY; Tang, C; Li, JS				Wang, Fan; Li, Qiurong; Wang, Chenyang; Tang, Chun; Li, Jieshou			Dynamic Alteration of the Colonic Microbiota in Intestinal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; REAL-TIME PCR; BACTERIAL TRANSLOCATION; BARRIER FUNCTION; GUT FLORA; COLITIS; RATS; INFLAMMATION; POPULATIONS; MICROFLORA	Background: Intestinal ischemia-reperfusion (I/R) plays an important role in critical illnesses. Gut flora participate in the pathogenesis of the injury. This study is aimed at unraveling colonic microbiota alteration pattern and identifying specific bacterial species that differ significantly as well as observing colonic epithelium change in the same injury model during the reperfusion time course. Methodology/Principal Findings: Denaturing gradient gel electrophoresis (DGGE) was used to monitor the colonic microbiota of control rats and experimental rats that underwent 0.5 hour ischemia and 1, 3, 6, 12, 24, and 72 hours following reperfusion respectively. The microbiota similarity, bacterial diversity and species that characterized the dysbiosis were estimated based on the DGGE profiles using a combination of statistical approaches. The interested bacterial species in the gel were cut and sequenced and were subsequently quantified and confirmed with real-time PCR. Meanwhile, the epithelial barrier was checked by microscopy and D-lactate analysis. Colonic flora changed early and differed significantly at 6 hours after reperfusion and then started to recover. The shifts were characterized by the increase of Escherichia coli and Prevotella oralis, and Lactobacilli proliferation together with epithelia healing. Conclusion/Significance: This study shows for the first time that intestinal ischemia-reperfusion results in colonic flora dysbiosis that follows epithelia damage, and identifies the bacterial species that contribute most.	[Wang, Fan; Li, Qiurong; Wang, Chenyang; Tang, Chun; Li, Jieshou] Nanjing Univ, Jinling Hosp, Sch Med, Res Inst Gen Surg, Nanjing 210008, Peoples R China	Nanjing University	Wang, F (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Res Inst Gen Surg, Nanjing 210008, Peoples R China.	lijieshoumed@gmail.com	Li, jie/GXG-4583-2022		Key Project of National Natural Science Foundation in China [30830098]; National Natural Science Foundation in China [81070375]; National High-tech R&D Program (863 Program) of China [2012AA021007]; National Basic Research Program (973 Program) in China [2009CB522405]; Scientific Research Fund in Jiangsu Province [BK2009317]	Key Project of National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); National Basic Research Program (973 Program) in China(National Basic Research Program of China); Scientific Research Fund in Jiangsu Province	This work was supported by the Key Project of National Natural Science Foundation in China (30830098), National Natural Science Foundation in China (81070375), National High-tech R&D Program (863 Program) of China (2012AA021007), National Basic Research Program (973 Program) in China (no. 2009CB522405) and Scientific Research Fund in Jiangsu Province (BK2009317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Gastroenterology, V118, P951; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Cicalese L, 2001, TRANSPLANTATION, V71, P1414, DOI 10.1097/00007890-200105270-00010; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; CUMMINGS JH, 1987, AM J CLIN NUTR, V45, P1243, DOI 10.1093/ajcn/45.5.1243; Di Paola R, 2005, EUR J PHARMACOL, V507, P281, DOI 10.1016/j.ejphar.2004.11.041; Diebel LN, 2003, SURGERY, V134, P574, DOI 10.1016/S0039-6060(03)00302-7; Doty JM, 2002, J TRAUMA, V52, P13, DOI 10.1097/00005373-200201000-00005; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eleftheriadis E, 1996, WORLD J SURG, V20, P11, DOI 10.1007/s002689900002; FRANKEL WL, 1994, GASTROENTEROLOGY, V106, P375, DOI 10.1016/0016-5085(94)90595-9; Garcez AS, 2007, LASER SURG MED, V39, P59, DOI 10.1002/lsm.20415; Garcia-Lafuente A, 2001, GUT, V48, P503, DOI 10.1136/gut.48.4.503; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haarman M, 2006, APPL ENVIRON MICROB, V72, P2359, DOI 10.1128/AEM.72.4.2359-2365.2006; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; Jiang HT, 2011, J SURG RES, V168, P127, DOI 10.1016/j.jss.2009.07.035; Kourbeti I, 2010, J MED CASE REPORTS, V4, P1; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Li QR, 2008, FEBS J, V275, P6022, DOI 10.1111/j.1742-4658.2008.06731.x; Li QR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020460; Li QR, 2009, J CELL MOL MED, V13, P4061, DOI 10.1111/j.1582-4934.2009.00975.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Mao YL, 1996, GASTROENTEROLOGY, V111, P334, DOI 10.1053/gast.1996.v111.pm8690198; MARINA M, 1993, CLIN INFECT DIS, V16, pS256, DOI 10.1093/clinids/16.Supplement_4.S256; MARSHALL JC, 1988, ARCH SURG-CHICAGO, V123, P309; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mondani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025771; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Morowitz MJ, 2011, ANN SURG, V253, P1094, DOI 10.1097/SLA.0b013e31821175d7; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Quaglio G, 1999, CLIN INFECT DIS, V28, P685, DOI 10.1086/517218; Reddy BS, 2007, CLIN NUTR, V26, P208, DOI 10.1016/j.clnu.2006.10.006; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SAKAI L, 1980, AM J SURG, V140, P755, DOI 10.1016/0002-9610(80)90111-7; Savarrio L, 2005, J DENT, V33, P293, DOI 10.1016/j.jdent.2004.09.008; Shimizu K, 2006, J TRAUMA, V60, P126, DOI 10.1097/01.ta.0000197374.99755.fe; Shimizu K, 2011, DIGEST DIS SCI, V56, P1171, DOI 10.1007/s10620-010-1418-8; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tadros T, 2003, ANN SURG, V237, P101, DOI 10.1097/00000658-200301000-00014; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Zhang Q, 2010, MICROB PATHOGENESIS, V48, P28, DOI 10.1016/j.micpath.2009.10.002	53	55	59	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42027	10.1371/journal.pone.0042027	http://dx.doi.org/10.1371/journal.pone.0042027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848694	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200147
J	Kosti, V; Lambrinidis, G; Myrianthopoulos, V; Diallinas, G; Mikros, E				Kosti, Vasiliki; Lambrinidis, George; Myrianthopoulos, Vassilios; Diallinas, George; Mikros, Emmanuel			Identification of the Substrate Recognition and Transport Pathway in a Eukaryotic Member of the Nucleobase-Ascorbate Transporter (NAT) Family	PLOS ONE			English	Article							YGFO XANTHINE PERMEASE; CYSTEINE-SCANNING ANALYSIS; ASPERGILLUS-NIDULANS; PURINE TRANSPORTERS; SIGNATURE MOTIF; FORCE-FIELD; UAPA; SPECIFICITY; BACTERIAL; MECHANISM	Using the crystal structure of the uracil transporter UraA of Escherichia coli, we constructed a 3D model of the Aspergillus nidulans uric acid-xanthine/H+ symporter UapA, which is a prototype member of the Nucleobase-Ascorbate Transporter (NAT) family. The model consists of 14 transmembrane segments (TMSs) divided into a core and a gate domain, the later being distinctly different from that of UraA. By implementing Molecular Mechanics (MM) simulations and quantitative structure-activity relationship (SAR) approaches, we propose a model for the xanthine-UapA complex where the substrate binding site is formed by the polar side chains of residues E356 (TMS8) and Q408 (TMS10) and the backbones of A407 (TMS10) and F155 (TMS3). In addition, our model shows several polar interactions between TMS1-TMS10, TMS1-TMS3, TMS8-TMS10, which seem critical for UapA transport activity. Using extensive docking calculations we identify a cytoplasm-facing substrate trajectory (D360, A363, G411, T416, R417, V463 and A469) connecting the proposed substrate binding site with the cytoplasm, as well as, a possible outward-facing gate leading towards the substrate major binding site. Most importantly, re-evaluation of the plethora of available and analysis of a number of herein constructed UapA mutations strongly supports the UapA structural model. Furthermore, modeling and docking approaches with mammalian NAT homologues provided a molecular rationale on how specificity in this family of carriers might be determined, and further support the importance of selectivity gates acting independently from the major central substrate binding site.	[Kosti, Vasiliki; Diallinas, George] Univ Athens, Fac Biol, Athens, Greece; [Lambrinidis, George; Myrianthopoulos, Vassilios; Mikros, Emmanuel] Univ Athens, Sch Pharm, Athens, Greece	National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Kosti, V (corresponding author), Univ Athens, Fac Biol, Athens, Greece.	diallina@biol.uoa.gr	Diallinas, George/AAE-8457-2019; Lambrinidis, George/AAD-2196-2020; Mikros, Emmanuel/E-4223-2017; Myrianthopoulos, Vassilios/AGN-8510-2022	Diallinas, George/0000-0002-3426-726X; Lambrinidis, George/0000-0002-2820-9338; Mikros, Emmanuel/0000-0002-5984-5169; Myrianthopoulos, Vassilios/0000-0001-8359-9634	John S. Latsis Public Benefit Foundation; European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II, Investing in knowledge society through the European Social Fund	John S. Latsis Public Benefit Foundation; European Union (European Social Fund-ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II, Investing in knowledge society through the European Social Fund	Work in the laboratory of G. D. was supported by the John S. Latsis Public Benefit Foundation. The research performed by V. K. has been co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Heracleitus II, Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amillis S, 2001, J MOL BIOL, V313, P765, DOI 10.1006/jmbi.2001.5087; Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; ARST HN, 1975, NATURE, V254, P31, DOI 10.1038/254031a0; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Conde A, 2010, INT J BIOCHEM CELL B, V42, P857, DOI 10.1016/j.biocel.2009.12.012; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; DIALLINAS G, 1989, GENETICS, V122, P341; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Diallinas G, 2008, CHANNELS, V2, P363, DOI 10.4161/chan.2.5.6902; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; GORFINKIEL L, 1993, J BIOL CHEM, V268, P23376; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; GREGORET LM, 1991, PROTEINS, V9, P99, DOI 10.1002/prot.340090204; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaback HR, 2011, J MEMBRANE BIOL, V239, P85, DOI 10.1007/s00232-010-9327-5; Karatza P, 2006, FEBS J, V273, P310; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kolossavary I, 1999, J COMPUT CHEM, V20, P1671, DOI 10.1002/(SICI)1096-987X(19991130)20:15<1671::AID-JCC7>3.0.CO;2-Y; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2003, J MICROBIOL METH, V55, P687, DOI 10.1016/S0167-7012(03)00208-2; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; Leung J, 2012, MOL MEMBRANE BIOL; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Meintanis C, 2000, MOL MEMBR BIOL, V17, P47; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Naftalin RJ, 2010, J MEMBRANE BIOL, V234, P75, DOI 10.1007/s00232-010-9228-7; Nielsen S, 2009, BIOORGAN MED CHEM, V17, P4900, DOI 10.1016/j.bmc.2009.06.007; Noskov SY, 2008, PROTEINS, V73, P851, DOI 10.1002/prot.22108; Nyola A, 2010, CURR OPIN STRUC BIOL, V20, P415, DOI 10.1016/j.sbi.2010.05.007; Pantazopoulou A, 2006, MOL MEMBR BIOL, V23, P337, DOI 10.1080/09687860600738239; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Schultes NP, 1996, PLANT CELL, V8, P463, DOI 10.1105/tpc.8.3.463; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Smirnova I, 2011, P NATL ACAD SCI USA, V108, P15147, DOI 10.1073/pnas.1112157108; Soares-Silva I, 2011, MOL MICROBIOL, V81, P805, DOI 10.1111/j.1365-2958.2011.07729.x; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; VEDANI A, 1990, J AM CHEM SOC, V112, P4759, DOI 10.1021/ja00168a021; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Zbinden P, 1998, QUANT STRUCT-ACT REL, V17, P122, DOI 10.1002/(SICI)1521-3838(199804)17:02<122::AID-QSAR122>3.3.CO;2-C; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	50	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41939	10.1371/journal.pone.0041939	http://dx.doi.org/10.1371/journal.pone.0041939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848666	Green Published, gold			2022-12-27	WOS:000306806600145
J	Liu, QL; Rehman, H; Shi, YJ; Krishnasamy, Y; Lemasters, JJ; Smith, CD; Zhong, Z				Liu, Qinlong; Rehman, Hasibur; Shi, Yanjun; Krishnasamy, Yasodha; Lemasters, John J.; Smith, Charles D.; Zhong, Zhi			Inhibition of Sphingosine Kinase-2 Suppresses Inflammation and Attenuates Graft Injury after Liver Transplantation in Rats	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; HEPATIC ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION INJURY; RETRACTED ARTICLE. SEE; NF-KAPPA-B; TNF-ALPHA; N-METHYL-4-ISOLEUCINE CYCLOSPORINE; PRIMARY NONFUNCTION; LYMPHOID ORGANS; COLD ISCHEMIA	Inflammation mediates/promotes graft injury after liver transplantation (LT). This study investigated the roles of sphingosine kinase-2 (SK2) in inflammation after LT. Liver grafts were stored in UW solution with and without ABC294640 (100 mu M), a selective inhibitor of SK2, before implantation. Hepatic sphingosine-1-phosphate (S1P) levels increased similar to 4-fold after LT, which was blunted by 40% by ABC294640. Hepatic toll-like receptor-4 (TLR4) expression and nuclear factor-kappa B (NF-kappa B) p65 subunit phosphorylation elevated substantially after transplantation. The pro-inflammatory cytokines/chemokines tumor necrosis factor-a, interleukin-1 beta and C-X-C motif chemokine 10 mRNAs increased 5.9-fold, 6.1-fold and 16-fold, respectively following transplantation, while intrahepatic adhesion molecule-1 increased 5.7-fold and monocytes/macrophage and neutrophil infiltration and expansion of residential macrophage population increased 7.8-13.4 fold, indicating enhanced inflammation. CD4+ T cell infiltration and interferon-gamma production also increased. ABC294640 blunted TLR4 expression by 60%, NF-kappa B activation by 84%, proinflammatory cytokine/chemokine production by 45-72%, adhesion molecule expression by 54% and infiltration of monocytes/macrophages and neutrophils by 62-67%. ABC294640 also largely blocked CD4+ T cell infiltration and interferon-c production. Focal necrosis and apoptosis occurred after transplantation with serum alanine aminotransferase (ALT) reaching similar to 6000 U/L and serum total bilirubin elevating to similar to 1.5 mg/dL. Inhibition of SK2 by ABC294640 blunted necrosis by 57%, apoptosis by 74%, ALT release by similar to 68%, and hyperbilirubinemia by 74%. Most importantly, ABC294640 also increased survival from similar to 25% to similar to 85%. In conclusion, SK2 plays an important role in hepatic inflammation responses and graft injury after cold storage/transplantation and represents a new therapeutic target for liver graft failure.	[Liu, Qinlong; Rehman, Hasibur; Shi, Yanjun; Krishnasamy, Yasodha; Lemasters, John J.; Smith, Charles D.; Zhong, Zhi] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA; [Liu, Qinlong; Rehman, Hasibur; Shi, Yanjun; Krishnasamy, Yasodha; Lemasters, John J.; Smith, Charles D.; Zhong, Zhi] Med Univ S Carolina, Dept Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lemasters, John J.; Zhong, Zhi] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Smith, Charles D.] Apogee Biotechnol Corp, Hummelstown, PA USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Liu, QL (corresponding author), Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health [DK84632, DK70844, DK70844S1, DK37034, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R41DK084632, R01DK037034, R37DK037034, R01DK070844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, by Grants DK84632, DK70844, DK70844S1, and DK37034 from the National Institutes of Health. Animals were housed in the animal facility of the Medical University of South Carolina supported by a grant C06 RR015455 from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Alqahtani SA, 2012, CURR OPIN GASTROEN, V28, P230, DOI 10.1097/MOG.0b013e3283527f16; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Brock RW, 2001, AM J PHYSIOL-GASTR L, V280, pG279, DOI 10.1152/ajpgi.2001.280.2.G279; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; Caldwell CC, 2007, J LEUKOCYTE BIOL, V82, P457, DOI 10.1189/jlb.0107062; Chen H, 2007, HEPATOB PANCREAT DIS, V6, P141; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Conzelmann LO, 2006, TRANSPLANTATION, V82, P1214, DOI 10.1097/01.tp.0000239190.95190.5e; Deutschman DH, 2003, AM HEART J, V146, P62, DOI 10.1016/S0002-8703(03)00118-2; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Duan HF, 2007, HUM GENE THER, V18, P1119, DOI 10.1089/hum.2007.036; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Fondevila C, 2008, LIVER TRANSPLANT, V14, P1133, DOI 10.1002/lt.21496; FOX IJ, 1993, AM J GASTROENTEROL, V88, P1876; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; French KJ, 2003, CANCER RES, V63, P5962; FURUKAWA H, 1991, TRANSPLANTATION, V51, P1000, DOI 10.1097/00007890-199105000-00013; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Gon Y, 2005, P NATL ACAD SCI USA, V102, P9270, DOI 10.1073/pnas.0501997102; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; Hanschen M, 2008, TRANSPLANTATION, V86, P710, DOI 10.1097/TP.0b013e3181821aa7; Harland RC, 1996, J HEPATOL, V25, P248, DOI 10.1016/S0168-8278(96)80082-1; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Husted TL, 2006, CURR PHARM DESIGN, V12, P2867, DOI 10.2174/138161206777947597; Jaeschke H, 2003, J INVEST SURG, V16, P127, DOI 10.1080/08941930390205773; Jo SK, 2008, KIDNEY INT; Kaczorowski David J, 2009, Front Biosci (Elite Ed), V1, P91; Kato A, 2000, INFLAMM RES, V49, P275, DOI 10.1007/PL00000207; Kato A, 2003, HEPATOLOGY, V37, P304, DOI 10.1053/jhep.2003.50075; Kemmer N, 2007, TRANSPL P, V39, P1477, DOI 10.1016/j.transproceed.2006.11.012; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Lai WQ, 2008, J IMMUNOL, V180, P4323, DOI 10.4049/jimmunol.180.6.4323; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lemasters JJ, 2001, TRANSPLANTATION LIVE, P251; LIMAYE V, 2009, CELL MOL BIOL LETT; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; MacKinnon AC, 2002, J IMMUNOL, V169, P6394, DOI 10.4049/jimmunol.169.11.6394; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; MUROHARA T, 1995, AM J PHYSIOL-HEART C, V269, pH504, DOI 10.1152/ajpheart.1995.269.2.H504; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Park SW, 2010, SHOCK, V33, P31, DOI 10.1097/SHK.0b013e3181c02c1f; PENG XX, 1995, TRANSPLANTATION, V59, P1537, DOI 10.1097/00007890-199506150-00006; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Santos M, 2009, J ANAT, V214, P744, DOI 10.1111/j.1469-7580.2009.01055.x; Schrage A, 2008, HEPATOLOGY, V48, P1262, DOI 10.1002/hep.22443; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shen XD, 2007, LIVER TRANSPLANT, V13, P1435, DOI 10.1002/lt.21251; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Stachlewitz RF, 1998, TRANSPLANT INT, V11, P353, DOI 10.1111/j.1432-2277.1998.tb00817.x; Theruvath TP, 2008, AM J TRANSPLANT, V8, P1819, DOI 10.1111/j.1600-6143.2008.02336.x; Theruvath TP, 2008, HEPATOLOGY, V47, P236, DOI 10.1002/hep.21912; Thurman R G, 1998, Langenbecks Arch Chir Suppl Kongressbd, V115, P185; Thurman RG, 1995, FALK SYMP, V78, P185; THURMAN RG, 1995, CELLS OF THE HEPATIC SINUSOID, VOL 5, P219; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vessey DA, 2006, MED SCI MONITOR, V12, pBR318; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Wertheim JA, 2011, AM J TRANSPLANT, V11, P1773, DOI 10.1111/j.1600-6143.2011.03587.x; Wertheim JA, 2012, CURR OPIN ORGAN TRAN, V17, P235, DOI 10.1097/MOT.0b013e3283534ec9; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhai YA, 2008, HEPATOLOGY, V47, P207, DOI 10.1002/hep.21986; Zhao Y, 2004, AM J TRANSPLANT, V4, P1399, DOI 10.1111/j.1600-6143.2004.00527.x; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646; Zhong Z, 1996, Liver Transpl Surg, V2, P383, DOI 10.1002/lt.500020509; Zhong Z, 2002, AM J PHYSIOL-GASTR L, V283, pG957, DOI 10.1152/ajpgi.00216.2001; Zhong Z, 1997, MOL PHARMACOL, V52, P912, DOI 10.1124/mol.52.5.912; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhu P, 2011, HUM GENE THER, V22, P853, DOI 10.1089/hum.2010.145; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698	87	19	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41834	10.1371/journal.pone.0041834	http://dx.doi.org/10.1371/journal.pone.0041834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848628	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600132
J	Mitra, S; Lukianov, S; Ruiz, WG; Cosentino, CC; Sanker, S; Traub, LM; Hukriede, NA; Apodaca, G				Mitra, Shalini; Lukianov, Stefan; Ruiz, Wily G.; Cosentino, Chiara Cianciolo; Sanker, Subramaniam; Traub, Linton M.; Hukriede, Neil A.; Apodaca, Gerard			Requirement for a Uroplakin 3a-Like Protein in the Development of Zebrafish Pronephric Tubule Epithelial Cell Function, Morphogenesis, and Polarity	PLOS ONE			English	Article							BARRIER FUNCTION; VESICOURETERAL REFLUX; III GENE; MUTATIONS; SYSTEM; KIDNEY; BIOLOGY; XENOPUS; EZRIN; FERTILIZATION	Uroplakin (UP)3a is critical for urinary tract development and function; however, its role in these processes is unknown. We examined the function of the UP3a-like protein Upk3l, which was expressed at the apical surfaces of the epithelial cells that line the pronephric tubules (PTs) of the zebrafish pronephros. Embryos treated with upk3l-targeted morpholinos showed decreased pronephros function, which was attributed to defects in PT epithelial cell morphogenesis and polarization including: loss of an apical brush border and associated phospho-ERM proteins, apical redistribution of the basolateral Na+/K+-ATPase, and altered or diminished expression of the apical polarity complex proteins Prkcz (atypical protein kinase C zeta) and Pard3 (Par3). Upk3l missing its C-terminal cytoplasmic domain or containing mutations in conserved tyrosine or proline residues did not rescue, or only partially rescued the effects of Upk3l depletion. Our studies indicate that Upk3l promotes epithelial polarization and morphogenesis, likely by forming or stimulating interactions with cytoplasmic signaling or polarity proteins, and that defects in this process may underlie the pathology observed in UP3a knockout mice or patients with renal abnormalities that result from altered UP3a expression.	[Mitra, Shalini; Lukianov, Stefan; Ruiz, Wily G.; Apodaca, Gerard] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA; [Cosentino, Chiara Cianciolo; Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Sanker, Subramaniam; Traub, Linton M.; Apodaca, Gerard] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mitra, S (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA.	gla6@pitt.edu	Apodaca, Gerard/HCJ-0048-2022	Traub, Linton/0000-0002-1303-0298	United States National Institutes of Health [R37-DK54425, R01-DK077777, P30-DK079307, DK069403, R01-DK53249]; Model Organisms and the Urinary Tract Epithelial Imaging Core of the Pittsburgh Center for Kidney Research [P30-DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054425, P30DK079307, R01DK069403, R01DK053249, R01DK077777] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Model Organisms and the Urinary Tract Epithelial Imaging Core of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States National Institutes of Health grants R37-DK54425, R01-DK077777, and P30-DK079307 (to G. A.), DK069403 (to N.H.), R01-DK53249 (to L. T.), and by the Model Organisms and the Urinary Tract Epithelial Imaging Core of the Pittsburgh Center for Kidney Research (P30-DK079307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Cianciolo Cosentino C, 2010, JOVE; Cibrian-Uhalte E, 2007, J CELL BIOL, V176, P223, DOI 10.1083/jcb.200606116; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; DENT JA, 1989, DEVELOPMENT, V105, P61; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond IA, 2000, PEDIATR NEPHROL, V14, P428, DOI 10.1007/s004670050788; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Giltay JC, 2004, J UROLOGY, V171, P931, DOI 10.1097/01.ju.0000094802.50650.3d; Hasan AKMM, 2005, DEV BIOL, V286, P483, DOI 10.1016/j.ydbio.2005.08.020; Hentschel DM, 2005, AM J PHYSIOL-RENAL, V288, pF923, DOI 10.1152/ajprenal.00386.2004; Hodges SJ, 2008, J UROLOGY, V179, P2046, DOI 10.1016/j.juro.2007.12.039; Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Jenkins D, 2007, KIDNEY INT, V71, P195, DOI 10.1038/sj.ki.5002053; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kiener TK, 2008, DEV BIOL, V316, P36, DOI 10.1016/j.ydbio.2007.12.047; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Mendelsohn C, 2004, J CLIN INVEST, V113, P957, DOI 10.1172/JCI21402; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Oztan Asli, 2008, V440, P157, DOI 10.1007/978-1-59745-178-9_12; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Sakakibara K, 2005, J BIOL CHEM, V280, P15029, DOI 10.1074/jbc.M410538200; Schonfelder EM, 2006, AM J KIDNEY DIS, V47, P1004, DOI 10.1053/j.ajkd.2006.02.177; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yu J, 2002, DEVELOPMENT, V129, P5301	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41816	10.1371/journal.pone.0041816	http://dx.doi.org/10.1371/journal.pone.0041816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848617	Green Published, Green Accepted, gold			2022-12-27	WOS:000306806600126
J	Nobili, E; Salvado, MD; Folkersen, L; Castiglioni, L; Kastrup, J; Wetterholm, A; Tremoli, E; Hansson, GK; Sironi, L; Haeggstrom, JZ; Gabrielsen, A				Nobili, Elena; Salvado, M. Dolores; Folkersen, Lasse; Castiglioni, Laura; Kastrup, Jens; Wetterholm, Anders; Tremoli, Elena; Hansson, Goran K.; Sironi, Luigi; Haeggstrom, Jesper Z.; Gabrielsen, Anders			Cysteinyl Leukotriene Signaling Aggravates Myocardial Hypoxia in Experimental Atherosclerotic Heart Disease	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; 5-LIPOXYGENASE/LEUKOTRIENE PATHWAY; CORONARY-ARTERIES; DEFICIENT MICE; SLEEP-APNEA; ISCHEMIA; EXPRESSION; INFARCTION; THERAPEUTICS; INHIBITION	Background: Cysteinyl-leukotrienes (cys-LT) are powerful spasmogenic and immune modulating lipid mediators involved in inflammatory diseases, in particular asthma. Here, we investigated whether cys-LT signaling, in the context of atherosclerotic heart disease, compromises the myocardial microcirculation and its response to hypoxic stress. To this end, we examined Apoe(-/-) mice fed a hypercholesterolemic diet and analysed the expression of key enzymes of the cys-LT pathway and their receptors (CysLT1/CysLT2) in normal and hypoxic myocardium as well as the potential contribution of cys-LT signaling to the acute myocardial response to hypoxia. Methods and principal findings: Myocardial biopsies from Apoe(-/-) mice demonstrated signs of chronic inflammation with fibrosis, increased apoptosis and expression of IL-6, as compared to biopsies from C57BL/6J control mice. In addition, we found increased leukotriene C-4 synthase (LTC4S) and CysLT1 expression in the myocardium of Apoe(-/-) mice. Acute bouts of hypoxia further induced LTC4S expression, increased LTC4S enzyme activity and CysLT1 expression, and were associated with increased extension of hypoxic areas within the myocardium. Inhibition of cys-LT signaling by treatment with montelukast, a selective CysLT1 receptor antagonist, during acute bouts of hypoxic stress reduced myocardial hypoxic areas in Apoe(-/-) mice to levels equal to those observed under normoxic conditions. In human heart biopsies from 14 patients with chronic coronary artery disease mRNA expression levels of LTC4S and CysLT1 were increased in chronic ischemic compared to non-ischemic myocardium, constituting a molecular basis for increased cys-LT signaling. Conclusion: Our results suggest that CysLT1 antagonists may have protective effects on the hypoxic heart, and improve the oxygen supply to areas of myocardial ischemia, for instance during episodes of sleep apnea.	[Nobili, Elena; Tremoli, Elena; Sironi, Luigi] IRCCS, Monzino Cardiol Ctr, Milan, Italy; [Nobili, Elena; Castiglioni, Laura; Tremoli, Elena; Sironi, Luigi] Univ Milan, Dept Pharmacol, Milan, Italy; [Salvado, M. Dolores; Wetterholm, Anders; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem MBB 2, Stockholm, Sweden; [Kastrup, Jens] Rigshosp, Cardiac Catheterizat Lab, Dept Cardiol B, DK-2100 Copenhagen, Denmark; [Folkersen, Lasse; Hansson, Goran K.; Gabrielsen, Anders] Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden	IRCCS Centro Cardiologico Monzino; University of Milan; Karolinska Institutet; Rigshospitalet; University of Copenhagen; Karolinska Institutet	Nobili, E (corresponding author), IRCCS, Monzino Cardiol Ctr, Milan, Italy.	jesper.haeggstrom@ki.se; anders.gabrielsen@ki.se	Sironi, Luigi/S-8174-2016; Sobrido, Maria/D-6697-2016; TREMOLI, ELENA/I-8126-2018	Sobrido, Maria/0000-0003-2060-4410; TREMOLI, ELENA/0000-0002-0929-6106; castiglioni, laura/0000-0002-0772-3231; SIRONI, LUIGI/0000-0002-4738-3454; Hansson, Goran/0000-0003-4148-5190; Folkersen, Lasse/0000-0003-0708-9530	Swedish Research Council [20854, 521-2009-4203, 10350, 349-2007-8703]; Swedish Heart-Lung Foundation; Swedish Foundation for Strategic Research (SSF); Vinnova Foundation; Stockholm County Council; Torsten och Ragnar Soderberg foundation; European Commission [201668]; Danish Agency for Science, Technology and Innovation (DASTI)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Vinnova Foundation(Vinnova); Stockholm County Council(Stockholm County Council); Torsten och Ragnar Soderberg foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Agency for Science, Technology and Innovation (DASTI)	This study was supported by The Swedish Research Council (grants 20854;521-2009-4203;10350;349-2007-8703 (CERIC Linneus support), The Swedish Heart-Lung Foundation, The Swedish Foundation for Strategic Research (SSF), Vinnova Foundation (CIDaT project), Stockholm County Council (ALF grant support), Torsten och Ragnar Soderberg foundation, and The European Commission FP7 funding (AtheroRemo grant no 201668), and a Ph.D. scholarship program to LF from Danish Agency for Science, Technology and Innovation (DASTI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 1998, CIRCULATION, V97, P2406, DOI 10.1161/01.CIR.97.24.2406; Becher UM, 2011, J MOL CELL CARDIOL, V50, P570, DOI 10.1016/j.yjmcc.2010.11.013; Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; Cao RY, 2009, ATHEROSCLEROSIS, V203, P395, DOI 10.1016/j.atherosclerosis.2008.07.045; CARRY M, 1992, CIRCULATION, V85, P230, DOI 10.1161/01.CIR.85.1.230; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; GOLDMAN MD, 1993, J AM GERIATR SOC, V41, P703, DOI 10.1111/j.1532-5415.1993.tb07457.x; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; Haeggstrom JZ, 2002, CELL MOL LIFE SCI, V59, P742, DOI 10.1007/s00018-002-8463-1; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Jiang W, 2008, AM J PATHOL, V172, P592, DOI 10.2353/ajpath.2008.070834; KOEHLER U, 1991, KLIN WOCHENSCHR, V69, P474, DOI 10.1007/BF01649418; Li RC, 2011, AM J RESP CRIT CARE, V184, P124, DOI 10.1164/rccm.201012-2039OC; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106; Miller DT, 2007, J AM COLL CARDIOL, V49, P1589, DOI 10.1016/j.jacc.2006.12.045; Ni NC, 2011, J PHARMACOL EXP THER, V339, P768, DOI 10.1124/jpet.111.186031; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Schafer H, 1997, CHEST, V111, P387, DOI 10.1378/chest.111.2.387; Stanke-Labesque F, 2009, J ALLERGY CLIN IMMUN, V124, P364, DOI 10.1016/j.jaci.2009.05.033; Wang YX, 2005, NEUROBIOL AGING, V26, P309, DOI 10.1016/j.neurobiolaging.2004.06.018; WARGOVICH T, 1985, J AM COLL CARDIOL, V6, P1047, DOI 10.1016/S0735-1097(85)80307-7	28	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41786	10.1371/journal.pone.0041786	http://dx.doi.org/10.1371/journal.pone.0041786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848603	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600117
J	Tolppanen, AM; Sayers, A; Fraser, WD; Lewis, G; Zammit, S; McGrath, J; Lawlor, DA				Tolppanen, Anna-Maija; Sayers, Adrian; Fraser, William D.; Lewis, Glyn; Zammit, Stanley; McGrath, John; Lawlor, Debbie A.			Serum 25-Hydroxyvitamin D-3 and D-2 and Non-Clinical Psychotic Experiences in Childhood	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; MENDELIAN RANDOMIZATION; GENERAL-POPULATION; COMMUNITY SAMPLE; D SUPPLEMENTS; RISK-FACTORS; SYMPTOMS; SCHIZOPHRENIA; CALCIUM; PREVALENCE	Objective: Non-clinical psychotic experiences are common and distressing. It has been hypothesized that early life vitamin D deficiency may be a risk factor for psychosis-related outcomes, but it is not known if circulating concentrations of 25-hydroxyvitamin D (25(OH)D) during childhood are associated with psychosis-related outcomes or whether the two different forms of 25(OH)D, (25(OH)D-3 and 25(OH)D-2, have similar associations with psychosis-related outcomes. Methods: We investigated the association between serum 25(OH)D-3 and 25(OH)D-2 concentrations and psychotic experiences in a prospective birth cohort study. Serum 25(OH)D-3 and 25(OH)D-2 concentrations were measured at mean age 9.8 years and psychotic experiences assessed at mean age 12.8 years by a psychologist (N = 3182). Results: Higher 25(OH)D-3 concentrations were associated with lower risk of definite psychotic experiences (adjusted odds ratio: OR (95% confidence interval: CI) 0.85 (0.75-0.95)). Higher concentrations of 25(OH)D-2 were associated with higher risk of suspected and definite psychotic experiences (adjusted odds ratio: OR (95% confidence interval: CI) 1.26 (1.11, 1.43)). Higher 25(OD)D-2 concentrations were also weakly associated with definite psychotic experiences (adjusted OR (95% CI) 1.17 (0.96, 1.43), though with wide confidence intervals including the null value. Conclusions: Our findings of an inverse association of 25(OH)D-3 with definite psychotic experiences is consistent with the hypothesis that vitamin D may protect against psychosis-related outcomes.	[Tolppanen, Anna-Maija; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Fraser, William D.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Zammit, Stanley] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [McGrath, John] Univ Queensland, Queensland Ctr Mental Hlth Res, St Lucia, Qld, Australia; [McGrath, John] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Bristol; University of East Anglia; Cardiff University; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland	Tolppanen, AM (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	D.A.Lawlor@bristol.ac.uk	Sayers, Adrian/AAU-8134-2020; McGrath, John Joseph/G-5493-2010; Lewis, Glyn/E-9944-2012	Sayers, Adrian/0000-0001-7452-5043; McGrath, John Joseph/0000-0002-4792-6068; Lewis, Glyn/0000-0001-5205-8245; Lawlor, Debbie A/0000-0002-6793-2262; Zammit, Stanley/0000-0002-2647-9211	United Kingdom Medical Research Council (MRC) [G0701603]; Wellcome Trust [079960]; MRC [G0600705]; Wellcome Trust; University of Bristol; Medical Research Council [G0801418B, G0701603, G0600705] Funding Source: researchfish; MRC [G0701603] Funding Source: UKRI	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work on this study is funded by an United Kingdom Medical Research Council (MRC) Grant G0701603), which also pays AMT's salary. Salary support for AS is provided by Wellcome Trust Grant 079960. The MRC, the Wellcome Trust and the University of Bristol provide core funding support for the ALSPAC study. The MRC (Grant G0600705) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras L, 2007, PROTEOMICS, V7, P769, DOI 10.1002/pmic.200600392; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Dhossche D, 2002, PSYCHOL MED, V32, P619, DOI 10.1017/S003329170200555X; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Finch JL, 1999, J AM SOC NEPHROL, V10, P980; Glendenning P, 2009, BONE, V45, P870, DOI 10.1016/j.bone.2009.07.015; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Hedelin M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-38; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Horwood J, 2008, BRIT J PSYCHIAT, V193, P185, DOI 10.1192/bjp.bp.108.051904; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Hypponen E, 2011, J NUTR, V141, P843, DOI 10.3945/jn.110.133009; Karani VK, 2010, LONGITUDINAL LIFE CO, V1, P234; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lincoln TM, 2007, SCHIZOPHR RES, V93, P211, DOI 10.1016/j.schres.2007.02.013; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 2011, SCHIZOPHRENIA BULL, V37, P272, DOI 10.1093/schbul/sbq121; McGrath J, 2011, PSYCHOL MED, V41, P892, DOI 10.1017/S0033291710002448; McGrath J, 2010, ACTA PSYCHIAT SCAND, V121, P321, DOI 10.1111/j.1600-0447.2010.01551.x; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Mundy GR, 1999, CLIN CHEM, V45, P1347; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Rai D, 2010, BRIT J PSYCHIAT, V197, P411, DOI 10.1192/bjp.bp.110.079244; Rossler W, 2007, SCHIZOPHR RES, V92, P1, DOI 10.1016/j.schres.2007.01.002; Schram MT, 2007, J AM GERIATR SOC, V55, P1786, DOI 10.1111/j.1532-5415.2007.01418.x; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; World Health Organization (WHO) Division of Mental Health, 1994, SCHED CLIN ASS NEUR; Zammit S, 2008, SCHIZOPHR RES, V104, P279, DOI 10.1016/j.schres.2008.04.036	42	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41575	10.1371/journal.pone.0041575	http://dx.doi.org/10.1371/journal.pone.0041575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848531	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306806600087
J	Ayyanathan, K; Kesaraju, S; Dawson-Scully, K; Weissbach, H				Ayyanathan, Kasirajan; Kesaraju, Shailaja; Dawson-Scully, Ken; Weissbach, Herbert			Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage	PLOS ONE			English	Article							CONGENITAL LACTIC-ACIDOSIS; CYCLOOXYGENASE-2 INHIBITORS; HYDROGEN-PEROXIDE; ARSENIC TRIOXIDE; IN-VITRO; APOPTOSIS; STRESS; INDUCTION; GROWTH; DEHYDROGENASE	Sulindac is an FDA-approved non-steroidal anti-inflammatory drug with documented anticancer activities. Our recent studies showed that sulindac selectively enhanced the killing of cancer cells exposed to oxidizing agents via production of reactive oxygen species (ROS) resulting in mitochondrial dysfunction. This effect of sulindac and oxidative stress on cancer cells could be related to the defect in respiration in cancer cells, first described by Warburg 50 years ago, known as the Warburg effect. We postulated that sulindac might enhance the selective killing of cancer cells when combined with any compound that alters mitochondrial respiration. To test this hypothesis we have used dichloroacetate (DCA), which is known to shift pyruvate metabolism away from lactic acid formation to respiration. One might expect that DCA, since it stimulates aerobic metabolism, could stress mitochondrial respiration in cancer cells, which would result in enhanced killing in the presence of sulindac. In this study, we have shown that the combination of sulindac and DCA enhances the selective killing of A549 and SCC25 cancer cells under the conditions used. As predicted, the mechanism of killing involves ROS production, mitochondrial dysfunction, JNK signaling and death by apoptosis. Our results suggest that the sulindac-DCA drug combination may provide an effective cancer therapy.	[Ayyanathan, Kasirajan; Kesaraju, Shailaja; Dawson-Scully, Ken; Weissbach, Herbert] Florida Atlantic Univ, Charles E Schmidt Coll Sci, Ctr Mol Biol & Biotechnol, Jupiter, FL USA; [Ayyanathan, Kasirajan; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Charles E Schmidt Coll Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University	Ayyanathan, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Sci, Ctr Mol Biol & Biotechnol, Jupiter, FL USA.	kayyanat@fau.edu			National Institutes of Health [5K01CA95620, R15 CA122001]; State of Florida (SURECAG) [R94007]; NATIONAL CANCER INSTITUTE [K01CA095620, R15CA122001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida (SURECAG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding assistance from the National Institutes of Health to KA (grant 5K01CA95620) and HW (grant R15 CA122001) and from the State of Florida to HW (SURECAG grant R94007) to carry out this work is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boolbol SK, 1996, CANCER RES, V56, P2556; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heshe D, 2011, CANCER CHEMOTH PHARM, V67, P647, DOI 10.1007/s00280-010-1361-6; Jiang TT, 2004, J EXP CLIN CANC RES, V23, P259; Jin HO, 2006, BIOCHEM PHARMACOL, V72, P1228, DOI 10.1016/j.bcp.2006.07.026; Jina HO, 2008, LUNG CANCER, V61, P317, DOI 10.1016/j.lungcan.2008.01.002; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Marchetti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005804; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Minami T, 2005, CLIN CANCER RES, V11, P5248, DOI 10.1158/1078-0432.CCR-05-0085; Moench I, 2009, P NATL ACAD SCI USA, V106, P19611, DOI 10.1073/pnas.0911046106; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Papandreou I, 2011, INT J CANCER, V128, P1001, DOI 10.1002/ijc.25728; RAO CV, 1995, CANCER RES, V55, P1464; Resnick L, 2009, J DRUGS DERMATOL, V8, P29; Richter M, 2001, CARCINOGENESIS, V22, P17, DOI 10.1093/carcin/22.1.17; Selimovic D, 2011, CARCINOGENESIS, V32, P1268, DOI 10.1093/carcin/bgr112; Seo SK, 2008, MOL PHARMACOL, V73, P1005, DOI 10.1124/mol.107.041293; Soriano AF, 1999, CANCER RES, V59, P6178; Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062; Stacpoole PW, 1997, ARCH DIS CHILD, V77, P535, DOI 10.1136/adc.77.6.535; STACPOOLE PW, 1983, NEW ENGL J MED, V309, P390, DOI 10.1056/NEJM198308183090702; Staley K, 1997, CELL DEATH DIFFER, V4, P66, DOI 10.1038/sj.cdd.4400207; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Vogt T, 2001, MELANOMA RES, V11, P587, DOI 10.1097/00008390-200112000-00005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	42	43	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e39949	10.1371/journal.pone.0039949	http://dx.doi.org/10.1371/journal.pone.0039949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22866174	Green Published, Green Submitted, gold			2022-12-27	WOS:000306507000010
J	Chen, LJ; Su, JG; Yang, CR; Peng, LM; Wan, QY; Wang, L				Chen, Lijun; Su, Jianguo; Yang, Chunrong; Peng, Limin; Wan, Quanyuan; Wang, Lan			Functional Characterizations of RIG-I to GCRV and Viral/Bacterial PAMPs in Grass Carp Ctenopharyngodon idella	PLOS ONE			English	Article							INDUCIBLE GENE-I; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR; NF-KAPPA-B; RECOGNITION RECEPTORS; PATHOGEN RECOGNITION; GENOMIC STRUCTURE; RNA; EXPRESSION; DOMAIN	Background: RIG-I (retinoic acid inducible gene-I) is one of the key cytosolic pattern recognition receptors (PRRs) for detecting nucleotide pathogen associated molecular patterns (PAMPs) and mediating the induction of type I interferon and inflammatory cytokines in innate immune response. Though the mechanism is well characterized in mammals, the study of the accurate function of RIG-I in teleosts is still in its infancy. Methodology/Principal Findings: To clarify the functional characterizations of RIG-I in grass carp Ctenopharyngodon idella (CiRIG-I), six representative overexpression plasmids were constructed and transfected into C. idella kidney (CIK) cell lines to obtain stably expressing recombinant proteins, respectively. A virus titer test and 96-well plate staining assay showed that all constructs exhibited the antiviral activity somewhat. The quantitative real-time RT-PCR (qRT-PCR) demonstrated that mRNA expressions of CiIPS-1, CiIFN-I and CiMx2 were regulated by not only virus (GCRV) or viral PAMP (poly(IC)) challenge but also bacterial PAMPs (LPS and PGN) stimulation in the steadily transfected cells. The results showed that the full-length CiRIG-I played a key role in RLR pathway. The repressor domain (RD) exerted an inhibitory function of the signaling channel under all utilized challenges. Caspase activation and recruitment domains (CARDs) showed a positive role in GCRV and poly(I: C) challenge. Helicase motifs were crucial for the signaling pathway upon LPS and PGN stimulation. Interestingly, DCARDs (CARDs deleted) showed postive modulation in RIG-I signal transduction. Conclusions/Significance: The results provided some novel insights into RIG-I sensing with a strikingly broad regulation in teleosts, responding not only to the dsRNA virus or synthetic dsRNA but also bacterial PAMPs.	[Chen, Lijun; Su, Jianguo; Yang, Chunrong; Peng, Limin; Wan, Quanyuan; Wang, Lan] NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Peoples R China	Northwest A&F University - China	Su, JG (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Peoples R China.	su.jianguo@gmail.com	Su, Jianguo/A-7444-2015; Wan, Quanyuan/AAD-5810-2022; Wan, Quanyuan/D-1149-2015; Su, Jianguo/G-9277-2012	Su, Jianguo/0000-0002-9083-0715; Wan, Quanyuan/0000-0003-4227-1530; Wan, Quanyuan/0000-0003-4227-1530; Su, Jianguo/0000-0002-9083-0715; Su, Jianguo/0000-0002-1340-6144	Program for New Century Excellent Talents in University [NCET-08-0466]; Chinese Universities Scientific Fund [QN2009022]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Chinese Universities Scientific Fund	The study was supported by Program for New Century Excellent Talents in University (NCET-08-0466) and Chinese Universities Scientific Fund (QN2009022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; Feng H, 2011, FISH SHELLFISH IMMUN, V30, P1159, DOI 10.1016/j.fsi.2011.03.002; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Huang T, 2010, FISH SHELLFISH IMMUN, V29, P349, DOI 10.1016/j.fsi.2010.04.001; Imaizumi T, 2002, BIOCHEM BIOPH RES CO, V292, P274, DOI 10.1006/bbrc.2002.6650; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Kubota K, 2006, ORAL MICROBIOL IMMUN, V21, P399, DOI 10.1111/j.1399-302X.2006.00326.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lauksund S, 2009, DEV COMP IMMUNOL, V33, P1196, DOI 10.1016/j.dci.2009.06.012; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Muller-Anstett MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013153; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Rajendran KV, 2012, DEV COMP IMMUNOL, V37, P381, DOI 10.1016/j.dci.2012.02.004; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Sharma S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001310; Su JG, 2008, MAR BIOTECHNOL, V10, P262, DOI 10.1007/s10126-007-9059-4; Su JG, 2012, DEV COMP IMMUNOL, V36, P450, DOI 10.1016/j.dci.2011.08.015; Su JG, 2011, FISH SHELLFISH IMMUN, V30, P830, DOI 10.1016/j.fsi.2011.01.006; Su JG, 2009, AQUACULTURE, V289, P1, DOI [10.1016/j.aquaculture.2008.12.027, 10.1016/j.aquaculture.2008.10.025]; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Wang L, 2011, MOL IMMUNOL, V49, P359, DOI 10.1016/j.molimm.2011.09.010; Yang CR, 2011, FISH SHELLFISH IMMUN, V30, P936, DOI 10.1016/j.fsi.2011.01.020; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	52	31	32	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42182	10.1371/journal.pone.0042182	http://dx.doi.org/10.1371/journal.pone.0042182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860079	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600070
J	Fliedner, SMJ; Kaludercic, N; Jiang, XS; Hansikova, H; Hajkova, Z; Sladkova, J; Limpuangthip, A; Backlund, PS; Wesley, R; Martiniova, L; Jochmanova, I; Lendvai, NK; Breza, J; Yergey, AL; Paolocci, N; Tischler, AS; Zeman, J; Porter, FD; Lehnert, H; Pacak, K				Fliedner, Stephanie M. J.; Kaludercic, Nina; Jiang, Xiao-Sheng; Hansikova, Hana; Hajkova, Zuzana; Sladkova, Jana; Limpuangthip, Andrea; Backlund, Peter S.; Wesley, Robert; Martiniova, Lucia; Jochmanova, Ivana; Lendvai, Nikoletta K.; Breza, Jan; Yergey, Alfred L.; Paolocci, Nazareno; Tischler, Arthur S.; Zeman, Jiri; Porter, Forbes D.; Lehnert, Hendrik; Pacak, Karel			Warburg Effect's Manifestation in Aggressive Pheochromocytomas and Paragangliomas: Insights from a Mouse Cell Model Applied to Human Tumor Tissue	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; UBIQUINONE-BINDING SITE; HIGH LACTATE LEVELS; SUCCINATE-DEHYDROGENASE; COMPLEX-II; HEREDITARY PARAGANGLIOMA; SUPEROXIDE-DISMUTASE; GENOMIC INSTABILITY; AEROBIC GLYCOLYSIS; ENZYMATIC-ACTIVITY	A glycolytic profile unifies a group of pheochromocytomas and paragangliomas (PHEOs/PGLs) with distinct underlying gene defects, including von Hippel-Lindau (VHL) and succinate dehydrogenase B (SDHB) mutations. Nevertheless, their tumor aggressiveness is distinct: PHEOs/PGLs metastasize rarely in VHL-, but frequently in SDHB-patients. To date, the molecular mechanisms causing the more aggressive phenotype in SDHB-PHEOs/PGLs remain largely unknown. Recently, however, an excellent model to study aggressive PHEOs (mouse tumor tissue (MTT) cells) has been developed from mouse PHEO cells (MPC). We employed this model for a proteomics based approach to identify changes characteristic for tumor aggressiveness, which we then explored in a homogeneous set of human SDHB- and VHL-PHEOs/PGLs. The increase of glucose transporter 1 in VHL, and of hexokinase 2 in VHL and SDHB, confirmed their glycolytic profile. In agreement with the cell model and in support of decoupling of glycolysis, the Krebs cycle and oxidative phosphorylation (OXPHOS), SDHB tumors showed increased lactate dehydrogenase levels. In SDHB-PGLs OXPHOS complex activity was increased at complex III and, as expected, decreased at complex II. Moreover, protein and mRNA expression of all tested OXPHOS-related genes were higher in SDHB-than in VHL-derived tumors. Although there was no direct evidence for increased reactive oxygen species production, elevated superoxide dismutase 2 expression may reflect elevated oxidative stress in SDHB-derived PHEOs/PGLs. For the first time, we show that despite dysfunction in complex II and evidence for a glycolytic phenotype, the Warburg effect does not seem to fully apply to SDHB-PHEOs/PGLs with respect to decreased OXPHOS. In addition, we present evidence for increased LDHA and SOD2 expression in SDHB-PHEOs/PGLs, proteins that have been proposed as promising therapeutic targets in other cancers. This study provides new insight into pathogenic mechanisms in aggressive human PHEOs/PGLs, which may lead to identifying new diagnostic and prognostic markers in the near future.	[Fliedner, Stephanie M. J.; Limpuangthip, Andrea; Martiniova, Lucia; Jochmanova, Ivana; Lendvai, Nikoletta K.; Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Kaludercic, Nina; Paolocci, Nazareno] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Jiang, Xiao-Sheng; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Dysmorphol, NIH, Bethesda, MD USA; [Hansikova, Hana; Hajkova, Zuzana; Sladkova, Jana; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Prague, Czech Republic; [Hansikova, Hana; Hajkova, Zuzana; Sladkova, Jana; Zeman, Jiri] Gen Univ Hosp Prague, Prague, Czech Republic; [Backlund, Peter S.; Yergey, Alfred L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mass Spectrometry & Metab, NIH, Bethesda, MD USA; [Wesley, Robert] NIH, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Jochmanova, Ivana] Safarik Univ, Dept Internal Med 1, Fac Med, Kosice, Slovakia; [Breza, Jan] Comenius Univ, Sch Med, Dept Urol, Bratislava, Slovakia; [Paolocci, Nazareno] Univ Perugia, Sect Pathol, Dept Clin Med, I-06100 Perugia, Italy; [Tischler, Arthur S.] Tufts Med Ctr, Dept Pathol, Boston, MA USA; [Fliedner, Stephanie M. J.; Lehnert, Hendrik] Univ Hosp Schleswig Holstein, Dept Med 1, Lubeck, Germany	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Charles University Prague; General University Hospital Prague; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; University of Pavol Jozef Safarik Kosice; Comenius University Bratislava; University of Perugia; Tufts Medical Center; University of Kiel; Schleswig Holstein University Hospital	Fliedner, SMJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA.	karel@mail.nih.gov	Jochmanova, Ivana/I-9011-2016; Fliedner, Stephanie MJ/D-3406-2012; Jochmanova, Ivana/AAG-1856-2020; Hansikova, Hana/E-9350-2017; paolocci, nazareno/A-7124-2009; Zeman, Jiri/K-2691-2017	Jochmanova, Ivana/0000-0003-2346-461X; Hansikova, Hana/0000-0002-2734-225X; Zeman, Jiri/0000-0002-2678-7919; Paolocci, Nazareno/0000-0001-7011-997X; Fliedner, Stephanie/0000-0001-5515-8196; Tischler, Arthur/0000-0002-9726-5739	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; Ministry of Education, Youth and Sports of the Czech Republic [MSM 0021620806]; Pheo Para Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735, ZIAHD000139, ZICHD001421] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Pheo Para Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD and partly by a grant from the Ministry of Education, Youth and Sports of the Czech Republic MSM 0021620806, http://www.msmt.cz/. AST was supported by a grant from the Pheo Para Alliance, http://www.pheo-para-alliance.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bacsi A, 2006, MITOCHONDRION, V6, P235, DOI 10.1016/j.mito.2006.07.008; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Cervera AM, 2008, CANCER RES, V68, P4058, DOI 10.1158/0008-5472.CAN-07-5580; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Dahia PLM, 2006, ANN NY ACAD SCI, V1073, P208, DOI 10.1196/annals.1353.023; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; Erlic Z, 2009, CLIN CANCER RES, V15, P6378, DOI 10.1158/1078-0432.CCR-09-1237; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Fliedner SMJ, 2010, CELL TISSUE RES, V340, P607, DOI 10.1007/s00441-010-0965-9; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Gimenez-Roqueplo AP, 2002, J CLIN ENDOCR METAB, V87, P4771, DOI 10.1210/jc.2002-020525; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Goffrini P, 2009, HUM MOL GENET, V18, P1860, DOI 10.1093/hmg/ddp102; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hempel N, 2011, ANTI-CANCER AGENT ME, V11, P191, DOI 10.2174/187152011795255911; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028; Jiang XS, 2005, ELECTROPHORESIS, V26, P4540, DOI 10.1002/elps.200500286; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lai EW, 2009, J CLIN ENDOCR METAB, V94, P2952, DOI 10.1210/jc.2009-0309; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCarty MF, 2010, ALTERN MED REV, V15, P264; Nelson TJ, 2002, MOL CELL PROTEOMICS, V1, P253, DOI 10.1074/mcp.T100006-MCP200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Owens KM, 2012, FREE RADICAL BIO MED, V52, P160, DOI 10.1016/j.freeradbiomed.2011.10.435; Pani G, 2004, CURR MED CHEM, V11, P1299, DOI 10.2174/0929867043365297; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Powers JF, 2007, NEUROSCIENCE, V147, P928, DOI 10.1016/j.neuroscience.2007.05.008; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Selak MA, 2006, BBA-BIOENERGETICS, V1757, P567, DOI 10.1016/j.bbabio.2006.05.015; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Srirangalingam U, 2009, ENDOCR-RELAT CANCER, V16, P515, DOI 10.1677/ERC-08-0239; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200; Thorn CC, 2009, GUT, V58, P404, DOI 10.1136/gut.2008.157255; Timmers HJLM, 2007, J CLIN ENDOCR METAB, V92, P779, DOI 10.1210/jc.2006.2315; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zhao ZW, 2006, BIOCHEM CELL BIOL, V84, P1013, DOI 10.1139/O06-188	70	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e40949	10.1371/journal.pone.0040949	http://dx.doi.org/10.1371/journal.pone.0040949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859959	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600012
J	Li, B; Yi, Y; Wang, Q; Woo, PCY; Tan, L; Jing, H; Gao, GF; Liu, CH				Li, Bin; Yi, Yong; Wang, Qi; Woo, Patrick C. Y.; Tan, Lin; Jing, Hua; Gao, George F.; Liu, Cui Hua			Analysis of Drug Resistance Determinants in Klebsiella pneumoniae Isolates from a Tertiary-Care Hospital in Beijing, China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; TEL-AVIV; MOLECULAR CHARACTERIZATION; QUINOLONE RESISTANCE; MEDIATED RESISTANCE; GLOBAL SPREAD; RISK-FACTORS; EMERGENCE; ENTEROBACTERIACEAE	Background: The rates of multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) isolates among Enterobacteriaceae isolates, particularly Klebsiella pneumoniae, have risen substantially worldwide. Methodology/Principal Findings: To better understand the molecular mechanisms of drug resistance in K. pneumoniae, we analyzed the drug resistance determinants for K. pneumoniae isolates collected from the 306 Hospital, a tertiary-care hospital in Beijing, China, for the period of September 1, 2010-October 31, 2011. Drug susceptibility testing, PCR amplification and sequencing of the drug resistance determinants were performed. Conjugation experiments were conducted to examine the natural ability of drug resistance to disseminate among Enterobacteriaceae strains using a sodium azide-resistant Escherichia coli J53 strain as a recipient. Among the 223 consecutive non-repetitive K. pneumoniae isolates included in this study, 101 (45.3%) were extended-spectrum beta-lactamases (ESBLs) positive. The rates of MDR, XDR, and PDR isolates were 61.4% (n = 137), 22.0% (n = 49), and 1.8% (n = 4), respectively. Among the tested drug resistance-associated genes, the following ones were detected at relatively high rates bla(CTX-M-10) (80, 35.9%), aacC2 (73, 32.7%), dhfr (62, 27.8%), qnrS (58, 26.0%), aacA4 (57, 25.6%), aadA1 (56, 25.1%). Results from conjugation experiments indicate that many of the drug resistance genes were transmissible. Conclusions/Significance: Our data give a "snapshot" of the complex genetic background responsible for drug resistance in K. pneumoniae in China and demonstrate that a high degree of awareness and monitoring of those drug resistance determinants are urgently needed in order to better control the emergence and transmission of drug-resistant K. pneumoniae isolates in hospital settings.	[Li, Bin; Wang, Qi; Tan, Lin; Gao, George F.; Liu, Cui Hua] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Li, Bin] Shandong Univ, State Key Lab Microbial Technol, Jinan, Peoples R China; [Yi, Yong; Jing, Hua] 306 Hosp, Beijing, Peoples R China; [Woo, Patrick C. Y.] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Shandong University; University of Hong Kong	Li, B (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn; liucuihua@im.ac.cn	Gao, George Fu/ABD-5229-2021; Woo, Patrick Chiu Yat/C-4449-2009	Woo, Patrick Chiu Yat/0000-0001-9401-1832	National Basic Research Program of China [2012CB518700]; Chinese Academy of Sciences [KSCX2-EW-J-6]; National Natural Science Foundation of China [30700975]; Merieux Research Grant program	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Merieux Research Grant program	This work was supported by the National Basic Research Program of China (2012CB518700), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6), the National Natural Science Foundation of China (grant No. 30700975), and the Merieux Research Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2010, INT J ANTIMICROB AG, V36, P239, DOI 10.1016/j.ijantimicag.2010.04.010; Bauernfeind A, 1996, ANTIMICROB AGENTS CH, V40, P509, DOI 10.1128/AAC.40.2.509; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; BISSONNETTE L, 1992, J BACTERIOL, V174, P1248, DOI 10.1128/jb.174.4.1248-1257.1992; Bogaerts P, 2007, J ANTIMICROB CHEMOTH, V59, P459, DOI 10.1093/jac/dkl527; Bradford PA, 2004, CLIN INFECT DIS, V39, P55, DOI 10.1086/421495; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005; Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272; Chudackova E, 2010, FEMS MICROBIOL LETT, V309, P62, DOI 10.1111/j.1574-6968.2010.02016.x; Clinical and Laboratory Standards Institute (CLSI), 2019, M100S21 CLSI; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Deguchi T, 1997, ANTIMICROB AGENTS CH, V41, P699, DOI 10.1128/AAC.41.3.699; Giakkoupi P, 2003, J CLIN MICROBIOL, V41, P3893, DOI 10.1128/JCM.41.8.3893-3896.2003; Goren MG, 2011, J ANTIMICROB CHEMOTH, V66, P672, DOI 10.1093/jac/dkq467; Hammerum AM, 2010, LANCET INFECT DIS, V10, P829, DOI 10.1016/S1473-3099(10)70276-0; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Jacoby GA, 1996, J CLIN MICROBIOL, V34, P908, DOI 10.1128/JCM.34.4.908-911.1996; Jean SS, 2009, EUR J CLIN MICROBIOL, V28, P215, DOI 10.1007/s10096-008-0610-7; Jemima SA, 2008, INDIAN J MED MICROBI, V26, P365, DOI 10.4103/0255-0857.43581; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Ko KS, 2008, DIAGN MICR INFEC DIS, V61, P453, DOI 10.1016/j.diagmicrobio.2008.03.005; Kohlenberg A, 2012, EPIDEMIOL INFECT, V140, P528, DOI 10.1017/S0950268811000781; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Leavitt A, 2010, J ANTIMICROB CHEMOTH, V65, P243, DOI 10.1093/jac/dkp417; Lee H, 2006, DIAGN MICR INFEC DIS, V56, P305, DOI 10.1016/j.diagmicrobio.2006.05.002; Lee YH, 2006, J ANTIMICROB CHEMOTH, V57, P1259, DOI 10.1093/jac/dkl115; Luo YP, 2011, INT J ANTIMICROB AG, V37, P352, DOI 10.1016/j.ijantimicag.2010.12.018; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; Marchaim D, 2010, ANTIMICROB AGENTS CH, V54, P5099, DOI 10.1128/AAC.00565-10; Mokracka J, 2011, J MED MICROBIOL, V60, P737, DOI 10.1099/jmm.0.027979-0; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pitout JDD, 2008, EXPERT REV ANTI-INFE, V6, P657, DOI 10.1586/14787210.6.5.657; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poulou A, 2010, J ANTIMICROB CHEMOTH, V65, P2538, DOI 10.1093/jac/dkq363; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Reinert RR, 2007, J ANTIMICROB CHEMOTH, V60, P1018, DOI 10.1093/jac/dkm310; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Sabate M, 2000, ANTIMICROB AGENTS CH, V44, P1970, DOI 10.1128/AAC.44.7.1970-1973.2000; Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Schultsz C, 2012, DRUGS, V72, P1, DOI 10.2165/11597960-000000000-00000; Tato M, 2010, J CLIN MICROBIOL, V48, P4089, DOI 10.1128/JCM.01130-10; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Veras DL, 2011, CURR MICROBIOL, V62, P1610, DOI 10.1007/s00284-011-9899-z; Wang XR, 2012, CHINESE MED J-PEKING, V125, P894, DOI 10.3760/cma.j.issn.0366-6999.2012.05.029; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	65	29	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42280	10.1371/journal.pone.0042280	http://dx.doi.org/10.1371/journal.pone.0042280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860106	gold, Green Published			2022-12-27	WOS:000307045600086
J	Shih, KS; Wang, JH; Wu, YW; Teng, CM; Chen, CC; Yang, CR				Shih, Kao-Shang; Wang, Jyh-Horng; Wu, Yi-Wen; Teng, Che-Ming; Chen, Chien-Chih; Yang, Chia-Ron			Aciculatin Inhibits Granulocyte Colony-Stimulating Factor Production by Human Interleukin 1 beta-Stimulated Fibroblast-Like Synoviocytes	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; HUMAN SYNOVIAL FIBROBLASTS; G-CSF; INFLAMMATORY ARTHRITIS; CYTOKINE REGULATION; IL-8 EXPRESSION; MACROPHAGE CSF; IN-VITRO; GM-CSF; NEUTROPHIL	The expression of granulocyte colony-stimulating factor (G-CSF), the major regulator of neutrophil maturation, by human fibroblast-like synoviocytes (FLS) can be stimulated by the inflammatory cytokine interleukin-1 beta (IL-1 beta). G-CSF is known to contribute to the pathologic processes of destructive arthritis, but the induction mechanism remains unknown. The aims of this study were to identify the signaling pathways involved in IL-1 beta-stimulated G-CSF production and to determine whether this process was inhibited by aciculatin (8-((2R,4S,5S,6R)-tetrahydro-4,5-dihydroxy-6-methyl-2H-pyran-2-yl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one), the major bioactive component of Chrysopogon aciculatus. IL-1 beta-induced cytokine expression was evaluated by measuring mRNA and protein levels by RT-PCR, ELISA, and Milliplex (R) assay. Whether aciculatin inhibited IL-1 beta-stimulated G-CSF expression, and if so, how, were evaluated using western blot assay, an electrophoretic mobility shift assay, and a reporter gene assay. Neutrophil differentiation was determined by Wright-Giemsa staining and flow cytometry. Aciculatin markedly inhibited G-CSF expression induced by IL-1 beta (10 ng/mL) in a concentration-dependent manner (1-10 mu M). In clarifying the mechanisms involved, aciculatin was found to inhibit the IL-1 beta-induced activation of the IkB kinase (IKK)/I kappa B/nuclear factor-kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) pathways by suppressing the DNA binding activity of the transcription factors NF-kappa B and activator protein (AP)-1. Furthermore, aciculatin significantly inhibited the G-CSF-mediated phosphorylation of Janus kinase-signal transducer and activator of transcription (JAK-STAT) and Akt and neutrophil differentiation from precursor cells. Our results show that aciculatin inhibits IL-1 beta-stimulated G-CSF expression and the subsequent neutrophil differentiation, suggesting that it might have therapeutic potential for inflammatory arthritis.	[Shih, Kao-Shang] Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan; [Shih, Kao-Shang] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Shih, Kao-Shang] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Wang, Jyh-Horng; Wu, Yi-Wen] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Chen, Chien-Chih] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan; [Yang, Chia-Ron] Natl Taiwan Univ, Sch Pharm, Coll Med, Taipei 10764, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Hungkuang University; National Taiwan University	Shih, KS (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan.	cryang@ntu.edu.tw	Huang, James/ADK-6342-2022	TENG, CHE-MING/0000-0002-9719-7334; YANG, CHIA-RON/0000-0001-5990-1346; Wang, Jyh- Horng/0000-0002-1531-5297	National Science Council of Taiwan [NSC100-2320-B-002-004-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work received grant support from National Science Council of Taiwan (NSC100-2320-B-002-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2001, FEBS LETT, V487, P318, DOI 10.1016/S0014-5793(00)02324-3; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Chakraborty A, 2003, AM J PHYSIOL-CELL PH, V284, pC103, DOI 10.1152/ajpcell.00165.2002; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Gouze JN, 2001, ARTHRITIS RHEUM, V44, P351, DOI 10.1002/1529-0131(200102)44:2<351::AID-ANR53>3.3.CO;2-D; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; GUERNE PA, 1990, J IMMUNOL, V144, P499; HAMILTON JA, 1992, BLOOD, V79, P1413; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Huebner JL, 2007, OSTEOARTHR CARTILAGE, V15, P354, DOI 10.1016/j.joca.2006.10.014; Huebner JL, 2006, OSTEOARTHR CARTILAGE, V14, P923, DOI 10.1016/j.joca.2006.03.007; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; KAWAKAMI M, 1990, BLOOD, V76, P1962; Kloesch B, 2011, LIFE SCI, V89, P473, DOI 10.1016/j.lfs.2011.07.015; Kojima H, 2011, BLOOD, V117, P1091, DOI 10.1182/blood-2010-05-286963; Lawlor KE, 2004, P NATL ACAD SCI USA, V101, P11398, DOI 10.1073/pnas.0404328101; LEIZER T, 1990, BLOOD, V76, P1989, DOI 10.1182/blood.V76.10.1989.1989; LORD BI, 1991, BLOOD, V77, P2154; LOTZ M, 1992, J IMMUNOL, V148, P466; Mangan JK, 2005, LEUKEMIA LYMPHOMA, V46, P21, DOI 10.1080/10428190400005320; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Nakamae-Akahori M, 2006, IMMUNOLOGY, V119, P393, DOI 10.1111/j.1365-2567.2006.02448.x; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Shen CC, 2012, J NAT PROD, V75, P198, DOI 10.1021/np2007796; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; TIAN SS, 1994, BLOOD, V84, P1760; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42389	10.1371/journal.pone.0042389	http://dx.doi.org/10.1371/journal.pone.0042389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860122	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600098
J	Uijen, AA; Heinst, CW; Schellevis, FG; van den Bosch, WJHM; van de Laar, FA; Terwee, CB; Schers, HJ				Uijen, Annemarie A.; Heinst, Claire W.; Schellevis, Francois G.; van den Bosch, Wil J. H. M.; van de Laar, Floris A.; Terwee, Caroline B.; Schers, Henk J.			Measurement Properties of Questionnaires Measuring Continuity of Care: A Systematic Review	PLOS ONE			English	Review							UPDATED METHOD GUIDELINES; SELF-REPORT MEASURE; CARDIAC PATIENTS; HEALTH OUTCOMES; CANCER CARE; VALIDATION; COORDINATION; PERCEPTIONS; QUALITY; RELIABILITY	Background: Continuity of care is widely acknowledged as a core value in family medicine. In this systematic review, we aimed to identify the instruments measuring continuity of care and to assess the quality of their measurement properties. Methods: We did a systematic review using the PubMed, Embase and PsycINFO databases, with an extensive search strategy including 'continuity of care', 'coordination of care', 'integration of care', 'patient centered care', 'case management' and its linguistic variations. We searched from 1995 to October 2011 and included articles describing the development and/or evaluation of the measurement properties of instruments measuring one or more dimensions of continuity of care (1) care from the same provider who knows and follows the patient (personal continuity), (2) communication and cooperation between care providers in one care setting (team continuity), and (3) communication and cooperation between care providers in different care settings (cross-boundary continuity). We assessed the methodological quality of the measurement properties of each instrument using the COSMIN checklist. Results: We included 24 articles describing the development and/or evaluation of 21 instruments. Ten instruments measured all three dimensions of continuity of care. Instruments were developed for different groups of patients or providers. For most instruments, three or four of the six measurement properties were assessed (mostly internal consistency, content validity, structural validity and construct validity). Six instruments scored positive on the quality of at least three of six measurement properties. Conclusions: Most included instruments have problems with either the number or quality of its assessed measurement properties or the ability to measure all three dimensions of continuity of care. Based on the results of this review, we recommend the use of one of the four most promising instruments, depending on the target population Diabetes Continuity of Care Questionnaire, Alberta Continuity of Services Scale-Mental Health, Heart Continuity of Care Questionnaire, and Nijmegen Continuity Questionnaire.	[Uijen, Annemarie A.; Heinst, Claire W.; van den Bosch, Wil J. H. M.; van de Laar, Floris A.; Schers, Henk J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Schellevis, Francois G.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Schellevis, Francois G.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Schellevis, Francois G.; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Radboud University Nijmegen; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Uijen, AA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	A.Uijen@elg.umcn.nl	Bosch, W.J.H.M./H-8016-2014; van de Laar, Floris/CAI-2875-2022; van de Laar, F.A./L-4467-2015; Uijen, A.A./L-4701-2015; Schers, H.J./L-4631-2015	van de Laar, Floris/0000-0001-7373-8864; Schers, H.J./0000-0002-9362-9451; Terwee, Caroline/0000-0003-4570-2826	Frans Huygen Stichting	Frans Huygen Stichting	The source of funding: Frans Huygen Stichting. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CE, 2005, PSYCHIAT SERV, V56, P1061, DOI 10.1176/appi.ps.56.9.1061; Adair CE, 2003, PSYCHIAT SERV, V54, P1351, DOI 10.1176/appi.ps.54.10.1351; Adair CE, 2004, CONTINUITY MENTAL HL; Ahgren Bengt, 2009, Int J Integr Care, V9, pe03; [Anonymous], 2002, HEALTH CARE; Bull M J, 2000, J Nurs Meas, V8, P41; Casparie AF, 1998, ONDERZOEKSPROGRAMMA; Dobrow Mark J, 2009, Healthc Policy, V5, P35; Dolovich LR, 2004, HEALTH SOC CARE COMM, V12, P475, DOI 10.1111/j.1365-2524.2004.00517.x; Durbin J, 2004, J BEHAV HEALTH SER R, V31, P279; Flocke SA, 1997, J FAM PRACTICE, V45, P64; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gulliford M, 2011, J HEALTH SERV RES PO, V16, P67, DOI 10.1258/jhsrp.2010.010015; Gulliford MC, 2006, ANN FAM MED, V4, P548, DOI 10.1370/afm.578; Hadjistavropoulos HD, 2004, CAN J CARDIOL, V20, P883; Hadjistavropoulos H, 2008, INT J QUAL HEALTH C, V20, P314, DOI 10.1093/intqhc/mzn030; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Hanninen J, 2001, DIABETES RES CLIN PR, V51, P21, DOI 10.1016/S0168-8227(00)00198-4; Hess BJ, 2009, ACAD MED, V84, pS109, DOI 10.1097/ACM.0b013e3181b37ac7; Hudon C, 2011, ANN FAM MED, V9, P155, DOI 10.1370/afm.1226; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; Joyce AS, 2010, COMMUNITY MENT HLT J, V46, P192, DOI 10.1007/s10597-009-9215-6; King M, 2008, BRIT J CANCER, V98, P529, DOI 10.1038/sj.bjc.6604164; Kowalyk KM, 2004, CAN J CARDIOL, V20, P205; Lawrence M, 2012, HEALTH EXPECT, V15, P295, DOI 10.1111/j.1369-7625.2011.00683.x; McGuiness C, 2003, INT J QUAL HEALTH C, V15, P309, DOI 10.1093/intqhc/mzg043; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Rose D, 2009, ACTA PSYCHIAT SCAND, V119, P320, DOI 10.1111/j.1600-0447.2008.01296.x; Schaefer JA, 2004, J STUD ALCOHOL, V65, P513, DOI 10.15288/jsa.2004.65.513; Stange KC, 2009, ANN FAM MED, V7, P293, DOI 10.1370/afm.1023; Strandberg-Larsen Martin, 2009, Int J Integr Care, V9, pe01; Terwee CB, 2009, QUAL LIFE RES, V18, P1115, DOI 10.1007/s11136-009-9528-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Terwee CB, 2011, QUAL LIFE RES; Uijen AA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652364; Uijen AA, 2012, FAM PRACT, V29, P264, DOI 10.1093/fampra/cmr104; Uijen AA, 2011, J CLIN EPIDEMIOL, V64, P1391, DOI 10.1016/j.jclinepi.2011.03.006; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Ware Norma C, 2003, Ment Health Serv Res, V5, P209, DOI 10.1023/A:1026276918081; Wei XL, 2008, J CLIN EPIDEMIOL, V61, P925, DOI 10.1016/j.jclinepi.2007.12.010; Young JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-298	45	62	63	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42256	10.1371/journal.pone.0042256	http://dx.doi.org/10.1371/journal.pone.0042256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860100	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600082
J	Wyllie, DH; Sogaard, KC; Holland, K; Xu, YB; Bregu, M; Hill, AVS; Kiss-Toth, E				Wyllie, David H.; Sogaard, Karen C.; Holland, Karen; Xu Yaobo; Bregu, Migena; Hill, Adrian V. S.; Kiss-Toth, Endre			Identification of 34 Novel Proinflammatory Proteins in a Genome-Wide Macrophage Functional Screen	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; CONTAINING ADAPTER; EXPRESSION; RECEPTOR; KINASE; FAMILY; ACTIVATION; POLYMORPHISM; REGULATOR	Signal transduction pathways activated by Toll-like Receptors and the IL-1 family of cytokines are fundamental to mounting an innate immune response and thus to clearing pathogens and promoting wound healing. Whilst mechanistic understanding of the regulation of innate signalling pathways has advanced considerably in recent years, there are still a number of critical controllers to be discovered. In order to characterise novel regulators of macrophage inflammation, we have carried out an extensive, cDNA-based forward genetic screen and identified 34 novel activators, based on their ability to induce the expression of cxcl2. Many are physiologically expressed in macrophages, although the majority of genes uncovered in our screen have not previously been linked to innate immunity. We show that expression of particular activators has profound but distinct impacts on LPS-induced inflammatory gene expression, including switch-type, amplifier and sensitiser behaviours. Furthermore, the novel genes identified here interact with the canonical inflammatory signalling network via specific mechanisms, as demonstrated by the use of dominant negative forms of IL1/TLR signalling mediators.	[Wyllie, David H.; Sogaard, Karen C.; Bregu, Migena; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Holland, Karen; Kiss-Toth, Endre] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Xu Yaobo] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	University of Oxford; Jenner Institute; University of Sheffield; Newcastle University - UK	Wyllie, DH (corresponding author), Univ Oxford, Jenner Inst, Old Rd,Campus Res Bldg, Oxford, England.	e.kiss-toth@sheffield.ac.uk	Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Gates Foundation; Sheffield National Institute for Health Research Cardiovascular Biomedical Research Unit	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Gates Foundation; Sheffield National Institute for Health Research Cardiovascular Biomedical Research Unit	This work was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Gates Foundation. Support to fund KH was received from the Sheffield National Institute for Health Research Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Caunt CJ, 2001, J BIOL CHEM, V276, P6280, DOI 10.1074/jbc.M006772200; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cooke EL, 2001, BIOCHEM J, V359, P403, DOI 10.1042/0264-6021:3590403; Eder K, 2008, INT IMMUNOL, V20, P1543, DOI 10.1093/intimm/dxn116; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gordon A, 2010, J ORTHOP RES, V28, P1127, DOI 10.1002/jor.21135; Guan HT, 2008, ADV BIOCHEM ENG BIOT, V110, P1, DOI 10.1007/10_2007_092; Guan HT, 2008, J IMMUNOL METHODS, V330, P96, DOI 10.1016/j.jim.2007.11.002; Guan HT, 2006, CELL IMMUNOL, V244, P158, DOI 10.1016/j.cellimm.2007.02.011; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hemmerich S, 2001, DRUG DISCOV TODAY, V6, P27, DOI 10.1016/S1359-6446(00)01581-6; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Kawashima H, 2012, ANN NY ACAD SCI, V1253, P112, DOI 10.1111/j.1749-6632.2011.06356.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiss-Toth E, 2005, BIOCHEM SOC T, V33, P1405, DOI 10.1042/BST0331405; Kiss-Toth E, 2006, CELL SIGNAL, V18, P202, DOI 10.1016/j.cellsig.2005.04.012; Kiss-Toth E, 2000, J IMMUNOL METHODS, V239, P125, DOI 10.1016/S0022-1759(00)00151-4; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kiss-Toth E, 2004, CYTOKINE GROWTH F R, V15, P97, DOI 10.1016/j.cytogfr.2004.02.002; Larsen KC, 2009, VACCINE, V27, P5589, DOI 10.1016/j.vaccine.2009.07.025; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Ozen S, 2006, J RHEUMATOL, V33, P2498; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Smith SM, 2011, J IMMUNOL; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trottein F, 2009, GLYCOCONJUGATE J, V26, P1259, DOI 10.1007/s10719-009-9244-y; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42388	10.1371/journal.pone.0042388	http://dx.doi.org/10.1371/journal.pone.0042388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860121	gold, Green Published, Green Accepted			2022-12-27	WOS:000307045600097
J	Braun, A; Auerswald, K; Geist, J				Braun, Alexander; Auerswald, Karl; Geist, Juergen			Drivers and Spatio-Temporal Extent of Hyporheic Patch Variation: Implications for Sampling	PLOS ONE			English	Article							SPATIAL HETEROGENEITY; HIERARCHICAL FRAMEWORK; HABITAT SUITABILITY; SOIL PROPERTIES; RIVER SYSTEM; STREAM; ECOLOGY; DENSITY; CLASSIFICATION; PHOSPHORUS	The hyporheic zone in stream ecosystems is a heterogeneous key habitat for species across many taxa. Consequently, it attracts high attention among freshwater scientists, but generally applicable guidelines on sampling strategies are lacking. Thus, the objective of this study was to develop and validate such sampling guidelines. Applying geostatistical analysis, we quantified the spatio-temporal variability of parameters, which characterize the physico-chemical substratum conditions in the hyporheic zone. We investigated eight stream reaches in six small streams that are typical for the majority of temperate areas. Data was collected on two occasions in six stream reaches (development data), and once in two additional reaches, after one year (validation data). In this study, the term spatial variability refers to patch contrast (patch to patch variance) and patch size (spatial extent of a patch). Patch contrast of hyporheic parameters (specific conductance, pH and dissolved oxygen) increased with macrophyte cover (r(2) = 0.95, p<0.001), while patch size of hyporheic parameters decreased from 6 to 2 m with increasing sinuosity of the stream course (r(2) = 0.91, p<0.001), irrespective of the time of year. Since the spatial variability of hyporheic parameters varied between stream reaches, our results suggest that sampling design should be adapted to suit specific stream reaches. The distance between sampling sites should be inversely related to the sinuosity, while the number of samples should be related to macrophyte cover.	[Braun, Alexander; Geist, Juergen] Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, Freising Weihenstephan, Germany; [Braun, Alexander; Auerswald, Karl] Tech Univ Munich, Dept Plant Sci, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich	Braun, A (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Aquat Syst Biol Unit, Freising Weihenstephan, Germany.	Geist@wzw.tum.de	Auerswald, Karl/C-5186-2008; Geist, Juergen/C-4933-2008; Braun, Alexander AB/G-2589-2010	Auerswald, Karl/0000-0001-5275-4320; Geist, Juergen/0000-0001-7698-3443; Braun, Alexander AB/0000-0003-0610-9827	Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany	We would like to thank Joachim Pander, Melanie Mueller and Kathrin Groissmeier for their help during the field sampling. A.B. gratefully acknowledges the support by the Faculty Graduate Center Weihenstephan of TUM Graduate School at Technische Universitat Munchen, Germany. We appreciate the valuable comments of two anonymous reviewers.	Albert CH, 2010, ECOGRAPHY, V33, P1028, DOI 10.1111/j.1600-0587.2010.06421.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; BELL G, 1991, J ECOL, V79, P663, DOI 10.2307/2260660; Blettler M, 2008, RIVER RES APPL, V24, P1124, DOI 10.1002/rra.1115; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buss S, 2009, SC050070 ENV AG BRIS; CANTRELL RS, 1991, J MATH BIOL, V29, P315, DOI 10.1007/BF00167155; DAVIS JA, 1989, FRESHWATER BIOL, V21, P271, DOI 10.1111/j.1365-2427.1989.tb01365.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; DUTILLEUL P, 1993, OIKOS, V66, P152, DOI 10.2307/3545210; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Flotemersch JE, 2011, RIVER RES APPL, V27, P520, DOI 10.1002/rra.1367; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Geist J, 2007, FRESHWATER BIOL, V52, P2299, DOI 10.1111/j.1365-2427.2007.01812.x; Geist J, 2011, ECOL INDIC, V11, P1507, DOI 10.1016/j.ecolind.2011.04.002; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; JACKSON RB, 1993, J ECOL, V81, P683, DOI 10.2307/2261666; Jowett IG, 2003, RIVER RES APPL, V19, P495, DOI 10.1002/rra.734; KELLER EA, 1978, GEOL SOC AM BULL, V89, P723, DOI 10.1130/0016-7606(1978)89<723:RSAOOP>2.0.CO;2; Kerry Ruth, 2003, Precision Agriculture, V4, P261, DOI 10.1023/A:1024952406744; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Ladson AR, 2006, RIVER RES APPL, V22, P853, DOI 10.1002/rra.940; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Lorenz AW, 2009, ENVIRON MANAGE, V44, P745, DOI 10.1007/s00267-009-9350-4; Matheron G, 1965, VARIABLES REGIONALIS; Palmer MA, 1997, J N AM BENTHOL SOC, V16, P189, DOI 10.2307/1468251; Pearson SM, 2001, ENVIRONMETRICS, V12, P81, DOI 10.1002/1099-095X(200102)12:1<81::AID-ENV449>3.0.CO;2-7; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; PRINGLE CM, 1990, ECOLOGY, V71, P905, DOI 10.2307/1937362; Rooney N, 2003, ECOSYSTEMS, V6, P797, DOI 10.1007/s10021-003-0184-2; Sachs L, 2009, ANGEW STAT METHODENS; Schulz M, 2005, AQUAT GEOCHEM, V11, P89, DOI 10.1007/s10498-004-2247-1; Schwoerbel J., 2005, EINFUHRUNG LIMNOLOGI; Smith DR, 2011, RIVER RES APPL, V27, P122, DOI 10.1002/rra.1334; STANFORD JA, 1993, J N AM BENTHOL SOC, V12, P48, DOI 10.2307/1467685; StatSoft Inc, 2008, STATISTICA DAT AN SO; Sternecker K, 2010, ECOL FRESHW FISH, V19, P537, DOI 10.1111/j.1600-0633.2010.00432.x; SVENDSEN LM, 1993, HYDROBIOLOGIA, V251, P123, DOI 10.1007/BF00007172; THOMPSON SK, 2002, SAMPLING; Tornes E, 2010, MAR FRESHWATER RES, V61, P441, DOI 10.1071/MF09095; WEBSTER R, 1992, J SOIL SCI, V43, P177, DOI 10.1111/j.1365-2389.1992.tb00128.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	49	39	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42046	10.1371/journal.pone.0042046	http://dx.doi.org/10.1371/journal.pone.0042046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860053	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900063
J	Heath, KD; McGhee, KE				Heath, Katy D.; McGhee, Katie E.			Coevolutionary Constraints? The Environment Alters Tripartite Interaction Traits in a Legume	PLOS ONE			English	Article							QUANTITATIVE GENETIC-ANALYSIS; JASMONIC ACID; PLANT; EVOLUTION; COMMUNITY; RESISTANCE; TOLERANCE; HERBIVORY; MUTUALISM; SELECTION	Third party species, which interact with one or both partners of a pairwise species interaction, can shift the ecological costs and the evolutionary trajectory of the focal interaction. Shared genes that mediate a host's interactions with multiple partners have the potential to generate evolutionary constraints, making multi-player interactions critical to our understanding of the evolution of key interaction traits. Using a field quantitative genetics approach, we studied phenotypic and genetic correlations among legume traits for rhizobium and herbivore interactions in two light environments. Shifts in plant biomass allocation mediated negative phenotypic correlations between symbiotic nodule number and herbivory in the field, whereas positive genetic covariances suggested shared genetic pathways between nodulation and herbivory response. Trait variance-covariance (G) matrices were not equal in sun and shade, but nevertheless responses to independent and correlated selection are expected to be similar in both environments. Interactions between plants and aboveground antagonists might alter the evolutionary potential of traits mediating belowground mutualisms (and vice versa). Thus our understanding of legume-rhizobium genetics and coevolution may be incomplete without a grasp of how these networks overlap with other plant interactions.	[Heath, Katy D.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [McGhee, Katie E.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Heath, KD (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	kheath@illinois.edu		McGhee, Katie/0000-0002-7965-5020	NSF IOS [1121980]	NSF IOS(National Science Foundation (NSF))	K.E.M. was supported by NSF IOS 1121980. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; Armbruster WS, 1996, J EVOLUTION BIOL, V9, P261, DOI 10.1046/j.1420-9101.1996.9030261.x; Babst BA, 2005, NEW PHYTOL, V167, P63, DOI 10.1111/j.1469-8137.2005.01388.x; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bonnin I, 1997, THEOR APPL GENET, V94, P641, DOI 10.1007/s001220050461; Bonnin I, 1996, GENETICS, V143, P1795; Calsbeek B, 2009, EVOLUTION, V63, P2627, DOI 10.1111/j.1558-5646.2009.00735.x; Cheverud JM, 1996, J EVOLUTION BIOL, V9, P5, DOI 10.1046/j.1420-9101.1996.9010005.x; Dean JM, 2009, PLANT SOIL, V323, P187, DOI 10.1007/s11104-009-9924-1; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Doroszuk A, 2008, AM NAT, V171, P291, DOI 10.1086/527478; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Ferguson BJ, 2003, J PLANT GROWTH REGUL, V22, P47, DOI 10.1007/s00344-003-0032-9; Fry J.D., 2004, GENETIC ANAL COMPLEX; Goodnight CJ, 2011, PHILOS T R SOC B, V366, P1401, DOI 10.1098/rstb.2010.0290; GOODNIGHT CJ, 1989, AM NAT, V133, P888, DOI 10.1086/284958; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2008, J WILDLIFE MANAGE, V72, P14, DOI 10.2193/2007-307; Hause B, 2007, PHYTOCHEMISTRY, V68, P101, DOI 10.1016/j.phytochem.2006.09.025; Hause B, 2009, PHYTOCHEMISTRY, V70, P1589, DOI 10.1016/j.phytochem.2009.07.003; Heath KD, 2007, P ROY SOC B-BIOL SCI, V274, P1905, DOI 10.1098/rspb.2007.0495; Heath KD, 2011, ACTA OECOL, V37, P87, DOI 10.1016/j.actao.2010.12.002; Heath KD, 2010, EVOLUTION, V64, P1446, DOI 10.1111/j.1558-5646.2009.00913.x; Henkes GJ, 2008, PLANT CELL ENVIRON, V31, P1229, DOI 10.1111/j.1365-3040.2008.01828.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Houle D, 2011, Q REV BIOL, V86, P3, DOI 10.1086/658408; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Kiers ET, 2010, FUNCT ECOL, V24, P434, DOI 10.1111/j.1365-2435.2009.01625.x; Kliebenstein DJ, 2010, PLANT PHYSIOL, V152, P480, DOI 10.1104/pp.109.149328; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Lau JA, 2008, ECOLOGY, V89, P1023, DOI 10.1890/06-1999.1; Lau JA, 2012, ACTA OECOL, V39, P80, DOI 10.1016/j.actao.2012.01.004; LAW R, 1986, BIOL J LINN SOC, V27, P251, DOI 10.1111/j.1095-8312.1986.tb01736.x; Marais DLD, 2010, ANN NY ACAD SCI, V1206, P56, DOI 10.1111/j.1749-6632.2010.05703.x; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Parker MA, 1999, AM NAT, V153, pS48, DOI 10.1086/303211; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Rudgers JA, 2004, P ROY SOC B-BIOL SCI, V271, P2481, DOI 10.1098/rspb.2004.2900; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Stinchcombe JR, 2010, EVOLUTION, V64, P2887, DOI 10.1111/j.1558-5646.2010.01060.x; Stinchcombe JR, 2002, P ROY SOC B-BIOL SCI, V269, P1241, DOI 10.1098/rspb.2002.2015; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; Tscharntke T, 2008, MULTITROPHIC LEVEL I; WADE MJ, 1977, EVOLUTION, V31, P134, DOI 10.1111/j.1558-5646.1977.tb00991.x; WOOTTON JT, 1994, ECOLOGY, V75, P1544, DOI 10.2307/1939615; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	55	7	7	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41567	10.1371/journal.pone.0041567	http://dx.doi.org/10.1371/journal.pone.0041567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859998	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900029
J	Del Cid, N; Shen, LJ; BelleIsle, J; Raghavan, M				Del Cid, Natasha; Shen, Lianjun; BelleIsle, Janice; Raghavan, Malini			Assessment of Roles for Calreticulin in the Cross-Presentation of Soluble and Bead-Associated Antigens	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; T-CELL-ACTIVATION; SCAVENGER RECEPTOR; ENDOPLASMIC-RETICULUM; PRESENTING CELLS; APOPTOTIC CELLS; STEADY-STATE; PEPTIDES; TLR4; RESPONSES	Antigen cross-presentation involves the uptake and processing of exogenously derived antigens and their assembly with major histocompatibility complex (MHC) class I molecules. Antigen presenting cells (APC) load peptides derived from the exogenous antigens onto MHC class I molecules for presentation to CD8 T cells. Calreticulin has been suggested to mediate and enhance antigen cross-presentation of soluble and cell-derived antigens. In this study, we examined roles for calreticulin in cross-presentation of ovalbumin using a number of models. Our findings indicate that calreticulin does not enhance in vitro cross-presentation of an ovalbumin-derived peptide, or of fused or bead-associated ovalbumin. Additionally, in vivo, calreticulin fusion or co-conjugation does not enhance the efficiency of CD8 T cell activation by soluble or bead-associated ovalbumin either in wild type mice or in mice lacking Toll-like receptor 4 (TLR4). Furthermore, we detect no significant differences in cross-presentation efficiencies of glycosylated vs. non-glycosylated forms of ovalbumin. Together, these results point to the redundancies in pathways for uptake of soluble and bead-associated antigens.	[Del Cid, Natasha; Raghavan, Malini] Univ Michigan, Grad Program Immunol, Sch Med, Ann Arbor, MI USA; [Del Cid, Natasha; Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Shen, Lianjun; BelleIsle, Janice] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester	Del Cid, N (corresponding author), Univ Michigan, Grad Program Immunol, Sch Med, Ann Arbor, MI USA.	malinir@umich.edu			National Institutes of Health [AI066131]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by the National Institutes of Health (grant number AI066131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; Berwin B, 2004, J BIOL CHEM, V279, P51250, DOI 10.1074/jbc.M406202200; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Binder RJ, 2005, NAT IMMUNOL, V6, P593, DOI 10.1038/ni1201; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Burgdorf S, 2010, P NATL ACAD SCI USA, V107, pE48, DOI 10.1073/pnas.1000598107; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hoshino K, 1999, J IMMUNOL, V162, P3749; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Nair S, 1999, J IMMUNOL, V162, P6426; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Peters LR, 2011, J IMMUNOL; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Segura E, 2009, P NATL ACAD SCI USA, V106, P20377, DOI 10.1073/pnas.0910295106; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41727	10.1371/journal.pone.0041727	http://dx.doi.org/10.1371/journal.pone.0041727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848581	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200097
J	Jiang, CM; Hamm, JP; Kim, VK; Kirk, IJ; Chen, XH; Yang, YF				Jiang, Cunmei; Hamm, Jeff P.; Kim, Vanessa K.; Kirk, Ian J.; Chen, Xuhai; Yang, Yufang			Amusia Results in Abnormal Brain Activity following Inappropriate Intonation during Speech Comprehension	PLOS ONE			English	Article							SPOKEN SENTENCE COMPREHENSION; GRAINED PITCH DISCRIMINATION; CONGENITAL AMUSIA; TONE-DEAFNESS; LANGUAGE EXPERIENCE; MANDARIN CHINESE; ABSOLUTE PITCH; WORKING-MEMORY; MUSIC; PERCEPTION	Pitch processing is a critical ability on which humans' tonal musical experience depends, and which is also of paramount importance for decoding prosody in speech. Congenital amusia refers to deficits in the ability to properly process musical pitch, and recent evidence has suggested that this musical pitch disorder may impact upon the processing of speech sounds. Here we present the first electrophysiological evidence demonstrating that individuals with amusia who speak Mandarin Chinese are impaired in classifying prosody as appropriate or inappropriate during a speech comprehension task. When presented with inappropriate prosody stimuli, control participants elicited a larger P600 and smaller N100 relative to the appropriate condition. In contrast, amusics did not show significant difference between the appropriate and inappropriate conditions in either the N100 or the P600 component. This provides further evidence that the pitch perception deficits associated with amusia may also affect intonation processing during speech comprehension in those who speak a tonal language such as Mandrian, and suggests music and language share some cognitive and neural resources.	[Jiang, Cunmei] Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China; [Jiang, Cunmei; Yang, Yufang] Chinese Acad Med Sci, Inst Psychol, Beijing 100730, Peoples R China; [Hamm, Jeff P.; Kim, Vanessa K.; Kirk, Ian J.] Univ Auckland, Res Ctr Cognit Neurosci, Auckland 1, New Zealand; [Chen, Xuhai] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China	Shanghai Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; University of Auckland; Shaanxi Normal University	Jiang, CM (corresponding author), Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China.	j.hamm@auckland.ac.nz; yangyf@psych.ac.cn	Jiang, Jan/ABF-1730-2020; Kirk, Ian/L-5954-2019	Kirk, Ian/0000-0002-0444-6718; Jiang, Cunmei/0000-0002-0264-5924	National Natural Science Foundation of China [31070988]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31070988) to YY. The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila A, 2010, LANG COGNITIVE PROC, V25, P946, DOI 10.1080/01690960903525481; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Beijing Institute of Language, 1986, MOD CHIN FREQ DICT; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Braun B, 2010, LANG COGNITIVE PROC, V25, P1024, DOI 10.1080/01690960903036836; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Christophe A, 2003, J PHONETICS, V31, P585, DOI 10.1016/S0095-4470(03)00040-8; Cole J, 2010, LANG COGNITIVE PROC, V25, P1141, DOI 10.1080/01690960903525507; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Dwivedi VD, 2006, BRAIN RES, V1117, P135, DOI 10.1016/j.brainres.2006.07.048; Eckstein K, 2005, COGNITIVE BRAIN RES, V25, P130, DOI 10.1016/j.cogbrainres.2005.05.003; feng s., 2000, PROSODIC SYNTAX CHIN; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Gosselin N, 2009, ANN NY ACAD SCI, V1169, P270, DOI 10.1111/j.1749-6632.2009.04762.x; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; HAGOORT P, 1999, NEUROCOGNITION LANGU, P271; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Hutchins S, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00236; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Jiang CM, 2012, MEM COGNITION, V40, P1109, DOI 10.3758/s13421-012-0208-2; Jiang CM, 2011, MUSIC PERCEPT, V28, P519, DOI 10.1525/MP.2011.28.5.519; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; Johnson BW, 2000, CLIN NEUROPHYSIOL, V111, P532, DOI 10.1016/S1388-2457(99)00270-9; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kaan E, 2003, COGNITIVE BRAIN RES, V17, P621, DOI 10.1016/S0926-6410(03)00175-7; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; KLUENDER R, 1993, J COGNITIVE NEUROSCI, V5, P196, DOI 10.1162/jocn.1993.5.2.196; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lim VK, 2009, BRAIN COGNITION, V71, P306, DOI 10.1016/j.bandc.2009.07.004; Lin M. C., 2006, CHINESE LANGUAGE, V4, P364; Lin Maocan, 2004, APPL LINGUISTICS, V3, P57; Liu F, 2005, PHONETICA, V62, P70, DOI 10.1159/000090090; Liu F, 2012, BRAIN COGNITION, V79, P209, DOI 10.1016/j.bandc.2012.03.008; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030374; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Mandell J, 2007, RESTOR NEUROL NEUROS, V25, P323; MARSLENWILSON WD, 1992, Q J EXP PSYCHOL-A, V45, P73, DOI 10.1080/14640749208401316; McKinnon R, 1996, LANG COGNITIVE PROC, V11, P495, DOI 10.1080/016909696387132; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Mietz A, 2008, BRAIN LANG, V104, P159, DOI 10.1016/j.bandl.2007.03.005; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nakano H, 2010, J COGNITIVE NEUROSCI, V22, P2886, DOI 10.1162/jocn.2009.21400; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Patel A.D., 2012, LANGUAGE MUSIC COGNI, P204, DOI [DOI 10.1093/ACPROF:OSO/9780199553426.003.0022, 10.1093/acprof:oso/9780195123753.001.0001, DOI 10.1093/ACPROF:OSO/9780195123753.001.0001]; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I., 1989, CONTEMP MUSIC REV, V4, P277, DOI [10.1080/07494468900640361, DOI 10.1080/07494468900640361]; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; Plantinga J, 2005, COGNITION, V98, P1, DOI 10.1016/j.cognition.2004.09.008; Schafer AJ, 2000, J PSYCHOLINGUIST RES, V29, P169, DOI 10.1023/A:1005192911512; Schepman A, 2000, Q J EXP PSYCHOL-A, V53, P377, DOI 10.1080/027249800390538; SHEN XS, 1993, PHONETICA, V50, P261, DOI 10.1159/000261946; Speer SR, 1996, J PSYCHOLINGUIST RES, V25, P249, DOI 10.1007/BF01708573; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; THOMPSON WF, 2007, P INT C MUS COMM SCI, P159; Tillmann B, 2011, J ACOUST SOC AM, V130, P4089, DOI 10.1121/1.3658447; Tillmann B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00120; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Xu Y., 2011, J SPEECH SCI, V1, P85, DOI DOI 10.20396/JOSS.V1I1.15014; Zhou XL, 2010, NEUROPSYCHOLOGIA, V48, P1551, DOI 10.1016/j.neuropsychologia.2010.02.001	85	68	70	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41411	10.1371/journal.pone.0041411	http://dx.doi.org/10.1371/journal.pone.0041411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22859982	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950200061
J	Liu, PP; Shi, YL; Yang, YX; Cao, YF; Shi, YJ; Li, H; Liu, JM; Lin, JJ; Jin, YM				Liu, Pingping; Shi, Yanli; Yang, Yunxia; Cao, Yufan; Shi, Yaojun; Li, Hao; Liu, Jinming; Lin, Jiaojiao; Jin, Yamei			Schistosoma Japonicum UDP-Glucose 4-Epimerase Protein Is Located on the Tegument and Induces Moderate Protection against Challenge Infection	PLOS ONE			English	Article							MANSONI; SURFACE; GALE; INTERLEUKIN-12; SM29	Schistosomiasis is an important global public health problem, as millions of people are at risk of acquiring this infection. An ideal method for sustainable control of schistosomiasis is using a vaccine alone or in combination with drugs. In the present study, we cloned the SjGALE gene and generated the expression product in E. coli. The expression level of SjGALE during different developmental stages of S. japonicum was evaluated by real-time RT-PCR and western blotting. Immunolocalization indicated that the protein was mainly located on the tegument of the parasite. Infection of rSjGALE-immunized mice demonstrated a 34% and 49% reduction of the mean worm burden and liver egg burden, respectively, in two independent experiments, indicating immune protection. The liver egg count from each female adult worm was significantly reduced by 63% in the two trials. The cytokine profile and IgG isotype analysis demonstrated the induction of a Th1 immune profile in response to immunization with this protein, further suggesting protection against infection. In conclusion, these findings indicated that SjGALE is a potential vaccine against S. japonicum.	[Liu, Pingping; Shi, Yanli; Yang, Yunxia; Cao, Yufan; Shi, Yaojun; Li, Hao; Liu, Jinming; Lin, Jiaojiao; Jin, Yamei] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Natl Lab Anim Schistosomiasis Control, Minist Agr,Key Lab Anim Parasitol, Shanghai, Peoples R China; [Shi, Yanli] NE Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Liu, PP (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Natl Lab Anim Schistosomiasis Control, Minist Agr,Key Lab Anim Parasitol, Shanghai, Peoples R China.	yameijin@shvri.ac.cn			Chinese National Natural Science Foundation [30800819, 31072129]; Shanghai Pujiang Program [09PJ14118]; Basic scientific research operation cost of state-leveled public welfare scientific research courtyard [2012ZL091]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Basic scientific research operation cost of state-leveled public welfare scientific research courtyard	This work was supported by Chinese National Natural Science Foundation (No. 30800819, No. 31072129), Shanghai Pujiang Program (No. 09PJ14118) and Basic scientific research operation cost of state-leveled public welfare scientific research courtyard (No. 2012ZL091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzone LE, 2008, INFECT IMMUN, V76, P5164, DOI 10.1128/IAI.00673-08; Bergquist NR, 2002, TRENDS PARASITOL, V18, P309, DOI 10.1016/S1471-4922(02)02301-2; Bergquist NR, 1998, PARASITOL TODAY, V14, P99, DOI 10.1016/S0169-4758(97)01207-6; Bergquist R, 2002, ACTA TROP, V82, P183, DOI 10.1016/S0001-706X(02)00048-7; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Boels IC, 2001, APPL ENVIRON MICROB, V67, P3033, DOI 10.1128/AEM.67.7.3033-3040.2001; Cardoso FC, 2006, CLIN EXP IMMUNOL, V144, P382, DOI 10.1111/j.1365-2249.2006.03081.x; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; CREMERS HCJC, 1990, J BIOL CHEM, V265, P21122; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Harder A, 2002, PARASITOL RES, V88, P395, DOI 10.1007/s00436-001-0588-x; Hewitson JP, 2005, PARASITE IMMUNOL, V27, P271, DOI 10.1111/j.1365-3024.2005.00764.x; Jones MK, 2004, BIOESSAYS, V26, P752, DOI 10.1002/bies.20058; Katae M, 2002, INFECT IMMUN, V70, P4833, DOI 10.1128/IAI.70.9.4833-4840.2002; Kresge N, 2005, J BIOL CHEM, V280, P158; Layland LE, 2005, EUR J IMMUNOL, V35, P3248, DOI 10.1002/eji.200526273; Letscher-Bru V, 1998, INFECT IMMUN, V66, P4503; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu YJ, 1996, BIOCHEMISTRY-US, V35, P7615, DOI 10.1021/bi960102v; Lopes DO, 2009, VACCINE, V27, P4127, DOI 10.1016/j.vaccine.2009.04.068; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; LoVerde PT, 2004, CAN J ZOOL, V82, P357, DOI 10.1139/Z03-217; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Novelli G, 2000, MOL GENET METAB, V71, P62, DOI 10.1006/mgme.2000.3073; Qian Men-bao, 2008, Chinese Journal of Parasitology and Parasitic Diseases, V26, P466; Sanders RD, 2010, DIS MODEL MECH, V3, P628, DOI 10.1242/dmm.005058; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Urbaniak MD, 2006, EUKARYOT CELL, V5, P1906, DOI 10.1128/EC.00156-06; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; von Lichtenberg F., 1987, P185; Zhou S. L., 2001, SCHISTOSOMA SCI	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42050	10.1371/journal.pone.0042050	http://dx.doi.org/10.1371/journal.pone.0042050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848700	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200150
J	Canestrelli, D; Salvi, D; Maura, M; Bologna, MA; Nascetti, G				Canestrelli, Daniele; Salvi, Daniele; Maura, Michela; Bologna, Marco A.; Nascetti, Giuseppe			One Species, Three Pleistocene Evolutionary Histories: Phylogeography the Italian Crested Newt, Triturus carnifex	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; GLACIAL REFUGIA; GENETIC DIVERSITY; MULTIPLE REFUGIA; MOLECULAR PHYLOGEOGRAPHY; MEDITERRANEAN REGION; SOFTWARE PACKAGE; CLIMATE CHANGES; SEQUENCE DATA; HYBRID ZONES	Phylogeographic patterns of temperate species from the Mediterranean peninsulas have been investigated intensively. Nevertheless, as more phylogeographies become available, either unique patterns or new lines of concordance continue to emerge, providing new insights on the evolution of regional biotas. Here, we investigated the phylogeography and evolutionary history of the Italian crested newt, Triturus carnifex, through phylogenetic, molecular dating and population structure analyses of two mitochondrial gene fragments (ND2 and ND4; overall 1273 bp). We found three main mtDNA lineages having parapatric distribution and estimated divergence times between Late Pliocene and Early Pleistocene. One lineage (S) was widespread south of the northern Apennine chain and was further geographically structured into five sublineages, likely of Middle Pleistocene origin. The second lineage (C) was widespread throughout the Padano-Venetian plain and did not show a clear phylogeographic structure. The third lineage (N) was observed in only two populations located on western Croatia/Slovenia. Results of analysis of molecular variance suggested that partitioning populations according to the geographic distribution of these lineages and sublineages explains 76% of the observed genetic variation. The phylogeographic structure observed within T. carnifex and divergence time estimates among its lineages, suggest that responses to Pleistocene environmental changes in this single species have been as diverse as those found previously among several codistributed temperate species combined. Consistent with the landscape heterogeneity, physiographic features, and palaeogeographical evolution of its distribution range, these responses encompass multiple refugia along the Apennine chain, lowland refugia in large peri-coastal plains, and a 'cryptic' northern refugium.	[Canestrelli, Daniele; Nascetti, Giuseppe] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy; [Salvi, Daniele] Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Maura, Michela; Bologna, Marco A.] Univ Roma Tre, Dipartimento Biol Ambientale, Rome, Italy	Tuscia University; Universidade do Porto; Roma Tre University	Canestrelli, D (corresponding author), Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy.	canestrelli@unitus.it	Canestrelli, Daniele/N-1724-2015; Salvi, Daniele/I-6360-2013; Nascetti, Giuseppe/AAA-6396-2020	Canestrelli, Daniele/0000-0001-9351-4972; Salvi, Daniele/0000-0002-3804-2690; BOLOGNA, Marco Alberto/0000-0003-2498-8917; Nascetti, Giuseppe/0000-0002-1159-8103	Agenzia Regionale dei Parchi (ARP-Lazio); PRIN project from 'Ministero dell'Istruzione, dell'Universita e della Ricerca' (MIUR, Italy) [20085YJMTC]; FCT [SFRH/BPD/66592/2009]	Agenzia Regionale dei Parchi (ARP-Lazio); PRIN project from 'Ministero dell'Istruzione, dell'Universita e della Ricerca' (MIUR, Italy); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by the Agenzia Regionale dei Parchi (ARP-Lazio) and by the PRIN project 20085YJMTC from 'Ministero dell'Istruzione, dell'Universita e della Ricerca' (MIUR, Italy). DS is supported by FCT post-doctoral grant SFRH/BPD/66592/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Amann Toni, 1997, Salamandra, V33, P255; Amorosi A, 2004, GLOBAL PLANET CHANGE, V40, P55, DOI 10.1016/S0921-8181(03)00098-5; Amorosi A, 1999, QUATERNARY RES, V52, P1, DOI 10.1006/qres.1999.2049; Andreone F., 2006, ATLANTE ANFIBI RETTI, P220; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arntzen JW, 2007, CONTRIB ZOOL, V76, P261, DOI 10.1163/18759866-07604005; ARNTZEN JW, 1991, EVOLUTION, V45, P805, DOI 10.1111/j.1558-5646.1991.tb04352.x; Arntzen JW, 2001, BIODIVERS CONSERV, V10, P971, DOI 10.1023/A:1016644814551; Audisio P, 2009, J ZOOL SYST EVOL RES, V47, P88, DOI 10.1111/j.1439-0469.2008.00475.x; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Babik W, 2005, MOL ECOL, V14, P2475, DOI 10.1111/j.1365-294X.2005.02605.x; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Barron E, 2002, QUATERNARY RES, V58, P296, DOI 10.1006/qres.2002.2374; Bertini A, 2003, QUATERNARIO, V16, P19; Bertini A, 2010, QUATERN INT, V225, P5, DOI 10.1016/j.quaint.2010.04.025; BERTOLDI R, 1989, PALAEOGEOGR PALAEOCL, V72, P263, DOI 10.1016/0031-0182(89)90146-6; Bisconti R, 2011, MOL ECOL, V20, P5313, DOI 10.1111/j.1365-294X.2011.05363.x; Blondel J, 2010, MEDITERRANEAN REGION; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Burns EL, 2007, CONSERV GENET, V8, P17, DOI 10.1007/s10592-006-9143-8; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Canestrelli D, 2008, MOL ECOL, V17, P3856, DOI 10.1111/j.1365-294X.2008.03870.x; Canestrelli D, 2008, J BIOGEOGR, V35, P1923, DOI 10.1111/j.1365-2699.2008.01946.x; Canestrelli D, 2007, MOL ECOL, V16, P4808, DOI 10.1111/j.1365-294X.2007.03534.x; Canestrelli D, 2006, MOL ECOL, V15, P3741, DOI 10.1111/j.1365-294X.2006.03055.x; Canestrelli D, 2012, BIOL J LINN SOC, V105, P42, DOI 10.1111/j.1095-8312.2011.01767.x; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Combourieu-Nebout N, 1991, QUATERNARY SCI REV, V10, P319; Correggiari A., 1996, ALP MEDITERR QUAT, V9, P697; Di Giovanni MV, 1998, ITAL J ZOOL, V65, P393; Doyle J. J., 1987, PHYTOCHEM B, P11; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Garzanti E, 2011, EARTH-SCI REV, V105, P25, DOI 10.1016/j.earscirev.2010.11.004; Geospiza Inc Finch TV, GEOSP INC FINCH TV V; GIACOMA C, 1988, MONIT ZOOL ITAL, V22, P449; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Goncalves H, 2009, MOL ECOL, V18, P5143, DOI 10.1111/j.1365-294X.2009.04426.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P78; Hewitt Godfrey M., 2011, P123; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Hornsby AD, 2012, J BIOGEOGR, V39, P289, DOI 10.1111/j.1365-2699.2011.02616.x; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Jehle R, 2011, CRESTED NEWT DWILLIN, P152; Joannin S, 2007, QUATERNARY RES, V67, P264, DOI 10.1016/j.yqres.2006.11.001; Kahlke RD, 2011, QUATERNARY SCI REV, V30, P1368, DOI 10.1016/j.quascirev.2010.07.020; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Klotz S, 2006, EARTH PLANET SC LETT, V241, P174, DOI 10.1016/j.epsl.2005.10.005; Kostopoulos DS, 2007, GEODIVERSITAS, V29, P401; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larmuseau MHD, 2009, J BIOGEOGR, V36, P1138, DOI 10.1111/j.1365-2699.2008.02072.x; Lucchi MR, 2008, QUATERNARY SCI REV, V27, P2456, DOI 10.1016/j.quascirev.2008.09.009; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Marske KA, 2009, MOL ECOL, V18, P5126, DOI 10.1111/j.1365-294X.2009.04418.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Nascetti G., 2005, REND LINCEI-SCI FIS, V16, P159, DOI DOI 10.1007/BF02904763; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavignano I, 1990, ALYTES, V7, P77; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Podnar M, 2005, MOL ECOL, V14, P575, DOI 10.1111/j.1365-294X.2005.02427.x; Porretta D, 2011, J BIOGEOGR, V38, P20, DOI 10.1111/j.1365-2699.2010.02385.x; Posada D., 2003, CURRENT PROTOCOLS BI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Provan J., 2011, P ROYAL SOC B, V279, P39; Recuero E, 2011, MOL PHYLOGENET EVOL, V60, P170, DOI 10.1016/j.ympev.2011.04.006; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rousset F, 1997, GENETICS, V145, P1219; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Santucci F, 1996, J EVOLUTION BIOL, V9, P429, DOI 10.1046/j.1420-9101.1996.9040429.x; Santucci F, 1998, MOL ECOL, V7, P1163, DOI 10.1046/j.1365-294x.1998.00436.x; Schabetsberger R, 2004, BIOL CONSERV, V117, P95, DOI 10.1016/S0006-3207(03)00268-4; Schneeweiss GM, 2011, MOL ECOL, V20, P190, DOI 10.1111/j.1365-294X.2010.04927.x; Scillitani G, 2000, HERPETOLOGICA, V56, P119; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Stefani F, 2004, ECOL FRESHW FISH, V13, P168, DOI 10.1111/j.1600-0633.2004.00060.x; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Themudo GE, 2009, MOL PHYLOGENET EVOL, V52, P321, DOI 10.1016/j.ympev.2009.03.024; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Ursenbacher S, 2006, MOL PHYLOGENET EVOL, V38, P546, DOI 10.1016/j.ympev.2005.08.004; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Vega R, 2010, BIOL J LINN SOC, V100, P774, DOI 10.1111/j.1095-8312.2010.01454.x; Verardi A, 2009, ANN ZOOL FENN, V46, P247, DOI 10.5735/086.046.0402; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wielstra B, 2010, MOL PHYLOGENET EVOL, V56, P888, DOI 10.1016/j.ympev.2010.04.030; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2011, MOL PHYLOGENET EVOL, V59, P342, DOI 10.1016/j.ympev.2011.01.017; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeisset I, 2001, P ROY SOC B-BIOL SCI, V268, P933, DOI 10.1098/rspb.2001.1600	114	48	48	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41754	10.1371/journal.pone.0041754	http://dx.doi.org/10.1371/journal.pone.0041754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848590	gold, Green Published, Green Submitted			2022-12-27	WOS:000309240600045
J	Kwong, AKY; Fung, CW; Chan, SY; Wong, VCN				Kwong, Anna Ka-Yee; Fung, Cheuk-Wing; Chan, Siu-Yuen; Wong, Virginia Chun-Nei			Identification of SCN1A and PCDH19 Mutations in Chinese Children with Dravet Syndrome	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; MENTAL-RETARDATION; SODIUM-CHANNEL; DE-NOVO; FEBRILE SEIZURES; FAMILY; FEMALES; SPECTRUM; INFANCY; GENES	Background: Dravet syndrome is a severe form of epilepsy. Majority of patients have a mutation in SCN1A gene, which encodes a voltage-gated sodium channel. A recent study has demonstrated that 16% of SCN1A-negative patients have a mutation in PCDH19, the gene encoding protocadherin-19. Mutations in other genes account for only a very small proportion of families. TSPYL4 is a novel candidate gene within the locus 6q16.3-q22.31 identified by linkage study. Objective: The present study examined the mutations in epileptic Chinese children with emphasis on Dravet syndrome. Methods: A hundred children with severe epilepsy were divided into Dravet syndrome and non-Dravet syndrome groups and screened for SCN1A mutations by direct sequencing. SCN1A-negative Dravet syndrome patients and patients with phenotypes resembling Dravet syndrome were checked for PCDH19 and TSPYL4 mutations. Results: Eighteen patients (9 males, 9 females) were diagnosed to have Dravet syndrome. Among them, 83% (15/18) had SCN1A mutations including truncating (7), splice site (2) and missense mutations (6). The truncating/splice site mutations were associated with moderate to severe degree of intellectual disability (p<0.05). During the progression of disease, 73% (11/15) had features fitting into the diagnostic criteria of autism spectrum disorder and 53% (8/15) had history of vaccination-induced seizures. A novel PCDH19 p. D377N mutation was identified in one SCN1A-negative female patient with Dravet syndrome and a known PCDH19 p.N340S mutation in a female non-Dravet syndrome patient. The former also inherited a TSPYL4 p.G60R variant. Conclusion: A high percentage of SCN1A mutations was identified in our Chinese cohort of Dravet syndrome patients but none in the rest of patients. We demonstrated that truncating/splice site mutations were linked to moderate to severe intellectual disability in these patients. A de novo PCDH19 missense mutation together with an inherited TSPYL4 missense variant were identified in a patient with Dravet syndrome.	[Kwong, Anna Ka-Yee; Fung, Cheuk-Wing; Chan, Siu-Yuen; Wong, Virginia Chun-Nei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Kwong, AKY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	vcnwong@hku.hk	Kwong, Ava/D-8005-2013	Kwong, Ava/0000-0002-6968-9489; Chan, Siu Yuen/0000-0001-7262-1293	Parthenon Trust via the Society for the Relief of Disabled Children	Parthenon Trust via the Society for the Relief of Disabled Children	Funding was provided by Parthenon Trust via the Society for the Relief of Disabled Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audenaert D, 2006, HUM MUTAT, V27, P391, DOI 10.1002/humu.20279; Berkovic SF, 2006, LANCET NEUROL, V5, P488, DOI 10.1016/S1474-4422(06)70446-X; Claes LRF, 2009, HUM MUTAT, V30, pE904, DOI 10.1002/humu.21083; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne Christel, 2006, Hum Mutat, V27, P389, DOI 10.1002/humu.9419; Depienne C, 2011, HUM MUTAT, V32, pE1959, DOI 10.1002/humu.21373; Depienne C, 2010, J MED GENET, V47, P404, DOI 10.1136/jmg.2009.074328; Depienne C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000381; Dibbens LM, 2011, NEUROLOGY, V76, P1514, DOI 10.1212/WNL.0b013e318217e7b6; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Dravet C., 2005, EPILEPTIC SYNDROMES, V4, P89; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Genmaro E, 2006, BIOCHEM BIOPH RES CO, V341, P489, DOI 10.1016/j.bbrc.2005.12.209; Gennaro E, 2003, EPILEPTIC DISORD, V5, P21; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guerrini R, 2011, DEV MED CHILD NEUROL, V53, P11, DOI 10.1111/j.1469-8749.2011.03966.x; Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002; Herini ES, 2010, PEDIATR INT, V52, P234, DOI 10.1111/j.1442-200X.2009.02916.x; Hynes K, 2010, J MED GENET, V47, P211, DOI 10.1136/jmg.2009.068817; Jamal SM, 2010, AM J MED GENET A, V152A, P2475, DOI 10.1002/ajmg.a.33611; Kanai K, 2004, NEUROLOGY, V63, P329, DOI 10.1212/01.WNL.0000129829.31179.5B; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Li BM, 2011, EPILEPSY BEHAV, V21, P291, DOI 10.1016/j.yebeh.2011.04.060; Mancardi MM, 2006, EPILEPSIA, V47, P1629, DOI 10.1111/j.1528-1167.2006.00641.x; Marini C, 2010, NEUROLOGY, V75, P646, DOI 10.1212/WNL.0b013e3181ed9e67; Marini C, 2007, EPILEPSIA, V48, P1678, DOI 10.1111/j.1528-1167.2007.01122.x; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Morimoto M, 2006, EPILEPSIA, V47, P1732, DOI 10.1111/j.1528-1167.2006.00645.x; Nalla VK, 2005, HUM MUTAT, V25, P334, DOI 10.1002/humu.20151; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Osaka H, 2007, EPILEPSY RES, V75, P46, DOI 10.1016/j.eplepsyres.2007.03.018; Piro RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023149; Poduri A, 2009, NEUROLOGY, V73, P1264, DOI 10.1212/WNL.0b013e3181bd10d3; Ragona F, 2011, EPILEPSIA, V52, P386, DOI 10.1111/j.1528-1167.2010.02925.x; Riva D, 2009, AM J MED GENET A, V149A, P2339, DOI 10.1002/ajmg.a.33029; Scheffer IE, 2008, BRAIN, V131, P918, DOI 10.1093/brain/awm338; Singh R, 2001, EPILEPSIA, V42, P837, DOI 10.1046/j.1528-1157.2001.042007837.x; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tro-Baumann B, 2011, EPILEPSIA, V52, P175, DOI 10.1111/j.1528-1167.2010.02885.x; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yamakawa K, 2006, EPILEPSY RES, V70, pS218, DOI 10.1016/j.eplepsyres.2005.11.025; Yu MJ, 2010, SEIZURE-EUR J EPILEP, V19, P443, DOI 10.1016/j.seizure.2010.06.010; Zuberi SM, 2011, NEUROLOGY, V76, P594, DOI 10.1212/WNL.0b013e31820c309b	50	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41802	10.1371/journal.pone.0041802	http://dx.doi.org/10.1371/journal.pone.0041802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848613	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600123
J	Xiao, O; Xie, ZL; Lin, BW; Yin, XF; Pi, RB; Zhou, SY				Xiao, Ou; Xie, Zhao-lian; Lin, Bin-wu; Yin, Xiao-fang; Pi, Rong-biao; Zhou, Shi-you			Minocycline Inhibits Alkali Burn-Induced Corneal Neovascularization in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MATRIX METALLOPROTEINASE-2; RECEPTOR ANTAGONIST; MULTIPLE-SCLEROSIS; EPITHELIAL DEFECTS; DOXYCYCLINE; ANGIOGENESIS; EXPRESSION; VEGF; DISEASE	The purpose of this study was to investigate the effects of minocycline on alkali burn-induced corneal neovascularization (CNV). A total of 105 mice treated with alkali burns were randomly divided into three groups to receive intraperitoneal injections of either phosphate buffered saline (PBS) or minocycline twice a day (60 mg/kg or 30 mg/kg) for 14 consecutive days. The area of CNV and corneal epithelial defects was measured on day 4, 7, 10, and14 after alkali burns. On day 14, a histopathological examination was performed to assess morphological change and the infiltration of polymorphonuclear neutrophils (PMNs). The mRNA expression levels of vascular endothelial growth factor (VEGF) and its receptors (VEGFRs), basic fibroblast growth factor (bFGF), matrix metalloproteinases (MMPs), interleukin-1 alpha, 1 beta, 6 (IL-1 alpha, IL-1 beta, IL-6) were analyzed using real-time quantitative polymerase chain reaction. The expression of MMP-2 and MMP-9 proteins was determined by gelatin zymography. In addition, enzyme-linked immunosorbent assay was used to analyze the protein levels of VEGFR1, VEGFR2, IL-1 beta and IL-6. Minocycline at a dose of 60 mg/kg or 30 mg/kg significantly enhanced the recovery of the corneal epithelial defects more than PBS did. There were significant decreases of corneal neovascularization in the group of high-dosage minocycline compared with the control group at all checkpoints. On day 14, the infiltrated PMNs was reduced, and the mRNA expression of VEGFR1, VEGFR2, bFGF, IL-1 beta, IL-6, MMP-2, MMP-9, -13 as well as the protein expression of VEGFR2, MMP-2, -9, IL-1 beta, IL-6 in the corneas were down-regulated with the use of 60 mg/kg minocycline twice a day. Our results showed that the intraperitoneal injection of minocycline (60 mg/kg b.i.d.) can significantly inhibit alkali burn-induced corneal neovascularization in mice, possibly by accelerating corneal wound healing and by reducing the production of angiogenic factors, inflammatory cytokines and MMPs.	[Xiao, Ou; Xie, Zhao-lian; Lin, Bin-wu; Yin, Xiao-fang; Zhou, Shi-you] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Pi, Rong-biao] Sun Yat Sen Univ, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xiao, O (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	pirb@mail.sysu.edu.cn; zhoushiy@mail.sysu.edu.cn			"Fundamental Research Funds for the Central Universities" in China [3030901009015]; NSFC-RGC HK joint project [30731160617]	"Fundamental Research Funds for the Central Universities" in China; NSFC-RGC HK joint project	The work was supported by "Fundamental Research Funds for the Central Universities" in China (grant number: 3030901009015, Shi-you Zhou) and the NSFC-RGC HK joint project (grant number: 30731160617, Rong-biao Pi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashshur ZF, 2006, AM J OPHTHALMOL, V142, P1, DOI 10.1016/j.ajo.2006.02.037; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Carter RT, 2007, CORNEA, V26, P1213, DOI 10.1097/ICO.0b013e31814b8a28; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Dana MR, 1998, CORNEA, V17, P403, DOI 10.1097/00003226-199807000-00011; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Federici TJ, 2011, PHARMACOL RES, V64, P614, DOI 10.1016/j.phrs.2011.06.013; Fortier LA, 2010, J ORTHOP RES, V28, P522, DOI 10.1002/jor.21006; GABLER WL, 1991, J PERIODONTAL RES, V26, P52, DOI 10.1111/j.1600-0765.1991.tb01626.x; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; JONAS M, 1982, THER DRUG MONIT, V4, P137; Kaiser JM, 2012, NANOMEDICIN IN PRESS; Kato T, 2001, FEBS LETT, V508, P187, DOI 10.1016/S0014-5793(01)02897-6; Kieburtz K, 2008, CLIN NEUROPHARMACOL, V31, P141, DOI 10.1097/WNF.0b013e3181342f32; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Korzyoski T, 1978, ANTIBIOTICS ORIGIN N, P508; Kvanta A, 2000, EXP EYE RES, V70, P419, DOI 10.1006/exer.1999.0790; Lahousen T, 2003, CLIN NEUROPHARMACOL, V26, P223, DOI 10.1097/00002826-200309000-00001; Li T, 2011, MOL VIS, V17, P797; Liang D, 2008, CURR EYE RES, V33, P653, DOI 10.1080/02713680802245772; Ma DHK, 2001, OPHTHALMIC RES, V33, P353, DOI 10.1159/000055693; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Masocha W, 2006, ANTIMICROB AGENTS CH, V50, P1798, DOI 10.1128/AAC.50.5.1798-1804.2006; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Pabreja K, 2011, EUR J PHARMACOL, V661, P15, DOI 10.1016/j.ejphar.2011.04.014; PERRY HD, 1986, OPHTHALMOLOGY, V93, P1320; Peyman GA, 2006, CORNEA, V25, P582, DOI 10.1097/01.ico.0000220767.73660.3a; PROIA AD, 1988, LAB INVEST, V58, P473; Ralph RA, 2000, CORNEA, V19, P274, DOI 10.1097/00003226-200005000-00003; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Stapleton WM, 2008, EXP EYE RES, V86, P753, DOI 10.1016/j.exer.2008.02.001; Su WR, 2011, INVEST OPHTH VIS SCI, V52, P9108, DOI 10.1167/iovs.11-7255; Su WR, 2011, GRAEF ARCH CLIN EXP, V249, P421, DOI 10.1007/s00417-010-1539-y; Takeshita S, 2002, J ANTIMICROB CHEMOTH, V49, P411, DOI 10.1093/jac/49.2.411; TAMARGO RJ, 1991, CANCER RES, V51, P672; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2; Yao JHS, 2007, NEUROCHEM INT, V50, P524, DOI 10.1016/j.neuint.2006.10.008; Zabad RK, 2007, MULT SCLER, V13, P517, DOI 10.1177/1352458506070319; Zhou SY, 2010, MOL VIS, V16, P1389; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	49	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41858	10.1371/journal.pone.0041858	http://dx.doi.org/10.1371/journal.pone.0041858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848638	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600136
J	Hawthorne, G; Hrisos, S; Stamp, E; Elovainio, M; Francis, JJ; Grimshaw, JM; Hunter, M; Johnston, M; Presseau, J; Steen, N; Eccles, MP				Hawthorne, Gillian; Hrisos, Susan; Stamp, Elaine; Elovainio, Marko; Francis, Jill J.; Grimshaw, Jeremy M.; Hunter, Margaret; Johnston, Marie; Presseau, Justin; Steen, Nick; Eccles, Martin P.			Diabetes Care Provision in UK Primary Care Practices	PLOS ONE			English	Article							QUALITY; OUTCOMES; ENGLAND	Background: Although most people with Type 2 diabetes receive their diabetes care in primary care, only a limited amount is known about the quality of diabetes care in this setting. We investigated the provision and receipt of diabetes care delivered in UK primary care. Methods: Postal surveys with all healthcare professionals and a random sample of 100 patients with Type 2 diabetes from 99 UK primary care practices. Results: 326/361 (90.3%) doctors, 163/186 (87.6%) nurses and 3591 patients (41.8%) returned a questionnaire. Clinicians reported giving advice about lifestyle behaviours (e. g. 88% would routinely advise about calorie restriction; 99.6% about increasing exercise) more often than patients reported having received it (43% and 42%) and correlations between clinician and patient report were low. Patients' reported levels of confidence about managing their diabetes were moderately high; a median (range) of 21% (3% to 39%) of patients reporting being not confident about various areas of diabetes self-management. Conclusions: Primary care practices have organisational structures in place and are, as judged by routine quality indicators, delivering high quality care. There remain evidence-practice gaps in the care provided and in the self confidence that patients have for key aspects of self management and further research is needed to address these issues. Future research should use robust designs and appropriately designed studies to investigate how best to improve this situation.	[Hawthorne, Gillian] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Hrisos, Susan; Stamp, Elaine; Hunter, Margaret; Presseau, Justin; Steen, Nick; Eccles, Martin P.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Elovainio, Marko] Natl Inst Hlth & Welf, Hlth Serv Res Unit, Helsinki, Finland; [Francis, Jill J.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Grimshaw, Jeremy M.] Ottawa Hosp, Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada; [Johnston, Marie] Univ Aberdeen, Coll Life Sci & Med, Aberdeen, Scotland	Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Finland National Institute for Health & Welfare; University of Aberdeen; University of Ottawa; Ottawa Hospital Research Institute; University of Aberdeen	Hawthorne, G (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.	gillian.hawthorne@newcastle-pct.nhs.uk	Presseau, Justin/B-6303-2009; Presseau, Justin/AAE-9961-2019; Grimshaw, Jeremy/D-8726-2013; McDowell, Joan R S/H-3159-2014; Francis, Jill/AHE-6998-2022; Eccles, Martin P/AAD-4029-2020	Presseau, Justin/0000-0002-2132-0703; Presseau, Justin/0000-0002-2132-0703; Elovainio, Marko/0000-0002-1401-1910; Grimshaw, Jeremy/0000-0001-8015-8243; Francis, Jill/0000-0001-5784-8895	Diabetes UK; MRC [MC_U122792691] Funding Source: UKRI; Medical Research Council [MC_U122792691] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10160] Funding Source: researchfish; Chief Scientist Office [HSRU2] Funding Source: researchfish	Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The study was funded by Diabetes UK (http://www.diabetes.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvert M, 2009, BRIT MED J, V26, pb1870; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Department of Health, 6 YEARS DEL DIAB NAT; Eccles MP, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-61; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-22; Heisler M, 2007, J GERONTOL A-BIOL, V62, P1435, DOI 10.1093/gerona/62.12.1435; House of Commons Committee of Public Accounts Department of Health, 2012, DEP HLTH MAN AD DIAB; Khunti K, 2001, BRIT J GEN PRACT, V51, P356; Millett C, 2007, J ROY SOC MED, V100, P275, DOI 10.1258/jrsm.100.6.275; NICE, 2009, TYP 2 DIAB MAN TYP 2, V87; Pierce M, 2000, BRIT J GEN PRACT, V50, P542; Secretary of State for Health, 2008, HIGH QUALITY CARE AL; Williams DRR, 2002, DIABETIC MED, V19, P21, DOI 10.1046/j.1464-5491.19.s4.5.x; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62	15	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41562	10.1371/journal.pone.0041562	http://dx.doi.org/10.1371/journal.pone.0041562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859997	Green Published, gold, Green Accepted			2022-12-27	WOS:000306950900028
J	Hennebelle, M; Balasse, L; Latour, A; Champeil-Potokar, G; Denis, S; Lavialle, M; Gisquet-Verrier, P; Denis, I; Vancassel, S				Hennebelle, Marie; Balasse, Laure; Latour, Alizee; Champeil-Potokar, Gaelle; Denis, Stephanie; Lavialle, Monique; Gisquet-Verrier, Pascale; Denis, Isabelle; Vancassel, Sylvie			Influence of Omega-3 Fatty Acid Status on the Way Rats Adapt to Chronic Restraint Stress	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GLUCOCORTICOID NEGATIVE FEEDBACK; RECEPTOR GENE-TRANSCRIPTION; MESSENGER-RNA EXPRESSION; N-3 PUFA; MATERNAL-DEPRIVATION; SPATIAL MEMORY; TIME-COURSE; ADULT RATS; BRAIN	Omega-3 fatty acids are important for several neuronal and cognitive functions. Altered omega-3 fatty acid status has been implicated in reduced resistance to stress and mood disorders. We therefore evaluated the effects of repeated restraint stress (6 h/day for 21 days) on adult rats fed omega-3 deficient, control or omega-3 enriched diets from conception. We measured body weight, plasma corticosterone and hippocampus glucocorticoid receptors and correlated these data with emotional and depression-like behaviour assessed by their open-field (OF) activity, anxiety in the elevated-plus maze (EPM), the sucrose preference test and the startle response. We also determined their plasma and brain membrane lipid profiles by gas chromatography. Repeated restraint stress caused rats fed a control diet to lose weight. Their plasma corticosterone increased and they showed moderate behavioural changes, with increases only in grooming (OF test) and entries into the open arms (EPM). Rats fed the omega-3 enriched diet had a lower stress-induced weight loss and plasma corticosterone peak, and reduced grooming. Rats chronically lacking omega-3 fatty acid exhibited an increased startle response, a stress-induced decrease in locomotor activity and exaggerated grooming. The brain omega-3 fatty acids increased as the dietary omega-3 fatty acids increased; diets containing preformed long-chain omega-3 fatty acid were better than diets containing the precursor alpha-linolenic acid. However, the restraint stress reduced the amounts of omega-3 incorporated. These data showed that the response to chronic restraint stress was modulated by the omega-3 fatty acid supply, a dietary deficiency was deleterious while enrichment protecting against stress.	[Hennebelle, Marie; Latour, Alizee; Champeil-Potokar, Gaelle; Denis, Stephanie; Lavialle, Monique; Denis, Isabelle; Vancassel, Sylvie] INRA, Unite Nutr & Regulat Lipid Fonct Cerebrales, NuReLiCe, UR909, Jouy En Josas, France; [Balasse, Laure; Gisquet-Verrier, Pascale] Univ Paris 11, CNRS, UMR 8195, Ctr Neurosci Paris Sud, Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Hennebelle, M (corresponding author), INRA, Unite Nutr & Regulat Lipid Fonct Cerebrales, NuReLiCe, UR909, Jouy En Josas, France.	sylvie.vancassel@jouy.inra.fr	Hennebelle, Marie/AAC-7730-2020; Vancassel, sylvie/GXG-5187-2022	Balasse, Laure/0000-0003-2057-7408; DENIS, Stephanie/0000-0001-7761-8843; Hennebelle, Marie/0000-0002-2279-1400	Institut National de la Recherche Agronomique, Paris, France; Agence Nationale pour la Recherche, France [ANR-09-ALIA-006 Neuromega3]; Unilever, Netherlands; Unilever	Institut National de la Recherche Agronomique, Paris, France; Agence Nationale pour la Recherche, France(French National Research Agency (ANR)); Unilever, Netherlands(Unilever); Unilever(Unilever)	This work was supported by the Institut National de la Recherche Agronomique, Paris, France, by the Agence Nationale pour la Recherche, France, ANR-09-ALIA-006 Neuromega3, and by Unilever, Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Unilever provided funding for supplying research reagents and a grant for Marie Hennebelle, graduate student. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aid S, 2003, J LIPID RES, V44, P1545, DOI 10.1194/jlr.M300079-JLR200; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Alessandri JM, 2001, LIPIDS, V36, P1141, DOI 10.1007/s11745-001-0825-2; Alessandri JM, 2004, REPROD NUTR DEV, V44, P1; Anuradha H, 2008, J NEURAL TRANSM, V115, P35, DOI 10.1007/s00702-007-0821-6; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Barnum CJ, 2007, J NEUROENDOCRINOL, V19, P632, DOI 10.1111/j.1365-2826.2007.01571.x; Beck KD, 2002, PHYSIOL BEHAV, V75, P661, DOI 10.1016/S0031-9384(02)00670-4; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Borcela E, 2008, BEHAV PHARMACOL, V19, P41, DOI 10.1097/FBP.0b013e3282f3fca9; Bowman RE, 2009, PHYSIOL BEHAV, V97, P21, DOI 10.1016/j.physbeh.2009.01.012; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Clarke G, 2009, BEHAV BRAIN RES, V205, P319, DOI 10.1016/j.bbr.2009.07.008; Cunnane SC, 2009, PROG LIPID RES, V48, P239, DOI 10.1016/j.plipres.2009.04.001; Cunnane SC, 2000, LIPIDS, V35, P105, DOI 10.1007/s11745-000-0501-6; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fedorova I, 2009, BEHAV NEUROSCI, V123, P1218, DOI 10.1037/a0017446; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Gomez F, 1996, NEUROENDOCRINOLOGY, V63, P327, DOI 10.1159/000126973; Gregus A, 2005, BEHAV BRAIN RES, V156, P105, DOI 10.1016/j.bbr.2004.05.013; Hamazaki K, 2005, NUTRITION, V21, P705, DOI 10.1016/j.nut.2004.07.020; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; Herman JP, 1998, J NEUROSCI, V18, P7462; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Laugero KD, 2011, PROSTAG LEUKOTR ESS, V84, P71, DOI 10.1016/j.plefa.2010.12.003; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Liperoti R, 2009, CURR PHARM DESIGN, V15, P4165, DOI 10.2174/138161209789909683; Llorente R, 2011, J NEUROENDOCRINOL, V23, P329, DOI 10.1111/j.1365-2826.2011.02109.x; Lucas M, 2010, J AM COLL NUTR, V29, P211, DOI 10.1080/07315724.2010.10719836; Lucca G, 2009, NEUROCHEM INT, V54, P358, DOI 10.1016/j.neuint.2009.01.001; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Mathieu G, 2008, PROSTAG LEUKOTR ESS, V78, P391, DOI 10.1016/j.plefa.2008.05.003; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McEwen BS, 2010, EUR J PHARMACOL, V583, P174; Mizoguchi K, 2001, PSYCHONEUROENDOCRINO, V26, P443, DOI 10.1016/S0306-4530(01)00004-X; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; Paskitti ME, 2000, MOL BRAIN RES, V80, P142, DOI 10.1016/S0169-328X(00)00121-2; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Romeo RD, 2008, NEUROENDOCRINOLOGY, V87, P160, DOI 10.1159/000109710; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Rybkin II, 1997, AM J PHYSIOL-REG I, V273, pR1612, DOI 10.1152/ajpregu.1997.273.5.R1612; Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022; SAPOLSKY RM, 1984, ENDOCRINOLOGY, V114, P287, DOI 10.1210/endo-114-1-287; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Talahalli RR, 2010, LIPIDS, V45, P799, DOI 10.1007/s11745-010-3464-6; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Vancassel S, 2008, J LIPID RES, V49, P340, DOI 10.1194/jlr.M700328-JLR200; VANERP AMM, 1994, BEHAV BRAIN RES, V65, P47, DOI 10.1016/0166-4328(94)90072-8; Vazquez V, 2005, PSYCHOPHARMACOLOGY, V181, P706, DOI 10.1007/s00213-005-0029-0; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Zafir A, 2009, INDIAN J BIOCHEM BIO, V46, P53	70	56	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42142	10.1371/journal.pone.0042142	http://dx.doi.org/10.1371/journal.pone.0042142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860066	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900072
J	McGowan, EM; Tran, N; Alling, N; Yagoub, D; Sedger, LM; Martiniello-Wilks, R				McGowan, Eileen M.; Nham Tran; Alling, Nikki; Yagoub, Daniel; Sedger, Lisa M.; Martiniello-Wilks, Rosetta			p14ARF Post-Transcriptional Regulation of Nuclear Cyclin D1 in MCF-7 Breast Cancer Cells: Discrimination between a Good and Bad Prognosis?	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; TRANSCRIPTIONAL ACTIVITY; DEPENDENT KINASES; IN-VIVO; P53; MDM2; P21	As part of a cell's inherent protection against carcinogenesis, p14ARF is upregulated in response to hyperproliferative signalling to induce cell cycle arrest. This property makes p14ARF a leading candidate for cancer therapy. This study explores the consequences of reactivating p14ARF in breast cancer and the potential of targeting p14ARF in breast cancer treatment. Our results show that activation of the p14ARF-p53-p21-Rb pathway in the estrogen sensitive MCF-7 breast cancer cells induces many hallmarks of senescence including a large flat cell morphology, multinucleation, senescence-associated-beta-gal staining, and rapid G1 and G2/M phase cell cycle arrest. P14ARF also induces the expression of the proto-oncogene cyclin D1, which is most often associated with a transition from G1-S phase and is highly expressed in breast cancers with poor clinical prognosis. In this study, siRNA knockdown of cyclin D1, p21 and p53 show p21 plays a pivotal role in the maintenance of high cyclin D1 expression, cell cycle and growth arrest post-p14ARF induction. High p53 and p14ARF expression and low p21/cyclin D1 did not cause cell-cycle arrest. Knockdown of cyclin D1 stops proliferation but does not reverse senescence-associated cell growth. Furthermore, cyclin D1 accumulation in the nucleus post-p14ARF activation correlated with a rapid loss of nucleolar Ki-67 protein and inhibition of DNA synthesis. Latent effects of the p14ARF-induced cellular processes resulting from high nuclear cyclin D1 accumulation included a redistribution of Ki-67 into the nucleoli, aberrant nuclear growth (multinucleation), and cell proliferation. Lastly, downregulation of cyclin D1 through inhibition of ER abrogated latent recurrence. The mediation of these latent effects by continuous expression of p14ARF further suggests a novel mechanism whereby dysregulation of cyclin D1 could have a double-edged effect. Our results suggest that p14ARF induced-senescence is related to late-onset breast cancer in estrogen responsive breast cancers and/or the recurrence of more aggressive breast cancer post-therapy.	[McGowan, Eileen M.; Nham Tran; Sedger, Lisa M.; Martiniello-Wilks, Rosetta] Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia; [McGowan, Eileen M.; Nham Tran; Sedger, Lisa M.; Martiniello-Wilks, Rosetta] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia; [McGowan, Eileen M.; Nham Tran] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Alling, Nikki] Garvan Inst Med Res, Flow Cytometry Unit, Sydney, NSW, Australia; [Yagoub, Daniel] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of Technology Sydney; University of Technology Sydney; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney	McGowan, EM (corresponding author), Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia.	Eileen.Mcgowan@uts.edu.au		Martiniello-Wilks, Rosetta/0000-0002-0038-3430; Tran, Nham/0000-0001-7747-2530; Sedger, Lisa/0000-0003-1009-5683; McGowan, Eileen/0000-0001-6371-3751	Cancer Institute of NSW Fellowship; University of Technology Sydney, Vice Chancellor's Research Fellowship; Prostate Cancer Foundation of Australia; Sydney Cancer Centre Foundation; Cancer Institute NSW; Rebecca L Cooper Foundation	Cancer Institute of NSW Fellowship; University of Technology Sydney, Vice Chancellor's Research Fellowship; Prostate Cancer Foundation of Australia; Sydney Cancer Centre Foundation; Cancer Institute NSW; Rebecca L Cooper Foundation	EMM is a recipient of a Cancer Institute of NSW Fellowship; NT is a recipient of a University of Technology Sydney, Vice Chancellor's Research Fellowship. RMW is supported by the Prostate Cancer Foundation of Australia, Sydney Cancer Centre Foundation, Cancer Institute NSW & the Rebecca L Cooper Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsafadi S, 2009, CURR MED CHEM, V16, P4328, DOI 10.2174/092986709789578196; Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001; Berns A, 2002, CANCER CELL, V1, P309, DOI 10.1016/S1535-6108(02)00063-6; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; CHEN XB, 1995, CANCER RES, V55, P4257; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; D'Amico M, 2004, CANCER RES, V64, P4122, DOI 10.1158/0008-5472.CAN-03-2519; D'Amico M, 2003, CANCER RES, V63, P3395; de Jong JS, 1999, J CLIN PATHOL-MOL PA, V52, P78, DOI 10.1136/mp.52.2.78; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Gallagher S, 2005, CELL CYCLE, V4, P465, DOI 10.4161/cc.4.3.1526; Gosselin K, 2009, CANCER RES, V69, P7917, DOI 10.1158/0008-5472.CAN-08-2510; HARPER JW, 1993, CELL, V75, P805; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Konduri SD, 2010, P NATL ACAD SCI USA, V107, P15081, DOI 10.1073/pnas.1009575107; Kurokawa K, 1999, ONCOGENE, V18, P2718, DOI 10.1038/sj.onc.1202628; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Matsuoka M, 2003, BIOCHEM BIOPH RES CO, V301, P1000, DOI 10.1016/S0006-291X(03)00080-9; McGowan EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020623; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Roninson IB, 2003, CANCER RES, V63, P2705; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2000, CANCER RES, V60, P3689; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sutherland R.L., 1999, HUMAN CELL CULTURE, P79; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; van der Meijden CMJ, 2002, CANCER RES, V62, P3233; Wilcken NRC, 1997, CLIN CANCER RES, V3, P849; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Yu SH, 2009, J MED CHEM, V52, P7970, DOI 10.1021/jm901400z; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42246	10.1371/journal.pone.0042246	http://dx.doi.org/10.1371/journal.pone.0042246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860097	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900082
J	Georgi, C; Buerger, J; Hillen, W; Berens, C				Georgi, Christiane; Buerger, Julia; Hillen, Wolfgang; Berens, Christian			Promoter Strength Driving TetR Determines the Regulatory Properties of Tet-Controlled Expression Systems	PLOS ONE			English	Article							COLI RNA-POLYMERASE; PROTEIN-PROTEIN INTERACTIONS; ESCHERICHIA-COLI; GENE-EXPRESSION; TETRACYCLINE-RESISTANCE; LAC REPRESSOR; TRANSCRIPTION INITIATION; SALMONELLA-TYPHIMURIUM; NONTEMPLATE STRAND; CHROMOSOMAL GENES	Bacteria frequently rely on transcription repressors and activators to alter gene expression patterns in response to changes in the surrounding environment. Tet repressor (TetR) is a paradigm transcription factor that senses the environmental state by binding small molecule effectors, the tetracyclines. However, recently isolated peptides that act as inducers of TetR after having been fused to the C-terminus of a carrier protein, suggest that TetR can also regulate gene expression in a signal-transduction pathway. For this shift in regulatory mechanism to be successful, induction of TetR must be sensitive enough to respond to an inducing protein expressed at its endogenous level. To determine this regulatory parameter, a synthetic Tet-regulated system was introduced into the human pathogen Salmonella enterica serovar Typhimurium and tested for inducibility by a peptide. Reporter gene expression was detected if the peptide-containing carrier protein Thioredoxin 1 was strongly overproduced, but not if it was expressed at a level similar to the physiological level of Thioredoxin 1. This was attributed to high steady-state amounts of TetR which was expressed by the promoter of the chloramphenicol acetyl transferase gene (P-cat). Reducing P-cat strength either by directed or by random mutagenesis of its -10 element concomitantly reduced the intracellular amounts of TetR. Sensitive and quantitative induction of TetR by an inducing peptide, when it was fused to Thioredoxin 1 at its native locus in the genome, was only obtained with weak P-cat promoter variants containing GC-rich -10 elements. A second important observation was that reducing the TetR steady-state level did not impair repression. This permits flexible adjustment of an inducible system's sensitivity simply by altering the expression level of the transcription factor. These two new layers of expression control will improve the quality and, thus, the applicability of the Tet and other regulatory systems.	[Georgi, Christiane; Buerger, Julia; Hillen, Wolfgang; Berens, Christian] Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, Dept Biol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Georgi, C (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, Dept Biol, D-91054 Erlangen, Germany.	cberens@biologie.uni-erlangen.de			German Federal Funding Agency "Deutsche Forschungsgemeinschaft'' [CRC796/C4]; Bayerische Elitefoerderung	German Federal Funding Agency "Deutsche Forschungsgemeinschaft''; Bayerische Elitefoerderung	This work was supported by a personal grant from the German Federal Funding Agency "Deutsche Forschungsgemeinschaft'' through CRC796/C4 to WH and CB. JB was supported by a Ph.D. fellowship from the Bayerische Elitefoerderung. The Open Access charges were paid for by the joint fund "Open Access Publizieren'' installed by the DFG and the UB Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; ALTON NK, 1979, NATURE, V282, P864, DOI 10.1038/282864a0; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Bachler C, 2005, EMBO J, V24, P283, DOI 10.1038/sj.emboj.7600517; Beckers G, 2005, MOL MICROBIOL, V58, P580, DOI 10.1111/j.1365-2958.2005.04855.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Berens Christian, 2004, Genet Eng (N Y), V26, P255; Bertram R, 2008, MICROB BIOTECHNOL, V1, P2, DOI 10.1111/j.1751-7915.2007.00001.x; BERTRAND KP, 1984, J BACTERIOL, V158, P910, DOI 10.1128/JB.158.3.910-919.1984; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Braatsch S, 2008, BIOTECHNIQUES, V45, P335, DOI 10.2144/000112907; BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CALOS MP, 1978, NATURE, V274, P762, DOI 10.1038/274762a0; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Corvec S, 2002, ANTIMICROB AGENTS CH, V46, P3265, DOI 10.1128/AAC.46.10.3265-3267.2002; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Crnkovic-Mertens I, 2010, CELL MOL LIFE SCI, V67, P1895, DOI 10.1007/s00018-010-0300-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; DEGENKOLB J, 1991, ANTIMICROB AGENTS CH, V35, P1591, DOI 10.1128/AAC.35.8.1591; Donovan RS, 1996, J IND MICROBIOL, V16, P145, DOI 10.1007/BF01569997; Doublet B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002060; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; EPE B, 1984, EMBO J, V3, P121, DOI 10.1002/j.1460-2075.1984.tb01771.x; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fenton MS, 2001, P NATL ACAD SCI USA, V98, P9020, DOI 10.1073/pnas.161085798; Fournier B, 1999, ANTIMICROB AGENTS CH, V43, P850, DOI 10.1128/AAC.43.4.850; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gauger T, 2012, MICROB BIOTECHNOL, V5, P129, DOI 10.1111/j.1751-7915.2011.00304.x; Gerlach RG, 2007, APPL ENVIRON MICROB, V73, P4234, DOI 10.1128/AEM.00509-07; Goeke D, 2012, J MOL BIOL, V416, P33, DOI 10.1016/j.jmb.2011.12.009; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Hoppe-Seyler F, 2004, CURR MOL MED, V4, P529, DOI 10.2174/1566524043360519; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jechlinger W, 2005, J BIOTECHNOL, V116, P11, DOI 10.1016/j.jbiotec.2004.10.002; Jensen PR, 1998, BIOTECHNOL BIOENG, V58, P191, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<191::AID-BIT11>3.0.CO;2-G; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Klotzsche M, 2005, J BIOL CHEM, V280, P24591, DOI 10.1074/jbc.M501872200; Klotzsche M, 2007, NUCLEIC ACIDS RES, V35, P3945, DOI 10.1093/nar/gkm357; Kodadek T, 2006, MOL BIOSYST, V2, P25, DOI 10.1039/b514349g; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; Lee HJ, 2004, J BIOL CHEM, V279, P16899, DOI 10.1074/jbc.C400054200; LEGRICE SFJ, 1981, J MOL BIOL, V150, P185, DOI 10.1016/0022-2836(81)90448-4; LEGRICE SFJ, 1980, FEBS LETT, V113, P42, DOI 10.1016/0014-5793(80)80490-X; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Lloyd G, 2001, ESSAYS BIOCHEM, V37, P17, DOI 10.1042/bse0370017; Luckner SR, 2007, J MOL BIOL, V368, P780, DOI 10.1016/j.jmb.2007.02.030; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MARCOLI R, 1980, FEBS LETT, V110, P11, DOI 10.1016/0014-5793(80)80011-1; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Martinez-Antonio A, 2006, TRENDS MICROBIOL, V14, P22, DOI 10.1016/j.tim.2005.11.002; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; MULLERHILL B, 1968, P NATL ACAD SCI USA, V59, P1259, DOI 10.1073/pnas.59.4.1259; Murphy KF, 2010, NUCLEIC ACIDS RES, V38, P2712, DOI 10.1093/nar/gkq091; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Park SH, 2000, NAT BIOTECHNOL, V18, P847, DOI 10.1038/78451; Plano GV, 2004, MOL MICROBIOL, V54, P287, DOI 10.1111/j.1365-2958.2004.04306.x; Porwollik S, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P1; Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Roberts CW, 1996, CELL, V86, P495; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; Saenger W, 2000, ANGEW CHEM INT EDIT, V39, P2042, DOI 10.1002/1521-3773(20000616)39:12<2042::AID-ANIE2042>3.0.CO;2-C; Saez E, 1997, CURR OPIN BIOTECH, V8, P608, DOI 10.1016/S0958-1669(97)80037-7; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J., 2001, MOL CLONING; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Schlicht M, 2006, APPL ENVIRON MICROB, V72, P5637, DOI 10.1128/AEM.00739-06; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Sevvana M, 2012, J MOL BIOL, V416, P46, DOI 10.1016/j.jmb.2011.12.008; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Sriubolmas N, 1997, APPL MICROBIOL BIOT, V47, P373, DOI 10.1007/s002530050943; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; TAKAHASHI M, 1986, J MOL BIOL, V187, P341, DOI 10.1016/0022-2836(86)90437-7; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; WINOGRAD E, 1993, BIOTECHNIQUES, V14, P886; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	98	9	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41620	10.1371/journal.pone.0041620	http://dx.doi.org/10.1371/journal.pone.0041620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848546	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200077
J	Li, CP; Yu, ZG; Han, GS; Chu, KH				Li, Chi Pang; Yu, Zu Guo; Han, Guo Sheng; Chu, Ka Hou			Analyzing Multi-locus Plant Barcoding Datasets with a Composition Vector Method Based on Adjustable Weighted Distance	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LARGE DSDNA VIRUSES; COMPLETE GENOMES; PHYLOGENY	Background: The composition vector (CV) method has been proved to be a reliable and fast alignment-free method to analyze large COI barcoding data. In this study, we modify this method for analyzing multi-gene datasets for plant DNA barcoding. The modified method includes an adjustable-weighted algorithm for the vector distance according to the ratio in sequence length of the candidate genes for each pair of taxa. Methodology/Principal Findings: Three datasets, matK+rbcL dataset with 2,083 sequences, matK+rbcL dataset with 397 sequences and matK+rbcL+trnH-psbA dataset with 397 sequences, were tested. We showed that the success rates of grouping sequences at the genus/species level based on this modified CV approach are always higher than those based on the traditional K2P/NJ method. For the matK+rbcL datasets, the modified CV approach outperformed the K2P-NJ approach by 7.9% in both the 2,083-sequence and 397-sequence datasets, and for the matK+rbcL+trnH-psbA dataset, the CV approach outperformed the traditional approach by 16.7%. Conclusions: We conclude that the modified CV approach is an efficient method for analyzing large multi-gene datasets for plant DNA barcoding. Source code, implemented in C++ and supported on MS Windows, is freely available for download at http://math.xtu.edu.cn/myphp/math/research/source/Barcode_source_codes.zip.	[Li, Chi Pang; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Yu, Zu Guo; Han, Guo Sheng] Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China; [Yu, Zu Guo] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia	Chinese University of Hong Kong; Xiangtan University; Queensland University of Technology (QUT)	Li, CP (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kahouchu@cuhk.edu.hk	Chu, Ka Hou/B-8010-2011	Chu, Ka Hou/0000-0001-8107-5415	School of Life Sciences, The Chinese University of Hong Kong	School of Life Sciences, The Chinese University of Hong Kong	The work was supported by research funding to KHC from the School of Life Sciences, The Chinese University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Chu KH, 2006, BIOINFORMATICS, V22, P1690, DOI 10.1093/bioinformatics/btl146; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Chu KH, 2004, MOL BIOL EVOL, V21, P200, DOI 10.1093/molbev/msh002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-41; Geiger DL, 2002, J MOL EVOL, V54, P191, DOI 10.1007/s00239-001-0001-5; Hebert P.D., 2003, P ROYAL SOC LONDON S, V270, P313, DOI [10.1098/rspb.2002.2218, DOI 10.1093/molbev/msy096]; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROYAL SOC B BIOL S, V270, P96; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2009, PROPOSAL CONSORITUM; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Pevzner P. A., 2000, COMPUTATIONAL MOL BI; Qi J, 2004, NUCLEIC ACIDS RES, V32, pW45, DOI 10.1093/nar/gkh362; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SAITOU N, 1987, MOL BIOL EVOL, V10, P471; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Yu ZG, 2005, J MOL EVOL, V60, P538, DOI 10.1007/s00239-004-0255-9; Yu ZG, 2001, PHYS LETT A, V286, P34, DOI 10.1016/S0375-9601(01)00336-X; Yu ZG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-192; Yu ZG, 2010, INT J MOL SCI, V11, P1141, DOI 10.3390/ijms11031141	33	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42154	10.1371/journal.pone.0042154	http://dx.doi.org/10.1371/journal.pone.0042154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848736	Green Published, gold			2022-12-27	WOS:000306950200175
J	Manzello, DP; Enochs, IC; Melo, N; Gledhill, DK; Johns, EM				Manzello, Derek P.; Enochs, Ian C.; Melo, Nelson; Gledhill, Dwight K.; Johns, Elizabeth M.			Ocean Acidification Refugia of the Florida Reef Tract	PLOS ONE			English	Article							CO2 ENRICHMENT; CORAL-REEFS; CARBONATE DISSOLUTION; SEAWATER; PHOTOSYNTHESIS; DISSOCIATION; MACROALGAE; SEDIMENTS; PACIFIC; ACID	Ocean acidification (OA) is expected to reduce the calcification rates of marine organisms, yet we have little understanding of how OA will manifest within dynamic, real-world systems. Natural CO2, alkalinity, and salinity gradients can significantly alter local carbonate chemistry, and thereby create a range of susceptibility for different ecosystems to OA. As such, there is a need to characterize this natural variability of seawater carbonate chemistry, especially within coastal ecosystems. Since 2009, carbonate chemistry data have been collected on the Florida Reef Tract (FRT). During periods of heightened productivity, there is a net uptake of total CO2 (TCO2) which increases aragonite saturation state (Omega(arag)) values on inshore patch reefs of the upper FRT. These waters can exhibit greater Omega(arag) than what has been modeled for the tropical surface ocean during preindustrial times, with mean (+/- std. error) Omega(arag)-values in spring = 4.69 (+/- 0.101). Conversely, Omega(arag)-values on offshore reefs generally represent oceanic carbonate chemistries consistent with present day tropical surface ocean conditions. This gradient is opposite from what has been reported for other reef environments. We hypothesize this pattern is caused by the photosynthetic uptake of TCO2 mainly by seagrasses and, to a lesser extent, macroalgae in the inshore waters of the FRT. These inshore reef habitats are therefore potential acidification refugia that are defined not only in a spatial sense, but also in time; coinciding with seasonal productivity dynamics. Coral reefs located within or immediately downstream of seagrass beds may find refuge from OA.	[Manzello, Derek P.; Enochs, Ian C.; Melo, Nelson] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33149 USA; [Manzello, Derek P.; Enochs, Ian C.; Melo, Nelson; Johns, Elizabeth M.] Natl Ocean & Atmospher Adm, Atlantic Oceanog & Meteorol Labs, Miami, FL USA; [Gledhill, Dwight K.] Natl Ocean & Atmospher Adm, Ocean Acidificat Program, Silver Spring, MD USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); National Oceanic Atmospheric Admin (NOAA) - USA	Manzello, DP (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	Derek.Manzello@noaa.gov	Johns, Elizabeth M/I-3547-2013; Manzello, Derek P/A-8661-2014; Melo, Nelson/A-5983-2011; Enochs, Ian/B-8051-2014	Johns, Elizabeth M/0000-0002-2181-5052; Manzello, Derek P/0000-0002-0720-3041; Melo, Nelson/0000-0001-7563-5420; Enochs, Ian/0000-0002-8867-0361	National Oceanic and Atmospheric Administration's (NOAA) Coral Reef Conservation Program; Mote's Protect Our Reef's License Plate Grant [POR-2008-046]; NOAA's Office of Oceanic and Atmospheric Research Charter Ship Fund; The United States Army Corps of Engineers Restoration Coordination and Verification Monitoring and Assessment Plan (RECOVER/MAP); NOAA's Supplemental Funds for Oil Spill Research	National Oceanic and Atmospheric Administration's (NOAA) Coral Reef Conservation Program; Mote's Protect Our Reef's License Plate Grant; NOAA's Office of Oceanic and Atmospheric Research Charter Ship Fund; The United States Army Corps of Engineers Restoration Coordination and Verification Monitoring and Assessment Plan (RECOVER/MAP); NOAA's Supplemental Funds for Oil Spill Research	The authors are grateful to funding from the National Oceanic and Atmospheric Administration's (NOAA) Coral Reef Conservation Program. Mote's Protect Our Reef's License Plate Grant # POR-2008-046 provided seed money that was responsible for the initiation of this project. Funding for the South Florida Program's repeat biophysical oceanographic cruises aboard the R/V F. G. Walton Smith provided by NOAA's Office of Oceanic and Atmospheric Research Charter Ship Fund, The United States Army Corps of Engineers Restoration Coordination and Verification Monitoring and Assessment Plan (RECOVER/MAP), and NOAA's Supplemental Funds for Oil Spill Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Ayoub L, 2009, P 11 INT COR REEF S, P572; Bates NR, 2009, BIOGEOSCI DISCUSS, V6, P7627; Beer S, 1996, MAR ECOL PROG SER, V141, P199, DOI 10.3354/meps141199; Burdige DJ, 2008, LIMNOL OCEANOGR, V53, P549, DOI 10.4319/lo.2008.53.2.0549; Burdige DJ, 2010, AM J SCI, V310, P492, DOI 10.2475/06.2010.03; Burdige DJ, 2002, LIMNOL OCEANOGR, V47, P1751, DOI 10.4319/lo.2002.47.6.1751; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Collado-Vides L, 2005, J PHYCOL, V41, P742, DOI 10.1111/j.1529-8817.2005.00099.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Duarte CM, 1998, MAR ECOL PROG SER, V171, P97, DOI 10.3354/meps171097; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Falter JL, 2011, CORAL REEFS, V30, P53, DOI 10.1007/s00338-010-0671-9; Fourqurean JW, 2001, MAR BIOL, V138, P341, DOI 10.1007/s002270000448; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Gattuso JP, 1997, J PHYCOL, V33, P729, DOI 10.1111/j.0022-3646.1997.00729.x; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; Ginsburg RN, 1964, AAPG BULL, V48, P527; Glynn P.W., 1974, Proceedings int Coral Reef Symp, V2, P183; Hakanson L, 2008, OCEAN COAST MANAGE, V51, P671, DOI 10.1016/j.ocecoaman.2008.07.003; HOFFMEISTER JE, 1968, GEOL SOC AM BULL, V79, P1487, DOI 10.1130/0016-7606(1968)79[1487:GAOOTF]2.0.CO;2; Jackson J.B.C., 1985, P297; Jiang ZJ, 2010, J INTEGR PLANT BIOL, V52, P904, DOI 10.1111/j.1744-7909.2010.00991.x; Jones J. A., 1977, Proceedings int Coral Reef Symp, V3, P231; Kemp DW, 2011, GLOBAL CHANGE BIOL, V17, P3468, DOI 10.1111/j.1365-2486.2011.02487.x; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 1999, AM ZOOL, V39, P146; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lidz BH, 2005, 1751 US GEOL SURV; Lirman D, 2000, BOT MAR, V43, P305, DOI 10.1515/BOT.2000.033; Lirman D, 2007, MAR POLLUT BULL, V54, P779, DOI 10.1016/j.marpolbul.2006.12.014; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; MARSZALEK DS, 1977, P 3 INT COR REEF S, V2, P223, DOI DOI 10.1016/J.TREE.2009.05.012; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Millero FJ, 2001, B MAR SCI, V68, P101; Morse JW, 2006, GEOCHIM COSMOCHIM AC, V70, P5814, DOI 10.1016/j.gca.2006.08.017; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Semesi IS, 2009, MAR ECOL PROG SER, V382, P41, DOI 10.3354/meps07973; SMITH NP, 1994, B MAR SCI, V54, P602; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.3402/tellusb.v55i2.16761; Zepp RG, 2008, LIMNOL OCEANOGR, V53, P1909, DOI 10.4319/lo.2008.53.5.1909; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599	52	101	103	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41715	10.1371/journal.pone.0041715	http://dx.doi.org/10.1371/journal.pone.0041715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848575	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200094
J	Ponnusamy, D; Clinkenbeard, KD				Ponnusamy, Duraisamy; Clinkenbeard, Kenneth D.			Yersinia pestis Intracellular Parasitism of Macrophages from Hosts Exhibiting High and Low Severity of Plague	PLOS ONE			English	Article							MOUSE PERITONEAL-MACROPHAGES; BACTERIAL-CELL DIVISION; FLEA-BORNE PLAGUE; MAMMALIAN CARNIVORES; ESCHERICHIA-COLI; DOMESTIC ANIMALS; III SECRETION; INFECTION; CATS; REPLICATION	Background: Yersinia pestis causes severe disease in natural rodent hosts, but mild to inapparent disease in certain rodent predators such as dogs. Y. pestis initiates infection in susceptible hosts by parasitizing and multiplying intracellularly in local macrophages prior to systemic dissemination. Thus, we hypothesize that Y. pestis disease severity may depend on the degree to which intracellular Y. pestis overcomes the initial host macrophage imposed stress. Methodology/Principal Findings: To test this hypothesis, the progression of in vitro infection by Y. pestis KIM62053.1+ of mouse splenic and RAW264.7 tissue culture macrophages and dog peripheral blood-derived and DH82 tissue culture macrophages was studied using microscopy and various parameters of infection. The study showed that during the early stage of infection, intracellular Y. pestis assumed filamentous cellular morphology with multiple copies of the genome per bacterium in both mouse and dog macrophages. Later, in mouse macrophages, the infection elicited spacious vacuolar extension of Yersinia containing vacuoles (YCV), and the filamentous Y. pestis reverted to coccobacillary morphology with genomic equivalents approximately equaling colony forming units. In contrast, Y. pestis infected dog macrophages did not show noticeable extension of YCV, and intracellular Y. pestis retained the filamentous cellular morphology for the entire experiment in DH82 cells or were killed by blood-derived macrophages. In addition, during the later stage of infection, Y. pestis infected mouse macrophages exhibited cell lysis whereas dog macrophages did not. Conclusion/Significance: Overall, these results support our hypothesis that Y. pestis in mouse macrophages can overcome the initial intracellular stress necessary for subsequent systemic infection. However, in dogs, failure of Y. pestis to overcome macrophage imposed stress may result in mild or in apparent disease in dogs.	[Ponnusamy, Duraisamy; Clinkenbeard, Kenneth D.] Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Ponnusamy, D (corresponding author), Oklahoma State Univ, Dept Vet Pathobiol, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA.	ken.clinkenbeard@okstate.edu			College of Veterinary Medicine, Oklahoma State University	College of Veterinary Medicine, Oklahoma State University	Research funding supported by College of Veterinary Medicine, Oklahoma State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P447; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Boone A, 2009, VECTOR-BORNE ZOONOT, V9, P185, DOI 10.1089/vbz.2008.0034; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; Cully JF, 2010, VECTOR-BORNE ZOONOT, V10, P7, DOI 10.1089/vbz.2009.0045; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; EIDSON M, 1991, J AM VET MED ASSOC, V199, P1191; Flannagan RS, 2011, ANNU REV PATHOL-MECH, V7, P49, DOI DOI 10.1146/ANNUREV-PATHOL-011811-132445; Fukuto HS, 2010, INFECT IMMUN, V78, P3700, DOI 10.1128/IAI.00062-10; GALYOV EE, 1990, FEBS LETT, V277, P230, DOI 10.1016/0014-5793(90)80852-A; GASPER PW, 1993, J MED ENTOMOL, V30, P20, DOI 10.1093/jmedent/30.1.20; Gould LH, 2008, ZOONOSES PUBLIC HLTH, V55, P448, DOI 10.1111/j.1863-2378.2008.01132.x; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; KARTMAN L, 1958, ANN NY ACAD SCI, V70, P668, DOI 10.1111/j.1749-6632.1958.tb35421.x; Laws TR, 2010, MICROBES INFECT, V12, P331, DOI 10.1016/j.micinf.2010.01.007; LINDLER LE, 1993, MOL MICROBIOL, V8, P311, DOI 10.1111/j.1365-2958.1993.tb01575.x; Liu FZ, 2006, INFECT IMMUN, V74, P5636, DOI 10.1128/IAI.00612-06; LORIAN V, 1975, AM J CLIN PATHOL, V64, P678; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; Nizet Victor, 1998, Methods in Cell Science, V20, P107, DOI 10.1023/A:1009830606819; Ogawa M, 2001, MICROBIOL IMMUNOL, V45, P557, DOI 10.1111/j.1348-0421.2001.tb02658.x; ORLOSKI KA, 1995, J AM VET MED ASSOC, V207, P316; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Perry RD, 2007, BIOMETALS, V20, P699, DOI 10.1007/s10534-006-9051-x; Ponnusamy D, 2011, VET MICROBIOL, V150, P146, DOI 10.1016/j.vetmic.2010.12.025; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rocke TE, 2004, J ZOO WILDLIFE MED, V35, P142, DOI 10.1638/03-021; ROLLAG OJ, 1981, J AM VET MED ASSOC, V179, P1381; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Rosenberger CM, 2002, J BIOL CHEM, V277, P18753, DOI 10.1074/jbc.M110649200; RUST JH, 1971, J INFECT DIS, V124, P522, DOI 10.1093/infdis/124.5.522; RUST JH, 1971, J INFECT DIS, V124, P527, DOI 10.1093/infdis/124.5.527; Salkeld DJ, 2006, VECTOR-BORNE ZOONOT, V6, P231, DOI 10.1089/vbz.2006.6.231; Schapiro JM, 2003, P NATL ACAD SCI USA, V100, P8496, DOI 10.1073/pnas.1033133100; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sha J, 2011, J CLIN MICROBIOL, V49, P1708, DOI 10.1128/JCM.00064-11; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; STRALEY SC, 1984, INFECT IMMUN, V45, P649, DOI 10.1128/IAI.45.3.649-654.1984; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; Thomson NR, 2007, ADV EXP MED BIOL, V603, P2; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vernati G, 2011, J WILDLIFE DIS, V47, P21, DOI 10.7589/0090-3558-47.1.21; Watson RP, 2001, VET PATHOL, V38, P165, DOI 10.1354/vp.38-2-165; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Wendte JM, 2011, ANTIMICROB AGENTS CH, V55, P3752, DOI 10.1128/AAC.01481-10; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09	62	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42211	10.1371/journal.pone.0042211	http://dx.doi.org/10.1371/journal.pone.0042211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848745	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200183
J	Yu, HP; Liu, ZS; Huang, YJ; Yin, M; Wang, LE; Wei, QY				Yu, Hongping; Liu, Zhensheng; Huang, Yu-Jing; Yin, Ming; Wang, Li-E; Wei, Qingyi			Association between Single Nucleotide Polymorphisms in ERCC4 and Risk of Squamous Cell Carcinoma of the Head and Neck	PLOS ONE			English	Article							REDUCED DNA-REPAIR; BINDING-SITE POLYMORPHISMS; NONMELANOMA SKIN-CANCER; EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; GENETIC POLYMORPHISMS; LUNG-CANCER; EXPRESSION; XPF; CAPACITY	Background: Excision repair cross-complementation group 4 gene (ERCC4/XPF) plays an important role in nucleotide excision repair and participates in removal of DNA interstrand cross-links and DNA double-strand breaks. Single nucleotide polymorphisms (SNPs) in ERCC4 may impact repair capacity and affect cancer susceptibility. Methodology/Principal Findings: In this case-control study, we evaluated associations of four selected potentially functional SNPs in ERCC4 with risk of squamous cell carcinoma of the head and neck (SCCHN) in 1,040 non-Hispanic white patients with SCCHN and 1,046 cancer-free matched controls. We found that the variant GG genotype of rs2276466 was significantly associated with a decreased risk of SCCHN (OR = 0.69, 95% CI 0.50-0.96), and that the variant TT genotype of rs3136038 showed a borderline significant decreased risk with SCCHN (OR = 0.76, 95% CI: 0.58-1.01) in the recessive model. Such protective effects were more evident in oropharyngeal cancer (OR = 0.61, 95% CI: 0.40-0.92 for rs2276466; OR = 0.69, 95% CI: 0.48-0.98 for rs3136038). No significant associations were found for the other two SNPs (rs1800067 and rs1799798). In addition, individuals with the rs2276466 GG or with the rs3136038 TT genotypes had higher levels of ERCC4 mRNA expression than those with the corresponding wild-type genotypes in 90 Epstein-Barr virus-transformed lymphoblastoid cell lines derived from Caucasians. Conclusions: These results suggest that these two SNPs (rs2276466 and rs3136038) in ERCC4 may be functional and contribute to SCCHN susceptibility. However, our findings need to be replicated in further large epidemiological and functional studies.	[Yu, Hongping] Guiling Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guilin, Peoples R China; [Yu, Hongping; Liu, Zhensheng; Huang, Yu-Jing; Yin, Ming; Wang, Li-E; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Yu, HP (corresponding author), Guiling Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guilin, Peoples R China.	yuhongping@hotmail.com; qwei@mdanderson.org			National Institutes of Health [R01 CA131274, R01 ES011740, P30 ES007784, P50 CA097007]; University of Texas M.D. Anderson Cancer Center [P30 CA016672]; NATIONAL CANCER INSTITUTE [P50CA097007, P30CA016672, R01CA131274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784, R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants R01 CA131274 and R01 ES011740 (Q. Wei), P30 ES007784 (D.G. Johnson), P50 CA097007 (S. Lippman), and P30 CA016672 (The University of Texas M.D. Anderson Cancer Center). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Andersson BS, 1996, CANCER CHEMOTH PHARM, V38, P406, DOI 10.1007/s002800050504; Blitzblau RC, 2010, MOL DIAGN THER, V14, P335, DOI 10.2165/11587600-000000000-00000; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Brookman KW, 1996, MOL CELL BIOL, V16, P6553; Chang LC, 2000, BIOCHEM BIOPH RES CO, V273, P454, DOI 10.1006/bbrc.2000.2960; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P393, DOI 10.1002/cncr.10231; Fan F, 1999, MUTAT RES-GENOMICS, V406, P115, DOI 10.1016/S1383-5726(99)00008-4; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Garfinkel David J., 2002, Journal of Biomedicine & Biotechnology, V2, P55, DOI 10.1155/S1110724302201023; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; HOY CA, 1985, CANCER RES, V45, P1737; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Koberle B, 2010, INT J ONCOL, V36, P1277, DOI 10.3892/ijo_00000612; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; Krupa R., 2011, Experimental Oncology, V33, P55; Langer R, 2004, VERH DEUT G, V88, P207; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Liu CY, 2007, LUNG CANCER, V55, P303, DOI 10.1016/j.lungcan.2006.10.019; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Milne RL, 2006, CANCER RES, V66, P9420, DOI 10.1158/0008-5472.CAN-06-1418; Mohrenweiser H, 2007, MUTAT RES-FUND MOL M, V616, P221, DOI 10.1016/j.mrfmmm.2006.11.008; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niu JG, 2009, CARCINOGENESIS, V30, P2053, DOI 10.1093/carcin/bgp265; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Shaoa MH, 2008, LUNG CANCER, V60, P332, DOI 10.1016/j.lungcan.2007.10.023; Shi QL, 2004, CARCINOGENESIS, V25, P1695, DOI 10.1093/carcin/bgh167; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Vaezi A, 2011, CLIN CANCER RES, V17, P5513, DOI 10.1158/1078-0432.CCR-11-0086; van Steeg H, 1999, MOL MED TODAY, V5, P86, DOI 10.1016/S1357-4310(98)01394-X; Wang LE, CLIN CANC RES, V16, P764; Wang LE, 2007, CLIN CANCER RES, V13, P6532, DOI 10.1158/1078-0432.CCR-07-0969; Wang LE, 2010, CLIN CANCER RES, V16, P764, DOI 10.1158/1078-0432.CCR-09-2156; Wei Q, 2005, CANCER EPIDEM BIOMAR, V14, P1961, DOI 10.1158/1055-9965.EPI-05-0101; Wei QY, 2003, J NATL CANCER I, V95, P308, DOI 10.1093/jnci/95.4.308; Wei QY, 1996, CANCER RES, V56, P4103; Winsey SL, 2000, CANCER RES, V60, P5612; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480	50	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41853	10.1371/journal.pone.0041853	http://dx.doi.org/10.1371/journal.pone.0041853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848636	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200115
J	Pierre-Eugene, C; Pagesy, P; Nguyen, TT; Neuille, M; Tschank, G; Tennagels, N; Hampe, C; Issad, T				Pierre-Eugene, Cecile; Pagesy, Patrick; Tuyet Thu Nguyen; Neuille, Marion; Tschank, Georg; Tennagels, Norbert; Hampe, Cornelia; Issad, Tarik			Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2	PLOS ONE			English	Article							GROWTH-FACTOR-I; RESONANCE ENERGY-TRANSFER; DIABETES-MELLITUS; TYROSINE PHOSPHORYLATION; INCREASED EXPRESSION; INCREASED ABUNDANCE; CELL-PROLIFERATION; SKELETAL-MUSCLE; BREAST-CANCER; DIFFERENTIATION	Background: In diabetic patients, the pharmacokinetics of injected human insulin does not permit optimal control of glycemia. Fast and slow acting insulin analogues have been developed, but they may have adverse properties, such as increased mitogenic or anti-apoptotic signaling. Insulin/IGF1 hybrid receptors (IR/IGF1R), present in most tissues, have been proposed to transmit biological effects close to those of IGF1R. However, the study of hybrid receptors is difficult because of the presence of IR and IGF1R homodimers. Our objective was to perform the first study on the pharmacological properties of the five marketed insulin analogues towards IR/IGF1R hybrids. Methodology: To study the effect of insulin analogues on IR/IGF1R hybrids, we used our previously developed Bioluminescence Resonance Energy Transfer (BRET) assay that permits specific analysis of the pharmacological properties of hybrid receptors. Moreover, we have developed a new, highly sensitive BRET-based assay to monitor phophatidylinositol-3 phosphate (PIP3) production in living cells. Using this assay, we performed a detailed pharmacological analysis of PIP3 production induced by IGF1, insulin and insulin analogues in living breast cancer-derived MCF-7 and MDA-MB231 cells. Results: Among the five insulin analogues tested, only glargine stimulated IR/IGF1R hybrids with an EC50 that was significantly lower than insulin and close to that of IGF1. Glargine more efficiently stimulated PIP3 production in MCF-7 cells but not in MDA-MB231 cells as compared to insulin. In contrast, glargine metabolites M1 and M2 showed lower potency for hybrid receptors stimulation, PIP3 production, Akt and Erk1/2 phosphorylation and DNA synthesis in MCF-7 cells, compared to insulin. Conclusion: Glargine, possibly acting through IR/IGF1R hybrids, displays higher potency, whereas its metabolites M1 and M2 display lower potency than insulin for the stimulation of proliferative/anti-apoptotic pathways in MCF-7 cells.	[Pierre-Eugene, Cecile; Pagesy, Patrick; Tuyet Thu Nguyen; Neuille, Marion; Hampe, Cornelia; Issad, Tarik] Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France; [Pierre-Eugene, Cecile; Pagesy, Patrick; Tuyet Thu Nguyen; Neuille, Marion; Hampe, Cornelia; Issad, Tarik] INSERM, U1016, Paris, France; [Tschank, Georg; Tennagels, Norbert] Sanofi Aventis, Frankfurt, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis	Issad, T (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR8104, Paris, France.	tarik.issad@inserm.fr	Pagesy, Patrick/GLN-4814-2022; Pagesy, Patrick/M-9345-2017	Pagesy, Patrick/0000-0002-6153-8926; Issad, Tarik/0000-0002-2638-6330	SFD-AFD grant (Societe Francophone du Diabete/Association Francaise des Diabetiques); Sanofi-Aventis; ADOCIA	SFD-AFD grant (Societe Francophone du Diabete/Association Francaise des Diabetiques); Sanofi-Aventis(Sanofi-Aventis); ADOCIA	This work was an investigator initiated study that was mainly supported by an SFD-AFD grant (Societe Francophone du Diabete/Association Francaise des Diabetiques). The study of the effect of M1 and M2 on hybrid receptors was supported by a non-conditional grant from Sanofi-Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Georg Tschank and Norbert Tennagels are employed by Sanofi-Aventis and also hold shares in Sanofi-Aventis. Tarik Issad has received in the past consulting fees from ADOCIA. The second part of the study (Fig. 3) was supported by a non-conditional grant from Sanofi-Aventis, the pharmaceutical company that marketed glargine. This part of the study was entirely performed in Tarik Issad's laboratory at the Cochin Institute, in Paris, and in the contract signed between INSERM and Sanofi-Aventis, it is clearly specified that INSERM researchers retain all rights for publication of the results obtained in this study. Measurements of DNA synthesis (thymidine incorporation, Figure 4, panel C) were performed at Sanofi-Aventis in Frankfurt. Raw data obtained by Sanofi-Aventis on thymidine incorporation were analyzed independently by a biostatistician of the Proteomic Facility Core of the University Paris Descartes. These data were combined to those obtained in T. Issad's laboratory in this collaborative publication. Glargine metabolites M1 (A21Gly-insulin), and 119 M2 (A21Gly, B30desThr-insulin), were made available by Process Development Biotechnology (Sanofi-Aventis, Frankfurt, Germany). Insulin Glargine is covered by claims of EP 0 368 187 81; Current patent holder: Sanofi-Aventis, Deutschland GmbH). The method for monitoring IR/IGF1R hybrids by BRET is covered by claims of FR 2824076/WO 020088752 (holder: Centre National de la Recherche Scientifique). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agin A, 2007, DIABETES METAB, V33, P205, DOI 10.1016/j.diabet.2006.12.002; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Baus D, 2008, CELL SIGNAL, V20, P2237, DOI 10.1016/j.cellsig.2008.08.010; Belfiore A, 1999, BIOCHIMIE, V81, P403, DOI 10.1016/S0300-9084(99)80088-1; Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027; Blanquart C, 2006, MOL PHARMACOL, V70, P1802, DOI 10.1124/mol.106.026989; Blanquart C, 2009, BIOCHEM BIOPH RES CO, V387, P748, DOI 10.1016/j.bbrc.2009.07.105; Blanquart C, 2010, BIOCHEM BIOPH RES CO, V392, P83, DOI 10.1016/j.bbrc.2009.12.176; Boute N, 2001, MOL PHARMACOL, V60, P640; Chisalita SI, 2005, DIABETOLOGIA, V48, P2155, DOI 10.1007/s00125-005-1890-4; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; Federici M, 1996, J CLIN INVEST, V98, P2887, DOI 10.1172/JCI119117; Federici M, 1997, MOL CELL ENDOCRINOL, V129, P121, DOI 10.1016/S0303-7207(97)04050-1; Federici M, 1997, MOL CELL ENDOCRINOL, V135, P41, DOI 10.1016/S0303-7207(97)00185-8; Federici M, 1999, DIABETES, V48, P2277, DOI 10.2337/diabetes.48.12.2277; Federici M, 1998, J CLIN ENDOCR METAB, V83, P2911, DOI 10.1210/jc.83.8.2911; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Garrouste FL, 1997, ENDOCRINOLOGY, V138, P2021, DOI 10.1210/en.138.5.2021; Gerich JE, 2002, AM J MED, V113, P308, DOI 10.1016/S0002-9343(02)01176-2; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; ISSAD T, 1995, EUR J BIOCHEM, V234, P108, DOI 10.1111/j.1432-1033.1995.108_c.x; Issad T, 2002, BIOCHEM PHARMACOL, V64, P813, DOI 10.1016/S0006-2952(02)01143-7; Issad T, 2007, EXPERT OPIN THER TAR, V11, P541, DOI 10.1517/14728222.11.4.541; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lacasa D, 2005, MOL PHARMACOL, V67, P1206, DOI 10.1124/mol.104.009514; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Liu JF, 1998, EUR J BIOCHEM, V258, P271, DOI 10.1046/j.1432-1327.1998.2580271.x; Luzio S, 2006, DIABETOLOGIA, V49, P1163, DOI 10.1007/s00125-006-0243-2; Modan-Moses D, 1998, BIOCHEM J, V333, P825, DOI 10.1042/bj3330825; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; Nitert MD, 2005, MOL CELL ENDOCRINOL, V229, P31, DOI 10.1016/j.mce.2004.10.003; Nouaille S, 2006, EMBO REP, V7, P512, DOI 10.1038/sj.embor.7400668; Ocheltree SM, 2010, EUR J ENDOCRINOL, V163, P217, DOI 10.1530/EJE-09-1086; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pollak M, 2010, INT J CLIN PRACT, V64, P628, DOI 10.1111/j.1742-1241.2010.02354.x; Rakatzi I, 2003, BIOCHEM BIOPH RES CO, V310, P852, DOI 10.1016/j.bbrc.2003.09.090; Renehan AG, 2012, DIABETOLOGIA, V55, P7, DOI 10.1007/s00125-011-2352-9; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1990, BIOCHEM J, V270, P383, DOI 10.1042/bj2700383; SOOS MA, 1989, P NATL ACAD SCI USA, V86, P5217, DOI 10.1073/pnas.86.14.5217; Strobel A, 1999, DIABETOLOGIA, V42, P527, DOI 10.1007/s001250051190; Vajo Z, 2000, PHARMACOL REV, V52, P1; Valensise H, 1996, DIABETOLOGIA, V39, P952; Wang ZH, 2010, DIABETES CARE, V33, P1555, DOI 10.2337/dc09-2011; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Zilberfarb V, 2001, DIABETOLOGIA, V44, P377, DOI 10.1007/s001250051630	52	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41992	10.1371/journal.pone.0041992	http://dx.doi.org/10.1371/journal.pone.0041992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848683	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600059
J	Czekaj, M; Haas, J; Gebhardt, M; Muller-Reichert, T; Humphries, P; Farrar, J; Bartsch, U; Ader, M				Czekaj, Magdalena; Haas, Jochen; Gebhardt, Marlen; Mueller-Reichert, Thomas; Humphries, Peter; Farrar, Jane; Bartsch, Udo; Ader, Marius			In Vitro Expanded Stem Cells from the Developing Retina Fail to Generate Photoreceptors but Differentiate into Myelinating Oligodendrocytes	PLOS ONE			English	Article							HUMAN NEURODEGENERATIVE DISORDERS; CILIARY EPITHELIAL-CELLS; NEURAL PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT-MOUSE RETINA; PRECURSOR CELLS; NEURONAL DIFFERENTIATION; CONE PHOTORECEPTORS; MAP2 EXPRESSION; SONIC-HEDGEHOG	Cell transplantation to treat retinal degenerative diseases represents an option for the replacement of lost photoreceptor cells. In vitro expandable cells isolated from the developing mammalian retina have been suggested as a potential source for the generation of high numbers of donor photoreceptors. In this study we used standardized culture conditions based on the presence of the mitogens FGF-2 and EGF to generate high numbers of cells in vitro from the developing mouse retina. These presumptive 'retinal stem cells' ('RSCs') can be propagated as monolayer cultures over multiple passages, express markers of undifferentiated neural cells, and generate neuronal and glial cell types upon withdrawal of mitogens in vitro or following transplantation into the adult mouse retina. The proportion of neuronal differentiation can be significantly increased by stepwise removal of mitogens and inhibition of the notch signaling pathway. However, 'RSCs', by contrast to their primary counterparts in vivo, i. e. retinal progenitor cells, loose the expression of retina-specific progenitor markers like Rax and Chx10 after passaging and fail to differentiate into photoreceptors both in vitro or after intraretinal transplantation. Notably, 'RSCs' can be induced to differentiate into myelinating oligodendrocytes, a cell type not generated by primary retinal progenitor cells. Based on these findings we conclude that 'RSCs' expanded in high concentrations of FGF-2 and EGF loose their retinal identity and acquire features of in vitro expandable neural stem-like cells making them an inappropriate cell source for strategies aimed at replacing photoreceptor cells in the degenerated retina.	[Czekaj, Magdalena; Haas, Jochen; Ader, Marius] Tech Univ Dresden, CRTD, Dresden, Germany; [Gebhardt, Marlen; Bartsch, Udo] Univ Med Ctr Hamburg Eppendorf, Eye Clin, Hamburg, Germany; [Humphries, Peter; Farrar, Jane] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Mueller-Reichert, Thomas] Tech Univ Dresden, Med Theoret Ctr, Dresden, Germany	Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Trinity College Dublin; Technische Universitat Dresden	Czekaj, M (corresponding author), Tech Univ Dresden, CRTD, Dresden, Germany.	marius.ader@crt-dresden.de	Ader, Marius/E-7535-2010	Ader, Marius/0000-0001-9467-7677	Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence [FZT 111]; Health Research Board Ireland (HRB); Fighting Blindness Ireland;  [SFB655]	Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence; Health Research Board Ireland (HRB); Fighting Blindness Ireland; 	This work was supported by the FZT 111 (Deutsche Forschungsgemeinschaft (DFG), Center for Regenerative Therapies Dresden, Cluster of Excellence) (http:/www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id = 22137416); SFB655 (http:/www.charite.de/sfb665/); Health Research Board Ireland (HRB) (http:/www.hrb.ie/); and Fighting Blindness Ireland (http:/www.fightingblindness.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2006, J NEUROSCI RES, V83, P731, DOI 10.1002/jnr.20762; Ader M, 2000, GLIA, V30, P301, DOI 10.1002/(SICI)1098-1136(200005)30:3<301::AID-GLIA9>3.3.CO;2-J; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Anelli R, 2005, J NEUROCYTOL, V34, P369, DOI 10.1007/s11068-006-8724-2; BARTSCH U, 1994, J NEUROSCI, V14, P4756; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1297, DOI 10.1001/archopht.122.9.1297; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Canola K, 2007, NEUROREPORT, V18, P851, DOI 10.1097/WNR.0b013e32815277c1; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Crawford TQ, 2007, DEV DYNAM, V236, P886, DOI 10.1002/dvdy.21083; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; Eberle D, 2011, INVEST OPHTH VIS SCI, V52, P6462, DOI 10.1167/iovs.11-7399; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Farrar GJ, 2010, CURR GENE THER, V10, P381; FFRENCHCONSTANT C, 1988, J NEUROCYTOL, V17, P13, DOI 10.1007/BF01735374; Fitzgibbon T, 1997, EXP EYE RES, V65, P809, DOI 10.1006/exer.1997.0388; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gamm DM, 2008, STEM CELLS, V26, P3182, DOI 10.1634/stemcells.2008-0300; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gualdoni S, 2010, STEM CELLS, V28, P1048, DOI 10.1002/stem.423; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; HAFIDI A, 1992, J COMP NEUROL, V323, P423, DOI 10.1002/cne.903230309; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Klassen H, 2004, PROG RETIN EYE RES, V23, P149, DOI 10.1016/j.preteyeres.2004.01.002; Klassen H, 2007, STEM CELLS, V25, P1222, DOI 10.1634/stemcells.2006-0541; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Livesey R, 2001, NATURE, V413, P471, DOI 10.1038/35097186; Lodi D, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-9; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; Mansergh FC, 2010, EXP EYE RES, V91, P500, DOI 10.1016/j.exer.2010.07.003; Marquardt T, 2003, PROG RETIN EYE RES, V22, P567, DOI 10.1016/S1350-9462(03)00036-3; Matsushima D, 2011, DEVELOPMENT, V138, P443, DOI 10.1242/dev.055178; Merhi-Soussi F, 2006, STEM CELLS, V24, P2060, DOI 10.1634/stemcells.2005-0311; Meyer S, 2010, MOL HUM REPROD, V16, P846, DOI 10.1093/molehr/gaq060; Michalakis S, 2010, HUM GENE THER, V21, P1181; Millington-Ward S, 2011, MOL THER, V19, P642, DOI 10.1038/mt.2010.293; Munkle MC, 2000, J CHEM NEUROANAT, V19, P155, DOI 10.1016/S0891-0618(00)00060-0; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; PERRY VH, 1990, J NEUROCYTOL, V19, P265, DOI 10.1007/BF01217304; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pressmar S, 2001, INVEST OPHTH VIS SCI, V42, P3311; Qiu GT, 2005, EXP EYE RES, V80, P515, DOI 10.1016/j.exer.2004.11.001; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schmitt S, 2009, INVEST OPHTH VIS SCI, V50, P5901, DOI 10.1167/iovs.08-3067; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Soderpalm AK, 2000, INVEST OPHTH VIS SCI, V41, P937; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tetreault N, 2009, DEV BIOL, V327, P541, DOI 10.1016/j.ydbio.2008.12.022; Torres-Fernandez O, 2005, INT J NEUROSCI, V115, P1375, DOI 10.1080/00207450590956396; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	90	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41798	10.1371/journal.pone.0041798	http://dx.doi.org/10.1371/journal.pone.0041798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848612	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600122
J	Maeda, T; Hirose, E; Chikaraishi, Y; Kawato, M; Takishita, K; Yoshida, T; Verbruggen, H; Tanaka, J; Shimamura, S; Takaki, Y; Tsuchiya, M; Iwai, K; Maruyama, T				Maeda, Taro; Hirose, Euichi; Chikaraishi, Yoshito; Kawato, Masaru; Takishita, Kiyotaka; Yoshida, Takao; Verbruggen, Heroen; Tanaka, Jiro; Shimamura, Shigeru; Takaki, Yoshihiro; Tsuchiya, Masashi; Iwai, Kenji; Maruyama, Tadashi			Algivore or Phototroph? Plakobranchus ocellatus (Gastropoda) Continuously Acquires Kleptoplasts and Nutrition from Multiple Algal Species in Nature	PLOS ONE			English	Article							SACOGLOSSAN OPISTHOBRANCHS; GIANT CLAM; FUNCTIONAL CHLOROPLASTS; PHOTOSYNTHETIC PRODUCTS; SYMBIOTIC CHLOROPLASTS; PHYLOGENETIC ANALYSES; ELYSIA-CLARKI; INDO-PACIFIC; GREEN-ALGAE; ASCOGLOSSA	The sea slug Plakobranchus ocellatus (Sacoglossa, Gastropoda) retains photosynthetically active chloroplasts from ingested algae (functional kleptoplasts) in the epithelial cells of its digestive gland for up to 10 months. While its feeding behavior has not been observed in natural habitats, two hypotheses have been proposed: 1) adult P. ocellatus uses kleptoplasts to obtain photosynthates and nutritionally behaves as a photoautotroph without replenishing the kleptoplasts; or 2) it behaves as a mixotroph (photoautotroph and herbivorous consumer) and replenishes kleptoplasts continually or periodically. To address the question of which hypothesis is more likely, we examined the source algae for kleptoplasts and temporal changes in kleptoplast composition and nutritional contribution. By characterizing the temporal diversity of P. ocellatus kleptoplasts using rbcL sequences, we found that P. ocellatus harvests kleptoplasts from at least 8 different siphonous green algal species, that kleptoplasts from more than one species are present in each individual sea slug, and that the kleptoplast composition differs temporally. These results suggest that wild P. ocellatus often feed on multiple species of siphonous algae from which they continually obtain fresh chloroplasts. By estimating the trophic position of wild and starved P. ocellatus using the stable nitrogen isotopic composition of amino acids, we showed that despite the abundance of kleptoplasts, their photosynthates do not contribute greatly to the nutrition of wild P. ocellatus, but that kleptoplast photosynthates form a significant source of nutrition for starved sea slugs. The herbivorous nature of wild P. ocellatus is consistent with insights from molecular analyses indicating that kleptoplasts are frequently replenished from ingested algae, leading to the conclusion that natural populations of P. ocellatus do not rely on photosynthesis but mainly on the digestion of ingested algae.	[Maeda, Taro; Yoshida, Takao; Tanaka, Jiro; Maruyama, Tadashi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, Tokyo, Japan; [Maeda, Taro; Chikaraishi, Yoshito; Kawato, Masaru; Takishita, Kiyotaka; Yoshida, Takao; Shimamura, Shigeru; Takaki, Yoshihiro; Tsuchiya, Masashi; Maruyama, Tadashi] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Hirose, Euichi] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan; [Verbruggen, Heroen] Univ Ghent, Phycol Res Grp, B-9000 Ghent, Belgium; [Verbruggen, Heroen] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Iwai, Kenji] Okinawa Prefectural Fisheries & Ocean Res Ctr, Itoman, Okinawa, Japan	Tokyo University of Marine Science & Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of the Ryukyus; Ghent University; University of Melbourne	Maeda, T (corresponding author), Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo, Japan.	tadashim@jamstec.go.jp	maeda, taro/I-2978-2019; Chikaraishi, Yoshito/O-5250-2019; Verbruggen, Heroen/C-6951-2009; Hirose, Euichi/I-5006-2013; Hirose, Euichi/I-5009-2013	maeda, taro/0000-0003-4185-0135; Chikaraishi, Yoshito/0000-0002-7506-1524; Verbruggen, Heroen/0000-0002-6305-4749; Hirose, Euichi/0000-0001-7002-4524; Hirose, Euichi/0000-0001-7002-4524	Mikimoto Fund for Marine Ecology; Grant-in-Aid for a Japan Society for the Promotion of Science [20234567]; Research Foundation Flanders; Australian Research Council [FT110100585]; Okinawa Intellectual Cluster Program	Mikimoto Fund for Marine Ecology(Mikimoto Fund for Marine Ecology); Grant-in-Aid for a Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Foundation Flanders(FWO); Australian Research Council(Australian Research Council); Okinawa Intellectual Cluster Program	The present research was supported by a grant from the Mikimoto Fund for Marine Ecology, a Grant-in-Aid for a Japan Society for the Promotion of Science Fellow (No. 20234567 to T. Maeda), a grant from the Research Foundation Flanders, a grant from the Australian Research Council (FT110100585 to H. Verbruggen), and a grant from the Okinawa Intellectual Cluster Program (to T. Maruyama). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi A, 1991, THESIS U RYUKYUS NIS; [Anonymous], 1980, ADV MAR BIOL; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CLARK KB, 1990, VELIGER, V33, P339; Clark Kerry B., 1992, P515; Curtis NE, 2007, MAR BIOL, V150, P797, DOI 10.1007/s00227-006-0398-x; Curtis NE, 2006, INVERTEBR BIOL, V125, P336, DOI 10.1111/j.1744-7410.2006.00065.x; DENG XW, 1989, P NATL ACAD SCI USA, V86, P4156, DOI 10.1073/pnas.86.11.4156; Dunlap M.F.S., 1975, THESIS U HAWAII; Evertsen J, 2007, MAR BIOL, V151, P2159, DOI 10.1007/s00227-007-0648-6; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; GREENE RW, 1972, MAR BIOL, V14, P253; GREENE RW, 1970, MAR BIOL, V7, P138, DOI 10.1007/BF00354917; Handeler K, 2010, MOL ECOL RESOUR, V10, P968, DOI 10.1111/j.1755-0998.2010.02853.x; Handeler K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-28; Haendeler Katharina, 2007, Bonner Zoologische Beitraege, V55, P231; Hanyuda T, 2000, J PLANT RES, V113, P403, DOI 10.1007/PL00013948; Hirose E, 2006, MAR BIOL, V148, P551, DOI 10.1007/s00227-005-0119-x; Hirose E, 2005, ZOOL SCI, V22, P905, DOI 10.2108/zsj.22.905; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; Ishikura M, 1999, MAR BIOL, V133, P665, DOI 10.1007/s002270050507; JENSEN KR, 1993, BIOL J LINN SOC, V48, P135, DOI 10.1111/j.1095-8312.1993.tb00883.x; JENSEN KR, 1992, J MOLLUS STUD, V58, P257, DOI 10.1093/mollus/58.3.257; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kawaguti S., 1965, Biological Journal of Okayama University, V11, P57; Kawaguti S., 1965, P JAPAN ACAD, V41, P614; KLUMPP DW, 1994, MAR ECOL PROG SER, V115, P103, DOI 10.3354/meps115103; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014663; Maruyama T, 1997, MAR BIOL, V127, P473, DOI 10.1007/s002270050035; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; Neubert K, 2007, COMPUT STAT DATA AN, V51, P5192, DOI 10.1016/j.csda.2006.05.024; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rumpho M. E., 2007, STRUCTURE FUNCTION P, P451; Rumpho ME, 2011, J EXP BIOL, V214, P303, DOI 10.1242/jeb.046540; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Team RDC, 2009, R LANG ENV STAT COMP; Teugels B, 2008, AQUAT BIOL, V4, P15, DOI 10.3354/ab00092; TRENCH RK, 1969, J CELL BIOL, V42, P404, DOI 10.1083/jcb.42.2.404; TRENCH RK, 1972, BIOL BULL-US, V142, P335, DOI 10.2307/1540236; Trowbridge CD, 2011, AM MALACOL BULL, V29, P1, DOI 10.4003/006.029.0201; Verbruggen H, 2009, J PHYCOL, V45, P726, DOI 10.1111/j.1529-8817.2009.00690.x; Verbruggen H, 2009, MOL PHYLOGENET EVOL, V50, P642, DOI 10.1016/j.ympev.2008.12.018; Wagele H, 2011, MOL BIOL EVOL, V28, P699, DOI 10.1093/molbev/msq239; WAUGH GR, 1986, MAR BIOL, V92, P483, DOI 10.1007/BF00392508; Williams SI, 1999, OCEANOGR MAR BIOL, V37, P87; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	57	48	49	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42024	10.1371/journal.pone.0042024	http://dx.doi.org/10.1371/journal.pone.0042024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848693	Green Published, gold			2022-12-27	WOS:000306806600161
J	More, M; Amorim, FW; Benitez-Vieyra, S; Medina, AM; Sazima, M; Cocucci, AA				More, Marcela; Amorim, Felipe W.; Benitez-Vieyra, Santiago; Martin Medina, A.; Sazima, Marlies; Cocucci, Andrea A.			Armament Imbalances: Match and Mismatch in Plant-Pollinator Traits of Highly Specialized Long-Spurred Orchids	PLOS ONE			English	Article							PHENOTYPIC SELECTION; NATURAL-SELECTION; RESOURCE COMPETITION; PLATANTHERA-BIFOLIA; MEDIATED SELECTION; FLORAL TRAITS; EVOLUTION; HAWKMOTH; FLOWERS; PATTERNS	Background: Some species of long-spurred orchids achieve pollination by a close association with long-tongued hawkmoths. Among them, several Habenaria species present specialized mechanisms, where pollination success depends on the attachment of pollinaria onto the heads of hawkmoths with very long proboscises. However, in the Neotropical region such moths are less abundant than their shorter-tongued relatives and are also prone to population fluctuations. Both factors may give rise to differences in pollinator-mediated selection on floral traits through time and space. Methodology/Principal Findings: We characterized hawkmoth assemblages and estimated phenotypic selection gradients on orchid spur lengths in populations of three South American Habenaria species. We examined the match between hawkmoth proboscis and flower spur lengths to determine whether pollinators may act as selective agents on flower morphology. We found significant directional selection on spur length only in Habenaria gourlieana, where most pollinators had proboscises longer than the mean of orchid spur length. Conclusions/Significance: Phenotypic selection is dependent on the mutual match between pollinator and flower morphologies. However, our findings indicate that pollinator-mediated selection may vary through time and space according to local variations in pollinator assemblages.	[More, Marcela; Benitez-Vieyra, Santiago; Martin Medina, A.; Cocucci, Andrea A.] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal, Lab Ecol Evolut & Biol Floral, RA-5000 Cordoba, Argentina; [Amorim, Felipe W.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, Programa Posgrad Biol Vegetal, Sao Paulo, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidade de Sao Paulo; Universidade Estadual de Campinas	More, M (corresponding author), Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Biol Vegetal, Lab Ecol Evolut & Biol Floral, RA-5000 Cordoba, Argentina.	amorimfelipe@yahoo.com.br	Amorim, Felipe W./AAE-6641-2020; Benitez-Vieyra, Santiago/AAT-3076-2020; Sazima, Marlies/B-6973-2013; Moré, Marcela/I-3873-2019	Amorim, Felipe W./0000-0002-6026-0395; Benitez-Vieyra, Santiago/0000-0003-4116-7969; Moré, Marcela/0000-0003-2982-8939; Cocucci, Andrea/0000-0002-3464-3309	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [11220080101264]; MINCYT [31]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as part of the Thematic Project Functional Gradient within the BIOTA/FAPESP Program - The Biodiversity Virtual Institute [03/12595-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302452/2008-7]; FAPESP [2007/58666-3]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); MINCYT; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as part of the Thematic Project Functional Gradient within the BIOTA/FAPESP Program - The Biodiversity Virtual Institute(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP # 11220080101264 to Alicia Sersic and MM], MINCYT [PID # 31 to AAC and SBV] and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as part of the Thematic Project Functional Gradient [03/12595-7], within the BIOTA/FAPESP Program - The Biodiversity Virtual Institute (http://www.biota.org.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [Grant 302452/2008-7 to MS]. This study is part of FWA's PhD supported by FAPESP [grant 2007/58666-3]. MM, SBV and AAC are staff researchers of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2005, OIKOS, V108, P183, DOI 10.1111/j.0030-1299.2005.13504.x; Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Amorim FW, 2013, PLANT BIOLOGY, V15, P317, DOI 10.1111/j.1438-8677.2012.00643.x; Amorim FW, 2009, J BIOGEOGR, V36, P662, DOI 10.1111/j.1365-2699.2008.02033.x; Anderson B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-204; Anderson B, 2010, EVOLUTION, V64, P960, DOI 10.1111/j.1558-5646.2009.00880.x; Armbruster WS, 2009, ANN BOT-LONDON, V103, P1529, DOI 10.1093/aob/mcp095; Balkenius A, 2004, ADAPT BEHAV, V12, P21, DOI 10.1177/105971230401200101; Batista JAN, 2006, BRITTONIA, V58, P10, DOI 10.1663/0007-196X(2006)58[10:AROHSM]2.0.CO;2; Beck J, 2006, BIODIVERS CONSERV, V15, P465, DOI 10.1007/s10531-005-0306-6; Benitez-Vieyra S, 2006, FUNCT ECOL, V20, P948, DOI 10.1111/j.1365-2435.2006.01179.x; Benitez-Vieyra S, 2010, J EVOLUTION BIOL, V23, P2760, DOI 10.1111/j.1420-9101.2010.02132.x; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Canty A., FUNCTIONS, V1; Colombo AF, 2010, BRAZ J BIOL, V70, P697, DOI 10.1590/S1519-69842010000400002; Cresswell JE, 1998, ANN BOT-LONDON, V81, P463, DOI 10.1006/anbo.1998.0594; Darrault Reisla Oliveira, 2002, Rev. Bras. Zool., V19, P429, DOI 10.1590/S0101-81752002000200009; Darwin C. R., 1904, VARIOUS CONTRIVANCES; Dixon Philip M., 1993, P290; Endress P. K., 1994, DIVERSITY EVOLUTIONA; Gross J, 1998, J EVOLUTION BIOL, V11, P589; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Ignatov II, 2011, ANN ENTOMOL SOC AM, V104, P68, DOI 10.1603/AN09083; Janzen D.H., 1988, Brenesia, V25-26, P51; Janzen Daniel H., 1993, P448; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; JOHNSTON MO, 1991, EVOLUTION, V45, P1468, DOI [10.2307/2409893, 10.1111/j.1558-5646.1991.tb02649.x]; Junior JAD, 2005, REV BRAS ZOOL, V22, P662, DOI 10.1590/S0101-81752005000300022; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kitching IJ, 2011, CATE CREATING TAXONO; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Maad J, 2004, J EVOLUTION BIOL, V17, P642, DOI 10.1111/j.1420-9101.2004.00703.x; Maad J, 2000, EVOLUTION, V54, P112, DOI 10.1111/j.0014-3820.2000.tb00012.x; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; More M., 2005, SPHINGIDAE ESFINGIDO; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; NILSSON LA, 1987, BIOTROPICA, V19, P310, DOI 10.2307/2388628; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; Perez-Barrales R, 2009, J BIOGEOGR, V36, P1411, DOI 10.1111/j.1365-2699.2008.01964.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBERTSON JL, 1990, EVOLUTION, V44, P121, DOI 10.1111/j.1558-5646.1990.tb04283.x; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Rodriguez-Girones MA, 2006, BEHAV ECOL, V17, P905, DOI 10.1093/beheco/arl024; Rodriguez-Girones MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002992; SCHEMSKE DW, 1989, EVOLUTION, V43, P461, DOI 10.1111/j.1558-5646.1989.tb04240.x; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Singer R, 1997, BOT ACTA, V110, P328, DOI 10.1111/j.1438-8677.1997.tb00648.x; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; STEINER KE, 1990, EVOLUTION, V44, P1701, DOI [10.2307/2409348, 10.1111/j.1558-5646.1990.tb03857.x]; Thompson J. N., 2005, INTERSPEC INTERACT; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Zhang ZQ, 2011, PLANT BIOLOGY, V13, P582, DOI 10.1111/j.1438-8677.2010.00423.x; Zuur Alain F., 2009, P1	60	37	38	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41878	10.1371/journal.pone.0041878	http://dx.doi.org/10.1371/journal.pone.0041878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848645	Green Published, gold			2022-12-27	WOS:000306806600138
J	Irimia, JM; Rovira, J; Nielsen, JN; Guerrero, M; Wojtaszewski, JFP; Cusso, R				Irimia, Jose M.; Rovira, Jordi; Nielsen, Jakob N.; Guerrero, Mario; Wojtaszewski, Jorgen F. P.; Cusso, Roser			Hexokinase 2, Glycogen Synthase and Phosphorylase Play a Key Role in Muscle Glycogen Supercompensation	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; RAT SKELETAL-MUSCLE; ACTIVATED PROTEIN-KINASE; II MESSENGER-RNA; GLUCOSE; EXPRESSION; EXERCISE; INSULIN; TRANSLOCATION; RESYNTHESIS	Background: Glycogen-depleting exercise can lead to supercompensation of muscle glycogen stores, but the biochemical mechanisms of this phenomenon are still not completely understood. Methods: Using chronic low-frequency stimulation (CLFS) as an exercise model, the tibialis anterior muscle of rabbits was stimulated for either 1 or 24 hours, inducing a reduction in glycogen of 90% and 50% respectively. Glycogen recovery was subsequently monitored during 24 hours of rest. Results: In muscles stimulated for 1 hour, glycogen recovered basal levels during the rest period. However, in those stimulated for 24 hours, glycogen was supercompensated and its levels remained 50% higher than basal levels after 6 hours of rest, although the newly synthesized glycogen had fewer branches. This increase in glycogen correlated with an increase in hexokinase-2 expression and activity, a reduction in the glycogen phosphorylase activity ratio and an increase in the glycogen synthase activity ratio, due to dephosphorylation of site 3a, even in the presence of elevated glycogen stores. During supercompensation there was also an increase in 5'-AMP-activated protein kinase phosphorylation, correlating with a stable reduction in ATP and total purine nucleotide levels. Conclusions: Glycogen supercompensation requires a coordinated chain of events at two levels in the context of decreased cell energy balance: First, an increase in the glucose phosphorylation capacity of the muscle and secondly, control of the enzymes directly involved in the synthesis and degradation of the glycogen molecule. However, supercompensated glycogen has fewer branches.	[Irimia, Jose M.; Rovira, Jordi; Guerrero, Mario; Cusso, Roser] Univ Barcelona, Dept Physiol Sci 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Nielsen, Jakob N.; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Mol Physiol Grp, Copenhagen Muscle Res Ctr, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen	Irimia, JM (corresponding author), Univ Barcelona, Dept Physiol Sci 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	mcusso@ub.edu	Rovira, Jordi/A-9603-2017; Wojtaszewski, Jørgen FP/P-6583-2014	Rovira, Jordi/0000-0001-8737-5005; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Guerrero, Mario/0000-0002-9912-661X; wojtaszewski, jorgen/0000-0001-8185-3408	Ministerio Espanol de Ciencia y Tecnologia [BFI2002-00218, BFU2005-08506]; FISS of the Instituto Carlos III (Red de Centros) [RCMN-C03708]; Agencia Espanola de Cooperacion Internacional; Danish Medical Reseach council; Novo Nordisk foundation; Danish Diabetes Association; European Union [LSHM-CT-2004-005272]; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain	Ministerio Espanol de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FISS of the Instituto Carlos III (Red de Centros); Agencia Espanola de Cooperacion Internacional; Danish Medical Reseach council; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; European Union(European Commission); Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain	This study was supported by the Ministerio Espanol de Ciencia y Tecnologia (BFI2002-00218 and BFU2005-08506), the FISS of the Instituto Carlos III (Red de Centros RCMN-C03708); and the Agencia Espanola de Cooperacion Internacional. JFPW and JNN were supported by the Danish Medical Reseach council, Novo Nordisk foundation, The Danish Diabetes Association and by an integrated project (LSHM-CT-2004-005272) from the European Union. JMI was supported by a predoctoral fellowship from Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain. JR was supported by a predoctoral fellowship from Universitat de Barcelona, Barcelona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Baque S, 1996, J BIOL CHEM, V271, P2594, DOI 10.1074/jbc.271.5.2594; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNO C, 1993, ANN NEUROL, V33, P88, DOI 10.1002/ana.410330114; Cadefau JA, 1999, J BIOL CHEM, V274, P31961, DOI 10.1074/jbc.274.45.31961; CADEFAU JA, 1993, PFLUG ARCH EUR J PHY, V424, P529, DOI 10.1007/BF00374918; CALDER PC, 1992, INT J BIOCHEM, V24, P71, DOI 10.1016/0020-711X(92)90231-O; CAO YJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P293, DOI 10.1006/abbi.1995.1295; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Fueger PT, 2005, CLIN EXP PHARMACOL P, V32, P314, DOI 10.1111/j.1440-1681.2005.04190.x; Fueger PT, 2004, AM J PHYSIOL-ENDOC M, V286, pE77, DOI 10.1152/ajpendo.00309.2003; Garcia-Roves P, 2003, AM J PHYSIOL-ENDOC M, V285, pE729, DOI 10.1152/ajpendo.00216.2003; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Greiwe JS, 1999, J APPL PHYSIOL, V87, P222, DOI 10.1152/jappl.1999.87.1.222; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hatfield DL, 2006, J STRENGTH COND RES, V20, P167; Hawley JA, 1997, SPORTS MED, V24, P73, DOI 10.2165/00007256-199724020-00001; HOFMANN S, 1994, EUR J BIOCHEM, V219, P307, DOI 10.1111/j.1432-1033.1994.tb19942.x; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Koval JA, 1998, AM J PHYSIOL-ENDOC M, V274, pE304, DOI 10.1152/ajpendo.1998.274.2.E304; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Lai YC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1622, DOI 10.1152/ajpendo.00113.2007; Laurent D, 2000, AM J PHYSIOL-ENDOC M, V278, pE663, DOI 10.1152/ajpendo.2000.278.4.E663; Mamedova LK, 2003, MOL CELL BIOCHEM, V250, P11, DOI 10.1023/A:1024980710799; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249; Nielsen JN, 2004, P NUTR SOC, V63, P233, DOI 10.1079/PNS2004348; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; ODOHERTY RM, 1994, AM J PHYSIOL, V266, pE171; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PETTE D, 1975, PFLUG ARCH EUR J PHY, V361, P1, DOI 10.1007/BF00587333; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prats C, 2005, J BIOL CHEM, V280, P23165, DOI 10.1074/jbc.M502713200; Prats C, 2002, BBA-GEN SUBJECTS, V1573, P68, DOI 10.1016/S0304-4165(02)00332-X; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; Putman CT, 2007, AM J PHYSIOL-REG I, V293, pR1325, DOI 10.1152/ajpregu.00609.2006; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Sandstrom ME, 2004, PFLUG ARCH EUR J PHY, V448, P533, DOI 10.1007/s00424-004-1280-7; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V289, pE508, DOI 10.1152/ajpendo.00100.2005; Skein M, 2011, EUR J APPL PHYSL; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; TAN AWH, 1979, BIOCHIM BIOPHYS ACTA, V582, P543, DOI 10.1016/0304-4165(79)90146-6; TULLSON PC, 1990, AM J PHYSIOL, V258, pC258, DOI 10.1152/ajpcell.1990.258.2.C258; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Wilson RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1815, DOI 10.1152/ajpendo.00598.2006; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	57	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42453	10.1371/journal.pone.0042453	http://dx.doi.org/10.1371/journal.pone.0042453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860128	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600102
J	Nie, QH; Sandford, EE; Zhang, XQ; Nolan, LK; Lamont, SJ				Nie, Qinghua; Sandford, Erin E.; Zhang, Xiquan; Nolan, Lisa K.; Lamont, Susan J.			Deep Sequencing-Based Transcriptome Analysis of Chicken Spleen in Response to Avian Pathogenic Escherichia coli (APEC) Infection	PLOS ONE			English	Article							RNA-SEQ DATA; GENE ONTOLOGY; EXPRESSION; GENOME; CELLS; AUTOTRANSPORTER; ACTIVATION; VIRULENCE; ADHESIN	Avian pathogenic Escherichia coli (APEC) leads to economic losses in poultry production and is also a threat to human health. The goal of this study was to characterize the chicken spleen transcriptome and to identify candidate genes for response and resistance to APEC infection using Solexa sequencing. We obtained 14422935, 14104324, and 14954692 Solexa read pairs for non-challenged (NC), challenged-mild pathology (MD), and challenged-severe pathology (SV), respectively. A total of 148197 contigs and 98461 unigenes were assembled, of which 134949 contigs and 91890 unigenes match the chicken genome. In total, 12272 annotated unigenes take part in biological processes (11664), cellular components (11927), and molecular functions (11963). Summing three specific contrasts, 13650 significantly differentially expressed unigenes were found in NC Vs. MD (6844), NC Vs. SV (7764), and MD Vs. SV (2320). Some unigenes (e. g. CD148, CD45 and LCK) were involved in crucial pathways, such as the T cell receptor (TCR) signaling pathway and microbial metabolism in diverse environments. This study facilitates understanding of the genetic architecture of the chicken spleen transcriptome, and has identified candidate genes for host response to APEC infection.	[Nie, Qinghua; Zhang, Xiquan] S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Nie, Qinghua; Sandford, Erin E.; Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Nie, Qinghua; Zhang, Xiquan] Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Nie, Qinghua; Zhang, Xiquan] Minist Agr, Key Lab Chicken Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Nolan, Lisa K.] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol, Ames, IA USA	South China Agricultural University; Iowa State University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Iowa State University	Nie, QH (corresponding author), S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China.	xqzhang@scau.edu.cn; sjlamont@iastate.edu			National High Technology Research and Development Program (863) of China [2011AA100301, 2010AA10A102]; National Broiler Industry Technology System [nycytx-42-G1-04]; National Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Program [2008-35604-18805]	National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China); National Broiler Industry Technology System; National Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Program	This research was supported by grants from the National High Technology Research and Development Program (863) of China (2011AA100301; 2010AA10A102) and the National Broiler Industry Technology System (nycytx-42-G1-04). Animal studies were supported by National Research Initiative Competitive Grant no. 2008-35604-18805 from the United States Department of Agriculture National Institute of Food and Agriculture Microbial Genome Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antao EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007796; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barnes H.J., 2008, DIS POULTRY, P691; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bliss TW, 2005, VET IMMUNOL IMMUNOP, V105, P289, DOI 10.1016/j.vetimm.2005.02.013; Burbach BJ, 2007, IMMUNOL REV, V218, P65, DOI 10.1111/j.1600-065X.2007.00527.x; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; Dai JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-236; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Dho-Moulin M, 1999, VET RES, V30, P299; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunther J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-17; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Karlsson M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-15; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasoudris F, 2011, EUR J IMMUNOL, V41, P1629, DOI 10.1002/eji.201041119; Lavric M, 2008, VET MICROBIOL, V126, P111, DOI 10.1016/j.vetmic.2007.06.011; Li GW, 2010, INFECT IMMUN, V78, P898, DOI 10.1128/IAI.00513-09; Lin J, 2001, J CELL SCI, V114, P243; Lu Y, 2009, CLIN VACCINE IMMUNOL, V16, P1639, DOI 10.1128/CVI.00254-09; Oliveira A, 2009, J APPL MICROBIOL, V106, P1919, DOI 10.1111/j.1365-2672.2009.04145.x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Ron EZ, 2006, CURR OPIN MICROBIOL, V9, P28, DOI 10.1016/j.mib.2005.12.001; Sandford EE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-469; Tyler CD, 2008, AVIAN DIS, V52, P23, DOI 10.1637/8026-053107-Reg; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wolf JBW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-91; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	39	28	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41645	10.1371/journal.pone.0041645	http://dx.doi.org/10.1371/journal.pone.0041645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860004	gold, Green Published			2022-12-27	WOS:000307045600036
J	Winkeler, CL; Kladney, RD; Maggi, LB; Weber, JD				Winkeler, Crystal L.; Kladney, Raleigh D.; Maggi, Leonard B., Jr.; Weber, Jason D.			Cathepsin K-Cre Causes Unexpected Germline Deletion of Genes in Mice	PLOS ONE			English	Article							OSTEOPOROSIS THERAPY; MOLECULAR-CLONING; TUMOR-SUPPRESSOR; BONE-RESORPTION; DEFICIENT MICE; OSTEOCLASTS; EXPRESSION; OSTEOPETROSIS; CELL	Osteoclasts are terminally differentiated cells that attach to bone and secrete proteases to degrade the bone matrix. The primary protease responsible for the degradation of the organic component of the bone matrix is Cathepsin K, which was largely thought to be unique to osteoclasts. Given its apparent selective expression in osteoclasts, the Cathepsin K promoter has been engineered to drive the expression of Cre recombinase in mice and has been the most relevant tool for generating osteoclast-specific gene loss. In an effort to understand the role of the ARF tumor suppressor in osteoclasts, we crossed Arf(fl/fl) mice to Ctsk(Cre/+) mice, which unexpectedly resulted in the germline loss of Arf. We subsequently confirmed Cre activity in gametes by generating Ctsk(Cre/+); Rosa(+) mice. These results raise significant concerns regarding in vivo bone phenotypes created using Ctsk(Cre/+) mice and warrant further investigation into the role of Cathepsin K in gametes as well as alternative tools for studying osteoclast-specific gene loss in vivo.	[Winkeler, Crystal L.] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Internal Med, Div Mol Oncol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Winkeler, CL (corresponding author), Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63130 USA.	jweber@dom.wustl.edu	Maggi, Leonard/L-5217-2019	Maggi, Leonard/0000-0003-0138-0984; Weber, Jason/0000-0002-1069-6983	National Institutes of Health [R01CA120436]; NATIONAL CANCER INSTITUTE [R01CA120436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health grant R01CA120436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; COCCIA PF, 1980, NEW ENGL J MED, V302, P701, DOI 10.1056/NEJM198003273021301; Fabra M, 2004, MOL REPROD DEV, V67, P282, DOI 10.1002/mrd.20018; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Gromley A, 2009, P NATL ACAD SCI USA, V106, P6285, DOI 10.1073/pnas.0902310106; Kamijo T, 1999, CANCER RES, V59, P2217; LittlewoodEvans A, 1997, BONE, V20, P81, DOI 10.1016/S8756-3282(96)00351-1; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Qin A, PLOS ONE, V6; QUELLE DE, 1995, CELL, V83, P993; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stoch SA, 2008, CLIN PHARMACOL THER, V83, P172, DOI 10.1038/sj.clpt.6100450; Troen BR, 2004, DRUG NEWS PERSPECT, V17, P19, DOI 10.1358/dnp.2004.17.1.829022; Zaidi M, 2001, J BONE MINER RES, V16, P1747, DOI 10.1359/jbmr.2001.16.10.1747	18	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42005	10.1371/journal.pone.0042005	http://dx.doi.org/10.1371/journal.pone.0042005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860046	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600050
J	Brown, TLY; Spencer, HJ; Beenken, KE; Alpe, TL; Bartel, TB; Bellamy, W; Gruenwald, JM; Skinner, RA; McLaren, SG; Smeltzer, MS				Brown, Tracy L. Y.; Spencer, Horace J.; Beenken, Karen E.; Alpe, Terri L.; Bartel, Twyla B.; Bellamy, William; Gruenwald, J. Michael; Skinner, Robert A.; McLaren, Sandra G.; Smeltzer, Mark S.			Evaluation of Dynamic [F-18]-FDG-PET Imaging for the Detection of Acute Post-Surgical Bone Infection	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STAPHYLOCOCCUS-AUREUS; OSTEOMYELITIS; PET; SCINTIGRAPHY; INFLAMMATION; F-18-FDG; MODEL	Diagnosing bone infection in its acute early stage is of utmost clinical importance as the failure to do so results in a therapeutically recalcitrant chronic infection that can only be resolved with extensive surgical intervention, the end result often being a structurally unstable defect requiring reconstructive procedures. [F-18]-FDG-PET has been extensively investigated for this purpose, but the results have been mixed in that, while highly sensitive, its specificity with respect to distinguishing between acute infection and sterile inflammatory processes, including normal recuperative post-surgical healing, is limited. This study investigated the possibility that alternative means of acquiring and analyzing FDG-PET data could be used to overcome this lack of specificity without an unacceptable loss of sensitivity. This was done in the context of an experimental rabbit model of post-surgical osteomyelitis with the objective of distinguishing between acute infection and sterile post-surgical inflammation. Imaging was done 7 and 14 days after surgery with continuous data acquisition for a 90-minute period after administration of tracer. Results were evaluated based on both single and dual time point data analysis. The results suggest that the diagnostic utility of FDG-PET is likely limited to well-defined clinical circumstances. We conclude that, in the complicated clinical context of acute post-surgical or post-traumatic infection, the diagnostic utility accuracy of FDG-PET is severely limited based on its focus on the increased glucose utilization that is generally characteristic of inflammatory processes.	[Brown, Tracy L. Y.; Alpe, Terri L.; Bartel, Twyla B.] Univ Arkansas Med Sci, Dept Radiol, Little Rock, AR 72205 USA; [Spencer, Horace J.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Beenken, Karen E.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Bellamy, William; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Gruenwald, J. Michael; Skinner, Robert A.; McLaren, Sandra G.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA; [Gruenwald, J. Michael; Skinner, Robert A.; McLaren, Sandra G.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Ctr Orthopaed Res, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Brown, TLY (corresponding author), Univ Arkansas Med Sci, Dept Radiol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692; Spencer, Horace/0000-0001-8176-881X	National Institute of Allergy and Infectious Diseases [AI069087]; Clinical and Translational Sciences Award [RR0298884]; Cubist Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069087] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clinical and Translational Sciences Award; Cubist Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI069087 (MSS) from the National Institute of Allergy and Infectious Diseases. Support was also obtained from resources provided through the Clinical and Translational Sciences Award (RR0298884) to the University of Arkansas for Medical Sciences. Professional and financial affiliations for MS: Study funding from Cubist Pharmaceuticals and served on Unique Properties Advisory Board, Cubist Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have received funding from a commercial source (Cubist Pharmaceuticals). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Cierny G, 2011, PLAST RECONSTR SURG, V127, p190S, DOI 10.1097/PRS.0b013e3182025070; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; Guhlmann A, 1998, J NUCL MED, V39, P2145; Jones-Jackson L, 2005, J ORTHOP RES, V23, P1484, DOI 10.1016/j.orthres.2005.03.010; Kalicke T, 2000, EUR J NUCL MED, V27, P524, DOI 10.1007/s002590050538; Koort JK, 2004, J NUCL MED, V45, P1406; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Makinen TJ, 2005, EUR J NUCL MED MOL I, V32, P1259, DOI 10.1007/s00259-005-1841-9; Parsons B, 2004, AM J SURG, V188, p57S, DOI 10.1016/S0002-9610(03)00292-7; Sahlmann CO, 2004, NUCL MED COMMUN, V25, P819, DOI 10.1097/01.mnm.0000135600.23896.9d; Smeltzer MS, 1997, J ORTHOPAED RES, V15, P414, DOI 10.1002/jor.1100150314; van der Bruggen W, 2010, SEMIN NUCL MED, V40, P3, DOI 10.1053/j.semnuclmed.2009.08.005; Vijayanathan S, 2009, SEMIN NUCL MED, V39, P357, DOI 10.1053/j.semnuclmed.2009.07.001; Visioni A, 2011, SURG CLIN N AM, V91, P249, DOI 10.1016/j.suc.2010.10.012	14	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41863	10.1371/journal.pone.0041863	http://dx.doi.org/10.1371/journal.pone.0041863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860021	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900043
J	Fulop, L; Mandity, IM; Juhasz, G; Szegedi, V; Hetenyi, A; Weber, E; Bozso, Z; Simon, D; Benko, R; Kiraly, Z; Martinek, TA				Fueloep, Livia; Mandity, Istvan M.; Juhasz, Gabor; Szegedi, Viktor; Hetenyi, Anasztazia; Weber, Edit; Bozso, Zsolt; Simon, Dora; Benko, Maria; Kiraly, Zoltan; Martinek, Tamas A.			A Foldamer-Dendrimer Conjugate Neutralizes Synaptotoxic beta-Amyloid Oligomers	PLOS ONE			English	Article							A-BETA; PEPTIDE INHIBITORS; SECONDARY STRUCTURES; SYNAPTIC PLASTICITY; BETA(3)-PEPTIDE INHIBITORS; STOICHIOMETRIC INHIBITION; PROTEIN AGGREGATION; MOUSE MODEL; HIV FUSION; AMINO-ACID	Background and Aims: Unnatural self-organizing biomimetic polymers (foldamers) emerged as promising materials for biomolecule recognition and inhibition. Our goal was to construct multivalent foldamer-dendrimer conjugates which wrap the synaptotoxic beta-amyloid (A beta) oligomers with high affinity through their helical foldamer tentacles. Oligomeric A beta species play pivotal role in Alzheimer's disease, therefore recognition and direct inhibition of this undruggable target is a great current challenge. Methods and Results: Short helical beta-peptide foldamers with designed secondary structures and side chain chemistry patterns were applied as potential recognition segments and their binding to the target was tested with NMR methods (saturation transfer difference and transferred-nuclear Overhauser effect). Helices exhibiting binding in the mu M region were coupled to a tetravalent G0-PAMAM dendrimer. In vitro biophysical (isothermal titration calorimetry, dynamic light scattering, transmission electron microscopy and size-exclusion chromatography) and biochemical tests (ELISA and dot blot) indicated the tight binding between the foldamer conjugates and the A beta oligomers. Moreover, a selective low nM interaction with the low molecular weight fraction of the A beta oligomers was found. Ex vivo electrophysiological experiments revealed that the new material rescues the long-term potentiation from the toxic A beta oligomers in mouse hippocampal slices at submicromolar concentration. Conclusions: The combination of the foldamer methodology, the fragment-based approach and the multivalent design offers a pathway to unnatural protein mimetics that are capable of specific molecular recognition, and has already resulted in an inhibitor for an extremely difficult target.	[Fueloep, Livia; Juhasz, Gabor; Hetenyi, Anasztazia; Bozso, Zsolt; Simon, Dora] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Mandity, Istvan M.; Weber, Edit; Martinek, Tamas A.] Univ Szeged, Inst Pharmaceut Chem, Szeged, Hungary; [Szegedi, Viktor] Bay Zoltan Fdn Appl Res BAYGEN, Szeged, Hungary; [Benko, Maria; Kiraly, Zoltan] Univ Szeged, Dept Phys Chem & Mat Sci, Szeged, Hungary	Szeged University; Szeged University; Szeged University	Fulop, L (corresponding author), Univ Szeged, Dept Med Chem, Szeged, Hungary.	martinek@pharm.u-szeged.hu	Fülöp, Livia/GRX-8140-2022; Fülöp, Livia/E-2543-2011; Mandity, Istvan/N-8041-2017	Mandity, Istvan/0000-0003-2865-6143; Hetenyi, Anasztazia/0000-0001-8080-6992; Szegedi, Viktor/0000-0003-4191-379X; Weber, Edit/0000-0002-5904-0619; Fulop, Livia/0000-0002-8010-0129; Juhasz, Gabor/0000-0001-6912-5109	EU FP7 [HEALTH-F2-2007-201159, HEALTH-F2-2007-211696]; COST [CM0803]; Hungarian Research Foundation [NK81371, PD83581, PD83600, K68152]; Hungarian Academy of Sciences, Lendulet programme	EU FP7(European Commission); COST(European Cooperation in Science and Technology (COST)); Hungarian Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences, Lendulet programme	This work was supported by the EU FP7 (HEALTH-F2-2007-201159, HEALTH-F2-2007-211696 and COST CM0803) (http://cordis.europa.eu/fp7/home_en.html); the Hungarian Research Foundation (NK81371, PD83581, PD83600 and K68152) (http://www.otka.hu/); and the Hungarian Academy of Sciences, Lendulet programme (http://mta.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales KR, 2006, J CLIN INVEST, V116, P825, DOI 10.1172/JCI27120; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bautista AD, 2010, J AM CHEM SOC, V132, P2904, DOI 10.1021/ja910715u; Bautista AD, 2009, BIOORG MED CHEM LETT, V19, P3736, DOI 10.1016/j.bmcl.2009.05.032; Bett CK, 2010, ACS CHEM NEUROSCI, V1, P608, DOI 10.1021/cn100045q; Blaskovich MA, 2000, NAT BIOTECHNOL, V18, P1065, DOI 10.1038/80257; Bozso Z, 2010, PEPTIDES, V31, P248, DOI 10.1016/j.peptides.2009.12.001; Chafekar SM, 2007, CHEMBIOCHEM, V8, P1857, DOI 10.1002/cbic.200700338; Chen ZJ, 2005, J MOL BIOL, V354, P760, DOI 10.1016/j.jmb.2005.09.055; Choi SH, 2008, J AM CHEM SOC, V130, P6544, DOI 10.1021/ja800355p; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Delsuc N, 2007, ANGEW CHEM INT EDIT, V46, P214, DOI 10.1002/anie.200603390; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Etienne MA, 2006, J AM CHEM SOC, V128, P3522, DOI 10.1021/ja0600678; Etienne MA, 2005, BIOPOLYMERS, V80, P566; Findeis MA, 1999, BIOCHEMISTRY-US, V38, P6791, DOI 10.1021/bi982824n; Fournel S, 2005, NAT CHEM BIOL, V1, P377, DOI 10.1038/nchembio746; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gademann K, 1999, ANGEW CHEM INT EDIT, V38, P1223, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1223::AID-ANIE1223>3.0.CO;2-A; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goodman CM, 2007, NAT CHEM BIOL, V3, P252, DOI 10.1038/nchembio876; Griffin JH, 2003, J AM CHEM SOC, V125, P6517, DOI 10.1021/ja021273s; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Horne WS, 2008, ACCOUNTS CHEM RES, V41, P1399, DOI 10.1021/ar800009n; Horne WS, 2008, ANGEW CHEM INT EDIT, V47, P2853, DOI 10.1002/anie.200705315; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Johnson LM, 2011, J AM CHEM SOC, V133, P10038, DOI 10.1021/ja203358t; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Kostiainen MA, 2005, ANGEW CHEM INT EDIT, V44, P2556, DOI 10.1002/anie.200500066; Kritzer JA, 2005, J AM CHEM SOC, V127, P14584, DOI 10.1021/ja055050o; Kritzer JA, 2005, J AM CHEM SOC, V127, P4118, DOI 10.1021/ja042933r; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Lelais G, 2006, HELV CHIM ACTA, V89, P361, DOI 10.1002/hlca.339; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LILIOM K, 1991, J IMMUNOL METHODS, V143, P119, DOI 10.1016/0022-1759(91)90280-S; Liu RT, 2004, BIOCHEMISTRY-US, V43, P6959, DOI 10.1021/bi049933o; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Mandity IM, 2009, ANGEW CHEM INT EDIT, V48, P2171, DOI 10.1002/anie.200805095; Martinek TA, 2003, EUR J BIOCHEM, V270, P3657, DOI 10.1046/j.1432-1033.2003.03756.x; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Michel J, 2009, J AM CHEM SOC, V131, P6356, DOI 10.1021/ja901478e; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; Pera NP, 2010, CHEMBIOCHEM, V11, P1896, DOI 10.1002/cbic.201000340; Petersson EJ, 2008, J AM CHEM SOC, V130, P821, DOI 10.1021/ja077245x; Pukin AV, 2007, CHEMBIOCHEM, V8, P1500, DOI 10.1002/cbic.200700266; Reinke AA, 2011, CHEM BIOL DRUG DES, V77, P399, DOI 10.1111/j.1747-0285.2011.01110.x; Reinke AA, 2010, J AM CHEM SOC, V132, P17655, DOI 10.1021/ja106291e; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Sadowsky JD, 2005, J AM CHEM SOC, V127, P11966, DOI 10.1021/ja053678t; Saraogi I, 2009, CHEM SOC REV, V38, P1726, DOI 10.1039/b819597h; Sattin S, 2010, ACS CHEM BIOL, V5, P301, DOI 10.1021/cb900216e; Seebach D, 2008, ACCOUNTS CHEM RES, V41, P1366, DOI 10.1021/ar700263g; Shandler SJ, 2011, J AM CHEM SOC, V133, P12378, DOI 10.1021/ja204215f; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shukla R, 2005, CHEM COMMUN, P5739, DOI 10.1039/b507350b; Sisu C, 2009, CHEMBIOCHEM, V10, P329, DOI 10.1002/cbic.200800550; Smith TJ, 2006, J AM CHEM SOC, V128, P14456, DOI 10.1021/ja065557e; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Stephens OM, 2005, J AM CHEM SOC, V127, P13126, DOI 10.1021/ja053444+; Takahashi T, 2007, CHEMBIOCHEM, V8, P985, DOI 10.1002/cbic.200700108; Takahashi T, 2010, PROTEINS, V78, P336, DOI 10.1002/prot.22546; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zeng Y, 2010, J ALZHEIMERS DIS, V21, P823, DOI 10.3233/JAD-2010-100264	80	33	34	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e39485	10.1371/journal.pone.0039485	http://dx.doi.org/10.1371/journal.pone.0039485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859942	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306950900007
J	Jones, KH; Ford, DV; Jones, PA; John, A; Middleton, RM; Lockhart-Jones, H; Osborne, LA; Noble, JG				Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Osborne, Lisa A.; Noble, J. Gareth			A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register	PLOS ONE			English	Article							HOSPITAL ANXIETY; IMPACT	Introduction: Studies have found that people with Multiple Sclerosis experience relatively high rates of anxiety and depression. Although methodologically robust, many of these studies had access to only modest sample sizes (N<200). The aims of this study were to use responses gained via the web portal of the UK MS Register (N>4000) to: describe the depression and anxiety profiles of people with MS; to determine if anxiety and depression are related to age or disease duration; and to assess whether the levels of anxiety and depression differ between genders and types of MS. Methods: From its launch in May 2011 to the end of December 2011, 7786 adults with MS enrolled to take part in the UK MS Register via the web portal. The responses to the Hospital Anxiety and Depression Scale (HADS) were collated with basic demographic and descriptive MS data provided at registration and the resulting dataset was analysed in SPSS (v. 16). Results: The mean HADS score among the 4178 respondents was 15.7 (SE 0.117, SD 7.55) with a median of 15.0 (IQR 11). Anxiety and depression rates were notably high, with over half (54.1%) scoring >= 8 for anxiety and 46.9% scoring >= 8 for depression. Women with relapsing-remitting MS were more anxious than men with this type (p<0.001), and than women with other types of MS (p = 0.017). Within each gender, men and women with secondary progressive MS were more depressed than men or women with other types of MS (p<0.001, p<0.001). Conclusions: This largest known study of its kind has shown that anxiety and depression are highly prevalent in people with MS, indicating that their mental health needs could be better addressed. These findings support service planning and further research to provide the best care for people with MS to help alleviate these debilitating conditions.	[Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Osborne, Lisa A.] Swansea Univ, Coll Human & Hlth Sci, Long Term & Chron Condit Ctr, Swansea, W Glam, Wales	Swansea University; Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Ford, David/0000-0001-6551-721X; John, Ann/0000-0002-5657-6995; Middleton, Rodden/0000-0002-2130-4420; Noble, Gareth/0000-0002-4588-049X; Jones, Kerina/0000-0001-8164-3718	MS Society of Great Britain; MS Society of Northern Ireland	MS Society of Great Britain; MS Society of Northern Ireland	The study is funded by the MS Society of Great Britain and Northern Ireland (http://www.mssociety.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ETH REV RES DAT; [Anonymous], 2009, ATL MS DAT PROF COUN; Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Beiske AG, 2008, EUR J NEUROL, V15, P239, DOI 10.1111/j.1468-1331.2007.02041.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; Bruce JM, 2011, J PSYCHOSOM RES, V70, P479, DOI 10.1016/j.jpsychores.2010.12.010; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; da Silva AM, 2011, J NEUROL SCI, V306, P66, DOI 10.1016/j.jns.2011.03.042; Dahl OP, 2009, MULT SCLER, V15, P495; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Ford DV, 2012, BMC MED IN PRESS JUN; Giordano A, 2011, J NEUROL SCI, V307, P86, DOI 10.1016/j.jns.2011.05.008; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Michalski D, 2010, MENT ILLN, V2, DOI 10.4081/mi.2010.e5; Minden SL, 2000, J NEUROVIROL, V6, pS160; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Sa MJ, 2008, CLIN NEUROL NEUROSUR, V110, P868, DOI 10.1016/j.clineuro.2007.10.001; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zajicek JP, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-88; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zorzon M, 2001, J NEUROL, V248, P416, DOI 10.1007/s004150170184	28	105	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41910	10.1371/journal.pone.0041910	http://dx.doi.org/10.1371/journal.pone.0041910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860028	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900047
J	McDowell, A; Barnard, E; Nagy, I; Gao, A; Tomida, S; Li, HY; Eady, A; Cove, J; Nord, CE; Patrick, S				McDowell, Andrew; Barnard, Emma; Nagy, Istvan; Gao, Anna; Tomida, Shuta; Li, Huiying; Eady, Anne; Cove, Jonathan; Nord, Carl E.; Patrick, Sheila			An Expanded Multilocus Sequence Typing Scheme for Propionibacterium acnes: Investigation of 'Pathogenic', 'Commensal' and Antibiotic Resistant Strains	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CUTANEOUS PROPIONIBACTERIA; CAMP FACTOR; INFECTION; EXPRESSION; DNA; IDENTIFICATION; EVOLUTION; PROTEINS; INDUCE	The Gram-positive bacterium Propionibacterium acnes is a member of the normal human skin microbiota and is associated with various infections and clinical conditions. There is tentative evidence to suggest that certain lineages may be associated with disease and others with health. We recently described a multilocus sequence typing scheme (MLST) for P. acnes based on seven housekeeping genes (http://pubmlst.org/pacnes). We now describe an expanded eight gene version based on six housekeeping genes and two 'putative virulence' genes (eMLST) that provides improved high resolution typing (91eSTs from 285 isolates), and generates phylogenies congruent with those based on whole genome analysis. When compared with the nine gene MLST scheme developed at the University of Bath, UK, and utilised by researchers at Aarhus University, Denmark, the eMLST method offers greater resolution. Using the scheme, we examined 208 isolates from disparate clinical sources, and 77 isolates from healthy skin. Acne was predominately associated with type IA(1) clonal complexes CC1, CC3 and CC4; with eST1 and eST3 lineages being highly represented. In contrast, type IA(2) strains were recovered at a rate similar to type IB and II organisms. Ophthalmic infections were predominately associated with type IA1 and IA2 strains, while type IB and II were more frequently recovered from soft tissue and retrieved medical devices. Strains with rRNA mutations conferring resistance to antibiotics used in acne treatment were dominated by eST3, with some evidence for intercontinental spread. In contrast, despite its high association with acne, only a small number of resistant CC1 eSTs were identified. A number of eSTs were only recovered from healthy skin, particularly eSTs representing CC72 (type II) and CC77 (type III). Collectively our data lends support to the view that pathogenic versus truly commensal lineages of P. acnes may exist. This is likely to have important therapeutic and diagnostic implications.	[McDowell, Andrew; Barnard, Emma; Patrick, Sheila] Queens Univ, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Nagy, Istvan] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary; [Gao, Anna] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Tomida, Shuta; Li, Huiying] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Eady, Anne] Harrogate & Dist NHS Fdn Trust, Dept Dermatol, Harrogate, England; [Cove, Jonathan] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Nord, Carl E.] Karolinska Inst, Dept Lab Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden	Queens University Belfast; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Warwick; University of California System; University of California Los Angeles; University of Leeds; Karolinska Institutet; Karolinska University Hospital	McDowell, A (corresponding author), Queens Univ, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	a.mcdowell@qub.ac.uk		EADY, Anne/0000-0001-6975-5557; McDowell, Andrew/0000-0002-9649-0504	R & D Office of the Health and Personal Social Services Northern Ireland [HSCNI 9.41]; Prostate Cancer Charity, United Kingdom [110831]; Public Health Agency [SUS/4334/10, RRG/3241/05] Funding Source: researchfish	R & D Office of the Health and Personal Social Services Northern Ireland; Prostate Cancer Charity, United Kingdom; Public Health Agency	The work was supported by funding from the R & D Office of the Health and Personal Social Services Northern Ireland (grant number HSCNI 9.41; http://www.dhsspsni.gov.uk/ahp_ research) and The Prostate Cancer Charity, United Kingdom (grant number 110831; http://www.prostate-cancer.org.uk/). IN: Hungarian National Office for Research and Technology Teller program OMFB-00441/2007, French-Hungarian Associated European Laboratory (LEA) SkinChroma OMFB-00272/2009, and TAMOP-4.2.1.B-10/2/KONV-2010-0002. AG: Micropathology Ltd and the Royal Commission for the Exhibition of 1851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojar RA, 2004, CLIN DERMATOL, V22, P375, DOI 10.1016/j.clindermatol.2004.03.005; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Butler-Wu SM, 2011, J BACTERIOL, V193, P3678, DOI 10.1128/JB.05036-11; Coates P, 2002, BRIT J DERMATOL, V146, P840, DOI 10.1046/j.1365-2133.2002.04690.x; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Dekio I, 2012, J MED MICROBIOL, V61, P622, DOI 10.1099/jmm.0.040949-0; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Furukawa A, 2009, MICROB PATHOGENESIS, V46, P80, DOI 10.1016/j.micpath.2008.10.013; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Horvath B, 2012, J BACTERIOL, V194, P202, DOI 10.1128/JB.06388-11; Hunyadkurti J, 2011, J BACTERIOL, V193, P4561, DOI 10.1128/JB.05372-11; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jahns AC, 2012, BR J DERMATOL; Javey Golnaz, 2010, Ophthalmic Surg Lasers Imaging, P1, DOI 10.3928/15428877-20100215-61; Jiang LL, 2008, INT J FOOD MICROBIOL, V121, P53, DOI 10.1016/j.ijfoodmicro.2007.10.007; Kilian M, 2012, J CLIN MICROBIOL, V50, P1158, DOI 10.1128/JCM.r06129-11; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Niazi SA, 2010, J CLIN MICROBIOL, V48, P3859, DOI 10.1128/JCM.01326-10; Oprica C, 2005, ANAEROBE, V11, P137, DOI 10.1016/j.anaerobe.2005.01.005; Patrick S, 2011, BERGEYS MANUAL SYSTE, V5; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X; Ross JI, 1997, ANTIMICROB AGENTS CH, V41, P1162, DOI 10.1128/AAC.41.5.1162; Ross JI, 2003, BRIT J DERMATOL, V148, P467, DOI 10.1046/j.1365-2133.2003.05067.x; Ross JI, 2002, J ANTIMICROB CHEMOTH, V49, P165, DOI 10.1093/jac/49.1.165; Ross JI, 2001, BRIT J DERMATOL, V144, P339, DOI 10.1046/j.1365-2133.2001.03956.x; Ross JI, 1998, ANTIMICROB AGENTS CH, V42, P1702, DOI 10.1128/AAC.42.7.1702; Sampedro MF, 2009, DIAGN MICR INFEC DIS, V64, P138, DOI 10.1016/j.diagmicrobio.2009.01.024; Schaeverbeke T, 1998, ARTHRITIS RHEUM, V41, P1889, DOI 10.1002/1529-0131(199810)41:10<1889::AID-ART23>3.0.CO;2-F; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Shannon BA, 2006, BJU INT, V98, P388, DOI 10.1111/j.1464-410X.2006.06273.x; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Voros A, 2012, J BACTERIOL, V194, P1621, DOI 10.1128/JB.06758-11; Yasuhara T, 2005, ACTA OPHTHALMOL SCAN, V83, P364, DOI 10.1111/j.1600-0420.2005.00449.x; Zeller V, 2007, J INFECTION, V55, P119, DOI 10.1016/j.jinf.2007.02.006; Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004	55	147	164	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41480	10.1371/journal.pone.0041480	http://dx.doi.org/10.1371/journal.pone.0041480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859988	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900024
J	Poisbleau, M; Muller, W; Carslake, D; Demongin, L; Groothuis, TGG; Van Camp, J; Eens, M				Poisbleau, Maud; Mueller, Wendt; Carslake, David; Demongin, Laurent; Groothuis, Ton G. G.; Van Camp, Jeff; Eens, Marcel			Penguin Chicks Benefit from Elevated Yolk Androgen Levels under Sibling Competition	PLOS ONE			English	Article							ROCKHOPPER PENGUINS; HATCHING ASYNCHRONY; TESTOSTERONE LEVELS; MATERNAL ANDROGENS; BEGGING BEHAVIOR; LAYING ORDER; EGGS; GROWTH; HORMONES; SEX	Crested penguins (genus Eudyptes) have a peculiar hatching pattern, with the first-laid egg (A-egg) hatching after the second-laid egg (B-egg) and chicks from A-eggs typically having a much lower survival probability. Maternal yolk androgens have been suggested to contribute to the competitive superiority of the B-chick in southern rockhopper penguins Eudyptes chrysocome, given their important role in mediating sibling competition in other species. We therefore increased the yolk androgen levels in freshly-laid eggs and examined the consequences for sibling competition - via effects on embryonic developmental times, chick growth and early survival. We placed one androgen-treated egg and one control egg into each foster nest, matching them for mass, laying date and laying order. The androgen treatment did not significantly affect embryonic developmental times or chick measurements at hatching. However, elevated yolk androgen levels benefitted chick growth in interaction with the number of siblings in a brood. Chicks from androgen-treated eggs had faster growth in the presence of a sibling than chicks from control eggs. Under these circumstances they also had a higher survival probability. Thus maternal androgens appear to reinforce the observed hatching pattern, facilitating brood reduction. This contrasts to most previous studies in other species where yolk androgens have been shown to compensate for the negative consequences of delayed hatching within the brood hierarchy.	[Poisbleau, Maud; Mueller, Wendt; Demongin, Laurent; Van Camp, Jeff; Eens, Marcel] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Carslake, David] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol, Avon, England; [Groothuis, Ton G. G.] Univ Groningen, Inst Behav Neurosci, Groningen, Netherlands	University of Antwerp; University of Bristol; University of Groningen	Poisbleau, M (corresponding author), Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium.	maud.poisbleau@ua.ac.be	Eens, Marcel/AAC-8466-2020; Poisbleau, Maud/B-9968-2014	Poisbleau, Maud/0000-0002-0729-3251; Muller, Wendt/0000-0001-7273-4095	University of Antwerp; FWO-Flanders [1.2.619.10.N.00, 1.5.020.11.N.00]	University of Antwerp; FWO-Flanders(FWO)	Financial support was provided by the University of Antwerp and FWO-Flanders (Application numbers 1.2.619.10.N.00 and 1.5.020.11.N.00) to ME and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T., 1991, P1707; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; Barnett CA, 2011, ANIM BEHAV, V81, P113, DOI 10.1016/j.anbehav.2010.09.019; Boncoraglio G, 2006, HORM BEHAV, V50, P442, DOI 10.1016/j.yhbeh.2006.05.005; Boncoraglio G, 2011, AM NAT, V178, P64, DOI 10.1086/660278; Bonisoli-Alquati A, 2011, HORM BEHAV, V59, P75, DOI 10.1016/j.yhbeh.2010.10.013; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; Demongin L, 2010, POLAR BIOL, V33, P469, DOI 10.1007/s00300-009-0722-2; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Gil D, 2004, HORM BEHAV, V45, P64, DOI 10.1016/j.yhbeh.2003.08.005; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2004, J EXP BIOL, V207, P2215, DOI 10.1242/jeb.01013; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Griffiths R, 1998, MOL ECOL, V7, P1701; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; HOWE HF, 1978, ECOLOGY, V59, P1109, DOI 10.2307/1938226; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; Lack D., 1954, P343; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lamey T.C., 1990, P399; MAGRATH RD, 1990, BIOL REV, V65, P587, DOI 10.1111/j.1469-185X.1990.tb01239.x; Massaro M, 2004, BEHAV ECOL SOCIOBIOL, V56, P426, DOI 10.1007/s00265-004-0803-8; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Moreno J, 1997, AUK, V114, P47, DOI 10.2307/4089064; Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Muller W, 2009, BIOL LETTERS, V5, P586, DOI 10.1098/rsbl.2009.0283; Muller W, 2009, BEHAV ECOL SOCIOBIOL, V63, P809, DOI 10.1007/s00265-009-0714-9; Muller W, 2009, HORM BEHAV, V55, P175, DOI 10.1016/j.yhbeh.2008.09.012; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; Poisbleau M, 2011, GEN COMP ENDOCR, V170, P622, DOI 10.1016/j.ygcen.2010.11.027; Poisbleau M, 2009, GEN COMP ENDOCR, V162, P139, DOI 10.1016/j.ygcen.2009.03.022; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2011, BIOL LETTERS, V7, P605, DOI 10.1098/rsbl.2010.1134; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Poisbleau M, 2009, HORM BEHAV, V55, P500, DOI 10.1016/j.yhbeh.2009.02.002; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rutkowska J, 2007, BEHAV ECOL SOCIOBIOL, V61, P1211, DOI 10.1007/s00265-007-0351-0; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1729, DOI 10.1098/rspb.2002.2088; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Sockman KW, 2008, BEHAV ECOL SOCIOBIOL, V62, P617, DOI 10.1007/s00265-007-0486-z; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; St Clair CC, 1998, AUK, V115, P478, DOI 10.2307/4089208; St Clair CC, 1996, J ANIM ECOL, V65, P485; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warham J., 1975, P189; Williams T.D., 1995, PENGUINS; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243	58	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42174	10.1371/journal.pone.0042174	http://dx.doi.org/10.1371/journal.pone.0042174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860073	gold, Green Published			2022-12-27	WOS:000306950900074
J	Ramirez-Velez, G; Medina, F; Ramirez-Montano, L; Zarazua-Lozada, A; Hernandez, R; Llorente, L; Moreno, J				Ramirez-Velez, Gabriela; Medina, Francisco; Ramirez-Montano, Luis; Zarazua-Lozada, Abraham; Hernandez, Ramiro; Llorente, Luis; Moreno, Jose			Constitutive Phosphorylation of Interferon Receptor A-Associated Signaling Proteins in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CYTOKINE SIGNALING-1; I INTERFERON; GENE-EXPRESSION; DENDRITIC CELLS; SUPPRESSOR; SOCS; ACTIVATION; DISEASE; SERUM; POLYMORPHISM	Background: Overexpression of type I interferon (IFN-I)-induced genes is a common feature of systemic lupus erythematosus (SLE) and its experimental models, but the participation of endogenous overproduction of IFN-I on it is not clear. To explore the possibility that abnormally increased IFN-I receptor (IFNAR) signaling could participate in IFN-I-induced gene overexpression of SLE, we examined the phosphorylation status of the IFNAR-associated signaling partners Jak1 and STAT2, and its relation with expression of its physiologic inhibitor SOCS1 and with plasma levels of IFN alpha and IFN-like activity. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMC) from SLE patients with or without disease activity and healthy controls cultured in the presence or in the absence of IFN beta were examined by immunoprecipitation and/or western blotting for expression of the two IFNAR chains, Jak1, Tyk2, and STAT2 and their phosphorylated forms. In SLE but not in healthy control PBMC, Jak1 and STAT2 were constitutively phosphorylated, even in the absence of disease activity (basal pJak1: controls vs. active SLE p<0.0001 and controls vs. inactive SLE p = 0.0006; basal pSTAT2: controls vs. active and inactive SLE p<0.0001). Although SOCS1 protein was slightly but significantly decreased in SLE in the absence or in the presence of IFN beta (p = 0.0096 to p<0.0001), in SOCS1 mRNA levels were markedly decreased (p = 0.036 to p, 0.0001). IFN beta induced higher levels of the IFN-I-dependent MxA protein mRNA in SLE than in healthy controls, whereas the opposite was observed for SOCS1. Although there was no relation to increased serum IFN alpha, active SLE plasma could induce expression of IFN-dependent genes by normal PBMC. Conclusions/Significance: These findings suggest that in some SLE patients IFN-I dependent gene expression could be the result of a low IFNAR signaling threshold.	[Ramirez-Velez, Gabriela; Medina, Francisco; Ramirez-Montano, Luis; Moreno, Jose] IMSS, Ctr Med Nacl Siglo 21, Hosp Especialidades, Autoimmune Dis Res Unit, Mexico City, DF, Mexico; [Medina, Francisco; Moreno, Jose] Univ LaSalle, Fac Mexicana Med, Mexico City, DF, Mexico; [Zarazua-Lozada, Abraham] IMSS, Ctr Med Nacl Siglo 21, Hosp Especialidades, Res Unit Pharmacol, Mexico City, DF, Mexico; [Hernandez, Ramiro] IMSS, Ctr Med Nacl Siglo 21, Hosp Especialidades, Dept Rheumatol, Mexico City, DF, Mexico; [Llorente, Luis] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Ramirez-Velez, G (corresponding author), IMSS, Ctr Med Nacl Siglo 21, Hosp Especialidades, Autoimmune Dis Res Unit, Mexico City, DF, Mexico.	jmoreno@insp.mx	Moreno-Rodríguez, José/C-7319-2016; Ramírez-Vélez, Robinson/D-5311-2016; Llorente, Luis/GQP-7202-2022	Moreno-Rodríguez, José/0000-0002-8887-6087; Ramírez-Vélez, Robinson/0000-0003-3075-6960; Llorente, Luis/0000-0002-3464-3747; Zarazua, Abraham/0000-0002-3074-0224; Ramirez Velez, Gabriela Lucila/0000-0002-4092-3809	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [1T24609 1T]; Instituto Mexicano del Seguro Social [IMSS-1T3601-065-20051T]; CONACYT [204508]; IMSS [2010178]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Mexicano del Seguro Social; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IMSS	This work was supported by grant No. 1T24609 1T from the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Instituto Mexicano del Seguro Social (IMSS-1T3601-065-20051T. GR-V was supported by scholarships from CONACYT (204508) and IMSS (2010178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Chan HC, 2010, LUPUS, V19, P696, DOI 10.1177/0961203309357437; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Crow Mary K, 2005, Curr Rheumatol Rep, V7, P463, DOI 10.1007/s11926-005-0053-4; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dong J, 2007, LUPUS, V16, P101, DOI 10.1177/0961203306075383; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Evel-Kabler K, 2006, J CLIN INVEST, V116, P90, DOI 10.1172/JCI26169; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hanada T, 2004, REV PHYSIOL BIOCH P, V149, P72, DOI 10.1007/s10254-003-0015-z; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hron JD, 2004, J IMMUNOL, V173, P2134, DOI 10.4049/jimmunol.173.3.2134; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Krebs DL, 2000, J CELL SCI, V113, P2813; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Kyttaris VC, 2005, CURR OPIN RHEUMATOL, V17, P518, DOI 10.1097/01.bor.0000170479.01451.ab; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Perl A, 2010, AUTOIMMUNITY, V43, P1, DOI 10.3109/08916930903374741; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Prokunina L, 2004, HUM MOL GENET, V13, pR143, DOI 10.1093/hmg/ddh076; RONNBLOM LE, 1990, J INTERN MED, V227, P207; Salloum R, 2010, ARTHRITIS RHEUM-US, V62, P553, DOI 10.1002/art.27182; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804; Schwarting A, 2005, J AM SOC NEPHROL, V16, P3264, DOI 10.1681/ASN.2004111014; SHOUNEE S, 1987, BRIT J DERMATOL, V117, P155, DOI 10.1111/j.1365-2133.1987.tb04111.x; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1998, INT J BIOCHEM CELL B, V30, P1081, DOI 10.1016/S1357-2725(98)00067-3; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WANDL UB, 1992, CLIN IMMUNOL IMMUNOP, V65, P70, DOI 10.1016/0090-1229(92)90250-R; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang Q, 2000, BLOOD, V96, P2093; Wang S, 2010, LUPUS, V19, P1171, DOI 10.1177/0961203310367660; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; YTTERBERG SR, 1982, ARTHRITIS RHEUM, V25, P401, DOI 10.1002/art.1780250407	60	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41414	10.1371/journal.pone.0041414	http://dx.doi.org/10.1371/journal.pone.0041414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859983	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950900022
J	Dambinova, SA; Bettermann, K; Glynn, T; Tews, M; Olson, D; Weissman, JD; Sowell, RL				Dambinova, Svetlana A.; Bettermann, Kerstin; Glynn, Theodore; Tews, Matthew; Olson, David; Weissman, Joseph D.; Sowell, Richard L.			Diagnostic Potential of the NMDA Receptor Peptide Assay for Acute Ischemic Stroke	PLOS ONE			English	Article							ATTACK; NEURORECEPTORS; BIOMARKERS	Background: The acute assessment of patients with suspected ischemic stroke remains challenging. The use of brain biomarker assays may improve the early diagnosis of ischemic stroke. The main goal of the study was to evaluate whether the NR2 peptide, a product of the proteolytic degradation of N-methyl-D-aspartate (NMDA) receptors, can differentiate acute ischemic stroke (IS) from stroke mimics and persons with vascular risk factors/healthy controls. A possible correlation between biomarker values and lesion sizes was investigated as the secondary objective. Methods and Findings: A total of 192 patients with suspected stroke who presented within 72 h of symptom onset were prospectively enrolled. The final diagnosis was determined based on clinical observations and radiological findings. Additionally gender- and age-matched healthy controls (n = 52) and persons with controlled vascular risk factors (n = 48) were recruited to compare NR2 peptide levels. Blinded plasma was assayed by rapid magnetic particles (MP) ELISA for NR2 peptide within 30 min and results for different groups compared using univariate and multivariate statistical analyses. There was a clinical diagnosis of IS in 101 of 192 (53%) and non-stroke in 91 (47%) subjects. The non-stroke group included presented with acute stroke symptoms who had no stroke (n = 71) and stroke mimics (n = 20). The highest NR2 peptide elevations where found in patients with IS that peaked at 12 h following symptom onset. When the biomarker cut off was set at 1.0 ug/L, this resulted in a sensitivity of 92% and a specificity of 96% to detect IS. A moderate correlation (r(s) = 0.73) between NR2 peptide values and acute ischemic cortical lesions (<200 mL) was found. Conclusions: This study suggests that the NR2 peptide may be a brain specific biomarker to diagnose acute IS and may allow the differentiation of IS from stroke mimics and controls. Additional larger scale clinical validation studies are required.	[Dambinova, Svetlana A.; Sowell, Richard L.] Kennesaw State Univ, WellStar Coll Hlth & Human Serv, Kennesaw, GA 30144 USA; [Bettermann, Kerstin] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Glynn, Theodore; Tews, Matthew] Michigan State Univ Emergency Med, Ingham Reg Med Ctr, Dept Emergency Med, Lansing, MI USA; [Olson, David; Weissman, Joseph D.] DeKalb Med, Decatur, GA USA	University System of Georgia; Kennesaw State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dambinova, SA (corresponding author), Kennesaw State Univ, WellStar Coll Hlth & Human Serv, Kennesaw, GA 30144 USA.	sdambino@kennesaw.edu	Dambinova, Svetlana A/G-1724-2017	Dambinova, Svetlana A/0000-0003-4411-5726; Tews, Matthew C/0000-0002-4304-3452	WellStar College of Health Human Services; Kennesaw State University Foundation	WellStar College of Health Human Services; Kennesaw State University Foundation	The study was supported by WellStar College of Health & Human Services and in part by the Kennesaw State University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An H, 2011, P INT SOC MAG RESON, V19, P463; Bettermann K, 2011, J STROKE CEREBROVASC, V20, P173, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.003; Betzen C, 2009, FREE RADICAL BIO MED, V47, P1212, DOI 10.1016/j.freeradbiomed.2009.07.034; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Dambinova SA, 2008, CLIN LAB INT, V32, P7; Dambinova SA, 2012, RSC DRUG DISCOV, V24, P66, DOI 10.1039/9781849734745-00066; Eng J., 2007, ROC ANAL WEB BASED C; Gappoeva MU, 2003, BIOCHEMISTRY-MOSCOW+, V68, P696, DOI 10.1023/A:1024678112357; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Hand PJ, 2005, J NEUROL NEUROSUR PS, V76, P1525, DOI 10.1136/jnnp.2005.062539; Hasan N, 2012, BR J CLIN PHARM, V124, P92; Hemmen Thomas M, 2008, J Stroke Cerebrovasc Dis, V17, P23, DOI 10.1016/j.jstrokecerebrovasdis.2007.09.008; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; vonKummer R, 1996, NEURORADIOLOGY, V38, P31, DOI 10.1007/BF00593212; Vroomen Patrick C A J, 2008, J Stroke Cerebrovasc Dis, V17, P418, DOI 10.1016/j.jstrokecerebrovasdis.2008.06.007; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8; Weissman JD, 2012, MAG J, V3, P20; Weissman JD, 2011, J NEUROL SCI, V300, P97, DOI 10.1016/j.jns.2010.09.023; Whiteley W, 2012, INT J STROKE, V7, P435, DOI 10.1111/j.1747-4949.2012.00784.x	20	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42362	10.1371/journal.pone.0042362	http://dx.doi.org/10.1371/journal.pone.0042362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848761	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200198
J	Gonda, RL; Garlena, RA; Stronach, B				Gonda, Rebecca L.; Garlena, Rebecca A.; Stronach, Beth			Drosophila Heat Shock Response Requires the JNK Pathway and Phosphorylation of Mixed Lineage Kinase at a Conserved Serine-Proline Motif	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; EXTENDS LIFE-SPAN; P38 MAPK PATHWAYS; N-TERMINAL KINASE; OXIDATIVE STRESS; GENE-EXPRESSION; INDUCED APOPTOSIS; PLANAR POLARITY; DORSAL CLOSURE	Defining context specific requirements for proteins and pathways is a major challenge in the study of signal transduction. For example, the stress-activated protein kinase (SAPK) pathways are comprised of families of closely related transducers that are activated in a variety of tissues and contexts during development and organismal homeostasis. Consequently, redundant and pleiotropic effects have hampered a complete understanding of the individual contributions of transducers in distinct contexts. Here, we report on the function of a context-specific regulatory phosphorylation site, PXSP, in the Drosophila mixed lineage kinase protein, Slpr, a mitogen-activated protein kinase kinase kinase (MAP3K) in the Jun Kinase (JNK) pathway. Genetic analysis of the function of non-phosphorylatable (PXAP) and phosphomimetic mutant (PXEP) Slpr transgenes in several distinct contexts revealed minimal effects in JNK-dependent tissue closure processes but differential requirements in heat stress response. In particular, PXAP expression resulted in sensitivity of adults to sustained heat shock, like p38 and JNK pathway mutants. In contrast, PXEP overexpression conferred some resistance. Indeed, phosphorylation of the PXSP motif is enriched under heat shock conditions and requires in part, the p38 kinases for the enrichment. These data suggest that coordination of signaling between p38 and Slpr serves to maintain JNK signaling during heat stress. In sum, we demonstrate a novel role for JNK signaling in the heat shock response in flies and identify a posttranslational modification on Slpr, at a conserved site among MAP3K mixed lineage kinase family members, which bolsters stress resistance with negligible effects on JNK-dependent developmental processes.	[Gonda, Rebecca L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Garlena, Rebecca A.; Stronach, Beth] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gonda, RL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	stronach@pitt.edu		Stronach, Beth/0000-0002-1699-8683; Gonda, Rebecca/0000-0003-1679-651X	National Institutes of Health [HD045836]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grant HD045836 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Bloomington Stock Center, the NIG-Fly Stock Center, and colleagues in the community for fly stocks, R. Cagan, S. Noselli, and T. Adachi-Yamada. We also acknowledge former undergraduates and staff for technical assistance, T. Zion, J. Malta, and L. O'Neill, and departmental colleagues for equipment, N. Deluca. Thanks also to Brooke McCartney for comments on the manuscript. The Fasciclin 3 antibody developed by C. Goodman was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biology, Iowa City, IA 52242.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Agnes F, 1999, DEVELOPMENT, V126, P5453; Baril C, 2009, GENETICS, V181, P567, DOI 10.1534/genetics.108.096461; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Davis MM, 2008, MOL CELL BIOL, V28, P4883, DOI 10.1128/MCB.02074-07; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorion S, 2002, CELL STRESS CHAPERON, V7, P200, DOI 10.1379/1466-1268(2002)007<0200:AOTMAP>2.0.CO;2; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garlena RA, 2010, J CELL SCI, V123, P3177, DOI 10.1242/jcs.063313; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Ishida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030265; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Karkali K, 2012, BIOCHEM BIOPH RES CO, V418, P301, DOI 10.1016/j.bbrc.2012.01.015; Karpac J, 2009, AGING CELL, V8, P288, DOI 10.1111/j.1474-9726.2009.00476.x; Kim KY, 2004, J BIOL CHEM, V279, P29478, DOI 10.1074/jbc.M313947200; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lesch C, 2010, GENETICS, V186, P943, DOI 10.1534/genetics.110.121822; Liou GY, 2010, BIOCHEM J, V427, P435, DOI 10.1042/BJ20091077; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Palacios C, 2001, CURR BIOL, V11, P1439, DOI 10.1016/S0960-9822(01)00426-2; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Polaski S, 2006, GENETICS, V174, P719, DOI 10.1534/genetics.106.056564; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Rothwell W.F., 2000, DROSOPHILA PROTOCOLS, P141; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; SHERMAN MY, 2006, SCI STKE, pPE16; Stone MC, 2010, MOL BIOL CELL, V21, P767, DOI 10.1091/mbc.E09-11-0967; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Suzanne M, 1999, GENE DEV, V13, P1464, DOI 10.1101/gad.13.11.1464; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Vacratsis PO, 2002, BIOCHEMISTRY-US, V41, P5613, DOI 10.1021/bi016075c; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Vrailas-Mortimer A, 2011, DEV CELL, V21, P783, DOI 10.1016/j.devcel.2011.09.002; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weber U, 2000, DEVELOPMENT, V127, P3619; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Yaglom J, 2003, MOL CELL BIOL, V23, P3813, DOI 10.1128/MCB.23.11.3813-3824.2003; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zhang H, 2001, J BIOL CHEM, V276, P45598, DOI 10.1074/jbc.M107176200; Zhou L, 2003, DEV CELL, V4, P599, DOI 10.1016/S1534-5807(03)00085-6; Zhuang ZH, 2006, CELL SIGNAL, V18, P441, DOI 10.1016/j.cellsig.2005.05.013	83	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42369	10.1371/journal.pone.0042369	http://dx.doi.org/10.1371/journal.pone.0042369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848763	Green Published, gold			2022-12-27	WOS:000306950200200
J	Menghini, M; Kloeckener-Gruissem, B; Fleischhauer, J; Kurz-Levin, MM; Sutter, FKP; Berger, W; Barthelmes, D				Menghini, Moreno; Kloeckener-Gruissem, Barbara; Fleischhauer, Johannes; Kurz-Levin, Malaika M.; Sutter, Florian K. P.; Berger, Wolfgang; Barthelmes, Daniel			Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; RANIBIZUMAB TREATMENT REGIMEN; INTRAVITREAL RANIBIZUMAB; GENETIC-FACTORS; POLYMORPHISM; MACULOPATHY; THERAPY; ASSOCIATION; Y402H; VEGF	Objective: Factors influencing the outcome of anti-VEGF treatment in neovascular AMD are still investigated. We analyzed the impact of a loading phase, the significance of an initial response for the long-term and the effect of the CFH polymorphism (p.His402Tyr) on treatment outcome. Methods: Patients treated with ranibizumab for neovascular AMD were analyzed over a period of 24 months by assessing effects of loading phase, initial response and genotype of CFH rs1061170 (c.1204C>T, p.His402Tyr). Results: 204 eyes were included. A change of +5.0 [-1;+11] letters and +1.5 [-5.5;+9.5] was observed with a median of 4 [3;7] and 10 [7;14] ranibizumab injections during 12 and 24 months, respectively. Loading phase was no significant predictor for treatment as VA outcome in eyes with and without loading phase was similar (p = 0.846 and p = 0.729) at 12 and 24 months. In contrast, initial response was a significant predictor for improving vision of 5 or more letters at 12 (p = 0.001; OR = 6.75) and 24 months (p = 0.01; OR = 4.66). Furthermore, the CT genotype at CFH rs1061170 was identified as a significant predictor for a favorable VA outcome at 12 and 24 months (OR = 6.75, p = 0.001 and OR = 4.66, p = 0.01). Conclusions: Our data suggest that clinical decisions regarding treatment may be guided by observing patients' initial response as well as their genotype of SNP rs1061170, while the criterion of loading phase may not bear the customary value.	[Menghini, Moreno; Fleischhauer, Johannes; Kurz-Levin, Malaika M.; Sutter, Florian K. P.; Barthelmes, Daniel] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland; [Kloeckener-Gruissem, Barbara; Berger, Wolfgang] Univ Zurich, Inst Med Mol Genet, CH-8603 Schwerzenbach, Switzerland; [Kloeckener-Gruissem, Barbara] Swiss Fed Inst Technol, Inst Biol, Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Barthelmes, Daniel] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Sydney	Menghini, M (corresponding author), Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland.	moreno@menghini.biz		Menghini, Moreno/0000-0002-1432-2524	Novartis; Swiss National Foundation; Holcim Foundation; Walter and Gertrud Siegenthaler Foundation, Switzerland	Novartis(Novartis); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Holcim Foundation; Walter and Gertrud Siegenthaler Foundation, Switzerland	This study was supported by an unrestricted fund from Novartis. DB was supported by the Swiss National Foundation, the Holcim Foundation and the Walter and Gertrud Siegenthaler Foundation, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Boyer DS, 2009, OPHTHALMOLOGY, V116, P1731, DOI 10.1016/j.ophtha.2009.05.024; Brantley MA, 2007, OPHTHALMOLOGY, V114, P2168, DOI 10.1016/j.ophtha.2007.09.008; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Gerding H, 2011, GRAEF ARCH CLIN EXP, V249, P653, DOI 10.1007/s00417-011-1636-6; Gupta B, 2011, BRIT J OPHTHALMOL, V95, P386, DOI 10.1136/bjo.2010.179499; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Heimes B, 2011, GRAEF ARCH CLIN EXP, V249, P639, DOI 10.1007/s00417-010-1524-5; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Holz FG, 2010, INVEST OPHTH VIS SCI, V51, P405, DOI 10.1167/iovs.09-3813; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kloeckener-Gruissem B, 2011, INVEST OPHTH VIS SCI, V52, P4694, DOI 10.1167/iovs.10-6080; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Lee AY, 2009, BRIT J OPHTHALMOL, V93, P610, DOI 10.1136/bjo.2008.150995; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McKibbin M, 2012, BRIT J OPHTHALMOL, V96, P208, DOI 10.1136/bjo.2010.193680; Menghini M, 2010, KLIN MONATSBL AUGENH, V227, P244, DOI 10.1055/s-0029-1245203; Mitchell P, 2010, BRIT J OPHTHALMOL, V94, P2, DOI 10.1136/bjo.2009.159160; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmidt-Erfurth U, 2011, OPHTHALMOLOGY, V118, P831, DOI 10.1016/j.ophtha.2010.09.004; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Taylor HR, 2005, MED J AUSTRALIA, V182, P565, DOI 10.5694/j.1326-5377.2005.tb06815.x; Teper SJ, 2010, MOL VIS, V16, P2598; Tsuchihashi T, 2011, OPHTHALMOLOGY, V118, P93, DOI 10.1016/j.ophtha.2010.04.007; Tuo JS, 2004, PROG RETIN EYE RES, V23, P229, DOI 10.1016/j.preteyeres.2004.02.001; VanNewkirk MR, 2000, OPHTHALMOLOGY, V107, P1593, DOI 10.1016/S0161-6420(00)00175-5; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449	34	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42014	10.1371/journal.pone.0042014	http://dx.doi.org/10.1371/journal.pone.0042014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848690	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306806600158
J	Zhang, ZP; Liang, GJ; Zhang, XF; Zhang, GL; Chao, HH; Li, L; Sun, XF; Min, LJ; Pan, QJ; Shi, QH; Sun, QY; De Felici, M; Shen, W				Zhang, Zhi-Peng; Liang, Gui-Jin; Zhang, Xi-Feng; Zhang, Guo-Liang; Chao, Hu-He; Li, Lan; Sun, Xiao-Feng; Min, Ling-Jiang; Pan, Qing-Jie; Shi, Qing-Hua; Sun, Qing-Yuan; De Felici, Massimo; Shen, Wei			Growth of Mouse Oocytes to Maturity from Premeiotic Germ Cells In Vitro	PLOS ONE			English	Article							STIMULATES MEIOTIC MATURATION; OVARIAN-FOLLICLE DEVELOPMENT; ACTIVIN-A; PRIMORDIAL FOLLICLES; GAP-JUNCTIONS; DEVELOPMENTAL COMPETENCE; EARLY FOLLICULOGENESIS; GRANULOSA-CELLS; GROWING OOCYTES; CULTURE-SYSTEM	In the present study, we established an in vitro culture system suitable for generating fertilizable oocytes from premeiotic mouse female germ cells. These results were achieved after first establishing an in vitro culture system allowing immature oocytes from 12-14 day- old mice to reach meiotic maturation through culture onto preantral granulosa cell (PAGC) monolayers in the presence of Activin A (ActA). To generate mature oocytes from premeiotic germ cells, pieces of ovaries from 12.5 days post coitum (dpc) embryos were cultured in medium supplemented with ActA for 28 days and the oocytes formed within the explants were isolated and cocultured onto PAGC monolayers in the presence of ActA for 6-7 days. The oocytes were then subjected to a final meiotic maturation assay to evaluate their capability to undergo germinal vesicle break down (GVBD) and reach the metaphase II (MII) stage. We found that during the first 28 days of culture, a significant number of oocytes within the ovarian explants reached nearly full growth and formed preantral follicle-like structures with the surrounding somatic cells. GSH level and Cx37 expression in the oocytes within the explants were indicative of proper developmental conditions. Moreover, the imprinting of Igf2r and Peg3 genes in these oocytes was correctly established. Further culture onto PAGCs in the presence of ActA allowed about 16% of the oocytes to undergo GVBD, among which 17% reached the MII stage during the final 16-18 hr maturation culture. These MII oocytes showed normal spindle and chromosome assembly and a correct ERK1/2 activity. About 35% of the in vitro matured oocytes were fertilized and 53.44% of them were able to reach the 2-cell stage. Finally, around 7% of the 2-cell embryos developed to the morula/blastocyst stage.	[Zhang, Zhi-Peng; Liang, Gui-Jin; Zhang, Xi-Feng; Zhang, Guo-Liang; Chao, Hu-He; Li, Lan; Sun, Xiao-Feng; Min, Ling-Jiang; Pan, Qing-Jie; Sun, Qing-Yuan; Shen, Wei] Qingdao Agr Univ, Shandong Univ, Key Lab Anim Reprod & Germplasm Enhancement, Qingdao, Peoples R China; [Shi, Qing-Hua] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Shi, Qing-Hua] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [De Felici, Massimo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Qingdao Agricultural University; Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Rome Tor Vergata	Zhang, ZP (corresponding author), Qingdao Agr Univ, Shandong Univ, Key Lab Anim Reprod & Germplasm Enhancement, Qingdao, Peoples R China.	shenwei427@163.com	De Felici, Massimo/J-4845-2018; Shi, Qinghua/N-2950-2013	De Felici, Massimo/0000-0001-8479-8264	National Basic Research Program of China (973 Program) [2012CB944401, 2011CB944501, 2007CB947401]; National Transgenic Biology Program of China [2009ZX08008-006B]; National Nature Science Foundation [31001010, 31171376, 31101716]; Foundation of Distinguished Young Scholars [JQ201109]; Doctoral Foundation [BS2010NY010]; Taishan Scholar Foundation of Shandong Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Transgenic Biology Program of China; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation of Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Doctoral Foundation; Taishan Scholar Foundation of Shandong Province	This work is supported by National Basic Research Program of China (973 Program, 2012CB944401, 2011CB944501 and 2007CB947401), National Transgenic Biology Program of China (2009ZX08008-006B), National Nature Science Foundation (31001010, 31171376 and 31101716), Foundation of Distinguished Young Scholars (JQ201109), Doctoral Foundation (BS2010NY010) and Taishan Scholar Foundation of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, J CELL SCI, V114, P257; Ackert CL, 2001, DEV BIOL, V233, P258, DOI 10.1006/dbio.2001.0216; Alak BM, 1998, FERTIL STERIL, V70, P1126, DOI 10.1016/S0015-0282(98)00386-0; Alak BM, 1996, FERTIL STERIL, V66, P646, DOI 10.1016/S0015-0282(16)58583-5; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Byskov AG, 1997, MOL HUM REPROD, V3, P795, DOI 10.1093/molehr/3.9.795; Chapman S., 2005, OVARY, P273; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Clark GF, 2011, GLYCOBIOLOGY, V21, P3, DOI 10.1093/glycob/cwq159; Cortvrindt RG, 2002, HUM REPROD UPDATE, V8, P243, DOI 10.1093/humupd/8.3.243; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; da Silva SJM, 2004, DEV BIOL, V266, P334, DOI 10.1016/j.ydbio.2003.10.030; DEFELICI M, 1987, CURR TOP DEV BIOL, V23, P147; Dong HS, 2009, THERIOGENOLOGY, V72, P219, DOI 10.1016/j.theriogenology.2009.02.021; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Epifano O, 2002, TRENDS ENDOCRIN MET, V13, P169, DOI 10.1016/S1043-2760(02)00576-3; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Eppig JJ, 1996, MOL REPROD DEV, V44, P260, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;260::AID-MRD17&gt;3.0.CO;2-6; Ethier JF, 2001, REPRODUCTION, V121, P667, DOI 10.1530/rep.0.1210667; Fan HY, 2002, MOL REPROD DEV, V63, P480, DOI 10.1002/mrd.10194; Gittens JEI, 2003, AM J PHYSIOL-CELL PH, V284, pC880, DOI 10.1152/ajpcell.00277.2002; Hashiyama K, 2011, SCIENCE, V333, P885, DOI 10.1126/science.1208146; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Honda A, 2009, INT J DEV BIOL, V53, P605, DOI 10.1387/ijdb.082607ah; ITOH M, 1990, BIOCHEM BIOPH RES CO, V166, P1479, DOI 10.1016/0006-291X(90)91034-P; Kim CG, 2008, J REPROD DEVELOP, V54, P250, DOI 10.1262/jrd.19185; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lees-Murdock DJ, 2008, DEV BIOL, V321, P238, DOI 10.1016/j.ydbio.2008.06.024; Lenie S, 2004, BIOL REPROD, V71, P1730, DOI 10.1095/biolreprod.104.028415; LI RH, 1995, ENDOCRINOLOGY, V136, P849, DOI 10.1210/en.136.3.849; Li ZB, 2011, HISTOCHEM CELL BIOL, V135, P513, DOI 10.1007/s00418-011-0812-4; Luberda Zofia, 2005, Reprod Biol, V5, P5; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Massague J, 2000, GENE DEV, V14, P627; MCLAREN A, 1990, CELL DIFFER DEV, V31, P185, DOI 10.1016/0922-3371(90)90131-F; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Niwa K, 2004, BIOL REPROD, V71, P1560, DOI 10.1095/biolreprod.104.030908; Norwitz ER, 2002, ENDOCRINOLOGY, V143, P985, DOI 10.1210/en.143.3.985; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Obata Y, 2002, NATURE, V418, P497, DOI 10.1038/418497a; ODOR DL, 1971, AM J ANAT, V131, P387, DOI 10.1002/aja.1001310402; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pesce M, 1996, INT J DEV BIOL S1, V1, p229S; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rossi P, 2005, CELL SIGNALING GROWT, V1, P39; Shen W, 2006, MOL REPROD DEV, V73, P589, DOI 10.1002/mrd.20401; Shen W, 2007, REPRODUCTION, V134, P223, DOI 10.1530/REP-06-0378; Shen W, 2006, BIOL REPROD, V75, P615, DOI 10.1095/biolreprod.106.051482; Shen W, 2006, MOL REPROD DEV, V73, P1312, DOI 10.1002/mrd.20535; Silva CC, 1998, BIOL REPROD, V58, P558, DOI 10.1095/biolreprod58.2.558; Silva JRV, 2006, J ENDOCRINOL, V189, P113, DOI 10.1677/joe.1.06487; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Song ZH, 2009, BIOCHEM BIOPH RES CO, V387, P800, DOI 10.1016/j.bbrc.2009.07.131; Stock AE, 1997, BIOL REPROD, V56, P1559, DOI 10.1095/biolreprod56.6.1559; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Thomas FH, 2003, HUM REPROD UPDATE, V9, P541, DOI 10.1093/humupd/dmg042; Thomas Fiona H, 2003, Reprod Biol Endocrinol, V1, P76, DOI 10.1186/1477-7827-1-76; Tong C, 2003, CELL RES, V13, P375, DOI 10.1038/sj.cr.7290183; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Veitch GI, 2004, J CELL SCI, V117, P2699, DOI 10.1242/jcs.01124; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Zhang P, 2010, HISTOCHEM CELL BIOL, V134, P75, DOI 10.1007/s00418-010-0708-8; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316	75	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41771	10.1371/journal.pone.0041771	http://dx.doi.org/10.1371/journal.pone.0041771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848595	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300073
J	Tajadura-Jimenez, A; Grehl, S; Tsakiris, M				Tajadura-Jimenez, Ana; Grehl, Stephanie; Tsakiris, Manos			The Other in Me: Interpersonal Multisensory Stimulation Changes the Mental Representation of the Self	PLOS ONE			English	Article							FACE RECOGNITION; BODY-OWNERSHIP; SOCIAL COGNITION; OWN FACE; BRAIN; CONSCIOUSNESS; PERCEPTION; MIRROR; CORTEX; HANDS	Background: Recent studies have shown that the well-known effect of multisensory stimulation on body-awareness can be extended to self-recognition. Seeing someone else's face being touched at the same time as one's own face elicits changes in the mental representation of the self-face. We sought to further elucidate the underlying mechanisms and the effects of interpersonal multisensory stimulation (IMS) on the mental representation of the self and others. Methodology/Principal Findings: Participants saw an unfamiliar face being touched synchronously or asynchronously with their own face, as if they were looking in the mirror. Following synchronous, but not asynchronous, IMS, participants assimilated features of the other's face in the mental representation of their own face as evidenced by the change in the point of subjective equality for morphed pictures of the two faces. Interestingly, synchronous IMS resulted in a unidirectional change in the self-other distinction, affecting recognition of one's own face, but not recognition of the other's face. The participants' autonomic responses to objects approaching the other's face were higher following synchronous than asynchronous IMS, but this increase was not specific to the pattern of IMS in interaction with the viewed object. Finally, synchronous, as compared to asynchronous, IMS resulted in significant differences in participants' ratings of their experience, but unlike other bodily illusions, positive changes in subjective experience were related to the perceived physical similarity between the two faces, and not to identification. Conclusions/Significance: Synchronous IMS produces quantifiable changes in the mental representations of one's face, as measured behaviorally. Changes in autonomic responses and in the subjective experience of self-identification were broadly consistent with patterns observed in other bodily illusions, but less robust. Overall, shared multisensory experiences between self and other can change the mental representation of one's identity, and the perceived similarity of others relative to one's self.	[Tajadura-Jimenez, Ana; Tsakiris, Manos] Univ London, Dept Psychol, Egham, Surrey, England; [Grehl, Stephanie] Univ Western Australia, Sch Anim Biol, Nedlands, WA 6009, Australia	University of London; Royal Holloway University London; University of Western Australia	Tajadura-Jimenez, A (corresponding author), Univ London, Dept Psychol, Egham, Surrey, England.	ana.tajadura@rhul.ac.uk	Tajadura-Jimenez, Ana/O-2906-2019; Tajadura-Jimenez, Ana/B-2355-2015; TSAKIRIS, MANOS/C-1529-2008	Tajadura-Jimenez, Ana/0000-0003-3166-3512; Tajadura-Jimenez, Ana/0000-0003-3166-3512; TSAKIRIS, MANOS/0000-0001-7753-7576	ESRC [RES-061-25-0233]; European Research Council [ERC-2010-StG-262853]; Volkswagen Foundation; ESRC [ES/G000719/1] Funding Source: UKRI; Economic and Social Research Council [ES/G000719/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); Volkswagen Foundation(Volkswagen); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by the ESRC First Grant RES-061-25-0233 (http://www.esrc.ac.uk), European Research Council grant ERC-2010-StG-262853 under the FP7 (http://erc.europa.eu), and the Volkswagen Foundation "European Platform for Life Sciences, Mind Sciences and the Humanities" grant (http://www.volkswagenstiftung.de/index.html?L = 1) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli A, 2008, Q J EXP PSYCHOL, V61, P690, DOI 10.1080/17470210701399305; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; BERTENTHAL BI, 1978, DEV PSYCHOL, V14, P44; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Brady N, 2005, BRAIN COGNITION, V58, P334, DOI 10.1016/j.bandc.2005.01.001; Brady N, 2004, NEUROPSYCHOLOGIA, V42, P1156, DOI 10.1016/j.neuropsychologia.2004.02.007; Bredart S, 2003, PERCEPTION, V32, P805, DOI 10.1068/p3354; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; EDELBERG ROBERT, 1967, P1; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Feinberg TE, 2005, CONSCIOUS COGN, V10, P1; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Guterstam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017208; Heinisch C, 2010, SOCIAL COGNITIVE AFF, V1093, P1; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Ishida H, 2010, J COGNITIVE NEUROSCI, V22, P83, DOI 10.1162/jocn.2009.21185; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Lewis M, 2003, ANN NY ACAD SCI, V1001, P104, DOI 10.1196/annals.1279.007; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, ACTA PSYCHOL, V132, P166, DOI 10.1016/j.actpsy.2009.02.003; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; MEESE TS, 1995, PERCEPT PSYCHOPHYS, V57, P267, DOI 10.3758/BF03213053; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Moor BG, 2010, PSYCHOL SCI, V21, P1326, DOI 10.1177/0956797610379236; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Povinelli DJ, 1998, DEV PSYCHOL, V34, P188, DOI 10.1037/0012-1649.34.1.188; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Rochat P, 2011, CONSCIOUS COGN, V20, P204, DOI 10.1016/j.concog.2010.06.007; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Tanaka J, 1998, COGNITION, V68, P199, DOI 10.1016/S0010-0277(98)00048-1; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Uddin LQ, 2005, CONSCIOUS COGN, V14, P633, DOI 10.1016/j.concog.2005.01.008; Uddin LQ, 2004, NEUROIMAGE, V25, P1; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; VENABLES PH, 1973, ELECTRODERMAL ACTIVI, P1, DOI DOI 10.1016/B978-0-12-565950-5.50006-5; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Yoon HW, 2005, INT J NEUROSCI, V115, P839, DOI 10.1080/00207450590882235; Zahavi D, 2011, CONSCIOUS COGN, V20, P141, DOI 10.1016/j.concog.2010.10.011	65	92	97	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e40682	10.1371/journal.pone.0040682	http://dx.doi.org/10.1371/journal.pone.0040682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22866177	Green Published, gold			2022-12-27	WOS:000306406700044
J	Aquilino, C; Rubio, MLG; Seco, EM; Escudero, L; Corvo, L; Soto, M; Fresno, M; Malpartida, F; Bonay, P				Aquilino, Carolina; Gonzalez Rubio, Maria Luisa; Maria Seco, Elena; Escudero, Leticia; Corvo, Laura; Soto, Manuel; Fresno, Manuel; Malpartida, Francisco; Bonay, Pedro			Differential Trypanocidal Activity of Novel Macrolide Antibiotics; Correlation to Genetic Lineage	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI STRAINS; PROGRAMMED CELL-DEATH; CHAGAS HEART-DISEASE; MULTILOCUS ENZYME ELECTROPHORESIS; PROTOZOAN PARASITE LEISHMANIA; IN-VITRO SUSCEPTIBILITY; PHYLOGENETIC LINEAGES; MODIFIED STREPTOMYCES; BENZNIDAZOLE; EXPRESSION	Here we report the systematic study of the anti-trypanocidal activity of some new products derived from S. diastatus on 14 different T. cruzi strains spanning the six genetic lineages of T. cruzi. As the traditional growth inhibition curves giving similar IC50 showed great differences on antibiotic and lineage tested, we decided to preserve the wealth of information derived from each inhibition curve and used an algorithm related to potency of the drugs, combined in a matrix data set used to generate a cluster tree. The cluster thus generated based just on drug susceptibility data closely resembles the phylogenies of the lineages derived from genetic data and provides a novel approach to correlate genetic data with phenotypes related to pathogenesis of Chagas disease. Furthermore we provide clues on the drugs mechanism of action.	[Aquilino, Carolina; Gonzalez Rubio, Maria Luisa; Corvo, Laura; Soto, Manuel; Fresno, Manuel; Bonay, Pedro] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Maria Seco, Elena; Escudero, Leticia; Malpartida, Francisco] Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Aquilino, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Campus Cantoblanco, Madrid, Spain.	pbonay@cbm.uam.es	Álvarez, Manuel Soto/Q-5234-2018	Álvarez, Manuel Soto/0000-0001-6825-841X; Seco, Elena M./0000-0003-1431-4441; Fresno Escudero, Manuel/0000-0002-9223-5477; Corvo, Laura/0000-0001-5907-4993	Fondo de Investigaciones Sanitarias-Ministerio de Sanidad [FIS-PI08/0960, FIS-PI08/0101]; ChagasEpiNet (European VII framework Program); Network RICET (Red Investigacion Cooperativa en Enfermedades Tropicales) from the FIS (Fondo de Investigaciones Sanitarias), Ministerio de Sanidad	Fondo de Investigaciones Sanitarias-Ministerio de Sanidad(Spanish Government); ChagasEpiNet (European VII framework Program); Network RICET (Red Investigacion Cooperativa en Enfermedades Tropicales) from the FIS (Fondo de Investigaciones Sanitarias), Ministerio de Sanidad	This work was supported by Fondo de Investigaciones Sanitarias-Ministerio de Sanidad (FIS-PI08/0960) to PB and (FIS-PI08/0101) to MS; ChagasEpiNet (European VII framework Program) to MF; and Network RICET (Red Investigacion Cooperativa en Enfermedades Tropicales) from the FIS (Fondo de Investigaciones Sanitarias), Ministerio de Sanidad. Institutional support from Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMILS R, 1989, CAN J MICROBIOL, V35, P141, DOI 10.1139/m89-021; ANDRADE SG, 1985, B WORLD HEALTH ORGAN, V63, P721; [Anonymous], 2009, LANCET NEUROL, V8, P501, DOI 10.1016/S1474-4422(09)70113-9; [Anonymous], 2010, WKLY EPIDEMIOL REC, V85, P334; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Biolo A, 2010, PROG CARDIOVASC DIS, V52, P300, DOI 10.1016/j.pcad.2009.11.008; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Cardin GB, 2009, BIOMETALS, V22, P753, DOI 10.1007/s10534-009-9223-6; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; Croft SL, 1996, J ANTIMICROB CHEMOTH, V38, P1041, DOI 10.1093/jac/38.6.1041; Debrabant A, 2003, INT J PARASITOL, V33, P257, DOI 10.1016/S0020-7519(03)00008-0; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; FILARDI LS, 1987, T ROY SOC TROP MED H, V81, P755, DOI 10.1016/0035-9203(87)90020-4; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Girones N, 2003, TRENDS PARASITOL, V19, P19, DOI 10.1016/S1471-4922(02)00006-5; GORLA NB, 1989, MUTAT RES, V224, P263, DOI 10.1016/0165-1218(89)90165-1; GORLA NB, 1988, MUTAT RES, V206, P217, DOI 10.1016/0165-1218(88)90163-2; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Hacker G, 2007, EXPERT OPIN THER TAR, V11, P515, DOI 10.1517/14728222.11.4.515; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kayama H, 2010, MICROBES INFECT; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Liu W, 2010, MOL BIOCHEM PARASIT, V169, P20, DOI 10.1016/j.molbiopara.2009.09.004; Macedo Andra M, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004118; MANTEL N, 1967, CANCER RES, V27, P209; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Matsuda NM, 2009, CLINICS, V64, P1219, DOI 10.1590/S1807-59322009001200013; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Miranzo D, 2010, APPL MICROBIOL BIOT, V85, P1809, DOI 10.1007/s00253-009-2195-1; Nguewa PA, 2004, TRENDS PARASITOL, V20, P375, DOI 10.1016/j.pt.2004.05.006; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Luna KP, 2009, BIOMEDICA, V29, P448; Perez-Zuniga FJ, 2004, J ANTIBIOT, V57, P197, DOI 10.7164/antibiotics.57.197; Piazza RMF, 1996, ACTA TROP, V61, P41, DOI 10.1016/0001-706X(95)00139-6; Dias JCP, 2006, ANN INTERN MED, V144, P772, DOI 10.7326/0003-4819-144-10-200605160-00012; Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007; Piron M, 2008, TRANSFUSION, V48, P1862, DOI 10.1111/j.1537-2995.2008.01789.x; Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021; Risso MG, 2004, J INFECT DIS, V189, P2250, DOI 10.1086/420831; Rolon M, 2006, INT J ANTIMICROB AG, V28, P104, DOI 10.1016/j.ijantimicag.2006.02.025; Ruiz RC, 1998, BIOCHEM J, V330, P505; Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105; Sangenito LS, 2009, PARASITOLOGY, V136, P433, DOI 10.1017/S0031182009005629; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Seco EM, 2005, CHEM BIOL, V12, P535, DOI 10.1016/j.chembiol.2005.02.015; Soeiro MNC, 2009, EXPERT OPIN THER TAR, V13, P105, DOI [10.1517/14728220802623881, 10.1517/14728220802623881 ]; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Taylor J, 2009, EUR HEART J, V30, P2063, DOI 10.1093/eurheartj/ehp277; Telleria J, 2004, MOL BIOCHEM PARASIT, V137, P133, DOI 10.1016/j.molbiopara.2004.05.006; TELLERIA J, 2010, P NATL ACAD SCI US; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; TIBAYRENC M, 1988, EVOLUTION, V42, P277, DOI 10.1111/j.1558-5646.1988.tb04132.x; Toledo MJD, 2003, ANTIMICROB AGENTS CH, V47, P223, DOI 10.1128/AAC.47.1.223-230.2003; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; Villarreal D, 2005, ANTIMICROB AGENTS CH, V49, P2701, DOI 10.1128/AAC.49.7.2701-2709.2005; Villarreal D, 2004, EXP PARASITOL, V108, P24, DOI 10.1016/j.exppara.2004.07.001; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	68	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e40901	10.1371/journal.pone.0040901	http://dx.doi.org/10.1371/journal.pone.0040901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859958	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000307045600011
J	Batra, S; Ayaz, A; Murtaza, A; Ahmad, S; Hasan, R; Pfau, R				Batra, Srichand; Ayaz, Afsheen; Murtaza, Ali; Ahmad, Shakil; Hasan, Rumina; Pfau, Ruth			Childhood Tuberculosis in Household Contacts of Newly Diagnosed TB Patients	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; GLOBAL EPIDEMIOLOGY; CHILDREN; MALNUTRITION; DISEASE; MALAWI; GENDER	Introduction: Childhood tuberculosis (TB), although estimated to account for a major proportion of the global TB disease burden, has a lower public health priority. Reliable research and surveillance data on childhood TB is limited in most regions of the world. This study was conducted to assess the burden of childhood TB among the household contacts of new TB patients in Karachi, Pakistan. Methods: A retrospective analysis of children (<15 years) who were household contacts of new adult TB patients presenting to Marie Adelaide Leprosy Center (MALC) clinics in Karachi during the period of 2008 to 2010 was conducted. Results: Of the household children contacts (n = 6613) screened, 317 were suspected and 121(1.8%) diagnosed with TB. These included 89 (73.6%) with pulmonary and 32 (26.4%) with extra-pulmonary disease. Smear positivity rate in pulmonary cases was 32.6%. Mean age of children diagnosed with TB was 11.7 (+/- 2.8) years. Within the child-contacts screened, disease was found to be significantly higher among females (2.3%) in comparison to males (1.2%) (p-value <0.01). The commonest relationship of source cases to diagnosed children was the mother (n = 51, 42.1%). The source case was a female for 66.1% (n = 76) of the children. Conclusion: A smear positivity rate of 32.6% amongst pulmonary cases suggests their potential to spread disease and emphasizes a need to review the contribution of children in transmission of TB within communities. Greater vulnerability of the female child and considerable role of mother in disease transmission highlights a need to increase focus on females in TB control programs in Pakistan.	[Batra, Srichand; Murtaza, Ali; Ahmad, Shakil; Pfau, Ruth] Marie Adelaide Leprosy Ctr, Karachi, Pakistan; [Ayaz, Afsheen; Hasan, Rumina] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan	Aga Khan University	Batra, S (corresponding author), Marie Adelaide Leprosy Ctr, Karachi, Pakistan.	rumina.hasan@aku.edu	Hasan, Rumina/F-4420-2015					Asian Development Bank, 2000, COUNTR BRIEF PAP WOM, px; Atre SR, 2004, TROP MED INT HEALTH, V9, P1228, DOI 10.1111/j.1365-3156.2004.01321.x; de Pontual L, 2004, INT J TUBERC LUNG D, V8, P976; Eamranond P, 2001, INT J TUBERC LUNG D, V5, P594; Haddad L., 1999, Asian Development Review, V17, P96; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; National TB control programme Ministry of Health Government of Pakistan, 2007, NAT GUID DIAGN MAN T; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Ruwende JET, 2011, J PUBLIC HEALTH-UK, V33, P175, DOI 10.1093/pubmed/fdq046; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Sinfield R, 2006, ANN TROP PAEDIATR, V26, P205, DOI 10.1179/146532806X120291; Starke JR, 2002, INT J TUBERC LUNG D, V6, P373; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; WHO, 2008, GLOBAL TUBERCULOSIS; WHO, 2009, WHOHTMTB2009411; World Health Organization, 2002, GEND TUB; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2007, WHOHTMTB2007381; World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children, 2006, WHOHTMTB2006371; World Health Organization TB/HIV Working Group Stop TB Partnership, 2010, WHOHTMTB2010	23	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e40880	10.1371/journal.pone.0040880	http://dx.doi.org/10.1371/journal.pone.0040880			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859957	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600010
J	Godeke, J; Binnenkade, L; Thormann, KM				Goedeke, Julia; Binnenkade, Lucas; Thormann, Kai M.			Transcriptome Analysis of Early Surface-Associated Growth of Shewanella oneidensis MR-1	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; SWARMER CELL-DIFFERENTIATION; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; VIBRIO-PARAHAEMOLYTICUS; BACTERIAL BIOFILMS; SIGNALING PATHWAY; DI-GMP; IRON	Bacterial biofilm formation starts with single cells attaching to a surface, however, little is known about the initial attachment steps and the adaptation to the surface-associated life style. Here, we describe a hydrodynamic system that allows easy harvest of cells at very early biofilm stages. Using the metal ion-reducing gammaproteobacterium Shewanella oneidensis MR-1 as a model organism, we analyzed the transcriptional changes occurring during surface-associated growth between 15 and 60 minutes after attachment. 230 genes were significantly upregulated and 333 were downregulated by a factor of >= 2. Main functional categories of the corresponding gene products comprise metabolism, uptake and transport, regulation, and hypothetical proteins. Among the genes highly upregulated those implicated in iron uptake are highly overrepresented, strongly indicating that S. oneidensis MR-1 has a high demand for iron during surface attachment and initial biofilm stages. Subsequent microscopic analysis of biofilm formation under hydrodynamic conditions revealed that addition of Fe(II) significantly stimulated biofilm formation of S. oneidensis MR-1 while planktonic growth was not affected. Our approach to harvest cells for transcriptional analysis of early biofilm stages is expected to be easily adapted to other bacterial species.	[Goedeke, Julia; Binnenkade, Lucas; Thormann, Kai M.] Max Planck Inst Terr Mikrobiol, Dept Ecophysiol, Marburg, Germany	Max Planck Society	Godeke, J (corresponding author), TWINCORE Zentrum Expt & Klin Infekt Forsch GmbH, Feodor Lynen Str 7-9, Hannover, Germany.	thormann@mpi-marburg.mpg.de			Deutsche Forschungsgemeinschaft (DFG) [831/3-1]; Max-Planck-Gesellschaft (MPG); International Max Planck Research School (IMPRS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max-Planck-Gesellschaft (MPG)(Max Planck Society); International Max Planck Research School (IMPRS)	The work was funded by the Deutsche Forschungsgemeinschaft (DFG, grant 831/3-1), the Max-Planck-Gesellschaft (MPG), and the International Max Planck Research School (IMPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; AIBA H, 1981, J BIOL CHEM, V256, P1905; An DD, 2007, CURR OPIN MICROBIOL, V10, P292, DOI 10.1016/j.mib.2007.05.011; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Baum M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng151; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Chourey K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-395; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Dorel C, 1999, FEMS MICROBIOL LETT, V178, P169, DOI 10.1016/S0378-1097(99)00347-X; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Glick R, 2010, J BACTERIOL, V192, P2973, DOI 10.1128/JB.01601-09; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Godeke J, 2011, ISME J, V5, P613, DOI 10.1038/ismej.2010.153; GRISHIN SI, 1988, APPL ENVIRON MICROB, V54, P3092, DOI 10.1128/AEM.54.12.3092-3100.1988; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Heun M, 2012, APPL ENVIRON MICROB, V78, P4400, DOI 10.1128/AEM.07895-11; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Learman DR, 2009, APPL ENVIRON MICROB, V75, P1301, DOI 10.1128/AEM.01393-08; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Liang YL, 2012, ARCH MICROBIOL, V194, P473, DOI 10.1007/s00203-011-0782-x; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; MCCARTER L, 1989, J BACTERIOL, V171, P731, DOI 10.1128/jb.171.2.731-736.1989; MCCARTER L, 1990, MOL MICROBIOL, V4, P1057, DOI 10.1111/j.1365-2958.1990.tb00678.x; McLean JS, 2008, J MICROBIOL METH, V74, P47, DOI 10.1016/j.mimet.2008.02.015; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Rakshe S, 2011, APPL ENVIRON MICROB, V77, P2196, DOI 10.1128/AEM.01985-10; Ren DC, 2004, APPL ENVIRON MICROB, V70, P2038, DOI 10.1128/AEM.70.4.2038-2043.2004; Rosenbaum MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030827; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Saville RM, 2011, J BACTERIOL, V193, P3257, DOI 10.1128/JB.00251-11; Saville RM, 2010, FEMS MICROBIOL LETT, V308, P76, DOI 10.1111/j.1574-6968.2010.01995.x; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Singh PK, 2004, BIOMETALS, V17, P267, DOI 10.1023/B:BIOM.0000027703.77456.27; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Theunissen S, 2010, RES MICROBIOL, V161, P144, DOI 10.1016/j.resmic.2009.12.002; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Trappetti C, 2011, INFECT IMMUN, V79, P4550, DOI 10.1128/IAI.05644-11; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang Y, 2008, J TURBUL, V9, P1, DOI 10.1080/14685240801905360; Yang YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-131	78	12	12	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42160	10.1371/journal.pone.0042160	http://dx.doi.org/10.1371/journal.pone.0042160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860070	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600063
J	Chen, CC; Balaban, E; Jarvis, ED				Chen, Chun-Chun; Balaban, Evan; Jarvis, Erich D.			Interspecies Avian Brain Chimeras Reveal That Large Brain Size Differences Are Influenced by Cell-Interdependent Processes	PLOS ONE			English	Article							QUAIL-CHICK CHIMERAS; SPECIES-DIFFERENCES; MELOPSITTACUS-UNDULATUS; SUBVENTRICULAR ZONES; BOBWHITE QUAIL; BIGGER BRAINS; EVOLUTION; BIRDS; TELENCEPHALON; NEUROGENESIS	Like humans, birds that exhibit vocal learning have relatively delayed telencephalon maturation, resulting in a disproportionately smaller brain prenatally but enlarged telencephalon in adulthood relative to vocal non-learning birds. To determine if this size difference results from evolutionary changes in cell-autonomous or cell-interdependent developmental processes, we transplanted telencephala from zebra finch donors (a vocal-learning species) into Japanese quail hosts (a vocal non-learning species) during the early neural tube stage (day 2 of incubation), and harvested the chimeras at later embryonic stages (between 9-12 days of incubation). The donor and host tissues fused well with each other, with known major fiber pathways connecting the zebra finch and quail parts of the brain. However, the overall sizes of chimeric finch telencephala were larger than non-transplanted finch telencephala at the same developmental stages, even though the proportional sizes of telencephalic subregions and fiber tracts were similar to normal finches. There were no significant changes in the size of chimeric quail host midbrains, even though they were innervated by the physically smaller zebra finch brain, including the smaller retinae of the finch eyes. Chimeric zebra finch telencephala had a decreased cell density relative to normal finches. However, cell nucleus size differences between each species were maintained as in normal birds. These results suggest that telencephalic size development is partially cell-interdependent, and that the mechanisms controlling the size of different brain regions may be functionally independent.	[Chen, Chun-Chun; Jarvis, Erich D.] Duke Univ, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27706 USA; [Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada	Duke University; Howard Hughes Medical Institute; McGill University	Chen, CC (corresponding author), Duke Univ, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27706 USA.	cc229@duke.edu; jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008; Balaban, Evan/AAV-2353-2020	Jarvis, Erich D/0000-0001-8931-5049; Balaban, Evan/0000-0002-0391-3433	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The funding source is from Howard Hughes Medical Institute to the investigator, Dr. Erich Jarvis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2010, J COMP NEUROL, V518, P3512, DOI 10.1002/cne.22410; ALVAREZBUYLLA A, 1994, J COMP NEUROL, V347, P233, DOI 10.1002/cne.903470207; Apanius V., 1998, AVIAN GROWTH DEV EVO; Balaban E, 1997, P NATL ACAD SCI USA, V94, P2001, DOI 10.1073/pnas.94.5.2001; Balaban E, 2005, INT J DEV BIOL, V49, P117, DOI 10.1387/ijdb.041934eb; BALABAN E, 1988, SCIENCE, V241, P1339, DOI 10.1126/science.3413496; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Boire Denis, 1994, Journal of Brain Research, V35, P49; Bronner-Fraser M, 2008, METHOD CELL BIOL, V87, P75, DOI 10.1016/S0091-679X(08)00204-5; Burish MJ, 2004, BRAIN BEHAV EVOLUT, V63, P107, DOI 10.1159/000075674; Charvet CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00004; Charvet CJ, 2010, P ROY SOC B-BIOL SCI, V277, P3469, DOI 10.1098/rspb.2010.0811; Charvet CJ, 2009, P R SOC B, V276, P3421, DOI 10.1098/rspb.2009.0888; Charvet CJ, 2009, BRAIN BEHAV EVOLUT, V73, P285, DOI 10.1159/000230673; Charvet CJ, 2008, BRAIN BEHAV EVOLUT, V72, P295, DOI 10.1159/000184744; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eames BF, 2005, DEVELOPMENT, V132, P1499, DOI 10.1242/dev.01719; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Finlay BL, 2010, BRAIN BEHAV EVOLUT, V75, P4, DOI 10.1159/000295350; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LeDouarin NM, 1997, INT REV CYTOL, V175, P241, DOI 10.1016/S0074-7696(08)62128-2; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; Long KD, 2001, P NATL ACAD SCI USA, V98, P5862, DOI 10.1073/pnas.091080098; McGowan L, 2011, EVOLUTION, V65, P907, DOI 10.1111/j.1558-5646.2010.01126.x; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; Nikolakopoulou AM, 2006, BRAIN RES BULL, V70, P107, DOI 10.1016/j.brainresbull.2006.04.005; Nobrega-Pereira S, 2009, CEREB CORTEX, V19, pI107, DOI 10.1093/cercor/bhp044; NOTTEBOH.F, 1970, SCIENCE, V167, P950, DOI 10.1126/science.167.3920.950; Nottebohm F, 2010, BRAIN LANG, V115, P3, DOI 10.1016/j.bandl.2010.05.002; Osmon, 2005, ATLAS CHICK DEV; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Pombero A, 2009, J COMP NEUROL, V512, P784, DOI 10.1002/cne.21933; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; Scharff C, 2004, ANN NY ACAD SCI, V1016, P325, DOI 10.1196/annals.1298.032; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; SENUT MC, 1986, DEV BRAIN RES, V29, P123, DOI 10.1016/0165-3806(86)90088-X; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SOHAL GS, 1991, INT J DEV NEUROSCI, V9, P563, DOI 10.1016/0736-5748(91)90017-G; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Striedter GF, 2008, J COMP NEUROL, V507, P1663, DOI 10.1002/cne.21640; Striedter GF, 2009, BIOL LETTERS, V5, P134, DOI 10.1098/rsbl.2008.0439; TANAKA H, 1990, DEVELOPMENT, V110, P565; Teillet Marie-Aimee, 2008, V461, P337, DOI 10.1007/978-1-60327-483-8_24; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; White SA, 2010, BRAIN LANG, V115, P21, DOI 10.1016/j.bandl.2009.10.002; Windle WF, 1936, J COMP NEUROL, V63, P431, DOI 10.1002/cne.900630304	60	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42477	10.1371/journal.pone.0042477	http://dx.doi.org/10.1371/journal.pone.0042477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860132	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900093
J	Zheng, R; Yue, SJ; Xu, XY; Liu, JY; Xu, Q; Wang, XL; Han, L; Yu, DY				Zheng, Rui; Yue, Sijun; Xu, Xiaoyan; Liu, Jianyu; Xu, Qing; Wang, Xiaolin; Han, Lu; Yu, Deyue			Proteome Analysis of the Wild and YX-1 Male Sterile Mutant Anthers of Wolfberry (Lycium barbarum L.)	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; MALE GAMETOPHYTE DEVELOPMENT; POLLEN EXINE DEVELOPMENT; CYSTEINE-RICH PROTEIN; PROGRAMMED CELL-DEATH; ARABIDOPSIS-THALIANA; BRASSICA-NAPUS; MATURE POLLEN; MOLECULAR CHARACTERIZATION; DIFFERENTIAL EXPRESSION	Pollen development is disturbed in the early tetrad stage of the YX-1 male sterile mutant of wolfberry (Lycium barbarum L.). The present study aimed to identify differentially expressed anther proteins and to reveal their possible roles in pollen development and male sterility. To address this question, the proteomes of the wild-type (WT) and YX-1 mutant were compared. Approximately 1760 protein spots on two-dimensional differential gel electrophoresis (2D-DIGE) gels were detected. A number of proteins whose accumulation levels were altered in YX-1 compared with WT were identified by mass spectrometry and the NCBInr and Viridiplantae EST databases. Proteins down-regulated in YX-1 anthers include ascorbate peroxidase (APX), putative glutamine synthetase (GS), ATP synthase subunits,chalcone synthase (CHS), CHS-like, putative callose synthase catalytic subunit, cysteine protease, 5B protein, enoyl-ACP reductase, 14-3-3 protein and basic transcription factor 3 (BTF3). Meanwhile, activities of APX and GS, RNA expression levels of apx and atp synthase beta subunit were low in YX-1 anthers which correlated with the expression of male sterility. In addition, several carbohydrate metabolism-related and photosynthesis-related enzymes were also present at lower levels in the mutant anthers. In contrast, 26S proteasome regulatory subunits, cysteine protease inhibitor, putative S-phase Kinase association Protein 1(SKP1), and aspartic protease, were expressed at higher levels in YX-1 anthers relative to WT anthers. Regulation of wolfberry pollen development involves a complex network of differentially expressed genes. The present study lays the foundation for future investigations of gene function linked with wolfberry pollen development and male sterility.	[Zheng, Rui; Xu, Xiaoyan; Liu, Jianyu; Wang, Xiaolin; Yu, Deyue] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China; [Zheng, Rui; Yue, Sijun; Xu, Qing; Han, Lu] Ningxia Univ, Coll Life Sci, Yinchuan, Peoples R China; [Xu, Xiaoyan] Jiangsu Polytech Coll Agr & Forestry, Jurong, Peoples R China	Nanjing Agricultural University; Ningxia University	Zheng, R (corresponding author), Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China.	dyyu@njau.edu.cn			National Natural Science Foundation of China [30960208, 31060162, 30800692, 31000718, 31171573]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (30960208, 31060162, 30800692, 31000718 and 31171573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE PJ, 1993, PLANT MOL BIOL, V23, P477, DOI 10.1007/BF00019296; Ariizumi T, 2003, PLANT MOL BIOL, V53, P107, DOI 10.1023/B:PLAN.0000009269.97773.70; Atanassov IRE, 1998, PLANT MOL BIOL, V38, P10; Benedetti CE, 1998, PLANT PHYSIOL, V116, P1037, DOI 10.1104/pp.116.3.1037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Carlsson J, 2007, PLANT J, V49, P452, DOI 10.1111/j.1365-313X.2006.02975.x; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; Dai SJ, 2007, MOL CELL PROTEOMICS, V6, P207, DOI 10.1074/mcp.M600146-MCP200; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; DEPAEPE R, 1993, P NATL ACAD SCI USA, V90, P5934, DOI 10.1073/pnas.90.13.5934; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dong XY, 2005, PLANT J, V42, P315, DOI 10.1111/j.1365-313X.2005.02379.x; Endo M, 2004, GENES GENET SYST, V79, P213, DOI 10.1266/ggs.79.213; Ferl RJ, 2002, GENOME BIOL, V3; Ge XC, 2005, EMBO REP, V6, P282, DOI 10.1038/sj.embor.7400357; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Han L, 2012, THESIS NINGXIA U, P40; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Hu SW, 2006, THEOR APPL GENET, V113, P397, DOI 10.1007/s00122-006-0303-5; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; Imin N, 2001, PROTEOMICS, V1, P1149, DOI 10.1002/1615-9861(200109)1:9<1149::AID-PROT1149>3.3.CO;2-I; Jiang PD, 2007, PLANT CELL REP, V26, P1627, DOI 10.1007/s00299-007-0351-6; Jiang SY, 2007, DEV BIOL, V304, P579, DOI 10.1016/j.ydbio.2007.01.008; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kaiser M, 2010, CHEMBIOCHEM, V11, P2085, DOI 10.1002/cbic.201000483; Kaul M, 1987, MALE STERILITY HIGHE, V1005, P116; Kerim T, 2003, PROTEOMICS, V3, P738, DOI 10.1002/pmic.200300424; Kim OK, 2010, PLANTA, V232, P353, DOI 10.1007/s00425-010-1178-x; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; KYO M, 1986, PLANTA, V168, P427, DOI 10.1007/BF00392260; LAVER HK, 1991, PLANT J, V1, P185, DOI 10.1111/j.1365-313X.1991.00185.x; LEVINGS CS, 1993, PLANT CELL, V5, P1285, DOI 10.2307/3869781; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li Q, 2001, HLTH FUNCTIONS MED P; Li XL, 2007, MED CHEM RES, V15, P471, DOI 10.1007/s00044-007-9002-2; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; Liu JJ, 2008, MOL PLANT, V1, P564, DOI 10.1093/mp/ssn033; Lou P, 2007, PLANT SCI, V172, P111, DOI 10.1016/j.plantsci.2006.07.015; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; McNeil KJ, 2010, PLANTA, V231, P793, DOI 10.1007/s00425-009-1089-x; McNeil KJ, 2005, J PLANT PHYSIOL, V162, P457, DOI 10.1016/j.jplph.2004.08.005; Mihr C, 2001, J PLANT PHYSIOL, V158, P787, DOI 10.1078/0176-1617-00292; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Mou ZL, 2000, PLANT CELL, V12, P405, DOI 10.1105/tpc.12.3.405; Nakajima Y, 2001, PLANT MOL BIOL, V46, P99, DOI 10.1023/A:1010652118518; Napoli CA, 1999, PLANT PHYSIOL, V120, P8; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; OAKS A, 1980, PLANTA, V148, P477, DOI [10.1007/BF00552663, 10.1007/BF02395318]; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; PACINI E, 1985, PLANT SYST EVOL, V149, P155, DOI 10.1007/BF00983304; Qin Ken, 2006, Xibei Zhiwu Xuebao, V26, P1838; Ribarits A, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P285, DOI 10.1007/978-1-4020-8854-4_23; Ribarits A, 2007, PLANT BIOTECHNOL J, V5, P483, DOI 10.1111/j.1467-7652.2007.00256.x; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; SCOTT R, 1991, PLANT SCI, V80, P167, DOI 10.1016/0168-9452(91)90281-C; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Sehnke PC, 2000, SCI STKE 2000, V56, P1, DOI [10.1126/stke.2000.56.pe1, DOI 10.1126/STKE.2000.56.PE1]; SHEN JB, 1992, MOL GEN GENET, V234, P379, DOI 10.1007/BF00538697; Sheoran IS, 2007, J EXP BOT, V58, P3525, DOI 10.1093/jxb/erm199; Sheoran IS, 2006, SEX PLANT REPROD, V19, P185, DOI 10.1007/s00497-006-0035-3; Sheoran IS, 2010, BOTANY, V88, P217, DOI 10.1139/B09-085; Sheoran IS, 2009, PLANTA, V230, P779, DOI 10.1007/s00425-009-0983-6; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Sorensen AM, 2003, PLANT J, V33, P413, DOI 10.1046/j.1365-313X.2003.01644.x; Sun QP, 2009, PROTEIN J, V28, P341, DOI 10.1007/s10930-009-9199-7; Tabuchi M, 2005, PLANT J, V42, P641, DOI 10.1111/j.1365-313X.2005.02406.x; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; Vizcay-Barrena G, 2006, J EXP BOT, V57, P2709, DOI 10.1093/jxb/erl032; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang DX, 2010, PLANT J, V63, P939, DOI 10.1111/j.1365-313X.2010.04294.x; Wang W, 2004, SEX PLANT REPROD, V17, P41, DOI 10.1007/s00497-004-0207-y; Wang YR, 2002, J ETHNOPHARMACOL, V82, P169, DOI 10.1016/S0378-8741(02)00169-1; WARMKE HE, 1972, J HERED, V63, P103, DOI 10.1093/oxfordjournals.jhered.a108244; Wei Lei, 2010, Advances in Bioscience and Biotechnology, V1, P145, DOI 10.4236/abb.2010.13020; WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759; Wu HM, 2000, PLANT MOL BIOL, V44, P267, DOI 10.1023/A:1026536324081; Wu SB, 2008, PLANT CELL REP, V27, P1441, DOI 10.1007/s00299-008-0572-3; [徐青 Xu Qing], 2009, [宁夏大学学报. 自然科学版, Journal of Ningxia University. Natural Science Edition], V30, P263; Yang S, 2008, ANN BOT-LONDON, V102, P483, DOI 10.1093/aob/mcn116; Zhao DH, 2003, PLANT MOL BIOL, V53, P163, DOI 10.1023/B:PLAN.0000009273.81702.b5	92	22	24	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41861	10.1371/journal.pone.0041861	http://dx.doi.org/10.1371/journal.pone.0041861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860020	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900042
J	Zhang, XL; Chen, Q; He, CY; Mao, WH; Zhang, L; Xu, XW; Zhu, JF; Chen, BF				Zhang, Xuelin; Chen, Qun; He, Chunya; Mao, Weihua; Zhang, Ling; Xu, Xiaowen; Zhu, Junfei; Chen, Baofu			Polymorphisms on 8q24 Are Associated with Lung Cancer Risk and Survival in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; COLORECTAL-CANCER; CHROMOSOME 8Q24; SUSCEPTIBILITY LOCI; BREAST-CANCER; THYROID-CANCER; MYC; RS6983267; VARIANTS	Chromosome 8q24 is commonly amplified in many types of cancer, particularly lung cancer. Polymorphisms in this region are associated with risk of different cancers. To investigate the relationship between three single nucleotide polymorphisms (SNPs) (rs1447295, rs16901979 and rs6983267) on 8q24 and lung cancer risk, we conducted an association study in two Han Chinese populations: one population was from Zhejiang Province (576 case patients and 576 control subjects), whereas the other was from Fujian Province (576 case patients and 576 control subjects). We found that rs6983267 was significantly associated with an increased risk of lung cancer in both populations. Compared with the TT genotype, the GG genotype was associated with a significant 1.555-fold increased risk of lung cancer [95% confidence interval (CI) 1.218-1.986, P = 4.0 x 10(-4)]. This effect was more pronounced in never-smokers [odds ratio (OR) = 2.366, 95% CI 1.605-3.488, P = 1.4 x 10(-5)]. Analyses stratified by histology revealed that rs6983267 GG genotype was most associated with patients with other histological types (OR = 3.012, 95% CI 1.675-5.417, P = 2.3 x 10(-4)). The AA genotype of rs1447295 was associated with increased risk for adenocarcinoma compared with the CC genotype (OR = 2.260, 95% CI 1.174-4.353, P = 0.015). Furthermore, the GG genotype of rs6983267 was associated with worse survival in the Zhejiang population (hazard ratio (HR) = 1.646, 95% CI 1.099-2.464, P = 0.016). No association was observed for rs16901979. These results suggest that genetic variations on 8q24 may play significant roles in the development and progression of lung cancer.	[Zhang, Xuelin; Mao, Weihua; Xu, Xiaowen; Chen, Baofu] Taizhou Cent Hosp, Dept Thorac Surg, Taizhou, Zhejiang, Peoples R China; [Chen, Qun] Fujian Med Univ, Fuzhou Pulm Hosp, Dept Oncol, Fuzhou, Fujian, Peoples R China; [He, Chunya] Taizhou Cent Hosp, Dept Surg Oncol, Taizhou, Zhejiang, Peoples R China; [Zhang, Ling] Taizhou Cent Hosp, Dept Obstet & Gynaecol, Taizhou, Zhejiang, Peoples R China; [Zhu, Junfei] Taizhou Cent Hosp, Dept Resp Med, Taizhou, Zhejiang, Peoples R China; [Chen, Baofu] Taizhou Hosp, Dept Thorac Surg, Taizhou, Zhejiang, Peoples R China	Taizhou University; Fujian Medical University; Taizhou University; Taizhou University; Taizhou University	Zhang, XL (corresponding author), Taizhou Cent Hosp, Dept Thorac Surg, Taizhou, Zhejiang, Peoples R China.	chbaofu@hotmail.com			Taizhou Science and Technology Agency [111ky07-7]	Taizhou Science and Technology Agency	This work was supported by grant from the Taizhou Science and Technology Agency (111ky07-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Cappuzzo F, 2009, J THORAC ONCOL, V4, P472, DOI 10.1097/JTO.0b013e31819a5767; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Cicek MS, 2009, CANCER EPIDEM BIOMAR, V18, P2492, DOI 10.1158/1055-9965.EPI-09-0362; Dai J, 2012, CARCINOGENESIS; Daraei A, 2012, MED ONCOL, V29, P1044, DOI 10.1007/s12032-011-9980-2; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Guarrera S, 2012, AM J EPIDEMIOL, V175, P479, DOI 10.1093/aje/kwr430; Guo Y, 2011, WORLD J GASTROENTERO, V17, P1759, DOI 10.3748/wjg.v17.i13.1759; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Iwakawa R, 2011, CLIN CANCER RES, V17, P1481, DOI 10.1158/1078-0432.CCR-10-2484; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Kang JU, 2007, J KOREAN MED SCI, V22, pS47, DOI 10.3346/jkms.2007.22.S.S47; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Kubokura H, 2001, Ann Thorac Cardiovasc Surg, V7, P197; Lochhead P, 2011, EUR J CANCER PREV, V20, P54, DOI 10.1097/CEJ.0b013e328341e320; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Mirabello L, 2010, CARCINOGENESIS, V31, P1400, DOI 10.1093/carcin/bgq117; Neta G, 2012, LARYNGOSCOPE, V122, P1040, DOI 10.1002/lary.23209; Park SL, 2008, CANCER EPIDEM BIOMAR, V17, P3193, DOI 10.1158/1055-9965.EPI-08-0523; PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Pomerantz MM, 2009, CANCER RES, V69, P5568, DOI 10.1158/0008-5472.CAN-09-0387; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x	40	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41930	10.1371/journal.pone.0041930	http://dx.doi.org/10.1371/journal.pone.0041930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848662	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200130
J	Pirooznia, SK; Sarthi, J; Johnson, AA; Toth, MS; Chiu, K; Koduri, S; Elefant, F				Pirooznia, Sheila K.; Sarthi, Jessica; Johnson, Ashley A.; Toth, Meridith S.; Chiu, Kellie; Koduri, Sravanthi; Elefant, Felice			Tip60 HAT Activity Mediates APP Induced Lethality and Apoptotic Cell Death in the CNS of a Drosophila Alzheimer's Disease Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INTRACELLULAR DOMAIN AICD; GENE-EXPRESSION; HISTONE ACETYLTRANSFERASE; CYTOSKELETAL DYNAMICS; NEURONAL APOPTOSIS; CO-REPRESSOR; TRANSCRIPTION; PRESENILIN; INTERACTS	Histone acetylation of chromatin promotes dynamic transcriptional responses in neurons that influence neuroplasticity critical for cognitive ability. It has been demonstrated that Tip60 histone acetyltransferase (HAT) activity is involved in the transcriptional regulation of genes enriched for neuronal function as well as the control of synaptic plasticity. Accordingly, Tip60 has been implicated in the neurodegenerative disorder Alzheimer's disease (AD) via transcriptional regulatory complex formation with the AD linked amyloid precursor protein (APP) intracellular domain (AICD). As such, inappropriate complex formation may contribute to AD-linked neurodegeneration by misregulation of target genes involved in neurogenesis; however, a direct and causative epigenetic based role for Tip60 HAT activity in this process during neuronal development in vivo remains unclear. Here, we demonstrate that nervous system specific loss of Tip60 HAT activity enhances APP mediated lethality and neuronal apoptotic cell death in the central nervous system (CNS) of a transgenic AD fly model while remarkably, overexpression of Tip60 diminishes these defects. Notably, all of these effects are dependent upon the C-terminus of APP that is required for transcriptional regulatory complex formation with Tip60. Importantly, we show that the expression of certain AD linked Tip60 gene targets critical for regulating apoptotic pathways are modified in the presence of APP. Our results are the first to demonstrate a functional interaction between Tip60 and APP in mediating nervous system development and apoptotic neuronal cell death in the CNS of an AD fly model in vivo, and support a novel neuroprotective role for Tip60 HAT activity in AD neurodegenerative pathology.	[Pirooznia, Sheila K.; Sarthi, Jessica; Johnson, Ashley A.; Toth, Meridith S.; Chiu, Kellie; Koduri, Sravanthi; Elefant, Felice] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Drexel University	Elefant, F (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	fe22@drexel.edu			NIH grant [R01HD057939]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057939] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant R01HD057939 to FE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Anne-Laurence Boutillier, 2007, Subcell Biochem, V41, P263; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Blum D, 2004, NEUROSCI LETT, V368, P309, DOI 10.1016/j.neulet.2004.07.046; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Checler F, 1999, IUBMB LIFE, V48, P33, DOI 10.1080/152165499307396; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Galindo KA, 2009, DEVELOPMENT, V136, P275, DOI 10.1242/dev.019042; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Graff J, 2009, EUR J NEUROSCI, V30, P1, DOI 10.1111/j.1460-9568.2009.06787.x; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Guo YQ, 1999, J NEUROSCI, V19, P8435; Hemming FJ, 2004, NEUROSCIENCE, V123, P887, DOI 10.1016/j.neuroscience.2003.10.036; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Jellinger KA, 2001, J ALZHEIMERS DIS, V3, P31, DOI 10.3233/JAD-2001-3106; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kinoshita A, 2002, J BIOL CHEM, V277, P28530, DOI 10.1074/jbc.M203372200; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lorbeck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018412; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sarthi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026202; Sax JK, 2003, J BIOL CHEM, V278, P36435, DOI 10.1074/jbc.M303191200; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P840, DOI 10.1016/j.bbagrm.2010.08.012; Slomnicki LP, 2008, ACTA NEUROBIOL EXP, V68, P219; Sykes SM, 2009, J BIOL CHEM, V284, P20197, DOI 10.1074/jbc.M109.026096; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Xu LJ, 2009, NEOPLASIA, V11, P345, DOI 10.1593/neo.81524	52	53	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41776	10.1371/journal.pone.0041776	http://dx.doi.org/10.1371/journal.pone.0041776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848598	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600047
J	Savkovic, B; Symonds, G; Murray, JM				Savkovic, Borislav; Symonds, Geoff; Murray, John M.			Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; STRUCTURED TREATMENT INTERRUPTIONS; SYNCYTIUM-INDUCING PHENOTYPE; CORECEPTOR SWITCH; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; HEMATOPOIETIC STEM; CXCR4-USING HIV-1; LYMPHOID-TISSUE	The emergence of X4 tropic viral strains throughout the course of HIV infection is associated with poorer prognostic outcomes and faster progressions to AIDS than for patients in whom R5 viral strains predominate. Here we investigate a stochastic model to account for the emergence of X4 virus via mutational intermediates of lower fitness that exhibit dual/mixed (D/M) tropism, and employ the model to investigate whether the administration of CCR5 blockers in-vivo is likely to promote a shift towards X4 tropism. We show that the proposed stochastic model can account for X4 emergence with a median time of approximately 4 years post-infection as a result of: 1.) random stochastic mutations in the V3 region of env during the reverse transcription step of infection; 2.) increasing numbers of CXCR4-expressing activated naive CD4+ T cells with declining total CD4+ T cell counts, thereby providing increased numbers of activated target cells for productive infection by X4 virus. Our model indicates that administration of the CCR5 blocker maraviroc does not promote a shift towards X4 tropism, assuming sufficient efficacy of background therapy (BT). However our modelling also indicates that administration of maraviroc as a monotherapy or with BT of suboptimal efficacy can promote emergence of X4 tropic virus, resulting in accelerated progression to AIDS. Taken together, our results demonstrate that maraviroc is safe and effective if co-administered with sufficiently potent BT, but that suboptimal BT may promote X4 emergence and accelerated progression to AIDS. These results underscore the clinical importance for careful selection of BT when CCR5 blockers are administered in-vivo.	[Savkovic, Borislav; Murray, John M.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Symonds, Geoff] St Vincents Ctr Appl Med Res, Darlinghurst, NSW, Australia; [Murray, John M.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute	Savkovic, B (corresponding author), Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia.	b.savkovic@unsw.edu.au	Murray, John/B-5481-2009	Murray, John/0000-0001-9314-2283	Australian Research Council (ARC) [LP100100242]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC) under an ARC Linkage grant held by GS and JMM (LP100100242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007387; Carter CC, 2011, CELL HOST MICROBE, V9, P223, DOI 10.1016/j.chom.2011.02.005; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Corbeau P, 2009, AIDS, V23, P1931, DOI 10.1097/QAD.0b013e32832e71cd; Davenport MP, 2002, TRENDS MICROBIOL, V10, P275, DOI 10.1016/S0966-842X(02)02370-3; de Silva E, 2004, FEMS MICROBIOL LETT, V241, P1, DOI 10.1016/j.femsle.2004.09.040; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Del Prete GQ, 2010, J VIROL, V84, P8777, DOI 10.1128/JVI.00333-10; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; ESSUNGER P, 1994, J THEOR BIOL, V170, P367, DOI 10.1006/jtbi.1994.1199; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Frost SDW, 2002, J VIROL, V76, P968, DOI 10.1128/JVI.76.3.968-979.2002; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Garrido C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Huenecke S, 2008, EUR J HAEMATOL, V80, P532, DOI 10.1111/j.1600-0609.2008.01052.x; Igarashi T, 2002, J VIROL, V76, P379, DOI 10.1128/JVI.76.1.379-391.2002; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; KLEIN J, 1990, IMMUNOLOGY; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Lee S, 2000, J VIROL, V74, P5016, DOI 10.1128/JVI.74.11.5016-5023.2000; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lewin SR, 2008, JAIDS-J ACQ IMM DEF, V47, P140, DOI 10.1097/QAI.0b013e31815dbf7f; Lewin SR, 1996, AIDS RES HUM RETROV, V12, P877, DOI 10.1089/aid.1996.12.877; Lewis M, 2007, ANTIVIR THER, V12, pS65; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; Murray JM, 1998, MATH BIOSCI, V154, P57, DOI 10.1016/S0025-5564(98)10046-9; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Murray JM, 2012, AIDS, V26, P543, DOI 10.1097/QAD.0b013e328350fb3c; Murray JM, 2009, J GENE MED, V11, P1077, DOI 10.1002/jgm.1401; Nazari R, 2008, J GEN VIROL, V89, P2252, DOI 10.1099/vir.0.2008/001222-0; Nazari R, 2008, CURR GENE THER, V8, P264, DOI 10.2174/156652308785160674; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Notermans DW, 1999, J INFECT DIS, V180, P1050, DOI 10.1086/315013; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Pastore C, 2006, J VIROL, V80, P750, DOI 10.1128/JVI.80.2.750-758.2006; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Poizot-Martin I, 2010, MED MALADIES INFECT, V40, P245, DOI 10.1016/j.medmal.2010.03.007; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Ren WZ, 2010, J VIROL, V84, P340, DOI 10.1128/JVI.01865-09; Ribeiro RM, 2006, J VIROL, V80, P802, DOI 10.1128/JVI.80.2.802-809.2006; Ribeiro RM, 1999, AIDS, V13, P351, DOI 10.1097/00002030-199902250-00007; Shakirzyanova M, 2010, J VIROL, V84, P12862, DOI 10.1128/JVI.01478-10; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Svicher V, 2011, ANTIVIR RES, V90, P42, DOI 10.1016/j.antiviral.2011.02.005; Symons J, 2011, J ANTIMICROB CHEMOTH, V66, P890, DOI 10.1093/jac/dkq535; Tasca S, 2008, J VIROL, V82, P7089, DOI 10.1128/JVI.00570-08; Tebit DM, 2007, AIDS REV, V9, P75; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Troia-Cancio P, 2011, EXPERT REV ANTI-INFE, V9, P649, DOI [10.1586/eri.11.52, 10.1586/ERI.11.52]; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Weinberger AD, 2011, MATH BIOSCI ENG, V8, P605, DOI 10.3934/mbe.2011.8.605; Weinberger Ariel D, 2009, PLoS Comput Biol, V5, pe1000467, DOI 10.1371/journal.pcbi.1000467; Westby Mike, 2010, Antiviral Chemistry & Chemotherapy, V20, P179, DOI 10.3851/IMP1507; Wolinsky SM, 2004, VIROLOGY, V328, P19, DOI 10.1016/j.virol.2004.07.021; ZAUNDERS J, 1995, AIDS, V9, P561, DOI 10.1097/00002030-199506000-00005; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	72	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2012	7	7							e38755	10.1371/journal.pone.0038755	http://dx.doi.org/10.1371/journal.pone.0038755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JG	22866173	gold, Green Published, Green Submitted			2022-12-27	WOS:000306507000004
J	Martinez-Mora, C; Mrowiec, A; Garcia-Vizcaino, EM; Alcaraz, A; Cenis, JL; Nicolas, FJ				Martinez-Mora, Celia; Mrowiec, Anna; Maria Garcia-Vizcaino, Eva; Alcaraz, Antonia; Luis Cenis, Jose; Jose Nicolas, Francisco			Fibroin and Sericin from Bombyx mori Silk Stimulate Cell Migration through Upregulation and Phosphorylation of c-Jun	PLOS ONE			English	Article							N-TERMINAL KINASE; WOUND CLOSURE; GROWTH; EXPRESSION; PROLIFERATION; ACTIVATION; ATTACHMENT; FILM; DISRUPTION; MECHANISMS	Wound healing is a biological process directed to the restoration of tissue that has suffered an injury. An important phase of wound healing is the generation of a basal epithelium able to wholly replace the epidermis of the wound. A broad range of products derived from fibroin and sericin from Bombyx mori silk are used to stimulate wound healing. However, so far the molecular mechanism underlying this phenomenon has not been elucidated. The aim of this work was to determine the molecular basis underlying wound healing properties of silk proteins using a cell model. For this purpose, we assayed fibroin and sericin in a wound healing scratch assay using MDA-MB-231 and Mv1Lu cells. Both proteins stimulated cell migration. Furthermore, treatment with sericin and fibroin involved key factors of the wound healing process such as upregulation of c-Jun and c-Jun protein phosphorylation. Moreover, fibroin and sericin stimulated the phosphorylation of ERK 1/2 and JNK 1/2 kinases. All these experiments were done in the presence of specific inhibitors for some of the cell signalling pathways referred above. The obtained results revealed that MEK, JNK and PI3K pathways are involved in fibroin and sericin stimulated cells migration. Inhibition of these three kinases prevented c-Jun upregulation and phosphorylation by fibroin or sericin. Fibroin and sericin were tested in the human keratinocyte cell line, HaCaT, with similar results. Altogether, our results showed that fibroin and sericin initiate cell migration by activating the MEK, JNK and PI3K signalling pathways ending in c-Jun activation.	[Martinez-Mora, Celia; Luis Cenis, Jose] Inst Murciano Invest & Desarrollo Agr & Alimentar, Murcia, Spain; [Mrowiec, Anna; Maria Garcia-Vizcaino, Eva; Alcaraz, Antonia; Jose Nicolas, Francisco] Hosp Univ Virgen Arrixaca, Lab Oncol Mol & TGF, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca	Martinez-Mora, C (corresponding author), Inst Murciano Invest & Desarrollo Agr & Alimentar, Murcia, Spain.	franciscoj.nicolas2@carm.es	Cenis, Jose Luis/G-8363-2015; Martínez-Mora, Celia/AAS-4254-2020; Nicolás, Francisco José/H-9422-2019	Cenis, Jose Luis/0000-0003-3925-7842; Nicolás, Francisco José/0000-0002-3969-1430; Mrowiec, Anna/0000-0001-8745-5494	Fundacion Seneca de la Region de Murcia [12035/PI/09]; FEDER Operative Program of the Region of Murcia; Spanish Ministry of Science and Innovation; Spanish Ministry for Education and Science; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Hospital Universitario Virgen de la Arrixaca	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); FEDER Operative Program of the Region of Murcia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry for Education and Science(Spanish Government); Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia; Hospital Universitario Virgen de la Arrixaca	This work was supported by a grant from the Fundacion Seneca de la Region de Murcia, grant number 12035/PI/09 (http://www.f-seneca.org/seneca2) and the FEDER Operative Program of the Region of Murcia 2007-2013. CMM was recipient of a grant by the FEDER Operative Program of the Region of Murcia 2007-2013. EMGV was recipient of a fellowship from Fundacion Seneca de la Region de Murcia. AA was recipient of a fellowship of the Spanish Ministry of Science and Innovation. FJN was supported by the Ramon y Cajal program of the Spanish Ministry for Education and Science and the Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. The authors are indebted to the Hospital Universitario Virgen de la Arrixaca that strongly supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Czekay R. P., 2011, INT J CELL BIOL, V2011; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Desai LP, 2010, J BIOL CHEM, V285, P4511, DOI 10.1074/jbc.M109.084335; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Geh E, 2011, P NATL ACAD SCI; Ghosh AK, 2011, J CELLULAR PHYSL; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Insausti CL, 2010, WOUND REPAIR REGEN, V18, P368, DOI 10.1111/j.1524-475X.2010.00604.x; Javelaud D, 2003, J BIOL CHEM, V278, P24624, DOI 10.1074/jbc.M301942200; Khalil AA, 2010, INTEGR BIOL-UK, V2, P568, DOI 10.1039/c0ib00052c; Kimura T., 2007, Journal of Applied Sciences Research, P1306; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163; Manes S, 2000, IUBMB LIFE, V49, P89; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pontillo CA, 2011, TOXICOL SCI, V120, P284, DOI 10.1093/toxsci/kfq390; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Providence KM, 2004, J CELL PHYSIOL, V200, P297, DOI 10.1002/jcp.20016; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rodriguez Luis G., 2004, V294, P23; Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x; TAO WH, 1995, INVEST OPHTH VIS SCI, V36, P2614; Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608; Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375; Tetreault MP, 2008, J CELL BIOCHEM, V105, P1240, DOI 10.1002/jcb.21924; Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403; Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb Donna J., 2004, V294, P3; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	66	75	76	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42271	10.1371/journal.pone.0042271	http://dx.doi.org/10.1371/journal.pone.0042271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860103	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600083
J	Arcipowski, KM; Bishop, GA				Arcipowski, Kelly M.; Bishop, Gail A.			Roles of the Kinase TAK1 in TRAF6-Dependent Signaling by CD40 and Its Oncogenic Viral Mimic, LMP1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASES; CRITICAL MEDIATOR; TERMINAL KINASE; FACTORS TRAFS; BINDING-SITE; MAPK KINASE	The Epstein-Barr virus (EBV)-encoded protein latent membrane protein 1 (LMP1) is essential for EBV-mediated B cell transformation and plays a critical role in the development of post-transplant B cell lymphomas. LMP1 also contributes to the exacerbation of autoimmune diseases such as systemic lupus erythematosus (SLE). LMP1 is a functional mimic of the tumor necrosis factor receptor (TNFR) superfamily member CD40, and relies on TNFR-associated factor (TRAF) adaptor proteins to mediate signaling. However, LMP1 activation signals to the B cell are amplified and sustained compared to CD40 signals. We previously demonstrated that LMP1 and CD40 use TRAF molecules differently. Although associating with CD40 and LMP1 via separate mechanisms, TRAF6 plays a significant role in signal transduction by both. It is unknown whether TRAF6 mediates CD40 versus LMP1 functions via distinct or shared pathways. In this study, we tested the hypothesis that TRAF6 uses the kinase TAK1 to trigger important signaling pathways following both CD40 and LMP1 stimulation. We determined that TAK1 was required for JNK activation and interleukin-6 (IL-6) production mediated by CD40 and LMP1, in both mouse and human B cells. Additionally, TRAF3 negatively regulated TRAF6-dependent, CD40-mediated TAK1 activation by limiting TRAF6 recruitment. This mode of regulation was not observed for LMP1 and may contribute to the dysregulation of LMP1 compared to CD40 signals.	[Arcipowski, Kelly M.; Bishop, Gail A.] Univ Iowa, Dept Microbiol, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Bishop, Gail A.] Univ Iowa, Dept Internal Med, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Bishop, Gail A.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Arcipowski, KM (corresponding author), Univ Iowa, Dept Microbiol, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA.	gail-bishop@uiowa.edu		Bishop, Gail/0000-0002-1291-5078	National Institutes of Health [NIH R01 CA099997]; American Heart Association Predoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA099997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from National Institutes of Health NIH R01 CA099997 to GAB and the American Heart Association Predoctoral fellowship to KMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya A, 2006, AUTOIMMUN REV, V5, P331, DOI 10.1016/j.autrev.2005.12.006; Adam P, 2011, ADV ANAT PATHOL, V18, P349, DOI 10.1097/PAP.0b013e318229bf08; Arcipowski KM, 2011, J BIOL CHEM, V286, P9948, DOI 10.1074/jbc.M110.185983; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Bishop GA, 2002, MICROBES INFECT, V4, P853, DOI 10.1016/S1286-4579(02)01605-2; BISHOP GA, 1986, P NATL ACAD SCI USA, V83, P7410, DOI 10.1073/pnas.83.19.7410; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; BISHOP GA, 1991, J IMMUNOL, V147, P1107; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Busch LK, 1999, J IMMUNOL, V162, P2555; Busch LK, 2001, J IMMUNOL, V167, P5805, DOI 10.4049/jimmunol.167.10.5805; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Graham JP, 2009, J IMMUNOL, V183, P2966, DOI 10.4049/jimmunol.0900442; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hammaker DR, 2004, J IMMUNOL, V172, P1612, DOI 10.4049/jimmunol.172.3.1612; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; KIM KJ, 1979, J IMMUNOL, V122, P549; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Kraus ZJ, 2009, P NATL ACAD SCI USA, V106, P17140, DOI 10.1073/pnas.0903786106; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Martin SE, 2011, CURR CANCER DRUG TAR, V11, P976; Melisi D, 2011, JNCI-J NATL CANCER I, V103, P1190, DOI 10.1093/jnci/djr243; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Nakano H, 1999, P NATL ACAD SCI USA, V96, P9803, DOI 10.1073/pnas.96.17.9803; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2010, CANCER RES, V70, P8417, DOI 10.1158/0008-5472.CAN-10-1227; Pai S, 2001, SEMIN CANCER BIOL, V11, P455, DOI 10.1006/scbi.2001.0412; Peters AL, 2010, J IMMUNOL, V185, P6555, DOI 10.4049/jimmunol.1000135; Peters AL, 2010, J IMMUNOL, V185, P4053, DOI 10.4049/jimmunol.0904065; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Safina A, 2011, MOL CANCER RES, V9, P1042, DOI 10.1158/1541-7786.MCR-10-0196; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schubert S, 2009, PEDIATR TRANSPLANT, V13, P54, DOI 10.1111/j.1399-3046.2008.00969.x; Schultheiss U, 2001, EMBO J, V20, P5678, DOI 10.1093/emboj/20.20.5678; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Stunz LL, 2004, IMMUNITY, V21, P255, DOI 10.1016/j.immuni.2004.07.008; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Vanden Bush T.J., 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019468; WARREN WD, 1995, J IMMUNOL, V155, P5637; Wu LM, 2006, J BIOL CHEM, V281, P2162, DOI 10.1074/jbc.M505903200; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Xie P, 2004, J IMMUNOL, V173, P5546, DOI 10.4049/jimmunol.173.9.5546; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Xie P, 2011, J LEUKOCYTE BIOL, V90, P1149, DOI 10.1189/jlb.0111044; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	71	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42478	10.1371/journal.pone.0042478	http://dx.doi.org/10.1371/journal.pone.0042478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860133	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900094
J	He, M; Wang, Y; Hua, WP; Zhang, Y; Wang, ZZ				He, Miao; Wang, Ying; Hua, Wenping; Zhang, Yuan; Wang, Zhezhi			De Novo Sequencing of Hypericum perforatum Transcriptome to Identify Potential Genes Involved in the Biosynthesis of Active Metabolites	PLOS ONE			English	Article							ST-JOHNS-WORT; III POLYKETIDE SYNTHASE; MOLECULAR-CLONING; EXPRESSION; TRYPTOPHAN; MELATONIN; L.; HYPERFORIN; IDENTIFICATION; REPEATS	Background: Hypericum perforatum L. (St. John's wort) is a medicinal plant with pharmacological properties that are antidepressant, anti-inflammatory, antiviral, anti-cancer, and antibacterial. Its major active metabolites are hypericins, hyperforins, and melatonin. However, little genetic information is available for this species, especially that concerning the biosynthetic pathways for active ingredients. Methodology/Principal Findings: Using de novo transcriptome analysis, we obtained 59,184 unigenes covering the entire life cycle of these plants. In all, 40,813 unigenes (68.86%) were annotated and 2,359 were assigned to secondary metabolic pathways. Among them, 260 unigenes are involved in the production of hypericin, hyperforin, and melatonin. Another 2,291 unigenes are classified as potential Type III polyketide synthase. Our BlastX search against the AGRIS database reveals 1,772 unigenes that are homologous to 47 known Arabidopsis transcription factor families. Further analysis shows that 10.61% (6,277) of these unigenes contain 7,643 SSRs. Conclusion: We have identified a set of putative genes involved in several secondary metabolism pathways, especially those related to the synthesis of its active ingredients. Our results will serve as an important platform for public information about gene expression, genomics, and functional genomics in H. perforatum.	[He, Miao; Zhang, Yuan; Wang, Zhezhi] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Crude Drugs, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Xian, Shaanxi, Peoples R China; [Wang, Ying] Northwest Univ, Inst Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Shaanxi, Peoples R China; [Hua, Wenping] Shaanxi Inst Educ, Dept Life Sci, Xian, Shaanxi, Peoples R China	Shaanxi Normal University; Northwest University Xi'an	He, M (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Dev Endangered Crude Drugs, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Xian, Shaanxi, Peoples R China.	zzwang@snnu.edu.cn		Hua, wenping/0000-0003-3692-4953	"Twelve-Five technology support program funding [2011BAI06B06]; Graduate student Innovation Fund of Shaanxi Normal University, Shaanxi, P. R. China [2008CXB014]	"Twelve-Five technology support program funding; Graduate student Innovation Fund of Shaanxi Normal University, Shaanxi, P. R. China	This work benefited from financial support from the "Twelve-Five technology support program funding (2011BAI06B06)" and the "Graduate student Innovation Fund of Shaanxi Normal University (2008CXB014), Shaanxi, P. R. China". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adam P, 2002, J MED CHEM, V45, P4786, DOI 10.1021/jm0209782; Altun A, 2007, INT J CLIN PRACT, V61, P835, DOI 10.1111/j.1742-1241.2006.01191.x; Bais HP, 2003, J BIOL CHEM, V278, P32413, DOI 10.1074/jbc.M301681200; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Boubakir Z, 2005, PHYTOCHEMISTRY, V66, P51, DOI 10.1016/j.phytochem.2004.10.020; Boutin JA, 2005, TRENDS PHARMACOL SCI, V26, P412, DOI 10.1016/j.tips.2005.06.006; Butterweck V, 2003, CNS DRUGS, V17, P539, DOI 10.2165/00023210-200317080-00001; Caraci F, 2011, CURR DRUG METAB, V12, P570; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Flores-Sanchez IJ, 2009, PLANT PHYSIOL BIOCH, V47, P167, DOI 10.1016/j.plaphy.2008.11.005; Franklin G, 2009, PHYTOCHEMISTRY, V70, P60, DOI 10.1016/j.phytochem.2008.10.016; Gantet P, 2002, TRENDS PHARMACOL SCI, V23, P563, DOI 10.1016/S0165-6147(02)02098-9; Germ M, 2010, FOOD CHEM, V122, P471, DOI 10.1016/j.foodchem.2010.03.008; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Karioti A, 2010, INT J MOL SCI, V11, P562, DOI 10.3390/ijms11020562; Karppinen K, 2008, FEBS J, V275, P4329, DOI 10.1111/j.1742-4658.2008.06576.x; Karppinen K, 2008, J PLANT PHYSIOL, V165, P1079, DOI 10.1016/j.jplph.2007.04.008; Klingauf P, 2005, PHYTOCHEMISTRY, V66, P139, DOI 10.1016/j.phytochem.2004.11.003; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; LI JY, 1995, PLANT PHYSIOL, V108, P877, DOI 10.1104/pp.108.2.877; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; Mallika V, 2011, EVOL BIOINFORM, V7, P41, DOI 10.4137/EBO.S6854; Murch SJ, 1997, LANCET, V350, P1598, DOI 10.1016/S0140-6736(05)64014-7; Murch SJ, 2000, PLANT CELL REP, V19, P698, DOI 10.1007/s002990000206; NORMANLY J, 2010, COLD SPRING HARB PER, V2, P1; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Palombella AL, 1998, PLANT PHYSIOL, V117, P455, DOI 10.1104/pp.117.2.455; Paredes SD, 2009, J EXP BOT, V60, P57, DOI 10.1093/jxb/ern284; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Smelcerovic A, 2006, PHARMAZIE, V61, P251; Smolen GA, 2002, GENETICS, V161, P1235; Song J, 2009, MOL BIOL REP, V36, P939, DOI 10.1007/s11033-008-9266-8; Umek A, 1999, PLANTA MED, V65, P388, DOI 10.1055/s-2006-960798; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vijayan M, 2011, BIOINFORMATION, V6, P125, DOI 10.6026/97320630006125; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026426; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043	47	41	51	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42081	10.1371/journal.pone.0042081	http://dx.doi.org/10.1371/journal.pone.0042081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860059	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900065
J	McDonald, TJ; Perry, MH; Peake, RWA; Pullan, NJ; O'Connor, J; Shields, BM; Knight, BA; Hattersley, AT				McDonald, Timothy J.; Perry, Mandy H.; Peake, Roy W. A.; Pullan, Nicola J.; O'Connor, John; Shields, Beverley M.; Knight, Beatrice A.; Hattersley, Andrew T.			EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature	PLOS ONE			English	Article							BETA-CELL FUNCTION; DIABETES-MELLITUS; PLASMA; STANDARDIZATION; IMMUNOASSAYS; HORMONE; STORAGE	Introduction: C-peptide and insulin measurements in blood provide useful information regarding endogenous insulin secretion. Conflicting evidence on sample stability and handling procedures continue to limit the widespread clinical use of these tests. We assessed the factors that altered the stability of insulin and C-peptide in blood. Methods: We investigated the impact of preservative type, time to centrifugation, storage conditions and duration of storage on the stability of C-peptide and insulin on three different analytical platforms. Results: C-peptide was stable for at least 24 hours at room temperature in both centrifuged and whole blood collected in K+-EDTA and serum gel tubes, with the exception of whole blood serum gel, which decreased to 78% of baseline at 24 hours, (p = 0.008). Insulin was stable at room temperature for 24 hours in both centrifuged and whole blood collected in K+-EDTA tubes. In contrast insulin levels decreased in serum gel tubes both centrifuged and whole blood (66% of baseline, p = 0.01 and 76% of baseline p = 0.01, by 24 hours respectively). C-peptide and insulin remained stable after 6 freeze-thaw cycles. Conclusions: The stability of C-peptide and insulin in whole blood K+-EDTA tubes negates the need to conform to strict sample handling procedures for these assays, greatly increasing their clinical utility.	[McDonald, Timothy J.; Perry, Mandy H.; O'Connor, John] Royal Devon & Exeter NHS Fdn Trust, Dept Clin Chem, Exeter, Devon, England; [McDonald, Timothy J.; Shields, Beverley M.; Knight, Beatrice A.; Hattersley, Andrew T.] Univ Exeter, NIHR Clin Res Facil, Peninsula Coll Med & Dent, Exeter, Devon, England; [Peake, Roy W. A.] NHS Grampian Hlth Board, Dept Clin Biochem, Aberdeen, Scotland; [Pullan, Nicola J.] Nottingham Univ Hosp NHS Trust, Nottingham, England	University of Exeter; University of Exeter; University of Plymouth; University of Aberdeen; Nottingham University Hospital NHS Trust	McDonald, TJ (corresponding author), Royal Devon & Exeter NHS Fdn Trust, Dept Clin Chem, Exeter, Devon, England.	Timothy.McDonald@nhs.net		Hattersley, Andrew/0000-0001-5620-473X; McDonald, Timothy James/0000-0003-3559-6660	National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bolner A, 2005, CLIN LAB, V51, P153; BRISTOW AF, 1988, J BIOL STAND, V16, P179, DOI 10.1016/0092-1157(88)90005-4; Ellis MJ, 2003, CLIN BIOCHEM, V36, P109, DOI 10.1016/S0009-9120(02)00440-X; Evans MJ, 2001, CLIN BIOCHEM, V34, P107, DOI 10.1016/S0009-9120(01)00196-5; Jermendy G, 1996, J DIABETES COMPLICAT, V10, P223, DOI 10.1016/1056-8727(95)00006-2; KOSKINEN PJ, 1988, DIABETES CARE, V11, P318, DOI 10.2337/diacare.11.4.318; KUBASIK NP, 1982, CLIN CHEM, V28, P164; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P1664, DOI 10.1210/jc.2002-021018; Little RR, 2008, CLIN CHEM, V54, P1023, DOI 10.1373/clinchem.2007.101287; LIVESEY JH, 1980, CLIN BIOCHEM, V13, P151, DOI 10.1016/S0009-9120(80)91040-1; MADSBAD S, 1981, ACTA MED SCAND, V210, P153; Marcovina S, 2007, CLIN CHEM, V53, P711, DOI 10.1373/clinchem.2006.082214; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller WG, 2009, CLIN CHEM, V55, P1011, DOI 10.1373/clinchem.2008.118380; Prando R, 1996, DIABETES METAB, V22, P185; Saddig Christiane, 2002, JOP, V3, P16; Smith S., 1996, Journal of Endocrinology, V151, pP20; Van Uytfanghe K, 2010, MED NUCL, V34, P566, DOI 10.1016/j.mednuc.2010.07.005; WALTERS E, 1986, CLIN CHEM, V32, P224; Wiedmeyer HM, 2007, CLIN CHEM, V53, P784, DOI 10.1373/clinchem.2006.081570	20	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42084	10.1371/journal.pone.0042084	http://dx.doi.org/10.1371/journal.pone.0042084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860060	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900066
J	Stanton, PG; Sluka, P; Foo, CFH; Stephens, AN; Smith, AI; McLachlan, RI; O'Donnell, L				Stanton, Peter G.; Sluka, Pavel; Foo, Caroline F. H.; Stephens, Andrew N.; Smith, A. Ian; McLachlan, Robert I.; O'Donnell, Liza			Proteomic Changes in Rat Spermatogenesis in Response to In Vivo Androgen Manipulation; Impact on Meiotic Cells	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MALE GERM-CELLS; SERTOLI-CELLS; OXIDATIVE-STRESS; SEMINIFEROUS EPITHELIUM; ADULT RATS; ECTOPLASMIC SPECIALIZATIONS; APOPTOSIS PROTEIN; NUCLEAR ANTIGEN; BINDING-PROTEIN	The production of mature sperm is reliant on androgen action within the testis, and it is well established that androgens act on receptors within the somatic Sertoli cells to stimulate male germ cell development. Mice lacking Sertoli cell androgen receptors (AR) show late meiotic germ cell arrest, suggesting Sertoli cells transduce the androgenic stimulus co-ordinating this essential step in spermatogenesis. This study aimed to identify germ cell proteins responsive to changes in testicular androgen levels and thereby elucidate mechanisms by which androgens regulate meiosis. Testicular androgen levels were suppressed for 9 weeks using testosterone and estradiol-filled silastic implants, followed by a short period of either further androgen suppression (via an AR antagonist) or the restoration of intratesticular testosterone levels. Comparative proteomics were performed on protein extracts from enriched meiotic cell preparations from adult rats undergoing androgen deprivation and replacement in vivo. Loss of androgenic stimulus caused changes in proteins with known roles in meiosis (including Nasp and Hsp70-2), apoptosis (including Diablo), cell signalling (including 14-3-3 isoforms), oxidative stress, DNA repair, and RNA processing. Immunostaining for oxidised DNA adducts confirmed spermatocytes undergo oxidative stress-induced DNA damage during androgen suppression. An increase in PCNA and an associated ubiquitin-conjugating enzyme (Ubc13) suggested a role for PCNA-mediated regulation of DNA repair pathways in spermatocytes. Changes in cytoplasmic SUMO1 localisation in spermatocytes were paralleled by changes in the levels of free SUMO1 and of a subunit of its activating complex, suggesting sumoylation in spermatocytes is modified by androgen action on Sertoli cells. We conclude that Sertoli cells, in response to androgens, modulate protein translation and post-translational events in spermatocytes that impact on their metabolism, survival, and completion of meiosis.	[Stanton, Peter G.; Sluka, Pavel; Foo, Caroline F. H.; Stephens, Andrew N.; McLachlan, Robert I.; O'Donnell, Liza] Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia; [Stanton, Peter G.; Smith, A. Ian] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [McLachlan, Robert I.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [O'Donnell, Liza] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Monash University; Prince Henry's Institute of Medical Research; Monash University; Monash University; Monash University	Stanton, PG (corresponding author), Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia.	peter.stanton@princehenrys.org	Sluka, Pavel/ABH-5049-2020; Sluka, Pavel/I-1443-2013; Stephens, Andrew/G-5161-2013; O'Donnell, Liza/E-7058-2013	Sluka, Pavel/0000-0002-6043-0809; Sluka, Pavel/0000-0002-6043-0809; Stanton, Peter/0000-0002-6104-1565; Smith, Ian/0000-0002-4143-2892; O'Donnell, Liza/0000-0001-5848-6136	National Health and Medical Research Council (Australia) [494802]; NHMRC Research Fellowship [441103]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by a National Health and Medical Research Council (Australia, www.nhmrc.gov.au) Program Grant No. 494802 (PGS, RIM, and LOD.), NHMRC Research Fellowship #441103 (RIM), and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2008, ENDOCRINOLOGY, V149, P3279, DOI 10.1210/en.2008-0086; Alekseev OM, 2009, BIOL REPROD, V81, P739, DOI 10.1095/biolreprod.109.076497; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; AWONIYI CA, 1989, ENDOCRINOLOGY, V124, P1217, DOI 10.1210/endo-124-3-1217; Baek HY, 2004, BIOCHEM J, V379, P291, DOI 10.1042/BJ20031208; Caron D, 2008, J PROTEOME RES, V7, P4492, DOI 10.1021/pr8002497; Chainy GBN, 1997, ANDROLOGIA, V29, P343; Chapin RE, 2001, J ANDROL, V22, P1030; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Chen JIC, 2009, J PROTEOME RES, V8, P2032, DOI 10.1021/pr801024g; Clifton RJ, 2002, J ENDOCRINOL, V172, P565, DOI 10.1677/joe.0.1720565; Cui YG, 2008, J PROTEOME RES, V7, P3984, DOI 10.1021/pr800259t; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2012, MOL CELL ENDOCRINOL, V352, P13, DOI 10.1016/j.mce.2011.08.008; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Elliott DJ, 2006, REPRODUCTION, V132, P811, DOI 10.1530/REP-06-0147; Friry-Santini C, 2007, TOXICOL SCI, V97, P81, DOI 10.1093/toxsci/kfm022; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Gartner W, 2003, CELL MOTIL CYTOSKEL, V56, P79, DOI 10.1002/cm.10136; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Handelsman DJ, 1999, ENDOCRINOLOGY, V140, P3938, DOI 10.1210/en.140.9.3938; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hikim APS, 1999, REV REPROD, V4, P38; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hu ZY, 2010, MOL ENDOCRINOL, V24, P60, DOI 10.1210/me.2009-0303; Jarvis S, 2005, HUM REPROD, V20, P108, DOI 10.1093/humrep/deh565; Johnston DS, 2008, P NATL ACAD SCI USA, V105, P8315, DOI 10.1073/pnas.0709854105; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Kido T, 2000, DEV GROWTH DIFFER, V42, P359; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; La Salle S, 2008, DEV BIOL, V321, P227, DOI 10.1016/j.ydbio.2008.06.020; Lee YH, 2008, CELL BIOCHEM FUNCT, V26, P502, DOI 10.1002/cbf.1473; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; McCabe MJ, 2010, ENDOCRINOLOGY, V151, P2911, DOI 10.1210/en.2009-1278; MCLACHLAN RI, 1994, BIOL REPROD, V51, P945, DOI 10.1095/biolreprod51.5.945; Meachem SJ, 1997, INT J ANDROL, V20, P70, DOI 10.1046/j.1365-2605.1997.d01-121.x; Meachem SJ, 1998, J ANDROL, V19, P725; Meng J, 2011, BIOL REPROD, V85, P254, DOI 10.1095/biolreprod.110.090621; Moffit JS, 2007, J ANDROL, V28, P883, DOI 10.2164/jandrol.107.002964; MONESI V, 1964, J CELL BIOL, V22, P521, DOI 10.1083/jcb.22.3.521; Mori C, 1997, DEV DYNAM, V208, P125; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MOUSSA F, 1994, CELL TISSUE RES, V278, P363, DOI 10.1007/BF00414179; O'Donnell L, 2000, BIOL REPROD, V63, P99, DOI 10.1095/biolreprod63.1.99; O'Donnell L, 1999, J ANDROL, V20, P109; O'Donnell L, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1017; O'Donnell L, 2009, ENDOCRINOLOGY, V150, P5074, DOI 10.1210/en.2009-0755; O'Shaughnessy PJ, 2010, ENDOCRINOLOGY, V151, P2343, DOI 10.1210/en.2009-1333; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; ODONNELL L, 1994, ENDOCRINOLOGY, V135, P2608, DOI 10.1210/en.135.6.2608; Ohsawa I, 2003, J NEUROCHEM, V84, P1110, DOI 10.1046/j.1471-4159.2003.01619.x; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Puri Pawan, 2011, Spermatogenesis, V1, P354; Rainczuk A, 2010, PROTEOMICS, V10, P332, DOI 10.1002/pmic.200900187; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Roberts DL, 2001, J CELL BIOL, V153, P221, DOI 10.1083/jcb.153.1.221; Rowe JD, 1998, J BIOL CHEM, V273, P9593, DOI 10.1074/jbc.273.16.9593; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; SAUNDERS PTK, 1995, MOL CELL ENDOCRINOL, V107, P221, DOI 10.1016/0303-7207(94)03447-2; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shrivastava V, 2010, REPRODUCTION, V139, P999, DOI 10.1530/REP-09-0492; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Sluka P, 2006, J ENDOCRINOL, V189, P381, DOI 10.1677/joe.1.06634; Stephens AN, 2010, J PROTEOME RES, V9, P2438, DOI 10.1021/pr901131p; Stephens AN, 2010, J PROTEOME RES, V9, P1437, DOI 10.1021/pr900976f; Stone JE, 2008, GENETICS, V178, P1221, DOI 10.1534/genetics.107.085415; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Tanaka SS, 2000, GENE DEV, V14, P841; Toshima JY, 2001, J BIOL CHEM, V276, P43471, DOI 10.1074/jbc.M104620200; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Tsai MY, 2006, P NATL ACAD SCI USA, V103, P18975, DOI 10.1073/pnas.0608565103; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; van der Laan R, 2004, J CELL SCI, V117, P5023, DOI 10.1242/jcs.01368; Vera Y, 2006, MOL ENDOCRINOL, V20, P1597, DOI 10.1210/me.2005-0395; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Vigodner M, 2005, DEV BIOL, V282, P480, DOI 10.1016/j.ydbio.2005.03.034; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Welsh M, 2009, FASEB J, V23, P4218, DOI 10.1096/fj.09-138347; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168; Yan W, 2003, P NATL ACAD SCI USA, V100, P7189, DOI 10.1073/pnas.1236145100; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	93	44	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41718	10.1371/journal.pone.0041718	http://dx.doi.org/10.1371/journal.pone.0041718			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860010	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900035
J	Zubiaurre-Elorza, L; Soria-Pastor, S; Junque, C; Sala-Llonch, R; Segarra, D; Bargallo, N; Macaya, A				Zubiaurre-Elorza, Leire; Soria-Pastor, Sara; Junque, Carme; Sala-Llonch, Roser; Segarra, Dolors; Bargallo, Nuria; Macaya, Alfons			Cortical Thickness and Behavior Abnormalities in Children Born Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; HUMAN CEREBRAL-CORTEX; REGIONAL BRAIN VOLUME; PERIVENTRICULAR LEUKOMALACIA; NEUROBEHAVIORAL OUTCOMES; GEOMETRICALLY ACCURATE; ADOLESCENTS; MRI; AGE; AUTISM	Aim: To identify long-term effects of preterm birth and of periventricular leukomalacia (PVL) on cortical thickness (CTh). To study the relationship between CTh and cognitive-behavioral abnormalities. Methods: We performed brain magnetic resonance imaging on 22 preterm children with PVL, 14 preterm children with no evidence of PVL and 22 full-term peers. T1-weighted images were analyzed with FreeSurfer software. All participants underwent cognitive and behavioral assessments by means of the Wechsler Intelligence Scales for Children-Fourth Edition (WISC-IV) and the Child Behavior Checklist (CBCL). Results: We did not find global CTh differences between the groups. However, a thinner cortex was found in left postcentral, supramarginal, and caudal middle rostral gyri in preterm children with no evidence of PVL than in the full-term controls, while PVL preterm children showed thicker cortex in right pericalcarine and left rostral middle frontal areas than in preterm children with no evidence of PVL. In the PVL group, internalizing and externalizing scores correlated mainly with CTh in frontal areas. Attentional scores were found to be higher in PVL and correlated with CTh increments in right frontal areas. Interpretation: The preterm group with no evidence of PVL, when compared with full-term children, showed evidence of a different pattern of regional thinning in the cortical gray matter. In turn, PVL preterm children exhibited atypical increases in CTh that may underlie their prevalent behavioral problems.	[Zubiaurre-Elorza, Leire; Soria-Pastor, Sara; Junque, Carme; Sala-Llonch, Roser; Segarra, Dolors] Univ Barcelona, Fac Med, Dept Psychiat & Clin Psychobiol, Barcelona 7, Spain; [Zubiaurre-Elorza, Leire; Soria-Pastor, Sara; Junque, Carme; Sala-Llonch, Roser; Segarra, Dolors] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Soria-Pastor, Sara] Hosp Clin Barcelona, Clin Inst Neurosci, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge CDIC, Dept Radiol, Neuroradiol Sect, Barcelona, Spain; [Macaya, Alfons] Autonomous Univ Barcelona, Grp Recerca Neurol Pediat, Inst Recerca Vall dHebron, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Zubiaurre-Elorza, L (corresponding author), Univ Barcelona, Fac Med, Dept Psychiat & Clin Psychobiol, Barcelona 7, Spain.	cjunque@ub.edu	Junque, Carme/B-4400-2011; Bargallo, Nuria/G-6854-2016; Sala-Llonch, Roser/L-4135-2015; Sala-Llonch, Roser/E-7882-2012; Zubiaurre-Elorza, Leire/F-2431-2016; Soria Pastor, Sara/L-5103-2017	Junque, Carme/0000-0002-6381-3063; Bargallo, Nuria/0000-0001-6284-5402; Sala-Llonch, Roser/0000-0003-3576-0475; Sala-Llonch, Roser/0000-0003-3576-0475; Zubiaurre-Elorza, Leire/0000-0001-9830-3939; Soria Pastor, Sara/0000-0001-7275-7166; Macaya Ruiz, Alfons/0000-0001-7998-4185	Ministerio de Ciencia y Tecnologia [SAF2005-007340]; Generalitat de Catalunya [2009 SGR 00941, 2009 SGR 0078]; Ministerio de Educacion y Ciencia [AP2005-0047, BES-2011-047053, AP2008-0935]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion y Ciencia(Spanish Government)	This study was supported by grants from the Ministerio de Ciencia y Tecnologia (SAF2005-007340), and the Generalitat de Catalunya (2009 SGR 00941, 2009 SGR 0078). S. Soria-Pastor, R. Sala-Llonch, and L. Zubiaurre-Elorza hold fellowships from the Ministerio de Educacion y Ciencia (AP2005-0047), (BES-2011-047053) and (AP2008-0935) respectively. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anderson PJ, 2011, DEV NEUROPSYCHOL, V36, P57, DOI 10.1080/87565641.2011.540538; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FLODMARK O, 1987, RADIOLOGY, V162, P119, DOI 10.1148/radiology.162.1.3538143; Gray RF, 2004, PEDIATRICS, V114, P736, DOI 10.1542/peds.2003-1150-L; Gurka MJ, 2010, ARCH PEDIAT ADOL MED, V164, P525, DOI 10.1001/archpediatrics.2010.83; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Kulseng S, 2006, ACTA PAEDIATR, V95, P224, DOI 10.1080/08035250500421568; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; Mak-Fan KM, 2012, J AUTISM DEV DISORD, V42, P419, DOI 10.1007/s10803-011-1261-6; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Northam GB, 2011, ANN NEUROL, V69, P702, DOI 10.1002/ana.22263; Nosarti C, 2005, BIOL PSYCHIAT, V57, P661, DOI 10.1016/j.biopsych.2004.12.003; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Raznahan A, 2010, CEREB CORTEX, V20, P1332, DOI 10.1093/cercor/bhp198; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Samara M, 2008, PEDIATRICS, V122, P562, DOI 10.1542/peds.2007-3231; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Soria-Pastor S, 2009, PEDIATRICS, V124, pE1161, DOI 10.1542/peds.2009-0244; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Stjernqvist K, 1999, ACTA PAEDIATR, V88, P557, DOI 10.1080/08035259950169594; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tosun D, 2011, HUM BRAIN MAPP, V32, P580, DOI 10.1002/hbm.21045; Tzarouchi LC, 2009, PEDIATR RADIOL, V39, P1327, DOI 10.1007/s00247-009-1389-0; Wechsler, 2007, ESCALA WECHSLER INTE; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Zubiaurre-Elorza L, 2012, PEDIATR RES, V71, P354, DOI 10.1038/pr.2011.70; Zubiaurre-Elorza L, 2011, PEDIATR RES, V69, P554, DOI 10.1203/PDR.0b013e3182182366	48	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42148	10.1371/journal.pone.0042148	http://dx.doi.org/10.1371/journal.pone.0042148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860067	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900073
J	Ebine, K; Uemura, T; Nakano, A; Ueda, T				Ebine, Kazuo; Uemura, Tomohiro; Nakano, Akihiko; Ueda, Takashi			Flowering Time Modulation by a Vacuolar SNARE via FLOWERING LOCUS C in Arabidopsis thaliana	PLOS ONE			English	Article							PROTEIN STORAGE VACUOLE; FLORAL INITIATION; CELLS; COMPARTMENT; PATHWAY; COMPLEX; GENES; TRAFFICKING; VAM3/SYP22; INTERACTS	The transition of plant growth from vegetative to reproductive phases is one of the most important and dramatic events during the plant life cycle. In Arabidopsis thaliana, flowering promotion involves at least four genetically defined regulatory pathways, including the photoperiod-dependent, vernalization-dependent, gibberellin-dependent, and autonomous promotion pathways. Among these regulatory pathways, the vernalization-dependent and autonomous pathways are integrated by the expression of FLOWERING LOCUS C (FLC), a negative regulator of flowering; however, the upstream regulation of this locus has not been fully understood. The SYP22 gene encodes a vacuolar SNARE protein that acts in vacuolar and endocytic trafficking pathways. Loss of SYP22 function was reported to lead to late flowering in A. thaliana plants, but the mechanism has remained completely unknown. In this study, we demonstrated that the late flowering phenotype of syp22 was due to elevated expression of FLC caused by impairment of the autonomous pathway. In addition, we investigated the DOC1/BIG pathway, which is also suggested to regulate vacuolar/endosomal trafficking. We found that elevated levels of FLC transcripts accumulated in the doc1-1 mutant, and that syp22 phenotypes were exaggerated with a double syp22 doc1-1 mutation. We further demonstrated that the elevated expression of FLC was suppressed by ara6-1, a mutation in the gene encoding plant-unique Rab GTPase involved in endosomal trafficking. Our results indicated that vacuolar and/or endocytic trafficking is involved in the FLC regulation of flowering time in A. thaliana.	[Ebine, Kazuo; Uemura, Tomohiro; Nakano, Akihiko; Ueda, Takashi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Nakano, Akihiko] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama, Japan; [Ueda, Takashi] Japan Sci & Technol Agcy JST, PRESTO, Honcho Kawaguchi, Saitama, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Ebine, K (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan.	tueda@biol.s.u-tokyo.ac.jp	UEDA, TAKASHI/G-4939-2014; Ueda, Takashi/G-6984-2011; Uemura, Tomohiro/F-7616-2012; Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/A-6420-2016	Ueda, Takashi/0000-0002-5190-892X; Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; ebine, kazuo/0000-0003-3020-7208	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [195010]; JST, PRESTO; Grants-in-Aid for Scientific Research [24114001, 20001009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST, PRESTO(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grants-in-Aid for Scientific Research and the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (AN and TU), and a research fellowship for young scientists from the Japan Society for the Promotion of Science (KE, 195010). This research was also partly supported by JST, PRESTO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Banach-Orlowska M, 2009, BIOCHEM J, V423, P389, DOI 10.1042/BJ20090086; Chou ML, 1998, PLANT J, V15, P231, DOI 10.1046/j.1365-313X.1998.00204.x; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Henderson IR, 2005, DEVELOPMENT, V132, P3597, DOI 10.1242/dev.01924; Kanyuka K, 2003, PLANT J, V35, P57, DOI 10.1046/j.1365-313X.2003.01779.x; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; LI HM, 1994, GENE DEV, V8, P339, DOI 10.1101/gad.8.3.339; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mutasa-Gottgens E, 2009, J EXP BOT, V60, P1979, DOI 10.1093/jxb/erp040; Ohtomo I, 2005, PLANT CELL PHYSIOL, V46, P1358, DOI 10.1093/pcp/pci146; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Page T, 1999, PLANT J, V17, P231, DOI 10.1046/j.1365-313X.1999.00364.x; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Saito C, 2009, INT REV CEL MOL BIO, V274, P183, DOI 10.1016/S1937-6448(08)02004-2; Sanderfoot AA, 1999, PLANT PHYSIOL, V121, P929, DOI 10.1104/pp.121.3.929; Sanderfoot AA, 2001, MOL BIOL CELL, V12, P3733, DOI 10.1091/mbc.12.12.3733; Sato MH, 1997, J BIOL CHEM, V272, P24530, DOI 10.1074/jbc.272.39.24530; Shirakawa M, 2009, PLANT CELL PHYSIOL, V50, P1319, DOI 10.1093/pcp/pcp076; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Thomas B, 2006, J EXP BOT, V57, P3387, DOI 10.1093/jxb/erl071; Ueda H, 2006, PLANT CELL PHYSIOL, V47, P164, DOI 10.1093/pcp/pci232; Uemura T, 2002, GENES CELLS, V7, P743, DOI 10.1046/j.1365-2443.2002.00550.x; Uemura T, 2010, PLANT J, V64, P864, DOI 10.1111/j.1365-313X.2010.04372.x; Yamaguchi N, 2007, PLANT CELL PHYSIOL, V48, P1275, DOI 10.1093/pcp/pcm094; Yano D, 2003, P NATL ACAD SCI USA, V100, P8589, DOI 10.1073/pnas.1430749100	35	11	17	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42239	10.1371/journal.pone.0042239	http://dx.doi.org/10.1371/journal.pone.0042239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848750	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200187
J	Srinivasan, U; Quader, S				Srinivasan, Umesh; Quader, Suhel			To Eat and Not Be Eaten: Modelling Resources and Safety in Multi-Species Animal Groups	PLOS ONE			English	Article							MIXED-SPECIES FLOCKS; BIRD FLOCKS; ATLANTIC FOREST; FEEDING FLOCKS; GROUP-SIZE; SEASONALITY; BENEFITS; BEHAVIOR; VIGILANCE; ABUNDANCE	Using mixed-species bird flocks as an example, we model the payoffs for two types of species from participating in multi-species animal groups. Salliers feed on mobile prey, are good sentinels and do not affect prey capture rates of gleaners; gleaners feed on prey on substrates and can enhance the prey capture rate of salliers by flushing prey, but are poor sentinels. These functional types are known from various animal taxa that form multi-species associations. We model costs and benefits of joining groups for a wide range of group compositions under varying abundances of two types of prey-prey on substrates and mobile prey. Our model predicts that gleaners and salliers show a conflict of interest in multi-species groups, because gleaners benefit from increasing numbers of salliers in the group, whereas salliers benefit from increasing gleaner numbers. The model also predicts that the limits to size and variability in composition of multi-species groups are driven by the relative abundance of different types of prey, independent of predation pressure. Our model emphasises resources as a primary driver of temporal and spatial group dynamics, rather than reproductive activity or predation per se, which have hitherto been thought to explain patterns of multi-species group formation and cohesion. The qualitative predictions of the model are supported by empirical patterns from both terrestrial and marine multi-species groups, suggesting that similar mechanisms might underlie group dynamics in a range of taxa. The model also makes novel predictions about group dynamics that can be tested using variation across space and time.	[Srinivasan, Umesh; Quader, Suhel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Quader, Suhel] Nat Conservat Fdn, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Srinivasan, U (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	umesh.srinivasan@gmail.com			National Centre for Biological Sciences	National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Both authors were supported by the National Centre for Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON RB, 1987, ENVIRON BIOL FISH, V18, P303, DOI 10.1007/BF00004883; Barbosa Andres, 2002, Acta Ethologica, V5, P51, DOI 10.1007/s10211-002-0059-0; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Bates H. W., 1863, NATURALIST RIVER AMA; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; BELL HL, 1980, EMU, V80, P227, DOI 10.1071/MU9800227; BERNER TO, 1985, ECOLOGY, V66, P1229, DOI 10.2307/1939176; Bshary R, 1997, ANIM BEHAV, V54, P1461, DOI 10.1006/anbe.1997.0553; Chapman CA, 2000, BEHAV ECOL SOCIOBIOL, V47, P129, DOI 10.1007/s002650050003; CIMPRICH DA, 1994, ECOLOGY, V75, P1615, DOI 10.2307/1939622; CROXALL JP, 1976, IBIS, V118, P333, DOI 10.1111/j.1474-919X.1976.tb02024.x; DAVIS DE, 1946, ECOLOGY, V27, P168, DOI 10.2307/1932511; DEL-NEVO A, 1983, Journal of the Bombay Natural History Society, V80, P413; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; Develey PF, 2000, J TROP ECOL, V16, P33, DOI 10.1017/S0266467400001255; FITZGIBBON CD, 1990, ANIM BEHAV, V39, P1116, DOI 10.1016/S0003-3472(05)80784-5; Goodale E, 2005, J TROP ECOL, V21, P669, DOI 10.1017/S0266467405002609; Goodale E, 2006, ANIM BEHAV, V72, P471, DOI 10.1016/j.anbehav.2006.02.004; GRADWOHL J, 1980, AUK, V97, P385; Hart PJ, 2003, AUK, V120, P82, DOI 10.1642/0004-8038(2003)120[0082:SADOMF]2.0.CO;2; Hino Teruaki, 2009, Ornithological Science, V8, P43, DOI 10.2326/048.008.0107; Hobson KA, 2006, WILSON J ORNITHOL, V118, P164, DOI 10.1676/05-012.1; HODGE MA, 1992, J ARACHNOL, V20, P212; Hoeksema JD, 2006, EC  NATURE SOCIAL DI; ITZKOWITZ M, 1977, BEHAV ECOL SOCIOBIOL, V2, P361, DOI 10.1007/BF00299506; Kaby U, 2003, BEHAV ECOL SOCIOBIOL, V54, P534, DOI 10.1007/s00265-003-0665-5; Kokko H, 2007, MODELLING FOR FIELD BIOLOGISTS AND OTHER INTERESTING PEOPLE, P1, DOI 10.1017/CBO9780511811388; Krause J, 2002, LIVING GROUPS; LOWMAN MD, 1982, AUST J ECOL, V7, P353, DOI 10.1111/j.1442-9993.1982.tb01310.x; Maldonado-Coelho M, 2004, BIOL CONSERV, V116, P19, DOI 10.1016/S0006-3207(03)00169-1; MCCLURE HE, 1967, WILSON BULL, V79, P131; Mizuta T, 2002, OSTRICH, V73, P5, DOI 10.2989/00306520209485345; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; MORSE DH, 1977, BIOSCIENCE, V27, P332, DOI 10.2307/1297632; MOYNIHAN M., 1962, SMITHSONIAN MIS COLLECTIONS, V143, P1; Munn C.A., 1985, Ornithological Monographs, P683; MUNN CA, 1979, CONDOR, V81, P338, DOI 10.2307/1366956; Oommen MA, 2010, BIOL LETTERS, V6, P304, DOI 10.1098/rsbl.2009.0945; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; PERES CA, 1992, BEHAV ECOL SOCIOBIOL, V31, P339; Pidwirny M., 2006, FUNDAMENTALS PHYS GE, DOI DOI 10.1007/s00248-018-1217-x; Powell G.V., 1985, ORNITH MONOGR, V36, P713, DOI DOI 10.2307/40168313; POWELL GVN, 1989, BEHAV ECOL SOCIOBIOL, V24, P387, DOI 10.1007/BF00293266; Psarakos Suchi, 2003, Aquatic Mammals, V29, P390, DOI 10.1578/01675420360736578; Ranta E, 1998, ANIM BEHAV, V55, P737, DOI 10.1006/anbe.1997.0649; RASA OAE, 1983, BEHAV ECOL SOCIOBIOL, V12, P181; Ratnayake CP, 2010, NATURWISSENSCHAFTEN, V97, P103, DOI 10.1007/s00114-009-0617-7; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Sazima C, 2007, ENVIRON BIOL FISH, V80, P351, DOI 10.1007/s10641-006-9123-3; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; Srinivasan U, 2008, THESIS MANIPAL U MAN; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Thiollay JM, 1999, J AVIAN BIOL, V30, P282, DOI 10.2307/3677354; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245	57	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42071	10.1371/journal.pone.0042071	http://dx.doi.org/10.1371/journal.pone.0042071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848706	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200155
J	de Melo, DPO; Scherrer, LR; Eiras, AE				Ornelas de Melo, Diogo Portella; Scherrer, Luciano Rios; Eiras, Alvaro Eduardo			Dengue Fever Occurrence and Vector Detection by Larval Survey, Ovitrap and MosquiTRAP: A Space-Time Clusters Analysis	PLOS ONE			English	Article							RIO-DE-JANEIRO; AEDES-AEGYPTI; BELO-HORIZONTE; MINAS-GERAIS; DISEASE CLUSTERS; BRAZIL; VIRUS; CANCER; STATE; CITY	The use of vector surveillance tools for preventing dengue disease requires fine assessment of risk, in order to improve vector control activities. Nevertheless, the thresholds between vector detection and dengue fever occurrence are currently not well established. In Belo Horizonte (Minas Gerais, Brazil), dengue has been endemic for several years. From January 2007 to June 2008, the dengue vector Aedes (Stegomyia) aegypti was monitored by ovitrap, the sticky-trap MosquiTRAP (TM) and larval surveys in an study area in Belo Horizonte. Using a space-time scan for clusters detection implemented in SaTScan software, the vector presence recorded by the different monitoring methods was evaluated. Clusters of vectors and dengue fever were detected. It was verified that ovitrap and MosquiTRAP vector detection methods predicted dengue occurrence better than larval survey, both spatially and temporally. MosquiTRAP and ovitrap presented similar results of space-time intersections to dengue fever clusters. Nevertheless ovitrap clusters presented longer duration periods than MosquiTRAP ones, less acuratelly signalizing the dengue risk areas, since the detection of vector clusters during most of the study period was not necessarily correlated to dengue fever occurrence. It was verified that ovitrap clusters occurred more than 200 days (values ranged from 97.0 +/- 35.35 to 283.0 +/- 168.4 days) before dengue fever clusters, whereas MosquiTRAP clusters preceded dengue fever clusters by approximately 80 days (values ranged from 65.5 +/- 58.7 to 94.0 +/- 14. 3 days), the former showing to be more temporally precise. Thus, in the present cluster analysis study MosquiTRAP presented superior results for signaling dengue transmission risks both geographically and temporally. Since early detection is crucial for planning and deploying effective preventions, MosquiTRAP showed to be a reliable tool and this method provides groundwork for the development of even more precise tools.	[Ornelas de Melo, Diogo Portella; Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Ecol Quim Insetos Vetores, Belo Horizonte, MG, Brazil; [Scherrer, Luciano Rios] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Melo, DPO (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Ecol Quim Insetos Vetores, Av Presidente Antonio Carlos, Belo Horizonte, MG, Brazil.	diogopom@gmail.com	Eiras, Alvaro/Z-6023-2019	Eiras, Alvaro/0000-0002-3045-0673	 [CNPq - PRONEX-Dengue 550131/2010-8]		Funding was provided by Grant # CNPq - PRONEX-Dengue 550131/2010-8. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt G, 2007, DIABETES CARE, V30, P884, DOI 10.2337/dc06-1568; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Assuncao R, 2006, STAT MED, V25, P723, DOI 10.1002/sim.2411; Bonilla R. E., 2006, POBLACION SALUD MESO, V3, P2; Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113; Brazil, 2002, PROGR NAC CONTR DENG; Caiaffa Waleska Teixeira, 2005, Cad. Saúde Pública, V21, P958, DOI 10.1590/S0102-311X2005000300032; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Christophers SR, 1960, YELLOW FEVER MOSQUIT; Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005; de Castro MG, 2004, MEM I OSWALDO CRUZ, V99, P809, DOI 10.1590/S0074-02762004000800005; Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2; DeChello LM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-20; Degallier N, 2003, REV SAUDE PUBL, V37, P386, DOI 10.1590/S0034-89102003000300019; Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005; Eisen RJ, 2008, J MED ENTOMOL, V45, P181, DOI 10.1603/0022-2585(2008)45[181:SMOHRO]2.0.CO;2; Favaro EA, 2008, J VECTOR ECOL, V33, P8, DOI 10.3376/1081-1710(2008)33[8:AOEIOA]2.0.CO;2; FAY R. W., 1966, MOSQUITO NEWS, V26, P531; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Forattini OP, 2002, CULICIDOLOGIA MED; Fukuda Yoshiharu, 2005, Int J Health Geogr, V4, P16, DOI 10.1186/1476-072X-4-16; [Fundacao Nacional de Saude Ministerio da Saude], 2001, DENG INSTR PESS COMB; Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; HIEN D S, 1975, Acta Parasitologica Polonica, V23, P537; HIEN D S, 1975, Acta Parasitologica Polonica, V23, P553; Higgs BW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001284; Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505; Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2002, PERF MUN; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003; Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003; Almeida MCD, 2008, CAD SAUDE PUBLICA, V24, P2385, DOI 10.1590/S0102-311X2008001000019; McNally RJQ, 2009, HEPATOLOGY, V50, P1169, DOI 10.1002/hep.23139; MINISTERIO DA SAUDE, 2005, DIAGN RAP NOS MUN VI; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; Nisha V., 2005, Journal of Communicable Diseases, V37, P39; Nunes C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-30; Olson KL, 2006, AM J PUBLIC HEALTH, V96, P2002, DOI 10.2105/AJPH.2005.069526; Panamerican Health Organization (PAHO), 1995, PAN HLTH ORG PUB CIE, P548; Pessanha JEM, 2007, B EPIDEMIOLOGICO SEC, VX, P10; Resende MC., 2010, EPIDEMIOL SERV SAUDE, V19, P329, DOI [10.5123/S1679-49742010000400003, DOI 10.5123/S1679-49742010000400003]; San Martin JL, 2007, SCI WORK GROUP M DEN, P150; SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Waller LA, 2004, APPL SPATIAL STAT PU, DOI [10.1002/0471662682.ch7, DOI 10.1002/0471662682.CH7]; World Health Organization, 2009, DENGUE GUIDELINES DI; Yang HM, 2008, EPIDEMIOLOGY INFECT, V4, P1; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	60	42	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42125	10.1371/journal.pone.0042125	http://dx.doi.org/10.1371/journal.pone.0042125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848729	Green Published, gold			2022-12-27	WOS:000306806600169
J	Popova, L; Smith, K; West, AH; Wilson, PC; James, JA; Thompson, LF; Air, GM				Popova, Lyubov; Smith, Kenneth; West, Ann H.; Wilson, Patrick C.; James, Judith A.; Thompson, Linda F.; Air, Gillian M.			Immunodominance of Antigenic Site B over Site A of Hemagglutinin of Recent H3N2 Influenza Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODY; MEMBRANE GLYCOPROTEIN; A VIRUSES; VARIANTS; DRIFT; SELECTION; MECHANISM; RECOGNITION	H3N2 influenza viruses have now circulated in the human population for 43 years since the pandemic of 1968, accumulating sequence changes in the hemagglutinin (HA) and neuraminidase (NA) that are believed to be predominantly due to selection for escape from antibodies. Examination of mutations that persist and accumulate led to identification of antigenically significant mutations that are contained in five antigenic sites (A-E) mapped on to the H3 HA. In early H3N2 isolates, antigenic site A appeared to be dominant while in the 1990s site B seemed more important. To obtain experimental evidence for dominance of antigenic sites on modern H3 HAs, we have measured antibodies in plasma of human subjects who received the 2006-07 trivalent subunit influenza vaccine (H3 component A/Wisconsin/67/05) or the 2008-09 formulation (H3 component A/Uruguay/716/07). Plasmas were tested against expressed HA of Wisconsin-like influenza A/Oklahoma/309/06 and site-directed mutants in antigenic site A (NNES121-124ITEG, N126T, N133D, TSSS135-138GSNA, K140I, RSNNS142-146PGSG), and antigenic site B (HL156-157KS, KFK158-160GST, NDQI189-192QEQT, A196V). "Native ELISA" analysis and escape mutant selection with two human monoclonal antibodies demonstrated that antibody E05 binds to antigenic site A and 1_C02 binds to site B. We find that most individuals, after vaccination in seasons 2006-07 and/or 2008-09, showed dominance of antigenic site B recognition over antigenic site A. A minority showed dominance of site A in 2006 but these were reduced in 2008 when the vaccine virus had a site A mutation. A better understanding of immunodominance may allow prediction of future antigenic drift and assist in vaccine strain selection.	[Popova, Lyubov; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Popova, Lyubov; West, Ann H.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Smith, Kenneth; Wilson, Patrick C.; James, Judith A.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Wilson, Patrick C.; Thompson, Linda F.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma - Norman; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Chicago; University of Chicago	Popova, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	gillian-air@ouhsc.edu	Wilson, Patrick/HGC-3157-2022	Air, Gillian/0000-0001-5724-3108	National Institutes of Health (NIAID) [R01 AI-50933, N01A150026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIAID grant R01 AI-50933 and contract N01A150026 (PI Linda Thompson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chen ZY, 2010, VACCINE, V28, P4079, DOI 10.1016/j.vaccine.2010.03.078; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Feng JQ, 2009, VACCINE, V27, P6358, DOI 10.1016/j.vaccine.2009.06.090; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; GARTEN W, 1981, VIROLOGY, V115, P361, DOI 10.1016/0042-6822(81)90117-3; GERHARD W, 1978, J EXP MED, V148, P383, DOI 10.1084/jem.148.2.383; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; Gulati U, 2005, VIROLOGY, V339, P12, DOI 10.1016/j.virol.2005.05.009; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; LAVER WG, 1981, J MOL BIOL, V145, P339, DOI 10.1016/0022-2836(81)90209-6; LAVER WG, 1979, VIROLOGY, V98, P226, DOI 10.1016/0042-6822(79)90540-3; LIU CG, 1993, VIROLOGY, V194, P403, DOI 10.1006/viro.1993.1276; Nobusawa E, 2012, MICROBIOL IMMUNOL, V56, P99, DOI 10.1111/j.1348-0421.2012.00412.x; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Okada J, 2011, J GEN VIROL, V92, P326, DOI 10.1099/vir.0.026419-0; Pan KY, 2011, J MOL EVOL, V72, P90, DOI 10.1007/s00239-010-9405-4; ROSSMANN M G, 1989, Viral Immunology, V2, P143, DOI 10.1089/vim.1989.2.143; Sato K, 2004, EPIDEMIOL INFECT, V132, P399, DOI 10.1017/S0950268803001821; SEIDEL W, 1991, ARCH VIROL, V120, P289, DOI 10.1007/BF01310484; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; TEMOLTZINPALACIOS F, 1994, J EXP MED, V179, P1719, DOI 10.1084/jem.179.5.1719; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Wanzeck K, 2011, AM J RESP CRIT CARE, V183, P767, DOI 10.1164/rccm.201007-1184OC; Webster R G, 1980, Ann N Y Acad Sci, V354, P142, DOI 10.1111/j.1749-6632.1980.tb27964.x; WEBSTER RG, 1980, VIROLOGY, V104, P139, DOI 10.1016/0042-6822(80)90372-4; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	52	72	77	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41895	10.1371/journal.pone.0041895	http://dx.doi.org/10.1371/journal.pone.0041895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848649	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600139
J	Ringkamp, M; Tal, M; Hartke, TV; Wooten, M; McKelvy, A; Turnquist, BP; Guan, Y; Meyer, RA; Raja, SN				Ringkamp, Matthias; Tal, Michael; Hartke, Timothy V.; Wooten, Matthew; McKelvy, Alvin; Turnquist, Brian P.; Guan, Yun; Meyer, Richard A.; Raja, Srinivasa N.			Local Loperamide Injection Reduces Mechanosensitivity of Rat Cutaneous, Nociceptive C-Fibers	PLOS ONE			English	Article							OPIOID-RECEPTOR AGONIST; NEUROPATHIC PAIN; MECHANICAL ALLODYNIA; PHARMACOLOGICAL-TREATMENT; POLYMODAL NOCICEPTORS; MORPHINE; SKIN; HYPERALGESIA; ANALGESIA; CHANNELS	Loperamide reverses signs of mechanical hypersensitivity in an animal model of neuropathic pain suggesting that peripheral opioid receptors may be suitable targets for the treatment of neuropathic pain. Since little is known about loperamide effects on the responsiveness of primary afferent nerve fibers, in vivo electrophysiological recordings from unmyelinated afferents innervating the glabrous skin of the hind paw were performed in rats with an L5 spinal nerve lesion or sham surgery. Mechanical threshold and responsiveness to suprathreshold stimulation were tested before and after loperamide (1.25, 2.5 and 5 mu g in 10 mu l) or vehicle injection into the cutaneous receptive field. Loperamide dose-dependently decreased mechanosensitivity in unmyelinated afferents of nerve-injured and sham animals, and this effect was not blocked by naloxone pretreatment. We then investigated loperamide effects on nerve conduction by recording compound action potentials in vitro during incubation of the sciatic nerve with increasing loperamide concentrations. Loperamide dose-dependently decreased compound action potentials of myelinated and unmyelinated fibers (ED50 = 8 and 4 mu g/10 mu l, respectively). This blockade was not prevented by pre-incubation with naloxone. These results suggest that loperamide reversal of behavioral signs of neuropathic pain may be mediated, at least in part, by mechanisms independent of opioid receptors, most probably by local anesthetic actions.	[Ringkamp, Matthias; Hartke, Timothy V.; Wooten, Matthew; Meyer, Richard A.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Tal, Michael] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Fac Med Dent, Dept Anat & Cell Biol, Jerusalem, Israel; [McKelvy, Alvin; Guan, Yun; Raja, Srinivasa N.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Turnquist, Brian P.] Bethel Univ, Dept Math & Comp Sci, St Paul, MN USA	Johns Hopkins University; Hebrew University of Jerusalem; Hadassah University Medical Center; Johns Hopkins University	Ringkamp, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	platelet@jhmi.edu		Yang, Shuman/0000-0002-9638-0890; Wooten, Matthew/0000-0001-8629-9899	NIH [NS26363]; Johns Hopkins Blaustein Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Blaustein Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the NIH (NS26363) and the Johns Hopkins Blaustein Pain Research Fund. The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; ANDREEV N, 1994, NEUROSCIENCE, V58, P793, DOI 10.1016/0306-4522(94)90456-1; ARNER S, 1985, ACTA ANAESTH SCAND, V29, P32, DOI 10.1111/j.1399-6576.1985.tb02155.x; ARNER S, 1988, PAIN, V33, P11, DOI 10.1016/0304-3959(88)90198-4; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Coggeshall RE, 1997, BRAIN RES, V764, P126, DOI 10.1016/S0006-8993(97)00446-0; COOMBS DW, 1984, J CLIN ONCOL, V2, P1414, DOI 10.1200/JCO.1984.2.12.1414; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; DeHaven-Hudkins DL, 2004, CURR PHARM DESIGN, V10, P743, DOI 10.2174/1381612043453036; Dehaven-Hudkins DL, 1999, J PHARMACOL EXP THER, V289, P494; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; DEVOR M, 1992, PAIN, V48, P261, DOI 10.1016/0304-3959(92)90067-L; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dong XW, 2008, PSYCHOPHARMACOLOGY, V195, P559, DOI 10.1007/s00213-007-0942-5; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; FOSTER RS, 1967, J PHARMACOL EXP THER, V157, P185; GILLY H, 1985, ANAESTHESIST, V34, P619; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; GISSEN AJ, 1987, ANESTH ANALG, V66, P1272; Guan Y, 2008, PAIN, V138, P318, DOI 10.1016/j.pain.2008.01.004; Hagiwara K, 2003, NEUROSCI RES, V46, P493, DOI 10.1016/S0168-0102(03)00126-3; HASSENBUSCH SJ, 1995, J PAIN SYMPTOM MANAG, V10, P527, DOI 10.1016/0885-3924(95)00087-F; HU SL, 1983, EUR J PHARMACOL, V95, P185, DOI 10.1016/0014-2999(83)90633-7; JAFFE JH, 1980, CLIN PHARMACOL THER, V28, P812, DOI 10.1038/clpt.1980.239; Jaffe RA, 1996, ANESTH ANALG, V83, P776, DOI 10.1097/00000539-199610000-00021; Jonker JW, 1999, BRIT J PHARMACOL, V127, P43, DOI 10.1038/sj.bjp.0702497; Kalso E, 2002, PAIN, V98, P269, DOI 10.1016/S0304-3959(02)00019-2; Karim A, 1976, SYNTHETIC ANTIDIARRH, P132; Khalefa BI, 2012, EUR J PAIN, V16, P690, DOI 10.1002/j.1532-2149.2011.00070.x; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; KOREY A, 1980, CLIN PHARMACOL THER, V27, P659, DOI 10.1038/clpt.1980.93; Koulousakis A, 2007, ACTA NEUROCHIR SUPPL, V97, P43; Lee YT, 2008, EUR J PHARMACOL, V581, P97, DOI 10.1016/j.ejphar.2007.11.058; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Martinez V, 2002, PAIN, V99, P537, DOI 10.1016/S0304-3959(02)00270-1; Mizuta K, 2008, LIFE SCI, V83, P198, DOI 10.1016/j.lfs.2008.06.002; Nagasaka H, 1996, ANESTHESIOLOGY, V85, P808, DOI 10.1097/00000542-199610000-00016; Nozaki-Taguchi N, 1999, ANESTHESIOLOGY, V90, P225, DOI 10.1097/00000542-199901000-00029; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Obara I, 2004, NEUROSCI LETT, V360, P85, DOI 10.1016/j.neulet.2004.01.056; PENN RD, 1987, J NEUROSURG, V67, P182, DOI 10.3171/jns.1987.67.2.0182; Pertovaara A, 2001, EUR J PHARMACOL, V429, P139, DOI 10.1016/S0014-2999(01)01315-2; RAJA SN, 1986, ANESTHESIOLOGY, V65, P468, DOI 10.1097/00000542-198611000-00003; Raja SN, 2002, NEUROLOGY, V59, P1015, DOI 10.1212/WNL.59.7.1015; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Ringkamp M, 1999, PAIN, V79, P143, DOI 10.1016/S0304-3959(98)00186-9; Rowbotham MC, 2003, NEW ENGL J MED, V348, P1223, DOI 10.1056/NEJMoa021420; RUSSELL NJW, 1987, NEUROSCI LETT, V76, P107, DOI 10.1016/0304-3940(87)90201-1; Sasaki A, 2007, J PHARMACOL SCI, V104, P218, DOI 10.1254/jphs.FP0070294; SHAKHANBEH J, 1993, BRAIN RES, V607, P314, DOI 10.1016/0006-8993(93)91522-T; Shim B, 2005, NEUROSCIENCE, V132, P193, DOI 10.1016/j.neuroscience.2004.12.036; Shim B, 2007, PAIN, V128, P40, DOI 10.1016/j.pain.2006.08.023; Shinoda K, 2007, NEUROSCI LETT, V411, P143, DOI 10.1016/j.neulet.2006.10.027; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Stein C, 2009, CURR OPIN PHARMACOL, V9, P3, DOI 10.1016/j.coph.2008.12.009; Truong W, 2003, ANN NEUROL, V53, P366, DOI 10.1002/ana.10465; Vasilyev DV, 2007, J NEUROPHYSIOL, V97, P3713, DOI 10.1152/jn.00841.2006; Wagner LE, 1999, ANESTHESIOLOGY, V91, P1481, DOI 10.1097/00000542-199911000-00042; Watson CPN, 1998, NEUROLOGY, V50, P1837; Wenk HN, 2006, J NEUROPHYSIOL, V95, P2083, DOI 10.1152/jn.00394.2005; Winkelmuller M, 1996, J NEUROSURG, V85, P458, DOI 10.3171/jns.1996.85.3.0458; Wu G, 2001, J NEUROSCI, V21; WUSTER M, 1978, N-S ARCH PHARMACOL, V301, P187, DOI 10.1007/BF00507036; YUGE O, 1985, ANESTH ANALG, V64, P667	66	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42105	10.1371/journal.pone.0042105	http://dx.doi.org/10.1371/journal.pone.0042105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848720	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600166
J	Stringer, JM; Suzuki, S; Pask, AJ; Shaw, G; Renfree, MB				Stringer, Jessica M.; Suzuki, Shunsuke; Pask, Andrew J.; Shaw, Geoff; Renfree, Marilyn B.			Promoter-Specific Expression and Imprint Status of Marsupial IGF2	PLOS ONE			English	Article							GROWTH-FACTOR-II; MESSENGER-RNA; ALLELIC METHYLATION; LEADER EXON; MOUSE; GENE; FETAL; TRANSCRIPTION; IDENTIFICATION; LOCALIZATION	In mice and humans, IGF2 has multiple promoters to maintain its complex tissue-and developmental stage-specific imprinting and expression. IGF2 is also imprinted in marsupials, but little is known about its promoter region. In this study, three IGF2 transcripts were isolated from placental and liver samples of the tammar wallaby, Macropus eugenii. Each transcript contained a unique 5' untranslated region, orthologous to the non-coding exons derived from promoters P1-P3 in the human and mouse IGF2 locus. The expression of tammar IGF2 was predominantly from the P2 promoter, similar to humans. Expression of IGF2 was higher in pouch young than in the adult and imprinting was highly tissue and developmental-stage specific. Interestingly, while IGF2 was expressed throughout the placenta, imprinting seemed to be restricted to the vascular, trilaminar region. In addition, IGF2 was monoallelically expressed in the adult mammary gland while in the liver it switched from monoalleleic expression in the pouch young to biallelic in the adult. These data suggest a complex mode of IGF2 regulation in marsupials as seen in eutherian mammals. The conservation of the IGF2 promoters suggests they originated before the divergence of marsupials and eutherians, and have been selectively maintained for at least 160 million years.	[Stringer, Jessica M.; Suzuki, Shunsuke; Shaw, Geoff; Renfree, Marilyn B.] Univ Melbourne, ARC Ctr Excellence Kangaroo Genom, Melbourne, Vic 3010, Australia; [Stringer, Jessica M.; Suzuki, Shunsuke; Shaw, Geoff; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia; [Suzuki, Shunsuke] Shinshu Univ, Fac Agr, Frontier Agriscience & Technol Ctr, Epigen Div, Nagano, Japan; [Pask, Andrew J.] Univ Connecticut, Dept Mol & Cellular Biol, Storrs, CT USA	University of Melbourne; University of Melbourne; Shinshu University; University of Connecticut	Stringer, JM (corresponding author), Univ Melbourne, ARC Ctr Excellence Kangaroo Genom, Melbourne, Vic 3010, Australia.	m.renfree@unimelb.edu.au	Stringer, Jessica/I-5525-2013; Shaw, Geoff/A-6916-2012	Stringer, Jessica/0000-0003-4729-3026; Shaw, Geoff/0000-0002-7421-7136; Pask, Andrew/0000-0002-1900-2263; Suzuki, Shunsuke/0000-0002-5716-8838; Renfree, Marilyn/0000-0002-4589-0436	Australian Research Council (ARC) Centre of Excellence in Kangaroo Genomics; ARC Federation Fellowship; National Health and Medical Research Council; Japan Society for the Promotion of Science; Australian Postgraduate Award	Australian Research Council (ARC) Centre of Excellence in Kangaroo Genomics(Australian Research Council); ARC Federation Fellowship(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Australian Postgraduate Award(Australian Government)	This work was supported by the Australian Research Council (ARC) Centre of Excellence in Kangaroo Genomics; an ARC Federation Fellowship to MBR and a National Health and Medical Research Council R.D. Wright Fellowship to AP and the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad to SS. JMS received an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager EI, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-17; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BROWN AL, 1986, J BIOL CHEM, V261, P3144; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEPAGTERHOLTHUIZEN P, 1986, FEBS LETT, V195, P179, DOI 10.1016/0014-5793(86)80156-9; DEPAGTERHOLTHUIZEN P, 1985, HUM GENET, V69, P170, DOI 10.1007/BF00293291; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; DEPAGTERHOLTHUIZEN P, 1988, BIOCHIM BIOPHYS ACTA, V950, P282, DOI 10.1016/0167-4781(88)90124-8; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; FEIL R, 1994, DEVELOPMENT, V120, P2933; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Freyer C, 2009, J EXP ZOOL PART B, V312B, P545, DOI 10.1002/jez.b.21239; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; HASELBACHER GK, 1985, P NATL ACAD SCI USA, V82, P2153, DOI 10.1073/pnas.82.7.2153; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HOLTHUIZEN P, 1990, BIOCHIM BIOPHYS ACTA, V1087, P341, DOI 10.1016/0167-4781(90)90010-Y; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; IKEJIRI K, 1991, BIOCHIM BIOPHYS ACTA, V1089, P77, DOI 10.1016/0167-4781(91)90087-3; IRMINGER JC, 1987, P NATL ACAD SCI USA, V84, P6330, DOI 10.1073/pnas.84.18.6330; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lawton BR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-205; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li X, 1996, J ENDOCRINOL, V149, P117, DOI 10.1677/joe.0.1490117; Li XR, 1998, INT J DEV BIOL, V42, P687; Lopez MF, 1996, ENDOCRINOLOGY, V137, P2100, DOI 10.1210/en.137.5.2100; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Menzies BR, 2012, MOL CELL ENDOCRINOL, V349, P189, DOI 10.1016/j.mce.2011.10.016; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Nissley SP, 1986, HORM PROTEINS PEPT, V12, P127; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; OHLSSON R, 1994, DEVELOPMENT, V120, P361; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; PEDONE PV, 1994, J BIOL CHEM, V269, P23970; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renfree MB, 2010, PLACENTA, V31, pS21, DOI 10.1016/j.placenta.2009.12.023; RENFREE MB, 1973, DEV BIOL, V32, P28, DOI 10.1016/0012-1606(73)90217-0; RENFREE MB, 1973, DEV BIOL, V33, P62, DOI 10.1016/0012-1606(73)90165-6; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Rozen S, 2000, Methods Mol Biol, V132, P365; SANDBERG AC, 1988, NEUROSCI LETT, V93, P114, DOI 10.1016/0304-3940(88)90022-5; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHNEID H, 1993, J MED GENET, V30, P353, DOI 10.1136/jmg.30.5.353; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; Stringer JM, 2012, EPIGENETICS IN PRESS; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Suzuki S, 2005, MECH DEVELOP, V122, P213, DOI 10.1016/j.mod.2004.10.003; Tyndale-Biscoe H., 1987, MONOGRAPHS MARSUPIAL; UENO T, 1987, BIOCHEM BIOPH RES CO, V148, P344, DOI 10.1016/0006-291X(87)91116-8; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6	67	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41690	10.1371/journal.pone.0041690	http://dx.doi.org/10.1371/journal.pone.0041690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848567	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600106
J	Brevoord, D; Kranke, P; Kuijpers, M; Weber, N; Hollmann, M; Preckel, B				Brevoord, Daniel; Kranke, Peter; Kuijpers, Marijn; Weber, Nina; Hollmann, Markus; Preckel, Benedikt			Remote Ischemic Conditioning to Protect against Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BYPASS GRAFT-SURGERY; ACUTE KIDNEY INJURY; MYOCARDIAL-INFARCTION; CARDIAC PROTECTION; ANEURYSM REPAIR; ANGIOPLASTY; STENT	Background: Remote ischemic conditioning is gaining interest as potential method to induce resistance against ischemia reperfusion injury in a variety of clinical settings. We performed a systematic review and meta-analysis to investigate whether remote ischemic conditioning reduces mortality, major adverse cardiovascular events, length of stay in hospital and in the intensive care unit and biomarker release in patients who suffer from or are at risk for ischemia reperfusion injury. Methods and Results: Medline, EMBASE and Cochrane databases were searched for randomized clinical trials comparing remote ischemic conditioning, regardless of timing, with no conditioning. Two investigators independently selected suitable trials, assessed trial quality and extracted data. 23 studies in patients undergoing cardiac surgery (15 studies), percutaneous coronary intervention (four studies) and vascular surgery (four studies), comprising in total 1878 patients, were included in this review. Compared to no conditioning, remote ischemic conditioning did not reduce mortality (odds ratio 1.22 [95% confidence interval 0.48, 3.07]) or major adverse cardiovascular events (0.65 [0.38, 1.14]). However, the incidence of myocardial infarction was reduced with remote ischemic conditioning (0.50 [0.31, 0.82]), as was peak troponin release (standardized mean difference -.28 [20.47, 20.09]). Conclusion: There is no evidence that remote ischemic conditioning reduces mortality associated with ischemic events; nor does it reduce major adverse cardiovascular events. However, remote ischemic conditioning did reduce the incidence of peri-procedural myocardial infarctions, as well as the release of troponin.	[Brevoord, Daniel; Weber, Nina; Hollmann, Markus; Preckel, Benedikt] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Brevoord, Daniel; Kuijpers, Marijn; Hollmann, Markus; Preckel, Benedikt] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Kranke, Peter] Univ Hosp Wurzburg, Dept Anesthesia & Crit Care, Wurzburg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Wurzburg	Brevoord, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.w.hollmann@amc.uva.nl	Weber, Nina/CAH-0231-2022	Weber, Nina/0000-0003-1111-9042; Preckel, Benedikt/0000-0003-4412-9183; Brevoord, Daniel/0000-0002-3701-2924	Department of Anesthesiology of Academic Medical Center, Amsterdam.	Department of Anesthesiology of Academic Medical Center, Amsterdam.	This review was funded by the Department of Anesthesiology of the Academic Medical Center, Amsterdam. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2010, JCPSP-J COLL PHYSICI, V20, P427, DOI 07.2010/JCPSP.427431; Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; [Anonymous], 2011, REV MAN REVMAN COMP; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Choi YS, 2011, J THORAC CARDIOV SUR, V142, P148, DOI 10.1016/j.jtcvs.2010.11.018; Gunaydin B, 2000, PHARMACOL RES, V41, P493, DOI 10.1006/phrs.1999.0611; Hansen PR, 2010, INT J CARDIOL, V144, P22, DOI 10.1016/j.ijcard.2009.03.118; Hong DM, 2010, ANAESTH INTENS CARE, V38, P924, DOI 10.1177/0310057X1003800518; Hoole SP, 2009, ANGIOLOGY, V60, P403, DOI 10.1177/0003319708328921; Hoole SP, 2009, EUR J HEART FAIL, V11, P497, DOI 10.1093/eurjhf/hfp040; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hu S, 2010, J NEUROSURG ANESTH, V22, P46, DOI 10.1097/ANA.0b013e3181c572bd; Iliodromitis EK, 2006, HEART, V92, P1821, DOI 10.1136/hrt.2006.089060; Karuppasamy P, 2011, BASIC RES CARDIOL, V106, P511, DOI 10.1007/s00395-011-0185-9; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Kranke P, 2010, EUR J ANAESTH, V27, P763, DOI 10.1097/EJA.0b013e32833a560a; Li L, 2010, J SURG RES, V164, pE21, DOI 10.1016/j.jss.2010.06.016; Loukogeorgakis SP, 2007, CIRCULATION, V116, P1386, DOI 10.1161/CIRCULATIONAHA.106.653782; Luo WJ, 2011, CARDIOL YOUNG, V21, P266, DOI 10.1017/S1047951110001915; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Rentoukas I, 2010, JACC-CARDIOVASC INTE, V3, P49, DOI 10.1016/j.jcin.2009.10.015; Takagi H, 2011, VASC ENDOVASC SURG, V45, P511, DOI 10.1177/1538574410379654; Takagi H, 2008, AM J CARDIOL, V102, P1487, DOI 10.1016/j.amjcard.2008.07.036; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Venugopal V, 2010, AM J KIDNEY DIS, V56, P1043, DOI 10.1053/j.ajkd.2010.07.014; Wagner R, 2010, INTERACT CARDIOV TH, V11, P758, DOI 10.1510/icvts.2010.243600; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P434, DOI 10.1177/1538574410369709; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P334, DOI 10.1177/1538574410370788; Walsh SR, 2009, J ENDOVASC THER, V16, P680, DOI 10.1583/09-2817.1; Zhou WW, 2010, PEDIATR CARDIOL, V31, P22, DOI 10.1007/s00246-009-9536-9; Zimmerman RF, 2011, KIDNEY INT, V80, P861, DOI 10.1038/ki.2011.156	40	91	99	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42179	10.1371/journal.pone.0042179	http://dx.doi.org/10.1371/journal.pone.0042179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860077	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600068
J	Nemri, A; Barrett, LG; Laine, AL; Burdon, JJ; Thrall, PH				Nemri, Adnane; Barrett, Luke G.; Laine, Anna-Liisa; Burdon, Jeremy J.; Thrall, Peter H.			Population Processes at Multiple Spatial Scales Maintain Diversity and Adaptation in the Linum marginale - Melampsora lini Association	PLOS ONE			English	Article							HOST GENETIC DIVERSITY; FREQUENCY-DEPENDENT SELECTION; RED QUEEN HYPOTHESIS; PATHOGEN INTERACTIONS; NATURAL-POPULATIONS; DISEASE RESISTANCE; ANTAGONISTIC COEVOLUTION; MATING SYSTEM; RUST; EVOLUTION	Host-pathogen coevolution is a major driver of species diversity, with an essential role in the generation and maintenance of genetic variation in host resistance and pathogen infectivity. Little is known about how resistance and infectivity are structured across multiple geographic scales and what eco-evolutionary processes drive these patterns. Across southern Australia, the wild flax Linum marginale is frequently attacked by its rust fungus Melampsora lini. Here, we compare the genetic and phenotypic structure of resistance and infectivity among population pairs from two regions where environmental differences associate with specific life histories and mating systems. We find that both host and pathogen populations are genetically distinct between these regions. The region with outcrossing hosts and pathogens that go through asexual cycles followed by sexual reproduction showed greater diversity of resistance and infectivity phenotypes, higher levels of resistance and less clumped within-population spatial distribution of resistance. However, in the region where asexual pathogens infect selfing hosts, pathogens were more infective and better adapted to sympatric hosts. Our findings largely agree with expectations based on the distinctly different host mating systems in the two regions, with a likely advantage for hosts undergoing recombination. For the pathogen in this system, sexual reproduction may primarily be a survival mechanism in the region where it is observed. While it appears to potentially have adverse effects on local adaptation in the short term, it may be necessary for longer-term coevolution with outcrossing hosts.	[Nemri, Adnane; Barrett, Luke G.; Laine, Anna-Liisa; Burdon, Jeremy J.; Thrall, Peter H.] CSIRO Plant Ind, Canberra, ACT, Australia; [Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Helsinki, Finland	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Helsinki	Nemri, A (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	peter.thrall@csiro.au	Barrett, Luke G/I-5711-2015; Burdon, Jeremy J/B-9913-2009; Nemri, Adnane/I-3830-2012; Laine, Anna-Liisa/B-1398-2016; Thrall, Peter/J-6672-2013	Barrett, Luke G/0000-0001-6530-0731; Laine, Anna-Liisa/0000-0002-0703-5850; 	National Institutes of Health [5RO1 GMO74265-01A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (http://www.nih.gov/) grant 5RO1 GMO74265-01A2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, EVOLUTION, V55, P869, DOI 10.1554/0014-3820(2001)055[0869:PATEOS]2.0.CO;2; Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; [Anonymous], 2006, SAS MIXED MODELS; Antonovics J, 2011, EVOLUTION, V65, P512, DOI 10.1111/j.1558-5646.2010.01146.x; Barrett LG, 2008, MOL ECOL, V17, P3401, DOI 10.1111/j.1365-294X.2008.03843.x; Barrett LG, 2007, EVOLUTION, V61, P1613, DOI 10.1111/j.1558-5646.2007.00141.x; Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017; Bell G, 1982, MASTERPIECE NATURE E; Berenos C, 2011, P ROY SOC B-BIOL SCI, V278, P218, DOI 10.1098/rspb.2010.1211; BURDON JJ, 1991, EVOLUTION, V45, P205, DOI [10.1111/j.1558-5646.1991.tb05278.x, 10.2307/2409494]; BURDON JJ, 1989, ANNU REV ECOL SYST, V20, P119, DOI 10.1146/annurev.es.20.110189.001003; BURDON JJ, 1995, PLANT PATHOL, V44, P270, DOI 10.1111/j.1365-3059.1995.tb02778.x; BURDON JJ, 1994, EVOLUTION, V48, P1564, DOI 10.1111/j.1558-5646.1994.tb02196.x; Burdon JJ, 1999, EVOLUTION, V53, P704, DOI [10.1111/j.1558-5646.1999.tb05365.x, 10.2307/2640711]; CHIN KM, 1984, PLANT PATHOL, V33, P89, DOI 10.1111/j.1365-3059.1984.tb00592.x; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; Degen B, 2001, J HERED, V92, P447, DOI 10.1093/jhered/92.5.447; DEICHSEL G, 1985, CLUSTERANALYSE DISKR; Dodds PN, 2001, PLANT J, V27, P439, DOI 10.1046/j.1365-313X.2001.01114.x; Doligez A, 1998, GENETICS, V148, P905; Ellis JG, 2007, MOL PLANT PATHOL, V8, P103, DOI 10.1111/J.1364-3703.2006.00375.X; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Galvani AP, 2003, P ROY SOC B-BIOL SCI, V270, P19, DOI 10.1098/rspb.2002.2182; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Ganz HH, 2010, ECOLOGY, V91, P1263, DOI 10.1890/09-1243.1; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Garcia-Guzman G, 2007, ECOLOGY, V88, P589, DOI 10.1890/05-1174; GROTH JV, 1995, HEREDITY, V75, P234, DOI 10.1038/hdy.1995.131; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hoebe PN, 2011, J EVOLUTION BIOL, V24, P391, DOI 10.1111/j.1420-9101.2010.02177.x; Howard RS, 2002, J EVOLUTION BIOL, V15, P648, DOI 10.1046/j.1420-9101.2002.00415.x; JAROSZ AM, 1992, OECOLOGIA, V89, P53, DOI 10.1007/BF00319015; JAROSZ AM, 1991, EVOLUTION, V45, P1618, DOI [10.2307/2409783, 10.1111/j.1558-5646.1991.tb02667.x]; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; King KC, 2009, CURR BIOL, V19, P1438, DOI 10.1016/j.cub.2009.06.062; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Koslow JM, 2006, P ROY SOC B-BIOL SCI, V273, P1825, DOI 10.1098/rspb.2006.3519; Laine AL, 2006, P ROY SOC B-BIOL SCI, V273, P267, DOI 10.1098/rspb.2005.3303; Laine AL, 2008, OIKOS, V117, P1281, DOI 10.1111/j.0030-1299.2008.16563.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LAWRENCE GJ, 1989, CAN J BOT, V67, P3192, DOI 10.1139/b89-398; Lawrence GJ, 2007, MOL PLANT PATHOL, V8, P349, DOI [10.1111/j.1364-3703.2007.00405.x, 10.1111/J.1364-3703.2007.00405.X]; Lawrence GJ, 2010, MOL PLANT PATHOL, V11, P19, DOI [10.1111/j.1364-3703.2009.00563.X, 10.1111/j.1364-3703.2009.00563.x]; LIVELY CM, 1994, PHILOS T R SOC B, V346, P271, DOI 10.1098/rstb.1994.0144; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Lively CM, 2008, EVOL ECOL RES, V10, P95; Lively CM, 2010, J HERED, V101, pS13, DOI 10.1093/jhered/esq010; Lively CM, 2010, AM NAT, V175, pE149, DOI 10.1086/652430; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Mundt CC, 2008, EVOL ECOL, V22, P637, DOI 10.1007/s10682-007-9187-3; Neiman M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P133, DOI 10.1007/978-90-481-2770-2_7; Ooi K, 1999, MOL ECOL, V8, P89, DOI 10.1046/j.1365-294X.1999.00537.x; PARKER MA, 1991, EVOLUTION, V45, P1209, DOI 10.1111/j.1558-5646.1991.tb04387.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; ROELFS AP, 1980, PHYTOPATHOLOGY, V70, P855, DOI 10.1094/Phyto-70-855; Salvaudon L, 2008, CURR OPIN PLANT BIOL, V11, P135, DOI 10.1016/j.pbi.2008.02.002; Schmid-Hempel P, 1999, PHILOS T R SOC B, V354, P507, DOI 10.1098/rstb.1999.0401; Steets JA, 2007, EVOLUTION, V61, P2043, DOI 10.1111/j.1558-5646.2007.00184.x; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thrall PH, 2012, ECOL LETT, V15, P425, DOI 10.1111/j.1461-0248.2012.01749.x; Thrall PH, 2002, EVOLUTION, V56, P1340; Thrall PH, 2000, PLANT PATHOL, V49, P767, DOI 10.1046/j.1365-3059.2000.00523.x; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Thrall PH, 1999, EVOL ECOL RES, V1, P681; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	75	15	15	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41366	10.1371/journal.pone.0041366	http://dx.doi.org/10.1371/journal.pone.0041366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859978	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600023
J	Pejanovic, N; Hochrainer, K; Liu, T; Aerne, BL; Soares, MP; Anrather, J				Pejanovic, Nadja; Hochrainer, Karin; Liu, Tao; Aerne, Birgit L.; Soares, Miguel P.; Anrather, Josef			Regulation of Nuclear Factor kappa B (NF-kappa B) Transcriptional Activity via p65 Acetylation by the Chaperonin Containing TCP1 (CCT)	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; CELL-CYCLE PROGRESSION; CYTOSOLIC CHAPERONIN; POSTTRANSLATIONAL MODIFICATIONS; DEPENDENT TRANSCRIPTION; CYTOPLASMIC CHAPERONIN; RELA PHOSPHORYLATION; DROSOPHILA; PROTEIN; ACTIVATION	The NF-kappa B family member p65 is central to inflammation and immunity. The purpose of this study was to identify and characterize evolutionary conserved genes modulating p65 transcriptional activity. Using an RNAi screening approach, we identified chaperonin containing TCP1 subunit eta (CCT eta) as a regulator of Drosophila NF-kappa B proteins, Dorsal and Dorsal-related immunity factor (Dif). CCT eta was also found to regulate NF-kappa B-driven transcription in mammalian cells, acting in a promoter-specific context, downstream of I kappa B kinase (IKK). CCT eta knockdown repressed I kappa B alpha and CXCL2/MIP2 transcription during the early phase of NF-kappa B activation while impairing the termination of CCL5/RANTES and CXCL10/IP10 transcription. The latter effect was associated with increased DNA binding and reduced p65 acetylation, presumably by altering the activity of histone acetyltransferase CREB-binding protein (CBP). We identified p65 lysines (K) 122 and 123 as target residues mediating the CCT eta-driven termination of NF-kappa B-dependent transcription. We propose that CCT eta regulates NF-kappa B activity in a manner that resolves inflammation.	[Pejanovic, Nadja; Hochrainer, Karin; Anrather, Josef] Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY USA; [Liu, Tao] UCL, MRC, Mol Cell Biol Lab, London, England; [Pejanovic, Nadja; Soares, Miguel P.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Aerne, Birgit L.] London Res Inst, Canc Res UK, Apoptosis & Proliferat Control Lab, London, England	Cornell University; University of London; University College London; Instituto Gulbenkian de Ciencia; Cancer Research UK	Pejanovic, N (corresponding author), Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY USA.	joa2006@med.cornell.edu	Hochrainer, Karin/AAN-6145-2020; Soares, Miguel P/G-4188-2011	Hochrainer, Karin/0000-0001-5147-0633; Soares, Miguel/0000-0002-9314-4833	"Fundacao para a Ciencia e a Tecnologia'', Portugal [SFRH/BD/28016/2006, PTDC/BIA-BCM/101311/2008, PTDC/SAU-FCF/100762/2008]; European Community; National Institutes of Health [HL077308];  [LSH-2005-1.2.5-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077308] Funding Source: NIH RePORTER	"Fundacao para a Ciencia e a Tecnologia'', Portugal(Portuguese Foundation for Science and Technology); European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by "Fundacao para a Ciencia e a Tecnologia'', Portugal grants SFRH/BD/28016/2006 (NP), PTDC/BIA-BCM/101311/2008 and PTDC/SAU-FCF/100762/2008 (MPS), European Community and LSH-2005-1.2.5-1 (MPS), and National Institutes of Health grant HL077308 (JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Briggs LJ, 1998, J BIOL CHEM, V273, P22745, DOI 10.1074/jbc.273.35.22745; Brostjan C, 1997, J IMMUNOL, V158, P3836; Brown CR, 1996, J BIOL CHEM, V271, P824, DOI 10.1074/jbc.271.2.824; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gerner C, 2002, CELL DEATH DIFFER, V9, P671, DOI 10.1038/sj.cdd.4401010; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; KUBOTA H, 1995, GENE, V154, P231, DOI 10.1016/0378-1119(94)00880-2; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Roobol A, 1999, EUR J CELL BIOL, V78, P21, DOI 10.1016/S0171-9335(99)80004-1; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Soues S, 2003, EXP CELL RES, V288, P363, DOI 10.1016/S0014-4827(03)00248-9; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tanji T, 2010, P NATL ACAD SCI USA, V107, P14715, DOI 10.1073/pnas.1009473107; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Uvell H, 2003, MOL CELL BIOL, V23, P8272, DOI 10.1128/MCB.23.22.8272-8281.2003; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zebol JR, 2009, INT J BIOCHEM CELL B, V41, P822, DOI 10.1016/j.biocel.2008.08.012; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	66	23	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42020	10.1371/journal.pone.0042020	http://dx.doi.org/10.1371/journal.pone.0042020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860050	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600052
J	Wang, K; Yuan, Y; Cho, JH; McClarty, S; Baxter, D; Galas, DJ				Wang, Kai; Yuan, Yue; Cho, Ji-Hoon; McClarty, Sara; Baxter, David; Galas, David J.			Comparing the MicroRNA Spectrum between Serum and Plasma	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNAS; POTENTIAL BIOMARKER; PEPTIDOMIC ANALYSIS; PROTEOME-PROJECT; DIAGNOSIS; CELLS; COLLECTION; MICROARRAY; SAMPLES	MicroRNAs (miRNAs) are small, non-coding RNAs that regulate various biological processes, primarily through interaction with messenger RNAs. The levels of specific, circulating miRNAs in blood have been shown to associate with various pathological conditions including cancers. These miRNAs have great potential as biomarkers for various pathophysiological conditions. In this study we focused on different sample types' effects on the spectrum of circulating miRNA in blood. Using serum and corresponding plasma samples from the same individuals, we observed higher miRNA concentrations in serum samples compared to the corresponding plasma samples. The difference between serum and plasma miRNA concentration showed some associations with miRNA from platelets, which may indicate that the coagulation process may affect the spectrum of extracellular miRNA in blood. Several miRNAs also showed platform dependent variations in measurements. Our results suggest that there are a number of factors that might affect the measurement of circulating miRNA concentration. Caution must be taken when comparing miRNA data generated from different sample types or measurement platforms.	[Wang, Kai; Yuan, Yue; Cho, Ji-Hoon; McClarty, Sara; Baxter, David; Galas, David J.] Inst Syst Biol, Seattle, WA USA; [Galas, David J.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg	Institute for Systems Biology (ISB); University of Luxembourg	Wang, K (corresponding author), Inst Syst Biol, Seattle, WA USA.	kwang@systemsbiology.org			ISB-University of Luxemburg program; Department of Defense [W911SR-07-C-0101, W81XWH-09-1-0107, HDTRA 1-08-C-0023]	ISB-University of Luxemburg program; Department of Defense(United States Department of Defense)	This work was supported by the ISB-University of Luxemburg program and research contracts from the Department of Defense (W911SR-07-C-0101, W81XWH-09-1-0107 and HDTRA 1-08-C-0023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Eidelman O., 2010, HUM GENOMICS PROTEOM, V2010; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Hsieh SY, 2006, PROTEOMICS, V6, P3189, DOI 10.1002/pmic.200500535; Iguchi Haruhisa, 2010, Commun Integr Biol, V3, P478, DOI 10.4161/cib.3.5.12693; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Miike K, 2010, PROTEOMICS, V10, P2678, DOI 10.1002/pmic.200900496; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Nedelkov D, 2007, MOL CELL PROTEOMICS, V6, P1183, DOI 10.1074/mcp.M700023-MCP200; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Tammen H, 2005, COMB CHEM HIGH T SCR, V8, P725, DOI 10.2174/138620705774962508; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhao S, 2009, SCI CHINA SER C, V52, P1111, DOI 10.1007/s11427-009-0152-y; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	33	470	489	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41561	10.1371/journal.pone.0041561	http://dx.doi.org/10.1371/journal.pone.0041561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859996	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600033
J	Khan, A; Faucett, J; Lichtenberg, P; Kirsch, I; Brown, WA				Khan, Arif; Faucett, James; Lichtenberg, Pesach; Kirsch, Irving; Brown, Walter A.			A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression	PLOS ONE			English	Review							DIAGNOSTIC-CRITERIA; PSYCHOTHERAPY; TRIALS; PLACEBO; PHARMACOTHERAPY; ANTIDEPRESSANTS; METAANALYSIS; SEVERITY	Background: Although previous meta-analyses have examined effects of antidepressants, psychotherapy, and alternative therapies for depression, the efficacy of these treatments alone and in combination has not been systematically compared. We hypothesized that the differences between approved depression treatments and controls would be small. Methods and Findings: The authors first reviewed data from Food and Drug Administration Summary Basis of Approval reports of 62 pivotal antidepressant trials consisting of data from 13,802 depressed patients. This was followed by a systematic review of data from 115 published trials evaluating efficacy of psychotherapies and alternative therapies for depression. The published depression trials consisted of 10,310 depressed patients. We assessed the percentage symptom reduction experienced by the patients based on treatment assignment. Overall, antidepressants led to greater symptom reduction compared to placebo among both unpublished FDA data and published trials (F = 38.5, df = 239, p<0.001). In the published trials we noted that the magnitude of symptom reduction with active depression treatments compared to controls was significantly larger when raters evaluating treatment effects were un-blinded compared to the trials with blinded raters (F = 2.17, df = 313, p<0.05). In the blinded trials, the combination of antidepressants and psychotherapy provided a slight advantage over antidepressants (p = 0.027) and psychotherapy (p = 0.022) alone. The magnitude of symptom reduction was greater with psychotherapies compared to placebo (p = 0.019), treatment-as-usual (p = 0.012) and waiting-list (p<0.001). Differences were not seen with psychotherapy compared to antidepressants, alternative therapies or active intervention controls. Conclusions: In conclusion, the combination of psychotherapy and antidepressants for depression may provide a slight advantage whereas antidepressants alone and psychotherapy alone are not significantly different from alternative therapies or active intervention controls. These data suggest that type of treatment offered is less important than getting depressed patients involved in an active therapeutic program. Future research should consider whether certain patient profiles might justify a specific treatment modality.	[Khan, Arif; Faucett, James] NW Clin Res Ctr, Bellevue, WA USA; [Khan, Arif] Duke Univ, Sch Med, Dept Psychiat, Durham, NC USA; [Lichtenberg, Pesach] Hebrew Univ Jerusalem, Sch Med, Dept Psychiat, IL-91010 Jerusalem, Israel; [Lichtenberg, Pesach] Hebrew Univ Jerusalem, Herzog Hosp, Jerusalem, Israel; [Kirsch, Irving] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA USA; [Kirsch, Irving] Univ Plymouth, Plymouth PL4 8AA, Devon, England; [Brown, Walter A.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Brown, Walter A.] Tufts Univ, Dept Psychiat, Boston, MA 02111 USA	Duke University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Herzog Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Plymouth; Brown University; Tufts University	Khan, A (corresponding author), NW Clin Res Ctr, Bellevue, WA USA.	akhan@nwcrc.net	Kirsch, Irving/P-9316-2019					Allen JJB, 1998, PSYCHOL SCI, V9, P397, DOI 10.1111/1467-9280.00074; American-Psychiatric-Association, 2013, DIAGN STAT MAN MENT; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Coryel W, 2011, AM J PSYCHIAT, V168, P664, DOI 10.1176/appi.ajp.2011.11030510; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Cuijpers P, 2008, PSYCHOTHERAPY RANDOM; Cuijpers P, 2008, J CLIN PSYCHIAT, V69, P1675, DOI 10.4088/JCP.v69n1102; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Cuijpers P, 2009, DEPRESS ANXIETY, V26, P279, DOI 10.1002/da.20519; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frank JD, 1991, PERSUASION HEALING C; Khan A, 2004, AM J PSYCHIAT, V161, P2045, DOI 10.1176/appi.ajp.161.11.2045; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; Khan A, 2001, INT J NEUROPSYCHOPH, V4, P113, DOI 10.1017/S1461145701002322; Khan Arif, 2007, Ann Clin Psychiatry, V19, P31, DOI 10.1080/10401230601163550; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Kushner SC, 2009, DEPRESS ANXIETY, V26, P666, DOI 10.1002/da.20566; Kwan BM, 2010, BEHAV RES THER, V48, P799, DOI 10.1016/j.brat.2010.04.003; Leichsenring F, 2001, CLIN PSYCHOL REV, V21, P401, DOI 10.1016/S0272-7358(99)00057-4; Lichtenberg P, 2010, PSYCHOTHER PSYCHOSOM, V79, P131, DOI 10.1159/000286957; Luborsky L, 2002, CLIN PSYCHOL-SCI PR, V9, P2, DOI 10.1093/clipsy/9.1.2; MARTINSEN EW, 1985, BRIT MED J, V291, P109, DOI 10.1136/bmj.291.6488.109; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; National Collaborating Centre for Mental Health The Royal College of Psychiatrists, 2010, DEPR NICE GUID TREAT; Nierenberg AA, 2010, CNS SPECTRUMS, V15, P146, DOI 10.1017/S1092852900027395; Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714; PRIOLEAU L, 1983, BEHAV BRAIN SCI, V6, P275, DOI 10.1017/S0140525X00015867; Raue PJ, 2009, PSYCHIAT SERV, V60, P337, DOI 10.1176/appi.ps.60.3.337; Rosenzweig S, 1936, AM J ORTHOPSYCHIAT, V6, P412, DOI 10.1111/j.1939-0025.1936.tb05248.x; Rutherford BR, 2009, PSYCHOTHER PSYCHOSOM, V78, P172, DOI 10.1159/000209348; Segal Z, 2002, J PSYCHIATR NEUROSCI, V27, P281; Sinyor M, 2010, J CLIN PSYCHIAT, V71, P270, DOI 10.4088/JCP.08r04516blu; Smith CA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004046.pub3; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Ullman D, 2010, HUFFINGTON POST HLTH; United States Department of Justice, 2004, FREED INF ACT GUID; Zimmerman M, 2002, AM J PSYCHIAT, V159, P469, DOI 10.1176/appi.ajp.159.3.469	42	151	153	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41778	10.1371/journal.pone.0041778	http://dx.doi.org/10.1371/journal.pone.0041778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860015	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900038
J	Poke, FS; Upcher, WR; Sprod, OR; Young, A; Brettingham-Moore, KH; Holloway, AF				Poke, Fiona S.; Upcher, William R.; Sprod, Owen R.; Young, Arabella; Brettingham-Moore, Kate H.; Holloway, Adele F.			Depletion of c-Rel from Cytokine Gene Promoters Is Required for Chromatin Reassembly and Termination of Gene Responses to T Cell Activation	PLOS ONE			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; GM-CSF PROMOTER; TRANSCRIPTIONAL ACTIVATORS; LYMPHOCYTE-PROLIFERATION; HISTONE METHYLATION; EXHIBIT DEFECTS; IL-2 GENE; ALPHA; EXPRESSION	The role of the Nuclear Factor kappa B (NF-kappa B) transcription factor family in T cell function has been well described. The c-Rel family member is of particular importance in initiating T cell responses to antigen and regulating activation of inflammatory cytokine genes, including the Interleukin-2 (IL-2) and Granulocyte macrophage colony stimulating factor (GM-CSF) genes. c-Rel is required for chromatin remodeling of these gene promoters, which involves depletion of histones from the promoters in response to T cell activating signals. These chromatin remodeling events precede transcriptional activation of the genes. The subsequent down-regulation of cytokine gene expression is important in the termination of an immune response and here we examine this process at the murine GM-CSF and IL-2 genes. We show that the cytokine mRNA levels rapidly return to basal levels following stimulus removal and this is associated with reassembly of histones onto the promoter. Histone reassembly at the GM-CSF and IL-2 promoters occurs concomitantly with depletion of RelA, c-Rel and RNA polymerase II from the promoters. Furthermore we show that transcriptional down-regulation and chromatin reassembly is dependent on depletion of c-Rel from the nucleus, and that this is regulated by the nuclear translocation of the NF-kappa B inhibitor, I kappa B alpha. The nuclear activation of c-Rel therefore not only regulates the initiation of GM-CSF and IL-2 gene activation in response to T cell activation, but also the termination of these gene responses following the removal of the activating signal.	[Poke, Fiona S.; Upcher, William R.; Sprod, Owen R.; Young, Arabella; Holloway, Adele F.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Brettingham-Moore, Kate H.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	University of Tasmania; University of Tasmania	Poke, FS (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	a.f.holloway@utas.edu.au	Brettingham-Moore, Kate/N-7500-2017	Brettingham-Moore, Kate/0000-0002-4304-4586; Holloway, Adele/0000-0003-2213-1717; Young, Arabella/0000-0002-6845-9753	National Health and Medical Research Council, Australia; David Collins Leukemia Foundation; Australian Cancer Research Foundation	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); David Collins Leukemia Foundation; Australian Cancer Research Foundation	This work was supported by the National Health and Medical Research Council, Australia, the David Collins Leukemia Foundation, and the Australian Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Brettingham-Moore KH, 2008, NUCLEIC ACIDS RES, V36, P2639, DOI 10.1093/nar/gkn117; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Cakouros D, 2001, J IMMUNOL, V167, P302, DOI 10.4049/jimmunol.167.1.302; Castro-Alcaraz S, 2002, J IMMUNOL, V169, P3947, DOI 10.4049/jimmunol.169.7.3947; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Coiras M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-56; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Espinosa L, 2011, AM J CANCER RES, V1, P446; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Himes SR, 1996, IMMUNITY, V5, P479, DOI 10.1016/S1074-7613(00)80503-8; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jensen MM, 2008, FEBS J, V275, P2956, DOI 10.1111/j.1742-4658.2008.06451.x; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Ohsawa R, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-11; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; SHANNON MF, 1995, J LEUKOCYTE BIOL, V57, P767, DOI 10.1002/jlb.57.5.767; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41734	10.1371/journal.pone.0041734	http://dx.doi.org/10.1371/journal.pone.0041734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860011	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900036
J	Akerstrom, T; Crona, J; Verdugo, AD; Starker, LF; Cupisti, K; Willenberg, HS; Knoefel, WT; Saeger, W; Feller, A; Ip, J; Soon, P; Anlauf, M; Alesina, PF; Schmid, KW; Decaussin, M; Levillain, P; Waangberg, B; Peix, JL; Robinson, B; Zedenius, J; Backdahl, M; Caramuta, S; Iwen, KA; Botling, J; Stalberg, P; Kraimps, JL; Dralle, H; Hellman, P; Sidhu, S; Westin, G; Lehnert, H; Walz, MK; Akerstrom, G; Carling, T; Choi, M; Lifton, RP; Bjorklund, P				Akerstrom, Tobias; Crona, Joakim; Verdugo, Alberto Delgado; Starker, Lee F.; Cupisti, Kenko; Willenberg, Holger S.; Knoefel, Wolfram T.; Saeger, Wolfgang; Feller, Alfred; Ip, Julian; Soon, Patsy; Anlauf, Martin; Alesina, Pier F.; Schmid, Kurt W.; Decaussin, Myriam; Levillain, Pierre; Wangberg, Bo; Peix, Jean-Louis; Robinson, Bruce; Zedenius, Jan; Backdahl, Martin; Caramuta, Stefano; Iwen, K. Alexander; Botling, Johan; Stalberg, Peter; Kraimps, Jean-Louis; Dralle, Henning; Hellman, Per; Sidhu, Stan; Westin, Gunnar; Lehnert, Hendrik; Walz, Martin K.; Akerstrom, Goran; Carling, Tobias; Choi, Murim; Lifton, Richard P.; Bjorklund, Peyman			Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter	PLOS ONE			English	Article							HYPERTENSION; DIAGNOSIS; HYPERPLASIA; ADENOMAS	Background: Aldosterone producing lesions are a common cause of hypertension, but genetic alterations for tumorigenesis have been unclear. Recently, either of two recurrent somatic missense mutations (G151R or L168R) was found in the potassium channel KCNJ5 gene in aldosterone producing adenomas. These mutations alter the channel selectivity filter and result in Na+ conductance and cell depolarization, stimulating aldosterone production and cell proliferation. Because a similar mutation occurs in a Mendelian form of primary aldosteronism, these mutations appear to be sufficient for cell proliferation and aldosterone production. The prevalence and spectrum of KCNJ5 mutations in different entities of adrenocortical lesions remain to be defined. Materials and Methods: The coding region and flanking intronic segments of KCNJ5 were subjected to Sanger DNA sequencing in 351 aldosterone producing lesions, from patients with primary aldosteronism and 130 other adrenocortical lesions. The specimens had been collected from 10 different worldwide referral centers. Results: G151R or L168R somatic mutations were identified in 47% of aldosterone producing adenomas, each with similar frequency. A previously unreported somatic mutation near the selectivity filter, E145Q, was observed twice. Somatic G151R or L168R mutations were also found in 40% of aldosterone producing adenomas associated with marked hyperplasia, but not in specimens with merely unilateral hyperplasia. Mutations were absent in 130 non-aldosterone secreting lesions. KCNJ5 mutations were overrepresented in aldosterone producing adenomas from female compared to male patients (63 vs. 24%). Males with KCNJ5 mutations were significantly younger than those without (45 vs. 54, respectively; p < 0.005) and their APAs with KCNJ5 mutations were larger than those without (27.1 mm vs. 17.1 mm; p < 0.005). Discussion: Either of two somatic KCNJ5 mutations are highly prevalent and specific for aldosterone producing lesions. These findings provide new insight into the pathogenesis of primary aldosteronism.	[Akerstrom, Tobias; Crona, Joakim; Verdugo, Alberto Delgado; Starker, Lee F.; Stalberg, Peter; Hellman, Per; Westin, Gunnar; Akerstrom, Goran; Bjorklund, Peyman] Uppsala Univ, Dept Surg Sci Genet & Pathol, Uppsala, Sweden; [Starker, Lee F.; Carling, Tobias] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Cupisti, Kenko; Knoefel, Wolfram T.] Univ Hosp Dusseldorf, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany; [Dralle, Henning] Univ Halle Wittenberg, Univ Hosp, Dept Gen Visceral & Vasc Surg, Halle, Germany; [Zedenius, Jan; Backdahl, Martin] Karolinska Inst, Karolinska Univ Hosp, Endocrine Surg Unit, Dept Mol Med & Surg, Stockholm, Sweden; [Caramuta, Stefano] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Willenberg, Holger S.] Univ Hosp Dusseldorf, Dept Endocrinol Diabet & Rheumatol, Dusseldorf, Germany; [Anlauf, Martin] Univ Hosp Dusseldorf, Inst Pathol, Dusseldorf, Germany; [Botling, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ip, Julian; Soon, Patsy; Robinson, Bruce; Sidhu, Stan] Royal N Shore Hosp, Kolling Inst Med Res, Canc Genet Hormones & Canc Grp, Sydney, NSW, Australia; [Ip, Julian; Soon, Patsy; Robinson, Bruce; Sidhu, Stan] Univ Sydney, Endocrine Surg Unit, Sydney, NSW 2006, Australia; [Alesina, Pier F.; Walz, Martin K.] Univ Duisburg Essen, Kliniken Essen Mitte, Klin Chirurg, Essen, Germany; [Alesina, Pier F.; Walz, Martin K.] Univ Duisburg Essen, Kliniken Essen Mitte, Zentrum Minimal Invas Chirurg, Essen, Germany; [Schmid, Kurt W.] Univ Duisburg Essen, Univ Klinikum, Inst Pathol & Neuropathol, Essen, Germany; [Decaussin, Myriam] Ctr Hosp Lyon Sud, Dept Pathol, Lyon, France; [Peix, Jean-Louis] Ctr Hosp Lyon Sud, Dept Endocrine Surg, Lyon, France; [Feller, Alfred] Univ Hosp Lubeck, Dept Pathol, Lubeck, Germany; [Saeger, Wolfgang] Marien Hosp, Dept Pathol, Hamburg, Germany; [Iwen, K. Alexander; Lehnert, Hendrik] Univ Klinikum Schleswig Holstein, Med Klin, D-23538 Lubeck, Germany; [Levillain, Pierre] Ctr Hosp Poitiers, Dept Pathol, Poitiers, France; [Wangberg, Bo] Univ Gothenburg, Sahlgrenska Akad, Gothenburg, Sweden; [Soon, Patsy] Univ New S Wales, S Western Sydney Clin Sch, Bankstown Hosp, Dept Surg, Sydney, NSW, Australia	Uppsala University; Yale University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Martin Luther University Halle Wittenberg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Uppsala University; Yale University; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Kliniken Essen-Mitte; University of Duisburg Essen; Kliniken Essen-Mitte; University of Duisburg Essen; University of Duisburg Essen; CHU Lyon; CHU Lyon; University of Lubeck; St. Marien Hospital; University of Kiel; Schleswig Holstein University Hospital; Universite de Poitiers; University of Gothenburg; University of New South Wales Sydney	Akerstrom, T (corresponding author), Uppsala Univ, Dept Surg Sci Genet & Pathol, Uppsala, Sweden.	peyman.bjorklund@surgsci.uu.se	Walz, Martin/AHE-7790-2022; Björklund, Peyman/A-1509-2014; Sidhu, Stan/K-1555-2015; Choi, Murim/AAP-9120-2021; Dralle, Henning/ABD-4454-2020; Hellman, Per/AAL-9817-2021; ALESINA, Pier Francesco/O-5067-2019; Botling, Johan/ABA-2586-2020; Crona, Joakim/D-3474-2013	Björklund, Peyman/0000-0002-9398-4496; Hellman, Per/0000-0002-5322-5073; ALESINA, Pier Francesco/0000-0002-8508-9934; Botling, Johan/0000-0003-2226-3517; Crona, Joakim/0000-0003-0677-4894; Levillain, Pierre/0000-0003-0337-2793; Stalberg, Peter/0000-0002-9625-1394	Swedish Cancer Society; Swedish Research Council; Swedish Society for Medical Research; Ake Wiberg Foundation; Selander Foundation; Jeanssons Foundation; Leducq Transatlantic Network for Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Ake Wiberg Foundation; Selander Foundation; Jeanssons Foundation; Leducq Transatlantic Network for Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Swedish Cancer Society to P Bjorklund and G Akerstrom, the Swedish Research Council to G Westin, Swedish Society for Medical Research, Ake Wiberg Foundation, Selander Foundation and Jeanssons Foundation to P Bjorklund and the Leducq Transatlantic Network for Hypertension to R Lifton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizan E. A., 2012, HYPERTENSION; Bjorklund P, 2007, PLOS MED, V4, P1829, DOI 10.1371/journal.pmed.0040328; Born-Frontsberg E, 2009, J CLIN ENDOCR METAB, V94, P1125, DOI 10.1210/jc.2008-2116; Boulkroun S, 2012, HYPERTENSION; Charmandari E, 2012, J CLIN ENDOCRINOL ME; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; CONN JW, 1964, AM J SURG, V107, P159, DOI 10.1016/0002-9610(64)90252-1; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; GORDON RD, 1992, LANCET, V340, P159, DOI 10.1016/0140-6736(92)93225-C; McKenzie TJ, 2009, SURG CLIN N AM, V89, P1241, DOI 10.1016/j.suc.2009.06.017; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Mulatero P, 2012, HYPERTENSION, V59, P235, DOI 10.1161/HYPERTENSIONAHA.111.183996; Mulatero P, 2011, REV ENDOCR METAB DIS, V12, P3, DOI 10.1007/s11154-011-9156-6; Nishimura M, 1999, AM J KIDNEY DIS, V33, P261, DOI 10.1016/S0272-6386(99)70298-2; Oki K, 2012, ENDOCRINOLOGY; Plouin PF, 2008, CLIN EXP PHARMACOL P, V35, P522, DOI 10.1111/j.1440-1681.2008.04909.x; Rossi GP, 2008, J HYPERTENS, V26, P613, DOI 10.1097/HJH.0b013e3282f4b3e6; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2011, ENDOCRIN METAB CLIN, V40, P313, DOI 10.1016/j.ecl.2011.01.005; Sawka AM, 2001, ANN INTERN MED, V135, P258, DOI 10.7326/0003-4819-135-4-200108210-00010; Scholl UI, 2012, P NATL ACAD SCI US; Scholl UI, 2012, P NATL ACAD SCI USA, V109, P2533, DOI 10.1073/pnas.1121407109; Stowasser M, 2003, BEST PRACT RES CL EN, V17, P591, DOI 10.1016/S1521-690X(03)00050-2; Taguchi R, 2012, J CLIN ENDOCRINOL ME; Walz MK, 2008, WORLD J SURG, V32, P847, DOI 10.1007/s00268-008-9513-0; Xekouki P, 2012, ENDOCR RELAT CANC; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	28	133	143	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41926	10.1371/journal.pone.0041926	http://dx.doi.org/10.1371/journal.pone.0041926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848660	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200128
J	Balbo, AL; Iriarte, E; Arranz, A; Zapata, L; Lancelotti, C; Madella, M; Teira, L; Jimenez, M; Braemer, F; Ibanez, JJ				Balbo, Andrea L.; Iriarte, Eneko; Arranz, Amaia; Zapata, Lydia; Lancelotti, Carla; Madella, Marco; Teira, Luis; Jimenez, Miguel; Braemer, Frank; Jose Ibanez, Juan			Squaring the Circle. Social and Environmental Implications of Pre-Pottery Neolithic Building Technology at Tell Qarassa (South Syria)	PLOS ONE			English	Article							ARCHITECTURE; SETTLEMENT; REMAINS; SCALE; HUT	We present the results of the microstratigraphic, phytolith and wood charcoal study of the remains of a 10.5 ka roof. The roof is part of a building excavated at Tell Qarassa (South Syria), assigned to the Pre-Pottery Neolithic B period (PPNB). The Pre-Pottery Neolithic (PPN) period in the Levant coincides with the emergence of farming. This fundamental change in subsistence strategy implied the shift from mobile to settled aggregated life, and from tents and huts to hard buildings. As settled life spread across the Levant, a generalised transition from round to square buildings occurred, that is a trademark of the PPNB period. The study of these buildings is fundamental for the understanding of the ever-stronger reciprocal socio-ecological relationship humans developed with the local environment since the introduction of sedentism and domestication. Descriptions of buildings in PPN archaeological contexts are usually restricted to the macroscopic observation of wooden elements (posts and beams) and mineral components (daub, plaster and stone elements). Reconstructions of microscopic and organic components are frequently based on ethnographic analogy. The direct study of macroscopic and microscopic, organic and mineral, building components performed at Tell Qarassa provides new insights on building conception, maintenance, use and destruction. These elements reflect new emerging paradigms in the relationship between Neolithic societies and the environment. A square building was possibly covered here with a radial roof, providing a glance into a topologic shift in the conception and understanding of volumes, from round-based to square-based geometries. Macroscopic and microscopic roof components indicate buildings were conceived for year-round residence rather than seasonal mobility. This implied performing maintenance and restoration of partially damaged buildings, as well as their adaptation to seasonal variability.	[Balbo, Andrea L.; Jose Ibanez, Juan] CSIC, IMF, Dept Arqueol & Antropol, Barcelona, Spain; [Iriarte, Eneko] Univ Burgos, Dept Ciencias Hist & Geog, Burgos, Spain; [Arranz, Amaia; Zapata, Lydia] Univ Basque Country UPV EHU, Vitoria, Spain; [Lancelotti, Carla] CSIC, CCHS, Hist Inst, Madrid, Spain; [Madella, Marco] CSIC, IMF, ICREA, Barcelona, Spain; [Teira, Luis] IIIPC, Santander, Spain; [Jimenez, Miguel] Donato Arquitectos Asociados, Barcelona, Spain; [Braemer, Frank] Univ Nice, CNRS, CEPAM, F-06034 Nice, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Universidad de Burgos; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Historia (IH); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); ICREA; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Balbo, AL (corresponding author), CSIC, IMF, Dept Arqueol & Antropol, Barcelona, Spain.	balbo@imf.csic.es	Iriarte, Eneko/L-4707-2014; Madella, Marco/M-3320-2014; Lancelotti, Carla/L-2655-2014; otaegui, amaia arranz/AAO-8496-2020; Otaegui, Amaia Arranz/X-2096-2018	Iriarte, Eneko/0000-0001-8365-5616; Madella, Marco/0000-0002-9324-1545; Lancelotti, Carla/0000-0003-1099-7329; Arranz Otaegui, Amaia/0000-0002-5091-6426; Balbo, Andrea Luca/0000-0002-3906-375X	Spanish Ministry of Science and Innovation (MICINN) [HAR2011-21545-C02-01]; Ministry of Culture Spanish Institute of Cultural Heritage (Excavations Abroad); French Ministry of Foreign and European Affairs; JAEDoc; SimulPast Consolider; European Social Found; Basque Government [BFI.09.249]; Programa de Movilidad del Personal Investigador del Gobierno Vasco; AGRIWESTMED (European Research Council funded); ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Culture Spanish Institute of Cultural Heritage (Excavations Abroad); French Ministry of Foreign and European Affairs; JAEDoc; SimulPast Consolider; European Social Found(European Social Fund (ESF)); Basque Government(Basque Government); Programa de Movilidad del Personal Investigador del Gobierno Vasco; AGRIWESTMED (European Research Council funded); ICREA(ICREA)	Research is sponsored by the former Spanish Ministry of Science and Innovation (MICINN, HAR2011-21545-C02-01 The last hunter-gatherers and the first producing societies in Central and Southern Syria), the Ministry of Culture Spanish Institute of Cultural Heritage (Excavations Abroad) and the French Ministry of Foreign and European Affairs. A. Balbo has worked on this paper on contracts from JAEDoc, SimulPast Consolider and European Social Found. A. Arranz has the financial support of the Basque Government (Pre-doctoral grant Number: BFI.09.249). L. Zapata is a member of Research Group UPV/EHU IT-288-07 (Basque Government), UFI11/09 Cuaternario of the UPV/EHU and Project HAR2011-23716 (I+D+i). She is also funded by the Programa de Movilidad del Personal Investigador del Gobierno Vasco 2012. C. Lancelotti has worked on this paper on a contract from AGRIWESTMED (European Research Council funded). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci DE, 2010, GEOARCHAEOLOGY, V25, P220, DOI 10.1002/gea.20303; Arranz A, 2011, QUAT STUD ENV CHANGE, V1, P3; Aurenche O, 1980, MOYEN EUPHRATE ZONE, P35; Balter M, 2005, GODDESS BULL; Banning EB, 2003, NEAR EAST ARCHAEOL, V66, P4, DOI 10.2307/3210928; Banning EB, 1984, B AM SCH ORIENT RES, V255, P15; Braadbaart F, 2008, J ARCHAEOL SCI, V35, P2434, DOI 10.1016/j.jas.2008.03.016; Bullock P., 1985, HDB SOIL THIN SECTIO; Byrd BF, 2005, EARLY VILLAGE LIFE B; Carrion Marco Y., 2005, SERIE TRABAJOS VARIO, V104; Cauvin J., 1997, NAISSANCE DIVINITES; Coqueugniot E., 2000, PREMIERS PAYSANS MON, P63; Edwards P. C., 2004, PALEORIENT, V30, P21, DOI DOI 10.3406/PALEO.2004.1010; Fahn A., 1986, Wood anatomy and identification of trees and shrubs from Israel and adjacent regions., pplates; Finlayson B, 2011, P NATL ACAD SCI USA, V108, P8183, DOI 10.1073/pnas.1017642108; Fitzpatrick EA., 1993, SOIL MICROSCOPY MICR; Gebel HGK, 2007, NEOLITHICS NEWSLETTE, V1, P24; Gopher A, 1996, STUDIES EARLY NEAR E, V3, P151; Goring-Morris AN, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P239, DOI 10.1007/978-1-4020-8539-0_10; Iriarte E, 2011, CR PALEVOL, V10, P35, DOI 10.1016/j.crpv.2010.10.011; Khalaily H, 2007, PALEORIENT, V33, P5, DOI DOI 10.3406/PALE0.2007.5218; Kinzel M, 2004, NEOLITHICS, V2, P18; Kuijt I, 2002, J WORLD PREHISTORY, V16; Love S, 2012, GEOARCHAEOLOGY, V27, P140, DOI 10.1002/gea.21401; Macphail RI, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P589, DOI 10.1016/B978-0-444-53156-8.00026-X; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Matthews W, 1997, WORLD ARCHAEOL, V29, P281, DOI 10.1080/00438243.1997.9980378; Matthews W, 2010, QUATERN INT, V214, P98, DOI 10.1016/j.quaint.2009.10.019; McParland LC, 2010, J ARCHAEOL SCI, V37, P2679, DOI 10.1016/j.jas.2010.06.006; Moskal-del Hoyo M, 2010, J ARCHAEOL SCI, V37, P2106, DOI 10.1016/j.jas.2010.02.007; Mouterde P, 1953, FLORE DJEBEL DRUZE; Nadel D, 2004, P NATL ACAD SCI USA, V101, P6821, DOI 10.1073/pnas.0308557101; Nadel D, 1999, ANTIQUITY, V73, P755, DOI 10.1017/S0003598X00065509; Neumann K., 2001, WOODS SAHARA SAHEL A; PHILLIPS SE, 1987, AUST J SOIL RES, V25, P429, DOI 10.1071/SR9870429; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Purschwitz C, 2006, NEOLITHICS 2 07 NEWS, P22; Rosen AM, 2012, P NATL ACAD SCI USA, V109, P3640, DOI 10.1073/pnas.1113931109; Ryan P, 2011, J ANTHROPOL ARCHAEOL, V30, P292, DOI 10.1016/j.jaa.2011.06.002; SCHIRMER W, 1990, WORLD ARCHAEOL, V21, P363, DOI 10.1080/00438243.1990.9980114; Schweingruber FH, 1990, ANATOMY EUROPEAN WOO; SIMMONS AH, 1988, SCIENCE, V240, P35, DOI 10.1126/science.240.4848.35; SMITH PEL, 1990, WORLD ARCHAEOL, V21, P323, DOI 10.1080/00438243.1990.9980111; Stoops G, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P1; Stoops G., 2003, GUIDELINES ANAL DESC; Stordeur D, 2002, B SOC PREHISTORIQUE, V99, P563, DOI DOI 10.3406/BSPF.2002.12712; Stordeur D, 2008, SACRED LANDSCAPES AN, V1843, P33; Stordeur D., 2000, PALE ORIENT, V26, P29, DOI DOI 10.3406/paleo.2000.4696; Stordeur D., 1997, B SOC PREHISTORIQUE, V94, P282, DOI [10.3406/bspf.1997.10869, DOI 10.3406/BSPF.1997.10869]; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Thery-Parisot I, 2001, DOSSIERS DOCUMENTATI, V20; Willcox G, 1999, VEG HIST ARCHAEOBOT, V8, P21, DOI 10.1007/BF02042838; Willcox G, 2012, ANTIQUITY, V86, P99, DOI 10.1017/S0003598X00062487	54	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42109	10.1371/journal.pone.0042109	http://dx.doi.org/10.1371/journal.pone.0042109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	981ER	22848723	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200166
J	Luscher, BP; Baur, R; Goeldner, M; Sigel, E				Luescher, Benjamin P.; Baur, Roland; Goeldner, Maurice; Sigel, Erwin			Influence of GABA(A) Receptor alpha Subunit Isoforms on the Benzodiazepine Binding Site	PLOS ONE			English	Article							AMINOBUTYRIC ACID(A) RECEPTORS; INTERNATIONAL UNION; PHARMACOLOGY; SUBTYPES; STOICHIOMETRY; DIAZEPAM; CLASSIFICATION; MODULATION; EXPRESSION; POCKET	Classical benzodiazepines, such as diazepam, interact with alpha(x)beta(2)gamma(2) GABA(A) receptors, x = 1, 2, 3, 5 and modulate their function. Modulation of different receptor isoforms probably results in selective behavioural effects as sedation and anxiolysis. Knowledge of differences in the structure of the binding pocket in different receptor isoforms is of interest for the generation of isoform-specific ligands. We studied here the interaction of the covalently reacting diazepam analogue 3-NCS with alpha(1)S204C beta(2)gamma(2), alpha(1)S205C beta(2)gamma(2) and alpha(1)T206C beta(2)gamma(2) and with receptors containing the homologous mutations in alpha(2)beta(2)gamma(2), alpha(3)beta(2)gamma(2), alpha(5)beta(1/2)gamma(2) and alpha(6)beta(2)gamma(2). The interaction was studied using radioactive ligand binding and at the functional level using electrophysiological techniques. Both strategies gave overlapping results. Our data allow conclusions about the relative apposition of alpha(1)S204C beta(2)gamma(2), alpha(1)S205C beta(2)gamma(2) and alpha(1)T206C beta(2)gamma(2) and homologous positions in alpha(2), alpha(3), alpha(5) and alpha(6) with C-atom adjacent to the keto-group in diazepam. Together with similar data on the C-atom carrying Cl in diazepam, they indicate that the architecture of the binding site for benzodiazepines differs in each GABAA receptor isoform alpha(1)beta(2)gamma(2), alpha(2)beta(2)gamma(2), alpha(3)beta(2)gamma(2), alpha(5)beta(1/2)gamma(2) and alpha(6)beta(2)gamma(2).	[Luescher, Benjamin P.; Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Biol, Bern, Switzerland; [Goeldner, Maurice] Univ Strasbourg, Fac Pharm, Lab Concept & Applicat Mol Bioact, CNRS,Unite Mixte Rech, Illkirch Graffenstaden, France	University of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Luscher, BP (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Bern, Switzerland.	erwin.sigel@ibmm.unibe.ch	Luscher, Bernhard/C-3528-2009; Sigel, Erwin/F-7736-2015	Luscher, Bernhard/0000-0003-1375-1906; 	Swiss National Foundation [31003A_132806/1]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation (http://www.snf.ch) grant 31003A_132806/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard EA, 1998, PHARMACOL REV, V50, P291; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2008, J NEUROCHEM, V106, P2353, DOI 10.1111/j.1471-4159.2008.05574.x; Benson JA, 1998, FEBS LETT, V431, P400, DOI 10.1016/S0014-5793(98)00803-5; Berezhnoy D, 2005, J NEUROCHEM, V92, P859, DOI 10.1111/j.1471-4159.2004.02913.x; Berezhnoy D, 2004, J BIOL CHEM, V279, P3160, DOI 10.1074/jbc.M311371200; BERTOCCI B, 1991, P NATL ACAD SCI USA, V88, P1416, DOI 10.1073/pnas.88.4.1416; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Chang YC, 1996, J NEUROSCI, V16, P5415; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Crestani F, 2001, MOL PHARMACOL, V59, P442, DOI 10.1124/mol.59.3.442; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Dias R, 2005, J NEUROSCI, V25, P10682, DOI 10.1523/JNEUROSCI.1166-05.2005; Dunn SMJ, 1999, MOL PHARMACOL, V56, P768; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Foucaud B, 2001, TRENDS PHARMACOL SCI, V22, P170, DOI 10.1016/S0165-6147(00)01674-6; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Sigel E, 2011, CURR TOP MED CHEM, V11, P241, DOI 10.2174/156802611794863562; Tan KR, 2007, FEBS LETT, V581, P4718, DOI 10.1016/j.febslet.2007.08.068; Tan KR, 2007, J BIOL CHEM, V282, P26316, DOI 10.1074/jbc.M702153200; Tan KR, 2009, J NEUROCHEM, V111, P1264, DOI 10.1111/j.1471-4159.2009.06419.x; Tretter V, 1997, J NEUROSCI, V17, P2728; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; WIELAND HA, 1992, J BIOL CHEM, V267, P1426	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42101	10.1371/journal.pone.0042101	http://dx.doi.org/10.1371/journal.pone.0042101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848717	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200165
J	Rodrigues, JR; Fernandez, A; Canales, J; Cabezas, A; Ribeiro, JM; Costas, MJ; Cameselle, JC				Rui Rodrigues, Joaquim; Fernandez, Ascension; Canales, Jose; Cabezas, Alicia; Meireles Ribeiro, Joao; Jesus Costas, Maria; Carlos Cameselle, Jose			Characterization of Danio rerio Mn2+-Dependent ADP-Ribose/CDP-Alcohol Diphosphatase, the Structural Prototype of the ADPRibase-Mn-Like Protein Family	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; PURPLE ACID-PHOSPHATASE; MUTATIONAL ANALYSIS; MYCOBACTERIUM-TUBERCULOSIS; RIBOSYL CYCLASE; IDENTIFICATION; SUBSTRATE; BINDING; TRPM2; PYROPHOSPHATASE	The ADPRibase-Mn-like protein family, that belongs to the metallo-dependent phosphatase superfamily, has different functional and structural prototypes. The functional one is the Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase from Rattus norvegicus, which is essentially inactive with Mg2+ and active with low micromolar Mn2+ in the hydrolysis of the phosphoanhydride linkages of ADP-ribose, CDP-alcohols and cyclic ADP-ribose (cADPR) in order of decreasing efficiency. The structural prototype of the family is a Danio rerio protein with a known crystallographic structure but functionally uncharacterized. To estimate the structure-function correlation with the same protein, the activities of zebrafish ADPRibase-Mn were studied. Differences between zebrafish and rat enzymes are highlighted. The former showed a complex activity dependence on Mn2+, significant (approximate to 25%) Mg2+-dependent activity, but was almost inactive on cADPR (150-fold less efficient than the rat counterpart). The low cADPR hydrolase activity agreed with the zebrafish genome lacking genes coding for proteins with significant homology with cADPR-forming enzymes. Substrate-docking to zebrafish wild-type protein, and characterization of the ADPRibase-Mn H97A mutant pointed to a role of His-97 in catalysis by orientation, and to a bidentate water bridging the dinuclear metal center as the potential nucleophile. Finally, three structural elements that delimit the active site entrance in the zebrafish protein were identified as unique to the ADPRibase-Mn-like family within the metallo-dependent phosphatase superfamily.	[Rui Rodrigues, Joaquim; Fernandez, Ascension; Canales, Jose; Cabezas, Alicia; Meireles Ribeiro, Joao; Jesus Costas, Maria; Carlos Cameselle, Jose] Univ Extremadura, Fac Med, Dept Bioquim & Biol Mol & Genet, Grp Enzimol, Badajoz, Spain; [Rui Rodrigues, Joaquim] Inst Politecn Leiria, Escola Super Tecnol & Gestao, Leiria, Portugal	Universidad de Extremadura; Polytechnic Institute of Leiria; Polytechnic Institute of Porto	Rodrigues, JR (corresponding author), Univ Extremadura, Fac Med, Dept Bioquim & Biol Mol & Genet, Grp Enzimol, Badajoz, Spain.	camselle@unex.es	Ribeiro, João Meireles/K-6555-2014; Costas, Maria Jesus/K-7394-2014; Cabezas, Alicia/K-6564-2014; Canales, Jose/K-8793-2014; Rodrigues, Joaquim Rui/L-4137-2014; Cameselle, Jose Carlos/K-6421-2014	Ribeiro, João Meireles/0000-0002-6548-1402; Costas, Maria Jesus/0000-0001-8815-1839; Cabezas, Alicia/0000-0002-2908-9147; Canales, Jose/0000-0002-7897-9832; Rodrigues, Joaquim Rui/0000-0002-9756-1124; Cameselle, Jose Carlos/0000-0003-0005-081X	Ministerio de Ciencia e Innovacion, Spain [BFU2009-07296]; Consejeria de Economia, Comercio e Innovacion, Junta de Extremadura, Spain [GRU09135, GR10133]; Fondo Social Europeo; Fondo Europeo de Desarrollo Regional	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Comercio e Innovacion, Junta de Extremadura, Spain; Fondo Social Europeo(European Social Fund (ESF)European Commission); Fondo Europeo de Desarrollo Regional(European Commission)	This work was supported by the Ministerio de Ciencia e Innovacion, Spain [grant number BFU2009-07296], and the Consejeria de Economia, Comercio e Innovacion, Junta de Extremadura, Spain [grant numbers GRU09135 and GR10133], co-financed by Fondo Social Europeo and Fondo Europeo de Desarrollo Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bitte E, 2006, CRYSTAL STRUCTURE DI; Bitte E, 2006, DIMETAL PHOSPHATASE; CANALES J, 1995, BBA-PROTEIN STRUCT M, V1246, P167, DOI 10.1016/0167-4838(94)00191-I; Canales J, 2008, BIOCHEM J, V413, P103, DOI 10.1042/BJ20071471; Canales J, 2009, FEBS LETT, V583, P1593, DOI 10.1016/j.febslet.2009.04.023; Fehrst A, 1998, STRUCTURE MECH PROTE; Fontes R, 2000, ACTA BIOCHIM POL, V47, P233, DOI 10.18388/abp.2000_4082; Funhoff EG, 2005, FEBS J, V272, P2968, DOI 10.1111/j.1742-4658.2005.04686.x; GU QM, 1994, J AM CHEM SOC, V116, P7481, DOI 10.1021/ja00096a002; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; Kimura E, 2000, CURR OPIN CHEM BIOL, V4, P207, DOI 10.1016/S1367-5931(99)00076-9; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kuhn FJP, 2005, PFLUG ARCH EUR J PHY, V451, P212, DOI 10.1007/s00424-005-1446-y; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; LONDON WP, 1969, BIOCHEMISTRY-US, V8, P1767, DOI 10.1021/bi00832a061; McMillen L, 2003, BIOCHEM J, V372, P625, DOI 10.1042/BJ20021800; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Phillips George N. Jr., 2007, Journal of Structural and Functional Genomics, V8, P73, DOI 10.1007/s10969-007-9023-6; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanner MF, 2005, STRUCTURE, V13, P447, DOI 10.1016/j.str.2005.01.010; Segel I.H., 1975, ENZYME KINETICS; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Smoukov SK, 2002, J AM CHEM SOC, V124, P2595, DOI 10.1021/ja003169l; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; White DJ, 2001, BIOCHEMISTRY-US, V40, P8918, DOI 10.1021/bi010637a; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234; Ziegler M, 1997, BIOCHEM J, V326, P401, DOI 10.1042/bj3260401	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42249	10.1371/journal.pone.0042249	http://dx.doi.org/10.1371/journal.pone.0042249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848751	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200188
J	Connan, C; Brueggemann, H; Mazuet, C; Raffestin, S; Cayet, N; Popoff, MR				Connan, Chloe; Brueggemann, Holger; Mazuet, Christelle; Raffestin, Stephanie; Cayet, Nadege; Popoff, Michel R.			Two-Component Systems Are Involved in the Regulation of Botulinum Neurotoxin Synthesis in Clostridium botulinum Type A Strain Hall	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; GENE-EXPRESSION; CARBON-DIOXIDE; PROGENITOR TOXIN; PROTEIN GENES; HEMAGGLUTININ; TRANSCRIPTION; COMPLEX; BINDING; SEQUENCE	Clostridium botulinum synthesizes a potent neurotoxin (BoNT) which associates with non-toxic proteins (ANTPs) to form complexes of various sizes. The bont and antp genes are clustered in two operons. In C. botulinum type A, bont/A and antp genes are expressed during the end of the exponential growth phase and the beginning of the stationary phase under the control of an alternative sigma factor encoded by botR/A, which is located between the two operons. In the genome of C. botulinum type A strain Hall, 30 gene pairs predicted to encode two-component systems (TCSs) and 9 orphan regulatory genes have been identified. Therefore, 34 Hall isogenic antisense strains on predicted regulatory genes (29 TCSs and 5 orphan regulatory genes) have been obtained by a mRNA antisense procedure. Two TCS isogenic antisense strains showed more rapid growth kinetics and reduced BoNT/A production than the control strain, as well as increased bacterial lysis and impairment of the bacterial cell wall structure. Three other TCS isogenic antisense strains induced a low level of BoNT/A and ANTP production. Interestingly, reduced expression of bont/A and antp genes was shown to be independent of botR/A. These results indicate that BoNT/A synthesis is under the control of a complex network of regulation including directly at least three TCSs.	[Connan, Chloe; Mazuet, Christelle; Raffestin, Stephanie; Cayet, Nadege; Popoff, Michel R.] Inst Pasteur, Paris, France; [Brueggemann, Holger] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Aarhus University	Popoff, MR (corresponding author), Inst Pasteur, Paris, France.	mpopoff@pasteur.fr	Popoff, Michel/O-7719-2016; Mazuet, Christelle/O-7731-2016	Popoff, Michel/0000-0001-9305-8989; Mazuet, Christelle/0000-0001-7619-9050; Bruggemann, Holger/0000-0001-7433-0190	Institut Pasteur; DGA fellowship	Institut Pasteur(European Commission); DGA fellowship	Funding was provided by the Institut Pasteur and a DGA fellowship to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artin I, 2008, APPL ENVIRON MICROB, V74, P2391, DOI 10.1128/AEM.02587-07; Artin I, 2010, APPL ENVIRON MICROB, V76, P1168, DOI 10.1128/AEM.02247-09; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Brunger AT, 2009, TOXICON, V54, P550, DOI 10.1016/j.toxicon.2008.12.027; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Cheung JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005849; Cooksley CM, 2010, APPL ENVIRON MICROB, V76, P4448, DOI 10.1128/AEM.03038-09; Couesnon A, 2006, MICROBIOL-SGM, V152, P759, DOI 10.1099/mic.0.28561-0; Dineen SS, 2004, FEMS MICROBIOL LETT, V235, P9, DOI 10.1016/j.femsle.2004.04.002; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841, DOI 10.1099/00221287-143-12-3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Hassan S, 2010, J MICROBIOL, V48, P96, DOI 10.1007/s12275-009-0384-3; HAUSER D, 1995, TOXICON, V33, P515, DOI 10.1016/0041-0101(94)00190-J; Henderson I, 1996, FEMS MICROBIOL LETT, V140, P151, DOI 10.1016/0378-1097(96)00172-3; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovenklev M, 2004, APPL ENVIRON MICROB, V70, P2928, DOI 10.1128/AEM.70.5.2928-2934.2004; Ma ML, 2011, MBIO, V2, DOI 10.1128/mBio.00338-10; Marvaud JC, 1998, MOL MICROBIOL, V29, P1009, DOI 10.1046/j.1365-2958.1998.00985.x; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17, DOI 10.3109/15569549909036015; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; Popoff M.R., 1999, COMPREHENSIVE SOURCE, VVolume 2, P174; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; Quinn CP, 2001, CLOSTRIDIA: BIOTECHNOLOGY AND MEDICAL APPLICATIONS, P211; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Raffestin S, 2005, MOL MICROBIOL, V55, P235, DOI 10.1111/j.1365-2958.2004.04377.x; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Sharma SK, 2003, TOXICON, V41, P321, DOI 10.1016/S0041-0101(02)00309-4; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006	37	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41848	10.1371/journal.pone.0041848	http://dx.doi.org/10.1371/journal.pone.0041848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848632	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600053
J	Bahat, A; Caplan, SR; Eisenbach, M				Bahat, Anat; Caplan, S. Roy; Eisenbach, Michael			Thermotaxis of Human Sperm Cells in Extraordinarily Shallow Temperature Gradients Over a Wide Range	PLOS ONE			English	Article							HEAT-INDUCED HYPERACTIVATION; FEMALE GENITAL-TRACT; HUMAN SPERMATOZOA; FOLLICULAR FACTORS; CHEMOTAXIS; MOTILITY; CAPACITATION; DICTYOSTELIUM; MAMMALS; EGG	On the basis of the finding that capacitated (ready to fertilize) rabbit and human spermatozoa swim towards warmer temperatures by directing their movement along a temperature gradient, sperm thermotaxis has been proposed to be one of the processes guiding these spermatozoa to the fertilization site. Although the molecular mechanism underlying sperm thermotaxis is gradually being revealed, basic questions related to this process are still open. Here, employing human spermatozoa, we addressed the questions of how wide the temperature range of thermotaxis is, whether this range includes an optimal temperature or whether spermatozoa generally prefer swimming towards warmer temperatures, whether or not they can sense and respond to descending temperature gradients, and what the minimal temperature gradient is to which they can thermotactically respond. We found that human spermatozoa can respond thermotactically within a wide temperature range (at least 29-41 degrees C), that within this range they preferentially accumulate in warmer temperatures rather than at a single specific, preferred temperature, that they can respond to both ascending and descending temperature gradients, and that they can sense and thermotactically respond to temperature gradients as low as <0.014 degrees C/mm. This temperature gradient is astonishingly low because it means that as a spermatozoon swims through its entire body length (46 mm) it can sense and respond to a temperature difference of <0.0006 degrees C. The significance of this surprisingly high temperature sensitivity is discussed.	[Bahat, Anat; Caplan, S. Roy; Eisenbach, Michael] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bahat, A (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.eisenbach@weizmann.ac.il		Eisenbach, Michael/0000-0001-9048-4720	Chief Scientist Office of the Ministry of Health, Israel [3-00000-5183]	Chief Scientist Office of the Ministry of Health, Israel	This study was supported by a research grant no. 3-00000-5183 from the Chief Scientist Office of the Ministry of Health, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Bahat A, 2005, HUM REPROD, V20, P2118, DOI 10.1093/humrep/dei006; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Bahat A, 2007, THESIS WEIZMANN I SC; Bahat A, 2006, MOL CELL ENDOCRINOL, V252, P115, DOI 10.1016/j.mce.2006.03.027; Bahat A, 2010, BIOL REPROD, V82, P606, DOI 10.1095/biolreprod.109.080127; Chan PJ, 1998, J ASSIST REPROD GEN, V15, P32, DOI 10.1023/A:1022526305186; Chan PJ, 1998, FERTIL STERIL, V69, P118, DOI 10.1016/S0015-0282(97)00440-8; CHEN Q, 1992, J BIOL CHEM, V267, P8207; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; DAVID A, 1972, International Journal of Gynecology and Obstetrics, V10, P52; DAVIS RO, 1993, J ANDROL, V14, P385; Davis RO, 1995, REPROD FERT DEVELOP, V7, P857, DOI 10.1071/RD9950857; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Fraser LR, 2010, MOL REPROD DEV, V77, P197, DOI 10.1002/mrd.21124; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; GERHARD I, 1989, ANDROLOGIA, V21, P146; Giojalas LC, 2004, FERTIL STERIL, V82, P247, DOI 10.1016/j.fertnstert.2003.11.046; Green S, 1999, HUM REPROD, V14, P123, DOI 10.1093/humrep/14.1.123; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hendricks KEM, 2009, J REPROD DEVELOP, V55, P69, DOI 10.1262/jrd.20097; Jaiswal BS, 2002, FERTILIZATION, P57, DOI DOI 10.1016/B978-012311629-1/50005-X; Kaupp UB, 2006, J CELL PHYSIOL, V208, P487, DOI 10.1002/jcp.20669; Keppler EL, 1999, ARCH ANDROLOGY, V42, P35, DOI 10.1080/014850199263020; Kucuk T, 2008, J ASSIST REPROD GEN, V25, P235, DOI 10.1007/s10815-008-9226-1; Lewus P, 1999, J BACTERIOL, V181, P4020, DOI 10.1128/JB.181.13.4020-4025.1999; MAEDA K, 1976, J BACTERIOL, V127, P1039, DOI 10.1128/JB.127.3.1039-1046.1976; Marchetti C, 2004, HUM REPROD, V19, P2267, DOI 10.1093/humrep/deh416; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Miller VL, 2001, AM J OBSTET GYNECOL, V184, P1057, DOI 10.1067/mob.2001.114505; MIZUNO T, 1992, ANAL BIOCHEM, V207, P208, DOI 10.1016/0003-2697(92)90002-O; Mortimer ST, 1997, HUM REPROD UPDATE, V3, P403, DOI 10.1093/humupd/3.5.403; PLINE M, 1988, J NEMATOL, V20, P605; POFF KL, 1977, P NATL ACAD SCI USA, V74, P2007, DOI 10.1073/pnas.74.5.2007; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; WHITAKER BD, 1980, EXP CELL RES, V128, P87, DOI 10.1016/0014-4827(80)90390-0; *WHO, 1993, WHO LAB MAN EX HUM S	39	62	62	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41915	10.1371/journal.pone.0041915	http://dx.doi.org/10.1371/journal.pone.0041915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848657	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600142
J	Hackett, ML; Glozier, N; Jan, S; Lindley, R				Hackett, Maree L.; Glozier, Nick; Jan, Stephen; Lindley, Richard			Returning to Paid Employment after Stroke: The Psychosocial Outcomes In StrokE (POISE) Cohort Study	PLOS ONE			English	Article							COMMUNITY STROKE; WORK; DEPRESSION; ADULTS; HEALTH	Objectives: To determine which early modifiable factors are associated with younger stroke survivors' ability to return to paid work in a cohort study with 12-months of follow-up conducted in 20 stroke units in the Stroke Services NSW clinical network. Participants: Were aged >17 and <65 years, recent (within 28 days) stroke, able to speak English sufficiently to respond to study questions, and able to provide written informed consent. Participants with language or cognitive impairment were eligible to participate if their proxy provided consent and completed assessments on the participants' behalf. The main outcome measure was return to paid work during the 12 months following stroke. Results: Of 441 consented participants (average age 52 years, 68% male, 83% with ischemic stroke), 218 were in paid full-time and 53 in paid part-time work immediately before their stroke, of whom 202 (75%) returned to paid part-or full-time work within 12 months. Being male, female without a prior activity restricting illness, younger, independent in activities of daily living (ADL) at 28 days after stroke, and having private health insurance was associated with return to paid work, following adjustment for other illnesses and a history of depression before stroke (C statistic 0.81). Work stress and post stroke depression showed no such independent association. Conclusions: Given that independence in ADL is the strongest predictor of return to paid work within 12 months of stroke, these data reinforce the importance of reducing stroke-related disability and increasing independence for younger stroke survivors.	[Hackett, Maree L.; Lindley, Richard] Univ Sydney, George Inst Global Hlth, Neurol & Mental Hlth Div, Sydney, NSW 2006, Australia; [Glozier, Nick] Univ Sydney, Sydney Med Sch, Psychol Med Brain & Mind Res Inst, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney; University of Sydney	Hackett, ML (corresponding author), Univ Sydney, George Inst Global Hlth, Neurol & Mental Hlth Div, Sydney, NSW 2006, Australia.	mhackett@george.org.au	Hackett, Maree L/O-8752-2016; Jan, Stephen/AAG-3333-2021; Lindley, Richard/B-8148-2013	Hackett, Maree L/0000-0003-1211-9087; Lindley, Richard/0000-0002-0104-5679; Jan, Stephen/0000-0003-2839-1405; Glozier, Nick/0000-0002-0476-9146	National Health and Medical Research Council (NHMRC) of Australia [512429]; National Health and Medical Research Council (NHMRC) Public Health (Australia) Fellowship [402849]; National Health and Medical Research Council Population Health Career Development Award (CDA) [632925]; National Health and Medical Research Council Career Development Award (NHMRC CDA) [457117]; New South Wales Health and the Commonwealth of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Public Health (Australia) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Population Health Career Development Award (CDA); National Health and Medical Research Council Career Development Award (NHMRC CDA)(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Health and the Commonwealth of Australia	This study was funded by project grant 512429 from the National Health and Medical Research Council (NHMRC) of Australia. During the completion of this work MH was in receipt of a National Health and Medical Research Council (NHMRC) Public Health (Australia) Fellowship 402849 (2006-2009) and a National Health and Medical Research Council Population Health Career Development Award (CDA) 632925 (2010-2013); SJ was in receipt of a National Health and Medical Research Council Career Development Award (NHMRC CDA) 457117 (2007-2011); and RL was supported by infrastructure grants from New South Wales Health and the Commonwealth of Australia, and funded by the Moran Foundation for Older Australians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CS, 1993, MED J AUSTRALIA, V158, P80, DOI 10.5694/j.1326-5377.1993.tb137528.x; [Anonymous], 2008, SAS 9 2; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Australian Bureau of Statistics, 2007, 63610 AUSTR BUR STAT; Barker G, 2006, GETTING BACK WORK ST; Busch MA, 2009, J NEUROL NEUROSUR PS, V80, P888, DOI 10.1136/jnnp.2008.163295; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cadilhac DA, 2008, QUAL SAF HEALTH CARE, V17, P329, DOI 10.1136/qshc.2007.024604; Cai L, 2006, DISABILITY SUPPORT P; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.535088, 10.1161/STROKEAHA.108.534487]; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Glozier N, 2008, STROKE, V39, P1526, DOI 10.1161/STROKEAHA.107.503219; Hackett ML, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-24; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; McNamara M, 2011, APPL ERGON, V42, P225, DOI 10.1016/j.apergo.2010.06.013; O'Neil A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-95; OECD, 2007, SICK DIS WORK BREAK, V2; Paradise M, 2012, AUSTR NZ J IN PRESS; Private Health Insurance Administration Council, 2010, Q STAT 2010; Saeki S, 2010, J REHABIL MED, V42, P254, DOI 10.2340/16501977-0503; Schofield DJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-418; Schofield DJ, 2011, BRIT J PSYCHIAT, V198, P123, DOI 10.1192/bjp.bp.110.081679; The Royal Australasian College of Physician, 2010, ROYAL AUSTR COLL PHY ROYAL AUSTR COLL PHY; Thrift AG, 2000, CEREBROVASC DIS, V10, P1; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Wade D T, 1985, Int Rehabil Med, V7, P176; Ware J., 1993, SF 36 HLTH SURVEY MA; Warren D., 2006, ASPECTS RETIREMENT O; Whiteford P, 2011, WILL BUDGET SLOW GRO; Wozniak MA, 2002, NEUROEPIDEMIOLOGY, V21, P159, DOI 10.1159/000059516; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	71	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41795	10.1371/journal.pone.0041795	http://dx.doi.org/10.1371/journal.pone.0041795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979GX	22848610	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600121
J	Kassambara, A; Hose, D; Moreaux, J; Reme, T; Torrent, J; Rossi, JF; Goldschmidt, H; Klein, B				Kassambara, Alboukadel; Hose, Dirk; Moreaux, Jerome; Reme, Thierry; Torrent, Jennifer; Rossi, Jean Francois; Goldschmidt, Hartmut; Klein, Bernard			Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma	PLOS ONE			English	Article							RISK-ADAPTED TREATMENT; MOLECULAR CLASSIFICATION; TUMOR ANGIOGENESIS; SELF-RENEWAL; B-CELL; EXPRESSION; MODEL; CANCER; GROWTH; INDUCTION	Gene expression-based scores used to predict risk in cancer frequently include genes coding for DNA replication, repair or recombination. Using two independent cohorts of 206 and 345 previously-untreated patients with Multiple Myeloma (MM), we identified 50 cell cycle-unrelated genes overexpressed in multiple myeloma cells (MMCs) compared to normal human proliferating plasmablasts and non-proliferating bone marrow plasma cells and which have prognostic value for overall survival. Thirty-seven of these 50 myeloma genes (74%) were enriched in genes overexpressed in one of 3 normal human stem cell populations - pluripotent (18), hematopoietic (10) or mesenchymal stem cells (9) - and only three genes were enriched in one of 5 populations of differentiated cells (memory B lymphocytes, T lymphocytes, polymorphonuclear cells, monocytes, osteoclasts). These 37 genes shared by MMCs and adult or pluripotent stem cells were used to build a stem cell score ((SC)score), which proved to be strongly prognostic in the 2 independent cohorts of patients compared to other gene expression-based risk scores or usual clinical scores using multivariate Cox analysis. This finding highlights cell cycleun-related prognostic genes shared by myeloma cells and normal stem cells, whose products might be important for normal and malignant stem cell biology.	[Moreaux, Jerome; Reme, Thierry; Torrent, Jennifer; Rossi, Jean Francois; Klein, Bernard] CHU Montpellier, Inst Res Biotherapy, Montpellier, France; [Kassambara, Alboukadel; Moreaux, Jerome; Reme, Thierry; Klein, Bernard] INSERM, U1040, Montpellier, France; [Klein, Bernard] Univ Montpellier I, UFR Med, Montpellier, France; [Hose, Dirk; Goldschmidt, Hartmut] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany; [Hose, Dirk; Goldschmidt, Hartmut] Natl Ctr Tumorerkrankungen, Heidelberg, Germany	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kassambara, A (corresponding author), CHU Montpellier, Inst Res Biotherapy, Montpellier, France.	bernard.klein@inserm.fr	Xiao, Yang/B-5668-2012; Goldschmidt, Hartmut/AAL-8069-2021; moreaux, jerome/HGA-5649-2022; J, Moreaux/ABA-2974-2021	J, Moreaux/0000-0002-5717-3207	ARC "Association pour la Recherche sur le 355 Cancer'' (Paris, France) [SL220110603450]; European Community; Tumorzentrum Heidelberg/Mannheim, Germany; Deutsche Krebshilfe, Bonn, Germany; Deutsche Forschungsgemeinschaft, Bonn, Germany [Transregio TRR 79]	ARC "Association pour la Recherche sur le 355 Cancer'' (Paris, France); European Community(European Commission); Tumorzentrum Heidelberg/Mannheim, Germany; Deutsche Krebshilfe, Bonn, Germany(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was supported by grants from ARC "Association pour la Recherche sur le 355 Cancer'' (SL220110603450, Paris, France), the European Community (FP7- OVERMYR), the Tumorzentrum Heidelberg/Mannheim, Germany, and the Deutsche Krebshilfe, Bonn, Germany, the Deutsche Forschungsgemeinschaft (Transregio TRR 79), Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber KE, 2007, GENE CHROMOSOME CANC, V46, P478, DOI 10.1002/gcc.20431; Barlogie B, 2006, BLOOD, V107, P2633, DOI 10.1182/blood-2005-10-4084; Bjerke GA, 2011, MOL CELL BIOL, V31, P3723, DOI 10.1128/MCB.01456-10; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chiron D, 2011, BR J HAEMATOL; Chiron D, 2012, BRIT J HAEMATOL, V156, P679, DOI 10.1111/j.1365-2141.2011.08904.x; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Cremer FW, 2005, GENE CHROMOSOME CANC, V44, P194, DOI 10.1002/gcc.20231; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Groen RWJ, 2011, HAEMATOL-HEMATOL J, V96, P1653, DOI 10.3324/haematol.2010.038133; Gu ZJ, 2000, LEUKEMIA, V14, P188, DOI 10.1038/sj.leu.2401632; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Hose D, 2011, HAEMATOL-HEMATOL J, V96, P87, DOI 10.3324/haematol.2010.030296; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Jakubikova J, 2011, BLOOD, V117, P4409, DOI 10.1182/blood-2010-02-267344; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Moreaux J, 2005, BLOOD, V106, P1021, DOI 10.1182/blood-2004-11-4512; Moreaux J, 2011, HAEMATOL-HEMATOL J, V96, P574, DOI 10.3324/haematol.2010.033456; Moreaux J, 2011, BLOOD, V117, P1280, DOI 10.1182/blood-2010-04-279760; Paraoanu LE, 2007, LIFE SCI, V80, P2375, DOI 10.1016/j.lfs.2007.03.008; Rebouissou C, 1998, BLOOD, V91, P4727, DOI 10.1182/blood.V91.12.4727.412k35_4727_4737; Reme T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-16; Rickelt S, 2009, INT J CANCER, V125, P2036, DOI 10.1002/ijc.24552; Schmid BC, 2007, BREAST CANCER RES TR, V106, P333, DOI 10.1007/s10549-007-9504-0; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Sperling LE, 2008, CHEM-BIOL INTERACT, V175, P156, DOI 10.1016/j.cbi.2008.05.034; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Szymanski P, 2011, PHARMAZIE, V66, P399, DOI 10.1691/ph.2011.0815; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Team RDC, 2019, R LANG ENV STAT COMP; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Wessler I, 1999, CLIN EXP PHARMACOL P, V26, P198, DOI 10.1046/j.1440-1681.1999.03016.x; Wessler I, 2001, JPN J PHARMACOL, V85, P2, DOI 10.1254/jjp.85.2; Xiong W, 2008, BLOOD, V112, P4235, DOI 10.1182/blood-2007-10-119123; ZHANG XG, 1994, BLOOD, V83, P3654	51	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42161	10.1371/journal.pone.0042161	http://dx.doi.org/10.1371/journal.pone.0042161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860071	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600064
J	Lehmann, FM; Feicht, S; Helm, F; Maurberger, A; Ladinig, C; Zimber-Strobl, U; Kuhn, R; Mautner, J; Gerbitz, A; Bornkamm, GW				Lehmann, Frank M.; Feicht, Samantha; Helm, Florian; Maurberger, Anna; Ladinig, Camilla; Zimber-Strobl, Ursula; Kuehn, Ralf; Mautner, Josef; Gerbitz, Armin; Bornkamm, Georg W.			Humanized c-Myc Mouse	PLOS ONE			English	Article							CANCER; MICE; GENE; DIFFERENTIATION; ANTISENSE; PROTEIN; CELLS; LYMPHOMAGENESIS; INACTIVATION; ONCOGENES	Background: A given tumor is usually dependent on the oncogene that is activated in the respective tumor entity. This phenomenon called oncogene addiction provides the rationale for attempts to target oncogene products in a therapeutic manner, be it by small molecules, by small interfering RNAs (siRNA) or by antigen-specific T cells. As the proto-oncogene product is required also for the function of normal cells, this raises the question whether there is a therapeutic window between the adverse effects of specific inhibitors or T cells to normal tissue that may limit their application, and their beneficial tumor-specific therapeutic action. To address this crucial question, suitable mouse strains need to be developed, that enable expression of the human proto-oncogene not only in tumor but also in normal cells. The aim of this work is to provide such a mouse strain for the human proto-oncogene product c-MYC. Principal Findings: We generated C57BL/6-derived embryonic stem cells that are transgenic for a humanized c-Myc gene and established a mouse strain (hc-Myc) that expresses human c-MYC instead of the murine ortholog. These transgenic animals harbor the humanized c-Myc gene integrated into the endogenous murine c-Myc locus. Despite the lack of the endogenous murine c-Myc gene, homozygous mice show a normal phenotype indicating that human c-MYC can replace its murine ortholog. Conclusions: The newly established hc-Myc mouse strain provides a model system to study in detail the adverse effects of therapies that target the human c-MYC protein. To mimic the clinical situation, hc-Myc mice may be cross-bred to mice that develop tumors due to overexpression of human c-MYC. With these double transgenic mice it will be possible to study simultaneously the therapeutic efficiency and adverse side effects of MYC-specific therapies in the same mouse.	[Lehmann, Frank M.; Ladinig, Camilla; Bornkamm, Georg W.] Helmholtz Ctr Munich, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Feicht, Samantha; Zimber-Strobl, Ursula] Helmholtz Ctr Munich, Dept Gene Vectors, Munich, Germany; [Helm, Florian] Charite, Dept Immunol, Berlin, Germany; [Kuehn, Ralf] Helmholtz Ctr Munich, Inst Dev Genet, Neuherberg, Germany; [Maurberger, Anna; Gerbitz, Armin] Univ Erlangen Nurnberg, Dept Hematol Oncol, D-91054 Erlangen, Germany; [Mautner, Josef] Tech Univ Munich, Clin Cooperat Grp Pediat Tumor Immunol, Munich, Germany; [Mautner, Josef] Tech Univ TU Munich, Dept Pediat, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Technical University of Munich	Lehmann, FM (corresponding author), Helmholtz Ctr Munich, Inst Clin Mol Biol & Tumor Genet, Munich, Germany.	Bornkamm@helmholtz-muenchen.de	Zimber-Strobl, Ursula/M-4618-2014; Kühn, Ralf/U-1278-2017	Zimber-Strobl, Ursula/0000-0002-9765-5251; Kühn, Ralf/0000-0003-1694-9803; Lehmann, Frank Michael/0000-0002-0381-9033	Deutsche Forschungsgemeinschaft (DFG) [Transregio SFB-TRR36]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG, Transregio SFB-TRR36, URL: http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Avet-Loiseau H, 2001, BLOOD, V98, P3082, DOI 10.1182/blood.V98.10.3082; BAKER VV, 1990, GYNECOL ONCOL, V38, P340, DOI 10.1016/0090-8258(90)90069-W; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Cutrona G, 2000, NAT BIOTECHNOL, V18, P300, DOI 10.1038/73745; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Hudziak RM, 2000, ANTISENSE NUCLEIC A, V10, P163, DOI 10.1089/oli.1.2000.10.163; Iversen PL, 2003, CLIN CANCER RES, V9, P2510; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Marinkovic D, 2004, INT J CANCER, V110, P336, DOI 10.1002/ijc.20099; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Pastorino F, 2008, J CONTROL RELEASE, V126, P85, DOI 10.1016/j.jconrel.2007.11.010; Prochownik Edward V, 2010, Genes Cancer, V1, P650; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Torres RM, 1997, LAB PROTOCOLS CONDIT, Vxii; Treszl A, 2004, CYTOM PART B-CLIN CY, V60B, P37, DOI 10.1002/cyto.b.20016; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42021	10.1371/journal.pone.0042021	http://dx.doi.org/10.1371/journal.pone.0042021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860051	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000307045600053
J	Levy-Gigi, E; Keri, S				Levy-Gigi, Einat; Keri, Szabolcs			Falling Out of Time: Enhanced Memory for Scenes Presented at Behaviorally Irrelevant Points in Time in Posttraumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							SCRIPT-DRIVEN IMAGERY; TRAUMATIC MEMORIES; AMYGDALA; ASSOCIATION; INFORMATION; MECHANISMS; DEPRESSION; STIMULI; EMOTION; SCALE	Spontaneous encoding of the visual environment depends on the behavioral relevance of the task performed simultaneously. If participants identify target letters or auditory tones while viewing a series of briefly presented natural and urban scenes, they demonstrate effective scene recognition only when a target, but not a behaviorally irrelevant distractor, appears together with the scene. Here, we show that individuals with posttraumatic stress disorder (PTSD), who witnessed the red sludge disaster in Hungary, show the opposite pattern of performance: enhanced recognition of scenes presented together with distractors and deficient recognition of scenes presented with targets. The recognition of trauma-related and neutral scenes was not different in individuals with PTSD. We found a positive correlation between memory for scenes presented with auditory distractors and re-experiencing symptoms (memory intrusions and flashbacks). These results suggest that abnormal encoding of visual scenes at behaviorally irrelevant events might be associated with intrusive experiences by disrupting the flow of time.	[Levy-Gigi, Einat] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Levy-Gigi, Einat; Keri, Szabolcs] Natl Psychiat Ctr, Budapest, Hungary; [Keri, Szabolcs] Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary	Rutgers State University Newark; Rutgers State University New Brunswick; Szeged University	Levy-Gigi, E (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	szkeri2000@yahoo.com		Levy-Gigi, Einat/0000-0001-5759-6480				Adenauer H, 2010, BIOL PSYCHIAT, V68, P451, DOI 10.1016/j.biopsych.2010.05.015; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amir N, 2009, J ANXIETY DISORD, V23, P1080, DOI 10.1016/j.janxdis.2009.07.010; Antal A, 2000, COGNITIVE BRAIN RES, V9, P117, DOI 10.1016/S0926-6410(99)00053-1; Beevers CG, 2011, AM J PSYCHIAT, V168, P735, DOI 10.1176/appi.ajp.2011.10091309; Blake D. D., 1990, BEHAV THERAPIST, V18, P187, DOI DOI 10.1007/BF02105408; BREMNER JD, 1995, J TRAUMA STRESS, V8, P527, DOI 10.1002/jts.2490080403; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Brewin CR, 2007, MEMORY, V15, P227, DOI 10.1080/09658210701256423; Brewin CR, 2011, ANNU REV CLIN PSYCHO, V7, P203, DOI 10.1146/annurev-clinpsy-032210-104544; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Chao LL, 2012, NEUROREPORT, V23, P412, DOI 10.1097/WNR.0b013e328352025e; Conway MA, 1994, FLASHBULB MEMORIES; Cunningham WA, 2012, CURR DIR PSYCHOL SCI, V21, P54, DOI 10.1177/0963721411430832; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; De Baene W, 2007, J NEUROPHYSIOL, V97, P2900, DOI 10.1152/jn.00741.2006; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Elbert T, 2011, Z PSYCHOL, V219, P167, DOI 10.1027/2151-2604/a000064; Evans C, 2007, J CONSULT CLIN PSYCH, V75, P134, DOI 10.1037/0022-006X.75.1.134; Fenker DB, 2008, J COGNITIVE NEUROSCI, V20, P1250, DOI 10.1162/jocn.2008.20086; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; First M.B., 2014, STRUCTURED CLIN INTE; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harvey AG, 1999, BRIT J CLIN PSYCHOL, V38, P401, DOI 10.1348/014466599162999; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Hovens JE, 2000, PSYCHOL REP, V87, P750, DOI 10.2466/PR0.87.7.750-752; Jacoby O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024255; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Kroes MCW, 2011, EUR PSYCHIAT, V26, P525, DOI 10.1016/j.eurpsy.2011.03.002; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lin JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000337; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pessoa L, 2010, NEUROPSYCHOLOGIA, V48, P3416, DOI 10.1016/j.neuropsychologia.2010.06.038; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; POTTER MC, 1993, MEM COGNITION, V21, P156, DOI 10.3758/BF03202727; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Swallow KM, 2010, COGNITION, V115, P118, DOI 10.1016/j.cognition.2009.12.003; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; Wechsler D., 2011, WASI 2 WECHSLER ABBR	50	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42502	10.1371/journal.pone.0042502	http://dx.doi.org/10.1371/journal.pone.0042502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860135	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000307045600107
J	Lin, WC; Chuang, YC; Chang, YS; Lai, MD; Teng, YN; Su, IJ; Wang, CCC; Lee, KH; Hung, JH				Lin, Wan-Chi; Chuang, Yu-Chi; Chang, Yung-Sheng; Lai, Ming-Derg; Teng, Yen-Ni; Su, Ih-Jen; Wang, Clay C. C.; Lee, Kuan-Han; Hung, Jui-Hsiang			Endoplasmic Reticulum Stress Stimulates p53 Expression through NF-kappa B Activation	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; DNA-DAMAGE; ER STRESS; PHOSPHORYLATION; KINASE	Background: Induction of apoptosis by endoplasmic reticulum (ER) stress is implicated as the major factor in the development of multiple diseases. ER stress also appears to be a potentially useful major response to many chemotherapeutic drugs and environmental chemical compounds. A previous study has indicated that one major apoptotic regulator, p53, is significantly increased in response to ER stress, and participates in ER stress-induced apoptosis. However, the regulators of p53 expression during ER stress are still not fully understood. Principal Findings: In this report, we demonstrate that induction of p53 expression is mediated through NF-kappa B signaling pathways during ER stress in MCF-7 cells. Tunicamycin or brefeldin A, two ER stress inducers, increased p53 expression in MCF-7 and Hela cells. We found p53 nuclear localization, activity, and phosphorylation at serine 15 on p53 increased during ER stress. Nuclear translocation of NF-kappa B and activity of NF-kappa B were also observed during ER stress. ER stress-induced p53 expression was significantly inhibited by coincubation with the NF-kappa B inhibitor, Bay 11-7082 and downregulation of NF-kappa B p65 expression. The role of p53 in mediating Brefeldin A-induced apoptosis was also investigated. Induction of p53 expression by Brefeldin A was correlated to Brefeldin A-induced apoptosis. Furthermore, downregulation of p53 expression by p53 siRNA significantly reduced Brefeldin A-induced apoptosis in MCF-7 cells. Significance: Taken together, NF-kappa B activation and induction of p53 expression is essential for ER stress-induced cell death which is important for therapeutic effects of clinical cancer drugs. Our results may provide insight into the mechanism of cancer chemotherapy efficacy that is associated with induction of ER stress.	[Lin, Wan-Chi] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Chuang, Yu-Chi; Chang, Yung-Sheng; Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chang, Yung-Sheng; Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Inst Basic Med, Tainan 70101, Taiwan; [Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Teng, Yen-Ni] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan; [Su, Ih-Jen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Wang, Clay C. C.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Lee, Kuan-Han] Chia Nan Univ Pharm & Sci, Inst Pharmaceut Sci, Tainan, Taiwan; [Hung, Jui-Hsiang] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	University of Nebraska System; University of Nebraska Medical Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National University Tainan; National Health Research Institutes - Taiwan; University of Southern California; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science	Lin, WC (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	hung86@mail.chna.edu.tw	Su, Ih-Jen/B-2655-2010; Wang, Clay/ABG-9056-2021; Lai, Ming-Derg/M-8028-2014; LEE, KH/AAP-8972-2021	LEE, KH/0000-0003-2693-4496; Hung, Jui-Hsiang/0000-0002-7649-4823; TENG, YEN-NI/0000-0002-3340-8577	National Science Council on Taiwan [NSC 99-2320-B-041-001]; Chia-Nan University of Pharmacy & Science, Tainan, Taiwan [CN9911]	National Science Council on Taiwan; Chia-Nan University of Pharmacy & Science, Tainan, Taiwan	This work has been supported by a research grant from the National Science Council on Taiwan (NSC 99-2320-B-041-001), and in part by grant CN9911 to Dr. Jui-Hsiang Hung from Chia-Nan University of Pharmacy & Science, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang YS, 2011, J CELL BIOCHEM, V112, P881, DOI 10.1002/jcb.22996; Dimcheff DE, 2003, J VIROL, V77, P12617, DOI 10.1128/JVI.77.23.12617-12629.2003; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Furlong EEM, 1996, MOL CELL BIOL, V16, P5933; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hill DS, 2009, CLIN CANCER RES, V15, P1192, DOI 10.1158/1078-0432.CCR-08-2150; Huang WC, 2009, J PHARMACOL EXP THER, V329, P524, DOI 10.1124/jpet.108.148122; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jiang C, 2004, MOL CANCER THER, V3, P877; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kraus M, 2008, MOL CANCER THER, V7, P1940, DOI 10.1158/1535-7163.MCT-07-2375; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Mak BC, 2008, J BIOL CHEM, V283, P23462, DOI 10.1074/jbc.M803194200; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Meares GP, 2011, EXP CELL RES, V317, P1621, DOI 10.1016/j.yexcr.2011.02.012; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Paschen W, 2001, J NEUROCHEM, V79, P719, DOI 10.1046/j.1471-4159.2001.00623.x; Pluquet O, 2005, MOL CELL BIOL, V25, P9392, DOI 10.1128/MCB.25.21.9392-9405.2005; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; SUN XG, 1995, MOL CELL BIOL, V15, P4489; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; WATOWICH SS, 1991, J VIROL, V65, P3590, DOI 10.1128/JVI.65.7.3590-3597.1991; WU HY, 1994, J BIOL CHEM, V269, P20067; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao H, 2008, CELL CYCLE, V7, P3048, DOI 10.4161/cc.7.19.6750; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	57	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e39120	10.1371/journal.pone.0039120	http://dx.doi.org/10.1371/journal.pone.0039120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859938	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900004
J	Maruyama, Y; Kawano, A; Okamoto, S; Ando, T; Ishitobi, Y; Tanaka, Y; Inoue, A; Imanaga, J; Kanehisa, M; Higuma, H; Ninomiya, T; Tsuru, J; Hanada, H; Akiyoshi, J				Maruyama, Yoshihiro; Kawano, Aimi; Okamoto, Shizuko; Ando, Tomoko; Ishitobi, Yoshinobu; Tanaka, Yoshihiro; Inoue, Ayako; Imanaga, Junko; Kanehisa, Masayuki; Higuma, Haruka; Ninomiya, Taiga; Tsuru, Jusen; Hanada, Hiroaki; Akiyoshi, Jotaro			Differences in Salivary Alpha-Amylase and Cortisol Responsiveness following Exposure to Electrical Stimulation versus the Trier Social Stress Tests	PLOS ONE			English	Article							SEX-DIFFERENCES; PSYCHOLOGICAL STRESS; EMOTIONAL EVENTS; RESPONSES; GENDER; FEAR; INHIBITION; MODULATION; REACTIVITY; ANXIETY	Background: Cortisol is an essential hormone in the regulation of the stress response along the HPA axis, and salivary cortisol has been used as a measure of free circulating cortisol levels. Recently, salivary alpha-amylase (sAA) has also emerged as a novel biomarker for psychosocial stress responsiveness within the sympathetic adrenomedullary (SAM) system. Principal Findings: We measured sAA and salivary cortisol in healthy volunteers after exposure to the Trier Social Stress Test (TSST) and electric stimulation stress. One hundred forty-nine healthy volunteers participated in this study. All subjects were exposed to both the TSST and electric stimulation stress on separate days. We measured sAA and salivary cortisol levels three times immediately before, immediately after, and 20 min after the stress challenge. The State (STAI-S) and Trait (STA-IT) versions of the Spielberger Anxiety Inventory test and the Profile of Mood State (POMS) tests were administered to participants before the electrical stimulation and TSST protocols. We also measured HF, LF and LF/HF Heart Rate Variability ratio immediately after electrical stimulation and TSST exposure. Following TSST exposure or electrical stimulation, sAA levels displayed a rapid increase and recovery, returning to baseline levels 20 min after the stress challenge. Salivary cortisol responses showed a delayed increase, which remained significantly elevated from baseline levels 20 min after the stress challenge. Analyses revealed no differences between men and women with regard to their sAA response to the challenges (TSST or electric stimulations), while we found significantly higher salivary cortisol responses to the TSST in females. We also found that younger subjects tended to display higher sAA activity. Salivary cortisol levels were significantly correlated with the strength of the applied electrical stimulation. Conclusions: These preliminary results suggest that the HPA axis (but not the SAM system) may show differential response patterns to distinct kinds of stressors.	[Maruyama, Yoshihiro; Kawano, Aimi; Okamoto, Shizuko; Ando, Tomoko; Ishitobi, Yoshinobu; Tanaka, Yoshihiro; Inoue, Ayako; Imanaga, Junko; Kanehisa, Masayuki; Higuma, Haruka; Ninomiya, Taiga; Tsuru, Jusen; Hanada, Hiroaki; Akiyoshi, Jotaro] Oita Univ, Fac Med, Dept Neuropsychiat, Yufu, Oita, Japan	Oita University	Maruyama, Y (corresponding author), Oita Univ, Fac Med, Dept Neuropsychiat, Yufu, Oita, Japan.	akiyoshi@oita-u.ac.jp			Ministry of Health and Welfare, Japan [23591719]	Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-aid for scientific research (C)23591719 from the Ministry of Health and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Buchanan TW, 2012, SOC NEUROSCI-UK, V7, P191, DOI 10.1080/17470919.2011.588723; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P81, DOI 10.1016/S1074-7427(02)00019-9; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Cannon W.B., 1932, WISDOM BODY; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Drummond Peter D, 2004, Int J Low Extrem Wounds, V3, P35, DOI 10.1177/1534734604263365; Ehlert U, 2006, J CLIN ENDOCR METAB, V91, P5130, DOI 10.1210/jc.2006-0461; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Filaire E, 2009, EUR J APPL PHYSIOL, V106, P71, DOI 10.1007/s00421-009-0991-z; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Hammerfald K, 2006, PSYCHONEUROENDOCRINO, V31, P333, DOI 10.1016/j.psyneuen.2005.08.007; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Higashi T, 2005, P ANN INT IEEE EMBS, P3538, DOI 10.1109/IEMBS.2005.1617243; Inagaki T, 2011, J BEHAV BRAIN SCI, V1, P12; Ishitobi Y, 2010, INT J PSYCHIAT CLIN, V14, P268, DOI 10.3109/13651501.2010.500737; Isogawa K, 2010, NEUROSCI RES PROG SE, P113; Jackson ED, 2006, BIOL PSYCHIAT, V59, P516, DOI 10.1016/j.biopsych.2005.08.002; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kivlighan KT, 2006, PSYCHONEUROENDOCRINO, V31, P703, DOI 10.1016/j.psyneuen.2006.01.007; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; Perroni F, 2009, ERGONOMICS, V52, P484, DOI 10.1080/00140130802707873; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Robles TF, 2011, BIOL PSYCHOL, V86, P50, DOI 10.1016/j.biopsycho.2010.10.006; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Rondo PHC, 2004, BRAZ J MED BIOL RES, V37, P1403, DOI 10.1590/S0100-879X2004000900016; Roy RA, 2009, J MANIP PHYSIOL THER, V32, P277, DOI 10.1016/j.jmpt.2009.03.003; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Selye H, 1935, PROC R SOC SER B-BIO, V119, P1, DOI 10.1098/rspb.1935.0073; Selye H, 1956, J BONE JOINT SURG; Shertty V, 2011, PSYCHONEUROENDOCRINO, V36, P193; SHIMADA M, 1995, HORM RES, V44, P213, DOI 10.1159/000184628; Shirasaki S, 2007, REGION ANESTH PAIN M, V32, P120, DOI 10.1016/j.rapm.2006.11.008; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Spielberger CD., 1983, STAI MANUAL STATE TR, DOI DOI 10.1037/T06496-000; STAHL F, 1982, ENDOKRINOLOGIE, V80, P158; Strahler J, 2010, PSYCHOPHYSIOLOGY, V47, P587, DOI 10.1111/j.1469-8986.2009.00957.x; Takahashi T, 2010, NEUROENDOCRINOL LETT, V31, P616; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Takai N, 2007, ANN NY ACAD SCI, V1098, P510, DOI 10.1196/annals.1384.014; Tanaka Y, 2012, NEUROSCI RES, V73, P80, DOI 10.1016/j.neures.2012.01.006; Tanaka Y, 2012, PROG NEURO-PSYCHOPH, V36, P220, DOI 10.1016/j.pnpbp.2011.10.005; Tasker JG, 2011, STRESS, V14, P398, DOI 10.3109/10253890.2011.586446; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; van Stegeren AH, 1998, PSYCHOPHARMACOLOGY, V138, P305, DOI 10.1007/s002130050675; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Vedhara K, 2003, BIOL PSYCHOL, V62, P89, DOI 10.1016/S0301-0511(02)00128-X; Yamaguchi M, 2006, BIOSENS BIOELECTRON, V21, P1007, DOI 10.1016/j.bios.2005.03.014; Yamaguchi M, 2004, BIOSENS BIOELECTRON, V20, P491, DOI 10.1016/j.bios.2004.02.012; Zorawski M, 2005, COGN AFFECT BEHAV NE, V5, P191, DOI 10.3758/CABN.5.2.191; Zorawski M, 2006, LEARN MEMORY, V13, P441, DOI 10.1101/lm.189106	64	66	67	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e39375	10.1371/journal.pone.0039375	http://dx.doi.org/10.1371/journal.pone.0039375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859941	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900006
J	Choi, JW; Ko, D; Lee, GT; Jung, KY; Kim, KH				Choi, Jeong Woo; Ko, Deokwon; Lee, Gwan-Taek; Jung, Ki-Young; Kim, Kyung Hwan			Reduced Neural Synchrony in Patients with Restless Legs Syndrome during a Visual Oddball Task	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; GAMMA-BAND ACTIVITY; PHASE SYNCHRONIZATION; SYNDROME RLS; SUBTHALAMIC NUCLEUS; MATTER ALTERATIONS; BETA-OSCILLATIONS; TARGET DETECTION; CEREBRAL-CORTEX; SCALE	Background: Restless legs syndrome (RLS) is a sensorimotor neurological disorder characterized by an irresistible urge to move the legs. It has been reported that RLS patients show cognitive deficits, presumably due to hyperactivity causing loss of attention, or malfunctions in the frontal region resulting from sleep deprivation. However, the mechanism underlying cognitive deficits in RLS patients is mostly unknown. As an effort to clarifying this, we investigated the differences in neural activity and phase synchrony between healthy controls and RLS patients during cognitive task performances. Methodology/Principal Findings: Seventeen female drug-naive RLS patients were enrolled in the study, and an age-matched group of thirteen healthy female volunteers served as controls. Multichannel event-related potentials (ERPs) were recorded from RLS patients and normal controls while performing a visual oddball task. In addition to conventional analyses of ERP waveforms and spectra, interregional gamma-band phase synchrony (GBPS) was investigated to observe the differences in interregional neural synchronies between normal and RLS patient groups. Strong GBPS was observed primarily between anterior and posterior regions along the midline for both groups. Along with significant reduction and delay of P300 ERP and induced gamma-band activity (GBA), the GBPS was considerably decreased in RLS patients compared to normal subjects, especially at frontal region. Conclusions: Overall, our results support that cognitive dysfunction in RLS patients is associated with reduced interregional neural synchrony as well as alterations in local neural activity.	[Choi, Jeong Woo; Kim, Kyung Hwan] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, South Korea; [Ko, Deokwon; Lee, Gwan-Taek; Jung, Ki-Young] Korea Univ, Coll Med, Anam Hosp, Dept Neurol,Med Ctr, Seoul 136705, South Korea	Yonsei University; Korea University; Korea University Medicine (KU Medicine)	Choi, JW (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, South Korea.	jungky@korea.ac.kr; khkim0604@yonsei.ac.kr		Kim, Kyung Hwan/0000-0001-9044-0437; Choi, Jeong Woo/0000-0001-5824-8859	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20110018295]; National Research Foundation of Korea (NRF); Korea government (MEST) [20110029740]	Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This research was supported by the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 20110018295), and supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 20110029740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R, 2004, SLEEP MED, V5, P385, DOI 10.1016/j.sleep.2004.01.012; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2001, J CLIN NEUROPHYSIOL, V18, P128, DOI 10.1097/00004691-200103000-00004; Astrakas LG, 2008, NEUROLOGY, V71, P911, DOI 10.1212/01.wnl.0000325914.50764.a2; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benes H, 2007, MOVEMENT DISORD, V22, pS401, DOI 10.1002/mds.21604; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Choi JW, 2010, NEUROSCI LETT, V468, P156, DOI 10.1016/j.neulet.2009.10.088; Connor JR, 2011, SLEEP MED, V12, P614, DOI 10.1016/j.sleep.2010.10.009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2008, EXP BRAIN RES, V185, P11, DOI 10.1007/s00221-007-1127-5; Etgen T, 2005, NEUROIMAGE, V24, P1242, DOI 10.1016/j.neuroimage.2004.10.021; Falkingham M, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-4; Fulda S, 2010, MOVEMENT DISORD, V25, P2641, DOI 10.1002/mds.23353; Gamaldo CE, 2008, SLEEP MED, V9, P500, DOI 10.1016/j.sleep.2007.07.014; Herrmann CS, 2010, NEUROSCI BIOBEHAV R, V34, P981, DOI 10.1016/j.neubiorev.2009.09.001; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jung KY, 2011, SLEEP MED, V12, P416, DOI 10.1016/j.sleep.2010.08.018; Kim KH, 2008, BRAIN RES, V1236, P105, DOI 10.1016/j.brainres.2008.07.118; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Michaud M, 2002, J NEUROL, V249, P164, DOI 10.1007/PL00007859; Ondo William G, 2005, Curr Neurol Neurosci Rep, V5, P266, DOI 10.1007/s11910-005-0071-7; Pearson VE, 2006, SLEEP MED, V7, P25, DOI 10.1016/j.sleep.2005.05.006; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Potts GF, 2001, COGNITIVE BRAIN RES, V11, P147, DOI 10.1016/S0926-6410(00)00075-6; Roth T, 2002, SLEEP MED, V3, P99, DOI 10.1016/S1389-9457(01)00131-9; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schober T, 2004, SLEEP, V27, P147, DOI 10.1093/sleep/27.1.147; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2002, NEUROSCIENCE DATABAS, P121; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tyvaert L, 2009, SLEEP MED, V10, P1090, DOI 10.1016/j.sleep.2008.11.008; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Unrath A, 2008, MOVEMENT DISORD, V23, P1250, DOI 10.1002/mds.22074; Unrath A, 2007, MOVEMENT DISORD, V22, P1751, DOI 10.1002/mds.21608; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winkelman JW, 2009, SLEEP, V32, P772, DOI 10.1093/sleep/32.6.772	56	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42312	10.1371/journal.pone.0042312	http://dx.doi.org/10.1371/journal.pone.0042312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848757	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200194
J	Mori, M; Matsuki, K; Maekawa, T; Tanaka, M; Sriwanthana, B; Yokoyama, M; Ariyoshi, K				Mori, Masahiko; Matsuki, Kei; Maekawa, Tomoyuki; Tanaka, Mari; Sriwanthana, Busarawan; Yokoyama, Masaru; Ariyoshi, Koya			Development of a Novel In Silico Docking Simulation Model for the Fine HIV-1 Cytotoxic T Lymphocyte Epitope Mapping	PLOS ONE			English	Article							PEPTIDE-MHC BINDING; STRUCTURAL PREDICTION; HLA-C; LIGANDS; SETS	Introduction: Class I HLA's polymorphism has hampered CTL epitope mapping with laborious experiments. Objectives are 1) to evaluate the novel in silico model in predicting previously reported epitopes in comparison with existing program, and 2) to apply the model to predict optimal epitopes with HLA using experimental results. Materials and Methods: We have developed a novel in silico epitope prediction method, based on HLA crystal structure and a peptide docking simulation model, calculating the peptide-HLA binding affinity at four amino acid residues in each terminal. It was applied to predict 52 HIV best-defined CTL epitopes from 15-mer overlapping peptides, and its predictive ability was compared with the HLA binding motif-based program of HLArestrictor. It was then used to predict HIV-1 Gag optimal epitopes from previous ELISpot results. Results: 43/52 (82.7%) epitopes were detected by the novel model, whereas 37 (71.2%) by HLArestrictor. We also found a significant reduction in epitope detection rates for longer epitopes in HLArestrictor (p = 0.027), but not in the novel model. Improved epitope prediction was also found by introducing both models, especially in specificity (p < 0.001). Eight peptides were predicted as novel, immunodominant epitopes in both models. Discussion: This novel model can predict optimal CTL epitopes, which were not detected by an existing program. This model is potentially useful not only for narrowing down optimal epitopes, but predicting rare HLA alleles with less information. By introducing different principal models, epitope prediction will be more precise.	[Mori, Masahiko; Matsuki, Kei; Maekawa, Tomoyuki; Tanaka, Mari; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Mori, Masahiko] Univ Oxford, Dept Paediat, Oxford, England; [Sriwanthana, Busarawan] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Yokoyama, Masaru] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan	Nagasaki University; University of Oxford; Ministry of Public Health - Thailand; National Institute of Infectious Diseases (NIID)	Mori, M (corresponding author), Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp			Japan foundation for AIDS prevention (JFAP); Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science	Japan foundation for AIDS prevention (JFAP); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Japan foundation for AIDS prevention (JFAP), and the Ministry of Health, Labour and Welfare of Japan and the Grand-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Bui HH, 2006, PROTEINS, V63, P43, DOI 10.1002/prot.20870; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jojic N, 2006, BIOINFORMATICS, V22, pE227, DOI 10.1093/bioinformatics/btl255; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Liao WWP, 2011, AUTOIMMUN REV, V10, P469, DOI 10.1016/j.autrev.2011.02.003; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Makadzange AT, 2010, EUR J IMMUNOL, V40, P1036, DOI 10.1002/eji.200939634; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mori M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022680; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ranasinghe SRF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001341; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Tong JC, 2004, PROTEIN SCI, V13, P2523, DOI 10.1110/ps.04631204; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004	35	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41703	10.1371/journal.pone.0041703	http://dx.doi.org/10.1371/journal.pone.0041703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848572	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200091
J	Yen, CJ; Lin, YJ; Yen, CS; Tsai, HW; Tsai, TF; Chang, KY; Huang, WC; Lin, PW; Chiang, CW; Chang, TT				Yen, Chia-Jui; Lin, Yih-Jyh; Yen, Chia-Sheng; Tsai, Hung-Wen; Tsai, Ting-Fen; Chang, Kwang-Yu; Huang, Wei-Chien; Lin, Pin-Wen; Chiang, Chi-Wu; Chang, Ting-Tsung			Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKK beta to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma	PLOS ONE			English	Article							NF-KAPPA-B; FACTOR-ALPHA; LINKS INFLAMMATION; TUMOR ANGIOGENESIS; RAPAMYCIN PATHWAY; TNF-ALPHA; ACTIVATION; CANCER; EXPRESSION; TRANSCRIPTION	Hepatocellular carcinoma (HCC), a major cause of cancer-related death in Southeast Asia, is frequently associated with hepatitis B virus (HBV) infection. HBV X protein (HBx), encoded by a viral non-structural gene, is a multifunctional regulator in HBV-associated tumor development. We investigated novel signaling pathways underlying HBx-induced liver tumorigenesis and found that the signaling pathway involving I kappa B kinase beta (IKK beta), tuberous sclerosis complex 1 (TSC1), and mammalian target of rapamycin (mTOR) downstream effector S6 kinase (S6K1), was upregulated when HBx was overexpressed in hepatoma cells. HBx-induced S6K1 activation was reversed by IKK beta inhibitor Bay 11-7082 or silencing IKK beta expression using siRNA. HBx upregulated cell proliferation and vascular endothelial growth factor (VEGF) production, and these HBx-upregulated phenotypes were abolished by treatment with IKK beta inhibitor Bay 11-7082 or mTOR inhibitor rapamycin. The association of HBx-modulated IKK beta/mTOR/S6K1 signaling with liver tumorigenesis was verified in a HBx transgenic mouse model in which pIKK beta, pS6K1, and VEGF expression was found to be higher in cancerous than non-cancerous liver tissues. Furthermore, we also found that pIKK beta levels were strongly correlated with pTSC1 and pS6K1 levels in HBV-associated hepatoma tissue specimens taken from 95 patients, and that higher pIKK beta, pTSC1, and pS6K1 levels were correlated with a poor prognosis in these patients. Taken together, our findings demonstrate that HBx deregulates TSC1/mTOR signaling through IKK beta, which is crucially linked to HBV-associated HCC development.	[Yen, Chia-Jui; Chang, Kwang-Yu] Natl Cheng Kung Univ, Coll Med & Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Yen, Chia-Jui; Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Lin, Yih-Jyh; Lin, Pin-Wen] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Surg, Tainan 70101, Taiwan; [Yen, Chia-Sheng] Chi Mei Med Ctr, Dept Gen Surg, Tainan, Taiwan; [Tsai, Hung-Wen] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Pathol, Tainan 70101, Taiwan; [Tsai, Ting-Fen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Tsai, Ting-Fen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Inst Canc Res, Tainan, Taiwan; [Huang, Wei-Chien] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; China Med Univ & Hosp, Grad Inst Canc Biol, Taichung, Taiwan; [Chiang, Chi-Wu; Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University	Yen, CJ (corresponding author), Natl Cheng Kung Univ, Coll Med & Hosp, Inst Clin Med, Tainan 70101, Taiwan.	chiangcw@mail.ncku.edu.tw; ttchang@mail.ncku.edu.tw	Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019	Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716	National Science Council NSC [98-2314-B-006-018-MY2]; National Cheng Kung University Comprehensive Cancer Center in Southern Taiwan [DOH99-TD-C-111-003]; Ministry of Education's 'Five Year, 50 Billion' project, NCKU Infectious Diseases and Signaling Research Center	National Science Council NSC(Ministry of Science and Technology, Taiwan); National Cheng Kung University Comprehensive Cancer Center in Southern Taiwan; Ministry of Education's 'Five Year, 50 Billion' project, NCKU Infectious Diseases and Signaling Research Center	This study was supported by grants from the National Science Council NSC 98-2314-B-006-018-MY2, National Cheng Kung University Comprehensive Cancer Center in Southern Taiwan (DOH99-TD-C-111-003), and the Ministry of Education's 'Five Year, 50 Billion' project, NCKU Infectious Diseases and Signaling Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barazani Y, 2007, WORLD J SURG, V31, P1243, DOI 10.1007/s00268-007-9041-3; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bu XX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-208; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Cavin LG, 2004, CANCER RES, V64, P7030, DOI 10.1158/0008-5472.CAN-04-1647; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dewantoro Okto, 2006, Acta Med Indones, V38, P154; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Gish RG, 2008, IDRUGS, V11, P198; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Guo SP, 2001, WORLD J GASTROENTERO, V7, P340; Kaido T, 2008, HEPATO-GASTROENTEROL, V55, P1460; Kasai Y, 1996, SEMIN SURG ONCOL, V12, P155, DOI 10.1002/(SICI)1098-2388(199605/06)12:3<155::AID-SSU2>3.0.CO;2-6; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Koskinas J, 2005, J VIRAL HEPATITIS, V12, P635, DOI 10.1111/j.1365-2893.2005.00635.x; Kulik LM, 2007, J CLIN GASTROENTEROL, V41, P839, DOI 10.1097/MCG.0b013e318060ac52; Lara-Pezzi E, 1998, HEPATOLOGY, V28, P1013, DOI 10.1002/hep.510280416; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Marotta F, 2004, Clin Ter, V155, P187; Mazzanti R, 2008, MOL ASPECTS MED, V29, P130, DOI 10.1016/j.mam.2007.09.008; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Pang RWC, 2007, ONCOLOGY-BASEL, V72, P30, DOI 10.1159/000111705; Park US, 2000, GENE, V251, P73, DOI 10.1016/S0378-1119(00)00183-9; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Rougier P, 2007, SEMIN ONCOL, V34, pS12, DOI 10.1053/j.seminoncol.2007.01.007; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Semela D, 2007, J HEPATOL, V46, P840, DOI 10.1016/j.jhep.2006.11.021; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; SIDDIQUI A, 1989, VIROLOGY, V169, P479, DOI 10.1016/0042-6822(89)90177-3; Sieghart W, 2007, TRANSPLANTATION, V83, P425, DOI 10.1097/01.tp.0000252780.42104.95; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; Wu YF, 2008, CANCER RES, V68, P2033, DOI 10.1158/0008-5472.CAN-07-2450; Yamazaki S, 2008, WORLD J GASTROENTERO, V14, P685, DOI 10.3748/wjg.14.685; Yen CJ, 2008, CANCER RES, V68, P2632, DOI 10.1158/0008-5472.CAN-07-5460; Yoo YG, 2004, FEBS LETT, V577, P121, DOI 10.1016/j.febslet.2004.10.004; Yoo YG, 2003, J BIOL CHEM, V278, P39076, DOI 10.1074/jbc.M305101200; Zhou Y, 2010, J BIOL CHEM, V285, P12159, DOI 10.1074/jbc.M109.067629	58	48	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41931	10.1371/journal.pone.0041931	http://dx.doi.org/10.1371/journal.pone.0041931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848663	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200131
J	Itonaga, K; Jones, SM; Wapstra, E				Itonaga, Keisuke; Jones, Susan M.; Wapstra, Erik			Effects of Maternal Basking and Food Quantity during Gestation Provide Evidence for the Selective Advantage of Matrotrophy in a Viviparous Lizard	PLOS ONE			English	Article							NIVEOSCINCUS-METALLICUS SCINCIDAE; INCUBATION-TEMPERATURE; ADAPTIVE SIGNIFICANCE; SWIMMING PERFORMANCE; OCELLATUS SQUAMATA; PLACENTAL-TRANSFER; OFFSPRING SIZE; LIFE-HISTORY; EVOLUTION; SURVIVAL	The evolution of matrotrophy (i.e., direct supply of nutrients by the mother during gestation) may be associated with high maternal energy availability during gestation. However, we lack knowledge about the selective advantages of matrotrophic viviparity (live-bearing) in reptiles. In reptiles, the interaction between body temperature and food intake affect maternal net energy gain. In the present study, we examined the effects of basking and food availability (2 by 2 factorial design) during gestation on offspring phenotype in a matrotrophic viviparous lizard (Pseudemoia entrecasteauxii). Subsequently, we investigated if the maternal effects were context-dependent using offspring growth rate as an indicator of the adaptive significance of matrotrophy. Offspring were exposed either to the same thermal conditions as their mothers experienced or to thermal conditions different from those experienced by their mothers. We provide the first evidence that an interaction between maternal thermal and maternal food conditions during gestation strongly affects offspring phenotype, including date of birth, body size and performance ability, which affect offspring fitness. Offspring growth rate was dependent on offspring thermal conditions, but was not influenced by maternal effects or offspring sex. Matrotrophic viviparity provided gravid females with the means to enhance offspring fitness through greater energetic input to offspring when conditions allowed it (i.e., extended basking opportunity with high food availability). Therefore, we suggest that selective advantages of matrotrophic viviparity in P. entrecasteauxii may be associated with high maternal energy availability during gestation.	[Itonaga, Keisuke; Jones, Susan M.; Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia	University of Tasmania	Wapstra, E (corresponding author), Univ Tasmania, Sch Zool, Hobart, Tas, Australia.	Erik.Wapstra@utas.edu.au	Wapstra, Erik/J-7482-2014	Wapstra, Erik/0000-0002-2050-8026	Ecological Society of Australia Student Research Awards; Australian Research Council	Ecological Society of Australia Student Research Awards; Australian Research Council(Australian Research Council)	Funding was provided by Ecological Society of Australia Student Research Awards (http://www.ecolsoc.org.au/What%20we%20do/Prizes/StudentResearchPrize.html). EW thanks the Australian Research Council for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins N, 2007, BIOL J LINN SOC, V90, P735, DOI 10.1111/j.1095-8312.2007.00770.x; Baron JP, 2010, J ANIM ECOL, V79, P640, DOI 10.1111/j.1365-2656.2010.01661.x; Blackburn DG, 2010, HERPETOL CONSERV BIO, V5, P263; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Blackburn DG, 2002, J MORPHOL, V254, P121, DOI 10.1002/jmor.10005; BROWN G, 1988, AUST WILDLIFE RES, V15, P605, DOI 10.1071/WR9880605; Brown GP, 2005, ECOLOGY, V86, P2763, DOI 10.1890/04-1805; Buckley CR, 2007, EVOL ECOL RES, V9, P169; BURGER J, 1991, BEHAV ECOL SOCIOBIOL, V28, P297; Burgess EA, 2006, CORAL REEFS, V25, P341, DOI 10.1007/s00338-006-0116-7; Cadby CD, 2011, J EXP BIOL, V214, P4234, DOI 10.1242/jeb.057349; Cadby CD, 2010, FUNCT ECOL, V24, P409, DOI 10.1111/j.1365-2435.2009.01637.x; Caley MJ, 2004, EVOLUTION, V58, P862; Chapple DG, 2002, AUSTRAL ECOL, V27, P565, DOI 10.1046/j.1442-9993.2002.01217.x; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; Dobzhansky T, 1935, P NATL ACAD SCI USA, V21, P443, DOI 10.1073/pnas.21.7.443; Einum S, 2004, EVOL ECOL RES, V6, P443; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Feder C, 2008, OECOLOGIA, V156, P773, DOI 10.1007/s00442-008-1035-9; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Harlow PS, 2000, AUSTRAL ECOL, V25, P640, DOI 10.1046/j.1442-9993.2000.01064.x; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; Itonaga K, 2012, ETHOL ECOL IN PRESS; Itonaga K., 2012, J EXP ZOO B IN PRESS; Itonaga K, 2012, PHYSIOL BIOCHEM ZOOL, V85, P231, DOI 10.1086/665567; Itonaga K, 2011, FUNCT ECOL, V25, P1318, DOI 10.1111/j.1365-2435.2011.01882.x; Itonaga K, 2011, COMP BIOCHEM PHYS A, V160, P184, DOI 10.1016/j.cbpa.2011.05.028; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P275, DOI 10.1016/j.applanim.2006.10.002; Janzen FJ, 2000, ECOLOGY, V81, P2290; Jones Geoffrey P., 2002, P221, DOI 10.1016/B978-012615185-5/50013-X; Jones SM, 1996, J HERPETOL, V30, P140, DOI 10.2307/1565504; Jones SM, 2006, HERPETOL MONOGR, V20, P186, DOI 10.1655/0733-1347(2007)20[186:PTOHOA]2.0.CO;2; Kissner KJ, 2005, J ANIM ECOL, V74, P259, DOI 10.1111/j.1365-2656.2005.00919.x; KOZLOWSKI J, 1989, EVOLUTION, V43, P1369, DOI 10.1111/j.1558-5646.1989.tb02588.x; Li H, 2009, EVOL ECOL, V23, P777, DOI 10.1007/s10682-008-9272-2; Liang H, 2007, ZOOLOGY, V110, P118, DOI 10.1016/j.zool.2006.11.004; Lindholm AK, 2006, BIOL LETTERS, V2, P586, DOI 10.1098/rsbl.2006.0546; Lourdais O, 2002, J EXP ZOOL, V292, P487, DOI 10.1002/jez.10065; Mainwaring MC, 2010, J EVOLUTION BIOL, V23, P1302, DOI 10.1111/j.1420-9101.2010.01997.x; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Melville J, 2003, J ZOOL, V261, P79, DOI 10.1017/S0952836903003984; Melville J., 1998, THESIS U TASMANIA HO; Miles DB, 2004, EVOL ECOL RES, V6, P63; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mousseau TA, 2009, PHILOS T R SOC B, V364, P1035, DOI 10.1098/rstb.2008.0303; Murphy K, 2006, J HERPETOL, V40, P454, DOI 10.1670/0022-1511(2006)40[454:RSOTCV]2.0.CO;2; Olsson M, 2002, EVOLUTION, V56, P1867; Ostrovsky AN, 2009, MAR ECOL PROG SER, V378, P113, DOI 10.3354/meps07850; Pen I, 2010, NATURE, V468, P436, DOI 10.1038/nature09512; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Robert KA, 2010, SEX DEV, V4, P119, DOI 10.1159/000260373; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; SHINE R, 1995, AM NAT, V145, P809, DOI 10.1086/285769; SINERVO B, 1994, ECOLOGY, V75, P776, DOI 10.2307/1941734; SINERVO B, 1991, J EXP BIOL, V155, P323; Sokal R.R., 2012, BIOMETRY; Spencer RJ, 1998, COMP BIOCHEM PHYS A, V121, P341, DOI 10.1016/S1095-6433(98)10132-0; Stapley J, 2006, J THERM BIOL, V31, P362, DOI 10.1016/j.jtherbio.2006.01.008; STEWART JR, 1993, J EXP BIOL, V174, P97; Stewart JR, 2003, J EXP ZOOL PART A, V299A, P13, DOI 10.1002/jez.a.10288; Swain R, 1997, J EXP ZOOL, V277, P139, DOI 10.1002/(SICI)1097-010X(19970201)277:2<139::AID-JEZ5>3.0.CO;2-Q; Swain R, 2000, HERPETOL MONOGR, V14, P432, DOI 10.2307/1467056; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Thompson MB, 1997, COMP BIOCHEM PHYS A, V118, P647, DOI 10.1016/S0300-9629(97)00081-9; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; Tsai TS, 2009, COMP BIOCHEM PHYS A, V154, P394, DOI 10.1016/j.cbpa.2009.07.011; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2011, EVOLUTION, V65, P2313, DOI 10.1111/j.1558-5646.2011.01303.x; Uller T, 2010, OECOLOGIA, V162, P663, DOI 10.1007/s00442-009-1503-x; VANDAMME R, 1992, HERPETOLOGICA, V48, P220; Wapstra E, 1996, AUST J ZOOL, V44, P205, DOI 10.1071/ZO9960205; Wapstra E, 2004, P ROY SOC B-BIOL SCI, V271, pS230, DOI 10.1098/rsbl.2003.0152; Wapstra E, 2010, J EVOLUTION BIOL, V23, P651, DOI 10.1111/j.1420-9101.2009.01924.x; Wapstra E, 1999, AUST J ZOOL, V47, P539, DOI 10.1071/ZO99038; Wapstra E, 2000, FUNCT ECOL, V14, P345, DOI 10.1046/j.1365-2435.2000.00428.x; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Warner DA, 2002, BIOL J LINN SOC, V76, P105, DOI 10.1111/j.1095-8312.2002.tb01718.x; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; Watkins TB, 1996, PHYSIOL ZOOL, V69, P154, DOI 10.1086/physzool.69.1.30164205; Webb JK, 2006, EVOLUTION, V60, P115, DOI 10.1554/05-460.1; While GM, 2009, EVOL ECOL RES, V11, P1259; While GM, 2009, ANIM BEHAV, V77, P1465, DOI 10.1016/j.anbehav.2009.03.001; WOURMS JP, 1992, AM ZOOL, V32, P276	88	21	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41835	10.1371/journal.pone.0041835	http://dx.doi.org/10.1371/journal.pone.0041835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848629	gold, Green Submitted, Green Published			2022-12-27	WOS:000309240600051
J	Wang, JW; Beck, ES; McCabe, BD				Wang, Ji-Wu; Beck, Erin S.; McCabe, Brian D.			A Modular Toolset for Recombination Transgenesis and Neurogenetic Analysis of Drosophila	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; FASCICLIN-II; FLUORESCENT PROTEIN; WHITE GENE; VECTORS; RNAI; TRANSFORMATION; CONSTRUCTION; RESOURCE; GROWTH	Transgenic Drosophila have contributed extensively to our understanding of nervous system development, physiology and behavior in addition to being valuable models of human neurological disease. Here, we have generated a novel series of modular transgenic vectors designed to optimize and accelerate the production and analysis of transgenes in Drosophila. We constructed a novel vector backbone, pBID, that allows both phiC31 targeted transgene integration and incorporates insulator sequences to ensure specific and uniform transgene expression. Upon this framework, we have built a series of constructs that are either backwards compatible with existing restriction enzyme based vectors or utilize Gateway recombination technology for high-throughput cloning. These vectors allow for endogenous promoter or Gal4 targeted expression of transgenic proteins with or without fluorescent protein or epitope tags. In addition, we have generated constructs that facilitate transgenic splice isoform specific RNA inhibition of gene expression. We demonstrate the utility of these constructs to analyze proteins involved in nervous system development, physiology and neurodegenerative disease. We expect that these reagents will facilitate the proficiency and sophistication of Drosophila genetic analysis in both the nervous system and other tissues.	[Wang, Ji-Wu; Beck, Erin S.; McCabe, Brian D.] Columbia Univ, Dept Pathol & Cell Biol, Dept Neurosci, Ctr Motor Neuron Biol & Dis, New York, NY 10027 USA	Columbia University	Wang, JW (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Dept Neurosci, Ctr Motor Neuron Biol & Dis, New York, NY 10027 USA.	brian@mccabelab.org	Beck, Erin/AAA-8399-2022	McCabe, Brian/0000-0003-1620-0501; Wang, Jiwu/0000-0002-9516-3384	NIH [GM07367, NS075572]; Gatsby Initiative in Brain Circuitry; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gatsby Initiative in Brain Circuitry; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	ES was funded by NIH GM07367. BDM was funded by NIH NS075572 and the Gatsby Initiative in Brain Circuitry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; An X, 2000, J NEUROGENET, V14, P227, DOI 10.3109/01677060009084500; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Beck ES, 2012, J NEUROSCI, V32, P7058, DOI 10.1523/JNEUROSCI.3717-11.2012; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Esposito Dominic, 2009, V498, P31, DOI 10.1007/978-1-59745-196-3_3; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; Gontijo AM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1328; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Huang J, 2009, FLY, V3, P274, DOI 10.4161/fly.9978; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Kondo T, 2006, GENES GENET SYST, V81, P129, DOI 10.1266/ggs.81.129; Kristiansen LV, 2010, ADV EXP MED BIOL, V663, P387, DOI 10.1007/978-1-4419-1170-4_24; Kuhn EJ, 2003, EMBO J, V22, P2463, DOI 10.1093/emboj/cdg241; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mehta S, 2011, ANNU REV BIOCHEM, V80, P375, DOI 10.1146/annurev-biochem-060409-093259; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MOCHIDA S, 1990, P NATL ACAD SCI USA, V87, P7844, DOI 10.1073/pnas.87.20.7844; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Ohtsuka M, 2009, CURR PHARM BIOTECHNO, V10, P244, DOI 10.2174/138920109787315033; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525; Zhu Q, 2007, FLY, V1, P55, DOI 10.4161/fly.3892	65	59	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42102	10.1371/journal.pone.0042102	http://dx.doi.org/10.1371/journal.pone.0042102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848718	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600165
J	Wu, JF; Kharebava, G; Piao, C; Stoica, BA; Dinizo, M; Sabirzhanov, B; Hanscom, M; Guanciale, K; Faden, AI				Wu, Junfang; Kharebava, Giorgi; Piao, Chunshu; Stoica, Bogdan A.; Dinizo, Michael; Sabirzhanov, Boris; Hanscom, Marie; Guanciale, Kelsey; Faden, Alan I.			Inhibition of E2F1/CDK1 Pathway Attenuates Neuronal Apoptosis In Vitro and Confers Neuroprotection after Spinal Cord Injury In Vivo	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; ADHESION MOLECULE L1; CELL-CYCLE; DEGENERATING NEURONS; PROMOTE SURVIVAL; CLOSE HOMOLOG; DEATH; EXPRESSION; ROSCOVITINE; ACTIVATION	Apoptosis of post-mitotic neurons plays a significant role in secondary tissue damage following traumatic spinal cord injury (SCI). Activation of E2F1-dependent transcription promotes expression of pro-apoptotic factors, including CDK1; this signal transduction pathway is believed to represent an important mechanism for the physiological or pathological neuronal cell death. However, a specific role for this pathway in neuronal apoptosis induced by SCI has not yet been reported. Here we demonstrate up-regulation of the E2F1/CDK1 pathway that is associated with neuronal apoptosis following impact SCI in rats. Expression of E2F1 and CDK1 were robustly up-regulated as early as 15 min after injury and sustained until 3 days post-injury. CDK1 activity and E2F1 downstream targets bim and c-Myb were significantly increased after SCI. Activation of E2F1/CDK1 signaling also was associated with death of neurons in vitro; this was attenuated by shRNA knockdown or pharmacological inhibition of the E2F1/CDK1 pathway. CR8, a novel and potent CDK1 inhibitor, blocked apoptosis of primary cortical neurons at low-micromolar concentrations. Moreover, SCI-induced up-regulation of E2F1/CDK1 and associated neuronal apoptosis was significantly attenuated by systemic injection of CR8 (1 mg/kg, i.p.) at 5 min after injury. CR8 significantly decreased posttraumatic elevation of biochemical markers of apoptosis, such as products of caspase-3 and a-fodrin cleavage, as well as neuronal cell death, as indicated by TUNEL staining. Importantly, CR8 treatment also increased the number of surviving neurons at 5 weeks after injury. Together, these findings indicate that activation of the E2F1/CDK1 pathway contributes to the pathophysiology of SCI and that selective inhibition of this signaling cascade may represent an attractive therapeutic strategy.	[Wu, Junfang] Univ Maryland Sch Med, Dept Anesthesiol, Baltimore, MD USA; Univ Maryland Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wu, JF (corresponding author), Univ Maryland Sch Med, Dept Anesthesiol, Baltimore, MD USA.	jwu@anes.umm.edu	STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434; Hanscom, Marie/0000-0001-8308-135X	National Institute of Health [NIH-NINDS-01 (NS054221-03)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054221] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institute of Health contract NIH-NINDS-01 (NS054221-03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulia S, 2006, BIOCHEM BIOPH RES CO, V339, P1, DOI 10.1016/j.bbrc.2005.10.059; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Gendron TF, 2001, J NEUROCHEM, V78, P316, DOI 10.1046/j.1471-4159.2001.00423.x; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Hardingham GE, 2006, BIOCHEM SOC T, V34, P936, DOI 10.1042/BST0340936; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Hetman M, 2000, J NEUROSCI, V20, P2567; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Jorda EG, 2003, NEUROPHARMACOLOGY, V45, P672, DOI 10.1016/S0028-3908(03)00204-1; Kabadi SV, 2011, J CEREB BLO IN PRESS; Kharebava G, 2008, J NEUROSCI, V28, P11409, DOI 10.1523/JNEUROSCI.2135-08.2008; Komina Oxane, 2011, J Exp Ther Oncol, V9, P27; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Liu DZ, 2010, NEUROBIOL DIS, V37, P549, DOI 10.1016/j.nbd.2009.11.013; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; MacManus JP, 1999, NEUROREPORT, V10, P2711, DOI 10.1097/00001756-199909090-00004; Maestre C, 2008, EMBO J, V27, P2736, DOI 10.1038/emboj.2008.195; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Sheline CT, 2010, EUR J NEUROSCI, V32, P894, DOI 10.1111/j.1460-9568.2010.07372.x; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Verdaguer E, 2004, NEUROCHEM INT, V44, P251, DOI 10.1016/S0197-0186(03)00147-5; Vincent I, 1997, J NEUROSCI, V17, P3588; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Wen Y, 2004, J BIOL CHEM, V279, P22684, DOI 10.1074/jbc.M311768200; Wesierska-Gadek J, 2011, J CELL BIOCHEM, V112, P1103, DOI 10.1002/jcb.23024; Wu JF, 2011, J NEUROSCI RES, V89, P628, DOI 10.1002/jnr.22598; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yang Y, 2003, J NEUROSCI, V23, P2557; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	53	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42129	10.1371/journal.pone.0042129	http://dx.doi.org/10.1371/journal.pone.0042129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848730	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600170
J	Micheli, F; Saenz-Arroyo, A; Greenley, A; Vazquez, L; Montes, JAE; Rossetto, M; De Leo, GA				Micheli, Fiorenza; Saenz-Arroyo, Andrea; Greenley, Ashley; Vazquez, Leonardo; Espinoza Montes, Jose Antonio; Rossetto, Marisa; De Leo, Giulio A.			Evidence That Marine Reserves Enhance Resilience to Climatic Impacts	PLOS ONE			English	Article							ABALONE HALIOTIS-RUBRA; PROTECTED AREAS; BIODIVERSITY LOSS; CALIFORNIA; ECOSYSTEM; FISHERY; HYPOXIA; DECLINE; MANAGEMENT; SETTLEMENT	Establishment of marine protected areas, including fully protected marine reserves, is one of the few management tools available for local communities to combat the deleterious effect of large scale environmental impacts, including global climate change, on ocean ecosystems. Despite the common hope that reserves play this role, empirical evidence of the effectiveness of local protection against global problems is lacking. Here we show that marine reserves increase the resilience of marine populations to a mass mortality event possibly caused by climate-driven hypoxia. Despite high and widespread adult mortality of benthic invertebrates in Baja California, Mexico, that affected populations both within and outside marine reserves, juvenile replenishment of the species that supports local economies, the pink abalone Haliotis corrugata, remained stable within reserves because of large body size and high egg production of the protected adults. Thus, local protection provided resilience through greater resistance and faster recovery of protected populations. Moreover, this benefit extended to adjacent unprotected areas through larval spillover across the edges of the reserves. While climate change mitigation is being debated, coastal communities have few tools to slow down negative impacts of global environmental shifts. These results show that marine protected areas can provide such protection.	[Micheli, Fiorenza; Greenley, Ashley] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Saenz-Arroyo, Andrea; Vazquez, Leonardo] Comunidad & Biodiversidad AC, Mexico City, DF, Mexico; [Espinoza Montes, Jose Antonio] Soc Cooperativa Prod Pesquera Buzos & Pescadores, Isla Natividad, Baja California, Mexico; [Rossetto, Marisa; De Leo, Giulio A.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy	Stanford University; University of Parma	Micheli, F (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	micheli@stanford.edu	De Leo, Giulio/AAC-5098-2019	De Leo, Giulio/0000-0002-4186-3369; Micheli, Fiorenza/0000-0002-6865-1438; Saenz-Arroyo, Andrea/0000-0002-5659-4608	Walton Family Foundation; NSF-Biocomplexity in the Environment Grant [OCE-0410439]; MIUR [2008E7KBAE]; REEFCHECK of California	Walton Family Foundation; NSF-Biocomplexity in the Environment Grant; MIUR(Ministry of Education, Universities and Research (MIUR)); REEFCHECK of California	This work was supported through a grant from the Walton Family Foundation, and an NSF-Biocomplexity in the Environment Grant (OCE-0410439). GDL and MR were partially supported by a MIUR PRIN2008 grant (2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank REEFCHECK of California for their support and participation in the monitoring, members of the fishing cooperative Buzos y Pescadores for help in the field and in the laboratory, and L. Bourillon, J. Torre, and S. Palumbi for their advice and insights. All necessary permits were obtained for the described field studies. Collecting and research permits were obtained from SAGARPA and from the Vizcaino Biosphere Reserve, Mexico.	[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Botsford LW, 2003, ECOL APPL, V13, pS25; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Clavier J, 1992, ABALONE WORLD BIOL F; Connolly TP, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005283; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Cox KW, 1962, FISH B, V118, P1; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; DELPROO SAG, 1992, ABALONE WORLD BIOL F; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Falkowski P.G., 2011, EOS T AM GEOPHYS UN, V92, P409, DOI [DOI 10.1029/2011E0460001, 10.1029/2011EO460001, DOI 10.1029/2011EO460001]; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; KEESING JK, 1995, MAR FRESHWATER RES, V46, P539, DOI 10.1071/MF9950539; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Litaay M, 2003, AQUAT LIVING RESOUR, V16, P353, DOI 10.1016/S0990-7440(03)00067-6; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Morales-Bojorquez E, 2008, J SHELLFISH RES, V27, P865, DOI 10.2983/0730-8000(2008)27[865:AOTDOT]2.0.CO;2; MOSS GA, 1992, NEW ZEAL J MAR FRESH, V26, P75, DOI 10.1080/00288330.1992.9516502; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Musick JA, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:CTDERI>2.0.CO;2; Nam S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049549; NASH WJ, 1995, MAR FRESHWATER RES, V46, P531, DOI 10.1071/MF9950531; Paddack MJ, 2000, ECOL APPL, V10, P855, DOI 10.2307/2641050; Rogers-Bennett L, 2002, CAL COOP OCEAN FISH, V43, P97; Shepherd SA, 1998, J SHELLFISH RES, V17, P839; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Tetreault I, 2007, ECOL APPL, V17, P2251, DOI 10.1890/06-0161.1; Tutschulte TC, 1976, THESIS U CALIFORNIA; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	50	202	207	5	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2012	7	7							e40832	10.1371/journal.pone.0040832	http://dx.doi.org/10.1371/journal.pone.0040832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975YY	22855690	gold, Green Published, Green Submitted			2022-12-27	WOS:000306548900054
J	Buckley, CM; O'Farrell, A; Canavan, RJ; Lynch, AD; De La Harpe, DV; Bradley, CP; Perry, IJ				Buckley, Claire M.; O'Farrell, Anne; Canavan, Ronan J.; Lynch, Anthony D.; De La Harpe, Davida V.; Bradley, Colin P.; Perry, Ivan J.			Trends in the Incidence of Lower Extremity Amputations in People with and without Diabetes over a Five-Year Period in the Republic of Ireland	PLOS ONE			English	Article							LOWER-LIMB AMPUTATIONS; FOOT CARE; POPULATION; PREVALENCE; INDIVIDUALS; VARIABILITY; REDUCTION; MORTALITY; DISEASE; QUALITY	Aims: To describe trends in the incidence of non-traumatic amputations among people with and without diabetes and estimate the relative risk of an individual with diabetes undergoing a lower extremity amputation compared to an individual without diabetes in the Republic of Ireland. Methods: All adults who underwent a nontraumatic amputation during 2005 to 2009 were identified using HIPE (Hospital In-patient Enquiry) data. Participants were classified as having diabetes or not having diabetes. Incidence rates were calculated using the number of discharges for diabetes and non-diabetes related lower extremity amputations as the numerator and estimates of the resident population with and without diabetes as the denominator. Age-adjusted incidence rates were used for trend analysis. Results: Total diabetes-related amputation rates increased non-significantly during the study period; 144.2 in 2005 to 175.7 in 2009 per 100,000 people with diabetes (p = 0.11). Total non-diabetes related amputation rates dropped non-significantly from 12.0 in 2005 to 9.2 in 2009 per 100,000 people without diabetes (p = 0.16). An individual with diabetes was 22.3 (95% CI 19.1-26.1) times more likely to undergo a nontraumatic amputation than an individual without diabetes in 2005 and this did not change significantly by 2009. Discussion: This study provides the first national estimate of lower extremity amputation rates in the Republic of Ireland. Diabetes-related amputation rates have remained steady despite an increase in people with diabetes. These estimates provide a base-line and will allow follow-up over time.	[Buckley, Claire M.; Lynch, Anthony D.; Bradley, Colin P.] Natl Univ Ireland Univ Coll Cork, Dept Gen Practice, Cork, Ireland; [Buckley, Claire M.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [O'Farrell, Anne; De La Harpe, Davida V.] HSE, Clin & Serv Strategy, Hlth Intelligence, Dublin, Ireland; [Canavan, Ronan J.] St Vincents Hosp, Dept Endocrinol, Dublin 4, Ireland	University College Cork; University College Cork; University College Dublin	Buckley, CM (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Gen Practice, Cork, Ireland.	Claire.buckley@ucc.ie		Bradley, Colin/0000-0002-3595-9567; Perry, Ivan/0000-0002-4965-9792	HRB (Health Research Board), Ireland [HPF/2009/79]; ICGP (Irish College of General Practitioners) Research and Education Foundation	HRB (Health Research Board), Ireland; ICGP (Irish College of General Practitioners) Research and Education Foundation	This project is partially funded by the HRB (Health Research Board), Ireland - Grant Reference Number: HPF/2009/79 and partially funded by the ICGP (Irish College of General Practitioners) Research and Education Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Sanchez Javier, 2009, Diabetes Res Clin Pract, V86, pe6, DOI 10.1016/j.diabres.2009.06.015; Balanda K.P., MAKING CHRONIC CONDI; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Burns EM, 2011, J PUBLIC HLTH; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Canavan RJ, 2008, DIABETES CARE, V31, P459, DOI 10.2337/dc07-1159; Coffey L, 2009, DIABETIC MED, V26, P1063, DOI 10.1111/j.1464-5491.2009.02802.x; Department of Health and Children Ireland, 2010, CHANG CARD HLTH NAT; Driver VR, 2005, DIABETES CARE, V28, P248, DOI 10.2337/diacare.28.2.248; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; Fikri R, 2011, DIABETES CARE, V34, pe134; Fosse S, 2009, DIABETIC MED, V26, P391, DOI 10.1111/j.1464-5491.2009.02698.x; Greenfield S, 2004, OECD HLTH TECHNICAL, V15; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Jeffcoate WJ, 2005, ACTA CHIR BELG, V105, P140, DOI 10.1080/00015458.2005.11679687; Jeffcoate WJ, 2004, DIABETOLOGIA, V47, P2051, DOI 10.1007/s00125-004-1584-3; Johnson H, HLTH ATLAS IRELAND; Khwaja HA, 2002, BJU INT, V89, P178, DOI 10.1046/j.1464-4096.2001.01428.x; Krishnan S, 2008, DIABETES CARE, V31, P99, DOI 10.2337/dc07-1178; Lavery LA, 2003, DIABETES CARE, V26, P1435, DOI 10.2337/diacare.26.5.1435; Lee JM, 2010, INT J OBESITY, V34, P614, DOI 10.1038/ijo.2009.235; Leese GP, 2011, PRACTICAL DIABETES I, V28, P7; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lopez-de-Andres A, 2011, DIABETES CARE, V34, P1570, DOI 10.2337/dc11-0077; Margolis DJ, 2011, DIABETES CARE; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; O'Farrell A, 2007, J PUBLIC HEALTH-UK, V29, P398, DOI 10.1093/pubmed/fdm069; O'Farrell A, 2004, ADDICTION, V99, P1279, DOI 10.1111/j.1360-0443.2004.00822.x; Peters EJG, 2001, DIABETES CARE, V24, P1799, DOI 10.2337/diacare.24.10.1799; Price P, 2004, CLIN INFECT DIS, V39, pS129, DOI 10.1086/383274; Rogers LC, 2010, J AM PODIAT MED ASSN, V100, P101, DOI 10.7547/1000101; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tseng CL, 2011, DIABETES CARE, V34, P1157, DOI 10.2337/dc10-1775; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; van Houtum WH, 1997, DIABETES RES CLIN PR, V38, P177, DOI 10.1016/S0168-8227(97)00105-8; van Houtum WH, 2004, DIABETES CARE, V27, P1042, DOI 10.2337/diacare.27.5.1042; Van Houtum WH, 2008, DIABETES-METAB RES, V24, pS14, DOI 10.1002/dmrr.826; Witso E, 2001, PROSTHET ORTHOT INT, V25, P181, DOI 10.1080/03093640108726600; Wraight PR, 2006, INTERN MED J, V36, P197, DOI 10.1111/j.1445-5994.2006.01039.x	40	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41492	10.1371/journal.pone.0041492	http://dx.doi.org/10.1371/journal.pone.0041492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859991	Green Published, gold			2022-12-27	WOS:000307045600030
J	Wright, B; Alderson-Day, B; Prendergast, G; Bennett, S; Jordan, J; Whitton, C; Gouws, A; Jones, N; Attur, R; Tomlinson, H; Green, G				Wright, Barry; Alderson-Day, Ben; Prendergast, Garreth; Bennett, Sophie; Jordan, Jo; Whitton, Clare; Gouws, Andre; Jones, Nick; Attur, Ram; Tomlinson, Heather; Green, Gary			Gamma Activation in Young People with Autism Spectrum Disorders and Typically-Developing Controls When Viewing Emotions on Faces	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; FREQUENCY OSCILLATIONS; FACIAL EXPRESSION; ILLUSORY FIGURES; NEURAL CIRCUITRY; BAND RESPONSES; BRAIN ACTIVITY; GAZE-FIXATION; RECOGNITION; INDIVIDUALS	Background: Behavioural studies have highlighted irregularities in recognition of facial affect in children and young people with autism spectrum disorders (ASDs). Recent findings from studies utilising electroencephalography (EEG) and magnetoencephalography (MEG) have identified abnormal activation and irregular maintenance of gamma (>30 Hz) range oscillations when ASD individuals attempt basic visual and auditory tasks. Methodology/Principal Fndings: The pilot study reported here is the first study to use spatial filtering techniques in MEG to explore face processing in children with ASD. We set out to examine theoretical suggestions that gamma activation underlying face processing may be different in a group of children and young people with ASD (n = 13) compared to typically developing (TD) age, gender and IQ matched controls. Beamforming and virtual electrode techniques were used to assess spatially localised induced and evoked activity. While lower-band (3-30 Hz) responses to faces were similar between groups, the ASD gamma response in occipital areas was observed to be largely absent when viewing emotions on faces. Virtual electrode analysis indicated the presence of intact evoked responses but abnormal induced activity in ASD participants. Conclusions/Significance: These findings lend weight to previous suggestions that specific components of the early visual response to emotional faces is abnormal in ASD. Elucidation of the nature and specificity of these findings is worthy of further research.	[Wright, Barry; Alderson-Day, Ben; Bennett, Sophie; Jordan, Jo; Whitton, Clare; Jones, Nick; Attur, Ram; Tomlinson, Heather] N Yorkshire & York Primary Care Trust, Lime Trees Child Family & Adolescent Unit, York, N Yorkshire, England; [Wright, Barry; Green, Gary] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Prendergast, Garreth; Gouws, Andre; Green, Gary] Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Wright, B (corresponding author), N Yorkshire & York Primary Care Trust, Lime Trees Child Family & Adolescent Unit, York, N Yorkshire, England.	barry.wright1@nhs.net	Green, Gary GR/D-3543-2009	Green, Gary GR/0000-0003-1977-7509; Wright, Barry/0000-0002-8692-6001; Prendergast, Garreth/0000-0002-7255-6708; Gouws, Andre/0000-0003-0674-7829				Adjamian P, 2008, J VISION, V8, DOI 10.1167/8.7.4; Adolphs R, 2008, CURR BIOL, V18, P1090, DOI 10.1016/j.cub.2008.06.073; Ashwin C, 2006, SOC NEUROSCI-UK, V1, P349, DOI 10.1080/17470910601040772; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Bailey AJ, 2005, EUR J NEUROSCI, V21, P2575, DOI 10.1111/j.1460-9568.2005.04061.x; Baranek GT, 2002, J AUTISM DEV DISORD, V32, P397, DOI 10.1023/A:1020541906063; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Batty M, 2011, J EXP CHILD PSYCHOL, V109, P430, DOI 10.1016/j.jecp.2011.02.001; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Brock J, 2002, DEV PSYCHOPATHOL, V14, P209, DOI 10.1017/S0954579402002018; Brown C, 2005, CORTEX, V41, P364, DOI 10.1016/S0010-9452(08)70273-9; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Deeley Q, 2007, BIOL PSYCHIAT, V62, P207, DOI 10.1016/j.biopsych.2006.09.037; EKMAN P, 2006, PICTURES FACIAL AFFE; Gandal M, 2011, BIOL PSYCHIAT, V68, P1100; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Grice SJ, 2001, NEUROREPORT, V12, P2697, DOI 10.1097/00001756-200108280-00021; Gross TF, 2005, J AUTISM DEV DISORD, V35, P773, DOI 10.1007/s10803-005-0023-8; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Honaga E, 2010, NEUROSCI LETT, V478, P141, DOI 10.1016/j.neulet.2010.05.004; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Humphreys K, 2008, AUTISM RES, V1, P52, DOI 10.1002/aur.1; Humphreys K, 2007, NEUROPSYCHOLOGIA, V45, P685, DOI 10.1016/j.neuropsychologia.2006.08.003; Hymers M, 2010, NEUROIMAGE, V49, P1385, DOI 10.1016/j.neuroimage.2009.09.055; Jemel B, 2006, J AUTISM DEV DISORD, V36, P91, DOI 10.1007/s10803-005-0050-5; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Johnson RT, 2003, MAGNETIC SOURCE IMAGING OF THE HUMAN BRAIN, P217; Joseph RM, 2002, J CHILD PSYCHOL PSYC, V43, P1, DOI [DOI 10.1111/1469-7610.00142, https://doi.org/10.1111/1469-7610.00142]; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Klin A, 2008, BIOL PSYCHIAT, V64, P549, DOI 10.1016/j.biopsych.2008.07.028; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; Kylliainen A, 2006, EUR J NEUROSCI, V24, P2679, DOI 10.1111/j.1460-9568.2006.05132.x; Lee LC, 2010, NEUROPSYCHOLOGIA, V48, P477, DOI 10.1016/j.neuropsychologia.2009.10.005; Lenz D, 2010, NEUROPSYCHOLOGIA, V48, P1985, DOI 10.1016/j.neuropsychologia.2010.03.019; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maratos FA, 2007, NEUROIMAGE, V34, P371, DOI 10.1016/j.neuroimage.2006.09.017; McPartland J, 2004, J CHILD PSYCHOL PSYC, V45, P1235, DOI 10.1111/j.1469-7610.2004.00318.x; Millman RE, 2010, NEUROIMAGE, V49, P745, DOI 10.1016/j.neuroimage.2009.08.029; Monk CS, 2010, J PSYCHIATR NEUROSCI, V35, P105, DOI 10.1503/jpn.090085; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Muthukumaraswamy SD, 2008, NEUROIMAGE, V40, P1552, DOI 10.1016/j.neuroimage.2008.01.052; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Connor K, 2007, INT J PSYCHOPHYSIOL, V63, P283, DOI 10.1016/j.ijpsycho.2006.12.001; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Prendergast G, 2011, NEUROIMAGE, V54, P906, DOI 10.1016/j.neuroimage.2010.08.005; Pulvermuller F, 1997, PROG NEUROBIOL, V52, P427, DOI 10.1016/S0301-0082(97)00023-3; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rojas DC, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-11; Rojas DC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-66; Rump KM, 2009, CHILD DEV, V80, P1434, DOI 10.1111/j.1467-8624.2009.01343.x; Scherf KS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00026; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Sokhadze EM, 2009, J AUTISM DEV DISORD, V39, P619, DOI 10.1007/s10803-008-0662-7; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Stroganova TA, 2011, CORTEX IN PRESS; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tracy JL, 2011, J AUTISM DEV DISORD, V41, P102, DOI 10.1007/s10803-010-1030-y; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wechsler D, 1999, WASI WECHSLER ABBREV; WEEKS SJ, 1987, J CHILD PSYCHOL PSYC, V28, P137, DOI 10.1111/j.1469-7610.1987.tb00658.x; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; WHO, 2012, ICD 10 CLASS MENT BE; Wicker B, 2008, SOC COGN AFFECT NEUR, V3, P135, DOI 10.1093/scan/nsn007; Williams S, 2010, J PSYCHIATR NEUROSCI, V35, P75, DOI 10.1503/jpn.100021; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Wong TKW, 2008, EUR J NEUROSCI, V28, P407, DOI 10.1111/j.1460-9568.2008.06328.x; Wright B, 2008, AUTISM, V12, P607, DOI 10.1177/1362361308097118; Young AW, 2002, FACIAL EXPRESSIONS E	90	48	48	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41326	10.1371/journal.pone.0041326	http://dx.doi.org/10.1371/journal.pone.0041326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22859975	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000307045600020
J	Zeidan, A; Ziv, NE				Zeidan, Adel; Ziv, Noam E.			Neuroligin-1 Loss Is Associated with Reduced Tenacity of Excitatory Synapses	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; AMPA RECEPTORS; SYNAPTIC PLASTICITY; NMDA RECEPTORS; IN-VIVO; PRESYNAPTIC TERMINALS; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; NEUREXINS; PSD-95	Neuroligins (Nlgns) are postsynaptic, integral membrane cell adhesion molecules that play important roles in the formation, validation, and maturation of synapses in the mammalian central nervous system. Given their prominent roles in the life cycle of synapses, it might be expected that the loss of neuroligin family members would affect the stability of synaptic organization, and ultimately, affect the tenacity and persistence of individual synaptic junctions. Here we examined whether and to what extent the loss of Nlgn-1 affects the dynamics of several key synaptic molecules and the constancy of their contents at individual synapses over time. Fluorescently tagged versions of the postsynaptic scaffold molecule PSD-95, the AMPA-type glutamate receptor subunit GluA2 and the presynaptic vesicle molecule SV2A were expressed in primary cortical cultures from Nlgn-1 KO mice and wild-type (WT) littermates, and live imaging was used to follow the constancy of their contents at individual synapses over periods of 8-12 hours. We found that the loss of Nlgn-1 was associated with larger fluctuations in the synaptic contents of these molecules and a poorer preservation of their contents at individual synapses. Furthermore, rates of synaptic turnover were somewhat greater in neurons from Nlgn-1 knockout mice. Finally, the increased GluA2 redistribution rates observed in neurons from Nlgn-1 knockout mice were negated by suppressing spontaneous network activity. These findings suggest that the loss of Nlgn-1 is associated with some use-dependent destabilization of excitatory synapse organization, and indicate that in the absence of Nlgn-1, the tenacity of excitatory synapses might be somewhat impaired.	[Zeidan, Adel] Technion Fac Med, Dept Physiol & Biophys, Haifa, Israel; Technion Fac Med, Rappaport Inst, Haifa, Israel; Lorry Lokey Ctr Life Sci & Engn, Network Biol Res Labs, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Zeidan, A (corresponding author), Technion Fac Med, Dept Physiol & Biophys, Haifa, Israel.	noamz@netvision.net.il	Ziv, Noam/ABA-6551-2020	Ziv, Noam/0000-0001-9197-326X	European Union [HEALTH-F2-2009-241498]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement no HEALTH-F2-2009-241498 ("EUROSPIN" project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Fisher-Lavie A, 2011, J NEUROSCI, V31, P16770, DOI 10.1523/JNEUROSCI.3384-11.2011; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Herzog E, 2011, J NEUROSCI, V31, P15544, DOI 10.1523/JNEUROSCI.2073-11.2011; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Khosravani H, 2005, FEBS LETT, V579, P6587, DOI 10.1016/j.febslet.2005.10.051; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Lee H, 2010, J NEUROSCI, V30, P11435, DOI 10.1523/JNEUROSCI.2946-10.2010; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lucido AL, 2009, J NEUROSCI, V29, P12449, DOI 10.1523/JNEUROSCI.1381-09.2009; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; McMahon SA, 2011, CURR OPIN NEUROBIOL, V21, P221, DOI 10.1016/j.conb.2010.12.005; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; SNYDER M, 1982, CELL, V29, P1027, DOI 10.1016/0092-8674(82)90466-4; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Staras Kevin, 2010, Front Synaptic Neurosci, V2, P20, DOI 10.3389/fnsyn.2010.00020; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tallafuss A, 2010, EUR J NEUROSCI, V32, P198, DOI 10.1111/j.1460-9568.2010.07340.x; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Tsuriel S, 2009, J NEUROSCI, V29, P351, DOI 10.1523/JNEUROSCI.4777-08.2009; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001	75	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42314	10.1371/journal.pone.0042314	http://dx.doi.org/10.1371/journal.pone.0042314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860111	gold, Green Submitted, Green Published			2022-12-27	WOS:000307045600089
J	Bye, A; Vettukattil, R; Aspenes, ST; Giskeodegard, GF; Gribbestad, IS; Wisloff, U; Bathen, TF				Bye, Anja; Vettukattil, Riyas; Aspenes, Stian T.; Giskeodegard, Guro F.; Gribbestad, Ingrid S.; Wisloff, Ulrik; Bathen, Tone F.			Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; WHOLE-BLOOD CHOLINE; CARDIORESPIRATORY FITNESS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PLASMA CHOLINE; MEN; CAPACITY; EXERCISE; INDIVIDUALS	Background: Cardiovascular disease (CVD) is a leading cause of death worldwide, and the number of people at risk is continuously growing. New methods for early risk prediction are therefore needed to actuate prevention strategies before the individuals are diagnosed with CVD. Several studies report that aerobic fitness level, measured as maximal oxygen uptake (VO2max), is the single best predictor of future CVD mortality in healthy people. Based on this, we wanted to study differences between healthy individuals with a large difference in VO2max-level to identify new biomarkers of low aerobic fitness that may also have potential as early biomarkers of CVD risk. Methodology/Principal Findings: Serum samples from 218 healthy individuals with a low VO2max (n = 108, 63 women) or high VO2max (n = 110, 64 women) were analysed with MR metabolomics. In addition, standard clinical-chemical analyses for glucose, lipids, liver enzymes, micro-CRP, and colorimetric analysis on circulating choline were performed. Individuals in the low VO2max-group had increased serum levels of free choline, decreased phosphatidylcholine, increased glucose, and decreased unsaturated fatty acids compared to the individuals in the high VO2max-group. Conclusions/Significance: Aerobic fitness dependent differences in serum levels of free choline and phosphatidylcholine are observed. They should be further studied as potential early markers of CVD risk.	[Bye, Anja; Vettukattil, Riyas; Aspenes, Stian T.; Giskeodegard, Guro F.; Gribbestad, Ingrid S.; Wisloff, Ulrik; Bathen, Tone F.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Bye, Anja; Aspenes, Stian T.; Wisloff, Ulrik] KG Jebsen Ctr Exercise Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Bye, A (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.	muhammad.r.vettukattil@ntnu.no	Bye, Anja/K-8041-2019; Wisloff, Ulrik/K-2899-2012	Wisloff, Ulrik/0000-0002-7211-3587; Vettukattil, Riyas/0000-0002-2152-4933; Bye, Anja/0000-0003-1259-5542	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; St. Olavs Hospital; Liaison Committee; Faculty of Medicine, Norwegian University of Science and Technology (NTNU); Norwegian Research Council Funding for Outstanding Young Investigators; Royal Norwegian Society of Sciences and Letters (DKNVS); Foundation for Cardiovascular Research at St. Olavs Hospital; NTNU	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; St. Olavs Hospital; Liaison Committee; Faculty of Medicine, Norwegian University of Science and Technology (NTNU); Norwegian Research Council Funding for Outstanding Young Investigators; Royal Norwegian Society of Sciences and Letters (DKNVS); Foundation for Cardiovascular Research at St. Olavs Hospital; NTNU	The study was supported by grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease, St. Olavs Hospital and the Liaison Committee between the St. Olavs Hospital and the Faculty of Medicine, Norwegian University of Science and Technology (NTNU), the Norwegian Research Council Funding for Outstanding Young Investigators, the Royal Norwegian Society of Sciences and Letters (DKNVS) and the Foundation for Cardiovascular Research at St. Olavs Hospital and NTNU. There are no disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Barba I, 2008, MAGN RESON MED, V60, P27, DOI 10.1002/mrm.21632; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Bougle D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/580897; Buchman AL, 1999, J AM COLL NUTR, V18, P598, DOI 10.1080/07315724.1999.10718894; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Danne O, 2003, AM J CARDIOL, V91, P1060, DOI 10.1016/S0002-9149(03)00149-8; Danne O, 2007, CLIN CHIM ACTA, V383, P103, DOI 10.1016/j.cca.2007.05.001; Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; Dhalla NS, 1997, J MOL CELL CARDIOL, V29, P2865, DOI 10.1006/jmcc.1997.0522; Dvorak RV, 2000, J CLIN ENDOCR METAB, V85, P957, DOI 10.1210/jc.85.3.957; Farrell SW, 2004, OBES RES, V12, P824, DOI 10.1038/oby.2004.99; Idle JR, 2007, CELL METAB, V6, P348, DOI 10.1016/j.cmet.2007.10.005; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kim DJ, 2005, DIABETIC MED, V22, P1134, DOI 10.1111/j.1464-5491.2005.01581.x; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kuo HK, 2007, INT J CARDIOL, V114, P28, DOI 10.1016/j.ijcard.2005.11.110; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Laukkanen JA, 2001, ARCH INTERN MED, V161, P825, DOI 10.1001/archinte.161.6.825; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Maxwell Mark S., 2008, Metabolic Syndrome and Related Disorders, V6, P8, DOI 10.1089/met.2007.0013; Messier V, 2010, METABOLISM, V59, P20, DOI 10.1016/j.metabol.2009.06.020; Meyer T, 2005, INT J SPORTS MED, V26, pS19, DOI 10.1055/s-2004-830507; MIETTINEN TA, 1982, BRIT MED J, V285, P993, DOI 10.1136/bmj.285.6347.993; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sassen B, 2009, EUR J CARDIOV PREV R, V16, P677, DOI 10.1097/HJR.0b013e3283312e94; Shephard RJ, 2000, ENDURANCE SPORT, P301; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Tappia PS, 2006, FREE RADICAL BIO MED, V41, P349, DOI 10.1016/j.freeradbiomed.2006.03.025; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; WHO, 1999, REP WHO CONS DEF MET, P1; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413	39	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42330	10.1371/journal.pone.0042330	http://dx.doi.org/10.1371/journal.pone.0042330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860113	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900089
J	Gloyn, AL; Faber, JH; Malmodin, D; Thanabalasingham, G; Lam, F; Ueland, PM; McCarthy, MI; Owen, KR; Baunsgaard, D				Gloyn, Anna L.; Faber, Johan H.; Malmodin, Daniel; Thanabalasingham, Gaya; Lam, Francis; Ueland, Per Magne; McCarthy, Mark I.; Owen, Katharine R.; Baunsgaard, Dorrit			Metabolic Profiling in Maturity-Onset Diabetes of the Young (MODY) and Young Onset Type 2 Diabetes Fails to Detect Robust Urinary Biomarkers	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; GLYCINE BETAINE; SENSITIVITY; MUTATIONS; MELLITUS; IDENTIFICATION; HYPERGLYCEMIA; DYSFUNCTION; HNF1A-MODY; SUBTYPES	It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes. Biomarkers could facilitate the prioritisation of patients for genetic testing. We hypothesised that patients with different underlying genetic aetiologies for their diabetes could have distinct metabolic profiles which may uncover novel biomarkers. The aim of this study was to perform metabolic profiling in urine from patients with MODY due to mutations in the genes encoding glucokinase (GCK) or hepatocyte nuclear factor 1 alpha (HNF1A), type 2 diabetes (T2D) and normoglycaemic control subjects. Urinary metabolic profiling by Nuclear Magnetic Resonance (NMR) and ultra performance liquid chromatography hyphenated to Q-TOF mass spectrometry (UPLC-MS) was performed in a Discovery set of subjects with HNF1A-MODY (n = 14), GCK-MODY (n = 17), T2D (n = 14) and normoglycaemic controls (n = 34). Data were used to build a valid partial least squares discriminate analysis (PLS-DA) model where HNF1A-MODY subjects could be separated from the other diabetes subtypes. No single metabolite contributed significantly to the separation of the patient groups. However, betaine, valine, glycine and glucose were elevated in the urine of HNF1A-MODY subjects compared to the other subgroups. Direct measurements of urinary amino acids and betaine in an extended dataset did not support differences between patients groups. Elevated urinary glucose in HNF1A-MODY is consistent with the previously reported low renal threshold for glucose in this genetic subtype. In conclusion, we report the first metabolic profiling study in monogenic diabetes and show that, despite the distinct biochemical pathways affected, there are unlikely to be robust urinary biomarkers which distinguish monogenic subtypes from T2D. Our results have implications for studies investigating metabolic profiles in complex traits including T2D.	[Gloyn, Anna L.; Thanabalasingham, Gaya; McCarthy, Mark I.; Owen, Katharine R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Gloyn, Anna L.; Thanabalasingham, Gaya; McCarthy, Mark I.; Owen, Katharine R.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England; [Faber, Johan H.; Malmodin, Daniel; Baunsgaard, Dorrit] Novo Nordisk AS, Novo Nordisk, Malov, Denmark; [Lam, Francis] John Radcliffe Hosp, Dept Clin Biochem, Oxford OX3 9DU, England; [Ueland, Per Magne] Univ Bergen, Pharmacol Sect, Bergen, Norway; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; Novo Nordisk; University of Oxford; University of Bergen; University of Oxford; Wellcome Centre for Human Genetics	Gloyn, AL (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	Katharine.Owen@drl.ox.ac.uk; doba@novonordisk.com	Ueland, Per M/C-7340-2013; McCarthy, Mark/M-3763-2015	Ueland, Per Magne/0000-0002-1903-0571; McCarthy, Mark/0000-0002-4393-0510; Gloyn, Anna/0000-0003-1205-1844	European Union FP6 programme (project MolPAGE "Molecular Phenotyping to Accelerate Genomic Epidemiology''); Oxford by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme, European Community FP7 programme CEED3 [HEALTH-F2-2008-223211]; Medical Research Council [81696]; European Union project MolPAGE; MRC [G0700222] Funding Source: UKRI; Medical Research Council [G0700222] Funding Source: researchfish; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish	European Union FP6 programme (project MolPAGE "Molecular Phenotyping to Accelerate Genomic Epidemiology''); Oxford by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme, European Community FP7 programme CEED3; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union project MolPAGE; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the European Union FP6 programme (project MolPAGE "Molecular Phenotyping to Accelerate Genomic Epidemiology'') and in Oxford by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme, European Community FP7 programme CEED3 (HEALTH-F2-2008-223211) and the Medical Research Council (Grant Reference 81696). ALG is a Wellcome Trust Senior Fellow in Basic and Biomedical Science (095101/Z/10/Z) and KRO is an NIHR Clinician Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: the authors Dorrit Baunsgaard and Johan Faber are currently employed by the company Novo Nordisk A/S, Copenhagen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Johan Faber and Daniel Malmodin received their salary from the European Union project MolPAGE whilst carrying out the work described in this manuscript.	Bingham C, 2001, DIABETES, V50, P2047, DOI 10.2337/diabetes.50.9.2047; Bonzo JA, 2010, MOL ENDOCRINOL, V24, P2343, DOI 10.1210/me.2010-0130; Cervin C, 2010, J INTERN MED, V267, P316, DOI 10.1111/j.1365-2796.2009.02145.x; Dellow WJ, 1999, DIABETES RES CLIN PR, V43, P91, DOI 10.1016/S0168-8227(98)00115-6; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Karlsson E, 2008, DIABETIC MED, V25, P788, DOI 10.1111/j.1464-5491.2008.02467.x; Kropff J, 2011, DIABETOLOGIA, V54, P1261, DOI 10.1007/s00125-011-2090-z; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-34; McDonald TJ, 2011, DIABETES CARE, V34, P1860, DOI 10.2337/dc11-0323; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; Pal A, 2010, DIABETES CARE, V33, P252, DOI 10.2337/dc09-1246; Patterson AD, 2011, J BIOL CHEM, V286, P19511, DOI 10.1074/jbc.M111.221739; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Pontoglio M, 2000, EMBO REP, V1, P359, DOI 10.1093/embo-reports/kvd071; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; Skupien J, 2008, DIABETES CARE, V31, P1496, DOI 10.2337/dc07-2334; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stride A, 2005, DIABETES CARE, V28, P1751, DOI 10.2337/diacare.28.7.1751; Stride A, 2004, DIABETIC MED, V21, P928, DOI 10.1111/j.1464-5491.2004.01107.x; Thanabalasingham G, 2011, DIABETOLOGIA, V54, P2801, DOI 10.1007/s00125-011-2261-y; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510	29	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40962	10.1371/journal.pone.0040962	http://dx.doi.org/10.1371/journal.pone.0040962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859960	Green Published, gold			2022-12-27	WOS:000306950900014
J	Hutti, JE; Porter, MA; Cheely, AW; Cantley, LC; Wang, XD; Kireev, D; Baldwin, AS; Janzen, WP				Hutti, Jessica E.; Porter, Melissa A.; Cheely, Adam W.; Cantley, Lewis C.; Wang, Xiaodong; Kireev, Dmitri; Baldwin, Albert S.; Janzen, William P.			Development of a High-Throughput Assay for Identifying Inhibitors of TBK1 and IKK epsilon	PLOS ONE			English	Article							NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; BREAST-CANCER ONCOGENE; ANTIVIRAL IMMUNITY; KINASE; PHOSPHORYLATION; ACTIVATION; SPECIFICITY; PROGRESSION; DISCOVERY	IKK epsilon and TBK1 are noncanonical IKK family members which regulate inflammatory signaling pathways and also play important roles in oncogenesis. However, few inhibitors of these kinases have been identified. While the substrate specificity of IKK epsilon has recently been described, the substrate specificity of TBK1 is unknown, hindering the development of high-throughput screening technologies for inhibitor identification. Here, we describe the optimal substrate phosphorylation motif for TBK1, and show that it is identical to the phosphorylation motif previously described for IKK epsilon. This information enabled the design of an optimal TBK1/IKK epsilon substrate peptide amenable to high-throughput screening and we assayed a 6,006 compound library that included 4,727 kinase-focused compounds to discover in vitro inhibitors of TBK1 and IKK epsilon. 227 compounds in this library inhibited TBK1 at a concentration of 10 mu M, while 57 compounds inhibited IKK epsilon. Together, these data describe a new high-throughput screening assay which will facilitate the discovery of small molecule TBK1/IKK epsilon inhibitors possessing therapeutic potential for both inflammatory diseases and cancer.	[Hutti, Jessica E.; Baldwin, Albert S.; Janzen, William P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Porter, Melissa A.; Cheely, Adam W.; Wang, Xiaodong; Kireev, Dmitri; Janzen, William P.] Univ N Carolina, Div Med Chem & Nat Prod, Ctr Integrated Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Baldwin, Albert S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Hutti, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	bjanzen@email.unc.edu	Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Cantley, Lewis C/D-1800-2014; Kireev, Dmitri/B-7225-2012	Cantley, Lewis C/0000-0002-1298-7653; Kireev, Dmitri/0000-0001-8479-8555	National Institutes of Health (NIH) grants [CA75080, AI35098, CA73756, R01-GM56203]; Department of Defense CDMRP BCRP grant [W81XWH-10-1-0342]; Samuel Waxman Cancer Research Foundation; NC TraCS grant [3-13400]; NATIONAL CANCER INSTITUTE [R01CA073756, R01CA075080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098, R01AI035098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense CDMRP BCRP grant; Samuel Waxman Cancer Research Foundation; NC TraCS grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants CA75080 (Dr. Baldwin), AI35098 (Dr. Baldwin), CA73756 (Dr. Baldwin), and R01-GM56203 (Dr. Cantley). Additional support was provided by Department of Defense CDMRP BCRP grant W81XWH-10-1-0342 (Dr. Hutti), the Samuel Waxman Cancer Research Foundation (Dr. Baldwin), and NC TraCS grant 3-13400 (Dr. Wang). Dr. Hutti is a Lilly Research Labs fellow of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PIP PIL VER 8 5; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bernasconi P, 2007, J BIOMOL SCREEN, V12, P972, DOI 10.1177/1087057107306759; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Card A, 2009, J BIOMOL SCREEN, V14, P31, DOI 10.1177/1087057108326663; Casella G, 2002, STAT INFERENCE, Vxxviii; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Guo JP, 2009, AM J PATHOL, V175, P324, DOI 10.2353/ajpath.2009.080767; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Kotturi P, 2003, AM LAB, V35, P32; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marinis JM, 2012, MOL CELL BIOL, V32, P2479, DOI 10.1128/MCB.00106-12; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Sundberg SA, 2000, DRUG DISCOV TODAY, V5, pS92, DOI 10.1016/S1359-6446(00)80100-2; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Turk BE, 2006, NAT PROTOC, V1, P375, DOI 10.1038/nprot.2006.57; Walters WP, 1999, CURR OPIN CHEM BIOL, V3, P384, DOI 10.1016/S1367-5931(99)80058-1; Wang T, 2012, BIOORG MED CHEM LETT, V22, P2063, DOI 10.1016/j.bmcl.2012.01.018; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405	36	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41494	10.1371/journal.pone.0041494	http://dx.doi.org/10.1371/journal.pone.0041494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859992	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900026
J	Passet, B; Young, R; Makhzami, S; Vilotte, M; Jaffrezic, F; Halliez, S; Bouet, S; Marthey, S; Khalife, M; Kanellopoulos-Langevin, C; Beringue, V; Le Provost, F; Laude, H; Vilotte, JL				Passet, Bruno; Young, Rachel; Makhzami, Samira; Vilotte, Marthe; Jaffrezic, Florence; Halliez, Sophie; Bouet, Stephan; Marthey, Sylvain; Khalife, Manal; Kanellopoulos-Langevin, Colette; Beringue, Vincent; Le Provost, Fabienne; Laude, Hubert; Vilotte, Jean-Luc			Prion Protein and Shadoo Are Involved in Overlapping Embryonic Pathways and Trophoblastic Development	PLOS ONE			English	Article							CELLULAR PRION; EXPRESSION; MOUSE; GENE; PRP; MICE; LACKING; GENERATION; LETHALITY; KNOCKOUT	The potential requirement of either the Prion or Shadoo protein for early mouse embryogenesis was recently suggested. However, the current data did not allow to precise the developmental process that was affected in the absence of both proteins and that led to the observed early lethal phenotype. In the present study, using various Prnp transgenic mouse lines and lentiviral vectors expressing shRNAs that target the Shadoo-encoding mRNA, we further demonstrate the specific requirement of at least one of these two PrP-related proteins at early developmental stages. Histological analysis reveals developmental defect of the ectoplacental cone and important hemorrhage surrounding the Prnp-knockout-Sprn-knockdown E7.5 embryos. By restricting the RNA interference to the trophoblastic cell lineages, the observed lethal phenotype could be attributed to the sole role of these proteins in this trophectoderm-derived compartment. RNAseq analysis performed on early embryos of various Prnp and Sprn genotypes indicated that the simultaneous down-regulation of these two proteins affects cell-adhesion and inflammatory pathways as well as the expression of ectoplacental-specific genes. Overall, our data provide biological clues in favor of a crucial and complementary embryonic role of the prion protein family in Eutherians and emphasizes the need to further evaluate its implication in normal and pathological human placenta biology.	[Passet, Bruno; Young, Rachel; Makhzami, Samira; Vilotte, Marthe; Jaffrezic, Florence; Bouet, Stephan; Marthey, Sylvain; Khalife, Manal; Le Provost, Fabienne; Vilotte, Jean-Luc] INRA, UMR1313, Jouy En Josas, France; [Halliez, Sophie; Beringue, Vincent; Laude, Hubert] INRA, UR892, Jouy En Josas, France; [Kanellopoulos-Langevin, Colette] CNRS, Lab Inflammat Gestat & Autoimmun, J Monod Inst, UMR 7592, Paris, France; [Kanellopoulos-Langevin, Colette] Univ Diderot, Lab Inflammat Gestat & Autoimmun, J Monod Inst, UMR 7592, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Passet, B (corresponding author), INRA, UMR1313, Jouy En Josas, France.	jean-luc.vilotte@jouy.inra.fr	Vilotte, Jean-Luc/AAF-4688-2019; Halliez, Sophie/ABA-1356-2020	Halliez, Sophie/0000-0002-6173-9752	Institut National de la Recherche Agronomique-Transfert fellowship; Institut National de la Recherche Agronomique AIP BioRessources PRIFASTEM;  [ANR-09-BLAN-0015-01]	Institut National de la Recherche Agronomique-Transfert fellowship; Institut National de la Recherche Agronomique AIP BioRessources PRIFASTEM; 	RY is a post-doctoral scientist supported by the ANR-09-BLAN-0015-01. SH is a post-doctoral scientist supported by an Institut National de la Recherche Agronomique-Transfert fellowship and by the ANR-09-BLAN-0015-01. This work was supported by the ANR-09-BLAN-0015-01 and by the Institut National de la Recherche Agronomique AIP BioRessources PRIFASTEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caucheteux SM, 2003, IMMUNITY, V18, P169, DOI 10.1016/S1074-7613(03)00028-1; Chadi S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-448; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; Daude N, 2011, FRONT BIOSCI-LANDMRK, V16, P1505, DOI 10.2741/3801; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donadio S, 2007, PLACENTA, V28, P907, DOI 10.1016/j.placenta.2006.11.006; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Girardi G, 2011, THROMB RES, V127, pS43, DOI 10.1016/S0049-3848(11)70012-3; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Hajj GNM, 2009, J COMP NEUROL, V517, P371, DOI 10.1002/cne.22157; HAMLIN GP, 1994, ENDOCRINOLOGY, V134, P2390, DOI 10.1210/en.134.6.2390; Hwang HS, 2010, ACTA OBSTET GYN SCAN, V89, P1155, DOI 10.3109/00016349.2010.498497; Khalife M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023253; Kovacs GG, 2009, INT J MOL SCI, V10, P976, DOI 10.3390/ijms10030976; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu YH, 2009, CANCER BIOL THER, V8, P1352, DOI 10.4161/cbt.8.14.8695; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malaga-Trillo E, 2011, BBA-MOL BASIS DIS, V1812, P402, DOI 10.1016/j.bbadis.2010.09.013; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; MANSON J, 1992, DEVELOPMENT, V115, P117; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Miele G, 2003, GENE EXPRESSION, V11, P1, DOI 10.3727/000000003783992324; Muller H, 1999, ENDOCRINOLOGY, V140, P2711, DOI 10.1210/en.140.6.2711; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Paisley D, 2004, AM J PATHOL, V164, P2279, DOI 10.1016/S0002-9440(10)63784-4; Peralta OA, 2011, DIFFERENTIATION, V81, P68, DOI 10.1016/j.diff.2010.09.181; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Sakthivelu V, 2011, J BIOL CHEM, V286, P8901, DOI 10.1074/jbc.M110.185470; Schneider B, 2011, FRONT BIOSCI-LANDMRK, V16, P169, DOI 10.2741/3682; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Tremblay P, 2007, BRAIN RES, V1139, P60, DOI 10.1016/j.brainres.2006.12.055; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Young R, 2011, BIOCHEM BIOPH RES CO, V416, P184, DOI 10.1016/j.bbrc.2011.11.021; Young R, 2011, BIOCHEM BIOPH RES CO, V412, P752, DOI 10.1016/j.bbrc.2011.08.049; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zeltser LM, 2011, P NATL ACAD SCI USA, V108, P15667, DOI 10.1073/pnas.1112239108; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	51	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41959	10.1371/journal.pone.0041959	http://dx.doi.org/10.1371/journal.pone.0041959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860039	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900055
J	Sun, DX; Liu, Z; Tan, XD; Cui, DX; Wang, BS; Dai, XW				Sun, Da-Xin; Liu, Zhen; Tan, Xiao-Dong; Cui, Dong-Xu; Wang, Bao-Sheng; Dai, Xian-Wei			Nanoparticle-Mediated Local Delivery of an Antisense TGF-beta 1 Construct Inhibits Intimal Hyperplasia in Autogenous Vein Grafts in Rats	PLOS ONE			English	Article							PORCINE CORONARY-ARTERIES; TRANSFORMING GROWTH-FACTOR-BETA-1; TGF-BETA; VASCULAR INJURY; ACCELERATES ATHEROSCLEROSIS; MATRIX METALLOPROTEINASES; BALLOON CATHETER; RESTENOSIS; ANGIOPLASTY; GROWTH	Background: Intimal hyperplasia is one of the most important causes of vascular graft failure. Numerous studies have correlated transforming growth factor-beta 1 (TGF-beta 1) with extracellular matrix (ECM) deposition, a hallmark of intimal thickening. Principal Findings: In the present study, we performed immunohistochemistry, RT-PCR, and Western blot to examine the dynamic expression of TGF-beta 1, TGF-beta 1 receptor type I (TGF-beta RI), matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) during intimal hyperplasia in grafted veins of a rat model generated by grafting a portion of the right internal jugular vein to the ipisiliary caroid artery. Additionally, we determined whether nanoparticle-mediated delivery of a TGF-beta 1 antisense-expressing construct prevented TGF-beta 1 expression and intimal hyperplasia in grafted veins. In grafted veins, the expression of TGF-beta 1 significantly increased on day 3 after transplantation, peaked on day 7, slightly decreased on day 14, and returned to baseline levels on day 28. The positive expression of TGF-beta RI in grafted veins remarkably increased on day 7, peaked on day 14, and decreased thereafter. MMP-1 expression decreased significantly, while TIMP-1 expression increased, significantly on days 14 and 28. Nanoparticle-mediated delivery of a TGF-beta 1 antisense-expressing construct down-regulated TGF-beta 1 expression and inhibited intimal hyperplasia in grafted veins. Conclusions: Our findings provide further evidence that TGF-beta 1 plays an integral role in the development of intimal hyperplasia after vascular injury. Nanoparticle-mediated delivery of a TGF-beta 1 antisense-expressing construct is a feasible strategy to target TGF-beta 1-induced intimal thickening.	[Sun, Da-Xin; Liu, Zhen; Tan, Xiao-Dong; Cui, Dong-Xu; Wang, Bao-Sheng; Dai, Xian-Wei] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Sun, DX (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Liaoning Provin, Peoples R China.	sundx@sj-hospital.org; daixw@sj-hospital.org	babakinejad, babak/G-2674-2012					Banai S, 2005, BIOMATERIALS, V26, P451, DOI 10.1016/j.biomaterials.2004.02.040; Chamberlain J, 2001, CARDIOVASC RES, V50, P125, DOI 10.1016/S0008-6363(01)00199-7; Chen Yuxiang, 2003, Current Gene Therapy, V3, P273, DOI 10.2174/1566523034578339; Cohen-Sela E, 2006, J NANOSCI NANOTECHNO, V6, P3226, DOI 10.1166/jnn.2006.428; Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1; Friedl R, 2004, ANN THORAC SURG, V78, P1312, DOI 10.1016/j.athoracsur.2004.02.066; Guzman LA, 1996, CIRCULATION, V94, P1441, DOI 10.1161/01.CIR.94.6.1441; Holmes DR, 2002, CIRCULATION, V106, P1243, DOI 10.1161/01.CIR.0000028335.31300.DA; Joshua DS, 1999, CIRC RES, V84, P1212; KANZAKI T, 1995, ARTERIOSCL THROM VAS, V15, P1951, DOI 10.1161/01.ATV.15.11.1951; Khan R, 2007, CARDIOVASC RES, V74, P223, DOI 10.1016/j.cardiores.2007.02.012; Kingston PA, 2001, CIRCULATION, V104, P2595, DOI 10.1161/hc4601.099405; Kobayashi K, 2005, CIRC RES, V96, P904, DOI 10.1161/01.RES.0000163980.55495.44; Kubota K, 2003, J SURG RES, V109, P43, DOI 10.1016/S0022-4804(02)00037-9; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Medina C, 2007, BRIT J PHARMACOL, V150, P552, DOI 10.1038/sj.bjp.0707130; Merrilees M, 2000, J VASC RES, V37, P50, DOI 10.1159/000025713; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smith JE, 1999, AFR AM REV, V33, P84, DOI 10.2307/2901304; Tamai H, 2002, AM HEART J, V143, P506, DOI 10.1067/mhj.2002.120770; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Ward MR, 2002, ARTERIOSCL THROM VAS, V22, P940, DOI 10.1161/01.ATV.0000019405.84384.9C; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Yamamoto K, 2000, CIRCULATION, V102, P1308, DOI 10.1161/01.CIR.102.11.1308; Yutani C, 1999, CARDIOLOGY, V92, P171, DOI 10.1159/000006967	32	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41857	10.1371/journal.pone.0041857	http://dx.doi.org/10.1371/journal.pone.0041857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860019	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900041
J	Zhang, YG; Zhang, J; Zeng, LJ; Huang, HL; Yang, M; Fu, XW; Tian, C; Xiang, ZP; Huang, J; Fan, H				Zhang, Yonggang; Zhang, Jie; Zeng, Lingjun; Huang, Honglang; Yang, Min; Fu, Xiaowei; Tian, Can; Xiang, Zhangpeng; Huang, Jin; Fan, Hong			The -2518A/G Polymorphism in the MCP-1 Gene and Tuberculosis Risk: A Meta-Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; AFRICAN POPULATION; SUSCEPTIBILITY	Background: The -2518A/G polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene has been implicated in the susceptibility to tuberculosis (TB), but the results are not conclusive. The aim of this study is to investigate the association between the -2518A/G polymorphism in the MCP-1 gene and the risk of tuberculosis by meta-analysis. Methods: We searched Pubmed, Embase, CNKI and Wanfang databases, covering all studies until April 29th, 2011. Statistical analyses were performed using the Revman4.2 and STATA10.0 software. Results: A total of 5341 cases and 6075 controls in 13 case-control studies were included in the meta-analysis. The results indicated that the GG homozygote carriers had a 67% increased risk of TB compared with the A allele carriers (GG vs. GA+AA: OR = 1.67, 95%CI = 1.25-2.23, P = 0.0006). In the subgroup analysis by ethnicity, significant elevated risks were found in Asians and Latinos, but not in Africans (GG vs. GA+AA: OR = 1.79, 95% CI = 1.19-2.70 and P = 0.005 for Asians; OR = 2.15, 95% CI = 1.32-3.51 and P = 0.002 for Latinos; OR = 1.28, 95% CI = 0.45-3.64 and P = 0.65 for Africans). Conclusion: This meta-analysis suggested that the -2518A/G polymorphism of MCP-1 gene would be a risk factor for TB in Asians and Latinos, while not in Africans.	[Zhang, Yonggang; Huang, Honglang; Yang, Min; Fu, Xiaowei; Tian, Can; Fan, Hong] Sichuan Univ, W China Hosp, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Jie] Wenzhou Med Coll, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med, Minist Educ, Wenzhou, Zhejiang, Peoples R China; [Zeng, Lingjun] First Hosp Ziyang City, Dept Resp Med, Ziyang, Sichuan, Peoples R China; [Huang, Honglang; Xiang, Zhangpeng; Huang, Jin] Sichuan Univ, W China Med Sch, Chengdu 610064, Sichuan, Peoples R China; [Yang, Min] Anhui Med Univ, Hosp 2, Dept Intens Care Unit, Hefei, Anhui, Peoples R China	Sichuan University; Wenzhou Medical University; Sichuan University; Anhui Medical University	Zhang, YG (corresponding author), Sichuan Univ, W China Hosp, Dept Resp Med, Chengdu 610064, Sichuan, Peoples R China.	michael.huangjin@gmail.com; z85445417@yahoo.cn	Zhang, Yonggang/I-2028-2018	Zhang, Yonggang/0000-0002-5251-3815	National Natural Science Foundation of China [30470761, 30871117]; Science and Technology Department of Sichuan province [2012JY0013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Sichuan province	This study was supported by grants #30470761 and 30871117 from the National Natural Science Foundation of China and grant #2012JY0013 from the Science and Technology Department of Sichuan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarasu K, 2009, INDIAN J MED RES, V130, P444; Ben-Selma W, 2011, FEMS IMMUNOL MED MIC; Ben-Selma W, 2011, MOL BIOL REP, P1; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Ganachari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008881; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; KIM JUS, 2011, AM J RESP CRIT CARE, V183, pA3346; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Mokrousov I, 2011, INFECT GENETICS EVOL; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Thye T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006307; WHO, 2010, GLOB TUB CONTR 2010; Xu Zhen-e, 2009, Zhonghua Er Ke Za Zhi, V47, P200; Yang Ben-fu, 2009, Zhonghua Jiehe He Huxi Zazhi, V32, P454, DOI 10.3760/cma.j.issn.1001-0939.2009.06.015; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019127; Zhang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013679; Zhang SY, 2009, ASS MCP 1 GENE POLYM; Zhang YG, 2011, ALLERGY, V66, P197, DOI 10.1111/j.1398-9995.2010.02438.x	25	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e38918	10.1371/journal.pone.0038918	http://dx.doi.org/10.1371/journal.pone.0038918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859936	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900003
J	Ao, A; Hao, JJ; Hopkins, CR; Hong, CC				Ao, Ada; Hao, Jijun; Hopkins, Corey R.; Hong, Charles C.			DMH1, a Novel BMP Small Molecule Inhibitor, Increases Cardiomyocyte Progenitors and Promotes Cardiac Differentiation in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							WNT/BETA-CATENIN; CARDIOVASCULAR PROGENITORS; SMOOTH-MUSCLE; TGF-BETA; MESODERM; INDUCTION; CARDIOGENESIS; SPECIFICATION; ESTABLISHMENT; REQUIREMENT	The possibility of using cell-based therapeutics to treat cardiac failure has generated significant interest since the initial introduction of stem cell-based technologies. However, the methods to quickly and robustly direct stem cell differentiation towards cardiac cell types have been limited by a reliance on recombinant growth factors to provide necessary biological cues. We report here the use of dorsomorphin homologue 1 (DMH1), a second-generation small molecule BMP inhibitor based on dorsomorphin, to efficiently induce beating cardiomyocyte formation in mouse embryonic stem cells (ESCs) and to specifically upregulate canonical transcriptional markers associated with cardiac development. DMH1 differs significantly from its predecessor by its ability to enrich for pro-cardiac progenitor cells that respond to late-stage Wnt inhibition using XAV939 and produce secondary beating cardiomyocytes. Our study demonstrates the utility of small molecules to complement existing in vitro cardiac differentiation protocols and highlights the role of transient BMP inhibition in cardiomyogenesis.	[Ao, Ada; Hao, Jijun; Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Hopkins, Corey R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Vanderbilt Inst Chem Biol,Ctr Neurosci Drug Disco, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Hong, Charles C.] Vet Affairs Tennessee Valley Healthcare Syst, Res Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ao, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA.	adaao05@gmail.com; charles.c.hong@vanderbilt.edu		Hopkins, Corey/0000-0003-4958-1697	National Heart, Lung, and Blood Institute, [5R01HL104040-02]; United States Public Health Service training grant [1T32HL105334-1A1]; Veterans Affair, and International Fibrodysplasia Ossificans Progressiva Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040, T32HL105334] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Public Health Service training grant; Veterans Affair, and International Fibrodysplasia Ossificans Progressiva Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The project is supported by grant number 5R01HL104040-02 from National Heart, Lung, and Blood Institute, Veterans Affair, and International Fibrodysplasia Ossificans Progressiva Association. AA is supported in part by United States Public Health Service training grant number 1T32HL105334-1A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao A, 2011, JOVE-J VIS EXP, DOI 10.3791/2656; Ao A, 2011, CHEM BIOL, V18, P413, DOI 10.1016/j.chembiol.2011.03.011; Barron M, 2000, DEV DYNAM, V218, P383, DOI 10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Cross EE, 2011, ACS CHEM BIOL, V6, P952, DOI 10.1021/cb200205z; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Emre N, 2007, CURR OPIN CHEM BIOL, V11, P252, DOI 10.1016/j.cbpa.2007.04.024; Engleka KA, 2012, CIRCULATION RES; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fuegemann Christopher J, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01f11s15; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hill CR, 2012, CELL SIGNAL, V24, P1012, DOI 10.1016/j.cellsig.2011.12.022; Hutson MR, 2010, DEVELOPMENT, V137, P3001, DOI 10.1242/dev.051565; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Liu WR, 2011, WIRES SYST BIOL MED, V3, P191, DOI 10.1002/wsbm.112; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Marques SR, 2009, DEV BIOL, V328, P472, DOI 10.1016/j.ydbio.2009.02.010; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mine N, 2008, DEVELOPMENT, V135, P2425, DOI 10.1242/dev.018986; Misfeldt AM, 2009, DEV BIOL, V333, P78, DOI 10.1016/j.ydbio.2009.06.033; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mummery Christine, 2007, V140, P249; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Tirosh-Finkel L, 2010, DEVELOPMENT, V137, P2989, DOI 10.1242/dev.051649; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wang HM, 2011, ACS CHEM BIOL, V6, P192, DOI 10.1021/cb100323z; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	41	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41627	10.1371/journal.pone.0041627	http://dx.doi.org/10.1371/journal.pone.0041627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848549	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200079
J	Huang, TP; Tzeng, DDS; Wong, ACL; Chen, CH; Lu, KM; Lee, YH; Huang, WD; Hwang, BF; Tzeng, KC				Huang, Tzu-Pi; Tzeng, Dean Der-Syh; Wong, Amy C. L.; Chen, Chun-Han; Lu, Kuan-Min; Lee, Ya-Huei; Huang, Wen-Di; Hwang, Bing-Fang; Tzeng, Kuo-Ching			DNA Polymorphisms and Biocontrol of Bacillus Antagonistic to Citrus Bacterial Canker with Indication of the Interference of Phyllosphere Biofilms	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; GROWTH-PROMOTING RHIZOBACTERIA; BIOLOGICAL-CONTROL; PLANT-GROWTH; FIELD CONDITIONS; SUBTILIS; CEREUS; XANTHOMONAS; SURFACTIN; LIPOPEPTIDES	Citrus bacterial canker caused by Xanthomonas axonopodis pv. citri is a devastating disease resulting in significant crop losses in various citrus cultivars worldwide. A biocontrol agent has not been recommended for this disease. To explore the potential of bacilli native to Taiwan to control this disease, Bacillus species with a broad spectrum of antagonistic activity against various phytopathogens were isolated from plant potting mixes, organic compost and the rhizosphere soil. Seven strains TKS1-1, OF3-16, SP4-17, HSP1, WG6-14, TLB7-7, and WP8-12 showing superior antagonistic activity were chosen for biopesticide development. The genetic identity based on 16S rDNA sequences indicated that all seven native strains were close relatives of the B. subtilis group and appeared to be discrete from the B. cereus group. DNA polymorphisms in strains WG6-14, SP4-17, TKS1-1, and WP8-12, as revealed by repetitive sequence-based PCR with the BOXA1R primers were similar to each other, but different from those of the respective Bacillus type strains. However, molecular typing of the strains using either tDNA-intergenic spacer regions or 16S-23S intergenic transcribed spacer regions was unable to differentiate the strains at the species level. Strains TKS1-1 and WG6-14 attenuated symptom development of citrus bacterial canker, which was found to be correlated with a reduction in colonization and biofilm formation by X. axonopodis pv. citri on leaf surfaces. The application of a Bacillus strain TKS1-1 endospore formulation to the leaf surfaces of citrus reduced the incidence of citrus bacterial canker and could prevent development of the disease.	[Huang, Tzu-Pi; Tzeng, Dean Der-Syh; Chen, Chun-Han; Lu, Kuan-Min; Lee, Ya-Huei; Huang, Wen-Di; Tzeng, Kuo-Ching] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Wong, Amy C. L.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Hwang, Bing-Fang] China Med Univ, Dept Occupat Safety & Hlth, Taichung, Taiwan	National Chung Hsing University; University of Wisconsin System; University of Wisconsin Madison; China Medical University Taiwan	Huang, TP (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	tphuang@nchu.edu.tw	Hwang, Bing-Fang/O-2709-2015	Hwang, Bing-Fang/0000-0002-5951-9662; Huang, Tzu-Pi/0000-0003-2904-3373	National Science Council [NSC97-2313-B-005-039-MY3, NSC99-2321-B-005-014-MY3]; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan [(99AS-9.2.2-BQ-B2(13), 100AS-9.2.2-BQ-B2(1)]	National Science Council(Ministry of Science and Technology, Taiwan); Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan	This research was supported by the National Science Council (NSC97-2313-B-005-039-MY3 and NSC99-2321-B-005-014-MY3) to TPH, the Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan (99AS-9.2.2-BQ-B2(13) and 100AS-9.2.2-BQ-B2(1)) to TPH and DDST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, BERGEYS MANUAL SYSTE; Arias RS, 1999, J BASIC MICROB, V39, P283, DOI 10.1002/(SICI)1521-4028(199912)39:5/6<283::AID-JOBM283>3.0.CO;2-G; ASH C, 1991, LETT APPL MICROBIOL, V13, P202, DOI 10.1111/j.1472-765X.1991.tb00608.x; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Bargabus RL, 2002, PHYSIOL MOL PLANT P, V61, P289, DOI 10.1006/pmpp.2003.0443; Bradley CA, 2008, PLANT DIS, V92, P120, DOI 10.1094/PDIS-92-1-0120; Bull CT, 2010, J PLANT PATHOL, V92, P551; Cavaglieri L, 2005, RES MICROBIOL, V156, P748, DOI 10.1016/j.resmic.2005.03.001; Characklis WG, 1990, BIOFILMS, P3; Chithrashree, 2011, BIOL CONTROL, V59, P114, DOI 10.1016/j.biocontrol.2011.06.010; Daffonchio D, 2003, APPL ENVIRON MICROB, V69, P5128, DOI 10.1128/AEM.69.9.5128-5137.2003; Daffonchio D, 1998, INT J SYST BACTERIOL, V48, P107, DOI 10.1099/00207713-48-1-107; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Duc LH, 2004, APPL ENVIRON MICROB, V70, P2161, DOI 10.1128/AEM.70.4.2161-2171.2004; Enebak SA, 2000, PLANT DIS, V84, P306, DOI 10.1094/PDIS.2000.84.3.306; Freitas Dulcecleide B, 2008, BMC Res Notes, V1, P92, DOI 10.1186/1756-0500-1-92; Govan JRW, 1998, MICROBIOL-SGM, V144, P2373, DOI 10.1099/00221287-144-9-2373; Handelsman J, 1996, PLANT CELL, V8, P1855, DOI 10.1105/tpc.8.10.1855; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; HUANG TC, 1975, BOT BULL ACAD SINICA, V16, P137; Kim PI, 2004, FEMS MICROBIOL LETT, V234, P177, DOI 10.1111/j.1574-6968.2004.tb09530.x; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kuhls K, 1996, P NATL ACAD SCI USA, V93, P7755, DOI 10.1073/pnas.93.15.7755; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lemessa F, 2007, BIOL CONTROL, V42, P336, DOI 10.1016/j.biocontrol.2007.05.014; Li Y-H, 2010, PLANT PROTECTION MAN; Lin D, 2001, J APPL MICROBIOL, V91, P1044, DOI 10.1046/j.1365-2672.2001.01475.x; Lin HsinCheng, 2005, Plant Pathology Bulletin, V14, P227; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; McKillip JL, 2000, ANTON LEEUW INT J G, V77, P393, DOI 10.1023/A:1002706906154; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mohammadipour M, 2009, CAN J MICROBIOL, V55, P395, DOI [10.1139/W08-141, 10.1139/w08-141]; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Ongena M, 2009, PLANT PATH 21ST, V1, P59, DOI 10.1007/978-1-4020-8804-9_5; Padgham JL, 2007, CROP PROT, V26, P971, DOI 10.1016/j.cropro.2006.09.004; Parsek MR, 2004, J BACTERIOL, V186, P4427, DOI 10.1128/JB.186.14.4427-4440.2004; Priest Fergus G., 1993, P3; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Sambrook J., 2001, MOL CLONING LAB MANU; Schaad NW, 2005, SYST APPL MICROBIOL, V28, P494, DOI 10.1016/j.syapm.2005.03.017; Shang HZ, 1999, CURR MICROBIOL, V38, P199, DOI 10.1007/PL00006787; SILOSUH LA, 1994, APPL ENVIRON MICROB, V60, P2023, DOI 10.1128/AEM.60.6.2023-2030.1994; Souto GI, 2004, J APPL MICROBIOL, V97, P1247, DOI 10.1111/j.1365-2672.2004.02408.x; STALL RE, 1991, ANNU REV PHYTOPATHOL, V29, P399, DOI 10.1146/annurev.py.29.090191.002151; Toure Y, 2004, J APPL MICROBIOL, V96, P1151, DOI 10.1111/j.1365-2672.2004.02252.x; Tzeng DD-S, 2009, United States Patent Number US7632493B2, P19, Patent No. 7632493; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Voloudakis AE, 2005, APPL ENVIRON MICROB, V71, P782, DOI 10.1128/AEM.71.2.782-789.2005; Wei G, 1996, PHYTOPATHOLOGY, V86, P221, DOI 10.1094/Phyto-86-221; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wu W. C., 1989, Plant Protection Bulletin, Taiwan, V31, P139; WUNSCHEL D, 1995, SYST APPL MICROBIOL, V17, P625, DOI 10.1016/S0723-2020(11)80085-8	57	29	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42124	10.1371/journal.pone.0042124	http://dx.doi.org/10.1371/journal.pone.0042124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848728	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200171
J	Liu, F; Yu, G; Wang, GJ; Liu, HY; Wu, XL; Wang, Q; Liu, M; Liao, K; Wu, MQ; Cheng, XF; Hao, HP				Liu, Fang; Yu, Guo; Wang, Guangji; Liu, Huiying; Wu, Xiaolan; Wang, Qiong; Liu, Miao; Liao, Ke; Wu, Mengqiu; Cheng, Xuefang; Hao, Haiping			An NQO1-Initiated and p53-Independent Apoptotic Pathway Determines the Anti-Tumor Effect of Tanshinone IIA against Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NAD(P)H-QUINONE OXIDOREDUCTASE-1 NQO1; DT-DIAPHORASE; GROWTH-INHIBITION; OXIDATIVE STRESS; QUINONE REDUCTION; BETA-LAPACHONE; MITOMYCIN-C; PHASE-III; IN-VITRO; P53	NQO1 is an emerging and promising therapeutic target in cancer therapy. This study was to determine whether the antitumor effect of tanshinone IIA (TSA) is NQO1 dependent and to elucidate the underlying apoptotic cell death pathways. NQO1(+) A549 cells and isogenically matched NQO1 transfected and negative H596 cells were used to test the properties and mechanisms of TSA induced cell death. The in vivo anti-tumor efficacy and the tissue distribution properties of TSA were tested in tumor xenografted nude mice. We observed that TSA induced an excessive generation of ROS, DNA damage, and dramatic apoptotic cell death in NQO1(+) A549 cells and H596-NQO1 cells, but not in NQO1(-) H596 cells. Inhibition or silence of NQO1 as well as the antioxidant NAC markedly reversed TSA induced apoptotic effects. TSA treatment significantly retarded the tumor growth of A549 tumor xenografts, which was significantly antagonized by dicoumarol co-treatment in spite of the increased and prolonged TSA accumulations in tumor tissues. TSA activated a ROS triggered, p53 independent and caspase dependent mitochondria apoptotic cell death pathway that is characterized with increased ratio of Bax to Bcl-xl, mitochondrial membrane potential disruption, cytochrome c release, and subsequent caspase activation and PARP-1 cleavage. The results of these findings suggest that TSA is a highly specific NQO1 target agent and is promising in developing as an effective drug in the therapy of NQO1 positive NSCLC.	[Liu, Fang; Yu, Guo; Wang, Guangji; Liu, Huiying; Wu, Xiaolan; Wang, Qiong; Liu, Miao; Liao, Ke; Wu, Mengqiu; Cheng, Xuefang; Hao, Haiping] China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Liu, F (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@yahoo.com.cn	Hao, Haiping/L-8265-2019; Wu, Mengqiu/HHS-9267-2022; liao, ke/B-7004-2019	Hao, Haiping/0000-0003-2522-7546; Wu, Mengqiu/0000-0001-9488-5572; Liu, Miao/0000-0002-7975-6702	Foundation for the Author of National Excellent Doctoral Dissertation of China [200979]; Natural Science Foundation of Jiangsu province [BK2011065]; Science Foundation for Youth Scholars of Ministry of Education of China [200803161012]; Program for New Century Excellent Talents in University [NCET-09-0770]; National Natural Science Foundation China [91029746, 3080142]	Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Science Foundation for Youth Scholars of Ministry of Education of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation China(National Natural Science Foundation of China (NSFC))	This study was financially supported by a Foundation for the Author of National Excellent Doctoral Dissertation of China (200979), Natural Science Foundation of Jiangsu province (BK2011065), Science Foundation for Youth Scholars of Ministry of Education of China (200803161012), the Program for New Century Excellent Talents in University (NCET-09-0770), and National Natural Science Foundation China (Nos. 91029746, 30801422). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; [Anonymous], 1984, J Tradit Chin Med, V4, P20; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; CADENAS E, 1995, BIOCHEM PHARMACOL, V49, P127, DOI 10.1016/S0006-2952(94)00333-5; Chang LC, 2011, J BIOMED NANOTECHNOL, V7, P558, DOI 10.1166/jbn.2011.1315; Chiu TL, 2010, INT J MOL MED, V25, P231, DOI 10.3892/ijmm_00000335; David GL, 2003, AM J RESP CRIT CARE, V168, P1199, DOI 10.1164/rccm.200305-684OC; Digby T, 2005, CANCER CHEMOTH PHARM, V56, P307, DOI 10.1007/s00280-004-0961-4; Dong YZ, 2011, NAT PROD REP, V28, P529, DOI 10.1039/c0np00035c; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Hao HP, 2007, CURR DRUG METAB, V8, P137, DOI 10.2174/138920007779816011; Hao HP, 2006, PLANTA MED, V72, P1311, DOI 10.1055/s-2006-951698; Hao HP, 2006, J PHARMACEUT BIOMED, V40, P382, DOI 10.1016/j.jpba.2005.07.029; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Ho John W., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P273, DOI 10.2174/187152507782109854; Jiang BH, 2009, FOOD CHEM TOXICOL, V47, P1538, DOI 10.1016/j.fct.2009.03.038; Lewis A, 2004, CLIN CANCER RES, V10, P4550, DOI 10.1158/1078-0432.CCR-03-0667; Li LS, 2011, CLIN CANCER RES, V17, P275, DOI 10.1158/1078-0432.CCR-10-1983; Long DJ, 2002, CANCER RES, V62, P3030; MALKINSON AM, 1992, CANCER RES, V52, P4752; Martoni A, 2005, EUR J CANCER, V41, P81, DOI 10.1016/j.ejca.2004.08.029; Muller M, 2009, FREE RADICAL BIO MED, V47, P84, DOI 10.1016/j.freeradbiomed.2009.04.011; Noh JY, 2010, J PHARMACOL EXP THER, V333, P414, DOI 10.1124/jpet.109.164608; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Park MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025976; Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; ROSS D, 1994, ONCOL RES, V6, P493; Ross D, 2004, METHOD ENZYMOL, V382, P115; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Rudd RM, 2005, J CLIN ONCOL, V23, P142, DOI 10.1200/JCO.2005.03.037; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; SmitskampWilms E, 1996, GEN PHARMACOL-VASC S, V27, P421, DOI 10.1016/0306-3623(95)00118-2; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Su CC, 2008, PLANTA MED, V74, P1357, DOI 10.1055/s-2008-1081299; Su CC, 2008, INT J MOL MED, V22, P847, DOI 10.3892/ijmm_00000094; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wang J, 2007, J NEURO-ONCOL, V82, P11, DOI 10.1007/s11060-006-9242-x; Wang JYJ, 2001, CELL DEATH DIFFER, V8, P1047, DOI 10.1038/sj.cdd.4400938; Wang QO, 2010, DRUG METAB DISPOS, V38, P1132, DOI 10.1124/dmd.109.031864; Wenz HM, 1998, MUTAT RES-GENOMICS, V382, P121, DOI 10.1016/S1383-5726(98)00004-1; Xu W, 2009, PHARMAZIE, V64, P332, DOI 10.1691/ph.2009.8771; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Yuan SL, 2004, WORLD J GASTROENTERO, V10, P2024, DOI 10.3748/wjg.v10.i14.2024; Zhang ZC, 2009, BIOCHEM PHARMACOL, V78, P1316, DOI 10.1016/j.bcp.2009.06.110	53	66	74	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42138	10.1371/journal.pone.0042138	http://dx.doi.org/10.1371/journal.pone.0042138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848731	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200172
J	Msefula, CL; Kingsley, RA; Gordon, MA; Molyneux, E; Molyneux, ME; MacLennan, CA; Dougan, G; Heyderman, RS				Msefula, Chisomo L.; Kingsley, Robert A.; Gordon, Melita A.; Molyneux, Elizabeth; Molyneux, Malcolm E.; MacLennan, Calman A.; Dougan, Gordon; Heyderman, Robert S.			Genotypic Homogeneity of Multidrug Resistant S. Typhimurium Infecting Distinct Adult and Childhood Susceptibility Groups in Blantyre, Malawi	PLOS ONE			English	Article							INVASIVE NONTYPHOIDAL SALMONELLA; PROVIDES INSIGHTS; ESCHERICHIA-COLI; BACTEREMIA; EVOLUTIONARY; ENTERITIDIS; MACROPHAGES; ADAPTATION; CHILDREN; SEQUENCE	Nontyphoidal Salmonella (NTS) serovars are a common cause of bacteraemia in young children and HIV-infected adults in Malawi and elsewhere in sub-Saharan Africa. These patient populations provide diverse host-immune environments that have the potential to drive bacterial adaptation and evolution. We therefore investigated the diversity of 27 multidrug resistant (MDR) Salmonella Typhimurium strains isolated over 6 years (2002-2008) from HIV-infected adults and children and HIV-uninfected children. Sequence reads from whole-genome sequencing of these isolates using the Illumina GA platform were mapped to the genome of the laboratory strain S. Typhimurium SL1344 excluding homoplastic regions that contained prophage and insertion elements. A phylogenetic tree generated from single nucleotide polymorphisms showed that all 27 strains clustered with the prototypical MDR strain D23580. There was no clustering of strains based on host HIV status or age, suggesting that these susceptible populations acquire S. Typhimurium from common sources or that isolates are transmitted freely between these populations. However, 7/14 of the most recent isolates (2006/2008) formed a distinct clade that branched off 22 SNPs away from the cluster containing earlier isolates. These data suggest that the MDR bacterial population is not static, but is undergoing microevolution which might result in further epidemiology change.	[Msefula, Chisomo L.] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Msefula, Chisomo L.; Molyneux, Malcolm E.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Molyneux, Elizabeth] Univ Malawi, Coll Med, Dept Paediat, Blantyre, Malawi; [Kingsley, Robert A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Molyneux, Malcolm E.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth Srl NVGH, Siena, Italy; [MacLennan, Calman A.] Univ Birmingham, MRC Ctr Immune Regulat, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Gordon, Melita A.] Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Molyneux, Malcolm E.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi	University of Malawi; University of Malawi; University of Malawi; Wellcome Trust Sanger Institute; University of Liverpool; Novartis; University of Birmingham; University of Liverpool; University of Malawi	Msefula, CL (corresponding author), Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi.	cmsefula@medcol.mw	Msefula, Chisomo/AAY-9107-2020; MacLennan, Calman A/L-9343-2014; Gordon, Melita/F-5563-2012	MacLennan, Calman A/0000-0001-9694-0846; Msefula, Chisomo/0000-0003-2304-886X; Kingsley, Robert/0000-0002-0194-6485; Heyderman, Robert/0000-0003-4573-449X; Gordon, Melita/0000-0002-0629-0884	Malawi-Liverpool-Wellcome Trust Core Programme Grant from the Wellcome Trust; Tropical Research Fellowships from the Wellcome Trust; Clinical Research Fellowship from GlaxoSmithKline; Wellcome Trust Funding; Medical Research Council [G9818340B] Funding Source: researchfish	Malawi-Liverpool-Wellcome Trust Core Programme Grant from the Wellcome Trust; Tropical Research Fellowships from the Wellcome Trust; Clinical Research Fellowship from GlaxoSmithKline; Wellcome Trust Funding(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Malawi-Liverpool-Wellcome Trust Core Programme Grant from the Wellcome Trust (Robert S. Heyderman); Tropical Research Fellowships from the Wellcome Trust (Calman A. MacLennan and Melita A. Gordon); a Clinical Research Fellowship from GlaxoSmithKline (Calman A. MacLennan); and Wellcome Trust Funding for the Wellcome Trust Sanger Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Clemens John D, 2009, Emerg Infect Dis, V15, pe2, DOI 10.3201/eid1507.090416; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; Dione MM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001148; Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Gordon DM, 2005, MICROBIOL-SGM, V151, P15, DOI 10.1099/mic.0.27425-0; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2007, AIDS, V21, P2399, DOI 10.1097/QAD.0b013e3282f25107; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Kariuki S, 2005, INT J ANTIMICROB AG, V25, P38, DOI 10.1016/j.ijantimicag.2004.08.015; Kariuki S, 2002, FEMS IMMUNOL MED MIC, V33, P165, DOI 10.1111/j.1574-695X.2002.tb00587.x; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Nyirenda TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013667; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Paiva JB, 2009, BRAZ J MICROBIOL, V40, P994, DOI 10.1590/S1517-838220090004000035; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pei YL, 2007, CAN J VET RES, V71, P1; Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0; Schreiber F, 2011, J INFECT DIS, V204, P1237, DOI 10.1093/infdis/jir512; Sohaskey CD, 2008, J BACTERIOL, V190, P2981, DOI 10.1128/JB.01857-07; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Song J, 2005, BIOINFORMATICS, V21, P2083, DOI 10.1093/bioinformatics/bti176; Sow AG, 2007, J INFECT DEV COUNTR, V1, P284; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Usha G, 2008, DIAGN MICR INFEC DIS, V62, P86, DOI 10.1016/j.diagmicrobio.2008.04.014; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	49	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42085	10.1371/journal.pone.0042085	http://dx.doi.org/10.1371/journal.pone.0042085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848711	Green Published, gold			2022-12-27	WOS:000306950200159
J	Poignard, P; Moldt, B; Maloveste, K; Campos, N; Olson, WC; Rakasz, E; Watkins, DI; Burton, DR				Poignard, Pascal; Moldt, Brian; Maloveste, Karla; Campos, Noelie; Olson, William C.; Rakasz, Eva; Watkins, David I.; Burton, Dennis R.			Protection against High-Dose Highly Pathogenic Mucosal SIV Challenge at Very Low Serum Neutralizing Titers of the Antibody-Like Molecule CD4-IgG2	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1/SIV CHIMERIC VIRUS; MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; RHESUS-MONKEYS; VACCINE; HIV; MACAQUES; INFECTION; CELL	Passive transfer studies using monoclonal or polyclonal antibodies in the macaque model have been valuable for determining conditions for antibody protection against immunodeficiency virus challenge. Most studies have employed hybrid simian/human immunodeficiency virus (SHIV) challenge in conjunction with neutralizing human monoclonal antibodies. Passive protection against SIV, particularly the pathogenic prototype virus SIVmac239, has been little studied because of the paucity of neutralizing antibodies to this virus. Here, we show that the antibody-like molecule CD4-IgG2 potently neutralizes SIVmac239 in vitro. When administered by an osmotic pump to maintain concentrations given the short half-life of CD4-IgG2 in macaques, the molecule provided sterilizing immunity/protection against high-dose mucosal viral challenge to a high proportion of animals (5/7 at a 200 mg dose CD4-IgG2 and 3/6 at a 20 mg dose) at serum concentrations below 1.5 mu g/ml. The neutralizing titers of such sera were predicted to be very low and indeed sera at a 1: 4 dilution produced no neutralization in a pseudovirus assay. Macaque anti-human CD4 titers did develop weakly at later time points in some animals but were not associated with the level of protection against viral challenge. The results show that, although SIVmac239 is considered a highly pathogenic virus for which vaccine-induced T cell responses in particular have provided limited benefit against high dose challenge, the antibody-like CD4-IgG2 molecule at surprisingly low serum concentration affords sterilizing immunity/protection to a majority of animals.	[Poignard, Pascal; Moldt, Brian; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Poignard, Pascal; Moldt, Brian; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY USA; [Poignard, Pascal; Maloveste, Karla; Campos, Noelie] CNRS, Marseille, France; [Poignard, Pascal; Maloveste, Karla; Campos, Noelie] INSERM, F-13258 Marseille, France; [Poignard, Pascal; Maloveste, Karla; Campos, Noelie] Ctr Immunol Marseille Luminy, Marseille, France; [Olson, William C.] Progen Pharmaceut Inc, Tarrytown, NY USA; [Rakasz, Eva; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison; University of Miami; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Poignard, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	poignard@scripps.edu; burton@scripps.edu	poignard, pascal/N-6678-2013; Rakasz, Eva G/H-9197-2019; poignard, pascal/AAB-4613-2020	Poignard, Pascal/0000-0002-0021-7192	National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases [R01 AI055332]; The International AIDS Vaccine Initiative through the Neutralizing Antibody Consortium; The Ragon Institute of Massachusetts General Hospital; Massachusetts Institute of Technology and Harvard; NIH/National Center for Research Resources [P51 RR000167]; Alfred Benzon Fellowship; Research Facilities Improvement Program [RR15459, RR020141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI055332] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The International AIDS Vaccine Initiative through the Neutralizing Antibody Consortium; The Ragon Institute of Massachusetts General Hospital; Massachusetts Institute of Technology and Harvard; NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Alfred Benzon Fellowship; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases grant R01 AI055332 (DRB), The International AIDS Vaccine Initiative through the Neutralizing Antibody Consortium (DRB), The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard (DRB), NIH/National Center for Research Resources grant P51 RR000167 (Wisconsin National Primate Research Center) and by an Alfred Benzon Fellowship (BM). This work was conducted in part at a facility constructed with support from Research Facilities Improvement Program grants RR15459 and RR020141 (Wisconsin National Primate Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Friedrich TC, 2008, CURR OPIN HIV AIDS, V3, P393, DOI 10.1097/COH.0b013e3282faa461; Gauduin MC, 1996, J VIROL, V70, P2586, DOI 10.1128/JVI.70.4.2586-2592.1996; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Jacobson JM, 2004, ANTIMICROB AGENTS CH, V48, P423, DOI 10.1128/AAC.48.2.423-429.2004; Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Kowalski WB, 1997, J SOC GYNECOL INVEST, V4, P152, DOI 10.1016/S1071-5576(97)00018-X; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lifson JD, 2002, NATURE, V415, P272, DOI 10.1038/415272b; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Means RE, 1997, J VIROL, V71, P7895, DOI 10.1128/JVI.71.10.7895-7902.1997; Nagashima KA, 2001, J INFECT DIS, V183, P1121, DOI 10.1086/319284; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Shearer WT, 2000, J INFECT DIS, V182, P1774, DOI 10.1086/317622; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Watkins DI, 2008, MEM I OSWALDO CRUZ, V103, P119, DOI 10.1590/S0074-02762008000200001; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09	37	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42209	10.1371/journal.pone.0042209	http://dx.doi.org/10.1371/journal.pone.0042209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848744	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200182
J	Wan, P; Huang, YX; Tabashnik, BE; Huang, MS; Wu, KM				Wan, Peng; Huang, Yunxin; Tabashnik, Bruce E.; Huang, Minsong; Wu, Kongming			The Halo Effect: Suppression of Pink Bollworm on Non-Bt Cotton by Bt Cotton in China	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; INSECT RESISTANCE; LEPIDOPTERA; EVOLUTION; CROPS	In some previously reported cases, transgenic crops producing insecticidal proteins from Bacillus thuringiensis (Bt) have suppressed insect pests not only in fields planted with such crops, but also regionally on host plants that do not produce Bt toxins. Here we used 16 years of field data to determine if Bt cotton caused this "halo effect'' against pink bollworm (Pectinophora gossypiella) in six provinces of the Yangtze River Valley of China. In this region, the percentage of cotton hectares planted with Bt cotton increased from 9% in 2000 to 94% in 2009 and 2010. We found that Bt cotton significantly decreased the population density of pink bollworm on non-Bt cotton, with net decreases of 91% for eggs and 95% for larvae on non-Bt cotton after 11 years of Bt cotton use. Insecticide sprays targeting pink bollworm and cotton bollworm (Helicoverpa armigera) decreased by 69%. Previously reported evidence of the early stages of evolution of pink bollworm resistance to Bt cotton in China has raised concerns that if unchecked, such resistance could eventually diminish or eliminate the benefits of Bt cotton. The results reported here suggest that it might be possible to find a percentage of Bt cotton lower than the current level that causes sufficient regional pest suppression and reduces the risk of resistance.	[Wan, Peng; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wan, Peng; Huang, Minsong] Hubei Acad Agr Sci, Inst Plant Protect & Soil Sci, Wuhan, Peoples R China; [Huang, Yunxin] Hubei Univ, Sch Resource & Environm Sci, Wuhan 430062, Hubei, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hubei Academy of Agricultural Sciences; Hubei University; University of Arizona	Wan, P (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			Key Project for Breeding Genetically Modified Organisms [2011ZX08012-004]; United States Department of Agriculture, Agriculture and Food Research Initiative [2008-35302-0390]	Key Project for Breeding Genetically Modified Organisms; United States Department of Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA))	This work was funded by the Key Project for Breeding Genetically Modified Organisms (2011ZX08012-004) and grant 2008-35302-0390 from the United States Department of Agriculture, Agriculture and Food Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstad DN, 1996, AGBIOTECH NEWS INFOR, V8, P177; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Guo SanDui, 1995, Scientia Agricultura Sinica, V28, P8; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Liu YB, 2002, J ECON ENTOMOL, V95, P143, DOI 10.1603/0022-0493-95.1.143; Naranjo SE, 2010, SOUTHWEST ENTOMOL, V35, P437, DOI 10.3958/059.035.0329; National Agro-Technical Extension and Service Center (NATESC), 2005, HDB CROP PEST MONITO; National Research Council, 2010, IMP GEN ENG CROPS FA; Royama T., 1992, Analytical population dynamics.; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2012, J INVERTEBR PATHOL, V110, P301, DOI 10.1016/j.jip.2012.04.008; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tabashnik BE, 2010, SCIENCE, V330, P189, DOI 10.1126/science.1196864; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Wan P, 2004, CROP PROT, V23, P463, DOI 10.1016/j.cropro.2003.09.017; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yu S, 2010, BIOBUSINESS, V3, P35; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	33	28	36	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42004	10.1371/journal.pone.0042004	http://dx.doi.org/10.1371/journal.pone.0042004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848685	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200145
J	Baisley, K; Doyle, AM; Changalucha, J; Maganja, K; Watson-Jones, D; Hayes, R; Ross, D				Baisley, Kathy; Doyle, Aoife M.; Changalucha, John; Maganja, Kaballa; Watson-Jones, Deborah; Hayes, Richard; Ross, David			Uptake of Voluntary Counselling and Testing among Young People Participating in an HIV Prevention Trial: Comparison of Opt-Out and Opt-In Strategies	PLOS ONE			English	Article							SEXUAL HEALTH INTERVENTION; COMMUNITY-RANDOMIZED-TRIAL; SUB-SAHARAN AFRICA; SOUTH-AFRICA; RURAL TANZANIA; CAPE-TOWN; PROJECT; ACCEPTABILITY; ZIMBABWE; DESIGN	Background: HIV voluntary counselling and testing (VCT) is an integral component of HIV prevention and treatment programmes. However, testing coverage in sub-Saharan Africa is still low, particularly among young people. As treatment becomes more widely available, strategies to expand VCT coverage are critically important. We compare VCT uptake using two delivery strategies (opt-in and opt-out) within the MEMA kwa Vijana trial in 20 communities in northwest Tanzania. Methods: We analysed data from 12,590 young persons (median (IQR) age 22 years (20-23)) to assess the effect of delivery strategy on VCT uptake. Ten communities used an opt-in approach and 10 used opt-out, balanced across intervention and control. Conditional logistic regression was used to examine factors associated with uptake within each strategy. Results: VCT uptake was significantly higher with the opt-out approach (90.9% vs 60.5%, prevalence ratio = 1.51, CI = 1.41-1.62). Among females, uptake in the opt-out approach was associated with decreased knowledge of HIV acquisition, sex with a casual partner, and being HSV-2 seronegative; among males, uptake was associated with lower education and increasing lifetime partners. In contrast, uptake using the opt-in approach varied by ethnic group, religion and marital status, and increased with increasing knowledge of STI acquisition (males) or pregnancy prevention (females). Conclusion: VCT uptake among young people was extremely high when offered an opt-out strategy. Sociodemographic and knowledge factors affected uptake in different ways depending on delivery strategy. Increased knowledge may increase young persons' self-efficacy, which may have a different impact on testing uptake, depending on the approach used.	[Baisley, Kathy; Doyle, Aoife M.; Watson-Jones, Deborah; Hayes, Richard; Ross, David] London Sch Hyg & Trop Med, London WC1, England; [Doyle, Aoife M.; Maganja, Kaballa; Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Baisley, K (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	david.ross@lshtm.ac.uk	Doyle, Aoife/AAX-3525-2020	Doyle, Aoife/0000-0002-3305-7738; Hayes, Richard/0000-0002-1729-9892	European Commission; UK Department for International Development; Irish Aid; Medical Research Council of Great Britain; United Nations Joint Programme on HIV/AIDS (UNAIDS); Medical Research Council [G0700837, G0902121] Funding Source: researchfish; MRC [G0902121, G0700837] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department for International Development; Irish Aid(CGIAR); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Nations Joint Programme on HIV/AIDS (UNAIDS); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded through grants from the European Commission, the UK Department for International Development and Irish Aid. Additional funding was received from the Medical Research Council of Great Britain and The United Nations Joint Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Leon N, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-8; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; MBOPIKEOU FX, 2007, 17 INT AIDS C MEX CI, V21, P1994; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; National Bureau of Statistics (NBS/Tanzania) ICF Macro, 2011, TANZ DEM HLTH SURV 2; Obasi AI, 2006, AIDS CARE, V18, P311, DOI 10.1080/09540120500161983; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; WHO, 2007, ACC HLTH SERV YOUNG; [WHO UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; WHO/UNAIDS, 2011, GLOB HIV AIDS RESP E; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x	24	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42108	10.1371/journal.pone.0042108	http://dx.doi.org/10.1371/journal.pone.0042108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848722	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600168
J	de Menorval, MA; Mir, LM; Fernandez, ML; Reigada, R				de Menorval, Marie-Amelie; Mir, Lluis M.; Laura Fernandez, M.; Reigada, Ramon			Effects of Dimethyl Sulfoxide in Cholesterol-Containing Lipid Membranes: A Comparative Study of Experiments In Silico and with Cells	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ELECTROPORATION; DIMETHYLSULFOXIDE; BILAYER; FIELD; DMSO; CRYOPRESERVATION; MECHANISM; PORES; PHASE	Dimethyl sulfoxide (DMSO) has been known to enhance cell membrane permeability of drugs or DNA. Molecular dynamics (MD) simulations with single-component lipid bilayers predicted the existence of three regimes of action of DMSO: membrane loosening, pore formation and bilayer collapse. We show here that these modes of action are also reproduced in the presence of cholesterol in the bilayer, and we provide a description at the atomic detail of the DMSO-mediated process of pore formation in cholesterol-containing lipid membranes. We also successfully explore the applicability of DMSO to promote plasma membrane permeability to water, calcium ions (Ca2+) and Yo-Pro-1 iodide (Yo-Pro-1) in living cell membranes. The experimental results on cells in culture can be easily explained according to the three expected regimes: in the presence of low doses of DMSO, the membrane of the cells exhibits undulations but no permeability increase can be detected, while at intermediate DMSO concentrations cells are permeabilized to water and calcium but not to larger molecules as Yo-Pro-1. These two behaviors can be associated to the MD-predicted consequences of the effects of the DMSO at low and intermediate DMSO concentrations. At larger DMSO concentrations, permeabilization is larger, as even Yo-Pro-1 can enter the cells as predicted by the DMSO-induced membrane-destructuring effects described in the MD simulations.	[de Menorval, Marie-Amelie; Mir, Lluis M.] Univ Paris 11, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, Orsay, France; [de Menorval, Marie-Amelie; Mir, Lluis M.] CNRS, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, F-91405 Orsay, France; [de Menorval, Marie-Amelie; Mir, Lluis M.] Inst Gustave Roussy, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, Villejuif, France; [Laura Fernandez, M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Comp, Lab Sistemas Complejos, Buenos Aires, DF, Argentina; [Laura Fernandez, M.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Reigada, Ramon] Univ Barcelona, Dept Quim Fis, E-08028 Barcelona, Spain; [Reigada, Ramon] Univ Barcelona, Inst Quim Teor & Comp, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Barcelona; University of Barcelona	de Menorval, MA (corresponding author), Univ Paris 11, Lab Vectorol & Therapeut Anticancereuses, UMR 8203, Orsay, France.	reigada@ub.edu	MIR, Lluis M/AAJ-9110-2020	Reigada, Ramon/0000-0003-2177-7014	Secretaria de Estado de Investigacion i Desarrollo [BFU2010-21847-C02-02]; Departament d'Universitats, Recerca i Sistemes de la Informacio [2009-SGR-1055]; Centre National de la Recherche Scientifique; Institut Gustave Roussy; Universite Paris-Sud XI; French National Agency for Research [ANR-10-BLAN-916, ANR-11-BS01-006]; Universidad de Buenos Aires [UBACyT X132/08]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-01080/09]; Ministerio de Ciencia y Tecnologia [SLO-AR 08/02/09]	Secretaria de Estado de Investigacion i Desarrollo; Departament d'Universitats, Recerca i Sistemes de la Informacio; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Gustave Roussy; Universite Paris-Sud XI; French National Agency for Research(French National Research Agency (ANR)); Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support is provided by Secretaria de Estado de Investigacion i Desarrollo through project BFU2010-21847-C02-02 and by Departament d'Universitats, Recerca i Sistemes de la Informacio through project 2009-SGR-1055. This work was supported by Centre National de la Recherche Scientifique, Institut Gustave Roussy and Universite Paris-Sud XI and by the French National Agency for Research through the Intcell ANR-10-BLAN-916 and Memove ANR-11-BS01-006 grants. The work was also supported by grants from Universidad de Buenos Aires (UBACyT X132/08), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-200801-01080/09), and Ministerio de Ciencia y Tecnologia (SLO-AR 08/02/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHKONG QF, 1975, NATURE, V253, P194, DOI 10.1038/253194a0; Aittoniemi J, 2006, J PHYS CHEM B, V110, P25562, DOI 10.1021/jp064931u; AMODEO P, 1991, J MAGN RESON, V95, P201, DOI 10.1016/0022-2364(91)90339-U; Bachar M, 2004, J PHYS CHEM B, V108, P7170, DOI 10.1021/jp036981u; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BIEDLER JL, 1970, CANCER RES, V30, P1174; Bordat P, 2003, CHEM PHYS LETT, V374, P201, DOI 10.1016/S0009-2614(03)00550-5; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; CALLAGHAN R, 1992, BRIT J CANCER, V66, P781, DOI 10.1038/bjc.1992.360; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAY JG, 2007, CRYOPRESERVATION FRE; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P13379, DOI 10.1021/jp075631v; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; KINOSITA K, 1977, NATURE, V268, P438, DOI 10.1038/268438a0; KLIGMAN AM, 1965, J AMER MED ASSOC, V193, P796, DOI 10.1001/jama.1965.03090100042010; Fernandez ML, 2010, J PHYS CHEM B, V114, P6855, DOI 10.1021/jp911605b; Levine ZA, 2010, J MEMBRANE BIOL, V236, P27, DOI 10.1007/s00232-010-9277-y; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Martinez-Seara H, 2008, BIOPHYS J, V95, P3295, DOI 10.1529/biophysj.108.138123; Martinez-Seara H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976443; Melkonyan H, 1996, NUCLEIC ACIDS RES, V24, P4356, DOI 10.1093/nar/24.21.4356; Notman R, 2007, BIOPHYS J, V93, P2056, DOI 10.1529/biophysj.107.104703; Notman R, 2006, J AM CHEM SOC, V128, P13982, DOI 10.1021/ja063363t; Okada Y, 2004, CELL BIOCHEM BIOPHYS, V41, P233, DOI 10.1385/CBB:41:2:233; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Reigada R, 2011, 30 URSI GASS C BOOK; RUNCKEL DN, 1980, CLIN CHEM, V26, P1745; Sum AK, 2003, BIOPHYS J, V85, P3636, DOI 10.1016/S0006-3495(03)74781-X; Tarek M, 2005, BIOPHYS J, V88, P4045, DOI 10.1529/biophysj.104.050617; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tristram-Nagle S, 1998, BBA-BIOMEMBRANES, V1369, P19, DOI 10.1016/S0005-2736(97)00197-1; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; VALDEZ CA, 1992, J REPROD FERTIL, V96, P793, DOI 10.1530/jrf.0.0960793; Vernier PT, 2007, J PHYS CHEM B, V111, P12993, DOI 10.1021/jp077148q; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007966; Yu ZW, 2000, BBA-BIOMEMBRANES, V1509, P440, DOI 10.1016/S0005-2736(00)00326-6; Ziegler MJ, 2008, J PHYS CHEM B, V112, P13588, DOI 10.1021/jp8027726	42	97	98	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41733	10.1371/journal.pone.0041733	http://dx.doi.org/10.1371/journal.pone.0041733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848583	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600110
J	Ghatge, MS; Contestabile, R; di Salvo, ML; Desai, JV; Gandhi, AK; Camara, CM; Florio, R; Gonzalez, IN; Parroni, A; Schirch, V; Safo, MK				Ghatge, Mohini S.; Contestabile, Roberto; di Salvo, Martino L.; Desai, Jigar V.; Gandhi, Amit K.; Camara, Christina M.; Florio, Rita; Gonzalez, Isabel N.; Parroni, Alessia; Schirch, Verne; Safo, Martin K.			Pyridoxal 5 '-Phosphate Is a Slow Tight Binding Inhibitor of E. coli Pyridoxal Kinase	PLOS ONE			English	Article							X-RAY-STRUCTURE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PDXK GENE; OXIDASE; VITAMIN-B-6; MECHANISM; PURIFICATION; PHOSPHATASE	Pyridoxal 5'-phosphate (PLP) is a cofactor for dozens of B-6 requiring enzymes. PLP reacts with apo-B-6 enzymes by forming an aldimine linkage with the e-amino group of an active site lysine residue, thus yielding the catalytically active holo-B-6 enzyme. During protein turnover, the PLP is salvaged by first converting it to pyridoxal by a phosphatase and then back to PLP by pyridoxal kinase. Nonetheless, PLP poses a potential toxicity problem for the cell since its reactive 4'-aldehyde moiety forms covalent adducts with other compounds and non-B-6 proteins containing thiol or amino groups. The regulation of PLP homeostasis in the cell is thus an important, yet unresolved issue. In this report, using site-directed mutagenesis, kinetic, spectroscopic and chromatographic studies we show that pyridoxal kinase from E. coli forms a complex with the product PLP to form an inactive enzyme complex. Evidence is presented that, in the inhibited complex, PLP has formed an aldimine bond with an active site lysine residue during catalytic turnover. The rate of dissociation of PLP from the complex is very slow, being only partially released after a 2-hour incubation with PLP phosphatase. Interestingly, the inactive pyridoxal kinase.PLP complex can be partially reactivated by transferring the tightly bound PLP to an apo-B-6 enzyme. These results open new perspectives on the mechanism of regulation and role of pyridoxal kinase in the Escherichia coli cell.	[Ghatge, Mohini S.; Desai, Jigar V.; Gandhi, Amit K.; Camara, Christina M.; Schirch, Verne; Safo, Martin K.] Virginia Commonwealth Univ, Dept Med Chem, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Contestabile, Roberto; di Salvo, Martino L.; Florio, Rita; Parroni, Alessia] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Contestabile, Roberto; di Salvo, Martino L.; Florio, Rita; Parroni, Alessia] Sapienza Univ Roma, Dipartimento Sci Biochim, Rome, Italy; [Gonzalez, Isabel N.] Ist Biol Agroambientale & Forestale, Consiglio Nazl Ric, Rome, Italy; [Gonzalez, Isabel N.] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain	Virginia Commonwealth University; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); University of Zaragoza	Ghatge, MS (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA.	msafo@vcu.edu	Ghatge, Mohini/AAY-3381-2020; Desai, Jigar V/I-3109-2019; Contestabile, Roberto/J-3467-2019; Nogues, Isabel/AAA-7499-2019; Safo, Martin/AAJ-9833-2020; Gonzalez, Isabel Nogues/K-2118-2012	Contestabile, Roberto/0000-0002-5235-9993; Gonzalez, Isabel Nogues/0000-0002-7475-2411; Desai, Jigar/0000-0002-8823-0796; di Salvo, Martino Luigi/0000-0003-1233-9338	AD Williams Fund (VCU); Jeffress Research Grant Award; Ministero dell'Universita e della Ricerca; Istituto Pasteur-Fondazione Cenci Bolognetti	AD Williams Fund (VCU); Jeffress Research Grant Award; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	The work was supported by AD Williams Fund (VCU) and the Jeffress Research Grant Award to MKS; and by Ministero dell'Universita e della Ricerca and a grant from Istituto Pasteur-Fondazione Cenci Bolognetti to MLDS and RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS ML, 1970, J AM CHEM SOC, V92, P6134; Boe AS, 2004, BRIT J CANCER, V91, P1508, DOI 10.1038/sj.bjc.6602142; Cao P, 2006, J STRUCT BIOL, V154, P327, DOI 10.1016/j.jsb.2006.02.008; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; CHOI SY, 1987, J BIOL CHEM, V262, P12013; Christen P, 1985, TRANSAMINASES, P307; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; di Salvo ML, 2004, PROTEIN EXPRES PURIF, V36, P300, DOI 10.1016/j.pep.2004.04.021; di Salvo ML, 2003, BBA-PROTEINS PROTEOM, V1647, P76, DOI 10.1016/S1570-9639(03)00060-8; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fitzpatrick TB, 2010, CHEMBIOCHEM, V11, P1185, DOI 10.1002/cbic.201000084; FONDA ML, 1992, J BIOL CHEM, V267, P15978; FRIEDEN C, 1980, BIOCHEMISTRY-US, V19, P5303, DOI 10.1021/bi00564a024; Fu TF, 2001, ANAL BIOCHEM, V298, P314, DOI 10.1006/abio.2001.5401; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; Li MH, 2002, J BIOL CHEM, V277, P46385, DOI 10.1074/jbc.M208600200; McCormick DB, 1999, J NUTR, V129, P325; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; METZLER CM, 1987, ANAL BIOCHEM, V166, P313, DOI 10.1016/0003-2697(87)90580-X; Moccand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016042; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Musayev FN, 2007, PROTEIN SCI, V16, P2184, DOI 10.1110/ps.073022107; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Newman JA, 2006, J MOL BIOL, V363, P520, DOI 10.1016/j.jmb.2006.08.013; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; Safo MK, 2006, J BACTERIOL, V188, P4542, DOI 10.1128/JB.00122-06; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2004, J BACTERIOL, V186, P8074, DOI 10.1128/JB.186.23.8074-8082.2004; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; WHITE RS, 1970, BIOCHEMISTRY-US, V9, P4057, DOI 10.1021/bi00823a005; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737; Yang Y, 1996, FEMS MICROBIOL LETT, V141, P89, DOI 10.1016/0378-1097(96)00203-0; Yang Y, 1998, J BACTERIOL, V180, P1814, DOI 10.1128/JB.180.7.1814-1821.1998; ZHAO GS, 1995, J BACTERIOL, V177, P883, DOI 10.1128/jb.177.4.883-891.1995	35	32	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41680	10.1371/journal.pone.0041680	http://dx.doi.org/10.1371/journal.pone.0041680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848564	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600103
J	Martinez-Abundis, E; Rajapurohitam, V; Haist, JV; Gan, XHT; Karmazyn, M				Martinez-Abundis, Eduardo; Rajapurohitam, Venkatesh; Haist, James V.; Gan, Xiaohong T.; Karmazyn, Morris			The Obesity-Related Peptide Leptin Sensitizes Cardiac Mitochondria to Calcium-Induced Permeability Transition Pore Opening and Apoptosis	PLOS ONE			English	Article							HEART-FAILURE; CELL-DEATH; VENTRICULAR MYOCYTES; PLASMA LEPTIN; RAT; HYPERTROPHY; RECEPTOR; STAT3; INHIBITION; MODULATION	The obesity-related 16 kDa peptide leptin is synthesized primarily in white adipocytes although its production has been reported in other tissues including the heart. There is emerging evidence that leptin may contribute to cardiac pathology especially that related to myocardial remodelling and heart failure. In view of the importance of mitochondria to these processes, the goal of the present study is to determine the effect of leptin on mitochondria permeability transition pore opening and the potential consequence in terms of development of apoptosis. Experiments were performed using neonatal rat ventricular myocytes exposed to 3.1 nM (50 ng/ml) leptin for 24 hours. Mitochondrial transition pore opening was analyzed as the capacity of mitochondria to retain the dye calcein-AM in presence of 200 mu M CaCl2. Leptin significantly increased pore opening although the effect was markedly more pronounced in digitonin-permeabilized myocytes in the presence of calcium with both effects prevented by the transition pore inhibitor sanglifehrin A. These effects were associated with increased apoptosis as evidenced by increased TUNEL staining and caspase 3 activity, both of which were prevented by the transition pore inhibitor sanglifehrin A. Leptin enhanced Stat3 activation whereas a Stat 3 inhibitor peptide prevented leptin-induced mitochondrial transition pore opening as well as the hypertrophic and pro-apoptotic effects of the peptide. Inhibition of the RhoA/ROCK pathway prevented the hypertrophic response to leptin but had no effect on increased pore opening following leptin administration. We conclude that leptin can enhance calcium-mediated, Stat3-dependent pro-apoptotic effects as a result of increased mitochondrial transition pore opening and independently of its hypertrophic actions. Leptin may therefore contribute to mitochondrial dysfunction and the development of apoptosis in the diseased myocardium particularly under conditions of excessive intracellular calcium accumulation.	[Martinez-Abundis, Eduardo; Rajapurohitam, Venkatesh; Haist, James V.; Gan, Xiaohong T.; Karmazyn, Morris] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Martinez-Abundis, E (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada.	Morris.Karmazyn@schulich.uwo.ca		Martinez-Abundis, Eduardo/0000-0001-6369-5880	Canadian Institutes of Health Research [MOP 62764]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant number MOP 62764). M. Karmazyn holds a Tier 1 Canada Research Chair in Experimental Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, AM J PHYSIOL-HEART C, V292, pH2387, DOI 10.1152/ajpheart.00579.2006; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Barry SP, 2009, BIOCHEM BIOPH RES CO, V385, P324, DOI 10.1016/j.bbrc.2009.05.051; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bulcao CF, 2010, J HEART LUNG TRANSPL, V29, P346, DOI 10.1016/j.healun.2009.09.007; Deswal A, 2011, J AM COLL CARDIOL, V58, P1878, DOI 10.1016/j.jacc.2011.07.030; Dhingra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025009; Dobaczewski M, 2011, CARDIOVASC RES, V89, P9, DOI 10.1093/cvr/cvq354; Doehner W, 2001, EUR J ENDOCRINOL, V145, P727, DOI 10.1530/eje.0.1450727; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Karmazyn M, 2008, CARDIOVASC RES, V79, P279, DOI 10.1093/cvr/cvn115; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li XM, 2009, CLIN EXP PHARMACOL P, V36, P1054, DOI 10.1111/j.1440-1681.2009.05243.x; Li Y, 2011, AM J PHYSIOL-HEART C, V301, pH1941, DOI 10.1152/ajpheart.00338.2011; Madani S, 2006, CARDIOVASC RES, V69, P716, DOI 10.1016/j.cardiores.2005.11.022; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; McGaffin KR, 2011, CARDIOVASC RES, V89, P60, DOI 10.1093/cvr/cvq288; McGaffin KR, 2009, CIRC-HEART FAIL, V2, P676, DOI 10.1161/CIRCHEARTFAILURE.109.869909; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Moorjani N, 2009, AM J CARDIOL, V103, P1261, DOI 10.1016/j.amjcard.2009.01.013; Moro C, 2011, J CELL MOL MED, V15, P1688, DOI 10.1111/j.1582-4934.2010.01154.x; Nickola MW, 2000, HYPERTENSION, V36, P501, DOI 10.1161/01.HYP.36.4.501; Niemann B, 2011, J AM COLL CARDIOL, V57, P577, DOI 10.1016/j.jacc.2010.09.040; Parra V, 2011, J BIOENERG BIOMEMBR, V43, P47, DOI 10.1007/s10863-011-9332-0; Peterson JM, 2008, J APPL PHYSIOL, V105, P1934, DOI 10.1152/japplphysiol.00037.2008; Purdham DM, 2008, AM J PHYSIOL-HEART C, V295, pH441, DOI 10.1152/ajpheart.91537.2007; Purdham DM, 2004, AM J PHYSIOL-HEART C, V287, pH2877, DOI 10.1152/ajpheart.00499.2004; Rajapurohitam V, 2003, CIRC RES, V93, P277, DOI 10.1161/01.RES.0000089255.37804.72; Rajapurohitam V, 2006, J MOL CELL CARDIOL, V41, P265, DOI 10.1016/j.yjmcc.2006.05.001; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Regula KA, 2005, J MOL CELL CARDIOL, V38, P3, DOI 10.1016/j.yjmcc.2004.11.003; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Schulze PC, 2005, CLIN CHIM ACTA, V362, P1, DOI 10.1016/j.cccn.2005.05.019; Schulze PC, 2003, EUR J HEART FAIL, V5, P33, DOI 10.1016/S1388-9842(02)00177-0; Smith CCT, 2010, AM J PHYSIOL-HEART C, V299, pH1265, DOI 10.1152/ajpheart.00092.2010; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Toth MJ, 1997, METABOLISM, V46, P450, DOI 10.1016/S0026-0495(97)90065-2; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P1870, DOI 10.1016/j.jacc.2011.06.057; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Yamashita T, 1998, BIOCHEM BIOPH RES CO, V246, P752, DOI 10.1006/bbrc.1998.8689; Zeidan A, 2008, CARDIOVASC RES, V77, P64, DOI 10.1093/cvr/cvm020; Zeidan A, 2006, CARDIOVASC RES, V72, P101, DOI 10.1016/j.cardiores.2006.06.024; Zibadi S, 2011, CARDIOVASC TOXICOL, V11, P325, DOI 10.1007/s12012-011-9124-0	49	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41612	10.1371/journal.pone.0041612	http://dx.doi.org/10.1371/journal.pone.0041612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848545	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600096
J	Zijnge, V; Kieselbach, T; Oscarsson, J				Zijnge, Vincent; Kieselbach, Thomas; Oscarsson, Jan			Proteomics of Protein Secretion by Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; OUTER-MEMBRANE PROTEINS; HIDDEN-MARKOV-MODEL; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SUBCELLULAR-LOCALIZATION; LEGIONELLA-PNEUMOPHILA; SIGNAL PEPTIDES; PORPHYROMONAS-GINGIVALIS; AUTOTRANSPORTER ADHESIN; NATURAL TRANSFORMATION	The extracellular proteome (secretome) of periodontitis-associated bacteria may constitute a major link between periodontitis and systemic diseases. To obtain an overview of the virulence potential of Aggregatibacter actinomycetemcomitans, an oral and systemic human pathogen implicated in aggressive periodontitis, we used a combined LC-MS/MS and bioinformatics approach to characterize the secretome and protein secretion pathways of the rough-colony serotype a strain D7S. LC-MS/MS revealed 179 proteins secreted during biofilm growth. Further to confirming the release of established virulence factors (e. g. cytolethal distending toxin [CDT], and leukotoxin [LtxA]), we identified additional putative virulence determinants in the secretome. These included DegQ, fHbp, LppC, Macrophage infectivity protein (MIP), NlpB, Pcp, PotD, TolB, and TolC. This finding indicates that the number of extracellular virulence-related proteins is much larger than previously demonstrated, which was also supported by in silico analysis of the strain D7S genome. Moreover, our LC-MS/MS and in silico data revealed that at least Type I, II, and V secretion are actively used to excrete proteins directly into the extracellular space, or via two-step pathways involving the Sec/Tat systems for transport across the inner membrane, and outer membrane factors, secretins and auto-transporters, respectively for delivery across the outer membrane. Taken together, our results provide a molecular basis for further elucidating the role of A. actinomycetemcomitans in periodontal and systemic diseases.	[Zijnge, Vincent; Oscarsson, Jan] Umea Univ, Dept Odontol, Umea, Sweden; [Kieselbach, Thomas] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Umea University	Zijnge, V (corresponding author), Umea Univ, Dept Odontol, Umea, Sweden.	jan.oscarsson@odont.umu.se	Kieselbach, Thomas/O-6023-2015	Kieselbach, Thomas/0000-0001-5577-2938	County Council of Vasterbotten, Sweden; Swedish Research Council [822-2007-3473]; Wallenberg Foundation; Kempe Foundation	County Council of Vasterbotten, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Foundation(European Commission); Kempe Foundation	This work was supported by TUA grants from the County Council of Vasterbotten, Sweden (JO), and by a grant from the Swedish Research Council (822-2007-3473; TK). The instrumentation and bioinformatics infrastructure of the proteomics platform of the Chemistry Biology Center (KBC) at Umea University and SLU/Umea was supported by grants of the Wallenberg and the Kempe Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akifusa S, 2005, MICROBIOL-SGM, V151, P1395, DOI 10.1099/mic.0.27671-0; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Asikainen SE, 2009, FUTURE MICROBIOL, V4, P495, DOI [10.2217/fmb.09.21, 10.2217/FMB.09.21]; Beck JD, 2000, PERIODONTOL 2000, V23, P110, DOI 10.1034/j.1600-0757.2000.2230111.x; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Bland DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017352; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Chen C, 2010, J BACTERIOL, V192, P2643, DOI 10.1128/JB.00157-10; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen I, 2003, FRONT BIOSCI, V8, pS544; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; Crosby JA, 2007, GENE, V388, P83, DOI 10.1016/j.gene.2006.10.004; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Demuth DR, 2003, CELL MICROBIOL, V5, P111, DOI 10.1046/j.1462-5822.2003.00259.x; Desvaux M, 2010, J PROTEOME RES, V9, P5076, DOI 10.1021/pr1003642; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Fletcher JM, 2001, MICROB PATHOGENESIS, V30, P359, DOI 10.1006/mpat.2000.0439; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Galli DM, 2006, PLASMID, V55, P158, DOI 10.1016/j.plasmid.2005.07.003; Garrow AG, 2005, NUCLEIC ACIDS RES, V33, pW188, DOI 10.1093/nar/gki384; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Hazes B, 2008, BBA-BIOMEMBRANES, V1778, P1839, DOI 10.1016/j.bbamem.2008.03.011; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hugoson A, 2008, J CLIN PERIODONTOL, V35, P338, DOI 10.1111/j.1600-051X.2008.01279.x; Hung MC, 2011, INFECT IMMUN, V79, P3784, DOI 10.1128/IAI.05019-11; Ihalin R, 2006, J CHROMATOGR B, V831, P116, DOI 10.1016/j.jchromb.2005.11.052; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; INOUYE T, 1990, FEMS MICROBIOL LETT, V69, P13, DOI 10.1016/0378-1097(90)90405-F; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kajiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018287; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Karched M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-18; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; KILEY P, 1980, INFECT IMMUN, V30, P862; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Komatsuzawa H, 2002, GENE, V288, P195, DOI 10.1016/S0378-1119(02)00500-0; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kucz N, 2007, PERIPLASM, P150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Maeda T, 2010, FEMS IMMUNOL MED MIC, V58, P226, DOI 10.1111/j.1574-695X.2009.00624.x; Marrero J, 2007, J BACTERIOL, V189, P6469, DOI 10.1128/JB.00522-07; Mullen LM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003991; Myers-Morales T, 2007, APPL ENVIRON MICROB, V73, P5750, DOI 10.1128/AEM.02968-06; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Novak KF, 2001, MICROBIOL-SGM, V147, P3027, DOI 10.1099/00221287-147-11-3027; Oldfield NJ, 2008, VACCINE, V26, P1942, DOI 10.1016/j.vaccine.2008.02.022; Oscarsson J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-206; Paju S, 2000, FEMS MICROBIOL LETT, V182, P231, DOI 10.1016/S0378-1097(99)00595-9; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Perez BA, 2006, J BACTERIOL, V188, P6361, DOI 10.1128/JB.00496-06; Permpanich P, 2006, CELL MICROBIOL, V8, P72, DOI 10.1111/j.1462-5822.2005.00601.x; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Posadas DM, 2007, INFECT IMMUN, V75, P379, DOI 10.1128/IAI.01349-06; Prasadarao NV, 1999, INFECT IMMUN, V67, P4153, DOI 10.1128/IAI.67.8.4153-4160.1999; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Rose JE, 2003, INFECT IMMUN, V71, P2384, DOI 10.1128/IAI.71.5.2384-2393.2003; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Rylev M, 2011, J PROTEOMICS, V74, P2972, DOI 10.1016/j.jprot.2011.07.022; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; SIMPSON DL, 1988, INFECT IMMUN, V56, P1162, DOI 10.1128/IAI.56.5.1162-1166.1988; SLOTS J, 1984, J DENT RES, V63, P412, DOI 10.1177/00220345840630031101; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Song Catharine, 2009, Genomics Proteomics & Bioinformatics, V7, P37, DOI 10.1016/S1672-0229(08)60031-5; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; SUZUKI T, 1994, MOL MICROBIOL, V11, P31, DOI 10.1111/j.1365-2958.1994.tb00287.x; Tang G, 2012, MOL ORAL MICROBIOL, V27, P70, DOI 10.1111/j.2041-1014.2011.00632.x; Tang GY, 2007, MICROBIOL-SGM, V153, P2447, DOI 10.1099/mic.0.2007/005892-0; Teng YTA, 2003, BIOCHEM BIOPH RES CO, V303, P1086, DOI 10.1016/S0006-291X(03)00471-6; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Trost M, 2005, PROTEOMICS, V5, P1544, DOI 10.1002/pmic.200401024; TSAI CC, 1979, INFECT IMMUN, V25, P427, DOI 10.1128/IAI.25.1.427-439.1979; Tullius MV, 2001, INFECT IMMUN, V69, P6348, DOI 10.1128/IAI.69.10.6348-6363.2001; van Winkelhoff AJ, 1999, PERIODONTOL 2000, V20, P122; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; Wang Y, 2005, GENE, V351, P61, DOI 10.1016/j.gene.2005.02.010; Wang Y, 2003, GENE, V312, P249, DOI 10.1016/S0378-1119(03)00620-6; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; Westermeier R, 2002, PROTEOMICS PRACTICE; WILSON ME, 1995, INFECT IMMUN, V63, P1062, DOI 10.1128/IAI.63.3.1062-1069.1995; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06; Zhou HY, 2003, PROTEIN SCI, V12, P1547, DOI 10.1110/ps.0305103	123	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41662	10.1371/journal.pone.0041662	http://dx.doi.org/10.1371/journal.pone.0041662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848560	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600100
J	Gonon, AT; Jung, C; Katz, A; Westerblad, H; Shemyakin, A; Sjoquist, PO; Lundberg, JO; Pernow, J				Gonon, Adrian T.; Jung, Christian; Katz, Abram; Westerblad, Hakan; Shemyakin, Alexey; Sjoquist, Per-Ove; Lundberg, Jon O.; Pernow, John			Local Arginase Inhibition during Early Reperfusion Mediates Cardioprotection via Increased Nitric Oxide Production	PLOS ONE			English	Article							L-ARGININE; ENDOTHELIAL DYSFUNCTION; ISCHEMIA-REPERFUSION; MYOCARDIAL INJURY; HEART; CONTRIBUTES; TRANSPORT	Consumption of L-arginine contributes to reduced bioavailability of nitric oxide (NO) that is critical for the development of ischemia-reperfusion injury. The aim of the study was to determine myocardial arginase expression and activity in ischemic-reperfusion myocardium and whether local inhibition of arginase within the ischemic myocardium results in increased NO production and protection against myocardial ischemia-reperfusion. Anesthetized pigs were subjected to coronary artery occlusion for 40 min followed by 4 h reperfusion. The pigs were randomized to intracoronary infusion of vehicle (n = 7), the arginase inhibitor N-hydroxy-nor-L-arginine (nor-NOHA, 2 mg/min, n = 7), the combination of nor-NOHA and the NO synthase inhibitor N-G-monomethyl-L-arginine (L-NMMA, 0.35 mg/min, n = 6) into the jeopardized myocardial area or systemic intravenous infusion of nor-NOHA (2 mg/min, n = 5) at the end of ischemia and start of reperfusion. The infarct size of the vehicle group was 80 +/- 4% of the area at risk. Intracoronary nor-NOHA reduced infarct size to 46 +/- 5% (P < 0.01). Co-administration of L-NMMA abrogated the cardioprotective effect mediated by nor-NOHA (infarct size 72 +/- 6%). Intravenous nor-NOHA did not reduce infarct size. Arginase I and II were expressed in cardiomyocytes, endothelial, smooth muscle and poylmorphonuclear cells. There was no difference in cytosolic arginase I or mitochondrial arginase II expression between ischemic-reperfused and non-ischemic myocardium. Arginase activity increased 2-fold in the ischemic-reperfused myocardium in comparison with non-ischemic myocardium. In conclusion, ischemia-reperfusion increases arginase activity without affecting cytosolic arginase I or mitochondrial arginase II expression. Local arginase inhibition during early reperfusion reduces infarct size via a mechanism that is dependent on increased bioavailability of NO.	[Gonon, Adrian T.] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden; [Jung, Christian; Shemyakin, Alexey; Sjoquist, Per-Ove; Pernow, John] Karolinska Inst, Karolinska Univ Hosp, Div Cardiol, Dept Med, Stockholm, Sweden; [Katz, Abram; Westerblad, Hakan; Lundberg, Jon O.] Karolinska Inst, Dept Physiol & Pharmacol, Karolinska Univ Hosp, Stockholm, Sweden; [Sjoquist, Per-Ove] AstraZeneca, Dept Biosci, Molndal, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca	Gonon, AT (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden.	adrian.gonon@ki.se	Jung, Christian/AAN-4537-2021; Katz, Abram/AAL-2244-2020	Jung, Christian/0000-0001-8325-250X; Pernow, John/0000-0003-4766-0922; Lundberg, Jon/0000-0002-0174-5210; Westerblad, Hakan/0000-0002-8180-3029; GONON, ADRIAN/0000-0002-9337-3679	Swedish Research Council Medicine [10857]; Swedish Heart and Lung Foundation; Stockholm County Council (ALF); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Gustav V and Queen Victoria Foundation; Novo Nordisk Foundation	Swedish Research Council Medicine(Swedish Research Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Gustav V and Queen Victoria Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by the Swedish Research Council Medicine (10857), the Swedish Heart and Lung Foundation, the Stockholm County Council (ALF), Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme, Gustav V and Queen Victoria Foundation and Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnost T, 2008, J HYPERTENS, V26, P1110, DOI 10.1097/HJH.0b013e3282fcc357; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Cotton JM, 2002, HEART, V88, P564, DOI 10.1136/heart.88.6.564; Darra E, 2010, THROMB HAEMOSTASIS, V104, P200, DOI 10.1160/TH09-08-0554; Dunn J, 2011, MOL CELL BIOCHEM, V355, P83, DOI 10.1007/s11010-011-0841-2; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Durante W, 2001, CELL BIOCHEM BIOPHYS, V35, P19, DOI 10.1385/CBB:35:1:19; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Gao X, 2007, ARTERIOSCL THROM VAS, V27, P1269, DOI 10.1161/ATVBAHA.107.142521; Gonon AT, 2011, ACTA PHYSIOL, V201, P219, DOI 10.1111/j.1748-1716.2010.02168.x; Gonon AT, 2000, J CARDIOVASC PHARM, V36, P405, DOI 10.1097/00005344-200009000-00018; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; JI LL, 1994, BIOCHEM PHARMACOL, V47, P877; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Nielsen PH, 2010, CIRCULATION, V121, P1484, DOI 10.1161/CIRCULATIONAHA.109.873224; PERNOW J, 1994, EUR HEART J, V15, P1712, DOI 10.1093/oxfordjournals.eurheartj.a060456; Reid KM, 2007, AM J PHYSIOL-GASTR L, V292, pG512, DOI 10.1152/ajpgi.00227.2006; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Romero MJ, 2006, CARDIOVASC DRUG REV, V24, P275, DOI 10.1111/j.1527-3466.2006.00275.x; Santhanam L, 2007, CIRC RES, V101, P692, DOI 10.1161/CIRCRESAHA.107.157727; Talukder MAH, 2009, CARDIOVASC RES, V84, P345, DOI 10.1093/cvr/cvp264; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; WEYRICH AS, 1992, CIRCULATION, V86, P279, DOI 10.1161/01.CIR.86.1.279; Zhang CH, 2001, FASEB J, V15, P1264, DOI 10.1096/fj.00-0681fje	25	55	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42038	10.1371/journal.pone.0042038	http://dx.doi.org/10.1371/journal.pone.0042038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860052	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600054
J	Jiang, H; He, CZ; Geng, SS; Sheng, HH; Shen, XY; Zhang, XY; Li, H; Zhu, SZ; Chen, XM; Yang, CQ; Gao, HJ				Jiang, Hua; He, Chengzhi; Geng, Shasha; Sheng, Haihui; Shen, Xiaoying; Zhang, Xiaoyan; Li, Hang; Zhu, Shizhang; Chen, Ximei; Yang, Changqing; Gao, HengJun			RhoT1 and Smad4 Are Correlated with Lymph Node Metastasis and Overall Survival in Pancreatic Cancer	PLOS ONE			English	Article							GTPASES; EXPRESSION; INVASION; PROTEIN; P16; PROGNOSIS; CARCINOMA; MARKER; ROLES	Cancer cell invasion and metastasis are the most important adverse prognostic factors for pancreatic cancer. Identification of biomarkers associated with outcome of pancreatic cancer may provide new approaches and targets for anticancer therapy. The aim of this study is to examine the relationship between the expression of RhoT1, Smad4 and p16 and metastasis and survival in patients with pancreatic cancer. The analysis showed that the high cytoplasmic expression levels of RhoT1, Smad4 and p16 in pancreatic cancer tissues had significantly negative correlation with lymph node metastasis (LNM) (P = 0.017, P = 0.032, P = 0.042, respectively). However, no significant association was observed between perineural invasion (PNI) and the expression of above three proteins (all P > 0.05). Additionally, the survival analysis showed that the low expression levels of RhoT1 and Smad4 were significantly associated with worse survival (P = 0.034, P = 0.047, respectively). In conclusion, these results indicated that the low-expression levels of RhoT1 and Smad4 were significantly associated with LNM and shorter survival. RhoT1 may be considered as a potential novel marker for predicting the outcome in patients with pancreatic cancer.	[Jiang, Hua; Geng, Shasha] Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai E Hosp, Shanghai 200092, Peoples R China; [He, Chengzhi; Chen, Ximei; Yang, Changqing; Gao, HengJun] Tongji Univ, Sch Med, Dept Gastroenterol, Inst Digest Dis,Tongji Hosp, Shanghai 200092, Peoples R China; [Sheng, Haihui; Shen, Xiaoying; Zhang, Xiaoyan; Li, Hang; Zhu, Shizhang; Gao, HengJun] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China	Tongji University; Tongji University	Jiang, H (corresponding author), Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai E Hosp, Shanghai 200092, Peoples R China.	huajiang666@yahoo.com.cn; hengjun_gao@shbiochip.com			Pudong Health Bureau of Shanghai, China [PWZxkq2010-05]; China National 863 Project Foundation for Cancer Genomics (Pancreas Genomics) [1006AA02A302]	Pudong Health Bureau of Shanghai, China; China National 863 Project Foundation for Cancer Genomics (Pancreas Genomics)	HJ is supported by Key Discipline Construction Project of Pudong Health Bureau of Shanghai, China (Grant No: PWZxkq2010-05). HG is supported by China National 863 Project Foundation for Cancer Genomics (Pancreas Genomics) (Grant No: 1006AA02A302), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Fu ZJ, 2008, CLIN EXP METASTAS, V25, P887, DOI 10.1007/s10585-008-9207-x; Gerdes B, 2002, ANN SURG, V235, P51, DOI 10.1097/00000658-200201000-00007; He SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-70; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hua J, 2009, CHINESE J PANCREATOL, V9, P187; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-164; Li DH, 2010, CLIN CANCER RES, V16, P4313, DOI 10.1158/1078-0432.CCR-09-1942; Liu F, 2001, CLIN CANCER RES, V7, P3853; Maitra A, 2000, AM J PATHOL, V157, P1105, DOI 10.1016/S0002-9440(10)64625-1; Mihic-Probst D, 2006, INT J CANCER, V118, P2262, DOI 10.1002/ijc.21608; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Ohtsubo K, 2003, J GASTROENTEROL, V38, P663, DOI 10.1007/s00535-003-1119-6; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Schulz P, 2008, BRIT J CANCER, V99, P110, DOI 10.1038/sj.bjc.6604457; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Tanaka T, 2006, BRIT J CANCER, V95, P1562, DOI 10.1038/sj.bjc.6603460; Tanaka T, 2008, J SURG ONCOL, V97, P69, DOI 10.1002/jso.20896; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wan M, 2005, AM J PATHOL, V166, P1379, DOI 10.1016/S0002-9440(10)62356-5; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	37	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42234	10.1371/journal.pone.0042234	http://dx.doi.org/10.1371/journal.pone.0042234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860091	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600077
J	Thiyagarajan, R; Subramanian, SK; Sampath, N; Trakroo, M; Pal, P; Bobby, Z; Paneerselvam, S; Das, AK				Thiyagarajan, Ramkumar; Subramanian, Senthil Kumar; Sampath, Nishanth; Trakroo, Madanmohan; Pal, Pravati; Bobby, Zachariah; Paneerselvam, Sankar; Das, Ashok Kumar			Association between Cardiac Autonomic Function, Oxidative Stress and Inflammatory Response in Impaired Fasting Glucose Subjects: Cross-Sectional Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CARDIOVASCULAR-DISEASE RISK; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; LIFE-STYLE; FOLLOW-UP; TOLERANCE	Background: The worldwide burden of diabetes in 2030 is projected around 552 million. Diabetes leads to higher risk for cardiovascular diseases (CVD). Altered cardiac autonomic function (CAF) measured by heart rate variability (HRV) is observed in early stages of diabetes but the relationship between impaired fasting glucose (IFG) and HRV is still debatable. The aim of the study was to evaluate the association between CAF, oxidative stress, insulin resistance (IR), and inflammatory response in IFG subjects. Subjects and Methods: Cross-sectional blinded study. Volunteers recruited from health awareness camps underwent CAF and biochemical tests. Based on fasting plasma glucose (FPG) participants (n = 123) were divided into two groups, normal fasting glucose (n = 76) and IFG (n = 47). The comparison of parameters between the groups was carried out using student t test and Mann-Whitney U test for parametric and non-parametric data respectively. The correlation between the parameters was analyzed by Spearman's rank correlation using SPSS 13.0. Results: The resting cardiovagal modulation parameters, heart rate response to forced timed breathing, and orthostatic stress were reduced in IFG subjects. Fasting plasma lipid profile, coronary atherogenic lipid risk factors, IR, thiobarbituric acid reactive substance (TBARS), high sensitive C-reactive protein, and tumor necrosis factor alpha were increased and total antioxidant capacity (TAC) was decreased significantly in IFG group but no significant alteration was observed in high-density lipoprotein (HDL-c). Cardiovagal modulation parameters were negatively correlated with triglycerides, FPG, insulin, IR, TBARS, and inflammatory markers and positively with TAC. Conclusion: There is a continuous interplay between the altered CAF, hyperinsulinemia, IR, oxidative stress parameters, inflammatory response, and IFG in which one factor perpetuates another leading to the progression of disease.	[Thiyagarajan, Ramkumar; Subramanian, Senthil Kumar; Sampath, Nishanth; Trakroo, Madanmohan; Pal, Pravati] Jawaharlal Inst Postgrad Med Educ & Res, Dept Physiol, Pondicherry, India; [Bobby, Zachariah; Paneerselvam, Sankar] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem, Pondicherry, India; [Das, Ashok Kumar] Jawaharlal Inst Postgrad Med Educ & Res, Dept Med, Pondicherry, India; [Trakroo, Madanmohan] Jawaharlal Inst Postgrad Med Educ & Res, Adv Ctr Yoga Therapy Educ & Res, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Thiyagarajan, R (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Physiol, Pondicherry, India.	ashokdas82@gmail.com	Subramanian, Senthil Kumar/AAB-5236-2019; Das, Ashok Kumar Umar/K-7202-2017	Subramanian, Senthil Kumar/0000-0001-7990-611X; 	Advanced Centre for Yoga Therapy, Education and Research (ACYTER), JIPMER, Pondicherry, India; Department of Science and Technology, Government of India, New Delhi	Advanced Centre for Yoga Therapy, Education and Research (ACYTER), JIPMER, Pondicherry, India; Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	Source of funding: 1. Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India has provided the place and instruments to conduct the study; 2. Advanced Centre for Yoga Therapy, Education and Research (ACYTER), JIPMER, Pondicherry, India has provided funding to procure the kits for biochemical analysis; 3. Department of Science and Technology, Government of India, New Delhi has supported the Mr. Ramkumar, PhD scholar, through scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Blake DR, 2004, DIABETES, V53, P2095, DOI 10.2337/diabetes.53.8.2095; Chakarova N, 2009, DIABETES RES CLIN PR, V86, P56, DOI 10.1016/j.diabres.2009.04.005; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Foy CG, 2006, AM J EPIDEMIOL, V163, P921, DOI 10.1093/aje/kwj113; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Genuth S, 2003, DIABETES CARE, V26, P3160; Gerritsen J, 2000, DIABETOLOGIA, V43, P561, DOI 10.1007/s001250051344; Gerritsen J, 2001, DIABETES CARE, V24, P1793, DOI 10.2337/diacare.24.10.1793; Haffner SM, 2003, DIABETES RES CLIN PR, V61, pS9, DOI 10.1016/S0168-8227(03)00122-0; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Laederach-Hofmann K, 1999, CLIN PHYSIOL, V19, P97; Larsson H, 2000, DIABETOLOGIA, V43, P1224, DOI 10.1007/s001250051516; Lee S, 2011, J PEDIATR NURS, V26, P416, DOI 10.1016/j.pedn.2010.08.008; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; McCarty MF, 2002, MED HYPOTHESES, V58, P472, DOI 10.1054/mehy.2001.1455; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OBRIEN IAD, 1986, BRIT HEART J, V55, P348; Rennie KL, 2003, AM J EPIDEMIOL, V158, P135, DOI 10.1093/aje/kwg120; RYAN SM, 1994, J AM COLL CARDIOL, V24, P1700, DOI 10.1016/0735-1097(94)90177-5; Shah B, 2010, INDIAN J MED RES, V132, P634; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Smith NL, 2002, ARCH INTERN MED, V162, P209, DOI 10.1001/archinte.162.2.209; Styskal J, 2011, FREE RADIC BIOL MED, DOI [10.1016/j.freerad-biomed.2011.10.441, DOI 10.1016/J.FREERAD-BI0MED.2011.10.441]; Su Y, 2008, INT J CLIN PRACT, V62, P877, DOI 10.1111/j.1742-1241.2008.01776.x; Teff KL, 2008, JPEN-PARENTER ENTER, V32, P569, DOI 10.1177/0148607108321705; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Turk HM, 2002, ACTA DIABETOL, V39, P117, DOI 10.1007/s005920200029; Verschuren W. M. Monique, 1995, JAMA (Journal of the American Medical Association), V274, P131, DOI 10.1001/jama.274.2.131; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703; Wu JS, 2007, J CLIN ENDOCR METAB, V92, P3885, DOI 10.1210/jc.2006-2175; Wu JS, 2009, DIABETES CARE, V32, P69, DOI 10.2337/dc08-1389; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796	45	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41889	10.1371/journal.pone.0041889	http://dx.doi.org/10.1371/journal.pone.0041889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860025	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600045
J	Beucher, J; Boelle, PY; Busson, PF; Muselet-Charlier, C; Clement, A; Corvol, H				Beucher, Julie; Boelle, Pierre-Yves; Busson, Pierre-Francois; Muselet-Charlier, Celine; Clement, Annick; Corvol, Harriet		French C F Modifier Gene Study Inv	AGER-429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FLOW-VOLUME CURVE; RECEPTOR; RAGE; POLYMORPHISMS; MARKER; CELLS; GENE	The clinical course of cystic fibrosis (CF) varies between patients bearing identical CFTR mutations, suggesting the involvement of modifier genes. We assessed the association of lung disease severity with the variant AGER -429 T/C, coding for RAGE, a pro-inflammatory protein, in CF patients from the French CF Gene Modifier Study. We analyzed the lung function of 967 CF patients p.Phe508del homozygous. FEV1 was analyzed as CF-specific percentile adjusted on age, height and mortality. AGER -429T/C polymorphism was genotyped and its function was evaluated in vitro by measurement of the luciferase activity. AGER - 429 minor allele (C) was associated with poorer lung function (p = 0.03). In vitro, the promoter activity was higher in cells transfected with AGER -429C compared to cells transfected with the AGER -429T allele (p = 0.016 in BEAS-2B cells). AGER seems to be a modifier gene of lung disease severity in CF, and could be an interesting biomarker of CF airway inflammation. The functional promoter AGER -429C variant is associated with an increased RAGE expression that can lead to an increased lung inflammation and a more severe lung disease.	[Beucher, Julie; Muselet-Charlier, Celine; Clement, Annick; Corvol, Harriet] Hop Trousseau, AP HP, INSERM, Pediat Pulm Dept,U938, F-75571 Paris, France; [Beucher, Julie] CHU Rennes, Hop Sud, Rennes, France; [Beucher, Julie; Boelle, Pierre-Yves; Clement, Annick; Corvol, Harriet] Univ Paris 06, Paris, France; [Boelle, Pierre-Yves; Busson, Pierre-Francois] Hop St Antoine, AP HP, INSERM, Biostat Dept,UMR S707, F-75571 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Beucher, J (corresponding author), Hop Trousseau, AP HP, INSERM, Pediat Pulm Dept,U938, F-75571 Paris, France.	harriet.corvol@trs.aphp.fr	Reynaud-Gaubert, Martine LM/P-6958-2016; Corvol, Harriet/N-5922-2018; Busson, Pierre-François/D-3589-2015; Dubus, Jean-Christophe/P-8242-2016	Corvol, Harriet/0000-0002-7026-7523; Boelle, Pierre-Yves/0000-0002-5367-8232	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique-Hopitaux de Paris (AP-HP); Universite Pierre et Marie Curie Paris (UPMC); Agence Nationale de la Recherche (ANR); Direction Generale de la sante (DGS); Association Vaincre La Mucoviscidose; Societe francaise de la mucoviscidose; Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose (AICM); GIS-Institut des Maladies Rares; Rennes CHU-Hospital; SFP2A fellowship	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique-Hopitaux de Paris (AP-HP); Universite Pierre et Marie Curie Paris (UPMC); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Direction Generale de la sante (DGS); Association Vaincre La Mucoviscidose; Societe francaise de la mucoviscidose; Chancellerie des Universites (Legs Poix); Association Agir Informer Contre la Mucoviscidose (AICM); GIS-Institut des Maladies Rares; Rennes CHU-Hospital; SFP2A fellowship	Institut National de la Sante et de la Recherche Medicale (Inserm), Assistance Publique-Hopitaux de Paris (AP-HP), Universite Pierre et Marie Curie Paris (UPMC), Agence Nationale de la Recherche (ANR), Direction Generale de la sante (DGS), Association Vaincre La Mucoviscidose, Societe francaise de la mucoviscidose, Chancellerie des Universites (Legs Poix), Association Agir Informer Contre la Mucoviscidose (AICM), GIS-Institut des Maladies Rares. JB was supported by Rennes CHU-Hospital and SFP2A fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellis G, 2010, REGISTRE FRANCAIS MU; Corvol H, 2003, AM J PHYSIOL-LUNG C, V284, pL997, DOI 10.1152/ajplung.00156.2002; Corvol H, 2011, J CYST FIBROS; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Gaens KHJ, 2009, J CLIN ENDOCR METAB, V94, P5174, DOI 10.1210/jc.2009-1067; Han SH, 2011, MOL CELLS, V31, P91, DOI 10.1007/s10059-011-0030-x; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Kalousova M, 2007, NEPHROL DIAL TRANSPL, V22, P2020, DOI 10.1093/ndt/gfm050; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Laki J, 2006, INT IMMUNOL, V18, P1585, DOI 10.1093/intimm/dxl091; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Mukherjee TK, 2008, RESP PHYSIOL NEUROBI, V162, P210, DOI 10.1016/j.resp.2008.07.001; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Saadane A, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-26; Taylor C, 2011, PEDIATR PULM, V46, P857, DOI 10.1002/ppul.21456; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Wu LA, 2011, RESP MED, V105, P329, DOI 10.1016/j.rmed.2010.11.001	23	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41913	10.1371/journal.pone.0041913	http://dx.doi.org/10.1371/journal.pone.0041913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860029	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900048
J	Bozzacco, L; Yu, HQ; Dengjel, J; Trumpfheller, C; Zebroski, HA; Zhang, NW; Kuttner, V; Ueberheide, BM; Deng, H; Chait, BT; Steinman, RM; Mojsov, S; Fenyo, D				Bozzacco, Leonia; Yu, Haiqiang; Dengjel, Joern; Trumpfheller, Christine; Zebroski, Henry A., III; Zhang, Nawei; Kuettner, Victoria; Ueberheide, Beatrix M.; Deng, Haiteng; Chait, Brian T.; Steinman, Ralph M.; Mojsov, Svetlana; Fenyoe, David			Strategy for Identifying Dendritic Cell-Processed CD4(+) T Cell Epitopes from the HIV Gag p24 Protein	PLOS ONE			English	Article							MHC CLASS-I; MASS-SPECTROMETRY; ANTIGEN PRESENTATION; DEC-205 RECEPTOR; PEPTIDE BINDING; VACCINE; QUANTITATION; ACTIVATION; IMMUNITY; VIRUS	Mass Spectrometry (MS) is becoming a preferred method to identify class I and class II peptides presented on major histocompability complexes (MHC) on antigen presenting cells (APC). We describe a combined computational and MS approach to identify exogenous MHC II peptides presented on mouse spleen dendritic cells (DCs). This approach enables rapid, effective screening of a large number of possible peptides by a computer-assisted strategy that utilizes the extraordinary human ability for pattern recognition. To test the efficacy of the approach, a mixture of epitope peptide mimics (mimetopes) from HIV gag p24 sequence were added exogenously to Fms-like tyrosine kinase 3 ligand (Flt3L)-mobilized splenic DCs. We identified the exogenously added peptide, VDRFYKTLRAEQASQ, and a second peptide, DRFYKLTRAEQASQ, derived from the original exogenously added 15-mer peptide. Furthermore, we demonstrated that our strategy works efficiently with HIV gag p24 protein when delivered, as vaccine protein, to Flt3L expanded mouse splenic DCs in vitro through the DEC-205 receptor. We found that the same MHC II-bound HIV gag p24 peptides, VDRFYKTLRAEQASQ and DRFYKLTRAEQASQ, were naturally processed from anti-DEC-205 HIV gag p24 protein and presented on DCs. The two identified VDRFYKTLRAEQASQ and DRFYKLTRAEQASQ MHC II-bound HIV gag p24 peptides elicited CD4(+) T-cell mediated responses in vitro. Their presentation by DCs to antigen-specific T cells was inhibited by chloroquine (CQ), indicating that optimal presentation of these exogenously added peptides required uptake and vesicular trafficking in mature DCs. These results support the application of our strategy to identify and characterize peptide epitopes derived from vaccine proteins processed by DCs and thus has the potential to greatly accelerate DC-based vaccine development.	[Bozzacco, Leonia; Trumpfheller, Christine; Steinman, Ralph M.; Mojsov, Svetlana] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Bozzacco, Leonia; Trumpfheller, Christine; Steinman, Ralph M.; Mojsov, Svetlana] Rockefeller Univ, Chris Browne Ctr, New York, NY 10021 USA; [Yu, Haiqiang; Zebroski, Henry A., III; Zhang, Nawei; Deng, Haiteng] Rockefeller Univ, Prote Resource Ctr, New York, NY 10021 USA; [Dengjel, Joern; Kuettner, Victoria] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Dengjel, Joern; Kuettner, Victoria] Univ Freiburg, Ctr Biol Syst Anal, D-79106 Freiburg, Germany; [Ueberheide, Beatrix M.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Fenyoe, David] NYU, Med Ctr, Ctr Hlth Informat & Bioinformat, Lab Computat Prote, New York, NY 10016 USA	Rockefeller University; Rockefeller University; Rockefeller University; University of Freiburg; University of Freiburg; Rockefeller University; New York University	Bozzacco, L (corresponding author), Rockefeller Univ, Lab Cellular Physiol & Immunol, 1230 York Ave, New York, NY 10021 USA.	lbozzacco@rockefeller.edu	Dengjel, Joern/AAI-3682-2020; Steinman, Ralph/F-7729-2012	Bozzacco, Leonia/0000-0001-9817-0443; Ueberheide, Beatrix/0000-0003-2512-0204; Fenyo, David/0000-0001-5049-3825; Deng, Haiteng/0000-0001-9496-1280; Dengjel, Joern/0000-0002-9453-4614	National Institute of Allergy and Infectious Diseases [AI13013, 081677, AI051573, RR000862]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI013013, P01AI051573, R01AI013013] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases, AI13013, 081677 and AI051573 to RMS and RR000862 to BTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Bozzacco L, 2011, J PROTEOME RES, V10, P5016, DOI 10.1021/pr200503g; Bozzacco L, 2010, EUR J IMMUNOL, V40, P36, DOI 10.1002/eji.200939748; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; Deutsch EW, 2008, PHYSIOL GENOMICS, V33, P18, DOI 10.1152/physiolgenomics.00298.2007; Ercolini AM, 2003, J IMMUNOL, V170, P4273, DOI 10.4049/jimmunol.170.8.4273; Eriksson J, 2007, NAT BIOTECHNOL, V25, P651, DOI 10.1038/nbt1315; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; GRANT KI, 1990, J BIOL CHEM, V265, P4041; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Herr W, 1999, P NATL ACAD SCI USA, V96, P12033, DOI 10.1073/pnas.96.21.12033; Hogan KT, 2005, CANCER IMMUNOL IMMUN, V54, P359, DOI 10.1007/s00262-004-0592-y; Huang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012936; Kalkum M, 2003, P NATL ACAD SCI USA, V100, P2795, DOI 10.1073/pnas.0436605100; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Ondondo BO, 2008, EUR J IMMUNOL, V38, P3549, DOI 10.1002/eji.200838759; Ovsyannikova IG, 2007, CLIN PHARMACOL THER, V82, P644, DOI 10.1038/sj.clpt.6100389; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Sette A, 2002, TISSUE ANTIGENS, V59, P443, DOI 10.1034/j.1399-0039.2002.590601.x; Sherman MA, 1997, CELL IMMUNOL, V182, P1, DOI 10.1006/cimm.1997.1219; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Tan CT, 2011, PROTEOMICS, V11, P2336, DOI 10.1002/pmic.201000531; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Tsai SL, 1996, J CLIN INVEST, V97, P577, DOI 10.1172/JCI118450; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780; Wang B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3135; Zhang GA, 2010, METHODS MOL BIOL, V673, P211, DOI 10.1007/978-1-60761-842-3_13; Zheng H, 2008, MOL CELL BIOL, V28, P4040, DOI 10.1128/MCB.00136-08	42	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41897	10.1371/journal.pone.0041897	http://dx.doi.org/10.1371/journal.pone.0041897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860026	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900045
J	Chandry, PS; Gladman, S; Moore, SC; Seemann, T; Crandall, KA; Fegan, N				Chandry, P. Scott; Gladman, Simon; Moore, Sean C.; Seemann, Torsten; Crandall, Keith A.; Fegan, Narelle			A Genomic Island in Salmonella enterica ssp salamae Provides New Insights on the Genealogy of the Locus of Enterocyte Effacement	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHYLOGENETIC ANALYSIS; PATHOGENICITY ISLAND; SEROVAR SOFIA; AUSTRALIA; EVOLUTION; SEQUENCES; SELECTION; GENES; RECOMBINATION	The genomic island encoding the locus of enterocyte effacement (LEE) is an important virulence factor of the human pathogenic Escherichia coli. LEE typically encodes a type III secretion system (T3SS) and secreted effectors capable of forming attaching and effacing lesions. Although prominent in the pathogenic E. coli such as serotype O157:H7, LEE has also been detected in Citrobacter rodentium, E. albertii, and although not confirmed, it is likely to also be in Shigella boydii. Previous phylogenetic analysis of LEE indicated the genomic island was evolving through stepwise acquisition of various components. This study describes a new LEE region from two strains of Salmonella enterica subspecies salamae serovar Sofia along with a phylogenetic analysis of LEE that provides new insights into the likely evolution of this genomic island. The Salmonella LEE contains 36 of the 41 genes typically observed in LEE within a genomic island of 49, 371 bp that encodes a total of 54 genes. A phylogenetic analysis was performed on the entire T3SS and four T3SS genes (escF, escJ, escN, and escV) to elucidate the genealogy of LEE. Phylogenetic analysis inferred that the previously known LEE islands are members of a single lineage distinct from the new Salmonella LEE lineage. The previously known lineage of LEE diverged between islands found in Citrobacter and those in Escherichia and Shigella. Although recombination and horizontal gene transfer are important factors in the genealogy of most genomic islands, the phylogeny of the T3SS of LEE can be interpreted with a bifurcating tree. It seems likely that the LEE island entered the Enterobacteriaceae through horizontal gene transfer as a single unit, rather than as separate subsections, which was then subjected to the forces of both mutational change and recombination.	[Chandry, P. Scott; Gladman, Simon; Moore, Sean C.; Fegan, Narelle] CSIRO Div Anim Food & Hlth Sci, Werribee, Vic, Australia; [Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Crandall, Keith A.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; George Washington University	Chandry, PS (corresponding author), CSIRO Div Anim Food & Hlth Sci, Werribee, Vic, Australia.	scott.chandry@csiro.au	Fegan, Narelle/K-5316-2012; Seemann, Torsten/B-2318-2010; Crandall, Keith A./H-2789-2019; Moore, Sean/O-4238-2018	Fegan, Narelle/0000-0002-1729-9630; Seemann, Torsten/0000-0001-6046-610X; Crandall, Keith A./0000-0002-0836-3389; Moore, Sean/0000-0003-3158-0434	CSIRO (The Commonwealth Scientific and Industrial Research Organisation); Department of Primary Industries in Victoria	CSIRO (The Commonwealth Scientific and Industrial Research Organisation); Department of Primary Industries in Victoria	This study was supported by strategic research funds from CSIRO (The Commonwealth Scientific and Industrial Research Organisation)(http://www.csiro.au/) and Department of Primary Industries in Victoria (http://www.dpi.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; [Anonymous], 2006, THESIS U TEXAS AUSTI; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Castillo A, 2005, P NATL ACAD SCI USA, V102, P1542, DOI 10.1073/pnas.0408633102; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chia TWR, 2008, J FOOD PROTECT, V71, P2421, DOI 10.4315/0362-028X-71.12.2421; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Dean P, 2005, CURR OPIN MICROBIOL, V8, P28, DOI 10.1016/j.mib.2004.12.010; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Duffy LL, 2012, FOOD RES INT, V45, P770, DOI 10.1016/j.foodres.2011.04.024; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Gadagkar SR, 2005, J EXP ZOOL PART B, V304B, P64, DOI 10.1002/jez.b.21026; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARRINGTON CS, 1991, APPL ENVIRON MICROB, V57, P223, DOI 10.1128/AEM.57.1.223-227.1991; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Heuzenroeder M.W.C.J., 2001, MOL BASIS BENIGN COL; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hyma KE, 2005, J BACTERIOL, V187, P619, DOI 10.1128/JB.187.2.619-628.2005; IMVS, 2010, NCEA ANN REP; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jermiin LS, 2009, METHODS MOL BIOL, V537, P65, DOI 10.1007/978-1-59745-251-9_4; Jores J, 2004, INT J MED MICROBIOL, V294, P103, DOI 10.1016/j.ijmm.2004.06.024; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Muller D, 2009, INFECT IMMUN, V77, P3501, DOI 10.1128/IAI.00090-09; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qi J, 2011, NUCLEIC ACIDS RES, V39, pW567, DOI 10.1093/nar/gkr506; Rambaut A, 2010, MOL EVOLUTION PHLYOG; Rambaut A, 2009, MOL EVOLUTION PHLYOG; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross IL, 2003, INT J MED MICROBIOL, V293, P371, DOI 10.1078/1438-4221-00272; Rumer L, 2003, INT J MED MICROBIOL, V292, P463, DOI 10.1078/1438-4221-00229; SMITH JM, 1992, J MOL EVOL, V34, P126; Sukumaran J., SUMTREES PHYLOGENETI; Sullivan M. J., 2011, EASYFIG GENOME COMP; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8	48	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41615	10.1371/journal.pone.0041615	http://dx.doi.org/10.1371/journal.pone.0041615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860002	gold, Green Published			2022-12-27	WOS:000306950900031
J	Delaby, C; Rondeau, C; Pouzet, C; Willemetz, A; Pilard, N; Desjardins, M; Canonne-Hergaux, F				Delaby, Constance; Rondeau, Christiane; Pouzet, Cecile; Willemetz, Alexandra; Pilard, Nathalie; Desjardins, Michel; Canonne-Hergaux, Francois			Subcellular Localization of Iron and Heme Metabolism Related Proteins at Early Stages of Erythrophagocytosis	PLOS ONE			English	Article							TAIL-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; NATURAL-RESISTANCE; INTRACELLULAR INFECTIONS; MEDIATED PHAGOCYTOSIS; PHAGOSOME MATURATION; PLASMA-MEMBRANE; FORMERLY NRAMP1; CELL-DEATH; IN-VIVO	Background: Senescent red blood cells (RBC) are recognized, phagocytosed and cleared by tissue macrophages. During this erythrophagocytosis (EP), RBC are engulfed and processed in special compartments called erythrophagosomes. We previously described that following EP, heme is rapidly degraded through the catabolic activity of heme oxygenase (HO). Extracted heme iron is then either exported or stored by macrophages. However, the cellular localization of the early steps of heme processing and iron extraction during EP remains to be clearly defined. Methodology/Principal Findings: We took advantage of our previously described cellular model of EP, using bone marrow-derived macrophages (BMDM). The subcellular localization of both inducible and constitutive isoforms of HO (HO-1 and HO-2), of the divalent metal transporters (Nramp1, Nramp2/DMT1, Fpn), and of the recently identified heme transporter HRG-1, was followed by fluorescence and electron microscopy during the earliest steps of EP. We also looked at some ER [calnexin, glucose-6-phosphatase (G6Pase) activity] and lysosomes (Lamp1) markers during EP. In both quiescent and LPS-activated BMDM, Nramp1 and Lamp1 were shown to be strong markers of the erythrophagolysosomal membrane. HRG-1 was also recruited to the erythrophagosome. Furthermore, we observed calnexin labeling and G6Pase activity at the erythrophagosomal membrane, indicating the contribution of ER in this phagocytosis model. In contrast, Nramp2/DMT1, Fpn, HO-1 and HO-2 were not detected at the membrane of erythrophagosomes. Conclusions/Significance: Our study highlights the subcellular localization of various heme- and iron-related proteins during early steps of EP, thereby suggesting a model for heme catabolism occurring outside the phagosome, with heme likely being transported into the cytosol through HRG1. The precise function of Nramp1 at the phagosomal membrane in this model remains to be determined.	[Delaby, Constance; Pilard, Nathalie; Canonne-Hergaux, Francois] Ctr Rech Bichat Beaujon, INSERM, U773, CRB3, Paris, France; [Delaby, Constance] Hop St Eloi, CHU Montpellier, IRB, Biochim Prote Clin, Montpellier, France; [Rondeau, Christiane; Desjardins, Michel] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Pouzet, Cecile] Inst Federatif Rech 02, UFR Med Paris, Paris, France; [Willemetz, Alexandra; Canonne-Hergaux, Francois] CNRS, Inst Chim Subst Nat, UPR 2301, Ctr Rech Gif Sur Yvette, Gif Sur Yvette, France; [Canonne-Hergaux, Francois] CPTP, INSERM, U1043, Toulouse, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse, UPS, CPTP, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Delaby, C (corresponding author), Ctr Rech Bichat Beaujon, INSERM, U773, CRB3, Paris, France.	francois.canonne-Hergaux@inserm.fr	CANONNE-HERGAUX, François/AAC-2073-2020; Canonne-Hergaux, Francois/L-5363-2016	CANONNE-HERGAUX, François/0000-0002-0621-2157; Canonne-Hergaux, Francois/0000-0002-0621-2157; DELABY, Constance/0000-0002-8606-6814; Desjardins, Michel/0000-0002-5684-5980	INSERM (Institut National de la Sante et de la Recherche Medicale); CNRS (Centre National de la Recherche Scientifique); France Canada Research Fund (FCRF)	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); France Canada Research Fund (FCRF)	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale), CNRS (Centre National de la Recherche Scientifique), and by a research grant to FCH and MD from the France Canada Research Fund (FCRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont C, 2005, TRANSFUS CLIN BIOL, V12, P123, DOI 10.1016/j.tracli.2005.04.017; Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Deiss A, 1999, DESTRUCTION ERYTHROC; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Delaby C, 2008, BIOCHEM J, V411, P123, DOI 10.1042/BJ20071474; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2007, IMMUNOBIOLOGY, V212, P751, DOI 10.1016/j.imbio.2007.09.014; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gottlieb Y, 2012, HAEMATOLOGICA; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Huynh KK, 2007, PHYSIOLOGY, V22, P366, DOI 10.1152/physiol.00028.2007; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jabado N, 2003, P NATL ACAD SCI USA, V100, P6127, DOI 10.1073/pnas.0937287100; Jabado N, 2002, BLOOD, V100, P2617, DOI 10.1182/blood-2002-04-1182; Khan AA, 2011, BIOCH BIOPHYS ACTA; Kim HP, 2011, BIOCHEM BIOPH RES CO, V404, P1, DOI 10.1016/j.bbrc.2010.11.067; Kim HP, 2004, FASEB J, V18, P1080, DOI 10.1096/fj.03-1391com; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Mulero V, 2002, BIOCHEM J, V363, P89, DOI 10.1042/0264-6021:3630089; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rogers LD, 2008, CELL MICROBIOL, V10, P1405, DOI 10.1111/j.1462-5822.2008.01140.x; Schaer CA, 2008, J LEUKOCYTE BIOL, V83, P325, DOI 10.1189/jlb.0407226; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Soe-Lin S, 2010, EXP HEMATOL, V38, P609, DOI 10.1016/j.exphem.2010.04.003; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Touret N, 2005, J LEUKOCYTE BIOL, V77, P878, DOI 10.1189/jlb.1104630; VERSIECK J, 1974, CLIN CHEM, V20, P1141; Vidal SM, 1996, J IMMUNOL, V157, P3559; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Yanatori I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-39; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2; Zhou Z, 2008, TRENDS CELL BIOL, V18, P474, DOI 10.1016/j.tcb.2008.08.002; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	62	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42199	10.1371/journal.pone.0042199	http://dx.doi.org/10.1371/journal.pone.0042199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860081	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900076
J	Frank, S; Zhang, M; Scholer, HR; Greber, B				Frank, Stefan; Zhang, Miao; Schoeler, Hans R.; Greber, Boris			Small Molecule-Assisted, Line-Independent Maintenance of Human Pluripotent Stem Cells in Defined Conditions	PLOS ONE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; HUMAN ES; MAINTAIN PLURIPOTENCY; DIFFERENTIATION; GROWTH; DERIVATION; CULTURE; FGF; INDUCTION; COOPERATE	Human pluripotent stem cells (hPSCs) are conventionally grown in a mouse feeder cell-dependent manner. Chemically defined culture conditions are, however, desirable not only for potential medically oriented applications but also for investigating mechanisms of self-renewal and differentiation. In light of the rather high complexity and cost of existing defined hPSC culture systems, we have systematically evaluated over 20 potential media ingredients. Only components that reproducibly gave beneficial effects were ultimately combined to yield a simple and cost-effective formulation termed FTDA. This xeno-free medium is based on mimicking self-renewal factor activities present in mouse embryonic fibroblast-conditioned medium, at minimal dosages. Additionally, small molecule inhibitors of BMP and WNT signaling served to specifically suppress typical types of spontaneous differentiation seen in hPSC cultures. FTDA medium was suitable for the generation of human induced pluripotent stem cells and enabled robust long-term maintenance of diverse hPSC lines including hard-to-grow ones. Comparisons with existing defined media suggested reduced spontaneous differentiation rates in FTDA. Our results imply that using supportive factors at minimal concentrations may still promote robust self-renewal and preserve pluripotency of hPSCs.	[Frank, Stefan; Zhang, Miao; Schoeler, Hans R.; Greber, Boris] Max Planck Inst Mol Biomed, Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, Munster, Germany; [Greber, Boris] Max Planck Gesell, Chem Genom Ctr, Dortmund, Germany	Max Planck Society; University of Munster; Max Planck Society	Frank, S (corresponding author), Max Planck Inst Mol Biomed, Munster, Germany.	boris.greber@mpi-muenster.mpg.de	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136; Greber, Boris/0000-0002-9404-7293				Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wang L, 2007, BLOOD; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	40	61	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41958	10.1371/journal.pone.0041958	http://dx.doi.org/10.1371/journal.pone.0041958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860038	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900054
J	Khajah, MA; Al Saleh, S; Mathew, PM; Luqmani, YA				Khajah, Maitham A.; Al Saleh, Sanaa; Mathew, Princy M.; Luqmani, Yunus A.			Differential Effect of Growth Factors on Invasion and Proliferation of Endocrine Resistant Breast Cancer Cells	PLOS ONE			English	Article							FACTOR-BETA; TGF-BETA; MESENCHYMAL TRANSITION; FACTOR RECEPTOR; CHEMOKINES INDUCE; P38 MAPK; MIGRATION; EXPRESSION; CARCINOMA; ACTIVATION	We have established several breast cancer cell lines that exhibit a permanent ER-depleted phenotype, induced by shRNA transfection of MCF-7 cells, which afford a useful model for studying acquired endocrine resistance. Previously we showed that MDA-231 as well as ER-silenced cells could invade through simulated extracellular matrix components. However, the contribution of individual serum components responsible for cell invasion was not determined. In the present study, an under-agarose gel assay was used to quantitatively assess the invasive movement of two ER-silenced cell lines (pII and YS2.5) in comparison to the parental MCF-7, the ER negative MDA-231, and normal HBL100 cells, as well as a line that was ER-shRNA transfected but failed to exhibit ER down-regulation (YS1.2). We also examined the effect of the growth factors EGF, IGF-1, TGF beta, PDGFC and RANTES on pII cell invasion and proliferation. All breast cancer cell lines which had reduced ER expression exhibited a serum-dependent invasive ability related to the degree of induced ER loss. TGF beta treatment inhibited pII cell proliferation and enhanced their invasive ability but at a relatively high dose. IGF-1 and EGF enhanced pII cell proliferation, with the latter playing the major role in promoting cell invasion. PDGFC did not affect either process although it is highly expressed in pII cells. Differential effects were observed on activation of Akt and ERK1/2 suggesting their involvement as intracellular mediators of EGF induced invasion, in part through the regulation of matrix metalloproteinase activity. Targeting EGF receptor tyrosine kinase activity by erlotinib resulted in significant inhibition of both pII cell proliferation and directional invasion towards EGF suggesting that this drug has potential therapeutic usefulness for preventing spread of particularly endocrine resistant breast cancer.	[Khajah, Maitham A.; Mathew, Princy M.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Safat, Kuwait; [Al Saleh, Sanaa] Kuwait Univ, Fac Med, Safat, Kuwait	Kuwait University; Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	yunus@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University research grant [PT02/11]; Kuwait University Research Administration [GM01/01, GM01/05]	Kuwait University research grant; Kuwait University Research Administration	This work was supported by Kuwait University research grant No. PT02/11. Parts of this work were supported by Grants GM01/01 and GM01/05 to the Research Core Facility from Kuwait University Research Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Casey TM, 2007, EXP BIOL MED, V232, P1027, DOI 10.3181/0609-RM-218; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; Desruisseau S, 2006, BRIT J CANCER, V94, P239, DOI 10.1038/sj.bjc.6602920; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Garcia R, 2006, CELL CYCLE, V5, P1840; Ghellal A, 2000, ANTICANCER RES, V20, P4413; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Hankinson SE, 2008, ADV EXP MED BIOL, V617, P161, DOI 10.1007/978-0-387-69080-3_15; Harris A L, 1992, J Natl Cancer Inst Monogr, P181; Heit B, 2003, SCI STKE, V18; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; Jahkola T, 1998, EUR J CANCER, V34, P1687, DOI 10.1016/S0959-8049(98)00215-9; Khajah M, 2011, J LEUKOCYTE BIOL, V2011, P10; Kim S, 2011, ANTICANCER RES, V31, P3767; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Kleuser B, 2008, MOL PHARMACOL, V74, P1533, DOI 10.1124/mol.108.046854; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Li J, 2000, J BIOL CHEM, V275, P2951, DOI 10.1074/jbc.275.4.2951; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Malek D, 2006, EUR J PHARMACOL, V534, P39, DOI 10.1016/j.ejphar.2006.01.025; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mira E, 1999, ENDOCRINOLOGY, V140, P1657, DOI 10.1210/en.140.4.1657; Mira E, 2001, EMBO REP, V2, P151, DOI 10.1093/embo-reports/kve027; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Naber HP, 2011, CELL ONCOL, V2011, P21; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Normanno N, 2001, FRONT BIOSCI-LANDMRK, V6, pD685, DOI 10.2741/Normano; Normanno N, 2009, ENDOCR-RELAT CANCER, V16, P675, DOI 10.1677/ERC-08-0208; Ollinger R, 2008, TRANSPLANTATION, V85, P293, DOI 10.1097/TP.0b013e318160130f; Park S, 2011, BIOCHEM BIOPH RES CO, V407, P680, DOI 10.1016/j.bbrc.2011.03.075; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prest SJ, 1999, CLIN EXP METASTAS, V17, P389, DOI 10.1023/A:1006657109866; Price JT, 1999, CANCER RES, V59, P5475; RADINSKY R, 1995, CLIN CANCER RES, V1, P19; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sheen-Chen SM, 2001, ARCH SURG-CHICAGO, V136, P937, DOI 10.1001/archsurg.136.8.937; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; Tang FY, 2008, MOL NUTR FOOD RES, V52, P683, DOI 10.1002/mnfr.200700325; Tian G, 2011, BIOCHEM BIOPH RES CO, V409, P506, DOI 10.1016/j.bbrc.2011.05.035; Tong GM, 1999, IN VITRO CELL DEV-AN, V35, P19, DOI 10.1007/s11626-999-0039-z; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; VALVERIUS EM, 1989, CANCER RES, V49, P6269; Walsh LA, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-10; Wan WZ, 2007, CELL SIGNAL, V19, P2227, DOI 10.1016/j.cellsig.2007.06.007; Wiercinska E, 2011, BREAST CANCER RES TR, V128, P657, DOI 10.1007/s10549-010-1147-x; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Ye Y, 2010, ONCOGENE, V29, P1451, DOI 10.1038/onc.2009.433; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D; Zhang YM, 2009, ONCOL REP, V21, P1113, DOI 10.3892/or_00000331; ZUGMAIER G, 1989, J CELL PHYSIOL, V141, P353, DOI 10.1002/jcp.1041410217	64	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41847	10.1371/journal.pone.0041847	http://dx.doi.org/10.1371/journal.pone.0041847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860018	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900040
J	Mazumdar, S; Liu, KY; Susser, E; Bearman, P				Mazumdar, Soumya; Liu, Ka-Yuet; Susser, Ezra; Bearman, Peter			The Disappearing Seasonality of Autism Conceptions in California	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; SPECTRUM DISORDERS; VITAMIN-D; INCREASED PREVALENCE; PRENATAL INFLUENZA; PRETERM BIRTH; TIME-SERIES; SCHIZOPHRENIA; EPIDEMIOLOGY; AGGREGATION	Background: Autism incidence and prevalence have increased dramatically in the last two decades. The autism caseload in California increased 600% between 1992 and 2006, yet there is little consensus as to the cause. Studying the seasonality of conceptions of children later diagnosed with autism may yield clues to potential etiological drivers. Objective: To assess if the conceptions of children later diagnosed with autism cluster temporally in a systematic manner and whether any pattern of temporal clustering persists over time. Method: We searched for seasonality in conceptions of children later diagnosed with autism by applying a one-dimensional scan statistic with adaptive temporal windows on case and control population data from California for 1992 through 2000. We tested for potential confounding effects from known risk factors using logistic regression models. Results: There is a consistent but decreasing seasonal pattern in the risk of conceiving a child later diagnosed with autism in November for the first half of the study period. Temporal clustering of autism conceptions is not an artifact of composition with respect to known risk factors for autism such as socio-economic status. Conclusion: There is some evidence of seasonality in the risk of conceiving a child later diagnosed with autism. Searches for environmental factors related to autism should allow for the possibility of risk factors or etiological drivers that are seasonally patterned and that appear and remain salient for a discrete number of years.	[Mazumdar, Soumya; Liu, Ka-Yuet; Bearman, Peter] Columbia Univ, Paul F Lazarsfeld Ctr Social Sci, New York, NY 10027 USA; [Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, New York State Psychiat Inst, New York, NY USA	Columbia University; Columbia University; New York State Psychiatry Institute	Mazumdar, S (corresponding author), Columbia Univ, Paul F Lazarsfeld Ctr Social Sci, New York, NY 10027 USA.	soumyamazumdar@yahoo.com	Mazumdar, Soumya/D-3017-2013; Mazumdar, Soumya/AAF-7402-2020	bearman, peter/0000-0002-3745-3164	NIH Director's Pioneer Award Program; NIH Roadmap for Medical Research [1.DP1 OD003635-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041022] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003635] Funding Source: NIH RePORTER	NIH Director's Pioneer Award Program; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for this article comes from the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research through grant number 1.DP1 OD003635-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal KS, 2002, ARCH DIS CHILD, V87, P111, DOI 10.1136/adc.87.2.111; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Atladottir HO, 2007, EPIDEMIOLOGY, V18, P240, DOI 10.1097/01.ede.0000254064.92806.13; Barak Y, 1995, AM J PSYCHIAT, P52; Bartlik B D, 1981, J Am Med Womens Assoc (1972), V36, P363; Bearman P, 2012, EXPANDING DEFI UNPUB; BOLTON P, 1992, J CHILD PSYCHOL PSYC, V33, P509, DOI 10.1111/j.1469-7610.1992.tb00888.x; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Campbell KM, 2004, LINK KING; Cannell JJ, 2008, MED HYPOTHESES, V70, P750, DOI 10.1016/j.mehy.2007.08.016; Castrogiovanni P, 1998, NEUROPSYCHOBIOLOGY, V37, P175, DOI 10.1159/000026499; CDPH, 2010, CAL INFL SURV PROJ C; Cheslack-Postava K, 2011, PEDIATRICS; Croen LA, 2002, J AUTISM DEV DISORD, V32, P207, DOI 10.1023/A:1015453830880; Croen LA, 2005, ARCH PEDIAT ADOLESCE, P159; DDS. California Department of Developmental Services, 2002, AUT SPECTR DIS BEST; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Gilberg C, 1990, ACTA PSYCHIAT SCAND, V82, P152; Glaz J., 1999, SCAN STAT APPL; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Harley KG, 2009, THORAX, V64, P353, DOI 10.1136/thx.2007.090241; Herbert K. J., 2010, AUTISM RES, V3, P185; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Jea R, 2005, J OPER RES SOC, V56, P1303, DOI 10.1057/palgrave.jors.2601947; King M, 2009, INT J EPIDEMIOL, V38, P1224, DOI 10.1093/ije/dyp261; King MD, 2011, AM SOCIOL REV, V76, P320, DOI 10.1177/0003122411399389; King MD, 2009, AM J PUBLIC HEALTH, V99, P1673, DOI 10.2105/AJPH.2008.149021; Kirkpatrick B, 1998, AM J PSYCHIAT, V155, P1221, DOI 10.1176/ajp.155.9.1221; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Kolevzon A, 2006, AM J PSYCHIAT, V163, P1288, DOI 10.1176/appi.ajp.163.7.1288; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2011, SATSCANTM V8 0 SOFTW; Landau EC, 1999, J AUTISM DEV DISORD, V29, P385, DOI 10.1023/A:1023030911527; LATHI BP, 1998, MODERN DIGITAL ANALO; Lee LC, 2008, PAEDIATR PERINAT EP, V22, P172, DOI 10.1111/j.1365-3016.2007.00919.x; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Liu K, 2010, DEMOGRAPHY, P48; Liu KY, 2010, AM J SOCIOL, V115, P1387, DOI 10.1086/651448; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Louie JK, 2006, PEDIATRICS, V117, pE610, DOI 10.1542/peds.2005-1373; Maimburg RD, 2010, PEDIATRICS, V126, P872, DOI 10.1542/peds.2010-0052; Mazumdar S, 2012, SOCIAL SCI IN PRESS; MEDNICK SA, 1994, SCHIZOPHRENIA BULL, V20, P263, DOI 10.1093/schbul/20.2.263; NELSON CR, 1981, ECONOMETRICA, V49, P741, DOI 10.2307/1911520; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Procopio M, 2006, SEIZURE-EUR J EPILEP, V15, P17, DOI 10.1016/j.seizure.2005.10.001; Schervish, 2011, PROBABILITY STAT; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Stevens MC, 2000, J CLIN EXP NEUROPSYC, V22, P399, DOI 10.1076/1380-3395(200006)22:3;1-V;FT399; Suvisaari JM, 2001, AM J PSYCHIAT, V158, P754, DOI 10.1176/appi.ajp.158.5.754; Teles P, 2000, COMPUT STAT DATA AN, V34, P91, DOI 10.1016/S0167-9473(99)00072-9; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675	56	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41265	10.1371/journal.pone.0041265	http://dx.doi.org/10.1371/journal.pone.0041265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22859972	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900020
J	Monahan, WB; Tingley, MW				Monahan, William B.; Tingley, Morgan W.			Niche Tracking and Rapid Establishment of Distributional Equilibrium in the House Sparrow Show Potential Responsiveness of Species to Climate Change	PLOS ONE			English	Article							DISTRIBUTION MODELS; CHANGE PROJECTIONS; RESPONSES; HABITAT; TEMPERATURE; POPULATIONS; ECOLOGY; SHIFTS; RANGE; SPACE	The ability of species to respond to novel future climates is determined in part by their physiological capacity to tolerate climate change and the degree to which they have reached and continue to maintain distributional equilibrium with the environment. While broad-scale correlative climatic measurements of a species' niche are often described as estimating the fundamental niche, it is unclear how well these occupied portions actually approximate the fundamental niche per se, versus the fundamental niche that exists in environmental space, and what fitness values bounding the niche are necessary to maintain distributional equilibrium. Here, we investigate these questions by comparing physiological and correlative estimates of the thermal niche in the introduced North American house sparrow (Passer domesticus). Our results indicate that occupied portions of the fundamental niche derived from temperature correlations closely approximate the centroid of the existing fundamental niche calculated on a fitness threshold of 50% population mortality. Using these niche measures, a 75-year time series analysis (1930-2004) further shows that: (i) existing fundamental and occupied niche centroids did not undergo directional change, (ii) interannual changes in the two niche centroids were correlated, (iii) temperatures in North America moved through niche space in a net centripetal fashion, and consequently, (iv) most areas throughout the range of the house sparrow tracked the existing fundamental niche centroid with respect to at least one temperature gradient. Following introduction to a new continent, the house sparrow rapidly tracked its thermal niche and established continent-wide distributional equilibrium with respect to major temperature gradients. These dynamics were mediated in large part by the species' broad thermal physiological tolerances, high dispersal potential, competitive advantage in human-dominated landscapes, and climatically induced changes to the realized environmental space. Such insights may be used to conceptualize mechanistic climatic niche models in birds and other taxa.	[Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA; [Tingley, Morgan W.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA	United States Department of the Interior; Princeton University	Monahan, WB (corresponding author), Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO USA.	Bill_Monahan@nps.gov	Tingley, Morgan W/F-8519-2011	Tingley, Morgan W/0000-0002-1477-2218				Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Barrows WB, 1889, USDA B, V1, P1; Blem C.R., 1973, Ornithological Monographs, VNo. 14, P96; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cassini MH, 2011, J BIOGEOGR, V38, P2057, DOI 10.1111/j.1365-2699.2011.02552.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; KENDEIGH SC, 1969, WILSON BULL, V81, P441; Long J.L., 1981, INTRO BIRDS WORLD WO; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Moulton MP, 2010, BIOL INVASIONS, V12, P2955, DOI 10.1007/s10530-010-9692-0; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson R, 2010, LESSONS CONSERVATION, V3, P56; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rubidge EM, 2011, GLOBAL CHANGE BIOL, V17, P696, DOI 10.1111/j.1365-2486.2010.02297.x; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Stankowski PA, 2011, ECOL MODEL, V222, P567, DOI 10.1016/j.ecolmodel.2010.10.018; Summers-Smith JD, 1988, SPARROWS; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; ZAR JH, 1977, COMP BIOCHEM PHYS A, V57, P127, DOI 10.1016/0300-9629(77)90362-0; Zurell D, 2009, ECOGRAPHY, V32, P733, DOI 10.1111/j.1600-0587.2009.05810.x	49	22	26	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42097	10.1371/journal.pone.0042097	http://dx.doi.org/10.1371/journal.pone.0042097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860062	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950900068
J	Benavides-Vallve, C; Corbacho, D; Iglesias-Garcia, O; Pelacho, B; Albiasu, E; Castano, S; Munoz-Barrutia, A; Prosper, F; Ortiz-de-Solorzano, C				Benavides-Vallve, Carolina; Corbacho, David; Iglesias-Garcia, Olalla; Pelacho, Beatriz; Albiasu, Edurne; Castano, Sara; Munoz-Barrutia, Arrate; Prosper, Felipe; Ortiz-de-Solorzano, Carlos			New Strategies for Echocardiographic Evaluation of Left Ventricular Function in a Mouse Model of Long-Term Myocardial Infarction	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; MURINE ECHOCARDIOGRAPHY; MICE; TRANSPLANTATION; ULTRASOUND; COMMITTEE; SOCIETY; DISEASE; INDEX	Background: The aim of this article is to present an optimized acquisition and analysis protocol for the echocardiographic evaluation of left ventricle (LV) remodeling in a mouse model of myocardial infarction (MI). Methodology: 13 female DBA/2J mice underwent permanent occlusion of the left anterior descending (LAD) coronary artery leading to MI. Mice echocardiography was performed using a Vevo 770 (Visualsonics, Canada) before infarction, and 7, 14, 30, 60, 90 and 120 days after LAD ligation. LV systolic function was evaluated using different parameters, including the fractional area change (FAC%) computed in four high-temporal resolution B-mode short axis images taken at different ventricular levels, and in one parasternal long axis. Pulsed wave and tissue Doppler modes were used to evaluate the diastolic function and Tei Index for global cardiac function. The echocardiographic measurements of infarct size were validated histologically using collagen deposition labeled by Sirius red staining. All data was analyzed using Shapiro-Wilk and Student's t-tests. Principal Findings: Our results reveal LV dilation resulting in marked remodeling an severe systolic dysfunction, starting seven days after MI (LV internal apical diameter, basal = 2.82 +/- 0.24, 7d = 3.49 +/- 0.42; p < 0.001. End-diastolic area, basal = 18.98 +/- 1.81, 7d = 22.04 +/- 2.11; p < 0.001). A strong statistically significant negative correlation exists between the infarct size and long-axis FAC% (r = -0.946; R-2 = 0.90; p < 0.05). Moreover, the measured Tei Index values confirmed significant post-infarction impairment of the global cardiac function (basal = 0.46 +/- 0.07, 7d = 0.55 +/- 0.08, 14 d = 0.57 +/- 0.06, 30 d = 0.54 +/- 0.06, 60 d = 0.54 +/- 0.07, 90 d = 0.57 +/- 0.08; p < 0.01). Conclusions/Significance: In summary, we have performed a complete characterization of LV post-infarction remodeling in a DBA/2J mouse model of MI, using parameters adapted to the particular characteristics of the model In the future, this well characterized model will be used in both investigative and pharmacological studies that require accurate quantitative monitoring of cardiac recovery after myocardial infarction.	[Benavides-Vallve, Carolina; Corbacho, David; Iglesias-Garcia, Olalla; Pelacho, Beatriz; Albiasu, Edurne; Munoz-Barrutia, Arrate; Prosper, Felipe; Ortiz-de-Solorzano, Carlos] Univ Navarra, Imaging Unit, Fdn Invest Med Aplicada, Navarra, Spain; [Castano, Sara] Univ Navarra Clin, Dept Cardiol, Navarra, Spain	University of Navarra; University of Navarra	Benavides-Vallve, C (corresponding author), Univ Navarra, Imaging Unit, Fdn Invest Med Aplicada, Navarra, Spain.	codesolorzano@unav.es	Prosper, Felipe/H-6859-2017; Ortiz-de-Solorzano, Carlos/G-3278-2010; Munoz-Barrutia, Arrate/G-1776-2016	Prosper, Felipe/0000-0001-6115-8790; Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Munoz-Barrutia, Arrate/0000-0002-1573-1661; Benavides-Vallve, Carolina/0000-0003-2949-0253	UTE Project CIMA; Spanish Science and Innovation Ministry [MICINN PSS-010000-2008-2]; Instituto de Salud Carlos III [ISCIII PI050168, PI10/01621, CP09/00333, ISCIII-RETIC RD06/0014]; Ministerio de Ciencia e Innovacion [PLE2009-0116, PSE SINBAD, PSS 0100000-2008-1]; MICINN [PTA2008-1228-I]	UTE Project CIMA; Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This project was partially funded by the UTE Project CIMA, the subprogram for unique strategic projects of the Spanish Science and Innovation Ministry (MICINN PSS-010000-2008-2) and the Instituto de Salud Carlos III (ISCIII PI050168, PI10/01621, CP09/00333 and ISCIII-RETIC RD06/0014), Ministerio de Ciencia e Innovacion (PLE2009-0116 and PSE SINBAD, PSS 0100000-2008-1). Carolina Benavides-Vallve is partially funded by the MICINN's program of Promotion of Technical Personal Support (PTA2008-1228-I). Arrate Munoz-Barrutia holds a Ramon y Cajal Fellowship of the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruch C, 2000, EUR HEART J, V21, P1888, DOI 10.1053/euhj.2000.2246; Chin BB, 2007, RADIOLOGY, V245, P440, DOI 10.1148/radiol.2452061973; DOMANSKI MJ, 1992, AM J CARDIOL, V70, P1367, DOI 10.1016/0002-9149(92)90777-V; FEIGENBAUM H, 1990, AM J CARDIOL, V66, pH17, DOI 10.1016/0002-9149(90)90571-H; Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; INO T, 1989, BRIT HEART J, V61, P182; Kanno S, 2002, J AM SOC ECHOCARDIOG, V15, P601, DOI 10.1067/mje.2002.117560; Katare R, 2010, J MOL CELL CARDIOL, V49, P625, DOI 10.1016/j.yjmcc.2010.05.014; Kiessling F, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P1, DOI 10.1007/978-3-642-12945-2; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Mazo M, 2010, CELL TRANSPLANT, V19, P313, DOI 10.3727/096368909X480323; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Monassier L, 2004, DRUG DISC TODAY DIS, V1, P235; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Parthenakis FI, 2002, CHEST, V121, P1935, DOI 10.1378/chest.121.6.1935; Pelacho B, 2007, J TISSUE ENG REGEN M, V1, P51, DOI 10.1002/term.7; Quian A, 2012, NATURE IN PRESS; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rottman JN, 2007, ECHOCARDIOGRAPHY J C, V24, P1; Salto-Tellez M, 2004, CARDIOVASC PATHOL, V13, P91, DOI 10.1016/s1054-8807(03)00129-7; Schaefer Arnd, 2005, Eur J Echocardiogr, V6, P367; Scherrer-Crosbie M, 1999, AM J PHYSIOL, V277, P86; Scherrer-Crosbie M, 2008, J AM SOC ECHOCARDIOG, V21, P1083, DOI 10.1016/j.echo.2008.07.001; Scherrer-Crosbie M, 2010, J MOL CELL CARDIOL, V48, P512, DOI 10.1016/j.yjmcc.2009.07.004; Stypmann J, 2007, ECHOCARDIOGR-J CARD, V24, P97, DOI 10.1111/j.1540-8175.2006.00358.x; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Syed F, 2005, J AM SOC ECHOCARDIOG, V18, P982, DOI 10.1016/j.echo.2005.05.001; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tei C, 1995, J Cardiol, V26, P357; TEICHHOLZ LE, 1974, NEW ENGL J MED, V291, P1220, DOI 10.1056/NEJM197412052912304; Tournoux F, 2011, J AM SOC ECHOCARDIOG, V24, P465, DOI 10.1016/j.echo.2010.12.019; Voelkl JGJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/185683; World Health Organization, 2011, INT J PUBLIC HLTH ME	36	39	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41691	10.1371/journal.pone.0041691	http://dx.doi.org/10.1371/journal.pone.0041691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848568	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200087
J	Ferro, F; Ouille, A; Tran, TA; Fontanaud, P; Bois, P; Babuty, D; Labarthe, F; Le Guennec, JY				Ferro, Fabio; Ouille, Aude; Tran, Truong-An; Fontanaud, Pierre; Bois, Patrick; Babuty, Dominique; Labarthe, Francois; Le Guennec, Jean-Yves			Long-Chain Acylcarnitines Regulate the hERG Channel	PLOS ONE			English	Article							DIABETES-MELLITUS; CARNITINE; PALMITOYLCARNITINE; DISORDERS; LYSOPHOSPHATIDYLCHOLINE; ACCUMULATION; RISK	Background and purpose: In some pathological conditions carnitine concentration is high while in othersitis low. In bothcases, cardiac arrhythmiascan occur and lead to sudden cardiac death. It has been proposed that in ischaemia, acylcarnitine (acyl-CAR), but not carnitine, is involved in arrhythmiasthrough modulation of ionic currents. We studied the effects of acyl-CARs on hERG, K(IR)2.1 and K(v)7.1/minKchannels (channels responsible for I-KR, I-K1 and I-KS respectively). Experimental approach: HEK293 cells stably expressing hERG, K(IR)2.1 or Kv7.1/minK were studied using the patch clamp technique. Free carnitine (CAR) and acyl-CAR derivatives from medium- (C8 and C10) and long-chain (C16 and C18:1) fatty acids were applied intra-and extracellularly at different concentrations. Forstudies onhERG, C16 and C18:1 free fatty acid were also used. Key results: Extracellular long-chain (LCAC), but not medium-chain, acyl-CAR, induced an increase of I-hERG amplitude associated with a dose-dependent speeding of deactivation kinetics. They had no effect on K(IR)2.1 or Kv7.1/minK currents. Computer simulations of these effects wereconsistent with changes in action potential profile. Conclusions and applications: Extracellular LCAC tonically regulates IhERG amplitude and kineticsunder physiological conditions. This modulation maycontribute to the changes in action potential duration thatprecede cardiac arrhythmias in ischaemia, diabetes and primary systemic carnitine deficiency.	[Ferro, Fabio; Tran, Truong-An; Labarthe, Francois] Univ Tours, INSERM U921, Tours, France; [Ouille, Aude; Le Guennec, Jean-Yves] Univ Montpellier 2, Univ Montpellier 1, INSERM U1046, Montpellier, France; [Fontanaud, Pierre] Univ Montpellier 2, Univ Montpellier 1, IGF CNRS INSERM 661, Montpellier, France; [Bois, Patrick] Univ Poitiers, CNRS, IPBC, UMR 6187, Poitiers, France; [Babuty, Dominique] Hop Trousseau, CHRU Tours, Serv Cardiol B, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU Tours	Ferro, F (corresponding author), Univ Tours, INSERM U921, Tours, France.	aude.ouille@inserm.fr	LE GUENNEC, Jean-Yves/P-1067-2016; Bois, patrick/G-2242-2014		Boston Scientific; conseil Regional du Centre	Boston Scientific(Boston Scientific); conseil Regional du Centre(Region Centre-Val de Loire)	This work was financially supported by Boston Scientific and the conseil Regional du Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Bergner DW, 2010, CARDIOL J, V17, P117; Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248; Brugada R, 2005, CAN MED ASSOC J, V173, P1349, DOI 10.1503/cmaj.050596; Champeroux P, 2005, BRIT J PHARMACOL, V144, P376, DOI 10.1038/sj.bjp.0706070; Clancy CE, 2001, CARDIOVASC RES, V50, P301, DOI 10.1016/S0008-6363(00)00293-5; DATORRE SD, 1991, J MOL CELL CARDIOL, V23, P11, DOI 10.1016/0022-2828(91)90019-I; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Ford DA, 1996, BIOCHEMISTRY-US, V35, P7903, DOI 10.1021/bi960552n; Haruna T, 2000, PFLUG ARCH EUR J PHY, V441, P200, DOI 10.1007/s004240000428; Hedley PL, 2009, HUM MUTAT, V30, P1256, DOI 10.1002/humu.21066; Jones MG, 2005, CLIN CHIM ACTA, V360, P173, DOI 10.1016/j.cccn.2005.04.029; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; Liu QY, 1996, BIOCHEM BIOPH RES CO, V228, P252, DOI 10.1006/bbrc.1996.1649; Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087; Lopaschuk GD, 1996, CORONARY ARTERY DIS, V7, P116, DOI 10.1097/00019501-199602000-00004; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Opalka JR, 2001, CLIN CHEM, V47, P2150; Pappone C, 2010, MINERVA CARDIOANGIOL, V58, P269; Pascarel C, 1998, BRIT J PHARMACOL, V124, P356, DOI 10.1038/sj.bjp.0701835; Rudy Y, 2006, Q REV BIOPHYS, V39, P57, DOI 10.1017/S0033583506004227; SATO T, 1993, CARDIOVASC DRUG THER, V7, P575, DOI 10.1007/BF00877623; SATO T, 1992, PFLUG ARCH EUR J PHY, V420, P94, DOI 10.1007/BF00378647; Schimpf R, 2005, CARDIOVASC RES, V67, P357, DOI 10.1016/j.cardiores.2005.03.026; Siscovick DS, 2010, REV ENDOCR METAB DIS, V11, P53, DOI 10.1007/s11154-010-9133-5; Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004; Su X, 2005, BIOCHEMISTRY-US, V44, P5234, DOI 10.1021/bi047773a; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Wang JX, 2004, BRIT J PHARMACOL, V141, P586, DOI 10.1038/sj.bjp.0705646; WU JY, 1992, AM J PHYSIOL, V263, pH410, DOI 10.1152/ajpheart.1992.263.2.H410; WU JY, 1995, AM J PHYSIOL-HEART C, V268, pH2405, DOI 10.1152/ajpheart.1995.268.6.H2405; Xu Z, 1998, AM J PHYSIOL-CELL PH, V275, pC1660, DOI 10.1152/ajpcell.1998.275.6.C1660; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	34	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41686	10.1371/journal.pone.0041686	http://dx.doi.org/10.1371/journal.pone.0041686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848566	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600105
J	Gaby, JC; Buckley, DH				Gaby, John Christian; Buckley, Daniel H.			A Comprehensive Evaluation of PCR Primers to Amplify the nifH Gene of Nitrogenase	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHYLOGENETIC DIVERSITY; BACTERIAL DIVERSITY; FIXATION GENES; SOIL; AMPLIFICATION; BIODIVERSITY; ASSEMBLAGES; RHIZOSPHERE; DIAZOTROPHS	The nifH gene is the most widely sequenced marker gene used to identify nitrogen-fixing Bacteria and Archaea. Numerous PCR primers have been designed to amplify nifH, but a comprehensive evaluation of nifH PCR primers has not been performed. We performed an in silico analysis of the specificity and coverage of 51 universal and 35 group-specific nifH primers by using an aligned database of 23,847 nifH sequences. We found that there are 15 universal nifH primers that target 90% or more of nitrogen fixers, but that there are also 23 nifH primers that target less than 50% of nifH sequences. The nifH primers we evaluated vary in their phylogenetic bias and their ability to recover sequences from commonly sampled environments. In addition, many of these primers will amplify genes that do not mediate nitrogen fixation, and thus it would be advisable for researchers to screen their sequencing results for the presence of non-target genes before analysis. Universal primers that performed well in silico were tested empirically with soil samples and with genomic DNA from a phylogenetically diverse set of nitrogen-fixing strains. This analysis will be of great utility to those engaged in molecular analysis of nifH genes from isolates and environmental samples.	[Gaby, John Christian; Buckley, Daniel H.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Cornell University	Gaby, JC (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	dhb28@cornell.edu	Buckley, Daniel H/B-8089-2008; Gaby, John/AAA-1219-2020	Buckley, Daniel H/0000-0003-1654-2907; Gaby, John/0000-0003-2980-729X	National Science Foundation [0447586, 0221658, 1069193]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grants No. 0447586, 0221658, and 1069193. The funders had no role in study design, data collection and analysis, decision to publish, of preparation of the manuscript.	Ando S, 2005, SOIL SCI PLANT NUTR, V51, P303, DOI 10.1111/j.1747-0765.2005.tb00034.x; Arahal DR, 2004, SYST APPL MICROBIOL, V27, P581, DOI 10.1078/0723202041748208; Bagwell CE, 1998, APPL ENVIRON MICROB, V64, P4276; Barbieri E, 2010, FUNGAL BIOL-UK, V114, P936, DOI 10.1016/j.funbio.2010.09.001; Benita Y, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng101; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Burgmann H, 2004, APPL ENVIRON MICROB, V70, P240, DOI 10.1128/AEM.70.1.240-247.2004; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; CHIEN YT, 1994, J BACTERIOL, V176, P6590, DOI 10.1128/JB.176.21.6590-6598.1994; Deslippe JR, 2005, FEMS MICROBIOL ECOL, V53, P41, DOI 10.1016/j.femsec.2004.12.002; Duc L, 2009, MICROB ECOL, V57, P179, DOI 10.1007/s00248-008-9408-5; Dyble J, 2002, APPL ENVIRON MICROB, V68, P2567, DOI 10.1128/AEM.68.5.2567-2571.2002; Fedorov D N, 2008, Mikrobiologiia, V77, P286; Flores-Mireles AL, 2007, APPL ENVIRON MICROB, V73, P7308, DOI 10.1128/AEM.01892-06; Gaby JC, 2011, ENVIRON MICROBIOL, V13, P1790, DOI 10.1111/j.1462-2920.2011.02488.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hery M, 2005, ENVIRON MICROBIOL, V7, P486, DOI 10.1111/j.1462-2920.2005.00705.x; Hewson I, 2007, ISME J, V1, P78, DOI 10.1038/ismej.2007.5; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; KIRSHTEIN JD, 1991, APPL ENVIRON MICROB, V57, P2645, DOI 10.1128/AEM.57.9.2645-2650.1991; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Lovell CR, 2000, APPL ENVIRON MICROB, V66, P3814, DOI 10.1128/AEM.66.9.3814-3822.2000; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Man-Aharonovich D, 2007, ENVIRON MICROBIOL, V9, P2354, DOI 10.1111/j.1462-2920.2007.01353.x; Marusina A. I., 2001, Mikrobiologiya, V70, P86; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Mirza BS, 2009, SYST APPL MICROBIOL, V32, P558, DOI 10.1016/j.syapm.2009.07.008; Mirza BS, 2009, MICROB ECOL, V58, P384, DOI 10.1007/s00248-009-9513-0; Moebius BN, 2007, SOIL SCI, V172, P895, DOI 10.1097/ss.0b013e318154b520; Ogilvie LA, 2008, MICROB ECOL, V56, P525, DOI 10.1007/s00248-008-9372-0; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P2747, DOI 10.1128/AEM.62.8.2747-2752.1996; Olson JB, 1998, MICROBIAL ECOL, V36, P231, DOI 10.1007/s002489900110; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Piceno YM, 1999, MICROB ECOL, V38, P157, DOI 10.1007/s002489900164; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Reed SC, 2010, OECOLOGIA, V164, P521, DOI 10.1007/s00442-010-1649-6; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosch C, 2009, EUR J SOIL SCI, V60, P883, DOI 10.1111/j.1365-2389.2009.01167.x; Roesch LFW, 2008, PLANT SOIL, V302, P91, DOI 10.1007/s11104-007-9458-3; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rosch C, 2005, APPL ENVIRON MICROB, V71, P2026, DOI 10.1128/AEM.71.4.2026-2035.2005; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Rubio L. M., 2002, Nitrogen fixation at the millennium, P101, DOI 10.1016/B978-044450965-9/50004-5; Schlessman JL, 1998, J MOL BIOL, V280, P669, DOI 10.1006/jmbi.1998.1898; SIMONET P, 1991, APPL ENVIRON MICROB, V57, P3278, DOI 10.1128/AEM.57.11.3278-3286.1991; Singh Vinay K., 2000, Molecular Biology Today, V1, P67; Soares RA, 2006, APPL SOIL ECOL, V33, P221, DOI 10.1016/j.apsoil.2006.01.001; UEDA T, 1995, J BACTERIOL, V177, P1414, DOI 10.1128/jb.177.5.1414-1417.1995; Widmer F, 1999, APPL ENVIRON MICROB, V65, P374; Yamada A, 2007, MOL ECOL, V16, P3768, DOI 10.1111/j.1365-294X.2007.03326.x; Yeager CM, 2004, APPL ENVIRON MICROB, V70, P973, DOI 10.1128/AEM.70.2.973-983.2004; Yeates C, 1998, Biol Proced Online, V1, P40, DOI 10.1251/bpo6; Young J. P. W., 1992, BIOL NITROGEN FIXATI, V1544, P43; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989	60	229	242	16	240	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42149	10.1371/journal.pone.0042149	http://dx.doi.org/10.1371/journal.pone.0042149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848735	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600172
J	Gao, YL; Wen, ZY; Dong, K; Zhong, GX; Wang, XM; Bu, ZG; Chen, HL; Ye, L; Yang, CL				Gao, Yulong; Wen, Zhiyuan; Dong, Ke; Zhong, Gongxun; Wang, Xiaomei; Bu, Zhigao; Chen, Hualan; Ye, Ling; Yang, Chinglai			Characterization of Immune Responses Induced by Immunization with the HA DNA Vaccines of Two Antigenically Distinctive H5N1 HPAIV Isolates	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; A H1N1 VIRUS; PANDEMIC INFLUENZA; WILD BIRDS; ANTIBODY-RESPONSES; CYTOPLASMIC DOMAIN; MOLECULAR ANALYSIS; DOMESTIC POULTRY; HONG-KONG; CHINA	The evolution of the H5N1 highly pathogenic avian influenza virus (HPAIV) has resulted in high sequence variations and diverse antigenic properties in circulating viral isolates. We investigated immune responses induced by HA DNA vaccines of two contemporary H5N1 HPAIV isolates, A/bar-headed goose/Qinghai/3/2005 (QH) and A/chicken/Shanxi/2/2006 (SX) respectively, against the homologous as well as the heterologous virus isolate for comparison. Characterization of antibody responses induced by immunization with QH-HA and SX-HA DNA vaccines showed that the two isolates are antigenically distinctive. Interestingly, after immunization with the QH-HA DNA vaccine, subsequent boosting with the SX-HA DNA vaccine significantly augmented antibody responses against the QH isolate but only induced low levels of antibody responses against the SX isolate. Conversely, after immunization with the SX-HA DNA vaccine, subsequent boosting with the QH-HA DNA vaccine significantly augmented antibody responses against the SX isolate but only induced low levels of antibody responses against the QH isolate. In contrast to the antibody responses, cross-reactive T cell responses are readily detected between these two isolates at similar levels. These results indicate the existence of original antigenic sin (OAS) between concurrently circulating H5N1 HPAIV strains, which may need to be taken into consideration in vaccine development against the potential H5N1 HPAIV pandemic.	[Gao, Yulong; Wen, Zhiyuan; Zhong, Gongxun; Wang, Xiaomei; Bu, Zhigao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China; [Gao, Yulong; Wen, Zhiyuan; Dong, Ke; Ye, Ling; Yang, Chinglai] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Gao, Yulong; Wen, Zhiyuan; Dong, Ke; Ye, Ling; Yang, Chinglai] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Dong, Ke] Fourth Mil Med Univ, Tangdu Hosp, Cent Lab, Xian 710032, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Emory University; Emory University; Air Force Military Medical University	Gao, YL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China.	chyang@emory.edu	Wen, Zhiyuan/AAT-1639-2020; Yang, Chinglai/D-1409-2014	Wen, Zhiyuan/0000-0003-3112-0243; Yang, Chinglai/0000-0002-9308-7760; Zhong, Gongxun/0000-0002-0748-9641	National Natural Science Foundation of China [81001311, 30825032]; Chinese National Key Basic Research Program (973) [2011CB505000]; Public Health Service from the National Institutes of Health [HHSN266200700006C]; Emory Global Health Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research Program (973)(National Basic Research Program of China); Public Health Service from the National Institutes of Health; Emory Global Health Institute	This work was supported in parts by the National Natural Science Foundation of China grant 81001311 to Zhiyuan Wen, the National Natural Science Foundation of China grant 30825032 and the Chinese National Key Basic Research Program (973, 2011CB505000) to Hualan Chen, the Public Health Service grant HHSN266200700006C from the National Institutes of Health and funding from the Emory Global Health Institute to Chinglai Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adalja AA, 2010, EMERG INFECT DIS, V16, P1028, DOI [10.3201/eid1606.091563, 10.3201/eid1606.091653]; ANGELOVA LA, 1982, IMMUNOLOGY, V46, P183; Boon ACM, 2009, CURR TOP MICROBIOL, V333, P25, DOI 10.1007/978-3-540-92165-3_2; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; BRIDGES CB, 2003, MMWR RECOMM REP, V52, pCE31; Bu ZG, 2004, VIROLOGY, V328, P62, DOI 10.1016/j.virol.2004.06.041; CDC, 2009, JAMA-J AM MED ASSOC, V301, P2319; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen HL, 2009, CURR TOP MICROBIOL, V333, P153, DOI 10.1007/978-3-540-92165-3_7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; DAVENPORT FM, 1956, J EXP MED, V104, P85, DOI 10.1084/jem.104.1.85; DESTFAZEKAS G, 1966, J EXP MED, V124, P331, DOI DOI 10.1084/JEM.124.3.331; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fazekas St de G, 1966, J EXP MED, V124, P347; FISH S, 1989, J EXP MED, V170, P1191, DOI 10.1084/jem.170.4.1191; FRANCIS T, 1953, T ASSOC AM PHYSICIAN, V66, P231; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Giles BM, 2011, CLIN VACCINE IMMUNOL; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Haaheim L R, 2003, Dev Biol (Basel), V115, P49; HENNESSY AV, 1955, J IMMUNOL, V75, P401; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; JENSEN KE, 1953, J EXP MED, V98, P619, DOI 10.1084/jem.98.6.619; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; KLINMAN NR, 1973, J EXP MED, V138, P1276, DOI 10.1084/jem.138.5.1276; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Nguyen T, 2009, VIROLOGY, V387, P250, DOI 10.1016/j.virol.2009.03.006; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Siengsanan J, 2009, J WILDLIFE DIS, V45, P740, DOI 10.7589/0090-3558-45.3.740; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; VIRELIZIER JL, 1974, J EXP MED, V140, P1571, DOI 10.1084/jem.140.6.1571; VIRELIZIER JL, 1974, J EXP MED, V140, P1559, DOI 10.1084/jem.140.6.1559; Wang SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028757; Weber S, 2007, J GEN VIROL, V88, P554, DOI 10.1099/vir.0.82300-0; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; WEBSTER RG, 1966, J IMMUNOL, V97, P177; Wen ZY, 2009, ANTIVIR RES, V84, P215, DOI 10.1016/j.antiviral.2009.09.005; WHO, 2009, COMMUNICATION   0611; WHO, 2012, CUM NUMB CONF HUM CA; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; YARCHOAN R, 1984, J IMMUNOL, V132, P928; Ye L, 2004, J VIROL, V78, P13409, DOI 10.1128/JVI.78.24.13409-13419.2004; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	68	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41332	10.1371/journal.pone.0041332	http://dx.doi.org/10.1371/journal.pone.0041332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859976	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600021
J	Harris, CA; Buckley, CL; Nowotny, T; Passaro, PA; Seth, AK; Kemenes, G; O'Shea, M				Harris, Christopher A.; Buckley, Christopher L.; Nowotny, Thomas; Passaro, Peter A.; Seth, Anil K.; Kemenes, Gyoergy; O'Shea, Michael			Multi-Neuronal Refractory Period Adapts Centrally Generated Behaviour to Reward	PLOS ONE			English	Article							CEREBRAL GIANT-CELLS; SNAIL LYMNAEA-STAGNALIS; DEVELOPING SPINAL-CORD; POND SNAIL; FEEDING SYSTEM; MODULATORY ROLE; MOTOR PATTERN; NETWORK; INTERNEURONS; DOPAMINE	Oscillating neuronal circuits, known as central pattern generators (CPGs), are responsible for generating rhythmic behaviours such as walking, breathing and chewing. The CPG model alone however does not account for the ability of animals to adapt their future behaviour to changes in the sensory environment that signal reward. Here, using multi-electrode array (MEA) recording in an established experimental model of centrally generated rhythmic behaviour we show that the feeding CPG of Lymnaea stagnalis is itself associated with another, and hitherto unidentified, oscillating neuronal population. This extra-CPG oscillator is characterised by high population-wide activity alternating with population-wide quiescence. During the quiescent periods the CPG is refractory to activation by food-associated stimuli. Furthermore, the duration of the refractory period predicts the timing of the next activation of the CPG, which may be minutes into the future. Rewarding food stimuli and dopamine accelerate the frequency of the extra-CPG oscillator and reduce the duration of its quiescent periods. These findings indicate that dopamine adapts future feeding behaviour to the availability of food by significantly reducing the refractory period of the brain's feeding circuitry.	[Harris, Christopher A.; Kemenes, Gyoergy; O'Shea, Michael] Univ Sussex, Sussex Ctr Neurosci, Sch Life Sci, Brighton, E Sussex, England; [Buckley, Christopher L.; Nowotny, Thomas; Passaro, Peter A.; Seth, Anil K.] Univ Sussex, Sch Engn & Informat, Brighton, E Sussex, England; [Seth, Anil K.] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England	University of Sussex; University of Sussex; University of Sussex	Harris, CA (corresponding author), Univ Sussex, Sussex Ctr Neurosci, Sch Life Sci, Brighton, E Sussex, England.	C.A.Harris@sussex.ac.uk; M.O-Shea@sussex.ac.uk	Seth, Anil/AAE-8499-2019; Kemenes, George/L-4910-2019; Nowotny, Thomas/C-3883-2012	Seth, Anil/0000-0002-1421-6051; Kemenes, George/0000-0003-2004-8725; Nowotny, Thomas/0000-0002-4451-915X; Harris, Christopher/0000-0003-4791-1496; Buckley, Christopher L/0000-0002-8551-9121	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H009906/1]; BBSRC Studentship; Engineering and Physical Sciences Research Council [EP/G007543/1]; BBSRC [BB/H009906/1] Funding Source: UKRI; EPSRC [EP/G007543/1] Funding Source: UKRI; MRC [G0400551] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009906/1] Funding Source: researchfish; Medical Research Council [G0400551] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk) grant BB/H009906/1 and BBSRC Studentship to C.A. Harris and the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant EP/G007543/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1984, J NEUROBIOL, V15, P67, DOI 10.1002/neu.480150107; ASCHER P, 1972, J PHYSIOL-LONDON, V225, P173, DOI 10.1113/jphysiol.1972.sp009933; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Darbon P, 2003, J NEUROPHYSIOL, V90, P3119, DOI 10.1152/jn.00579.2003; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; ELEKES K, 1991, J COMP NEUROL, V307, P214, DOI 10.1002/cne.903070205; ELLIOTT CJH, 1985, J NEUROPHYSIOL, V54, P1412, DOI 10.1152/jn.1985.54.6.1412; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Garcia-Campmany L, 2010, CURR OPIN NEUROBIOL, V20, P116, DOI 10.1016/j.conb.2010.01.002; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; GROSS GW, 1979, IEEE T BIO-MED ENG, V26, P273, DOI 10.1109/TBME.1979.326402; Harris CA, 2010, J NEUROSCI METH, V186, P171, DOI 10.1016/j.jneumeth.2009.11.014; KEMENES G, 1986, J EXP BIOL, V122, P113; KEMENES G, 1989, BEHAV NEURAL BIOL, V52, P260, DOI 10.1016/S0163-1047(89)90383-X; Kemenes G, 2001, J NEUROSCI, V21, P2903, DOI 10.1523/JNEUROSCI.21-08-02903.2001; Kemenes G, 2009, CURR BIOL, V19, pR9, DOI 10.1016/j.cub.2008.10.013; Kemenes I, 2011, EUR J NEUROSCI, V33, P143, DOI 10.1111/j.1460-9568.2010.07479.x; Kojima S, 2000, NEUROSCIENCE, V100, P893, DOI 10.1016/S0306-4522(00)00338-9; Kojima S, 2001, J NEUROBIOL, V49, P118, DOI 10.1002/neu.1069; KYRIAKIDES MA, 1989, J NEUROBIOL, V20, P635, DOI 10.1002/neu.480200704; LONDON JA, 1987, J NEUROSCI, V7, P649; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marra V, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00161; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; NOVAK JL, 1986, IEEE T BIO-MED ENG, V33, P196, DOI 10.1109/TBME.1986.325891; ROSE RM, 1979, J EXP BIOL, V80, P137; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; Staras K, 1998, J NEUROPHYSIOL, V79, P3030, DOI 10.1152/jn.1998.79.6.3030; Staras K, 2003, CURR BIOL, V13, P116, DOI 10.1016/S0960-9822(02)01435-5; Staras K, 1998, J NEUROSCI, V18, P3669; Straub VA, 2002, J NEUROPHYSIOL, V88, P1569, DOI 10.1152/jn.2002.88.4.1569; Streit J, 2006, ADV NETWORK ELECTROP, P377, DOI DOI 10.1007/0-387-25858-2_16; Tabak J, 2000, J NEUROSCI, V20, P3041; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; TUERSLEY MD, 1987, BEHAV NEURAL BIOL, V48, P222, DOI 10.1016/S0163-1047(87)90780-1; Vavoulis DV, 2007, EUR J NEUROSCI, V25, P2805, DOI 10.1111/j.1460-9568.2007.05517.x; Vehovszky A, 2001, J NEUROPHYSIOL, V86, P792, DOI 10.1152/jn.2001.86.2.792; WHITE NM, 1989, NEUROSCI BIOBEHAV R, V13, P181, DOI 10.1016/S0149-7634(89)80028-4; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; YEOMAN MS, 1994, J NEUROPHYSIOL, V72, P1372, DOI 10.1152/jn.1994.72.3.1372; Yeoman MS, 1996, J NEUROPHYSIOL, V75, P11, DOI 10.1152/jn.1996.75.1.11; YEOMAN MS, 1994, J NEUROPHYSIOL, V72, P1357, DOI 10.1152/jn.1994.72.3.1357	46	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42493	10.1371/journal.pone.0042493	http://dx.doi.org/10.1371/journal.pone.0042493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860134	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000307045600106
J	Kolahi, KS; Donjacour, A; Liu, XW; Lin, WK; Simbulan, RK; Bloise, E; Maltepe, E; Rinaudo, P				Kolahi, Kevin S.; Donjacour, Annemarie; Liu, Xiaowei; Lin, Wingka; Simbulan, Rhodel K.; Bloise, Enrrico; Maltepe, Emin; Rinaudo, Paolo			Effect of Substrate Stiffness on Early Mouse Embryo Development	PLOS ONE			English	Article							GENE-EXPRESSION; ZONA-PELLUCIDA; CELL; FERTILIZATION; CULTURE; MICROGRAVITY; IMPLANTATION; PROJECTIONS; INVITRO; STRESS	It is becoming increasingly clear that cells are remarkably sensitive to the biophysical cues of their microenvironment and that these cues play a significant role in influencing their behaviors. In this study, we investigated whether the early preimplantation embryo is sensitive to mechanical cues, i.e. the elasticity of the culture environment. To test this, we have developed a new embryo culture system where the mechanical properties of the embryonic environment can be precisely defined. The contemporary standard environment for embryo culture is the polystyrene petri dish (PD), which has a stiffness (1 GPa) that is six orders of magnitude greater than the uterine epithelium (1 kPa). To approximate more closely the mechanical aspects of the in vivo uterine environment we used polydimethyl-siloxane (PDMS) or fabricated 3D type I collagen gels (1 kPa stiffness, Col-1k group). Mouse embryo development on alternate substrates was compared to that seen on the petri dish; percent development, hatching frequency, and cell number were observed. Our results indicated that embryos are sensitive to the mechanical environment on which they are cultured. Embryos cultured on Col-1k showed a significantly greater frequency of development to 2-cell (68 +/- 15% vs. 59 +/- 18%), blastocyst (64 +/- 9.1% vs. 50 +/- 18%) and hatching blastocyst stages (54 +/- 25% vs. 21 +/- 16%) and an increase in the number of trophectodermal cell (TE, 65 +/- 13 vs. 49 +/- 12 cells) compared to control embryos cultured in PD (mean +/- S.D.; p<.01). Embryos cultured on Col-1k and PD were transferred to recipient females and observed on embryonic day 12.5. Both groups had the same number of fetuses, however the placentas of the Col-1k fetuses were larger than controls, suggesting a continued effect of the preimplantation environment. In summary, characteristics of the preimplantation microenvironment affect pre- and post-implantation growth.	[Kolahi, Kevin S.; Donjacour, Annemarie; Liu, Xiaowei; Lin, Wingka; Simbulan, Rhodel K.; Bloise, Enrrico; Rinaudo, Paolo] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Maltepe, Emin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kolahi, KS (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	rinaudop@obgyn.ucsf.edu	Bloise, Enrrico/O-6710-2018	Bloise, Enrrico/0000-0003-0275-8686	National Institute of Child Health and Human Development (NICHD) [R01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072455, R01HD062803] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development (NICHD) grant (R01) to PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Bavister BD, 1995, HUM REPROD UPDATE, V1, P91, DOI 10.1093/humupd/1.2.91; BERTRAND E, 1995, HUM REPROD, V10, P1189, DOI 10.1093/oxfordjournals.humrep.a136116; Bloise E, 2012, ENDOCRINOLOGY; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Crawford-Young SJ, 2006, INT J DEV BIOL, V50, P183, DOI 10.1387/ijdb.052077sc; Delle Piane L, 2010, HUM REPROD, V25, P2039, DOI 10.1093/humrep/deq165; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; EATON NL, 1990, J IN VITRO FERTIL EM, V7, P28, DOI 10.1007/BF01133880; Elgarrai A, 2008, AFRICAN J BIOTECHNOL; Elsheikh AS, 1997, ANIM REPROD SCI, V48, P317, DOI 10.1016/S0378-4320(97)00048-1; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Filas BA, 2011, ANN BIOMED ENG, V39, P443, DOI 10.1007/s10439-010-0171-7; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Fox R. W., 2010, INTRO FLUID MECH; Giritharan G, 2007, REPRODUCTION, V134, P63, DOI 10.1530/REP-06-0247; Gonzales DS, 1996, HUM REPROD, V11, P2739; Joo BS, 2001, FERTIL STERIL, V75, P193, DOI 10.1016/S0015-0282(00)01671-X; Kojima Y, 2000, FERTIL STERIL, V74, P1142, DOI 10.1016/S0015-0282(00)01583-1; KRENTZ KJ, 1993, THERIOGENOLOGY, V39, P655, DOI 10.1016/0093-691X(93)90251-Y; Lopez-Garcia MC, 2009, YOUNGS MODULUS COLLA; Manoogian SJ, 2008, J BIOMECH, V41, P3436, DOI 10.1016/j.jbiomech.2008.09.020; Matsuura K, 2010, REPROD BIOMED ONLINE, V20, P358, DOI 10.1016/j.rbmo.2009.12.002; MCRAE AC, 1990, J REPROD FERTIL, V88, P31; Murayama Yoshinobu, 2006, Hum Cell, V19, P119, DOI 10.1111/j.1749-0774.2006.00019.x; Nagy A., 2003, MANIPULATING MOUSE E; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Popov VL, 2010, CONTACT MECHANIC AND FRICTION: PHYSICAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1007/978-3-642-10803-7; Redel BK, 2012, REPROD FERT DEVELOP, V24, P161, DOI 10.1071/RDv24n1Ab97; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Russ A, 2000, NATURE; Salonen MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022302; Saruwatari L, 2005, J BONE MINERAL RES; Seshagiri PB, 2009, J REPROD IMMUNOL, V83, P79, DOI 10.1016/j.jri.2009.06.264; Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178; Thie M, 1998, HUM REPROD, V13, P3211, DOI 10.1093/humrep/13.11.3211; Titushkin Igor A., 2010, Critical Reviews in Biomedical Engineering, V38, P393, DOI 10.1615/CritRevBiomedEng.v38.i5.10; TURNER K, 1992, HUM REPROD, V7, P112, DOI 10.1093/oxfordjournals.humrep.a137541; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Xie YF, 2006, BIOL REPROD, V75, P45, DOI 10.1095/biolreprod.105.049791; Yaniz JL, 2002, J VET MED A, V49, P393, DOI 10.1046/j.1439-0442.2002.00463.x	45	64	64	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41717	10.1371/journal.pone.0041717	http://dx.doi.org/10.1371/journal.pone.0041717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860009	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600039
J	Achanta, SS; Varunan, SM; Bhattacharyya, S; Bhattacharyya, MK				Achanta, Sita Swati; Varunan, Shalu M.; Bhattacharyya, Sunanda; Bhattacharyya, Mrinal Kanti			Characterization of Rad51 from Apicomplexan Parasite Toxoplasma gondii: An Implication for Inefficient Gene Targeting	PLOS ONE			English	Article							STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION; YEAST RAD51; DNA; PROTEIN; IDENTIFICATION; REPLACEMENTS; PATHWAYS; EXCHANGE; CHOICE	Repairing double strand breaks (DSBs) is absolutely essential for the survival of obligate intracellular parasite Toxoplasma gondii. Thus, DSB repair mechanisms could be excellent targets for chemotherapeutic interventions. Recent genetic and bioinformatics analyses confirm the presence of both homologous recombination (HR) as well as non homologous end joining (NHEJ) proteins in this lower eukaryote. In order to get mechanistic insights into the HR mediated DSB repair pathway in this parasite, we have characterized the key protein involved in homologous recombination, namely TgRad51, at the biochemical and genetic levels. We have purified recombinant TgRad51 protein to 99% homogeneity and have characterized it biochemically. The ATP hydrolysis activity of TgRad51 shows a higher K-M and much lower k(cat) compared to bacterial RecA or Rad51 from other related protozoan parasites. Taking yeast as a surrogate model system we have shown that TgRad51 is less efficient in gene conversion mechanism. Further, we have found that TgRad51 mediated gene integration is more prone towards random genetic loci rather than targeted locus. We hypothesize that compromised ATPase activity of TgRad51 is responsible for inefficient gene targeting and poor gene conversion efficiency in this protozoan parasite. With increase in homologous flanking regions almost three fold increments in targeted gene integration is observed, which is similar to the trend found with ScRad51. Our findings not only help us in understanding the reason behind inefficient gene targeting in T. gondii but also could be exploited to facilitate high throughput knockout as well as epitope tagging of Toxoplasma genes.	[Achanta, Sita Swati; Varunan, Shalu M.; Bhattacharyya, Mrinal Kanti] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Bhattacharyya, Sunanda] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Achanta, SS (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	mkbsl@uohyd.ernet.in			Indian funding agency, Department of Biotechnology, India [BT/PR 11174/MED/29/98/2008]	Indian funding agency, Department of Biotechnology, India	This work is supported by a grant from the Indian funding agency, Department of Biotechnology, India, to MKB (grant BT/PR 11174/MED/29/98/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2009, NUCLEIC ACIDS RES, V37, P5081, DOI 10.1093/nar/gkp495; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bhattacharyya MK, 2005, MOL BIOCHEM PARASIT, V139, P33, DOI 10.1016/j.molbiopara.2004.09.007; Bhattacharyya MK, 2003, INT J PARASITOL, V33, P1385, DOI 10.1016/S0020-7519(03)00212-1; Bhattacharyya MK, 2004, INFECT GENET EVOL, V4, P91, DOI 10.1016/j.meegid.2004.01.008; Bianco P R, 1998, Front Biosci, V3, pD570; Burton P, 2007, EUKARYOT CELL, V6, P1773, DOI 10.1128/EC.00212-07; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Glover L, 2008, NUCLEIC ACIDS RES, V36, P2608, DOI 10.1093/nar/gkn104; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jain S, 2009, GENE DEV, V23, P291, DOI 10.1101/gad.1751209; Janzen CJ, 2004, NUCLEIC ACIDS RES, V32, P6575, DOI 10.1093/nar/gkh991; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Laskar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023406; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McKean PG, 2001, MOL BIOCHEM PARASIT, V115, P209, DOI 10.1016/S0166-6851(01)00288-2; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morrison C, 1999, MOL CELL BIOL, V19, P6891; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41925	10.1371/journal.pone.0041925	http://dx.doi.org/10.1371/journal.pone.0041925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860032	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900051
J	Bratcher, PE; Weathington, NM; Nick, HJ; Jackson, PL; Snelgrove, RJ; Gaggar, A				Bratcher, Preston E.; Weathington, Nathaniel M.; Nick, Heidi J.; Jackson, Patricia L.; Snelgrove, Robert J.; Gaggar, Amit			MMP-9 Cleaves SP-D and Abrogates Its Innate Immune Functions In Vitro	PLOS ONE			English	Article							SURFACTANT-PROTEIN-D; OBSTRUCTIVE PULMONARY-DISEASE; IMPAIRS HOST-DEFENSE; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; BRONCHOALVEOLAR LAVAGE; NEUTROPHIL GELATINASE; ALLERGEN CHALLENGE; LUNG-DISEASE; MATRIX-METALLOPROTEINASE-9	Possession of a properly functioning innate immune system in the lung is vital to prevent infections due to the ongoing exposure of the lung to pathogens. While mechanisms of pulmonary innate immunity have been well studied, our knowledge of how these systems are altered in disease states, leading to increased susceptibility to infections, is limited. One innate immune protein in the lung, the pulmonary collectin SP-D, has been shown to be important in innate immune defense, as well as clearance of allergens and apoptotic cells. MMP-9 is a protease with a wide variety of substrates, and has been found to be dysregulated in a myriad of lung diseases ranging from asthma to cystic fibrosis; in many of these conditions, there are decreased levels of SP-D. Our results indicate that MMP-9 is able to cleave SP-D in vitro and this cleavage leads to loss of its innate immune functions, including its abilities to aggregate bacteria and increase phagocytosis by mouse alveolar macrophages. However, MMP-9-cleaved SP-D was still detected in a solid-phase E. coli LPS-binding assay, while NE-cleaved SP-D was not. In addition, MMP-9 seems to cleave SP-D much more efficiently than NE at physiological levels of calcium. Previous studies have shown that in several diseases, including cystic fibrosis and asthma, patients have increased expression of MMP-9 in the lungs as well as decreased levels of intact SP-D. As patients suffering from many of the diseases in which MMP-9 is over-expressed can be more susceptible to pulmonary infections, it is possible that MMP-9 cleavage of SP-D may contribute to this phenotype.	[Bratcher, Preston E.; Nick, Heidi J.; Jackson, Patricia L.; Gaggar, Amit] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Weathington, Nathaniel M.] Univ Pittsburgh, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Snelgrove, Robert J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Gaggar, Amit] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL USA; [Gaggar, Amit] Univ Alabama Birmingham, Lung Hlth Ctr, Birmingham, AL USA; [Gaggar, Amit] United States Dept Vet Affairs Med Ctr, Med Serv, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bratcher, PE (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bratcher@uab.edu		NICK, HEIDI/0000-0002-7853-6302	National Institutes of Health [HL102371, 5T32HL105346-02, P30 DK072482]; Cystic Fibrosis Foundation [GAGGAR07, RDP R464]; Wellcome Trust [WHRL_P34016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102371, T32HL105346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institutes of Health (HL102371 to AG, 5T32HL105346-02 to PEB, P30 DK072482), the Cystic Fibrosis Foundation (GAGGAR07 to AG, RDP R464 (pilot to PLJ)), and the Wellcome Trust (WHRL_P34016 to RJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Atochina EN, 2004, J INFECT DIS, V189, P1528, DOI 10.1086/383130; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Bergin PJ, 2004, HELICOBACTER, V9, P201, DOI 10.1111/j.1083-4389.2004.00232.x; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Bottcher T, 2003, NEUROSCI LETT, V338, P201, DOI 10.1016/S0304-3940(02)01406-4; Boulay ME, 2004, RESPIRATION, V71, P216, DOI 10.1159/000077418; Cataldo DD, 2002, CHEST, V122, P1553, DOI 10.1378/chest.122.5.1553; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; Davidson J, 1998, IMMUNOLOGY, V94, P228, DOI 10.1046/j.1365-2567.1998.00511.x; Duvoix A, 2011, IMMUNOBIOLOGY, V216, P72, DOI 10.1016/j.imbio.2010.03.006; El-Solh AA, 2009, J INFECTION, V59, P49, DOI 10.1016/j.jinf.2009.05.004; Erpenbeck VJ, 2006, ALLERGY, V61, P598, DOI 10.1111/j.1398-9995.2006.01062.x; Gaggar A, 2011, EUR RESPIR J, V38, P721, DOI 10.1183/09031936.00173210; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Griese M, 2003, BBA-MOL BASIS DIS, V1638, P157, DOI 10.1016/S0925-4439(03)00063-2; Hartl D, 2006, EUR J CLIN INVEST, V36, P423, DOI 10.1111/j.1365-2362.2006.01648.x; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Imtiaz MT, 2007, MICROBES INFECT, V9, P1561, DOI 10.1016/j.micinf.2007.08.010; Ito A, 1996, J BIOL CHEM, V271, P14657, DOI 10.1074/jbc.271.25.14657; Jounblat R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-126; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; Lanchou J, 2003, CRIT CARE MED, V31, P536, DOI 10.1097/01.CCM.0000048626.02184.F8; LeVine AM, 2004, AM J RESP CELL MOL, V31, P193, DOI 10.1165/rcmb.2003-0107OC; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Louhelainen N, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-13; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; Olesen HV, 2010, J CYST FIBROS, V9, P257, DOI 10.1016/j.jcf.2010.03.011; Oshita Y, 2003, THORAX, V58, P757, DOI 10.1136/thorax.58.9.757; Renckens R, 2006, J IMMUNOL, V176, P3735, DOI 10.4049/jimmunol.176.6.3735; Roderfeld M, 2009, J CYST FIBROS, V8, P338, DOI 10.1016/j.jcf.2009.06.001; Sin DD, 2008, CHEST, V134, P582, DOI 10.1378/chest.08-0600; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P1109, DOI 10.1164/ajrccm.162.3.9910080; Tsai HC, 2008, INFLAMMATION, V31, P247, DOI 10.1007/s10753-008-9071-5; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Yoshida M, 2001, J IMMUNOL, V166, P7514, DOI 10.4049/jimmunol.166.12.7514	51	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41881	10.1371/journal.pone.0041881	http://dx.doi.org/10.1371/journal.pone.0041881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860023	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306950900044
J	Caliceti, C; Zambonin, L; Prata, C; Dalla Sega, FV; Hakim, G; Hrelia, S; Fiorentini, D				Caliceti, Cristiana; Zambonin, Laura; Prata, Cecilia; Dalla Sega, Francesco Vieceli; Hakim, Gabriele; Hrelia, Silvana; Fiorentini, Diana			Effect of Plasma Membrane Cholesterol Depletion on Glucose Transport Regulation in Leukemia Cells	PLOS ONE			English	Article							LIPID RAFTS; GLUT4 TRANSLOCATION; DEPENDENT MECHANISM; CYCLODEXTRINS; ACTIVATION; PATHWAYS; TRAFFICKING; PROTEINS; SURVIVAL; AFFINITY	GLUT1 is the predominant glucose transporter in leukemia cells, and the modulation of glucose transport activity by cytokines, oncogenes or metabolic stresses is essential for their survival and proliferation. However, the molecular mechanisms allowing to control GLUT1 trafficking and degradation are still under debate. In this study we investigated whether plasma membrane cholesterol depletion plays a role in glucose transport activity in M07e cells, a human megakaryocytic leukemia line. To this purpose, the effect of cholesterol depletion by methyl-beta-cyclodextrin (MBCD) on both GLUT1 activity and trafficking was compared to that of the cytokine Stem Cell Factor (SCF). Results show that, like SCF, MBCD led to an increased glucose transport rate and caused a subcellular redistribution of GLUT1, recruiting intracellular transporter molecules to the plasma membrane. Due to the role of caveolae/lipid rafts in GLUT1 stimulation in response to many stimuli, we have also investigated the GLUT1 distribution along the fractions obtained after non ionic detergent treatment and density gradient centrifugation, which was only slightly changed upon MBCD treatment. The data suggest that MBCD exerts its action via a cholesterol-dependent mechanism that ultimately results in augmented GLUT1 translocation. Moreover, cholesterol depletion triggers GLUT1 translocation without the involvement of c-kit signalling pathway, in fact MBCD effect does not involve Akt and PLC gamma phosphorylation. These data, together with the observation that the combined MBCD/SCF cell treatment caused an additive effect on glucose uptake, suggest that the action of SCF and MBCD may proceed through two distinct mechanisms, the former following a signalling pathway, and the latter possibly involving a novel cholesterol dependent mechanism.	[Caliceti, Cristiana; Zambonin, Laura; Prata, Cecilia; Dalla Sega, Francesco Vieceli; Hakim, Gabriele; Hrelia, Silvana; Fiorentini, Diana] Alma Mater Studiorum Univ Bologna, Biochem Dept G Moruzzi, Bologna, Italy	University of Bologna	Caliceti, C (corresponding author), Alma Mater Studiorum Univ Bologna, Biochem Dept G Moruzzi, Bologna, Italy.	diana.fiorentini@unibo.it	Vieceli Dalla Sega, Francesco/GQZ-1869-2022; caliceti, cristiana/AAW-9614-2020; Hrelia, Silvana/P-2864-2015; Zambonin, Laura/J-4883-2012	caliceti, cristiana/0000-0002-6740-5331; Hrelia, Silvana/0000-0001-7857-4512; Vieceli Dalla Sega, Francesco/0000-0003-3445-3983; ZAMBONIN, LAURA/0000-0001-7050-7825	Ministero dell'Instruzione, dell'Universita, e della Ricerca (MIUR); Fondazione del Monte di Bologna e Ravenna, Italy	Ministero dell'Instruzione, dell'Universita, e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna e Ravenna, Italy	This work was supported by grants from Ministero dell'Instruzione, dell'Universita, e della Ricerca (MIUR) (PRIN 2008 http://prin.miur.it/) and Fondazione del Monte di Bologna e Ravenna (www.fondazionedelmonte.it), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Barnes K, 2002, J CELL SCI, V115, P2433; Barnes K, 2004, BIOCHEM J, V378, P343, DOI 10.1042/BJ20031186; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown Deborah A., 2007, V398, P9, DOI 10.1007/978-1-59745-513-8_2; CARRUTHERS A, 1984, BIOCHEMISTRY-US, V23, P6901, DOI 10.1021/bi00321a096; Casalou C, 2011, MOL CANCER RES, V9, P215, DOI 10.1158/1541-7786.MCR-10-0155; Chen GL, 2006, MOL ENDOCRINOL, V20, P857, DOI 10.1210/me.2005-0255; Christian AE, 1997, J LIPID RES, V38, P2264; COOPER RA, 1981, CANCER RES, V41, P1847; Elmendorf JS, 2002, J MEMBRANE BIOL, V190, P167, DOI 10.1007/s00232-002-1035-3; Fiorentini D, 2004, FREE RADICAL BIO MED, V37, P1402, DOI 10.1016/j.freeradbiomed.2004.07.022; Fiorentini D, 2001, FREE RADICAL BIO MED, V31, P923, DOI 10.1016/S0891-5849(01)00678-5; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Gaus K, 2005, J LIPID RES, V46, P1526, DOI 10.1194/jlr.M500103-JLR200; Jahn T, 2007, BLOOD, V110, P1739, DOI 10.1182/blood-2006-05-020925; Kasahara T, 2009, BBA-BIOMEMBRANES, V1788, P1051, DOI 10.1016/j.bbamem.2009.01.014; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Liu P, 2004, AM J PHYSIOL-CELL PH, V286, pC317, DOI 10.1152/ajpcell.00073.2003; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Maraldi T, 2004, BIOFACTORS, V20, P97, DOI 10.1002/biof.5520200204; Maraldi T, 2007, FREE RADICAL RES, V41, P1348, DOI 10.1080/10715760701730347; Maraldi T, 2007, ANTIOXID REDOX SIGN, V9, P271, DOI 10.1089/ars.2007.9.271; Maraldi T, 2006, CELL CALCIUM, V40, P373, DOI 10.1016/j.ceca.2006.04.006; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Sakyo T, 2002, BBA-BIOMEMBRANES, V1567, P165, DOI 10.1016/S0005-2736(02)00613-2; Sassano A, 2007, CANCER RES, V67, P4524, DOI 10.1158/0008-5472.CAN-06-3686; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Watson RT, 2001, EXP CELL RES, V271, P75, DOI 10.1006/excr.2001.5375; Welsh GL, 2005, BIOCHEM SOC T, V33, P346, DOI 10.1042/BST0330346; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Zambrano A, 2010, J CELL BIOCHEM, V110, P1471, DOI 10.1002/jcb.22711; Zhang JZ, 1999, AM J KIDNEY DIS, V34, P189, DOI 10.1016/S0272-6386(99)70131-9; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	37	25	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41246	10.1371/journal.pone.0041246	http://dx.doi.org/10.1371/journal.pone.0041246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859971	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900019
J	Lloyd-Price, J; Gupta, A; Ribeiro, AS				Lloyd-Price, Jason; Gupta, Abhishekh; Ribeiro, Andre S.			Robustness and Information Propagation in Attractors of Random Boolean Networks	PLOS ONE			English	Article							GENETIC NETWORK; MODELS; CELLS	Attractors represent the long-term behaviors of Random Boolean Networks. We study how the amount of information propagated between the nodes when on an attractor, as quantified by the average pairwise mutual information (I-A), relates to the robustness of the attractor to perturbations (R-A). We find that the dynamical regime of the network affects the relationship between I-A and R-A. In the ordered and chaotic regimes, I-A is anti-correlated with R-A, implying that attractors that are highly robust to perturbations have necessarily limited information propagation. Between order and chaos (for so-called "critical" networks) these quantities are uncorrelated. Finite size effects cause this behavior to be visible for a range of networks, from having a sensitivity of 1 to the point where I-A is maximized. In this region, the two quantities are weakly correlated and attractors can be almost arbitrarily robust to perturbations without restricting the propagation of information in the network.	[Lloyd-Price, Jason; Gupta, Abhishekh; Ribeiro, Andre S.] Tampere Univ Technol, Dept Signal Proc, Computat Syst Biol Res Grp, Lab Biosyst Dynam, FIN-33101 Tampere, Finland	Tampere University	Lloyd-Price, J (corresponding author), Tampere Univ Technol, Dept Signal Proc, Computat Syst Biol Res Grp, Lab Biosyst Dynam, FIN-33101 Tampere, Finland.	jason.lloyd-price@tut.fi	Ribeiro, Andre S/G-4294-2014; Gupta, Abhishekh/I-9114-2019	Ribeiro, Andre S/0000-0002-7255-5211; Gupta, Abhishekh/0000-0002-0212-3958; Lloyd-Price, Jason/0000-0002-0112-190X	TUT President's Doctoral Programme; FiDiPro programme; Academy of Finland	TUT President's Doctoral Programme; FiDiPro programme; Academy of Finland(Academy of Finland)	Work supported by TUT President's Doctoral Programme (JLP), FiDiPro programme (AG, ASR), and Academy of Finland (ASR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SIGKDD EXPLORATIONS; Arkin A, 1998, GENETICS, V149, P1633; Berdahl A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/043024; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Chowdhury S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-143; DERRIDA B, 1986, J PHYS-PARIS, V47, P1297, DOI 10.1051/jphys:019860047080129700; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Grefenstette J, 2006, BIOSYSTEMS, V84, P81, DOI 10.1016/j.biosystems.2005.09.009; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Nykter M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058702; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Ramo P, 2006, J THEOR BIOL, V242, P164, DOI 10.1016/j.jtbi.2006.02.011; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Ribeiro AS, 2011, BIOSYSTEMS, V104, P136, DOI 10.1016/j.biosystems.2011.02.003; Ribeiro AS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.056108; Samuelsson B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.098701; Schmal C, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113054; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shmulevich I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048701; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102	26	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42018	10.1371/journal.pone.0042018	http://dx.doi.org/10.1371/journal.pone.0042018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860048	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900062
J	Metz, VV; Kojro, E; Rat, D; Postina, R				Metz, Verena V.; Kojro, Elzbieta; Rat, Dorothea; Postina, Rolf			Induction of RAGE Shedding by Activation of G Protein-Coupled Receptors	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; AMYLOID PRECURSOR PROTEIN; CEREBELLAR GRANULE NEURONS; ALZHEIMERS-DISEASE; POLYPEPTIDE PACAP; ALPHA-SECRETASE; SOLUBLE RECEPTOR; GROWTH; CLEAVAGE; PATHWAY	The multiligand Receptor for Advanced Glycation End products (RAGE) is involved in various pathophysiological processes, including diabetic inflammatory conditions and Alzheimer's disease. Full-length RAGE, a cell surface-located type I membrane protein, can proteolytically be converted by metalloproteinases ADAM10 and MMP9 into a soluble RAGE form. Moreover, administration of recombinant soluble RAGE suppresses activation of cell surface-located RAGE by trapping RAGE ligands. Therefore stimulation of RAGE shedding might have a therapeutic value regarding inflammatory diseases. We aimed to investigate whether RAGE shedding is inducible via ligand-induced activation of G protein-coupled receptors (GPCRs). We chose three different GPCRs coupled to distinct signaling cascades: the V2 vasopressin receptor (V2R) activating adenylyl cyclase, the oxytocin receptor (OTR) linked to phospholipase C beta, and the PACAP receptor (subtype PAC1) coupled to adenylyl cyclase, phospholipase C beta, calcium signaling and MAP kinases. We generated HEK cell lines stably coexpressing an individual GPCR and full-length RAGE and then investigated GPCR ligand-induced activation of RAGE shedding. We found metalloproteinase-mediated RAGE shedding on the cell surface to be inducible via ligand-specific activation of all analyzed GPCRs. By using specific inhibitors we have identified Ca2+ signaling, PKC alpha/PKC beta I, CaMKII, PI3 kinases and MAP kinases to be involved in PAC1 receptor-induced RAGE shedding. We detected an induction of calcium signaling in all our cell lines coexpressing RAGE and different GPCRs after agonist treatment. However, we did not disclose a contribution of adenylyl cyclase in RAGE shedding induction. Furthermore, by using a selective metalloproteinase inhibitor and siRNA-mediated knock-down approaches, we show that ADAM10 and/or MMP9 are playing important roles in constitutive and PACAP-induced RAGE shedding. We also found that treatment of mice with PACAP increases the amount of soluble RAGE in the mouse lung. Our findings suggest that pharmacological stimulation of RAGE shedding might open alternative treatment strategies for Alzheimers disease and diabetes-induced inflammation.	[Metz, Verena V.; Kojro, Elzbieta; Rat, Dorothea; Postina, Rolf] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany	Johannes Gutenberg University of Mainz	Metz, VV (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany.	postina@uni-mainz.de			Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany) [07807]; Dr. Georg Scheuing-Stiftung (Mainz, Germany)	Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany); Dr. Georg Scheuing-Stiftung (Mainz, Germany)	This work was supported by the Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany), grant 07807 (E.K.) and the Dr. Georg Scheuing-Stiftung (Mainz, Germany to R.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Bhave SV, 2004, J NEUROCHEM, V88, P359, DOI 10.1046/j.1471-4159.2003.02167.x; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BRETT J, 1993, AM J PATHOL, V143, P1699; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Cho HJ, 2009, FASEB J, V23, P2639, DOI 10.1096/fj.08-126383; Fahrenholz F, 2000, ANN NY ACAD SCI, V920, P215; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gimpl G, 2000, EUR J BIOCHEM, V267, P2483, DOI 10.1046/j.1432-1327.2000.01280.x; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Illum L, 2002, J PHARMACOL EXP THER, V301, P391, DOI 10.1124/jpet.301.1.391; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Kojro E, 2009, J ALZHEIMERS DIS, V16, P865, DOI 10.3233/JAD-2009-0998; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Moroo I, 1998, BRAIN RES, V795, P191, DOI 10.1016/S0006-8993(98)00291-1; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; O'Connor PM, 2007, AM J PHYSIOL-RENAL, V293, pF526, DOI 10.1152/ajprenal.00052.2007; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Rat D, 2011, FASEB J, V25, P3208, DOI 10.1096/fj.10-180133; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Smit AJ, 2004, CURR MED CHEM, V11, P2767, DOI 10.2174/0929867043364342; Solano DC, 2000, FASEB J, V14, P1015, DOI 10.1096/fasebj.14.7.1015; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; UFER E, 1995, FEBS LETT, V362, P19, DOI 10.1016/0014-5793(95)00150-8; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Wautier JL, 1996, J CLIN INVEST, V97, P238, DOI 10.1172/JCI118397; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wong AOL, 2005, ENDOCRINOLOGY, V146, P5407, DOI 10.1210/en.2005-0294; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200	46	40	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41823	10.1371/journal.pone.0041823	http://dx.doi.org/10.1371/journal.pone.0041823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860017	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900039
J	Ponsaerts, R; D'hondt, C; Hertens, F; Parys, JB; Leybaert, L; Vereecke, J; Himpens, B; Bultynck, G				Ponsaerts, Raf; D'hondt, Catheleyne; Hertens, Frederic; Parys, Jan B.; Leybaert, Luc; Vereecke, Johan; Himpens, Bernard; Bultynck, Geert			RhoA GTPase Switch Controls Cx43-Hemichannel Activity through the Contractile System	PLOS ONE			English	Article							INTERCELLULAR CALCIUM WAVE; THROMBIN-INDUCED INHIBITION; VASCULAR ENDOTHELIAL-CELLS; GAP-JUNCTION CHANNELS; ATP RELEASE; MYOSIN-II; MEMBRANE PERMEABILIZATION; CONNEXIN HEMICHANNELS; COMMUNICATION; MODULATION	ATP-dependent paracrine signaling, mediated via the release of ATP through plasma membrane-embedded hemichannels of the connexin family, coordinates a synchronized response between neighboring cells. Connexin 43 (Cx43) hemichannels that are present in the plasma membrane need to be tightly regulated to ensure cell viability. In monolayers of bovine corneal endothelial cells (BCEC),Cx43-mediated ATP release is strongly inhibited when the cells are treated with inflammatory mediators, in particular thrombin and histamine. In this study we investigated the involvement of RhoA activation in the inhibition of hemichannel-mediated ATP release in BCEC. We found that RhoA activation occurs rapidly and transiently upon thrombin treatment of BCEC. The RhoA activity correlated with the onset of actomyosin contractility that is involved in the inhibition of Cx43 hemichannels. RhoA activation and inhibition of Cx43-hemichannel activity were both prevented by pre-treatment of the cells with C3-toxin as well as knock down of RhoA by siRNA. These findings provide evidence that RhoA activation is a key player in thrombin-induced inhibition of Cx43-hemichannel activity. This study demonstrates that RhoA GTPase activity is involved in the acute inhibition of ATP-dependent paracrine signaling, mediated by Cx43 hemichannels, in response to the inflammatory mediator thrombin. Therefore, RhoA appears to be an important molecular switch that controls Cx43 hemichannel openings and hemichannel-mediated ATP-dependent paracrine intercellular communication under (patho) physiological conditions of stress.	[Ponsaerts, Raf; D'hondt, Catheleyne; Hertens, Frederic; Parys, Jan B.; Vereecke, Johan; Himpens, Bernard; Bultynck, Geert] Katholieke Univ Leuven, Fac Med, Campus Gasthuisberg ON 1, Lab Mol & Cellular Signaling,Dept Cellular & Mol, Louvain, Belgium; [Leybaert, Luc] Univ Ghent, Fac Med & Hlth Sci, Physiol Grp, Dept Basic Med Sci, B-9000 Ghent, Belgium	KU Leuven; Ghent University	Ponsaerts, R (corresponding author), Katholieke Univ Leuven, Fac Med, Campus Gasthuisberg ON 1, Lab Mol & Cellular Signaling,Dept Cellular & Mol, Louvain, Belgium.	raf.ponsaerts@med.kuleuven.be; geert.bultynck@med.kuleuven.be	Leybaert, Luc/F-4079-2015	Leybaert, Luc/0000-0001-6452-6982; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Research Foundation - Flanders [G.0545.08, G.0298.11]; Interuniversity Attraction Poles Program (Belgian Science Policy) [P6/28]	Research Foundation - Flanders(FWO); Interuniversity Attraction Poles Program (Belgian Science Policy)(Belgian Federal Science Policy Office)	The work was supported by grants from the Research Foundation - Flanders (G.0545.08 to B.H. and J.V.; G.0298.11 to G. B and L. L.) and the Interuniversity Attraction Poles Program (Belgian Science Policy; P6/28 to G.B., J.B.P. and B. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktories K, 2005, REV PHYSIOL BIOCH P, V152, P1, DOI 10.1007/s10254-004-0034-4; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Blum AE, 2008, AM J PHYSIOL-CELL PH, V295, pC231, DOI 10.1152/ajpcell.00175.2008; Blum AE, 2010, AM J PHYSIOL-CELL PH, V298, pC386, DOI 10.1152/ajpcell.00430.2009; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P1518, DOI 10.1167/iovs.06-1062; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Goedecke S, 2011, AM J PHYSL CELL PHYS; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P104, DOI 10.1167/iovs.04-0846; Gomes P, 2006, EXP EYE RES, V83, P1225, DOI 10.1016/j.exer.2006.06.012; Iyer S, 2007, COMPUT METH PROG BIO, V85, P203, DOI 10.1016/j.cmpb.2006.11.004; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2010, J PHYSIOL-LONDON, V588, P2255, DOI 10.1113/jphysiol.2009.186643; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Ponsaerts R, 2012, BIOL CELL; PONSAERTS R, 2010, SPRINGER SCI, P161, DOI DOI 10.1007/978-90-481-3435-9_10; Ponsaerts R, 2008, INVEST OPHTH VIS SCI, V49, P4816, DOI 10.1167/iovs.07-1533; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Retamal MA, 2007, J MEMBRANE BIOL, V218, P49, DOI 10.1007/s00232-007-9043-y; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Satpathy M, 2004, EXP EYE RES, V79, P477, DOI 10.1016/j.exer.2004.06.018; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; Stehberg J, 2012, FASEB J; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x	34	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42074	10.1371/journal.pone.0042074	http://dx.doi.org/10.1371/journal.pone.0042074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860057	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900064
J	Stals, I; Karkehabadi, S; Kim, S; Ward, M; Van Landschoot, A; Devreese, B; Sandgren, M				Stals, Ingeborg; Karkehabadi, Saeid; Kim, Steve; Ward, Michael; Van Landschoot, Anita; Devreese, Bart; Sandgren, Mats			High Resolution Crystal Structure of the Endo-N-Acetyl-beta-D- Glucosaminidase Responsible for the Deglycosylation of Hypocrea jecorina Cellulases	PLOS ONE			English	Article							FACTORS INFLUENCING GLYCOSYLATION; TRICHODERMA-REESEI CELLULASES; SUBSTRATE-ASSISTED CATALYSIS; FLAVOBACTERIUM-MENINGOSEPTICUM; CELLOBIOHYDROLASE-I; ANGSTROM RESOLUTION; HIGH-MANNOSE; ACETYLGLUCOSAMINIDASE; IDENTIFICATION; SEQUENCE	Endo-N-acetyl-beta-D-glucosaminidases (ENGases) hydrolyze the glycosidic linkage between the two N-acetylglucosamine units that make up the chitobiose core of N-glycans. The endo-N-acetyl-beta-D-glucosaminidases classified into glycoside hydrolase family 18 are small, bacterial proteins with different substrate specificities. Recently two eukaryotic family 18 deglycosylating enzymes have been identified. Here, the expression, purification and the 1.3 angstrom resolution structure of the ENGase ( Endo T) from the mesophilic fungus Hypocrea jecorina (anamorph Trichoderma reesei) are reported. Although the mature protein is C-terminally processed with removal of a 46 amino acid peptide, the protein has a complete (beta/alpha) 8 TIM-barrel topology. In the active site, the proton donor (E131) and the residue stabilizing the transition state (D129) in the substrate assisted catalysis mechanism are found in almost identical positions as in the bacterial GH18 ENGases: Endo H, Endo F1, Endo F3, and Endo BT. However, the loops defining the substrate-binding cleft vary greatly from the previously known ENGase structures, and the structures also differ in some of the alpha-helices forming the barrel. This could reflect the variation in substrate specificity between the five enzymes. This is the first three-dimensional structure of a eukaryotic endo-N-acetyl-beta-D-glucosaminidase from glycoside hydrolase family 18. A glycosylation analysis of the cellulases secreted by a Hypocrea jecorina Endo T knock-out strain shows the in vivo function of the protein. A homology search and phylogenetic analysis show that the two known enzymes and their homologues form a large but separate cluster in subgroup B of the fungal chitinases. Therefore the future use of a uniform nomenclature is proposed.	[Stals, Ingeborg; Van Landschoot, Anita] Univ Coll Ghent, Fac Appl Biosci Engn, Ghent, Belgium; [Stals, Ingeborg; Van Landschoot, Anita; Devreese, Bart] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Karkehabadi, Saeid; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden; [Kim, Steve; Ward, Michael] DuPont Ind Biosci, Palo Alto, CA USA	HOGENT University College of Applied Sciences & Arts; Ghent University; Swedish University of Agricultural Sciences	Stals, I (corresponding author), Univ Coll Ghent, Fac Appl Biosci Engn, Ghent, Belgium.	mats.sandgren@slu.se	Devreese, Bart/K-2841-2019; Devreese, Bart/B-2011-2009	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Sandgren, Mats/0000-0002-2358-4534	Research Fund of the University College Ghent	Research Fund of the University College Ghent	Research was partially funded by the Research Fund of the University College Ghent. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Brameld KA, 1998, J MOL BIOL, V280, P913, DOI 10.1006/jmbi.1998.1890; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Fujita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1542, DOI 10.1271/bbb.65.1542; Genomics JCFS, 2010, CRYSTAL STRUCTURE EN; Grosse-Kunstleve RW, 1999, ACTA CRYSTALLOGR D, V55, P1568, DOI 10.1107/S0907444999007763; Gruber S, 2012, MICROBIOL-SGM, V158, P26, DOI 10.1099/mic.0.052613-0; Hamaguchi T, 2010, GLYCOBIOLOGY, V20, P420, DOI 10.1093/glycob/cwp188; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HENNIG M, 1995, J MOL BIOL, V254, P237, DOI 10.1006/jmbi.1995.0614; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hui JPM, 2002, GLYCOBIOLOGY, V12, P837, DOI 10.1093/glycob/cwf089; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; Karlsson M, 2008, EVOL BIOINFORM, V4, P47; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Kimura Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1019, DOI 10.1271/bbb.110148; Klarskov K, 1997, CARBOHYD RES, V304, P143, DOI 10.1016/S0008-6215(97)00215-2; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Maeda M, 2010, J BIOCHEM, V148, P681, DOI 10.1093/jb/mvq102; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Samyn B, 2000, ANAL CHEM, V72, P1389, DOI 10.1021/ac991049u; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; SHEIRNEISS G, 1984, APPL MICROBIOL BIOT, V20, P46; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TARENTINO AL, 1994, GLYCOBIOLOGY, V4, P771, DOI 10.1093/glycob/4.6.771; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; VANROEY P, 1994, BIOCHEMISTRY-US, V33, P13989, DOI 10.1021/bi00251a005; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200	57	20	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40854	10.1371/journal.pone.0040854	http://dx.doi.org/10.1371/journal.pone.0040854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859955	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900013
J	Teh, CA; Lee, TS; Kuchibhatla, M; Ashley-Koch, A; MacFall, J; Krishnan, R; Beyer, J				Teh, Cheryl Ann; Lee, Tih-Shih; Kuchibhatla, Margaratha; Ashley-Koch, Allison; MacFall, James; Krishnan, Ranga; Beyer, John			Bipolar Disorder, Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism and Brain Morphology	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; ACTIVITY-DEPENDENT SECRETION; FAMILY-BASED ASSOCIATION; AMYGDALA VOLUME; PREFRONTAL GRAY; META-REGRESSION; FACTOR GENE; INDIVIDUALS; SCHIZOPHRENIA; ABNORMALITIES	In this study of the effect of bipolar status and presence of BDNF Val66Met polymorphism on differences in regional brain volumes, we hypothesized based on previous studies that 1) bipolar subjects will have smaller regional brain volumes than healthy controls; 2) BDNF Met66 allele carriers within the same population are likely to have smaller regional brain volumes as compared to Val66 homozygyotes. In our Caucasian sample of 166 bipolar subjects and 64 gender-matched healthy controls, we found significant decreases in total (p = 0.005) and regional gray matter volumes in bipolar patients compared to healthy controls, more pronounced in the inferior and posterior parts of the brain, together with a concomitant increase in total CSF (p = 0.012) particularly in the lateral ventricles (p = 0.023). However, there was no difference in white matter volumes noted by other studies. Furthermore we did not find significant differences in other brain regions that have been reported by other authors. Nor did we find a significant effect of BDNF on these measurements.	[Teh, Cheryl Ann; Krishnan, Ranga] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore; [Lee, Tih-Shih; Krishnan, Ranga; Beyer, John] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Kuchibhatla, Margaratha] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Ashley-Koch, Allison] Duke Univ, Med Ctr, Dept Med Genet, Durham, NC USA; [MacFall, James] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA	National University of Singapore; Duke University; Duke University; Duke University; Duke University	Teh, CA (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore.	tish.lee@duke.edu		Ashley-Koch, Allison/0000-0001-5409-9155	National Institute of Mental Health (NIMH) [MH57027, MH68848]; NARSAD Junior Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057027, U01MH068848] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD Junior Investigator Award(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Institute of Mental Health (NIMH) grants #MH57027 and #MH68848, and a NARSAD Junior Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Bearden CE, 2007, BIOL PSYCHIAT, V62, P7, DOI 10.1016/j.biopsych.2006.10.027; Benjamin S, 2010, AM J GERIAT PSYCHIAT, V18, P323, DOI 10.1097/JGP.0b013e3181cabd2b; Beyer JL, 2009, INT J GERIATR PSYCH, V24, P1445, DOI 10.1002/gps.2285; Buckley Peter F, 2005, Neuropsychiatr Dis Treat, V1, P193; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chepenik LG, 2009, NEUROPSYCHOPHARMACOL, V34, P944, DOI 10.1038/npp.2008.107; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Heng S, 2010, J NEURAL TRANSM, V117, P639, DOI 10.1007/s00702-010-0368-9; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Lang UE, 2005, PSYCHOPHARMACOLOGY, V180, P95, DOI 10.1007/s00213-004-2137-7; Lin PY, 2009, NEUROSCI LETT, V466, P139, DOI 10.1016/j.neulet.2009.09.044; Liu LX, 2008, PSYCHIAT GENET, V18, P267, DOI 10.1097/YPG.0b013e3283060f59; Lopez-Larson MP, 2002, BIOL PSYCHIAT, V52, P93, DOI 10.1016/S0006-3223(02)01350-1; Matsuo K, 2009, NEUROPSYCHOPHARMACOL, V34, P1904, DOI 10.1038/npp.2009.23; Monkul ES, 2007, NEUROSCI LETT, V429, P7, DOI 10.1016/j.neulet.2007.09.074; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RIMMLER J, 1998, AM J HUM GENET S, V63, pA240; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Strakowski SM, 2000, BIPOLAR DISORD, V2, P148, DOI 10.1034/j.1399-5618.2000.020302.x; Szeszko PR, 2005, MOL PSYCHIATR, V10, P631, DOI 10.1038/sj.mp.4001656; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Taylor WD, 2011, PHARMACOGENOMICS J, V11, P146, DOI 10.1038/tpj.2010.12; Taylor WD, 2008, AM J MED GENET B, V147B, P1205, DOI 10.1002/ajmg.b.30754; Taylor WD, 2008, AM J GERIAT PSYCHIAT, V16, P263, DOI 10.1097/JGP.0b013e3181591c30; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Toro R, 2009, BRAIN STRUCT FUNCT, V213, P501, DOI 10.1007/s00429-009-0203-y; Tramontina J, 2007, MOL PSYCHIATR, V12, P230, DOI 10.1038/sj.mp.4001941; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109	45	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e38469	10.1371/journal.pone.0038469	http://dx.doi.org/10.1371/journal.pone.0038469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859933	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950900001
J	Lai, K; She, HC; Chen, SC; Chou, WC; Huang, LY; Jung, TP; Gramann, K				Lai, Kevin; She, Hsiao-Ching; Chen, Sheng-Chang; Chou, Wen-Chi; Huang, Li-Yu; Jung, Tzyy-Ping; Gramann, Klaus			Encoding of Physics Concepts: Concreteness and Presentation Modality Reflected by Human Brain Dynamics	PLOS ONE			English	Article							PREFRONTAL CORTEX; THETA-OSCILLATIONS; EEG DYNAMICS; ALPHA-RHYTHM; MEMORY; LANGUAGE; SYNCHRONIZATION; RETRIEVAL; RESPONSES	Previous research into working memory has focused on activations in different brain areas accompanying either different presentation modalities (verbal vs. non-verbal) or concreteness (abstract vs. concrete) of non-science concepts. Less research has been conducted investigating how scientific concepts are learned and further processed in working memory. To bridge this gap, the present study investigated human brain dynamics associated with encoding of physics concepts, taking both presentation modality and concreteness into account. Results of this study revealed greater theta and low-beta synchronization in the anterior cingulate cortex (ACC) during encoding of concrete pictures as compared to the encoding of both high and low imageable words. In visual brain areas, greater theta activity accompanying stimulus onsets was observed for words as compared to pictures while stronger alpha suppression was observed in responses to pictures as compared to words. In general, the EEG oscillation patterns for encoding words of different levels of abstractness were comparable but differed significantly from encoding of pictures. These results provide insights into the effects of modality of presentation on human encoding of scientific concepts and thus might help in developing new ways to better teach scientific concepts in class.	[Lai, Kevin; She, Hsiao-Ching; Chen, Sheng-Chang; Chou, Wen-Chi; Huang, Li-Yu] Natl Chiao Tung Univ, Inst Educ, Hsinchu, Taiwan; [Jung, Tzyy-Ping] Univ Calif San Diego, Inst Neural Computat, San Diego, CA 92103 USA; [Gramann, Klaus] Tech Univ Berlin, Inst Psychol & Ergon, Berlin, Germany	National Yang Ming Chiao Tung University; University of California System; University of California San Diego; Technical University of Berlin	Lai, K (corresponding author), Natl Chiao Tung Univ, Inst Educ, Hsinchu, Taiwan.	hcshe@mail.nctu.edu.tw	Gramann, Klaus/AAD-7313-2019	CHEN, SHENG-CHANG/0000-0002-9894-5867; Gramann, Klaus/0000-0003-2673-1832	National Science Council, Taiwan (NSC) [98-2511-S009-002-MY3]; Taiwan National Science Council [NSC-100-2911-I-009-101]; UST-UCSD International Center of Excellence in Advanced Bio-engineering	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering	This work was supported mainly by the National Science Council, Taiwan, under Grant Number NSC 98-2511-S009-002-MY3. This was also partially funded by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: NSC-100-2911-I-009-101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAEV YG, 1993, INT J PSYCHOPHYSIOL, V14, P167, DOI 10.1016/0167-8760(93)90031-J; Antonenko P, 2010, EDUC PSYCHOL REV, V22, P425, DOI 10.1007/s10648-010-9130-y; BADDELEY A, 1992, SCIENCE, V255, P556, DOI 10.1126/science.1736359; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cairo TA, 2004, COGNITIVE BRAIN RES, V21, P377, DOI 10.1016/j.cogbrainres.2004.06.014; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desmond JE, 1995, BRAIN, V118, P1411, DOI 10.1093/brain/118.6.1411; Duit R., 2007, HDB RES SCI ED, P599; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Goswami U, 2006, NAT REV NEUROSCI, V7, P406, DOI 10.1038/nrn1907; Hwang G, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-20; Inanaga K, 1998, PSYCHIAT CLIN NEUROS, V52, P555, DOI 10.1046/j.1440-1819.1998.00452.x; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Paivio A, 1971, IMAGERY VERBAL PROCE; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Vanni S, 1997, J NEUROSCI, V17, P7141; VANWINSUM W, 1984, ELECTROEN CLIN NEURO, V58, P519, DOI 10.1016/0013-4694(84)90042-7; Zhu ZD, 2012, NEUROIMAGE, V60, P2230, DOI 10.1016/j.neuroimage.2012.02.036	36	10	10	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41784	10.1371/journal.pone.0041784	http://dx.doi.org/10.1371/journal.pone.0041784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848602	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200106
J	Langhans, B; Nischalke, HD; Arndt, S; Braunschweiger, I; Nattermann, J; Sauerbruch, T; Spengler, U				Langhans, Bettina; Nischalke, Hans Dieter; Arndt, Simone; Braunschweiger, Ingrid; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich			Ribavirin Exerts Differential Effects on Functions of Cd4(+) Th1, Th2, and Regulatory T Cell Clones in Hepatitis C	PLOS ONE			English	Article							PEGYLATED INTERFERON; VIRUS-INFECTION; COMBINATION; THERAPY; RESPONSES; REACTIVITY; BALANCE; LIVER	Ribavirin improves outcomes of therapy in chronic hepatitis C but its mode of action has still remained unclear. Since ribavirin has been proposed to modulate the host's T cell responses, we studied its direct effects on CD4(+) T cell clones with diverse functional polarization which had been generated from patients with chronic hepatitis C. We analysed in vitro proliferation ([H-3] thymidine uptake) and cytokine responses (IL-10, IFN-gamma) at varying concentrations of ribavirin (0-10 mu g/ml) in 8, 9 and 7 CD4(+) TH1, TH2 and regulatory T cell (Treg) clones, respectively. In co-culture experiments, we further determined effects of ribarivin on inhibition of TH1 and TH2 effector cells by Treg clones. All clones had been generated from peripheral blood of patients with chronic hepatitis C in the presence of HCV core protein. Ribavirin enhanced proliferation of T effector cells and increased production of IFN-gamma in TH1 clones, but had only little effect on IL-10 secretion in TH2 clones. However, ribavirin markedly inhibited IL-10 release in Treg clones in a dose dependent fashion. These Treg clones suppressed proliferation of T effector clones by their IL-10 secretion, and in co-culture assays ribavirin reversed Treg-mediated suppression of T effector cells. Our in vitro data suggest that - in addition to its immunostimulatory effects on TH1 cells - ribavirin can inhibit functions of HCV-specific Tregs and thus reverses Treg-mediated suppression of T effector cells in chronic hepatitis C.	[Langhans, Bettina; Nischalke, Hans Dieter; Arndt, Simone; Braunschweiger, Ingrid; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany	University of Bonn	Langhans, B (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	bettina.langhans@ukb.uni-bonn.de		Nischalke, Hans Dieter/0000-0002-3457-0023	Deutsche Forschungsgemeinschaft [SP 483/4-1, SP483/4-2, SFB/TRR57]; Wilhelm Sander Stiftung [2009.045.1]; H.W. and J. Hector Foundation [M42]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Stiftung; H.W. and J. Hector Foundation	Work has been supported by a grant from the Deutsche Forschungsgemeinschaft (SP 483/4-1, SP483/4-2 and SFB/TRR57), the Wilhelm Sander Stiftung (2009.045.1) and the H.W. and J. Hector Foundation (M42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2009, EXPERT REV ANTI-INFE, V7, P925, DOI [10.1586/eri.09.70, 10.1586/ERI.09.70]; Akiyama M, 2010, INTERVIROLOGY, V53, P154, DOI 10.1159/000274976; Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Atsukawa M, 2012, J GASTROEN HEPATOL, V27, P823, DOI 10.1111/j.1440-1746.2011.06882.x; Barnes E, 2002, HEPATOLOGY, V36, P743, DOI 10.1053/jhep.2002.35344; Brenndorfer ED, 2012, HCV NS3 4A MEDIATED; Burton JR, 2008, J HEPATOL, V49, P329, DOI 10.1016/j.jhep.2008.05.020; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Claassen MAA, 2011, J VIROL, V85, P5323, DOI 10.1128/JVI.02551-10; Clark V, 2012, LIVER INT, V32, P103, DOI 10.1111/j.1478-3231.2011.02711.x; Cramp ME, 2000, GASTROENTEROLOGY, V118, P346, DOI 10.1016/S0016-5085(00)70217-4; Dolganiuc A, 2008, J LEUKOCYTE BIOL, V84, P614, DOI 10.1189/jlb.1107770; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Fang SH, 2000, J HEPATOL, V33, P791, DOI 10.1016/S0168-8278(00)80312-8; Fang SH, 2001, J BIOMED SCI, V8, P484, DOI 10.1159/000046170; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Golding A, 2010, IMMUNOLOGY, V131, P107, DOI 10.1111/j.1365-2567.2010.03280.x; Hultgren C, 1998, J GEN VIROL, V79, P2381, DOI 10.1099/0022-1317-79-10-2381; Khakoo S, 1998, BRIT J CLIN PHARMACO, V46, P563, DOI 10.1046/j.1365-2125.1998.00836.x; Langhans B, 2010, CLIN SCI, V119, P97, DOI 10.1042/CS20090661; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Nicot F, 2008, J MED VIROL, V80, P1523, DOI 10.1002/jmv.21227; Rahman F, 2004, HEPATOLOGY, V40, P87, DOI 10.1002/hep.20253; Reiser M, 1997, J HEPATOL, V26, P471, DOI 10.1016/S0168-8278(97)80409-6; Rigopoulou EI, 2007, ANTIVIR RES, V75, P36, DOI 10.1016/j.antiviral.2006.11.008; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Slavenburg S, 2011, THER DRUG MONIT, V33, P40, DOI 10.1097/FTD.0b013e318205f892; Spengler U, 2007, CLIN SCI, V112, P141, DOI 10.1042/CS20060171; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Weglarz L, 2006, ACTA BIOCHIM POL, V53, P349; Westin J, 2011, J VIRAL HEPATITIS, V18, P149, DOI 10.1111/j.1365-2893.2010.01277.x	35	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42094	10.1371/journal.pone.0042094	http://dx.doi.org/10.1371/journal.pone.0042094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848715	Green Submitted, Green Published			2022-12-27	WOS:000306950200163
J	Mercier, BC; Ventre, E; Fogeron, ML; Debaud, AL; Tomkowiak, M; Marvel, J; Bonnefoy, N				Mercier, Blandine C.; Ventre, Erwan; Fogeron, Marie-Laure; Debaud, Anne-Laure; Tomkowiak, Martine; Marvel, Jacqueline; Bonnefoy, Nathalie			NOD1 Cooperates with TLR2 to Enhance T Cell Receptor-Mediated Activation in CD8 T Cells	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; INNATE IMMUNE RECEPTORS; NF-KAPPA-B; BACTERIAL PEPTIDOGLYCAN; PATHOGEN RECOGNITION; TOXOPLASMA-GONDII; EFFECTOR FUNCTION; EPITHELIAL-CELLS; CO-STIMULATION; IN-VIVO	Pattern recognition receptors (PRR), like Toll-like receptors (TLR) and NOD-like receptors (NLR), are involved in the detection of microbial infections and tissue damage by cells of the innate immune system. Recently, we and others have demonstrated that TLR2 can additionally function as a costimulatory receptor on CD8 T cells. Here, we establish that the intracytosolic receptor NOD1 is expressed and functional in CD8 T cells. We show that C12-iEDAP, a synthetic ligand for NOD1, has a direct impact on both murine and human CD8 T cells, increasing proliferation and effector functions of cells activated via their T cell receptor (TCR). This effect is dependent on the adaptor molecule RIP2 and is associated with an increased activation of the NF-kappa B, JNK and p38 signaling pathways. Furthermore, we demonstrate that NOD1 stimulation can cooperate with TLR2 engagement on CD8 T cells to enhance TCR-mediated activation. Altogether our results indicate that NOD1 might function as an alternative costimulatory receptor in CD8 T cells. Our study provides new insights into the function of NLR in T cells and extends to NOD1 the recent concept that PRR stimulation can directly control T cell functions.	[Mercier, Blandine C.; Ventre, Erwan; Fogeron, Marie-Laure; Debaud, Anne-Laure; Tomkowiak, Martine; Marvel, Jacqueline; Bonnefoy, Nathalie] Univ Lyon, Lyon, France; [Mercier, Blandine C.; Ventre, Erwan; Fogeron, Marie-Laure; Debaud, Anne-Laure; Tomkowiak, Martine; Marvel, Jacqueline; Bonnefoy, Nathalie] INSERM, U851, F-69008 Lyon, France; [Mercier, Blandine C.; Ventre, Erwan; Fogeron, Marie-Laure; Debaud, Anne-Laure; Tomkowiak, Martine; Marvel, Jacqueline; Bonnefoy, Nathalie] Univ Lyon 1, F-69365 Lyon, France; [Bonnefoy, Nathalie] Hosp Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Mercier, BC (corresponding author), Univ Lyon, Lyon, France.	blandinemercier7@gmail.com; nathalie.bonnefoy@inserm.fr	Bonnefoy, Nathalie/J-2536-2012; marvel, jacqueline/H-8638-2014	Bonnefoy, Nathalie/0000-0003-4814-6722; marvel, jacqueline/0000-0001-6241-459X; Mathieu, Anne-Laure/0000-0002-2893-7001	Institut National de la Sante et de la Recherche Medicale; University Claude Bernard Lyon 1; French Ministry of Education and Research	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Claude Bernard Lyon 1; French Ministry of Education and Research	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale and University Claude Bernard Lyon 1. BCM was supported by a fellowship from the French Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Asano J, 2010, J IMMUNOL, V184, P736, DOI 10.4049/jimmunol.0900726; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asprodites N, 2008, FASEB J, V22, P3628, DOI 10.1096/fj.08-108274; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Betts RJ, 2009, PHARMACOL THERAPEUT, V121, P123, DOI 10.1016/j.pharmthera.2008.09.001; Biswas A, 2009, MOL IMMUNOL, V46, P3076, DOI 10.1016/j.molimm.2009.06.006; Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Cottalorda A, 2009, EUR J IMMUNOL, V39, P2673, DOI 10.1002/eji.200939627; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Crozat K, 2009, IMMUNOL REV, V227, P129, DOI 10.1111/j.1600-065X.2008.00736.x; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fairhead T, 2008, AM J TRANSPLANT, V8, P1143, DOI 10.1111/j.1600-6143.2008.02236.x; Forward NA, 2010, J LEUKOCYTE BIOL, V87, P117, DOI 10.1189/jlb.0908559; Frasnelli ME, 2005, ARTHRITIS RES THER, V7, pR370, DOI 10.1186/ar1494; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; Geng DG, 2010, BLOOD, V116, P3494, DOI 10.1182/blood-2010-02-268169; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Hennino A, 2007, J IMMUNOL, V178, P5571, DOI 10.4049/jimmunol.178.9.5571; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Jenkins D, 2000, J PATHOL, V190, P184, DOI 10.1002/(SICI)1096-9896(200002)190:2<184::AID-PATH531>3.0.CO;2-E; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; LaRosa DF, 2007, IMMUNOL LETT, V108, P183, DOI 10.1016/j.imlet.2006.12.007; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lee Sun-Mi, 2009, Immune Netw, V9, P127, DOI 10.4110/in.2009.9.4.127; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marischen L, 2011, SCAND J IMMUNOL, V74, P126, DOI 10.1111/j.1365-3083.2011.02560.x; Marques R, 2011, CELL MOL LIFE SCI, V68, P3661, DOI 10.1007/s00018-011-0829-9; Marsland BJ, 2007, CURR OPIN IMMUNOL, V19, P611, DOI 10.1016/j.coi.2007.07.022; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; McCarron M, 2009, J IMMUNOL, V182, P55, DOI 10.4049/jimmunol.182.1.55; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Mercier BC, 2009, J IMMUNOL, V182, P1860, DOI 10.4049/jimmunol.0801167; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Nembrini C, 2008, MICROBES INFECT, V10, P522, DOI 10.1016/j.micinf.2008.01.016; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; Quigley M, 2009, BLOOD, V113, P2256, DOI 10.1182/blood-2008-03-148809; Rahman AH, 2009, IMMUNOL RES, V45, P25, DOI 10.1007/s12026-009-8113-x; Rahman MK, 2010, J IMMUNOL, V184, P7247, DOI 10.4049/jimmunol.0901479; Ruefli-Brasse AA, 2004, J BIOL CHEM, V279, P1570, DOI 10.1074/jbc.C300460200; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sobek V, 2004, ARTHRITIS RES THER, V6, pR433, DOI 10.1186/ar1212; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Urry Z, 2009, J CLIN INVEST, V119, P387, DOI 10.1172/JCI32354; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423	78	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42170	10.1371/journal.pone.0042170	http://dx.doi.org/10.1371/journal.pone.0042170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848741	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200179
J	Stieler, K; Schumacher, U; Horst, AK; Fischer, N				Stieler, Kristin; Schumacher, Udo; Horst, Andrea Kristina; Fischer, Nicole			XMRV Induces Cell Migration, Cytokine Expression and Tumor Angiogenesis: Are 22Rv1 Cells a Suitable Prostate Cancer Model?	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; CHRONIC-FATIGUE-SYNDROME; HUMAN RETROVIRUS XMRV; REACTIVE STROMA; GAMMARETROVIRUS XMRV; XENOGRAFT MODEL; LINE; RECEPTOR; VECTORS; XPR1	22Rv1 is a common prostate cancer cell line used in xenograft mouse experiments as well as in vitro cell culture assays to study aspects of prostate cancer tumorigenesis. Recently, this cell line was shown to harbor multiple copies of a gammaretrovirus, called XMRV, integrated in its genome. While the original prostate cancer xenograft CWR22 is free of any retrovirus, subsequently generated cell lines 22Rv1 and CWR-R1, carry this virus and additionally shed infectious gammaretroviral particles in their supernatant. Although XMRV most likely was generated by recombination events in cell culture this virus has been demonstrated to infect human cells in vitro and 22Rv1 as well as CWR-R1 cells are now considered biosafety 2 reagents. Here, we demonstrate that 22Rv1 cells with reduced retroviral transcription show reduced tumor angiogenesis and increased necrosis of the primary tumor derived from xenografted cells in scid mice when compared to the parental cell line. The presence of XMRV transcripts significantly increases secretion of osteopontin (OPN), CXCL14, IL13 and TIMP2 in 22Rv1 cells. Furthermore, these data are supported by in vitro cell invasion and differentiation assays. Collectively, our data suggest that the presence of XMRV transcripts at least partially contributes to 22Rv1 characteristics observed in vitro and in vivo with regard to migration, invasion and tumor angiogenesis. We propose that data received with 22Rv1 cells or equivalent cells carrying xenotropic gammaretroviruses should be carefully controlled including other prostate cancer cell lines tested for viral sequences.	[Stieler, Kristin; Fischer, Nicole] Univ Med Ctr Eppendorf, Inst Microbiol & Virol, Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Eppendorf, Dept Anat & Expt Morphol, Hamburg, Germany; [Horst, Andrea Kristina] Univ Med Ctr Eppendorf, Inst Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stieler, K (corresponding author), Univ Med Ctr Eppendorf, Inst Microbiol & Virol, Hamburg, Germany.	nfischer@uke.de						Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; BOSSELMAN RA, 1989, J VIROL, V63, P2680, DOI 10.1128/JVI.63.6.2680-2689.1989; Cmarik JL, 2011, VIRUSES-BASEL, V3, P2442, DOI 10.3390/v3122442; Dong BH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003144; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Farley Suzanne J, 2011, Nat Rev Urol, V8, P409, DOI 10.1038/nrurol.2011.101; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Gerdes MJ, 2004, PROSTATE, V58, P299, DOI 10.1002/pros.10327; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2011, VIRUSES-BASEL, V3, P1312, DOI 10.3390/v3081312; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kenyon JC, 2011, BRIT MED BULL, V98, P61, DOI 10.1093/bmb/ldr010; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; LUSSO P, 1990, SCIENCE, V247, P848, DOI 10.1126/science.2305256; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Metzger MJ, 2010, J VIROL, V84, P7908, DOI 10.1128/JVI.00389-10; Mo F, 2011, J CLIN MICROBIOL; Pandhare-Dash J, 2011, PROSTATE; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2012, NAT REV UROL, V9, P111, DOI 10.1038/nrurol.2011.225; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; TRAVERSARI C, 1989, J IMMUNOL, V142, P2887; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2012, LANCET, V379, pE27, DOI 10.1016/S0140-6736(11)60899-4; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Yan Y, 2007, J VIROL, V81, P10550, DOI 10.1128/JVI.00933-07; Yang JW, 2011, ONCOTARGET, V2, P358; Yu JD, 2009, MOL MED REP, V2, P831, DOI 10.3892/mmr_00000180	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42321	10.1371/journal.pone.0042321	http://dx.doi.org/10.1371/journal.pone.0042321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848758	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200195
J	Craven, M; Egan, CE; Dowd, SE; McDonough, SP; Dogan, B; Denkers, EY; Bowman, D; Scherl, EJ; Simpson, KW				Craven, Melanie; Egan, Charlotte E.; Dowd, Scot E.; McDonough, Sean P.; Dogan, Belgin; Denkers, Eric Y.; Bowman, Dwight; Scherl, Ellen J.; Simpson, Kenneth W.			Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn's Disease	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; CD4(+) T-LYMPHOCYTES; BOWEL-DISEASE; E. COLI; TOXOPLASMA-GONDII; ORAL INFECTION; ADHERENT; NOD2; MUCOSA; MICROBIOTA	Background and Aims: Understanding the interplay between genetic susceptibility, the microbiome, the environment and the immune system in Crohn's Disease (CD) is essential for developing optimal therapeutic strategies. We sought to examine the dynamics of the relationship between inflammation, the ileal microbiome, and host genetics in murine models of ileitis. Methods: We induced ileal inflammation of graded severity in C57BL6 mice by gavage with Toxoplasma gondii, Giardia muris, low dose indomethacin (LDI;0.1 mg/mouse), or high dose indomethacin (HDI;1 mg/mouse). The composition and spatial distribution of the mucosal microbiome was evaluated by 16S rDNA pyrosequencing and fluorescence in situ hybridization. Mucosal E. coli were enumerated by quantitative PCR, and characterized by phylogroup, genotype and pathotype. Results: Moderate to severe ileitis induced by T. gondii (day 8) and HDI caused a consistent shift from > 95% Gram + Firmicutes to > 95% Gram - Proteobacteria. This was accompanied by reduced microbial diversity and mucosal invasion by adherent and invasive E. coli, mirroring the dysbiosis of ileal CD. In contrast, dysbiosis and bacterial invasion did not develop in mice with mild ileitis induced by Giardia muris. Superimposition of genetic susceptibility and T. Gondii infection revealed greatest dysbiosis and bacterial invasion in the CD-susceptible genotype, NOD2(-/-), and reduced dysbiosis in ileitis-resistant CCR2(-)/- mice. Abrogating inflammation with the CD therapeutic anti-TNF-alpha-mAb tempered dysbiosis and bacterial invasion. Conclusions: Acute ileitis induces dysbiosis and proliferation of mucosally invasive E. coli, irrespective of trigger and genotype. The identification of CCR2 as a target for therapeutic intervention, and discovery that host genotype and therapeutic blockade of inflammation impact the threshold and extent of ileal dysbiosis are of high relevance to developing effective therapies for CD.	[Craven, Melanie; Dogan, Belgin; Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Egan, Charlotte E.; Denkers, Eric Y.; Bowman, Dwight] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Dowd, Scot E.] MR DNA Mol Res, Shallowater, TX USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Pathol, Ithaca, NY 14853 USA; [Scherl, Ellen J.] Cornell Univ, Weill Cornell Med Coll, Jill Roberts Inflammatory Bowel Dis Ctr, Div Gastroenterol & Hepatol, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; Cornell University	Craven, M (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	kws5@cornell.edu	denkers, eric/Q-3173-2019; Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427	NY Presbyterian/Weill Cornell Medical College; NIH [AI083526]; Jill Roberts Center for Inflammatory Bowel Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083526] Funding Source: NIH RePORTER	NY Presbyterian/Weill Cornell Medical College; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jill Roberts Center for Inflammatory Bowel Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NY Presbyterian/Weill Cornell Medical College, the Jill Roberts Center for Inflammatory Bowel Disease and NIH (Eric Denkers: AI083526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Bach S, 2000, FEMS MICROBIOL LETT, V183, P289, DOI 10.1016/S0378-1097(00)00005-7; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bernstein CN, 2010, AM J GASTROENTEROL, V105, P1994, DOI 10.1038/ajg.2010.140; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; Bringer MA, 2012, LAB INVEST, V92, P411, DOI 10.1038/labinvest.2011.156; Connor SJ, 2004, GUT, V53, P1287, DOI 10.1136/gut.2003.028225; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; DebRoy Chitrita, 2001, Animal Health Research Reviews, V2, P129; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Felder JB, 2000, AM J GASTROENTEROL, V95, P1949; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; GILLON J, 1982, GUT, V23, P498, DOI 10.1136/gut.23.6.498; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Jones J, 2008, CURR OPIN GASTROEN, V24, P475, DOI 10.1097/MOG.0b013e3283043596; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mann EA, 2011, CURR OPIN GASTROENTE; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; Massey DCO, 2007, AUTOPHAGY, V3, P649, DOI 10.4161/auto.5075; Meconi S, 2007, CELL MICROBIOL, V9, P1252, DOI 10.1111/j.1462-5822.2006.00868.x; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Okazaki T, 2008, INFLAMM BOWEL DIS, V14, P1528, DOI 10.1002/ibd.20512; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Perez LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010915; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Ramasundara M, 2009, J GASTROEN HEPATOL, V24, P202, DOI 10.1111/j.1440-1746.2008.05772.x; Rolhion N, 2010, GUT, V59, P1355, DOI 10.1136/gut.2010.207456; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Singh S, 2009, AM J GASTROENTEROL, V104, P1298, DOI 10.1038/ajg.2009.15; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	61	140	142	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41594	10.1371/journal.pone.0041594	http://dx.doi.org/10.1371/journal.pone.0041594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848538	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600090
J	Hawkes, CA; Sullivan, PM; Hands, S; Weller, RO; Nicoll, JAR; Carare, RO				Hawkes, Cheryl A.; Sullivan, Patrick M.; Hands, Sarah; Weller, Roy O.; Nicoll, James A. R.; Carare, Roxana O.			Disruption of Arterial Perivascular Drainage of Amyloid-beta from the Brains of Mice Expressing the Human APOE epsilon 4 Allele	PLOS ONE			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; BASEMENT-MEMBRANE COMPONENTS; ALZHEIMERS-DISEASE BRAIN; APOLIPOPROTEIN-E; A-BETA; FIBRIL FORMATION; PRECURSOR PROTEIN; DEGRADING ENZYME; TRANSGENIC MICE; WILD-TYPE	Failure of elimination of amyloid-beta (A beta) from the brain and vasculature appears to be a key factor in the etiology of sporadic Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). In addition to age, possession of an apolipoprotein E (APOE) epsilon 4 allele is a strong risk factor for the development of sporadic AD. The present study tested the hypothesis that possession of the APOE epsilon 4 allele is associated with disruption of perivascular drainage of A beta from the brain and with changes in cerebrovascular basement membrane protein levels. Targeted replacement (TR) mice expressing the human APOE3 (TRE3) or APOE4 (TRE4) genes and wildtype mice received intracerebral injections of human A beta(40). A beta(40) aggregated in peri-arterial drainage pathways in TRE4 mice, but not in TRE3 or wildtype mice. The number of A beta deposits was significantly higher in the hippocampi of TRE4 mice than in the TRE3 mice, at both 3- and 16-months of age, suggesting that clearance of A beta was disrupted in the brains of TRE4 mice. Immunocytochemical and Western blot analysis of vascular basement membrane proteins demonstrated significantly raised levels of collagen IV in 3-month-old TRE4 mice compared with TRE3 and wild type mice. In 16-month-old mice, collagen IV and laminin levels were unchanged between wild type and TRE3 mice, but were lower in TRE4 mice. The results of this study suggest that APOE4 may increase the risk for AD through disruption and impedance of perivascular drainage of soluble A beta from the brain. This effect may be mediated, in part, by changes in age-related expression of basement membrane proteins in the cerebral vasculature.	[Hawkes, Cheryl A.; Weller, Roy O.; Nicoll, James A. R.; Carare, Roxana O.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Sullivan, Patrick M.] Duke Univ, Dept Med, Durham VA Med Ctr, Durham, NC USA; [Sullivan, Patrick M.] GRECC, Durham, NC USA; [Hands, Sarah] Univ Southampton, Fac Nat & Environm Sci, Southampton, Hants, England	University of Southampton; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Geriatric Research Education & Clinical Center; University of Southampton	Hawkes, CA (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	rcn@soton.ac.uk	Carare, Roxana/G-9726-2011; Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246	Alzheimer's Research UK; Alzheimers Research UK [ART-RF2009-2, ARUK-SRF2012-2] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was funded by Alzheimer's Research UK (C.H, J.N, R.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Bronfman FC, 1998, AMYLOID, V5, P16, DOI 10.3109/13506129809007285; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Chung YA, 2009, J NUCL MED, V50, P1969, DOI 10.2967/jnumed.109.062315; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; COUCHMAN JR, 1993, KIDNEY INT, V43, P79, DOI 10.1038/ki.1993.14; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Du J, 2009, NEUROSCI LETT, V464, P140, DOI 10.1016/j.neulet.2009.07.032; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Haglund M, 2006, ACTA NEUROPATHOL, V111, P430, DOI 10.1007/s00401-006-0054-z; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; HUANG DY, 1995, EXP NEUROL, V136, P251, DOI 10.1006/exnr.1995.1101; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kiuchi Y, 2002, LIFE SCI, V70, P2421, DOI 10.1016/S0024-3205(02)01501-1; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Kuhnke D, 2007, BRAIN PATHOL, V17, P347, DOI 10.1111/j.1750-3639.2007.00075.x; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Masliah E, 1996, PROG NEUROBIOL, V50, P493, DOI 10.1016/S0301-0082(96)00038-X; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Monji A, 1998, BRAIN RES, V796, P171, DOI 10.1016/S0006-8993(98)00342-4; Natte R, 2001, ANN NEUROL, V50, P765, DOI 10.1002/ana.10040; PERLMUTTER LS, 1994, MOL NEUROBIOL, V9, P33, DOI 10.1007/BF02816103; Pfeifer LA, 2002, NEUROLOGY, V58, P1629, DOI 10.1212/WNL.58.11.1629; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Premkumar DRD, 1996, AM J PATHOL, V148, P2083; Rolyan H, 2011, J NEURAL TRANSM, V118, P699, DOI 10.1007/s00702-010-0572-7; Salloway S, 2002, J NEUROL SCI, V203, P183, DOI 10.1016/S0022-510X(02)00288-5; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Sullivan Patrick M, 2008, J Stroke Cerebrovasc Dis, V17, P303, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Thal DR, 2007, NEUROBIOL AGING, V28, P1221, DOI 10.1016/j.neurobiolaging.2006.05.029; Thal DR, 2010, ACTA NEUROPATHOL, V120, P169, DOI 10.1007/s00401-010-0707-9; Tian J, 2006, NEUROPATH APPL NEURO, V32, P332, DOI 10.1111/j.1365-2990.2006.00732.x; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; van Horssen J, 2001, ACTA NEUROPATHOL, V102, P604; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Weller RO, 2004, PANMINERVA MED, V46, P239; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	55	123	126	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41636	10.1371/journal.pone.0041636	http://dx.doi.org/10.1371/journal.pone.0041636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848551	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000306806600098
J	Barbati, C; Pierdominici, M; Gambardella, L; Albedi, FM; Karas, RH; Rosano, G; Malorni, W; Ortona, E				Barbati, Cristiana; Pierdominici, Marina; Gambardella, Lucrezia; Albedi, Fiorella Malchiodi; Karas, Richard H.; Rosano, Giuseppe; Malorni, Walter; Ortona, Elena			Cell Surface Estrogen Receptor Alpha Is Upregulated during Subchronic Metabolic Stress and Inhibits Neuronal Cell Degeneration	PLOS ONE			English	Article							ER-ALPHA; HIPPOCAMPAL-NEURONS; PROTEIN-DEGRADATION; AUTOPHAGY; BETA; EXPRESSION; HOMEOSTASIS; ESTRADIOL; SURVIVAL; NUCLEAR	In addition to the classical nuclear estrogen receptor, the expression of non-nuclear estrogen receptors localized to the cell surface membrane (mER) has recently been demonstrated. Estrogen and its receptors have been implicated in the development or progression of numerous neurodegenerative disorders. Furthermore, the pathogenesis of these diseases has been associated with disturbances of two key cellular programs: apoptosis and autophagy. An excess of apoptosis or a defect in autophagy has been implicated in neurodegeneration. The aim of this study was to clarify the role of ER in determining neuronal cell fate and the possible implication of these receptors in regulating either apoptosis or autophagy. The human neuronal cell line SH-SY5Y and mouse neuronal cells in primary culture were thus exposed to chronic minimal peroxide treatment (CMP), a form of subcytotoxic minimal chronic stress previously that mimics multiple aspects of long-term cell stress and represents a limited molecular proxy for neurodegenerative processes. We actually found that either E2 or E2-bovine serum albumin construct (E2BSA, i.e. a non-permeant form of E2) was capable of modulating intracellular cell signals and regulating cell survival and death. In particular, under CMP, the up-regulation of mER alpha, but not mER beta, was associated with functional signals (ERK phosphorylation and p38 dephosphorylation) compatible with autophagic cytoprotection triggering and leading to cell survival. The mER alpha trafficking appeared to be independent of the microfilament system cytoskeletal network but was seemingly associated with microtubular apparatus network, i.e., to MAP2 molecular chaperone. Importantly, antioxidant treatments, administration of siRNA to ER alpha, or the presence of antagonist of ER alpha hindered these events. These results support that the surface expression of mER alpha plays a pivotal role in determining cell fate, and that ligand-induced activation of mER signalling exerts a powerful cell-survival signal. These results shed new light on the pathogenetic mechanisms leading to neuronal cell degeneration.	[Barbati, Cristiana; Malorni, Walter; Ortona, Elena] San Raffaele Inst Sulmona, Laquila, Italy; [Barbati, Cristiana; Pierdominici, Marina; Albedi, Fiorella Malchiodi; Ortona, Elena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Gambardella, Lucrezia; Malorni, Walter] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Rosano, Giuseppe] IRCCS San Raffaele Pisana, Dept Med Sci, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Tufts Medical Center; IRCCS San Raffaele Pisana	Barbati, C (corresponding author), San Raffaele Inst Sulmona, Laquila, Italy.	ortona@iss.it	Malorni, Walter/G-5874-2016; Rosano, Giuseppe M. C./K-8718-2018; Malchiodi-Albedi, Fiorella/A-5944-2015; Pierdominici, Marina/J-6436-2016; ortona, elena/J-6395-2016	Rosano, Giuseppe M. C./0000-0003-4023-2263; Malchiodi-Albedi, Fiorella/0000-0001-7202-0391; Pierdominici, Marina/0000-0002-6372-3754; ortona, elena/0000-0001-9845-8105; malorni, walter/0000-0002-1223-7000	Italian Ministry of Health; Italian Association for Cancer Research (AIRC)	Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by research grants from the Italian Ministry of Health (to EO and WM) and from the Italian Association for Cancer Research (AIRC) (WM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Bodart JF, J CELL BIOCH, V109, P850; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; Camacho-Arroyo I, 2011, LIFE SCI, V89, P123, DOI 10.1016/j.lfs.2011.05.008; Carrer HF, 2005, J STEROID BIOCHEM, V93, P319, DOI 10.1016/j.jsbmb.2004.12.007; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Colasanti T, 2012, ARTHRITIS RHEUM-US, V64, P778, DOI 10.1002/art.33400; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Dehmelt L, 2005, GENOME BIOL, V6; Gillies GE, 2010, PHARMACOL REV, V62, P155, DOI 10.1124/pr.109.002071; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lista P, 2011, J CELL MOL MED, V15, P1443, DOI 10.1111/j.1582-4934.2011.01293.x; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Malchiodi-Albedi F, 2001, GLIA, V34, P68, DOI 10.1002/glia.1041; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Mendelsohn ME, 2010, J CLIN INVEST, V120, P2277, DOI 10.1172/JCI43756; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; O'Neill EE, 2008, BRAIN RES, V1222, P1, DOI 10.1016/j.brainres.2008.05.036; Ohtani-Kaneko R, 2010, NEUROSCI RES, V66, P180, DOI 10.1016/j.neures.2009.10.012; Pierdominici M, 2010, IMMUNOL LETT, V132, P79, DOI 10.1016/j.imlet.2010.06.003; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Sanchez AM, 2010, STEROIDS, V75, P528, DOI 10.1016/j.steroids.2009.12.003; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Srivastava DP, 2011, J NEUROSCI, V31, P16056, DOI 10.1523/JNEUROSCI.4097-11.2011; Vacirca D, 2012, NEUROBIOL AGING, V33, P753, DOI 10.1016/j.neurobiolaging.2010.05.013; Vasudevan N, 2008, FRONT NEUROENDOCRIN, V29, P238, DOI 10.1016/j.yfrne.2007.08.003; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	46	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42339	10.1371/journal.pone.0042339	http://dx.doi.org/10.1371/journal.pone.0042339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860116	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600092
J	Carter, AJ; Feeney, WE				Carter, Alecia J.; Feeney, William E.			Taking a Comparative Approach: Analysing Personality as a Multivariate Behavioural Response across Species	PLOS ONE			English	Article							CORAL-REEF FISH; CANONICAL VARIATE ANALYSIS; ANIMAL PERSONALITY; GASTEROSTEUS-ACULEATUS; PHENOTYPIC PLASTICITY; SETTLEMENT BEHAVIOR; MARINE FISH; POPULATIONS; EVOLUTION; STICKLEBACKS	Animal personality, repeatable behaviour through time and across contexts, is ecologically and evolutionarily important as it can account for the exhibition of sub-optimal behaviours. Interspecific comparisons have been suggested as important for understanding the evolution of animal personality; however, these are seldom accomplished due, in part, to the lack of statistical tools for quantifying differences and similarities in behaviour between groups of individuals. We used nine species of closely-related coral reef fishes to investigate the usefulness of ecological community analyses for the analysis of between-species behavioural differences and behavioural heterogeneity. We first documented behavioural carryover across species by observing the fishes' behaviour and measuring their response to a threatening stimulus to quantify boldness. Bold fish spent more time away from the reef and fed more than shy fish. We then used ecological community analysis tools (canonical variate analysis, multi-response permutation procedure, and permutational analysis of multivariate dispersion) and identified four 'clusters' of behaviourally similar fishes, and found that the species differ in the behavioural variation expressed; some species are more behaviourally heterogeneous than others. We found that ecological community analysis tools are easily and fruitfully applied to comparative studies of personality and encourage their use by future studies.	[Carter, Alecia J.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Feeney, William E.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Feeney, William E.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia	Australian National University; James Cook University; Australian National University	Carter, AJ (corresponding author), Univ Cambridge, Dept Zool, Cambridge CB2 1TN, England.	william.feeney@anu.edu.au	Feeney, William E/D-3180-2013	Feeney, William E/0000-0002-7475-4724; Carter, Alecia/0000-0001-5550-9312	Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561432]	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research was funded by the Australian Research Council Centre of Excellence for Coral Reef Studies (Grant Number: CE0561432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2004, PERMDISP FORTRAN COM; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; CAMPBELL NA, 1981, SYST ZOOL, V30, P268, DOI 10.2307/2413249; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Carter AJ, 2012, BEHAV ECOL SOCIOBIOL, V66, P153, DOI 10.1007/s00265-011-1263-6; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; DOHERTY PJ, 1987, B MAR SCI, V41, P423; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Duckworth RA, 2010, AUK, V127, P752, DOI 10.1525/auk.2010.127.4.752; Edgell TC, 2009, AM NAT, V174, P434, DOI 10.1086/603639; Eriksson AC, 2010, MAR ECOL PROG SER, V420, P273, DOI 10.3354/meps08899; Feeney WE, 2012, CORAL REEFS; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Fuiman LA, 2010, OECOLOGIA, V164, P99, DOI 10.1007/s00442-010-1712-3; Herczeg G, 2012, BEHAV ECOL SOCIOBIOL, V66, P161, DOI 10.1007/s00265-011-1291-2; Holmes T, 2010, MARINE ECOLOGY PROGR, V399; HOLT C, 1995, APPL ENVIRON MICROB, V61, P377, DOI 10.1128/AEM.61.1.377-378.1995; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; la Grange A, 2009, J STAT SOFTW, V30, P1; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2002, MAR FRESHWATER RES, V53, P319, DOI 10.1071/MF01082; Leis JM, 2002, J FISH BIOL, V61, P325, DOI 10.1006/jfbi.2002.2030; Lessells CM, 2008, PHILOS T R SOC B, V363, P1589, DOI 10.1098/rstb.2007.0008; McCormick MI, 2010, MAR ECOL PROG SER, V407, P173, DOI 10.3354/meps08583; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; McCormick MI, 2004, OIKOS, V106, P225, DOI 10.1111/j.0030-1299.2004.13131.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; Meekan MG, 2001, MAR BIOL, V139, P373; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; MISCHEL W, 1973, PSYCHOL REV, V80, P252, DOI 10.1037/h0035002; Mischel W, 1973, INTERACTION PERSON S; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nowicki JP, 2012, J EXP MAR BIOL ECOL, V412, P46, DOI 10.1016/j.jembe.2011.10.020; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ohman MC, 1998, J EXP MAR BIOL ECOL, V225, P219, DOI 10.1016/S0022-0981(97)00224-4; Oksanen J., 2016, R PACKAG; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; SWEATMAN HPA, 1984, COPEIA, P187; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Uher J, 2011, DEV PSYCHOBIOL, V53, P521, DOI 10.1002/dev.20544; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; Webster MM, 2009, BEHAV ECOL SOCIOBIOL, V63, P511, DOI 10.1007/s00265-008-0685-2; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; ZIMMERMAN GM, 1985, ECOLOGY, V66, P606, DOI 10.2307/1940409	62	24	24	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42440	10.1371/journal.pone.0042440	http://dx.doi.org/10.1371/journal.pone.0042440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860126	Green Published, Green Accepted, gold			2022-12-27	WOS:000307045600100
J	Gaynes, BN; Pence, BW; Atashili, J; O'Donnell, J; Kats, D; Ndumbe, PM				Gaynes, Bradley N.; Pence, Brian W.; Atashili, Julius; O'Donnell, Julie; Kats, Dmitry; Ndumbe, Peter M.			Prevalence and Predictors of Major Depression in HIV-Infected Patients on Antiretroviral Therapy in Bamenda, a Semi-Urban Center in Cameroon	PLOS ONE			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; WORLD-HEALTH-ORGANIZATION; QUALITY-OF-LIFE; MENTAL-HEALTH; PSYCHIATRIC-DISORDERS; ANXIETY DISORDERS; DRUG-USE; HIV/AIDS; ADHERENCE; COMORBIDITY	Recent blue-ribbon panel reports have concluded that HIV treatment programs in less wealthy countries must integrate mental health identification and treatment into normal HIV clinical care and that research on mental health and HIV in these settings should be a high priority. We assessed the epidemiology of depression in HIV patients on antiretroviral therapy in a small urban setting in Cameroon by administering a structured interview for depression to 400 patients consecutively attending the Bamenda Regional Hospital AIDS Treatment Center. One in five participants met lifetime criteria for MDD, and 7% had MDD within the prior year. Only 33% had ever spoken with a health professional about depression, and 12% reported ever having received depression treatment that was helpful or effective. Over 2/3 with past-year MDD had severe or very severe episodes. The number of prior depressive episodes and the number of HIV symptoms were the strongest predictors of past-year MDD. The prevalence of MDD in Cameroon is as high as that of other HIV-associated conditions, such as tuberculosis and Hepatitis B virus, whose care is incorporated into World Health Organization guidelines. The management of depression needs to be incorporated in HIV-care guidelines in Cameroon and other similar settings.	[Gaynes, Bradley N.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA; [Pence, Brian W.] Duke Univ, Dept Community & Family Med, Duke Global Hlth Inst, Durham, NC USA; [Pence, Brian W.] Duke Univ, Ctr Hlth Policy & Inequal Res, Durham, NC USA; [Atashili, Julius] Univ Buea, Dept Publ Hlth & Hyg, Buea, Cameroon; [O'Donnell, Julie; Kats, Dmitry] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Ndumbe, Peter M.] Univ Yaounde I, Dept Microbiol & Immunol, Buea, Cameroon; [Ndumbe, Peter M.] Univ Buea, Dept Biomed Sci, Buea, Cameroon	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Yaounde I	Gaynes, BN (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA.	bradley_gaynes@med.unc.edu		Gaynes, Bradley/0000-0002-8283-5030	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD, USA [R34 MH084673]; NC TRACS Institute; NIH National Center for Research Resources [UL1RR025747, KL2RR025746, TLRR025745]; National Center for Advancing Translational Sciences, NIH; National Institute of Mental Health [R25 MH080916-01A2]; Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI); NIH [2P30 AI064518]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746, UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH080916, R34MH084673] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD, USA; NC TRACS Institute; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grant R34 MH084673 of the National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD, USA. BNG receives funding from the NC TRACS Institute, which is supported by grants UL1RR025747, KL2RR025746, and TLRR025745 from the NIH National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH. BWP is an investigator with the Implementation Research Institute (IRI), at the George Warren Brown School of Social Work, Washington University in St. Louis, MO, through an award from the National Institute of Mental Health (R25 MH080916-01A2) and the Department of Veterans Affairs, Health Services Research & Development Service, Quality Enhancement Research Initiative (QUERI). This publication was made possible with help from the Duke University Center for AIDS Research (CFAR), an NIH-funded program (2P30 AI064518). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMH or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2008, INT J PSYCHIAT MED, V38, P43, DOI 10.2190/PM.38.1.d; Adewuya AO, 2007, J PSYCHOSOM RES, V63, P203, DOI 10.1016/j.jpsychores.2007.03.006; Amirkhanian YA, 2003, AIDS, V17, P2367, DOI 10.1097/00002030-200311070-00012; [Anonymous], 2009, AIDS EP UPD; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bartlett JA, 2002, J ACQ IMMUN DEF SYND, V29, pS2, DOI 10.1097/00126334-200202011-00002; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Ferrando SJ, 2002, PSYCHIAT QUART, V73, P33, DOI 10.1023/A:1012840717735; Freeman M, 2007, AIDS CARE, V19, P1201, DOI 10.1080/09540120701426482; Freeman MC, 2005, BRIT J PSYCHIAT, V187, P1, DOI 10.1192/bjp.187.1.1; Gaynes BN, 2005, GEN HOSP PSYCHIAT, V27, P87, DOI 10.1016/j.genhosppsych.2004.10.003; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Kaiser Family Foundation, 2010, US GLOB HLTH POL ONL; Kelly B, 1998, AUST NZ J PSYCHIAT, V32, P441, DOI 10.3109/00048679809065539; KELLY JA, 1993, HEALTH PSYCHOL, V12, P215, DOI 10.1037/0278-6133.12.3.215; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P122, DOI 10.1002/mpr.169; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kilbourne AM, 2001, J CLIN EPIDEMIOL, V54, pS22, DOI 10.1016/S0895-4356(01)00443-7; Kinyanda E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-205; Laurence J, 2004, MEDICATION ADHERENCE; Laurent C, 2010, HIV MED, V11, P85, DOI 10.1111/j.1468-1293.2009.00742.x; Lawler K, 2011, AIDS BEHAV, V15, P204, DOI 10.1007/s10461-009-9622-2; LYKETSOS CG, 1994, INT J PSYCHIAT MED, V24, P103, DOI 10.2190/URTC-AQVJ-N9KG-0RL4; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P39; Marwick KFM, 2010, AIDS CARE, V22, P415, DOI 10.1080/09540120903253981; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; National Institute of Statistics of Cameroon, 2010, 2005 CENS; Olley BO, 2003, SAMJ S AFR MED J, V93, P928; Pence BW, 2006, JAIDS-J ACQ IMM DEF, V42, P298, DOI 10.1097/01.qai.0000219773.82055.aa; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sherbourne CD, 2000, AM J PSYCHIAT, V157, P248, DOI 10.1176/appi.ajp.157.2.248; Sikkema KJ, 2011, JAIDS-J ACQ IMM DEF, V57, P230, DOI 10.1097/QAI.0b013e3182167e7a; Singh N, 1996, AIDS CARE, V8, P261, DOI 10.1080/09540129650125696; Spies G, 2009, AIDS CARE, V21, P1163, DOI 10.1080/09540120902729965; Spire B, 2002, SOC SCI MED, V54, P1481, DOI 10.1016/S0277-9536(01)00125-3; UN AIDS, 2011, GLOB PLAN EL NEW HIV; UN AIDS, 2011, UNAIDS WORLD AIDS DA; WHO, 2010, ANT THER HIV INF AD	44	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41699	10.1371/journal.pone.0041699	http://dx.doi.org/10.1371/journal.pone.0041699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860006	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600037
J	Rockweit, JT; Franklin, AB; Bakken, GS; Gutierrez, RJ				Rockweit, Jeremy T.; Franklin, Alan B.; Bakken, George S.; Gutierrez, R. J.			Potential Influences of Climate and Nest Structure on Spotted Owl Reproductive Success: A Biophysical Approach	PLOS ONE			English	Article							NORTHWESTERN CALIFORNIA; HABITAT SELECTION; PREDATION RISK; CLUTCH SIZE; TEMPERATURE; ANIMALS; ORIENTATION; PASSERINES; INCUBATION; WEATHER	Many bird species do not make their own nests; therefore, selection of existing sites that provide adequate microclimates is critical. This is particularly true for owls in north temperate climates that often nest early in the year when inclement weather is common. Spotted owls use three main types of nest structures, each of which are structurally distinct and may provide varying levels of protection to the eggs or young. We tested the hypothesis that spotted owl nest configuration influences nest microclimate using both experimental and observational data. We used a wind tunnel to estimate the convective heat transfer coefficient (h(c)) of eggs in 25 potential nest configurations that mimicked 2 nest types (top-cavity and platform nests), at 3 different wind speeds. We then used the estimates of h(c) in a biophysical heat transfer model to estimate how long it would take unattended eggs to cool from incubation temperature (similar to 36 degrees C) to physiological zero temperature (PZT; similar to 26 degrees C) under natural environmental conditions. Our results indicated that the structural configuration of nests influences the cooling time of the eggs inside those nests, and hence, influences the nest microclimate. Estimates of time to PZT ranged from 10.6 minutes to 33.3 minutes. Nest configurations that were most similar to platform nests always had the fastest egg cooling times, suggesting that platform nests were the least protective of those nests we tested. Our field data coupled with our experimental results suggested that nest choice is important for the reproductive success of owls during years of inclement weather or in regions characterized by inclement weather during the nesting season.	[Rockweit, Jeremy T.; Gutierrez, R. J.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Franklin, Alan B.] USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Bakken, George S.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); Indiana State University	Rockweit, JT (corresponding author), Colorado State Univ, Cooperat Fish & Wildlife Res Unit, Ft Collins, CO 80523 USA.	rockweit@rams.colostate.edu		Franklin, Alan/0000-0001-9491-795X	USDA Forest Service, Region 5	USDA Forest Service, Region 5	Funding for this project was provided by USDA Forest Service, Region 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken GS, 2006, J AVIAN BIOL, V37, P561, DOI 10.1111/j.0908-8857.2006.03685.x; BAKKEN GS, 1976, J THEOR BIOL, V60, P337, DOI 10.1016/0022-5193(76)90063-1; Barrientos R, 2009, ACTA OECOL, V35, P499, DOI 10.1016/j.actao.2009.03.005; Britt J, 2011, BIRD STUDY, V58, P78, DOI 10.1080/00063657.2010.524916; BUCHANAN JB, 1993, J RAPTOR RES, V27, P1; Burnham K P, 2003, MODEL SELECT MULTIMO; Burton NHK, 2007, CONDOR, V109, P441, DOI 10.1650/0010-5422(2007)109[441:ILVINO]2.0.CO;2; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Carey AB, 1995, J RAPTOR RES, V29, P223; Chalfoun AD, 2010, OECOLOGIA, V163, P885, DOI 10.1007/s00442-010-1679-0; Chen JN, 2011, J ORNITHOL, V152, P603, DOI 10.1007/s10336-010-0622-9; Crossman CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019086; Delaney DK, 1999, CONDOR, V101, P42, DOI 10.2307/1370444; Drent R., 1975, AVIAN BIOL, P333; Folliard LB, 1993, NEST SITE CHARACTERI; Forsman ED, 1997, WILSON BULL, V109, P28; FORSMAN ED, 1984, WILDLIFE MONOGR, V87, P1; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gill FB, 1994, ORNITHOLOGY, V2nd; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Glenn EM, 2011, J WILDLIFE MANAGE, V75, P1279, DOI 10.1002/jwmg.177; Gutierrez R.J., 1995, Birds of North America, V179, P1; HAFTORN S, 1988, ORNIS SCAND, V19, P97, DOI 10.2307/3676458; Hartman CA, 2003, CONDOR, V105, P158, DOI 10.1650/0010-5422(2003)105[158:OAMOHL]2.0.CO;2; HIRONS GJM, 1982, MAMMAL REV, V12, P155, DOI 10.1111/j.1365-2907.1982.tb00011.x; KERN MD, 1984, CONDOR, V86, P455, DOI 10.2307/1366826; LaHaye WS, 1999, CONDOR, V101, P324, DOI 10.2307/1369995; LaHaye WS, 1997, WILSON BULL, V109, P42; LIMA SL, 1987, ECOLOGY, V68, P1062, DOI 10.2307/1938378; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lundy H., 1969, FERTILITY HATCHABILI, P143; LYON BE, 1985, BEHAV ECOL SOCIOBIOL, V17, P279, DOI 10.1007/BF00300147; Major J., 1988, TERRESTRIAL VEGETATI, P11; McCracken KG, 1997, AUK, V114, P610, DOI 10.2307/4089280; Mote P. W., 2009, FUTURE CLIMATE PACIF; NICE MARGARET MORSE, 1962, TRANS LINN SOC NY, V8, P1; North M, 2000, J WILDLIFE MANAGE, V64, P797, DOI 10.2307/3802750; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; Olson GS, 2004, J WILDLIFE MANAGE, V68, P1039, DOI 10.2193/0022-541X(2004)068[1039:MDPONS]2.0.CO;2; Orians G.H., 1979, P155; POLLEY SL, 1980, FOOD TECHNOL-CHICAGO, V34, P76; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Reid JM, 2002, FUNCT ECOL, V16, P305, DOI 10.1046/j.1365-2435.2002.00632.x; Rockweit JT, 2008, POTENTIAL EFFECTS NE; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; SCHAEFER VH, 1980, WILSON BULL, V92, P466; SIDIS Y, 1994, AUK, V111, P1001; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Thomson RL, 2006, ECOGRAPHY, V29, P507; Vogel S, 1994, LIFE MOVING FLUIDS; Wagner FF, 1996, STUDIES AVIAN BIOL, P67; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WEESE J, 1993, COMPUT PHYS COMMUN, V77, P429, DOI 10.1016/0010-4655(93)90187-H	54	15	15	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41498	10.1371/journal.pone.0041498	http://dx.doi.org/10.1371/journal.pone.0041498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859993	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600031
J	Karczewski, P; Pohlmann, A; Wagenhaus, B; Wisbrun, N; Hempel, P; Lemke, B; Kunze, R; Niendorf, T; Bimmler, M				Karczewski, Peter; Pohlmann, Andreas; Wagenhaus, Babette; Wisbrun, Natali; Hempel, Petra; Lemke, Bernd; Kunze, Rudolf; Niendorf, Thoralf; Bimmler, Marion			Antibodies to the alpha(1)-Adrenergic Receptor Cause Vascular Impairments in Rat Brain as Demonstrated by Magnetic Resonance Angiography	PLOS ONE			English	Article							AGONISTIC AUTOANTIBODIES; AUTOIMMUNITY; ALZHEIMERS	Background: Circulating agonistic autoantibodies acting at G protein-coupled receptors have been associated with numerous sever pathologies in humans. Antibodies directed predominantly against the alpha(1)-adrenergig receptor were detected in patients suffering from widespread diseases such as hypertension and type 2 diabetes. Their deleterious action has been demonstrated for peripheral organs. We postulate that antibodies to the alpha(1)-adrenergig receptor are relevant pathomolecules in diseases of the central nervous system associated with vascular impairments. Methodology/Principal Findings: Using a rat model we studied the long-term action of antibodies against the alpha(1)-adrenergig receptor either induced by immunization with a receptor peptide or applied by intravenous injection. The vasculature in the rat brains was investigated by time-of-flight magnetic resonance angiography using a 9.4 Tesla small animal MR imaging system. Visual examination of maximum-intensity-projections (MIPs) of brain angiographs revealed the development of vascular defects in antibody-exposed animals between three and eight months of treatment. Relative vascular areas were derived from representative MIP image sections by grayscale analysis and used to form an index of vascular circulation. Animals exposed to the action of alpha(1)-adrenergig receptor antibodies showed significantly reduced vascular areas (p<0.05). Calculated index values indicated attenuated blood flow in both antibody-treated cohorts compared to their respective controls reaching with (relative units +/- standard error, n = 10) 0.839 +/- 0.026 versus 0.919 +/- 0.026 statistical significance (p<0.05) for peptide-immunized rats. Conclusion/Significance: We present evidence that antibodies to the alpha(1)-adrenergig receptor cause cerebrovascular impairments in the rat. Our findings suggest the pathological significance of these antibodies in pathologies of the human central nervous system linked to impairments of brain vasculature such as stroke and dementia.	[Karczewski, Peter; Hempel, Petra] ERDE AAK Diagnost GmbH, Berlin, Germany; [Pohlmann, Andreas; Wagenhaus, Babette; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Wisbrun, Natali] Max Delbruck Ctr Mol Med, Anim Facil, Berlin, Germany; [Lemke, Bernd] Max Delbruck Ctr Mol Med, IT Dept, Berlin, Germany; [Niendorf, Thoralf] Expt & Clin Res Ctr, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Karczewski, P (corresponding author), ERDE AAK Diagnost GmbH, Berlin, Germany.	karczewski@aak-diagnostik.de	Pohlmann, Andreas/K-7869-2016; Niendorf, Thoralf/H-7738-2013	Pohlmann, Andreas/0000-0002-8572-2568; Niendorf, Thoralf/0000-0001-7584-6527	ProFIT program of the European Community [10145576]; European Community Grant [10145576]	ProFIT program of the European Community; European Community Grant(European Commission)	The present work was supported by a grant from the ProFIT program of the European Community (Grant No. 10145576 to Dr. Bimmler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Kunze is employed by ERDE eV, a non-profit incorporated society. Dr. Karczewski and Dr. Hempel are employees of ERDE AAK-Diagnostik GmbH, a research enterprise. There is no product development or marketing of products by these companies. Both are authorized to acquire public research funds. Research work in particular of ERDE AAK-Diagnostik GmbH led to the formation of the research group Autoimmunity and G Protein-Coupled Receptors at the Max Delbrueck Center for Molecular Medicine headed by Dr. Bimmler who is executive director of ERDE AAK-Diagnostik GmbH and member of the executive board of ERDE eV. The European Community Grant No. 10145576 to Dr. Bimmler as research group leader supports a common research project of the Max Delbrueck Center for Molecular Medicine and of ERDE AAK-Diagnostik GmbH. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bartl J, 2012, WORLD J BIOL PSYCHIA; Busch HJ, 2003, J CEREBR BLOOD F MET, V23, P621, DOI 10.1097/01.WCB.0000057741.00152.E4; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; De Ronchi D, 2007, DEMENT GERIATR COGN, V24, P266, DOI 10.1159/000107102; Dragun D, 2009, THROMB HAEMOSTASIS, V101, P643, DOI 10.1160/TH08-10-0710; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Hempel P, 2009, SCAND J IMMUNOL, V70, P159, DOI 10.1111/j.1365-3083.2009.02280.x; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Karczewski P, 2012, SCAND J IMMUNOL, V75, P524, DOI 10.1111/j.1365-3083.2012.02684.x; Karczewski P, 2010, MOL CELL BIOCHEM, V333, P233, DOI 10.1007/s11010-009-0224-0; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; Luchsinger JA, 2012, J ALZHEIMERS DIS, V29, P1; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Muller J, 2000, CIRCULATION, V101, P385, DOI 10.1161/01.CIR.101.4.385; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Wenzel K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009409; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011; Zhou ZB, 2008, CELL MOL IMMUNOL, V5, P349, DOI 10.1038/cmi.2008.43	23	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41602	10.1371/journal.pone.0041602	http://dx.doi.org/10.1371/journal.pone.0041602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860001	Green Accepted, gold, Green Published			2022-12-27	WOS:000306950900030
J	Almgren, M; Atkinson, R; He, J; Hilding, A; Hagman, E; Wolk, A; Thorell, A; Marcus, C; Naslund, E; Ostenson, CG; Schalling, M; Lavebratt, C				Almgren, Malin; Atkinson, Richard; He, Jia; Hilding, Agneta; Hagman, Emilia; Wolk, Alicja; Thorell, Anders; Marcus, Claude; Naslund, Erik; Ostenson, Claes-Goran; Schalling, Martin; Lavebratt, Catharina			Adenovirus-36 Is Associated with Obesity in Children and Adults in Sweden as Determined by Rapid ELISA	PLOS ONE			English	Article							INSULIN SENSITIVITY; ANTIBODY-RESPONSE; GLUCOSE-UPTAKE; ADIPOSITY; ADOLESCENTS; CELLS; AD36; DIFFERENTIATION; DEFINITION; OVERWEIGHT	Background: Experimental and natural human adenovirus-36 (Adv36) infection of multiple animal species results in obesity through increasing adipogenesis and lipid accumulation in adipocytes. Presence of Adv36 antibodies detected by serum neutralization assay has previously been associated with obesity in children and adults living in the USA, South Korea and Italy, whereas no association with adult obesity was detected in Belgium/the Netherlands nor among USA military personnel. Adv36 infection has also been shown to reduce blood lipid levels, increase glucose uptake by adipose tissue and skeletal muscle biopsies, and to associate with improved glycemic control in non-diabetic individuals. Principal Findings: Using a novel ELISA, 1946 clinically well-characterized individuals including 424 children and 1522 nondiabetic adults, and 89 anonymous blood donors, residing in central Sweden representing the population in Stockholm area, were studied for the presence of antibodies against Adv36 in serum. The prevalence of Adv36 positivity in lean individuals increased from similar to 7% in 1992-1998 to 15-20% in 2002-2009, which paralleled the increase in obesity prevalence. We found that Adv36-positive serology was associated with pediatric obesity and with severe obesity in females compared to lean and overweight/mildly obese individuals, with a 1.5 to 2-fold Adv36 positivity increase in cases. Moreover, Adv36 positivity was less common among females and males on antilipid pharmacological treatment or with high blood triglyceride level. Insulin sensitivity, measured as lower HOMA-IR, showed a higher point estimate in Adv36-positive obese females and males, although it was not statistically significant (p = 0.08). Conclusion: Using a novel ELISA we show that Adv36 infection is associated with pediatric obesity, severe obesity in adult females and lower risk of high blood lipid levels in non-diabetic Swedish individuals.	[Almgren, Malin; Hilding, Agneta; Ostenson, Claes-Goran; Schalling, Martin; Lavebratt, Catharina] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Almgren, Malin; Schalling, Martin; Lavebratt, Catharina] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Almgren, Malin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Atkinson, Richard; He, Jia] Obetech Obes Res Ctr, Richmond, VA USA; [Atkinson, Richard; He, Jia] Virginia Commonwealth Univ, Richmond, VA USA; [Hagman, Emilia; Marcus, Claude] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Pediat, Stockholm, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Surg, Stockholm, Sweden; [Thorell, Anders] Ersta Hosp, Dept Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Virginia Commonwealth University; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Ersta Sjukhus	Almgren, M (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	ratkinson2@vcu.edu; catharina.lavebratt@ki.se	Schalling, Martin/F-1518-2015; Atkinson, Richard/AAK-4953-2021; Hagman, Emilia/AAM-4291-2020; Marcus, Claude/ABE-1177-2020	Schalling, Martin/0000-0001-5011-2922; Hagman, Emilia/0000-0003-1433-2295; Marcus, Claude/0000-0003-0890-2650; Lavebratt, Catharina/0000-0003-4987-2718; Thorell, Anders/0000-0001-7238-1728; Atkinson, Richard L./0000-0003-1745-5645	VINNOVA [2009-00223]; Swedish Research Council [2010-3631]; Karolinska Institutet Foundation; Swedish Council for Working Life and Social Research (FAS); Swedish Diabetes Association; Swedish Heart and Lung Foundation; Swedish Childhood Diabetes Foundation; Jerring Foundation; Swedish Order of Freemasons; Obetech Obesity Research Center	VINNOVA(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Foundation(Karolinska Institutet); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Diabetes Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Childhood Diabetes Foundation; Jerring Foundation; Swedish Order of Freemasons; Obetech Obesity Research Center	This work was supported by grants from the VINNOVA (2009-00223, www.vinnova.se), the Swedish Research Council (2010-3631, www.vr.se), the Karolinska Institutet Foundation (www.ki.se), the Swedish Council for Working Life and Social Research (FAS, www.fas.se), the Swedish Diabetes Association (www.diabetes.se), the Swedish Heart and Lung Foundation (www.hjart-lungfonden.se), Swedish Childhood Diabetes Foundation (www.barndiabetesfonden), the Jerring Foundation (www.jerringfonden.org), the Swedish Order of Freemasons (www.frimurarordern.se) and the Obetech Obesity Research Center (www.obesityvirus.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arnold J, 2010, VIRUS RES, V149, P152, DOI 10.1016/j.virusres.2010.01.011; Atkinson RL, 2010, INT J PEDIATR OBES, V5, P157, DOI 10.3109/17477160903111789; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Broderick MP, 2010, INT J OBESITY, V34, P302, DOI 10.1038/ijo.2009.224; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dhurandhar NV, 2002, J NUTR, V132, P3155, DOI 10.1093/jn/131.10.3155; Dhurandhar NV, 2000, INT J OBESITY, V24, P989, DOI 10.1038/sj.ijo.0801319; DHURANDHAR NV, 1992, VET MICROBIOL, V31, P101, DOI 10.1016/0378-1135(92)90068-5; Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19; Eliakim A, 2006, AUTOIMMUNITY, V39, P137, DOI 10.1080/08916930600597326; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goossens VJ, 2011, OBESITY, V19, P220, DOI 10.1038/oby.2009.452; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Mitra AK, 2010, OBES REV, V11, P289, DOI 10.1111/j.1467-789X.2009.00677.x; Morinder G, 2009, ACTA PAEDIATR, V98, P132, DOI 10.1111/j.1651-2227.2008.01030.x; Na HN, 2010, INT J OBESITY, V34, P89, DOI 10.1038/ijo.2009.207; Na HN, 2011, INT J OBES LOND; Neovius M, 2008, INT J OBESITY, V32, P832, DOI 10.1038/sj.ijo.0803784; Pasarica M, 2008, ARCH VIROL, V153, P2097, DOI 10.1007/s00705-008-0219-2; Pasarica M, 2008, STEM CELLS, V26, P969, DOI 10.1634/stemcells.2007-0868; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; ROLLANDCACHERA MF, 1982, AM J CLIN NUTR, V36, P178, DOI 10.1093/ajcn/36.1.178; Rossner SM, 2008, DIABETES CARE, V31, P802, DOI 10.2337/dc07-1655; Sheridan PA, 2011, INT J OBES LOND; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Travers ME, 2011, HUM GENET, V130, P41, DOI 10.1007/s00439-011-1023-8; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Trovato GM, 2011, DIG DIS SCI; Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x; Vangipuram SD, 2007, INT J OBESITY, V31, P87, DOI 10.1038/sj.ijo.0803366; Vangipuram SD, 2004, OBES RES, V12, P770, DOI 10.1038/oby.2004.93; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; WEBER DJ, 1986, NEW ENGL J MED, V314, P1393; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; WIGAND R, 1980, ARCH VIROL, V64, P225, DOI 10.1007/BF01322702	41	59	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41652	10.1371/journal.pone.0041652	http://dx.doi.org/10.1371/journal.pone.0041652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848557	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200083
J	Kaneko, S; Yoshida, J; Ishikawa, H; Takamatsu, K				Kaneko, Satoru; Yoshida, Joji; Ishikawa, Hiromichi; Takamatsu, Kiyoshi			Single-Cell Pulsed-Field Gel Electrophoresis to Detect the Early Stage of DNA Fragmentation in Human Sperm Nuclei	PLOS ONE			English	Article							DENSITY GRADIENT; COMET ASSAY; DAMAGE; MATRIX; REPAIR; MOLECULES; INTEGRITY; TUNEL; SEMEN	Single-cell pulsed-field gel electrophoresis (SCPFGE) with dual electrode pairs was developed to detect the early stage of DNA fragmentation in human sperm. The motile sperm were purified by the commonly used density-gradient centrifugation technique and subsequent swim-up. The sperm were embedded in a thin film of agarose containing bovine trypsin (20 mu g/mL) and were then lysed. Prior to SCPFGE, proteolysis of DNA-binding components, such as protamine and the nuclear matrix was essential to separate the long chain fibers from the fibrous and granular fragments derived from a single nucleus. The overall electrophoretic profiles elucidated the course of DNA fragmentation. A few large fibrous fragments were observed at the beginning of the process, however, as the fragmentation advanced, the long chain fibers decreased and shortened, and, conversely, the granular fragments increased until finally almost all the DNA was shredded. Although the ejaculate contained sperm with heterogeneous stages, the purified motile sperm exhibited several dozens of uniformly elongated fibers arising from the tangled DNA at the origin, whereas a part of these fibers gave rise to fibrous fragments beyond the tip of the elongated fibers, and their numbers and sizes varied among the sperm. Conventional intracytoplasmic sperm injection (ICSI) usually depends on intra-operative light microscopic observation to select a sperm for injection. The present results revealed that sperm motility could not give full assurance of DNA integrity. SCPFGE is likely to serve an important role in the preoperative differential diagnosis to determine the competence of the sperm population provided for injection.	[Kaneko, Satoru; Yoshida, Joji; Ishikawa, Hiromichi; Takamatsu, Kiyoshi] Tokyo Dent Coll, Ichikawa Gen Hosp, Reprod Ctr, Ichikawa, Chiba, Japan	Tokyo Dental College	Kaneko, S (corresponding author), Tokyo Dent Coll, Ichikawa Gen Hosp, Reprod Ctr, Ichikawa, Chiba, Japan.	kaneko@tdc.ac.jp	t, lf/AAJ-4924-2020; Takamatsu, Kiyoshi/ABA-2896-2020		Japan Society for the Promotion of Science (JSPS) [C-17591761]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Grant-in-Aid for Scientific Research (C-17591761), Japan Society for the Promotion of Science (JSPS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Aitken R John, 2007, Soc Reprod Fertil Suppl, V65, P81; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; Dominguez-Fandos D, 2007, CYTOM PART A, V71A, P1011, DOI 10.1002/cyto.a.20484; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fernandez JL, 2003, J ANDROL, V24, P59; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Hughes CM, 1999, MUTAGENESIS, V14, P71; Irvine DS, 2000, J ANDROL, V21, P33; KANEKO S, 1986, BIOL REPROD, V35, P1059, DOI 10.1095/biolreprod35.4.1059; KANEKO S, 1987, ARCH ANDROLOGY, V19, P75, DOI 10.3109/01485018708986803; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kramer JA, 1996, J BIOL CHEM, V271, P11619, DOI 10.1074/jbc.271.20.11619; Marchetti F, 2007, P NATL ACAD SCI USA, V104, P17725, DOI 10.1073/pnas.0705257104; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Nickerson JA, 2001, J CELL SCI, V114, P463; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Shaman JA, 2007, ARCH ANDROLOGY, V53, P135, DOI 10.1080/01485010701329378; Sharma RK, 2010, UROLOGY, V76, P1380, DOI 10.1016/j.urology.2010.04.036; Simon L, 2011, FERTIL STERIL, V95, P652, DOI 10.1016/j.fertnstert.2010.08.019; Simon L, 2010, HUM REPROD, V25, P1594, DOI 10.1093/humrep/deq103; VANLOON AAWM, 1991, EXP CELL RES, V193, P303, DOI 10.1016/0014-4827(91)90101-Y; Zheng P, 2005, BIOL REPROD, V72, P1359, DOI 10.1095/biolreprod.104.039073; ZIEGLER A, 1987, J CLIN CHEM CLIN BIO, V25, P578; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42257	10.1371/journal.pone.0042257	http://dx.doi.org/10.1371/journal.pone.0042257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848752	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200189
J	Taechalertpaisarn, T; Crosnier, C; Bartholdson, SJ; Hodder, AN; Thompson, J; Bustamante, LY; Wilson, DW; Sanders, PR; Wright, GJ; Rayner, JC; Cowman, AF; Gilson, PR; Crabb, BS				Taechalertpaisarn, Tana; Crosnier, Cecile; Bartholdson, S. Josefin; Hodder, Anthony N.; Thompson, Jenny; Bustamante, Leyla Y.; Wilson, Danny W.; Sanders, Paul R.; Wright, Gavin J.; Rayner, Julian C.; Cowman, Alan F.; Gilson, Paul R.; Crabb, Brendan S.			Biochemical and Functional Analysis of Two Plasmodium falciparum Blood-Stage 6-Cys Proteins: P12 and P41	PLOS ONE			English	Article							TRANSMISSION-BLOCKING ANTIBODIES; ANCHORED MEMBRANE-PROTEINS; GAMETE-SURFACE PROTEIN; ERYTHROCYTE INVASION; STRUCTURAL-CHARACTERIZATION; TOXOPLASMA-GONDII; PARASITE INVASION; MALARIA PARASITES; TARGET ANTIGENS; IDENTIFICATION	The genomes of Plasmodium parasites that cause malaria in humans, other primates, birds, and rodents all encode multiple 6-cys proteins. Distinct 6-cys protein family members reside on the surface at each extracellular life cycle stage and those on the surface of liver infective and sexual stages have been shown to play important roles in hepatocyte growth and fertilization respectively. However, 6-cys proteins associated with the blood-stage forms of the parasite have no known function. Here we investigate the biochemical nature and function of two blood-stage 6-cys proteins in Plasmodium falciparum, the most pathogenic species to afflict humans. We show that native P12 and P41 form a stable heterodimer on the infective merozoite surface and are secreted following invasion, but could find no evidence that this complex mediates erythrocyte-receptor binding. That P12 and P41 do not appear to have a major role as adhesins to erythrocyte receptors was supported by the observation that antisera to these proteins did not substantially inhibit erythrocyte invasion. To investigate other functional roles for these proteins their genes were successfully disrupted in P. falciparum, however P12 and P41 knockout parasites grew at normal rates in vitro and displayed no other obvious phenotypic changes. It now appears likely that these blood-stage 6-cys proteins operate as a pair and play redundant roles either in erythrocyte invasion or in host-immune interactions.	[Taechalertpaisarn, Tana; Sanders, Paul R.; Gilson, Paul R.; Crabb, Brendan S.] Burnet Inst, Melbourne, Vic, Australia; [Taechalertpaisarn, Tana; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Crosnier, Cecile; Bartholdson, S. Josefin; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge, England; [Hodder, Anthony N.; Thompson, Jenny; Wilson, Danny W.; Cowman, Alan F.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Bustamante, Leyla Y.; Rayner, Julian C.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge, England; [Gilson, Paul R.; Crabb, Brendan S.] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia; [Gilson, Paul R.; Crabb, Brendan S.] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Crabb, Brendan S.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	Burnet Institute; University of Melbourne; Wellcome Trust Sanger Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Wellcome Trust Sanger Institute; Monash University; Monash University; University of Melbourne	Taechalertpaisarn, T (corresponding author), Burnet Inst, Melbourne, Vic, Australia.	crabb@burnet.edu.au	Cowman, Alan F/C-7642-2013; Wilson, Danny W/E-6186-2019; Crabb, Brendan/F-5287-2013	Cowman, Alan F/0000-0001-5145-9004; Wilson, Danny W/0000-0002-5073-1405; Rayner, Julian/0000-0002-9835-1014; Bartholdson Scott, Sara Josefin/0000-0003-3380-4446; Wright, Gavin/0000-0003-0537-0863	Australian National Health and Medical Research Council [406601, 637406]; Wellcome Trust [077108/Z/05/Z]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by grants from the Australian National Health and Medical Research Council (406601 and 637406). CC, SJB and GJW were supported by the Wellcome Trust (grant number 077108/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo SA, 2012, P NATL ACAD SCI US; Black CG, 2005, MOL BIOCHEM PARASIT, V144, P27, DOI 10.1016/j.molbiopara.2005.06.010; Boulanger MJ, 2010, CURR OPIN STRUC BIOL, V20, P551, DOI 10.1016/j.sbi.2010.08.003; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; COOPER JA, 1992, MOL BIOCHEM PARASIT, V51, P301, DOI 10.1016/0166-6851(92)90080-4; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Mills KE, 2002, MOL MICROBIOL, V43, P1401, DOI 10.1046/j.1365-2958.2002.02834.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; READ D, 1994, PARASITE IMMUNOL, V16, P511, DOI 10.1111/j.1365-3024.1994.tb00305.x; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Templeton TJ, 1999, MOL BIOCHEM PARASIT, V101, P223, DOI 10.1016/S0166-6851(99)00066-3; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015121; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460; Waisberg M, 2012, P NATL ACAD SCI USA, V109, P5429, DOI 10.1073/pnas.1202689109; Waters A, 2006, CELL, V124, P689, DOI 10.1016/j.cell.2006.02.011; Williamson KC, 2003, PARASITE IMMUNOL, V25, P351, DOI 10.1046/j.1365-3024.2003.00643.x; World Health Organization, 2010, WORLD MAL REP 2010; Zupan AL, 2004, J BIOTECHNOL, V109, P115, DOI 10.1016/j.jbiotec.2003.11.013	56	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41937	10.1371/journal.pone.0041937	http://dx.doi.org/10.1371/journal.pone.0041937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848665	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200133
J	Voorham, QJM; Carvalho, B; Spiertz, AJ; Claes, B; Mongera, S; van Grieken, NCT; Grabsch, H; Kliment, M; Rembacken, B; van de Wiel, MA; Quirke, P; Mulder, CJJ; Lambrechts, D; van Engeland, M; Meijer, GA				Voorham, Quirinus J. M.; Carvalho, Beatriz; Spiertz, Angela J.; Claes, Bart; Mongera, Sandra; van Grieken, Nicole C. T.; Grabsch, Heike; Kliment, Martin; Rembacken, Bjorn; van de Wiel, Mark A.; Quirke, Philip; Mulder, Chris J. J.; Lambrechts, Diether; van Engeland, Manon; Meijer, Gerrit A.			Comprehensive Mutation Analysis in Colorectal Flat Adenomas	PLOS ONE			English	Article							LATERALLY SPREADING TUMORS; BETA-CATENIN MUTATIONS; SOMATIC MUTATIONS; SIGNALING PATHWAY; KRAS MUTATIONS; APC MUTATIONS; RAS; CANCER; COLON; GENE	Background: Flat adenomas are a subgroup of colorectal adenomas that have been associated with a distinct biology and a more aggressive clinical behavior compared to their polypoid counterparts. In the present study, we aimed to compare the mutation spectrum of 14 cancer genes, between these two phenotypes. Methods: A consecutive series of 106 flat and 93 polypoid adenomas was analyzed retrospectively for frequently occurring mutations in "hot spot'' regions of KRAS, BRAF, PIK3CA and NRAS, as well as selected mutations in CTNNB1 (beta-catenin), EGFR, FBXW7 (CDC4), PTEN, STK11, MAP2K4, SMAD4, PIK3R1 and PDGFRA using a high-throughput genotyping technique. Additionally, APC was analyzed using direct sequencing. Results: APC mutations were more frequent in polypoid adenomas compared to flat adenomas (48.5% versus 30.3%, respectively, p = 0.02). Mutations in KRAS, BRAF, NRAS, FBXW7 and CTNNB1 showed similar frequencies in both phenotypes. Between the different subtypes of flat adenomas (0-IIa, LST-F and LST-G) no differences were observed for any of the investigated genes. Conclusion: The lower APC mutation rate in flat adenomas compared to polypoid adenomas suggests that disruption of the Wnt-pathway may occur via different mechanisms in these two phenotypes. Furthermore, in contrast to previous observations our results in this large well-defined sample set indicate that there is no significant association between the different morphological phenotypes and mutations in key genes of the RAS-RAF-MAPK pathway.	[Voorham, Quirinus J. M.; Carvalho, Beatriz; Mongera, Sandra; van Grieken, Nicole C. T.; Meijer, Gerrit A.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Spiertz, Angela J.; van Engeland, Manon] Univ Maastricht, Dept Pathol, Maastricht, Netherlands; [Claes, Bart; Lambrechts, Diether] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium; [Claes, Bart; Lambrechts, Diether] VIB, Louvain, Belgium; [Claes, Bart; Lambrechts, Diether] Univ Louvain, Vesalius Res Ctr, Louvain, Belgium; [Grabsch, Heike; Quirke, Philip] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Kliment, Martin] Hosp Vitkovice, Ostrava, Czech Republic; [Rembacken, Bjorn] Leeds Gen Infirm, Ctr Digest Dis, Leeds, W Yorkshire, England; [van de Wiel, Mark A.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Mulder, Chris J. J.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Leeds; Leeds General Infirmary; University of Leeds; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Voorham, QJM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands.	ga.meijer@vumc.nl	Lambrechts, Diether/AAJ-3167-2020; van de Wiel, Mark/F-6759-2013; Quirke, Philip/AAI-1362-2019; van Engeland, Manon/A-7479-2009; Carvalho, Beatriz/GXA-0720-2022; Verdrengh, Evelien/H-4571-2012	Lambrechts, Diether/0000-0002-3429-302X; van Engeland, Manon/0000-0002-7952-6843; Quirke, Philip/0000-0002-3597-5444; Meijer, Gerrit/0000-0003-0330-3130; van Grieken, Nicole/0000-0001-9992-0760; van de Wiel, Mark/0000-0003-4780-8472	Dutch Cancer Society [KWF2006-3513]	Dutch Cancer Society(KWF Kankerbestrijding)	Dutch Cancer Society grant KWF2006-3513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Alberici P, 2006, GENOME DYN, V1, P149, DOI 10.1159/000092506; Albuquerque C, 2010, GENE CHROMOSOME CANC, V49, P746, DOI 10.1002/gcc.20786; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bianco MA, 2010, ENDOSCOPY, V42, P279, DOI 10.1055/s-0029-1244020; Chan TL, 2003, CANCER RES, V63, P4878; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Diosdado B, 2010, CLIN CANCER RES, V16, P1391, DOI 10.1158/1078-0432.CCR-09-1773; Esteller M, 2000, CANCER RES, V60, P4366; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; FUJIMORI T, 1994, INT J CANCER, V57, P51, DOI 10.1002/ijc.2910570110; Gylfe AE, 2010, INT J CANCER, V127, P2974, DOI 10.1002/ijc.25529; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; Huang K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-252; Iwao K, 1998, CANCER RES, V58, P1021; JARAMILLO E, 1995, GASTROINTEST ENDOSC, V42, P114, DOI 10.1016/S0016-5107(95)70066-8; Johnson V, 2005, GUT, V54, P264, DOI 10.1136/gut.2004.048132; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; KUDO S, 1995, EUR J CANCER, V31A, P1118, DOI 10.1016/0959-8049(95)00251-D; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Mikami M, 2006, EUR J CANCER, V42, P3065, DOI 10.1016/j.ejca.2006.06.029; MINAMOTO T, 1994, CANCER RES, V54, P2841; MUTO T, 1985, DIS COLON RECTUM, V28, P847, DOI 10.1007/BF02555490; Noro A, 2003, PATHOL INT, V53, P828, DOI 10.1046/j.1440-1827.2003.01564.x; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Sakamoto N, 2004, ONCOGENE, V23, P8900, DOI 10.1038/sj.onc.1207993; Samowitz WS, 1999, CANCER RES, V59, P1442; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sillars-Hardebol AH, 2011, J PATHOL; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; Sugimoto T, 2010, INT J CANCER, V127, P1562, DOI 10.1002/ijc.25180; Takahashi T, 2007, MODERN PATHOL, V20, P139, DOI 10.1038/modpathol.3800722; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Togashi K, 2003, ANN ACAD MED SINGAP, V32, P152; Umetani N, 2000, BRIT J CANCER, V82, P9, DOI 10.1054/bjoc.1999.0869; Urban O, 2008, HEPATO-GASTROENTEROL, V55, P351; van Wyk R, 1999, EUR J HUM GENET, V7, P928, DOI 10.1038/sj.ejhg.5200386; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Voorham QJM, 2012, CLIN CANCER RES, V18, P4560, DOI 10.1158/1078-0432.CCR-11-2385; Weiss MM, 1999, J CLIN PATHOL-MOL PA, V52, P243; WOLBER RA, 1991, HUM PATHOL, V22, P70, DOI 10.1016/0046-8177(91)90064-V; YAMAGATA S, 1995, CANCER, V75, P953, DOI 10.1002/1097-0142(19950215)75:4<953::AID-CNCR2820750409>3.0.CO;2-R; Yashiro M, 2001, CANCER RES, V61, P2676; Yoshida S, 2008, INT J COLORECTAL DIS, V23, P7, DOI 10.1007/s00384-007-0349-0; YOUNG J, 1993, HUM MUTAT, V2, P351, DOI 10.1002/humu.1380020505; Yuen ST, 2002, CANCER RES, V62, P6451	56	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41963	10.1371/journal.pone.0041963	http://dx.doi.org/10.1371/journal.pone.0041963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848674	Green Published, gold			2022-12-27	WOS:000306950200136
J	Luo, J; Mitra, A; Tian, F; Chang, S; Zhang, HM; Cui, KR; Yu, Y; Zhao, KJ; Song, JZ				Luo, Juan; Mitra, Apratim; Tian, Fei; Chang, Shuang; Zhang, Huanmin; Cui, Kairong; Yu, Ying; Zhao, Keji; Song, Jiuzhou			Histone Methylation Analysis and Pathway Predictions in Chickens after MDV Infection	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; DNA METHYLATION; NITRIC-OXIDE; GENES; RESISTANCE; EXPRESSION; GENOME; PATTERNS; CANCER; IDENTIFICATION	Marek's disease (MD) is a lymphoproliferative disease in chicken induced by Marek's disease virus (MDV). Although studies have focused on the genetic differences between the resistant and susceptible chicken, less is known about the role of epigenetic factors in MD. In this study, genome-wide histone modifications in the non-MHC-associated resistant and susceptible chicken lines were examined. We found that tri-methylation at histone H3 Lys4 (H3K4me3) enrichment is positively correlated with the expression of protein coding genes as well as microRNA (miRNA) genes, whereas tri-methylation at histone H3 Lys27 (H3K27me3) exhibits a negative correlation. By identifying line-specific histone modifications in MDV infection, we found unique H3K4me3 islands in the resistant chicken activated genes, which are related to immune response and cell adhesion. Interestingly, we also found some miRNAs from unique H3K27me3 patterns in the susceptible chickens that targeted genes involved in 5-hydroxytryptamine (5-HT)-receptor and adrenergic receptor pathways. In conclusion, dynamic line-specific histone modifications in response to MDV infection suggested that intrinsic epigenetic mechanisms may play a role in MD-resistance and -susceptibility.	[Luo, Juan; Mitra, Apratim; Tian, Fei; Yu, Ying; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Chang, Shuang; Zhang, Huanmin] ARS, USDA, Avian Dis & Oncol Lab, E Lansing, MI USA; [Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Chang, Shuang] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Michigan State University	Song, JZ (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Zhang, Huanmin/M-9792-2019; Song, Jiuzhou/AAD-6440-2020	Zhang, Huanmin/0000-0003-4896-2391; 	National Research Initiative from USDA National Institute of Food and Agriculture [USDA-NRI/NIFA 2008-35204-04660, USDA-NRI/NIFA 2010-65205-20588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801, ZIAHL006030] Funding Source: NIH RePORTER	National Research Initiative from USDA National Institute of Food and Agriculture; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by National Research Initiative Competitive Grant no. USDA-NRI/NIFA 2008-35204-04660 and USDA-NRI/NIFA 2010-65205-20588 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton JA, 2011, ONCOGENE, V30, P2037, DOI 10.1038/onc.2010.579; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; ASMUNDSON V. S., 1932, CANADIAN JOUR RES, V6, P171; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergquist J, 1998, IMMUNOL TODAY, V19, P562, DOI 10.1016/S0167-5699(98)01367-X; BUCKMASTER AE, 1988, J GEN VIROL, V69, P2033, DOI 10.1099/0022-1317-69-8-2033; BUONOMO FC, 1984, GEN COMP ENDOCR, V54, P360, DOI 10.1016/0016-6480(84)90148-5; Burgess SC, 2004, P NATL ACAD SCI USA, V101, P13879, DOI 10.1073/pnas.0305789101; Burgess SC, 2002, J VIROL, V76, P7276, DOI 10.1128/JVI.76.14.7276-7292.2002; Burgess SC, 2001, VET PATHOL, V38, P129, DOI 10.1354/vp.38-2-129; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calnek BW, 2001, CURR TOP MICROBIOL, V255, P25; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; COLE RK, 1968, AVIAN DIS, V12, P9, DOI 10.2307/1588081; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; Fred Davidson VN, 2004, MAREKS DIS EVOLVING; FREDERICKSEN TL, 1977, IMMUNOGENETICS, V5, P535, DOI 10.1007/BF01570512; GILMOUR DG, 1976, IMMUNOGENETICS, V3, P549, DOI 10.1007/BF01576985; Greer EL, 2012, NATURE REV GENETICS; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ha M, 2011, GENOME RES; Ha M, 2011, GENOME RES, V21, P590, DOI 10.1101/gr.116467.110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heidari M, 2010, VIRAL IMMUNOL, V23, P309, DOI 10.1089/vim.2009.0079; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; HUTT FB, 1947, SCIENCE, V106, P379, DOI 10.1126/science.106.2756.379; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhnlein U, 1997, ANIM GENET, V28, P116, DOI 10.1111/j.1365-2052.1997.00076.x; Li TG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001349; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Liu HC, 2001, ANIM GENET, V32, P351, DOI 10.1046/j.1365-2052.2001.00798.x; Liu HC, 2001, P NATL ACAD SCI USA, V98, P9203, DOI 10.1073/pnas.161466898; Luo Juan, 2011, BMC Proc, V5 Suppl 4, pS7, DOI 10.1186/1753-6561-5-S4-S7; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; MORIMURA T, 1995, J GEN VIROL, V76, P2979, DOI 10.1099/0022-1317-76-12-2979; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Papageorgiou A, 2007, ENDOCRINOLOGY, V148, P4509, DOI 10.1210/en.2007-0034; Park YS, 2008, ANN SURG ONCOL, V15, P1968, DOI 10.1245/s10434-008-9927-9; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; SCHAT KA, 1981, AVIAN PATHOL, V10, P171, DOI 10.1080/03079458108418471; Schorr EC, 1999, BRAIN BEHAV IMMUN, V13, P271, DOI 10.1006/brbi.1999.0549; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Stone H. A., 1975, USE HIGHLY INBRED CH; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Tian F, 2012, GENOMICS, V99, P152, DOI 10.1016/j.ygeno.2011.11.004; Tulman ER, 2000, J VIROL, V74, P7980, DOI 10.1128/JVI.74.17.7980-7988.2000; Vallejo RL, 1997, ANIM GENET, V28, P331, DOI 10.1111/j.1365-2052.1997.00178.x; van Dijk K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-238; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Xing Z, 2000, J VIROL, V74, P3605, DOI 10.1128/JVI.74.8.3605-3612.2000; Xing Z, 2000, IMMUNOLOGY, V100, P70, DOI 10.1046/j.1365-2567.2000.00008.x; Yonash N, 1999, ANIM GENET, V30, P126, DOI 10.1046/j.1365-2052.1999.00457.x; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-501; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002672; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001731; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155	79	14	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41849	10.1371/journal.pone.0041849	http://dx.doi.org/10.1371/journal.pone.0041849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848633	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600054
J	Danilova, AB; Grinkevich, LN				Danilova, Alexandra B.; Grinkevich, Larisa N.			Failure of Long-Term Memory Formation in Juvenile Snails Is Determined by Acetylation Status of Histone H3 and Can Be Improved by NaB Treatment	PLOS ONE			English	Article							FOOD-AVERSION NETWORK; CELLULAR MECHANISMS; IDENTIFIED NEURONS; SEROTONIN; APLYSIA; CASCADE; SENSITIZATION; EXCITABILITY; FACILITATION; EXPRESSION	Background: Animals' capacities for different forms of learning do not mature simultaneously during ontogenesis but the molecular mechanisms behind the delayed development of specific types of memory are not fully understood. Mollusks are considered to be among the best models to study memory formation at the molecular level. Chromatin remodeling in developmental processes, as well as in long-term memory formation, was recently shown to play a major role. Histone acetylation is a key process in the chromatin remodeling and is regulated through the signaling cascades, for example MAPK/ERK. Previously, we found that MAPK/ERK is a key pathway in the formation of the food aversion reflex in Helix. Pretreatment with upstream ERK kinase inhibitor PD98059 prevented food avoidance learning in adult Helix. In contrast to adult snails, juveniles possess immature plasticity mechanisms of the avoidance reflex until the age of 2-3 months while the MAPK/ERK cascade is not activated after aversive learning. In the present study, we focused on the potential MAPK/ERK target - histone H3. Methodology/Principal Findings: Here we found that a significant increase in histone H3 acetylation occurs in adult animals after learning, whereas no corresponding increase was observed in juveniles. The acetylation of histone H3 is regulated by ERK kinase, since the upstream ERK kinase inhibitor PD98059 prevented the increase of histone H3 acetylation upon learning. We found that the injection of histone deacetylase inhibitor sodium butyrate (NaB) prior to training led to induction in histone H3 acetylation and significantly ameliorated long-term memory formation in juvenile snails. Conclusions/Significance: Thus, MAPK/ERK-dependent histone H3 acetylation plays an essential role in the formation of food aversion in Helix. Dysfunction of the MAPK/ERK dependent histone H3 acetylation might determine the deficiency of avoidance behavior and long-term plasticity in juvenile animals. Stimulation of histone H3 acetylation in juvenile animals by NaB promoted avoidance plasticity.	[Danilova, Alexandra B.; Grinkevich, Larisa N.] Russian Acad Sci, Pavlov Inst Physiol, Lab Regulat Funct Brain Neurons, St Petersburg 196140, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences	Danilova, AB (corresponding author), Russian Acad Sci, Pavlov Inst Physiol, Lab Regulat Funct Brain Neurons, St Petersburg 196140, Russia.	LARISA_GR_SPB@mail.ru	Grinkevich, Larisa/AAC-8676-2022	Grinkevich, Larisa/0000-0003-3744-5946	 [RFBR 08-04-01325];  [11-04-01968]	; 	This work was supported by the grants RFBR 08-04-01325; 11-04-01968. http://www.rfbr.ru/rffi/eng/about. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Balaban PM, 2002, NEUROSCI BIOBEHAV R, V26, P597, DOI 10.1016/S0149-7634(02)00022-2; Barbas D, 2003, LEARN MEMORY, V10, P373, DOI 10.1101/lm.66103; Danilova AB, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00180; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; EMSON P, 1971, COMP BIOCHEM PHYSIOL, V40, P223, DOI 10.1016/0305-0491(71)90079-4; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gainutdinov Kh. L., 2011, Uspekhi Fiziologicheskikh Nauk, V42, P33; Gainutdinov KL, 1998, NEUROREPORT, V9, P517, DOI 10.1097/00001756-199802160-00026; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gerhardt CC, 1997, EUR J PHARMACOL, V334, P1, DOI 10.1016/S0014-2999(97)01115-1; Grinkevich L N, 2003, Neurosci Behav Physiol, V33, P39, DOI 10.1023/A:1021175230674; Grinkevich L N, 2007, Neurosci Behav Physiol, V37, P715, DOI 10.1007/s11055-007-0072-x; Grinkevich LN, 2008, BRAIN RES, V1187, P12, DOI 10.1016/j.brainres.2007.08.029; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kharchenko OA, 2010, NEUROBIOL LEARN MEM, V94, P158, DOI 10.1016/j.nlm.2010.05.002; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Litvinov E G, 1980, Neurosci Behav Physiol, V10, P539, DOI 10.1007/BF01195528; Nikitin V P, 1994, Neurosci Behav Physiol, V24, P133, DOI 10.1007/BF02355663; NOLEN TG, 1988, J NEUROSCI, V8, P212; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stark LL, 1999, J NEUROSCI, V19, P334, DOI 10.1523/JNEUROSCI.19-01-00334.1999; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Wood MA, 2006, LEARN MEMORY, V13, P241, DOI 10.1101/lm.278206; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; ZAKHAROV IS, 1987, NEUROSCIENCE, V23, P721, DOI 10.1016/0306-4522(87)90089-3	36	6	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41828	10.1371/journal.pone.0041828	http://dx.doi.org/10.1371/journal.pone.0041828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848623	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600129
J	Gao, P; Zhou, X; Wang, ZN; Song, YX; Tong, LL; Xu, YY; Yue, ZY; Xu, HM				Gao, Peng; Zhou, Xin; Wang, Zhen-ning; Song, Yong-xi; Tong, Lin-lin; Xu, Ying-ying; Yue, Zhen-yu; Xu, Hui-mian			Which Is a More Accurate Predictor in Colorectal Survival Analysis? Nine Data Mining Algorithms vs. the TNM Staging System	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; LUNG-CANCER PATIENTS; LOGISTIC-REGRESSION; NODE-METASTASIS; 7TH EDITION; CARCINOMA; CLASSIFICATION; RADIOTHERAPY; MODELS; CART	Objective: Over the past decades, many studies have used data mining technology to predict the 5-year survival rate of colorectal cancer, but there have been few reports that compared multiple data mining algorithms to the TNM classification of malignant tumors (TNM) staging system using a dataset in which the training and testing data were from different sources. Here we compared nine data mining algorithms to the TNM staging system for colorectal survival analysis. Methods: Two different datasets were used: 1) the National Cancer Institute's Surveillance, Epidemiology, and End Results dataset; and 2) the dataset from a single Chinese institution. An optimization and prediction system based on nine data mining algorithms as well as two variable selection methods was implemented. The TNM staging system was based on the 7th edition of the American Joint Committee on Cancer TNM staging system. Results: When the training and testing data were from the same sources, all algorithms had slight advantages over the TNM staging system in predictive accuracy. When the data were from different sources, only four algorithms (logistic regression, general regression neural network, Bayesian networks, and Naive Bayes) had slight advantages over the TNM staging system. Also, there was no significant differences among all the algorithms (p>0.05). Conclusions: The TNM staging system is simple and practical at present, and data mining methods are not accurate enough to replace the TNM staging system for colorectal cancer survival prediction. Furthermore, there were no significant differences in the predictive accuracy of all the algorithms when the data were from different sources. Building a larger dataset that includes more variables may be important for furthering predictive accuracy.	[Gao, Peng; Wang, Zhen-ning; Song, Yong-xi; Tong, Lin-lin; Xu, Ying-ying; Yue, Zhen-yu; Xu, Hui-mian] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Zhou, Xin] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	wang, zhen ning/E-1878-2011; Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013; yue, zhenyu/GRF-4856-2022	wang, zhen ning/0000-0003-0557-3097; Xu, Yingying/0000-0003-4924-9379; 	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Program of Education Department of Liaoning Province [L2011137]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Program of Education Department of Liaoning Province	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), the Program of Scientific and Technological Department of Liaoning Province (No. 2010225032) and the Program of Education Department of Liaoning Province (L2011137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo MB, 2010, 2010 SEER PROGRAM CO; Anderson Billie, 2010, Front Biosci (Elite Ed), V2, P849; Bardan R, 2009, TMJ, V59, P70; Bartfay E, 2006, EUR J CANCER CARE, V15, P115, DOI 10.1111/j.1365-2354.2005.00638.x; Bottaci L, 1997, LANCET, V350, P469, DOI 10.1016/S0140-6736(96)11196-X; Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y; Catto JWF, 2003, CLIN CANCER RES, V9, P4172; Chang C.-C., LIBSVM LIB SUPPORT V; Cruz JA, 2006, CANCER INFORM, V2, P59; Delen D, 2005, ARTIF INTELL MED, V34, P113, DOI 10.1016/j.artmed.2004.07.002; Edge SB, 2010, AJCC CANC STAGING MA; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gayou O, 2008, MED PHYS, V35, P5426, DOI 10.1118/1.3005974; Greene FL, 2007, LANCET ONCOL, V8, P572, DOI 10.1016/S1470-2045(07)70185-7; Grumett Simon, 2003, Clin Colorectal Cancer, V2, P239, DOI 10.3816/CCC.2003.n.005; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HOUCK C, 1995, NCSUIETR9509; Jayasurya K, 2010, MED PHYS, V37, P1401, DOI 10.1118/1.3352709; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim KH, 2011, COLORECTAL DIS, V13, pE220, DOI 10.1111/j.1463-1318.2011.02625.x; Lai DT, 2010, HUM MOVEMENT SCI, V31, P271; Murphy K., BAYES NET TOOLBOX MA; Naguib RNG, 1998, NEUROCOMPUTING, V19, P145, DOI 10.1016/S0925-2312(97)00090-8; Schwarzer G, 2003, METHOD INFORM MED, V42, P572; Snow PB, 2001, CANCER, V91, P1673, DOI 10.1002/1097-0142(20010415)91:8+<1673::AID-CNCR1182>3.0.CO;2-T; Tanabe K, 2010, MOL DIVERS, V14, P789, DOI 10.1007/s11030-010-9232-y; Tong LL, 2012, ANN SURG, V255, P208, DOI 10.1097/SLA.0b013e31821ad8a2; Valera VA, 2007, ANN SURG ONCOL, V14, P34, DOI 10.1245/s10434-006-9145-2; Venkatesan P, 2006, CURR SCI INDIA, V91, P1195; Witten I. H., 2005, DATA MINING PRACTICA	30	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42015	10.1371/journal.pone.0042015	http://dx.doi.org/10.1371/journal.pone.0042015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848691	gold, Green Published			2022-12-27	WOS:000306806600159
J	Hultqvist, G; Daza, DO; Larhammar, D; Kilimann, MW				Hultqvist, Greta; Daza, Daniel Ocampo; Larhammar, Dan; Kilimann, Manfred W.			Evolution of the Vertebrate Paralemmin Gene Family: Ancient Origin of Gene Duplicates Suggests Distinct Functions	PLOS ONE			English	Article							GENOME DUPLICATION; MOLECULAR CHARACTERIZATION; CHROMOSOME DUPLICATIONS; MEMBRANE DYNAMICS; AMPHIOXUS GENOME; TELEOST FISHES; PROTEIN FAMILY; INSIGHTS; REVEALS; IDENTIFICATION	Paralemmin-1 is a protein implicated in plasma membrane dynamics, the development of filopodia, neurites and dendritic spines, as well as the invasiveness and metastatic potential of cancer cells. However, little is known about its mode of action, or about the biological functions of the other paralemmin isoforms: paralemmin-2, paralemmin-3 and palmdelphin. We describe here evolutionary analyses of the paralemmin gene family in a broad range of vertebrate species. Our results suggest that the four paralemmin isoform genes (PALM1, PALM2, PALM3 and PALMD) arose by quadruplication of an ancestral gene in the two early vertebrate genome duplications. Paralemmin-1 and palmdelphin were further duplicated in the teleost fish specific genome duplication. We identified a unique sequence motif common to all paralemmins, consisting of 11 highly conserved residues of which four are invariant. A single full-length paralemmin homolog with this motif was identified in the genome of the sea lamprey Petromyzon marinus and an isolated putative paralemmin motif could be detected in the genome of the lancelet Branchiostoma floridae. This allows us to conclude that the paralemmin gene family arose early and has been maintained throughout vertebrate evolution, suggesting functional diversification and specific biological roles of the paralemmin isoforms. The paralemmin genes have also maintained specific features of gene organisation and sequence. This includes the occurrence of closely linked downstream genes, initially identified as a readthrough fusion protein with mammalian paralemmin-2 (Palm2-AKAP2). We have found evidence for such an arrangement for paralemmin-1 and -2 in several vertebrate genomes, as well as for palmdelphin and paralemmin-3 in teleost fish genomes, and suggest the name paralemmin downstream genes (PDG) for this new gene family. Thus, our findings point to ancient roles for paralemmins and distinct biological functions of the gene duplicates.	[Hultqvist, Greta; Kilimann, Manfred W.] Uppsala Univ, Unit Mol Cell Biol, Dept Neurosci, Uppsala, Sweden; [Daza, Daniel Ocampo; Larhammar, Dan] Uppsala Univ, Pharmacol Unit, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Hultqvist, G (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Greta.Hultqvist@neuro.uu.se	Ocampo Daza, Daniel/E-4635-2011	Ocampo Daza, Daniel/0000-0002-6521-8807; Hultqvist, Greta/0000-0002-4136-6792	Swedish Research Council (VR-NT) [2003-3389]	Swedish Research Council (VR-NT)(Swedish Research Council)	This work was supported by the Swedish Research Council (VR-NT grant # 2003-3389 to MWK www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreu N, 2001, GENE, V278, P33, DOI 10.1016/S0378-1119(01)00719-3; Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Basile M, 2006, ARCH BIOCHEM BIOPHYS, V446, P60, DOI 10.1016/j.abb.2005.10.027; Braasch I, 2009, MOL BIOL EVOL, V26, P783, DOI 10.1093/molbev/msp015; Chen XX, 2011, BIOCHEM BIOPH RES CO, V404, P1029, DOI 10.1016/j.bbrc.2010.12.104; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dong F, 1998, J BIOL CHEM, V273, P6533, DOI 10.1074/jbc.273.11.6533; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gadjev Ilya, INT REV CELL MOL BIO, P87, DOI [DOI 10.1016/S1937-6448(10)8305-9, 10.1016/S1937-6448(08)01403-2, DOI 10.1016/S1937-6448(08)01403-2]; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; Hu B, 2001, BIOCHEM BIOPH RES CO, V285, P1369, DOI 10.1006/bbrc.2001.5329; Hu B, 2005, EUR J CELL BIOL, V84, P853, DOI 10.1016/j.ejcb.2005.07.002; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Kutzleb C, 1998, J CELL BIOL, V143, P795, DOI 10.1083/jcb.143.3.795; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson TA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-184; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Morgenbesser SD, 2007, PROSTATE, V67, P83, DOI 10.1002/pros.20505; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scholten A, 2007, J PROTEOME RES, V6, P1705, DOI 10.1021/pr060601a; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stein RA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-79; Sundstrom G, 2008, GEN COMP ENDOCR, V155, P705, DOI 10.1016/j.ygcen.2007.08.016; Sundstrom G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-254; Turk CM, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-17; Widmark J, 2011, MOL BIOL EVOL, V28, P859, DOI 10.1093/molbev/msq257	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41850	10.1371/journal.pone.0041850	http://dx.doi.org/10.1371/journal.pone.0041850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22855693	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600134
J	Karlas, T; Neuschulz, M; Oltmanns, A; Guttler, A; Petroff, D; Wirtz, H; Mainz, JG; Mossner, J; Berg, T; Troltzsch, M; Keim, V; Wiegand, J				Karlas, Thomas; Neuschulz, Marie; Oltmanns, Annett; Guettler, Andrea; Petroff, David; Wirtz, Hubert; Mainz, Jochen G.; Moessner, Joachim; Berg, Thomas; Troeltzsch, Michael; Keim, Volker; Wiegand, Johannes			Non-Invasive Evaluation of Cystic Fibrosis Related Liver Disease in Adults with ARFI, Transient Elastography and Different Fibrosis Scores	PLOS ONE			English	Article							HEPATIC-FIBROSIS; VIRAL-HEPATITIS; ULTRASOUND; DIAGNOSIS; CHILDREN; MANAGEMENT	Background: Cystic fibrosis-related liver disease (CFLD) is present in up to 30% of cystic fibrosis patients and can result in progressive liver failure. Diagnosis of CFLD is challenging. Non-invasive methods for staging of liver fibrosis display an interesting diagnostic approach for CFLD detection. Aim: We evaluated transient elastography (TE), acoustic radiation force impulse imaging (ARFI), and fibrosis indices for CFLD detection. Methods: TE and ARFI were performed in 55 adult CF patients. In addition, AST/Platelets-Ratio-Index (APRI), and Forns' score were calculated. Healthy probands and patients with alcoholic liver cirrhosis served as controls. Results: Fourteen CF patients met CFLD criteria, six had liver cirrhosis. Elastography acquisition was successful in >89% of cases. Non-cirrhotic CFLD individuals showed elastography values similar to CF patients without liver involvement. Cases with liver cirrhosis differed significantly from other CFLD patients (ARFI: 1.49 vs. 1.13 m/s; p = 0.031; TE: 7.95 vs. 4.16 kPa; p = 0.020) and had significantly lower results than individuals with alcoholic liver cirrhosis (ARFI: 1.49 vs. 2.99 m/s; p = 0.002). APRI showed the best diagnostic performance for CFLD detection (AUROC 0.815; sensitivity 85.7%, specificity 70.7%). Conclusions: ARFI, TE, and laboratory based fibrosis indices correlate with each other and reliably detect CFLD related liver cirrhosis in adult CF patients. CF specific cut-off values for cirrhosis in adults are lower than in alcoholic cirrhosis.	[Karlas, Thomas; Neuschulz, Marie; Moessner, Joachim; Berg, Thomas; Troeltzsch, Michael; Keim, Volker; Wiegand, Johannes] Univ Hosp Leipzig, Dept Internal Med Dermatol & Neurol, Med Clin Gastroenterol & Rheumatol, Leipzig, Germany; [Oltmanns, Annett; Guettler, Andrea; Wirtz, Hubert] Univ Hosp Leipzig, Dept Internal Med Dermatol & Neurol, Div Pulm Med, Leipzig, Germany; [Petroff, David] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Mainz, Jochen G.] Univ Hosp Jena, Dept Pediat, Jena, Germany; [Troeltzsch, Michael; Keim, Volker] Univ Hosp Leipzig, Interdisciplinary Ultrasound Unit, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Friedrich Schiller University of Jena; Leipzig University	Karlas, T (corresponding author), Univ Hosp Leipzig, Dept Internal Med Dermatol & Neurol, Med Clin Gastroenterol & Rheumatol, Leipzig, Germany.	johannes.wiegand@medizin.uni-leipzig.de	Karlas, Thomas/I-1782-2019; Mainz, Jochen G/AFO-0929-2022	Karlas, Thomas/0000-0002-8109-8526; Mainz, Jochen G./0000-0003-3780-7759; Berg, Thomas/0000-0003-0003-6241				Bota S, 2011, MED ULTRASON, V13, P135; Chen AH, 2005, AM J CLIN NUTR, V81, P686; Colombo C, 2004, J HEPATOL, V41, P1041, DOI 10.1016/j.jhep.2004.10.002; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; D'Onofrio M, 2010, AM J ROENTGENOL, V195, P132, DOI 10.2214/AJR.09.3923; de Ledinghen V, 2010, EXPERT REV MED DEVIC, V7, P811, DOI 10.1586/ERD.10.46; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; England K, 2009, J PEDIATR GASTR NUTR, V49, P71, DOI 10.1097/MPG.0b013e31818fc63b; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Gaia S, 2011, J HEPATOL, V54, P64, DOI 10.1016/j.jhep.2010.06.022; Karlas T, 2011, SCAND J GASTROENTERO, V46, P1458, DOI 10.3109/00365521.2011.610004; Lewindon PJ, 2011, HEPATOLOGY, V53, P193, DOI 10.1002/hep.24014; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lindblad A, 1999, HEPATOLOGY, V30, P1151, DOI 10.1002/hep.510300527; Malbrunot-Wagner AC, 2011, J CYST FIBROS, V10, P338, DOI 10.1016/j.jcf.2011.04.004; Manco M, 2011, HEPATOLOGY, V53, P1779, DOI 10.1002/hep.24245; Menten R, 2010, PEDIATR RADIOL, V40, P1231, DOI 10.1007/s00247-009-1531-z; Moyer K, 2009, CURR OPIN GASTROEN, V25, P272, DOI 10.1097/MOG.0b013e3283298865; Mueller-Abt PR, 2008, J CYST FIBROS, V7, P215, DOI 10.1016/j.jcf.2007.08.001; Nash KL, 2008, J CYST FIBROS, V7, P252, DOI 10.1016/j.jcf.2007.10.004; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sokol RJ, 1999, J PEDIATR GASTR NUTR, V28, pS1, DOI 10.1097/00005176-199900001-00001; Sporea I, 2011, Ultraschall Med, V32 Suppl 1, pS46, DOI 10.1055/s-0029-1245360; WILLIAMS SGJ, 1995, J HEPATOL, V22, P513, DOI 10.1016/0168-8278(95)80444-7; Williams SM, 2002, CLIN RADIOL, V57, P365, DOI 10.1053/crad.2001.0861; Witters P, 2009, J CYST FIBROS, V8, P392, DOI 10.1016/j.jcf.2009.08.001	28	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42139	10.1371/journal.pone.0042139	http://dx.doi.org/10.1371/journal.pone.0042139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848732	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600171
J	Lee, SE; Yang, H; Jeong, SI; Jin, YH; Park, CS; Park, YS				Lee, Seung Eun; Yang, Hana; Jeong, Seong Il; Jin, Young-Ho; Park, Cheung-Seog; Park, Yong Seek			Induction of Heme Oxygenase-1 Inhibits Cell Death in Crotonaldehyde-Stimulated HepG2 Cells via the PKC-delta-p38-Nrf2 Pathway	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; BRONCHIAL EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; GENE-EXPRESSION; CIGARETTE-SMOKE; DNA-ADDUCTS; OXIDATIVE STRESS; TUMOR-GROWTH; CANCER	Background: Crotonaldehyde, an alpha, beta-unsaturated aldehyde present in cigarette smoke, is an environmental pollutant and a product of lipid peroxidation. It also produces adverse effects to humans and is considered as a risk factor for various diseases. Heme oxygenase-1 (HO-1) plays important roles in protecting cells against oxidative stress as a prime cellular defense mechanism. However, HO-1 may be associated with cell proliferation and resistance to apoptosis in cancer cells. The aim of this study was to examine the effects of HO-1 induction on cell survival in crotonaldehyde-stimulated human hepatocellular carcinoma (HepG2) cells. Methods: To investigate the signaling pathway involved in crotonaldehyde-induced HO-1 expression, we compared levels of inhibition efficiency of specific inhibitors and specific small interfering RNAs (siRNAs) of several kinases. The cell-cycle and cell death was measured by FACS and terminal dUTP nick-end labeling (TUNEL) staining. Results: Treatment with crotonaldehyde caused a significant increase in nuclear translocation of NF-E2 related factor (Nrf2). Treatment with inhibitors of the protein kinase C-delta (PKC-delta) and p38 pathways resulted in obvious blockage of crotonaldehyde-induced HO-1 expression. Furthermore, treatment with HO-1 siRNA and the specific HO-1 inhibitor zinc-protoporphyrin produced an increase in the G(0)/G(1) phase of the cell cycle in crotonaldehyde-stimulated HepG2 cells. Conclusions: Taken together, the results support an anti-apoptotic role for HO-1 in crotonaldehyde-stimulated human hepatocellular carcinoma cells and provide a mechanism by which induction of HO-1 expression via PKC-delta-p38 MAPK-Nrf2 pathway may promote tumor resistance to oxidative stress.	[Lee, Seung Eun; Yang, Hana; Jeong, Seong Il; Park, Cheung-Seog; Park, Yong Seek] Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Jin, Young-Ho] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Lee, SE (corresponding author), Kyung Hee Univ, Sch Med, Dept Microbiol, Seoul, South Korea.	yongseek@khu.ac.kr	Park, Yong Seek/ABG-6398-2021	Park, Yong Seek/0000-0002-9260-3102	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0005490]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0005490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Chen P. X., 2003, Beitraege zur Tabakforschung International, V20, P448; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; CHUNG FL, 1986, CANCER RES, V46, P1285; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Dong JZ, 2004, J CHROMATOGR A, V1027, P25, DOI 10.1016/j.chroma.2003.08.104; Eder E, 1999, IARC SCI PUBL, P219; EISERICH JP, 1995, AM J CLIN NUTR, V62, P1490, DOI 10.1093/ajcn/62.6.1490S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Fernandes PH, 2005, ENVIRON MOL MUTAGEN, V45, P455, DOI 10.1002/em.20117; Hecht SS, 2001, TOXICOLOGY, V166, P31, DOI 10.1016/S0300-483X(01)00436-X; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045; Jeong SI, 2011, MOL CELL TOXICOL, V7, P127, DOI 10.1007/s13273-011-0017-x; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Kawaguchi-Niida M, 2006, ACTA NEUROPATHOL, V111, P422, DOI 10.1007/s00401-006-0044-1; Kim YS, 2009, J PERIODONTOL, V80, P2045, DOI 10.1902/jop.2009.090145; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Lee SE, 2011, J CELL BIOCHEM, V112, P2352, DOI 10.1002/jcb.23158; Lee SE, 2011, TOXICOL LETT, V201, P240, DOI 10.1016/j.toxlet.2011.01.006; Lee SE, 2010, MOL CELL TOXICOL, V6, P33, DOI 10.1007/s13273-010-0005-6; Lee SE, 2010, BIOCHIP J, V4, P264, DOI 10.1007/s13206-010-4402-7; Liu XY, 2010, TOXICOL LETT, V197, P113, DOI 10.1016/j.toxlet.2010.05.005; Liu XY, 2010, TOXICOL LETT, V195, P90, DOI 10.1016/j.toxlet.2010.02.004; Luczaj W, 2003, CELL MOL BIOL LETT, V8, P391; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; NEUDECKER T, 1989, ENVIRON MOL MUTAGEN, V14, P146, DOI 10.1002/em.2850140303; Ohnishi M, 2010, BRAIN RES, V1347, P170, DOI 10.1016/j.brainres.2010.05.077; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pae HO, 2008, BIOCHEM BIOPH RES CO, V371, P361, DOI 10.1016/j.bbrc.2008.04.054; Randle LE, 2008, TOXICOLOGY, V243, P249, DOI 10.1016/j.tox.2007.10.011; Rushworth SA, 2006, BIOCHEM BIOPH RES CO, V341, P1007, DOI 10.1016/j.bbrc.2006.01.065; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Schwartsburd PM, 2004, MECH AGEING DEV, V125, P581, DOI 10.1016/j.mad.2004.08.003; Seidel P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-145; Simon SA, 2008, J CLIN INVEST, V118, P2383, DOI 10.1172/JCI36111; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Stein S, 2006, MUTAT RES-GEN TOX EN, V608, P1, DOI 10.1016/j.mrgentox.2006.01.009; Volti GL, 2002, BIOCHEM BIOPH RES CO, V296, P1077, DOI 10.1016/S0006-291X(02)02054-5; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Yang H, 2011, J GINSENG RES, V35, P352, DOI 10.5142/jgr.2011.35.3.352	52	67	72	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41676	10.1371/journal.pone.0041676	http://dx.doi.org/10.1371/journal.pone.0041676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848562	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600101
J	Rosenberg, A; Sinai, L; Smith, Y; Ben-Yehuda, S				Rosenberg, Alex; Sinai, Lior; Smith, Yoav; Ben-Yehuda, Sigal			Dynamic Expression of the Translational Machinery during Bacillus subtilis Life Cycle at a Single Cell Level	PLOS ONE			English	Article							RIBOSOMAL-RNA OPERONS; ESCHERICHIA-COLI; GENE-EXPRESSION; RIBONUCLEIC-ACID; STREPTOMYCES-COELICOLOR; STRINGENT RESPONSE; BALANCED GROWTH; MESSENGER-RNA; COPY NUMBER; IN-VIVO	The ability of bacteria to responsively regulate the expression of translation components is crucial for rapid adaptation to fluctuating environments. Utilizing Bacillus subtilis (B. subtilis) as a model organism, we followed the dynamics of the translational machinery at a single cell resolution during growth and differentiation. By comprehensive monitoring the activity of the major rrn promoters and ribosomal protein production, we revealed diverse dynamics between cells grown in rich and poor medium, with the most prominent dissimilarities exhibited during deep stationary phase. Further, the variability pattern of translational activity varied among the cells, being affected by nutrient availability. We have monitored for the first time translational dynamics during the developmental process of sporulation within the two distinct cellular compartments of forespore and mother-cell. Our study uncovers a transient forespore specific increase in expression of translational components. Finally, the contribution of each rrn promoter throughout the bacterium life cycle was found to be relatively constant, implying that differential expression is not the main purpose for the existence of multiple rrn genes. Instead, we propose that coordination of the rrn operons serves as a strategy to rapidly fine tune translational activities in a synchronized fashion to achieve an optimal translation level for a given condition.	[Rosenberg, Alex; Sinai, Lior; Ben-Yehuda, Sigal] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Smith, Yoav] Hebrew Univ Jerusalem, Hadassah Med Sch, Genom Data Anal Unit, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosenberg, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	sigalb@ekmd.huji.ac.il		Rosenberg, Alex/0000-0001-9672-1360	European Research Council (ERC) [209130]; Israel Science Foundation [696/07]	European Research Council (ERC)(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation)	This work was supported by the European Research Council (ERC) Starting Grant (209130), and by the Israel Science Foundation (696/07) awarded to S B-Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Akanuma G, 2006, J BACTERIOL, V188, P2715, DOI 10.1128/JB.188.7.2715-2720.2006; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BERCOVIER H, 1986, BIOCHEM BIOPH RES CO, V136, P1136, DOI 10.1016/0006-291X(86)90452-3; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BONAMY C, 1973, J BACTERIOL, V113, P1296, DOI 10.1128/JB.113.3.1296-1306.1973; Botella E, 2010, MICROBIOL-SGM, V156, P1600, DOI 10.1099/mic.0.035758-0; Bremer H, 1996, ESCHERICHIA COLI SAL; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Camp AH, 2008, MOL MICROBIOL, V69, P402, DOI 10.1111/j.1365-2958.2008.06289.x; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Chary VK, 2005, J BACTERIOL, V187, P6832, DOI 10.1128/JB.187.19.6832-6840.2005; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; Condon C, 1996, P NATL ACAD SCI USA, V93, P6992, DOI 10.1073/pnas.93.14.6992; CONDON C, 1992, EMBO J, V11, P4175, DOI 10.1002/j.1460-2075.1992.tb05511.x; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; Harwood CR, 1990, MOL BIOL METHODS BAC, pxxxv; Henkin T. M., 2002, BACILLUS SUBTILIS IT, P313; HUSSEY C, 1971, J MOL BIOL, V57, P59, DOI 10.1016/0022-2836(71)90119-7; KARMAZYNCAMPELLI C, 1989, GENE DEV, V3, P150, DOI 10.1101/gad.3.2.150; Kim HL, 2007, J MICROBIOL BIOTECHN, V17, P1708; Kim HL, 2008, CURR MICROBIOL, V57, P537, DOI 10.1007/s00284-008-9238-1; KJELDGAARD N, 1961, BIOCHIM BIOPHYS ACTA, V49, P64, DOI 10.1016/0006-3002(61)90870-8; KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Koch A L, 1971, Adv Microb Physiol, V6, P147, DOI 10.1016/S0065-2911(08)60069-7; KOCH AL, 1971, J MOL BIOL, V55, P549, DOI 10.1016/0022-2836(71)90336-6; Koga K, 2006, J GEN APPL MICROBIOL, V52, P119, DOI 10.2323/jgam.52.119; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Lopez-Lopez A, 2007, J MOL EVOL, V65, P687, DOI 10.1007/s00239-007-9047-3; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; Meyerovich M, 2010, P NATL ACAD SCI USA, V107, P11543, DOI 10.1073/pnas.0912989107; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Nanamiya H, 2006, J GEN APPL MICROBIOL, V52, P249, DOI 10.2323/jgam.52.249; Nanamiya H, 2010, MICROBIOL-SGM, V156, P2944, DOI 10.1099/mic.0.035295-0; Natori Y, 2009, J BACTERIOL, V191, P4555, DOI 10.1128/JB.00263-09; NEIDHARDT FC, 1960, BIOCHIM BIOPHYS ACTA, V42, P99, DOI 10.1016/0006-3002(60)90757-5; Niranjanakumari S, 1998, NUCLEIC ACIDS RES, V26, P3090, DOI 10.1093/nar/26.13.3090; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; OCHI K, 1981, J BIOL CHEM, V256, P6866; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; OGASAWARA N, 1983, NUCLEIC ACIDS RES, V11, P6301, DOI 10.1093/nar/11.18.6301; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; OKAMOTO K, 1992, BIOCHIMIE, V74, P613, DOI 10.1016/0300-9084(92)90132-X; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Pelchat M, 1999, RNA, V5, P281, DOI 10.1017/S1355838299980858; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; QI FX, 1991, J BACTERIOL, V173, P7050, DOI 10.1128/jb.173.21.7050-7054.1991; Samarrai W, 2011, J BACTERIOL, V193, P723, DOI 10.1128/JB.00708-10; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SLOMA A, 1979, MOL GEN GENET, V175, P113, DOI 10.1007/BF00425526; Sojka L, 2011, NUCLEIC ACIDS RES, V39, P4598, DOI 10.1093/nar/gkr032; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P6670, DOI 10.1128/AEM.70.11.6670-6677.2004; Stevenson BS, 1998, J BACTERIOL, V180, P1970, DOI 10.1128/JB.180.7.1970-1972.1998; STEWART GC, 1983, NUCLEIC ACIDS RES, V11, P6289, DOI 10.1093/nar/11.18.6289; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; SUN DX, 1989, GENE DEV, V3, P141, DOI 10.1101/gad.3.2.141; TESTA D, 1975, NATURE, V254, P630, DOI 10.1038/254630a0; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; Wang LF, 1999, J BACTERIOL, V181, P353, DOI 10.1128/JB.181.1.353-356.1999; WELLINGTON SR, 1993, J BIOL CHEM, V268, P7205; YATES JL, 1980, P NATL ACAD SCI-BIOL, V77, P1837, DOI 10.1073/pnas.77.4.1837; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	78	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41921	10.1371/journal.pone.0041921	http://dx.doi.org/10.1371/journal.pone.0041921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848659	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600144
J	Selva, L; Ciruela, P; Blanchette, K; del Amo, E; Pallares, R; Orihuela, CJ; Munoz-Almagro, C				Selva, Laura; Ciruela, Pilar; Blanchette, Krystle; del Amo, Eva; Pallares, Roman; Orihuela, Carlos J.; Munoz-Almagro, Carmen			Prevalence and Clonal Distribution of pcpA, psrP and Pilus-1 among Pediatric Isolates of Streptococcus pneumoniae	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; UNITED-STATES; PARAPNEUMONIC EMPYEMA; INVASIVE-DISEASE; CHILDREN; PROTEIN; IDENTIFICATION; ANTIBODIES; CARRIAGE	Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective of this study was to determine the distribution and clonal type variability of three potential vaccine antigens: Pneumococcal serine-rich repeat protein (PsrP), Pilus-1, and Pneumococcal choline binding protein A (PcpA) among pneumococcal isolates from children with invasive pneumococcal disease and healthy nasopharyngeal carriers. We studied by Real-Time PCR a total of 458 invasive pneumococcal isolates and 89 nasopharyngeal pneumococcal isolates among children (total = 547 strains) collected in Barcelona, Spain, from January 2004 to July 2010. pcpA, psrP and pilus-1 were detected in 92.8%, 51.7% and 14.4% of invasive isolates and in 92.1%, 48.3% and 18% of carrier isolates, respectively. Within individual serotypes the prevalence of psrP and pilus-1 was highly dependent on the clonal type. pcpA was highly prevalent in all strains with the exception of those belonging to serotype 3 (33.3% in serotype 3 isolates vs. 95.1% in other serotypes; P <.001). psrP was significantly more frequent in those serotypes that are less apt to be detected in carriage than in disease; 58.7% vs. 39.1% P <.001. Antibiotic resistance was associated with the presence of pilus-1 and showed a negative correlation with psrP. These results indicate that PcpA, and subsequently Psrp and Pilus-1 together might be good candidates to be used in a next-generation of multivalent pneumococcal protein vaccine.	[Selva, Laura; del Amo, Eva; Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Dept Mol Microbiol, Barcelona, Spain; [Blanchette, Krystle; Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Pallares, Roman] Univ Barcelona, Bellvitge Hosp, Ciberes, Dept Infect Dis,Idibell, Barcelona, Spain	University of Texas System; University of Texas Health San Antonio; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Selva, L (corresponding author), Univ Hosp St Joan de Deu, Dept Mol Microbiol, Barcelona, Spain.	cma@hsjdbcn.org	PALLARES, Roman/B-5710-2008; Munoz-Almagro, Carmen/B-4308-2015; Muñoz-Almagro, Carmen/N-7248-2015	PALLARES, Roman/0000-0003-3262-8508; Munoz-Almagro, Carmen/0000-0001-5586-404X; Muñoz-Almagro, Carmen/0000-0001-5586-404X	Caja Navarra Foundation; Agency for Management of University and Research Grants (AGAUR) [2009/SGR 136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078972] Funding Source: NIH RePORTER	Caja Navarra Foundation; Agency for Management of University and Research Grants (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Caja Navarra Foundation and by Agency for Management of University and Research Grants (AGAUR) (expedient number 2009/SGR 136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; [Anonymous], PNEUM VACC SUPP; [Anonymous], PNEUM STRAT OV; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Eastham KM, 2004, THORAX, V59, P522, DOI 10.1136/thx.2003.016105; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Hagerman A, 2012, CLIN MICROBIOL INFEC, V18, P756, DOI 10.1111/j.1469-0691.2011.03629.x; Harfouche C, 2012, INFECT IMMUN, V80, P451, DOI 10.1128/IAI.05780-11; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Huang SS, 2011, VACCINE, V29, P3398, DOI 10.1016/j.vaccine.2011.02.088; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Kaur R, 2011, PEDIATR INFECT DIS J, V30, P645, DOI 10.1097/INF.0b013e31821c2d8b; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Li STT, 2010, PEDIATRICS, V125, P26, DOI 10.1542/peds.2009-0184; Moschioni M, 2010, CLIN MICROBIOL INFEC, V16, P1501, DOI [10.1111/j.1469-0691.2009.03105.x, 10.1111/j.1469-0691.2010.03105.x]; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Munoz-Almagro C, 2011, EUR J CLIN MICROBIOL, V30, P327, DOI 10.1007/s10096-010-1086-9; Munoz-Almagro C, 2010, CLIN VACCINE IMMUNOL, V17, P1672, DOI 10.1128/CVI.00271-10; National Committee for Clinical Laboratory Standards (NCCLS), 2008, M100S18 CLSI; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obando I, 2008, EMERG INFECT DIS, V14, P1390, DOI 10.3201/eid1409.071094; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pulido M, 2010, VACCINE, V28, P889, DOI 10.1016/j.vaccine.2009.10.121; Regev-Yochay G, 2010, VACCINE, V28, P4842, DOI 10.1016/j.vaccine.2010.04.042; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Tarrago D, 2011, ANTIMICROB AGENTS CH, V55, P2297, DOI 10.1128/AAC.01494-10; Vainio A, 2011, EUR J CLIN MICROBIOL, V30, P515, DOI 10.1007/s10096-010-1112-y	44	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41587	10.1371/journal.pone.0041587	http://dx.doi.org/10.1371/journal.pone.0041587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848535	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600089
J	Zhang, YC; Buonanno, A; Vertes, RP; Hoover, WB; Lisman, JE				Zhang, Yuchun; Buonanno, Andres; Vertes, Robert P.; Hoover, Walter B.; Lisman, John E.			NR2C in the Thalamic Reticular Nucleus; Effects of the NR2C Knockout	PLOS ONE			English	Article							NMDA RECEPTOR SUBTYPES; RAT-BRAIN; REGIONAL EXPRESSION; SCHIZOPHRENIA; SUBUNIT; NEURONS	NMDAR antagonists can evoke delta frequency bursting in the nucleus reticularis of the thalamus (nRT). The mechanism of this oscillation was determined; antagonist blocks an NR2C-like conductance that has low Mg block at resting potential and thus can contribute a resting inward current in response to ambient glutamate. Block of this current hyperpolarizes the cell, deinactivating T-type Ca channels and thus triggering delta frequency bursting. The basis for assuming a NR2C-like conductance was that (1) transcripts for NR2C are abundant in the thalamus and (2) the current-voltage curve of the synaptically evoked NMDAR current has the low rectification characteristic of NR2C. In the current study, we have sought to determine whether the channels that generate the NMDAR current are NR2C-like or are actually comprised of receptors containing NR2C. We studied the current-voltage curve of synaptically evoked NMDAR current in the nRT of NR2C knockout mice. In wild-type mice, the current was weakly voltage dependent, as previously observed in rats. This weak rectification was absent in NR2C KO mice. In contrast, NR2C KO had no effect on the strongly rectifying NMDAR current in pyramidal cells of the prefrontal cortex. These results demonstrate that the low rectification normally observed in the nRT is due to NR2C.	[Zhang, Yuchun; Lisman, John E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Zhang, Yuchun; Lisman, John E.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA; [Buonanno, Andres] NICHHD, Mol Neurobiol Sect, NIH, Bethesda, MD 20892 USA; [Vertes, Robert P.; Hoover, Walter B.] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA	Brandeis University; Brandeis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University System of Florida; Florida Atlantic University	Zhang, YC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	Lisman@brandeis.edu			National Institutes of Health [MH086518]; Eunice Shriver Kennedy National Institutes of Child Health and Human Development intramural research program; National Science Foundation [IOS 0820639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Shriver Kennedy National Institutes of Child Health and Human Development intramural research program; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	YZ and JEL acknowledge the support of National Institutes of Health grant MH086518. AB is supported by the Eunice Shriver Kennedy National Institutes of Child Health and Human Development intramural research program. RPV and WBH acknowledge the support of National Science Foundation grant IOS 0820639. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Lu CY, 2006, J NEUROPHYSIOL, V96, P2282, DOI 10.1152/jn.00078.2006; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mullasseril P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1085; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Takahashi T, 1996, J NEUROSCI, V16, P4376; Vertes RP, 2006, J COMP NEUROL, V499, P768, DOI 10.1002/cne.21135; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wenzel A, 1996, J NEUROCHEM, V66, P1240; Zhang YC, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.020.2009	17	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41908	10.1371/journal.pone.0041908	http://dx.doi.org/10.1371/journal.pone.0041908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848654	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600140
J	Evangelou, M; Rendon, A; Ouwehand, WH; Wernisch, L; Dudbridge, F				Evangelou, Marina; Rendon, Augusto; Ouwehand, Willem H.; Wernisch, Lorenz; Dudbridge, Frank			Comparison of Methods for Competitive Tests of Pathway Analysis	PLOS ONE			English	Article							GENOMEWIDE ASSOCIATION; BIOLOGICAL PATHWAYS; MULTIPLE SNPS; GENE	It has been suggested that pathway analysis can complement single-SNP analysis in exploring genomewide association data. Pathway analysis incorporates the available biological knowledge of genes and SNPs and is expected to improve the chances of revealing the underlying genetic architecture of complex traits. Methods for pathway analysis can be classified as competitive (enrichment) or self-contained (association) according to the hypothesis tested. Although association tests are statistically more powerful than enrichment tests they can be difficult to calibrate because biases in analysis accumulate across multiple SNPs or genes. Furthermore, enrichment tests can be more scientifically relevant than association tests, as they detect pathways with relatively more evidence for association than the remaining genes. Here we show how some well known association tests can be simply adapted to test for enrichment, and compare their performance to some established enrichment tests. We propose versions of the Adaptive Rank Truncated Product (ARTP), Tail Strength Measure and Fisher's combination of p-values for testing the enrichment null hypothesis. We compare the behaviour of these proposed methods with the established Hypergeometric Test and Gene-Set Enrichment Analysis (GSEA). The results of the simulation study show that the modified version of the ARTP method has generally the best performance across the situations considered. The methods were also applied for finding enriched pathways for body mass index (BMI) and platelet function phenotypes. The pathway analysis of BMI identified the Vasoactive Intestinal Peptide pathway as significantly associated with BMI. This pathway has been previously reported as associated with BMI and the risk of obesity. The ARTP method was the method that identified the largest number of enriched pathways across all tested pathway databases and phenotypes. The simulation and data application results are in agreement with previous work on association tests and suggests that the ARTP should be preferred for both enrichment and association testing.	[Evangelou, Marina; Rendon, Augusto; Wernisch, Lorenz] Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; [Rendon, Augusto; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Rendon, Augusto; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Cambridge, England; [Dudbridge, Frank] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	MRC Biostatistics Unit; University of Cambridge; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine	Evangelou, M (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England.	marina.evangelou@mrc-bsu.cam.ac.uk		Rendon, Augusto/0000-0001-8994-0039; Dudbridge, Frank/0000-0002-8817-8908; Ouwehand, Willem/0000-0002-7744-1790; Evangelou, Marina/0000-0003-0789-8944	Medical Research Council [U105260799]; 6th Framework Program of the European Union [LSHM-CT-2004-503485]; National Institute for Health Research (NIHR) [RP-PG-0310-1002]; British Heart Foundation [RG/09/12/28096]; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; Medical Research Council [G1000718, MC_U105260799] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1002] Funding Source: researchfish; MRC [G1000718, MC_U105260799] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 6th Framework Program of the European Union(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council U105260799. The platelets GWAS is part of the Bloodomics project (www.bloodomics.org), funded by the 6th Framework Program of the European Union (LSHM-CT-2004-503485). This was supported in part by program grants from the National Institute for Health Research (NIHR) (RP-PG-0310-1002, to Willem H. Ouwehand) and from the British Heart Foundation (RG/09/12/28096, to Augusto Rendon). The EPIC-Norfolk GWAS data are part of the EPIC study (http://www.srl.cam.ac.uk/epic/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Chasman DI, 2008, GENET EPIDEMIOL, V32, P658, DOI 10.1002/gepi.20334; Chen L, 2009, BIOINFORMATICS, V25, P237, DOI 10.1093/bioinformatics/btn613; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dadd T, 2009, GENET EPIDEMIOL, V33, P290, DOI 10.1002/gepi.20379; Day N, 1999, BRIT J CANCER, V80, P95; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LANCASTER HO, 1949, BIOMETRIKA, V36, P370, DOI 10.2307/2332674; LITTLE RJA, 1989, AM STAT, V43, P283, DOI 10.2307/2685390; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	29	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41018	10.1371/journal.pone.0041018	http://dx.doi.org/10.1371/journal.pone.0041018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859961	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600013
J	Ortmann, AC; Anders, J; Shelton, N; Gong, LM; Moss, AG; Condon, RH				Ortmann, Alice C.; Anders, Jennifer; Shelton, Naomi; Gong, Limin; Moss, Anthony G.; Condon, Robert H.			Dispersed Oil Disrupts Microbial Pathways in Pelagic Food Webs	PLOS ONE			English	Article							DEEP-WATER HORIZON; GULF-OF-MEXICO; CRUDE-OIL; BACTERIAL OXIDATION; DEGRADING BACTERIA; MARINE ECOSYSTEM; BIODEGRADATION; COMMUNITY; DYNAMICS; SPILL	Most of the studies of microbial processes in response to the Deepwater Horizon oil spill focused on the deep water plume, and not on the surface communities. The effects of the crude oil and the application of dispersants on the coastal microbial food web in the northern Gulf of Mexico have not been well characterized even though these regions support much of the fisheries production in the Gulf. A mesocosm experiment was carried out to determine how the microbial community off the coast of Alabama may have responded to the influx of surface oil and dispersants. While the addition of glucose or oil alone resulted in an increase in the biomass of ciliates, suggesting transfer of carbon to higher trophic levels was likely; a different effect was seen in the presence of dispersant. The addition of dispersant or dispersed oil resulted in an increase in the biomass of heterotrophic prokaryotes, but a significant inhibition of ciliates, suggesting a reduction in grazing and decrease in transfer of carbon to higher trophic levels. Similar patterns were observed in two separate experiments with different starting nutrient regimes and microbial communities suggesting that the addition of dispersant and dispersed oil to the northern Gulf of Mexico waters in 2010 may have reduced the flow of carbon to higher trophic levels, leading to a decrease in the production of zooplankton and fish on the Alabama shelf.	[Ortmann, Alice C.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Ortmann, Alice C.; Anders, Jennifer; Shelton, Naomi; Condon, Robert H.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Gong, Limin; Moss, Anthony G.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	University of South Alabama; Dauphin Island Sea Lab; Auburn University System; Auburn University	Ortmann, AC (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	aortmann@disl.org			Marine Environmental Science Consortium British Petroleum Gulf of Mexico Research Initiative (MESC/BP GRI)	Marine Environmental Science Consortium British Petroleum Gulf of Mexico Research Initiative (MESC/BP GRI)	Funding was provided by individual grants to ACO, AGM and RHC through the Marine Environmental Science Consortium British Petroleum Gulf of Mexico Research Initiative (MESC/BP GRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OR, 2001, MICROBIAL ECOL, V42, P474, DOI 10.1007/s00248-001-0008-x; [Anonymous], 2010, OIL BUDGET CALCULATO; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Bronk DA, 2000, MAR CHEM, V69, P163, DOI 10.1016/S0304-4203(99)00103-6; Bruheim P, 1999, APPL ENVIRON MICROB, V65, P1658; Bruheim P, 1998, CAN J MICROBIOL, V44, P195, DOI 10.1139/cjm-44-2-195; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carassou L, 2011, MAR COAST FISH, V3, P411, DOI 10.1080/19425120.2011.642492; Echeveste P, 2010, ENVIRON POLLUT, V158, P299, DOI 10.1016/j.envpol.2009.07.006; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Huang YJ, 2011, ENVIRON MONIT ASSESS, V176, P517, DOI 10.1007/s10661-010-1601-6; Jean JS, 2008, BIORESOURCE TECHNOL, V99, P7807, DOI 10.1016/j.biortech.2008.01.064; Jimenez N, 2007, APPL MICROBIOL BIOT, V77, P935, DOI 10.1007/s00253-007-1229-9; Jung SW, 2010, J MICROBIOL, V48, P594, DOI 10.1007/s12275-010-0199-2; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Koshikawa H, 2007, ESTUAR COAST SHELF S, V71, P68, DOI 10.1016/j.ecss.2006.08.008; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; LINDEN O, 1987, ENVIRON SCI TECHNOL, V21, P374, DOI 10.1021/es00158a007; Lindstrom JE, 2002, MAR POLLUT BULL, V44, P739, DOI 10.1016/S0025-326X(02)00050-4; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MULKINSPHILLIPS GJ, 1974, APPL MICROBIOL, V28, P547, DOI 10.1128/AEM.28.4.547-552.1974; Operational Science Advisory Team (OSAT-2), 2011, SUMM REP FAT EFF REM; OSAT, 2010, SUMM REP SUBS SUBS O; PARSONS TR, 1984, MAR ENVIRON RES, V13, P265, DOI 10.1016/0141-1136(84)90033-3; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Sharp JH, 2002, BIOGEOCHEMISTRY MARI, P35, DOI DOI 10.1016/B978-012323841-2/50004-X; Sherr E.B., 1993, HDB METHODS AQUATIC, P207; Sherr EB, 1993, HDB METHODS AQUATIC, p[213, 227]; SIRON R, 1993, MAR ENVIRON RES, V35, P273, DOI 10.1016/0141-1136(93)90098-K; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004; Yoshida A, 2006, MAR POLLUT BULL, V52, P89, DOI 10.1016/j.marpolbul.2005.08.015	40	47	48	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42548	10.1371/journal.pone.0042548	http://dx.doi.org/10.1371/journal.pone.0042548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860136	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600108
J	Pandey, D; Vanya, V; Bhagat, S; Vs, B; Shetty, J				Pandey, Deeksha; Vanya, Vidhi; Bhagat, Saurav; Vs, Binu; Shetty, Jyothi			Awareness and Attitude towards Human Papillomavirus (HPV) Vaccine among Medical Students in a Premier Medical School in India	PLOS ONE			English	Article							CERVICAL-CANCER; KNOWLEDGE; WOMEN	Background: As preventing cancer with the help of a vaccine is a comparatively new concept, awareness and education about it will have important implication in the implementation of this strategy. Materials and Methods: Present explorative questionnaire based survey included 618 MBBS students for final analysis. Results: Majority of participants (89.6%) were well aware of the preventable nature of cervical cancer. Most of them (89.2%) knew that necessary factor responsible for cervical cancer is infection with high risk HPV. Awareness regarding the availability of vaccine against cervical cancer was 75.6%. Females had a better awareness regarding availability of vaccine, target population for vaccination and about the catch up program. Overall acceptance of HPV vaccine among the population studied was 67.8%. Medical teaching had a definitive impact on the understanding of this important public health issue. Females seemed to be more ready to accept the vaccine and recommend it to others. For our study population the most common source of information was medical school teaching. Majority of participants agreed that the most important obstacle in implementation of HPV vaccination program in our country is inadequate information and 86.2% wanted to be educated by experts in this regard. Conclusion: HPV vaccine for primary prevention of cervical cancer is a relatively new concept. Health professional will be able to play a pivotal role in popularizing this strategy.	[Pandey, Deeksha; Shetty, Jyothi] Manipal Univ, Kasturba Med Coll, Dept Obstet & Gynecol, Manipal, Karnataka, India; [Vs, Binu] Manipal Univ, Dept Stat, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE)	Pandey, D (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Obstet & Gynecol, Manipal, Karnataka, India.	deekshiiiobg@gmail.com		SHETTY, DR JYOTHI/0000-0002-4523-7437				Baykal C, 2008, EUR J GYNAECOL ONCOL, V29, P76; Bharadwaj M, 2009, INDIAN J MED RES, V130, P327; Bhatla N, 2009, INDIAN J MED RES, V130, P334; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Donders GGG, 2008, ARCH GYNECOL OBSTET, V277, P291, DOI 10.1007/s00404-007-0487-1; Joy T, 2011, ASIAN PAC J CANCER P, V12, P1707; Kwan TTC, 2008, SEX TRANSM INFECT, V84, P227, DOI 10.1136/sti.2007.029363; Laikangbam P, 2007, INT J GYNECOL CANCER, V17, P107, DOI 10.1111/j.1525-1438.2007.00827.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Redman M, 2001, AM J OBSTET GYNECOL, V185, pS119, DOI 10.1016/S0002-9378(01)80175-7; Saha A, 2010, ASIAN PAC J CANCER P, V11, P1085; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	13	46	47	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e40619	10.1371/journal.pone.0040619	http://dx.doi.org/10.1371/journal.pone.0040619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859950	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600008
J	Vacchi-Suzzi, C; Bauer, Y; Berridge, BR; Bongiovanni, S; Gerrish, K; Hamadeh, HK; Letzkus, M; Lyon, J; Moggs, J; Paules, RS; Pognan, F; Staedtler, F; Vidgeon-Hart, MP; Grenet, O; Couttet, P				Vacchi-Suzzi, Caterina; Bauer, Yasmina; Berridge, Brian R.; Bongiovanni, Sandrine; Gerrish, Kevin; Hamadeh, Hisham K.; Letzkus, Martin; Lyon, Jonathan; Moggs, Jonathan; Paules, Richard S.; Pognan, Francois; Staedtler, Frank; Vidgeon-Hart, Martin P.; Grenet, Olivier; Couttet, Philippe			Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; GENE; MECHANISMS; RNA; CARDIOTOXICITY; SIPA1; DNA	Anti-cancer therapy based on anthracyclines (DNA intercalating Topoisomerase II inhibitors) is limited by adverse effects of these compounds on the cardiovascular system, ultimately causing heart failure. Despite extensive investigations into the effects of doxorubicin on the cardiovascular system, the molecular mechanisms of toxicity remain largely unknown. MicroRNAs are endogenously transcribed non-coding 22 nucleotide long RNAs that regulate gene expression by decreasing mRNA stability and translation and play key roles in cardiac physiology and pathologies. Increasing doses of doxorubicin, but not etoposide (a Topoisomerase II inhibitor devoid of cardiovascular toxicity), specifically induced the up-regulation of miR-208b, miR-216b, miR-215, miR-34c and miR-367 in rat hearts. Furthermore, the lowest dosing regime (1 mg/kg/week for 2 weeks) led to a detectable increase of miR-216b in the absence of histopathological findings or alteration of classical cardiac stress biomarkers. In silico microRNA target predictions suggested that a number of doxorubicin-responsive microRNAs may regulate mRNAs involved in cardiac tissue remodeling. In particular miR-34c was able to mediate the DOX-induced changes of Sipa1 mRNA (a mitogen-induced Rap/Ran GTPase activating protein) at the post-transcriptional level and in a seed sequence dependent manner. Our results show that integrated heart tissue microRNA and mRNA profiling can provide valuable early genomic biomarkers of drug-induced cardiac injury as well as novel mechanistic insight into the underlying molecular pathways.	[Vacchi-Suzzi, Caterina; Bongiovanni, Sandrine; Letzkus, Martin; Moggs, Jonathan; Pognan, Francois; Staedtler, Frank; Grenet, Olivier; Couttet, Philippe] Novartis Inst Biomed Res, Basel, Switzerland; [Bauer, Yasmina] Actel Pharmaceut Ltd, Translat Sci Biol, Allschwil, Switzerland; [Berridge, Brian R.] GlaxoSmithKline, Safety Assessment, Res Triangle Pk, NC USA; [Gerrish, Kevin; Paules, Richard S.] Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC USA; [Hamadeh, Hisham K.] Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA; [Lyon, Jonathan; Vidgeon-Hart, Martin P.] GlaxoSmithKline, Investigat Preclin Toxicol, Ware, Herts, England	Novartis; Actelion Pharmaceuticals Ltd; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Amgen; GlaxoSmithKline	Vacchi-Suzzi, C (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	philippe.couttet@novartis.com	Couttet, Philippe/AAH-5489-2019	Paules, Richard S/0000-0001-9106-7486; Couttet, Philippe/0000-0002-5255-6647	HESI Application of Genomics to Mechanism-Based Risk Assessment Technical Committee; International Life Sciences Institute (ILSI); Health and Environmental Sciences Institutes (HESI); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES023026] Funding Source: NIH RePORTER	HESI Application of Genomics to Mechanism-Based Risk Assessment Technical Committee; International Life Sciences Institute (ILSI); Health and Environmental Sciences Institutes (HESI); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the HESI Application of Genomics to Mechanism-Based Risk Assessment Technical Committee, whose work is funded through the International Life Sciences Institute (ILSI) and the Health and Environmental Sciences Institutes (HESI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardi E, 2007, PATHOL ONCOL RES, V13, P249, DOI 10.1007/BF02893506; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; CAULFIELD JB, 1990, TOXICOL PATHOL, V18, P488, DOI 10.1177/0192623390004Part_107; Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5; Crawford NPS, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1389; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; deBold AJ, 1996, CARDIOVASC RES, V31, P7, DOI 10.1016/S0008-6363(95)00121-2; Deng G., 2010, J BIOL CHEM; DORN GW, 1994, AM J PHYSIOL, V267, pH400, DOI 10.1152/ajpheart.1994.267.1.H400; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hasinoff BB, 2007, CARDIOVASC TOXICOL, V7, P140, DOI 10.1007/s12012-007-0023-3; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Herman EH, 1998, SEMIN ONCOL, V25, P15; Horie T, 2010, CARDIOVASCULAR RES; Jeyaraj SC, 2011, LIFE SCI, V88, P645, DOI 10.1016/j.lfs.2011.01.023; Jones RL, 2006, EXPERT OPIN DRUG SAF, V5, P791, DOI 10.1517/14740338.5.6.791; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Minato N, 2009, CANCER SCI, V100, P17, DOI 10.1111/j.1349-7006.2008.01011.x; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shimizu Y, 2011, CANCER SCI, V102, P828, DOI 10.1111/j.1349-7006.2011.01876.x; STORM G, 1989, CANCER CHEMOTH PHARM, V24, P341, DOI 10.1007/BF00257439; Suzuki T, 1998, AM HEART J, V136, P362, DOI 10.1053/hj.1998.v136.89908; Taylor EL, 2008, TOXICOLOGY, V246, P34, DOI 10.1016/j.tox.2007.12.030; Thompson K, 2009, CANC CHEMOTHERAPY PH; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728	45	78	80	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e40395	10.1371/journal.pone.0040395	http://dx.doi.org/10.1371/journal.pone.0040395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859947	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600007
J	Zook, JM; Samarov, D; McDaniel, J; Sen, SK; Salit, M				Zook, Justin M.; Samarov, Daniel; McDaniel, Jennifer; Sen, Shurjo K.; Salit, Marc			Synthetic Spike-in Standards Improve Run-Specific Systematic Error Analysis for DNA and RNA Sequencing	PLOS ONE			English	Article							GENOME; DISCOVERY; MUTATIONS; FRAMEWORK	While the importance of random sequencing errors decreases at higher DNA or RNA sequencing depths, systematic sequencing errors (SSEs) dominate at high sequencing depths and can be difficult to distinguish from biological variants. These SSEs can cause base quality scores to underestimate the probability of error at certain genomic positions, resulting in false positive variant calls, particularly in mixtures such as samples with RNA editing, tumors, circulating tumor cells, bacteria, mitochondrial heteroplasmy, or pooled DNA. Most algorithms proposed for correction of SSEs require a data set used to calculate association of SSEs with various features in the reads and sequence context. This data set is typically either from a part of the data set being "recalibrated" (Genome Analysis ToolKit, or GATK) or from a separate data set with special characteristics (SysCall). Here, we combine the advantages of these approaches by adding synthetic RNA spike-in standards to human RNA, and use GATK to recalibrate base quality scores with reads mapped to the spike-in standards. Compared to conventional GATK recalibration that uses reads mapped to the genome, spike-ins improve the accuracy of Illumina base quality scores by a mean of 5 Phred-scaled quality score units, and by as much as 13 units at CpG sites. In addition, since the spike-in data used for recalibration are independent of the genome being sequenced, our method allows run-specific recalibration even for the many species without a comprehensive and accurate SNP database. We also use GATK with the spike-in standards to demonstrate that the Illumina RNA sequencing runs overestimate quality scores for AC, CC, GC, GG, and TC dinucleotides, while SOLiD has less dinucleotide SSEs but more SSEs for certain cycles. We conclude that using these DNA and RNA spike-in standards with GATK improves base quality score recalibration.	[Zook, Justin M.; McDaniel, Jennifer; Salit, Marc] NIST, Div Biochem Sci, Gaithersburg, MD 20899 USA; [Samarov, Daniel] NIST, Stat Engn Div, Gaithersburg, MD 20899 USA; [Sen, Shurjo K.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Zook, JM (corresponding author), NIST, Div Biochem Sci, Gaithersburg, MD 20899 USA.	zook@nist.gov	Zook, Justin/B-7000-2008	Zook, Justin/0000-0003-2309-8402	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bolton Bryan J., 1996, P283; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobrowolski SF, 2009, HUM MUTAT, V30, P891, DOI 10.1002/humu.21003; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Nachman MW, 2000, GENETICS, V156, P297; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pine PS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-38; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110	24	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41356	10.1371/journal.pone.0041356	http://dx.doi.org/10.1371/journal.pone.0041356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859977	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600022
J	Hable, V; Drexler, GA; Bruning, T; Burgdorf, C; Greubel, C; Derer, A; Seel, J; Strickfaden, H; Cremer, T; Friedl, AA; Dollinger, G				Hable, Volker; Drexler, Guido A.; Bruening, Tino; Burgdorf, Christian; Greubel, Christoph; Derer, Anja; Seel, Judith; Strickfaden, Hilmar; Cremer, Thomas; Friedl, Anna A.; Dollinger, Guenther			Recruitment Kinetics of DNA Repair Proteins Mdc1 and Rad52 but Not 53BP1 Depend on Damage Complexity	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; MAMMALIAN-CELLS; CELLULAR-RESPONSE; EARLY PARTICIPANT; FOCI; RADIATION; CHROMATIN; DYNAMICS; TRACKS	The recruitment kinetics of double-strand break (DSB) signaling and repair proteins Mdc1, 53BP1 and Rad52 into radiation-induced foci was studied by live-cell fluorescence microscopy after ion microirradiation. To investigate the influence of damage density and complexity on recruitment kinetics, which cannot be done by UV laser irradiation used in former studies, we utilized 43 MeV carbon ions with high linear energy transfer per ion (LET = 370 keV/mu m) to create a large fraction of clustered DSBs, thus forming complex DNA damage, and 20 MeV protons with low LET (LET = 2.6 keV/mu m) to create mainly isolated DSBs. Kinetics for all three proteins was characterized by a time lag period T-0 after irradiation, during which no foci are formed. Subsequently, the proteins accumulate into foci with characteristic mean recruitment times tau(1). Mdc1 accumulates faster (T-0 = 17 +/- 2 s, tau(1) = 98 +/- 11 s) than 53BP1 (T-0 = 77 +/- 7 s, tau(1) = 310 +/- 60 s) after high LET irradiation. However, recruitment of Mdc1 slows down (T-0 = 73 +/- 16 s, tau(1) = 1050 +/- 270 s) after low LET irradiation. The recruitment kinetics of Rad52 is slower than that of Mdc1, but exhibits the same dependence on LET. In contrast, the mean recruitment time tau(1) of 53BP1 remains almost constant when varying LET. Comparison to literature data on Mdc1 recruitment after UV laser irradiation shows that this rather resembles recruitment after high than low LET ionizing radiation. So this work shows that damage quality has a large influence on repair processes and has to be considered when comparing different studies.	[Hable, Volker; Bruening, Tino; Burgdorf, Christian; Greubel, Christoph; Seel, Judith; Dollinger, Guenther] UniBw Munchen, Angew Phys & Messtechn LRT2, Neubiberg, Germany; [Drexler, Guido A.; Derer, Anja; Friedl, Anna A.] LMU Munchen, Klin & Poliklin Strahlentherapie & Radioonkol, Munich, Germany; [Strickfaden, Hilmar; Cremer, Thomas] LMU Munchen, Dept Biol 2, Martinsried, Germany	Bundeswehr University Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich	Hable, V (corresponding author), UniBw Munchen, Angew Phys & Messtechn LRT2, Neubiberg, Germany.	guenther.dollinger@unibw.de	Cremer, Thomas/D-7979-2011; Friedl, Anna A/B-1628-2010; Strickfaden, Hilmar/AAW-3522-2021; Drexler, Guido/O-1699-2015	Cremer, Thomas/0000-0002-1830-9589; Friedl, Anna A/0000-0002-7425-6151; Drexler, Guido/0000-0002-8104-2557; Cremer, Thomas/0000-0001-7135-7216	DFG Cluster of Excellence: Munich-Centre for Advanced Photonics (MAP); German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) [3610S30015, 3610S0016]; Maier Leibnitz Laboratory Munich	DFG Cluster of Excellence: Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU); Maier Leibnitz Laboratory Munich	The authors acknowledge the financial support of the DFG Cluster of Excellence: Munich-Centre for Advanced Photonics (MAP), the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) (Project No. 3610S30015 and 3610S0016), and by the Maier Leibnitz Laboratory Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; DIRKS W, 1993, GENE, V128, P247, DOI 10.1016/0378-1119(93)90569-O; Du G, 2008, RADIAT RES, V170, P316, DOI 10.1667/RR1270.1; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Feuerhahn S, 2008, TRENDS GENET, V24, P467, DOI 10.1016/j.tig.2008.07.003; Giesen U, 2011, RADIAT PROT DOSIM, V143, P349, DOI 10.1093/rpd/ncq477; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Greubel C, 2008, RADIAT ENVIRON BIOPH, V47, P423, DOI 10.1007/s00411-008-0182-z; Grigaravicius P, 2009, CHEMPHYSCHEM, V10, P79, DOI 10.1002/cphc.200800725; Hable V, 2009, NUCL INSTRUM METH B, V267, P2090, DOI 10.1016/j.nimb.2009.03.071; Harper JV, 2008, PHOTOCHEM PHOTOBIOL, V84, P1506, DOI 10.1111/j.1751-1097.2008.00378.x; Hauptner A, 2006, KONG DANSK VIDENSK, V52, P59; Hauptner A, 2006, RADIAT PROT DOSIM, V122, P147, DOI 10.1093/rpd/ncl420; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kitao H, 2002, J BIOL CHEM, V277, P48944, DOI 10.1074/jbc.M208151200; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mallette FA, 2012, CELL RES, V22, P1221, DOI 10.1038/cr.2012.58; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mosconi M, 2011, RADIAT ENVIRON BIOPH, V50, P345, DOI 10.1007/s00411-011-0366-9; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Rupnik A, 2010, CHROMOSOMA, V119, P115, DOI 10.1007/s00412-009-0242-4; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schettino G, 2011, RADIAT PROT DOSIM, V143, P340, DOI 10.1093/rpd/ncq485; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Shi W, 2008, J BIOL CHEM, V283, P31608, DOI 10.1074/jbc.M801082200; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; van Oven C, 2009, EUR BIOPHYS J BIOPHY, V38, P721, DOI 10.1007/s00249-009-0472-7; van Royen ME, 2011, CHROMOSOME RES, V19, P83, DOI 10.1007/s10577-010-9172-5; Walter J, 2003, J MICROSC-OXFORD, V209, P71, DOI 10.1046/j.1365-2818.2003.01117.x; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200	52	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41943	10.1371/journal.pone.0041943	http://dx.doi.org/10.1371/journal.pone.0041943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860035	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900053
J	He, ZM; Cassaday, HJ; Park, SBG; Bonardi, C				He, Zhimin; Cassaday, Helen J.; Park, S. Bert G.; Bonardi, Charlotte			When to Hold That Thought: An Experimental Study Showing Reduced Inhibition of Pre-trained Associations in Schizophrenia	PLOS ONE			English	Article							PAVLOVIAN CONDITIONED INHIBITION; LATENT INHIBITION; PREPULSE INHIBITION; STARTLE REFLEX; PERSONALITY; SYMPTOMS; BLOCKING; PSYCHOSIS; DEFICITS; HUMANS	Schizophrenia encompasses a wide variety of cognitive dysfunctions, a number of which can be understood as deficits of inhibition. To date, no research has examined 'conditioned inhibition' in schizophrenia - the ability of a stimulus that signals the absence of an expected outcome to counteract the conditioned response produced by a signal for that outcome (a conditioned excitor). A computer-based task was used to measure conditioned excitation and inhibition in the same discrimination procedure, in 25 patients with a confirmed diagnosis of schizophrenia and a community-based comparison sample. Conditioned inhibition was measured by a ratio score, which compared the degree to which the inhibitory stimulus and a neutral control stimulus reduced conditioned responding to the excitatory cue: the lower the ratio, the greater the inhibitory learning. At test the ratios were 0.45 and 0.39 for patient and control groups respectively, and the relevant interaction term of the ANOVA confirmed that the degree of inhibition was reduced in the patient group, with an effect size of r = 0.28. These results demonstrate for the first time that inhibitory learning is impaired in schizophrenia. Such an impairment provides an attractive framework for the interpretation of the positive symptoms of schizophrenia. However, we were unable to demonstrate any relationship between the level of conditioned inhibition and medication. Similarly, in the present study it must be emphasised that the available data did not demonstrate any relationship between individual variation in inhibitory learning and the level of positive symptoms as measured by the PANSS. In fact inhibitory learning impairment was relatively greater in participants with a predominantly negative symptom profile and their excitatory learning was also reduced. Accordingly the next step will be to investigate such relationships in a larger sample with a priori defined sub-groups displaying predominantly positive versus predominantly negative symptoms.	[He, Zhimin; Cassaday, Helen J.; Bonardi, Charlotte] Univ Nottingham, Div Psychiat, Sch Psychol, Nottingham NG7 2RD, England; [Park, S. Bert G.] Univ Nottingham, Sch Community Hlth Sci, Div Psychiat, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	He, ZM (corresponding author), Univ Nottingham, Div Psychiat, Sch Psychol, Nottingham NG7 2RD, England.	helen.cassaday@nottingham.ac.uk		bonardi, charlotte/0000-0001-8073-8184; Cassaday, Helen/0000-0002-9227-373X; He, Zhimin/0000-0001-9713-7457	School of Psychology, University of Nottingham	School of Psychology, University of Nottingham	Funding for this study was provided by the School of Psychology, University of Nottingham. Nottingham Psychology had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; BAKER AG, 1977, ANIM LEARN BEHAV, V5, P315, DOI 10.3758/BF03209246; BARUCH I, 1988, J NERV MENT DIS, V176, P598, DOI 10.1097/00005053-198810000-00004; BEECH A, 1989, BRIT J CLIN PSYCHOL, V28, P109, DOI 10.1111/j.2044-8260.1989.tb00821.x; Bender S, 2001, SCHIZOPHR RES, V49, P157, DOI 10.1016/S0920-9964(00)00040-2; Bleuler E., 1911, DEMENTIA PRAECOX GRO; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 1999, AM J PSYCHIAT, V156, P596; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; CLARK DM, 1982, J ABNORM PSYCHOL, V91, P87, DOI 10.1037/0021-843X.91.2.87; Cohen E, 2004, BEHAV BRAIN RES, V149, P113, DOI 10.1016/S0166-4328(03)00221-3; Daskalakis ZJ, 2000, SCHIZOPHR RES, V41, P153, DOI 10.1016/S0920-9964(00)90673-X; Daskalakis ZJ, 2002, ARCH GEN PSYCHIAT, V59, P347, DOI 10.1001/archpsyc.59.4.347; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Gray JA, 1997, BEHAV BRAIN RES, V88, P27, DOI 10.1016/S0166-4328(97)02313-9; GRAY JA, 1991, BEHAV BRAIN SCI, V14, P1, DOI 10.1017/S0140525X00065055; Gray JA, 1999, PSYCHOBIOLOGY, V27, P225; GRAY NS, 1992, NEUROL PSYCHIAT BR, V1, P83; Guterman Y, 1996, SCHIZOPHR RES, V20, P315, DOI 10.1016/0920-9964(95)00086-0; Hall G., 1991, PERCEPTUAL ASS LEARN; Harmer CJ, 1999, PSYCHOPHARMACOLOGY, V142, P120, DOI 10.1007/s002130050870; He ZM, 2011, Q J EXP PSYCHOL, V64, P2334, DOI 10.1080/17470218.2011.616933; Jones SH, 1997, BEHAV BRAIN RES, V88, P103, DOI 10.1016/S0166-4328(97)02312-7; JONES SH, 1992, BIOL PSYCHIAT, V32, P739, DOI 10.1016/0006-3223(92)90078-E; Kaiser S, 2008, BRAIN COGNITION, V66, P73, DOI 10.1016/j.bandc.2007.05.007; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Kane JM, 1996, NEW ENGL J MED, V334, P34, DOI 10.1056/NEJM199601043340109; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; Kathmann N, 2000, SCHIZOPHR RES, V45, P103, DOI 10.1016/S0920-9964(99)00172-3; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E., 1919, GERMAN EDITION TXB P, P282; KRAWIECKA M, 1977, ACTA PSYCHIAT SCAND, V55, P299, DOI 10.1111/j.1600-0447.1977.tb00174.x; Kumari V, 2000, ARCH GEN PSYCHIAT, V57, P609, DOI 10.1001/archpsyc.57.6.609; Kunugi H, 2007, NEUROSCI RES, V59, P23, DOI 10.1016/j.neures.2007.05.006; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; LIPP OV, 1992, J EXP PSYCHOL ANIM B, V18, P115, DOI 10.1037/0097-7403.18.2.115; LUBOW RE, 1959, J COMP PHYSIOL PSYCH, V52, P415, DOI 10.1037/h0046700; LUBOW RE, 1995, PSYCHOL BULL, V117, P87, DOI 10.1037/0033-2909.117.1.87; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Menon M, 2007, BIOL PSYCHIAT, V62, P765, DOI 10.1016/j.biopsych.2006.10.020; Menon M, 2011, BIOL PSYCHIAT, V70, P1127, DOI 10.1016/j.biopsych.2011.05.037; Migo EA, 2006, BEHAV BRAIN RES, V168, P299, DOI 10.1016/j.bbr.2005.11.021; Moran PM, 2008, PROG NEURO-PSYCHOPH, V32, P116, DOI 10.1016/j.pnpbp.2007.07.021; Niv Y, 2009, J MATH PSYCHOL, V53, P139, DOI 10.1016/j.jmp.2008.12.005; Oades RD, 1996, J PSYCHIAT RES, V30, P369, DOI 10.1016/0022-3956(96)00006-4; Osborne J., 2002, PRACTICAL ASSESSMENT, V8, P6, DOI [DOI 10.7275/4VNG-5608, 10.7275/4vng-5608]; Pavlov I.P., 1927, CONDITIONED REFLEXES; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; REISS S, 1972, Learning and Motivation, V3, P237, DOI 10.1016/0023-9690(72)90020-3; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RESCORLA RA, 1969, PSYCHOL BULL, V72, P77, DOI 10.1037/h0027760; Rhodes SEV, 2007, EUR J NEUROSCI, V26, P2654, DOI 10.1111/j.1460-9568.2007.05855.x; Simon VM, 2000, EUR NEUROPSYCHOPHARM, V10, P159, DOI 10.1016/S0924-977X(00)00070-5; Sitskoorn MM, 2001, SCHIZOPHR RES, V49, P145; Tobler PN, 2003, J NEUROSCI, V23, P10402; VENABLES PH, 1960, BRAIN, V83, P77, DOI 10.1093/brain/83.1.77; Wagner AR, 1981, INFORM PROCESSING AN, P95; Weike AI, 2000, BIOL PSYCHIAT, V47, P61, DOI 10.1016/S0006-3223(99)00229-2; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; World Health Organization, 1992, INT STAT CLASS DIS R; Zito JM, 1994, PSYCHOTHERAPEUTIC DR	68	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42175	10.1371/journal.pone.0042175	http://dx.doi.org/10.1371/journal.pone.0042175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860074	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900075
J	Lauridsen, LH; Shamaileh, HA; Edwards, SL; Taran, E; Veedu, RN				Lauridsen, Lasse H.; Shamaileh, Hadi A.; Edwards, Stacey L.; Taran, Elena; Veedu, Rakesh N.			Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against alpha-Bungarotoxin	PLOS ONE			English	Article							IN-VITRO; EMERGING CLASS; EVOLUTION; SELEX; RECOGNITION; MICRORNAS; MOLECULES	Background: Nucleic acids based therapeutic approaches have gained significant interest in recent years towards the development of therapeutics against many diseases. Recently, research on aptamers led to the marketing of Macugen (R), an inhibitor of vascular endothelial growth factor (VEGF) for the treatment of age related macular degeneration (AMD). Aptamer technology may prove useful as a therapeutic alternative against an array of human maladies. Considering the increased interest in aptamer technology globally that rival antibody mediated therapeutic approaches, a simplified selection, possibly in one-step, technique is required for developing aptamers in limited time period. Principal Findings: Herein, we present a simple one-step selection of DNA aptamers against alpha-bungarotoxin. A toxin immobilized glass coverslip was subjected to nucleic acid pool binding and extensive washing followed by PCR enrichment of the selected aptamers. One round of selection successfully identified a DNA aptamer sequence with a binding affinity of 7.58 mu M. Conclusion: We have demonstrated a one-step method for rapid production of nucleic acid aptamers. Although the reported binding affinity is in the low micromolar range, we believe that this could be further improved by using larger targets, increasing the stringency of selection and also by combining a capillary electrophoresis separation prior to the one-step selection. Furthermore, the method presented here is a user-friendly, cheap and an easy way of deriving an aptamer unlike the time consuming conventional SELEX-based approach. The most important application of this method is that chemically-modified nucleic acid libraries can also be used for aptamer selection as it requires only one enzymatic step. This method could equally be suitable for developing RNA aptamers.	[Lauridsen, Lasse H.; Shamaileh, Hadi A.; Edwards, Stacey L.; Veedu, Rakesh N.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Lauridsen, Lasse H.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Taran, Elena] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Australian Natl Fabricat Facil, Brisbane, Qld, Australia	University of Queensland; Technical University of Denmark; University of Queensland	Lauridsen, LH (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	rakesh@uq.edu.au	Edwards, Stacey/A-4980-2011; Taran, Elena/C-5833-2009	Taran, Elena/0000-0001-7575-5545; Edwards, Stacey/0000-0001-7428-4139	University of Queensland ECR grant [2010002143]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	University of Queensland ECR grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	The work was supported by The University of Queensland ECR grant (Project ID 2010002143) awarded to RNV. LHL acknowledges the Novo Nordisk Foundation for supporting his stay at The University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Aquino-Jarquin G, 2011, INT J MOL SCI, V12, P9155, DOI 10.3390/ijms12129155; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; Crooke S. T., 2008, ANTISENSE DRUG TECHN; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; Fan Maomian, 2008, J Biomol Tech, V19, P311; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hung H, 2010, J MED TOXICOL, V6, P393, DOI 10.1007/s13181-010-0051-4; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Hoon S, 2011, BIOTECHNIQUES, V51, P413, DOI 10.2144/000113786; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Lauridsen LH, 2012, CHEMBIOCHEM, V13, P19, DOI 10.1002/cbic.201100648; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mendonsa SD, 2004, J AM CHEM SOC, V126, P20, DOI 10.1021/ja037832s; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; Nitsche A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-48; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Peng L, 2007, MICROSC RES TECHNIQ, V70, P372, DOI 10.1002/jemt.20421; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	44	45	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41702	10.1371/journal.pone.0041702	http://dx.doi.org/10.1371/journal.pone.0041702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860007	Green Published, gold			2022-12-27	WOS:000306950900034
J	Delatorre, EO; Bello, G				Delatorre, Edson Oliveira; Bello, Gonzalo			Phylodynamics of HIV-1 Subtype C Epidemic in East Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENETIC DIVERSITY; POL GENE; INTERSUBTYPE RECOMBINANTS; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; DRUG-RESISTANCE; PREGNANT-WOMEN; ADDIS-ABABA; POPULATION	The HIV-1 subtype C accounts for an important fraction of HIV infections in east Africa, but little is known about the genetic characteristics and evolutionary history of this epidemic. Here we reconstruct the origin and spatiotemporal dynamics of the major HIV-1 subtype C clades circulating in east Africa. A large number (n = 1,981) of subtype C pol sequences were retrieved from public databases to explore relationships between strains from the east, southern and central African regions. Maximum-likelihood phylogenetic analysis of those sequences revealed that most (> 70%) strains from east Africa segregated in a single regional-specific monophyletic group, here called C-EA. A second major Ethiopian subtype C lineage and a large collection of minor Kenyan and Tanzanian subtype C clades of southern African origin were also detected. A Bayesian coalescent-based method was then used to reconstruct evolutionary parameters and migration pathways of the C-EA African lineage. This analysis indicates that the C-EA clade most probably originated in Burundi around the early 1960s, and later spread to Ethiopia, Kenya, Tanzania and Uganda, giving rise to major country-specific monophyletic sub-clusters between the early 1970s and early 1980s. The results presented here demonstrate that a substantial proportion of subtype C infections in east Africa resulted from dissemination of a single HIV local variant, probably originated in Burundi during the 1960s. Burundi was the most important hub of dissemination of that subtype C clade in east Africa, fueling the origin of new local epidemics in Ethiopia, Kenya, Tanzania and Uganda. Subtype C lineages of southern African origin have also been introduced in east Africa, but seem to have had a much more restricted spread.	[Delatorre, Edson Oliveira; Bello, Gonzalo] Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-20001 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Delatorre, EO (corresponding author), Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-20001 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Bentancor, Gonzalo Jose Bello/N-7377-2019; Delatorre, Edson/J-8330-2015; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Delatorre, Edson/0000-0002-5746-0820; 	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grants	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grants	This study was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1997, AIDS RES HUM RETROV, V13, P1071, DOI 10.1089/aid.1997.13.1071; Abebe A, 2001, AIDS, V15, P1555, DOI 10.1097/00002030-200108170-00013; Abebe A, 2001, AIDS RES HUM RETROV, V17, P657, DOI 10.1089/088922201300119770; Abebe A, 2000, AIDS RES HUM RETROV, V16, P1909, DOI 10.1089/08892220050195865; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Ayele W, 2010, AIDS RES HUM RETROV, V26, P805, DOI 10.1089/aid.2009.0152; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Brennan CA, 1997, AIDS, V11, P1823, DOI 10.1097/00002030-199715000-00006; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Deho L, 2008, AIDS RES HUM RETROV, V24, P323, DOI 10.1089/aid.2007.0233; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; FRANSEN S, 2010, PAPER SERIES MIGRATI; Gale CV, 2006, AIDS RES HUM RETROV, V22, P985, DOI 10.1089/aid.2006.22.985; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbeck JT, 2007, AIDS RES HUM RETROV, V23, P755, DOI 10.1089/aid.2006.0237.A; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Hu DJ, 2000, EMERG INFECT DIS, V6, P609, DOI 10.3201/eid0606.000609; Hue S, 2012, AIDS RES HUM RETROV, V28, P220, DOI 10.1089/aid.2011.0048; Hussein M, 2000, J ACQ IMMUN DEF SYND, V23, P120; Kageha S, 2012, AIDS RES HUM RETROV, V28, P228, DOI 10.1089/aid.2011.0089; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Khamadi SA, 2005, AIDS RES HUM RETROV, V21, P810, DOI 10.1089/aid.2005.21.810; Khamadi SA, 2009, AIDS RES HUM RETROV, V25, P919, DOI 10.1089/aid.2009.0005; Khamadi SA, 2008, AIDS RES HUM RETROV, V24, P1561, DOI 10.1089/aid.2008.0085; Kiwelu IE, 2003, AIDS RES HUM RETROV, V19, P57, DOI 10.1089/08892220360473970; Koch N, 2001, AIDS RES HUM RETROV, V17, P269, DOI 10.1089/088922201750063205; Lahuerta M, 2008, AIDS RES HUM RETROV, V24, P327, DOI 10.1089/aid.2007.0134; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lihana RW, 2006, AIDS RES HUM RETROV, V22, P1172, DOI 10.1089/aid.2006.22.1172; Maslin JR, 2005, JAIDS-J ACQ IMM DEF, V39, P129; Mosha F, 2011, AIDS RES HUM RETROV, V27, P377, DOI 10.1089/aid.2010.0113; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Nyagaka B, 2011, AIDS RES HUM RETROVI; Nyombi BM, 2008, AIDS RES HUM RETROV, V24, P761, DOI 10.1089/aid.2007.0311; Oyaro M, 2011, AIDS RES HUM RETROV, V27, P257, DOI 10.1089/aid.2010.0061; Parreira R, 2006, MICROBES INFECT, V8, P2442, DOI 10.1016/j.micinf.2006.05.005; Pollakis G, 2003, AIDS RES HUM RETROV, V19, P999, DOI 10.1089/088922203322588350; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rainwater S, 2005, AIDS RES HUM RETROV, V21, P1060, DOI 10.1089/aid.2005.21.1060; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Rayfield MA, 1998, AIDS, V12, P521, DOI 10.1097/00002030-199805000-00014; Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Servais J, 2004, AIDS RES HUM RETROV, V20, P279, DOI 10.1089/088922204322996518; Ssemwanga D, 2011, AIDS RES HUM RETROVI; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang CF, 2004, AIDS RES HUM RETROV, V20, P565, DOI 10.1089/088922204323087822	67	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41904	10.1371/journal.pone.0041904	http://dx.doi.org/10.1371/journal.pone.0041904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848653	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200126
J	Kwak, MS; Lee, DH; Cho, Y; Cho, EJ; Lee, JH; Yu, SJ; Yoon, JH; Lee, HS; Kim, CY; Cheong, JY; Cho, SW; Shin, HD; Kim, YJ				Kwak, Min-Sun; Lee, Dong Hyeon; Cho, Yuri; Cho, Eun-Ju; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Chung Yong; Cheong, Jae Youn; Cho, Sung Won; Shin, Hyoung Doo; Kim, Yoon Jun			Association of Polymorphism in Pri-microRNAs-371-372-373 with the Occurrence of Hepatocellular Carcinoma in Hepatitis B Virus Infected Patients	PLOS ONE			English	Article							MICRORNA EXPRESSION; HBV INFECTION; COLORECTAL-CANCER; LIVER-CANCER; RISK; GENE; POPULATION; TARGET; IDENTIFICATION; REPLICATION	Background: Micro RNAs-371-372-373 (miRNAs-371-373), originating from the same pri-miRNA transcript, are reported to be upregulated in hepatocellular carcinoma (HCC) and to be related to the regulation of hepatitis B virus (HBV) infection. Our study investigated whether pri-miRNAs-371-373 polymorphisms are associated with the risk of HCC occurrence and HBV clearance. Methods: Genetic variations were identified through direct DNA sequencing using TaqMan assay. Three sequence variants of pri-miRNAs-371-373 were identified. Genetic associations of those with HCC occurrence and HBV clearance among patients with HBV infection were analyzed using logistic regression analyses with adjustment for age and gender (n = 1439). Results: For the occurrence of HCC, polymorphism rs3859501C > A acted as a protective factor both in chronic carriers (OR = 0.75, P = 0.005 in a codominant model; OR = 0.71, P = 0.02 in a dominant model; OR = 0.66, P = 0.03 in recessive model) and liver cirrhosis patients (OR = 0.69, P = 0.001 in a codominant model; OR = 0.60, P = 0.003 in a dominant model; OR = 0.63, P = 0.03 in a recessive model). The pri-miRNAs-371-373_ht2 [C-A-C] also showed a protective effect on HCC occurrence both in the chronic carrier and liver cirrhosis groups (P < 0.05 in both). However, there was no significant association between pri-miRNAs-371-373 polymorphisms and HBV clearance. Conclusions: In conclusion, among chronic carriers and liver cirrhosis patients, the A allele of rs3859501 and the haplotype pri-miRNAs-371-373_ht2 were more protective to HCC than other genotypes and haplotypes. Further studies into the roles of rs3859501 and pri-miRNAs-371-373_ht2 haplotype in hepatocarcinogenesis are needed.	[Kwak, Min-Sun; Lee, Dong Hyeon; Cho, Yuri; Cho, Eun-Ju; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Chung Yong; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kwak, Min-Sun; Lee, Dong Hyeon; Cho, Yuri; Cho, Eun-Ju; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Lee, Hyo-Suk; Kim, Chung Yong; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul 151, South Korea; [Cheong, Jae Youn; Cho, Sung Won] Ajou Univ, Sch Med, Dept Gastroenterol, Suwon 441749, South Korea; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ajou University; Sogang University	Kwak, MS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yoonjun@snu.ac.kr	Lee, Jeong-Hoon/Q-1055-2018; Lee, Hyo-Suk/J-5618-2012; Kwak, Min-Sun/C-4283-2013; Kim, Yoon Jun/J-2746-2012	Lee, Jeong-Hoon/0000-0002-0315-2080; Kim, Yoon Jun/0000-0001-9141-7773; Yu, Su Jong/0000-0001-8888-7977; Yoon, Jung-Hwan/0000-0002-9128-3610; Cho, Eun Ju/0000-0002-2677-3189	Seoul National University Hospital Research Fund [04-2011-023]; Basic Science Research Program [2010-0009943]; Basic Research Laboratory Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0001200]	Seoul National University Hospital Research Fund; Basic Science Research Program; Basic Research Laboratory Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants from the Seoul National University Hospital Research Fund (04-2011-023), the Basic Science Research Program (2010-0009943) and the Basic Research Laboratory Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0001200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bae JS, 2011, DIGEST DIS SCI, V56, P2735, DOI 10.1007/s10620-011-1657-3; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brunetto MR, 1999, INTERVIROLOGY, V42, P69, DOI 10.1159/000024968; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guo HY, 2011, HEPATOLOGY, V54, P808, DOI 10.1002/hep.24441; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harnprasopwat R, 2010, BIOCHEM BIOPH RES CO, V399, P117, DOI 10.1016/j.bbrc.2010.07.009; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Ito K, 2010, SCAND J GASTROENTERO, V45, P243, DOI 10.3109/00365520903450113; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jung YJ, 2007, INTERVIROLOGY, V50, P369, DOI 10.1159/000109751; Kim H, 2007, INTERVIROLOGY, V50, P52, DOI 10.1159/000096313; Kim JH, 2011, DIGEST DIS, V29, P278, DOI 10.1159/000327559; Koziel MJ, 1998, ANTIVIR THER, V3, P13; Kudo M, 2011, DIGEST DIS, V29, P273, DOI 10.1159/000327558; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Park BL, 2007, BIOCHEM BIOPH RES CO, V363, P776, DOI 10.1016/j.bbrc.2007.09.026; Park TJ, 2010, J HUM GENET, V55, P416, DOI 10.1038/jhg.2010.36; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suk Ki Tae, 2012, Korean J Hepatol, V18, P1, DOI 10.3350/kjhep.2012.18.1.1; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; Turati F, 2012, HEPATOLOGY, V55, P1416, DOI 10.1002/hep.24794; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Zhang LS, 2012, DNA CELL BIOL, V31, P761, DOI 10.1089/dna.2011.1326; Zhou AD, 2012, ONCOGENE, V31, P2968, DOI 10.1038/onc.2011.461	44	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41983	10.1371/journal.pone.0041983	http://dx.doi.org/10.1371/journal.pone.0041983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848681	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200142
J	Wu, LW; Hu, AB; Tam, N; Zhang, JW; Lin, M; Guo, ZY; He, XS				Wu, LinWei; Hu, AnBin; Tam, Ngalei; Zhang, JianWei; Lin, Min; Guo, ZhiYong; He, XiaoShun			Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection	PLOS ONE			English	Article							MILAN CRITERIA; RISK-FACTORS; SURVIVAL; FEASIBILITY; CIRRHOSIS	Objective: To summarize the experience with salvage liver transplantation (SLT) for patients with recurrent hepatocellular carcinoma (HCC) after primary hepatic resection in a single center. Methods: A total of 376 adult patients with HCC underwent orthotopic liver transplantation (OLT) at Organ Transplantation Center, the First Affiliated Hospital of Sun Yat-sen University, between 2004 and 2008. Among these patients, 36 underwent SLT after primary liver curative resection due to intrahepatic recurrence. During the same period, one hundred and forty-seven patients with HCC within Milan criteria underwent primary OLT (PLTW group), the intra-operative and post-operative parameters were compared between these two groups. Furthermore, we compared tumor recurrence and patient survival of patients with SLT to 156 patients with HCC beyond Milan criteria (PLTB group). Cox Hazard regression was made to identify the risk factors for tumor recurrence. Results: The median interval between initial liver resection and SLT was 35 months (1-63 months). The intraoperative blood loss (P<0.05) and transfusion volume (P<0.05) were larger in the SLT group than in the PLTW group. The operation time was longer in the SLT group (P<0.05). The post-operative complications incidence, tumor recurrence rate, patients' survival rate, and tumor-free survival rate were comparable between these two groups (all P>0.05). When compared to those patients with HCC beyond Milan criteria undergoing primary OLT, patients undergoing SLT achieved a better survival and a lower tumor recurrence. Cox Proportional Hazards model showed that vascular invasion, including macrovascular and microvascular invasion, as well as AFP level >400 IU/L were risk factors for tumor recurrence after LT. Conclusions: In comparison with primary OLT, although SLT is associated with increased operation difficulties, it provides a good option for patients with HCC recurrence after curative resection.	[Wu, LinWei; Hu, AnBin; Tam, Ngalei; Guo, ZhiYong; He, XiaoShun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, JianWei; Lin, Min] Sun Yat Sen Univ, Zhongshan Med Sch, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Guo, ZY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@126.com			National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Key Clinical Project from the Ministry of Health [2010159]; National Natural Science Foundation of China [30972951, 81102244, 81102245, 81170448]; Special Fund for science research by Ministry of Health [201002004]; Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education [20100171110063, 20110171120077]; Science and Technology Planning Key Clinical Project of Guangdong Province [2011A030400005]; Science and Technology Planning Project of Guangdong Province [2011B0318000099]; Medical Scientific Research Foundation of Guangdong Province [B2011072]; Project by Division of Medical Service Management of Ministry of Health	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Clinical Project from the Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for science research by Ministry of Health; Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education; Science and Technology Planning Key Clinical Project of Guangdong Province; Science and Technology Planning Project of Guangdong Province; Medical Scientific Research Foundation of Guangdong Province; Project by Division of Medical Service Management of Ministry of Health	This study was supported by the National High Technology Research and Development Program of China (863 Program) (2012AA021008), the Key Clinical Project from the Ministry of Health (2010159), the National Natural Science Foundation of China (30972951, 81102244, 81102245, and 81170448), the Special Fund for science research by Ministry of Health (201002004), the Research Fund for the Doctoral Program of Higher Education of China by Ministry of Education (20100171110063 and 20110171120077), the Science and Technology Planning Key Clinical Project of Guangdong Province (2011A030400005), Science and Technology Planning Project of Guangdong Province (2011B0318000099), Medical Scientific Research Foundation of Guangdong Province (B2011072) and Project by Division of Medical Service Management of Ministry of Health (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Cucchetti A, 2010, AM J TRANSPLANT, V10, P619, DOI 10.1111/j.1600-6143.2009.02984.x; Eguchi S, 2009, J GASTROENTEROL, V44, P624, DOI 10.1007/s00535-009-0043-9; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Facciuto ME, 2008, ANN SURG ONCOL, V15, P1383, DOI 10.1245/s10434-008-9851-z; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Hu RH, 2005, CLIN TRANSPLANT, V19, P175, DOI 10.1111/j.1399-0012.2005.00277.x; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kim BW, 2008, TRANSPL P, V40, P3558, DOI 10.1016/j.transproceed.2008.03.175; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; Mazzaferro V, 2008, ANN SURG ONCOL, V15, P1001, DOI 10.1245/s10434-007-9559-5; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Sala M, 2004, LIVER TRANSPLANT, V10, P1294, DOI 10.1002/lt.20202; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wu YM, 2001, TRANSPLANTATION, V72, P1389, DOI 10.1097/00007890-200110270-00010	17	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41820	10.1371/journal.pone.0041820	http://dx.doi.org/10.1371/journal.pone.0041820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848619	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600049
J	Defoirdt, T; Benneche, T; Brackman, G; Coenye, T; Sorgeloos, P; Scheie, AA				Defoirdt, Tom; Benneche, Tore; Brackman, Gilles; Coenye, Tom; Sorgeloos, Patrick; Scheie, Anne Aamdal			A Quorum Sensing-Disrupting Brominated Thiophenone with a Promising Therapeutic Potential to Treat Luminescent Vibriosis	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; GENE-EXPRESSION; ARTEMIA-FRANCISCANA; BIOFILM FORMATION; HARVEYI; REGULATOR; VIRULENCE; SYSTEMS; PROTEIN; LUXR	Vibrio harveyi is amongst the most important bacterial pathogens in aquaculture. Novel methods to control this pathogen are needed since many strains have acquired resistance to antibiotics. We previously showed that quorum sensing-disrupting furanones are able to protect brine shrimp larvae against vibriosis. However, a major problem of these compounds is that they are toxic toward higher organisms and therefore, they are not safe to be used in aquaculture. The synthesis of brominated thiophenones, sulphur analogues of the quorum sensing-disrupting furanones, has recently been reported. In the present study, we report that these compounds block quorum sensing in V. harveyi at concentrations in the low micromolar range. Bioluminescence experiments with V. harveyi quorum sensing mutants and a fluorescence anisotropy assay indicated that the compounds disrupt quorum sensing in this bacterium by decreasing the ability of the quorum sensing master regulator LuxR to bind to its target promoter DNA. In vivo challenge tests with gnotobiotic brine shrimp larvae showed that thiophenone compound TF310, (Z)-4-((5-(bromomethylene)-2-oxo- 2,5-dihydrothiophen-3-yl)methoxy)-4- oxobutanoic acid, completely protected the larvae from V. harveyi BB120 when dosed to the culture water at 2.5 mu M or more, whereas severe toxicity was only observed at 250 mu M. This makes TF310 showing the highest therapeutic index of all quorum sensing-disrupting compounds tested thus far in our brine shrimp model system.	[Defoirdt, Tom; Sorgeloos, Patrick] Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium; [Defoirdt, Tom; Sorgeloos, Patrick] Univ Ghent, Artemia Reference Ctr, B-9000 Ghent, Belgium; [Benneche, Tore] Univ Oslo, Dept Chem, Fac Chem, Oslo, Norway; [Brackman, Gilles; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Scheie, Anne Aamdal] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway	Ghent University; Ghent University; University of Oslo; Ghent University; University of Oslo	Defoirdt, T (corresponding author), Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium.	Tom.Defoirdt@UGent.be	Defoirdt, Tom/A-5120-2009; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014	Defoirdt, Tom/0000-0002-7446-2246; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601	Fund for Scientific Research - Flanders (FWO-Vlaanderen); Norwegian Research Council; University of Oslo	Fund for Scientific Research - Flanders (FWO-Vlaanderen)(FWO); Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo	This work was funded by the Fund for Scientific Research - Flanders (FWO-Vlaanderen), and by The Norwegian Research Council and The University of Oslo. TD and GB are postdoctoral fellows of FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Benneche T, 2012, SYNTH COMMU IN PRESS; Benneche T, 2008, NEW J CHEM, V32, P1567, DOI 10.1039/b803926g; Benneche T, 2011, RSC ADV, V1, P323, DOI 10.1039/c1ra00254f; Brackman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016084; Brackman G, 2009, MICROBIOL-SGM, V155, P4114, DOI 10.1099/mic.0.032474-0; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Defoirdt T, 2005, ENVIRON MICROBIOL, V7, P1239, DOI 10.1111/j.1462-2920.2005.00807.x; Defoirdt T, 2008, ISME J, V2, P19, DOI 10.1038/ismej.2007.92; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P2486, DOI 10.1111/j.1462-2920.2007.01367.x; Defoirdt T, 2006, APPL ENVIRON MICROB, V72, P6419, DOI 10.1128/AEM.00753-06; Defoirdt T, 2010, ENV MICROBIOL REP, V2, P44, DOI 10.1111/j.1758-2229.2009.00043.x; Freeman JA, 1999, J BACTERIOL, V181, P899, DOI 10.1128/JB.181.3.899-906.1999; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Janssens JCA, 2008, CURR MED CHEM, V15, P2144, DOI 10.2174/092986708785747580; Janssens JCA, 2008, APPL ENVIRON MICROB, V74, P6639, DOI 10.1128/AEM.01262-08; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Lonn-Stensrud J, 2011, SCIENCE AND TECHNOLOGY AGAINST MICROBIAL PATHOGENS: RESEARCH, DEVELOPMENT AND EVALUATION, P155; Lonn-Stensrud J, 2012, FEMS IMMUNOL MED MIC, V65, P326, DOI 10.1111/j.1574-695X.2012.00964.x; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Natrah FMI, 2011, VET MICROBIOL, V154, P124, DOI 10.1016/j.vetmic.2011.06.024; Pan JC, 2009, EXPERT OPIN THER PAT, V19, P1581, DOI 10.1517/13543770903222293; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rasch M, 2004, SYST APPL MICROBIOL, V27, P350, DOI 10.1078/0723-2020-00268; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Steenackers HP, 2010, BIOORGAN MED CHEM, V18, P5224, DOI 10.1016/j.bmc.2010.05.055; Tinh NTN, 2007, J APPL MICROBIOL, V103, P194, DOI 10.1111/j.1365-2672.2006.03217.x; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Zang TZ, 2009, BIOORG MED CHEM LETT, V19, P6200, DOI 10.1016/j.bmcl.2009.08.095	38	38	38	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41788	10.1371/journal.pone.0041788	http://dx.doi.org/10.1371/journal.pone.0041788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848604	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600118
J	Gan, W; Wu, J; Lu, L; Xiao, X; Huang, H; Wang, FL; Zhu, JW; Sun, L; Liu, G; Pan, Y; Li, HX; Lin, X; Chen, Y				Gan, Wei; Wu, Johnna; Lu, Ling; Xiao, Xu; Huang, Heng; Wang, Fulong; Zhu, Jingwen; Sun, Liang; Liu, Gang; Pan, Yi; Li, Huaixing; Lin, Xu; Chen, Yan			Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; COMPLEMENT C3; MYOCARDIAL-INFARCTION; SERUM C3; RISK; VARIANT; SUSCEPTIBILITY; INFLAMMATION	Dysregulation of the complement system has been linked to pathogenesis of hypertension. However, whether genetic changes of complement factor H (CFH) and its related genes are associated with hypertension is unknown. We genotyped three SNPs in the CFH gene cluster that are closely linked to age-related macular degeneration, namely rs1061170 (Y402H), rs2274700 (A473A) and rs7542235 (CFHR1-3 Delta), and tested for their associations with blood pressure and hypertension risk in a population-based cohort including 3,210 unrelated Chinese Hans (50-70 years of age) from Beijing and Shanghai. We found that rs2274700 (A473A) and rs7542235 (CFHR1-3 Delta) were both significantly associated with diastolic blood pressure (DBP) (beta = 0.632-1.431, P <= 0.038) and systolic blood pressure (SBP) (beta = 1.567-4.445, P <= 0.008), and rs2274700 (A473A) was associated with hypertension risk (OR [95%CI]: 1.175 [1.005-1.373], P = 0.048). Notably, the associations of rs2274700 (A473A) with DBP (P = 2.1x10(-3)), SBP (P = 8x10(-5)) and hypertension risk (P = 7.9x10(-3)) were significant only in the individuals with low CRP levels (<2.0 mg/l), but not in those with CRP levels >= 2.0 mg/l (P >= 0.0807) (P for interaction <= 0.0467). However, no significant association between rs1061170 (Y402H) and blood pressure or hypertension risk was observed (P >= 0.259). In conclusion, our results suggest that genetic variations in CFH and its related genes may contribute to hypertension risk in Chinese Hans.	[Gan, Wei; Wu, Johnna; Lu, Ling; Huang, Heng; Wang, Fulong; Zhu, Jingwen; Sun, Liang; Liu, Gang; Pan, Yi; Li, Huaixing; Lin, Xu; Chen, Yan] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Xiao, Xu] Sichuan Prov Peoples Hosp, Dept Emergency Med, Chengdu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Sichuan Provincial People's Hospital	Gan, W (corresponding author), Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China.	lihx@sibs.ac.cn; xlin@sibs.ac.cn; ychen3@sibs.ac.cn	Liu, Gang/H-6420-2019; Wang, Fulong/AAY-1178-2021	Liu, Gang/0000-0002-1430-3016; Wang, Fulong/0000-0002-7083-9675	Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [30830037, 81021002, 81130077]; Chinese Academy of Sciences [KSCX2-EW-R-08, KSCX2-EW-R-10]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by research grants from Ministry of Science and Technology of China (2012CB524900 to Y.C. and 2010CB529506 to Y.P.), National Natural Science Foundation of China (30830037, 81021002 and 81130077 to Y.C.), and Chinese Academy of Sciences (KSCX2-EW-R-08 to Y.C. and KSCX2-EW-R-10 to X. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Engstrom G, 2007, EUR J CARDIOV PREV R, V14, P392, DOI 10.1097/01.hjr.0000244582.30421.b2; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Hage FG, 2010, ARTERIOSCL THROM VAS, V30, P1189, DOI 10.1161/ATVBAHA.110.205377; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jiang S, 2009, AM J CARDIOL, V103, P1727, DOI 10.1016/j.amjcard.2009.02.028; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Magen E, 2010, AM J MED SCI, V339, P415, DOI 10.1097/MAJ.0b013e3181d7d496; Magen E, 2008, J CLIN HYPERTENS, V10, P677, DOI 10.1111/j.1751-7176.2008.00002.x; MUSCARI A, 1995, AM J MED, V98, P357, DOI 10.1016/S0002-9343(99)80314-3; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; Nadar SK, 2007, J HUM HYPERTENS, V21, P261, DOI 10.1038/sj.jhh.1002160; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Sofat R, 2010, ATHEROSCLEROSIS, V213, P184, DOI 10.1016/j.atherosclerosis.2010.07.021; Wright AF, 2011, NAT GENET, V43, P1176, DOI 10.1038/ng.1012; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42010	10.1371/journal.pone.0042010	http://dx.doi.org/10.1371/journal.pone.0042010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848687	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600156
J	Gebauer, JE; Goritz, AS; Hofmann, W; Sedikides, C				Gebauer, Jochen E.; Goeritz, Anja S.; Hofmann, Wilhelm; Sedikides, Constantine			Self-Love or Other-Love? Explicit Other-Preference but Implicit Self-Preference	PLOS ONE			English	Article							ASSOCIATION TEST; SOCIAL DESIRABILITY; ESTEEM; ATTITUDES; COGNITION; NAME	Do humans prefer the self even over their favorite other person? This question has pervaded philosophy and social-behavioral sciences. Psychology's distinction between explicit and implicit preferences calls for a two-tiered solution. Our evolutionarily-based Dissociative Self-Preference Model offers two hypotheses. Other-preferences prevail at an explicit level, because they convey caring for others, which strengthens interpersonal bonds-a major evolutionary advantage. Self-preferences, however, prevail at an implicit level, because they facilitate self-serving automatic behavior, which favors the self in life-or-die situations-also a major evolutionary advantage. We examined the data of 1,519 participants, who completed an explicit measure and one of five implicit measures of preferences for self versus favorite other. The results were consistent with the Dissociative Self-Preference Model. Explicitly, participants preferred their favorite other over the self. Implicitly, however, they preferred the self over their favorite other (be it their child, romantic partner, or best friend). Results are discussed in relation to evolutionary theorizing on self-deception.	[Gebauer, Jochen E.] Humboldt Univ, D-10099 Berlin, Germany; [Goeritz, Anja S.] Univ Freiburg, D-79106 Freiburg, Germany; [Hofmann, Wilhelm] Univ Chicago, Chicago, IL 60637 USA; [Sedikides, Constantine] Univ Southampton, Southampton, Hants, England	Humboldt University of Berlin; University of Freiburg; University of Chicago; University of Southampton	Gebauer, JE (corresponding author), Humboldt Univ, D-10099 Berlin, Germany.	mail@JochenGebauer.info		Sedikides, Contantine/0000-0003-4036-889X; Goritz, Anja/0000-0002-4638-0489; Gebauer, Jochen/0000-0002-3789-3629	DFG [GO 1107/4-1]	DFG(German Research Foundation (DFG))	This work was partially supported by DFG grant (www.DFG.de) GO 1107/4-1 to Anja Goritz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aristotle, NICOMACHEAN ETHICS; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BAUMEISTER RF, 1990, PSYCHOL REV, V97, P90, DOI 10.1037/0033-295X.97.1.90; Baumeister RF, 2005, CULTURAL ANIMAL; Botero G, 1956, REASON STATE; Campbell KL, 1988, NATURAL HUMAN FERTIL, P39, DOI DOI 10.1007/978-1-349-09961-0_4; Cialdini RB, 1991, PSYCHOL INQ, V2, P124, DOI DOI 10.1207/S15327965PLI0202_; Crutzen R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-720; Darwin C, 1872, ORIGIN SPECIES; De Houwer J, 2001, J EXP SOC PSYCHOL, V37, P443, DOI 10.1006/jesp.2000.1464; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gebauer JE, 2008, J EXP SOC PSYCHOL, V44, P1346, DOI 10.1016/j.jesp.2008.03.016; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregg AP, 2010, SELF IDENTITY, V9, P142, DOI 10.1080/15298860902815451; Hoorens V, 2012, J PERS, V80, P1237, DOI 10.1111/j.1467-6494.2011.00759.x; Hume D., 2009, TREATISE HUMAN NATUR; Koole SL, 2001, J PERS SOC PSYCHOL, V80, P669, DOI 10.1037//0022-3514.80.4.669; Lebel EP, 2009, J EXP SOC PSYCHOL, V45, P1291, DOI 10.1016/j.jesp.2009.07.003; Musch J, 2002, DIAGNOSTICA, V48, P121, DOI 10.1026//0012-1924.48.3.121; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Nosek BA, 2007, EXP PSYCHOL, V54, P14, DOI 10.1027/1618-3169.54.1.14; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Sedikides C., 2012, HDB SELF IDENTITY, P327, DOI DOI 10.1177/1359105308090930; Sedikides C., 2000, PSYCHOL PERSPECTIVES, P91, DOI [10.1037/10357-004, DOI 10.1037/10357-004]; Sedikides C, 2008, PERSPECT PSYCHOL SCI, V3, P102, DOI 10.1111/j.1745-6916.2008.00068.x; Sedikides C, 2007, FRONT SOC PSYCHOL, P163; Stober J, 2001, EUR J PSYCHOL ASSESS, V17, P222, DOI 10.1027//1015-5759.17.3.222; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Teige-Mocigemba S, 2008, EUR J PSYCHOL ASSESS, V24, P237, DOI 10.1027/1015-5759.24.4.237; von Hippel W, 2011, BEHAV BRAIN SCI, V34, DOI 10.1017/S0140525X10001354; WILSON DS, 1994, BEHAV BRAIN SCI, V17, P585, DOI 10.1017/S0140525X00036104; Xunzi, 1985, 12 PHILOS	36	25	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41789	10.1371/journal.pone.0041789	http://dx.doi.org/10.1371/journal.pone.0041789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979GX	22848605	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000306806600119
J	Bose, JL; Lehman, MK; Fey, PD; Bayles, KW				Bose, Jeffrey L.; Lehman, McKenzie K.; Fey, Paul D.; Bayles, Kenneth W.			Contribution of the Staphylococcus aureus Atl AM and GL Murein Hydrolase Activities in Cell Division, Autolysis, and Biofilm Formation	PLOS ONE			English	Article							L-ALANINE AMIDASE; BETA-N-ACETYLGLUCOSAMINIDASE; PENICILLIN TOLERANCE; SEQUENCE-ANALYSIS; DNA RELEASE; ENZYMES; IDENTIFICATION; EPIDERMIDIS; SEPARATION; DOMAINS	The most prominent murein hydrolase of Staphylococcus aureus, AtlA, is a bifunctional enzyme that undergoes proteolytic cleavage to yield two catalytically active proteins, an amidase (AM) and a glucosaminidase (GL). Although the bifunctional nature of AtlA has long been recognized, most studies have focused on the combined functions of this protein in cell wall metabolism and biofilm development. In this study, we generated mutant derivatives of the clinical S. aureus isolate, UAMS-1, in which one or both of the AM and GL domains of AtlA have been deleted. Examination of these strains revealed that each mutant exhibited growth rates comparable to the parental strain, but showed clumping phenotypes and lysis profiles that were distinct from the parental strain and each other, suggesting distinct roles in cell wall metabolism. Given the known function of autolysis in the release of genomic DNA for use as a biofilm matrix molecule, we also tested the mutants in biofilm assays and found both AM and GL necessary for biofilm development. Furthermore, the use of enzymatically inactive point mutations revealed that both AM and GL must be catalytically active for S. aureus to form a biofilm. The results of this study provide insight into the relative contributions of AM and GL in S. aureus and demonstrate the contribution of Atl-mediated lysis in biofilm development.	[Bose, Jeffrey L.; Lehman, McKenzie K.; Fey, Paul D.; Bayles, Kenneth W.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Bose, JL (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA.	kbayles@unmc.edu			National Institutes of Health [1F32AI081437, P01AI83211, R01AI038901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083211, F32AI081437, R01AI038901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants 1F32AI081437 (J.L.B.), P01AI83211 (K.W.B.), and R01AI038901 (K.W.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kennedy AD, 2010, J CLIN MICROBIOL, V48, P4504, DOI 10.1128/JCM.01050-10; MANI N, 1993, J BACTERIOL, V175, P1493, DOI 10.1128/JB.175.5.1493-1499.1993; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SUGAI M, 1990, J BACTERIOL, V172, P6494, DOI 10.1128/jb.172.11.6494-6498.1990; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Wadstrom T, 1970, Biochem J, V120, P735; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yokoi KJ, 2008, GENE, V416, P66, DOI 10.1016/j.gene.2008.03.004; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	25	128	129	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42244	10.1371/journal.pone.0042244	http://dx.doi.org/10.1371/journal.pone.0042244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860095	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600081
J	Carrigan, MA; Uryasev, O; Davis, RP; Zhai, LM; Hurley, TD; Benner, SA				Carrigan, Matthew A.; Uryasev, Oleg; Davis, Ross P.; Zhai, LanMin; Hurley, Thomas D.; Benner, Steven A.			The Natural History of Class I Primate Alcohol Dehydrogenases Includes Gene Duplication, Gene Loss, and Gene Conversion	PLOS ONE			English	Article							DEPENDENT FORMALDEHYDE DEHYDROGENASE; LAST COMMON ANCESTOR; CLASS-III ALCOHOL; MOLECULAR EVOLUTION; SUBSTITUTION RATES; PROTEIN EVOLUTION; PLANETARY BIOLOGY; DIGESTIVE RNASES; LEAF MONKEYS; RIBONUCLEASE	Background: Gene duplication is a source of molecular innovation throughout evolution. However, even with massive amounts of genome sequence data, correlating gene duplication with speciation and other events in natural history can be difficult. This is especially true in its most interesting cases, where rapid and multiple duplications are likely to reflect adaptation to rapidly changing environments and life styles. This may be so for Class I of alcohol dehydrogenases (ADH1s), where multiple duplications occurred in primate lineages in Old and New World monkeys (OWMs and NWMs) and hominoids. Methodology/Principal Findings: To build a preferred model for the natural history of ADH1s, we determined the sequences of nine new ADH1 genes, finding for the first time multiple paralogs in various prosimians (lemurs, strepsirhines). Database mining then identified novel ADH1 paralogs in both macaque (an OWM) and marmoset (a NWM). These were used with the previously identified human paralogs to resolve controversies relating to dates of duplication and gene conversion in the ADH1 family. Central to these controversies are differences in the topologies of trees generated from exonic (coding) sequences and intronic sequences. Conclusions/Significance: We provide evidence that gene conversions are the primary source of difference, using molecular clock dating of duplications and analyses of microinsertions and deletions (micro-indels). The tree topology inferred from intron sequences appear to more correctly represent the natural history of ADH1s, with the ADH1 paralogs in platyrrhines (NWMs) and catarrhines (OWMs and hominoids) having arisen by duplications shortly predating the divergence of OWMs and NWMs. We also conclude that paralogs in lemurs arose independently. Finally, we identify errors in database interpretation as the source of controversies concerning gene conversion. These analyses provide a model for the natural history of ADH1s that posits four ADH1 paralogs in the ancestor of Catarrhine and Platyrrhine primates, followed by the loss of an ADH1 paralog in the human lineage.	[Carrigan, Matthew A.; Uryasev, Oleg; Davis, Ross P.; Benner, Steven A.] Fdn Appl Mol Evolut, Gainesville, FL USA; [Zhai, LanMin; Hurley, Thomas D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Carrigan, MA (corresponding author), Fdn Appl Mol Evolut, Gainesville, FL USA.	mcarrigan@ffame.org		HURLEY, THOMAS/0000-0002-5942-1163; Carrigan, Matthew/0000-0003-1459-2265	National Institute of Alcohol Abuse and Alcoholism [RO1AA017723]; National Aeronautics and Space Administration [NNX08A023G]; National Center for Research Resources [p51RR013986]; Office of Research Infrastructure Programs/OD [P51OD011107];  [RR000167]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017723] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This grant was funded by the National Institute of Alcohol Abuse and Alcoholism (niaaa.nih.gov, RO1AA017723), and the National Aeronautics and Space Administration (nasa.gov, NNX08A023G). The Wisconsin National Primate Research Center provided samples used in this research, and was supported by grant number RR000167. The Southwest National Primate Research Center also provided samples used in this research, and was supported by the National Center for Research Resources (grant number p51RR013986) and the Office of Research Infrastructure Programs/OD (grant number P51OD011107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi Herve, 2007, ENCYCL MEASUR STATIS, V2, P651; Arndt PF, 2005, J MOL EVOL, V60, P748, DOI 10.1007/s00239-004-0222-5; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benner S. A., 2007, EXPT PALEOGENETICS, P3; Benner SA, 1998, ADV ENZYME REGUL, V38, P155, DOI 10.1016/S0065-2571(97)00019-8; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; Benner SA, 1989, ADV ENZYME REGUL, V28, P219; Bradley ME, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-22; Budowle V, 2004, J FORENSIC SCI, V49, P1256; Chang MSS, 2004, J MOL BIOL, V341, P617, DOI 10.1016/j.jmb.2004.05.045; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cheung B, 1999, MOL BIOL EVOL, V16, P23, DOI 10.1093/oxfordjournals.molbev.a026035; deSa MM, 1996, MOL BIOL EVOL, V13, P1198, DOI 10.1093/oxfordjournals.molbev.a025685; Dohmen K, 1996, ALCOHOL CLIN EXP RES, V20, P1569, DOI 10.1111/j.1530-0277.1996.tb01701.x; Drouin G, 1999, MOL BIOL EVOL, V16, P1369, DOI 10.1093/oxfordjournals.molbev.a026047; Duester G, 1999, BIOCHEM PHARMACOL, V58, P389, DOI 10.1016/S0006-2952(99)00065-9; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; Eriksson CJP, 2001, ALCOHOL CLIN EXP RES, V25, p157S, DOI 10.1097/00000374-200105051-00027; Fitch DHA, 1990, J BIOL CHEM, V265, P781; Fukami-Kobayashi K, 2002, J MOL BIOL, V319, P729, DOI 10.1016/S0022-2836(02)00239-5; Gaucher EA, 2002, TRENDS BIOCHEM SCI, V27, P315, DOI 10.1016/S0968-0004(02)02094-7; Gaucher EA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-19; Gibbons BJ, 2004, BIOCHEMISTRY-US, V43, P12555, DOI 10.1021/bi0489107; GINGERICH PD, 1994, J HUM EVOL, V27, P443, DOI 10.1006/jhev.1994.1058; Gonzalez-Duarte R, 2005, HEREDITY, V95, P184, DOI 10.1038/sj.hdy.6800723; HICKEY DA, 1991, P NATL ACAD SCI USA, V88, P1611, DOI 10.1073/pnas.88.5.1611; HOLMQUIST B, 1991, BIOCHEM BIOPH RES CO, V178, P1371, DOI 10.1016/0006-291X(91)91045-E; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; HUGHES AL, 1989, MOL BIOL EVOL, V6, P559; IKUTA T, 1986, P NATL ACAD SCI USA, V83, P634, DOI 10.1073/pnas.83.3.634; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Li T, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-25; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; MARTIN RD, 1993, NATURE, V363, P223, DOI 10.1038/363223a0; Miller R. G., 1981, SIMULTANEOUS STAT IN, P6; Niederhut MS, 2001, PROTEIN SCI, V10, P697, DOI 10.1110/ps.45001; Oota H, 2007, GENE, V392, P64, DOI 10.1016/j.gene.2006.11.008; Oota Hiroki, 2012, P149; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sassi SO, 2007, MOL BIOL EVOL, V24, P1012, DOI 10.1093/molbev/msm020; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schienman JE, 2006, MOL BIOL EVOL, V23, P1465, DOI 10.1093/molbev/msl025; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SMITH M, 1973, ANN HUM GENET, V37, P49, DOI 10.1111/j.1469-1809.1973.tb01814.x; Su ZX, 2009, MOL PHYLOGENET EVOL, V53, P610, DOI 10.1016/j.ympev.2009.07.009; SUN HW, 1992, J MOL EVOL, V34, P522, DOI 10.1007/BF00160465; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; TREZISE AEO, 1989, P NATL ACAD SCI USA, V86, P5454, DOI 10.1073/pnas.86.14.5454; TREZISE AEO, 1991, GENE, V103, P211, DOI 10.1016/0378-1119(91)90275-G; Uotila L., 1989, COENZYMES COFACTOR A, P517; Wilson MA, 2009, PLOS GENET, V5, P1; Xu L, 2009, MOL PHYLOGENET EVOL, V50, P397, DOI 10.1016/j.ympev.2008.11.003; YASUNAMI M, 1990, BIOCHEM GENET, V28, P591, DOI 10.1007/BF00553952; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; YOKOYAMA S, 1987, MOL BIOL EVOL, V4, P504; YOKOYAMA S, 1993, MOL BIOL EVOL, V10, P1215; YOKOYAMA S, 1990, MOL BIOL EVOL, V7, P143; Yu L, 2010, MOL BIOL EVOL, V27, P121, DOI 10.1093/molbev/msp216; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhang JZ, 2009, MOL PHYLOGENET EVOL, V53, P608, DOI 10.1016/j.ympev.2009.07.003	74	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41175	10.1371/journal.pone.0041175	http://dx.doi.org/10.1371/journal.pone.0041175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859968	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600017
J	Eltschinger, S; Greganova, E; Heller, M; Butikofer, P; Altmann, M				Eltschinger, Sandra; Greganova, Eva; Heller, Manfred; Buetikofer, Peter; Altmann, Michael			Eukaryotic Translation Elongation Factor 1A (eEF1A) Domain I from S. cerevisiae Is Required but Not Sufficient for Inter-Species Complementation	PLOS ONE			English	Article							AMINOACYL-TRANSFER-RNA; INITIATION-FACTOR 4G; TRYPANOSOMA-BRUCEI; ETHANOLAMINE-PHOSPHOGLYCEROL; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; PROTEIN-SYNTHESIS; POSTTRANSLATIONAL MODIFICATION; FACTOR 1-ALPHA; YEAST	Ethanolamine phosphoglycerol (EPG) is a protein modification attached exclusively to eukaryotic elongation factor 1A (eEF1A). In mammals and plants, EPG is linked to conserved glutamate residues located in eEF1A domains II and III, whereas in the unicellular eukaryote Trypanosoma brucei, only domain III is modified by a single EPG. A biosynthetic precursor of EPG and structural requirements for EPG attachment to T. brucei eEF1A have been reported, but nothing is known about the EPG modifying enzyme(s). By expressing human eEF1A in T. brucei, we now show that EPG attachment to eEF1A is evolutionarily conserved between T. brucei and Homo sapiens. In contrast, S. cerevisiae eEF1A, which has been shown to lack EPG is not modified in T. brucei. Furthermore, we show that eEF1A cannot functionally complement across species when using T. brucei and S. cerevisiae as model organisms. However, functional complementation in yeast can be obtained using eEF1A chimera containing domains II or III from other species. In contrast, yeast domain I is strictly required for functional complementation in S. cerevisiae.	[Eltschinger, Sandra; Greganova, Eva; Buetikofer, Peter; Altmann, Michael] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Greganova, Eva] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Heller, Manfred] Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Bern; University Hospital of Bern	Eltschinger, S (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch; michael.altmann@ibmm.unibe.ch		Heller, Manfred/0000-0002-6364-7325	Swiss National Science Foundation [31003A-119996, 31003A-130815]; Bern University Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern University Research Foundation	This work was supported by Swiss National Science Foundation grants 31003A-119996 M.A. and 31003A-130815 to P.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; P.B. thanks the Bern University Research Foundation for support and A. Atkins for valuable input. E.G. is grateful to P. Maser for support.	ALTMANN M, 1989, J BIOL CHEM, V264, P12145; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Arcari P, 1999, BIOCHEMISTRY-US, V38, P12288, DOI 10.1021/bi990418d; Barhoumi M, 2006, FEBS J, V273, P5086, DOI 10.1111/j.1742-4658.2006.05506.x; Bates PA, 2001, PROTEINS, P39; Bates PA, 1999, PROTEINS, P47; Beverley S M, 1993, Methods Mol Biol, V21, P333; Butikofer P, 1997, BIOCHEM J, V326, P415; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; DEVER TE, 1989, J BIOL CHEM, V264, P20518; FONZI WA, 1985, MOL CELL BIOL, V5, P1100, DOI 10.1128/MCB.5.5.1100; Greganova E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00254; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Greganova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009486; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Imataka H, 1997, EMBO J, V16, P817, DOI 10.1093/emboj/16.4.817; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; LevyStrumpf N, 1997, MOL CELL BIOL, V17, P1615, DOI 10.1128/MCB.17.3.1615; Li QY, 1999, MOL CELL BIOL, V19, P7336; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; PRAT A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P140, DOI 10.1016/0167-4781(90)90155-U; Ransom WD, 1998, PLANT PHYSIOL, V117, P949, DOI 10.1104/pp.117.3.949; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; Sasikumar AN, 2012, WILEY INTERDISCIPLIN; Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; VANHEMERT FJ, 1984, EMBO J, V3, P1109, DOI 10.1002/j.1460-2075.1984.tb01937.x; vanOostveen I, 1997, ANAL BIOCHEM, V247, P310, DOI 10.1006/abio.1997.2052; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42338	10.1371/journal.pone.0042338	http://dx.doi.org/10.1371/journal.pone.0042338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860115	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000306950900090
J	Fang, X; Fang, Y; Liu, L; Liu, GJ; Wu, JH				Fang, Xiang; Fang, Ying; Liu, Li; Liu, Guangjian; Wu, Jianhua			Mapping Paratope on Antithrombotic Antibody 6B4 to Epitope on Platelet Glycoprotein Ibalpha via Molecular Dynamic Simulations	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; IB-ALPHA; MONOCLONAL-ANTIBODIES; BETA-SWITCH; COMPLEX; DISEASE; TRANSITION; GENERATION; MUTATIONS; PROTEINS	Binding of platelet receptor glycoprotein Ib alpha (GPIb alpha) to the A1 domain of von Willebrand factor (vWF) is a critical step in both physiologic hemostasis and pathologic thrombosis, for initiating platelet adhesion to subendothelium of blood vessels at sites of vascular injury. Gain-of-function mutations in GPIb alpha contribute to an abnormally high-affinity binding of platelets to vWF and can lead to thrombosis, an accurate complication causing heart attack and stroke. Of various antithrombotic monoclonal antibodies (mAbs) targeting human GPIb alpha, 6B4 is a potent one to inhibit the interaction between GPIb alpha and vWF-A1 under static and flow conditions. Mapping paratope to epitope with mutagenesis experiments, a traditional route in researches of these antithrombotic mAbs, is usually expensive and time-consuming. Here, we suggested a novel computational procedure, which combines with homology modeling, rigid body docking, free and steered molecular dynamics (MD) simulations, to identify key paratope residues on 6B4 and their partners on GPIb alpha, with hypothesis that the stable hydrogen bonds and salt bridges are the important linkers between paratope and epitope residues. Based on a best constructed model of 6B4 bound with GPIb alpha, the survival ratios and rupture times of all detected hydrogen bonds and salt bridges in binding site were examined via free and steered MD simulations and regarded as indices of thermal and mechanical stabilizations of the bonds, respectively. Five principal paratope residues with their partners were predicted with their high survival ratios and/or long rupture times of involved hydrogen bonds, or with their hydrogen bond stabilization indices ranked in top 5. Exciting, the present results were in good agreement with previous mutagenesis experiment data, meaning a wide application prospect of our novel computational procedure on researches of molecular of basis of ligand-receptor interactions, various antithrombotic mAbs and other antibodies as well as theoretically design of biomolecular drugs.	[Fang, Xiang; Fang, Ying; Liu, Li; Liu, Guangjian; Wu, Jianhua] S China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Fang, X (corresponding author), S China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	yfang@scut.edu.cn; wujianhua@scut.edu.cn			National Natural Science Foundation of China [10972081, 11072080]; Guangdong Province Natural Science Foundation grant [S2011010005451]; Specialized Research Fund for the Doctoral Program of Higher Education grant [20110172110030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation grant; Specialized Research Fund for the Doctoral Program of Higher Education grant	This work was supported by The National Natural Science Foundation of China grants 10972081 (YF) and 11072080 (JW) and by Guangdong Province Natural Science Foundation grant S2011010005451(JW) and Specialized Research Fund for the Doctoral Program of Higher Education grant 20110172110030 (JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arcangeli C, 2008, J STRUCT BIOL, V164, P119, DOI 10.1016/j.jsb.2008.06.013; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347, DOI 10.1161/01.ATV.20.5.1347; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Chen ZZ, 2008, BIOPHYS J, V95, P1303, DOI 10.1529/biophysj.108.132324; Dai KS, 2003, THROMB RES, V109, P137, DOI 10.1016/S0049-3848(03)00152-X; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Fontayne A, 2007, J BIOL CHEM, V282, P23517, DOI 10.1074/jbc.M701826200; Huang QS, 2011, CELL MOL BIOENG, V4, P495, DOI 10.1007/s12195-011-0171-1; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Long M, 2011, CELL MOL BIOENG, V4, P327, DOI 10.1007/s12195-011-0183-x; Lou JZ, 2008, P NATL ACAD SCI USA, V105, P13847, DOI 10.1073/pnas.0801965105; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; RUSSELL SD, 1993, BLOOD, V81, P1787; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 2002, SCIENCE, V297, P1128, DOI 10.1126/science.1075452; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilkinson IC, 2009, J BIOL CHEM, V284, P31928, DOI 10.1074/jbc.M109.025304; Wu DM, 2002, ARTERIOSCL THROM VAS, V22, P323, DOI 10.1161/hq0202.102321; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhang B, 2010, J MOL MODEL, V16, P1159, DOI 10.1007/s00894-009-0629-4; Zhao Y, 2007, J THROMB HAEMOST, V5, P1963, DOI 10.1111/j.1538-7836.2007.02682.x	38	13	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42263	10.1371/journal.pone.0042263	http://dx.doi.org/10.1371/journal.pone.0042263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860101	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900085
J	Chatterjee, P; Weaver, LE; Doersch, KM; Kopriva, SE; Chiasson, VL; Allen, SJ; Narayanan, AM; Young, KJ; Jones, KA; Kuehl, TJ; Mitchell, BM				Chatterjee, Piyali; Weaver, Laura E.; Doersch, Karen M.; Kopriva, Shelley E.; Chiasson, Valorie L.; Allen, Samantha J.; Narayanan, Ajay M.; Young, Kristina J.; Jones, Kathleen A.; Kuehl, Thomas J.; Mitchell, Brett M.			Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice	PLOS ONE			English	Article							MATERNAL-FETAL INTERFACE; ISCHEMIC-HEART-DISEASE; INFLAMMATORY RESPONSE; TROPHOBLAST CELLS; NORMAL-PREGNANCY; IMMUNE-SYSTEM; EXPRESSION; RISK; COHORT; WOMEN	Preeclampsia (PE) is a pregnancy-specific hypertensive syndrome characterized by excessive maternal immune system activation, inflammation, and endothelial dysfunction. Toll-like receptor (TLR) 3 activation by double-stranded RNA (dsRNA) and TLR7/8 activation by single-stranded RNA (ssRNA) expressed by viruses and/or released from necrotic cells initiates a pro-inflammatory immune response; however it is unknown whether viral/endogenous RNA is a key initiating signal that contributes to the development of PE. We hypothesized that TLR3/7/8 activation will be evident in placentas of women with PE, and sufficient to induce PE-like symptoms in mice. Placental immunoreactivity and mRNA levels of TLR3, TLR7, and TLR8 were increased significantly in women with PE compared to normotensive women. Treatment of human trophoblasts with the TLR3 agonist polyinosine-polycytidylic acid (poly I:C), the TLR7-specific agonist imiquimod (R-837), or the TLR7/8 agonist CLO97 significantly increased TLR3/7/8 levels. Treatment of mice with poly I:C, R-837, or CLO97 caused pregnancy-dependent hypertension, endothelial dysfunction, splenomegaly, and placental inflammation. These data demonstrate that RNA-mediated activation of TLR3 and TLR7/8 plays a key role in the development of PE.	[Chatterjee, Piyali; Weaver, Laura E.; Doersch, Karen M.; Kopriva, Shelley E.; Chiasson, Valorie L.; Allen, Samantha J.; Narayanan, Ajay M.; Young, Kristina J.; Mitchell, Brett M.] Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Dept Internal Med, Temple, TX 76508 USA; [Jones, Kathleen A.] Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Dept Pathol, Temple, TX 76508 USA; [Kuehl, Thomas J.] Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Dept Obstet & Gynecol, Temple, TX 76508 USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chatterjee, P (corresponding author), Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Dept Internal Med, Temple, TX 76508 USA.	bmitchell@tamhsc.edu		Narayanan, Ajay/0000-0002-8461-1516; Doersch, Karen/0000-0001-8374-9639; Jones, Kathleen/0000-0001-8420-1894; Chatterjee, Piyali/0000-0002-7655-0485	American Heart Association [10GRNT448033]	American Heart Association(American Heart Association)	American Heart Association Grant in Aid # 10GRNT448033 www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; Abrahams VM, 2006, HUM REPROD, V21, P2432, DOI 10.1093/humrep/del178; Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Abrahams VM, 2005, PLACENTA, V26, P540, DOI 10.1016/j.placenta.2004.08.010; Aldo PB, 2010, AM J REPROD IMMUNOL, V64, P27, DOI 10.1111/j.1600-0897.2010.00817.x; Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781; Bonney EA, 2007, J REPROD IMMUNOL, V76, P68, DOI 10.1016/j.jri.2007.03.006; Chatterjee P, 2011, PLACENTA, V32, P201, DOI 10.1016/j.placenta.2010.12.026; Chatterjee P, 2011, HYPERTENSION, V58, P489, DOI 10.1161/HYPERTENSIONAHA.111.172114; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; Demaria O, 2010, J CLIN INVEST, V120, P3651, DOI 10.1172/JCI42081; Dempsey JC, 2003, J REPROD MED, V48, P509; Gonzalez JM, 2007, AM J OBSTET GYNECOL, V197, pe291, DOI DOI 10.1016/J.AJ0G.2007.06.021; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847; LaMarca HL, 2006, PLACENTA, V27, P137, DOI 10.1016/j.placenta.2005.03.003; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Luppi P, 2006, CLIN IMMUNOL, V118, P268, DOI 10.1016/j.clim.2005.11.001; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; Mor G, 2005, CRIT REV IMMUNOL, V25, P375, DOI 10.1615/CritRevImmunol.v25.i5.30; Paine MA, 2006, J REPROD IMMUNOL, V69, P165, DOI 10.1016/j.jri.2005.09.008; Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252; Pineda A, 2011, ARCH MED RES, V42, P382, DOI 10.1016/j.arcmed.2011.08.003; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Riley JK, 2010, CLIN REV ALLERG IMMU, V39, P185, DOI 10.1007/s12016-009-8178-2; Rustveld LO, 2008, MATERN CHILD HLTH J, V12, P223, DOI 10.1007/s10995-007-0224-1; Saito S, 2007, J REPROD IMMUNOL, V76, P30, DOI 10.1016/j.jri.2007.08.002; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Schiessl B, 2007, MOL ASPECTS MED, V28, P210, DOI 10.1016/j.mam.2007.04.004; SCHNEIDER K, 1994, GYNECOL OBSTET INVES, V37, P87, DOI 10.1159/000292531; SIBAI BM, 1991, CLIN OBSTET GYNECOL, V34, P27, DOI 10.1097/00003081-199103000-00007; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Tinsley JH, 2009, AM J HYPERTENS, V22, P1314, DOI 10.1038/ajh.2009.185; Toldi G, 2011, AM J REPROD IMMUNOL, V66, P223, DOI 10.1111/j.1600-0897.2011.00987.x; Trogstad LIS, 2001, ACTA OBSTET GYN SCAN, V80, P1036, DOI 10.1034/j.1600-0412.2001.801112.x; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; Whitley GSJ, 2010, PLACENTA, V31, P465, DOI 10.1016/j.placenta.2010.03.002; Whitley GS, 2006, METH MOLEC MED, V121, P219; Whitley GSJ, 2007, AM J PATHOL, V170, P1903, DOI 10.2353/ajpath.2007.070006; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Xia JX, 2009, J HUAZHONG U SCI-MED, V29, P755, DOI 10.1007/s11596-009-0617-z; Xie F, 2010, BJOG-INT J OBSTET GY, V117, P99, DOI 10.1111/j.1471-0528.2009.02428.x; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	53	78	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41884	10.1371/journal.pone.0041884	http://dx.doi.org/10.1371/journal.pone.0041884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848646	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200121
J	Nguyen, MQ; Ryba, NJP				Nguyen, Minh Q.; Ryba, Nicholas J. P.			A Smell That Causes Seizure	PLOS ONE			English	Article							ANTERIOR PIRIFORM CORTEX; OLFACTORY SENSORY MAP; ODORANT RECEPTORS; TOPOGRAPHIC MAP; EVOKED ACTIVITY; C-FOS; BULB; REPRESENTATIONS; INHIBITION; SYSTEM	In mammals, odorants are detected by a large family of receptors that are each expressed in just a small subset of olfactory sensory neurons (OSNs). Here we describe a strain of transgenic mice engineered to express an octanal receptor in almost all OSNs. Remarkably, octanal triggered a striking and involuntary phenotype in these animals, with passive exposure regularly inducing seizures. Octanal exposure invariably resulted in widespread activation of OSNs but interestingly seizures only occurred in 30-40% of trials. We hypothesized that this reflects the need for the olfactory system to filter strong but slowly-changing backgrounds from salient signals. Therefore we used an olfactometer to control octanal delivery and demonstrated suppression of responses whenever this odorant is delivered slowly. By contrast, rapid exposure of the mice to octanal induced seizure in every trial. Our results expose new details of olfactory processing and provide a robust and non-invasive platform for studying epilepsy.	[Nguyen, Minh Q.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, Taste & Smell Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Nguyen, MQ (corresponding author), Natl Inst Dent & Craniofacial Res, Taste & Smell Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA.	mqnguyen@mail.nih.gov		Ryba, Nicholas/0000-0002-2060-8393	United States National Institutes of Health; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the intramural research program of the United States National Institutes of Health and National Institute of Dental and Craniofacial Research to N.J.P.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CHIASSON BJ, 1995, MOL BRAIN RES, V29, P191, DOI 10.1016/0169-328X(94)00250-I; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Loscher W, 1996, PROG NEUROBIOL, V50, P427, DOI 10.1016/S0301-0082(96)00036-6; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; Norlin EM, 2005, J NEUROCHEM, V93, P1594, DOI 10.1111/j.1471-4159.2005.03159.x; Poo C, 2011, NEURON, V72, P41, DOI 10.1016/j.neuron.2011.08.015; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Sugai T, 2005, NEUROSCIENCE, V130, P769, DOI 10.1016/j.neuroscience.2004.09.059; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Szyndler J, 2009, EPILEPSY BEHAV, V16, P216, DOI 10.1016/j.yebeh.2009.07.030; Treloar HB, 2010, NEUROBIOLOGY OLFACTI; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhan C, 2010, J NEUROSCI, V30, P16662, DOI 10.1523/JNEUROSCI.4400-10.2010; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41899	10.1371/journal.pone.0041899	http://dx.doi.org/10.1371/journal.pone.0041899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848650	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200124
J	Vaccaro, A; Patten, SA; Ciura, S; Maios, C; Therrien, M; Drapeau, P; Kabashi, E; Parker, JA				Vaccaro, Alexandra; Patten, Shunmoogum A.; Ciura, Sorana; Maios, Claudia; Therrien, Martine; Drapeau, Pierre; Kabashi, Edor; Parker, J. Alex			Methylene Blue Protects against TDP-43 and FUS Neuronal Toxicity in C. elegans and D. rerio	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS; NEUROPROTECTION; PATHOGENESIS; AGGREGATION; MUTATIONS; SCREENS; DISEASE; GENE; TAU	The DNA/RNA-binding proteins TDP-43 and FUS are found in protein aggregates in a growing number of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and related dementia, but little is known about the neurotoxic mechanisms. We have generated Caenorhabditis elegans and zebrafish animal models expressing mutant human TDP-43 (A315T or G348C) or FUS (S57 Delta or R521H) that reflect certain aspects of ALS including motor neuron degeneration, axonal deficits, and progressive paralysis. To explore the potential of our humanized transgenic C. elegans and zebrafish in identifying chemical suppressors of mutant TDP-43 and FUS neuronal toxicity, we tested three compounds with potential neuroprotective properties: lithium chloride, methylene blue and riluzole. We identified methylene blue as a potent suppressor of TDP-43 and FUS toxicity in both our models. Our results indicate that methylene blue can rescue toxic phenotypes associated with mutant TDP-43 and FUS including neuronal dysfunction and oxidative stress.	[Vaccaro, Alexandra; Therrien, Martine; Parker, J. Alex] Univ Montreal Hosp Res Ctr, Montreal, PQ, Canada; [Vaccaro, Alexandra; Patten, Shunmoogum A.; Ciura, Sorana; Maios, Claudia; Therrien, Martine; Drapeau, Pierre; Kabashi, Edor; Parker, J. Alex] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Vaccaro, Alexandra; Patten, Shunmoogum A.; Ciura, Sorana; Maios, Claudia; Therrien, Martine; Drapeau, Pierre; Kabashi, Edor; Parker, J. Alex] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Vaccaro, Alexandra; Patten, Shunmoogum A.; Ciura, Sorana; Therrien, Martine; Drapeau, Pierre; Parker, J. Alex] Univ Montreal, Ctr Excellence Neur, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Vaccaro, A (corresponding author), Univ Montreal Hosp Res Ctr, Montreal, PQ, Canada.	edor.kabashi@icm-institute.org; ja.parker@umontreal.ca	Parker, Alex/F-4953-2014; Kabashi, Edor/C-5408-2014	Parker, Alex/0000-0002-3333-2445; Kabashi, Edor/0000-0003-4118-251X; Vaccaro, Alexandra/0000-0002-3183-7343; Therrien, Martine/0000-0003-3150-4052	Montreal University Hospital Foundation; Canadian Institutes of Health Research New Investigator Award; Frick Foundation for ALS Research; Bernice Ramsay Discovery Grant from the ALS Society of Canada	Montreal University Hospital Foundation; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Frick Foundation for ALS Research; Bernice Ramsay Discovery Grant from the ALS Society of Canada	This research was supported by: Montreal University Hospital Foundation (http://fondationduchum.com/fr) to JAP, Canadian Institutes of Health Research New Investigator Award (http://www.cihr-irsc.gc.ca) to JAP, Frick Foundation for ALS Research (http://frick-fondation.ch) to JAP, EK, PD, and a Bernice Ramsay Discovery Grant from the ALS Society of Canada (http://www.als.ca/) to JAP. Genome Quebec to EK and PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Audet JN, 2012, NEUROSCIENCE; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Deng J, 2009, AQUAT TOXICOL, V93, P29, DOI 10.1016/j.aquatox.2009.03.001; Gitcho MA, 2008, ANN NEUROL; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Kabashi E, 2008, NAT GENET       0527; Kabashi E, 2011, PLOS GENET IN PRESS, VPLoS Genet; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lomen-Hoerth C, 2008, SEMIN NEUROL, V28, P205, DOI 10.1055/s-2008-1062265; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Naganska E, 2011, FOLIA NEUROPATHOL, V49, P1; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Rojas JC, 2009, NEUROSCIENCE, V163, P877, DOI 10.1016/j.neuroscience.2009.07.012; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031321; van Bebber F, 2010, NEUROBIOL DIS, V39, P265, DOI 10.1016/j.nbd.2010.03.023; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Wang JW, 2011, J CLIN INVEST; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042	35	76	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42117	10.1371/journal.pone.0042117	http://dx.doi.org/10.1371/journal.pone.0042117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848727	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200170
J	Biasi, F; Guina, T; Maina, M; Nano, M; Falcone, A; Aroasio, E; Saracco, GM; Papotti, M; Leonarduzzi, G; Poli, G				Biasi, Fiorella; Guina, Tina; Maina, Marco; Nano, Mario; Falcone, Alessandro; Aroasio, Emiliano; Saracco, Giorgio Maria; Papotti, Mauro; Leonarduzzi, Gabriella; Poli, Giuseppe			Progressive Increase of Matrix Metalloprotease-9 and Interleukin-8 Serum Levels during Carcinogenic Process in Human Colorectal Tract	PLOS ONE			English	Article							COLON-CANCER; TUMOR-GROWTH; TGF-BETA; VEGF; SENESCENCE; EXPRESSION; CELLS; IL-8	Background: Inflammatory reactions, known to promote tumor growth and invasion, have been found associated with colorectal carcinoma (CRC). Macrophages are the chief component of the inflammatory infiltration that occurs early in the progression from non-invasive to malignant tumor, with a switch from the pro-inflammatory phenotype to the tumor-promoting phenotype. Tumor and stroma are additional sources of inflammation-related molecules. The study aimed to evaluate, during colorectal carcinogenesis from benign to malignant phases: i) the trend of serum levels of IL-8, IL-6, TGF beta 1, VEGF and MMPs; ii) the parallel trend of CRP serum levels; iii) derangement of the principal TGF beta 1 receptors (TGF beta 1RI/RII) in tumor tissues. Methodology/Principal findings: 96 patients with colon adenomas or CRC at different stages of progression, and 17 controls, were recruited. Serum IL-8, IL-6, TGF beta 1, VEGF, MMPs and CRP levels were analyzed before endoscopy or surgery. TGF beta 1 receptors were evaluated in adenoma biopsies and surgically-removed colorectal adenocarcinomas. Serum levels of IL-8 in adenocarcinoma patients were increased from stage II, when also the enzymatic activity of MMP-9 increased. Of note, the increasing trend of the two serum markers was found significantly correlated. Trend of serum CRP was also very similar to that of IL-8 and MMP-9, but just below statistical significance. TGF beta 1 levels were lower at stage III CRC, while IL-6 and VEGF levels had no significant variations. In tissue specimens, TGF beta 1 receptors were already absent in about 50% of adenomas, and this percentage of missing receptors markedly increased in CRC stages III and IV. Conclusions: Combined quantification of serum IL-8, MMP-9 and CRP, appears a reliable and advanced index of inflammation-related processes during malignant phase of colorectal carcinogenesis, since these molecules remain within normal range in colorectal adenoma bearing patients, while consistently increase in the blood of CRC patients, even if from stage II only.	[Biasi, Fiorella; Guina, Tina; Maina, Marco; Nano, Mario; Falcone, Alessandro; Saracco, Giorgio Maria; Papotti, Mauro; Leonarduzzi, Gabriella; Poli, Giuseppe] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Turin, Italy; [Aroasio, Emiliano] San Luigi Gonzaga Hosp, Clin Biochem Lab, Turin, Italy	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga	Biasi, F (corresponding author), Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Turin, Italy.	giuseppe.poli@unito.it	Aroasio, Emiliano/S-8035-2019; Leonarduzzi, Gabriella/AAA-6575-2019	LEONARDUZZI, Gabriella Marisa/0000-0002-3422-821X; NANO, Mario/0000-0002-0657-596X; Saracco, Giorgio Maria/0000-0001-5310-4143	Italian Ministry of University; Piedmontese Regional Government (Ricerca Sanitaria Finalizzata); CRT Foundation, Turin; University of Turin, Italy	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Piedmontese Regional Government (Ricerca Sanitaria Finalizzata); CRT Foundation, Turin; University of Turin, Italy	The authors thank the Italian Ministry of University, PRIN 2008, PRIN 2009, the Piedmontese Regional Government (Ricerca Sanitaria Finalizzata 2008, 2008 II, 2009), the CRT Foundation, Turin, and the University of Turin, Italy, for supporting this work. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Becker C, 2005, CELL CYCLE, V4, P217; Bellam N, 2010, CANCER TREAT RES, V155, P85, DOI 10.1007/978-1-4419-6033-7_5; Biasi F, 2002, GUT, V50, P361, DOI 10.1136/gut.50.3.361; Biasi F, 2008, CARCINOGENESIS, V29, P890, DOI 10.1093/carcin/bgn106; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bunger S, 2011, J BIOMOL SCREEN, V16, P1018, DOI 10.1177/1087057111414894; Chu DK, 2012, ANN SURG ONCOL, V19, P318, DOI 10.1245/s10434-011-1686-3; Chung YC, 2003, HEPATO-GASTROENTEROL, V50, P1910; Csiszar A, 2004, PATHOL ONCOL RES, V10, P109, DOI 10.1007/BF02893465; de Gramont A, 2011, SEMIN ONCOL, V38, P521, DOI 10.1053/j.seminoncol.2011.05.006; Dimberg J, 2011, INT J COLORECTAL DIS; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gala M, 2011, SEMIN ONCOL, V38, P490, DOI 10.1053/j.seminoncol.2011.05.003; Hasan MR, 2011, INT J CANCER, V129, P2115, DOI 10.1002/ijc.26179; Hurst NG, 2007, BRIT J CANCER, V97, P971, DOI 10.1038/sj.bjc.6603958; Kaminska Janina, 2000, Pathology Oncology and Research, V6, P38; Kemik O, 2012, HUM EXP TOXICOL, V31, P117, DOI 10.1177/0960327111417271; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Lanza G, 2011, DIGEST LIVER DIS, V43, pS344, DOI 10.1016/S1590-8658(11)60590-2; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Miyazaki T, 2008, JPN J CLIN ONCOL, V38, P839, DOI 10.1093/jjco/hyn106; Mysliwiec Angela G, 2002, Clin Colorectal Cancer, V1, P208, DOI 10.3816/CCC.2002.n.002; Ning Y, 2012, EXPERT OPIN THER TAR, V16, P491, DOI 10.1517/14728222.2012.677440; Oshima H, 2012, J GASTROENTEROL, V47, P97, DOI 10.1007/s00535-011-0523-6; Quirke P, 2011, VIRCHOWS ARCH, V458, P1, DOI 10.1007/s00428-010-0977-6; Rubie C, 2007, WORLD J GASTROENTERO, V13, P4996, DOI 10.3748/wjg.v13.i37.4996; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486	35	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41839	10.1371/journal.pone.0041839	http://dx.doi.org/10.1371/journal.pone.0041839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848630	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600133
J	Morimoto, N; Zollikofer, CPE; de Leon, MSP				Morimoto, Naoki; Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce			Shared Human-Chimpanzee Pattern of Perinatal Femoral Shaft Morphology and Its Implications for the Evolution of Hominin Locomotor Adaptations	PLOS ONE			English	Article							KNUCKLE-WALKING ANCESTOR; ARDIPITHECUS-RAMIDUS; AFRICAN APES; BODY-SIZE; POSITIONAL BEHAVIOR; MORPHOMETRIC MAPS; HUMAN BIPEDALISM; GROWTH-PLATE; MUSCLE SIZE; AGE-CHANGES	Background: Acquisition of bipedality is a hallmark of human evolution. How bipedality evolved from great ape-like locomotor behaviors, however, is still highly debated. This is mainly because it is difficult to infer locomotor function, and even more so locomotor kinematics, from fossil hominin long bones. Structure-function relationships are complex, as long bone morphology reflects phyletic history, developmental programs, and loading history during an individual's lifetime. Here we discriminate between these factors by investigating the morphology of long bones in fetal and neonate great apes and humans, before the onset of locomotion. Methodology/Principal Findings: Comparative morphometric analysis of the femoral diaphysis indicates that its morphology reflects phyletic relationships between hominoid taxa to a greater extent than taxon-specific locomotor adaptations. Diaphyseal morphology in humans and chimpanzees exhibits several shared-derived features, despite substantial differences in locomotor adaptations. Orangutan and gorilla morphologies are largely similar, and likely represent the primitive hominoid state. Conclusions/Significance: These findings are compatible with two possible evolutionary scenarios. Diaphyseal morphology may reflect retained adaptive traits of ancestral taxa, hence human-chimpanzee shared-derived features may be indicative of the locomotor behavior of our last common ancestor. Alternatively, diaphyseal morphology might reflect evolution by genetic drift (neutral evolution) rather than selection, and might thus be more informative about phyletic relationships between taxa than about locomotor adaptations. Both scenarios are consistent with the hypothesis that knuckle-walking in chimpanzees and gorillas resulted from convergent evolution, and that the evolution of human bipedality is unrelated to extant great ape locomotor specializations.	[Morimoto, Naoki; Zollikofer, Christoph P. E.; de Leon, Marcia S. Ponce] Univ Zurich, Inst Anthropol, Zurich, Switzerland	University of Zurich	Morimoto, N (corresponding author), Univ Zurich, Inst Anthropol, Zurich, Switzerland.	morimoto@aim.uzh.ch		Morimoto, Naoki/0000-0002-8367-4777	Swiss National Science Foundation [3100A0-109344/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Grant sponsor: Swiss National Science Foundation; Grant number: 3100A0-109344/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Crompton RH, 2008, J ANAT, V212, P501, DOI 10.1111/j.1469-7580.2008.00870.x; DeSilva JM, 2011, P NATL ACAD SCI USA, V108, P1022, DOI 10.1073/pnas.1003865108; Doran D. M., 1996, GREAT APE SOC; Doran DM, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P14, DOI 10.1017/CBO9780511606397.004; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; DORAN DM, 1992, J HUM EVOL, V23, P139, DOI 10.1016/0047-2484(92)90104-H; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; Gibbs S, 2000, P NATL ACAD SCI USA, V97, P11130, DOI 10.1073/pnas.190252697; Gibbs S, 2002, J ANAT, V200, P3, DOI 10.1046/j.0021-8782.2001.00001.x; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Hogler W, 2008, BONE, V42, P982, DOI 10.1016/j.bone.2008.01.008; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kivell TL, 2009, P NATL ACAD SCI USA, V106, P14241, DOI 10.1073/pnas.0901280106; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Kuwata T, 2011, J OBSTET GYNAECOL RE, V37, P921, DOI 10.1111/j.1447-0756.2010.01438.x; Lacquaniti F, 2012, CURR OPIN NEUROBIOL, V22, P822, DOI 10.1016/j.conb.2012.03.012; Leigh SR, 1996, AM J PHYS ANTHROPOL, V99, P43, DOI 10.1002/(SICI)1096-8644(199601)99:1<43::AID-AJPA3>3.0.CO;2-0; Lieberman DE, 2006, J EXP BIOL, V209, P2143, DOI 10.1242/jeb.02255; Lockwood CA, 2004, P NATL ACAD SCI USA, V101, P4356, DOI 10.1073/pnas.0306235101; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Lovejoy CO, 2003, ANNU REV ANTHROPOL, V32, P85, DOI 10.1146/annurev.anthro.32.061002.093223; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; Morimoto N, 2011, ANAT REC, V294, P1433, DOI 10.1002/ar.21424; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; Rauch F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P194; REMIS M, 1995, AM J PHYS ANTHROPOL, V97, P413, DOI 10.1002/ajpa.1330970408; Remis MJ, 1998, PRIMATE LOCOMOTION, P95; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff C, 2003, BONE, V33, P317, DOI 10.1016/S8756-3282(03)00161-3; Ruff C, 2003, J HUM EVOL, V45, P317, DOI 10.1016/j.jhevol.2003.08.006; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHULTZ AH, 1973, FOLIA PRIMATOL, V19, P338, DOI 10.1159/000155550; Schwartz J. H., 1995, SKELETON KEYS INTRO; Serrat MA, 2007, ANAT REC, V290, P375, DOI 10.1002/ar.20480; Smith RJ, 1998, J HUM EVOL, V34, P173, DOI 10.1006/jhev.1997.0190; Standring S, 2004, GRAYS ANATOMY, V39th; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Tuttle R.H., 1985, P261; Van Der Eerden BCJ, 2000, J BONE MINER RES, V15, P1045, DOI 10.1359/jbmr.2000.15.6.1045; Wallace IJ, 2012, AM J PHYS ANTHROPOL, V148, P24, DOI 10.1002/ajpa.22028; Wallace IJ, 2010, AM J PHYS ANTHROPOL, V143, P21, DOI 10.1002/ajpa.21286; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wolff J, 1892, GESETZ TRANSFORMATIO; Young NM, 2010, P NATL ACAD SCI USA, V107, P3400, DOI 10.1073/pnas.0911856107; Young NM, 2005, EVOLUTION, V59, P2691; Zollikofer CPE, 2001, HOM EVOLUT CLIMAT CH, V2, P50	66	15	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41980	10.1371/journal.pone.0041980	http://dx.doi.org/10.1371/journal.pone.0041980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848680	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000306806600152
J	Pattacini, L; Mize, GJ; Graham, JB; Fluharty, TR; Graham, TM; Lingnau, K; Wizel, B; Perdiguero, B; Esteban, M; Pantaleo, G; Shen, MC; Spies, GA; McElrath, MJ; Lund, JM				Pattacini, Laura; Mize, Gregory J.; Graham, Jessica B.; Fluharty, Tayler R.; Graham, Tisha M.; Lingnau, Karen; Wizel, Benjamin; Perdiguero, Beatriz; Esteban, Mariano; Pantaleo, Giuseppe; Shen, Mingchao; Spies, Gregory A.; McElrath, M. Juliana; Lund, Jennifer M.			A Novel HIV Vaccine Adjuvanted by IC31 Induces Robust and Persistent Humoral and Cellular Immunity	PLOS ONE			English	Article							T-CELLS; PROTECTIVE IMMUNITY; NONHUMAN-PRIMATES; RESPONSES; NYVAC; VIRUS; IMMUNIZATION; PROTEIN; PRIME; MICE	The HIV vaccine strategy that, to date, generated immune protection consisted of a prime-boost regimen using a canarypox vector and an HIV envelope protein with alum, as shown in the RV144 trial. Since the efficacy was weak, and previous HIV vaccine trials designed to generate antibody responses failed, we hypothesized that generation of T cell responses would result in improved protection. Thus, we tested the immunogenicity of a similar envelope-based vaccine using a mouse model, with two modifications: a clade C CN54gp140 HIV envelope protein was adjuvanted by the TLR9 agonist IC31(R), and the viral vector was the vaccinia strain NYVAC-CN54 expressing HIV envelope gp120. The use of IC31(R) facilitated immunoglobulin isotype switching, leading to the production of Env-specific IgG2a, as compared to protein with alum alone. Boosting with NYVAC-CN54 resulted in the generation of more robust Th1 T cell responses. Moreover, gp140 prime with IC31(R) and alum followed by NYVAC-CN54 boost resulted in the formation and persistence of central and effector memory populations in the spleen and an effector memory population in the gut. Our data suggest that this regimen is promising and could improve the protection rate by eliciting strong and long-lasting humoral and cellular immune responses.	[Pattacini, Laura; Mize, Gregory J.; Graham, Jessica B.; Fluharty, Tayler R.; Graham, Tisha M.; Shen, Mingchao; Spies, Gregory A.; McElrath, M. Juliana; Lund, Jennifer M.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Lingnau, Karen; Wizel, Benjamin] Intercell AG, Vienna, Austria; [Perdiguero, Beatriz; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Pantaleo, Giuseppe] Univ Lausanne Hosp, Swiss Vaccine Res Inst, Lausanne, Switzerland; [Pantaleo, Giuseppe] Univ Lausanne Hosp, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland; [McElrath, M. Juliana; Lund, Jennifer M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Intercell; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle	Pattacini, L (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	jlund@fhcrc.org	Pantaleo, Giuseppe/K-6163-2016; Perdiguero, Beatriz/K-6587-2017; Esteban, Mariano/ABG-5375-2020	Perdiguero, Beatriz/0000-0001-6276-7766; Esteban, Mariano/0000-0003-0846-2827; Lund, Jennifer/0000-0003-3284-979X	Bill & Melinda Gates Foundation [38645, 38599]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org) Collaboration for AIDS Vaccine Discovery [grant numbers 38645 to MJM, 38599 to GP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo L, 2011, VACCINE, V29, P4256, DOI 10.1016/j.vaccine.2011.03.040; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cheng CM, 2011, VACCINE, V29, P2437, DOI 10.1016/j.vaccine.2011.01.031; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Fritz JH, 2004, VACCINE, V22, P3274, DOI 10.1016/j.vaccine.2004.03.007; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Krieg Arthur M, 2007, Proc Am Thorac Soc, V4, P289, DOI 10.1513/pats.200701-021AW; Kwant A, 2004, VACCINE, V22, P3098, DOI 10.1016/j.vaccine.2004.01.059; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Perreau M, 2011, J VIROL, V85, P9854, DOI 10.1128/JVI.00788-11; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Riedl K, 2008, VACCINE, V26, P3461, DOI 10.1016/j.vaccine.2008.04.029; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Stoecklinger A, 2011, J IMMUNOL, V186, P1377, DOI 10.4049/jimmunol.1002557; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; Tritel M, 2003, J IMMUNOL, V171, P2538, DOI 10.4049/jimmunol.171.5.2538; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	34	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42163	10.1371/journal.pone.0042163	http://dx.doi.org/10.1371/journal.pone.0042163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848738	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600173
J	Leonard, SN				Leonard, Steven N.			Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; CLINICAL-FEATURES; ANTIBIOTIC-RESISTANCE; PRACTICE GUIDELINES; TREATMENT OUTCOMES; BETA-LACTAMS; S. AUREUS; INTERMEDIATE; IMPACT; DAPTOMYCIN	Introduction: Continued pressure from glycopeptide use has led to non-susceptible strains of Staphylococcus aureus including heterogeneously vancomycin-intermediate S. aureus (hVISA). Infections with hVISA are associated with poor patient outcomes, thus incentivizing novel treatments. Evidence suggests that vancomycin and anti-staphylococcal penicillin susceptibility are inversely related which indicates that the use of this combination may be particularly useful against methicillin-resistant S. aureus with reduced susceptibility to vancomycin, such as hVISA. The aim of this study was to evaluate the potential for synergy between vancomycin and nafcillin against hVISA. Methods: Twenty-five hVISA strains were evaluated for vancomycin and nafcillin minimum inhibitory concentration (MIC) by broth microdilution in duplicate. Potential for synergy was assessed by time-kill at 1/2x MIC in triplicate. Five strains were chosen, representing the range nafcillin MIC's available in the cohort -4, 16, 64, 128, and 256 mu g/mL, and were run in an in vitro pharmacokinetic/pharmacodynamic (PK/PD) model in duplicate over 72 hours to evaluate the potential of the combination with simulated human pharmacokinetics. In addition, 4 fully glycopeptide susceptible strains of S. aureus including 2 methicillin-susceptible (MSSA) and 2 methicillin-resistant (MRSA) were run in the PK/PD model for comparison. Results: In the time-kill, 92% of strains (23 of 25) displayed synergy with the combination of vancomycin and nafcillin. In the PK/PD model, all five strains of hVISA showed an improvement in overall activity (P <= 0.004) and organism burden at 72 hours (P <= 0.001) with the combination compared to either drug alone. The combination was also successful against both MRSA and MSSA in overall activity (P <= 0.009) and organism burden at 72 hours (P <= 0.016), though the magnitude of the effect was diminished against MSSA. Conclusions: The combination of vancomycin and nafcillin significantly improved antibacterial activity against hVISA, MRSA, and MSSA compared to either drug alone.	[Leonard, Steven N.] Northeastern Univ, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Leonard, Steven N.] Brigham & Womens Hosp, Dept Pharm, Boston, MA 02115 USA	Northeastern University; Harvard University; Brigham & Women's Hospital	Leonard, SN (corresponding author), Northeastern Univ, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA.	s.leonard@neu.edu			Northeastern University; Bouve College of Health Sciences Proposal Development Grant	Northeastern University; Bouve College of Health Sciences Proposal Development Grant	This work was supported in part by a Northeastern University, Bouve College of Health Sciences Proposal Development Grant. No other specific funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; BLASER J, 1985, J ANTIMICROB CHEMOTH, V15, P125, DOI 10.1093/jac/15.suppl_A.125; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Climo MW, 1999, ANTIMICROB AGENTS CH, V43, P1747, DOI 10.1128/AAC.43.7.1747; Clinical and Laboratory Standards Institute, 2008, M07A8 CLIN LAB STAND; Domaracki BE, 2000, ANTIMICROB AGENTS CH, V44, P1394, DOI 10.1128/AAC.44.5.1394-1396.2000; Fong RKC, 2009, EUR J CLIN MICROBIOL, V28, P983, DOI 10.1007/s10096-009-0741-5; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hagihara M, 2012, ANTIMICROB AGENTS CH, V56, P202, DOI 10.1128/AAC.05473-11; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Howden BP, 2006, ANTIMICROB AGENTS CH, V50, P3039, DOI 10.1128/AAC.00422-06; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; KIND AC, 1970, ARCH INTERN MED, V125, P685, DOI 10.1001/archinte.125.4.685; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Leonard SN, 2009, J ANTIMICROB CHEMOTH, V63, P155, DOI 10.1093/jac/dkn439; Lin GR, 2010, ANTIMICROB AGENTS CH, V54, P2201, DOI 10.1128/AAC.01143-09; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3731, DOI 10.1128/AAC.00101-07; Maor Y, 2007, J CLIN MICROBIOL, V45, P1511, DOI 10.1128/JCM.01262-06; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; Rand KH, 2004, ANTIMICROB AGENTS CH, V48, P2871, DOI 10.1128/AAC.48.8.2871-2875.2004; Rose WE, 2010, J ANTIMICROB CHEMOTH, V65, P2149, DOI 10.1093/jac/dkq292; Rose WE, 2009, ANTIMICROB AGENTS CH, V53, P805, DOI 10.1128/AAC.01009-08; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sieradzki K, 1999, J BACTERIOL, V181, P7566, DOI 10.1128/JB.181.24.7566-7570.1999; Sieradzki K, 1997, J ANTIMICROB CHEMOTH, V39, P47, DOI 10.1093/jac/39.suppl_1.47; Sieradzki K, 2003, J CLIN MICROBIOL, V41, P1687, DOI 10.1128/JCM.41.4.1687-1693.2003; STANDIFORD HC, 1970, J INFECT DIS, V122, pS9, DOI 10.1093/infdis/122.Supplement_1.S9; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Turnidge JD, 1998, CLIN INFECT DIS, V27, P10, DOI 10.1086/514622; WALKER CA, 1978, ANTIMICROB AGENTS CH, V13, P30, DOI 10.1128/AAC.13.1.30; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3161, DOI 10.1128/AAC.00487-10	39	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e42103	10.1371/journal.pone.0042103	http://dx.doi.org/10.1371/journal.pone.0042103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848719	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300091
J	Larcombe, L; Orr, P; Turner-Brannen, E; Slivinski, CR; Nickerson, PW; Mookherjee, N				Larcombe, Linda; Orr, Pamela; Turner-Brannen, Emily; Slivinski, Caroline R.; Nickerson, Peter W.; Mookherjee, Neeloffer			Effect of Vitamin D Supplementation on Mycobacterium tuberculosis-Induced Innate Immune Responses in a Canadian Dene First Nations Cohort	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; HOST-DEFENSE; CATHELICIDIN LL-37; INFECTION; SYSTEM; POPULATIONS; EXPRESSION; PROTECTION; INDUCTION; MECHANISM	Canadian First Nations (FN) population experiences a high burden of tuberculosis. Vitamin D is known to enhance the expression of innate immune effectors, including cathelicidin LL-37, for protection against infections. In this study we performed longitudinal analyses to investigate the impact of vitamin D supplementation on macrophage responses to Mycobacterium tuberculosis (Mtb) lipoprotein (TLR2/1L), in Canadian Dene FN participants compared to Caucasian participants. Serum 25(OH) D and LL-37 levels were evaluated by ELISA. Transcriptional responses and protein expression of TLR2/1L-induced LL-37 and other innate immune cytokines were monitored in monocyte-derived macrophages (MDMs) before and after 8 months of vitamin D supplementation. In this study we showed that serum levels of LL-37 decreased after vitamin D supplementation in both Dene and Caucasian participants. There was no difference in TLR2/1L-induced LL-37 expression in MDMs in the two groups, either pre-or post-vitamin D supplementation. However, vitamin D supplementation markedly enhanced TLR2/1L-induced responses in MDMs e. g. IL-6, IL-12 and IL-23 among Caucasians but not in the Dene participants. In contrast, after vitamin D supplementation TLR2/1L-induced responses e. g. IL-1 beta, IL-8 and IL-12 were significantly reduced in the Dene MDMs. These results indicate that vitamin D supplementation enhanced TLR2/1L-induced innate immune macrophage responses in the Caucasian but not in the Dene participants. We hypothesize that cytokines may be differentially regulated in Canadian FN compared to Caucasians, in particular those that influence Th1 and Th-17 responses required for the control of Mtb.	[Larcombe, Linda; Orr, Pamela; Turner-Brannen, Emily; Slivinski, Caroline R.; Nickerson, Peter W.; Mookherjee, Neeloffer] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Turner-Brannen, Emily; Nickerson, Peter W.; Mookherjee, Neeloffer] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Larcombe, L (corresponding author), Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada.	mookherj@cc.umanitoba.ca		Nickerson, Peter/0000-0002-7393-7799; Larcombe, Linda/0000-0002-7828-1290; Mookherjee, Neeloffer/0000-0002-9350-4157	Canadian Institutes for Health Research (CIHR); National Sanitarium Association	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sanitarium Association	This study was supported by funding from the Canadian Institutes for Health Research (CIHR) and the National Sanitarium Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Baeke F, 2008, MOL ASPECTS MED, V29, P376, DOI 10.1016/j.mam.2008.05.004; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Bera A, 2003, MOL BIOCHEM PARASIT, V127, P23, DOI 10.1016/S0166-6851(02)00300-6; Bikle DD, 2008, CURR OPIN NEPHROL HY, V17, P348, DOI 10.1097/MNH.0b013e3282ff64a3; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Cantorna MT, 2004, EXP BIOL MED, V229, P1136, DOI 10.1177/153537020422901108; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gough M, 1996, INFECT IMMUN, V64, P4922, DOI 10.1128/IAI.64.12.4922-4927.1996; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Kanda N, 2010, HUM IMMUNOL, V71, P1161, DOI 10.1016/j.humimm.2010.09.005; Larcombe L, 2005, GENES IMMUN, V6, P140, DOI 10.1038/sj.gene.6364157; Larcombe L, 2011, INT J CIRCUMPOL HEAL, V70, P141, DOI 10.3402/ijch.v70i2.17806; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; REMPEL JD, 2011, EUR J HUM GENET; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Saiga H, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/347594; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Yamshchikov AV, 2010, AM J CLIN NUTR, V92, P603, DOI 10.3945/ajcn.2010.29411; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388	42	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40692	10.1371/journal.pone.0040692	http://dx.doi.org/10.1371/journal.pone.0040692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22866178	Green Published, gold, Green Submitted			2022-12-27	WOS:000306466100056
J	Walker, WA				Walker, Wade A.			The Repeated Replacement Method: A Pure Lagrangian Meshfree Method for Computational Fluid Dynamics	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; HYPERBOLIC CONSERVATION-LAWS; MOVING FINITE-ELEMENTS; MASS METHOD; SCHEMES; DESIGN	In this paper we describe the repeated replacement method (RRM), a new meshfree method for computational fluid dynamics (CFD). RRM simulates fluid flow by modeling compressible fluids' tendency to evolve towards a state of constant density, velocity, and pressure. To evolve a fluid flow simulation forward in time, RRM repeatedly "chops out'' fluid from active areas and replaces it with new "flattened'' fluid cells with the same mass, momentum, and energy. We call the new cells "flattened'' because we give them constant density, velocity, and pressure, even though the chopped-out fluid may have had gradients in these primitive variables. RRM adaptively chooses the sizes and locations of the areas it chops out and replaces. It creates more and smaller new cells in areas of high gradient, and fewer and larger new cells in areas of lower gradient. This naturally leads to an adaptive level of accuracy, where more computational effort is spent on active areas of the fluid, and less effort is spent on inactive areas. We show that for common test problems, RRM produces results similar to other high-resolution CFD methods, while using a very different mathematical framework. RRM does not use Riemann solvers, flux or slope limiters, a mesh, or a stencil, and it operates in a purely Lagrangian mode. RRM also does not evaluate numerical derivatives, does not integrate equations of motion, and does not solve systems of equations.				wwalker3@austin.rr.com		Walker, Wade/0000-0003-2453-8043				Benz W., 1990, P NATO ADV RES WORKS, P269; BERGER MJ, 1984, J COMPUT PHYS, V53, P484, DOI 10.1016/0021-9991(84)90073-1; Carlson NN, 1998, SIAM J SCI COMPUT, V19, P766, DOI 10.1137/S1064827594269561; Carlson NN, 1998, SIAM J SCI COMPUT, V19, P728, DOI 10.1137/S106482759426955X; Catmull E, 1974, UTECCSC74133 U UT; Chaikin G, 1974, COMPUT VISION GRAPH, V3, P346, DOI DOI 10.1016/0146-664X(74)90028-8; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Clough R.W., P 2 ASCE C EL COMP P, P345; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; Crowley WP, 1971, LECT NOTE PHYS, V8, P37; Gauger C, 2000, SIAM J NUMER ANAL, V37, P1768, DOI 10.1137/S0036142999352564; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Godunov S, 1959, MAT SBORNIK, V47, P271; HARTEN A, 1987, J COMPUT PHYS, V71, P231, DOI [10.1016/0021-9991(87)90031-3, 10.1006/jcph.1996.5632]; HARTEN A, 1983, J COMPUT PHYS, V49, P357, DOI 10.1016/0021-9991(83)90136-5; HIRT CW, 1974, J COMPUT PHYS, V14, P227, DOI 10.1006/jcph.1997.5702; Huerta A, 2004, ENCY COMPUTATIONAL M, V1, P279, DOI DOI 10.1002/0470091355.ECM005; Kitsionas S, 2002, MON NOT R ASTRON SOC, V330, P129, DOI 10.1046/j.1365-8711.2002.05115.x; Klingler M, 2005, SIAM J SCI COMPUT, V26, P1744, DOI 10.1137/S1064827502420483; Koshizuka S, 1996, NUCL SCI ENG, V123, P421, DOI 10.13182/NSE96-A24205; Kuprat AP, 1992, GAX9304972 UMI U CAL; Laney, 1998, COMPUTATIONAL GASDYN; Lastiwka M, 2005, INT J NUMER METH FL, V47, P1403, DOI 10.1002/fld.891; Li S., 2002, APPL MECH REV, V55, P1, DOI DOI 10.1115/1.1431547; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Martin HC, 1968, P 2 C MATR METH STRU, P517; MEGLICKI Z, 1993, MON NOT R ASTRON SOC, V264, P691, DOI 10.1093/mnras/264.3.691; MILLER K, 1981, SIAM J NUMER ANAL, V18, P1019, DOI 10.1137/0718070; MILLER K, 1981, SIAM J NUMER ANAL, V18, P1033, DOI 10.1137/0718071; OSHER S, 1983, MATH COMPUT, V41, P321, DOI 10.2307/2007679; Owen JM, 1998, ASTROPHYS J SUPPL S, V116, P155, DOI 10.1086/313100; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; Toro E.F., 2009, RIEMANN SOLVERS NUME, P456; VAN LEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; WHITEHURST R, 1995, MON NOT R ASTRON SOC, V277, P655, DOI 10.1093/mnras/277.2.655	35	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2012	7	7							e39999	10.1371/journal.pone.0039999	http://dx.doi.org/10.1371/journal.pone.0039999			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974UB	22866175	Green Published, gold, Green Submitted			2022-12-27	WOS:000306461800031
J	Duclos, A; Carty, MJ; Peix, JL; Colin, C; Lipsitz, SR; Kraimps, JL; Menegaux, F; Pattou, F; Sebag, F; Voirin, N; Touzet, S; Bourdy, S; Lifante, JC				Duclos, Antoine; Carty, Matthew J.; Peix, Jean-Louis; Colin, Cyrille; Lipsitz, Stuart R.; Kraimps, Jean-Louis; Menegaux, Fabrice; Pattou, Francois; Sebag, Frederic; Voirin, Nicolas; Touzet, Sandrine; Bourdy, Stephanie; Lifante, Jean-Christophe		CATHY Study Grp	Development of a Charting Method to Monitor the Individual Performance of Surgeons at the Beginning of Their Career	PLOS ONE			English	Article							LEARNING-CURVE; MEDICAL-EDUCATION; THYROID-SURGERY; QUALITY-CONTROL; FUNNEL PLOTS; HEALTH-CARE; EXPERIENCE; MULTICENTER; MORTALITY; CUSUM	Background: Efforts to provide a valid picture of surgeons' individual performance evolution should frame their outcomes in relation to what is expected depending on their experience. We derived the learning curve of young thyroidectomy surgeons as a baseline to enable the accurate assessment of their individual outcomes and avoid erroneous conclusions that may derive from more traditional approaches. Methods: Operative time and postoperative recurrent laryngeal nerve palsy of 2006 patients who underwent a thyroidectomy performed by 19 young surgeons in five academic hospitals were monitored from April 2008 to December 2009. The database was randomly divided into training and testing datasets. The training data served to determine the expected performance curve of surgeons during their career and factors influencing outcome variation using generalized estimating equations (GEEs). To simulate prospective monitoring of individual surgeon outcomes, the testing data were plotted on funnel plots and cumulative sum charts (CUSUM). Performance charting methods were utilized to present outcomes adjusted both for patient case-mix and surgeon experience. Results: Generation of performance curves demonstrated a gradual reduction in operative time from 139 (95% CI, 137 to 141) to 75 (71 to 80) minutes, and from 15.7% (15.1% to 16.3%) to 3.3% (3.0% to 3.6%) regarding the nerve palsy rate. Charts interpretation revealed that a very young surgeon had better outcomes than expected, whereas a more experienced surgeon appeared to be a poor performer given the number of years that he had already spent in practice. Conclusions: Not considering the initial learning curve of surgeons exposes them to biased measurement and to misinterpretation in assessing their individual performance for thyroidectomy. The performance chart represents a valuable tool to monitor the outcome of surgeons with the expectation to provide safe and efficient care to patients.	[Duclos, Antoine; Lifante, Jean-Christophe] Hop Edouard Herriot, Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France; [Duclos, Antoine; Colin, Cyrille; Touzet, Sandrine; Bourdy, Stephanie] Univ Lyon, EA Sante Individu Soc 4129, Lyon, France; [Duclos, Antoine; Carty, Matthew J.; Lipsitz, Stuart R.; Lifante, Jean-Christophe] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Peix, Jean-Louis] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Chirurg Gen & Endocrinienne, Pierre Benite, France; [Kraimps, Jean-Louis] Univ Poitiers, Dept Endocrine Surg, Jean Bernard Hosp, Poitiers, France; [Menegaux, Fabrice] Hop La Pitie Salpetriere, AP HP, Serv Chirurg Gen Viscerale & Endocrinienne, Paris, France; [Pattou, Francois] CHRU Lille, Lille, France; [Pattou, Francois] Univ Lille N France, INSERM, UMR 859, Lille, France; [Sebag, Frederic] CHU Timone Adulte, Assistance Publ Hop Marseille, Marseille, France; [Lifante, Jean-Christophe] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69365 Lyon, France	CHU Lyon; Harvard University; Brigham & Women's Hospital; Harvard Medical School; CHU Lyon; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Duclos, A (corresponding author), Hop Edouard Herriot, Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France.	antoineduclos@yahoo.fr	Duclos, Antoine/N-3756-2016; Pattou, Francois/O-6151-2017; Le Pogam, Marie-Annick/AAU-5486-2020; Colombet, Isabelle/J-8186-2017; Lifante, Jean-Christophe/AAX-2606-2020; Triponez, Frederic/A-6237-2013	Duclos, Antoine/0000-0002-8915-4203; Pattou, Francois/0000-0001-8388-3766; Le Pogam, Marie-Annick/0000-0003-1672-3644; Colombet, Isabelle/0000-0002-8721-1526; Triponez, Frederic/0000-0001-7808-496X; Voirin, Nicolas/0000-0003-3317-056X; LEPAPE, Alain/0000-0001-5950-7533	Programme de Recherche en Qualite Hospitaliere of the French Ministry of Health (Ministere charge de la Sante, Direction de l'Hospitalisation et de l'Organisation des Soins), Hospices Civils de Lyon	Programme de Recherche en Qualite Hospitaliere of the French Ministry of Health (Ministere charge de la Sante, Direction de l'Hospitalisation et de l'Organisation des Soins), Hospices Civils de Lyon	This study was supported by a grant from the Programme de Recherche en Qualite Hospitaliere 2007 of the French Ministry of Health (Ministere charge de la Sante, Direction de l'Hospitalisation et de l'Organisation des Soins), Hospices Civils de Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco FJ, 2010, ACAD MED, V85, P863, DOI 10.1097/ACM.0b013e3181d73a45; Biau DJ, 2007, QUAL SAF HEALTH CARE, V16, P203, DOI 10.1136/qshc.2006.020776; Biau DJ, 2010, STAT MED, V29, P1900, DOI 10.1002/sim.3947; Carty MJ, 2009, PLAST RECONSTR SURG, V124, P706, DOI 10.1097/PRS.0b013e3181b17a13; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Cohen MS, 2007, CARDIOL YOUNG, V17, P164, DOI 10.1017/S1047951107001266; Cook JA, 2007, INT J TECHNOL ASSESS, V23, P255, DOI 10.1017/S0266462307070341; Cook Jonathan A, 2004, Clin Trials, V1, P421, DOI 10.1191/1740774504cn042oa; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; Dionigi G, 2008, Int J Surg, V6 Suppl 1, pS7, DOI 10.1016/j.ijsu.2008.12.023; Dionigi G, 2008, Int J Surg, V6 Suppl 1, pS1, DOI 10.1016/j.ijsu.2008.12.004; Dralle H, 2004, SURGERY, V136, P1310, DOI 10.1016/j.surg.2004.07.018; Duclos A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8041; Duclos A, 2011, JAMA-J AM MED ASSOC, V306, P267, DOI 10.1001/jama.2011.987; Duclos A, 2011, WORLD J SURG, V35, P773, DOI 10.1007/s00268-011-0963-4; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; GASTER B, 1993, JAMA-J AM MED ASSOC, V270, P1280, DOI 10.1001/jama.270.11.1280; Hasan A, 2000, BRIT MED J, V320, P171, DOI 10.1136/bmj.320.7228.171; Hastie T., 2009, UNSUPERVISED LEARNIN; Jeannon JP, 2009, INT J CLIN PRACT, V63, P624, DOI 10.1111/j.1742-1241.2008.01875.x; Lee J, 2011, ANN SURG ONCOL, V18, P226, DOI 10.1245/s10434-010-1220-z; Liu S, 2009, SURG ENDOSC, V23, P1802, DOI 10.1007/s00464-009-0332-7; Mayer EK, 2009, ANN SURG, V249, P376, DOI 10.1097/SLA.0b013e31819a47b1; Miccoli P, 2002, WORLD J SURG, V26, P972, DOI 10.1007/s00268-002-6627-7; Montgomery D, 2013, STAT QUALITY CONTROL, V7th; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Ramsay C R, 2001, Health Technol Assess, V5, P1; Reynolds T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6260; Rogers DA, 2001, ANN SURG, V233, P159, DOI 10.1097/00000658-200102000-00003; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Southern WN, 2011, AM J MED, V124, P868, DOI 10.1016/j.amjmed.2011.04.011; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Steiner S H, 2000, Biostatistics, V1, P441, DOI 10.1093/biostatistics/1.4.441; Tekkis PP, 2003, BMJ-BRIT MED J, V327, P1196, DOI 10.1136/bmj.327.7425.1196; WILLIAMS SM, 1992, BRIT MED J, V304, P1359, DOI 10.1136/bmj.304.6838.1359	35	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41944	10.1371/journal.pone.0041944	http://dx.doi.org/10.1371/journal.pone.0041944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860036	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600047
J	Lacroux, C; Bougard, D; Litaise, C; Simmons, H; Corbiere, F; Dernis, D; Tardivel, R; Morel, N; Simon, S; Lugan, S; Costes, P; Weisbecker, JL; Schelcher, F; Grassi, J; Coste, J; Andreoletti, O				Lacroux, Caroline; Bougard, Daisy; Litaise, Claire; Simmons, Hugh; Corbiere, Fabien; Dernis, Dominique; Tardivel, Rene; Morel, Nathalie; Simon, Stephanie; Lugan, Severine; Costes, Pierrette; Weisbecker, Jean Louis; Schelcher, Francois; Grassi, Jacques; Coste, Joliette; Andreoletti, Olivier			Impact of Leucocyte Depletion and Prion Reduction Filters on TSE Blood Borne Transmission	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY; VARIANT CJD; PROTEIN ACCUMULATION; ATYPICAL SCRAPIE; NATURAL SCRAPIE; TISSUE SAMPLES; RISK-FACTORS; TRANSFUSION; INFECTIVITY	The identification in the UK of 4 v-CJD infected patients thought to be due to the use of transfused Red Blood Cell units prepared from blood of donors incubating v-CJD raised major concerns in transfusion medicine. The demonstration of leucocyte associated infectivity using various animal models of TSE infection led to the implementation of systematic leucodepletion (LD) of Red Blood cells concentrates (RBCs) in a number of countries. In the same models, plasma also demonstrated a significant level of infectivity which raised questions on the impact of LD on the v-CJD transmission risk. The recent development of filters combining LD and the capture of non-leucocyte associated prion infectivity meant a comparison of the benefits of LD alone versus LD/prion-reduction filters (LD/PR) on blood-borne TSE transmission could be made. Due to the similarity of blood/plasma volumes to human transfusion medicine an experimental TSE sheep model was used to characterize the abilities of whole blood, RBCs, plasma and buffy-coat to transmit the disease through the transfusion route. The impact of a standard RBCs LD filter and of two different RBCs LD/PR prototype filters on the disease transmission was then measured. Homologous recipients transfused with whole-blood, buffy-coat and RBCs developed the disease with 100% efficiency. Conversely, plasma, when intravenously administered resulted in an inconstant infection of the recipients and no disease transmission was observed in sheep that received cryo-precipitated fraction or supernatant obtained from infectious plasma. Despite their high efficacy, LD and LD/PR filtration of the Red Blood Cells concentrate did not provide absolute protection from infection. These results support the view that leuco-depletion strongly mitigates the v-CJD blood borne transmission risk and provide information about the relative benefits of prion reduction filters.	[Lacroux, Caroline; Litaise, Claire; Corbiere, Fabien; Lugan, Severine; Costes, Pierrette; Schelcher, Francois; Andreoletti, Olivier] Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Toulouse, France; [Bougard, Daisy; Coste, Joliette] EFS Pyrenees Mediterranee, UPR CNRS 1142, R&D TransDiag, Montpellier, France; [Simmons, Hugh] ASU, AHVLA Weybridge, Surrey, England; [Dernis, Dominique] EFS No France, Prod Dept, Lille, France; [Tardivel, Rene] EFS Bretagne, Prod Dept, Rennes, France; [Morel, Nathalie; Simon, Stephanie; Grassi, Jacques] CEA Saclay, DSV, IBiTec S, CEA,Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France; [Weisbecker, Jean Louis] INRA Domaine Langlade, Pompertuzat, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Lacroux, C (corresponding author), Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Toulouse, France.	o.andreoletti@envt.fr	Morel, Nathalie/O-9012-2016; Simmons, Hugh/C-6888-2011; Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255; BOUGARD, Daisy/0000-0002-8779-9251; CORBIERE, Fabien/0000-0003-3006-5561	Alliance Biosecure foundation; EU	Alliance Biosecure foundation; EU(European Commission)	This work was funded by the Alliance Biosecure foundation and the EU FP7 project 'Priority'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; Evatt B, 1998, TRANSFUSION, V38, P817, DOI 10.1046/j.1537-2995.1998.38998409000.x; Garske T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015626; Gregori L, 2006, TRANSFUSION, V46, P1152, DOI 10.1111/j.1537-2995.2006.00865.x; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lacroux C, 2012, J VIROL; Lefrere JJ, 2009, TRANSFUSION, V49, P797, DOI 10.1111/j.1537-2995.2008.02044.x; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Pincock S, 2004, LANCET, V363, P43, DOI 10.1016/S0140-6736(03)15247-6; Saunders C, 2005, VOX SANG, V89, P220, DOI 10.1111/j.1423-0410.2005.00703.x; Simmons HA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-8; Sowemimo-Coker S, 2005, TRANSFUSION, V45, P1839, DOI 10.1111/j.1537-2995.2005.00640.x; Sowemimo-Coker SO, 2006, VOX SANG, V90, P265, DOI 10.1111/j.1423-0410.2006.00765.x; STORMONT CJ, 1982, J AM VET MED ASSOC, V181, P1120; Tabouret G, 2011, J GEN VIROL; Wientjens DPWM, 1996, NEUROLOGY, V46, P1287, DOI 10.1212/WNL.46.5.1287; Zerr I, 2000, J CLIN EPIDEMIOL, V53, P747, DOI 10.1016/S0895-4356(99)00207-3	39	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42019	10.1371/journal.pone.0042019	http://dx.doi.org/10.1371/journal.pone.0042019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860049	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600051
J	Margolis, EB; Toy, B; Himmels, P; Morales, M; Fields, HL				Margolis, Elyssa B.; Toy, Brian; Himmels, Patricia; Morales, Marisela; Fields, Howard L.			Identification of Rat Ventral Tegmental Area GABAergic Neurons	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MIDBRAIN DOPAMINE NEURONS; IN-VIVO MICRODIALYSIS; MEDIATING OPIATE REWARD; GABA-CONTAINING NEURONS; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; MORPHINE; RECEPTORS	The canonical two neuron model of opioid reward posits that mu opioid receptor (MOR) activation produces reward by disinhibiting midbrain ventral tegmental area (VTA) dopamine neurons through inhibition of local GABAergic interneurons. Although indirect evidence supports the neural circuit postulated by this model, its validity has been called into question by growing evidence for VTA neuronal heterogeneity and the recent demonstration that MOR agonists inhibit GABAergic terminals in the VTA arising from extrinsic neurons. In addition, VTA MOR reward can be dopamine-independent. To directly test the assumption that MOR activation directly inhibits local GABAergic neurons, we investigated the properties of rat VTA GABA neurons directly identified with either immunocytochemistry for GABA or GAD65/67, or in situ hybridization for GAD65/67 mRNA. Utilizing co-labeling with an antibody for the neural marker NeuN and in situ hybridization against GAD65/67, we found that 23 +/- 3% of VTA neurons are GAD65/67(+). In contrast to the assumptions of the two neuron model, VTA GABAergic neurons are heterogeneous, both physiologically and pharmacologically. Importantly, only 7/13 confirmed VTA GABA neurons were inhibited by the MOR selective agonist DAMGO. Interestingly, all confirmed VTA GABA neurons were insensitive to the GABA(B) receptor agonist baclofen (0/6 inhibited), while all confirmed dopamine neurons were inhibited (19/19). The heterogeneity of opioid responses we found in VTA GABAergic neurons, and the fact that GABA terminals arising from neurons outside the VTA are inhibited by MOR agonists, make further studies essential to determine the local circuit mechanisms underlying VTA MOR reward.	[Margolis, Elyssa B.; Toy, Brian; Himmels, Patricia; Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA; [Margolis, Elyssa B.; Toy, Brian; Himmels, Patricia; Fields, Howard L.] Univ Calif San Francisco, Res Ctr, Emeryville, CA USA; [Margolis, Elyssa B.; Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Fields, Howard L.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA; [Morales, Marisela] Natl Inst Drug Abuse, Baltimore, MD USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Margolis, EB (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA USA.	elyssam@gallo.ucsf.edu	Fields, Howard/ABG-9073-2020	Toy, Brian/0000-0002-9612-5697	National Institute On Drug Abuse [R01DA030529]; Irene and Eric Simon Brain Research Foundation; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030529] Funding Source: NIH RePORTER	National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Irene and Eric Simon Brain Research Foundation; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by Grant Number R01DA030529 from the National Institute On Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute On Drug Abuse or the National Institutes of Health. This project was also supported by the Irene and Eric Simon Brain Research Foundation, funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco, and funds to the Intramural Research Program of the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; BECHARA A, 1992, BEHAV NEUROSCI, V106, P798, DOI 10.1037/0735-7044.106.5.798; Bonci A, 1997, J NEUROSCI, V17, P796; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; CHURCHILL L, 1992, NEUROCHEM RES, V17, P101, DOI 10.1007/BF00966870; Cohen JY, 2012, NATURE; CONRAD LCA, 1976, BRAIN RES, V113, P589, DOI 10.1016/0006-8993(76)90060-3; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DEVINE DP, 1993, J PHARMACOL EXP THER, V266, P1236; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Geisler S, 2005, J COMP NEUROL, V490, P270, DOI 10.1002/cne.20668; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kaufling J, 2010, BIOL PSYCHIAT, V67, P88, DOI 10.1016/j.biopsych.2009.08.001; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KELLEY AE, 1980, BEHAV BRAIN RES, V1, P3, DOI 10.1016/S0166-4328(80)80047-7; Kirouac GJ, 2004, J COMP NEUROL, V469, P170, DOI 10.1002/cne.11005; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Laviolette SR, 2002, BEHAV BRAIN RES, V129, P17, DOI 10.1016/S0166-4328(01)00327-8; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2003, J NEUROSCI, V23, P9981; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2008, J NEUROSCI, V28, P12672, DOI 10.1523/JNEUROSCI.4569-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Matsui A, 2011, J NEUROSCI, V31, P17729, DOI 10.1523/JNEUROSCI.4570-11.2011; MATTHEWS RT, 1984, NEUROSCIENCE, V11, P617, DOI 10.1016/0306-4522(84)90048-4; Nader K, 1997, J NEUROSCI, V17, P383, DOI 10.1523/JNEUROSCI.17-01-00383.1997; NICOLL RA, 1980, NATURE, V287, P22, DOI 10.1038/287022a0; NOWYCKY MC, 1978, J NEURAL TRANSM, V42, P99, DOI 10.1007/BF01675349; Numan M, 2009, BEHAV NEUROSCI, V123, P740, DOI 10.1037/a0016204; Olmstead MC, 1997, BEHAV NEUROSCI, V111, P1324, DOI 10.1037/0735-7044.111.6.1324; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Omelchenko N, 2010, J NEUROSCI RES, V88, P981, DOI 10.1002/jnr.22265; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Sahraei H, 2005, EUR J PHARMACOL, V524, P95, DOI 10.1016/j.ejphar.2005.09.012; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Shoji Y, 1999, J NEUROSCI, V19, P2347; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Steffensen SC, 2006, EXP NEUROL, V202, P139, DOI 10.1016/j.expneurol.2006.05.023; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; WELZL H, 1989, NEUROPHARMACOLOGY, V28, P1017, DOI 10.1016/0028-3908(89)90112-3; Wirtshafter D, 2001, BRAIN RES BULL, V56, P1, DOI 10.1016/S0361-9230(01)00487-7; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Xia YF, 2010, J PHYSIOL-LONDON, V588, P1541, DOI 10.1113/jphysiol.2010.188367; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; YOSHIDA M, 1993, BRAIN RES, V624, P277, DOI 10.1016/0006-8993(93)90087-4; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zangen A, 2002, J NEUROSCI, V22, P7225; Zhang Y, 2009, NEUROSCIENCE, V158, P474, DOI 10.1016/j.neuroscience.2008.09.039	66	118	118	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42365	10.1371/journal.pone.0042365	http://dx.doi.org/10.1371/journal.pone.0042365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860119	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600095
J	Jing-Feng, W; Zhi-Gang, Q; Zhi-Qiang, C; Jun-Wen, L; Yi-Hong, Z; Xuan, W; Bin, Z				Jing-Feng, Wang; Zhi-Gang, Qiu; Zhi-Qiang, Chen; Jun-Wen, Li; Yi-Hong, Zhang; Xuan, Wang; Bin, Zhang			Comparison and Analysis of Membrane Fouling between Flocculent Sludge Membrane Bioreactor and Granular Sludge Membrane Bioreactor	PLOS ONE			English	Article							WASTE-WATER TREATMENT; ACTIVATED-SLUDGE; AEROBIC GRANULES; REACTOR; FILTRATION; SUBSTANCES; STABILITY; DYNAMICS; REMOVAL; POLYMER	The goal of this study is to investigate the effect of inoculating granules on reducing membrane fouling. In order to evaluate the differences in performance between flocculent sludge and aerobic granular sludge in membrane reactors (MBRs), two reactors were run in parallel and various parameters related to membrane fouling were measured. The results indicated that specific resistance to the fouling layer was five times greater than that of mixed liquor sludge in the granular MBR. The floc sludge more easily formed a compact layer on the membrane surface, and increased membrane resistance. Specifically, the floc sludge had a higher moisture content, extracellular polymeric substances concentration, and negative surface charge. In contrast, aerobic granules could improve structural integrity and strength, which contributed to the preferable permeate performance. Therefore, inoculating aerobic granules in a MBR presents an effective method of reducing the membrane fouling associated with floc sludge the perspective of from the morphological characteristics of microbial aggregates.	[Jing-Feng, Wang; Zhi-Gang, Qiu; Zhi-Qiang, Chen; Jun-Wen, Li; Yi-Hong, Zhang; Bin, Zhang] Acad Mil Med Sci, Inst Hlth & Environm Med, Tianjin, Peoples R China; [Jing-Feng, Wang; Zhi-Gang, Qiu; Zhi-Qiang, Chen; Jun-Wen, Li; Yi-Hong, Zhang; Bin, Zhang] Tianjin Key Lab Risk Assessment & Control Environ, Tianjin, Peoples R China; [Xuan, Wang] Tianjin Polytech Univ, Tianjin Key Lab Hollow Fiber Membrane Mat & Membr, Inst Biol & Chem Engn, Tianjin, Peoples R China	Academy of Military Medical Sciences - China; Tiangong University	Jing-Feng, W (corresponding author), Acad Mil Med Sci, Inst Hlth & Environm Med, Tianjin, Peoples R China.	wangxuan0116@163.com; tjzhb@hotmail.com	Xuan, Wang/ABA-5348-2021	Xuan, Wang/0000-0002-9030-212X	National High Technology Research and Development Program of China [2009AA06Z312]; National Science Fund of China [5090827, 51108456]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by National High Technology Research and Development Program of China (Grant No. 2009AA06Z312) and National Science Fund of China (Grant No. 5090827 and 51108456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2008, BIOTECHNOL ADV, V26, P411, DOI 10.1016/j.biotechadv.2008.05.002; Apha, 2012, AM PUBLIC HLTH ASS, V22nd; de Bruin LMM, 2004, WATER SCI TECHNOL, V49, P1; De Sanctis M, 2010, BIORESOURCE TECHNOL, V101, P2152, DOI 10.1016/j.biortech.2009.11.018; Fang F, 2009, BIORESOURCE TECHNOL, V100, P59, DOI 10.1016/j.biortech.2008.06.016; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; Gerhardt P., 1994, METHODS GEN MOL BACT; Han SS, 2005, PROCESS BIOCHEM, V40, P2393, DOI 10.1016/j.procbio.2004.09.017; Hilal N, 2005, SEP SCI TECHNOL, V40, P1957, DOI 10.1081/SS-200068409; Iversen V, 2009, WATER RES, V43, P822, DOI 10.1016/j.watres.2008.11.022; Jang A, 2003, J BIOTECHNOL, V105, P71, DOI 10.1016/S0168-1656(03)00142-1; Jia XS, 1996, WATER SCI TECHNOL, V34, P309, DOI 10.2166/wst.1996.0565; Juang YC, 2010, ENVIRON SCI TECHNOL, V44, P1267, DOI 10.1021/es9024657; Judd S., 2006, MBR BOOK PRINCIPLES; Jun BH, 2003, BIOCHEM ENG J, V14, P37, DOI 10.1016/S1369-703X(02)00119-5; Kong YH, 2009, ENZYME MICROB TECH, V45, P379, DOI 10.1016/j.enzmictec.2009.06.014; Koseoglu H, 2008, J MEMBRANE SCI, V320, P57, DOI 10.1016/j.memsci.2008.03.053; Laguna A, 1999, WATER SCI TECHNOL, V40, P1, DOI 10.1016/S0273-1223(99)00602-2; Le-Clech P, 2006, J MEMBRANE SCI, V284, P17, DOI 10.1016/j.memsci.2006.08.019; Liu XW, 2009, BIOTECHNOL ADV, V27, P1061, DOI 10.1016/j.biotechadv.2009.05.020; Liu YQ, 2008, BIORESOURCE TECHNOL, V99, P980, DOI 10.1016/j.biortech.2007.03.011; MAGARA Y, 1991, WATER SCI TECHNOL, V23, P1583, DOI 10.2166/wst.1991.0612; Metzger U, 2007, J MEMBRANE SCI, V301, P180, DOI 10.1016/j.memsci.2007.06.016; Ng HY, 2005, WATER ENVIRON RES, V77, P187, DOI 10.2175/106143005X41753; Toh SK, 2003, APPL MICROBIOL BIOT, V60, P687, DOI 10.1007/s00253-002-1145-y; Wang JF, 2008, APPL MICROBIOL BIOT, V79, P679, DOI 10.1007/s00253-008-1466-6; Wang Q, 2004, PROCESS BIOCHEM, V39, P557, DOI 10.1016/S0032-9592(03)00128-6; Wang X, 2010, BIORESOURCE TECHNOL, V101, P8046, DOI 10.1016/j.biortech.2010.05.074; Wu JL, 2006, DESALINATION, V197, P124, DOI 10.1016/j.desal.2005.11.026; Wu JL, 2009, J MEMBRANE SCI, V342, P88, DOI 10.1016/j.memsci.2009.06.024; Xavier JB, 2007, ENVIRON SCI TECHNOL, V41, P6410, DOI 10.1021/es070264m; Yoon SH, 2006, DESALINATION, V191, P52, DOI 10.1016/j.desal.2005.04.124; Zhang B, 2011, BIORESOURCE TECHNOL, V102, P2474, DOI 10.1016/j.biortech.2010.11.017	33	7	7	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40819	10.1371/journal.pone.0040819	http://dx.doi.org/10.1371/journal.pone.0040819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859954	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900012
J	Zarraonaindia, I; Iriondo, M; Albaina, A; Pardo, MA; Manzano, C; Grant, WS; Irigoien, X; Estonba, A				Zarraonaindia, Iratxe; Iriondo, Mikel; Albaina, Aitor; Angel Pardo, Miguel; Manzano, Carmen; Grant, W. Stewart; Irigoien, Xabier; Estonba, Andone			Multiple SNP Markers Reveal Fine-Scale Population and Deep Phylogeographic Structure in European Anchovy (Engraulis encrasicolus L.)	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MITOCHONDRIAL-DNA; GENETIC-DIFFERENCES; STATISTICAL-METHOD; MEDITERRANEAN SEA; STOCK STRUCTURE; NORTH-SEA; ESTUARY; SOFTWARE; ATLANTIC	Geographic surveys of allozymes, microsatellites, nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) have detected several genetic subdivisions among European anchovy populations. However, these studies have been limited in their power to detect some aspects of population structure by the use of a single or a few molecular markers, or by limited geographic sampling. We use a multi-marker approach, 47 nDNA and 15 mtDNA single nucleotide polymorphisms (SNPs), to analyze 626 European anchovies from the whole range of the species to resolve shallow and deep levels of population structure. Nuclear SNPs define 10 genetic entities within two larger genetically distinctive groups associated with oceanic variables and different life-history traits. MtDNA SNPs define two deep phylogroups that reflect ancient dispersals and colonizations. These markers define two ecological groups. One major group of Iberian-Atlantic populations is associated with upwelling areas on narrow continental shelves and includes populations spawning and overwintering in coastal areas. A second major group includes northern populations in the North East (NE) Atlantic (including the Bay of Biscay) and the Mediterranean and is associated with wide continental shelves with local larval retention currents. This group tends to spawn and overwinter in oceanic areas. These two groups encompass ten populations that differ from previously defined management stocks in the Alboran Sea, Iberian-Atlantic and Bay of Biscay regions. In addition, a new North Sea-English Channel stock is defined. SNPs indicate that some populations in the Bay of Biscay are genetically closer to North Western (NW) Mediterranean populations than to other populations in the NE Atlantic, likely due to colonizations of the Bay of Biscay and NW Mediterranean by migrants from a common ancestral population. Northern NE Atlantic populations were subsequently established by migrants from the Bay of Biscay. Populations along the Iberian-Atlantic coast appear to have been founded by secondary waves of migrants from a southern refuge.	[Zarraonaindia, Iratxe; Iriondo, Mikel; Albaina, Aitor; Manzano, Carmen; Estonba, Andone] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Genet Lab, Leioa, Bizkaia, Spain; [Angel Pardo, Miguel] AZTI Tecnalia, Food Res Unit, Derio, Bizkaia, Spain; [Grant, W. Stewart] Alaska Dept Fish & Game, Commercial Fisheries Div, Anchorage, AK 99518 USA; [Irigoien, Xabier] AZTI Tecnalia, Div Marine Res, Pasaia, Gipuzkoa, Spain	University of Basque Country; AZTI; Alaska Department of Fish & Game; AZTI	Zarraonaindia, I (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Genet Lab, Leioa, Bizkaia, Spain.	iratxe.zarraonaindia@ehu.es	Iriondo, Mikel/AAA-7997-2019; Albaina, Aitor/E-6267-2015; Zarraonaindia, Iratxe/ABF-4618-2020; Irigoien, Xabier/B-8171-2009; Pardo, Miguel Angel/H-5133-2015	Iriondo, Mikel/0000-0001-7835-0041; Albaina, Aitor/0000-0003-3353-6090; Zarraonaindia, Iratxe/0000-0002-0615-0187; Irigoien, Xabier/0000-0002-5411-6741; Manzano, Carmen/0000-0002-8261-0608; Pardo, Miguel Angel/0000-0002-3395-3380; Estonba, Andone/0000-0003-2851-5201	Education, Universities and Investigation Department of the Basque Government; European Commission (FACTS) [FP7-KBBE-2009-3, 244966]; Ministry of Science and Innovation of Spain [RTA2006-00068-C02-02]; Agriculture and Fisheries Department of the Basque Government (ECOANCHOA)	Education, Universities and Investigation Department of the Basque Government; European Commission (FACTS)(European Commission); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agriculture and Fisheries Department of the Basque Government (ECOANCHOA)	This work was supported by a research grant to IZ from the Education, Universities and Investigation Department of the Basque Government, by the European Commission (FACTS, FP7-KBBE-2009-3, grant agreement 244966) and two funded projects from the Ministry of Science and Innovation of Spain (RTA2006-00068-C02-02) and the Agriculture and Fisheries Department of the Basque Government (ECOANCHOA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AG, 2012, MOL ECOL RESOUR, V12, P374, DOI 10.1111/j.1755-0998.2011.03109.x; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Aldanondo N, 2010, FISH OCEANOGR, V19, P196, DOI 10.1111/j.1365-2419.2010.00537.x; Baldo F, 2002, J FISH BIOL, V61, P21, DOI 10.1006/jfbi.2002.2064; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Bembo DG, 1996, ICES J MAR SCI, V53, P115, DOI 10.1006/jmsc.1996.0011; Bembo DG, 1996, MAR BIOL, V126, P529, DOI 10.1007/BF00354635; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Borsa P, 2004, CR BIOL, V327, P1113, DOI 10.1016/j.crvi.2004.09.003; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Bouchenak-Khelladi Y, 2008, J SEA RES, V59, P269, DOI 10.1016/j.seares.2008.03.001; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Caneco B, 2004, 2004EE24 ICES CM; Chashchin AK, 1996, SCI MAR, V60, P219; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; Drake P, 2007, J FISH BIOL, V70, P1689, DOI 10.1111/j.1095-8649.2007.01433.x; Drake P, 2002, ESTUARIES, V25, P451, DOI 10.1007/BF02695987; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grant WS, 2005, J FISH BIOL, V67, P1242, DOI 10.1111/j.1095-8649.2005.00820.x; Grant WS, 2005, GENETICA, V125, P293, DOI 10.1007/s10709-005-0717-z; GRANT WS, 1985, J FISH BIOL, V27, P23, DOI 10.1111/j.1095-8649.1985.tb04006.x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hilbish TJ, 1996, J EXP MAR BIOL ECOL, V200, P67, DOI 10.1016/S0022-0981(96)02645-7; ICES, 2007, 2007ACFM31 ICES CM; ICES, 2010, 2010ACOM16 ICES CM; Irigoien X, 2007, PROG OCEANOGR, V74, P132, DOI 10.1016/j.pocean.2007.04.011; Ivanova Petya P., 2006, Acta Adriatica, V47, P13; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones B, 2009, MOL ECOL RESOUR, V9, P487, DOI 10.1111/j.1755-0998.2008.02444.x; Junquera S, 1986, REV TRAV I PECHES, V48, P133; KALNINA OV, 1984, GENETIKA+, V20, P309; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Kristoffersen JB, 2008, FISH RES, V91, P187, DOI 10.1016/j.fishres.2007.11.024; LAMBECK K, 1995, J GEOL SOC LONDON, V152, P437, DOI 10.1144/gsjgs.152.3.0437; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Langella O., 1999, POPULATIONS 1 2 32; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Magoulas A, 1996, MOL BIOL EVOL, V13, P178, DOI 10.1093/oxfordjournals.molbev.a025554; Magoulas A, 2006, MOL PHYLOGENET EVOL, V39, P734, DOI 10.1016/j.ympev.2006.01.016; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mesnick SL, 2011, MOL ECOL RESOUR, V11, P278, DOI 10.1111/j.1755-0998.2010.02973.x; Motos L, 1996, SCI MAR, V60, P117; PALOMERA I, 1992, MAR ECOL PROG SER, V79, P215; Palomera I, 1993, SCI MAR, V57, P243; Pasteur N, 1985, STRUCTURE GENETIQUE; Pestana G, 1989, THESIS U LISBOA; Petitgas P, 2012, MAR ECOL PROG SER, V444, P1, DOI 10.3354/meps09451; Pritchard JK, 2000, GENETICS, V155, P945; Re P, 1996, SCI MAR, V60, P141; REYNOLDS J, 1983, GENETICS, V105, P767; Ribeiro R, 1996, ESTUAR COAST SHELF S, V42, P467, DOI 10.1006/ecss.1996.0030; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Ryynanen HJ, 2007, J HERED, V98, P692, DOI 10.1093/jhered/esm093; Sanz N, 2008, ICES J MAR SCI, V65, P1635, DOI 10.1093/icesjms/fsn128; Sinovcic Gorenka, 2000, Acta Adriatica, V41, P3; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SPANAKIS E, 1989, J FISH BIOL, V35, P417, DOI 10.1111/j.1095-8649.1989.tb02993.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; TAJIMA F, 1989, GENETICS, V123, P585; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; Zardoya R, 2004, MOL ECOL, V13, P1785, DOI 10.1111/j.1365-294X.2004.02198.x; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187	76	59	59	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42201	10.1371/journal.pone.0042201	http://dx.doi.org/10.1371/journal.pone.0042201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860082	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900077
J	Babu, MA; Nahed, BV; Heary, RF				Babu, Maya A.; Nahed, Brian V.; Heary, Robert F.			Investigating the Scope of Resident Patient Care Handoffs within Neurosurgery	PLOS ONE			English	Article							MEDICAL ERRORS; HOUSE STAFF; COMMUNICATION; STRATEGIES; OPPORTUNITIES; CONTINUITY; INTERNS; IMPACT; SLEEP	Introduction: Handoffs are defined as verbal and written communications during patient care transitions. With the passage of recent ACMGE work hour rules further limiting the hours interns can spend in the hospital, many fear that more handoffs will occur, putting patient safety at risk. The issue of handoffs has not been studied in the neurosurgical literature. Methods: A validated, 20-question online-survey was sent to neurosurgical residents in all 98 accredited U.S. neurosurgery programs. Survey results were analyzed using tabulations. Results: 449 surveys were completed yielding a 56% response rate. 63% of neurosurgical residents surveyed had not received formal instruction in what constitutes an effective handoff; 24% believe there is high to moderate variability among their co-residents in terms of the quality of the handoff provided; 55% experience three or more interruptions during handoffs on average. 90% of neurosurgical residents surveyed say that handoff most often occurs in a quiet, private area and 56% report a high level of comfort for knowing the potential acute, critical issues affecting a patient when receiving a handoff. Conclusions: There needs to be more focused education devoted to learning effective patient-care handoffs in neurosurgical training programs. Increasingly, handing off a patient adequately and safely is becoming a required skill of residency.	[Babu, Maya A.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Neurol Surg, Rochester, MN 55905 USA; [Nahed, Brian V.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Heary, Robert F.] Neurol Inst New Jersey, Dept Neurosurg, Newark, NJ USA	Mayo Clinic; Harvard University; Massachusetts General Hospital	Babu, MA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Neurol Surg, Rochester, MN 55905 USA.	babu.maya@mayo.edu	Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X				Alpers A, 2001, AM J MED, V111, P5, DOI 10.1016/S0002-9343(01)00962-7; Apker J, 2010, ANN EMERG MED, V55, P161, DOI 10.1016/j.annemergmed.2009.09.021; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Arora VM, 2007, ARCH INTERN MED, V167, P1738, DOI 10.1001/archinte.167.16.1738; Arora VM, 2009, J HOSP MED, V4, P433, DOI 10.1002/jhm.573; Block M, 2010, JT COMM J QUAL PATIE, V36, P282, DOI 10.1016/S1553-7250(10)36044-2; Burton MC, 2010, J HOSP MED; Catalano Kathleen, 2009, Plast Surg Nurs, V29, P266, DOI 10.1097/PSN.0b013e3181c20136; Catchpole K, 2010, QUAL SAF HEALTH CARE, V19, P318, DOI 10.1136/qshc.2009.026542; Chang VY, 2010, PEDIATRICS, V125, P491, DOI 10.1542/peds.2009-0351; Cheung DS, 2010, ANN EMERG MED, V55, P171, DOI 10.1016/j.annemergmed.2009.07.016; Chu ES, 2010, J HOSP MED, V5, P344, DOI 10.1002/jhm.633; Cima RR, 2010, J NEUROSURG, V113, P458, DOI 10.3171/2009.10.JNS091399; Clancy Carolyn M, 2008, AORN J, V88, P625, DOI 10.1016/j.aorn.2008.09.007; Cohen FL, 2010, J NEUROSURG, V113, P461, DOI 10.3171/2009.10.JNS091282; Commission J, 2007, IMPR AM HOSP JOINT C; Crum Gregory Brenda S, 2006, AORN J, V84, P1059; Education ACfGM, 2011, COMM PROGR REQ; Education ACfGM, 2003, COMM PROGR REQ DUTY; Frank Gary, 2005, J Healthc Inf Manag, V19, P68; Gakhar B, 2010, ACAD MED, V85, P1182, DOI 10.1097/ACM.0b013e3181da8370; Gibson SC, 2010, ANN EMERG MED, V55, P181, DOI 10.1016/j.annemergmed.2009.10.009; Gleason KM, 2010, J GEN INTERN MED, V25, P441, DOI 10.1007/s11606-010-1256-6; Gordon CJ, 2009, J CONTIN EDUC NURS, V40, P491, DOI 10.3928/00220124-20091023-06; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Hsiao AL, 2009, JT COMM J QUAL PATIE, V35, P467, DOI 10.1016/S1553-7250(09)35065-5; Iacono MV, 2009, J PERIANESTH NURS, V24, P324, DOI 10.1016/j.jopan.2009.08.003; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; Kim George R, 2007, AMIA Annu Symp Proc, P414; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; Malter L, 2010, AM J GASTROENTEROL, V105, P490, DOI 10.1038/ajg.2009.735; McMurray A, 2010, J CLIN NURS, V19, P2580, DOI 10.1111/j.1365-2702.2009.03033.x; Organizations. JCoAoH, 2006, 2007 NAT PAT SAF GOA; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Philibert I, 2009, QUAL SAF HEALTH CARE, V18, P261, DOI 10.1136/qshc.2008.031609; Rhabra G, 2007, ANN ROY COLL SURG, V89, P298, DOI 10.1308/003588407X168352; Riesenberg LA, 2010, AM J NURS, V110, P24, DOI 10.1097/01.NAJ.0000370154.79857.09; Salerno SM, 2009, TEACH LEARN MED, V21, P121, DOI 10.1080/10401330902791354; Scovell Sles, 2010, Nurs Stand, V24, P35; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Solet DJ, 2005, ACAD MED, V80, P1094, DOI 10.1097/00001888-200512000-00005; Stewart BA, 2010, J AM MED INFORM ASSN, V17, P341, DOI 10.1136/jamia.2009.001750; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; Vidyarthi AR, 2006, J HOSP MED, V1, P257, DOI 10.1002/jhm.103; Willis RE, 2009, J SURG EDUC, V66, P216, DOI 10.1016/j.jsurg.2009.06.005; Women in Neurosurgery, 2009, SO YOU WANT BE NEUR	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41810	10.1371/journal.pone.0041810	http://dx.doi.org/10.1371/journal.pone.0041810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848615	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200110
J	Sun, H; Xiong, WF; Arrick, DM; Mayhan, WG				Sun, Hong; Xiong, Wanfen; Arrick, Denise M.; Mayhan, William G.			Low-Dose Alcohol Consumption Protects against Transient Focal Cerebral Ischemia in Mice: Possible Role of PPAR gamma	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTORS; HEART-DISEASE; ADULT-RAT; EXPRESSION; STROKE; AGONIST; TISSUE; BRAIN; ALPHA; NEUROPROTECTION	Background: We examined the influence of low-dose alcohol consumption on cerebral ischemia/reperfusion (I/R) injury in mice and a potential mechanism underlying the neuroprotective effect of low-dose alcohol consumption. Methodology/Principal Findings: C57BL/6 J mice were fed a liquid diet without or with 1% alcohol for 8 weeks, orally treated with rosiglitazone (20 mg/kg/day), a peroxisome proliferator-activated receptor gamma (PPAR gamma)-selective agonist, or GW9662 (3 mg/kg/day), a selective PPAR gamma antagonist, for 2 weeks. The mice were subjected to unilateral middle cerebral artery occlusion (MCAO) for 90 minutes. Brain injury, DNA fragmentation and nuclear PPAR gamma protein/activity were evaluated at 24 hours of reperfusion. We found that the brain injury and DNA fragmentation were reduced in 1% alcohol-fed mice compared to nonalcohol-fed mice. Rosiglitazone suppressed the brain injury in nonalcohol-fed mice, but didn't alter the brain injury in alcohol-fed mice. In contrast, GW9662 worsened the brain injury in alcohol-fed mice, but didn't alter the brain injury in nonalcohol-fed mice. Nuclear PPAR gamma protein/activity at peri-infarct and the contralateral corresponding areas of the parietal cortex was greater in alcohol-fed mice compared to nonalcohol-fed mice. Using differentiated catecholaminergic (CATH. a) neurons, we measured dose-related influences of chronic alcohol exposure on nuclear PPAR gamma protein/activity and the influence of low-dose alcohol exposure on 2-hour oxygen-glucose deprivation (OGD)/24-hour reoxygenation-induced apoptosis. We found that low-dose alcohol exposure increased nuclear PPAR gamma protein/activity and protected against the OGD/reoxygenation-induced apoptosis. The beneficial effect of low-dose alcohol exposure on OGD/reoxygenation-induced apoptosis was abolished by GW9662. Conclusions/Significance: Our findings suggest that chronic consumption of low-dose alcohol protects the brain against I/R injury. The neuroprotective effect of low-dose alcohol consumption may be related to an upregulated PPAR gamma.	[Sun, Hong; Arrick, Denise M.; Mayhan, William G.] Louisiana State Univ Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA USA; [Xiong, Wanfen] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Nebraska System; University of Nebraska Medical Center	Sun, H (corresponding author), Louisiana State Univ Hlth Sci Ctr Shreveport, Dept Cellular Biol & Anat, Shreveport, LA USA.	hsun1@lsuhsc.edu			National Institutes of Health [DA 14258, HL79587, HL090657, AA 11288]; American Heart Association [0635052N]; Louisiana State University Health Sciences Center-Shreveport; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090657, R01HL079587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Louisiana State University Health Sciences Center-Shreveport; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health Grants DA 14258, HL79587, HL090657, AA 11288, a Scientist Development Grant from the American Heart Association (0635052N), and funds from Louisiana State University Health Sciences Center-Shreveport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Buettner GR, 2011, ANTI-CANCER AGENT ME, V11, P341; Chavez PRG, 2011, J NUTR, V141, P1049, DOI 10.3945/jn.110.136531; Cherian PP, 2008, ALCOHOL CLIN EXP RES, V32, P1884, DOI 10.1111/j.1530-0277.2008.00769.x; Chtistophe M, 2006, CURR PHARM DESIGN, V12, P739, DOI 10.2174/138161206775474242; Chu K, 2006, BRAIN RES, V1093, P208, DOI 10.1016/j.brainres.2006.03.114; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; Fortunato F, 2007, J PATHOL, V213, P441, DOI 10.1002/path.2243; HANSAGI H, 1995, STROKE, V26, P1768, DOI 10.1161/01.STR.26.10.1768; Ikehara S, 2008, STROKE, V39, P2936, DOI 10.1161/STROKEAHA.108.520288; Kaundal RK, 2011, CURR NEUROVASC RES, V8, P236; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Mitra SK, 2008, MOL CELL BIOCHEM, V315, P9, DOI 10.1007/s11010-008-9782-9; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; Ou ZS, 2006, BRAIN RES, V1096, P196, DOI 10.1016/j.brainres.2006.04.062; Patzer A, 2008, EUR J NEUROSCI, V28, P1786, DOI 10.1111/j.1460-9568.2008.06478.x; Raghubir R, 2011, CHEM BIOL DRUG DES, V78, P445, DOI 10.1111/j.1747-0285.2011.01153.x; Rist PM, 2010, STROKE, V41, P141, DOI 10.1161/STROKEAHA.109.562173; Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438; Sasaki T, 2011, J NEUROSCI RES, V89, P601, DOI 10.1002/jnr.22581; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; Shimazu T, 2005, STROKE, V36, P353, DOI 10.1161/01.STR.0000152271.21943.a2; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Takahashi M, 1997, J EXP BIOL, V200, P401; Victor NA, 2006, EUR J NEUROSCI, V24, P1653, DOI 10.1111/j.1460-9568.2006.05037.x; Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537; Zhao HG, 2011, ALCOHOL CLIN EXP RES, V35, P1265, DOI 10.1111/j.1530-0277.2011.01461.x; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	32	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41716	10.1371/journal.pone.0041716	http://dx.doi.org/10.1371/journal.pone.0041716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848576	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200095
J	Chung, BH; Kim, KW; Kim, BM; Piao, SG; Lim, SW; Choi, BS; Park, CW; Kim, YS; Cho, ML; Yang, CW				Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Piao, Shang Guo; Lim, Sun Woo; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Cho, Mi-La; Yang, Chul Woo			Dysregulation of Th17 Cells during the Early Post-Transplant Period in Patients under Calcineurin Inhibitor Based Immunosuppression	PLOS ONE			English	Article							RENAL-TRANSPLANT RECIPIENTS; REGULATORY T-CELLS; PREDICTIVE PARAMETER; ALLOGRAFT REJECTION; MYCOPHENOLIC-ACID; IMMUNE-RESPONSE; EXPRESSION; T(H)17; IL-17; INTERLEUKIN-17	Accumulating evidence suggests that Th17 cells play a role in the development of chronic allograft injury in transplantation of various organs. However, the influence of current immunosuppressants on Th17-associated immune responses has not been fully investigated. We prospectively investigated the changes in Th17 cells in peripheral blood mononuclear cells (PBMCs) collected before and 1 and 3 months after KT in 26 patients and we investigated the suppressive effect of tacrolimus on Th17 in vitro. In the early posttransplant period, the percentage of Th17 cells and the proportion of IL-17-producing cells in the effector memory T cells (TEM) were significantly increased at 3 months after transplantation compared with before transplantation (P<0.05), whereas Th1/Th2 cells and TEM cells were significantly decreased. The degree of increase in Th17 during the early posttransplant period was significantly associated with allograft function at 1 year after transplantation (r = 0.4, P<0.05). In vitro, tacrolimus suppressed Th1 and Th2 cells in a concentration-dependent manner, but did not suppress Th17 cells even at high concentration. This suggests that current immunosuppression based on tacrolimus is inadequate to suppress Th17 cells in KTRs, and dysregulation of Th17 may be associated with the progression of CAD.	[Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Piao, Shang Guo; Lim, Sun Woo; Cho, Mi-La; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Chung, Byung Ha; Piao, Shang Guo; Lim, Sun Woo; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Choi, Bum Soon; Park, Cheol Whee; Kim, Yong-Soo; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Chung, BH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	iammila@catholic.ac.kr; yangch@catholic.ac.kr			Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant (A092258) from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadja F, 2011, TRANSPLANTATION, V92, P396, DOI 10.1097/TP.0b013e3182247b5f; Alvarez-Lara MA, 2004, NEPHROL DIAL TRANSPL, V19, P3084, DOI 10.1093/ndt/gfh382; Braun RK, 2010, J HEART LUNG TRANSPL, V29, P873, DOI 10.1016/j.healun.2010.03.012; Calvo-Turrubiartes M, 2009, TRANSPL IMMUNOL, V21, P43, DOI 10.1016/j.trim.2009.02.002; Chung BH, 2011, EXP MOL MED; Crispim JCO, 2009, TRANSPL P, V41, P1562, DOI 10.1016/j.transproceed.2009.01.092; Decraene A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-177; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hsieh HG, 2001, TRANSPL INT, V14, P287; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Loong CC, 2000, TRANSPL P, V32, P1773, DOI 10.1016/S0041-1345(00)01382-8; Mas V, 2007, TRANSPLANTATION, V83, P448, DOI 10.1097/01.tp.0000251373.17997.9a; Mas VR, 2010, EXPERT REV MOL DIAGN, V10, P269, DOI 10.1586/ERM.10.6; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mitchell P, 2009, CURR OPIN ORGAN TRAN, V14, P326, DOI 10.1097/MOT.0b013e32832ce88e; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Ochs HD, 2009, J ALLERGY CLIN IMMUN, V123, P977, DOI 10.1016/j.jaci.2009.03.030; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Rentenaar RJ, 2002, KIDNEY INT, V62, P319, DOI 10.1046/j.1523-1755.2002.00425.x; Segundo DS, 2008, TRANSPL P, V40, P2885, DOI 10.1016/j.transproceed.2008.09.043; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Syrjala SO, 2010, J HEART LUNG TRANSPL, V29, P1047, DOI 10.1016/j.healun.2010.04.012; Takatsuki M, 2001, TRANSPL IMMUNOL, V8, P279, DOI 10.1016/S0966-3274(01)00027-2; Warrens AN, 2002, BJU INT, V90, P784, DOI 10.1046/j.1464-410X.2002.03006.x; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Weimer R, 2000, HUM IMMUNOL, V61, P884, DOI 10.1016/S0198-8859(00)00152-X	33	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42011	10.1371/journal.pone.0042011	http://dx.doi.org/10.1371/journal.pone.0042011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848688	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600157
J	Jaiseng, W; Fang, Y; Ma, Y; Sugiura, R; Kuno, T				Jaiseng, Wurentuya; Fang, Yue; Ma, Yan; Sugiura, Reiko; Kuno, Takayoshi			Studies on the Roles of Clathrin-Mediated Membrane Trafficking and Zinc Transporter Cis4 in the Transport of GPI-Anchored Proteins in Fission Yeast	PLOS ONE			English	Article							CELL-WALL PROTEINS; DISTINCT PHENOTYPES; CANDIDA-ALBICANS; ER EXIT; CALCINEURIN; HOMOLOG; ENCODES; 1,10-PHENANTHROLINE; IDENTIFICATION; DISRUPTION	We previously identified Cis4, a zinc transporter belonging to the cation diffusion facilitator protein family, and we demonstrated that Cis4 is implicated in Golgi membrane trafficking in fission yeast. Here, we identified three glycosylphosphatidylinositol (GPI)-anchored proteins, namely Ecm33, Aah3, and Gaz2, as multicopy suppressors of the MgCl2-sensitive phenotype of cis4-1 mutant. The phenotypes of ecm33, aah3 and gaz2 deletion cells were distinct from each other, and Cis4 overexpression suppressed Delta ecm33 phenotypes but did not suppress Delta aah3 defects. Notably, green fluorescent protein-tagged Ecm33, which was observed at the cell surface in wild-type cells, mostly localized as intracellular dots that are presumed to be the Golgi and endosomes in membrane-trafficking mutants, including Delta apm1, ypt3-i5, and chc1-1 mutants. Interestingly, all these membrane-trafficking mutants showed hypersensitivity to BE49385A, an inhibitor of Its8 that is involved in GPI-anchored protein synthesis. Taken together, these results suggest that GPI-anchored proteins are transported through a clathrin-mediated post-Golgi membrane trafficking pathway and that zinc transporter Cis4 may play roles in membrane trafficking of GPI-anchored proteins in fission yeast.	[Fang, Yue; Kuno, Takayoshi] China Med Univ, Sch Pharmaceut Sci, Dept Pharmacol, Shenyang, Peoples R China; [Jaiseng, Wurentuya; Ma, Yan] Kobe Univ, Grad Sch Med, Div Mol Pharmacol & Pharmacogenom, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogenom, Higashiosaka, Osaka 577, Japan	China Medical University; Kobe University; Kindai University (Kinki University)	Fang, Y (corresponding author), China Med Univ, Sch Pharmaceut Sci, Dept Pharmacol, Shenyang, Peoples R China.	fangyue@mail.cmu.edu.cn			National Natural Science Foundation of China [30900795, 31071094]; Japan Society for the Promotion of Science	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the National Natural Science Foundation of China (No. 30900795 and No. 31071094) and research grants from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Benli M, 1996, EMBO J, V15, P6460, DOI 10.1002/j.1460-2075.1996.tb01037.x; Caro LHP, 1997, YEAST, V13, P1477, DOI 10.1002/(SICI)1097-0061(199712)13:15<1477::AID-YEA184>3.0.CO;2-L; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Fang Y, 2008, MOL BIOL CELL, V19, P1295, DOI 10.1091/mbc.E07-08-0805; Fang Y, 2009, GENES CELLS, V14, P759, DOI 10.1111/j.1365-2443.2009.01308.x; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Fujita M, 2012, BIOCH BIOPHYS ACTA; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; He Y, 2006, GENES CELLS, V11, P207, DOI 10.1111/j.1365-2443.2006.00935.x; Iwaki T, 2007, BIOSCI BIOTECH BIOCH, V71, P623, DOI 10.1271/bbb.60609; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; LISANTI MP, 1990, J MEMBRANE BIOL, V117, P1, DOI 10.1007/BF01871561; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moreno-Ruiz E, 2009, MICROBIOL-SGM, V155, P2004, DOI 10.1099/mic.0.028902-0; Morita T, 2006, BIOSCI BIOTECH BIOCH, V70, P1454, DOI 10.1271/bbb.50693; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Powner D, 1998, MOL CELL BIOL, V18, P400, DOI 10.1128/MCB.18.1.400; Rivier AS, 2010, TRAFFIC, V11, P1017, DOI 10.1111/j.1600-0854.2010.01081.x; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sevlever D, 2001, BIOCHEM BIOPH RES CO, V288, P1112, DOI 10.1006/bbrc.2001.5900; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Toda T, 1996, MOL CELL BIOL, V16, P6752; Wang W, 2002, MOL BIOL CELL, V13, P3336, DOI 10.1091/mbc.01-12-0577; Watanabe R, 2004, CURR OPIN CELL BIOL, V16, P350, DOI 10.1016/j.ceb.2004.06.010; Yada T, 2001, J BIOL CHEM, V276, P13579, DOI 10.1074/jbc.M009260200; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	43	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41946	10.1371/journal.pone.0041946	http://dx.doi.org/10.1371/journal.pone.0041946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848669	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600148
J	Lin, JH; Gunter, MJ; Manson, JE; Rexrode, KM; Cook, NR; Kraft, P; Cochrane, BB; Chlebowski, RT; Ho, GYF; Zhang, SMM				Lin, Jennifer H.; Gunter, Marc J.; Manson, Joann E.; Rexrode, Kathryn M.; Cook, Nancy R.; Kraft, Peter; Cochrane, Barbara B.; Chlebowski, Rowan T.; Ho, Gloria Y. F.; Zhang, Shumin M.			The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women	PLOS ONE			English	Article							COLORECTAL-CANCER RISK; C-MET; ASSOCIATION; OBESITY; ESTROGEN; EXPRESSION; POLYMORPHISMS; RECEPTOR; MODULATION; ESTRADIOL	Background: Estrogen and androgen have been linked to the regulation of circulating hepatocyte growth factor (HGF), an adipose tissue-derived cytokine. It is possible that the CYP19A1 gene which alters sex hormones production may influence HGF levels. We examined the association between the CYP19A1 gene variants and plasma HGF concentrations. Design: We evaluated 45 common and putative functional variants of CYP19A1 and circulating levels of HGF among 260 postmenopausal women who later developed colorectal cancer from the Women's Health Initiative Observational Cohort. As the distribution of HGF levels was highly skewed, we transformed HGF concentrations for all women into a log-, ranked-, or normal score-scale value. Multiple linear regression with adjustment for age was used to evaluate the associations. Results: We observed an association between the rs7172156, rs1008805, rs6493494, rs749292, and rs11636639 variants and HGF levels in ranked and normal score scales (corrected p values <= 0.02), although the association of these 5 SNPs with log-scale HGF was not significant (corrected p values >= 0.16). The associations remained unchanged after additional adjustment for hormone therapy use and estradiol levels. These 5 SNPs, which were in linkage disequilibrium (pairwise D'>= 97%, r(2)>= 56%), constituted a block with 2 common haplotypes accounting for 82% frequency. The most common haplotype, TCCCA, was associated with lower ranked-or normal score-transformed HGF levels (corrected p values <= 0.001), whereas the second most common haplotype, CTTCA, was associated with higher ranked-or normal score-transformed HGF levels (corrected p values <= 0.02). Conclusion: Our findings of a potential association between the CYP19A1 variants and circulating HGF levels warrant confirmation in studies with larger sample size.	[Lin, Jennifer H.; Manson, Joann E.; Rexrode, Kathryn M.; Cook, Nancy R.; Zhang, Shumin M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Lin, Jennifer H.; Manson, Joann E.; Rexrode, Kathryn M.; Cook, Nancy R.; Zhang, Shumin M.] Harvard Univ, Sch Med, Boston, MA USA; [Manson, Joann E.; Cook, Nancy R.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Cochrane, Barbara B.] Univ Washington, de Tornyay Ctr Hlth Aging, Seattle, WA 98195 USA; [Gunter, Marc J.; Ho, Gloria Y. F.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Med, Torrance, CA 90509 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Yeshiva University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Lin, JH (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA.	jhlin@rics.bwh.harvard.edu	Gunter, Marc/AAP-8621-2020; Rexrode, Kathryn M/I-1177-2018	Gunter, Marc/0000-0001-5472-6761; Rexrode, Kathryn/0000-0003-3387-8429	National Institutes of Health [CA123089, CA126846, HL088521]; National Heart, Lung, and Blood Institute, National Institutes of Health, United States Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NATIONAL CANCER INSTITUTE [R01CA126846, R01CA123089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088521] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032113, N01WH032102, N01WH042132, N01WH032108, N01WH042130, N01WH042113, N01WH042118, N01WH042110, N01WH042124, N01WH042117, N01WH032100, N01WH032105, N01WH032112, N01WH032119, N01WH042131, N01WH032106, N01WH042108, N01WH042111, N01WH032111, N01WH042115, N01WH042123, N01WH022110, N01WH042126, N01WH032101, N01WH032118, N01WH042120, N01WH042109, N01WH042121, N01WH042112, N01WH032115, N01WH042107, N01WH042116, N01WH032109, N01WH042125, N01WH042122, N01WH032122, N01WH042114, N01WH042119, N01WH042129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health, United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants CA123089, CA126846, and HL088521 from the National Institutes of Health. The WHI program is funded by contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221 from the National Heart, Lung, and Blood Institute, National Institutes of Health, United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baruscotti I, 2010, HYPERTENSION, V56, P397, DOI 10.1161/HYPERTENSIONAHA.110.153262; Beckmann L, 2011, J CLIN ENDOCR METAB, V96, pE360, DOI 10.1210/jc.2010-0912; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Cai H, 2008, PHARMACOGENET GENOM, V18, P657, DOI 10.1097/FPC.0b013e3282fe3326; Coleman KD, 2012, AM J REPROD IMMUNOL, V67, P44, DOI 10.1111/j.1600-0897.2011.01063.x; Dudkowska M, 2001, BIOCHEM J, V353, P317, DOI 10.1042/0264-6021:3530317; Goodman MT, 2008, ENDOCR-RELAT CANCER, V15, P1055, DOI 10.1677/ERC-08-0104; Gunter MJ, 2008, CANCER RES, V68, P329, DOI 10.1158/0008-5472.CAN-07-2946; Gupta A, 2008, CLIN CANCER RES, V14, P7385, DOI 10.1158/1078-0432.CCR-07-5110; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Hayashi Y, 2002, HYPERTENS RES, V25, P655; Hiratsuka A, 2005, J CLIN ENDOCR METAB, V90, P2927, DOI 10.1210/jc.2004-1588; Ho GYF, 2012, CANCER RES, V72, P3029, DOI 10.1158/0008-5472.CAN-11-2771; Hursting SD, 2007, CANCER RES, V67, P2391, DOI 10.1158/0008-5472.CAN-06-4237; Kaplan RC, 2007, CANCER EPIDEM BIOMAR, V16, P1291, DOI 10.1158/1055-9965.EPI-06-1089; Lin JH, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-78; MEANS GD, 1989, J BIOL CHEM, V264, P19385; Mendelson CR, 2005, J STEROID BIOCHEM, V95, P25, DOI 10.1016/j.jsbmb.2005.04.016; Morishita R, 2002, ENDOCR J, V49, P273, DOI 10.1507/endocrj.49.273; Naim R, 2008, IN VIVO, V22, P77; Otsuka M, 2012, J EPIDEMIOL; Petry CJ, 2006, J STEROID BIOCHEM, V98, P199, DOI 10.1016/j.jsbmb.2005.09.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajpathak SN, 2010, DIABETES CARE, V33, P2013, DOI 10.2337/dc10-0710; Rajpathak SN, 2010, STROKE, V41, P857, DOI 10.1161/STROKEAHA.109.567719; Rehman J, 2003, J AM COLL CARDIOL, V41, P1408, DOI 10.1016/S0735-1097(03)00231-6; Riancho JA, 2007, J CLIN ENDOCR METAB, V92, P660, DOI 10.1210/jc.2006-1616; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Sheen-Chen SM, 2005, CANCER EPIDEM BIOMAR, V14, P715, DOI 10.1158/1055-9965.EPI-04-0340; Simpson ER, 2000, J MOL ENDOCRINOL, V25, P149, DOI 10.1677/jme.0.0250149; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Tam NNC, 2000, CARCINOGENESIS, V21, P2183, DOI 10.1093/carcin/21.12.2183; Toiyama Y, 2009, INT J CANCER, V125, P1657, DOI 10.1002/ijc.24554; Vistoropsky Y, 2008, ANN HUM BIOL, V35, P93, DOI 10.1080/03014460701822003; Wake DJ, 2007, CLIN ENDOCRINOL, V66, P440, DOI 10.1111/j.1365-2265.2007.02755.x; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Zhang X, 2010, BIOL REPROD, V82, P1037, DOI 10.1095/biolreprod.109.079772	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42079	10.1371/journal.pone.0042079	http://dx.doi.org/10.1371/journal.pone.0042079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848710	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600164
J	Postic, G; Dubail, I; Frapy, E; Dupuis, M; Dieppedale, J; Charbit, A; Meibom, KL				Postic, Guillaume; Dubail, Iharilalao; Frapy, Eric; Dupuis, Marion; Dieppedale, Jennifer; Charbit, Alain; Meibom, Karin L.			Identification of a Novel Small RNA Modulating Francisella tularensis Pathogenicity	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; REGULATOR; NOVICIDA; SURVIVAL; REVEALS; BINDING; ISLAND	Francisella tularensis is a highly virulent bacterium responsible for the zoonotic disease tularemia. It is a facultative intracellular pathogen that replicates in the cytoplasm of host cells, particularly in macrophages. Here we show that F. tularensis live vaccine strain (LVS) expresses a novel small RNA (sRNA), which modulates the virulence capacities of the bacterium. When this sRNA, designated FtrC (for Francisella tularensis RNA C), is expressed at high levels, F. tularensis replicates in macrophages less efficiently than the wild-type parent strain. Similarly, high expression of FtrC reduces the number of viable bacteria recovered from the spleen and liver of infected mice. Our data demonstrate that expression of gene FTL_1293 is regulated by FtrC. Furthermore, we show by in vitro gel shift assays that FtrC interacts specifically with FTL_1293 mRNA and that this happens independently of the RNA chaperone Hfq. Remarkably, FtrC interacts only with full-length FTL_1293 mRNA. These results, combined with a bioinformatic analysis, indicate that FtrC interacts with the central region of the mRNA and hence does not act by sterically hindering access of the ribosome to the mRNA. We further show that gene FTL_1293 is not required for F. tularensis virulence in vitro or in vivo, which indicates that another unidentified FtrC target modulates the virulence capacity of the bacterium.	[Postic, Guillaume; Dubail, Iharilalao; Frapy, Eric; Dupuis, Marion; Dieppedale, Jennifer; Charbit, Alain; Meibom, Karin L.] Univ Paris 05, INSERM, U1002, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Postic, G (corresponding author), Univ Paris 05, INSERM, U1002, Fac Med, Paris, France.	karin.meibom@inserm.fr	Postic, Guillaume/AAH-2739-2019	Postic, Guillaume/0000-0002-0380-0092; Eric, FRAPY/0000-0002-2958-6960; charbit, alain/0000-0001-5243-4861; Meibom, Karin/0000-0002-2612-6424	INSERM; CNRS; Universite Paris Descartes; la delegation generale de l'armement (DGA); la Region Ile de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; la delegation generale de l'armement (DGA); la Region Ile de France(Region Ile-de-France)	This work was supported by INSERM, CNRS, Universite Paris Descartes, la delegation generale de l'armement (DGA), and la Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asare R, 2010, ENVIRON MICROBIOL, V12, P2587, DOI 10.1111/j.1462-2920.2010.02230.x; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chambers JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019797; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; de Bruin OM, 2011, MICROBIOLOGY; DECHASTELLIER C, 1994, INFECT IMMUN, V62, P543, DOI 10.1128/IAI.62.2.543-553.1994; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Grall N, 2009, MICROBIOL-SGM, V155, P2560, DOI 10.1099/mic.0.029058-0; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; LoVullo ED, 2009, MICROBIOL-SGM, V155, P1152, DOI 10.1099/mic.0.022491-0; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; Meibom KL, 2010, CURR OPIN MICROBIOL, V13, P11, DOI 10.1016/j.mib.2009.11.007; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Postic G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-625; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Zaide G, 2011, APPL ENVIRON MICROB, V77, P1608, DOI 10.1128/AEM.01862-10	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41999	10.1371/journal.pone.0041999	http://dx.doi.org/10.1371/journal.pone.0041999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848684	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600154
J	Pottorff, M; Wanamaker, S; Ma, YQQ; Ehlers, JD; Roberts, PA; Close, TJ				Pottorff, Marti; Wanamaker, Steve; Ma, Yaqin Q.; Ehlers, Jeffrey D.; Roberts, Philip A.; Close, Timothy J.			Genetic and Physical Mapping of Candidate Genes for Resistance to Fusarium oxysporum f.sp tracheiphilum Race 3 in Cowpea [Vigna unguiculata (L.) Walp]	PLOS ONE			English	Article							DISEASE RESISTANCE; WILT RESISTANCE; TOMATO; KINASE; LOCUS; REGISTRATION; INHERITANCE; HOMOLOGS; ENCODES; CLONING	Fusarium oxysporum f.sp. tracheiphilum (Fot) is a soil-borne fungal pathogen that causes vascular wilt disease in cowpea. Fot race 3 is one of the major pathogens affecting cowpea production in California. Identification of Fot race 3 resistance determinants will expedite delivery of improved cultivars by replacing time-consuming phenotypic screening with selection based on perfect markers, thereby generating successful cultivars in a shorter time period. Resistance to Fot race 3 was studied in the RIL population California Blackeye 27 (resistant) x 24-125B-1 (susceptible). Biparental mapping identified a Fot race 3 resistance locus, Fot3-1, which spanned 3.56 cM on linkage group one of the CB27 x 24-125B-1 genetic map. A marker-trait association narrowed the resistance locus to a 1.2 cM region and identified SNP marker 1_1107 as co-segregating with Fot3-1 resistance. Macro and microsynteny was observed for the Fot3-1 locus region in Glycine max where six disease resistance genes were observed in the two syntenic regions of soybean chromosomes 9 and 15. Fot3-1 was identified on the cowpea physical map on BAC clone CH093L18, spanning approximately 208,868 bp on BAC contig250. The Fot3-1 locus was narrowed to 0.5 cM distance on the cowpea genetic map linkage group 6, flanked by SNP markers 1_0860 and 1_1107. BAC clone CH093L18 was sequenced and four cowpea sequences with similarity to leucine-rich repeat serine/threonine protein kinases were identified and are cowpea candidate genes for the Fot3-1 locus. This study has shown how readily candidate genes can be identified for simply inherited agronomic traits when appropriate genetic stocks and integrated genomic resources are available. High co-linearity between cowpea and soybean genomes illustrated that utilizing synteny can transfer knowledge from a reference legume to legumes with less complete genomic resources. Identification of Fot race 3 resistance genes will enable transfer into high yielding cowpea varieties using marker-assisted selection (MAS).	[Pottorff, Marti; Wanamaker, Steve; Ma, Yaqin Q.; Ehlers, Jeffrey D.; Close, Timothy J.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Ehlers, Jeffrey D.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Roberts, Philip A.] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA	University of California System; University of California Riverside; Bill & Melinda Gates Foundation; University of California System; University of California Riverside	Pottorff, M (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	timothy.close@ucr.edu			Bill and Melinda Gates Foundation; U.S. Agency for International Development Collaborative Research Support Program [GDG-G-00-02-00012-00, EDH-A-00-07-00005]; University of California Agricultural Experiment Station	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U.S. Agency for International Development Collaborative Research Support Program(United States Agency for International Development (USAID)); University of California Agricultural Experiment Station(University of California System)	This work was supported in part by the Generation Challenge Program through a grant from the Bill and Melinda Gates Foundation, the U.S. Agency for International Development Collaborative Research Support Program Grants GDG-G-00-02-00012-00 and EDH-A-00-07-00005 and the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG G M, 1980, Plant Disease, V64, P954, DOI 10.1094/PD-64-954; ARMSTRONG GM, 1981, FUSARIUM DIS BIOL TA, P391; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Assuncao I. P., 2003, Fitopatologia Brasileira, V28, P615, DOI 10.1590/S0100-41582003000600006; Becraft PW, 1998, TRENDS PLANT SCI, V3, P384, DOI 10.1016/S1360-1385(98)01301-6; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Diop N, 2012, ENHANCING C IN PRESS; Ehlers JD, 2009, J PLANT REGIST, V3, P236, DOI 10.3198/jpr2009.01.0039crc; Ehlers JD, 2000, CROP SCI, V40, P854, DOI 10.2135/cropsci2000.403611x; Feuillet C, 1997, PLANT J, V11, P45, DOI 10.1046/j.1365-313X.1997.11010045.x; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Hall AE, 2003, FIELD CROP RES, V82, P103, DOI 10.1016/S0378-4290(03)00033-9; HARE WW, 1953, PHYTOPATHOLOGY, V43, P291; Hemming MN, 2004, THEOR APPL GENET, V109, P409, DOI 10.1007/s00122-004-1646-4; Joobeur T, 2004, PLANT J, V39, P283, DOI 10.1111/j.1365-313X.2004.02134.x; Kitch LW, 2001, CROP SCI, V40, P854; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MCGRATH DJ, 1987, AUST J AGR RES, V38, P729, DOI 10.1071/AR9870729; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Patel P.N., 1985, COWPEA RES PRODUCTIO, P205; RIGERT KS, 1987, CROP SCI, V27, P220, DOI 10.2135/cropsci1987.0011183X002700020018x; Rubio J, 2003, PLANT BREEDING, V122, P188, DOI 10.1046/j.1439-0523.2003.00814.x; SARFATTI M, 1991, THEOR APPL GENET, V82, P22, DOI 10.1007/BF00231273; SCOTT JW, 1989, EUPHYTICA, V40, P49; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Smith S N, 1999, Plant Dis, V83, P694, DOI 10.1094/PDIS.1999.83.7.694C; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Summerell BA, 2011, FUNGAL DIVERS, V46, P1, DOI 10.1007/s13225-010-0075-8; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; ZINK FW, 1990, PHYTOPATHOLOGY, V80, P1230, DOI 10.1094/Phyto-80-1230	41	40	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41600	10.1371/journal.pone.0041600	http://dx.doi.org/10.1371/journal.pone.0041600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860000	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600035
J	Schure, RM; de Rond, L; Ozturk, K; Hendrikx, L; Sanders, E; Berbers, G; Buisman, AM				Schure, Rose-Minke; de Rond, Lia; Ozturk, Kemal; Hendrikx, Lotte; Sanders, Elisabeth; Berbers, Guy; Buisman, Anne-Marie			Pertussis Circulation Has Increased T-Cell Immunity during Childhood More than a Second Acellular Booster Vaccination in Dutch Children 9 Years of Age	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; ADOLESCENTS; RESPONSES; EPIDEMIOLOGY; IMMUNIZATION; IMPACT; ADULTS; NETHERLANDS; POPULATION; VACCINES	Here we report the first evaluation of T-cell responses upon a second acellular pertussis booster vaccination in Dutch children at 9 years of age, 5 years after a preschool booster vaccination. Blood samples of children 9 years of age were studied longitudinally until 1 year after the second aP booster and compared with those after the first aP booster in children 4 and 6 years of age from a cross-sectional study. After stimulation with pertussis-vaccine antigens, Th1, Th2 and Th17 cytokine responses were measured and effector memory cells (CCR7-CD45RA-) were characterized by 8-colour FACS analysis. The second aP booster vaccination at pre-adolescent age in wP primed individuals did increase pertussis-specific Th1 and Th2 cytokine responses. Noticeably, almost all T-cell responses had increased with age and were already high before the booster vaccination at 9 years of age. The enhancement of T-cell immunity during the 5 year following the booster at 4 years of age is probably caused by natural boosting due to the a high circulation of pertussis. However, the incidence of pertussis is high in adolescents and adults who have only received the Dutch wP vaccine during infancy and no booster at 4 years of age. Therefore, an aP booster vaccination at adolescence or later in these populations might improve long-term immunity against pertussis and reduce the transmission to the vulnerable newborns.	[Schure, Rose-Minke; de Rond, Lia; Ozturk, Kemal; Hendrikx, Lotte; Berbers, Guy; Buisman, Anne-Marie] Natl Inst Publ Hlth, Ctr Infect Dis Control, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [Schure, Rose-Minke; Sanders, Elisabeth] Univ Med Ctr, Wilhelmina Kinder Ziekenhuis, Dept Pediat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Schure, RM (corresponding author), Natl Inst Publ Hlth, Ctr Infect Dis Control, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands.	Annemarie.Buisman@rivm.nl			European Commission under the Health Cooperation Work Programme of the 7th Framework Programme; Dutch government	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme; Dutch government	A part of the study was supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme. Additionally, this study was funded by the Dutch government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Carollo M, 2012, VACCINE, V30, P1667, DOI 10.1016/j.vaccine.2011.12.104; Darrah PA, 2010, J EXP MED, V207, P1421, DOI 10.1084/jem.20092532; de Greeff S C, 2005, Ned Tijdschr Geneeskd, V149, P937; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; de Greeff SC, 2009, VACCINE, V27, P1932, DOI 10.1016/j.vaccine.2009.01.106; de Greeff SC, CLIN INFECT DIS, V50, P1339; DiTommaso A, 1997, VACCINE, V15, P1218, DOI 10.1016/S0264-410X(97)00023-6; Edelman K, 2007, CLIN INFECT DIS, V44, P1271, DOI 10.1086/514338; Edelman KJ, 2004, CLIN INFECT DIS, V39, P179, DOI 10.1086/421943; Halperin SA, 2005, HUM VACCINES, V1, P140, DOI 10.4161/hv.1.4.1971; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Healy CM, 2011, CLIN INFECT DIS, V52, P157, DOI 10.1093/cid/ciq001; Hendrikx LH, 2011, VACCINE, V30, P51, DOI 10.1016/j.vaccine.2011.10.048; Hendrikx LH, 2011, VACCINE, V29, P5725, DOI 10.1016/j.vaccine.2011.05.094; Hendrikx LH, 2011, VACCINE, V29, P1431, DOI 10.1016/j.vaccine.2010.12.033; Hendrikx LH, 2009, VACCINE, V27, P6530, DOI 10.1016/j.vaccine.2009.08.052; Li WC, 2009, EXPERT REV VACCINES, V8, P1317, DOI [10.1586/erv.09.96, 10.1586/ERV.09.96]; LOOSMORE SM, 1995, VACCINE, V13, P571, DOI 10.1016/0264-410X(94)00015-F; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; Minh NNT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e70; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Pichichero ME, 2006, CLIN PEDIATR, V45, P613, DOI 10.1177/0009922806289593; Rendi-Wagner P, 2007, PEDIATR INFECT DIS J, V26, P806, DOI 10.1097/INF.0b013e318124a9dd; Rieber N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017271; Rieber N, 2008, VACCINE, V26, P6929, DOI 10.1016/j.vaccine.2008.09.064; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Sanger R, 2007, EUR J PEDIATR, V166, P1229, DOI 10.1007/s00431-006-0403-x; Van Damme P, 2011, VACCINE; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d	32	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41928	10.1371/journal.pone.0041928	http://dx.doi.org/10.1371/journal.pone.0041928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860033	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600046
J	Garcia-Fuster, MJ; Flagel, SB; Mahmood, ST; Watson, SJ; Akil, H				Julia Garcia-Fuster, M.; Flagel, Shelly B.; Mahmood, S. Taha; Watson, Stanley J.; Akil, Huda			Cocaine Withdrawal Causes Delayed Dysregulation of Stress Genes in the Hippocampus	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; PLASMA-CORTICOSTERONE; DRUG-ADDICTION; NEURAL SYSTEMS; BETA-ENDORPHIN; ANIMAL-MODEL; RATS; BRAIN; ANXIETY; NEUROGENESIS	Relapse, even following an extended period of withdrawal, is a major challenge in substance abuse management. Delayed neurobiological effects of the drug during prolonged withdrawal likely contribute to sustained vulnerability to relapse. Stress is a major trigger of relapse, and the hippocampus regulates the magnitude and duration of stress responses. Recent work has implicated hippocampal plasticity in various aspects of substance abuse. We asked whether changes in stress regulatory mechanisms in the hippocampus may participate in the neuroadaptations that occur during prolonged withdrawal. We therefore examined changes in the rat stress system during the course of withdrawal from extended daily access (5-hours) of cocaine self-administration, an animal model of addiction. Tissue was collected at 1, 14 and 28 days of withdrawal. Plasma corticosterone levels were determined and corticosteroid receptors (GR, MR, MR/GR mRNA ratios) and expression of other stress-related molecules (HSP90AA1 and HSP90AB1 mRNA) were measured in hippocampal subfields using in situ hybridization. Results showed a delayed emergence of dysregulation of stress genes in the posterior hippocampus following 28 days of cocaine withdrawal. This included increased GR mRNA in DG and CA3, increased MR and HSP90AA1 mRNA in DG, and decreased MR/GR mRNA ratio in DG and CA1. Corticosterone levels progressively decreased during the course of withdrawal, were normalized following 28 days of withdrawal, and were correlated negatively with GR and positively with MR/GR mRNA ratio in DG. These results suggest a role for the posterior hippocampus in the neuroadaptations that occur during prolonged withdrawal, and point to a signaling partner of GR, HSP90AA1, as a novel dysregulated target during cocaine withdrawal. These delayed neurobiological effects of extended cocaine exposure likely contribute to sustained vulnerability to relapse.	[Julia Garcia-Fuster, M.] Univ Balearic Isl, Univ Res Inst Hlth Sci, Palma De Mallorca, Spain; [Flagel, Shelly B.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Mahmood, S. Taha; Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA	Universitat de les Illes Balears; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Garcia-Fuster, MJ (corresponding author), Univ Balearic Isl, Univ Res Inst Hlth Sci, Palma De Mallorca, Spain.	j.garcia@uib.es	Flagel, Shelly B/G-5561-2012; Garcia-Fuster, M. Julia/L-8307-2014	Flagel, Shelly B/0000-0002-7309-9908; Garcia-Fuster, M. Julia/0000-0002-9177-3775	NIDA [5P01DA021633-02]; NIMH Conte Center Grant [L99MH60398]; Office of Naval Research (ONR) [N00014-09-1-0598]; Pritzker Neuropsychiatric Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060398] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH Conte Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research (ONR)(Office of Naval Research); Pritzker Neuropsychiatric Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIDA 5P01DA021633-02; NIMH Conte Center Grant #L99MH60398; Office of Naval Research (ONR) N00014-09-1-0598 to HA and SJW; and The Pritzker Neuropsychiatric Research Foundation. MJGF is a 'Ramon y Cajal' Researcher (El Ministerio de Economia y Competitividad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Andersen P., 2007, HIPPOCAMPUS BOOK; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; DALLMAN MF, 1987, ANN NY ACAD SCI, V512, P402, DOI 10.1111/j.1749-6632.1987.tb24976.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Deroche V, 1997, J PHARMACOL EXP THER, V281, P1401; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Erb S, 2010, PROG NEURO-PSYCHOPH, V34, P798, DOI 10.1016/j.pnpbp.2009.11.025; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Galici R, 2000, EUR J PHARMACOL, V387, P59, DOI 10.1016/S0014-2999(99)00780-3; Garcia-Fuster MJ, 2010, EUR J NEUROSCI, V31, P79, DOI 10.1111/j.1460-9568.2009.07045.x; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; GERLACH JL, 1972, SCIENCE, V175, P1133, DOI 10.1126/science.175.4026.1133; Goeders NE, 1996, NEUROENDOCRINOLOGY, V64, P337, DOI 10.1159/000127137; Goeders NE, 1996, BRAIN RES, V722, P145, DOI 10.1016/0006-8993(96)00206-5; Grimm JW, 2003, J NEUROSCI, V23, P742; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Guzman-Marin R, 2003, J PHYSIOL-LONDON, V549, P563, DOI 10.1113/jphysiol.2003.041665; Garcia-Fuster MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2303, DOI 10.1038/npp.2011.119; Kalivas Peter W, 2004, Curr Psychiatry Rep, V6, P347, DOI 10.1007/s11920-004-0021-0; Koob GF, 2012, HAND CLINIC, V106, P137, DOI 10.1016/B978-0-444-52002-9.00009-7; Koob GF, 2009, NEUROPHARMACOLOGY, V56, P18, DOI 10.1016/j.neuropharm.2008.07.043; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Mantsch JR, 2007, BRAIN RES, V1167, P101, DOI 10.1016/j.brainres.2007.05.080; Mantsch JR, 2000, PROG NEURO-PSYCHOPH, V24, P633, DOI 10.1016/S0278-5846(00)00098-1; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; MCEWEN BS, 1988, NEUROCHEM RES, V13, P663, DOI 10.1007/BF00973285; MOLDOW RL, 1987, PEPTIDES, V8, P819, DOI 10.1016/0196-9781(87)90065-9; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Pascale A, 2011, PSYCHOPHARMACOLOGY, V218, P249, DOI 10.1007/s00213-010-2152-9; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; SAPOLSKY RM, 1990, NEUROENDOCRINOLOGY, V51, P328, DOI 10.1159/000125357; Turner CA, 2011, P NATL ACAD SCI USA, V108, P8021, DOI 10.1073/pnas.1103732108; VESCOVI PP, 1992, HORM RES, V37, P221, DOI 10.1159/000182316; Wei Q, 2012, BIOL PSYCHIAT, V71, P224, DOI 10.1016/j.biopsych.2011.07.009; Wells AM, 2011, LEARN MEMORY, V18, P693, DOI 10.1101/lm.2273111; Zhe D, 2008, ACTA HISTOCHEM CYTOC, V41, P89, DOI 10.1267/ahc.08013	45	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42092	10.1371/journal.pone.0042092	http://dx.doi.org/10.1371/journal.pone.0042092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860061	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950900067
J	Lee, OYC; Wu, HHT; Donoghue, HD; Spigelman, M; Greenblatt, CL; Bull, ID; Rothschild, BM; Martin, LD; Minnikin, DE; Besra, GS				Lee, Oona Y-C.; Wu, Houdini H. T.; Donoghue, Helen D.; Spigelman, Mark; Greenblatt, Charles L.; Bull, Ian D.; Rothschild, Bruce M.; Martin, Larry D.; Minnikin, David E.; Besra, Gurdyal S.			Mycobacterium tuberculosis Complex Lipid Virulence Factors Preserved in the 17,000-Year-Old Skeleton of an Extinct Bison, Bison antiquus	PLOS ONE			English	Article							ACQUIRED GENOMIC ISLANDS; HOMO-ERECTUS; EVOLUTION; TREHALOSE; DNA	Tracing the evolution of ancient diseases depends on the availability and accessibility of suitable biomarkers in archaeological specimens. DNA is potentially information-rich but it depends on a favourable environment for preservation. In the case of the major mycobacterial pathogens, Mycobacterium tuberculosis and Mycobacterium leprae, robust lipid biomarkers are established as alternatives or complements to DNA analyses. A DNA report, a decade ago, suggested that a 17,000-year-old skeleton of extinct Bison antiquus, from Natural Trap Cave, Wyoming, was the oldest known case of tuberculosis. In the current study, key mycobacterial lipid virulence factor biomarkers were detected in the same two samples from this bison. Fluorescence high-performance liquid chromatography (HPLC) indicated the presence of mycolic acids of the mycobacterial type, but they were degraded and could not be precisely correlated with tuberculosis. However, pristine profiles of C-29, C-30 and C-32 mycocerosates and C-27 mycolipenates, typical of the Mycobacterium tuberculosis complex, were recorded by negative ion chemical ionization gas chromatography mass spectrometry of pentafluorobenzyl ester derivatives. These findings were supported by the detection of C-34 and C-36 phthiocerols, which are usually esterified to the mycocerosates. The existence of Pleistocene tuberculosis in the Americas is confirmed and there are many even older animal bones with well-characterised tuberculous lesions similar to those on the analysed sample. In the absence of any evidence of tuberculosis in human skeletons older than 9,000 years BP, the hypothesis that this disease evolved as a zoonosis, before transfer to humans, is given detailed consideration and discussion.	[Lee, Oona Y-C.; Wu, Houdini H. T.; Minnikin, David E.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Donoghue, Helen D.; Spigelman, Mark] UCL, Ctr Clin Microbiol M9, London, England; [Donoghue, Helen D.] UCL, Ctr Hist Med, London, England; [Spigelman, Mark; Greenblatt, Charles L.] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis & Ancient DNA, IL-91010 Jerusalem, Israel; [Bull, Ian D.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol, Avon, England; [Rothschild, Bruce M.] NE Ohio Med Univ, Dept Med, Rootstown, OH USA; [Rothschild, Bruce M.; Martin, Larry D.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Birmingham; University of London; University College London; University of London; University College London; Hebrew University of Jerusalem; University of Bristol; Northeast Ohio Medical University (NEOMED); University of Kansas	Lee, OYC (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	g.besra@bham.ac.uk	Bull, Ian/AAV-1474-2020; Donoghue, Helen D./D-6805-2013; Greenblatt, Chuck/ABC-8220-2021	Bull, Ian/0000-0002-5881-5654; Donoghue, Helen D./0000-0003-3918-5252; Besra, Gurdyal/0000-0002-5605-0395	Leverhulme Trust Project Grant [F/00 094/BL]; Wellcome Trust Grant [080988/Z/06/Z]; UK Natural and Environmental Research Council; NERC [lsmsf010001] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1239307] Funding Source: researchfish; Natural Environment Research Council [lsmsf010001] Funding Source: researchfish	Leverhulme Trust Project Grant; Wellcome Trust Grant(Wellcome Trust); UK Natural and Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by Leverhulme Trust Project Grant F/00 094/BL (GSB, DEM, OY-CL) and Wellcome Trust Grant 080988/Z/06/Z (GSB, OY-CL). A grant from the UK Natural and Environmental Research Council (DEM, GSB) provided access to the Mass Spectrometry Unit at the University of Bristol, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2006, FEMS MICROBIOL LETT, V256, P340, DOI 10.1111/j.1574-6968.2006.00142.x; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; BESRA GS, 1992, BIOCHEMISTRY-US, V31, P9832, DOI 10.1021/bi00155a040; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; DAFFE M, 1988, EUR J BIOCHEM, V172, P579, DOI 10.1111/j.1432-1033.1988.tb13928.x; Djelouadji Z, 2011, LANCET INFECT DIS, V11, P641, DOI 10.1016/S1473-3099(11)70093-7; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Donoghue HD, 2010, P R SOC B, V277, P51, DOI 10.1098/rspb.2009.1484; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gordon SV, 2009, BIOESSAYS, V31, P378, DOI 10.1002/bies.200800191; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Kappelman J, 2008, AM J PHYS ANTHROPOL, V135, P110, DOI 10.1002/ajpa.20739; Klaus HD, 2010, J ARCHAEOL SCI, V37, P2587, DOI 10.1016/j.jas.2010.05.019; Koeck JL, 2011, CLIN MICROBIOL INFEC, V17, P1013, DOI 10.1111/j.1469-0691.2010.03347.x; Korf J, 2005, EUR J IMMUNOL, V35, P890, DOI 10.1002/eji.200425332; Mackowiak PA, 2005, CLIN INFECT DIS, V41, P515, DOI 10.1086/432013; Martin LD, 1989, J VERT PALEONTOL, V9, p31A; Minnikin D. E., 1982, BIOL MYCOBACTERIA, P95; Minnikin DE, 2012, UNDERSTANDING TUBERCULOSIS - DECIPHERING THE SECRET LIFE OF THE BACILLI, P3; MINNIKIN DE, 1983, BIOCHIM BIOPHYS ACTA, V753, P445, DOI 10.1016/0005-2760(83)90069-3; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P1375; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P1369; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Nerlich Andreas G, 2009, Interdiscip Perspect Infect Dis, V2009, P437187, DOI 10.1155/2009/437187; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Onwueme KC, 2005, PROG LIPID RES, V44, P259, DOI 10.1016/j.plipres.2005.07.001; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Redman JE, 2009, TUBERCULOSIS, V89, P267, DOI 10.1016/j.tube.2009.04.001; Roberts CA, 2009, AM J PHYS ANTHROPOL, V139, P442, DOI 10.1002/ajpa.21056; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Rothschild B M, 2003, Reumatismo, V55, P58; Rothschild BM, 2001, CLIN INFECT DIS, V33, P305, DOI 10.1086/321886; Rothschild BM, 2006, NATURWISSENSCHAFTEN, V93, P557, DOI 10.1007/s00114-006-0144-8; Rothschild BM, 2006, NATURWISSENSCHAFTEN, V93, P565, DOI 10.1007/s00114-006-0145-7; Smith NH, 2006, PLOS PATHOG, V2, P809, DOI 10.1371/journal.ppat.0020098; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Taylor GM, 2009, J ARCHAEOL SCI, V36, P2408, DOI 10.1016/j.jas.2009.06.026; Tran TNN, 2011, BIOTECHNIQUES, V50, P370, DOI 10.2144/000113689; Wilbur AK, 2006, MEM I OSWALDO CRUZ, V101, P59, DOI 10.1590/S0074-02762006001000011; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	49	41	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41923	10.1371/journal.pone.0041923	http://dx.doi.org/10.1371/journal.pone.0041923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860031	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900050
J	Schimmer, B; Lenferink, A; Schneeberger, P; Aangenend, H; Vellema, P; Hautvast, J; van Duynhoven, Y				Schimmer, Barbara; Lenferink, Anke; Schneeberger, Peter; Aangenend, Helen; Vellema, Piet; Hautvast, Jeannine; van Duynhoven, Yvonne			Seroprevalence and Risk Factors for Coxiella burnetii (Q Fever) Seropositivity in Dairy Goat Farmers' Households in The Netherlands, 2009-2010	PLOS ONE			English	Article							OUTBREAK; POPULATION; INFECTION; WORKERS	Community Q fever epidemics occurred in the Netherlands in 2007-2009, with dairy goat and dairy sheep farms as the implicated source. The aim of the study was to determine the seroprevalence and risk factors for seropositivity in dairy goat farmers and their household members living or working on these farms. Sera of 268 people living or working on 111 dairy goat farms were tested for Coxiella burnetii IgG and IgM antibodies using immunofluorescence assay. Seroprevalences in farmers, spouses and children (12-17 years) were 73.5%, 66.7%, and 57.1%, respectively. Risk factors for seropositivity were: performing three or more daily goat-related tasks, farm location in the two southern provinces of the country, proximity to bulk milk-positive farms, distance from the nearest stable to residence of 10 meters or less, presence of cats and multiple goat breeds in the stable, covering stable air spaces and staff not wearing farm boots. Goat farmers have a high risk to acquire this occupational infection. Clinicians should consider Q fever in this population presenting with compatible symptoms to allow timely diagnosis and treatment to prevent severe sequelae. Based on the risk factors identified, strengthening general biosecurity measures is recommended such as consistently wearing boots and protective clothing by farm staff to avoid indirect transmission and avoiding access of companion animals in the goat stable. Furthermore, it provides an evidence base for continuation of the current vaccination policy for small ruminants, preventing spread from contaminated farms to other farms in the vicinity. Finally, vaccination of seronegative farmers and household members could be considered.	[Schimmer, Barbara; Lenferink, Anke; van Duynhoven, Yvonne] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Lenferink, Anke; Aangenend, Helen; Hautvast, Jeannine] Radboud Univ Nijmegen, Med Ctr, Acad Collaborat Ctr AMPHI, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Schneeberger, Peter] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands; [Vellema, Piet] Anim Hlth Serv, Dept Small Ruminant Hlth, Deventer, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Jeroen Bosch Ziekenhuis	Schimmer, B (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	yvonne.van.duynhoven@rivm.nl	Hautvast, J.L.A./L-4352-2015; Lenferink, Anke/H-6936-2015	Lenferink, Anke/0000-0002-2276-5691; Vellema, Piet/0000-0001-9381-9063	Netherlands organisation for health research and development; Ministery of Public Health; Ministry of Agriculture	Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development); Ministery of Public Health; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	The study was funded by the Netherlands organisation for health research and development, and co-financed by the Ministery of Public Health and the Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CC, 2010, ZOONOSES PUBLIC HLTH, V57, pE95, DOI 10.1111/j.1863-2378.2009.01290.x; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; de Rooij MMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032108; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Hogema BM, 2012, TRANSFUSION, V52, P144, DOI 10.1111/j.1537-2995.2011.03250.x; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; Marrie T. J., 1990, Q fever. Volume 1. The disease., P49; MARRIE TJ, 1989, EPIDEMIOL INFECT, V102, P119, DOI 10.1017/S0950268800029757; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McCaughey C, 2008, ZOONOSES PUBLIC HLTH, V55, P189, DOI 10.1111/j.1863-2378.2008.01109.x; McCaughey C, 2010, EPIDEMIOL INFECT, V138, P21, DOI 10.1017/S0950268809002854; Monno R, 2009, ANN AGR ENV MED, V16, P205; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; RICHARDUS JH, 1987, EPIDEMIOL INFECT, V98, P211, DOI 10.1017/S0950268800061938; Rodolakis A, 2009, ANN NY ACAD SCI, V1166, P90, DOI 10.1111/j.1749-6632.2009.04511.x; Roest HI, 2011, SURVIVAL COXIELLA BU, P1; Rousset E, 2009, APPL ENVIRON MICROB, V75, P428, DOI 10.1128/AEM.00690-08; Schimmer B, 2012, EPIDEMIOL INFECT, V140, P27, DOI 10.1017/S0950268811000136; Schimmer B, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-81; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Thibon M, 1996, EUR J EPIDEMIOL, V12, P509, DOI 10.1007/BF00144005; THOMAS DR, 1995, OCCUP ENVIRON MED, V52, P644, DOI 10.1136/oem.52.10.644; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Wegdam-Blans MCA, 2012, CLIN VACCINE IMMUNOL, V19, P1110, DOI 10.1128/CVI.05581-11; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Whelan J, 2011, EMERG INFECT DIS, V17, P1719, DOI 10.3201/eid1709.110051	26	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42364	10.1371/journal.pone.0042364	http://dx.doi.org/10.1371/journal.pone.0042364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848762	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200199
J	Schmidt, VJ; Jobs, A; von Maltzahn, J; Worsdorfer, P; Willecke, K; de Wit, C				Schmidt, Volker J.; Jobs, Alexander; von Maltzahn, Julia; Woersdoerfer, Philipp; Willecke, Klaus; de Wit, Cor			Connexin45 Is Expressed in Vascular Smooth Muscle but Its Function Remains Elusive	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; MICROCIRCULATION IN-VIVO; RENIN-PRODUCING CELLS; BLOOD-FLOW; DEPENDENT MECHANISM; NEURONS DISRUPTS; CUSHION DEFECT; BIPOLAR CELLS; MOUSE RETINA; ARTERIOLES	Connexins (Cx) form gap junctions and allow the coordination of cellular behaviour. In vessels, expression of Cx40, Cx37, and Cx43 is well established and specifically Cx40 serves important functions in endothelial cells. In contrast, expression and physiological functions of Cx45 is unclear although its expression has been suggested in vascular smooth muscle (VSM). Therefore, we studied expression and function of Cx45 in vessels using different mice models allowing to identify and delete Cx45. Smooth muscle cell (SMC)-specific deletion was achieved by the Cre/loxP system using Cre-recombinase driven by a Nestin promoter. Deletion of Cx45 leads concomitantly to the expression of enhanced green fluorescence protein (EGFP) in these mice. Conduction of vasomotor responses was studied in cremasteric arterioles using intravital microscopy and arterial pressure was measured telemetrically. Cx45 is transcriptionally expressed in VSM as detected by EGFP expression in SMC-specific Cx45-deficient mice (Cx45fl/fl:Nestin-Cre) but not in endothelial cells (Cx45fl/fl:TIE2-Cre). Moreover, EGFP was located at VSM cell borders in arterioles of transgenic mice carrying an EGFP-tagged Cx45. Expectedly, arteriolar conduction of dilations evoked by the endothelium-dependent agonist acetylcholine were not different between Cx45fl/fl:Nestin-Cre mice and controls carrying homozygously a floxed Cx45 gene (Cx45fl/fl). Surprisingly, the amplitude of locally initiated endothelium-independent constrictions (K+) and dilations (adenosine) declined similarly with distance in both genotypes indicating an intact VSM conduction pathway also in mice being deficient for Cx45 in VSM. Arterial pressure was not different between freely moving Cx45fl/fl and Cx45fl/fl:Nestin-Cre mice during day or night. We conclude that Cx45 is physiologically expressed in VSM, but not in EC in murine arterioles. However, Cx45 is dispensable for the conduction of vasomotor responses along these arterioles. Possibly, other Cx functionally replace the lack of Cx45 in VSM. The reported role of Cx45 in renin secretion does not seem to alter arterial pressure in freely moving mice.	[Schmidt, Volker J.; Jobs, Alexander; de Wit, Cor] Med Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany; [von Maltzahn, Julia; Woersdoerfer, Philipp; Willecke, Klaus] Univ Bonn, Inst Genet, Bonn, Germany; [Schmidt, Volker J.] Univ Klinikum Erlangen, Plastisch & Handchirurg Klin, Erlangen, Germany	University of Lubeck; University of Bonn; University of Erlangen Nuremberg	Schmidt, VJ (corresponding author), Med Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany.	dewit@uni-luebeck.de	von Maltzahn, Julia/AFP-2284-2022; von Maltzahn, Julia/A-6689-2017; de Wit, Cor/A-5560-2009	von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; de Wit, Cor/0000-0003-4621-0399; Worsdorfer, Philipp/0000-0003-3398-3229	Deutsche Forschungsgemeinschaft [WI2071/2-1, WI270/33-1, SFB645]; Deutsches Zentrum fur Herz-Kreislauf-Forschung; German Ministry of Education and Research; Interdisciplinary Center for Clinical Research at the University Hospital of the University Erlangen-Nuremberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Herz-Kreislauf-Forschung; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research at the University Hospital of the University Erlangen-Nuremberg	This work was supported by the Deutsche Forschungsgemeinschaft (WI2071/2-1 to CdW as well as WI270/33-1 and SFB645, project B2, to KW), the Deutsches Zentrum fur Herz-Kreislauf-Forschung and the German Ministry of Education and Research (to CdW) and the Interdisciplinary Center for Clinical Research at the University Hospital of the University Erlangen-Nuremberg (to VJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Boettcher M, 2011, HYPERTENSION, V57, P802, DOI 10.1161/HYPERTENSIONAHA.110.165894; Bolz SS, 2000, CIRCULATION, V102, P2402, DOI 10.1161/01.CIR.102.19.2402; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Brisset AC, 2009, ANTIOXID REDOX SIGN, V11, P267, DOI 10.1089/ars.2008.2115; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; de Wit C, 2004, NEWS PHYSIOL SCI, V19, P148, DOI 10.1152/nips.01520.2004; de Wit C, 2000, CIRC RES, V86, P649, DOI 10.1161/01.RES.86.6.649; de Wit C, 2007, CURR PHARM BIOTECHNO, V8, P11; de Wit C, 2010, PFLUG ARCH EUR J PHY, V459, P897, DOI 10.1007/s00424-010-0830-4; de Wit C, 2010, CARDIOVASC RES, V85, P604, DOI 10.1093/cvr/cvp340; Figueroa XF, 2008, AM J PHYSIOL-HEART C, V295, pH2001, DOI 10.1152/ajpheart.00063.2008; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Figueroa XF, 2004, PHYSIOLOGY, V19, P277, DOI 10.1152/physiol.00008.2004; Figueroa XF, 2003, CIRC RES, V92, P793, DOI 10.1161/01.RES.0000065918.90271.9A; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Hakim CH, 2008, MICROCIRCULATION, V15, P503, DOI 10.1080/10739680801982808; Hanner F, 2008, AM J PHYSIOL-REG I, V295, pR371, DOI 10.1152/ajpregu.00468.2007; Hilgen G, 2011, J COMP NEUROL, V519, P433, DOI 10.1002/cne.22526; Johnstone S, 2009, INT REV CEL MOL BIO, V278, P69, DOI 10.1016/S1937-6448(09)78002-5; Just A, 2009, J AM SOC NEPHROL, V20, P1577, DOI 10.1681/ASN.2008090943; KACHINSKY AM, 1994, DEV BIOL, V165, P216, DOI 10.1006/dbio.1994.1248; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Ko YS, 2001, ARTERIOSCL THROM VAS, V21, P355, DOI 10.1161/01.ATV.21.3.355; Koval M, 2011, AM J PATHOL, V178, P2536, DOI 10.1016/j.ajpath.2011.02.045; Kruger O, 2000, DEVELOPMENT, V127, P4179; Kumai M, 2000, DEVELOPMENT, V127, P3501; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kurt B, 2011, AM J PHYSIOL-RENAL, V300, pF743, DOI 10.1152/ajprenal.00647.2010; Kurtz L, 2009, J AM SOC NEPHROL, V20, P506, DOI 10.1681/ASN.2008030252; Li X, 2002, HYPERTENSION, V40, P940, DOI 10.1161/01.HYP.0000041882.39865.A8; Li X, 2001, AM J PHYSIOL-HEART C, V281, pH1890, DOI 10.1152/ajpheart.2001.281.5.H1890; Liao YB, 2007, ARTERIOSCL THROM VAS, V27, P1037, DOI 10.1161/ATVBAHA.106.137182; Maxeiner S, 2005, J NEUROSCI, V25, P566, DOI 10.1523/JNEUROSCI.3232-04.2005; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Milkau M, 2010, FASEB J, V24, P3572, DOI 10.1096/fj.10-158956; Nishii K, 2003, CELL COMMUN ADHES, V10, P365, DOI 10.1080/15419060390263173; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Rodenwaldt B, 2007, AM J PHYSIOL-HEART C, V292, pH2341, DOI 10.1152/ajpheart.01061.2006; Rummery NM, 2002, ARTERIOSCL THROM VAS, V22, P1427, DOI 10.1161/01.ATV.0000028814.45706.E5; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; Schubert T, 2005, J COMP NEUROL, V490, P29, DOI 10.1002/cne.20621; Schweda F, 2009, KIDNEY INT, V75, P482, DOI 10.1038/ki.2008.637; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Siegl D, 2005, CIRC RES, V97, P781, DOI 10.1161/01.RES.0000186193.22438.6c; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Ujiie H, 2003, STROKE, V34, P544, DOI 10.1161/01.STR.0000054158.72610.EC; van Veen TAB, 2000, CARDIOVASC RES, V46, P496, DOI 10.1016/S0008-6363(00)00047-X; von Maltzahn J, 2009, EUR J CELL BIOL, V88, P481, DOI 10.1016/j.ejcb.2009.04.004; Wagner C, 2008, KIDNEY INT, V73, P547, DOI 10.1038/sj.ki.5002720; Wagner C, 2010, KIDNEY INT, V78, P762, DOI 10.1038/ki.2010.257; Welsh DG, 1998, AM J PHYSIOL-HEART C, V274, pH178, DOI 10.1152/ajpheart.1998.274.1.H178; Wolfle SE, 2007, CIRC RES, V101, P1292, DOI 10.1161/CIRCRESAHA.107.163279; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Zlomuzica A, 2010, PHYSIOL BEHAV, V101, P245, DOI 10.1016/j.physbeh.2010.05.007	55	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42287	10.1371/journal.pone.0042287	http://dx.doi.org/10.1371/journal.pone.0042287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848755	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200192
J	Li, X; Cui, BS; Yang, QC; Tian, HQ; Lan, Y; Wang, TT; Han, Z				Li, Xia; Cui, Baoshan; Yang, Qichun; Tian, Hanqin; Lan, Yan; Wang, Tingting; Han, Zhen			Detritus Quality Controls Macrophyte Decomposition under Different Nutrient Concentrations in a Eutrophic Shallow Lake, North China	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; ORGANIC-MATTER; PHOSPHORUS ENRICHMENT; SURFACE-WATER; NET N; STREAM; NITROGEN; MIXTURES; WETLAND; NITRATE	Macrophyte decomposition is important for carbon and nutrient cycling in lake ecosystems. Currently, little is known about how this process responds to detritus quality and water nutrient conditions in eutrophic shallow lakes in which incomplete decomposition of detritus accelerates the lake terrestrialization process. In this study, we investigated the effects of detritus quality and water nutrient concentrations on macrophyte decomposition in Lake Baiyangdian, China, by analyzing the decomposition of three major aquatic plants at three sites with different pollution intensities (low, medium, and high pollution sites). Detritus quality refers to detritus nutrient contents as well as C:N, C:P, and N:P mass ratios in this study. Effects of detritus mixtures were tested by combining pairs of representative macrophytes at ratios of 75:25, 50:50 and 25:75 (mass basis). The results indicate that the influence of species types on decomposition was stronger than that of site conditions. Correlation analysis showed that mass losses at the end of the experimental period were significantly controlled by initial detritus chemistry, especially by the initial phosphorus (P) content, carbon to nitrogen (C:N), and carbon to phosphorus (C:P) mass ratios in the detritus. The decomposition processes were also influenced by water chemistry. The NO3-N and NH4-N concentrations in the lake water retarded detritus mass loss at the low and high pollution sites, respectively. Net P mineralization in detritus was observed at all sites and detritus P release at the high pollution site was slower than at the other two sites. Nonadditive effects of mixtures tended to be species specific due to the different nutrient contents in each species. Results suggest that the nonadditive effects varied significantly among different sites, indicating that interactions between the detritus quality in species mixtures and site water chemistry may be another driver controlling decomposition in eutrophic shallow lakes.	[Li, Xia; Cui, Baoshan; Lan, Yan; Wang, Tingting; Han, Zhen] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China; [Li, Xia; Yang, Qichun; Tian, Hanqin] Auburn Univ, Sch Forestry & Wildlife Sci, Ecosyst Dynam & Global Ecol EDGE Lab, Auburn, AL 36849 USA; [Yang, Qichun; Tian, Hanqin] Auburn Univ, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA	Beijing Normal University; Auburn University System; Auburn University; Auburn University System; Auburn University	Cui, BS (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100875, Peoples R China.	cuibs@163.com	wang, tingting/AAK-2640-2020; Tian, Hanqin/A-6484-2012	Tian, Hanqin/0000-0002-1806-4091; Yang, Qichun/0000-0002-8689-2550	National Natural Science Foundation of China [41071330]; Central Universities [2009SD-24]; National Major Water Project [2009ZX07209-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Universities; National Major Water Project	This study was financially supported by the National Natural Science Foundation of China (41071330), the Central Universities (2009SD-24), and the National Major Water Project (2009ZX07209-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Alvarez S, 2000, SOIL BIOL BIOCHEM, V32, P1941, DOI 10.1016/S0038-0717(00)00170-X; Baiser B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020672; Breeuwer A, 2008, OIKOS, V117, P1258, DOI 10.1111/j.0030-1299.2008.16518.x; CARPENTER SR, 1980, ECOLOGY, V61, P1145, DOI 10.2307/1936834; Chiang FY, 2007, FOOD CHEM, V105, P480, DOI 10.1016/j.foodchem.2007.04.003; Chimney MJ, 2006, ECOL ENG, V27, P301, DOI 10.1016/j.ecoleng.2006.05.016; Costantini ML, 2009, AQUAT CONSERV, V19, P566, DOI 10.1002/aqc.1004; Cui BS, 2010, J HYDROL, V385, P247, DOI 10.1016/j.jhydrol.2010.02.026; Davidson EA, 2003, GLOBAL CHANGE BIOL, V9, P228, DOI 10.1046/j.1365-2486.2003.00592.x; Debusk WF, 2005, BIOGEOCHEMISTRY, V75, P217, DOI 10.1007/s10533-004-7113-0; Eiland F, 2001, MICROBIAL ECOL, V41, P272, DOI 10.1007/s002480000071; ELWOOD JW, 1981, ECOLOGY, V62, P146, DOI 10.2307/1936678; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; FEDERLE TW, 1982, CAN J MICROBIOL, V28, P1199, DOI 10.1139/m82-178; Ferreira V, 2006, OECOLOGIA, V149, P718, DOI 10.1007/s00442-006-0478-0; Finzi AC, 1998, FOREST ECOL MANAG, V105, P129, DOI 10.1016/S0378-1127(97)00277-6; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Geurts JJM, 2010, WATER RES, V44, P3487, DOI 10.1016/j.watres.2010.03.030; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; Gulis V, 2006, FRESHWATER BIOL, V51, P1655, DOI 10.1111/j.1365-2427.2006.01615.x; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Hanamachi Y, 2008, LIMNOLOGY, V9, P57, DOI 10.1007/s10201-007-0232-2; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Hoorens B, 2002, J ECOL, V90, P1009, DOI 10.1046/j.1365-2745.2002.00732.x; Jonsson M, 2008, OIKOS, V117, P1674, DOI 10.1111/j.1600-0706.2008.16810.x; Kadam PC, 1996, APPL ENVIRON MICROB, V62, P4486, DOI 10.1128/AEM.62.12.4486-4492.1996; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Kominoski JS, 2009, OIKOS, V118, P457, DOI 10.1111/j.1600-0706.2008.17222.x; Kucuk MM, 1999, BIORESOURCE TECHNOL, V69, P141, DOI 10.1016/S0960-8524(98)00180-1; Lecerf A, 2007, ECOLOGY, V88, P219, DOI 10.1890/0012-9658(2007)88[219:DODLMI]2.0.CO;2; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; LINN JG, 1975, J ANIM SCI, V41, P601, DOI 10.2527/jas1975.412601x; McLaren JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023702; Menendez M, 2001, INT REV HYDROBIOL, V86, P475, DOI 10.1002/1522-2632(200107)86:4/5<475::AID-IROH475>3.0.CO;2-5; Moore TR, 2011, PLANT SOIL, V339, P163, DOI 10.1007/s11104-010-0563-3; Newman S, 2001, BIOGEOCHEMISTRY, V54, P229, DOI 10.1023/A:1010659016876; NYKVIST NILS, 1963, STUD FOREST SUECICQ, V3, P1; Papastergiadou ES, 2007, HYDROBIOLOGIA, V584, P361, DOI 10.1007/s10750-007-0606-9; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; PETERSON BJ, 1993, ECOLOGY, V74, P653, DOI 10.2307/1940794; Qualls RG, 2000, SOIL SCI SOC AM J, V64, P799, DOI 10.2136/sssaj2000.642799x; Quested HM, 2005, J ECOL, V93, P87, DOI 10.1111/j.0022-0477.2004.00951.x; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; RECOUS S, 1990, SOIL BIOL BIOCHEM, V22, P913, DOI 10.1016/0038-0717(90)90129-N; Rejmankova E, 2007, SOIL BIOL BIOCHEM, V39, P526, DOI 10.1016/j.soilbio.2006.08.022; Rejmankova E, 2006, BIOGEOCHEMISTRY, V80, P245, DOI 10.1007/s10533-006-9021-y; Reshi Z., 2007, DETRITUS DECOMPOSITI; RICE CW, 1989, SOIL BIOL BIOCHEM, V21, P597, DOI 10.1016/0038-0717(89)90135-1; Rosemond AD, 2010, OIKOS, V119, P326, DOI 10.1111/j.1600-0706.2009.17904.x; Royer TV, 2001, FRESHWATER BIOL, V46, P603, DOI 10.1046/j.1365-2427.2001.00694.x; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Sarneel JM, 2010, ECOSYSTEMS, V13, P1275, DOI 10.1007/s10021-010-9387-5; Scheffer RA, 2001, OIKOS, V92, P44, DOI 10.1034/j.1600-0706.2001.920106.x; SPROTT GD, 1986, SYST APPL MICROBIOL, V7, P358; Strauss EA, 2002, FRESHWATER BIOL, V47, P65, DOI 10.1046/j.1365-2427.2002.00776.x; SUBERKROPP K, 1980, CAN J BOT, V58, P1025, DOI 10.1139/b80-126; TAYLOR BR, 1989, CAN J FOREST RES, V19, P674, DOI 10.1139/x89-104; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1	61	26	33	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42042	10.1371/journal.pone.0042042	http://dx.doi.org/10.1371/journal.pone.0042042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848699	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600064
J	McClure, J; Lovelace, ES; Elahi, S; Maurice, NJ; Wagoner, J; Dragavon, J; Mittler, JE; Kraft, Z; Stamatatos, L; Horton, H; De Rosa, SC; Coombs, RW; Polyak, SJ				McClure, Janela; Lovelace, Erica S.; Elahi, Shokrollah; Maurice, Nicholas J.; Wagoner, Jessica; Dragavon, Joan; Mittler, John E.; Kraft, Zane; Stamatatos, Leonidis; Horton, Helen; De Rosa, Stephen C.; Coombs, Robert W.; Polyak, Stephen J.			Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; FIBROSIS PROGRESSION; ENVELOPE VARIANTS; SILYMARIN; NEUTRALIZATION; COINFECTION; SUBTYPE; REPLICATION; SENSITIVITY	Purified silymarin-derived natural products from the milk thistle plant (Silybum marianum) block hepatitis C virus (HCV) infection and inhibit T cell proliferation in vitro. An intravenous formulation of silibinin (SIL), a major component of silymarin, displays anti-HCV effects in humans and also inhibits T-cell proliferation in vitro. We show that SIL inhibited replication of HIV-1 in TZM-bl cells, PBMCs, and CEM cells in vitro. SIL suppression of HIV-1 coincided with dose-dependent reductions in actively proliferating CD19+, CD4+, and CD8+ cells, resulting in fewer CD4+ T cells expressing the HIV-1 co-receptors CXCR4 and CCR5. SIL inhibition of T-cell growth was not due to cytotoxicity measured by cell cycle arrest, apoptosis, or necrosis. SIL also blocked induction of the activation markers CD38, HLA-DR, Ki67, and CCR5 on CD4+ T cells. The data suggest that SIL attenuated cellular functions involved in T-cell activation, proliferation, and HIV-1 infection. Silymarin-derived compounds provide cytoprotection by suppressing virus infection, immune activation, and inflammation, and as such may be relevant for both HIV mono-infected and HIV/HCV co-infected subjects.	[McClure, Janela; Lovelace, Erica S.; Wagoner, Jessica; Dragavon, Joan; De Rosa, Stephen C.; Coombs, Robert W.; Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Coombs, Robert W.] Univ Washington, Dept Med, Seattle, WA USA; [Polyak, Stephen J.] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Mittler, John E.; Polyak, Stephen J.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Maurice, Nicholas J.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Elahi, Shokrollah; Kraft, Zane; Stamatatos, Leonidis; Horton, Helen] Seattle Biomed, Viral Vaccines Program, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Center for Infectious Disease Research	McClure, J (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	polyak@uw.edu		Maurice, Nicholas/0000-0002-2667-472X; Elahi, Shokrollah/0000-0002-7215-2009	University of Washington (UW) Center for AIDS Research (CFAR); National Institutes of Health (NIH) [P30 AI027757]; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse; National Institute of Child Health & Human Development; National Heart, Lung, and Blood Institute; National Institute on Aging; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1RR025014]; National Institute of Allergy and Infectious Disease [U19AI066328, R56AI091840, R21AI089373]; National Center for Complementary and Alternative Medicine [R01AT006842]; UW Virology Division Pilot Award; (UW) Center for AIDS Research (CFAR); National of Institutes of Health (NIH) [P30 AI027757]; National Center for Complementary & Integrative Health [R01AT006842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089373, R56AI091840, U19AI066328, P30AI027757] Funding Source: NIH RePORTER	University of Washington (UW) Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); UW Virology Division Pilot Award; (UW) Center for AIDS Research (CFAR); National of Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by the University of Washington (UW) Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Disease, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health & Human Development, National Heart, Lung, and Blood Institute, National Institute on Aging), and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1RR025014. SJP was also supported by National Institute of Allergy and Infectious Disease grants U19AI066328 and R56AI091840, National Center for Complementary and Alternative Medicine grant R01AT006842, and by the UW Virology Division Pilot Award. SE was supported by National Institute of Allergy and Infectious Disease grant R21AI089373, and a New Investigator Award from the (UW) Center for AIDS Research (CFAR), a National of Institutes of Health (NIH) funded program (P30 AI027757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, ANTICANCER RES, V26, P4457; Ahmed-Belkacem A, 2010, GASTROENTEROLOGY, V138, P1112, DOI 10.1053/j.gastro.2009.11.053; Beinhardt S, 2011, J HEPATOL, V54, P591, DOI 10.1016/j.jhep.2010.09.009; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Blish CA, 2007, AIDS, V21, P693, DOI 10.1097/QAD.0b013e32805e8727; Blish CA, 2009, J VIROL, V83, P7783, DOI 10.1128/JVI.00673-09; Cossarizza A, 2002, J BIOL REG HOMEOS AG, V16, P18; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; Deming P, 2011, PHARMACOTHERAPY, V31, P357, DOI 10.1592/phco.31.4.357; Dhanalakshmi S, 2002, ONCOGENE, V21, P1759, DOI 10.1038/sj.onc.1205240; Ferenci P, 2008, GASTROENTEROLOGY, V135, P1561, DOI 10.1053/j.gastro.2008.07.072; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gazak R, 2007, CURR MED CHEM, V14, P315, DOI 10.2174/092986707779941159; Gibson RM, 2012, CURR HIV RES, V10, P19, DOI 10.2174/157016212799304616; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Haas A, 2011, J VIROLOGY; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Koup RA, 2001, CURR PROTOC IMMUNOL; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lovelace E, 2011, VIROLOGY, V421, P235, DOI 10.1016/j.virol.2011.09.032; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; Morishima C, 2010, GASTROENTEROLOGY, V138, P671, DOI 10.1053/j.gastro.2009.09.021; Neumann UP, 2010, J HEPATOL; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Payer BA, 2010, J CLIN VIROL, V49, P131, DOI 10.1016/j.jcv.2010.07.006; Permanyer M, 2010, TRENDS MICROBIOL, V18, P543, DOI 10.1016/j.tim.2010.09.003; Polyak SJ, 2008, HEPATOLOGY, V48, P345, DOI 10.1002/hep.22235; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107; Poss M, 1999, J VIROL, V73, P5255, DOI 10.1128/JVI.73.7.5255-5264.1999; Rainwater SMJ, 2007, CURR HIV RES, V5, P189, DOI 10.2174/157016207780076986; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roe Barbara, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000847; Seeff LB, 2008, HEPATOLOGY, V47, P605, DOI 10.1002/hep.22044; Strader DB, 2002, AM J GASTROENTEROL, V97, P2391, DOI 10.1111/j.1572-0241.2002.05993.x; Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wagoner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016464; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; WAINHOBSON S, 1991, SCIENCE, V252, P961, DOI 10.1126/science.2035026; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	46	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41832	10.1371/journal.pone.0041832	http://dx.doi.org/10.1371/journal.pone.0041832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848626	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600130
J	Rutemark, C; Bergman, A; Getahun, A; Hallgren, J; Henningsson, F; Heyman, B				Rutemark, Christian; Bergman, Anna; Getahun, Andrew; Hallgren, Jenny; Henningsson, Frida; Heyman, Birgitta			Complement Receptors 1 and 2 in Murine Antibody Responses to IgM-Complexed and Uncomplexed Sheep Erythrocytes	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; HUMORAL IMMUNE-RESPONSE; T-DEPENDENT ANTIGEN; B-CELLS; MEDIATED ENHANCEMENT; IN-VIVO; CD19/CD21 COMPLEX; MICE DEFICIENT; INDUCTION; TRANSPORT	Early complement components are important for normal antibody responses. In this process, complement receptors 1 and 2 (CR1/2), expressed on B cells and follicular dendritic cells (FDCs) in mice, play a central role. Complement-activating IgM administered with the antigen it is specific for, enhances the antibody response to this antigen. Here, bone marrow chimeras between Cr2(-/-) and wildtype mice were used to analyze whether FDCs or B cells must express CR1/2 for antibody responses to sheep erythrocytes (SRBC), either administered alone or together with specific IgM. For robust IgG anti-SRBC responses, CR1/2 must be expressed on FDCs. Occasionally, weak antibody responses were seen when only B cells expressed CR1/2, probably reflecting extrafollicular antibody production enabled by co-crosslinking of CR2/CD19/CD81 and the BCR. When SRBC alone was administered to mice with CR1/2(+) FDCs, B cells from wildtype and Cr2(-/-) mice produced equal amounts of antibodies. Most likely antigen is then deposited on FDCs in a way that optimizes engagement of the B cell receptor, making CR2-facilitated signaling to the B cell superfluous. SRBC bound to IgM will have more C3 fragments, the ligands for CR1/2, on their surface than SRBC administered alone. Specific IgM, forming a complex with SRBC, enhances antibody responses in two ways when FDCs express CR1/2. One is dependent on CR1/2(+) B cells and probably acts via increased transport of IgM-SRBC-complement complexes bound to CR1/2 on marginal zone B cells. The other is independent on CR1/2(+) B cells and the likely mechanism is that IgM-SRBC-complement complexes bind better to FDCs than SRBC administered alone. These observations suggest that the immune system uses three different CR1/2-mediated effector functions to generate optimal antibody responses: capture by FDCs (playing a dominant role), transport by marginal zone B cells and enhanced B cell signaling.	[Rutemark, Christian; Bergman, Anna; Hallgren, Jenny; Henningsson, Frida; Heyman, Birgitta] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Getahun, Andrew] Univ Colorado, Dept Immunol, Denver Sch Med, Denver, CO 80202 USA; [Getahun, Andrew] Natl Jewish Hlth, Denver, CO USA	Uppsala University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Rutemark, C (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	birgitta.heyman@imbim.uu.se	Hallgren Martinsson, Jenny/AAZ-6356-2021; Hallgren Martinsson, Jenny/AAZ-5937-2021	Hallgren Martinsson, Jenny/0000-0002-3685-5364; Heyman, Birgitta/0000-0003-0869-0483	Uppsala University; Swedish Research Council; Ellen, Walter, and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; King Gustaf V's 80 Years Foundation; Ollie and Elof Ericsson's Foundation; Agnes and Mac Rudberg's Foundation	Uppsala University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ellen, Walter, and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; King Gustaf V's 80 Years Foundation; Ollie and Elof Ericsson's Foundation; Agnes and Mac Rudberg's Foundation	This work was supported by Uppsala University, the Swedish Research Council, Ellen, Walter, and Lennart Hesselman's Foundation, Hans von Kantzow's Foundation, King Gustaf V's 80 Years Foundation, Ollie and Elof Ericsson's Foundation, Agnes and Mac Rudberg's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2012, EUR J IMMUNOL, V42, P241, DOI 10.1002/eji.201141899; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Applequist SE, 2000, J IMMUNOL, V165, P2398, DOI 10.4049/jimmunol.165.5.2398; Bachmann M.F., 2012, J IMMUNOL; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; BOTTGER EC, 1985, J IMMUNOL, V135, P4100; Brockman MA, 2006, J VIROL, V80, P7111, DOI 10.1128/JVI.01421-05; Carlsson F, 2009, SCAND J IMMUNOL, V70, P77, DOI 10.1111/j.1365-3083.2009.02274.x; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1988, J IMMUNOL, V141, P457; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Cherukuri A, 2001, IMMUNITY, V14, P169; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Croix DA, 1996, J EXP MED, V183, P1857, DOI 10.1084/jem.183.4.1857; Cutler AJ, 1998, J EXP MED, V187, P1789, DOI 10.1084/jem.187.11.1789; DENNERT G, 1971, J IMMUNOL, V106, P951; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Fang YF, 1998, J IMMUNOL, V160, P5273; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Fischer MB, 1996, J IMMUNOL, V157, P549; GUSTAVSSON S, 1995, J IMMUNOL, V154, P6524; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; HARTE PG, 1983, NATURE, V302, P256, DOI 10.1038/302256a0; HENRY C, 1968, J EXP MED, V128, P133, DOI 10.1084/jem.128.1.133; HEYMAN B, 1988, J EXP MED, V167, P1999, DOI 10.1084/jem.167.6.1999; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; HEYMAN B, 1982, J EXP MED, V155, P994, DOI 10.1084/jem.155.4.994; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; JACKSON CG, 1979, NEW ENGL J MED, V300, P1124, DOI 10.1056/NEJM197905173002002; KINOSHITA T, 1990, INT IMMUNOL, V2, P651, DOI 10.1093/intimm/2.7.651; KINOSHITA T, 1985, J IMMUNOL, V134, P2564; KURTZ CB, 1990, J IMMUNOL, V144, P3581; LEHNER P, 1983, IMMUNOLOGY, V50, P503; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Mattsson J, 2011, J IMMUNOL, V187, P3641, DOI 10.4049/jimmunol.1101107; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; MOLINA H, 1990, J IMMUNOL, V145, P2974; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1994, J IMMUNOL, V153, P789; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; OCHS HD, 1983, CLIN EXP IMMUNOL, V53, P208; ONEIL KM, 1988, J IMMUNOL, V140, P1939; PEPYS MB, 1976, TRANSPLANT REV-DENMA, V32, P93; PEPYS MB, 1974, J EXP MED, V140, P126, DOI 10.1084/jem.140.1.126; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Prechl J, 2002, INT IMMUNOL, V14, P241, DOI 10.1093/intimm/14.3.241; Ruseva M, 2009, IMMUNOLOGY, V127, P279, DOI 10.1111/j.1365-2567.2008.03016.x; Rutemark C, 2011, P NATL ACAD SCI USA, V108, pE934, DOI 10.1073/pnas.1109831108; Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121; THYPHRONITIS G, 1991, J IMMUNOL, V147, P224; Youd ME, 2002, EUR J IMMUNOL, V32, P2328, DOI 10.1002/1521-4141(200208)32:8<2328::AID-IMMU2328>3.0.CO;2-T	56	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41968	10.1371/journal.pone.0041968	http://dx.doi.org/10.1371/journal.pone.0041968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848677	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600151
J	Wu, S; Peiffer, M; Luthe, DS; Felton, GW				Wu, Shuang; Peiffer, Michelle; Luthe, Dawn S.; Felton, Gary W.			ATP Hydrolyzing Salivary Enzymes of Caterpillars Suppress Plant Defenses	PLOS ONE			English	Article							GLUCOSE-OXIDASE ACTIVITY; EXTRACELLULAR ATP; NICOTIANA-ATTENUATA; GENE-EXPRESSION; WOUND RESPONSE; JASMONIC ACID; MANDUCA-SEXTA; ELICITORS; ARABIDOPSIS; HERBIVORY	The oral secretions of herbivores are important recognition cues that can be used by plants to mediate induced defenses. In this study, a degradation of adenosine-5'-triphosphate (ATP) in tomato leaves was detected after treatment with Helicoverpa zea saliva. Correspondingly, a high level of ATPase activity in saliva was detected and three ATP hydrolyzing enzymes: apyrase, ATP synthase and ATPase 13A1 were identified in salivary glands. To determine the functions of these proteins in mediating defenses, they were cloned from H. zea and expressed in Escherichia coli. By applying the purified expressed apyrase, ATP synthase or ATPase 13A1 to wounded tomato leaves, it was determined that these ATP hydrolyzing enzymes suppressed the defensive genes regulated by the jasmonic acid and ethylene pathways in tomato plant. Suppression of glandular trichome production was also observed after treatment. Blood-feeding arthropods employ 5'-nucleotidase family of apyrases to circumvent host responses and the H. zea apyrase, is also a member of this family. The comparatively high degree of sequence similarity of the H. zea salivary apyrase with mosquito apyrases suggests a broader evolutionary role for salivary apyrases than previously envisioned.	[Wu, Shuang; Peiffer, Michelle; Felton, Gary W.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Wu, Shuang; Peiffer, Michelle; Felton, Gary W.] Penn State Univ, Ctr Chem Ecol, University Pk, PA 16802 USA; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, University Pk, PA 16802 USA; [Luthe, Dawn S.] Penn State Univ, Ctr Chem Ecol, University Pk, PA 16802 USA; [Wu, Shuang] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Southwest University - China	Wu, S (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	gwf10@psu.edu	Felton, Gary W./E-8575-2013		USDA Agriculture and Food Research Initiative (AFRI) program [2010-65105-20639]	USDA Agriculture and Food Research Initiative (AFRI) program	This work was supported by USDA Agriculture and Food Research Initiative (AFRI) program 2010-65105-20639 grant to GWF and DSL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie B, 2007, J PLANT GROWTH REGUL, V26, P160, DOI 10.1007/s00344-007-0012-6; Afshar K, 2010, J INSECT PHYSIOL, V56, P1798, DOI 10.1016/j.jinsphys.2010.07.012; Alborn HT, 2007, P NATL ACAD SCI USA, V104, P12976, DOI 10.1073/pnas.0705947104; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; CHIPPENDALE GM, 1970, J INSECT PHYSIOL, V16, P1057, DOI 10.1016/0022-1910(70)90198-8; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Clark G, 2009, PLANT SCI, V177, P239, DOI 10.1016/j.plantsci.2009.05.004; Dalin Peter, 2008, P89, DOI 10.1007/978-1-4020-8182-8_4; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Faudry E, 2004, J BIOL CHEM, V279, P19607, DOI 10.1074/jbc.M401681200; Felton GW, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P19; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Howe GA, 1999, GENETICS, V153, P1411; Hu YH, 2008, ARCH INSECT BIOCHEM, V68, P113, DOI 10.1002/arch.20240; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; MUELLER MJ, 1993, P NATL ACAD SCI USA, V90, P7490, DOI 10.1073/pnas.90.16.7490; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; NELSON DE, 1992, PLANT MOL BIOL, V19, P577, DOI 10.1007/BF00026784; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Schmelz EA, 2007, PLANT PHYSIOL, V144, P793, DOI 10.1104/pp.107.097154; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Steinebrunner I, 2003, PLANT PHYSIOL, V131, P1638, DOI 10.1104/pp.102.014308; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tang WQ, 2003, PLANT PHYSIOL, V131, P147, DOI 10.1104/pp.013672; TERRY ME, 1980, PLANT PHYSIOL, V66, P321, DOI 10.1104/pp.66.2.321; Thomas C, 2000, PLANT CELL, V12, P519, DOI 10.1105/tpc.12.4.519; Tian DL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036168, 10.1371/journal.pone.0042833]; Vidya CSS, 1999, J BIOSCIENCE, V24, P287, DOI 10.1007/BF02941242; Wen PF, 2005, PLANT SCI, V169, P928, DOI 10.1016/j.plantsci.2005.06.011; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Zahoor Z, 2008, DEV COMP IMMUNOL, V32, P1561, DOI 10.1016/j.dci.2008.05.014; Zarnbrano-Villa S, 2002, TRENDS PARASITOL, V18, P272, DOI 10.1016/S1471-4922(02)02289-4; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	54	59	62	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41947	10.1371/journal.pone.0041947	http://dx.doi.org/10.1371/journal.pone.0041947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848670	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600149
J	Gao, MM; Li, DF; Hu, YL; Zhang, Y; Zou, QM; Wang, DC				Gao, Mingming; Li, Defeng; Hu, Yonglin; Zhang, Ying; Zou, Quanming; Wang, Da-Cheng			Crystal Structure of TNF-alpha-Inducing Protein from Helicobacter Pylori in Active Form Reveals the Intrinsic Molecular Flexibility for Unique DNA-Binding	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TIP-ALPHA; CARCINOGENIC FACTOR; CANCER; INFECTION; STOMACH; CELLS	Tip alpha (TNF-alpha-inducing protein) from Helicobacter pylori is a carcinogenic effector. Studies on this protein revealed that a homodimer linked by a pair of intermolecular disulfide bridges (Cys25-Cys25 and Cys27-Cys27) was absolutely necessary for its biological functions. The activities of Tip alpha would be abolished when both disulfide bridges were disrupted. The crystal structures of Tip alpha reported to date, however, were based on inactive, monomeric mutants with their N-terminal, including residues Cys25 and Cys27, truncated. Here we report the crystal structure of H. pylori Tip alpha protein, Tip alpha N-25, at 2.2 angstrom resolution, in which Cys25 and Cys27 form a pair of inter-chain disulfide bridges linking an active dimer. The disulfide bridges exhibit structural flexibility in the present structure. A series of structure-based mutagenesis, biochemical assays and molecular dynamic simulations on DNA-Tip alpha interactions reveal that Tip alpha utilizes the dimeric interface as the DNA-binding site and that residues His60, Arg77 and Arg81 located at the interface are crucial for DNA binding. Tip alpha could bind to one ssDNA, two ssDNA or one dsDNA in experiments, respectively, in the native or mutant states. The unique DNA-binding activities of Tip alpha indicate that the intrinsic flexible nature of disulfide bridges could endow certain elasticity to the Tip alpha dimer for its unique bioactivities. The results shed light on the possible structural mechanism for the functional performances of Tip alpha.	[Gao, Mingming; Li, Defeng; Hu, Yonglin; Zhang, Ying; Wang, Da-Cheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Gao, Mingming] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China; [Zou, Quanming] Third Mil Med Univ, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Army Medical University	Gao, MM (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	dcwang@ibp.ac.cn			973 grants from National Basic Research Program of China [2011CB910300, 2011CB911100]; Chinese Academy of Sciences [KSCX2-EW-J-3]; Ministry of Health, China [2009ZX09103-676]	973 grants from National Basic Research Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Health, China	This work was supported by the 973 grants from National Basic Research Program of China (2011CB910300, 2011CB911100, http://www.973.gov.cn/), the Chinese Academy of Sciences (KSCX2-EW-J-3, http://www.cas.ac.cn/) and the Ministry of Health, China (2009ZX09103-676, http://www.moh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Censini S, 2001, CURR OPIN MICROBIOL, V4, P41, DOI 10.1016/S1369-5274(00)00162-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Hunt RH, 1996, SCAND J GASTROENTERO, V31, P3, DOI 10.3109/00365529609094743; Jang JY, 2009, J MOL BIOL, V392, P191, DOI 10.1016/j.jmb.2009.07.010; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kuzuhara T, 2007, BIOCHEM BIOPH RES CO, V362, P805, DOI 10.1016/j.bbrc.2007.08.058; Kuzuhara T, 2007, J CANCER RES CLIN, V133, P287, DOI 10.1007/s00432-006-0169-6; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Piliarik Marek, 2009, V503, P65, DOI 10.1007/978-1-60327-567-5_5; Radosz-Komoniewska H, 2005, CLIN MICROBIOL INFEC, V11, P602, DOI 10.1111/j.1469-0691.2005.01207.x; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; Suganuma M, 2005, J CANCER RES CLIN, V131, P305, DOI 10.1007/s00432-004-0652-x; Suganuma M, 2006, J BIOCHEM MOL BIOL, V39, P1; Suganuma M, 2001, CANCER RES, V61, P6356; Suganuma Masami, 2007, Proceedings of the American Association for Cancer Research Annual Meeting, V48, P1337; Sujanuma M, 2008, INT J CANCER, V123, P117, DOI 10.1002/ijc.23484; Taylor G, 2003, ACTA CRYSTALLOGR D, V59, P1881, DOI 10.1107/S0907444903017815; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tosi T, 2009, FEBS LETT, V583, P1581, DOI 10.1016/j.febslet.2009.04.033; Tsuge H, 2009, BIOCHEM BIOPH RES CO, V388, P193, DOI 10.1016/j.bbrc.2009.07.121; Voland P, 2002, ALIMENT PHARM THER, V16, P533, DOI 10.1046/j.1365-2036.2002.01221.x; Watanabe T, 2010, J CANC RES CLIN ONCO; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10	32	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41871	10.1371/journal.pone.0041871	http://dx.doi.org/10.1371/journal.pone.0041871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860022	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600043
J	Gutierrez, JS; Abad-Gomez, JM; Sanchez-Guzman, JM; Navedo, JG; Masero, JA				Gutierrez, Jorge S.; Abad-Gomez, Jose M.; Sanchez-Guzman, Juan M.; Navedo, Juan G.; Masero, Jose A.			Avian BMR in Marine and Non-Marine Habitats: A Test Using Shorebirds	PLOS ONE			English	Article							BASAL METABOLIC-RATE; DISTANCE MIGRATORY SHOREBIRD; ENERGY-EXPENDITURE; MESIC ENVIRONMENTS; ARIDITY GRADIENT; TROPICAL BIRDS; DESERT BIRDS; RICE FIELDS; SLOW PACE; RATES	Basal metabolic rate (BMR) is closely linked to different habitats and way of life. In birds, some studies have noted that BMR is higher in marine species compared to those inhabiting terrestrial habitats. However, the extent of such metabolic dichotomy and its underlying mechanisms are largely unknown. Migratory shorebirds (Charadriiformes) offer a particularly interesting opportunity for testing this marine-non-marine difference as they are typically divided into two broad categories in terms of their habitat occupancy outside the breeding season: 'coastal' and 'inland' shorebirds. Here, we measured BMR for 12 species of migratory shorebirds wintering in temperate inland habitats and collected additional BMR values from the literature for coastal and inland shorebirds along their migratory route to make inter- and intraspecific comparisons. We also measured the BMR of inland and coastal dunlins Calidris alpina wintering at a similar latitude to facilitate a more direct intraspecific comparison. Our interspecific analyses showed that BMR was significantly lower in inland shorebirds than in coastal shorebirds after the effects of potentially confounding climatic (latitude, temperature, solar radiation, wind conditions) and organismal (body mass, migratory status, phylogeny) factors were accounted for. This indicates that part of the variation in basal metabolism might be attributed to genotypic divergence. Intraspecific comparisons showed that the mass-specific BMR of dunlins wintering in inland freshwater habitats was 15% lower than in coastal saline habitats, suggesting that phenotypic plasticity also plays an important role in generating these metabolic differences. We propose that the absence of tidally-induced food restrictions, low salinity, and less windy microclimates associated with inland freshwater habitats may reduce the levels of energy expenditure, and hence BMR. Further research including common-garden experiments that eliminate phenotypic plasticity as a source of phenotypic variation is needed to determine to what extent these general patterns are attributable to genotypic adaptation.	[Gutierrez, Jorge S.; Abad-Gomez, Jose M.; Sanchez-Guzman, Juan M.; Navedo, Juan G.; Masero, Jose A.] Univ Extremadura, Dept Anat Cell Biol & Zool, Badajoz, Spain	Universidad de Extremadura	Gutierrez, JS (corresponding author), Univ Extremadura, Dept Anat Cell Biol & Zool, Badajoz, Spain.	jorgesgutierrez@unex.es	Abad-Gómez, José M/R-2479-2019; Gutiérrez, Jorge/M-4869-2017; Masero, Jose A./P-3418-2019; SANCHEZ, JUAN MANUEL/M-1889-2014; Gutiérrez, Jorge S./AAM-6821-2020; Masero, Jose A./A-9478-2008	Abad-Gómez, José M/0000-0002-3757-8856; Gutiérrez, Jorge/0000-0001-8459-3162; Masero, Jose A./0000-0001-5318-4833; Gutiérrez, Jorge S./0000-0001-8459-3162; Masero, Jose A./0000-0001-5318-4833; Sanchez Guzman, Juan Manuel/0000-0002-0484-6308	Spanish Ministry of Education and Science [CGL2006-01227]; European Regional Development Fund [ERDF] [GR10174]; Government of Extremadura [GR10174, PRE07034]	Spanish Ministry of Education and Science(Spanish Government); European Regional Development Fund [ERDF](European Commission); Government of Extremadura	Projects CGL2006-01227 (Spanish Ministry of Education and Science) and GR10174 (Government of Extremadura and the European Regional Development Fund [ERDF]), and a PhD fellowship (PRE07034) to JSG from Government of Extremadura provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SJ, 1988, COMP BIOCHEM PHYS A, V89, P79, DOI 10.1016/0300-9629(88)91142-5; Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; ASCHOFF J, 1970, FED PROC, V29, P1541; Aschoff J, 1970, J. Orn., Berl., V111, P38, DOI 10.1007/BF01668180; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bozinovic F, 2010, CURR ZOOL, V56, P759, DOI 10.1093/czoolo/56.6.759; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Broggi J, 2005, EVOLUTION, V59, P1600; BRYANT DM, 1995, IBIS, V137, P219, DOI 10.1111/j.1474-919X.1995.tb03242.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cant JP, 1996, J ANIM SCI, V74, P2541; CASTRO G, 1987, WILSON BULL, V99, P267; Cramp S., 1993, HDB BIRDS EUROPE MID; Dawson WR, 2000, STURKIES AVIAN PHYSL, V5th, P390; Duriez O, 2004, ARDEA, V92, P31; Duriez Olivier, 2010, Wader Study Group Bulletin, V117, P119; Ellis H.I., 1984, P203; Ellis Hugh I., 2002, P359; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Frappell PB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P865, DOI 10.1086/425191; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gutierrez JS, 2012, FUNCT ECOL, V26, P236, DOI 10.1111/j.1365-2435.2011.01929.x; Gutierrez JS, 2011, J AVIAN BIOL, V42, P259, DOI 10.1111/j.1600-048X.2011.05323.x; Gutierrez JS, 2011, J EXP BIOL, V214, P829, DOI 10.1242/jeb.048223; HAILS CJ, 1983, CONDOR, V85, P61, DOI 10.2307/1367889; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; Hoyo J, 1996, HOATZIN AUKS; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261; Kaseloo PA, 2003, J COMP PHYSIOL B, V173, P207, DOI 10.1007/s00360-002-0321-9; Kendeigh S.C., 1977, GRANIVOROUS BIRDS EC, P127, DOI [10.1515/isspar-2015-0001, DOI 10.1515/ISSPAR-2015-0001]; Kersten M, 1998, ARDEA, V86, P71; KERSTEN M, 1987, ARDEA, V75, P175; Kvist A, 2003, OIKOS, V103, P397, DOI 10.1034/j.1600-0706.2003.12259.x; Kvist A, 2001, FUNCT ECOL, V15, P465, DOI 10.1046/j.0269-8463.2001.00549.x; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lindstrom A, 2003, CONDOR, V105, P420, DOI 10.1650/7222; Lindstrom A, 1997, J AVIAN BIOL, V28, P87, DOI 10.2307/3677098; Maddison WP, 2010, MESQUITE MOL SYSTEM; Masero JA, 2011, BIRD CONSERV INT, V21, P12, DOI 10.1017/S0959270910000092; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; McNab BK, 1997, PHYSIOL ZOOL, V70, P718, DOI 10.1086/515881; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; Meissner W, 2009, J FIELD ORNITHOL, V80, P289, DOI 10.1111/j.1557-9263.2009.00232.x; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Piersma Theunis, 2003, Wader Study Group Bulletin, V100, P5; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; RAHN H., 1984, COMPANION ANIMAL PHY, P124; Reynolds PS, 1996, AM NAT, V147, P735, DOI 10.1086/285877; Rezende EL, 2002, J EXP BIOL, V205, P101; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sanchez-Guzman JM, 2007, BIODIVERS CONSERV, V16, P3333, DOI 10.1007/s10531-006-9018-9; Speakman JR, 2000, ADV ECOL RES, V30, P177; STAALAND H, 1967, COMP BIOCHEM PHYSIOL, V23, P933, DOI 10.1016/0010-406X(67)90354-4; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; Taylor NAS, 2006, J THERM BIOL, V31, P90, DOI 10.1016/j.jtherbio.2005.11.007; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Tieleman BI, 2003, P ROY SOC B-BIOL SCI, V270, P207, DOI 10.1098/rspb.2002.2205; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Tieleman BI, 2002, PHYSIOL BIOCHEM ZOOL, V75, P305, DOI 10.1086/341998; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; VANDERHAEGEN WM, 1994, WILSON BULL, V106, P338; WEATHERS WW, 1979, OECOLOGIA, V42, P81, DOI 10.1007/BF00347620; Weber TP, 1996, J AVIAN BIOL, V27, P215, DOI 10.2307/3677225; White CR, 2007, P ROY SOC B-BIOL SCI, V274, P287, DOI 10.1098/rspb.2006.3727; WHITLOCK CH, 2002, NASA SURFACE METEORO; WIERSMA P, 1994, CONDOR, V96, P257, DOI 10.2307/1369313; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Wikelski M, 2003, P ROY SOC B-BIOL SCI, V270, P2383, DOI 10.1098/rspb.2003.2500; Williams JB, 2005, BIOSCIENCE, V55, P416, DOI 10.1641/0006-3568(2005)055[0416:PAIDB]2.0.CO;2	82	16	16	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42206	10.1371/journal.pone.0042206	http://dx.doi.org/10.1371/journal.pone.0042206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860084	gold, Green Submitted, Green Published			2022-12-27	WOS:000307045600073
J	Renoud, P; Toury, B; Benayoun, S; Attik, G; Grosgogeat, B				Renoud, Pauline; Toury, Berangere; Benayoun, Stephane; Attik, Ghania; Grosgogeat, Brigitte			Functionalization of Titanium with Chitosan via Silanation: Evaluation of Biological and Mechanical Performances	PLOS ONE			English	Article							ALAMAR BLUE ASSAY; COVALENT IMMOBILIZATION; COATED TITANIUM; CELL-GROWTH; IMPLANT; ATTACHMENT; SURFACES; BIOMATERIAL; COATINGS; BACTERIA	Complications in dentistry and orthopaedic surgery are mainly induced by peri-implant bacterial infections and current implant devices do not prevent such infections. The coating of antibacterial molecules such as chitosan on its surface would give the implant bioactive properties. The major challenge of this type of coating is the attachment of chitosan to a metal substrate. In this study, we propose to investigate the functionalization of titanium with chitosan via a silanation. Firstly, the surface chemistry and mechanical properties of such coating were evaluated. We also verified if the coated chitosan retained its biocompatibility with the peri-implant cells, as well as its antibacterial properties. FTIR and Tof-SIMS analyses confirmed the presence of chitosan on the titanium surface. This coating showed great scratch resistance and was strongly adhesive to the substrate. These mechanical properties were consistent with an implantology application. The Chitosan-coated surfaces showed strong inhibition of Actinomyces naeslundii growth; they nonetheless showed a non significant inhibition against Porphyromonas gingivalis after 32 hours in liquid media. The chitosan-coating also demonstrated good biocompatibility to NIH3T3 fibroblasts. Thus this method of covalent coating provides a biocompatible material with improved bioactive properties. These results proved that covalent coating of chitosan has significant potential in biomedical device implantation.	[Renoud, Pauline; Toury, Berangere; Attik, Ghania; Grosgogeat, Brigitte] Univ Lyon 1, Lab Multimat & Interfaces, F-69622 Villeurbanne, France; [Benayoun, Stephane] Ecole Cent Lyon, Lab Tribol & Dynam Syst, Ecully, France; [Grosgogeat, Brigitte] Hosp Civils Lyon, Serv Traitements & Consultat Dent, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; CHU Lyon	Renoud, P (corresponding author), Univ Lyon 1, Lab Multimat & Interfaces, F-69622 Villeurbanne, France.	brigitte.grosgogeat@univ-lyon1.fr	GROSGOGEAT, Brigitte/AAE-2810-2019	GROSGOGEAT, Brigitte/0000-0003-2194-7300; Benayoun, stephane/0000-0002-1585-0097	Lyon Science Transfert Department of the University of Lyon; Institut Francais de la Recherche (IFRO)	Lyon Science Transfert Department of the University of Lyon; Institut Francais de la Recherche (IFRO)	This work was supported by the Lyon Science Transfert Department of the University of Lyon. The departement had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their appreciation to the Lyon Science Transfert Department (LST) of the University of Lyon and to the Institut Francais de la Recherche (IFRO) for their financial support. The authors would like to thank Dr. Karen Moreau for her scientific assistance. The authors are also grateful to Dominique Decoret and Helene Dain-Mabru for their technical work on this project.	Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688; Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; [Anonymous], 2001, 145771 ISO; Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Bajaj G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030899; Barbour ME, 2007, J MATER SCI-MATER M, V18, P1439, DOI 10.1007/s10856-007-0141-2; Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5; Benayoun S, 1999, THIN SOLID FILMS, V352, P156, DOI 10.1016/S0040-6090(99)00319-3; Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x; Bobrova A.M., 1968, APPL SPECTROSC, V8, P59, DOI [DOI 10.1007/BF00938159, 10.1007/BF00938159]; Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048; Busscher HJ, 2008, EUR J ORAL SCI, V116, P493, DOI 10.1111/j.1600-0722.2008.00568.x; De Boever AL, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2005.01175.x; Deppe H, 2007, LASER MED SCI, V22, P223, DOI 10.1007/s10103-007-0441-2; FARGES G, 1989, THIN SOLID FILMS, V181, P365, DOI 10.1016/0040-6090(89)90505-1; Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g; Gu X, 2005, BIOMATERIALS, V30, P484; Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9; Heitz-Mayfield LJA, 2009, INT J ORAL MAX IMPL, V24, P39; Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032; Iacopino A M, 2001, Ann Periodontol, V6, P125, DOI 10.1902/annals.2001.6.1.125; Jeon YJ, 2001, CARBOHYD POLYM, V44, P71, DOI 10.1016/S0144-8617(00)00200-9; Kahraman MV, 2006, J NON-CRYST SOLIDS, V352, P2143, DOI 10.1016/j.jnoncrysol.2006.02.029; Kato K, 1995, SURF COAT TECH, V76-77, P469, DOI 10.1016/0257-8972(95)02570-7; Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035; Kumar S, 2011, INT J BIOL MACROMOL, V49, P356, DOI 10.1016/j.ijbiomac.2011.05.017; Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046; LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x; LEONHARDT A, 1995, EUR J ORAL SCI, V103, P382, DOI 10.1111/j.1600-0722.1995.tb01861.x; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; Martin HJ, 2008, APPL SURF SCI, V254, P4599, DOI 10.1016/j.apsusc.2008.01.066; Martin HJ, 2008, THIN SOLID FILMS, V516, P6277, DOI 10.1016/j.tsf.2007.12.001; Martin HJ, 2007, LANGMUIR, V23, P6645, DOI 10.1021/la063284v; Mendas M, 2008, INT REV MECH ENG IRE, V2; Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043; Mombelli A, 1993, Adv Dent Res, V7, P202; Mutsuzaki H, 2008, J BIOMED MATER RES B, V86B, P365, DOI 10.1002/jbm.b.31029; Muzzarelli RAA, 1999, EXS, V87, P251; Nanci A, 1998, J BIOMED MATER RES, V40, P324; No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6; O'Neill H., 1967, HARDNESS MEASUREMENT; Pelaez-Vargas A, 2011, DENT MATER, V27, P581, DOI 10.1016/j.dental.2011.02.014; Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005; Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010; Risbud M, 2001, BIOMATERIALS, V22, P1591, DOI 10.1016/S0142-9612(00)00325-2; Sarkonen N, 2005, ANAEROBE, V11, P231, DOI 10.1016/j.anaerobe.2005.01.002; Sato J, 2011, AUST DENT J, V56, P201, DOI 10.1111/j.1834-7819.2011.01324.x; Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P161, DOI 10.1111/j.1600-0501.2006.01320.x; Singh AV, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026803, 10.1371/journal.pone.0025029]; Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441; Sun T, 2007, EUR FOOD RES TECHNOL, V225, P451, DOI 10.1007/s00217-006-0439-1; van der Weijden GA, 1998, J CLIN PERIODONTOL, V25, P413; van Winkelhoff AJ, 2000, CLIN ORAL IMPLAN RES, V11, P511, DOI 10.1034/j.1600-0501.2000.011006511.x; Vingsbo O., 1986, MICROINDENTATION TEC, V889, P257; Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2; Yuan Y, 2008, J BIOMED MATER RES B, V86B, P245, DOI 10.1002/jbm.b.31012; Zhang JP, 2007, CARBOHYD POLYM, V68, P367, DOI 10.1016/j.carbpol.2006.11.018; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6	60	45	45	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e39367	10.1371/journal.pone.0039367	http://dx.doi.org/10.1371/journal.pone.0039367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859940	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600003
J	Li, BS; Zhao, YL; Guo, G; Li, W; Zhu, ED; Luo, X; Mao, XH; Zou, QM; Yu, PW; Zuo, QF; Li, N; Tang, B; Liu, KY; Xiao, B				Li, Bo-sheng; Zhao, Yong-liang; Guo, Gang; Li, Wei; Zhu, En-dong; Luo, Xiao; Mao, Xu-hu; Zou, Quan-ming; Yu, Pei-wu; Zuo, Qian-fei; Li, Na; Tang, Bin; Liu, Kai-yun; Xiao, Bin			Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection	PLOS ONE			English	Article							BREAST-CANCER; CIRCULATING MICRORNAS; EXPRESSION; SERUM; PROGNOSIS; DIAGNOSIS; INVASION; CELLS; MICROARRAY; CARCINOMA	Background: MicroRNAs (miRNAs), endogenous small non-coding RNAs, are stably detected in human plasma. Early diagnosis of gastric cancer (GC) is very important to improve the therapy effect and prolong the survival of patients. We aimed to identify whether four miRNAs (miR-223, miR-21, miR-218 and miR-25) closely associated with the tumorigenesis or metastasis of GC can serve as novel potential biomarkers for GC detection. Methodology: We initially measured the plasma levels of the four miRNAs in 10 GC patients and 10 healthy control subjects by quantitative reverse transcription polymerase chain reaction (qRT-PCR), and then compared plasma miRNA results with the expressions in cancer tissues from eight GC patients. Finally, the presence of miR-223, miR-21 and miR-218 in the plasma was validated in 60 GC patients and 60 healthy control subjects, and the areas under the receiver operating characteristic (ROC) curves of these miRNAs were analyzed. Results: We found that the plasma levels of miR-223 (P<0.001) and miR-21 (P<0.001) were significantly higher in GC patients than in healthy controls, while miR-218 (P<0.001) was significantly lower. The ROC analyses yielded the AUC values of 0.9089 for miR-223, 0.7944 for miR-21 and 0.7432 for miR-218, and combined ROC analysis revealed the highest AUC value of 0.9531 in discriminating GC patients from healthy controls. Moreover, the plasma levels of miR-223 (P<0.001) and miR-21 (P = 0.003) were significantly higher in GC patients with stage I than in healthy controls. Furthermore, the plasma levels of miR-223 were significantly higher in GC patients with helicobacter pylori (Hp) infection than those without (P = 0.014), and significantly higher in healthy control subjects with Hp infection than those without (P = 0.016). Conclusions: Plasma miR-223, miR-21 and miR-218 are novel potential biomarkers for GC detection.	[Li, Bo-sheng; Guo, Gang; Zhu, En-dong; Mao, Xu-hu; Zou, Quan-ming; Zuo, Qian-fei; Li, Na; Tang, Bin; Liu, Kai-yun; Xiao, Bin] Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China; [Zhao, Yong-liang; Luo, Xiao; Yu, Pei-wu] Third Mil Med Univ, Southwest Hosp, Ctr Minimally Invas Gastrointestinal Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, BS (corresponding author), Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China.	liukaiyun@sohu.com; binxiaotmmu@163.com		Li, Na/0000-0002-6227-8433	Natural Science Foundation of China (NSFC) [81071412]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Natural Science Foundation of China (NSFC, No. 81071412). The funders had role in data collection and analysis, but not role in study design, decision to publish, or preparation of the manuscript.	Chan SH, 2008, ANTICANCER RES, V28, P907; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Criscitiello C, 2010, CURR OPIN ONCOL, V22, P552, DOI 10.1097/CCO.0b013e32833de186; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao Cai-ping, 2010, Zhonghua Zhong Liu Za Zhi, V32, P249; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Imdahl A, 2008, MMW Fortschr Med, V150, P27; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Kim DW, 2011, J KOREAN MED SCI, V26, P875, DOI 10.3346/jkms.2011.26.7.875; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Li SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-24; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang J, 2012, SURG ONCOL, V21, P119, DOI 10.1016/j.suronc.2010.12.004; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	36	245	268	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41629	10.1371/journal.pone.0041629	http://dx.doi.org/10.1371/journal.pone.0041629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860003	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900032
J	Weber, F; del Campo, J; Wylezich, C; Massana, R; Jurgens, K				Weber, Felix; del Campo, Javier; Wylezich, Claudia; Massana, Ramon; Juergens, Klaus			Unveiling Trophic Functions of Uncultured Protist Taxa by Incubation Experiments in the Brackish Baltic Sea	PLOS ONE			English	Article							MICROBIAL FOOD-WEB; OLIGONUCLEOTIDE PROBES; COMMUNITY STRUCTURE; GENETIC DIVERSITY; SMALL EUKARYOTES; SURFACE WATERS; FLOW-CYTOMETRY; 18S RDNA; RNA; BACTERIA	Background: Our knowledge of the phylogeny and diversity of aquatic protists is rapidly increasing due to molecular surveys and next-generation sequencing approaches. This has led to a considerable discrepancy between the taxa known from cultures and those known from environmental 18S rRNA gene sequences. Hence, it is generally difficult to assign ecological functions to new taxa detected by culture-independent molecular approaches. Methodology/Principal Findings: A combination of unamended dark incubations and 18S rRNA sequencing was chosen to link molecular diversity data of uncultured protists with heterotrophic, presumably bacterivorous, growth. The incubations, conducted with Baltic Sea brackish water, resulted in a consistent shift from a protistan community dominated by phototrophs to one in which heterotrophs predominated. This was determined on the basis of cell abundance and 18S rRNA sequences derived from fingerprint analysis and clone libraries. The bulk of enriched phylotypes after incubation were related to hitherto uncultured marine taxa within chrysophytes, ochrophytes, choanoflagellates, cercozoans, and picobiliphytes, mostly represented in recently established or here defined environmental clades. Their growth in the dark, together with coinciding results from studies with a similar objective, provides evidence that these uncultured taxa represent heterotrophic or mixotrophic species. Conclusions/Significance: These findings shed some light into the trophic role of diverse uncultured protists especially within functionally heterogeneous groups (e.g., chrysophytes, ochrophytes) and groups that appear to be puzzling with regard to their nutrition (picobiliphytes). Additionally, our results indicate that the heterotrophic flagellate community in the southwestern Baltic Sea is dominated by species of marine origin. The combination of unamended incubations with molecular diversity analysis is thus confirmed as a promising approach to explore the trophic mode of environmentally relevant protist taxa for which only sequence data are currently available.	[Weber, Felix; Wylezich, Claudia; Juergens, Klaus] Leibniz Inst Balt Sea Res Warnemunde, Dept Biol Oceanog, Rostock, Germany; [del Campo, Javier; Massana, Ramon] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Catalonia, Spain	Leibniz Institut fur Ostseeforschung Warnemunde; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Weber, F (corresponding author), Leibniz Inst Balt Sea Res Warnemunde, Dept Biol Oceanog, Rostock, Germany.	felix.weber@io-warnemuende.de	del Campo, Javier/B-5233-2008; Massana, Ramon/F-4205-2016	del Campo, Javier/0000-0002-5292-1421; Massana, Ramon/0000-0001-9172-5418; Jurgens, Klaus/0000-0002-7999-9368; Wylezich, Claudia/0000-0002-0436-4480	Leibniz-Institute for Baltic Sea Research; German Academic Exchange Service (DAAD) [F2100GKSD]	Leibniz-Institute for Baltic Sea Research; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was financed by the Leibniz-Institute for Baltic Sea Research and partly funded by the German Academic Exchange Service (DAAD) (F2100GKSD), http://www.daad.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis M, 2007, J EXP MAR BIOL ECOL, V341, P176, DOI 10.1016/j.jembe.2006.09.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Arndt H, 2000, SYST ASSOC SPEC VOL, V59, P240; Behnke A, 2010, FEMS MICROBIOL ECOL, V72, P89, DOI 10.1111/j.1574-6941.2010.00836.x; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Calbet A, 2001, AQUAT MICROB ECOL, V23, P283, DOI 10.3354/ame023283; Calvo-Diaz A, 2011, APPL ENVIRON MICROB, V77, P5739, DOI 10.1128/AEM.00066-11; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; del Campo J, 2011, THESIS U BARCELONA; del Campo J, 2011, PROTIST, V162, P435, DOI 10.1016/j.protis.2010.10.003; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Ekelund F, 2001, PROTIST, V152, P301, DOI 10.1078/1434-4610-00069; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; FENCHEL T, 1986, ADV MICROB ECOL, V9, P57; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; Frias-Lopez J, 2009, ENVIRON MICROBIOL, V11, P512, DOI 10.1111/j.1462-2920.2008.01793.x; Gachter E, 2006, AQUAT MICROB ECOL, V45, P291, DOI 10.3354/ame045291; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Groisillier A, 2006, AQUAT MICROB ECOL, V42, P277, DOI 10.3354/ame042277; Guillou L, 1999, APPL ENVIRON MICROB, V65, P4528; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; HEINANEN A, 1991, APPL ENVIRON MICROB, V57, P3150; HEINANEN AP, 1991, MAR ECOL PROG SER, V70, P283, DOI 10.3354/meps070283; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Jurgens K, 2000, J EXP MAR BIOL ECOL, V245, P127, DOI 10.1016/S0022-0981(99)00156-2; Jurgens K., 2008, MICROB ECOL OCEAN, P383, DOI [DOI 10.1002/9780470281840.CH11, 10.1002/9780470281840.ch11]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim DY, 2011, MICROB ECOL, V62, P383, DOI 10.1007/s00248-011-9816-9; KIRCHMAN DL, 1990, MAR ECOL PROG SER, V62, P47, DOI 10.3354/meps062047; Koch TA, 2005, PROTIST, V156, P97, DOI 10.1016/j.protis.2004.12.001; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Leadbeater Barry S.C., 2002, P14; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; Lim EL, 1999, LIMNOL OCEANOGR, V44, P37, DOI 10.4319/lo.1999.44.1.0037; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Loquay N, 2009, FUND APPL LIMNOL, V174, P261, DOI 10.1127/1863-9135/2009/0174-0261; Mangot JF, 2009, APPL ENVIRON MICROB, V75, P6373, DOI 10.1128/AEM.00607-09; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; Massana R, 2006, AQUAT MICROB ECOL, V45, P171, DOI 10.3354/ame045171; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; Massana R, 2009, ISME J, V3, P588, DOI 10.1038/ismej.2008.130; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Nagata T., 2000, MICROBIAL ECOLOGY OC, P121; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Piwosz K, 2010, ENVIRON MICROBIOL, V12, P364, DOI 10.1111/j.1462-2920.2009.02074.x; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; Scheckenbach F, 2005, AQUAT MICROB ECOL, V38, P239, DOI 10.3354/ame038239; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Weinbauer MG, 2002, APPL ENVIRON MICROB, V68, P1082, DOI 10.1128/AEM.68.3.1082-1087.2002; WIKNER J, 1988, MAR ECOL PROG SER, V50, P137, DOI 10.3354/meps050137; Worden A Z, 2008, MICROECOL OCEANS, V2, P159, DOI [10.1002/9780470281840.ch6, DOI 10.1002/9780470281840.CH6]; Wylezich C, 2007, J EUKARYOT MICROBIOL, V54, P347, DOI 10.1111/j.1550-7408.2007.00274.x; Wylezich C, 2011, ENVIRON MICROBIOL, V13, P2939, DOI 10.1111/j.1462-2920.2011.02569.x; Yabuki A, 2011, J EUKARYOT MICROBIOL, V58, P94, DOI 10.1111/j.1550-7408.2010.00524.x; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zobell CE, 1936, BIOL BULL-US, V71, P324, DOI 10.2307/1537438; Zollner E, 2009, LIMNOL OCEANOGR, V54, P262, DOI 10.4319/lo.2009.54.1.0262	85	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41970	10.1371/journal.pone.0041970	http://dx.doi.org/10.1371/journal.pone.0041970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860041	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900057
J	Dovzhenok, A; Rubchinsky, LL				Dovzhenok, Andrey; Rubchinsky, Leonid L.			On the Origin of Tremor in Parkinson's Disease	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; RAT SUBTHALAMIC NUCLEUS; BASAL GANGLIA; GLOBUS-PALLIDUS; RESTING TREMOR; DOPAMINE-RECEPTORS; OSCILLATORY ACTIVITY; COMPUTATIONAL MODEL; NEURONAL-ACTIVITY; IN-VITRO	The exact origin of tremor in Parkinson's disease remains unknown. We explain why the existing data converge on the basal ganglia-thalamo-cortical loop as a tremor generator and consider a conductance-based model of subthalamo-pallidal circuits embedded into a simplified representation of the basal ganglia-thalamo-cortical circuit to investigate the dynamics of this loop. We show how variation of the strength of dopamine-modulated connections in the basal ganglia-thalamo-cortical loop (representing the decreasing dopamine level in Parkinson's disease) leads to the occurrence of tremor-like burst firing. These tremor-like oscillations are suppressed when the connections are modulated back to represent a higher dopamine level (as it would be the case in dopaminergic therapy), as well as when the basal ganglia-thalamo-cortical loop is broken (as would be the case for ablative anti-parkinsonian surgeries). Thus, the proposed model provides an explanation for the basal ganglia-thalamo-cortical loop mechanism of tremor generation. The strengthening of the loop leads to tremor oscillations, while the weakening or disconnection of the loop suppresses them. The loop origin of parkinsonian tremor also suggests that new tremor-suppression therapies may have anatomical targets in different cortical and subcortical areas as long as they are within the basal ganglia-thalamo-cortical loop.	[Dovzhenok, Andrey; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; [Dovzhenok, Andrey; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ, Ctr Math Biosci, Indianapolis, IN 46202 USA; [Rubchinsky, Leonid L.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Dovzhenok, A (corresponding author), Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA.	leo@math.iupui.edu	Rubchinsky, Leonid/L-1896-2017	Rubchinsky, Leonid/0000-0002-6596-4594	National Institutes of Health (NIH) [R01NS067200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) grant R01NS067200 (National Science Foundation/NIH Collaborative Research in Computational Neuroscience program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2005, BRAIN, V128, P570, DOI 10.1093/brain/awh397; Antonini A, 1998, NEUROLOGY, V51, P803, DOI 10.1212/WNL.51.3.803; Baufreton J, 2005, FASEB J, V19, P1771, DOI 10.1096/fj.04-3401hyp; Baufreton J, 2008, J PHYSIOL-LONDON, V586, P2121, DOI 10.1113/jphysiol.2008.151118; Beiser DG, 1998, J NEUROPHYSIOL, V79, P3168, DOI 10.1152/jn.1998.79.6.3168; Bergman H, 1998, MOVEMENT DISORD, V13, P29; Best J, 2007, J COMPUT NEUROSCI, V23, P217, DOI 10.1007/s10827-007-0029-7; BEUTER A, 1995, CHAOS, V5, P35, DOI 10.1063/1.166082; Bevan MD, 2006, CURR OPIN NEUROBIOL, V16, P621, DOI 10.1016/j.conb.2006.10.003; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; BURNE JA, 1987, EXP NEUROL, V97, P327, DOI 10.1016/0014-4886(87)90093-8; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Cooper AJ, 2001, NEUROPHARMACOLOGY, V41, P62, DOI 10.1016/S0028-3908(01)00038-7; Cragg SJ, 2004, EUR J NEUROSCI, V20, P1788, DOI 10.1111/j.1460-9568.2004.03629.x; Deuschl G, 2000, J NEUROL, V247, P33, DOI 10.1007/PL00007781; Deuschl G, 2002, MOVEMENT DISORD, V17, pS41, DOI 10.1002/mds.10141; Elble RJ, 2002, NEUROLOGY, V58, pS57, DOI 10.1212/WNL.58.suppl_1.S57; Elble RJ, 1990, TREMOR; Floran B, 2004, EUR J PHARMACOL, V498, P97, DOI 10.1016/j.ejphar.2004.07.078; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; Guehl D, 2003, EUR J NEUROSCI, V17, P2388, DOI 10.1046/j.1460-9568.2003.02685.x; Guo YX, 2008, J NEUROPHYSIOL, V99, P1477, DOI 10.1152/jn.01080.2007; HASSLER R, 1970, CONFIN NEUROL, V32, P79; Hernandez A, 2006, J NEUROPHYSIOL, V96, P2877, DOI 10.1152/jn.00664.2006; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; Hurtado JA, 2005, J NEUROPHYSIOL, V93, P1569, DOI 10.1152/jn.00829.2004; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Hutchison WD, 1997, EXP BRAIN RES, V113, P557, DOI 10.1007/PL00005606; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jellinger KA, 1999, J NEURAL TRANSM-SUPP, P1; Jones EG, 2001, SURG PARKINSONS DIS, P24; Kita H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00042; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; LENZ FA, 1994, BRAIN, V117, P531, DOI 10.1093/brain/117.3.531; Levy R, 2000, J NEUROSCI, V20, P7766; Llinas R, 1984, MOVEMENT DISORDERS T, P339; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; Moran A, 2008, BRAIN, V131, P3395, DOI 10.1093/brain/awn270; Ogura M, 2000, J NEUROPHYSIOL, V83, P3366, DOI 10.1152/jn.2000.83.6.3366; PARE D, 1990, NEUROSCIENCE, V35, P217, DOI 10.1016/0306-4522(90)90077-H; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Pollock LJ, 1930, ARCH NEURO PSYCHIATR, V23, P303, DOI 10.1001/archneurpsyc.1930.02220080087006; RACK PMH, 1986, BRAIN, V109, P115, DOI 10.1093/brain/109.1.115; Raethjen J, 2009, CLIN NEUROPHYSIOL, V120, P1866, DOI 10.1016/j.clinph.2009.06.028; Raethjen J, 2009, CURR OPIN NEUROL, V22, P400, DOI 10.1097/WCO.0b013e32832dc056; Ramanathan S, 2008, J NEUROPHYSIOL, V99, P442, DOI 10.1152/jn.00998.2007; Rivlin-Etzion M, 2006, CURR OPIN NEUROBIOL, V16, P629, DOI 10.1016/j.conb.2006.10.002; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Rubchinsky L.L., 2007, SCHOLARPEDIA, V2, P1379, DOI DOI 10.4249/SCHOLARPEDIA.1379; Rubchinsky LL, 2003, P NATL ACAD SCI USA, V100, P14427, DOI 10.1073/pnas.2036283100; Rubin JE, 2004, J COMPUT NEUROSCI, V16, P211, DOI 10.1023/B:JCNS.0000025686.47117.67; Shen KZ, 2000, J PHYSIOL-LONDON, V525, P331, DOI 10.1111/j.1469-7793.2000.00331.x; Shen KZ, 2005, NEUROREPORT, V16, P171, DOI 10.1097/00001756-200502080-00021; Shen KZ, 2003, EUR J NEUROSCI, V18, P2967, DOI 10.1046/j.1460-9568.2003.03058.x; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Speelman JD, 2002, MOVEMENT DISORD, V17, pS84, DOI 10.1002/mds.10147; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Tarsy D, 2003, SURG TREATMENT PARKI; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359; Weinberger M, 2009, J NEUROPHYSIOL, V101, P789, DOI 10.1152/jn.90837.2008; Wichmann T, 1999, NATURE, V400, P621, DOI 10.1038/23148; Wilms H, 1999, MOVEMENT DISORD, V14, P557, DOI 10.1002/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; Zirh TA, 1998, NEUROSCIENCE, V83, P107, DOI 10.1016/S0306-4522(97)00295-9	71	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41598	10.1371/journal.pone.0041598	http://dx.doi.org/10.1371/journal.pone.0041598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848541	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200076
J	Naseer, U; Olsson-Liljequist, BE; Woodford, N; Dhanji, H; Canton, R; Sundsfjord, A; Lindstedt, BA				Naseer, Umaer; Olsson-Liljequist, Barbro E.; Woodford, Neil; Dhanji, Hiran; Canton, Rafael; Sundsfjord, Arnfinn; Lindstedt, Bjorn-Arne			Multi-Locus Variable Number of Tandem Repeat Analysis for Rapid and Accurate Typing of Virulent Multidrug Resistant Escherichia coli Clones	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; CHANGING EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; CTX-M; EMERGENCE; CTX-M-15; DISSEMINATION; CORESISTANCE; INFECTIONS; O25B-ST131	One hundred E. coli isolates from Norway (n = 37), Sweden (n = 24), UK (n = 20) and Spain (n = 19), producing CTX-M-type - (n = 84), or SHV-12 (n = 4) extended spectrum beta-lactamases, or the plasmid mediated AmpC, CMY-2 (n = 12), were typed using multi-locus sequence typing (MLST) and multi-locus variable number of tandem repeat analysis (MLVA). Isolates clustered into 33 Sequence Types (STs) and 14 Sequence Type Complexes (STCs), and 58 MLVA-Types (MTs) and 25 different MLVA-Type Complexes (MTCs). A strong agreement between the MLST profile and MLVA typing results was observed, in which all ST131-isolates (n = 39) and most of the STC-648 (n = 10), STC-38 (n = 9), STC-10 (n = 9), STC-405 (n = 8) and STC-23 (n = 6) isolates were clustered distinctly into MTC-29, -36, -20, -14, -10 and -39, respectively. MLVA is a rapid and accurate tool for genotyping isolates of globally disseminated virulent multidrug resistant E. coli lineages, including ST131.	[Naseer, Umaer] Univ Tromso, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Olsson-Liljequist, Barbro E.] Swedish Inst Communicable Dis Control, Unit Antibiot & Infect Control, Solna, Sweden; [Woodford, Neil; Dhanji, Hiran] Hlth Protect Agcy, Antibiot Resistance Monitoring & Reference Lab, London, England; [Canton, Rafael] IRYCIS, Microbiol Serv, Madrid, Spain; [Canton, Rafael] IRYCIS, CIBERESP, Madrid, Spain; [Canton, Rafael] Hosp Univ Ramon & Cajal, Madrid, Spain; [Canton, Rafael] CSIC, Unidad Resistencia Antibiot & Virulencia Bacteria, Madrid, Spain; [Naseer, Umaer; Sundsfjord, Arnfinn] Univ Hosp N Norway, Dept Microbiol & Infect Control, Reference Ctr Detect Antimicrobial Resistance, Tromso, Norway; [Lindstedt, Bjorn-Arne] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway	UiT The Arctic University of Tromso; Swedish Institute for Infectious Disease Control; Health Protection Agency; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian Institute of Public Health (NIPH)	Naseer, U (corresponding author), Univ Tromso, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway.	umaer.naseer@uit.no	Staves, Peter/C-8219-2014; Cantón, Rafael/AAP-8669-2021; CANTON, RAFAEL/ABF-6353-2020; Woodford, Neil/D-4123-2011; Sundsfjord, Arnfinn/F-9668-2018	Woodford, Neil/0000-0003-1396-8953; Sundsfjord, Arnfinn/0000-0002-3728-2270; Canton, Rafael/0000-0003-1675-3173	Northern Norway Regional Health Authority Medical Research Program	Northern Norway Regional Health Authority Medical Research Program	This study was funded in part by the Northern Norway Regional Health Authority Medical Research Program. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Blanco M, 2009, J ANTIMICROB CHEMOTH, V63, P1135, DOI 10.1093/jac/dkp122; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Canton R, 2011, CURR OPIN PHARMACOL, V11, P477, DOI 10.1016/j.coph.2011.07.007; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Castanheira M, 2008, MICROB DRUG RESIST, V14, P211, DOI 10.1089/mdr.2008.0827; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Geue L, 2010, APPL ENVIRON MICROB, V76, P5510, DOI 10.1128/AEM.00743-10; Johnson JR, 2009, J CLIN MICROBIOL, V47, P3721, DOI 10.1128/JCM.01581-09; Johnson JR, 2009, ANTIMICROB AGENTS CH, V53, P2733, DOI 10.1128/AAC.00297-09; Karger A, 2011, APPL ENVIRON MICROB, V77, P896, DOI 10.1128/AEM.01686-10; Lau SH, 2010, CLIN MICROBIOL INFEC, V16, P232, DOI 10.1111/j.1469-0691.2009.02733.x; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Monecke S, 2011, APPL ENVIRON MICROB, V77, P8784, DOI 10.1128/AEM.06524-11; Morosini MI, 2006, ANTIMICROB AGENTS CH, V50, P2695, DOI 10.1128/AAC.00155-06; Morris D, 2011, ANTIMICROB AGENTS CH, V55, P4935, DOI 10.1128/AAC.05127-11; Naseer U, 2011, MICROB DRUG RESIST; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Peirano G, 2011, ANTIMICROB AGENTS CH, V55, P2986, DOI 10.1128/AAC.01763-10; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2539, DOI 10.1128/AAC.00061-09; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2009, J ANTIMICROB CHEMOTH, V63, P225, DOI 10.1093/jac/dkn467; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	30	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41232	10.1371/journal.pone.0041232	http://dx.doi.org/10.1371/journal.pone.0041232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22859970	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200048
J	Sudmeyer, M; Pieperhoff, P; Ferrea, S; Krause, H; Groiss, SJ; Elben, S; Wojtecki, L; Zilles, K; Amunts, K; Schnitzler, A				Suedmeyer, Martin; Pieperhoff, Peter; Ferrea, Stefano; Krause, Holger; Groiss, Stefan Jun; Elben, Saskia; Wojtecki, Lars; Zilles, Karl; Amunts, Katrin; Schnitzler, Alfons			Longitudinal Deformation-Based Morphometry Reveals Spatio-Temporal Dynamics of Brain Volume Changes in Patients with Corticobasal Syndrome	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PARKINSONS-DISEASE; INTERINDIVIDUAL VARIABILITY; PROBABILISTIC MAPS; PARIETAL CORTEX; CEREBRAL-CORTEX; MR-IMAGES; DEGENERATION; AREAS; PROGRESSION	Background/Objective: Corticobasal syndrome (CBS) is a rare neurodegenerative disorder characterized by a progressive and asymmetric manifestation of cortical and basal-ganglia symptoms of different origin. The spatio-temporal dynamics of cerebral atrophy in CBS is barely known. This study aimed to longitudinally quantify the individual dynamics of brain volume changes in patients with CBS as compared to healthy controls. Methods: We used deformation-field-based morphometry (DFM) to study volumetric changes of each individual brain in short intervals of a few months. DFM enabled the quantitative analysis of local volume changes without predefining regions of interest in MR images of 6 patients with CBS and 11 matched healthy controls. A total of 64 whole brain 3D-MR-scans were acquired two to eight times over periods of 14 to 26 months. Based on repeated registrations of MR observations to the initial scan, maps of local volume ratio changes were computed. Results: Compared to controls patients showed significant and increasing volume loss over time in premotor and primary-motor-cortices, somatosensory area 3a, superior parietal areas BA 5/7, and corticospinal tract. Furthermore, significant and asymmetric atrophy was identified in the caudate nucleus head, putamen, pallidum, motor-thalamus and substantia nigra. Temporal lobe was affected in those patients who presented progressive cognitive impairment. Conclusions: The analysis revealed localized, pathological changes in brains of patients with CBS, which differed significantly from those occurring during aging in healthy controls. As compared to age- and sex-matched controls, brains of CBS patients showed a common degenerating neural network comprising the motor circuit with basal ganglia and motor thalamic nuclei as well as the premotor and primary-motor-cortex.	[Suedmeyer, Martin; Ferrea, Stefano; Krause, Holger; Groiss, Stefan Jun; Elben, Saskia; Wojtecki, Lars; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, Fac Med, Ctr Movement Disorders & Neuromodulat, Dusseldorf, Germany; [Suedmeyer, Martin; Ferrea, Stefano; Krause, Holger; Groiss, Stefan Jun; Elben, Saskia; Schnitzler, Alfons] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany; [Pieperhoff, Peter; Zilles, Karl; Amunts, Katrin] Res Ctr Julich, Inst Neurosci & Med INM 1, INM 2, Julich, Germany; [Zilles, Karl] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany; [Amunts, Katrin] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Amunts, Katrin] JARA Translat Brain Med, Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; RWTH Aachen University	Sudmeyer, M (corresponding author), Univ Dusseldorf, Dept Neurol, Fac Med, Ctr Movement Disorders & Neuromodulat, Dusseldorf, Germany.	martin.suedmeyer@uni-duesseldorf.de	Schnitzler, Alfons/Q-5520-2019; Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019; Schnitzler, Alfons/AAT-1054-2021; Ferrea, Stefano/AAP-5169-2020; Wojtecki, Lars/AAT-6604-2021; Amunts, Katrin/I-3470-2013	Schnitzler, Alfons/0000-0002-6414-7939; Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Wojtecki, Lars/0000-0002-6205-4405; Amunts, Katrin/0000-0001-5828-0867	"Helmholtz Alliance for Mental Health in an Ageing Society" (HelMA) within "Helmholtz Impuls- und Vernetzungsfonds" [HA-215]; German "Bundesministerium fur Bildung und Forschung" (BMBF); Stiftung fur Altersforschung; "Forschungskommission", Heinrich-Heine-University, Dusseldorf (Germany)	"Helmholtz Alliance for Mental Health in an Ageing Society" (HelMA) within "Helmholtz Impuls- und Vernetzungsfonds"; German "Bundesministerium fur Bildung und Forschung" (BMBF)(Federal Ministry of Education & Research (BMBF)); Stiftung fur Altersforschung; "Forschungskommission", Heinrich-Heine-University, Dusseldorf (Germany)	The project underlying this report "Helmholtz Alliance for Mental Health in an Ageing Society" (HelMA, HA-215) was supported within the framework of the "Helmholtz Impuls- und Vernetzungsfonds" funded by the German "Bundesministerium fur Bildung und Forschung" (BMBF). Furthermore, this work was supported by the "Stiftung fur Altersforschung" and the "Forschungskommission", Heinrich-Heine-University, Dusseldorf (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2007, NEUROIMAGE, V37, P1061, DOI 10.1016/j.neuroimage.2007.02.037; Amunts K, 2001, NEUROIMAG CLIN N AM, V11, P151; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Boeve BE, 2005, CUR CLIN NEUROL, P309; Boeve BF, 2003, ANN NEUROL, V54, pS15, DOI 10.1002/ana.10570; Boxer AL, 2006, ARCH NEUROL-CHICAGO, V63, P81, DOI 10.1001/archneur.63.1.81; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Curiati PK, 2009, AM J NEURORADIOL, V30, P1850, DOI 10.3174/ajnr.A1727; Erbetta A, 2009, AM J NEURORADIOL, V30, P1482, DOI 10.3174/ajnr.A1615; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gorno-Tempini ML, 2004, NEUROCASE, V10, P426, DOI 10.1080/13554790490894011; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Homke L, 2009, HUM BRAIN MAPP, V30, P1444, DOI 10.1002/hbm.20617; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huey ED, 2009, ARCH NEUROL-CHICAGO, V66, P1274, DOI 10.1001/archneurol.2009.218; Josephs KA, 2008, NEUROBIOL AGING, V29, P280, DOI 10.1016/j.neurobiolaging.2006.09.019; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Litvan I, 1997, NEUROLOGY, V48, P119, DOI 10.1212/WNL.48.1.119; Mackenzie IRA, 2005, CUR CLIN NEUROL, P33; Mahapatra RK, 2004, LANCET NEUROL, V3, P736, DOI 10.1016/S1474-4422(04)00936-6; Mathew R, 2012, J NEUROL NEUROSUR PS, V83, P405, DOI 10.1136/jnnp-2011-300875; Mattis S, 1988, DEMENTIA RATING SCAL; Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Pieperhoff P, 2008, NEUROIMAGE, V43, P269, DOI 10.1016/j.neuroimage.2008.07.031; Pieperhoff P, 2008, J NEUROSCI, V28, P828, DOI 10.1523/JNEUROSCI.3732-07.2008; Pirker W, 2002, MOVEMENT DISORD, V17, P45, DOI 10.1002/mds.1265; Rothi LJG, 1997, BRAIN DAM B, P61; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schaefer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015010; Scheperjans F, 2008, CEREB CORTEX, V18, P2141, DOI 10.1093/cercor/bhm241; Schneider JA, 1997, NEUROLOGY, V48, P959, DOI 10.1212/WNL.48.4.959; Shelley BP, 2009, MOVEMENT DISORD, V24, P1593, DOI 10.1002/mds.22558; Tang Y, 2001, J NEUROIMAGING, V11, P393, DOI 10.1111/j.1552-6569.2001.tb00068.x; Vandenberghe R, 2009, BEHAV BRAIN RES, V199, P171, DOI 10.1016/j.bbr.2008.12.005; Wadia PM, 2007, PARKINSONISM RELAT D, V13, pS336, DOI 10.1016/S1353-8020(08)70027-0; Whitwell JL, 2010, NEUROLOGY, V75, P1879, DOI 10.1212/WNL.0b013e3181feb2e8; Whitwell JL, 2007, BRAIN, V130, P1148, DOI 10.1093/brain/awm021; Williams R, 2010, NATURE, V466, pS13, DOI 10.1038/466S13a; Zhang W, 2009, NEUROPATHOLOGY, V29, P720, DOI 10.1111/j.1440-1789.2009.01012.x; Zilles K., 2002, BRAIN MAPPING METHOD, P573, DOI DOI 10.1016/B978-012693019-1/50023-X	47	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41873	10.1371/journal.pone.0041873	http://dx.doi.org/10.1371/journal.pone.0041873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848644	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200120
J	Caccamo, N; Todaro, M; La Manna, MP; Sireci, G; Stassi, G; Dieli, F				Caccamo, Nadia; Todaro, Matilde; La Manna, Marco P.; Sireci, Guido; Stassi, Giorgio; Dieli, Francesco			IL-21 Regulates the Differentiation of a Human gamma delta T Cell Subset Equipped with B Cell Helper Activity	PLOS ONE			English	Article							GERMINAL CENTER FORMATION; CXC CHEMOKINE RECEPTOR-5; ANTIBODY-PRODUCTION; EXPRESSION; LYMPHOCYTES; STIMULATION; RESPONSES; ABSENCE; INDUCE; MICE	V gamma 9V delta 2 T lymphocytes recognize nonpeptidic antigens without presentation by MHC molecules and display pleiotropic features. Here we report that coculture of V gamma 9V delta 2 cells with phosphoantigen and IL-21 leads to selective expression of the transcription repressor Bcl-6 and polarization toward a lymphocyte subset displaying features of follicular B-helper T (TFH) cells. T-FH-like V gamma 9V delta 2 cells have a predominant central memory (CD27(+)CD45RA(-)) phenotype and express ICOS, CD40L and CXCR5. Upon antigen activation, they secrete IL-4, IL-10 and CXCL13, and provide B-cell help for antibody production in vitro. Our findings delineate a subset of human V gamma 9V delta 2 lymphocytes, which, upon interaction with IL-21-producing CD4 TFH cells and B cells in secondary lymphoid organs, is implicated in the production of high affinity antibodies against microbial pathogens.	[Caccamo, Nadia; La Manna, Marco P.; Sireci, Guido; Dieli, Francesco] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy; [Todaro, Matilde; Stassi, Giorgio] Univ Palermo, Dipartimento Discipline Chirurg & Oncol, Palermo, Italy	University of Palermo; University of Palermo	Caccamo, N (corresponding author), Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy.	francesco.dieli@unipa.it	La Manna, Marco Pio/AAN-8117-2020; todaro, matilde/AAC-1003-2022; Caccamo, Nadia/J-6808-2018; Sireci, Guido/K-3495-2018; Stassi, Giorgio/AAC-1175-2022	todaro, matilde/0000-0001-8686-8043; Sireci, Guido/0000-0002-3969-0155; LA MANNA, Marco Pio/0000-0002-3327-9541; CACCAMO, Nadia Rosalia/0000-0002-1018-5710; Dieli, Francesco/0000-0002-6685-352X	European Commission [LSHP-CT-2003-503367]; Italian Ministry for Instruction, University and Research [2008L57JXW]; Italian Ministry of Health (Progetto ricerca finalizzata); University of Palermo	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry for Instruction, University and Research; Italian Ministry of Health (Progetto ricerca finalizzata)(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); University of Palermo	This work has been supported by grants from the European Commission within the 6th Framework Programme, TB-VAC contract no. LSHP-CT-2003-503367 (The text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), the Italian Ministry for Instruction, University and Research (contract no. 2008L57JXW to FD), the Italian Ministry of Health (Progetto ricerca finalizzata 2007 "Stem cells in different pathological conditions innovative therapeutical approches" to FD) and the University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal RR, 2012, EUR J IMMUNOL, V42, P110, DOI 10.1002/eji.201142017; Brandes M, 2003, BLOOD, V102, P3693, DOI 10.1182/blood-2003-04-1016; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Caccamo N, 2006, J IMMUNOL, V177, P5290, DOI 10.4049/jimmunol.177.8.5290; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Casetti R, 2009, J IMMUNOL, V183, P3574, DOI 10.4049/jimmunol.0901334; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Devilder MC, 2006, J IMMUNOL, V176, P1386, DOI 10.4049/jimmunol.176.3.1386; Dianda L, 1996, EUR J IMMUNOL, V26, P1603, DOI 10.1002/eji.1830260729; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Eberl M, 2002, IMMUNOLOGY, V106, P200, DOI 10.1046/j.1365-2567.2002.01414.x; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Flynn S, 1998, J EXP MED, V188, P297, DOI 10.1084/jem.188.2.297; Forster R, 1997, BLOOD, V90, P520, DOI 10.1182/blood.V90.2.520.520_520_525; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Glatzel A, 2002, J IMMUNOL, V168, P4920, DOI 10.4049/jimmunol.168.10.4920; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; HORNER AA, 1995, J EXP MED, V181, P1239, DOI 10.1084/jem.181.3.1239; Iwasaki M, 2011, EUR J IMMUNOL, V41, P345, DOI 10.1002/eji.201040959; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jomaa H, 1999, FEMS IMMUNOL MED MIC, V25, P371, DOI 10.1111/j.1574-695X.1999.tb01362.x; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Maloy KJ, 1998, P NATL ACAD SCI USA, V95, P1160, DOI 10.1073/pnas.95.3.1160; Ness-Schwickerath KJ, 2010, J IMMUNOL, V184, P7268, DOI 10.4049/jimmunol.1000600; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Pao W, 1996, CURR BIOL, V6, P1317, DOI 10.1016/S0960-9822(02)70718-5; Peng SL, 1996, J IMMUNOL, V156, P4041; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; RAJAGOPALAN S, 1990, P NATL ACAD SCI USA, V87, P7020, DOI 10.1073/pnas.87.18.7020; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Sireci G, 1997, HUM IMMUNOL, V58, P70, DOI 10.1016/S0198-8859(97)00211-5; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Thedrez A, 2009, J IMMUNOL, V182, P3423, DOI 10.4049/jimmunol.0803068; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; WEN L, 1994, NATURE, V369, P654, DOI 10.1038/369654a0; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Wesch D, 2001, CELL IMMUNOL, V212, P110, DOI 10.1006/cimm.2001.1850; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	54	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41940	10.1371/journal.pone.0041940	http://dx.doi.org/10.1371/journal.pone.0041940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848667	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600146
J	Jackson, EM; Herbst-Kralovetz, MM				Jackson, Erin M.; Herbst-Kralovetz, Melissa M.			Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine	PLOS ONE			English	Article							SYNTHETIC IMMUNOMODULATOR MURABUTIDE; NOD-LIKE RECEPTORS; DENDRITIC CELLS; VAGINAL INFECTION; ADJUVANTS; MICE; PEPTIDE; MDP; IMMUNOTHERAPY; IMMUNIZATION	Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding oligomerization domain-containing protein 2 (NOD2) receptor on mammalian cells. MB has previously been approved for testing in multiple human clinical trials to determine its value as an antiviral therapeutic, and as an adjuvant for injected vaccines. We have found a new use for this immunomodulator; it functions as a mucosal adjuvant that enhances immunogenicity of virus-like particles (VLP) administered intranasally. MB enhanced Norwalk virus (NV) VLP-specific IgG systemically and IgA production at distal mucosal sites following intranasal (IN) vaccination. A dose escalation study identified 100 mu g as the optimal MB dosage in mice, based on the magnitude of VLP-specific IgG, IgG1, IgG2a and IgA production in serum and VLP-specific IgA production at distal mucosal sites. IN vaccination using VLP with MB was compared to IN delivery VLP with cholera toxin (CT) or gardiquimod (GARD) and to parenteral VLP delivery with alum; the MB groups were equivalent to CT and GARD and superior to alum in inducing mucosal immune responses and stimulated equivalent systemic VLP-specific antibodies. These data support the further testing of MB as a potent mucosal adjuvant for inducing robust and durable antibody responses to non-replicating subunit vaccines.	[Jackson, Erin M.; Herbst-Kralovetz, Melissa M.] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA	University of Arizona	Jackson, EM (corresponding author), Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA.	mherbst1@email.arizona.edu		Discianno, Erin/0000-0002-2350-2770; Herbst-Kralovetz, Melissa/0000-0002-8540-5917	National Institutes of Health; Sexually Transmitted Infections and Topical Microbicides Cooperative Research Center [1 U19 AI062150-01]; Science Foundation of Arizona [0309-08]; National Institute of Allergy and Infectious Disease (IAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sexually Transmitted Infections and Topical Microbicides Cooperative Research Center; Science Foundation of Arizona; National Institute of Allergy and Infectious Disease (IAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the National Institutes of Health, National Institute of Allergy and Infectious Disease (IAID), Sexually Transmitted Infections and Topical Microbicides Cooperative Research Center (1 U19 AI062150-01) and a grant # 0309-08 from the Science Foundation of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amiel C, 2002, J ACQ IMMUN DEF SYND, V30, P294, DOI [10.1097/01.QAI.0000017999.56638.C7, 10.1097/00126334-200207010-00005]; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; AUCI DL, 1993, IMMUNOPHARMACOLOGY, V26, P157, DOI 10.1016/0162-3109(93)90008-E; AUDIBERT FM, 1984, INFECT IMMUN, V45, P261, DOI 10.1128/IAI.45.1.261-266.1984; BAHR GM, 1995, INT J IMMUNOPHARMACO, V17, P117, DOI 10.1016/0192-0561(94)00094-5; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P1377, DOI 10.1093/jac/dkg244; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P5, DOI 10.1093/jac/dkg063; Bahr GM, 2006, INFEC DIS, P193; Ball JM, 1999, GASTROENTEROLOGY, V117, P40, DOI 10.1016/S0016-5085(99)70548-2; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; Berneman A, 1998, INFECT IMMUN, V66, P4163; BYARS NE, 1984, INFECT IMMUN, V44, P344, DOI 10.1128/IAI.44.2.344-350.1984; CHEDID LA, 1982, INFECT IMMUN, V35, P417, DOI 10.1128/IAI.35.2.417-424.1982; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; Cox E, 2006, VET RES, V37, P511, DOI 10.1051/vetres:2006014; Darcissac ECA, 1996, CYTOKINE, V8, P658, DOI 10.1006/cyto.1996.0088; Darcissac ECA, 2000, J VIROL, V74, P7794, DOI 10.1128/JVI.74.17.7794-7802.2000; De La Tribonniere Xavier, 2003, Med Sci Monit, V9, pPI43; Demento SL, 2012, BIOMATERIALS, V33, P4957, DOI 10.1016/j.biomaterials.2012.03.041; Dey AK, 2011, EXPERT REV VACCINES, V10, P227, DOI 10.1586/ERV.10.142; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Foote JB, 2012, J IMMUNOL, V188, P57, DOI 10.4049/jimmunol.1100783; Geddes K, 2009, NAT REV DRUG DISCOV, V8, P465, DOI 10.1038/nrd2783; Guerrero RA, 2001, J VIROL, V75, P9713, DOI 10.1128/JVI.75.20.9713-9722.2001; GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Higgins Sarah C, 2010, Curr Infect Dis Rep, V12, P4, DOI 10.1007/s11908-009-0080-9; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kang Suk-Jo, 2009, F1000 Biol Rep, V1, P15, DOI 10.3410/B1-15; Kool M, 2011, J MED MICROBIOL; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Lindesmith LC, 2010, J VIROL, V84, P1800, DOI 10.1128/JVI.02179-09; Mariotti J, 2012, EUR J HAEMATOL; Parr EL, 1998, J REPROD IMMUNOL, V38, P15, DOI 10.1016/S0165-0378(97)00081-8; Philpott DJ, 2004, MOL IMMUNOL, V41, P1099, DOI 10.1016/j.molimm.2004.06.012; Ravindran R, 2012, MOL PHARMACEUT, V9, P59, DOI 10.1021/mp2002494; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Strominger JL, 2007, NAT IMMUNOL, V8, P1269, DOI 10.1038/ni1207-1269; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; TELZAK E, 1986, J INFECT DIS, V153, P628, DOI 10.1093/infdis/153.3.628; Traub S, 2006, J ENDOTOXIN RES, V12, P69, DOI 10.1179/096805106X89044; Uppada SB, 2011, VACCINE, V29, P9352, DOI 10.1016/j.vaccine.2011.09.129; Velasquez LS, 2011, VACCINE, V29, P5221, DOI 10.1016/j.vaccine.2011.05.027; Velasquez LS, 2010, CLIN VACCINE IMMUNOL, V17, P1850, DOI 10.1128/CVI.00230-10; Viala M, 2004, CR BIOL, V327, P551, DOI 10.1016/j.crvi.2004.02.010; Vidal V, 2001, IMMUNOLOGY, V103, P479, DOI 10.1046/j.1365-2567.2001.01269.x; Vidal VF, 2001, EUR J IMMUNOL, V31, P1962, DOI 10.1002/1521-4141(200107)31:7<1962::AID-IMMU1962>3.0.CO;2-V; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	51	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41529	10.1371/journal.pone.0041529	http://dx.doi.org/10.1371/journal.pone.0041529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22855691	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600078
J	Martinez-Cruz, B; Ioana, M; Calafell, F; Arauna, LR; Sanz, P; Ionescu, R; Boengiu, S; Kalaydjieva, L; Pamjav, H; Makukh, H; Plantinga, T; van der Meer, JWM; Comas, D; Netea, MG				Martinez-Cruz, Begona; Ioana, Mihai; Calafell, Francesc; Arauna, Lara R.; Sanz, Paula; Ionescu, Ramona; Boengiu, Sandu; Kalaydjieva, Luba; Pamjav, Horolma; Makukh, Halyna; Plantinga, Theo; van der Meer, Jos W. M.; Comas, David; Netea, Mihai G.		Genographic Consortium	Y-Chromosome Analysis in Individuals Bearing the Basarab Name of the First Dynasty of Wallachian Kings	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; DIVERSITY; LINEAGES	Vlad III The Impaler, also known as Dracula, descended from the dynasty of Basarab, the first rulers of independent Wallachia, in present Romania. Whether this dynasty is of Cuman (an admixed Turkic people that reached Wallachia from the East in the 11th century) or of local Romanian (Vlach) origin is debated among historians. Earlier studies have demonstrated the value of investigating the Y chromosome of men bearing a historical name, in order to identify their genetic origin. We sampled 29 Romanian men carrying the surname Basarab, in addition to four Romanian populations (from counties Dolj, N = 38; Mehedinti, N = 11; Cluj, N = 50; and Brasov, N = 50), and compared the data with the surrounding populations. We typed 131 SNPs and 19 STRs in the non-recombinant part of the Y-chromosome in all the individuals. We computed a PCA to situate the Basarab individuals in the context of Romania and its neighboring populations. Different Y-chromosome haplogroups were found within the individuals bearing the Basarab name. All haplogroups are common in Romania and other Central and Eastern European populations. In a PCA, the Basarab group clusters within other Romanian populations. We found several clusters of Basarab individuals having a common ancestor within the period of the last 600 years. The diversity of haplogroups found shows that not all individuals carrying the surname Basarab can be direct biological descendants of the Basarab dynasty. The absence of Eastern Asian lineages in the Basarab men can be interpreted as a lack of evidence for a Cuman origin of the Basarab dynasty, although it cannot be positively ruled out. It can be therefore concluded that the Basarab dynasty was successful in spreading its name beyond the spread of its genes.	[Martinez-Cruz, Begona; Calafell, Francesc; Arauna, Lara R.; Sanz, Paula; Comas, David] Univ Pompeu Fabra, Dept Ciencies Salut & Vida, Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Ioana, Mihai; Plantinga, Theo; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Ioana, Mihai; Plantinga, Theo; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; [Ioana, Mihai] Univ Med & Pharm, Dept Genet, Craiova, Romania; [Ionescu, Ramona] Infect Dis Hosp, Brasov, Romania; [Ionescu, Ramona] Clin Cty Hosp, Brasov, Romania; [Boengiu, Sandu] Univ Craiova, Fac Geog, Craiova, Romania; [Kalaydjieva, Luba] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6009, Australia; [Kalaydjieva, Luba] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Pamjav, Horolma] Network Forens Sci Inst, DNA Lab, Inst Forens Med, Budapest, Hungary; [Makukh, Halyna] Ukrainian Acad Med Sci, Inst Hereditary Pathol, Lvov, Ukraine	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Radboud University Nijmegen; Radboud University Nijmegen; University of Medicine & Pharmacy of Craiova; University of Craiova; University of Western Australia; University of Western Australia; National Academy of Medical Sciences of Ukraine; Institute of Hereditary Pathology	Martinez-Cruz, B (corresponding author), Univ Pompeu Fabra, Dept Ciencies Salut & Vida, Inst Biol Evolut CSIC UPF, Barcelona, Spain.	david.comas@upf.edu; m.netea@aig.umcn.nl	Haber, Marc/Y-5090-2019; Balanovsky, Oleg/G-1549-2014; Netea, Mihai/N-5155-2014; Plantinga, Theo S./A-6895-2015; Comas, David/D-5382-2014; Cooper, Alan/E-8171-2012; Boengiu, Sandu/AAL-5283-2020; Haak, Wolfgang/C-2362-2014; Ioana, Mihai/N-4923-2016; Santos, Fabrício Rodrigues/H-2370-2011; van der Meer, Jos W.M./C-8521-2013; Arauna, Lara R/AFR-3858-2022; Calafell, Francesc/C-8595-2014	Haber, Marc/0000-0003-1000-1448; Plantinga, Theo S./0000-0003-4990-6084; Comas, David/0000-0002-5075-0956; Cooper, Alan/0000-0002-7738-7851; Haak, Wolfgang/0000-0003-2475-2007; Ioana, Mihai/0000-0002-2186-1606; Santos, Fabrício Rodrigues/0000-0001-9088-1750; van der Meer, Jos W.M./0000-0001-5120-3690; Calafell, Francesc/0000-0002-1083-9438; Royyuru, Ajay/0000-0003-4440-4755; Martinez-Cruz, Begona/0000-0003-1268-6620; Quintana-Murci, Lluis/0000-0003-2429-6320; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; mele, marta/0000-0001-8874-6453	Ministerio de Ciencia e Innovacion, Spain [CGL2010-14944]; Direccio General de Recerca, Generalitat de Catalunya [2009SGR1101]; Netherlands Organization for Scientific Research	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The present study was supported by the Ministerio de Ciencia e Innovacion, Spain (CGL2010-14944), Direccio General de Recerca, Generalitat de Catalunya (2009SGR1101) (both to DC), and a Vici Grant of the Netherlands Organization for Scientific Research (to MGN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogacsi-Szabo E, 2005, HUM BIOL, V77, P639, DOI 10.1353/hub.2006.0007; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Brezeanu S, 2002, IDENTITATI SOLIDARIT; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Djuvara N, 2007, THOCOMERIUS NEGRU VO; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Iorga N, 1985, ISTORIA POPORULUI RO; Martinez-Gonzalez LJ, 2012, EUR J HUM GENET, V20, P211, DOI 10.1038/ejhg.2011.162; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; King TE, 2006, CURR BIOL, V16, P384, DOI 10.1016/j.cub.2005.12.048; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Li CX, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-15; Lupulescu D, 2002, DREPT CIVIL; Martinez-Cruz Begona, 2011, Investig Genet, V2, P13, DOI 10.1186/2041-2223-2-13; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Popa VV, 2006, DREPT CIVIL PARTEA G; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Vasary I, 2005, CUMANS TATARS	18	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41803	10.1371/journal.pone.0041803	http://dx.doi.org/10.1371/journal.pone.0041803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848614	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600124
J	Ni, L; Qi, RF; Zhang, LJ; Zhong, JH; Zheng, G; Zhang, ZQ; Zhong, Y; Xu, Q; Liao, W; Jiao, Q; Wu, XJ; Fan, XX; Lu, GM				Ni, Ling; Qi, Rongfeng; Zhang, Long Jiang; Zhong, Jianhui; Zheng, Gang; Zhang, Zhiqiang; Zhong, Yuan; Xu, Qiang; Liao, Wei; Jiao, Qing; Wu, Xingjiang; Fan, Xinxin; Lu, Guang Ming			Altered Regional Homogeneity in the Development of Minimal Hepatic Encephalopathy: A Resting-State Functional MRI Study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; QUALITY-OF-LIFE; GLUCOSE-METABOLISM; AMMONIA METABOLISM; NEURAL MECHANISM; BRAIN ACTIVITY; LIVER-DISEASE; CIRRHOSIS; CONNECTIVITY; FMRI	Background: Little is known about how spontaneous brain activity progresses from non-hepatic encephalopathy (non-HE) to minimal HE (MHE). The purpose of this study was to evaluate the evolution pattern of spontaneous brain activities in cirrhotic patients using resting-state fMRI with a regional homogeneity (ReHo) method. Methodology/Principal Findings: Resting-state fMRI data were acquired in 47 cirrhotic patients (minimal HE [ MHE], n = 20, and non-HE, n = 27) and 25 age-and sex-matched healthy controls. The Kendall's coefficient of concordance (KCC) was used to measure the regional homogeneity. The regional homogeneity maps were compared with ANOVA tests among MHE, non-HE, and healthy control groups and t-tests between each pair in a voxel-wise way. Correlation analyses were performed to explore the relationships between regional ReHo values and Child-Pugh scores, number connection test type A (NCT-A), digit symbol test (DST) scores, venous blood ammonia levels. Compared with healthy controls, both MHE and non-HE patients showed decreased ReHo in the bilateral frontal, parietal and temporal lobes and increased ReHo in the bilateral caudate. Compared with the non-HE, MHE patients showed decreased ReHo in the bilateral precuneus, cuneus and supplementary motor area (SMA). The NCT-A of cirrhotic patients negatively correlated with ReHo values in the precuneus, cuneus and lingual gyrus. DST scores positively correlated with ReHo values in the cuneus, precuneus and lingual gyrus, and negatively correlated with ReHo values in the bilateral caudate (P<0.05, AlphaSim corrected). Conclusions/Significance: Diffused abnormal homogeneity of baseline brain activity was nonspecific for MHE, and only the progressively decreased ReHo in the SMA and the cuneus, especially for the latter, might be associated with the development of MHE. The ReHo analysis may be potentially valuable for detecting the development from non-HE to MHE.	[Ni, Ling; Qi, Rongfeng; Zhang, Long Jiang; Zheng, Gang; Zhang, Zhiqiang; Zhong, Yuan; Jiao, Qing; Lu, Guang Ming] Nanjing Univ, Dept Med Imaging, Jinling Hosp, Sch Clin,Med Coll, Nanjing 210008, Peoples R China; [Zhong, Jianhui] Zhejiang Univ, Dept Biomed Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Qiang; Liao, Wei] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Wu, Xingjiang; Fan, Xinxin] Nanjing Univ, Dept Gen Surg, Jinling Hosp, Sch Clin,Med Coll, Nanjing 210008, Peoples R China	Nanjing University; Zhejiang University; University of Electronic Science & Technology of China; Nanjing University	Ni, L (corresponding author), Nanjing Univ, Dept Med Imaging, Jinling Hosp, Sch Clin,Med Coll, Nanjing 210008, Peoples R China.	kevinzhanglongjiang@yahoo.com.cn; cjr.luguangming@vip.163.com	Zhong, Jianhui/AAE-6061-2020	Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [30700194, 81101039]; Natural Scientific Foundation of Jiangsu province, China [BK2007572]; China Postdoctoral Science Foundation of Jiangsu Province [100283C]; Chinese Key Grant for GML [BWS11J063, 10z026]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Foundation of Jiangsu province, China; China Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Chinese Key Grant for GML	This work was supported by grants from the Natural Scientific Foundation of China (Grant No. 30700194 for LJZ; Grant No. 81101039 for GZ), the Natural Scientific Foundation of Jiangsu province, China (Grant No. BK2007572 for LJZ), the China Postdoctoral Science Foundation of Jiangsu Province (Grant No. 100283C for GZ), and a Chinese Key Grant for GML (Grant Nos BWS11J063 and 10z026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl B, 2004, HEPATOLOGY, V40, P73, DOI 10.1002/hep.20290; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Bajaj JS, 2008, WORLD J GASTROENTERO, V14, P3609, DOI 10.3748/wjg.14.3609; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; Chen HJ, 2012, NEUROSCI LETT, V507, P5, DOI 10.1016/j.neulet.2011.11.033; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Joebges EM, 2003, J HEPATOL, V38, P273, DOI 10.1016/S0168-8278(02)00423-3; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P337, DOI 10.1038/jcbfm.1991.67; LOCKWOOD AH, 1986, J CLIN INVEST, V78, P86, DOI 10.1172/JCI112578; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Schneider J, 1984, BIOL PSYCHIAT; Schomerus H, 2001, METAB BRAIN DIS, V16, P37, DOI 10.1023/A:1011610427843; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Weissenborn K, 2001, METAB BRAIN DIS, V16, P13, DOI 10.1023/A:1011654210096; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang LJ, 2007, ACTA RADIOL, V48, P781, DOI 10.1080/02841850701422161; Zhang LJ, 2007, ACTA RADIOL, V48, P577, DOI 10.1080/02841850701308378; Zhang LJ, 2012, HUM BRAIN MAPP, V33, P1384, DOI 10.1002/hbm.21295; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049	34	41	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42016	10.1371/journal.pone.0042016	http://dx.doi.org/10.1371/journal.pone.0042016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848692	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600160
J	Hersch, M; Peter, B; Kang, HM; Schupfer, F; Abriel, H; Pedrazzini, T; Eskin, E; Beckmann, JS; Bergmann, S; Maurer, F				Hersch, Micha; Peter, Bastian; Kang, Hyun Min; Schuepfer, Fanny; Abriel, Hugues; Pedrazzini, Thierry; Eskin, Eleazar; Beckmann, Jacques S.; Bergmann, Sven; Maurer, Fabienne			Mapping Genetic Variants Associated with Beta-Adrenergic Responses in Inbred Mice	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; THYROTROPIN-RELEASING-HORMONE; FRIZZLED-RELATED PROTEIN-2; ARTERIAL BLOOD-PRESSURE; QUANTITATIVE TRAIT LOCI; RECEPTOR POLYMORPHISM; SEQUENCE VARIANTS; MOUSE STRAINS; CURRENT I-K1; HEART	beta-blockers and beta-agonists are primarily used to treat cardiovascular diseases. Inter-individual variability in response to both drug classes is well recognized, yet the identity and relative contribution of the genetic players involved are poorly understood. This work is the first genome-wide association study (GWAS) addressing the values and susceptibility of cardiovascular-related traits to a selective beta(1)-blocker, Atenolol (ate), and a beta-agonist, Isoproterenol (iso). The phenotypic dataset consisted of 27 highly heritable traits, each measured across 22 inbred mouse strains and four pharmacological conditions. The genotypic panel comprised 79922 informative SNPs of the mouse HapMap resource. Associations were mapped by Efficient Mixed Model Association (EMMA), a method that corrects for the population structure and genetic relatedness of the various strains. A total of 205 separate genome-wide scans were analyzed. The most significant hits include three candidate loci related to cardiac and body weight, three loci for electrocardiographic (ECG) values, two loci for the susceptibility of atrial weight index to iso, four loci for the susceptibility of systolic blood pressure (SBP) to perturbations of the beta-adrenergic system, and one locus for the responsiveness of QTc (p<10(-8)). An additional 60 loci were suggestive for one or the other of the 27 traits, while 46 others were suggestive for one or the other drug effects (p<10(-6)). Most hits tagged unexpected regions, yet at least two loci for the susceptibility of SBP to beta-adrenergic drugs pointed at members of the hypothalamic-pituitary-thyroid axis. Loci for cardiac-related traits were preferentially enriched in genes expressed in the heart, while 23% of the testable loci were replicated with datasets of the Mouse Phenome Database (MPD). Altogether these data and validation tests indicate that the mapped loci are relevant to the traits and responses studied.	[Hersch, Micha; Peter, Bastian; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Hersch, Micha; Peter, Bastian; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Kang, Hyun Min; Eskin, Eleazar] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Kang, Hyun Min; Eskin, Eleazar] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Kang, Hyun Min] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Schuepfer, Fanny; Beckmann, Jacques S.; Maurer, Fabienne] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Pedrazzini, Thierry] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hersch, M (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	fabienne.maurer@chuv.ch	Beckmann, Jacques S/A-9772-2008; Abriel, Hugues/B-9800-2009; Eskin, Eleazar/J-9187-2012	Beckmann, Jacques S/0000-0002-9741-1900; Abriel, Hugues/0000-0003-0465-5138; Eskin, Eleazar/0000-0003-1149-4758; Bergmann, Sven/0000-0002-6785-9034	Centre Hospitalier Universitaire Vaudois; University of Lausanne, Switzerland; Swiss Institute of Bioinformatics; Swiss National Science Foundation [310000-112552, 31003A-130691]; National Science Foundation [0513612, 0731455, 0729049, 0916676, 1065276]; National Institutes of Health [K25-HL080079, U01-DA024417, N01-ES-45530, P01-HL30568, PO1-HL28481]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, P01HL030568, K25HL080079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA024417] Funding Source: NIH RePORTER	Centre Hospitalier Universitaire Vaudois; University of Lausanne, Switzerland; Swiss Institute of Bioinformatics; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Centre Hospitalier Universitaire Vaudois and the University of Lausanne, Switzerland (M. H., B. P., F. S., H. A., T. P., J.S.B., S. B. and F. M.; www.chuv.ch and www.unil.ch), the Swiss Institute of Bioinformatics (M. H., B. P. and S. B.; www.sib.ch), the Swiss National Science Foundation (grants 310000-112552, J.S.B., H. A., T. P., F. M., and 31003A-130691, S. B.; www.snf.ch), the National Science Foundation (grants 0513612, 0731455, 0729049, 0916676 and 1065276, H. M. K. and E. E.; www.nsf.gov) and the National Institutes of Health (grants K25-HL080079, U01-DA024417, N01-ES-45530, P01-HL30568 and PO1-HL28481, H. M. K. and E. E.; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Al Moamen NJ, 2011, J MOL CELL CARDIOL, V50, P137, DOI 10.1016/j.yjmcc.2010.10.028; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Arnett DK, 2009, J HYPERTENS, V27, P1585, DOI 10.1097/HJH.0b013e32832be612; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Berthonneche C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006610; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Boyer JG, 2010, MUSCLE NERVE, V41, P299, DOI 10.1002/mus.21472; Boyer JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009465; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Chrysant SG, 2008, CLIN CARDIOL, V31, P249, DOI 10.1002/clc.20249; Dahlman I, 2007, AM J HUM GENET, V80, P1115, DOI 10.1086/518445; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Dorn GW, 2009, MOL PHARMACOL, V76, P466, DOI 10.1124/mol.109.056572; Duong CD, 2006, MAMM GENOME, V17, P1147, DOI 10.1007/s00335-006-0086-7; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Filigheddu F, 2010, PHARMACOGENOMICS, V11, P319, DOI [10.2217/pgs.09.158, 10.2217/PGS.09.158]; FITZ GERALD JD, 1978, EUR J CLIN PHARMACOL, V13, P81, DOI 10.1007/BF00609750; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Garcia SI, 2005, REGUL PEPTIDES, V128, P239, DOI 10.1016/j.regpep.2005.01.002; Garcia SI, 2001, HYPERTENSION, V37, P365, DOI 10.1161/01.HYP.37.2.365; Garcia SI, 2001, HYPERTENSION, V38, P683, DOI 10.1161/01.HYP.38.3.683; Garovic VD, 2003, J PHYSIOL-LONDON, V546, P583, DOI 10.1113/jphysiol.2002.031138; Gillies M, 2005, CRIT CARE, V9, P266, DOI 10.1186/cc3024; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hollenberg NK, 2005, AM J HYPERTENS, V18, p165S, DOI 10.1016/j.amjhyper.2005.09.010; Hou SC, 2009, FEBS LETT, V583, P2765, DOI 10.1016/j.febslet.2009.07.025; Jin HK, 2004, CIRCULATION, V109, P2240, DOI 10.1161/01.CIR.0000127951.13380.B4; Johnson JA, 2011, CLIN PHARMACOL THER, V89, P366, DOI 10.1038/clpt.2010.315; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kato N, 1999, MAMM GENOME, V10, P259, DOI 10.1007/s003359900983; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Koltes JE, 2009, P NATL ACAD SCI USA, V106, P19250, DOI 10.1073/pnas.0904513106; Koumi S, 1995, J CLIN INVEST, V96, P2870, DOI 10.1172/JCI118358; Kurnik D, 2008, PHARMACOGENET GENOM, V18, P895, DOI 10.1097/FPC.0b013e328309733f; Kurnik D, 2009, PHARMACOGENOMICS, V10, P1581, DOI [10.2217/pgs.09.92, 10.2217/PGS.09.92]; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Lovely RS, 2011, ARTERIOSCL THROM VAS, V31, P2345, DOI 10.1161/ATVBAHA.111.232710; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; MORGAN DJ, 1990, CLIN PHARMACOKINET, V18, P270, DOI 10.2165/00003088-199018040-00002; Navare HA, 2010, PHARMACOTHERAPY, V30, P872, DOI 10.1592/phco.30.9.872; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Prasad V, 2008, J BIOL CHEM, V283, P31303, DOI 10.1074/jbc.M803706200; Prenner BM, 2008, CURR OPIN PULM MED, V14, P57; REEVES PR, 1978, XENOBIOTICA, V8, P305, DOI 10.3109/00498257809060955; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shimoyama Mary, 2011, Human Genomics, V5, P124; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sofowora GG, 2003, CLIN PHARMACOL THER, V73, P366, DOI 10.1016/S0009-9236(02)17734-4; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; SUZUKI S, 1995, CIRC RES, V77, P679, DOI 10.1161/01.RES.77.4.679; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tsukahara C, 2004, MAMM GENOME, V15, P943, DOI 10.1007/s00335-004-2411-3; Vaidyanathan R, 2010, J BIOL CHEM, V285, P28000, DOI 10.1074/jbc.M110.110858; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x	86	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41032	10.1371/journal.pone.0041032	http://dx.doi.org/10.1371/journal.pone.0041032			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859963	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600015
J	Ju, CQ; Zhang, K; Wu, XY				Ju, Chengqun; Zhang, Kai; Wu, Xinyi			Derivation of Corneal Endothelial Cell-Like Cells from Rat Neural Crest Cells In Vitro	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ANTERIOR SEGMENT DYSGENESIS; ADULT SKIN; DIFFERENTIATION; TRANSPLANTATION; RABBIT; MODEL; GENE; CAT	The aim of this study was to investigate the feasibility of inducing rat neural crest cells (NCC) to differentiate to functional corneal endothelial cell (CEC)-like cells in vitro. Rat NCC were induced with adult CEC-derived conditioned medium. Immunofluorescence, flow cytometry and real time RT-PCR assay were used to detect expression of the corneal endothelium differentiation marker N-cadherin and transcription factors FoxC1 and Pitx2. CFDA SE-labeled CEC-like cells were transplanted to the corneal endothelium of a rat corneal endothelium deficiency model, and an eye-down position was maintained for 24 hours to allow cell attachment. The animals were observed for as long as 2 months after surgery and underwent clinical and histological examination. Spindle-like NCC turned to polygonal CEC-like after induction and expressed N-cadherin, FoxC1, Pitx2, zonula occludens-1 and sodium-potassium pump Na+/K+ ATPase. The corneas of the experimental group were much clearer than those of the control group and the mean corneal thickness in the experimental group was significantly less than in the control group7, 14, 21 and 28 days after surgery. Confocal microscopy through focusing and histological analysis confirmed that green fluorescence-positive CEC-like cells formed a monolayer covering the Descemet's membrane in the experimental group. In conclusion, CEC-like cells derived from NCCs displayed characters of native CEC, and the induction protocol provides guidance for future human CEC induction from NCC.	[Ju, Chengqun; Zhang, Kai; Wu, Xinyi] Shandong Univ, Dept Ophthalmol, Qilu Hosp, Jinan 250100, Peoples R China; [Ju, Chengqun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Chinese Minist Educ, Jinan 250100, Peoples R China; [Ju, Chengqun] Shandong Univ, Chinese Minist Hlth, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ju, CQ (corresponding author), Shandong Univ, Dept Ophthalmol, Qilu Hosp, Jinan 250100, Peoples R China.	xywu8868@163.com			Key Scientific and Technological Project of Shandong Province, People's Republic of China [2008GGB02111]	Key Scientific and Technological Project of Shandong Province, People's Republic of China	The work is supported by the Key Scientific and Technological Project of Shandong Province, People's Republic of China (grant number:2008GGB02111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Churchill A, 1996, BRIT J OPHTHALMOL, V80, P669, DOI 10.1136/bjo.80.7.669; Cook C S, 1988, J Pediatr Ophthalmol Strabismus, V25, P60; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539; DUBLIN I, 1970, ACTA ANAT, V76, P381; Dupin E, 2007, CR BIOL, V330, P521, DOI 10.1016/j.crvi.2007.04.004; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; GOSPODAROWICZ D, 1979, P NATL ACAD SCI USA, V76, P464, DOI 10.1073/pnas.76.1.464; GOSPODAROWICZ D, 1979, ARCH OPHTHALMOL-CHIC, V97, P2163, DOI 10.1001/archopht.1979.01020020481016; INSLER MS, 1986, CURR EYE RES, V5, P967, DOI 10.3109/02713688608995178; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135; KENYON KR, 1975, EXP EYE RES, V21, P125, DOI 10.1016/0014-4835(75)90077-9; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Koh SWM, 2008, INVEST OPHTH VIS SCI, V49, P3491, DOI 10.1167/iovs.07-1543; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; MCCULLEY JP, 1980, OPHTHALMOLOGY, V87, P194; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; MINKOWSKI JS, 1984, INVEST OPHTH VIS SCI, V25, P1416; Miron RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023375; Motohashi T, 2007, STEM CELLS, V25, P402, DOI 10.1634/stemcells.2006-0323; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6; Reneker LW, 2000, DEVELOPMENT, V127, P533; SIEBERBLUM M, 1985, EXP CELL RES, V158, P267, DOI 10.1016/0014-4827(85)90450-1; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; VANHORN DL, 1977, INVEST OPHTH VIS SCI, V16, P597; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Zhou Y, 2008, BIOCHEM BIOPH RES CO, V376, P542, DOI 10.1016/j.bbrc.2008.09.032; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	34	32	41	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42378	10.1371/journal.pone.0042378	http://dx.doi.org/10.1371/journal.pone.0042378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860120	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600096
J	Morales-Reyes, A; Erdogan, AT				Morales-Reyes, Alicia; Erdogan, Ahmet T.			Internal Lattice Reconfiguration for Diversity Tuning in Cellular Genetic Algorithms	PLOS ONE			English	Article							PARALLELISM	Cellular Genetic Algorithms (cGAs) have attracted the attention of researchers due to their high performance, ease of implementation and massive parallelism. Maintaining an adequate balance between exploitative and explorative search is essential when studying evolutionary optimization techniques. In this respect, cGAs inherently possess a number of structural configuration parameters that are able to sustain diversity during evolution. In this study, the internal reconfiguration of the lattice is proposed to constantly or adaptively control the exploration-exploitation trade-off. Genetic operators are characterized in their simplest form since algorithmic performance is assessed on implemented reconfiguration mechanisms. Moreover, internal reconfiguration allows the adjacency of individuals to be maintained. Hence, any improvement in performance is only a consequence of topological changes. Two local selection methods presenting opposite selection pressures are used in order to evaluate the influence of the proposed techniques. Problems ranging from continuous to real world and combinatorial are tackled. Empirical results are supported statistically in terms of efficiency and efficacy.	[Morales-Reyes, Alicia; Erdogan, Ahmet T.] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland; [Morales-Reyes, Alicia] Inst Nacl Astrofis Opt & Electr, Dept Comp Sci, Puebla, Mexico	University of Edinburgh; Instituto Nacional de Astrofisica, Optica y Electronica	Morales-Reyes, A (corresponding author), Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland.	a.morales@inaoep.mx		Erdogan, Ahmet/0000-0003-2451-9395; Morales-Reyes, Alicia/0000-0001-5052-7554	Mexican National Council for Science and Technology [168016]; National Institute for Astrophysics Optics and Electronics	Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute for Astrophysics Optics and Electronics	Alicia Morales-Reyes is supported by the Mexican National Council for Science and Technology (www.conacyt.mx) studentship number 168016 and the National Institute for Astrophysics Optics and Electronics (www.inaoep.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba E., 2000, Parallel Problem Solving from Nature PPSN VI. 6th International Conference. Proceedings (Lecture Notes in Computer Science Vol.1917), P29; Alba E, 2002, STAT COMPUT, V12, P91, DOI 10.1023/A:1014803900897; Alba E, 2002, IEEE T EVOLUT COMPUT, V6, P443, DOI 10.1109/TEVC.2002.800880; Alba E, 2002, J PARALLEL DISTR COM, V62, P1362, DOI 10.1006/jpdc.2002.1851; Alba E., 1999, Parallel and Distributed Processing. 11th IPPS/SPDP'99 Workshops Held in Conjunction with the 13th International Parallel Processing Symposium and 10th Symposium on Parallel and Distributed Processing. Proceedings, P248; Alba E, 2004, INT J APPL MATH COMP, V14, P101; Alba E., 2008, OPERATIONS RES COMPU; Alba Enrique, 1999, Complexity, V4, P31, DOI 10.1002/(SICI)1099-0526(199903/04)4:4<31::AID-CPLX5>3.0.CO;2-4; Andraka R., 1998, FPGA'98. ACM/SIGDA International Symposium on Field Programmable Gate Arrays, P191, DOI 10.1145/275107.275139; Back T, 2005, LECT NOTES COMPUT SC, V3699, P1; Baluja S, 1993, AB BAF MU MAG KASH B; Bersini H, 1996, 1996 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '96), PROCEEDINGS OF, P611, DOI 10.1109/ICEC.1996.542670; Cantu-Paz E, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P775; Cantu-Paz E, 1995, 95007 ILLIGAL U ILL; CANTUPAZ E, 2000, EFFICIENT ACCURATE P; Chen H, 1998, IEEE T PARALL DISTR, V9, P126, DOI 10.1109/71.663870; Dorronsoro B., 2005, IEEE T EVOLUTIONARY; Evans JR, 2002, 2002 NASA/DOD CONFERENCE ON EVOLABLE HARDWARE, PROCEEDINGS, P142, DOI 10.1109/EH.2002.1029878; Giacobini M, 2005, IEEE T EVOLUT COMPUT, V9, P489, DOI 10.1109/TEVC.2005.850298; Gordon S., 1994, P 1994 ACM S APPL CO, P237; Kohlmorgen U, 1996, ANN OPER RES, V90, P203; Moradi A., 2009, P 2009 NCIN C NAT CA, P1; Morales-Reyes A, 2008, PROCEEDINGS OF THE 2008 NASA/ESA CONFERENCE ON ADAPTIVE HARDWARE AND SYSTEMS, P398, DOI 10.1109/AHS.2008.44; Muhammad A, 1999, INT J COMPUT MATH, V73, P139, DOI 10.1080/00207169908804885; Muhammad A, 1990, FINE GRAINED PARALLE; Murata T, 2004, P 8 INT C KNOWL BAS; Oei C. K., 1991, 91011 ILLIGAL; Ortiz-Boyer D, 2012, BENCHMARK PROBLEMS; Sarma J., 1996, Parallel Problem Solving from Nature - PPSN IV. International Conference on Evolutionary Computation - The 4th International Conference on Parallel Problem Solving from Nature. Proceedings, P236, DOI 10.1007/3-540-61723-X_988; Simoncini D, 2007, P IEEE C EV COMP CEC; Simoncini D, 2006, 2006 INT C CELL AUT; Stefatos EF, 2004, 2004 IEEE WORKSHOP ON SIGNAL PROCESSING SYSTEMS DESIGN AND IMPLEMENTATION, PROCEEDINGS, P233; Stefatos EF, 2004, 2004 NASA/DOD CONFERENCE ON EVOLVABLE HARDWARE, PROCEEDINGS, P97; Tomassini M., 1999, PARALLEL DISTRIBUTED; Tomassini M, 2005, NAT COMP SER, DOI 10.1007/3-540-29938-6; Turton B, 1994, IEE C GEN ALG IM PRO, p11/1; Turton B. C. H., 1995, First International Conference on `Genetic Algorithms in Engineering Systems: Innovations and Applications' GALESIA (Conf. Publ. No.414), P493; Xu JN, 2002, 2002 NASA/DOD CONFERENCE ON EVOLABLE HARDWARE, PROCEEDINGS, P133; Xu JN, 2002, IEEE C EVOL COMPUTAT, P998, DOI 10.1109/CEC.2002.1007061	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41279	10.1371/journal.pone.0041279	http://dx.doi.org/10.1371/journal.pone.0041279			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859973	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600018
J	Quinto-Alemany, D; Canerina-Amaro, A; Hernandez-Abad, LG; Machin, F; Romesberg, FE; Gil-Lamaignere, C				Quinto-Alemany, David; Canerina-Amaro, Ana; Hernandez-Abad, Luis G.; Machin, Felix; Romesberg, Floyd E.; Gil-Lamaignere, Cristina			Yeasts Acquire Resistance Secondary to Antifungal Drug Treatment by Adaptive Mutagenesis	PLOS ONE			English	Article							SOS RESPONSE; SACCHAROMYCES-CEREVISIAE; MUTATIONS; FLUCYTOSINE; MECHANISMS; BACTERIA	Acquisition of resistance secondary to treatment both by microorganisms and by tumor cells is a major public health concern. Several species of bacteria acquire resistance to various antibiotics through stress-induced responses that have an adaptive mutagenesis effect. So far, adaptive mutagenesis in yeast has only been described when the stress is nutrient deprivation. Here, we hypothesized that adaptive mutagenesis in yeast (Saccharomyces cerevisiae and Candida albicans as model organisms) would also take place in response to antifungal agents (5-fluorocytosine or flucytosine, 5-FC, and caspofungin, CSP), giving rise to resistance secondary to treatment with these agents. We have developed a clinically relevant model where both yeasts acquire resistance when exposed to these agents. Stressful lifestyle associated mutation (SLAM) experiments show that the adaptive mutation frequencies are 20 (S. cerevisiae -5-FC), 600 (C. albicans -5-FC) or 1000 (S. cerevisiae - CSP) fold higher than the spontaneous mutation frequency, the experimental data for C. albicans -5-FC being in agreement with the clinical data of acquisition of resistance secondary to treatment. The spectrum of mutations in the S. cerevisiae -5-FC model differs between spontaneous and acquired, indicating that the molecular mechanisms that generate them are different. Remarkably, in the acquired mutations, an ectopic intrachromosomal recombination with an 87% homologous gene takes place with a high frequency. In conclusion, we present here a clinically relevant adaptive mutation model that fulfils the conditions reported previously.	[Quinto-Alemany, David; Canerina-Amaro, Ana; Hernandez-Abad, Luis G.; Machin, Felix; Gil-Lamaignere, Cristina] Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain; [Romesberg, Floyd E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Quinto-Alemany, D (corresponding author), Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain.	eukares@yahoo.com	Machín, Félix/K-6569-2017; Romesberg, Floyd/M-2821-2017; Amaro, Ana Canerina Luis/U-3741-2019; Canerina-Amaro, Ana/K-5763-2017; Gil-Lamaignere, Cristina/A-3866-2013	Machín, Félix/0000-0003-4559-7798; Romesberg, Floyd/0000-0001-6317-1315; Amaro, Ana Canerina Luis/0000-0001-6970-7942; Canerina-Amaro, Ana/0000-0001-6970-7942; Quinto Alemany, David/0000-0001-7167-9303; Garcia Hernandez-Abad, Luis/0000-0001-6012-3553	Spanish Ministry of Science and Innovation through a MEC/Fulbright postdoctoral grant [EX2004-1241]; "Ramon y Cajal" tenure track programs [RYC07/1263, RYC05/1354]; Instituto de Salud Carlos III [FIS PI08/1624, FIS PI09/00106]; European Regional Development Funds (ERDF)	Spanish Ministry of Science and Innovation through a MEC/Fulbright postdoctoral grant; "Ramon y Cajal" tenure track programs; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Funds (ERDF)(European Commission)	CGL was supported by the Spanish Ministry of Science and Innovation through a MEC/Fulbright postdoctoral grant (EX2004-1241), the "Ramon y Cajal" tenure track programs (RYC07/1263 to CGL and RYC05/1354 to FM) and by the Research Project Funding by the Instituto de Salud Carlos III (FIS PI08/1624 to CGL and FIS PI09/00106 to FM). All financial support was co-financed by the European Regional Development Funds (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke D., 2000, METHODS YEAST GENETI; Correia I, 2010, FUTURE MICROBIOL, V5, P1125, DOI 10.2217/FMB.10.72; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HALL BG, 1992, P NATL ACAD SCI USA, V89, P4300, DOI 10.1073/pnas.89.10.4300; Hara T, 2005, PROSTATE, V65, P268, DOI 10.1002/pros.20282; Heidenreich E, 2003, EMBO J, V22, P2274, DOI 10.1093/emboj/cdg203; Heidenreich E, 2007, CRIT REV BIOCHEM MOL, V42, P285, DOI 10.1080/10409230701507773; Hospenthal DR, 1998, CLIN INFECT DIS, V27, P260, DOI 10.1086/514669; Huff CA, 2006, BLOOD, V107, P431, DOI 10.1182/blood-2005-06-2517; Kang NH, 2012, REPROD FERT DEVELOP, V24, P216, DOI 10.1071/RDv24n1Ab207; Lee BF, 2012, CANCER GENE THER, V19, P255, DOI 10.1038/cgt.2011.87; LEWIN CS, 1991, J MED MICROBIOL, V34, P329, DOI 10.1099/00222615-34-6-329; Luria SE, 1943, GENETICS, V28, P491; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; MALAVASIC MJ, 1992, J MED VET MYCOL, V30, P421; Menacho-Marquez M, 2007, CLIN TRANSL ONCOL, V9, P221, DOI 10.1007/s12094-007-0043-2; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Rosenberg SM, 1998, GENETICS, V148, P1559; STEELE DF, 1992, GENETICS, V132, P9; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; WALDORF AR, 1983, ANTIMICROB AGENTS CH, V23, P79, DOI 10.1128/AAC.23.1.79	27	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42279	10.1371/journal.pone.0042279	http://dx.doi.org/10.1371/journal.pone.0042279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860105	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600085
J	Yaddanapudi, K; Mitchell, RA; Putty, K; Willer, S; Sharma, RK; Yan, J; Bodduluri, H; Eaton, JW				Yaddanapudi, Kavitha; Mitchell, Robert A.; Putty, Kalyani; Willer, Sharon; Sharma, Rajesh K.; Yan, Jun; Bodduluri, Haribabu; Eaton, John W.			Vaccination with Embryonic Stem Cells Protects against Lung Cancer: Is a Broad-Spectrum Prophylactic Vaccine against Cancer Possible?	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; ANTITUMOR IMMUNITY; ANTIGEN-EXPRESSION; SUPPRESSOR-CELLS; TUMOR; IDENTIFICATION; DIFFERENTIATION; DYSFUNCTION; TOLERANCE	The antigenic similarity between tumors and embryos has been appreciated for many years and reflects the expression of embryonic gene products by cancer cells and/or cancer-initiating stem cells. Taking advantage of this similarity, we have tested a prophylactic lung cancer vaccine composed of allogeneic murine embryonic stem cells (ESC). Naive C57BL/6 mice were vaccinated with ESC along with a source of granulocyte macrophage-colony stimulating factor (GM-CSF) in order to provide immunostimulatory adjuvant activity. Vaccinated mice were protected against subsequent challenge with implantable Lewis lung carcinoma (LLC). ESC-induced anti-tumor immunity was not due to a non-specific "allo-response" as vaccination with allogeneic murine embryonic fibroblasts did not protect against tumor outgrowth. Vaccine efficacy was associated with robust tumor-reactive primary and memory CD8(+) T effector responses, Th1 cytokine response, higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio, and reduced myeloid derived suppressor cells in the spleen. Prevention of tumorigenesis was found to require a CD8-mediated cytotoxic T lymphocyte (CTL) response because in vivo depletion of CD8(+) T lymphocytes completely abrogated the protective effect of vaccination. Importantly, this vaccination strategy also suppressed the development of lung cancer induced by the combination of carcinogen administration and chronic pulmonary inflammation. Further refinement of this novel vaccine strategy and identification of shared ESC/tumor antigens may lead to immunotherapeutic options for lung cancer patients and, perhaps more importantly, could represent a first step toward the development of prophylactic cancer vaccines.	[Yaddanapudi, Kavitha; Mitchell, Robert A.; Putty, Kalyani; Willer, Sharon; Eaton, John W.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA; [Sharma, Rajesh K.; Yan, Jun; Bodduluri, Haribabu] Univ Louisville, James Graham Brown Canc Ctr, Tumor Immunobiol Program, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Yaddanapudi, K (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA.	EatonRedox@aol.com	Yan, Jun/A-8988-2008; Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294	NIH/NCRR [P20RR018733]; American Lung Association; Kentucky Lung Cancer Research Program; Commonwealth of Kentucky Research Challenge Trust Fund	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Lung Association; Kentucky Lung Cancer Research Program; Commonwealth of Kentucky Research Challenge Trust Fund	This work was supported by NIH/NCRR P20RR018733 (KY), the American Lung Association (JWE, RAM) and the Kentucky Lung Cancer Research Program (RAM). JWE is supported by the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bai XF, 2003, J CLIN INVEST, V111, P1487, DOI 10.1172/JCI200317656; BALDWIN RW, 1972, ANN I PASTEUR PARIS, V122, P715; BALDWIN RW, 1972, INT J CANCER, V10, P233, DOI 10.1002/ijc.2910100202; Borrello I, 2002, CYTOKINE GROWTH F R, V13, P185, DOI 10.1016/S1359-6101(01)00034-X; Brewer BG, 2009, EXP MOL PATHOL, V86, P192, DOI 10.1016/j.yexmp.2008.12.002; BUTTLE GAH, 1967, NATURE, V215, P1495, DOI 10.1038/2151495a0; Cohen Jon, 2005, Science, V308, P619, DOI 10.1126/science.308.5722.619; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dong W, 2010, CANCER IMMUNOL IMMUN, V59, P1697, DOI 10.1007/s00262-010-0899-9; Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Errington F, 2006, CLIN CANCER RES, V12, P1333, DOI 10.1158/1078-0432.CCR-05-1113; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Hill HC, 2002, CANCER RES, V62, P7254; Horna P, 2007, CURR CANCER DRUG TAR, V7, P41, DOI 10.2174/156800907780006940; Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kisley LR, 2002, CARCINOGENESIS, V23, P1653, DOI 10.1093/carcin/23.10.1653; KLAVINS JV, 1971, NATURE-NEW BIOL, V234, P153, DOI 10.1038/newbio234153a0; Kumaraguru U, 2005, J LEUKOCYTE BIOL, V78, P879, DOI 10.1189/jlb.0105007; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li Y, 2009, STEM CELLS, V27, P3103, DOI 10.1002/stem.234; Malkinson AM, 1997, CANCER RES, V57, P2832; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Masopust D, 2004, CURR OPIN IMMUNOL, V16, P217, DOI 10.1016/j.coi.2004.02.005; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Melief CJM, 2002, IMMUNOL REV, V188, P177, DOI 10.1034/j.1600-065X.2002.18816.x; Nemunaitis J, 2004, J NATL CANCER I, V96, P326, DOI 10.1093/jnci/djh028; Quezada SA, 2008, J EXP MED, V205, P2125, DOI 10.1084/jem.20080099; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schone G, 1906, MUNCHEN MED WOCHEN, V51, P2517; Schubert C, 2006, NATURE NEWS, DOI [10.1038/news061106-17, DOI 10.1038/NEWS061106-17]; Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2254; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soiffer R, 2003, J CLIN ONCOL, V21, P3343, DOI 10.1200/JCO.2003.07.005; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; STONEHILL EH, 1970, NATURE, V228, P370, DOI 10.1038/228370a0; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; TRIOLO VA, 1965, CANCER RES, V25, P75; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	49	38	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42289	10.1371/journal.pone.0042289	http://dx.doi.org/10.1371/journal.pone.0042289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860107	gold, Green Submitted, Green Published			2022-12-27	WOS:000307045600087
J	Zhao, JL; He, H; Zhou, KC; Ren, YG; Shi, ZX; Wu, ZY; Wang, YZ; Lu, YC; Jiao, JW				Zhao, Junli; He, Hua; Zhou, Kechun; Ren, Yonggang; Shi, Zixiao; Wu, Zhiyuan; Wang, Yizheng; Lu, Yicheng; Jiao, Jianwei			Neuronal Transcription Factors Induce Conversion of Human Glioma Cells to Neurons and Inhibit Tumorigenesis	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA CELLS; FUNCTIONAL-NEURONS; MALIGNANT GLIOMAS; HUMAN FIBROBLASTS; GROWTH; SUPPRESSION; APOPTOSIS; ADULTS; CYCLE	Recent findings have demonstrated that the overexpression of lineage-specific transcription factors induces cell fate changes among diverse cell types. For example, neurons can be generated from mouse and human fibroblasts. It is well known that neurons are terminally differentiated cells that do not divide. Therefore, we consider how to induce glioma cells to become neurons by introducing transcription factors. Here, we describe the efficient generation of induced neuronal (iN) cells from glioma cells by the infection with three transcription factors: Ascl1, Brn2 and Ngn2 (ABN). iN cells expressed multiple neuronal markers and fired action potentials, similar to the properties of authentic neurons. Importantly, the proliferation of glioma cells following ABN overexpression was dramatically inhibited in both in vitro and in vivo experiments. In addition, iN cells that originated from human glioma cells did not continue to grow when they were sorted and cultured in vitro. The strategies by which glioma cells are induced to become neurons may be used to clinically study methods for inhibiting tumor growth.	[Zhao, Junli; Zhou, Kechun; Ren, Yonggang; Wang, Yizheng] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Shi, Zixiao; Jiao, Jianwei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [He, Hua; Lu, Yicheng] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Wu, Zhiyuan] Ruijin Hosp, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Naval Medical University; Shanghai Jiao Tong University	Zhao, JL (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China.	yichenglucz@gmail.com; jwjiao@ioz.ac.cn	Jiao, Jianwei/I-1452-2013; Jiao, Jianwei/AAA-7902-2020	Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721	973 Program [2011CBA00402]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01020301]; National Natural Science Foundation of China [30930094]; Hundred Talent Program	973 Program(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program(Chinese Academy of Sciences)	This work was supported by grants from the 973 Program (2011CBA00402, J.J.), "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01020301, J.J.), the National Natural Science Foundation of China (30930094, Y.L.) and the Hundred Talent Program (J.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Cuddapah VA, 2010, J BIOL CHEM, V285, P11188, DOI 10.1074/jbc.M109.097675; Dell'Albani P, 2008, NEUROCHEM RES, V33, P2407, DOI 10.1007/s11064-008-9723-8; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; GomezManzano C, 1996, CANCER RES, V56, P694; Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008; Hadziahmetovic M, 2011, FUTURE ONCOL, V7, P1169, DOI [10.2217/FON.11.102, 10.2217/fon.11.102]; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513; Kimmelman AC, 2004, ONCOGENE, V23, P5077, DOI 10.1038/sj.onc.1207662; Klatzmann D, 1998, HUM GENE THER, V9, P2595, DOI 10.1089/hum.1998.9.17-2595; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perek N, 2002, GEN PHYSIOL BIOPHYS, V21, P381; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Sukhdeo K, 2011, CELL, V146, P187, DOI 10.1016/j.cell.2011.06.047; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Walid Mohammad Sami, 2008, Perm J, V12, P45; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou YH, 2005, J NEURO-ONCOL, V71, P223, DOI 10.1007/s11060-004-1720-4; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	29	27	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41506	10.1371/journal.pone.0041506	http://dx.doi.org/10.1371/journal.pone.0041506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859994	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600032
J	Casey, OM; Fang, L; Hynes, PG; Abou-Kheir, WG; Martin, PL; Tillman, HS; Petrovics, G; Awwad, HO; Ward, Y; Lake, R; Zhang, LH; Kelly, K				Casey, Orla M.; Fang, Lei; Hynes, Paul G.; Abou-Kheir, Wassim G.; Martin, Philip L.; Tillman, Heather S.; Petrovics, Gyorgy; Awwad, Hibah O.; Ward, Yvona; Lake, Ross; Zhang, Luhua; Kelly, Kathleen			TMPRSS2- Driven ERG Expression In Vivo Increases Self-Renewal and Maintains Expression in a Castration Resistant Subpopulation	PLOS ONE			English	Article							PROSTATE-CANCER; STEM-CELLS; TRANSCRIPTION FACTORS; RECEPTOR; GENE; PATHWAYS; TUMORIGENESIS; PROGRESSION; ANTIBODY; TISSUES	Genomic rearrangements commonly occur in many types of cancers and often initiate or alter the progression of disease. Here we describe an in vivo mouse model that recapitulates the most frequent rearrangement in prostate cancer, the fusion of the promoter region of TMPRSS2 with the coding region of the transcription factor, ERG. A recombinant bacterial artificial chromosome including an extended TMPRSS2 promoter driving genomic ERG was constructed and used for transgenesis in mice. TMPRSS2-ERG expression was evaluated in tissue sections and FACS-fractionated prostate cell populations. In addition to the anticipated expression in luminal cells, TMPRSS2-ERG was similarly expressed in the Sca-1(hi)/EpCAM(+) basal/progenitor fraction, where expanded numbers of clonogenic self-renewing progenitors were found, as assayed by in vitro sphere formation. These clonogenic cells increased intrinsic self renewal in subsequent generations. In addition, ERG dependent self-renewal and invasion in vitro was demonstrated in prostate cell lines derived from the model. Clinical studies have suggested that the TMPRSS2-ERG translocation occurs early in prostate cancer development. In the model described here, the presence of the TMPRSS2-ERG fusion alone was not transforming but synergized with heterozygous Pten deletion to promote PIN. Taken together, these data suggest that one function of TMPRSS2-ERG is the expansion of self-renewing cells, which may serve as targets for subsequent mutations. Primary prostate epithelial cells demonstrated increased post transcriptional turnover of ERG compared to the TMPRSS2-ERG positive VCaP cell line, originally isolated from a prostate cancer metastasis. Finally, we determined that TMPRSS2-ERG expression occurred in both castration-sensitive and resistant prostate epithelial subpopulations, suggesting the existence of androgen-independent mechanisms of TMPRSS2 expression in prostate epithelium.	[Casey, Orla M.; Fang, Lei; Hynes, Paul G.; Abou-Kheir, Wassim G.; Martin, Philip L.; Tillman, Heather S.; Awwad, Hibah O.; Ward, Yvona; Lake, Ross; Zhang, Luhua; Kelly, Kathleen] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Petrovics, Gyorgy] Uniformed Serv Univ Hlth Sci, Dept Surg, Ctr Prostate Dis Res, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA	Casey, OM (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kellyka@mail.nih.gov	Abou-Kheir, Wassim/AAP-2587-2020; Tillman, Heather/N-2526-2018	Abou-Kheir, Wassim/0000-0001-9719-9324; Tillman, Heather/0000-0002-9623-2812; Petrovics, Gyorgy/0000-0003-3732-284X	Intramural Research Program, Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011053] Funding Source: NIH RePORTER	Intramural Research Program, Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Bostwick D G, 2000, Curr Urol Rep, V1, P65, DOI 10.1007/s11934-000-0037-x; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Furusato B, 2010, PROSTATE CANCER P D, V13, P228, DOI 10.1038/pcan.2010.23; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hu Y, 2008, CLIN CANCER RES, V14, P4719, DOI 10.1158/1078-0432.CCR-08-0531; Jacquinet E, 2001, EUR J BIOCHEM, V268, P2687, DOI 10.1046/j.1432-1327.2001.02165.x; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Maitland Norman J., 2011, Hormones & Cancer, V2, P47, DOI 10.1007/s12672-010-0058-y; Mohamed AA, 2010, J CANCER, V1, P197; Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Owczarek CM, 2004, GENE, V324, P65, DOI 10.1016/j.gene.2003.09.047; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Taoudi S, 2011, GENE DEV, V25, P251, DOI 10.1101/gad.2009211; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vaarala MH, 2001, J PATHOL, V193, P134, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wang JH, 2006, CANCER RES, V66, P8347, DOI 10.1158/0008-5472.CAN-06-1966; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	43	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41668	10.1371/journal.pone.0041668	http://dx.doi.org/10.1371/journal.pone.0041668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860005	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900033
J	Fong, MY; Jin, SY; Rane, M; Singh, RK; Gupta, R; Kakar, SS				Fong, Miranda Y.; Jin, Shunying; Rane, Madhavi; Singh, Raj K.; Gupta, Ramesh; Kakar, Sham S.			Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer	PLOS ONE			English	Article							INDUCED CELL-DEATH; HEPATOCELLULAR-CARCINOMA; LIPOSOMAL DOXORUBICIN; PROSTATE-CANCER; DOWN-REGULATION; UP-REGULATION; APOPTOSIS; CYTOTOXICITY; DYSFUNCTION; INHIBITION	Application of doxorubicin (Dox) for the treatment of cancer is restricted due to its severe side effects. We used combination strategy by combining doxorubicin (Dox) with withaferin A (WFA) to minimize the ill effects of Dox. Treatment of various epithelial ovarian cancer cell lines (A2780, A2780/CP70 and CaOV3) with combination of WFA and Dox (WFA/DOX) showed a time- and dose-dependent synergistic effect on inhibition of cell proliferation and induction of cell death, thus reducing the dosage requirement of Dox. Combination treatment resulted in a significant enhancement of ROS production resulting in immense DNA damage, induction of autophagy analyzed by transmission electron microscope and increase in expression of autophagy marker LC3B, and culminated in cell death analyzed by cleaved caspase 3. We validated combination therapy on tumor growth using an in vitro 3Dimension (3D) tumor model and the more classic in vivo xenograft model of ovarian cancer. Both tumor models showed a 70 to 80% reduction in tumor growth compared to control or animals treated with WFA or Dox alone. Immunohistochemical analysis of the tumor tissues from animals treated with WFA/Dox combination showed a significant reduction in cell proliferation and formation of microvessels accompanied by increased in LC3B level, cleaved caspase 3, and DNA damage. Taken together, our data suggest that combining WFA with Dox decreases the dosage requirement of Dox, therefore, minimizing/eliminating the severe side effects associated with high doses of DOX, suggesting the application of this combination strategy for the treatment of ovarian and other cancers with no or minimum side effects.	[Fong, Miranda Y.; Kakar, Sham S.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA; [Jin, Shunying; Rane, Madhavi] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Singh, Raj K.] Vivo Biosci Inc, Birmingham, AL USA; [Gupta, Ramesh] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Gupta, Ramesh; Kakar, Sham S.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Fong, MY (corresponding author), Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA.	sskaka01@louisville.edu		Singh, Raj/0000-0002-6331-9196	National Institutes of Health/National Cancer Institute [CA124630]; NATIONAL CANCER INSTITUTE [R01CA124630] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from National Institutes of Health/National Cancer Institute CA124630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achari C, 2011, MED CHEM, V7, P432, DOI 10.2174/157340611796799087; BEHRENS BC, 1987, CANCER RES, V47, P414; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Campos SM, 2001, GYNECOL ONCOL, V81, P206, DOI 10.1006/gyno.2000.5980; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Cosse JP, 2010, BIOCHEM PHARMACOL, V80, P1160, DOI 10.1016/j.bcp.2010.07.009; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; Dayton A, 2011, J PHARMACOL EXP THER, V339, P350, DOI 10.1124/jpet.111.183681; Donadelli M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.36; El-Naggar SM, 2007, J ENDOCRINOL, V194, P179, DOI 10.1677/JOE-06-0036; El-Naggar SM, 2007, INT J ONCOL, V31, P137; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; Hatchi E, 2011, AUTOPHAGY, V7, P1566, DOI 10.4161/auto.7.12.17991; KAUR K, 2007, TISS CULT RES COMMUN, V26, P193; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kudoh K, 2011, GYNECOL ONCOL, V122, P233, DOI 10.1016/j.ygyno.2011.04.046; Kuo CC, 2011, FREE RADICAL BIO MED, V51, P2195, DOI 10.1016/j.freeradbiomed.2011.09.023; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lee SB, 2007, DNA CELL BIOL, V26, P713, DOI 10.1089/dna.2007.0577; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Lee YJ, 2011, KOREAN J PHYSIOL PHA, V15, P1, DOI 10.4196/kjpp.2011.15.1.1; Lin CI, 2010, MOL CANCER RES, V8, P1217, DOI 10.1158/1541-7786.MCR-10-0162; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Manov I, 2011, FEBS J, V278, P3494, DOI 10.1111/j.1742-4658.2011.08271.x; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsuo K, 2010, EXPERT OPIN INV DRUG, V19, P1339, DOI 10.1517/13543784.2010.515585; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Oh JH, 2009, INT IMMUNOPHARMACOL, V9, P614, DOI 10.1016/j.intimp.2009.02.002; Pfisterer J, 2006, SEMIN ONCOL, V33, pS12, DOI 10.1053/j.seminoncol.2006.03.012; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Seales EC, 2007, DRUG DISCOVERY INT, P16; Shah PP, 2011, ONCOGENE; SIEGAL GP, 1993, CANCER LETT, V69, P123, DOI 10.1016/0304-3835(93)90164-5; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Thaiparambil JT, 2011, INT J CANC; Tomuleasa Ciprian, 2011, Hematol Oncol Stem Cell Ther, V4, P60; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	53	73	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42265	10.1371/journal.pone.0042265	http://dx.doi.org/10.1371/journal.pone.0042265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860102	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900086
J	Herrera, VLM; Pasion, KA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Dahl (S x R) Congenic Strain Analysis Confirms and Defines a Chromosome 5 Female-Specific Blood Pressure Quantitative Trait Locus to < 7 Mbp	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ESSENTIAL-HYPERTENSION; RAT MODEL; VARIANTS; MAP; GENES	The detection of multiple sex-specific blood pressure (BP) quantitative trait loci (QTLs) in independent total genome analyses of F2 (Dahl S x R)-intercross male and female rat cohorts confirms clinical observations of sex-specific disease cause and response to treatment among hypertensive patients, and mandate the identification of sex-specific hypertension genes/mechanisms. We developed and studied two congenic strains, S.R5A and S.R5B introgressing Dahl R-chromosome 5 segments into Dahl S chromosome 5 region spanning putative BP-f1 and BP-f2 QTLs. Radiotelemetric non-stressed 24-hour BP analysis at four weeks post-high salt diet (8% NaCl) challenge, identified only S.R5B congenic rats with lower SBP (-26.5 mmHg, P= 0.002), DBP (-23.7 mmHg, P= 0.004) and MAP (-25.1 mmHg, P= 0.002) compared with Dahl S female controls at four months of age confirming BP-f1 but not BP-f2 QTL on rat chromosome 5. The S.R5B congenic segment did not affect pulse pressure and relative heart weight indicating that the gene underlying BP-f1 does not influence arterial stiffness and cardiac hypertrophy. The results of our congenic analysis narrowed BP-f1 to chromosome 5 coordinates 134.9-141.5 Mbp setting up the basis for further fine mapping of BP-f1 and eventual identification of the specific gene variant accounting for BP-f1 effect on blood pressure.	[Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University; Boston University	Herrera, VLM (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Ruiz-Opazo, Nelson/0000-0001-8234-1332; Herrera, Victoria/0000-0001-8991-2134	National Heart, Lung and Blood Institute [HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung and Blood Institute HL086532 (to N.R-O). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MJ, 2000, J CARDIOVASC PHARM, V35, pS41, DOI 10.1097/00005344-200000002-00010; Charchar FJ, 2008, J HUM HYPERTENS, V22, P821, DOI 10.1038/jhh.2008.67; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Deng AY, 2008, CLIN EXP HYPERTENS, V30, P511, DOI 10.1080/10641960802251933; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; Deng AY, 2001, MAMM GENOME, V12, P612, DOI 10.1007/s00335-001-2054-6; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ehret GB, 2008, EUR J HUM GENET, V16, P1507, DOI 10.1038/ejhg.2008.102; Garrett MR, 2002, PHYSIOL GENOMICS, V8, P81, DOI 10.1152/physiolgenomics.00080.2001; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Gong M, 2006, CLIN SCI, V110, P315, DOI 10.1042/CS20050208; Guimaraes CL, 1992, HYPERTENSION, V19, pII79; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Kaneko Y, 2005, PHYSIOL GENOMICS, V20, P157, DOI 10.1152/physiolgenomics.00108.2004; Kloting I, 2001, BIOCHEM BIOPH RES CO, V284, P1126, DOI 10.1006/bbrc.2001.5091; Lee NH, 2007, HYPERTENSION, V50, P1126, DOI 10.1161/HYPERTENSIONAHA.107.093138; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Roman RJ, 2006, AM J PHYSIOL-RENAL, V290, pF1463, DOI 10.1152/ajprenal.00360.2005; Yagil C, 1998, HYPERTENSION, V31, P119, DOI 10.1161/01.HYP.31.1.119	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42214	10.1371/journal.pone.0042214	http://dx.doi.org/10.1371/journal.pone.0042214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860086	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900078
J	Hueper, K; Zapf, A; Skrok, J; Pinheiro, A; Goldstein, TA; Zheng, J; Zimmerman, SL; Kamel, IR; Abraham, R; Wacker, F; Bluemke, DA; Abraham, T; Vogel-Claussen, J				Hueper, Katja; Zapf, Antonia; Skrok, Jan; Pinheiro, Aurelio; Goldstein, Thomas A.; Zheng, Jie; Zimmerman, Stefan L.; Kamel, Ihab R.; Abraham, Roselle; Wacker, Frank; Bluemke, David A.; Abraham, Theodore; Vogel-Claussen, Jens			In Hypertrophic Cardiomyopathy Reduction of Relative Resting Myocardial Blood Flow Is Related to Late Enhancement, T2-Signal and LV Wall Thickness	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; OUTFLOW TRACT GRADIENT; MICROVASCULAR DYSFUNCTION; PERFUSION ABNORMALITIES; SUDDEN-DEATH; RISK; QUANTIFICATION; HEMODYNAMICS; SCINTIGRAPHY	Objectives: To quantify resting myocardial blood flow (MBF) in the left ventricular (LV) wall of HCM patients and to determine the relationship to important parameters of disease: LV wall thickness, late gadolinium enhancement (LGE), T2-signal abnormalities (dark and bright signal), LV outflow tract obstruction and age. Materials and Methods: Seventy patients with proven HCM underwent cardiac MRI. Absolute and relative resting MBF were calculated from cardiac perfusion MRI by using the Fermi function model. The relationship between relative MBF and LV wall thickness, T2-signal abnormalities (T2 dark and T2 bright signal), LGE, age and LV outflow gradient as determined by echocardiography was determined using simple and multiple linear regression analysis. Categories of reduced and elevated perfusion in relation to non- or mildly affected reference segments were defined, and T2-signal characteristics and extent as well as pattern of LGE were examined. Statistical testing included linear and logistic regression analysis, unpaired t-test, odds ratios, and Fisher's exact test. Results: 804 segments in 70 patients were included in the analysis. In a simple linear regression model LV wall thickness (p<0.001), extent of LGE (p<0.001), presence of edema, defined as focal T2 bright signal (p<0.001), T2 dark signal (p<0.001) and age (p = 0.032) correlated inversely with relative resting MBF. The LV outflow gradient did not show any effect on resting perfusion (p = 0.901). Multiple linear regression analysis revealed that LGE (p<0.001), edema (p = 0.026) and T2 dark signal (p = 0.019) were independent predictors of relative resting MBF. Segments with reduced resting perfusion demonstrated different LGE patterns compared to segments with elevated resting perfusion. Conclusion: In HCM resting MBF is significantly reduced depending on LV wall thickness, extent of LGE, focal T2 signal abnormalities and age. Furthermore, different patterns of perfusion in HCM patients have been defined, which may represent different stages of disease.	[Hueper, Katja; Skrok, Jan; Zimmerman, Stefan L.; Kamel, Ihab R.; Wacker, Frank; Vogel-Claussen, Jens] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Hueper, Katja; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Radiol, D-3000 Hannover, Germany; [Zapf, Antonia] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany; [Pinheiro, Aurelio; Abraham, Roselle; Abraham, Theodore] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; [Goldstein, Thomas A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Zheng, Jie] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Bluemke, David A.] NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Hannover Medical School; Hannover Medical School; Johns Hopkins University; Stanford University; Washington University (WUSTL); National Institutes of Health (NIH) - USA	Hueper, K (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA.	vogel-claussen.jens@mh-hannover.de	Zimmerman, Stefan L/U-3269-2019; Vogel-Claussen, Jens/Q-3374-2019; Hueper, Katja/J-9566-2016; Bluemke, David/GYU-8169-2022	Hueper, Katja/0000-0002-3195-4400; Bluemke, David/0000-0002-8323-8086; Vogel-Claussen, Jens/0000-0001-5595-6948	National Institutes of Health grant [HL 098046]; German Research Foundation in the framework of the program "Open Access Publishing."; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation in the framework of the program "Open Access Publishing."; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	Funding for this study was provided by National Institutes of Health grant # HL 098046. Publication charges for this article were supported by the German Research Foundation in the framework of the program "Open Access Publishing." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Abdel-Aty H, 2008, J MAGN RESON IMAGING, V28, P242, DOI 10.1002/jmri.21381; CAMICI P, 1991, J AM COLL CARDIOL, V17, P879, DOI 10.1016/0735-1097(91)90869-B; Cecchi F, 2003, NEW ENGL J MED, V349, P1027, DOI 10.1056/NEJMoa025050; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Christian TF, 2009, JACC-CARDIOVASC IMAG, V2, P1103, DOI 10.1016/j.jcmg.2009.06.009; CZERNIN J, 1993, CIRCULATION, V88, P62, DOI 10.1161/01.CIR.88.1.62; DILSIZIAN V, 1993, J AM COLL CARDIOL, V22, P796, DOI 10.1016/0735-1097(93)90193-5; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; Fenehel M, 2004, INVEST RADIOL, V39, P572, DOI 10.1097/01.rli.0000133816.83192.38; Geske JB, 2009, CLIN CARDIOL, V32, P397, DOI 10.1002/clc.20594; Goldstein TA, 2008, MAGN RESON MED, V59, P1394, DOI 10.1002/mrm.21559; Goldstein TA, 2006, MAGN RESON MED, V56, P439, DOI 10.1002/mrm.20950; Iida H, 2000, J NUCL MED, V41, P1737; Jerosch-Herold M, 1998, MED PHYS, V25, P73, DOI 10.1118/1.598163; Kim RJ, 2003, J AM COLL CARDIOL, V41, P1568, DOI 10.1016/S0735-1097(03)00190-6; Kizilbash AM, 1998, CIRCULATION, V97, P461; Knaapen P, 2005, J NUCL MED, V46, P923; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; OGARA PT, 1987, CIRCULATION, V76, P1214, DOI 10.1161/01.CIR.76.6.1214; Petersen SE, 2007, CIRCULATION, V115, P2418, DOI 10.1161/CIRCULATIONAHA.106.657023; Romero-Farina G, 2004, J NUCL CARDIOL, V11, P578, DOI 10.1016/j.nuclcard.2004.05.008; Schreiber WG, 2002, J MAGN RESON IMAGING, V16, P641, DOI 10.1002/jmri.10209; Selvanayagam JB, 2005, CIRCULATION, V112, P3289, DOI 10.1161/CIRCULATIONAHA.105.549170; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Timmer SAJ, 2011, AM J CARDIOL, V107, P1522, DOI 10.1016/j.amjcard.2011.01.029; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476; Vogel-Claussen J, 2011, RADIOLOGY, V258, P119, DOI 10.1148/radiol.10100725; VONDOHLEN TW, 1989, AM J CARDIOL, V64, P498, DOI 10.1016/0002-9149(89)90428-1; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; Yamada M, 1998, EUR HEART J, V19, P500, DOI 10.1053/euhj.1997.0769	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41974	10.1371/journal.pone.0041974	http://dx.doi.org/10.1371/journal.pone.0041974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860042	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900058
J	Pamilo, S; Malinen, S; Hlushchuk, Y; Seppa, M; Tikka, P; Hari, R				Pamilo, Siina; Malinen, Sanna; Hlushchuk, Yevhen; Seppa, Mika; Tikka, Pia; Hari, Riitta			Functional Subdivision of Group-ICA Results of fMRI Data Collected during Cinema Viewing	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; UNILATERAL SPATIAL NEGLECT; ANTERIOR CINGULATE CORTEX; DEFAULT MODE; HUMAN BRAIN; INTRAPARIETAL SULCUS; TIME-SERIES; BLOOD-FLOW; GROUP PICA; CONNECTIVITY	Independent component analysis (ICA) can unravel functional brain networks from functional magnetic resonance imaging (fMRI) data. The number of the estimated components affects both the spatial pattern of the identified networks and their time-course estimates. Here group-ICA was applied at four dimensionalities (10, 20, 40, and 58 components) to fMRI data collected from 15 subjects who viewed a 15-min silent film ("At land" by Maya Deren). We focused on the dorsal attention network, the default-mode network, and the sensorimotor network. The lowest dimensionalities demonstrated most prominent activity within the dorsal attention network, combined with the visual areas, and in the default-mode network; the sensorimotor network only appeared with ICA comprising at least 20 components. The results suggest that even very low-dimensional ICA can unravel the most prominent functionally-connected brain networks. However, increasing the number of components gives a more detailed picture and functionally feasible subdivision of the major networks. These results improve our understanding of the hierarchical subdivision of brain networks during viewing of a movie that provides continuous stimulation embedded in an attention-directing narrative.	[Pamilo, Siina; Malinen, Sanna; Hlushchuk, Yevhen; Seppa, Mika; Hari, Riitta] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland; [Hlushchuk, Yevhen; Hari, Riitta] Aalto Univ, Sch Sci, OV Lounasmaa Lab, Adv Magnet Imaging Ctr, Espoo, Finland; [Tikka, Pia] Aalto Univ, Sch Art Design & Architecture, Dept Mot Picture Televis & Prod Design, Helsinki, Finland	Aalto University; Aalto University; Aalto University	Pamilo, S (corresponding author), Aalto Univ, Sch Sci, OV Lounasmaa Lab, Brain Res Unit, Espoo, Finland.	spamilo@neuro.hut.fi	Seppä, Mika/J-2961-2012; Tikka, Pia/J-1907-2012; Hari, Riitta K/J-1880-2012	Seppä, Mika/0000-0001-6180-1758; Hari, Riitta K/0000-0002-3142-2703; Hlushchuk, Yevhen/0000-0001-6869-6305	Academy of Finland (National Centers of Excellence Program) [129678, 131483]; aivoAALTO project of the Aalto University, European Research Council [232946]; Finnish Graduate School of Neuroscience	Academy of Finland (National Centers of Excellence Program); aivoAALTO project of the Aalto University, European Research Council; Finnish Graduate School of Neuroscience	This work was supported by the Academy of Finland (National Centers of Excellence Program 2006-2011, grant # 129678, and grant # 131483) (http://www.aka.fi/en-GB/A/), the aivoAALTO project of the Aalto University, European Research Council (Advanced Grant # 232946)(http://erc.europa.eu/), and the Finnish Graduate School of Neuroscience (http://www.brain-mind.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; CHAIN F, 1979, REV NEUROL, V135, P105; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; De Renzi E, 1970, Cortex, V6, P191; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Esposito F, 2003, NEUROIMAGE, V20, P2209, DOI 10.1016/j.neuroimage.2003.08.012; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; GAINOTTI G, 1972, J NEUROL NEUROSUR PS, V35, P545, DOI 10.1136/jnnp.35.4.545; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gitelman DR, 2002, NEUROIMAGE, V15, P970, DOI 10.1006/nimg.2001.1006; Green C, 2002, NEUROIMAGE S, V16, P357; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Karhunen J, 1997, INT J NEURAL SYST, V8, P219, DOI 10.1142/S0129065797000239; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Lahnakoski JM, 2012, FRONT HUM N IN PRESS; Lahnakoski JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035215; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P368, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<368::AID-HBM7>3.3.CO;2-5; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; Nobre A. C., 1997, Society for Neuroscience Abstracts, V23, P300; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; OXBURY JM, 1974, BRAIN, V97, P551, DOI 10.1093/brain/97.1.551; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramsey R, 2011, J COGNITIVE NEUROSCI, V23, P3400, DOI 10.1162/jocn_a_00074; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; WAX M, 1985, IEEE T ACOUST SPEECH, V33, P387, DOI 10.1109/TASSP.1985.1164557; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014; Wolf I, 2010, NEUROIMAGE, V49, P894, DOI 10.1016/j.neuroimage.2009.08.060; Yourganov G, 2011, NEUROIMAGE, V56, P531, DOI 10.1016/j.neuroimage.2010.09.034	50	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42000	10.1371/journal.pone.0042000	http://dx.doi.org/10.1371/journal.pone.0042000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860044	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000306950900060
J	Cui, F; Gao, L; Yuan, F; Dong, ZF; Zhou, ZN; Kline, DD; Zhang, Y; Li, DP				Cui, Fang; Gao, Lu; Yuan, Fang; Dong, Ze-Fei; Zhou, Zhao-Nian; Kline, David D.; Zhang, Yi; Li, De-Pei			Hypobaric Intermittent Hypoxia Attenuates Hypoxia-induced Depressor Response	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; VASCULAR SMOOTH-MUSCLE; K-ATP CHANNELS; CARDIOVASCULAR AUTONOMIC MODULATION; NITRIC-OXIDE SYNTHASE; BAROREFLEX CONTROL; HEART-RATE; BLOOD-PRESSURE; HIGH-ALTITUDE; CARDIAC BAROREFLEX	Background: Hypobaric intermittent hypoxia (HIH) produces many favorable effects in the cardiovascular system such as anti-hypertensive effect. In this study, we showed that HIH significantly attenuated a depressor response induced by acute hypoxia. Methodology/Principal Findings: Sprague-Dawley rats received HIH in a hypobaric chamber simulating an altitude of 5000 m. The artery blood pressure (ABP), heart rate (HR) and renal sympathetic nerve activity (RSNA) were recorded in anesthetized control rats and rats received HIH. The baseline ABP, HR and RSNA were not different between HIH and control rats. Acute hypoxia-induced decrease in ABP was significantly attenuated in HIH rat compared with control rats. However, acute hypoxia-induced increases in HR and RSNA were greater in HIH rat than in control rats. After removal of bilateral ascending depressor nerves, acute hypoxia-induced depressor and sympathoexcitatory responses were comparable in control and HIH rats. Furthermore, acute hypoxia-induced depressor and sympathoexcitatory responses did not differ between control and HIH groups after blocking ATP-dependent K+ channels by glibenclamide. The baroreflex function evaluated by intravenous injection of phenylephrine and sodium nitroprusside was markedly augmented in HIH rats compared with control rats. The pressor and sympathoexcitatory responses evoked by intravenous injection of cyanide potassium were also significantly greater in HIH rats than in control rats. Conclusions/Significance: Our findings suggest that HIH suppresses acute hypoxia-induced depressor response through enhancement of baroreflex and chemoreflex function, which involves activation of ATP-dependent K+ channels. This study provides new information and underlying mechanism on the beneficiary effect of HIH on maintaining cardiovascular homeostasis.	[Cui, Fang; Gao, Lu; Yuan, Fang; Dong, Ze-Fei; Zhang, Yi; Li, De-Pei] Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China; [Zhou, Zhao-Nian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Kline, David D.] Univ Missouri, Dept Biomed Sci, Columbia, MO USA; [Kline, David D.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Li, De-Pei] Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA; [Zhang, Yi] Hebei Key Lab Med Biotechnol, Shijiazhuang, Peoples R China	Hebei Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Texas System; UTMD Anderson Cancer Center	Cui, F (corresponding author), Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China.	dpli@mdanderson.org	Kline, David D./AAC-7035-2019	Kline, David D./0000-0003-3269-0184	National Basic Research Development Program of China [2006CB504100, 2012CB518200]; National Natural Science Foundation of China [30393130, 30572086, 31071002]; Special Foundation for the Doctoral Point in High Educational Institute of China [20060089009]; Natural Science Foundation of Hebei Province Health Bureau, China [C2012206001]; American Heart Association National Center South Central Affiliate [10GRNT3450003]	National Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for the Doctoral Point in High Educational Institute of China; Natural Science Foundation of Hebei Province Health Bureau, China(Natural Science Foundation of Hebei Province); American Heart Association National Center South Central Affiliate	This study was supported by the Grants from National Basic Research Development Program of China (No. 2006CB504100, 2012CB518200), the National Natural Science Foundation of China (No. 30393130, 30572086, 31071002), the Special Foundation for the Doctoral Point in High Educational Institute of China (No. 20060089009), the Natural Science Foundation of Hebei Province Health Bureau, China (No. C2012206001), and American Heart Association National Center South Central Affiliate (Grant-in-Aid: # 10GRNT3450003, URL: http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akrouh A, 2009, IUBMB LIFE, V61, P971, DOI 10.1002/iub.246; Bao XP, 2002, AUTON NEUROSCI-BASIC, V102, P54, DOI 10.1016/S1566-0702(02)00174-1; Bernardi L, 2001, J HYPERTENS, V19, P947, DOI 10.1097/00004872-200105000-00016; Bernardi L, 2001, EUR HEART J, V22, P879, DOI 10.1053/euhj.2000.2466; Bernardi L, 1998, CLIN SCI, V95, P565, DOI 10.1042/cs0950565; CARRIER O, 1964, AM J PHYSIOL, V206, P951, DOI 10.1152/ajplegacy.1964.206.5.951; Chen XG, 2007, AM J PHYSIOL-HEART C, V293, pH3246, DOI 10.1152/ajpheart.00957.2007; Dallaporta M, 2000, NEUROSCI LETT, V278, P77, DOI 10.1016/S0304-3940(99)00898-8; Dematteis M, 2009, ILAR J, V50, P262, DOI 10.1093/ilar.50.3.262; DETAR R, 1972, AM J PHYSIOL, V222, P1269, DOI 10.1152/ajplegacy.1972.222.5.1269; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; FRANCHINI KG, 1993, J AUTONOM NERV SYST, V42, P63, DOI 10.1016/0165-1838(93)90342-R; Fu Q, 2007, AM J PHYSIOL-REG I, V292, pR1977, DOI 10.1152/ajpregu.00622.2006; Gao L, 2004, AM J PHYSIOL-HEART C, V286, pH1706, DOI 10.1152/ajpheart.01097.2003; Grabauskas G, J PHYSL, V588, P617; Haider T, 2009, J HYPERTENS, V27, P1648, DOI 10.1097/HJH.0b013e32832c0018; Heesch CM, 1996, AM J PHYSIOL-REG I, V270, pR728, DOI 10.1152/ajpregu.1996.270.4.R728; HUGHSON RL, 1994, J APPL PHYSIOL, V77, P2537; JOHNSON TS, 1983, J CLIN INVEST, V71, P1263, DOI 10.1172/JCI110876; Katayama B, 1998, EUR J APPL PHYSIOL, V78, P189, DOI 10.1007/s004210050406; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; KRAUHS JM, 1979, J NEUROCYTOL, V8, P401, DOI 10.1007/BF01214800; Krukoff TL, 1999, BRAIN RES REV, V30, P52, DOI 10.1016/S0165-0173(99)00010-7; Levine BD, 2002, HIGH ALT MED BIOL, V3, P177, DOI 10.1089/15270290260131911; Liu JL, 1996, AM J PHYSIOL-REG I, V270, pR1361, DOI 10.1152/ajpregu.1996.270.6.R1361; Manukhina EB, 2006, EXP BIOL MED, V231, P343, DOI 10.1177/153537020623100401; MARTICOR.E, 1969, AM J CARDIOL, V23, P364, DOI 10.1016/0002-9149(69)90516-5; MATSUKAWA K, 1989, AM J PHYSIOL, V256, pR371, DOI 10.1152/ajpregu.1989.256.2.R371; Murakami H, 1998, AM J PHYSIOL-REG I, V274, pR181, DOI 10.1152/ajpregu.1998.274.1.R181; Narkiewicz K, 1998, HYPERTENSION, V32, P1039, DOI 10.1161/01.HYP.32.6.1039; Paton JFR, 2001, J PHYSIOL-LONDON, V531, P445, DOI 10.1111/j.1469-7793.2001.0445i.x; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P156, DOI 10.1016/j.resp.2010.08.021; QUAST U, 1994, CARDIOVASC RES, V28, P805, DOI 10.1093/cvr/28.6.805; QUAYLE JM, 1994, CARDIOVASC RES, V28, P797, DOI 10.1093/cvr/28.6.797; Roche F, 2002, CLIN PHYSIOL FUNCT I, V22, P301, DOI 10.1046/j.1475-097X.2002.00434.x; SAITO M, 1988, J APPL PHYSIOL, V65, P1548, DOI 10.1152/jappl.1988.65.4.1548; Scheuer DA, 2001, AM J PHYSIOL-REG I, V280, pR1440, DOI 10.1152/ajpregu.2001.280.5.R1440; Scislo TJ, 1998, AM J PHYSIOL-REG I, V275, pR995, DOI 10.1152/ajpregu.1998.275.4.R995; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Serebrovskaya TV, 2008, EXP BIOL MED, V233, P627, DOI 10.3181/0710-MR-267; Serebrovskaya TV, 1999, CAN J PHYSIOL PHARM, V77, P967, DOI 10.1139/cjpp-77-12-967; Sevre K, 2001, ACTA PHYSIOL SCAND, V173, P409, DOI 10.1046/j.1365-201X.2001.00925.x; Sun H, 2009, J PHARMACOL EXP THER, V331, P851, DOI 10.1124/jpet.109.160473; TRANUMJENSEN J, 1975, J ANAT, V119, P255; Tsutsui M, 2009, CIRC J, V73, P986, DOI 10.1253/circj.CJ-09-0208; Vitela M, 2005, AM J PHYSIOL-REG I, V288, pR856, DOI 10.1152/ajpregu.00620.2004; Zhang WR, 2008, AM J PHYSIOL-REG I, V295, pR1555, DOI 10.1152/ajpregu.90390.2008; Zhang Y, 2004, JPN J PHYSIOL, V54, P171, DOI 10.2170/jjphysiol.54.171; Zoccal DB, 2009, EXP PHYSIOL, V94, P972, DOI 10.1113/expphysiol.2009.048306	49	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41656	10.1371/journal.pone.0041656	http://dx.doi.org/10.1371/journal.pone.0041656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848558	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200084
J	McDaneld, TG; Smith, TPL; Harhay, GP; Wiedmann, RT				McDaneld, Tara G.; Smith, Tim P. L.; Harhay, Gregory P.; Wiedmann, Ralph T.			Next-Generation Sequencing of the Porcine Skeletal Muscle Transcriptome for Computational Prediction of MicroRNA Gene Targets	PLOS ONE			English	Article							EXPRESSION; RNA; DIFFERENTIATION; SPECIFICITY; METABOLISM; MIRNAS	Background: MicroRNA are a class of small RNAs that regulate gene expression by inhibiting translation of protein encoding transcripts through targeting of a microRNA-protein complex by base-pairing of the microRNA sequence to cognate recognition sequences in the 3' untranslated region (UTR) of the mRNA. Target identification for a given microRNA sequence is generally accomplished by informatics analysis of predicted mRNA sequences present in the genome or in databases of transcript sequence for the tissue of interest. However, gene models for porcine skeletal muscle transcripts in current databases, specifically complete sequence of the 3' UTR, are inadequate for this exercise. Methodology/Principal Findings: To provide data necessary to identify gene targets for microRNA in porcine skeletal muscle, normalized cDNA libraries were sequenced using Roche 454 GS-FLX pyrosequencing and de novo assembly of transcripts enriched in the 3' UTR was performed using the MIRA sequence assembly program. Over 725 million bases of sequence were generated, which assembled into 18,202 contigs. Sequence reads were mapped to a 3' UTR database containing porcine sequences. The 3' UTR that mapped to the database were examined to predict targets for previously identified microRNA that had been separately sequenced from the same porcine muscle sample used to generate the cDNA libraries. For genes with microRNA-targeted 3' UTR, KEGG pathways were computationally determined in order to identify potential functional effects of these microRNA-targeted transcripts. Conclusions: Through next-generation sequencing of transcripts expressed in skeletal muscle, mapping reads to a 3' UTR database, and prediction of microRNA target sites in the 3' UTR, our results identified genes expressed in porcine skeletal muscle and predicted the microRNA that target these genes. Additionally, identification of pathways regulated by these microRNA-targeted genes provides us with a set of genes that can be further evaluated for their potential role in skeletal muscle development and growth.	[McDaneld, Tara G.; Smith, Tim P. L.] ARS, Genet & Breeding Res Unit, USDA, Meat Anim Res Ctr, Clay Ctr, NE USA; [Harhay, Gregory P.] ARS, Anim Hlth Res Unit, USDA, Meat Anim Res Ctr, Clay Ctr, NE USA; [Wiedmann, Ralph T.] ARS, Reprod Res Unit, USDA, Meat Anim Res Ctr, Clay Ctr, NE USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	McDaneld, TG (corresponding author), ARS, Genet & Breeding Res Unit, USDA, Meat Anim Res Ctr, Clay Ctr, NE USA.	tara.mcdaneld@ars.usda.gov	Harhay, Gregory/AAC-5411-2022; Wiedmann, Ralph T/F-6530-2016	Harhay, Gregory/0000-0002-0129-6822; 				Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Beam KG, 1998, J GEN PHYSIOL, V91, P799; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHALOVICH JM, 1992, PHARMACOL THERAPEUT, V55, P95, DOI 10.1016/0163-7258(92)90013-P; Chan Shih-Peng, 2006, RNA Biol, V3, P97; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; DAVIS TA, 1989, AM J PHYSIOL, V257, pR1141, DOI 10.1152/ajpregu.1989.257.5.R1141; DENNE SC, 1987, AM J PHYSIOL, V253, pE608, DOI 10.1152/ajpendo.1987.253.6.E608; Drummond A.J, 2010, GENEIOUS, V5, P3; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Goto S, 1996, PACIFIC SYMPOSIUM ON BIOCOMPUTING '97, P175; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; Harhay GP, 2003, BIOINFORMATICS, V19, P249, DOI 10.1093/bioinformatics/19.2.249; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kee AJ, 2009, J MUSCLE RES CELL M, V30, P187, DOI 10.1007/s10974-009-9193-x; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Trenerry Marissa K., 2011, BMC Physiology, V11, P6, DOI 10.1186/1472-6793-11-6; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566	47	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42039	10.1371/journal.pone.0042039	http://dx.doi.org/10.1371/journal.pone.0042039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848698	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200149
J	Shen, XJ; Wang, HB; Ma, XQ; Chen, JH				Shen, Xiu-Jin; Wang, Hai-Bing; Ma, Xiao-Qiong; Chen, Jiang-Hua			beta, beta-Dimethylacrylshikonin Induces Mitochondria Dependent Apoptosis through ERK Pathway in Human Gastric Cancer SGC-7901 Cells	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; CYTOCHROME-C; CARCINOMA-CELLS; DOWN-REGULATION; MAP KINASES; IN-VITRO; SHIKONIN; DEATH; ACTIVATION; DERIVATIVES	beta,beta-Dimethylacrylshikonin, one of the active components in the root extracts of Lithospermum erythrorhizon, posses antitumor activity. In this study, we discussed the molecular mechanisms of beta,beta-dimethylacrylshikonin in the apoptosis of SGC-7901 cells. beta,beta-Dimethylacrylshikonin reduced the cell viability of SGC-7901 cells in a dose-and time-dependent manner and induced cell apoptosis. beta,beta-Dimethylacrylshikonin treatment in SGC-7901 cells down-regulated the expression of XIAP, cIAP-2, and Bcl-2 and up-regulated the expression of Bak and Bax and caused the loss of mitochondrial membrane potential and release of cytochrome c. Additionally, beta,beta-dimethylacrylshikonin treatment led to activation of caspases-9, 8 and 3, and cleavage of poly (ADP-ribose) polymerase (PARP), which was abolished by pretreatment with the pan-caspase inhibitor Z-VAD-FMK. beta,beta-Dimethylacrylshikonin induced phosphorylation of extracellular signal-regulated kinase (ERK) in SGC-7901 cells. U0126, a specific MEK inhibitor, blocked the ERK activation by beta,beta-dimethylacrylshikonin and abrogated beta,beta-dimethylacrylshikonin induced apoptosis. Our results demonstrated that beta,beta-dimethylacrylshikonin inhibited growth of gastric cancer SGC-7901 cells by inducing ERK signaling pathway, and provided a clue for preclinical and clinical evaluation of beta,beta-dimethylacrylshikonin for gastric cancer therapy.	[Shen, Xiu-Jin; Chen, Jiang-Hua] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Hai-Bing; Ma, Xiao-Qiong] Zhejiang Chinese Med Univ, Zhejiang Hosp Tradit Chinese Med, Natl Clin Res Base Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University	Ma, XQ (corresponding author), Zhejiang Chinese Med Univ, Zhejiang Hosp Tradit Chinese Med, Natl Clin Res Base Tradit Chinese Med, Hangzhou, Zhejiang, Peoples R China.	maxq126126@126.com; chenjianghua@zju.edu.cn	Shen, Xiu/AAO-7556-2021		Zhejiang Provincial Natural Science Foundation of China [LY12H28005]; science foundation of Zhejiang Chinese Medical University [2011ZY05]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); science foundation of Zhejiang Chinese Medical University	This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China to X-QM (LY12H28005), and the science foundation of Zhejiang Chinese Medical University to H-BW (2011ZY05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Chang IC, 2010, BIOL PHARM BULL, V33, P816, DOI 10.1248/bpb.33.816; Chen MF, 2010, AMINO ACIDS, V38, P1505, DOI 10.1007/s00726-009-0366-0; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Chen X, 2003, ANTIMICROB AGENTS CH, V47, P2810, DOI 10.1128/AAC.47.9.2810-2816.2003; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fan YM, 2007, MOL CELLS, V23, P30; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Hisa T, 1998, ANTICANCER RES, V18, P783; Hsu PC, 2004, J AGR FOOD CHEM, V52, P6330, DOI 10.1021/jf0495993; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Ishida T, 2007, BIOL PHARM BULL, V30, P928, DOI 10.1248/bpb.30.928; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kim BW, 2008, CANCER BIOL THER, V7, P1080, DOI 10.4161/cbt.7.7.6164; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Lu G, 1990, Zhong Xi Yi Jie He Za Zhi, V10, P422; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Min R, 2011, ORAL DIS, V17, P362, DOI 10.1111/j.1601-0825.2010.01758.x; Nie YK, 2010, CAN J PHYSIOL PHARM, V88, P1138, DOI 10.1139/Y10-085; Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; SANKAWA U, 1977, CHEM PHARM BULL, V25, P2392; Sasaki K, 2002, BIOL PHARM BULL, V25, P669, DOI 10.1248/bpb.25.669; Shen CC, 2002, J NAT PROD, V65, P1857, DOI 10.1021/np010599w; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh F, 2003, CANCER LETT, V200, P115, DOI 10.1016/S0304-3835(03)00239-8; Susnow N, 2009, SEMIN CANCER BIOL, V19, P42, DOI 10.1016/j.semcancer.2008.12.002; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TANAKA S, 1986, J NAT PROD, V49, P466, DOI 10.1021/np50045a014; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wu YY, 2012, PHYTOTHER RES, V26, P764, DOI 10.1002/ptr.3623; Wu Z, 2004, J ASIAN NAT PROD RES, V6, P155, DOI 10.1080/1028602032000169622; Wu Z, 2004, J PHARMACOL SCI, V94, P166, DOI 10.1254/jphs.94.166; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xuan Y, 2002, CANC LETT, V274, P233; Yang F, 2006, INT J CANCER, V119, P1184, DOI 10.1002/ijc.21943; Yeh CC, 2007, IN VIVO, V21, P1011	40	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41773	10.1371/journal.pone.0041773	http://dx.doi.org/10.1371/journal.pone.0041773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848597	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200103
J	Raz, S; Schwartz, NP; Mienis, HK; Nevo, E; Graham, JH				Raz, Shmuel; Schwartz, Nathan P.; Mienis, Hendrik K.; Nevo, Eviatar; Graham, John H.			Fluctuating Helical Asymmetry and Morphology of Snails (Gastropoda) in Divergent Microhabitats at 'Evolution Canyons I and II,' Israel	PLOS ONE			English	Article							LOWER NAHAL-OREN; MOUNT-CARMEL; MICROCLIMATIC STRESSES; VASCULAR PLANTS; BIODIVERSITY; DESICCATION; DESERT; ADAPTATIONS; RESISTANCE; DIVERSITY	Background: Developmental instability of shelled gastropods is measured as deviations from a perfect equiangular (logarithmic) spiral. We studied six species of gastropods at 'Evolution Canyons I and II' in Carmel and the Galilee Mountains, Israel, respectively. The xeric, south-facing, 'African' slopes and the mesic, north-facing, 'European' slopes have dramatically different microclimates and plant communities. Moreover, 'Evolution Canyon II' receives more rainfall than 'Evolution Canyon I.' Methodology/Principal Findings: We examined fluctuating asymmetry, rate of whorl expansion, shell height, and number of rotations of the body suture in six species of terrestrial snails from the two 'Evolution Canyons.' The xeric 'African' slope should be more stressful to land snails than the 'European' slope, and 'Evolution Canyon I' should be more stressful than 'Evolution Canyon II.' Only Eopolita protensa jebusitica showed marginally significant differences in fluctuating helical asymmetry between the two slopes. Contrary to expectations, asymmetry was marginally greater on the 'European' slope. Shells of Levantina spiriplana caesareana at 'Evolution Canyon I,' were smaller and more asymmetric than those at 'Evolution Canyon II.' Moreover, shell height and number of rotations of the suture were greater on the north-facing slopes of both canyons. Conclusions/Significance: Our data is consistent with a trade-off between drought resistance and thermoregulation in snails; Levantina was significantly smaller on the 'African' slope, for increasing surface area and thermoregulation, while Eopolita was larger on the 'African' slope, for reducing water evaporation. In addition, 'Evolution Canyon I' was more stressful than Evolution Canyon II' for Levantina.	[Raz, Shmuel; Nevo, Eviatar] Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Raz, Shmuel] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA; [Schwartz, Nathan P.; Graham, John H.] Berry Coll, Dept Biol, Mt Berry, GA USA; [Mienis, Hendrik K.] Tel Aviv Univ, IL-69978 Tel Aviv, Israel	University of Haifa; Harvard University; Tel Aviv University	Raz, S (corresponding author), Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	razshmu@gmail.com	רז, שמואל/ABD-3478-2021	Graham, John/0000-0003-1974-132X				ABRAMSKY Z, 1990, OIKOS, V59, P225, DOI 10.2307/3545538; ALZIEU C, 1986, MAR POLLUT BULL, V17, P494, DOI 10.1016/0025-326X(86)90636-3; ALZIEU C, 1991, MAR ENVIRON RES, V32, P7, DOI 10.1016/0141-1136(91)90029-8; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; ARAD Z, 1989, J ZOOL, V218, P353; ARAD Z, 1993, ISRAEL J ZOOL, V39, P95; ARAD Z, 1992, J ZOOL, V226, P643, DOI 10.1111/j.1469-7998.1992.tb07507.x; Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; BATLEY GE, 1989, AUST J MAR FRESH RES, V40, P49, DOI 10.1071/MF9890049; Broza M, 1996, ISR J ZOOL, V42, P411; CATES RG, 1975, ECOLOGY, V56, P410, DOI 10.2307/1934971; CHUNHABUNDIT S., 2001, SPC TROCHUS INFORM B, V8, P15; Cloudsley-Thompson J.L., 1976, P96; Cowart NM, 1999, INT J PLANT SCI, V160, P116, DOI 10.1086/314104; Finkel M, 2001, ISRAEL J PLANT SCI, V49, P285, DOI 10.1560/H8TG-HL9L-2D2P-TAGJ; GARRITY SD, 1984, ECOLOGY, V65, P559, DOI 10.2307/1941418; Graham JH, 2003, BIOL J LINN SOC, V80, P57, DOI 10.1046/j.1095-8312.2003.00220.x; GRAHAM JH, 1993, AM SOC TEST MATER, V1179, P136, DOI 10.1520/STP19239S; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Hagele BF, 2001, OECOLOGIA, V128, P228, DOI 10.1007/s004420100644; HELLER J, 1979, ZOOL J LINN SOC-LOND, V67, P115, DOI 10.1111/j.1096-3642.1979.tb01109.x; Heller J., 2009, LAND SNAILS LAND ISR; HUEY RB, 1979, AM ZOOL, V19, P357; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; Meiri S, 2004, BIOL J LINN SOC, V81, P579, DOI 10.1111/j.1095-8312.2004.00310.x; NEVO E, 1981, OECOLOGIA, V48, P199, DOI 10.1007/BF00347965; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 1998, ACTA THERIOL, P9; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Pavlicek T, 2008, BIOL J LINN SOC, V93, P147; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pfeiffer K. L., 1949, Archiv fuer Molluskenkunde Frankfurt, V77, P1; Ponder WF, 2008, PHYLOGENY EVOLUTION; Prange HD, 1996, J INSECT PHYSIOL, V42, P493, DOI 10.1016/0022-1910(95)00126-3; Rankevich D, 1996, ISR J ZOOL, V42, P425; RANKEVICH D., 1997, GENETIC VARIATION RE; Raz S, 2011, BIOL J LINN SOC, V102, P786, DOI 10.1111/j.1095-8312.2011.01615.x; REMMERT H, 1981, OECOLOGIA, V50, P12, DOI 10.1007/BF00378789; Riddle W.A., 1983, P431; Schmidt-Nielsen K., 1964, DESERT ANIMALS PHYSL; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SCHMIDTNIELSEN K, 1971, J EXP BIOL, V55, P385; Urban K., 2011, ADV GENETIC RES, P67; Warburg M. R., 1965, Proceedings of the Malacological Society of London, V36, P297; YOMTOV Y, 1970, ECOLOGY, V51, P907, DOI 10.2307/1933987	50	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41840	10.1371/journal.pone.0041840	http://dx.doi.org/10.1371/journal.pone.0041840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848631	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600052
J	van Oosterhout, JJ; Mallewa, J; Kaunda, S; Chagoma, N; Njalale, Y; Kampira, E; Mukaka, M; Heyderman, RS				van Oosterhout, Joep J.; Mallewa, Jane; Kaunda, Symon; Chagoma, Newton; Njalale, Yassin; Kampira, Elizabeth; Mukaka, Mavuto; Heyderman, Robert S.			Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; AIDS CARE PROGRAM; SOUTH-AFRICA; PROSPECTIVE COHORT; RURAL UGANDA; REGIMENS; LIPODYSTROPHY; TUBERCULOSIS; PREVALENCE; WOMEN	Background: Stavudine is an effective and inexpensive antiretroviral drug, but no longer recommended by WHO for first-line antiretroviral regimens in resource-limited settings due to toxicity concerns. Because of the high cost of alternative drugs, it has not been feasible to replace stavudine in most adults in the Malawi ART programme. We aimed to provide policy makers with a detailed picture of stavudine toxicities in Malawians on longer-term ART, in order to facilitate prioritization of stavudine replacement among other measures to improve the quality of ART programmes. Methods: Prospective cohort of Malawian adults who had just completed one year of stavudine containing ART in an urban clinic, studying peripheral neuropathy, lipodystrophy, diabetes mellitus, high lactate syndromes, pancreatitis and dyslipidemia during 12 months follow up. Stavudine dosage was 30 mg irrespective of weight. Cox regression was used to determine associations with incident toxicities. Results: 253 patients were enrolled, median age 36 years, 62.5% females. Prevalence rates (95%-confidence interval) of toxicities after one year on stavudine were: peripheral neuropathy 21.3% (16.5-26.9), lipodystrophy 14.7% (2.4-8.1), high lactate syndromes 0.0% (0-1.4), diabetes mellitus 0.8% (0-2.8), pancreatitis 0.0% (0-1.5). Incidence rates per 100 person-years (95%-confidence interval) during the second year on stavudine were: peripheral neuropathy 19.8 (14.3-26.6), lipodystrophy 11.4 (7.5-16.3), high lactate syndromes 2.1 (0.7-4.9), diabetes mellitus 0.4 (0.0-1.4), pancreatitis 0.0 (0.0-0.2). Prevalence of hypercholesterolemia and hypertriglyceridemia increased from 12.1% to 21.1% and from 29.5% to 37.6% respectively between 12 and 24 months. 5.5% stopped stavudine, 1.3% died and 4.0% defaulted during follow up. Higher age was an independent risk factor for incident peripheral neuropathy and lipodystrophy. Conclusion: Stavudine associated toxicities continued to accumulate during the second year of ART, especially peripheral neuropathy and lipodystrophy and more so at increasing age. Our findings support investments for replacing stavudine in first-line regimens in sub-Saharan Africa.	[van Oosterhout, Joep J.; Mallewa, Jane; Kaunda, Symon; Chagoma, Newton; Mukaka, Mavuto; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [van Oosterhout, Joep J.; Mallewa, Jane; Njalale, Yassin; Heyderman, Robert S.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [Kampira, Elizabeth] Univ Malawi, Coll Med, Dept Pathol, Blantyre, Malawi; [Kampira, Elizabeth] Univ Cape Town, Fac Hlth Sci, Div Human Genet, ZA-7925 Cape Town, South Africa	University of Malawi; University of Malawi; University of Malawi; University of Cape Town	van Oosterhout, JJ (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	joepvanoosterhout@gmail.com			Malawi-Liverpool Wellcome Trust Clinical Research Programme Core Grant	Malawi-Liverpool Wellcome Trust Clinical Research Programme Core Grant	This study was funded by the Malawi-Liverpool Wellcome Trust Clinical Research Programme Core Grant (there was no grant number for this study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bendavid E, 2011, AIDS, V25, P211, DOI 10.1097/QAD.0b013e328340fdf8; Bolhaar MG, 2007, CLIN INFECT DIS, V45, P254, DOI 10.1086/518976; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Castelnuovo B, 2011, JAIDS-J ACQ IMM DEF, V56, P59, DOI 10.1097/QAI.0b013e3181f5bd03; Department of HIV and AIDS Ministry of Health, 2012, Q REP ANT TREATM PRO; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forna F, 2007, JAIDS-J ACQ IMM DEF, V44, P456, DOI 10.1097/QAI.0b013e318033ffa1; Geng EH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-46; Harries AD, 2004, T ROY SOC TROP MED H, V98, P695, DOI 10.1016/j.trstmh.2004.05.002; Harries AD, 2004, BMJ-BRIT MED J, V329, P1163, DOI 10.1136/bmj.329.7475.1163; Hoffmann CJ, 2009, AIDS, V23, P1784, DOI 10.1097/QAD.0b013e32832e0585; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Menezes CN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-244; Ministry of Health Government of Malawi, 2011, CLIN MAN HIV CHILDR; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Somanje C, 2011, NATION          0409; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P148, DOI 10.1016/j.trstmh.2009.07.009; Westreich DJ, 2009, CLIN INFECT DIS, V48, P1617, DOI 10.1086/598977; WHO, 2010, ART HIV INF AD AD RE; World Health Organization, 2006, DEF DIAGN DIAB MELL	26	35	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e42029	10.1371/journal.pone.0042029	http://dx.doi.org/10.1371/journal.pone.0042029			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848696	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600063
J	Fortier, P; Suei, S; Kreplak, L				Fortier, Patrick; Suei, Sandy; Kreplak, Laurent			Nanoscale Strain-Hardening of Keratin Fibres	PLOS ONE			English	Article							NANOMECHANICAL PROPERTIES; PROTEIN FIBERS; DEFORMATION; INDENTATION; MODEL; POLYMERS; MODULUS; HAIR; WOOL	Mammalian appendages such as hair, quill and wool have a unique structure composed of a cuticle, a cortex and a medulla. The cortex, responsible for the mechanical properties of the fibers, is an assemblage of spindle-shaped keratinized cells bound together by a lipid/protein sandwich called the cell membrane complex. Each cell is itself an assembly of macrofibrils around 300 nm in diameter that are paracrystalline arrays of keratin intermediate filaments embedded in a sulfur-rich protein matrix. Each macrofibril is also attached to its neighbors by a cell membrane complex. In this study, we combined atomic force microscopy based nano-indentation with peak-force imaging to study the nanomechanical properties of macrofibrils perpendicular to their axis. For indentation depths in the 200 to 500 nm range we observed a decrease of the dynamic elastic modulus at 1 Hz with increasing depth. This yielded an estimate of 1.6GPa for the lateral modulus at 1 Hz of porcupine quill's macrofibrils. Using the same data we also estimated the dynamic elastic modulus at 1 Hz of the cell membrane complex surrounding each macrofibril, i.e., 13GPa. A similar estimate was obtained independently through elastic maps of the macrofibrils surface obtained in peak-force mode at 1 kHz. Furthermore, the macrofibrillar texture of the cortical cells was clearly identified on the elasticity maps, with the boundaries between macrofibrils being 40-50% stiffer than the macrofibrils themselves. Elasticity maps after indentation also revealed a local increase in dynamic elastic modulus over time indicative of a relaxation induced strain hardening that could be explained in term of a alpha-helix to beta-sheet transition within the macrofibrils.	[Fortier, Patrick; Suei, Sandy; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada	Dalhousie University	Fortier, P (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.	kreplak@dal.ca		kreplak, laurent/0000-0001-9370-9809	Natural Sciences and Engineering Research Council; Canadian Fund for Innovation; Human Frontier of Science Program	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Fund for Innovation; Human Frontier of Science Program(Human Frontier Science Program)	LK acknowledges funding from Natural Sciences and Engineering Research Council discovery grants, Canadian Fund for Innovation and a Young investigator grant from the Human Frontier of Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDIT EG, 1957, NATURE, V179, P535, DOI 10.1038/179535a0; Briki F, 1998, BBA-PROTEIN STRUCT M, V1429, P57, DOI 10.1016/S0167-4838(98)00216-7; Carey BJ, 2011, ACS NANO, V5, P2715, DOI 10.1021/nn103104g; Chou SF, 2011, MAT SCI ENG C-MATER, V31, P1729, DOI 10.1016/j.msec.2011.08.002; Delafargue A, 2004, INT J SOLIDS STRUCT, V41, P7351, DOI 10.1016/j.ijsolstr.2004.06.019; Feughelman M, 2002, J APPL POLYM SCI, V83, P489, DOI 10.1002/app.2255; Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591; Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4; Harland DP, 2011, J MICROSC-OXFORD, V243, P184, DOI 10.1111/j.1365-2818.2011.03493.x; HEARLE JWS, 1969, TEXT RES J, V39, P1109, DOI 10.1177/004051756903901205; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0; Kreplak L, 2001, BIOPOLYMERS, V58, P526, DOI 10.1002/1097-0282(20010415)58:5<526::AID-BIP1028>3.0.CO;2-L; LAGAKOS N, 1986, J APPL PHYS, V59, P4017, DOI 10.1063/1.336707; MULLER VM, 1983, COLLOID SURFACE, V7, P251, DOI 10.1016/0166-6622(83)80051-1; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Paquin R, 2007, J RAMAN SPECTROSC, V38, P11; Parbhu AN, 1999, BIOCHEMISTRY-US, V38, P11755, DOI 10.1021/bi990746d; Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011; Prasad KE, 2011, ACTA MATER, V59, P4343, DOI 10.1016/j.actamat.2011.03.058; Qin Z, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425101; Qin Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007294; ROGERS GE, 1959, ANN NY ACAD SCI, V83, P378; Sneddon I.N., 1965, INT J ENG SCI, V3, P11; Tabor D, 1951, HARDNESS METALS, Vfirst; Yashima E, 2008, MACROMOLECULES, V41, P3, DOI 10.1021/ma071453s; Zahn H, 1980, IND ENG CHEM PROD RD, V19, P6	27	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41814	10.1371/journal.pone.0041814	http://dx.doi.org/10.1371/journal.pone.0041814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848616	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600125
J	Guo, YM; Jiang, F; Peng, L; Zhang, J; Geng, FH; Xu, JM; Zhen, CM; Shen, XM; Tong, SL				Guo, Yuming; Jiang, Fan; Peng, Li; Zhang, Jun; Geng, Fuhai; Xu, Jianming; Zhen, Canming; Shen, Xiaoming; Tong, Shilu			The Association between Cold Spells and Pediatric Outpatient Visits for Asthma in Shanghai, China	PLOS ONE			English	Article							AIR-POLLUTION; CARDIOVASCULAR MORTALITY; LUNG-FUNCTION; TEMPERATURE; PREVALENCE; SYMPTOMS; CHILDREN; WEATHER; CLIMATE; IMPACT	Background: Asthma is a serious global health problem. However, few studies have investigated the relationship between cold spells and pediatric outpatient visits for asthma. Objective: To examine the association between cold spells and pediatric outpatient visits for asthma in Shanghai, China. Methods: We collected daily data on pediatric outpatient visits for asthma, mean temperature, relative humidity, and ozone from Shanghai between 1 January 2007 and 31 December 2009. We defined cold spells as four or more consecutive days with temperature below the 5th percentile of temperature during 2007-2009. We used a Poisson regression model to examine the impact of temperature on pediatric outpatient visits for asthma in cold seasons during 2007 and 2009. We examined the effect of cold spells on asthma compared with non-cold spell days. Results: There was a significant relationship between cold temperatures and pediatric outpatient visits for asthma. The cold effects on children's asthma were observed at different lags. The lower the temperatures, the higher the risk for asthma attacks among children. Conclusion: Cold temperatures, particularly cold spells, significantly increase the risk of pediatric outpatient visits for asthma. The findings suggest that asthma children need to be better protected from cold effects in winter.	[Guo, Yuming; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Guo, Yuming; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Jiang, Fan; Shen, Xiaoming] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Translat Med, Dept Dev & Behav Pediat, Shanghai Childrens Med Ctr,Sch Med, Shanghai 200030, Peoples R China; [Jiang, Fan; Zhang, Jun; Shen, Xiaoming] Shanghai Jiao Tong Univ, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp, Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Peng, Li; Geng, Fuhai; Xu, Jianming; Zhen, Canming] Shanghai Meteorol Bur, Shanghai, Peoples R China	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Shanghai Jiao Tong University; Shanghai Jiao Tong University	Guo, YM (corresponding author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	xmshen@shsmu.edu.cn; s.tong@qut.edu.au	Jiang, Fan/AGX-9052-2022; Guo, Yuming/I-8353-2018; Jiang, Fan/AHA-6297-2022	Jiang, Fan/0000-0003-0634-101X; Guo, Yuming/0000-0002-1766-6592; 	Shanghai Science and Technology Committee [10231203903]; MOE-Shanghai Key Laboratory of Children's Environmental Health [10DZ2272200]; QUT Postgraduate Research Award (QUTPRA); NHMRC Research Fellowship [553043]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); MOE-Shanghai Key Laboratory of Children's Environmental Health; QUT Postgraduate Research Award (QUTPRA); NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by Shanghai Science and Technology Committee (10231203903), MOE-Shanghai Key Laboratory of Children's Environmental Health (10DZ2272200). YG is supported by the QUT Postgraduate Research Award (QUTPRA); ST is supported by a NHMRC Research Fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, AM J EMERG MED, V27, P153, DOI 10.1016/j.ajem.2008.01.013; Andersen ZJ, 2011, THORAX; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; BATES DV, 1995, ENVIRON HEALTH PERSP, V103, P49, DOI 10.2307/3432345; Donaldson GC, 1999, EUR RESPIR J, V13, P844, DOI 10.1034/j.1399-3003.1999.13d25.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Epton MJ, 1997, THORAX, V52, P528, DOI 10.1136/thx.52.6.528; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Guo YM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-36; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Guo YM, 2010, SCI TOTAL ENVIRON, V409, P300, DOI 10.1016/j.scitotenv.2010.10.013; Hales S, 1998, ENVIRON HEALTH PERSP, V106, P607, DOI 10.2307/3434236; Harju T, 2010, CLIN RESPIR J, V4, P176, DOI 10.1111/j.1752-699X.2009.00172.x; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Hwang BF, 2005, THORAX, V60, P467, DOI 10.1136/thx.2004.033977; Islam T, 2007, THORAX, V62, P957, DOI 10.1136/thx.2007.078964; Khadadah M, 2011, EUROPEAN J APPL PHYS, P1; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kysely J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-19; Larsson K, 1998, EUR RESPIR J, V12, P825, DOI 10.1183/09031936.98.12040825; Lee YL, 2003, EUR RESPIR J, V21, P964, DOI 10.1183/09031936.03.00094602; Li M, 2011, J ALLERGY CLIN IMMUN, V128; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Ma W, 2012, INT J BIOMETEOROLOGY; Makinen TM, 2009, RESP MED, V103, P456, DOI 10.1016/j.rmed.2008.09.011; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mortimer KM, 2002, EUR RESPIR J, V19, P699, DOI 10.1183/09031936.02.00247102; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Ren C, 2008, OCCUP ENVIRON MED, V65, P255, DOI 10.1136/oem.2007.033878; Rosas I, 1998, ALLERGY, V53, P394, DOI 10.1111/j.1398-9995.1998.tb03911.x; ROSSI OVJ, 1993, THORAX, V48, P244, DOI 10.1136/thx.48.3.244; Shanghai Statistic Bureau, 2010, 6 NAT POP CENS SHANG; Tatum AJ, 2005, IMMUNOL ALLERGY CLIN, V25, P15, DOI 10.1016/j.iac.2004.09.003; Tong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037500; Wong GWK, 2004, BMJ-BRIT MED J, V329, P486, DOI 10.1136/bmj.329.7464.486; Wood S.N., 2001, R R NEWS, V1, P20; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]	40	57	61	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42232	10.1371/journal.pone.0042232	http://dx.doi.org/10.1371/journal.pone.0042232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848748	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600174
J	Thiel, J; Hollmann, J; Rutten, T; Weber, H; Scholz, U; Weschke, W				Thiel, Johannes; Hollmann, Julien; Rutten, Twan; Weber, Hans; Scholz, Uwe; Weschke, Winfriede			454 Transcriptome Sequencing Suggests a Role for Two-Component Signalling in Cellularization and Differentiation of Barley Endosperm Transfer Cells	PLOS ONE			English	Article							ARABIDOPSIS HISTIDINE KINASE; FEMALE GAMETOPHYTE DEVELOPMENT; B RESPONSE REGULATORS; ABSCISIC-ACID; ASP PHOSPHORELAY; SEED DEVELOPMENT; CYTOKININ; PROTEIN; EXPRESSION; STRESS	Background: Cell specification and differentiation in the endosperm of cereals starts at the maternal-filial boundary and generates the endosperm transfer cells (ETCs). Besides the importance in assimilate transfer, ETCs are proposed to play an essential role in the regulation of endosperm differentiation by affecting development of proximate endosperm tissues. We attempted to identify signalling elements involved in early endosperm differentiation by using a combination of laser-assisted microdissection and 454 transcriptome sequencing. Principal Findings: 454 sequencing of the differentiating ETC region from the syncytial state until functionality in transfer processes captured a high proportion of novel transcripts which are not available in existing barley EST databases. Intriguingly, the ETC-transcriptome showed a high abundance of elements of the two-component signalling (TCS) system suggesting an outstanding role in ETC differentiation. All components and subfamilies of the TCS, including distinct kinds of membrane-bound receptors, have been identified to be expressed in ETCs. The TCS system represents an ancient signal transduction system firstly discovered in bacteria and has previously been shown to be co-opted by eukaryotes, like fungi and plants, whereas in animals and humans this signalling route does not exist. Transcript profiling of TCS elements by qRT-PCR suggested pivotal roles for specific phosphorelays activated in a coordinated time flow during ETC cellularization and differentiation. ETC-specificity of transcriptionally activated TCS phosphorelays was assessed for early differentiation and cellularization contrasting to an extension of expression to other grain tissues at the beginning of ETC maturation. Features of candidate genes of distinct phosphorelays and transcriptional activation of genes putatively implicated in hormone signalling pathways hint at a crosstalk of hormonal influences, putatively ABA and ethylene, and TCS signalling. Significance: Our findings suggest an integral function for the TCS in ETC differentiation possibly coupled to sequent hormonal regulation by ABA and ethylene.	[Thiel, Johannes; Rutten, Twan; Weber, Hans; Scholz, Uwe; Weschke, Winfriede] Leibniz Inst Pflanzengenet & Kulturpflanzenforsch, Gatersleben, Germany; [Hollmann, Julien] Univ Kiel, Inst Bot, D-2300 Kiel, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Kiel	Thiel, J (corresponding author), Leibniz Inst Pflanzengenet & Kulturpflanzenforsch, Gatersleben, Germany.	thielj@ipk-gatersleben.de	Bruckmüller, Julien/C-8973-2011; Weber, Hans/T-4818-2018	Bruckmüller, Julien/0000-0002-3900-9833; Rutten, Twan/0000-0001-5891-6503; Weber, Hans/0000-0003-3831-3267; Scholz, Uwe/0000-0001-6113-3518	Deutsche Forschungsgemeinschaft (DFG) [We 1608/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (We 1608/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Dibley SJ, 2009, NEW PHYTOL, V182, P863, DOI 10.1111/j.1469-8137.2009.02822.x; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Gruis D, 2006, PLANT PHYSIOL, V142, P1771; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Hejatko J, 2003, MOL GENET GENOMICS, V269, P443, DOI 10.1007/s00438-003-0858-7; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Muniz LM, 2006, PLANT J, V48, P17, DOI 10.1111/j.1365-313X.2006.02848.x; Muniz LM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-84; Neuberger T, 2008, PLANT BIOTECHNOL J, V6, P31, DOI 10.1111/j.1467-7652.2007.00294.x; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Pischke MS, 2002, P NATL ACAD SCI USA, V99, P15800, DOI 10.1073/pnas.232580499; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Roder MS, 2006, GENOME, V49, P1209, DOI 10.1139/G06-093; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Schaller GE, 2007, PLANT PHYSIOL, V143, P555, DOI 10.1104/pp.106.093666; Schaller G Eric, 2008, Arabidopsis Book, V6, pe0112, DOI 10.1199/tab.0112; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Schikora A, 2002, PLANTA, V215, P304, DOI 10.1007/s00425-002-0738-0; Schmid MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029685; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Sreenivasulu N, 2010, PLANT J, V64, P589, DOI 10.1111/j.1365-313X.2010.04350.x; Thiel J, 2008, PLANT PHYSIOL, V148, P1436, DOI 10.1104/pp.108.127001; Thiel J, 2012, PLANT J, V71, P639, DOI 10.1111/j.1365-313X.2012.05018.x; Thiel J, 2011, METHODS MOL BIOL, V755, P461, DOI 10.1007/978-1-61779-163-5_39; Thiel J, 2009, PLANTA, V230, P205, DOI 10.1007/s00425-009-0935-1; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Torti S, 2012, PLANT CELL, V24, P444, DOI 10.1105/tpc.111.092791; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tsai AYL, 2012, PLANT J, V69, P809, DOI 10.1111/j.1365-313X.2011.04832.x; Urao T, 2000, FEBS LETT, V478, P227, DOI 10.1016/S0014-5793(00)01860-3; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	62	28	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41867	10.1371/journal.pone.0041867	http://dx.doi.org/10.1371/journal.pone.0041867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848641	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600137
J	Morrison, G; Mahadevan, L				Morrison, Greg; Mahadevan, L.			Discovering Communities through Friendship	PLOS ONE			English	Article							NETWORK; RESOLUTION; EVOLUTION; PHYSICS	We introduce a new method for detecting communities of arbitrary size in an undirected weighted network. Our approach is based on tracing the path of closest-friendship between nodes in the network using the recently proposed Generalized Erdos Numbers. This method does not require the choice of any arbitrary parameters or null models, and does not suffer from a system-size resolution limit. Our closest-friend community detection is able to accurately reconstruct the true network structure for a large number of real world and artificial benchmarks, and can be adapted to study the multi-level structure of hierarchical communities as well. We also use the closeness between nodes to develop a degree of robustness for each node, which can assess how robustly that node is assigned to its community. To test the efficacy of these methods, we deploy them on a variety of well known benchmarks, a hierarchal structured artificial benchmark with a known community and robustness structure, as well as real-world networks of coauthorships between the faculty at a major university and the network of citations of articles published in Physical Review. In all cases, microcommunities, hierarchy of the communities, and variable node robustness are all observed, providing insights into the structure of the network.	[Morrison, Greg; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Morrison, G (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	gmorriso@seas.harvard.edu		Morrison, Greg/0000-0002-1400-8092				Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bilke S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.036106; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen P, 2010, J INFORMETR, V4, P278, DOI 10.1016/j.joi.2010.01.001; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2008, PHYS REV E, V70; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kumpula JM, 2007, EUR PHYS J B, V56, P41, DOI 10.1140/epjb/e2007-00088-4; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Morrison G, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/40002; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Porter MA, 2007, PHYSICA A, V386, P414, DOI 10.1016/j.physa.2007.07.039; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Wu F, 2004, EUR PHYS J B, V38, P331, DOI 10.1140/epjb/e2004-00125-x; Yan Koon-Kiu, 2010, Proc Natl Acad Sci U S A, V107, P9186, DOI 10.1073/pnas.0914771107	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e38704	10.1371/journal.pone.0038704	http://dx.doi.org/10.1371/journal.pone.0038704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977GL	22859934	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000306644600003
J	Rani, A; Pandita, E; Rahman, S; Deep, S; Sau, AK				Rani, Anjana; Pandita, Esha; Rahman, Safikur; Deep, Shashank; Sau, Apurba Kumar			Insight into Temperature Dependence of GTPase Activity in Human Guanylate Binding Protein-1	PLOS ONE			English	Article							INHIBITION; STABILITY; HGBP1; GMP; PH	Interferon-gamma induced human guanylate binding protein-1(hGBP1) belongs to a family of dynamin related large GTPases. Unlike all other GTPases, hGBP1 hydrolyzes GTP to a mixture of GDP and GMP with GMP being the major product at 37 degrees C but GDP became significant when the hydrolysis reaction was carried out at 15 degrees C. The hydrolysis reaction in hGBP1 is believed to involve with a number of catalytic steps. To investigate the effect of temperature in the product formation and on the different catalytic complexes of hGBP1, we carried out temperature dependent GTPase assays, mutational analysis, chemical and thermal denaturation studies. The Arrhenius plot for both GDP and GMP interestingly showed nonlinear behaviour, suggesting that the product formation from the GTP-bound enzyme complex is associated with at least more than one step. The negative activation energy for GDP formation and GTPase assay with external GDP together indicate that GDP formation occurs through the reversible dissociation of GDP-bound enzyme dimer to monomer, which further reversibly dissociates to give the product. Denaturation studies of different catalytic complexes show that unlike other complexes the free energy of GDP-bound hGBP1 decreases significantly at lower temperature. GDP formation is found to be dependent on the free energy of the GDP-bound enzyme complex. The decrease in the free energy of this complex at low temperature compared to at high is the reason for higher GDP formation at low temperature. Thermal denaturation studies also suggest that the difference in the free energy of the GTP-bound enzyme dimer compared to its monomer plays a crucial role in the product formation; higher stability favours GMP but lower favours GDP. Thus, this study provides the first thermodynamic insight into the effect of temperature in the product formation of hGBP1.	[Rani, Anjana; Pandita, Esha; Rahman, Safikur; Sau, Apurba Kumar] Natl Inst Immunol, New Delhi 110067, India; [Deep, Shashank] Indian Inst Technol, Dept Chem, New Delhi 110016, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Rani, A (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	apurbaksau@gmail.com	Rahman, Safikur/K-1264-2019	Rahman, Safikur/0000-0002-6282-8706	National Institute of Immunology; Department of Biotechnology, India	National Institute of Immunology; Department of Biotechnology, India(Department of Biotechnology (DBT) India)	The work was supported by core funding of the National Institute of Immunology and Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdullah N, 2010, BIOPHYS J, V99, P2235, DOI 10.1016/j.bpj.2010.07.025; Abdullah N, 2009, J MOL BIOL, V386, P690, DOI 10.1016/j.jmb.2008.12.060; Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; CHENG YSE, 1991, MOL CELL BIOL, V11, P4717, DOI 10.1128/MCB.11.9.4717; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Fang JD, 1995, P SOC EXP BIOL MED, V210, P242; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Johnson KA., 2003, KINETIC ANAL MACROMO; Kamal JKA, 2002, BIOCHEMISTRY-US, V41, P9034, DOI 10.1021/bi025621e; KHURANA R, 1995, PROTEIN SCI, V4, P1133, DOI 10.1002/pro.5560040612; Kunzelmann S, 2006, J BIOL CHEM, V281, P28627, DOI 10.1074/jbc.M604911200; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; MONDAL MS, 1994, BIOCHEMISTRY-US, V33, P10305, DOI 10.1021/bi00200a010; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Qiao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-107; SCHWEMMLE M, 1994, J BIOL CHEM, V269, P11299; Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200; Skugor M, 2006, THYROID DISORDERS CL; Sujak A, 2007, BIOPHYS J, V93, P2845, DOI 10.1529/biophysj.106.101162; Wilson ED, 1992, WILSONS TEMPERATURE	26	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40487	10.1371/journal.pone.0040487	http://dx.doi.org/10.1371/journal.pone.0040487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22859948	Green Submitted, Green Published, gold			2022-12-27	WOS:000306362400061
J	Cortez, C; Yoshida, N; Bahia, D; Sobreira, TJP				Cortez, Cristian; Yoshida, Nobuko; Bahia, Diana; Sobreira, Tiago J. P.			Structural Basis of the Interaction of a Trypanosoma cruzi Surface Molecule Implicated in Oral Infection with Host Cells and Gastric Mucin	PLOS ONE			English	Article							ACUTE CHAGAS-DISEASE; METACYCLIC TRYPOMASTIGOTES; ESCHERICHIA-COLI; TRANS-SIALIDASE; HELA-CELLS; INVASION; BINDING; ADHESION; TRANSMISSION; PROTEIN	Host cell invasion and dissemination within the host are hallmarks of virulence for many pathogenic microorganisms. As concerns Trypanosoma cruzi, which causes Chagas disease, the insect vector-derived metacyclic trypomastigotes (MT) initiate infection by invading host cells, and later blood trypomastigotes disseminate to diverse organs and tissues. Studies with MT generated in vitro and tissue culture-derived trypomastigotes (TCT), as counterparts of insect-borne and bloodstream parasites, have implicated members of the gp85/trans-sialidase superfamily, MT gp82 and TCT Tc85-11, in cell invasion and interaction with host factors. Here we analyzed the gp82 structure/function characteristics and compared them with those previously reported for Tc85-11. One of the gp82 sequences identified as a cell binding site consisted of an a-helix, which connects the N-terminal beta-propeller domain to the C-terminal beta-sandwich domain where the second binding site is nested. In the gp82 structure model, both sites were exposed at the surface. Unlike gp82, the Tc85-11 cell adhesion sites are located in the N-terminal beta-propeller region. The gp82 sequence corresponding to the epitope for a monoclonal antibody that inhibits MT entry into target cells was exposed on the surface, upstream and contiguous to the alpha-helix. Located downstream and close to the alpha-helix was the gp82 gastric mucin binding site, which plays a central role in oral T. cruzi infection. The sequences equivalent to Tc85-11 laminin-binding sites, which have been associated with the parasite ability to overcome extracellular matrices and basal laminae, was poorly conserved in gp82, compatible with its reduced capacity to bind laminin. Our study indicates that gp82 is structurally suited for MT to initiate infection by the oral route, whereas Tc85-11, with its affinity for laminin, would facilitate the parasite dissemination through diverse organs and tissues.	[Cortez, Cristian; Yoshida, Nobuko; Bahia, Diana] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Sobreira, Tiago J. P.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Cortez, C (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	nyoshida@unifesp.br	Yoshida, Nobuko/AAL-6082-2020; Sobreira, Tiago/C-1276-2008; Bahia, Diana/W-3974-2019; cortez, cristian/GLT-4441-2022	Yoshida, Nobuko/0000-0002-3925-8557; Sobreira, Tiago/0000-0002-0217-0084; Cortez, Cristian/0000-0003-1887-0808	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61450-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [300578/2010-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP #2006/61450-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #300578/2010-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Alves MJM, 2007, IUBMB LIFE, V59, P274, DOI 10.1080/15216540701200084; Alves Maria Julia M., 2008, V47, P58; Amaya MF, 2003, J MOL BIOL, V325, P773, DOI 10.1016/S0022-2836(02)01306-2; ARAYA JE, 1994, MOL BIOCHEM PARASIT, V65, P161, DOI 10.1016/0166-6851(94)90124-4; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Claser C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-68; Cortez M, 2006, MICROBES INFECT, V8, P36, DOI 10.1016/j.micinf.2005.05.016; Cortez M, 2006, MICROBES INFECT, V8, P1502, DOI 10.1016/j.micinf.2006.01.007; Covarrubias C, 2007, INT J PARASITOL, V37, P1609, DOI 10.1016/j.ijpara.2007.05.013; de Goes Cavalcanti LP, 2009, CAD SAUDE COLET, V17, P911; Dias JP, 2008, REV SOC BRAS MED TRO, V41, P296, DOI 10.1590/S0037-86822008000300014; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; Hoft DF, 1996, INFECT IMMUN, V64, P3800, DOI 10.1128/IAI.64.9.3800-3810.1996; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Maeda FY, 2011, ACTA TROP, V120, P231, DOI 10.1016/j.actatropica.2011.09.001; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Manque PM, 2000, INFECT IMMUN, V68, P478, DOI 10.1128/IAI.68.2.478-484.2000; Marroquin-Quelopana M, 2004, BIOCHEM BIOPH RES CO, V325, P612, DOI 10.1016/j.bbrc.2004.10.068; Martins RM, 2011, CELL MICROBIOL, V13, P943, DOI 10.1111/j.1462-5822.2011.01590.x; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Beltrao HDM, 2009, TROP DOCT, V39, P231, DOI 10.1258/td.2009.090035; MORTARA RA, 1992, INFECT IMMUN, V60, P4673, DOI 10.1128/IAI.60.11.4673-4678.1992; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Neira I, 2003, INFECT IMMUN, V71, P557, DOI 10.1128/IAI.71.1.557-561.2003; Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450; OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2; Pereira CM, 1999, INFECT IMMUN, V67, P4908, DOI 10.1128/IAI.67.9.4908-4911.1999; Rajkumar R, 1998, MOL CELL BIOCHEM, V178, P261, DOI 10.1023/A:1006844125976; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Staquicini DI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000613; Steindel M, 2008, DIAGN MICR INFEC DIS, V60, P25, DOI 10.1016/j.diagmicrobio.2007.07.016; Sudha PS, 2001, CURR MICROBIOL, V42, P381; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X; VALKONEN KH, 1991, MOL MICROBIOL, V5, P2133, DOI 10.1111/j.1365-2958.1991.tb02143.x; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Yoshida N, 2008, PARASITOL INT, V57, P105, DOI 10.1016/j.parint.2007.12.008	44	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42153	10.1371/journal.pone.0042153	http://dx.doi.org/10.1371/journal.pone.0042153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860068	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600060
J	Hendrie, CA; Brewer, G				Hendrie, Colin A.; Brewer, Gayle			Evidence to Suggest That Teeth Act as Human Ornament Displays Signalling Mate Quality	PLOS ONE			English	Article							TOOTH COLOR; BIRTH-WEIGHT; CARDIOVASCULAR-DISEASE; DENTAL-HEALTH; HEART-DISEASE; FETAL-GROWTH; SKIN COLOR; WOMEN; AGE; DISCOLORATION	Ornament displays seen in animals convey information about genetic quality, developmental history and current disease state to both prospective sexual partners and potential rivals. In this context, showing of teeth through smiles etc is a characteristic feature of human social interaction. Tooth development is influenced by genetic and environmental factors. Adult teeth record environmental and traumatic events, as well as the effects of disease and ageing. Teeth are therefore a rich source of information about individuals and their histories. This study examined the effects of digital manipulations of tooth colour and spacing. Results showed that deviation away from normal spacing and/or the presence of yellowed colouration had negative effects on ratings of attractiveness and that these effects were markedly stronger in female models. Whitening had no effect beyond that produced by natural colouration. This indicates that these colour induced alterations in ratings of attractiveness are mediated by increased/decreased yellowing rather than whitening per se. Teeth become yellower and darker with age. Therefore it is suggested that whilst the teeth of both sexes act as human ornament displays, the female display is more complex because it additionally signals residual reproductive value.	[Hendrie, Colin A.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Brewer, Gayle] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England	University of Leeds; University of Central Lancashire	Hendrie, CA (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	c.a.hendrie@leeds.ac.uk		Brewer, Gayle/0000-0003-0690-4548				Alkhatib MN, 2004, J DENT, V32, P561, DOI 10.1016/j.jdent.2004.06.002; ANDERSSON M, 1982, NATURE, V299, P818, DOI 10.1038/299818a0; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 1996, LANCET, V334, P577; Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014; Baydas B, 2005, EUR J ORTHODONT, V27, P98, DOI 10.1093/ejo/cjh088; BENDICH A, 1993, ANN NY ACAD SCI, V691, P61, DOI 10.1111/j.1749-6632.1993.tb26157.x; Bonato M, 2009, ANIM BEHAV, V77, P1033, DOI 10.1016/j.anbehav.2009.02.008; Boyce WT, 2010, SOC SCI MED, V71, P1644, DOI 10.1016/j.socscimed.2010.07.045; Brook AH, 2009, ARCH ORAL BIOL, V54, pS3, DOI 10.1016/j.archoralbio.2009.09.005; BROOK AH, 1984, ARCH ORAL BIOL, V29, P373, DOI 10.1016/0003-9969(84)90163-8; Cerqueira DF, 2008, ORAL SURG ORAL MED O, V105, P353, DOI 10.1016/j.tripleo.2007.05.032; Chatrchaiwiwatana S, 2007, PUBLIC HEALTH, V121, P106, DOI 10.1016/j.puhe.2006.06.010; Clarke LH, 2009, J WOMEN AGING, V21, P198, DOI 10.1080/08952840903054757; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DeSantis M, 2000, PSYCHOLOGY, V37, P21; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; FEARNE JM, 1993, EARLY HUM DEV, V33, P81, DOI 10.1016/0378-3782(93)90203-7; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Fink Bernhard, 2008, J Cosmet Dermatol, V7, P155, DOI 10.1111/j.1473-2165.2008.00382.x; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Gangestad SW., 1997, EVOLUTIONARY SOCIAL, P169; GARN SM, 1965, J DENT RES, V44, P439, DOI 10.1177/00220345650440022201; Godoy R, 2005, J ECON PSYCHOL, V26, P469, DOI 10.1016/j.joep.2004.10.004; GOODKIND RJ, 1987, J PROSTHET DENT, V58, P535, DOI 10.1016/0022-3913(87)90380-5; GORANSSON G, 1990, ANIM BEHAV, V40, P89, DOI 10.1016/S0003-3472(05)80668-2; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hall JA., 1986, PSYCHOL GENDER ADV M, P136; Hamalainen P, 2003, EUR J ORAL SCI, V111, P291, DOI 10.1034/j.1600-0722.2003.00055.x; Hassan A K, 2000, East Mediterr Health J, V6, P511; Hess U., 2002, EMPIRICAL REFLECTION, P187; Hill GE, 1999, AM NAT, V154, P589, DOI 10.1086/303264; HILL GE, 1994, P ROY SOC B-BIOL SCI, V258, P47, DOI 10.1098/rspb.1994.0140; HILL GE, 1990, ANIM BEHAV, V40, P563, DOI 10.1016/S0003-3472(05)80537-8; Hofel L, 2007, INT J PERIODONT REST, V27, P349; Houser M. L., 2007, HUMAN COMMUNICATION, V10, P69; Jahangiri L, 2002, J PROSTHET DENT, V87, P149, DOI 10.1067/mpr.2002.121109; Jansson L, 2001, J CLIN PERIODONTOL, V28, P762, DOI 10.1034/j.1600-051X.2001.280807.x; Joiner A, 2004, J DENT, V32, P3, DOI 10.1016/j.jdent.2003.10.013; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kim JM, 2007, INT J GERIATR PSYCH, V22, P850, DOI 10.1002/gps.1750; Koeppel LB., 1993, INTERPERSONAL COMMUN, P13; Kotsomitis N, 1996, Aust Orthod J, V14, P172; KOWALSKI RM, 1993, SEX ROLES, V29, P13, DOI 10.1007/BF00289994; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Krumhuber E, 2009, J NONVERBAL BEHAV, V33, P1, DOI 10.1007/s10919-008-0056-8; Lee HK, 2010, ARCH GERONTOL GERIAT, V50, P30, DOI 10.1016/j.archger.2009.01.005; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Marlowe FW, 1998, HUM NATURE-INT BIOS, V9, P263, DOI 10.1007/s12110-998-1005-2; Massaro M, 2003, BEHAV ECOL SOCIOBIOL, V55, P169, DOI 10.1007/s00265-003-0683-3; Mehu M, 2008, BEHAVIOUR, V145, P1747, DOI 10.1163/156853908786279619; Mitsuyoshi Y, 2011, JPN DENT SCI REV, V47, P157, DOI 10.1016/j.jdsr.2011.01.001; MOLLER AP, 1994, J PARASITOL, V80, P850, DOI 10.2307/3283433; MOORE MM, 1985, ETHOL SOCIOBIOL, V6, P237, DOI 10.1016/0162-3095(85)90016-0; Morley J, 1997, CURR OPIN COSMET D, V4, P35; MORSE C, 1982, J PSYCHOL, V110, P3, DOI 10.1080/00223980.1982.9915318; NAVEH Y, 1976, J MED GENET, V13, P277, DOI 10.1136/jmg.13.4.277; Newton JT, 2003, INT J PROSTHODONT, V16, P429; Odioso L L, 2000, Compend Contin Educ Dent Suppl, pS35; Okamoto N, 2010, BRAIN RES, V1349, P68, DOI 10.1016/j.brainres.2010.06.054; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Penin X, 2002, AM J PHYS ANTHROPOL, V118, P50, DOI 10.1002/ajpa.10044; Pfeiffer RA, 1964, Z KINDERHEILKD, V90, P301; Preuschoft S., 1997, NONVERBAL COMMUNICAT, P171; Qualtrough A J, 1994, Quintessence Int, V25, P7; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; Schmidt Christopher J, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P254, DOI 10.1097/01.moo.0000233596.68928.39; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Stein PS, 2007, J AM DENT ASSOC, V138, P1314, DOI 10.14219/jada.archive.2007.0046; Sulieman M, 2005, Dent Update, V32, P463; TENBOSCH JJ, 1995, J DENT RES, V74, P374, DOI 10.1177/00220345950740011401; Thornhill R, 1997, BIOL REV, V72, P497, DOI 10.1017/S0006323197005082; Thornton GR, 1943, J SOC PSYCHOL, V18, P127, DOI 10.1080/00224545.1943.9921704; Tosun G, 2009, J CLIN PEDIATR DENT, V34, P71, DOI 10.17796/jcpd.34.1.kr015833p1qg6873; Vallittu PK, 1996, J DENT, V24, P335, DOI 10.1016/0300-5712(95)00079-8; Van't Spijker A, 2009, INT J PROSTHODONT, V22, P35; Verhaegen M., 2007, ECOLOGY RES PROGR, P155; Watts A, 2001, BRIT DENT J, V190, P309, DOI 10.1038/sj.bdj.4800959a; Xiao J, 2007, J ORAL REHABIL, V34, P351, DOI 10.1111/j.1365-2842.2007.01729.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	89	18	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42178	10.1371/journal.pone.0042178	http://dx.doi.org/10.1371/journal.pone.0042178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860076	Green Published, gold, Green Accepted			2022-12-27	WOS:000307045600067
J	Kasson, TMD; Rexroth, S; Barry, BA				Kasson, Tina M. Dreaden; Rexroth, Sascha; Barry, Bridgette A.			Light-Induced Oxidative Stress, N-Formylkynurenine, and Oxygenic Photosynthesis	PLOS ONE			English	Article							EVOLVING PHOTOSYSTEM-II; SPINACH THYLAKOID MEMBRANES; BINDING PROTEIN CP43; CRYSTAL-STRUCTURE; TRYPTOPHAN OXIDATION; OXIDIZED TRYPTOPHAN; MEDIATED DAMAGE; D1 PROTEIN; IN-VIVO; PHOTOINHIBITION	Light stress in plants results in damage to the water oxidizing reaction center, photosystem II (PSII). Redox signaling, through oxidative modification of amino acid side chains, has been proposed to participate in this process, but the oxidative signals have not yet been identified. Previously, we described an oxidative modification, N-formylkynurenine (NFK), of W365 in the CP43 subunit. The yield of this modification increases under light stress conditions, in parallel with the decrease in oxygen evolving activity. In this work, we show that this modification, NFK365-CP43, is present in thylakoid membranes and may be formed by reactive oxygen species produced at the Mn4CaO5 cluster in the oxygen-evolving complex. NFK accumulation correlates with the extent of photoinhibition in PSII and thylakoid membranes. A modest increase in ionic strength inhibits NFK365-CP43 formation, and leads to accumulation of a new, light-induced NFK modification (NFK317) in the D1 polypeptide. Western analysis shows that D1 degradation and oligomerization occur under both sets of conditions. The NFK modifications in CP43 and D1 are found 17 and 14 Angstrom from the Mn4CaO5 cluster, respectively. Based on these results, we propose that NFK is an oxidative modification that signals for damage and repair in PSII. The data suggest a two pathway model for light stress responses. These pathways involve differential, specific, oxidative modification of the CP43 or D1 polypeptides.	[Kasson, Tina M. Dreaden; Barry, Bridgette A.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kasson, Tina M. Dreaden; Barry, Bridgette A.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Rexroth, Sascha] Ruhr Univ Bochum, Dept Biol, Bochum, Germany	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Ruhr University Bochum	Kasson, TMD (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	bridgette.barry@chemistry.gatech.edu	Rexroth, Sascha/H-3702-2011	Rexroth, Sascha/0000-0003-3819-2127	National Science Foundation [MCB 08-42246]; Direct For Biological Sciences [0842246] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Grant from National Science Foundation: MCB 08-42246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ANDERSON JM, 1994, PHOTOSYNTH RES, V41, P315, DOI 10.1007/BF00019409; Anderson LB, 2000, J BIOL CHEM, V275, P4920, DOI 10.1074/jbc.275.7.4920; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Barry BA, 2011, J PHOTOCH PHOTOBIO B, V104, P60, DOI 10.1016/j.jphotobiol.2011.01.026; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boda D, 2007, BIOPHYS J, V93, P1960, DOI 10.1529/biophysj.107.105478; Bollag DM, 1991, PROTEIN METHODS; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Dreaden TM, 2011, J BIOL CHEM, V286, P22632, DOI 10.1074/jbc.M110.212928; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Fedorova M, 2010, PROTEOMICS, V10, P2692, DOI 10.1002/pmic.201000147; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Giessauf A, 1996, FEBS LETT, V389, P136; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Helland R, 2008, J BIOL CHEM, V283, P13897, DOI 10.1074/jbc.M800340200; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HILLIER W, 1993, PHOTOSYNTH RES, V38, P417, DOI 10.1007/BF00046769; HIND G, 1974, P NATL ACAD SCI USA, V71, P1484, DOI 10.1073/pnas.71.4.1484; Huesgen PF, 2006, FEBS LETT, V580, P6929, DOI 10.1016/j.febslet.2006.11.058; Hunzinger C, 2006, J PROTEOME RES, V5, P625, DOI 10.1021/pr050377+; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Johnson PE, 1998, BIOCHEMISTRY-US, V37, P12772, DOI 10.1021/bi980978x; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Krieger A, 1998, BIOCHEMISTRY-US, V37, P16262, DOI 10.1021/bi981243v; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MACDONALD GM, 1995, J BIOL CHEM, V270, P8420, DOI 10.1074/jbc.270.15.8420; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Mizusawa N, 2003, BIOCHEMISTRY-US, V42, P10034, DOI 10.1021/bi0300534; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; MORI H, 1995, BBA-BIOENERGETICS, V1228, P37, DOI 10.1016/0005-2728(94)00156-Y; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Ouellette AJA, 1998, P NATL ACAD SCI USA, V95, P2204, DOI 10.1073/pnas.95.5.2204; Patsikka E, 2002, PLANT PHYSIOL, V129, P1359, DOI 10.1104/pp.004788; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; PREVIERO A, 1967, J MOL BIOL, V24, P261, DOI 10.1016/0022-2836(67)90331-2; Rexroth S, 2012, BBA-BIOENERGETICS, V1817, P381, DOI 10.1016/j.bbabio.2011.11.006; Rinalducci S, 2005, J PROTEOME RES, V4, P2327, DOI 10.1021/pr0502368; Rochu D, 2004, BIOCHEM J, V380, P627, DOI 10.1042/BJ20031861; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Rozak PR, 2002, PLANT CELL ENVIRON, V25, P421, DOI 10.1046/j.0016-8025.2001.00823.x; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; SIMAT T, 1994, J CHROMATOGR A, V661, P93, DOI 10.1016/0021-9673(94)85180-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VIRGIN I, 1988, FEBS LETT, V233, P408, DOI 10.1016/0014-5793(88)80472-1; WAGGONER CM, 1989, FEBS LETT, V244, P237, DOI 10.1016/0014-5793(89)81200-1; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	68	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42220	10.1371/journal.pone.0042220	http://dx.doi.org/10.1371/journal.pone.0042220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860088	gold, Green Submitted, Green Published			2022-12-27	WOS:000307045600075
J	Panter, J; Griffin, S; Ogilvie, D				Panter, Jenna; Griffin, Simon; Ogilvie, David			Correlates of Reported and Recorded Time Spent in Physical Activity in Working Adults: Results from the Commuting and Health in Cambridge Study	PLOS ONE			English	Article							ACCELEROMETRY; PEDOMETER; VALIDITY; WALKING	Background: The correlates of physical activity in adults are relatively well studied. However, many studies use self-reported ('reported') measures of activity and we know little about the possible differences between the correlates of reported and objective ('recorded') measures of physical activity. We compared the correlates of reported and recorded time spent in moderate-to-vigorous physical activity (MVPA) in a sample of working adults. Methods: In 2009, participants in the Commuting and Health in Cambridge study completed questionnaires assessing individual, socio-demographic, health and contextual characteristics. Recorded time spent in MVPA over seven days was ascertained using accelerometers and reported time spent in MVPA was assessed using the Recent Physical Activity Questionnaire (RPAQ). Correlates of MVPA were investigated using sex-specific linear regression models. Results: 486 participants (70% women) provided both reported and recorded physical activity data. 89% recorded at least 30 minutes of MVPA per day. In men, none of the potential explanatory variables were associated with both reported and recorded time spent in MVPA. In women, of all the potential explanatory variables only that of having a standing or manual occupation was associated with both reported (+42 min/day; 95% CI 16.4 to 68.4, p = 0.001) and recorded (+9 min/day; 95% CI: 3.5 to 15.7, p = 0.002) time spent in MVPA. Discussion: The use of an objective measure of physical activity may influence the correlates which are observed. Researchers may wish to consider using and analysing recorded and reported measures in combination to gain a more complete view of the correlates of physical activity.	[Panter, Jenna] MRC, Epidemiol Unit, Cambridge, England; UKCRC Ctr Diet & Act Res CEDAR, Inst Publ Hlth, Cambridge, England	University of Cambridge	Panter, J (corresponding author), MRC, Epidemiol Unit, Cambridge, England.	jenna.panter@mrc-epid.cam.ac.uk	Griffin, Simon/K-3106-2013	Griffin, Simon/0000-0002-2157-4797; Ogilvie, David/0000-0002-0270-4672	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; National Institute for Health Research Public Health Research programme [09/3001/06]; Medical Research Council [U106179474]; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_U106179474] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); National Institute for Health Research Public Health Research programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Commuting and Health in Cambridge study was developed by David Ogilvie, Simon Griffin, Andy Jones and Roger Mackett and initially funded under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The study is now funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/06: see http://www.phr.nihr.ac.uk/funded_projects). David Ogilvie and Simon Griffin are supported by the Medical Research Council [Unit Programme number U106179474]. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Bibby P., 2004, DEV NEW CLASSIFICATI; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cleland VJ, 2011, J SCI MED SPORT, V14, P496, DOI 10.1016/j.jsams.2011.04.006; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; Department for Communities and Local Government, 2005, GEN LAND US DAT STAT; Department of Health, 2011, START ACT STAY ACT R; Duncan MJ, 2005, INT J BEHAV NUTR PHY, V2; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Ishii K, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-61; Janz KF, 2006, BRIT J SPORT MED, V40, P191, DOI 10.1136/bjsm.2005.023036; Krenn PJ, 2011, AM J PREV MED, V41, P508, DOI 10.1016/j.amepre.2011.06.046; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Ogilvie D, 2010, J PHYS ACT HEALTH, V7, pS341, DOI 10.1123/jpah.7.s3.s341; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sallis J.F., 2002, ECOLOGICAL MODELS HL; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Van Dyck D, 2011, INT J BEHAV MED, V18, P235, DOI 10.1007/s12529-010-9127-4; Ware JE Jr, 2001, SCORE INTERPRET SING; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42202	10.1371/journal.pone.0042202	http://dx.doi.org/10.1371/journal.pone.0042202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860083	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600072
J	Gobec, M; Obreza, A; Prijatelj, M; Brus, B; Gobec, S; Mlinaric-Rascan, I				Gobec, Martina; Obreza, Ales; Prijatelj, Matevz; Brus, Boris; Gobec, Stanislav; Mlinaric-Rascan, Irena			Selective Cytotoxicity of Amidinopiperidine Based Compounds Towards Burkitt's Lymphoma Cells Involves Proteasome Inhibition	PLOS ONE			English	Article							NF-KAPPA-B; SERINE PROTEASES; APOPTOSIS; TARGET; PATHWAY; DESIGN; DEATH; LINES	Serine proteases have proven to be promising pharmacological targets in contemporary drug discovery for cancer treatment. Since azaphenylalanine-based compounds manifest cytotoxic activity, we have selected serine protease inhibitors designed and synthesized in-house with large hydrophobic naphthalene moiety for screening. The cytotoxic potential of screened molecules was correlated to modifications of R-1 residues. The most cytotoxic were compounds with greater basicity; amidinopiperidines, piperidines and benzamidines. Amidinopiperidine-based compounds exert cytotoxicity in low mu M range, with IC50 18 mu M and 22 mu M for inhibitors 15 and 16 respectively. These compounds exhibited selective cytotoxicity towards the Burkitt's lymphoma cells Ramos and Daudi, and proved nontoxic to PMBC, Jurkat and U937. They induce caspase-dependent apoptotic cell death, as demonstrated by the use of a pan-caspase inihibitor, zVADfmk, which was able to rescue Ramos cells from compound(s)-induced apoptosis. We confirm a disruption of the pro-survival pathway in Burkitt's lymphoma through NF kappa B inhibition. The accumulation of phosphorylated precursor (p105) and inhibitory (I kappa B) molecules with no subsequent release of active NFkB implicated the involvement of proteasome. Indeed, we show that the amidinopiperidine-based compounds inhibit all three proteolytical activities of the human 20S proteasome, with the most prominent effect being on the trypsin-like activity. Consistently, treatment of Ramos cells with these compounds led to an increase in ubiquitinated proteins. The amidinopiperidine-based serine protease inhibitors presented are, as selective inducers of apoptosis in Burkitt's lymphoma cells, promising leads for the development of novel chemotherapeutics.	[Gobec, Martina; Obreza, Ales; Prijatelj, Matevz; Brus, Boris; Gobec, Stanislav; Mlinaric-Rascan, Irena] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia	University of Ljubljana	Gobec, M (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	irena.mlinaric@ffa.uni-lj.si		Gobec, Martina/0000-0002-9476-601X; Gobec, Stanislav/0000-0002-9678-3083; Mlinaric-Rascan, Irena/0000-0002-7459-3502	Slovenian Research Agency grants [0787-P208]	Slovenian Research Agency grants(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency grants (No. 0787-P208; MG-research fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Celhar T, 2009, EUR J PHARMACOL, V602, P15, DOI 10.1016/j.ejphar.2008.11.008; Chen SJ, 1998, MOL CELL BIOCHEM, V178, P141, DOI 10.1023/A:1006893528428; de Koning PJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022645; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Frisan T, 2000, INT J CANCER, V88, P881, DOI 10.1002/1097-0215(20001215)88:6<881::AID-IJC7>3.0.CO;2-D; Gaczynska Maria, 2005, V301, P3; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara SS, 1996, EXP CELL RES, V223, P372, DOI 10.1006/excr.1996.0092; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jaulent AM, 2004, PROTEIN ENG DES SEL, V17, P681, DOI 10.1093/protein/gzh077; Jazirehi AR, 2005, CANCER RES, V65, P264; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keutgens A, 2006, BIOCHEM PHARMACOL, V72, P1069, DOI 10.1016/j.bcp.2006.06.011; KIM HK, 1995, J IMMUNOL, V154, P4741; King MA, 2004, CELL CYCLE, V3, P1566, DOI 10.4161/cc.3.12.1276; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Moffitt KL, 2007, BIOCHEM SOC T, V35, P559, DOI 10.1042/BST0350559; Murn J, 2004, GENES CELLS, V9, P1103, DOI 10.1111/j.1365-2443.2004.00794.x; Nazari M, 2011, EUR J PHARMACOL, V650, P526, DOI 10.1016/j.ejphar.2010.10.053; O'Connell AR, 2006, EXP CELL RES, V312, P27, DOI 10.1016/j.yexcr.2005.10.003; Obreza A, 2005, CHEMINFORM, V6; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Schonfeld-Dado E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025919; Smolnikar I, 2007, PHARMAZIE, V62, P243, DOI 10.1691/ph.2007.4.6547; Stenson-Cox C, 2003, BIOCHEM PHARMACOL, V66, P1469, DOI 10.1016/S0006-2952(03)00499-4; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Trapani JA, 2001, GENOME BIOL, V2; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang LW, 2008, CLIN CANCER RES, V14, P3503, DOI 10.1158/1078-0432.CCR-07-5150; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wu Kwou-Yeung, 1996, Kaohsiung Journal of Medical Sciences, V12, P388; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x	44	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41961	10.1371/journal.pone.0041961	http://dx.doi.org/10.1371/journal.pone.0041961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860040	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900056
J	Larsen, M; Sauce, D; Arnaud, L; Fastenackels, S; Appay, V; Gorochov, G				Larsen, Martin; Sauce, Delphine; Arnaud, Laurent; Fastenackels, Solene; Appay, Victor; Gorochov, Guy			Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index	PLOS ONE			English	Article							CD8(+) T-CELLS; HIV; RESPONSES; VACCINE; IMMUNIZATION; PROGRESSION; PROTECTION; INDUCTION; CORRELATE; POLLEN	Functional evaluation of naturally occurring or vaccination-induced T cell responses in mice, men and monkeys has in recent years advanced from single-parameter (e.g. IFN-gamma-secretion) to much more complex multidimensional measurements. Co-secretion of multiple functional molecules (such as cytokines and chemokines) at the single-cell level is now measurable due primarily to major advances in multiparametric flow cytometry. The very extensive and complex datasets generated by this technology raise the demand for proper analytical tools that enable the analysis of combinatorial functional properties of T cells, hence polyfunctionality. Presently, multidimensional functional measures are analysed either by evaluating all combinations of parameters individually or by summing frequencies of combinations that include the same number of simultaneous functions. Often these evaluations are visualized as pie charts. Whereas pie charts effectively represent and compare average polyfunctionality profiles of particular T cell subsets or patient groups, they do not document the degree or variation of polyfunctionality within a group nor does it allow more sophisticated statistical analysis. Here we propose a novel polyfunctionality index that numerically evaluates the degree and variation of polyfuntionality, and enable comparative and correlative parametric and non-parametric statistical tests. Moreover, it allows the usage of more advanced statistical approaches, such as cluster analysis. We believe that the polyfunctionality index will render polyfunctionality an appropriate end-point measure in future studies of T cell responsiveness.	[Larsen, Martin; Sauce, Delphine; Arnaud, Laurent; Fastenackels, Solene; Appay, Victor; Gorochov, Guy] INSERM, UMR S 945, Paris, France; [Larsen, Martin; Sauce, Delphine; Fastenackels, Solene; Appay, Victor; Gorochov, Guy] Univ Paris 06, Paris, France; [Arnaud, Laurent] Hop La Pitie Salpetriere, AP HP, Serv Med Interne, Paris, France; [Appay, Victor; Gorochov, Guy] Lab AP HP Immunol Cellulaire & Tissulaire, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP)	Larsen, M (corresponding author), INSERM, UMR S 945, Paris, France.	Martin.Larsen@upmc.fr	Appay, Victor/M-4830-2017; Appay, Victor/AAM-7701-2021; Gorochov, Guy/P-2911-2017; sauce, delphine/H-1990-2014; Larsen, Martin/A-7316-2014; SAUCE, Delphine/ABE-5975-2020	sauce, delphine/0000-0003-4596-7373; Larsen, Martin/0000-0003-1375-4816; SAUCE, Delphine/0000-0003-4596-7373; Appay, Victor/0000-0001-5434-3963; ARNAUD, Laurent/0000-0002-8077-8394; Gorochov, Guy/0000-0003-2097-9677	Inserm; Universite Pierre et Marie Curie "EMERGENCE'' program; European FP6 "ATTACK'' program [LSHC-CT-2005-018914]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie "EMERGENCE'' program; European FP6 "ATTACK'' program	The study was supported by Inserm, the Universite Pierre et Marie Curie "EMERGENCE'' program and by the European FP6 "ATTACK'' program (Contract: LSHC-CT-2005-018914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Appay Victor, 2008, P59, DOI 10.1007/978-3-7643-8334-3_6; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; Boulet S, 2007, J IMMUNOL METHODS, V320, P18, DOI 10.1016/j.jim.2006.11.010; Crack LR, 2011, CLIN EXP ALLERGY; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Ferrando-Martinez S, 2012, J VIROL; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Frey O, 2010, ANN RHEUM DIS, V69, P1495, DOI 10.1136/ard.2009.119164; Gasser O, 2009, AM J TRANSPLANT, V9, P794, DOI 10.1111/j.1600-6143.2008.02539.x; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Larsen M, 2011, EUR J IMMUNOL, V41, P2596, DOI 10.1002/eji.201041131; Lindstedt M, 2005, INT IMMUNOL, V17, P401, DOI 10.1093/intimm/dxh220; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Mittag D, 2010, J IMMUNOL, V184, P4708, DOI 10.4049/jimmunol.0901036; Mkhwanazi N, 2010, VIROLOGY, V405, P483, DOI 10.1016/j.virol.2010.06.002; Newell EW, 2012, IMMUNITY; Nomura T, 2012, J VIROL, V86, P6481, DOI 10.1128/JVI.07077-11; Papagno L, 2007, J IMMUNOL METHODS, V328, P182, DOI 10.1016/j.jim.2007.09.001; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Sauce D, 2009, J VIROL, V83, P9068, DOI 10.1128/JVI.00141-09; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Smith C, 2009, J VIROL, V83, P6192, DOI 10.1128/JVI.00239-09; Streeck H, 2011, BLOOD, V117, P5112, DOI 10.1182/blood-2010-12-321588; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	43	61	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42403	10.1371/journal.pone.0042403	http://dx.doi.org/10.1371/journal.pone.0042403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860124	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900091
J	Srinivasan, C; Dardick, C; Callahan, A; Scorza, R				Srinivasan, Chinnathambi; Dardick, Chris; Callahan, Ann; Scorza, Ralph			Plum (Prunus domestica) Trees Transformed with Poplar FT1 Result in Altered Architecture, Dormancy Requirement, and Continuous Flowering	PLOS ONE			English	Article							GENE; L.; GROWTH; PEACH; OVEREXPRESSION; ARABIDOPSIS; EXPRESSION; PHENOTYPE; IDENTITY; POPULUS	The Flowering Locus T1 (FT1) gene from Populus trichocarpa under the control of the 35S promoter was transformed into European plum (Prunus domestica L). Transgenic plants expressing higher levels of FT flowered and produced fruits in the greenhouse within 1 to 10 months. FT plums did not enter dormancy after cold or short day treatments yet field planted FT plums remained winter hardy down to at least -10 degrees C. The plants also displayed pleiotropic phenotypes atypical for plum including shrub-type growth habit and panicle flower architecture. The flowering and fruiting phenotype was found to be continuous in the greenhouse but limited to spring and fall in the field. The pattern of flowering in the field correlated with lower daily temperatures. This apparent temperature effect was subsequently confirmed in growth chamber studies. The pleitropic phenotypes associated with FT1 expression in plum suggests a fundamental role of this gene in plant growth and development. This study demonstrates the potential for a single transgene event to markedly affect the vegetative and reproductive growth and development of an economically important temperate woody perennial crop. We suggest that FT1 may be a useful tool to modify temperate plants to changing climates and/or to adapt these crops to new growing areas.	[Srinivasan, Chinnathambi; Dardick, Chris; Callahan, Ann; Scorza, Ralph] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA	United States Department of Agriculture (USDA)	Srinivasan, C (corresponding author), ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA.	chris.dardick@ars.usda.gov			USDA-ARS; USDA NIFA Specialty Crops Research Initiative [0220036]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA NIFA Specialty Crops Research Initiative	This work was funded by the USDA-ARS and a grant from the USDA NIFA Specialty Crops Research Initiative (#0220036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielenberg DG, 2004, J HERED, V95, P436, DOI 10.1093/jhered/esh057; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Byrne DH, 1992, TEXAS HORTICULTURIST, V19, P8; Byrne DH, 1992, TEXAS HORTICULTURIST, V19, P5; Diaz M.D., 1974, PROC 19 INT HORT C, V18, P525; Endo T, 2005, TRANSGENIC RES, V14, P703, DOI 10.1007/s11248-005-6632-3; Flachowsky H, 2007, PLANT BREEDING, V126, P137, DOI 10.1111/j.1439-0523.2007.01344.x; Flachowsky H, 2009, PLANT BREEDING, V128, P217, DOI 10.1111/j.1439-0523.2008.01591.x; Flachowsky H, 2011, NEW PHYTOL, V192, P364, DOI 10.1111/j.1469-8137.2011.03813.x; Hoenicka H, 2008, PLANTA, V227, P1001, DOI 10.1007/s00425-007-0674-0; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Matsuda N, 2009, J JPN SOC HORTIC SCI, V78, P410, DOI 10.2503/jjshs1.78.410; Mimida N, 2011, TREE PHYSIOL, V31, P555, DOI 10.1093/treephys/tpr028; Mohamed R, 2010, PLANT J, V62, P674, DOI 10.1111/j.1365-313X.2010.04185.x; Petri C, 2008, MOL BREEDING, V22, P581, DOI 10.1007/s11032-008-9200-8; RODRIGUEZ J, 1994, J AM SOC HORTIC SCI, V119, P789; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Trankner C, 2010, PLANTA, V232, P1309, DOI 10.1007/s00425-010-1254-2; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wang Y, 2002, J HERED, V93, P352, DOI 10.1093/jhered/93.5.352; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	26	102	109	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40715	10.1371/journal.pone.0040715	http://dx.doi.org/10.1371/journal.pone.0040715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859952	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900010
J	Zhen, AJ; Du, J; Zhou, XH; Xiong, Y; Yu, XF				Zhen, Anjie; Du, Juan; Zhou, Xiaohong; Xiong, Yong; Yu, Xiao-Fang			Reduced APOBEC3H Variant Anti-Viral Activities Are Associated with Altered RNA Binding Activities	PLOS ONE			English	Article							CYTIDINE DEAMINASE APOBEC3H; VIRUS-LIKE PARTICLES; 7SL RNA; HIV-1 VIRIONS; LINE-1 RETROTRANSPOSITION; FUNCTIONAL IMPLICATIONS; ALU RETROTRANSPOSITION; INTRINSIC IMMUNITY; CRYSTAL-STRUCTURE; ENZYME APOBEC3G	APOBEC3H (A3H) is a member of the APOBEC3 family of proteins with varying activities against retroviruses and retrotransposons. The A3H gene contains several single nucleotide polymorphisms and up to seven haplotypes have been detected in humans. Although variations in anti-viral function among A3H haplotypes are not fully understood, only 15N105R-containing A3H variants are known to have potent activities against Vif-deficient HIV-1. Unique motif RLYY(F/Y)W of APOBEC3G (A3G) and APOBEC3F (A3F) required for 7SL RNA binding and HIV-1 incorporation is also conserved in all A3H variants. Like A3G, A3H HapII also demonstrated high binding affinity to host small RNAs such as 7SL and Y RNAs. Mutation of a critical amino acid, W115A resulted in reduced expression level, decreased affinity for 7SL RNA, impairment of virion packaging and reduced anti-viral activity. By comparison, A3H HapI had lower binding affinities to host small RNAs and reduced efficiency of virion incorporation, resulting in significantly reduced anti-viral activity. The SNP Delta N15 commonly found in A3H HapIII and HapIV abolished their abilities to associate with RNAs, and A3H HapII Delta 15N failed to package into HIV-1 virions or exhibited any anti-viral activity. Finally, we showed that A3H variants had distinct cellular localization patterns, which correlated with their different RNA binding affinities. Thus, Pol-III RNA such as 7SL RNA binding is a conserved feature of potent anti-HIV human APOBEC3 cytidine deaminases.	[Zhen, Anjie; Zhou, Xiaohong; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Du, Juan; Zhou, Xiaohong; Yu, Xiao-Fang] Jilin Univ, Affiliated Hosp 1, Jilin, Peoples R China; [Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jilin University; Yale University	Zhen, AJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA.	xfyu@jhsph.edu	Zhou, Xiaohong/B-3416-2012	Zhou, Xiaohong/0000-0003-0519-2550	NIH [5R01DA026150-04]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH 5R01DA026150-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cullen BR, 2003, MOL THER, V8, P525, DOI 10.1016/j.ymthe.2003.08.010; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Gourraud PA, 2011, HUM IMMUNOL, V72, P207, DOI 10.1016/j.humimm.2010.12.008; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Li MMH, 2011, J VIROL, V85, P8197, DOI 10.1128/JVI.00624-11; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Malim MH, 2006, CR BIOL, V329, P871, DOI 10.1016/j.crvi.2006.01.012; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Ooms M, 2010, J VIROL, V84, P7961, DOI 10.1128/JVI.00754-10; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; Wang T, 2008, VIROLOGY, V377, P71, DOI 10.1016/j.virol.2008.04.012; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang WY, 2008, CELL MICROBIOL, V10, P1662, DOI 10.1111/j.1462-5822.2008.01157.x; Zhang WY, 2010, J VIROL, V84, P12903, DOI 10.1128/JVI.01632-10; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09	55	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e38771	10.1371/journal.pone.0038771	http://dx.doi.org/10.1371/journal.pone.0038771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859935	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900002
J	Baral, V; Chaoui, A; Watanabe, Y; Goossens, M; Attie-Bitach, T; Marlin, S; Pingault, V; Bondurand, N				Baral, Viviane; Chaoui, Asma; Watanabe, Yuli; Goossens, Michel; Attie-Bitach, Tania; Marlin, Sandrine; Pingault, Veronique; Bondurand, Nadege			Screening of MITF and SOX10 Regulatory Regions in Waardenburg Syndrome Type 2	PLOS ONE			English	Article							CONSERVED NONCODING ELEMENTS; AUTOSOMAL SEX REVERSAL; NEURAL CREST; MELANOCYTE DEVELOPMENT; CAMPOMELIC DYSPLASIA; MUTATIONS; FOXD3; IDENTIFICATION; EXPRESSION; ENHANCER	Waardenburg syndrome (WS) is a rare auditory-pigmentary disorder that exhibits varying combinations of sensorineural hearing loss and pigmentation defects. Four subtypes are clinically defined based on the presence or absence of additional symptoms. WS type 2 (WS2) can result from mutations within the MITF or SOX10 genes; however, 70% of WS2 cases remain unexplained at the molecular level, suggesting that other genes might be involved and/or that mutations within the known genes escaped previous screenings. The recent identification of a deletion encompassing three of the SOX10 regulatory elements in a patient presenting with another WS subtype, WS4, defined by its association with Hirschsprung disease, led us to search for deletions and point mutations within the MITF and SOX10 regulatory elements in 28 yet unexplained WS2 cases. Two nucleotide variations were identified: one in close proximity to the MITF distal enhancer (MDE) and one within the U1 SOX10 enhancer. Functional analyses argued against a pathogenic effect of these variations, suggesting that mutations within regulatory elements of WS genes are not a major cause of this neurocristopathy.	[Baral, Viviane; Chaoui, Asma; Watanabe, Yuli; Goossens, Michel; Pingault, Veronique; Bondurand, Nadege] Hop Henri Mondor, INSERM, U955, Equipe11, F-94010 Creteil, France; [Baral, Viviane; Chaoui, Asma; Watanabe, Yuli; Goossens, Michel; Pingault, Veronique; Bondurand, Nadege] Univ Paris Est, Fac Med, Creteil, France; [Goossens, Michel; Pingault, Veronique] Hop H Mondor A Chenevier, AP HP, Serv Biochim & Genet, Creteil, France; [Attie-Bitach, Tania] Univ Paris 05, INSERM, U781, Hop Necker Enfants Malad, Paris, France; [Marlin, Sandrine] Hop Armand Trousseau, APHP, INSERM, Serv Genet,Ctr Reference Surdites Genet,U587, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Baral, V (corresponding author), Hop Henri Mondor, INSERM, U955, Equipe11, F-94010 Creteil, France.	nadege.bondurand@inserm.fr	Watanabe, Yuli/R-6082-2018; ATTIE-BITACH, Tania/K-1453-2017; Bondurand, Nadege/H-4737-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; Bondurand, Nadege/0000-0002-1531-1544; marlin, sandrine/0000-0002-4115-9806; Pingault, Veronique/0000-0001-7064-0765; Watanabe, Yuli/0000-0003-2264-4731	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche (ANR-JCJC)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR-JCJC)(French National Research Agency (ANR))	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM) and Agence Nationale de la Recherche (ANR-JCJC-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 2010, ANN NY ACAD SCI, V1214, P34, DOI 10.1111/j.1749-6632.2010.05878.x; Antonellis A, 2006, HUM MOL GENET, V15, P259, DOI 10.1093/hmg/ddi442; Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Arnheiter H, 2010, PIGM CELL MELANOMA R, V23, P729, DOI 10.1111/j.1755-148X.2010.00759.x; Benko S, 2011, J MED GENET, V48, P825, DOI 10.1136/jmedgenet-2011-100255; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 2012, EURO J HUMA IN PRESS; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Georg I, 2010, SEX DEV, V4, P321, DOI 10.1159/000320142; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Ignatius MS, 2008, DEV BIOL, V313, P568, DOI 10.1016/j.ydbio.2007.10.045; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Thomas AJ, 2009, DEVELOPMENT, V136, P1849, DOI 10.1242/dev.031989; Tsuchida S, 2009, VET J, V182, P283, DOI 10.1016/j.tvjl.2008.06.004; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wahlbuhl M, 2011, NUCL ACIDS RES; Watanabe KI, 2002, PIGM CELL RES, V15, P201, DOI 10.1034/j.1600-0749.2002.01080.x; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001	37	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41927	10.1371/journal.pone.0041927	http://dx.doi.org/10.1371/journal.pone.0041927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848661	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200129
J	Hale, LP; Greer, PK				Hale, Laura P.; Greer, Paula K.			A Novel Murine Model of Inflammatory Bowel Disease and Inflammation-Associated Colon Cancer with Ulcerative Colitis-Like Features	PLOS ONE			English	Article							INTERLEUKIN-10-DEFICIENT MICE; COLORECTAL-CANCER; MAINTENANCE THERAPY; CROHNS-DISEASE; INFLIXIMAB; CELLS; NEOPLASIA	Mutations that increase susceptibility to inflammatory bowel disease (IBD) have been identified in a number of genes in both humans and mice, but the factors that govern how these mutations contribute to IBD pathogenesis and result in phenotypic presentation as ulcerative colitis (UC) or Crohn disease (CD) are not well understood. In this study, mice deficient in both TNF and IL-10 (T/I mice) were found to spontaneously develop severe colitis soon after weaning, without the need for exogenous triggers. Colitis in T/I mice had clinical and histologic features similar to human UC, including a markedly increased risk of developing inflammation-associated colon cancer. Importantly, development of spontaneous colitis in these mice was prevented by antibiotic treatment. Consistent with the known role of Th17-driven inflammation in response to bacteria, T/I mice had elevated serumTh17-type cytokines when they developed spontaneous colitis and after systemic bacterial challenge via NSAID-induced degradation of the mucosal barrier. Although TNF production has been widely considered to be be pathogenic in IBD, these data indicate that the ability to produce normal levels of TNF actually protects against the spontaneous development of colitis in response to intestinal colonization by bacteria. The T/I mouse model will be useful for developing new rationally-based therapies to prevent and/or treat IBD and inflammation-associated colon cancer and may further provide important insights into the pathogenesis of UC in humans.	[Hale, Laura P.; Greer, Paula K.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Hale, LP (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	laura.hale@duke.edu			Duke University Department of Pathology; National Institutes of Health [R21-DK75522, R01-CA115480]; NATIONAL CANCER INSTITUTE [R01CA115480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075522] Funding Source: NIH RePORTER	Duke University Department of Pathology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Duke University Department of Pathology as well as by National Institutes of Health grants R21-DK75522 and R01-CA115480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chichlowski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012220; Chichlowski M, 2008, AM J PHYSIOL-GASTR L, V295, pG1139, DOI 10.1152/ajpgi.90516.2008; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ericsson AC, 2010, NEOPLASIA, V12, P1054, DOI 10.1593/neo.10940; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hale LP, 2007, HELICOBACTER, V12, P598, DOI 10.1111/j.1523-5378.2007.00552.x; Hale LP, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-4; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Mahadevan U, 2009, GASTROENTEROL CLIN N, V38, P629, DOI 10.1016/j.gtc.2009.07.006; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nahar IK, 2003, ANN PHARMACOTHER, V37, P1256, DOI 10.1345/aph.1C039; NORDENHOLTZ KE, 1995, AM J GASTROENTEROL, V90, P927; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Stallmach A, 2010, BEST PRACT RES CL GA, V24, P167, DOI 10.1016/j.bpg.2010.01.002; Sturlan S, 2001, CARCINOGENESIS, V22, P665, DOI 10.1093/carcin/22.4.665; Tang CL, 2012, IMMUNOLOGY, V135, P112, DOI 10.1111/j.1365-2567.2011.03522.x; van der Linde K, 2003, SCAND J GASTROENTERO, V38, P611, DOI 10.1080/00365520310003011; Wilke CM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-217	36	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41797	10.1371/journal.pone.0041797	http://dx.doi.org/10.1371/journal.pone.0041797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848611	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950200109
J	Hurtado, M; Vilanova, S; Plazas, M; Gramazio, P; Fonseka, HH; Fonseka, R; Prohens, J				Hurtado, Maria; Vilanova, Santiago; Plazas, Mariola; Gramazio, Pietro; Fonseka, H. Hemal; Fonseka, Ramya; Prohens, Jaime			Diversity and Relationships of Eggplants from Three Geographically Distant Secondary Centers of Diversity	PLOS ONE			English	Article							SOLANUM-MELONGENA L.; GENETIC DIVERSITY; SSR MARKERS; VARIETIES; GERMPLASM; DOMESTICATION; CONSERVATION; VARIABILITY; SOLANACEAE; COLLECTION	Eggplant (Solanum melongena L.) was domesticated in the Indo-Birmanian region, which is also the primary center of diversity for this crop. From there eggplant spread to other regions, and diversity accumulated in several secondary centers of diversity. We have assessed the diversity and relationships of 52 accessions of eggplant from three geographically distant secondary centers of diversity (China, Spain, and Sri Lanka) using 28 morphological descriptors and 12 highly polymorphic genomic SSRs. A wide variation was found for most morphological traits, and significant differences among the three centers of diversity were detected for 22 of these traits. The PCA analysis showed that eggplants from the three origins were morphologically differentiated, and accessions from each of the three secondary centers of diversity presented a typical combination of morphological characteristics. In this respect, discriminant analysis showed that accessions could be correctly classified to their origin using only six traits. The SSR characterization identified 110 alleles and allowed obtaining a unique genetic fingerprint for each accession. Many alleles were found to be private to each origin, but no universal alleles were found for any of the origins. The PCA analysis showed that the genetic differentiation among origins was less clear than for morphological traits, although the analysis of the population structure shows that accessions mostly group according to the origin, but also provides evidence of migration among the three secondary centers of diversity. The genetic diversity (HT) within each origin was high, ranging between H-T = 0.5400 (Sri Lanka) and H-T = 0.4943 (China), while the standardized genetic differentiation (G'(ST)) among origins was moderate (G'(ST) = 0.2657). The correlation between morphological and SSR distances was non-significant (r = 0.044), indicating that both data are complementary for the conservation of germplasm and breeding of eggplant. These results are relevant for the management of genetic resources, breeding programmes, and evolutionary studies of eggplant.	[Hurtado, Maria; Vilanova, Santiago; Plazas, Mariola; Gramazio, Pietro; Prohens, Jaime] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valencia, E-46071 Valencia, Spain; [Fonseka, H. Hemal] Hort Crop Res & Dev Inst, Gannoruwa, Sri Lanka; [Fonseka, Ramya] Univ Peradeniya, Dept Crop Sci, Fac Agr, Peradeniya, Sri Lanka	Universitat Politecnica de Valencia; University of Peradeniya	Hurtado, M (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valencia, E-46071 Valencia, Spain.	jprohens@btc.upv.es	De La O Plazas Ávila, Maria/AAA-8711-2019; vilanova, santiago/AAA-5743-2019; Gramazio, Pietro/O-3143-2017; Prohens, Jaime/H-2228-2015; Prohens, Jaime/ABF-1229-2021	De La O Plazas Ávila, Maria/0000-0001-8090-7312; vilanova, santiago/0000-0003-4939-9713; Gramazio, Pietro/0000-0003-2226-7999; Prohens, Jaime/0000-0003-1181-9065; Prohens, Jaime/0000-0003-1181-9065	Ministerio de Ciencia e innovacion [AGL2009-07257, RF-2008-00008-00-00]	Ministerio de Ciencia e innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was financed by the Ministerio de Ciencia e innovacion (grants AGL2009-07257 and RF-2008-00008-00-00) (http://www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; Ali Z, 2011, GENET MOL RES, V10, P1141, DOI 10.4238/vol10-2gmr1279; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Bai YL, 2007, ANN BOT-LONDON, V100, P1085, DOI 10.1093/aob/mcm150; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Behera TK, 2006, SCI HORTIC-AMSTERDAM, V107, P352, DOI 10.1016/j.scienta.2005.11.004; Bretting P.K., 1995, PL BRED RE, V13, P11; Burle ML, 2010, THEOR APPL GENET, V121, P801, DOI 10.1007/s00122-010-1350-5; Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535; D'Arcy WG, 1993, SOLANACEAE NWSL, V3, P3; Daunay Marie-Christine, 2008, P163; Daunay MC, 2007, CHRONICA HORTICULTUR, V47, P16; Demir K, 2010, GENET MOL RES, V9, P1568, DOI 10.4238/vol9-3gmr878; Doganlar S, 2002, GENETICS, V161, P1713; Doyle J. J., 1987, PHYTOCHEM B, P11; ERSKINE W, 1991, THEOR APPL GENET, V83, P119, DOI 10.1007/BF00229234; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Furini A, 2004, THEOR APPL GENET, V108, P197, DOI 10.1007/s00122-003-1439-1; Ge HY, 2011, AFR J BIOTECHNOL, V10, P9023; Geleta LF, 2005, BIODIVERS CONSERV, V14, P2361, DOI 10.1007/s10531-004-1669-9; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; ISSHIKI S, 1994, SCI HORTIC-AMSTERDAM, V59, P171, DOI 10.1016/0304-4238(94)90010-8; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Karihaloo J. L., 1995, Plant Genetic Resources Newsletter, P24; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Lester R. N., 1991, SOLANACEAE, P369; Li HZ, 2010, SCI HORTIC-AMSTERDAM, V125, P19, DOI 10.1016/j.scienta.2010.02.023; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; MANTEL N, 1967, CANCER RES, V27, P209; Massolo JF, 2011, POSTHARVEST BIOL TEC, V59, P10, DOI 10.1016/j.postharvbio.2010.08.007; Meyer RS, 2012, MOL PHYLOGENET EVOL, DOI [10.1016/j.y,pev.2012.02.006, DOI 10.1016/J.YPEV92012.02.006]; Munoz-Falcon JE, 2008, EUPHYTICA, V164, P405, DOI 10.1007/s10681-008-9688-3; Munoz-Falcon JE, 2009, ANN APPL BIOL, V154, P453, DOI 10.1111/j.1744-7348.2009.00314.x; Munoz-Falcon JE, 2011, SCI HORTIC-AMSTERDAM, V129, P238, DOI 10.1016/j.scienta.2011.03.034; Munoz-Falcon JE, 2009, J SCI FOOD AGR, V89, P320, DOI 10.1002/jsfa.3452; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN, DOI [10.7312/nei-92038, DOI 10.7312/NEI-92038]; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Pessarakli MM, 2004, J FOOD AGRIC ENVIRON, V2, P218; Polignano G, 2010, GENET RES CROP, V57, P111; Pritchard JK, 2000, GENETICS, V155, P945; Prohens J, 2005, J AM SOC HORTIC SCI, V130, P54, DOI 10.21273/JASHS.130.1.54; Rodriguez-Burruezo A, 2008, EUR J HORTIC SCI, V73, P76; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Silvestrini M, 2007, GENET RESOUR CROP EV, V54, P1367, DOI 10.1007/s10722-006-9122-4; Singh AP, 2009, FOOD CHEM, V114, P955, DOI 10.1016/j.foodchem.2008.10.048; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; Strelchenko P, 2010, JARQ-JPN AGR RES Q, V44, P259, DOI 10.6090/jarq.44.259; Tumbilen Y., 2011, International Research Journal of Biotechnology, V2, P016; Van der Weerden GM, 2007, ACTA HORTIC, P503, DOI 10.17660/ActaHortic.2007.745.37; van Hintum TJL, 2000, CORE COLLECTONS PLAN; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vetelainen M, 2005, GENET RESOUR CROP EV, V52, P999, DOI 10.1007/s10722-003-6129-y; Vilanova S., 2010, ADV GENETICS BREEDIN, P435; Vilanova S, 2012, MOL BREEDING, V30, P647, DOI 10.1007/s11032-011-9650-2; Wang JX, 2008, ANN BOT-LONDON, V102, P891, DOI 10.1093/aob/mcn179; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10	62	52	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41748	10.1371/journal.pone.0041748	http://dx.doi.org/10.1371/journal.pone.0041748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848589	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200099
J	Rettig, M; Trinidad, K; Pezeshkpour, G; Frost, P; Sharma, S; Moatamed, F; Tamanoi, F; Mortazavi, F				Rettig, Matthew; Trinidad, Kenny; Pezeshkpour, G.; Frost, Patrick; Sharma, Sherven; Moatamed, Farhad; Tamanoi, Fuyuhiko; Mortazavi, Fariborz			PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; RHO-FAMILY GTPASES; P120 CATENIN; ADAPTER PROTEINS; P21-ACTIVATED-KINASE-1 PAK1; CADHERIN EXPRESSION; ONCOGENE PRODUCT; P120-CATENIN; APOPTOSIS	The role of c-Crk (CRK) in promoting metastasis is well described however the role of CRK phosphorylation and the corresponding signaling events are not well explained. We have observed CRK-II serine 41 phosphorylation is inversely correlated with p120-catenin and E-cadherin expressions in non-small cell lung cancer (NSCLC) cells. Therefore, we investigated the role of CRK-II serine 41 phosphorylation in the down-regulation of p120-catenin, cell motility and cell invasiveness in NSCLC cells. For this purpose, we expressed phosphomimetic and phosphodeficient CRK-II serine 41 mutants in NSCLC cells. NSCLC cells expressing phosphomimetic CRK-II seine 41 mutant showed lower p120-catenin level while CRK-II seine 41 phosphodeficient mutant expression resulted in higher p120-catenin. In addition, A549 cells expressing CRK-II serine 41 phosphomimetic mutant demonstrated more aggressive behavior in wound healing and invasion assays and, on the contrary, expression of phosphodeficient CRK-II serine 41 mutant in A549 cells resulted in reduced cell motility and invasiveness. We also provide evidence that PAK1 mediates CRK-II serine 41 phosphorylation. RNAi mediated silencing of PAK1 increased p120-catenin level in A549 and H157 cells. Furthermore, PAK1 silencing decreased cell motility and invasiveness in A549 cells. These effects were abrogated in A549 cells expressing phosphomimetic CRK-II serine 41. In summary, these data provide evidence for the role of PAK1 in the promotion of cell motility, cell invasiveness and the down regulation of p120-catenin through CRK serine 41 phosphorylation in NSCLC cells.	[Rettig, Matthew; Trinidad, Kenny; Frost, Patrick; Mortazavi, Fariborz] W Los Angeles VA, Div Hematol Oncol, Los Angeles, CA USA; [Rettig, Matthew; Sharma, Sherven; Mortazavi, Fariborz] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Rettig, Matthew; Tamanoi, Fuyuhiko; Mortazavi, Fariborz] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Pezeshkpour, G.; Moatamed, Farhad] W Los Angeles VA, Dept Pathol, Los Angeles, CA USA; [Sharma, Sherven] W Los Angeles VA, Div Mol Med, Los Angeles, CA USA; [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Rettig, M (corresponding author), W Los Angeles VA, Div Hematol Oncol, Los Angeles, CA USA.	fredmortazavi@ucla.edu		Frost, Patrick/0000-0003-3348-5983				BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Chung Y, 2007, ANN SURG ONCOL, V14, P3260, DOI 10.1245/s10434-007-9511-8; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Escalante M, 2000, J BIOL CHEM, V275, P24787, DOI 10.1074/jbc.M000711200; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; HEMPSTEAD BL, 1994, MOL CELL BIOL, V14, P1964, DOI 10.1128/MCB.14.3.1964; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Kain KH, 2003, ONCOGENE, V22, P6071, DOI 10.1038/sj.onc.1206930; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mortazavi F, 2011, CLIN EXP METASTAS, V28, P391, DOI 10.1007/s10585-011-9378-8; Mortazavi F, 2010, MOL CANCER RES, V8, P762, DOI 10.1158/1541-7786.MCR-10-0004; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; rias-Romero LE, 2008, BIOLCELL, V100, P97; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; Schraml P, 2003, AM J PATHOL, V163, P985, DOI 10.1016/S0002-9440(10)63458-X; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shi CS, 2000, BLOOD, V95, P776, DOI 10.1182/blood.V95.3.776.003k23_776_782; Stofega MR, 2004, MOL BIOL CELL, V15, P2965, DOI 10.1091/mbc.E03-08-0604; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zegers MMP, 2003, EMBO J, V22, P4155, DOI 10.1093/emboj/cdg398; Zhai B, 2008, WORLD J GASTROENTERO, V14, P3739, DOI 10.3748/wjg.14.3739; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	49	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42012	10.1371/journal.pone.0042012	http://dx.doi.org/10.1371/journal.pone.0042012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848689	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200146
J	Bray, K; Mathew, R; Lau, A; Kamphorst, JJ; Fan, J; Chen, J; Chen, HY; Ghavami, A; Stein, M; DiPaola, RS; Zhang, DN; Rabinowitz, JD; White, E				Bray, Kevin; Mathew, Robin; Lau, Alexandria; Kamphorst, Jurre J.; Fan, Jing; Chen, Jim; Chen, Hsin-Yi; Ghavami, Anahita; Stein, Mark; DiPaola, Robert S.; Zhang, Donna; Rabinowitz, Joshua D.; White, Eileen			Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; TRANSCRIPTION FACTOR NRF2; PROGRAMMED NECROSIS; TARGETING AUTOPHAGY; METABOLIC STRESS; DEATH MECHANISMS; MAMMALIAN-CELLS; MOUSE MODELS; CANCER; COMPLEX	mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is required for survival to mTOR inhibition. In RCC4 cells, inhibition of mTOR with CCI-779 stimulates autophagy and eliminates RIP kinases (RIPKs) and this is blocked by autophagy inhibition, which induces RIPK-and ROS-dependent necroptosis in vitro and suppresses xenograft growth. Autophagy of mitochondria is required for cell survival since mTOR inhibition turns off Nrf2 antioxidant defense. Thus, coordinate mTOR and autophagy inhibition leads to an imbalance between ROS production and defense, causing necroptosis that may enhance cancer treatment efficacy.	[Bray, Kevin; Mathew, Robin; Chen, Jim; Chen, Hsin-Yi; Ghavami, Anahita; Stein, Mark; DiPaola, Robert S.; White, Eileen] Canc Inst New Jersey, New Brunswick, NJ USA; [Stein, Mark; DiPaola, Robert S.] Univ Med & Dent New Jersey, Div Med Oncol, Piscataway, NJ 08854 USA; [Lau, Alexandria; Zhang, Donna] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [White, Eileen] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Kamphorst, Jurre J.; Fan, Jing; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Arizona; Rutgers State University New Brunswick; Princeton University	White, E (corresponding author), Canc Inst New Jersey, New Brunswick, NJ USA.	whiteei@umdnj.edu	White, Eileen/ABD-6745-2021; Lau, Alexandria/AAG-4232-2020; Rabinowitz, Joshua/GPP-4019-2022; Zhang, Donna/B-1015-2012	White, Eileen/0000-0003-2961-3065; Rabinowitz, Joshua/0000-0002-1247-4727; Fan, Jing/0000-0002-5326-5358; Kamphorst, Jurre/0000-0002-2042-5474	National Institutes of Health [R37 CA53370, RO1 CA130893]; Department of Defense [W81XWH06-1-0514, W81XWH05]; NATIONAL CANCER INSTITUTE [R37CA053370, P30CA072720, R01CA163591, R01CA130893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (R37 CA53370 and RO1 CA130893) and Department of Defense (W81XWH06-1-0514 and W81XWH05). http://www.nih.gov/; http://www.defense.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2011, ONCOGENE, V30, P1855, DOI 10.1038/onc.2010.561; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; ANGLARD P, 1992, CANCER RES, V52, P348; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Edinger AL, 2003, CANCER RES, V63, P8451; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; GROSSMAN HB, 1985, J SURG ONCOL, V28, P237; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Horita H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003909; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hu X, 2007, AUTOPHAGY, V3, P490, DOI 10.4161/auto.4592; Hudes GR, 2009, CANCER, V115, P2313, DOI 10.1002/cncr.24239; Jin SK, 2008, AUTOPHAGY, V4, P563, DOI 10.4161/auto.5830; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Merchan JR, 2009, J CLIN ONCOL, V27; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Turcotte S, 2008, AUTOPHAGY, V4, P944, DOI 10.4161/auto.6785; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; White E, 2012, NAT REV CANC; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	74	113	115	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41831	10.1371/journal.pone.0041831	http://dx.doi.org/10.1371/journal.pone.0041831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848625	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000309240600050
J	El-Hage, W; Leger, J; Delcuze, A; Giraudeau, B; Perrotin, F				El-Hage, Wissam; Leger, Julie; Delcuze, Aude; Giraudeau, Bruno; Perrotin, Franck			Amniocentesis, Maternal Psychopathology and Prenatal Representations of Attachment: A Prospective Comparative Study	PLOS ONE			English	Article							POSTNATAL DEPRESSION SCALE; FETAL ATTACHMENT; MOTHER; WOMEN; PREGNANCY; RISK; ADOLESCENTS; ENVIRONMENT; PREDICTORS; ULTRASOUND	Background: The aim of the study was to characterize the maternal dimensions of anxiety, depression and prenatal attachment in women undergoing an amniocentesis. Methodology/Principal Findings: A prospective observational study was conducted. Women were referred to early amniocentesis for increased nuchal translucency, elevated biochemical markers or advanced maternal age. All participants had 3 prenatal (16-18, 20-24, 30-34 weeks of gestation) and one postnatal (30-45 days) interviews reviewing for demographic, medical, and psychiatric information (STAI State-Trait Anxiety Inventory; EPDS: Edinburgh Postnatal Depression Scale; IRMAG: Interview of Maternal Representations of Attachment during pregnancy). We investigated 232 pregnant women who undergone an amniocentesis compared with 160 pregnant controls. Following the procedure, the amniocentesis group experienced transiently significantly higher levels of state-anxiety on the STAI (44.6 vs. 39.3) and depression as measured by the EPDS (9.4 vs. 6.3) than the controls. Overall in both groups, the maternal representations of attachment were well integrated and balanced, but the amniocentesis group experienced significantly more mother-directed representations. Conclusions/Significance: Amniocentesis is associated with higher affective adaptive reactions that tend to normalize during the pregnancy, with overall preserved maternal fetal representations of attachment.	[El-Hage, Wissam; Delcuze, Aude] CHRU Tours, Clin Psychiat Univ, Tours, France; [El-Hage, Wissam] Univ Francois Rabelais Tours, INSERM ERL U930, Tours, France; [Leger, Julie; Giraudeau, Bruno] CHRU Tours, INSERM CIC 0202, Tours, France; [Perrotin, Franck] CHRU Tours, Fetal Med Unit, Tours, France	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours	El-Hage, W (corresponding author), CHRU Tours, Clin Psychiat Univ, Tours, France.	wissam.elhage@univ-tours.fr	Horak, Peeter/A-2351-2009; Tammaru, Toomas/N-3892-2019; EL-HAGE, WISSAM/S-5014-2019; Giraudeau, Bruno/L-9003-2015; Perrotin, Franck/AAL-8833-2021	Horak, Peeter/0000-0002-1442-9903; EL-HAGE, WISSAM/0000-0003-3877-0855; Giraudeau, Bruno/0000-0003-3031-8258; Perrotin, Franck/0000-0001-9694-6658	Hospital Clinical Research Program (Hopital Promoteur, CHRU de Tours)	Hospital Clinical Research Program (Hopital Promoteur, CHRU de Tours)	This project was funded by a Hospital Clinical Research Program (Hopital Promoteur, CHRU de Tours). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; Al-Sahab B, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-20; Alhusen JL, 2008, JOGNN-J OBST GYN NEO, V37, P315, DOI 10.1111/j.1552-6909.2008.00241.x; AMMANITI M, 1991, INF MENTAL HLTH J, V12, P246, DOI 10.1002/1097-0355(199123)12:3<246::AID-IMHJ2280120310>3.0.CO;2-8; Arnott B, 2007, B MENNINGER CLIN, V71, P132, DOI 10.1521/bumc.2007.71.2.132; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Binder EB, 2010, J PSYCHIATR RES, V44, P640, DOI 10.1016/j.jpsychires.2009.12.001; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bloom KC, 1995, NURS RES, V44, P284; Bornstein M. H., 2006, J REPROD INFANT PSYC, V14, P133, DOI [10.1080/02646839608404510, DOI 10.1080/02646839608404510]; CACCIA N, 1991, AM J OBSTET GYNECOL, V165, P1122, DOI 10.1016/0002-9378(91)90484-9; Cannella BL, 2005, J ADV NURS, V50, P60, DOI 10.1111/j.1365-2648.2004.03349.x; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CRAMER B, 1988, INF MENTAL HLTH J, V9, P20, DOI 10.1002/1097-0355(198821)9:1<20::AID-IMHJ2280090105>3.0.CO;2-E; CRANLEY MS, 1981, NURS RES, V30, P281, DOI 10.1097/00006199-198109000-00008; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DiPietro JA, 2010, INFANT CHILD DEV, V19, P27, DOI 10.1002/icd.651; El Hage W, 2009, PSYCHOL MED, V39, P1407, DOI 10.1017/S0033291709005236; Fava Vizziello G, 1993, INFANT MENT HEALTH J, V14, P1; Green J M, 2004, Health Technol Assess, V8, pix; Green JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Green JM, 2004, HEALTH TECHNOL ASSES, V8, pix; HEIDRICH SM, 1989, NURS RES, V38, P81; Leckman JF, 2004, J NEURAL TRANSM, V111, P753, DOI 10.1007/s00702-003-0067-x; Leithner K, 2004, ULTRASOUND OBST GYN, V23, P240, DOI 10.1002/uog.978; Lumley MA, 2006, GENET TEST, V10, P131, DOI 10.1089/gte.2006.10.131; MARTEAU TM, 1992, J PSYCHOSOM RES, V36, P395, DOI 10.1016/0022-3999(92)90076-E; MICHELACCI L, 1988, PSYCHOTHER PSYCHOSOM, V50, P1, DOI 10.1159/000288093; Montmasson H, 2012, J GYNECOL O IN PRESS; Quinnell FA, 1999, J TRAUMA STRESS, V12, P193, DOI 10.1023/A:1024714903950; R Development Core Team, 2008, LANG ENV STAT COMP; RAPHAELLEFF J, 1983, BRIT J MED PSYCHOL, V56, P379, DOI 10.1111/j.2044-8341.1983.tb01571.x; Siddiqui A, 2000, J REPROD INFANT PSYC, V18, P67, DOI 10.1080/02646830050001690; Spielberger CD, 1985, SO PSYCHOL, V2, P6; Stern D., 1995, MOTHERHOOD CONSTELLA; Tercyak KP, 2001, PATIENT EDUC COUNS, V43, P73, DOI 10.1016/S0738-3991(00)00146-4; Thun-Hohenstein L, 2008, EUR CHILD ADOLES PSY, V17, P9, DOI 10.1007/s00787-007-0622-3; VANZUUREN FJ, 1993, J REPRODUCTIVE INFAN, V11, P57; WAYLAND J, 1993, BIRTH-ISS PERINAT C, V20, P198, DOI 10.1111/j.1523-536X.1993.tb00227.x; Yarcheski A, 2009, INT J NURS STUD, V46, P708, DOI 10.1016/j.ijnurstu.2008.10.013; ZACHARIAH R, 1994, RES NURS HEALTH, V17, P37, DOI 10.1002/nur.4770170106; Zeanah C. H., 1990, J REPROD INFANT PSYC, V8, P23, DOI [10.1080/02646839008403605, DOI 10.1080/02646839008403605]; ZEANAH CH, 1986, J CHILD PSYCHOL PSYC, V27, P499, DOI 10.1111/j.1469-7610.1986.tb00637.x	44	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41777	10.1371/journal.pone.0041777	http://dx.doi.org/10.1371/journal.pone.0041777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848599	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600116
J	Rainteau, D; Humbert, L; Delage, E; Vergnolle, C; Cantrel, C; Maubert, MA; Lanfranchi, S; Maldiney, R; Collin, S; Wolf, C; Zachowski, A; Ruelland, E				Rainteau, Dominique; Humbert, Lydie; Delage, Elise; Vergnolle, Chantal; Cantrel, Catherine; Maubert, Marie-Anne; Lanfranchi, Sandrine; Maldiney, Regis; Collin, Sylvie; Wolf, Claude; Zachowski, Alain; Ruelland, Eric			Acyl Chains of Phospholipase D Transphosphatidylation Products in Arabidopsis Cells: A Study Using Multiple Reaction Monitoring Mass Spectrometry	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; MEMBRANE-LIPIDS; PLASMA-MEMBRANE; D-ALPHA; SUBSTRATE PREFERENCE; POLAR LIPIDS; STRESS; ACTIVATION; PATHWAY; ORDER	Background: Phospholipases D (PLD) are major components of signalling pathways in plant responses to some stresses and hormones. The product of PLD activity is phosphatidic acid (PA). PAs with different acyl chains do not have the same protein targets, so to understand the signalling role of PLD it is essential to analyze the composition of its PA products in the presence and absence of an elicitor. Methodology/Principal findings: Potential PLD substrates and products were studied in Arabidopsis thaliana suspension cells treated with or without the hormone salicylic acid (SA). As PA can be produced by enzymes other than PLD, we analyzed phosphatidylbutanol (PBut), which is specifically produced by PLD in the presence of n-butanol. The acyl chain compositions of PBut and the major glycerophospholipids were determined by multiple reaction monitoring (MRM) mass spectrometry. PBut profiles of untreated cells or cells treated with SA show an over-representation of 160/18:2- and 16:0/18:3-species compared to those of phosphatidylcholine and phosphatidylethanolamine either from bulk lipid extracts or from purified membrane fractions. When microsomal PLDs were used in in vitro assays, the resulting PBut profile matched exactly that of the substrate provided. Therefore there is a mismatch between the acyl chain compositions of putative substrates and the in vivo products of PLDs that is unlikely to reflect any selectivity of PLDs for the acyl chains of substrates. Conclusions: MRM mass spectrometry is a reliable technique to analyze PLD products. Our results suggest that PLD action in response to SA is not due to the production of a stress-specific molecular species, but that the level of PLD products per se is important. The over-representation of 160/18:2- and 16:0/18:3-species in PLD products when compared to putative substrates might be related to a regulatory role of the heterogeneous distribution of glycerophospholipids in membrane sub-domains.	[Rainteau, Dominique; Humbert, Lydie; Maubert, Marie-Anne; Wolf, Claude] Univ Paris 06, UPMC, ERL, INSERM,UMR 7203,U1057, Paris, France; [Delage, Elise; Vergnolle, Chantal; Cantrel, Catherine; Lanfranchi, Sandrine; Maldiney, Regis; Collin, Sylvie; Zachowski, Alain; Ruelland, Eric] Univ Paris 06, UPMC, UR5, Paris, France; [Delage, Elise; Vergnolle, Chantal; Cantrel, Catherine; Lanfranchi, Sandrine; Maldiney, Regis; Collin, Sylvie; Zachowski, Alain; Ruelland, Eric] CNRS, EAC7180, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Rainteau, D (corresponding author), Univ Paris 06, UPMC, ERL, INSERM,UMR 7203,U1057, Paris, France.	eric.ruelland@upmc.fr	Ruelland, Eric/D-4863-2012	Ruelland, Eric/0000-0002-7877-4941	French Agence Nationale de la Recherche Programme Blanc PANACEA [NT09_517917]; Ministere de l'Enseignement Superieur et de la Recherche	French Agence Nationale de la Recherche Programme Blanc PANACEA(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	The authors acknowledge funding from the French Agence Nationale de la Recherche Programme Blanc PANACEA NT09_517917 (contracts to ER). ED is a recipient of a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisz SA, 2003, PLANT J, V34, P595, DOI 10.1046/j.1365-313X.2003.01750.x; Bargmann BOR, 2009, PLANT CELL ENVIRON, V32, P837, DOI 10.1111/j.1365-3040.2009.01962.x; Blom TS, 2001, BIOCHEMISTRY-US, V40, P14635, DOI 10.1021/bi0156714; Boutte Y, 2010, EMBO J, V29, P546, DOI 10.1038/emboj.2009.363; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burgos A, 2011, PLANT J, V66, P656, DOI 10.1111/j.1365-313X.2011.04531.x; Cantrel C, 2000, PHYSIOL PLANTARUM, V110, P443, DOI 10.1111/j.1399-3054.2000.1100403.x; Chatre L, 2005, PLANT PHYSIOL, V139, P1244, DOI 10.1104/pp.105.067447; DEMANDRE C, 1985, PHYTOCHEMISTRY, V24, P481, DOI 10.1016/S0031-9422(00)80752-9; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dippe M, 2009, PHYTOCHEMISTRY, V70, P361, DOI 10.1016/j.phytochem.2009.01.011; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRANKE WW, 1970, J CELL BIOL, V46, P379, DOI 10.1083/jcb.46.2.379; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; GUILLOTSALOMON T, 1987, PHYSIOL PLANTARUM, V69, P113, DOI 10.1111/j.1399-3054.1987.tb01953.x; Guo L, 2011, J BIOL CHEM, V286, P13336, DOI 10.1074/jbc.M110.190892; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; HOLTE LL, 1995, BIOPHYS J, V68, P2396, DOI 10.1016/S0006-3495(95)80422-4; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; HONG YY, 2008, MOL PLANT, V1, P262, DOI DOI 10.1093/mp/ssm025; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P783, DOI 10.1016/j.jasms.2006.12.012; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Krinke O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/pp.108.133595; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Mane SP, 2007, J EXP BOT, V58, P241, DOI 10.1093/jxb/erl262; Mishkind M, 2009, PLANT J, V60, P10, DOI 10.1111/j.1365-313X.2009.03933.x; Mitchell DC, 1998, BIOPHYS J, V74, P879, DOI 10.1016/S0006-3495(98)74011-1; MORRE DJ, 1991, PROTOPLASMA, V160, P49, DOI 10.1007/BF01539956; Pappan K, 1998, ARCH BIOCHEM BIOPHYS, V353, P131, DOI 10.1006/abbi.1998.0640; Qin CB, 2002, J BIOL CHEM, V277, P49685, DOI 10.1074/jbc.M209598200; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Steinhauer J, 2009, MOL BIOL CELL, V20, P5224, DOI 10.1091/mbc.E09-05-0382; STRAUME M, 1987, BIOCHEMISTRY-US, V26, P5113, DOI 10.1021/bi00390a033; Stubbs CD, 1996, CHEM PHYS LIPIDS, V81, P185, DOI 10.1016/0009-3084(96)02581-9; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; Tjellstrom H, 2010, FASEB J, V24, P1128, DOI 10.1096/fj.09-139410; Vaultier MN, 2008, FEBS LETT, V582, P1743, DOI 10.1016/j.febslet.2008.04.042; Vaultier MN, 2006, FEBS LETT, V580, P4218, DOI 10.1016/j.febslet.2006.06.083; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Whiteman SA, 2008, PROTEOMICS, V8, P3536, DOI 10.1002/pmic.200701104; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992	56	34	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41985	10.1371/journal.pone.0041985	http://dx.doi.org/10.1371/journal.pone.0041985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848682	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600153
J	Kudo, LC; Vi, N; Ma, ZC; Fields, T; Avliyakulov, NK; Haykinson, MJ; Bragin, A; Karsten, SL				Kudo, Lili C.; Vi, Nancy; Ma, Zhongcai; Fields, Tony; Avliyakulov, Nuraly K.; Haykinson, Michael J.; Bragin, Anatol; Karsten, Stanislav L.			Novel Cell and Tissue Acquisition System (CTAS): Microdissection of Live and Frozen Brain Tissues	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; NEURAL STEM-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; DENTATE GYRUS; RNA; MOUSE; DIFFERENTIATION; DISEASE; IDENTIFICATION	We developed a novel, highly accurate, capillary based vacuum-assisted microdissection device CTAS - Cell and Tissue Acquisition System, for efficient isolation of enriched cell populations from live and freshly frozen tissues, which can be successfully used in a variety of molecular studies, including genomics and proteomics. Specific diameter of the disposable capillary unit (DCU) and precisely regulated short vacuum impulse ensure collection of the desired tissue regions and even individual cells. We demonstrated that CTAS is capable of dissecting specific regions of live and frozen mouse and rat brain tissues at the cellular resolution with high accuracy. CTAS based microdissection avoids potentially harmful physical treatment of tissues such as chemical treatment, laser irradiation, excessive heat or mechanical cell damage, thus preserving primary functions and activities of the dissected cells and tissues. High quality DNA, RNA, and protein can be isolated from CTAS-dissected samples, which are suitable for sequencing, microarray, 2D gel-based proteomic analyses, and Western blotting. We also demonstrated that CTAS can be used to isolate cells from native living tissues for subsequent recultivation of primary cultures without affecting cellular viability, making it a simple and cost-effective alternative for laser-assisted microdissection.	[Kudo, Lili C.; Vi, Nancy; Ma, Zhongcai; Bragin, Anatol; Karsten, Stanislav L.] NeuroInDx Inc, Signal Hill, CA USA; [Ma, Zhongcai] Harbor Univ Calif Los Angeles UCLA Med Ctr, Div Neurosci, Dept Neurol, Los Angeles Biomed Res Inst, Torrance, CA USA; [Fields, Tony; Bragin, Anatol] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Avliyakulov, Nuraly K.; Haykinson, Michael J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kudo, LC (corresponding author), NeuroInDx Inc, Signal Hill, CA USA.	lckudo@neuroindx.com; skarsten@neuroindx.com	Karsten, Stan/AAI-4076-2021	Bragin, Anatol/0000-0003-1207-8481; Karsten, Stanislav/0000-0001-7387-4874	National Institutes of Health/National Center for Research Resources (NIH/NCRR) [5R44RR024059]; NIH/National Institute of Mental Health (NIMH) [1R43MH091909]; NATIONAL CENTER FOR RESEARCH RESOURCES [R44RR024059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH091909, R44MH091909] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NIH/National Institute of Mental Health (NIMH); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health/National Center for Research Resources (NIH/NCRR) Grant 5R44RR024059 (LCK) and NIH/National Institute of Mental Health (NIMH) 1R43MH091909 (SLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atkins N, 2011, JOVE-J VIS EXP, DOI 10.3791/3125; Becker I, 1996, LAB INVEST, V75, P801; Ben-Hur T, 1998, J NEUROSCI, V18, P5777, DOI 10.1523/jneurosci.18-15-05777.1998; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Choudhary J, 2004, NAT NEUROSCI, V7, P440, DOI 10.1038/nn1240; Clarke L, 2011, STEM CELLS, V29, P1448, DOI 10.1002/stem.692; Craven RA, 2001, PROTEOMICS, V1, P1200; DeCarlo K, 2011, METHODS MOL BIOL, V755, P1, DOI 10.1007/978-1-61779-163-5_1; DEWITH A, 1995, J PHOTOCH PHOTOBIO B, V30, P71, DOI 10.1016/1011-1344(95)07151-Q; Eisenstein M, 2006, NATURE, V441, P1179, DOI 10.1038/4411179a; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Espina V, 2007, EXPERT REV MOL DIAGN, V7, P647, DOI 10.1586/14737159.7.5.647; Etchevers H, 2011, NAT PROTOC, V6, P1568, DOI 10.1038/nprot.2011.398; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Ginsberg SD, 2006, CELL TISSUE MICRODIS, P109; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Harsch M, 2001, AM J PATHOL, V158, P1985, DOI 10.1016/S0002-9440(10)64669-X; Ibrahim SF, 2003, CURR OPIN BIOTECH, V14, P5, DOI 10.1016/S0958-1669(02)00009-5; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Kerman IA, 2006, J NEUROSCI METH, V153, P71, DOI 10.1016/j.jneumeth.2005.10.010; Kopper O, 2010, STEM CELLS, V28, P75, DOI 10.1002/stem.260; Kudo LC, 2010, HUM MOL GENET, V19, P3233, DOI 10.1093/hmg/ddq232; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liu Angen, 2010, J Biomol Tech, V21, P120; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Mercer E.H., 1963, J ROYAL MICROSCOPICA, V81, P179; Mikulowska-Mennis A, 2002, BIOTECHNIQUES, V33, P176, DOI 10.2144/02331md06; MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Schutze K, 1998, CELL MOL BIOL, V44, P735; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; SRINIVASAN R, 1986, SCIENCE, V234, P559, DOI 10.1126/science.3764428; Standaert DG, 2005, ARCH NEUROL-CHICAGO, V62, P203, DOI 10.1001/archneur.62.2.203; Su JMF, 2004, BRAIN PATHOL, V14, P175, DOI 10.1111/j.1750-3639.2004.tb00050.x; Tofighi R, 2011, METHODS MOL BIOL, V758, P67, DOI 10.1007/978-1-61779-170-3_5; Vercauteren FGG, 2007, PROTEOMICS, V7, P3569, DOI 10.1002/pmic.200700379; Wang WZ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-69; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4	50	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41564	10.1371/journal.pone.0041564	http://dx.doi.org/10.1371/journal.pone.0041564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22855692	gold, Green Submitted, Green Published			2022-12-27	WOS:000306751300055
J	Ramakrishnan, M; De Melo, FA; Kinsey, BM; Ladbury, JE; Kosten, TR; Orson, FM				Ramakrishnan, Muthu; De Melo, Fernando Alves; Kinsey, Berma M.; Ladbury, John E.; Kosten, Thomas R.; Orson, Frank M.			Probing Cocaine-Antibody Interactions in Buffer and Human Serum	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PROTEIN-BINDING; MICROSCALE THERMOPHORESIS; VACCINE; IMMUNIZATION; CALORIMETRY; EFFICACY; BRAIN; ABUSE; TOOL	Background: Despite progress in cocaine immunotherapy, the kinetic and thermodynamic properties of antibodies which bind to cocaine and its metabolites are not well understood. It is also not clear how the interactions between them differ in a complex matrix such as the serum present in the human body. In the present study, we have used microscale thermophoresis (MST), isothermal titration calorimetry (ITC), and surface plasmon resonance (SPR) we have evaluated the affinity properties of a representative mouse monoclonal (mAb08) as well as those of polyclonal antibodies purified from vaccinated mouse and human patient serum. Results: MST analysis of fluorescently tagged mAb08 binding to cocaine reveals an approximately 15 fold decrease in its equilibrium dissociation constant in 20-50% human serum compared with that in saline buffer. A similar trend was also found using enriched polyclonal antibodies purified from vaccinated mice and patient serum, for which we have used fluorescently tagged bovine serum albumin conjugated to succinyl norcocaine (BSA-SNC). This conjugate closely mimics both cocaine and the hapten used to raise these antibodies. The ITC data also revealed that cocaine has a moderate affinity of about 2 mu M to 20% human serum and very little interaction with human serum albumin or nonspecific human IgG at that concentration range. In a SPR inhibition experiment, the binding of mAb08 to immobilized BSA-SNC was inhibited by cocaine and benzoylecgonine in a highly competitive manner, whereas the purified polyclonal antibodies from vaccinated humans and mice, revealed preferential selectivity to pharmacologically active cocaine but not to the inactive metabolite benzoylecgonine. We have also developed a simple binding model to simulate the challenges associated with cocaine immunotherapy using the variable quantitative and kinetic properties of the antibodies. Conclusions: High sensitivity calorimetric determination of antibody binding to cocaine and its metabolites provide valuable information for characterization of their interactions and thermodynamic properties. In addition MST measurements of antibody affinity in the presence of biological fluids will provide a better opportunity to make reliable decisions and facilitate the design of cocaine vaccines and immunization conditions. The methods should be more widely adopted in characterization of antibody complexes.	[Ramakrishnan, Muthu; Kinsey, Berma M.; Kosten, Thomas R.; Orson, Frank M.] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Ramakrishnan, Muthu; Kinsey, Berma M.; Orson, Frank M.] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA; [Orson, Frank M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Ramakrishnan, Muthu; Orson, Frank M.] Baylor Coll Med, Dept Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Kosten, Thomas R.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; [De Melo, Fernando Alves; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [De Melo, Fernando Alves; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ramakrishnan, M (corresponding author), Vet Affairs Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.	forson@bcm.edu	Melo, Fernando A/A-6242-2013; Kosten, Thomas/AAI-5998-2021	Melo, Fernando A/0000-0002-8676-3150; Ladbury, John/0000-0002-6328-7200	Department of Veterans Affairs (VA) Merit Review Program and the National Institute on Drug Abuse [K05 DA 0454, P50-DA18197, 5R01DA030338, 1X02DA032939, R01DA026859, 3R01DA023979]; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026859, P50DA018197, DP1DA033502, R01DA023979, K05DA000454, R01DA030338] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA) Merit Review Program and the National Institute on Drug Abuse; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the Department of Veterans Affairs (VA) Merit Review Program and the National Institute on Drug Abuse grants K05 DA 0454 (Dr. Kosten), P50-DA18197 (Dr. Kosten), 5R01DA030338 (Dr. Orson), 1X02DA032939 (Dr. Kosten, Dr. Orson, Dr. Ramakrishnan), R01DA026859 (Dr. Orson), 3R01DA023979 (Dr. Orson, Dr. Ramakrishnan). This work was supported in part by the G. Harold and Leila Y. Mathers Foundation (Dr. Ladbury). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WT, 2011, NAT BIOT C HILT UN S; CARRERA MRA, 1995, NATURE, V378, P727, DOI 10.1038/378727a0; Chi KR, 2011, NAT MED, V17, P146, DOI 10.1038/nm0211-146; EDWARDS DJ, 1988, PHARMACEUT RES, V5, P440, DOI 10.1023/A:1015992502509; Everhart ET, 1999, J LABELLED COMPD RAD, V42, P1265, DOI 10.1002/(SICI)1099-1344(19991230)42:13<1265::AID-JLCR283>3.0.CO;2-Y; Fox BS, 1996, NAT MED, V2, P1129, DOI 10.1038/nm1096-1129; Hicks MJ, 2011, MOL THER, V19, P612, DOI 10.1038/mt.2010.280; Hrafnkelsdottir K, 2005, BIOL PHARM BULL, V28, P1038, DOI 10.1248/bpb.28.1038; Jenkins AJ, 2002, J ANAL TOXICOL, V26, P382, DOI 10.1093/jat/26.7.382; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kinsey BM, 2010, EXPERT REV VACCINES, V9, P1109, DOI 10.1586/ERV.10.102; LADBURY JE, 1995, STRUCTURE, V3, P635, DOI 10.1016/S0969-2126(01)00197-6; Ladbury JE, 2010, BIOCHEM SOC T, V38, P888, DOI 10.1042/BST0380888; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Lau CE, 1999, J PHARMACOL EXP THER, V288, P535; Livingstone JR, 1996, NATURE, V384, P491, DOI 10.1038/384491a0; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Meijler MM, 2005, J AM CHEM SOC, V127, P2477, DOI 10.1021/ja043935e; Mets B, 1999, LIFE SCI, V65, P1317, DOI 10.1016/S0024-3205(99)00367-7; Norman AB, 2009, J PHARMACOL EXP THER, V328, P873, DOI 10.1124/jpet.108.146407; Norman AB, 2007, J PHARMACOL EXP THER, V320, P145, DOI 10.1124/jpet.106.111781; Orson FM, 2008, ANN NY ACAD SCI, V1141, P257, DOI 10.1196/annals.1441.027; Orson FM, 2009, HUM VACCINES, V5, P194, DOI 10.4161/hv.5.4.7457; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; PARKER RB, 1995, J PHARMACOL EXP THER, V275, P605; Paula S, 2003, J MOL BIOL, V325, P515, DOI 10.1016/S0022-2836(02)01235-4; Paula S, 2004, J MED CHEM, V47, P133, DOI 10.1021/jm030351z; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093	28	25	26	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2012	7	7							e40518	10.1371/journal.pone.0040518	http://dx.doi.org/10.1371/journal.pone.0040518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973JD	22859949	Green Published, gold, Green Submitted			2022-12-27	WOS:000306355500051
J	Clark, KA; Howe, DK; Gafner, K; Kusuma, D; Ping, S; Estes, S; Denver, DR				Clark, Katie A.; Howe, Dana K.; Gafner, Kristin; Kusuma, Danika; Ping, Sita; Estes, Suzanne; Denver, Dee R.			Selfish Little Circles: Transmission Bias and Evolution of Large Deletion-Bearing Mitochondrial DNA in Caenorhabditis briggsae Nematodes	PLOS ONE			English	Article							LIFE-HISTORY; GENOME; MUTATION; GENETICS; FREQUENCY	Selfish DNA poses a significant challenge to genome stability and organismal fitness in diverse eukaryotic lineages. Although selfish mitochondrial DNA (mtDNA) has known associations with cytoplasmic male sterility in numerous gynodioecious plant species and is manifested as petite mutants in experimental yeast lab populations, examples of selfish mtDNA in animals are less common. We analyzed the inheritance and evolution of mitochondrial DNA bearing large heteroplasmic deletions including nad5 gene sequences (nad5 Delta mtDNA), in the nematode Caenorhabditis briggsae. The deletion is widespread in C. briggsae natural populations and is associated with deleterious organismal effects. We studied the inheritance patterns of nad5 Delta mtDNA using eight sets of C. briggsae mutation-accumulation (MA) lines, each initiated from a different natural strain progenitor and bottlenecked as single hermaphrodites across generations. We observed a consistent and strong drive toward higher levels of deletion-bearing molecules in the heteroplasmic pool of mtDNA after ten generations of bottlenecking. Our results demonstrate a uniform transmission bias whereby nad5 Delta mtDNA accumulates to higher levels relative to intact mtDNA in multiple genetically diverse natural strains of C. briggsae. We calculated an average 1% per-generation transmission bias for deletion-bearing mtDNA relative to intact genomes. Our study, coupled with known deleterious phenotypes associated with high deletion levels, shows that nad5 Delta mtDNA are selfish genetic elements that have evolved in natural populations of C. briggsae, offering a powerful new system to study selfish mtDNA dynamics in metazoans.	[Clark, Katie A.; Howe, Dana K.; Gafner, Kristin; Kusuma, Danika; Ping, Sita; Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Clark, Katie A.; Howe, Dana K.; Gafner, Kristin; Kusuma, Danika; Ping, Sita; Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Estes, Suzanne] Portland State Univ, Dept Biol, Portland, OR 97207 USA	Oregon State University; Oregon State University; Portland State University	Clark, KA (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	denver@cgrb.oregonstate.edu		Ping, Sita/0000-0003-2894-4356	National Institutes of Health [R01GM087628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01GM087628 to DRD and SE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Beagley CT, 1996, P NATL ACAD SCI USA, V93, P5619, DOI 10.1073/pnas.93.11.5619; CHAMBERS P, 1986, CURR GENET, V10, P565, DOI 10.1007/BF00418122; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Estes S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-11; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; Howe DK, 2010, GENOME BIOL EVOL, V2, P29, DOI 10.1093/gbe/evp055; Howe DK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-62; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Hwang BJ, 2009, GENE, V440, P23, DOI 10.1016/j.gene.2009.03.019; Jovelin R, 2011, GENETICS, V189, P967, DOI 10.1534/genetics.111.132795; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; MAY G, 1989, NATURE, V339, P320, DOI 10.1038/339320a0; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; Oliveira MT, 2010, EXP GERONTOL, V45, P489, DOI 10.1016/j.exger.2010.01.019; Phillips N, 2009, MOL BIOL EVOL, V26, P659, DOI 10.1093/molbev/msn287; POULTON J, 1991, AM J HUM GENET, V48, P649; Raboin MJ, 2010, MOL BIOL EVOL, V27, P1087, DOI 10.1093/molbev/msp318; RAND DM, 1986, GENETICS, V114, P955; RAND DM, 1989, GENETICS, V121, P551; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Stiernagle Theresa, 2006, WormBook, P1; Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299; Vassilieva LL, 1999, GENETICS, V151, P119	30	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41433	10.1371/journal.pone.0041433	http://dx.doi.org/10.1371/journal.pone.0041433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859984	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600026
J	Eick-Cost, AA; Tastad, KJ; Guerrero, AC; Johns, MC; Lee, SE; MacIntosh, VH; Burke, RL; Blazes, DL; Russell, KL; Sanchez, JL				Eick-Cost, Angelia A.; Tastad, Katie J.; Guerrero, Alicia C.; Johns, Matthew C.; Lee, Seung-eun; MacIntosh, Victor H.; Burke, Ronald L.; Blazes, David L.; Russell, Kevin L.; Sanchez, Jose L.			Effectiveness of Seasonal Influenza Vaccines against Influenza-Associated Illnesses among US Military Personnel in 2010-11: A Case-Control Approach	PLOS ONE			English	Article							UNITED-STATES; I-MOVE; VACCINATION; LIVE; SURVEILLANCE; INFECTION; EUROPE; H1N1	Introduction: Following the 2009 influenza A/H1N1 (pH1N1) pandemic, both seasonal and pH1N1 viruses circulated in the US during the 2010-2011 influenza season; influenza vaccine effectiveness (VE) may vary between live attenuated (LAIV) and trivalent inactivated (TIV) vaccines as well as by virus subtype. Materials and Methods: Vaccine type and virus subtype-specific VE were determined for US military active component personnel for the period of September 1, 2010 through April 30, 2011. Laboratory-confirmed influenza-related medical encounters were compared to matched individuals with a non-respiratory illness (healthy controls), and unmatched individuals who experienced a non-influenza respiratory illness (test-negative controls). Odds ratios (OR) and VE estimates were calculated overall, by vaccine type and influenza subtype. Results: A total of 603 influenza cases were identified. Overall VE was relatively low and similar regardless of whether healthy controls (VE = 26%, 95% CI: -1 to 45) or test-negative controls (VE = 29%, 95% CI: -6 to 53) were used as comparison groups. Using test-negative controls, vaccine type-specific VE was found to be higher for TIV (53%, 95% CI: 25 to 71) than for LAIV (VE = -13%, 95% CI: -77 to 27). Influenza subtype-specific analyses revealed moderate protection against A/H3 (VE = 58%, 95% CI: 21 to 78), but not against A/H1 (VE = -38%, 95% CI: -211 to 39) or B (VE = 34%, 95% CI: -122 to 80). Conclusion: Overall, a low level of protection against clinically-apparent, laboratory-confirmed, influenza was found for the 2010-11 seasonal influenza vaccines. TIV immunization was associated with higher protection than LAIV, however, no protection against A/H1 was noted, despite inclusion of a pandemic influenza strain as a vaccine component for two consecutive years. Vaccine virus mismatch or lower immunogenicity may have contributed to these findings and deserve further examination in controlled studies. Continued assessment of VE in military personnel is essential in order to better inform vaccination policy decisions.	[Eick-Cost, Angelia A.; Johns, Matthew C.; Lee, Seung-eun; Burke, Ronald L.; Blazes, David L.; Russell, Kevin L.; Sanchez, Jose L.] AFHSC, Silver Spring, MD USA; [Tastad, Katie J.; Guerrero, Alicia C.; MacIntosh, Victor H.] USAFSAM, Wright Patterson AFB, OH USA; [Eick-Cost, Angelia A.; Tastad, Katie J.; Sanchez, Jose L.] Henry M Jackson Fdn Adv Mil Med Inc, HJF, Bethesda, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Eick-Cost, AA (corresponding author), AFHSC, Silver Spring, MD USA.	Angie.Eick@us.army.mil; toti.sanchez@us.army.mil		Tastad, Katie/0000-0001-5904-6220				Armed Forces Health Surveillance Center, 2009, UPD PNEUM INFL SEV A; Armed Forces Health Surveillance Center, 2012, DEP DEF INFL SURV SU; Armed Forces Health Surveillance Center, 2010, SURV SNAPSH INFL REP; Armed Forces Health Surveillance Center, 2009, TRIS REP EV GUID CAS; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Ferdinands JM, 2012, CLIN INFECT DIS, V54, P25, DOI 10.1093/cid/cir750; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Gray GC., 1995, FED PRACT, V12, P27; Hardelid P, 2011, EUROSURVEILLANCE, V16, P12; Jimenez-Jorge S., 2012, Eurosurveillance, V17, P20129; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kissling E, 2012, EUROSURVEILLANCE, V17, P6; Kissling E, 2011, EUROSURVEILLANCE, V16, P11; Kissling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027622; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Myers CA, 2011, CLIN INFECT DIS, V53, P207, DOI 10.1093/cid/cir282; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Owens AB, 2009, AM J PREV MED, V37, P235, DOI 10.1016/j.amepre.2009.04.022; Pebody R, 2011, EUROSURVEILLANCE, V16, P8; Puig-Barbera J, 2011, EUROSURVEILLANCE, V16, P19821; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Savulescu C, 2011, EUROSURVEILLANCE, V16, P5; Setse Rosanna W., 2011, Morbidity and Mortality Weekly Report, V60, P38; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Steens A, 2011, EUROSURVEILLANCE, V16, P23; Vera D. M., 2010, Morbidity and Mortality Weekly Report, V59, P162; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005	31	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41435	10.1371/journal.pone.0041435	http://dx.doi.org/10.1371/journal.pone.0041435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859985	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600027
J	Ferraccioli, G; Tolusso, B; Bobbio-Pallavicini, F; Gremese, E; Ravagnani, V; Benucci, M; Podesta, E; Atzeni, F; Mannocci, A; Biasi, D; Manfredi, M; Sarzi-Puttini, P; Lagana, B; Montecucco, C				Ferraccioli, Gianfranco; Tolusso, Barbara; Bobbio-Pallavicini, Francesca; Gremese, Elisa; Ravagnani, Viviana; Benucci, Maurizio; Podesta, Edoardo; Atzeni, Fabiola; Mannocci, Alice; Biasi, Domenico; Manfredi, Mariangela; Sarzi-Puttini, Piercarlo; Lagana, Bruno; Montecucco, Carlomaurizio			Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis	PLOS ONE			English	Article							RITUXIMAB TREATMENT; DISEASE-ACTIVITY; TNF AGENTS; REMISSION; STEP; METHOTREXATE; MONOTHERAPY; MEDICINE; EFFICACY; CRITERIA	Objective: To find out whether a high number of auto-antibodies can increase the probability of a "good-EULAR response'' and to identify the possible biomarkers of response in seropositive rheumatoid arthritis (RA) patients undergoing the B cell depletion therapy (BCDT). Patients and Methods: One hundred and thirty-eight patients with long standing RA (LSRA), 75% non or poorly responsive to one or more TNF alpha blockers, all seropositive for at least one autoantibody (AAB) (RF-IgM, RF-IgA, RF-IgG, anti-MCV, ACPA-IgG, ACPA-IgA, ACPA-IgM) received one full course of BCDT. The major outcomes (moderate or good-EULAR response) were assessed after 6 months of therapy. The IL6 and BAFF levels were also determined. Results: At a 6-month follow-up, 33 (23.9%) of the RA patients achieved a good EULAR response. Having up to 5-AABs positivity increased the chances for treatment response. After a logistic regression analysis, however, only 4 baseline factors arose as associated with a good-EULAR response: no steroid therapy (OR = 6.25), a lymphocyte count, <1875/uL (OR = 10.74), a RF-IgG level >52.1 IU/ml (OR = 8.37) and BAFF levels <1011 pg/ml (OR = 7.38). When all the AABs, except for RF-IgM and ACPA-IgG, were left in the analysis, the two final predictors were no-steroid therapy and low lymphocyte count. Discussion: The number of AABs increased the chances of being a "good-EULAR'' responder. The only predictors, however, at the baseline of a good response in this seropositive cohort of RA patients were 2 simple variables - no steroids and lymphocyte count - and two laboratory assays - IgG-RF and BAFF.	[Ferraccioli, Gianfranco; Tolusso, Barbara; Gremese, Elisa] Univ Cattolica Sacro Cuore, Div Rheumatol, I-00168 Rome, Italy; [Bobbio-Pallavicini, Francesca; Montecucco, Carlomaurizio] Univ Pavia, IRCCS S Matteo Fdn, Div Rheumatol, I-27100 Pavia, Italy; [Ravagnani, Viviana; Biasi, Domenico] Univ Verona, Sect Rheumatol & Internal Med, Dept Clin & Expt Med, I-37100 Verona, Italy; [Benucci, Maurizio; Manfredi, Mariangela] Osped S Giovanni di Dio, Dept Internal Med, Rheumatol Unit, Florence, Italy; [Podesta, Edoardo; Lagana, Bruno] Univ Roma La Sapienza, S Andrea Univ Hosp, Sch Med 2, Div Clin Immunol & Rheumatol, Rome, Italy; [Atzeni, Fabiola; Sarzi-Puttini, Piercarlo] Univ Hosp L Sacco, Rheumatol Unit, Milan, Italy; [Mannocci, Alice] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Unit Hyg, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione San Matteo; University of Pavia; University of Verona; University of Florence; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Milan; Luigi Sacco Hospital; Sapienza University Rome	Ferraccioli, G (corresponding author), Univ Cattolica Sacro Cuore, Div Rheumatol, I-00168 Rome, Italy.	gf.ferraccioli@rm.unicatt.it	Tolusso, Barbara/K-8995-2018; Montecucco, Carlomaurizio/K-5236-2018; Sarzi-Puttini, Piercarlo/S-6457-2017	Tolusso, Barbara/0000-0002-9108-6609; Montecucco, Carlomaurizio/0000-0001-8263-3925; Mannocci, Alice/0000-0002-8527-6940; Sarzi-Puttini, Piercarlo/0000-0002-8673-5133; Ferraccioli, Gianfranco/0000-0002-6884-4301; bobbio pallavicini, francesca/0000-0003-0047-7610; Gremese, Elisa/0000-0002-2248-1058	Hoffmann-La Roche, Genentech, Inc.	Hoffmann-La Roche, Genentech, Inc.	This study was supported by Hoffmann-La Roche, Genentech, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Alivernini S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2848; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bosello S, 2008, J RHEUMATOL, V35, P1256; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P723, DOI 10.1002/art.21650; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Conaghan PG, 2010, RHEUMATOLOGY, V49, P1894, DOI 10.1093/rheumatology/keq178; Edwards JCW, 2006, BEST PRACT RES CL RH, V20, P915, DOI 10.1016/j.berh.2006.05.010; Edwards JCW, 1999, IMMUNOLOGY, V97, P188; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Emery P, 2009, J RHEUMATOL, V36, P1429, DOI 10.3899/jrheum.081018; Fabris M, 2009, ARTHRITIS RHEUM, V10, P1678; Ferraccioli GF, 2002, RHEUMATOLOGY, V41, P892, DOI 10.1093/rheumatology/41.8.892; Finckh A, 2010, ANN RHEUM DIS, V69, P387, DOI 10.1136/ard.2008.105064; Finckh A, 2007, ARTHRITIS RHEUM, V56, P1417, DOI 10.1002/art.22520; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Hyrich KL, 2008, RHEUMATOLOGY, V47, P1000, DOI 10.1093/rheumatology/ken127; Isaacs JD, 2011, ANN RHEUM DIS, V70, P4, DOI 10.1136/ard.2010.135376; Isaacs JD, 2010, NAT REV IMMUNOL, V10, P605, DOI 10.1038/nri2804; Lai P., 2011, ARTHR RHEUM, V63, P3681; O'Neill SK, 2007, FRONT BIOSCI-LANDMRK, V12, P1722, DOI 10.2741/2184; Peluso G, 2011, ANN RHEUM DIS, V70, P172, DOI 10.1136/ard.2010.129924; Pincus T, 2002, RHEUMATOLOGY, V41, P1346, DOI 10.1093/rheumatology/41.12.1346; Quartuccio L, 2009, RHEUMATOLOGY, V48, P1557, DOI 10.1093/rheumatology/kep314; Sellam J, 2011, ARTHRITIS RHEUM-US, V63, P933, DOI 10.1002/art.30233; Silverman GJ, 2006, ARTHRITIS RHEUM-US, V54, P2356, DOI 10.1002/art.22020; Smolen JS, 2008, ANN RHEUM DIS, V67, P1497, DOI 10.1136/ard.2008.098111; Teng YKO, 2009, ANN RHEUM DIS, V68, P1011, DOI 10.1136/ard.2008.092791; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P1602, DOI 10.1002/art.27415; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Vos K, 2007, ARTHRITIS RHEUM, V56, P772, DOI 10.1002/art.22400; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40362	10.1371/journal.pone.0040362	http://dx.doi.org/10.1371/journal.pone.0040362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859946	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900008
J	Haller, M; Amatschek, S; Wilflingseder, J; Kainz, A; Bielesz, B; Pavik, I; Serra, A; Mohebbi, N; Biber, J; Wagner, CA; Oberbauer, R				Haller, Maria; Amatschek, Stefan; Wilflingseder, Julia; Kainz, Alexander; Bielesz, Bernd; Pavik, Ivana; Serra, Andreas; Mohebbi, Nilufar; Biber, Juerg; Wagner, Carsten A.; Oberbauer, Rainer			Sirolimus Induced Phosphaturia is Not Caused by Inhibition of Renal Apical Sodium Phosphate Cotransporters	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANES; RAT-KIDNEY; QUANTITATIVE-ANALYSIS; TRANSPORT; EXPRESSION; RAPAMYCIN; GENE; HYPOPHOSPHATEMIA; STIMULATION; CLONING	The vast majority of glomerular filtrated phosphate is reabsorbed in the proximal tubule. Posttransplant phosphaturia is common and aggravated by sirolimus immunosuppression. The cause of sirolimus induced phosphaturia however remains elusive. Male Wistar rats received sirolimus or vehicle for 2 or 7 days (1.5mg/kg). The urine phosphate/creatinine ratio was higher and serum phosphate was lower in sirolimus treated rats, fractional excretion of phosphate was elevated and renal tubular phosphate reabsorption was reduced suggesting a renal cause for hypophosphatemia. PTH was lower in sirolimus treated rats. FGF 23 levels were unchanged at day 2 but lower in sirolimus treated rats after 7 days. Brush border membrane vesicle phosphate uptake was not altered in sirolimus treated groups or by direct incubation with sirolimus. mRNA, protein abundance, and subcellular transporter distribution of NaPi-IIa, Pit-2 and NHE3 were not different between groups but NaPi-IIc mRNA expression was lower at day 7. Transcriptome analyses revealed candidate genes that could be involved in the phosphaturic response. Sirolimus caused a selective renal phosphate leakage, which was not mediated by NaPi-IIa or NaPi-IIc regulation or localization. We hypothesize that another mechanism such as a basolateral phosphate transporter may be responsible for the sirolimus induced phosphaturia.	[Haller, Maria; Amatschek, Stefan; Wilflingseder, Julia; Kainz, Alexander; Bielesz, Bernd; Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol, Vienna, Austria; [Haller, Maria; Pavik, Ivana; Serra, Andreas; Mohebbi, Nilufar; Biber, Juerg; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Haller, Maria; Oberbauer, Rainer] KH Elisabethinen Linz, Dept Nephrol & Transplantat, Linz, Austria; [Oberbauer, Rainer] Austrian Dialysis & Transplant Registry, Linz, Austria	Medical University of Vienna; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Ordensklinikum Linz Elisabethinen	Haller, M (corresponding author), Med Univ Vienna, Dept Nephrol, Vienna, Austria.	rainer.oberbauer@meduniwien.ac.at	Bielesz, Bernhard/AAQ-2683-2021; Kainz, Alexander/AAM-7296-2021; Haller, Maria C./S-8390-2019	Bielesz, Bernhard/0000-0002-4491-0562; Haller, Maria C./0000-0003-4635-6291; Wilflingseder, Julia/0000-0002-0230-9349	Amgen-FDIME Fellowship; Wyeth IOP [468X1-1197]; Swiss National Science Foundation [31003A-138143)]	Amgen-FDIME Fellowship; Wyeth IOP; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Amgen-FDIME Fellowship 2008 http://www.fdime.org/, Wyeth IOP 468X1-1197 www.wyeth.com, and Swiss National Science Foundation (31003A-138143) www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl PM, 1999, AM J KIDNEY DIS, V34, P875, DOI 10.1016/S0272-6386(99)70045-4; Bhan I, 2006, KIDNEY INT, V70, P1486, DOI 10.1038/sj.ki.5001788; Biber J, 2009, PFLUG ARCH EUR J PHY, V458, P39, DOI 10.1007/s00424-008-0580-8; BIBER J, 1981, BIOCHIM BIOPHYS ACTA, V647, P169, DOI 10.1016/0005-2736(81)90243-1; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; BONINI P, 1992, EUR J CLIN CHEM CLIN, V30, P881; Busch AE, 1995, J AM SOC NEPHROL, V6, P1547; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; HAGENBUCH B, 1986, PFLUG ARCH EUR J PHY, V407, pS149, DOI 10.1007/BF00584944; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Kanaan N, 2010, CLIN J AM SOC NEPHRO, V5, P1887, DOI 10.2215/CJN.00950110; Kempe DS, 2010, NEPHROL DIAL TRANSPL, V25, P2938, DOI 10.1093/ndt/gfq172; KRIEG M, 1986, J CLIN CHEM CLIN BIO, V24, P863; LASSITER WE, 1982, ADV EXP MED BIOL, V151, P21; Loffing J, 1998, J AM SOC NEPHROL, V9, P1560; MAGAGNIN S, 1993, P NATL ACAD SCI USA, V90, P5979, DOI 10.1073/pnas.90.13.5979; Mohebbi N, 2009, AM J PHYSL RENAL PHY; MOORHEAD JF, 1974, LANCET, V1, P694; Moz Y, 2004, J AM SOC NEPHROL, V15, P2972, DOI 10.1097/01.ASN.0000144207.44469.BE; Murer H, 2003, ANNU REV PHYSIOL, V65, P531, DOI 10.1146/annurev.physiol.65.042902.092424; Nowik M, 2008, PFLUG ARCH EUR J PHY, V457, P539, DOI 10.1007/s00424-008-0530-5; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; RESHKIN SJ, 1990, PFLUG ARCH EUR J PHY, V416, P554, DOI 10.1007/BF00382689; Schwarz C, 2001, NEPHROL DIAL TRANSPL, V16, P378, DOI 10.1093/ndt/16.2.378; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Shibui A, 1999, J HUM GENET, V44, P190, DOI 10.1007/s100380050140; Shojaiefard M, 2005, BIOCHEM BIOPH RES CO, V334, P742, DOI 10.1016/j.bbrc.2005.06.164; Shojaiefard M, 2006, BIOCHEM BIOPH RES CO, V345, P1611, DOI 10.1016/j.bbrc.2006.05.067; Song HK, 2009, AM J TRANSPLANT, V9, P2024, DOI 10.1111/j.1600-6143.2009.02751.x; SZCZEPANSKAKONKEL M, 1987, J BIOL CHEM, V262, P8000; SZCZEPANSKAKONKEL M, 1986, J BIOL CHEM, V261, P6375; Taylor PJ, 1998, J CHROMATOGR B, V718, P251, DOI 10.1016/S0378-4347(98)00371-5; Tenenhouse HS, 1998, J BONE MINER RES, V13, P590, DOI 10.1359/jbmr.1998.13.4.590; Villa-Bellosta R, 2008, TOXICOL APPL PHARM, V232, P125, DOI 10.1016/j.taap.2008.05.026; Villa-Bellosta R, 2009, AM J PHYSIOL-RENAL, V296, pF691, DOI 10.1152/ajprenal.90623.2008; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608	41	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e39229	10.1371/journal.pone.0039229	http://dx.doi.org/10.1371/journal.pone.0039229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859939	Green Accepted, Green Published, gold			2022-12-27	WOS:000306950900005
J	Leal, MF; Chung, J; Calcagno, DQ; Assumpcao, PP; Demachki, S; da Silva, IDCG; Chammas, R; Burbano, RR; Smith, MDC				Leal, Mariana Ferreira; Chung, Janete; Calcagno, Danielle Queiroz; Assumpcao, Paulo Pimentel; Demachki, Samia; Cotrim Guerreiro da Silva, Ismael Dale; Chammas, Roger; Burbano, Rommel Rodriguez; Cardoso Smith, Marilia de Arruda			Differential Proteomic Analysis of Noncardia Gastric Cancer from Individuals of Northern Brazil	PLOS ONE			English	Article							2-DIMENSIONAL ELECTROPHORESIS; INTESTINAL METAPLASIA; INCREASED EXPRESSION; GEL-ELECTROPHORESIS; HELICOBACTER-PYLORI; PROTEIN EXPRESSION; GENE-EXPRESSION; TP53 GENE; MYC; IDENTIFICATION	Gastric cancer is the second leading cause of cancer-related death worldwide. The identification of new cancer biomarkers is necessary to reduce the mortality rates through the development of new screening assays and early diagnosis, as well as new target therapies. In this study, we performed a proteomic analysis of noncardia gastric neoplasias of individuals from Northern Brazil. The proteins were analyzed by two-dimensional electrophoresis and mass spectrometry. For the identification of differentially expressed proteins, we used statistical tests with bootstrapping resampling to control the type I error in the multiple comparison analyses. We identified 111 proteins involved in gastric carcinogenesis. The computational analysis revealed several proteins involved in the energy production processes and reinforced the Warburg effect in gastric cancer. ENO1 and HSPB1 expression were further evaluated. ENO1 was selected due to its role in aerobic glycolysis that may contribute to the Warburg effect. Although we observed two up-regulated spots of ENO1 in the proteomic analysis, the mean expression of ENO1 was reduced in gastric tumors by western blot. However, mean ENO1 expression seems to increase in more invasive tumors. This lack of correlation between proteomic and western blot analyses may be due to the presence of other ENO1 spots that present a slightly reduced expression, but with a high impact in the mean protein expression. In neoplasias, HSPB1 is induced by cellular stress to protect cells against apoptosis. In the present study, HSPB1 presented an elevated protein and mRNA expression in a subset of gastric cancer samples. However, no association was observed between HSPB1 expression and clinicopathological characteristics. Here, we identified several possible biomarkers of gastric cancer in individuals from Northern Brazil. These biomarkers may be useful for the assessment of prognosis and stratification for therapy if validated in larger clinical study sets.	[Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Cardoso Smith, Marilia de Arruda] Univ Fed Sao Paulo, Div Genet, Dept Morphol & Genet, Sao Paulo, Brazil; [Chung, Janete] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Assumpcao, Paulo Pimentel] Fed Univ Para, Joao de Barros Barreto Univ Hosp, Surg Serv, BR-66059 Belem, Para, Brazil; [Demachki, Samia] Fed Univ Para, Joao de Barros Barreto Univ Hosp, Pathol Serv, BR-66059 Belem, Para, Brazil; [Cotrim Guerreiro da Silva, Ismael Dale] Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, Brazil; [Chammas, Roger] Univ Sao Paulo, Sch Med, Expt Oncol Lab, Sao Paulo, Brazil; [Burbano, Rommel Rodriguez] Fed Univ Para, Human Cytogenet Lab, Inst Biol Sci, BR-66059 Belem, Para, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Universidade Federal do Para; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do Para	Leal, MF (corresponding author), Univ Fed Sao Paulo, Div Genet, Dept Morphol & Genet, Sao Paulo, Brazil.	mariana.morf@epm.br	de A. C. Smith, Marilia/C-4397-2012; Chammas, Roger/A-8004-2011; Leal, Mariana/C-4010-2012; Chung, Janete/E-9176-2015; Burbano, Rommel R/C-4149-2012	de A. C. Smith, Marilia/0000-0002-1441-1033; Chammas, Roger/0000-0003-0342-8726; Leal, Mariana/0000-0003-4375-2563; Chung, Janete/0000-0001-8335-9323; Burbano, Rommel R/0000-0002-4872-234X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Dr. Chammas, Dr. Smith and Dr. Burbano) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Dr. Leal, Dr. Chung and Dr. Calcagno) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Calcagno DQ, 2006, WORLD J GASTROENTERO, V12, P6207, DOI 10.3748/wjg.v12.i38.6207; Calcagno DQ, 2010, CANCER GENET CYTOGEN, V202, P63, DOI 10.1016/j.cancergencyto.2010.05.020; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Cesar ACG, 2004, CANCER GENET CYTOGEN, V153, P127, DOI 10.1016/j.cancergencyto.2004.01.017; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; Cheng Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-191; CLAYTON CL, 1992, J CLIN MICROBIOL, V30, P192, DOI 10.1128/JCM.30.1.192-200.1992; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dos Santos SEB, 1999, AM J PHYS ANTHROPOL, V109, P175, DOI 10.1002/(SICI)1096-8644(199906)109:2<175::AID-AJPA3>3.0.CO;2-#; Ebert MR, 2006, EUR J GASTROEN HEPAT, V18, P847, DOI 10.1097/00042737-200608000-00007; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; El-Serag HB, 2002, GUT, V50, P368, DOI 10.1136/gut.50.3.368; Forrest MS, 2005, ENVIRON HEALTH PERSP, V113, P801, DOI 10.1289/ehp.7635; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatti LL, 2003, CLIN EXP MED, V3, P166, DOI 10.1007/s10238-003-0021-0; Giaginis C, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-14; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; INCA, 2009, EST 2010 INC CANC BR, P98; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kapranos N, 2002, J CANCER RES CLIN, V128, P426, DOI 10.1007/s00432-002-0357-y; Khayat AS, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-55; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Li N, 2007, J PROTEOME RES, V6, P3304, DOI 10.1021/pr0702363; Lim BH, 2006, EXP MOL MED, V38, P455, DOI 10.1038/emm.2006.54; Lin LL, 2012, J PROTEOMICS; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meuwissen THE, 2004, GENET SEL EVOL, V36, P191, DOI 10.1051/gse:2003058; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nam NH, 2003, CURR DRUG TARGETS, V4, P159, DOI 10.2174/1389450033346966; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell J, 1992, Eur J Cancer Prev, V1, P265, DOI 10.1097/00008469-199204000-00008; Raiol LCC, 2008, CANCER GENET CYTOGEN, V181, P31, DOI 10.1016/j.cancergencyto.2007.10.011; Resende ALS, 2006, ARQUIVOS GASTROENTER, V43, P6; Ryu JW, 2003, J KOREAN MED SCI, V18, P505, DOI 10.3346/jkms.2003.18.4.505; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Shah MA, 2010, JAMA-J AM MED ASSOC, V303, P1753, DOI 10.1001/jama.2010.553; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; Sobin LH, 2002, TNM CLASSIFICATION M, V6th; Takeno S, 2001, ANN SURG ONCOL, V8, P215, DOI 10.1245/aso.2001.8.3.215; Takeno SS, 2009, CANCER GENET CYTOGEN, V190, P1, DOI 10.1016/j.cancergencyto.2008.09.007; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang KJ, 2004, WORLD J GASTROENTERO, V10, P2179; WARBURG O, 1956, SCIENCE, V124, P269; Werner M, 2001, J CANCER RES CLIN, V127, P207, DOI 10.1007/s004320000195; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Whelan SL, 1993, TRENDS CANC INCIDENC; Wu C, 2009, ONCOL REP, V21, P1429, DOI 10.3892/or_00000371; Yan GR, 2011, PROTEOMICS, V11, P3657, DOI 10.1002/pmic.201100215; Yang YX, 2009, J CANCER RES CLIN, V135, P181, DOI 10.1007/s00432-008-0460-9; Yoshihara T, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-75; Zhang J, 2007, J PROTEOME RES, V6, P4423, DOI 10.1021/pr0703425; Zoubeidi A, 2012, INT J BIOCH CELL BIO	74	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42255	10.1371/journal.pone.0042255	http://dx.doi.org/10.1371/journal.pone.0042255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860099	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950900084
J	Muratsu-Ikeda, S; Nangaku, M; Ikeda, Y; Tanaka, T; Wada, T; Inagi, R				Muratsu-Ikeda, Shiyo; Nangaku, Masaomi; Ikeda, Yoichiro; Tanaka, Tetsuhiro; Wada, Takehiko; Inagi, Reiko			Downregulation of miR-205 Modulates Cell Susceptibility to Oxidative and Endoplasmic Reticulum Stresses in Renal Tubular Cells	PLOS ONE			English	Article							KIDNEY-DISEASE; BREAST-CANCER; HYPOXIA; EXPRESSION; INJURY; MICRORNA-205; PROTEIN; INHIBITION; DEATH; PROLIFERATION	Background: Oxidative stress and endoplasmic reticulum (ER) stress play a crucial role in tubular damage in both acute kidney injury (AKI) and chronic kidney disease (CKD). While the pathophysiological contribution of microRNAs (miRNA) to renal damage has also been highlighted, the effect of miRNA on renal damage under oxidative and ER stresses conditions remains elusive. Methods: We assessed changes in miRNA expression in the cultured renal tubular cell line HK-2 under hypoxia-reoxygenation-induced oxidative stress or ER stress using miRNA microarray assay and real-time RT-PCR. The pathophysiological effect of miRNA was evaluated by cell survival rate, intracellular reactive oxygen species (ROS) level, and anti-oxidant enzyme expression in miRNA-inhibited HK-2 or miRNA-overexpressed HK-2 under these stress conditions. The target gene of miRNA was identified by 3'-UTR-luciferase assay. Results: We identified 8 and 10 miRNAs whose expression was significantly altered by oxidative and ER stresses, respectively. Among these, expression of miR-205 was markedly decreased in both stress conditions. Functional analysis revealed that decreased miR-205 led to an increase in cell susceptibility to oxidative and ER stresses, and that this increase was associated with the induction of intracellular ROS and suppression of anti-oxidant enzymes. While increased miR-205 by itself made no change in cell growth or morphology, cell viability under oxidative or ER stress conditions was partially restored. Further, miR-205 bound to the 3'-UTR of the prolyl hydroxylase 1 (PHD1/EGLN2) gene and suppressed the transcription level of EGLN2, which modulates both intracellular ROS level and ER stress state. Conclusions: miR-205 serves a protective role against both oxidative and ER stresses via the suppression of EGLN2 and subsequent decrease in intracellular ROS. miR-205 may represent a novel therapeutic target in AKI and CKD associated with oxidative or ER stress in tubules.	[Muratsu-Ikeda, Shiyo; Nangaku, Masaomi; Ikeda, Yoichiro; Tanaka, Tetsuhiro; Wada, Takehiko; Inagi, Reiko] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo 113, Japan	University of Tokyo	Muratsu-Ikeda, S (corresponding author), Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo 113, Japan.	mnangaku-tky@umin.ac.jp; inagi-npr@umin.ac.jp	Wada, Takehiko/AAA-9652-2020		Japan Society for the Promotion of Science [22590880, 2139036]; Japanese association of dialysis physicians for Human Science [22051]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese association of dialysis physicians for Human Science	This work was supported by Grant-in-Aids for Scientific Research 22590880 (to RI) and 2139036 (to MN) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) and Japanese association of dialysis physicians for Human Science (22051) (http://www.touseki-ikai.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arrington DD, 2008, AM J PHYSIOL-CELL PH, V294, pC641, DOI 10.1152/ajpcell.00400.2007; Bando Y, 2004, FASEB J, V18, P1401, DOI 10.1096/fj.03-1161fje; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beisswenger PJ, 2005, DIABETES, V54, P3274, DOI 10.2337/diabetes.54.11.3274; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Cybulsky AV, 2011, AM J PHYSIOL-RENAL, V301, pF496, DOI 10.1152/ajprenal.00728.2010; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1117, DOI 10.1097/01.WCB.0000089600.87125.AD; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hiwatashi Y, 2011, EXP CELL RES; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Inagi R, 2008, J AM SOC NEPHROL, V19, P915, DOI 10.1681/ASN.2007070745; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Kawakami T, 2010, AM J PHYSIOL-RENAL, V299, pF568, DOI 10.1152/ajprenal.00659.2009; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kojima I, 2007, J AM SOC NEPHROL, V18, P1218, DOI 10.1681/ASN.2006060639; Kumagai T, 2009, AM J PHYSIOL-RENAL, V296, pF912, DOI 10.1152/ajprenal.90575.2008; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Matsushima K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-30; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Mutharasan RK, 2011, AM J PHYSL HEART CIR; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Natarajan R, 2009, VASC PHARMACOL, V51, P110, DOI 10.1016/j.vph.2009.05.007; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Piovan C, 2012, MOL ONCOL; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Tsai CA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng052; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang G, 2010, LAB INVEST, V90, P98, DOI 10.1038/labinvest.2009.118; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105	50	85	92	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41462	10.1371/journal.pone.0041462	http://dx.doi.org/10.1371/journal.pone.0041462			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859986	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900023
J	Wang, TH; Ng, KF; Yeh, TS; Wang, YL; Liang, KH; Yeh, CT; Chen, TC				Wang, Tong-Hong; Ng, Kwai-Fong; Yeh, Ta-Sen; Wang, Yu-Ling; Liang, Kung-Hao; Yeh, Chau-Ting; Chen, Tse-Ching			Peritumoral Small EphrinA5 Isoform Level Predicts the Postoperative Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GROWTH-FACTOR RECEPTOR; SYNAPTIC FUNCTIONS; EPH RECEPTORS; MET RECEPTOR; RISK-FACTORS; CANCER; LIVER; EXPRESSION; RESECTION	Background: EphrinA5, a member of Eph/Ephrin family, possesses two alternative isoforms, large ephrinA5 isoform (ephrinA5L) and small ephrinA5 isoform (ephrinA5S). EphrinA5L is a putative tumor suppressor in several types of human cancers. However, the role of ephrinA5S in hepato-carcinogenesis remains unclear. In this study, we evaluate the role of ephrinA5 isoforms in human hepatocellular carcinomas (HCC). Methodology/Principal Findings: A total of 142 paired HCCs and peritumoral liver tissue was examined for relative expression of ephrinA5L and ephrinA5S by using quantitative real-time polymerase chain reaction. We analyzed their expression in relation to clinical parameters, disease-free survival and overall survival. Functional assays were performed to dissect the possible underlying mechanisms. Both ephrinA5L and ephrinA5S were significantly downregulated in HCCs, as compared to those in peritumoral tissue (p = 0.013 and 0.001). Univariate analysis demonstrated that ephrinA5S was positively correlated with old age and histological grade. In multivariate analysis, high ephrinA5S expression in peritumoral tissue had better disease-free survival (p = 0.002) and overall survival (p = 0.045) in patients with HCC after surgical resection. Functional analysis in HCC cell lines revealed that ephrinA5S had a more potent suppressive effect than ephrinA5L on cell proliferation (p<0.05) and migration (p<0.01). Furthermore, forced expression of both ephrinA5 isoforms in HCC cell lines significantly down-regulated epidermal growth factor receptor (EGFR) expression by promoting c-Cbl-mediated EGFR degradation. Conclusions/Significance: EphrinA5S might be a useful prognostic biomarker for HCCs after surgical resection. EphrinA5, especially ephrinA5S, acts as a tumor suppressor in hepatocarcinogenesis. Peritumoral small ephrinA5 isoform level could determine the postoperative survival in hepatocellular carcinoma.	[Wang, Tong-Hong; Chen, Tse-Ching] Chang Gung Mem Hosp, Tissue Bank, Tao Yuan, Taiwan; [Ng, Kwai-Fong; Wang, Yu-Ling; Chen, Tse-Ching] Chang Gung Univ, Chang Gung Mem Hosp, Dept Anat Pathol, Sch Med, Tao Yuan, Taiwan; [Yeh, Ta-Sen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Gen Surg, Sch Med, Tao Yuan, Taiwan; [Liang, Kung-Hao; Yeh, Chau-Ting] Chang Gung Mem Hosp, Liver Res Ctr, Dept Hepatogastroenterol, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Wang, TH (corresponding author), Chang Gung Mem Hosp, Tissue Bank, Tao Yuan, Taiwan.	chauting@adm.cgmh.org.tw; ctc323@adm.cgmh.org.tw			Department of Health, Taiwan [DOH99-TD-C-111-006]; Chang Gung Medical Research Program grants, Taiwan [CMRPG391051, CMRPG380372]	Department of Health, Taiwan; Chang Gung Medical Research Program grants, Taiwan	This work was partly supported by grant DOH99-TD-C-111-006 from Department of Health, Taiwan and Chang Gung Medical Research Program grants CMRPG391051 and CMRPG380372, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Campbell T, 2006, FORUM ITALICUM, V40, P5, DOI 10.1177/001458580604000101; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010; Feng YX, 2010, HEPATOLOGY, V51, P535, DOI 10.1002/hep.23313; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Haldimann M, 2009, INT J ONCOL, V35, P525, DOI 10.3892/ijo_00000364; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Hopfner M, 2008, WORLD J GASTROENTERO, V14, P1, DOI 10.3748/wjg.14.1; Hopfner M, 2004, J HEPATOL, V41, P1008, DOI 10.1016/j.jhep.2004.08.024; Huynh H, 2008, CLIN CANCER RES, V14, P6146, DOI 10.1158/1078-0432.CCR-08-0509; Kalinski T, 2009, HUM PATHOL, V40, P1679, DOI 10.1016/j.humpath.2009.03.024; Kaufmann R, 2009, CARCINOGENESIS, V30, P1487, DOI 10.1093/carcin/bgp153; Kawano Y, 2009, EJSO-EUR J SURG ONC, V35, P174, DOI 10.1016/j.ejso.2008.01.027; Kew MC, 2003, LIVER INT, V23, P405, DOI 10.1111/j.1478-3231.2003.00869.x; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Lai KO, 1999, FEBS LETT, V458, P265, DOI 10.1016/S0014-5793(99)01159-X; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lee HO, 2011, CANCER RES, V71, P6327, DOI 10.1158/0008-5472.CAN-11-0304; Li JJ, 2009, ONCOGENE, V28, P1759, DOI 10.1038/onc.2009.15; Li YY, 2001, AM J PHYSIOL-HEART C, V281, pH2738, DOI 10.1152/ajpheart.2001.281.6.H2738; Lin SB, 1997, J BIOCHEM, V122, P717; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Mathurin P, 1998, ALIMENT PHARM THERAP, V12, P111; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Shimizu M, 2008, CANCER LETT, V262, P10, DOI 10.1016/j.canlet.2007.11.026; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; TANAKA K, 1992, INT J CANCER, V51, P509, DOI 10.1002/ijc.2910510402; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Yanaga K, 2004, J GASTROENTEROL, V39, P919, DOI 10.1007/s00535-004-1422-x; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41749	10.1371/journal.pone.0041749	http://dx.doi.org/10.1371/journal.pone.0041749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860012	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950900037
J	Al-Ofi, E; Coffelt, SB; Anumba, DO				Al-ofi, Ebtisam; Coffelt, Seth B.; Anumba, Dilly O.			Monocyte Subpopulations from Pre-Eclamptic Patients Are Abnormally Skewed and Exhibit Exaggerated Responses to Toll-Like Receptor Ligands	PLOS ONE			English	Article							PERIPHERAL-BLOOD; BASAL PLATE; TNF-ALPHA; MACROPHAGES; PREGNANCY; WOMEN; PLACENTATION; EXPRESSION; LEUKOCYTES; SEPSIS	The leading cause of pregnancy-associated mortality and morbidity is pre-eclampsia (PE). Although information regarding the etiology of this disease is scant, its pathophysiology is characterized by abnormal placentation, endothelial dysfunction as well as an exaggerated inflammatory response. Clinical evidence also indicates that the abundance of many immune cells at the feto-maternal interface and in the circulation of PE patients is abnormal, when compared with normal pregnant (NP) controls. In addition, the phenotype and function of some of these cells is altered. To further characterize the systemic effects of PE on circulating cells, we analyzed monocytic subpopulations in NP and PE patients by flow cytometry. We found that non-classical CD14(low)CD16(+) monocytes are significantly increased in women with PE and they display irregular expression of several chemokine receptors and antigen presentation molecules. The most striking phenotypic difference among the cell surface molecules was the marked upregulation of TLR4 expression, where both CD14(high)CD16(+) and CD14(low)CD16(+) monocytes demonstrated higher levels than their NP counterparts. Stimulation of PE monocytes with TLR ligands resulted in profound secretion of various cytokines in comparison with NP controls. These data suggest that PE monocytes are hyper-responsive to TLR ligands and this may contribute to exacerbation of the disease.	[Al-ofi, Ebtisam; Anumba, Dilly O.] Univ Sheffield, Sch Med, Acad Unit Reprod Med, Sheffield, S Yorkshire, England; [Al-ofi, Ebtisam; Anumba, Dilly O.] Univ Sheffield, Sch Med, Acad Unit Dev Med, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Al-Ofi, E (corresponding author), Univ Sheffield, Sch Med, Acad Unit Reprod Med, Sheffield, S Yorkshire, England.	d.o.c.anumba@sheffield.ac.uk	Professor Dilly Anumba MBBS, FWACS/A-6358-2011; Coffelt, Seth/O-9929-2019	Professor Dilly Anumba MBBS, FWACS/0000-0003-2502-3033; Coffelt, Seth/0000-0003-2257-2862	government of the Kingdom of Saudi Arabia	government of the Kingdom of Saudi Arabia	E.A. was funded by the government of the Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn H, 2011, AM J REPROD IMMUNOL, V65, P377, DOI 10.1111/j.1600-0897.2010.00913.x; Blumenstein M, 1997, SHOCK, V8, P73, DOI 10.1097/00024382-199707000-00012; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burk MR, 2001, PLACENTA, V22, P309, DOI 10.1053/plac.2001.0624; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Faas MM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.013; FINGERLE G, 1993, BLOOD, V82, P3170; Furuya M, 2008, VASC HEALTH RISK MAN, V4, P1301, DOI 10.2147/VHRM.S4009; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Hennessy A, 1999, J IMMUNOL, V163, P3491; Holthe MR, 2004, OBSTET GYNECOL, V103, P913, DOI 10.1097/01.AOG.0000124806.39111.ba; Kawanaka N, 2002, NEPHRON, V90, P64, DOI 10.1159/000046316; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim JS, 2007, PLACENTA, V28, P571, DOI 10.1016/j.placenta.2006.07.007; Luppi P, 2006, CLIN IMMUNOL, V118, P268, DOI 10.1016/j.clim.2005.11.001; Mazouni C, 2008, J REPROD IMMUNOL, V78, P80, DOI 10.1016/j.jri.2007.10.002; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Nitsche JF, 2011, AM J REPROD IMMUNOL, V66, P242, DOI 10.1111/j.1600-0897.2011.00985.x; Nockher WA, 1998, INFECT IMMUN, V66, P2782, DOI 10.1128/IAI.66.6.2782-2790.1998; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Schonkeren D, 2011, AM J PATHOL, V178, P709, DOI 10.1016/j.ajpath.2010.10.011; Sharma A, 2007, AM J REPROD IMMUNOL, V58, P21, DOI 10.1111/j.1600-0897.2007.00486.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2004, AM J OBSTET GYNECOL, V191, P1061, DOI 10.1016/j.ajog.2004.03.042; Veas CJ, 2011, J MATERN FETAL NEONA; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Xie F, 2010, BJOG-INT J OBSTET GY, V117, P99, DOI 10.1111/j.1471-0528.2009.02428.x; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455; Zawada AM, 2011, BLOOD; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	39	34	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42217	10.1371/journal.pone.0042217	http://dx.doi.org/10.1371/journal.pone.0042217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848746	Green Accepted, Green Published, gold			2022-12-27	WOS:000306950200184
J	Barat, E; Boisseau, S; Bouyssieres, C; Appaix, F; Savasta, M; Albrieux, M				Barat, Elodie; Boisseau, Sylvie; Bouyssieres, Celine; Appaix, Florence; Savasta, Marc; Albrieux, Mireille			Subthalamic Nucleus Electrical Stimulation Modulates Calcium Activity of Nigral Astrocytes	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; GAMMA-AMINOBUTYRIC-ACID; PARS RETICULATA NEURONS; SUBSTANTIA-NIGRA; GLOBUS-PALLIDUS; BASAL GANGLIA; EXTRACELLULAR GLUTAMATE; RETRORUBRAL FIELD; INDIRECT PATHWAYS; GLIAL CALCIUM	Background: The substantia nigra pars reticulata (SNr) is a major output nucleus of the basal ganglia, delivering inhibitory efferents to the relay nuclei of the thalamus. Pathological hyperactivity of SNr neurons is known to be responsible for some motor disorders e.g. in Parkinson's disease. One way to restore this pathological activity is to electrically stimulate one of the SNr input, the excitatory subthalamic nucleus (STN), which has emerged as an effective treatment for parkinsonian patients. The neuronal network and signal processing of the basal ganglia are well known but, paradoxically, the role of astrocytes in the regulation of SNr activity has never been studied. Principal Findings: In this work, we developed a rat brain slice model to study the influence of spontaneous and induced excitability of afferent nuclei on SNr astrocytes calcium activity. Astrocytes represent the main cellular population in the SNr and display spontaneous calcium activities in basal conditions. Half of this activity is autonomous (i.e. independent of synaptic activity) while the other half is dependent on spontaneous glutamate and GABA release, probably controlled by the pace-maker activity of the pallido-nigral and subthalamo-nigral loops. Modification of the activity of the loops by STN electrical stimulation disrupted this astrocytic calcium excitability through an increase of glutamate and GABA releases. Astrocytic AMPA, mGlu and GABA(A) receptors were involved in this effect. Significance: Astrocytes are now viewed as active components of neural networks but their role depends on the brain structure concerned. In the SNr, evoked activity prevails and autonomous calcium activity is lower than in the cortex or hippocampus. Our data therefore reflect a specific role of SNr astrocytes in sensing the STN-GPe-SNr loops activity and suggest that SNr astrocytes could potentially feedback on SNr neuronal activity. These findings have major implications given the position of SNr in the basal ganglia network.	[Barat, Elodie; Boisseau, Sylvie; Bouyssieres, Celine; Appaix, Florence; Savasta, Marc; Albrieux, Mireille] Inst Natl Sante & Rech Med, Grenoble Inst Neurosci, Equipe Dynam & Physiopathol Gangl Base, U836, F-38043 Grenoble, France; [Barat, Elodie; Boisseau, Sylvie; Bouyssieres, Celine; Appaix, Florence; Savasta, Marc; Albrieux, Mireille] Univ Grenoble 1, F-38042 Grenoble, France; [Savasta, Marc] Ctr Hosp Univ Grenoble, F-38043 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Barat, E (corresponding author), Inst Natl Sante & Rech Med, Grenoble Inst Neurosci, Equipe Dynam & Physiopathol Gangl Base, U836, F-38043 Grenoble, France.	mireille.albrieux@ujf-grenoble.fr	Albrieux, Mireille/H-3824-2017; Savasta, Marc/M-4939-2017	Albrieux, Mireille/0000-0002-2817-2563; 	Institut National de la Sante et de la Recherche Medicale; Universite Joseph Fourier; France Parkinson; Fondation de France	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Joseph Fourier; France Parkinson; Fondation de France(Fondation de France)	Funding provided by the Institut National de la Sante et de la Recherche Medicale; Universite Joseph Fourier; France Parkinson; Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Appaix F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035169; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; BENAZZOUZ A, 1995, NEUROSCI LETT, V189, P77, DOI 10.1016/0304-3940(95)11455-6; Benazzouz A, 2000, NEUROLOGY, V55, pS13; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Beurrier C, 2006, NEUROSCIENCE, V140, P77, DOI 10.1016/j.neuroscience.2006.02.029; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosch C, 2011, J PHYSL, V589, P19; Boulet S, 2006, J NEUROSCI, V26, P10768, DOI 10.1523/JNEUROSCI.3065-06.2006; Degos B, 2005, J NEUROSCI, V25, P7687, DOI 10.1523/JNEUROSCI.1056-05.2005; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deniau JM, 2007, PROG BRAIN RES, V160, P151, DOI 10.1016/S0079-6123(06)60009-5; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Dostrovsky JO, 2002, MOVEMENT DISORD, V17, pS63, DOI 10.1002/mds.10143; Doube M, 2010, BONE; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Garcia L, 2003, J NEUROSCI, V23, P8743; Goubard V, 2011, J PHYSIOL-LONDON, V589, P2301, DOI 10.1113/jphysiol.2010.203125; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; GROENEWEGEN HJ, 1990, J COMP NEUROL, V294, P607, DOI 10.1002/cne.902940408; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x; Hikosaka O, 2007, PROG BRAIN RES, V160, P209, DOI 10.1016/S0079-6123(06)60012-5; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; Kita H, 2005, J NEUROSCI, V25, P8611, DOI 10.1523/JNEUROSCI.1719-05.2005; KITAI ST, 1981, BRAIN RES, V214, P411, DOI 10.1016/0006-8993(81)91204-X; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; Mailly P, 2001, J NEUROSCI, V21, P6874, DOI 10.1523/JNEUROSCI.21-17-06874.2001; Maurice N, 2003, J NEUROSCI, V23, P9929; MILLER WC, 1988, ANN NY ACAD SCI, V515, P287, DOI 10.1111/j.1749-6632.1988.tb32998.x; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Parri R, 2003, NAT NEUROSCI, V6, P5, DOI 10.1038/nn0103-5; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Platel JC, 2007, EUR J NEUROSCI, V25, P920, DOI 10.1111/j.1460-9568.2007.05367.x; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Porter JT, 1996, J NEUROSCI, V16, P5073; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Sasaki T, 2011, CEREB CORTEX, V21, P1889, DOI 10.1093/cercor/bhq256; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shen KZ, 2006, J PHYSIOL-LONDON, V573, P697, DOI 10.1113/jphysiol.2006.110031; Smith Y, 1998, NEUROSCIENCE, V86, P353; Takata N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002525; Tymianski M, 1997, CELL CALCIUM, V21, P175, DOI 10.1016/S0143-4160(97)90042-7; Verant P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041163; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Verkhratsky A, 2000, BRAIN RES REV, V32, P380, DOI 10.1016/S0165-0173(99)00093-4; Villalba RM, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00068; VONKROSIGK M, 1992, NEUROSCIENCE, V50, P531, DOI 10.1016/0306-4522(92)90445-8; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Windels F, 2005, J NEUROSCI, V25, P5079, DOI 10.1523/JNEUROSCI.0360-05.2005; Windels F, 2003, J NEUROSCI RES, V72, P259, DOI 10.1002/jnr.10577	70	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41793	10.1371/journal.pone.0041793	http://dx.doi.org/10.1371/journal.pone.0041793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848608	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200107
J	Cha, SW; McAdams, M; Kormish, J; Wylie, C; Kofron, M				Cha, Sang-Wook; McAdams, Meredith; Kormish, Jay; Wylie, Christopher; Kofron, Matthew			Foxi2 Is an Animally Localized Maternal mRNA in Xenopus, and an Activator of the Zygotic Ectoderm Activator Foxi1e	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; LAEVIS EMBRYOS; EVOLUTIONARY ORIGIN; MESODERM INDUCTION; MOLECULAR EVIDENCE; SENSORY PLACODES; CLASS GENES; EXPRESSION; VEGT; PATTERNS	Foxi1e is a zygotic transcription factor that is essential for the expression of early ectodermal genes. It is expressed in a highly specific pattern, only in the deep cell layers of the animal hemisphere, and in a mosaic pattern in which expressing cells are interspersed with non-expressing cells. Previous work has shown that several signals in the blastula control this expression pattern, including nodals, the TGF beta family member Vg1, and Notch. However, these are all inhibitory, which raises the question of what activates Foxi1e. In this work, we show that a related Forkhead family protein, Foxi2, is a maternal activator of Foxi1e. Foxi2 mRNA is maternally encoded, and highly enriched in animal hemisphere cells of the blastula. ChIP assays show that it acts directly on upstream regulatory elements of Foxi1e. Its effect is specific, since animal cells depleted of Foxi2 are able to respond normally to mesoderm inducing signals from vegetal cells. Foxi2 thus acts as a link between the oocyte and the early pathway to ectoderm, in a similar fashion to the vegetally localized VegT acts to initiate endoderm and mesoderm formation.	[Cha, Sang-Wook; McAdams, Meredith; Wylie, Christopher; Kofron, Matthew] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Kormish, Jay] Univ Calgary, Calgary, AB, Canada	Cincinnati Children's Hospital Medical Center; University of Calgary	Cha, SW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA.	matthew.kofron@cchmc.org	Cha, Sang-Wook/D-3523-2016	McAdams, Meredith/0000-0001-6184-6745; Kofron, Matthew/0000-0001-6427-4148	National Institute of Health [RO1HD45737]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045737] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors would like to acknowledge financial support from the National Institute of Health (RO1HD45737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birsoy B, 2006, DEVELOPMENT, V133, P15, DOI 10.1242/dev.02144; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; BOTERENBROOD EC, 1973, ROUX ARCH DEV BIOL, V173, P319, DOI 10.1007/BF00575837; DALE L, 1985, J EMBRYOL EXP MORPH, V89, P289; DALE L, 1987, DEVELOPMENT, V99, P527; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; GRAINGER RM, 1989, P NATL ACAD SCI USA, V86, P1900, DOI 10.1073/pnas.86.6.1900; Hulander M, 1998, NAT GENET, V20, P374, DOI 10.1038/3850; JONES EA, 1986, CELL, V44, P345, DOI 10.1016/0092-8674(86)90769-5; Knochel W, 1997, CELL MOL LIFE SCI, V53, P362, DOI 10.1007/PL00000612; Kofron M, 1999, DEVELOPMENT, V126, P5759; LEF J, 1994, MECH DEVELOP, V45, P117, DOI 10.1016/0925-4773(94)90025-6; Lustig KD, 1996, DEVELOPMENT, V122, P4001; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Mazet F, 2005, J EXP ZOOL PART B, V304B, P340, DOI 10.1002/jezmde.b.21054; Mir A, 2008, DEV BIOL, V315, P161, DOI 10.1016/j.ydbio.2007.12.022; Mir A, 2007, DEVELOPMENT, V134, P779, DOI 10.1242/dev.02768; Mir Adnan, 2008, V469, P417, DOI 10.1007/978-1-60327-469-2_26; MOODY SA, 1987, DEV BIOL, V122, P300, DOI 10.1016/0012-1606(87)90296-X; Ohyama T, 2004, DEV DYNAM, V231, P640, DOI 10.1002/dvdy.20160; Pohl BS, 2005, INT J DEV BIOL, V49, P53, DOI 10.1387/ijdb.051977bp; Pohl BS, 2005, GENE, V344, P21, DOI 10.1016/j.gene.2004.09.037; Pohl BS, 2004, DEV GENES EVOL, V214, P200, DOI 10.1007/s00427-004-0391-7; Pohl BS, 2002, MECH DEVELOP, V111, P181, DOI 10.1016/S0925-4773(01)00617-7; SMITH JC, 1987, DEVELOPMENT, V99, P3; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Solomon KS, 2003, DEV DYNAM, V228, P301, DOI 10.1002/dvdy.10373; Stennard F, 1996, DEVELOPMENT, V122, P4179; Suri C, 2005, DEVELOPMENT, V132, P2733, DOI 10.1242/dev.01865; Tadjuidje E, DEV DYN, V240, P1727; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Wijchers PJEC, 2005, BBA-GENE STRUCT EXPR, V1731, P133, DOI 10.1016/j.bbaexp.2005.09.003; Xanthos JB, 2001, DEVELOPMENT, V128, P167; Zeng MS, 2006, BIOL CHEM, V387, P741, DOI 10.1515/BC.2006.093; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zhang J, 1996, DEVELOPMENT, V122, P4119	39	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41782	10.1371/journal.pone.0041782	http://dx.doi.org/10.1371/journal.pone.0041782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848601	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200105
J	Herbert, AP; Riesen, M; Bloxam, L; Kosmidou, E; Wareing, BM; Johnson, JR; Phelan, MM; Pennington, SR; Lian, LY; Morgan, A				Herbert, Andrew P.; Riesen, Michele; Bloxam, Leanne; Kosmidou, Effie; Wareing, Brian M.; Johnson, James R.; Phelan, Marie M.; Pennington, Stephen R.; Lian, Lu-Yun; Morgan, Alan			NMR Structure of Hsp12, a Protein Induced by and Required for Dietary Restriction-Induced Lifespan Extension in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DETERGENT MICELLES; ALPHA-SYNUCLEIN; BUDDING YEAST; EXTENDS; SHOCK; SIR2; MECHANISMS; ASSIGNMENT	Dietary restriction (DR) extends lifespan in yeast, worms, flies and mammals, suggesting that it may act via conserved processes. However, the downstream mechanisms by which DR increases lifespan remain unclear. We used a gel based proteomic strategy to identify proteins whose expression was induced by DR in yeast and thus may correlate with longevity. One protein up-regulated by DR was Hsp12, a small heat shock protein induced by various manipulations known to retard ageing. Lifespan extension by growth on 0.5% glucose (DR) was abolished in an hsp12 Delta strain, indicating that Hsp12 is essential for the longevity effect of DR. In contrast, deletion of HSP12 had no effect on growth under DR conditions or a variety of environmental stresses, indicating that the effect of Hsp12 on lifespan is not due to increased general stress resistance. Unlike other small heat shock proteins, recombinant Hsp12 displayed negligible in vitro molecular chaperone activity, suggesting that its cellular function does not involve preventing protein aggregation. NMR analysis indicated that Hsp12 is monomeric and intrinsically unfolded in solution, but switches to a 4-helical conformation upon binding to membrane-mimetic SDS micelles. The structure of micelle-bound Hsp12 reported here is consistent with its recently proposed function as a membrane-stabilising 'lipid chaperone'. Taken together, our data suggest that DR-induced Hsp12 expression contributes to lifespan extension, possibly via membrane alterations.	[Herbert, Andrew P.; Riesen, Michele; Bloxam, Leanne; Kosmidou, Effie; Wareing, Brian M.; Johnson, James R.; Morgan, Alan] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Herbert, Andrew P.; Phelan, Marie M.; Lian, Lu-Yun] Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England; [Pennington, Stephen R.] Univ Coll Dublin, Univ Coll Dublin Conway Inst Biomed & Biomol Res, Dublin 2, Ireland	University of Liverpool; University of Liverpool; University College Dublin	Herbert, AP (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	amorgan@liverpool.ac.uk	Herbert, Andy P/F-6693-2010; Herbert, Andrew P/C-4755-2008; Morgan, Alan/AAI-8875-2020; Pennington, Stephen R/C-7505-2015; Johnson, James R/D-9721-2014	Herbert, Andy P/0000-0002-4549-6965; Herbert, Andrew P/0000-0002-4549-6965; Johnson, James R/0000-0002-8849-0993; Pennington, Stephen/0000-0001-7529-1015; Morgan, Alan/0000-0002-0346-1289	Biotechnology and Biological Sciences Research Council research grant [ERA16235]; Wellcome Trust project grant [090077/Z/09/Z]; Wellcome Trust Prize Studentships	Biotechnology and Biological Sciences Research Council research grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust project grant(Wellcome Trust); Wellcome Trust Prize Studentships(Wellcome Trust)	This work was supported by a Biotechnology and Biological Sciences Research Council research grant to AM and SRP (Grant Ref ERA16235; funder's URL http://www.bbsrc.ac.uk/home/home.aspx), a Wellcome Trust project grant to AM and LYL (Grant Ref 090077/Z/09/Z; funder's URL http://www.wellcome.ac.uk/), and Wellcome Trust Prize Studentships to MR and LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Brachmann CB, 1998, YEAST, V14, P115; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Craig TJ, 2004, J BIOCHEM BIOPH METH, V60, P49, DOI 10.1016/j.jbbm.2004.04.015; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Greenall A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r146; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2004, GENETICS, V166, P1661, DOI 10.1534/genetics.166.4.1661; Kaeberlein M, 2002, MOL CELL BIOL, V22, P8056, DOI 10.1128/MCB.22.22.8056-8066.2002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Madine J, 2006, BIOCHEMISTRY-US, V45, P5783, DOI 10.1021/bi052151q; Mankouri HW, 2001, MECH AGEING DEV, V122, P1107, DOI 10.1016/S0047-6374(01)00253-6; Merry BJ, 2005, MECH AGEING DEV, V126, P951, DOI 10.1016/j.mad.2005.03.015; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Riesen M, 2009, AGING CELL, V8, P624, DOI 10.1111/j.1474-9726.2009.00514.x; Singarapu KK, 2011, J BIOL CHEM, V286, P43447, DOI 10.1074/jbc.M111.306464; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171	42	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41975	10.1371/journal.pone.0041975	http://dx.doi.org/10.1371/journal.pone.0041975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848679	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200140
J	Kazantsev, V; Gordleeva, S; Stasenko, S; Dityatev, A				Kazantsev, Victor; Gordleeva, Susan; Stasenko, Sergey; Dityatev, Alexander			A Homeostatic Model of Neuronal Firing Governed by Feedback Signals from the Extracellular Matrix	PLOS ONE			English	Article							SYNAPTIC STRENGTH; PLASTICITY; MOLECULES	Molecules of the extracellular matrix (ECM) can modulate the efficacy of synaptic transmission and neuronal excitability. These mechanisms are crucial for the homeostatic regulation of neuronal firing over extended timescales. In this study, we introduce a simple mathematical model of neuronal spiking balanced by the influence of the ECM. We consider a neuron receiving random synaptic input in the form of Poisson spike trains and the ECM, which is modeled by a phenomenological variable involved in two feedback mechanisms. One feedback mechanism scales the values of the input synaptic conductance to compensate for changes in firing rate. The second feedback accounts for slow fluctuations of the excitation threshold and depends on the ECM concentration. We show that the ECM-mediated feedback acts as a robust mechanism to provide a homeostatic adjustment of the average firing rate. Interestingly, the activation of feedback mechanisms may lead to a bistability in which two different stable levels of average firing rates can coexist in a spiking network. We discuss the mechanisms of the bistability and how they may be related to memory function.	[Kazantsev, Victor; Gordleeva, Susan; Stasenko, Sergey] Russian Acad Sci, Inst Appl Phys, Lab Nonlinear Dynam Living Syst, Nizhnii Novgorod, Russia; [Kazantsev, Victor; Gordleeva, Susan; Stasenko, Sergey; Dityatev, Alexander] Univ Nizhny Novgorod, Lab Brain Extracellular Matrix Res, Nizhnii Novgorod, Russia; [Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Dityatev, Alexander] German Ctr Neurodegenerat Dis, DZNE, Mol Neuroplast Grp, Magdeburg, Germany	Russian Academy of Sciences; Institute of Applied Physics of the Russian Academy of Sciences; Lobachevsky State University of Nizhni Novgorod; Istituto Italiano di Tecnologia - IIT; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kazantsev, V (corresponding author), Russian Acad Sci, Inst Appl Phys, Lab Nonlinear Dynam Living Syst, Nizhnii Novgorod, Russia.	vkazan@neuron.appl.sci-nnov.ru	Gordleeva, Susanna/AAN-9758-2020; Gordleeva, Susan/E-5630-2014; Dityatev, Alexander/A-4034-2008; Stasenko, Sergey Victorovich/J-4825-2013; Kazantsev, Victor B/L-1424-2013	Gordleeva, Susanna/0000-0002-7687-3065; Dityatev, Alexander/0000-0002-0472-0553; Stasenko, Sergey/0000-0002-3032-5469; Kazantsev, Viktor/0000-0002-2881-6648	Ministry of Education and Science of Russian Federation [11.G34.31.0012]; Federal Program "Scientific and Scientific-educational brainpower of innovative Russia.''; Ministry of Education and Science of Russian Federation, under Federal Program on scientific and technological development [16.512.11.2136]; Molecular and Cellular Biology Program, Russian Academy of Science [NG-A5]; Russian President Grant [MD-5096.2011.2]	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Federal Program "Scientific and Scientific-educational brainpower of innovative Russia.''; Ministry of Education and Science of Russian Federation, under Federal Program on scientific and technological development; Molecular and Cellular Biology Program, Russian Academy of Science; Russian President Grant	Funding provided by: 1. Ministry of Education and Science of Russian Federation, Grant for Leading Scientists, No. 11.G34.31.0012. AED acknowledges individual support. 2. Federal Program "Scientific and Scientific-educational brainpower of innovative Russia.'' VBK, SYG and SVS acknowledge individual support. 3. Ministry of Education and Science of Russian Federation, Grant under Federal Program on scientific and technological development, contract No. 16.512.11.2136. VBK, SYG and SVS acknowledge individual support. 4. Molecular and Cellular Biology Program, Russian Academy of Science, Project NG-A5. VBK, SYG and SVS acknowledge individual support. 5. Russian President Grant No. MD-5096.2011.2. VBK acknowledges individual support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Dayan P, 2001, COMPUTATIONAL NEUROS; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Dityatev A, 2011, CURR OPIN NEUROBIOL, V21, P353, DOI 10.1016/j.conb.2010.12.006; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dityatev A, 2010, EPILEPSIA, V51, P61, DOI 10.1111/j.1528-1167.2010.02612.x; Dityatev A, 2008, NEURON GLIA BIOL, V4, P235, DOI 10.1017/S1740925X09000118; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; GUCKENHEIMER J, 1993, B MATH BIOL, V55, P937, DOI 10.1007/BF02460693; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Kazantsev VB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031913; Nadkarni S, 2007, PHYS BIOL, V4, P1, DOI 10.1088/1478-3975/4/1/001; Remme MWH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000493; Rich MM, 2007, TRENDS NEUROSCI, V30, P119, DOI 10.1016/j.tins.2007.01.004; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Volman V, 2007, NEURAL COMPUT, V19, P303, DOI 10.1162/neco.2007.19.2.303; Wlodarczyk J, 2011, DEV NEUROBIOL, V71, P1040, DOI 10.1002/dneu.20958	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41646	10.1371/journal.pone.0041646	http://dx.doi.org/10.1371/journal.pone.0041646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848555	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200082
J	Metzger, J; Ohnesorge, B; Distl, O				Metzger, Julia; Ohnesorge, Bernhard; Distl, Ottmar			Genome-Wide Linkage and Association Analysis Identifies Major Gene Loci for Guttural Pouch Tympany in Arabian and German Warmblood Horses	PLOS ONE			English	Article							FOALS; TESTS	Equine guttural pouch tympany (GPT) is a hereditary condition affecting foals in their first months of life. Complex segregation analyses in Arabian and German warmblood horses showed the involvement of a major gene as very likely. Genome-wide linkage and association analyses including a high density marker set of single nucleotide polymorphisms (SNPs) were performed to map the genomic region harbouring the potential major gene for GPT. A total of 85 Arabian and 373 German warmblood horses were genotyped on the Illumina equine SNP50 beadchip. Non-parametric multipoint linkage analyses showed genome-wide significance on horse chromosomes (ECA) 3 for German warmblood at 16-26 Mb and 34-55 Mb and for Arabian on ECA15 at 64-65 Mb. Genome-wide association analyses confirmed the linked regions for both breeds. In Arabian, genome-wide association was detected at 64 Mb within the region with the highest linkage peak on ECA15. For German warmblood, signals for genome-wide association were close to the peak region of linkage at 52 Mb on ECA3. The odds ratio for the SNP with the highest genome-wide association was 0.12 for the Arabian. In conclusion, the refinement of the regions with the Illumina equine SNP50 beadchip is an important step to unravel the responsible mutations for GPT.	[Metzger, Julia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Ohnesorge, Bernhard] Univ Vet Med Hannover, Clin Horses, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Metzger, J (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Metzger, Julia/0000-0002-2089-8933	German Research Council, DFG, Bonn [DI 333/11-2]	German Research Council, DFG, Bonn(German Research Foundation (DFG))	This study was supported by the German Research Council, DFG, Bonn (DI 333/11-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptiste KE, 1998, VET J, V155, P139, DOI 10.1016/S1090-0233(98)80009-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Blazyczek I, 2004, J HERED, V95, P195, DOI 10.1093/jhered/esh041; Blazyczek I, 2004, VET REC, V154, P261, DOI 10.1136/vr.154.9.261; Blazyczek I, 2003, BERL MUNCH TIERARZTL, V116, P346; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Leuwer R, 2003, HNO, V51, P431, DOI 10.1007/s00106-003-0868-0; Ohnesorge B., 2001, Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere, V29, P45; OHNESORGE B, 1995, PFERDEHEILKUNDE, V11, P233; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Zeitz A, 2009, ANIM GENET, V40, P917, DOI 10.1111/j.1365-2052.2009.01942.x	15	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41640	10.1371/journal.pone.0041640	http://dx.doi.org/10.1371/journal.pone.0041640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848553	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200081
J	O'Reilly, AO; Eberhardt, E; Weidner, C; Alzheimer, C; Wallace, BA; Lampert, A				O'Reilly, Andrias O.; Eberhardt, Esther; Weidner, Christian; Alzheimer, Christian; Wallace, B. A.; Lampert, Angelika			Bisphenol A Binds to the Local Anesthetic Receptor Site to Block the Human Cardiac Sodium Channel	PLOS ONE			English	Article							NA+-CHANNELS; MOLECULAR-BASIS; INNER PORE; EXPOSURE; URINARY; ASSOCIATION; INHIBITION; BENZOCAINE; PHENYTOIN; DYNAMICS	Bisphenol A (BPA) has attracted considerable public attention as it leaches from plastic used in food containers, is detectable in human fluids and recent epidemiologic studies link BPA exposure with diseases including cardiovascular disorders. As heart-toxicity may derive from modified cardiac electrophysiology, we investigated the interaction between BPA and hNav1.5, the predominant voltage-gated sodium channel subtype expressed in the human heart. Electrophysiology studies of heterologously-expressed hNav1.5 determined that BPA blocks the channel with a K-d of 25.4 +/- 1.3 mu M. By comparing the effects of BPA and the local anesthetic mexiletine on wild type hNav1.5 and the F1760A mutant, we demonstrate that both compounds share an overlapping binding site. With a key binding determinant thus identified, an homology model of hNav1.5 was generated based on the recently-reported crystal structure of the bacterial voltage-gated sodium channel NavAb. Docking predictions position both ligands in a cavity delimited by F1760 and contiguous with the DIII-IV pore fenestration. Steered molecular dynamics simulations used to assess routes of ligand ingress indicate that the DIII-IV pore fenestration is a viable access pathway. Therefore BPA block of the human heart sodium channel involves the local anesthetic receptor and both BPA and mexiletine may enter the closed-state pore via membrane-located side fenestrations.	[O'Reilly, Andrias O.; Eberhardt, Esther; Weidner, Christian; Alzheimer, Christian; Lampert, Angelika] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Bavaria, Germany; [O'Reilly, Andrias O.; Wallace, B. A.] Univ London, Birkbeck Coll, Dept Crystallog, Inst Struct & Mol Biol, London, England; [Weidner, Christian] Bavarian Hlth & Food Safety Author, Erlangen, Germany	University of Erlangen Nuremberg; University of London; Birkbeck University London; Bavarian Health & Food Safety Authority	O'Reilly, AO (corresponding author), Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Bavaria, Germany.	Lampert@physiologie1.uni-erlangen.de	Lampert, Angelika/F-7198-2010; O'Reilly, Andrias/AAC-7628-2022; Wallace, B A/C-3753-2008	Lampert, Angelika/0000-0001-6319-6272; O'Reilly, Andrias/0000-0003-3449-2368; Wallace, B A/0000-0001-9649-5092	United Kingdom Biotechnology and Biological Sciences Research Council; Marie-Curie-Fellowship [275768]; German Research Council (Deutsche Forschungsgemeinschaft, DFG LA) [2740/2-1]; Robert-Bosch-Foundation; Fast Track Fellowship; BBSRC [BB/H01070X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H01070X/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie-Curie-Fellowship(European Commission); German Research Council (Deutsche Forschungsgemeinschaft, DFG LA)(German Research Foundation (DFG)); Robert-Bosch-Foundation; Fast Track Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AOR was supported by a grant from the United Kingdom Biotechnology and Biological Sciences Research Council (to BAW) and a Marie-Curie-Fellowship (FP7-PEOPLE-2010-IEF, No 275768). AL was supported by the German Research Council (Deutsche Forschungsgemeinschaft, DFG LA 2740/2-1) and the Robert-Bosch-Foundation, "Fast Track Fellowship''. URLs of funder's Web sites: http://www.bbsrc.ac.uk/, http://ec.europa.eu/research/mariecurieactions/, http://www.dfg.de/and http://www.bosch-stiftung.de/content/language2/html/11732.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Borrell B, 2010, NATURE, V464, P1122, DOI 10.1038/4641122a; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bushnik T, 2010, HEALTH REP, V21; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Hanck DA, 2009, CIRC RES, V105, P492, DOI 10.1161/CIRCRESAHA.109.198572; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kuo CC, 1998, MOL PHARMACOL, V54, P712; KUO CC, 1994, MOL PHARMACOL, V46, P716; Lampert A, 2008, J BIOL CHEM, V283, P24118, DOI 10.1074/jbc.M802900200; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee YJ, 2008, REPROD TOXICOL, V25, P413, DOI 10.1016/j.reprotox.2008.05.058; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Lipkind GM, 2010, MOL PHARMACOL, V78, P631, DOI 10.1124/mol.110.064683; McNulty MM, 2006, MOL PHARMACOL, V70, P1514, DOI 10.1124/mol.106.027177; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pless SA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1351; RAGSDALE DS, 1991, MOL PHARMACOL, V40, P756; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Sunami A, 2001, MOL PHARMACOL, V59, P684, DOI 10.1124/mol.59.4.684; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Wang GK, 1998, PFLUG ARCH EUR J PHY, V435, P293; Wang QA, 2011, BRAIN RES, V1378, P1, DOI 10.1016/j.brainres.2011.01.022; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565	40	50	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41667	10.1371/journal.pone.0041667	http://dx.doi.org/10.1371/journal.pone.0041667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848561	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306950200086
J	Chao, KLL; Tsai, IW; Chen, C; Herzberg, O				Chao, Kinlin L.; Tsai, I-Wei; Chen, Chen; Herzberg, Osnat			Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine Kinase	PLOS ONE			English	Article							MACROPHAGE-STIMULATING PROTEIN; GROWTH-FACTOR RECEPTOR; JAAGSIEKTE SHEEP RETROVIRUS; DROSOPHILA S2 CELLS; CANCER-CELLS; TUMORIGENIC ACTIVITIES; BETA-CHAIN; SIGNALING PATHWAY; EPITHELIAL-CELLS; MET RECEPTOR	Human RON (Recepteur d'Origine Nantais) receptor tyrosine kinase is a cell surface receptor for Macrophage Stimulating Protein (MSP). RON mediates signal transduction pathways that regulate cell adhesion, invasion, motility and apoptosis processes. Elevated levels of RON and its alternatively spliced variants are implicated in the progression and metastasis of tumor cells. The binding of MSP alpha/beta heterodimer to the extracellular region of RON receptor induces receptor dimerization and activation by autophosphorylation of the intracellular kinase domains. The ectodomain of RON, containing the ligand recognition and dimerization domains, is composed of a semaphorin (Sema), Plexins-Semaphorins-Integrins domain (PSI), and four Immunoglobulins-Plexins-Transcription factor (IPT) domains. High affinity association between MSP and RON is mediated by the interaction between MSP beta-chain and RON Sema, although RON activation requires intact RON and MSP proteins. Here, we report the structure of RON Sema-PSI domains at 1.85 A resolution. RON Sema domain adopts a seven-bladed beta-propeller fold, followed by disulfide bond rich, cysteine-knot PSI motif. Comparison with the homologous Met receptor tyrosine kinase reveals that RON Sema-PSI contains distinguishing secondary structural features. These define the receptors' exclusive selectivity towards their respective ligands, RON for MSP and Met for HGF. The RON Sema-PSI crystal packing generates a homodimer with interface formed by the Sema domain. Mapping of the dimer interface using the RON homology to Met, MSP homology to Hepatocyte Growth Factor (HGF), and the structure of the Met/HGF complex shows the dimer interface overlapping with the putative MSP beta binding site. The crystallographically determined RON Sema-PSI homodimer may represent the dimer assembly that occurs during ligand-independent receptor activation and/or the inhibition of the constitutive activity of RON Delta 160 splice variant by the soluble RON splice variant, RON Delta 85.	[Chao, Kinlin L.; Tsai, I-Wei; Chen, Chen; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Chao, KLL (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA.	osnat@umd.edu		Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health (NIH) [R01-GM087922]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027024] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grant R01-GM087922 (URL: http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni D, 2004, J BIOL CHEM, V279, P3726, DOI 10.1074/jbc.M309342200; Angeloni D, 2000, GENE CHROMOSOME CANC, V29, P147, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1015>3.3.CO;2-E; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Caldwell CC, 2008, CRIT CARE MED, V36, P1585, DOI 10.1097/CCM.0b013e318170a8c2; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chen QY, 1997, HEPATOLOGY, V26, P59; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Danilkovitch A, 1999, J BIOL CHEM, V274, P29937, DOI 10.1074/jbc.274.42.29937; Danilkovitch-Miagkova A, 2003, P NATL ACAD SCI USA, V100, P4580, DOI 10.1073/pnas.0837136100; Danilkovitch-Miagkova A, 2001, APOPTOSIS, V6, P183, DOI 10.1023/A:1011384609811; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Dussault I, 2009, ANTI-CANCER AGENT ME, V9, P221, DOI 10.2174/187152009787313792; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gherardi E, 2004, CURR OPIN STRUC BIOL, V14, P669, DOI 10.1016/j.sbi.2004.10.010; Gorlatova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027269; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Guin S, 2010, MOL PHARMACEUT, V7, P386, DOI 10.1021/mp900168v; Hirayama I, 2007, HEPATO-GASTROENTEROL, V54, P1672; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu PY, 2006, J UROLOGY, V176, P2262, DOI 10.1016/j.juro.2006.07.048; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim YK, 2005, BIOTECHNOL BIOENG, V92, P452, DOI 10.1002/bit.20605; Kocks C, 2003, MOL CELL PROTEOMICS, V2, P1188, DOI 10.1074/mcp.M300067-MCP200; Kozlov G, 2004, BIOCHEM BIOPH RES CO, V321, P234, DOI 10.1016/j.bbrc.2004.06.132; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEONARD EJ, 1976, EXP CELL RES, V102, P434, DOI 10.1016/0014-4827(76)90065-3; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Liu HS, 2010, CARCINOGENESIS, V31, P1456, DOI 10.1093/carcin/bgq100; Liu SL, 2005, J VIROL, V79, P927, DOI 10.1128/JVI.79.2.927-933.2005; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Lu Y, 2007, CANCER LETT, V257, P157, DOI 10.1016/j.canlet.2007.08.007; Ma Q, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-307; Ma Q, 2010, INT J ONCOL, V36, P1551, DOI 10.3892/ijo_00000642; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Matsuzaki S, 2005, MOL HUM REPROD, V11, P345, DOI 10.1093/molehr/gah162; Matzke A, 2005, CANCER RES, V65, P6105, DOI 10.1158/0008-5472.CAN-05-0207; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miller M, 1998, FEBS LETT, V429, P1, DOI 10.1016/S0014-5793(98)00533-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RONSIN C, 1993, ONCOGENE, V8, P1195; SKEEL A, 1991, J EXP MED, V173, P1227, DOI 10.1084/jem.173.5.1227; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Varela M, 2006, VIROLOGY, V350, P347, DOI 10.1016/j.virol.2006.01.040; VAUPEL P, 1989, CANCER RES, V49, P6449; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Waltz SE, 1997, J BIOL CHEM, V272, P30526, DOI 10.1074/jbc.272.48.30526; Wang J, 2009, J BIOL CHEM, V284, P10912, DOI 10.1074/jbc.M809551200; Wang MH, 2003, CARCINOGENESIS, V24, P1291, DOI 10.1093/carcin/bgg089; Wang MH, 2002, SCAND J IMMUNOL, V56, P545, DOI 10.1046/j.1365-3083.2002.01177.x; WANG MH, 1994, SCIENCE, V266, P117, DOI 10.1126/science.7939629; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; Wang MH, 2007, CANCER BIOL THER, V6, P1121, DOI 10.4161/cbt.6.7.4337; Wei X, 2005, J BIOL CHEM, V280, P35098, DOI 10.1074/jbc.M505737200; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	76	25	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41912	10.1371/journal.pone.0041912	http://dx.doi.org/10.1371/journal.pone.0041912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848655	gold, Green Submitted, Green Published			2022-12-27	WOS:000306806600141
J	Mammoto, T; Chen, J; Jiang, E; Jiang, A; Smith, LE; Ingber, DE; Mammoto, A				Mammoto, Tadanori; Chen, Jing; Jiang, Elisabeth; Jiang, Amanda; Smith, Lois E.; Ingber, Donald E.; Mammoto, Akiko			LRP5 Regulates Development of Lung Microvessels and Alveoli through the Angiopoietin-Tie2 Pathway	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; BRONCHOPULMONARY DYSPLASIA; VASCULAR DEVELOPMENT; IN-VIVO; OVEREXPRESSING ANGIOPOIETIN-1; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; RAT LUNG; ANGIOGENESIS; GROWTH	Angiogenesis is crucial for lung development. Although there has been considerable exploration, the mechanism by which lung vascular and alveolar formation is controlled is still not completely understood. Here we show that low-density lipoprotein receptor-related protein 5 (LRP5), a component of the Wnt ligand-receptor complex, regulates angiogenesis and alveolar formation in the lung by modulating expression of the angiopoietin (Ang) receptor, Tie2, in vascular endothelial cells (ECs). Vascular development in whole mouse lungs and in cultured ECs is controlled by LRP5 signaling, which is, in turn, governed by a balance between the activities of the antagonistic Tie2 ligands, Ang1 and Ang2. Under physiological conditions when Ang1 is dominant, LRP5 knockdown decreases Tie2 expression and thereby, inhibits vascular and alveolar development in the lung. Conversely, when Ang2 dominates under hyperoxia treatment in neonatal mice, high LRP5 and Tie2 expression suppress angiogenesis and lung development. These findings suggest that the LRP5-Tie2-Ang signaling axis plays a central role in control of both angiogenesis and alveolarization during postnatal lung development, and that deregulation of this signaling mechanism might lead to developmental abnormalities of the lung, such as are observed in bronchopulmonary dysplasia (BPD).	[Mammoto, Tadanori; Jiang, Elisabeth; Jiang, Amanda; Ingber, Donald E.; Mammoto, Akiko] Boston Childrens Hosp, Vasc Biol Program, Dept Surg, Boston, MA USA; [Mammoto, Tadanori; Chen, Jing; Jiang, Elisabeth; Jiang, Amanda; Smith, Lois E.; Ingber, Donald E.; Mammoto, Akiko] Harvard Univ, Sch Med, Boston, MA USA; [Chen, Jing; Smith, Lois E.] Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA; [Chen, Jing] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Ingber, Donald E.] Wyss Inst Biol Inspired Engn, Boston, MA USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Mammoto, T (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Dept Surg, Boston, MA USA.	akiko.mammoto@childrens.harvard.edu	Ingber, Donald E/AAC-5894-2019		American Heart Association; William Randolph Hearst award; American Brain Tumor Association; Children's Hospital Boston Manton Center for Orphan Disease Research Innovation Fund; Charles H. Hood Foundation Child Heath Research Award; Children's Hospital Boston Ophthalmology Foundation, Blind Childrens Center; NIH (National Institutes of Health) [CA45548, DE019023, EY017017, EY022275, P01 HD18655]; Lowy Foundation; Research to Prevent Blindness Senior Investigator Award; Alcon Research Institute Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022275, R01EY017017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019023] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); William Randolph Hearst award; American Brain Tumor Association; Children's Hospital Boston Manton Center for Orphan Disease Research Innovation Fund; Charles H. Hood Foundation Child Heath Research Award; Children's Hospital Boston Ophthalmology Foundation, Blind Childrens Center; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lowy Foundation; Research to Prevent Blindness Senior Investigator Award(Research to Prevent Blindness (RPB)); Alcon Research Institute Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funds from American Heart Association (to A. M.), William Randolph Hearst award (to A. M.), American Brain Tumor Association (to A. M.), Children's Hospital Boston Manton Center for Orphan Disease Research Innovation Fund (to J.C.), Charles H. Hood Foundation Child Heath Research Award (to J.C.), Children's Hospital Boston Ophthalmology Foundation, Blind Childrens Center (to J.C.), NIH (National Institutes of Health) (CA45548, DE019023 to D. E. I., EY017017, EY022275, P01 HD18655 to L. E. S.), Lowy Foundation (to L. E. S.), Research to Prevent Blindness Senior Investigator Award (to L. E. S.), Alcon Research Institute Award (to L. E. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Aghai ZH, 2008, J PERINATOL, V28, P149, DOI 10.1038/sj.jp.7211886; Aghai ZH, 2007, J PERINATOL; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; [Anonymous], 2004, AM J RESP CRIT CARE, V170, P319; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bhandari V, 2007, CELL CYCLE, V6, P1049, DOI 10.4161/cc.6.9.4229; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Burri PH, 2006, BIOL NEONATE, V89, P313, DOI 10.1159/000092868; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030203; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; D'Angio CT, 2002, FRONT BIOSCI-LANDMRK, V7, pD1609, DOI 10.2741/angio; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Davis S, 1999, CURR TOP MICROBIOL, V237, P173; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hato T, 2009, BIOCHEM BIOPH RES CO, V381, P218, DOI 10.1016/j.bbrc.2009.02.030; Hislop Alison, 2005, Paediatr Respir Rev, V6, P35, DOI 10.1016/j.prrv.2004.11.009; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konerding MA, 2011, ANGIOGENESIS; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LANGSTON C, 1984, AM REV RESPIR DIS, V129, P607; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Mammoto T, 2011, DEV CELL, V21, P758, DOI 10.1016/j.devcel.2011.07.006; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; McLeod A, 1996, ARCH DIS CHILD, V74, P188, DOI 10.1136/adc.74.3.188; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; PATAN S, 1993, ANAT EMBRYOL, V187, P121; Patan S, 2001, CIRC RES, V89, P723, DOI 10.1161/hh2001.097870; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schwarz M, 1999, AM J PHYSIOL-LUNG C, V276, pL365, DOI 10.1152/ajplung.1999.276.2.L365; Shu WG, 2002, DEVELOPMENT, V129, P4831; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Subramaniam M, 2007, AM J RESP CRIT CARE, V176, P902, DOI 10.1164/rccm.200611-1734OC; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Thomas W, 2011, PEDIATR PULM, V46, P777, DOI 10.1002/ppul.21435; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tschanz SA, 2003, PEDIATR RES, V53, P72, DOI 10.1203/01.PDR.0000041513.93422.C8; Tuder RM, 2000, CHEST, V117, p281S, DOI 10.1378/chest.117.5_suppl_1.281S; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Xia CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011676; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhao LQ, 2005, MECH DEVELOP, V122, P877, DOI 10.1016/j.mod.2005.04.001	74	24	24	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41596	10.1371/journal.pone.0041596	http://dx.doi.org/10.1371/journal.pone.0041596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848540	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600092
J	Wang, B; Jiang, JP; Xie, F; Li, C				Wang, Bin; Jiang, Jianping; Xie, Feng; Li, Cheng			Postglacial Colonization of the Qinling Mountains: Phylogeography of the Swelled Vent Frog (Feirana quadranus)	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; HISTORICAL DEMOGRAPHY; TIBETAN PLATEAU; MOLECULAR PHYLOGENETICS; GENETIC CONSEQUENCES; NICHE CONSERVATISM; POPULATION HISTORY; TESTING HYPOTHESES	Background: The influence of Pleistocene climatic fluctuations on intraspecific diversification in the Qinling-Daba Mountains of East Asia remains poorly investigated. We tested hypotheses concerning refugia during the last glacial maximum (LGM) in this region by examining the phylogeography of the swelled vent frog (Feirana quadranus; Dicroglossidae, Anura, Amphibia). Methodology/Principal Findings: We obtained complete mitochondrial ND2 gene sequences of 224 individuals from 34 populations of Feirana quadranus for phylogeographic analyses. Additionally, we obtained nuclear tyrosinase gene sequences of 68 F. quadranus, one F. kangxianensis and three F. taihangnica samples to test for mitochondrial introgression among them. Phylogenetic analyses based on all genes revealed no introgression among them. Phylogenetic analyses based on ND2 datasets revealed that F. quadranus was comprised of six lineages which were separated by deep valleys; the sole exception is that the Main Qinling and Micang-Western Qinling lineages overlap in distribution. Analyses of population structure indicated restricted gene flow among lineages. Coalescent simulations and divergence dating indicated that the basal diversification within F. quadranus may be associated with the dramatic uplifts of the Tibetan Plateau during the Pliocene. Coalescent simulations indicated that Wuling, Daba, and Western Qinling-Micang-Longmen Mountains were refugia for F. quadranus during the LGM. Demographic analyses indicated that the Daba lineage experienced population size increase prior to the LGM but the Main Qinling and the Micang-Western Qinling lineages expanded in population size and range after the LGM, and the other lineages almost have stable population size or slight slow population size decline. Conclusions/Significance: The Qinling-Daba Mountains hosted three refugia for F. quadranus during the LGM. Populations that originated in the Daba Mountains colonized the Main Qinling Mountains after the LGM. Recent sharp expansion of the Micang-Western Qinling and Main Qinling lineages probably contribute to their present-day secondary contact.	[Wang, Bin; Jiang, Jianping; Xie, Feng; Li, Cheng] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Wang, B (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	jiangjp@cib.ac.cn			National Natural Sciences Foundation of China [NSFC-31071906, 30730029]; Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization in CIB of CAS; Ecological Restoration and Biodiversity Conservation Key Laboratory of Sichuan Province; CAS [Y1C2021200, Y1B3021, KSCX2-EW-J-22]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization in CIB of CAS; Ecological Restoration and Biodiversity Conservation Key Laboratory of Sichuan Province; CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Sciences Foundation of China (NSFC-31071906, 30730029: http://www.nsfc.gov.cn/Portal0/default152.htm), the Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization in CIB of CAS and Ecological Restoration and Biodiversity Conservation Key Laboratory of Sichuan Province, and the field front project of the knowledge innovation program of CAS 'Biodiversity conservation and sustainable use of characteristic biological resources' (Y1C2021200, Y1B3021, KSCX2-EW-J-22:http://www.bio.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Beerli P., 2008, MIGRATE VERSION 2 4; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; BERTORELLE G, 1995, MOL BIOL EVOL, V12, P887; Carey C, 2003, AMPHIBIAN DECLINE: AN INTEGRATED ANALYSIS OF MULTIPLE STRESSOR EFFECTS, P153; Carstens BC, 2004, MOL ECOL, V13, P2557, DOI 10.1111/j.1365-294X.2004.02250.x; Carstens BC, 2005, EVOLUTION, V59, P1639, DOI 10.1554/04-661.1; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Chen L., 2008, PRECISE BIOGEOGRAPHI; Chiari Y, 2004, MOL ECOL, V13, P3763, DOI 10.1111/j.1365-294X.2004.02367.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; [崔之久 Cui Zhijiu], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P510; Culling MA, 2006, MOL ECOL, V15, P173, DOI 10.1111/j.1365-294X.2005.02790.X; DeChaine EG, 2006, EVOLUTION, V60, P1004; Ding L, 2011, MOL ECOL, V20, P1905, DOI 10.1111/j.1365-294X.2011.05060.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2000, EVOLUTION, V54, P1839; Eizirik E, 1998, J MOL EVOL, V47, P613, DOI 10.1007/PL00006418; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fei L., 2010, COLORED ATLAS CHINES; Fei L, 2005, ILLUSTRATED KEY CHIN; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; FELSENSTEIN J, 1993, SYST BIOL, V42, P193, DOI 10.2307/2992541; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu YX, 1997, GENETICS, V147, P915; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo P, 2011, J BIOGEOGR, V38, P2326, DOI 10.1111/j.1365-2699.2011.02566.x; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; HEDGES SB, 1992, MOL BIOL EVOL, V9, P366; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hillis David M., 1996, P321; Hudson RR, 2003, EVOLUTION, V57, P182; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jiang JP, 2005, ZOOL SCI, V22, P353, DOI 10.2108/zsj.22.353; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; Ju LX, 2007, PALAEOGEOGR PALAEOCL, V248, P376, DOI 10.1016/j.palaeo.2006.12.012; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu C. c., 1960, Acta Zoologica Sinica, V12, P278; Macey JR, 2001, MOL PHYLOGENET EVOL, V19, P131, DOI 10.1006/mpev.2000.0908; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P320, DOI 10.1006/mpev.1999.0641; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Maddison W, 2000, SYST BIOL, V49, P400, DOI 10.1080/10635159950127312; Maddison W.P., 2008, MESQUITE MODULAR SYS; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Masta SE, 2000, EVOLUTION, V54, P1699; Molnar P, 2005, PALAEONTOL ELECTRON, V8; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; [潘保田 Pan Baotian], 2004, [第四纪研究, Quaternary Sciences], V24, P50; Parra-Olea G, 2004, BIOL J LINN SOC, V81, P325, DOI 10.1111/j.1095-8312.2003.00303.x; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Pinot S, 1999, CLIM DYNAM, V15, P857, DOI 10.1007/s003820050318; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Rambaut A., 2007, TRACER V1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; Shi YF, 2007, PLEISTOCENE GLACIATI; SLATKIN M, 1989, GENETICS, V123, P603; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchaicka L, 2007, MOL ECOL, V16, P819, DOI 10.1111/j.1365-294X.2006.03185.x; Wang B, 2007, ACTA ZOOTAX SIN, V3, P139; Wang B, 2009, ZOOL SCI, V26, P500, DOI 10.2108/zsj.26.500; Weisrock DW, 2006, BIOL J LINN SOC, V89, P25, DOI 10.1111/j.1095-8312.2006.00655.x; Weisrock DW, 2005, MOL ECOL, V14, P1457, DOI 10.1111/j.1365-294X.2005.02524.x; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; [邬光剑 Wu Guangjian], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P544; Xu R, 1981, AGE MAGNITUDE FORMS, P8; Yang X, 2011, ASIAN HERPETOL RES, V2, P72, DOI 10.3724/SP.J.1245.2011.00072; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhang Rong-Zu, 2004, Acta Zoologica Sinica, V50, P841; Zhong D.L., 1996, SCI CHINA SER D, V26, P289	109	41	42	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41579	10.1371/journal.pone.0041579	http://dx.doi.org/10.1371/journal.pone.0041579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848532	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600088
J	Dunai, ZA; Imre, G; Barna, G; Korcsmaros, T; Petak, I; Bauer, PI; Mihalik, R				Dunai, Zsuzsanna A.; Imre, Gergely; Barna, Gabor; Korcsmaros, Tamas; Petak, Istvan; Bauer, Pal I.; Mihalik, Rudolf			Staurosporine Induces Necroptotic Cell Death under Caspase-Compromised Conditions in U937 Cells	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; NF-KAPPA-B; CATHEPSIN-B; PROGRAMMED NECROSIS; APOPTOTIC CELLS; DOMAIN KINASE; TNF RECEPTOR; RIP; IDENTIFICATION; ALPHA	For a long time necrosis was thought to be an uncontrolled process but evidences recently have revealed that necrosis can also occur in a regulated manner. Necroptosis, a type of programmed necrosis is defined as a death receptor-initiated process under caspase-compromised conditions. The process requires the kinase activity of receptor-interacting protein kinase 1 and 3 (RIPK1 and RIPK3) and mixed lineage kinase domain-like protein (MLKL), as a substrate of RIPK3. The further downstream events remain elusive. We applied known inhibitors to characterize the contributing enzymes in necroptosis and their effect on cell viability and different cellular functions were detected mainly by flow cytometry. Here we report that staurosporine, the classical inducer of intrinsic apoptotic pathway can induce necroptosis under caspase-compromised conditions in U937 cell line. This process could be hampered at least partially by the RIPK1 inhibitor necrotstin-1 and by the heat shock protein 90 kDa inhibitor geldanamycin. Moreover both the staurosporine-triggered and the classical death ligand-induced necroptotic pathway can be effectively arrested by a lysosomal enzyme inhibitor CA-074-OMe and the recently discovered MLKL inhibitor necrosulfonamide. We also confirmed that the enzymatic role of poly(ADPribose) polymerase (PARP) is dispensable in necroptosis but it contributes to membrane disruption in secondary necrosis. In conclusion, we identified a novel way of necroptosis induction that can facilitate our understanding of the molecular mechanisms of necroptosis. Our results shed light on alternative application of staurosporine, as a possible anticancer therapeutic agent. Furthermore, we showed that the CA-074-OMe has a target in the signaling pathway leading to necroptosis. Finally, we could differentiate necroptotic and secondary necrotic processes based on participation of PARP enzyme.	[Dunai, Zsuzsanna A.; Barna, Gabor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Imre, Gergely] Goethe Univ Frankfurt, Fac Med, Inst Biochem 2, Frankfurt, Germany; [Korcsmaros, Tamas] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Petak, Istvan] KPS Med Biotechnol & Healthcare Serv Ltd, Budapest, Hungary; [Petak, Istvan] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Bauer, Pal I.] Semmelweis Univ, Dept Med Biochem, H-1085 Budapest, Hungary; [Dunai, Zsuzsanna A.; Mihalik, Rudolf] Natl Inst Oncol, Dept Pathogenet, Budapest, Hungary	Semmelweis University; Goethe University Frankfurt; Eotvos Lorand University; Semmelweis University; Semmelweis University; National Institute of Oncology Hungary	Dunai, ZA (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary.	zsuzsanna.dunai@gmail.com	Korcsmaros, Tamas/C-3526-2015; Petak, Istvan/X-3656-2019	Korcsmaros, Tamas/0000-0003-1717-996X; 	National Research Foundation [OTKA-T049008, T046665]	National Research Foundation	This work was supported by the National Research Foundation, OTKA-T049008 for RM and T046665 for IP [http://www.otka.hu/?akt_menu=991&set_lang=991]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andera L, 2009, BIOMED PAP, V153, P173, DOI 10.5507/bp.2009.029; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen WW, 2011, J NEUROCHEMISTRY; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cummings BS, 2004, J PHARMACOL EXP THER, V310, P126, DOI 10.1124/jpet.104.065862; Darzynkiewicz Z, 2000, METHOD ENZYMOL, V322, P18; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dong Z, 1997, AM J PATHOL, V151, P1205; Dunai Z, 2011, PATHOL ONCOL RES, V17, P791, DOI 10.1007/s12253-011-9433-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Gescher A, 2000, CRIT REV ONCOL HEMAT, V34, P127, DOI 10.1016/S1040-8428(00)00058-5; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Higuchi Y, 2003, BIOCHEM PHARMACOL, V66, P1527, DOI 10.1016/S0006-2952(03)00508-2; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Horita H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003909; Imre G, 2007, BBA-MOL CELL RES, V1773, P1546, DOI 10.1016/j.bbamcr.2007.07.003; Imre G, 2011, J MOL CELL BIOL, V3, P324, DOI 10.1093/jmcb/mjr034; Kitada S, 2000, BLOOD, V96, P393; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Marton A, 1997, EUR J BIOCHEM, V250, P467, DOI 10.1111/j.1432-1033.1997.0467a.x; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McCully JD, 2004, AM J PHYSIOL-HEART C, V286, pH1923, DOI 10.1152/ajpheart.00935.2003; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mihalik R, 2004, CELL DEATH DIFFER, V11, P1357, DOI 10.1038/sj.cdd.4401493; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Petak I, 2003, CELL DEATH DIFFER, V10, P729, DOI 10.1038/sj.cdd.4401232; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tafani M, 2001, CANCER RES, V61, P2459; Tenev T, 2011, MOL CELL, V43, P689, DOI 10.1016/j.molcel.2011.08.005; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Vande Walle L, 2010, CELL RES, V20, P421, DOI 10.1038/cr.2010.18; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; West T, 2006, NEUROBIOL DIS, V22, P523, DOI 10.1016/j.nbd.2005.12.017; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Ying S, 2007, APOPTOSIS, V12, P2003, DOI 10.1007/s10495-007-0117-1; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	65	82	86	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41945	10.1371/journal.pone.0041945	http://dx.doi.org/10.1371/journal.pone.0041945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860037	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600048
J	Jayanthi, S; Del Vecchio, D				Jayanthi, Shridhar; Del Vecchio, Domitilla			Tuning Genetic Clocks Employing DNA Binding Sites	PLOS ONE			English	Article							PRINCIPLES; BEHAVIOR; BIOLOGY; OPERON	Periodic oscillations play a key role in cell physiology from the cell cycle to circadian clocks. The interplay of positive and negative feedback loops among genes and proteins is ubiquitous in these networks. Often, delays in a negative feedback loop and/or degradation rates are a crucial mechanism to obtain sustained oscillations. How does nature control delays and kinetic rates in feedback networks? Known mechanisms include proper selection of the number of steps composing a feedback loop and alteration of protease activity, respectively. Here, we show that a remarkably simple means to control both delays and effective kinetic rates is the employment of DNA binding sites. We illustrate this design principle on a widely studied activator-repressor clock motif, which is ubiquitous in natural systems. By suitably employing DNA target sites for the activator and/or the repressor, one can switch the clock "on" and "off" and precisely tune its period to a desired value. Our study reveals a design principle to engineer dynamic behavior in biomolecular networks, which may be largely exploited by natural systems and employed for the rational design of synthetic circuits.	[Jayanthi, Shridhar] Univ Michigan, Ann Arbor, MI 48109 USA; [Jayanthi, Shridhar; Del Vecchio, Domitilla] MIT, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Jayanthi, S (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	ddv@mit.edu	Jayanthi, Shridhar/C-9566-2014	Jayanthi, Shridhar/0000-0002-4292-3247	AFOSR [FA9550-09-1-0211]; NSF-CIF [1058127]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF-CIF(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was in part funded by AFOSR Grant Number FA9550-09-1-0211 and NSF-CIF Grant Number 1058127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Cantor CR, 1980, BIOPHYSICAL CHEM BEH; Conrad E, 2008, J R SOC INTERFACE, V5, pS9, DOI 10.1098/rsif.2008.0046.focus; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Del Vecchio D, 2007, P1589; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goodwin B.C, 1963, TEMPORAL ORG CELLS D; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Jiang P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002152; Khalil H. K., 2002, NONLINEAR SYSTEMS 3, V3rd; Kokotovic P, 1999, SINGULAR PERTURBATIO; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; LITTLE R, 1979, J BACTERIOL, V137, P115, DOI 10.1128/JB.137.1.115-123.1979; Mutalik VK, 2007, BIOSYSTEMS, V90, P1, DOI 10.1016/j.biosystems.2006.06.003; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; SCHILLING D, 1968, ELECT CIRCUITS DISCR; Stamatakis M, 2009, BIOPHYS J, V96, P887, DOI 10.1016/j.bpj.2008.10.028; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Ventura AC, 2010, P NATL ACAD SCI USA, V107, P10032, DOI 10.1073/pnas.0913815107; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Wiggins S., 2003, INTRO APPL NONLINEAR, DOI 10.1007/b97481	35	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41019	10.1371/journal.pone.0041019	http://dx.doi.org/10.1371/journal.pone.0041019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859962	gold, Green Submitted, Green Published			2022-12-27	WOS:000307045600014
J	Kim, SJ; Lee, H; Lee, G; Oh, SJ; Shin, MK; Shim, I; Bae, H				Kim, Soo-Jeong; Lee, Hyojung; Lee, Gihyun; Oh, Sei-Joong; Shin, Min-Kyu; Shim, Insop; Bae, Hyunsu			CD4(+)CD25(+) Regulatory T Cell Depletion Modulates Anxiety and Depression-Like Behaviors in Mice	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; CHRONIC STRESS; BRAIN COMMUNICATION; MAJOR DEPRESSION; CYTOKINE PRODUCTION; ALZHEIMERS-DISEASE; INTERFERON-ALPHA; IMMUNE-RESPONSE; SOCIAL STRESS; BLOOD-BRAIN	Stress has been shown to suppress immune function and increase susceptibility to inflammatory disease and psychiatric disease. CD4(+)CD25(+) regulatory T (Treg) cells are prominent in immune regulation. This study was conducted to determine if anti-CD25 antibody (Ab) mediated depletion of Treg cells in mice susceptibility to stress-induced development of depression-like behaviors, as well as immunological and neurochemical activity. To accomplish this, an elevated plus-maze test (EPM), tail suspension test (TST), and forced swim test (FST) were used to examine depression-like behaviors upon chronic immobilization stress. Immune imbalance status was observed based on analysis of serum cytokines using a mouse cytometric bead array in conjunction with flow cytometry and changes in the levels of serotonin (5-HT) and dopamine (DA) in the brain were measured by high performance liquid chromatography (HPLC). The time spent in the open arms of the EPM decreased significantly and the immobility time in the FST increased significantly in the anti-CD25 Ab-treated group when compared with the non stressed wild-type group. In addition, interlukin-6 (IL-6), tumor necrosis factor-a (TNF-a), interlukin-2 (IL-2), interferon-gamma (IFN-gamma), interlukin-4 (IL-4) and interlukin-17A (IL-17A) concentrations were significantly upregulated in the stressed anti-CD25 Ab-treated group when compared with the non stressed wild-type group. Furthermore, the non stressed anti-CD25 Ab-treated group displayed decreased 5-HT levels within the hippocampus when compared with the non stressed wild-type group. These results suggest that CD4(+)CD25(+) Treg cell depletion modulated alterations in depressive behavior, cytokine and monoaminergic activity. Therefore, controlling CD4(+)CD25(+) Treg cell function during stress may be a potent therapeutic strategy for the treatment of depression-like symptoms.	[Kim, Soo-Jeong; Lee, Hyojung; Lee, Gihyun; Oh, Sei-Joong; Shin, Min-Kyu; Bae, Hyunsu] Kyung Hee Univ, Coll Oriental Med, Dept Physiol, Seoul, South Korea; [Shim, Insop] Kyung Hee Univ, Coll Oriental Med, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Kim, SJ (corresponding author), Kyung Hee Univ, Coll Oriental Med, Dept Physiol, Seoul, South Korea.	hbae@khu.ac.kr	Bae, Hyunsu/ABH-6248-2020	Bae, Hyunsu/0000-0002-0299-3582; Lee, Gihyun/0000-0001-6250-8852; Shim, Insop/0000-0002-8014-9782	Korea Science and Engineering Foundation (KOSEF); Korea government (MEST) [20090063466]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) ( No. 20090063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Anisman H, 2008, PSYCHOPHARMACOLOGY, V199, P231, DOI 10.1007/s00213-008-1166-z; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Berton O, 1998, NEUROSCIENCE, V82, P147; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britschgi M, 2007, INT REV NEUROBIOL, V82, P205, DOI 10.1016/S0074-7742(07)82011-3; Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9; Chung KKK, 1999, NEUROSCIENCE, V92, P613, DOI 10.1016/S0306-4522(99)00028-7; Cohen H, 2006, J NEUROBIOL, V66, P552, DOI 10.1002/neu.20249; Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DESOUZA EB, 1986, BRAIN RES, V367, P77, DOI 10.1016/0006-8993(86)91581-7; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497; GILAD GM, 1985, BRAIN RES, V347, P404, DOI 10.1016/0006-8993(85)90209-4; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Hayashi T, 2005, INT J EXP PATHOL, V86, P289, DOI 10.1111/j.0959-9673.2005.00438.x; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Kanba S, 1998, PSYCHOL MED, V28, P481, DOI 10.1017/S0033291797006454; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; Kim SJ, 2011, J NEUROIMMUNOL, V240, P45, DOI 10.1016/j.jneuroim.2011.09.008; Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-7; Laurie C, 2007, J NEUROIMMUNOL, V183, P60, DOI 10.1016/j.jneuroim.2006.11.009; Leipe J, 2005, ARTHRITIS RES THER, V7, P93, DOI 10.1186/ar1718; Li JM, 2003, LIFE SCI, V74, P55, DOI 10.1016/j.lfs.2003.06.030; Li Y, 2010, J AFFECT DISORDERS, V124, P68, DOI 10.1016/j.jad.2009.10.018; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P564; Maier SF, 1998, ANN NY ACAD SCI, V840, P289, DOI 10.1111/j.1749-6632.1998.tb09569.x; Malaguarnera M, 2001, J INTERF CYTOK RES, V21, P273, DOI 10.1089/107999001300177457; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Miyazaki I, 2008, ACTA MED OKAYAMA, V62, P141; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Natelson BH, 1999, J AFFECT DISORDERS, V53, P179, DOI 10.1016/S0165-0327(98)00118-9; Padovan CM, 2000, BRAZ J MED BIOL RES, V33, P79, DOI 10.1590/S0100-879X2000000100011; Pan WH, 1997, J NEUROIMMUNOL, V76, P105, DOI 10.1016/S0165-5728(97)00034-9; Park HJ, 2010, NEUROL RES S1, V32, P111; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; POWRIE F, 1994, RES IMMUNOL, V145, P347, DOI 10.1016/S0923-2494(94)80198-3; Romeo HE, 2001, J NEUROIMMUNOL, V115, P91, DOI 10.1016/S0165-5728(01)00270-3; ROTH KA, 1982, BRAIN RES, V239, P417, DOI 10.1016/0006-8993(82)90519-4; Rothermundt M, 2001, EUR ARCH PSY CLIN N, V251, P90, DOI 10.1007/s004060170058; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Schlatter J, 2004, PSYCHIAT RES, V128, P259, DOI 10.1016/j.psychres.2004.06.004; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; Simmons DA, 2005, PROG NEURO-PSYCHOPH, V29, P793, DOI 10.1016/j.pnpbp.2005.03.009; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Suarez EC, 2004, PSYCHONEUROENDOCRINO, V29, P1119, DOI 10.1016/j.psyneuen.2004.01.002; Swiergiel AH, 2007, PHARMACOL BIOCHEM BE, V86, P651, DOI 10.1016/j.pbb.2007.02.010; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thale C, 2005, IMMUNOBIOLOGY, V210, P673, DOI 10.1016/j.imbio.2005.07.003; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; WEIZMAN R, 1994, BIOL PSYCHIAT, V35, P42, DOI 10.1016/0006-3223(94)91166-5; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; Woods AB, 2005, AM J COMMUN PSYCHOL, V36, P159, DOI 10.1007/s10464-005-6240-7	64	62	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42054	10.1371/journal.pone.0042054	http://dx.doi.org/10.1371/journal.pone.0042054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860054	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600056
J	Kwee, RM; Truijman, MTB; van Oostenbrugge, RJ; Mess, WH; Prins, MH; Franke, CL; Korten, AGGC; Wildberger, JE; Kooi, ME				Kwee, Robert M.; Truijman, Martine T. B.; van Oostenbrugge, Robert J.; Mess, Werner H.; Prins, Martin H.; Franke, Cees L.; Korten, Arthur G. G. C.; Wildberger, Joachim E.; Kooi, M. Eline			Longitudinal MRI Study on the Natural History of Carotid Artery Plaques in Symptomatic Patients	PLOS ONE			English	Article							NECROTIC CORE SIZE; ATHEROSCLEROTIC PLAQUE; HIGH-RESOLUTION; FIBROUS CAP; STENOSIS; ENDARTERECTOMY; FEATURES; STROKE	Purpose: To investigate the natural history of carotid atherosclerosis in patients who experienced a TIA or ischemic stroke. Patients and Methods: Ninety-two TIA/stroke patients (57 men, mean age 67.7 +/- 9.8 years) with ipsilateral <70% carotid stenosis underwent multisequence MRI of the plaque ipsilateral to the symptomatic side at baseline and after one year. For each plaque, several parameters were assessed at both time points. Results: Carotid lumen, wall and total vessel (= carotid lumen and wall) volume did not significantly change. Forty-four patients had a plaque with a lipid-rich necrotic core (LRNC) at baseline, of which 34 also had a LRNC after one year. In three patients a LRNC appeared after one year. Thirty patients had a plaque with a thin and/or ruptured fibrous cap (FC) at both time points. In seven patients, FC status changed from thin and/or ruptured into thick and intact. In three patients, FC status changed from thick and intact into thin and/or ruptured. Twenty patients had intraplaque hemorrhage (IPH) at both time points. In four patients, IPH disappeared, whereas in three patients, new IPH appeared at follow-up. Conclusion: In TIA/stroke patients, carotid plaque morphology does not significantly change over a one-year period. IPH and FC status change in a minority of patients.	[Kwee, Robert M.; Truijman, Martine T. B.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands; [Kwee, Robert M.; Truijman, Martine T. B.; van Oostenbrugge, Robert J.; Mess, Werner H.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Truijman, Martine T. B.; Mess, Werner H.] Maastricht Univ Med Ctr, Dept Clin Neurophysiol, Maastricht, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands; [Prins, Martin H.] Maastricht Univ Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Franke, Cees L.] Atrium Med Ctr Parkstad, Dept Neurol, Heerlen, Netherlands; [Korten, Arthur G. G. C.] Laurentius Hosp, Dept Neurol, Roermond, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Atrium Medical Center	Kwee, RM (corresponding author), Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands.	rmkwee@gmail.com	Mess, Werner/AAB-9527-2020; Kooi, M. Eline/D-3848-2016	Kooi, M. Eline/0000-0001-7562-5724; Wildberger, Joachim/0000-0002-4810-6854	Netherlands Heart Foundation [2006B61]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Netherlands Heart Foundation (grant 2006B61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boussel L, 2009, RADIOLOGY, V252, P789, DOI 10.1148/radiol.2523081798; Cai JM, 2005, CIRCULATION, V112, P3437, DOI 10.1161/CIRCULATIONAHA.104.528174; Cappendijk VC, 2004, J MAGN RESON IMAGING, V20, P105, DOI 10.1002/jmri.20060; Cappendijk VC, 2008, J MAGN RESON IMAGING, V27, P1356, DOI 10.1002/jmri.21359; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Kwee RM, 2010, INVEST RADIOL, V45, P803, DOI 10.1097/RLI.0b013e3181ed15ff; Kwee RM, 2010, STROKE, V41, P1389, DOI 10.1161/STROKEAHA.109.575670; Kwee RM, 2009, STROKE, V40, P3017, DOI 10.1161/STROKEAHA.109.555052; Oikawa M, 2009, CIRC J, V73, P1765, DOI 10.1253/circj.CJ-09-0617; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Saam T, 2007, ATHEROSCLEROSIS, V194, pE34, DOI 10.1016/j.atherosclerosis.2006.08.016; Saam T, 2006, RADIOLOGY, V240, P464, DOI 10.1148/radiol.2402050390; Shaalan WE, 2008, J VASC SURG, V48, P104, DOI 10.1016/j.jvs.2008.02.068; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; Underhill HR, 2009, JACC-CARDIOVASC IMAG, V2, P1381, DOI 10.1016/j.jcmg.2009.08.007; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Zhao XQ, 2011, JACC-CARDIOVASC IMAG, V4, P977, DOI 10.1016/j.jcmg.2011.06.013	20	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42472	10.1371/journal.pone.0042472	http://dx.doi.org/10.1371/journal.pone.0042472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860130	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600104
J	Kikuchi, K; Poudel, KC; Muganda, J; Majyambere, A; Otsuka, K; Sato, T; Mutabazi, V; Nyonsenga, SP; Muhayimpundu, R; Jimba, M; Yasuoka, J				Kikuchi, Kimiyo; Poudel, Krishna C.; Muganda, John; Majyambere, Adolphe; Otsuka, Keiko; Sato, Tomoko; Mutabazi, Vincent; Nyonsenga, Simon Pierre; Muhayimpundu, Ribakare; Jimba, Masamine; Yasuoka, Junko			High Risk of ART Non-Adherence and Delay of ART Initiation among HIV Positive Double Orphans in Kigali, Rwanda	PLOS ONE			English	Article							ANTIRETROVIRAL MEDICATION ADHERENCE; INFECTED CHILDREN; WESTERN KENYA; PEDIATRIC ADHERENCE; THERAPY; HEALTH; MANAGEMENT; OUTCOMES; MOTHERS; AFRICA	Background: To reduce HIV/AIDS related mortality of children, adherence to antiretroviral treatment (ART) is critical in the treatment of HIV positive children. However, little is known about the association between ART adherence and different orphan status. The aims of this study were to assess the ART adherence and identify whether different orphan status was associated with the child's adherence. Methods: A total of 717 HIV positive children and the same number of caregivers participated in this cross-sectional study. Children's adherence rate was measured using a pill count method and those who took 85% or more of the prescribed doses were defined as adherent. To collect data about adherence related factors, we also interviewed caregivers using a structured questionnaire. Results: Of all children (N = 717), participants from each orphan category (double orphan, maternal orphan, paternal orphan, non-orphan) were 346, 89, 169, and 113, respectively. ART non-adherence rate of each orphan category was 59.3%, 44.9%, 46.7%, and 49.7%, respectively. The multivariate analysis indicated that maternal orphans (AOR 0.31, 95% CI 0.12-0.80), paternal orphans (AOR 0.35, 95% CI 0.14-0.89), and non-orphans (AOR 0.45, 95% CI 0.21-0.99) were less likely to be non-adherent compared to double orphans. Double orphans who had a sibling as a caregiver were more likely to be non-adherent. The first mean CD4 count prior to initiating treatment was 520, 601, 599, and 844 (cells/ml), respectively (p<0.001). Their mean age at sero-status detection was 5.9, 5.3, 4.8, and 3.9 (year old), respectively (p<0.001). Conclusions: Double orphans were at highest risk of ART non-adherence and especially those who had a sibling as a caregiver had high risk. They were also in danger of initiating ART at an older age and at a later stage of HIV/AIDS compared with other orphan categories. Double orphans need more attention to the promote child's adherence to ART.	[Kikuchi, Kimiyo; Poudel, Krishna C.; Otsuka, Keiko; Jimba, Masamine; Yasuoka, Junko] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Muganda, John] King Faisal Hosp, Div Obstet & Gynecol, Kigali, Rwanda; [Majyambere, Adolphe; Mutabazi, Vincent; Nyonsenga, Simon Pierre; Muhayimpundu, Ribakare] Rwanda Biomed Ctr, Inst HIV Dis Prevent & Control, HIV AIDS STIs & Other Blood Borne Infect Div, Kigali, Rwanda; [Sato, Tomoko] Meiji Gakuin Univ, Dept Psychol, Tokyo, Japan	University of Tokyo; Rwanda Biomedical Center	Kikuchi, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	jyasuoka@m.u-tokyo.ac.jp	Yasuoka, Junko/GVT-8950-2022; Jimba, Masamine/AAF-5630-2020	Nanishi, Keiko/0000-0001-7067-8413	Institutional Program for Young Researcher Overseas Visits; Japan Society for the Promotion of Science	Institutional Program for Young Researcher Overseas Visits; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financed in the framework of the Institutional Program for Young Researcher Overseas Visits, supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB G, 1994, PAR CHILD REL INV PC; [Anonymous], 2006, MULTIVARIABLE ANAL P; Ayaya S O, 2004, East Afr Med J, V81, P415; Biadgilign S, 2009, SAHARA J-J SOC ASP H, V6, P148, DOI 10.1080/17290376.2009.9724943; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Center for Treatment and Research on AIDS M Tuberculosis and Other Epidemics, 2009, TRAC ART REP NOV 200; Cupsa A, 2000, ANN NY ACAD SCI, V918, P351; Silveira Vera Lúcia da, 2003, Braz J Infect Dis, V7, P194; Elise A, 2005, JAIDS-J ACQ IMM DEF, V40, P498, DOI 10.1097/01.qai.0000168180.76405.5f; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff; Johnson MO, 2007, JAIDS-J ACQ IMM DEF, V46, P574, DOI 10.1097/QAI.0b013e318158a474; KASTRISSIOS H, 1998, 17 INT AIDS C MEX CI, V12, P2295; Lindblade KA, 2003, TROP MED INT HEALTH, V8, P67, DOI 10.1046/j.1365-3156.2003.00987.x; Ma A, 2010, AIDS CARE, V22, P1189, DOI 10.1080/09540121003668102; Mellins CA, 2004, PEDIATR INFECT DIS J, V23, P1035, DOI 10.1097/01.inf.0000143646.15240.ac; Mellins CA, 2003, AIDS PATIENT CARE ST, V17, P407, DOI 10.1089/108729103322277420; Naar-King S, 2009, J PEDIATR PSYCHOL, V34, P187, DOI 10.1093/jpepsy/jsn065; Nabukeera-Barungi N, 2007, ANN TROP PAEDIATR, V27, P123, DOI 10.1179/146532807X192499; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nicholson O, 2006, PATIENT EDUC COUNS, V61, P405, DOI 10.1016/j.pec.2005.05.006; Ntanda H, 2009, PEDIATR INFECT DIS J, V28, P153, DOI 10.1097/INF.0b013e318184eeeb; Nyandiko WM, 2006, JAIDS-J ACQ IMM DEF, V43, P418, DOI 10.1097/01.qai.0000243122.52282.89; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Panpanich R, 1999, ANN TROP PAEDIATR, V19, P279, DOI 10.1080/02724939992374; Polisset J, 2009, AIDS BEHAV, V13, P23, DOI 10.1007/s10461-008-9437-6; Safreed-Harmon K, 2007, CLIN INFECT DIS, V45, P669, DOI 10.1086/520784; Shetty Avinash K, 2003, Semin Pediatr Infect Dis, V14, P25, DOI 10.1053/spid.2003.127214; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; UNAIDS, 2010, REP GLOB AIDS EP 201; UNAIDS, 2010, EP FACT SHEET HIV AI; UNICEF, 2007, CHILDR AIDS STOCKT R; Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25; Vreeman RC, 2008, JAIDS-J ACQ IMM DEF, V49, P163, DOI 10.1097/QAI.0b013e318183a996; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; Watts H, 2007, TROP MED INT HEALTH, V12, P584, DOI 10.1111/j.1365-3156.2007.01832.x; World Health Organization, NUTR LANDSC INF SYST; World Health Organization, 2010, ANT THER HIV INF INF; Wrubel J, 2005, SOC SCI MED, V61, P2423, DOI 10.1016/j.socscimed.2005.04.034; Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P501, DOI 10.1093/jpepsy/jsj042; Yanagisawa S, 2010, HEALTH POLICY, V98, P121, DOI 10.1016/j.healthpol.2010.05.001	43	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41998	10.1371/journal.pone.0041998	http://dx.doi.org/10.1371/journal.pone.0041998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860043	Green Published, gold			2022-12-27	WOS:000306950900059
J	Pellet, J; Bried, JT; Parietti, D; Gander, A; Heer, PO; Cherix, D; Arlettaz, R				Pellet, Jerome; Bried, Jason T.; Parietti, David; Gander, Antoine; Heer, Patrick O.; Cherix, Daniel; Arlettaz, Raphael			Monitoring Butterfly Abundance: Beyond Pollard Walks	PLOS ONE			English	Article							RED LIST; RECAPTURE; CAPTURE; CONSERVATION; MANAGEMENT; MODELS; LEPIDOPTERA; POPULATIONS; PROBABILITY; INDICATOR	Most butterfly monitoring protocols rely on counts along transects (Pollard walks) to generate species abundance indices and track population trends. It is still too often ignored that a population count results from two processes: the biological process (true abundance) and the statistical process (our ability to properly quantify abundance). Because individual detectability tends to vary in space (e.g., among sites) and time (e.g., among years), it remains unclear whether index counts truly reflect population sizes and trends. This study compares capture-mark-recapture (absolute abundance) and count-index (relative abundance) monitoring methods in three species (Maculinea nausithous and Iolana iolas: Lycaenidae; Minois dryas: Satyridae) in contrasted habitat types. We demonstrate that intraspecific variability in individual detectability under standard monitoring conditions is probably the rule rather than the exception, which questions the reliability of count-based indices to estimate and compare specific population abundance. Our results suggest that the accuracy of count-based methods depends heavily on the ecology and behavior of the target species, as well as on the type of habitat in which surveys take place. Monitoring programs designed to assess the abundance and trends in butterfly populations should incorporate a measure of detectability. We discuss the relative advantages and inconveniences of current monitoring methods and analytical approaches with respect to the characteristics of the species under scrutiny and resources availability.	[Pellet, Jerome] A Maibach Sarl, Oron La Ville, Switzerland; [Pellet, Jerome; Heer, Patrick O.; Arlettaz, Raphael] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Bried, Jason T.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Parietti, David; Cherix, Daniel] Univ Lausanne, Dept Ecol & Evolut, Dorigny, Switzerland; [Gander, Antoine] Grande Caricaie, Grp Etud & Gest, Champ Pittet, Yverdon, Switzerland; [Cherix, Daniel] Musee Zool Lausanne, Lausanne, Switzerland	University of Bern; Oklahoma State University System; Oklahoma State University - Stillwater; University of Lausanne	Pellet, J (corresponding author), A Maibach Sarl, Oron La Ville, Switzerland.	jerome.pellet@amaibach.ch	Bried, Jason/GXZ-4934-2022; Bried, Jason/AAF-9492-2021; Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Pellet, Jerome/0000-0002-4760-8609				Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; ASHER J, 2001, MILLENIUM ATLAS BUTT; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P14, DOI 10.2193/0022-541X(2004)068[0014:SATVID]2.0.CO;2; Bart J, 2004, WILDLIFE SOC B, V32, P1242, DOI 10.2193/0091-7648(2004)032[1242:DEIWS]2.0.CO;2; Bergman KO, 2001, J APPL ECOL, V38, P1303, DOI 10.1046/j.0021-8901.2001.00672.x; Brereton TM, 2011, J INSECT CONSERV, V15, P279, DOI 10.1007/s10841-010-9345-8; Bried JT, 2007, J APPL ECOL, V44, P833, DOI 10.1111/j.1365-2664.2007.01299.x; Bried JT, 2012, J INSECT CONSERV, V16, P489, DOI 10.1007/s10841-011-9435-2; Brown JA, 1998, ENVIRON ECOL STAT, V5, P81, DOI 10.1023/A:1009620105039; Buckland S.T., 2001, pi; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Collier N, 2008, POPUL ECOL, V50, P17, DOI 10.1007/s10144-007-0056-2; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Dennis RLH, 2006, BIOL CONSERV, V128, P486, DOI 10.1016/j.biocon.2005.10.015; Dorazio RM, 2010, ECOLOGY, V91, P2466, DOI 10.1890/09-1033.1; Douwes P., 1976, Journal Res Lepid, V5, P146; ERHARDT A, 1985, J APPL ECOL, V22, P849, DOI 10.2307/2403234; Fox R, 2001, STATE BRITAINS BUTTE; FRAZER J F D, 1973, Biological Conservation, V5, P271, DOI 10.1016/0006-3207(73)90151-1; GALL LF, 1984, BIOL CONSERV, V28, P139, DOI 10.1016/0006-3207(84)90032-6; Gross K, 2007, POPUL ECOL, V49, P191, DOI 10.1007/s10144-007-0034-8; Groupe de travail des Lepidopteristes, 1987, PAP JOUR LEURS BIOT; Haddad NM, 2008, CONSERV BIOL, V22, P929, DOI 10.1111/j.1523-1739.2008.00932.x; Harker RJ, 2008, J INSECT CONSERV, V12, P125, DOI 10.1007/s10841-007-9068-7; Heer P, 2011, THESIS U BERN BERN; Isaac NJB, 2011, METHODS ECOLOGY EVOL, DOI [10.1111/j.2041-1210X.2011.00109.x, DOI 10.1111/J.2041-1210X.2011.00109.X]; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; MALLET J, 1987, J ANIM ECOL, V56, P377, DOI 10.2307/5054; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; MORTON AC, 1982, OECOLOGIA, V53, P105, DOI 10.1007/BF00377143; MOSS D, 1993, ECOL ENTOMOL, V18, P77, DOI 10.1111/j.1365-2311.1993.tb01083.x; Murphy D.D., 1988, Journal of Research on the Lepidoptera, V26, P236; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Nowicki P, 2008, ISR J ECOL EVOL, V54, P69, DOI 10.1560/IJEE.54.1.69; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pellet J, 2008, J INSECT CONSERV, V12, P155, DOI 10.1007/s10841-007-9075-8; Pellet Jerome, 2009, Entomo Helvetica, V2, P201; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; POLLARD E, 1982, BIOL CONSERV, V24, P317, DOI 10.1016/0006-3207(82)90018-0; POLLARD E, 1994, MONITORING BUTTERFLI; PRESTON FW, 1979, ECOLOGY, V60, P451, DOI 10.2307/1936061; Roy DB, 2007, J APPL ECOL, V44, P993, DOI 10.1111/j.1365-2664.2007.01340.x; Roy DB, 2001, J ANIM ECOL, V70, P201, DOI 10.1046/j.1365-2656.2001.00480.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Schtickzelle N, 2003, CAN ENTOMOL, V135, P313; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SINGER MC, 1981, ECOL ENTOMOL, V6, P215, DOI 10.1111/j.1365-2311.1981.tb00609.x; Skorka P, 2007, AGR ECOSYST ENVIRON, V121, P319, DOI 10.1016/j.agee.2006.11.001; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; THOMAS JA, 1983, BIOL CONSERV, V27, P195, DOI 10.1016/0006-3207(83)90019-8; van Swaay C, 2011, BIOL CONSERV, V144, P470, DOI 10.1016/j.biocon.2010.09.034; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Warren MS, 1997, BIOL CONSERV, V82, P317, DOI 10.1016/S0006-3207(97)00037-2; WATT WB, 1977, OECOLOGIA, V27, P1, DOI 10.1007/BF00345682; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wikstrom L, 2009, J INSECT CONSERV, V13, P203, DOI 10.1007/s10841-008-9144-7; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zuur Alain F., 2009, P1; [No title captured]	66	35	39	0	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41396	10.1371/journal.pone.0041396	http://dx.doi.org/10.1371/journal.pone.0041396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859980	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900021
J	Bannert, C; Bidmon-Fliegenschnee, B; Stary, G; Hotzy, F; Stift, J; Nurko, S; Szepfalusi, Z; Fiebiger, E; Dehlink, E				Bannert, Christina; Bidmon-Fliegenschnee, Bettina; Stary, Georg; Hotzy, Florian; Stift, Judith; Nurko, Samuel; Szepfalusi, Zsolt; Fiebiger, Edda; Dehlink, Eleonora			Fc-Epsilon-RI, the High Affinity IgE-Receptor, Is Robustly Expressed in the Upper Gastrointestinal Tract and Modulated by Mucosal Inflammation	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; TRANSEPITHELIAL ANTIGEN TRANSPORT; MAST-CELLS; DENDRITIC CELLS; GASTRIC-MUCOSA; FOOD ALLERGY; GALECTIN-3; COMPLEXES; GUT; QUANTIFICATION	Background: The role of the high affinity IgE receptor, Fc epsilon RI, in IgE-mediated immune responses of the gastrointestinal (GI) mucosa is poorly understood. Currently, a detailed characterization of FceRI expression throughout the human gut is lacking. The aim of this study was to define the expression pattern of FceRI in the GI tract. Methods/Principal Findings: We compared FceRI expression in children with gastritis/esophagitis (n = 10), celiac disease (n = 10), inflammatory bowel disease (IBD) (n = 9), and normal mucosa (n = 5). The alpha-subunit of Fc epsilon RI (Fc epsilon RI alpha), detected by immunohistochemistry, was found on cells infiltrating the mucosa of the esophagus, the stomach, and the duodenum, but was rarely detected in more distal sections of the GI tract. Accordingly, quantitative RT-PCR analysis on esophagus, stomach, duodenum, colon, and rectum biopsies revealed that Fc epsilon RI alpha and -beta expression levels decreased towards the distal intestine. mRNA transcripts of the common Fc-receptor-gamma chain were present in the entire GI mucosa. Double-immunofluorescence staining of esophageal specimens confirmed that Fc epsilon RI alpha was expressed on intraepithelial mast cells and Langerhans cells. The mRNA expression levels of the alpha, beta, and gamma subunits of Fc epsilon RI did not correlate with total serum IgE but were associated with mucosal inflammation. Conclusion/Significance: Our data define the upper GI tract as the main site for IgE-mediated immune activation via Fc epsilon RI. Tissue mRNA levels of Fc epsilon RIa are regulated by inflammatory conditions rather than serum IgE, indicating that Fc epsilon RI might also play a role in pathologies other than allergy.	[Bannert, Christina; Bidmon-Fliegenschnee, Bettina; Hotzy, Florian; Szepfalusi, Zsolt; Dehlink, Eleonora] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria; [Stary, Georg] Med Univ Vienna, Dept Dermatol, DIAID, Vienna, Austria; [Stift, Judith] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Nurko, Samuel; Fiebiger, Edda; Dehlink, Eleonora] Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA USA	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Harvard University; Boston Children's Hospital; Harvard Medical School	Bannert, C (corresponding author), Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria.	eleonora.dehlink@meduniwien.ac.at	Stary, Georg/M-8978-2014	Stary, Georg/0000-0003-1746-4250; Szepfalusi, Zsolt/0000-0003-4852-3102; Stift, Judith/0000-0001-5334-9343; Nurko, Samuel/0000-0003-0936-4807	APART-fellowship of the Austrian Academy of Sciences; Thrasher Research Fund; Gerber Foundation; National Institutes of Health (NIH) grants [AI075037, K24DK82792-1]; Harvard Digestive Diseases Center (NIH Grant) [P30DK037854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075037, R56AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082792] Funding Source: NIH RePORTER	APART-fellowship of the Austrian Academy of Sciences; Thrasher Research Fund; Gerber Foundation; National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (NIH Grant); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an APART-fellowship of the Austrian Academy of Sciences and the Thrasher Research Fund (both to E.D.). Further support came from the Gerber Foundation (to E.F. and S.N.), the National Institutes of Health (NIH) grants AI075037 (to E. F.) and K24DK82792-1 (to S.N.),and the Harvard Digestive Diseases Center (NIH Grant P30DK037854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; BENGTSSON U, 1991, INT ARCH ALLER A IMM, V95, P86, DOI 10.1159/000235459; DeBrosse CW, 2006, PEDIATR DEVEL PATHOL, V9, P210, DOI 10.2350/11-05-0130.1; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; HANDY LM, 1995, EUR J GASTROEN HEPAT, V7, P53; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; Li HX, 2007, GASTROENTEROLOGY, V133, P1905, DOI 10.1053/j.gastro.2007.09.024; Li HX, 2006, GASTROENTEROLOGY, V131, P47, DOI 10.1053/j.gastro.2006.03.044; LIU WL, 1991, AGENTS ACTIONS, V33, P13, DOI 10.1007/BF01993114; Liutu M, 2004, J EUR ACAD DERMATOL, V18, P69, DOI 10.1111/j.1468-3083.2004.00701.x; Lucendo AJ, 2007, AM J SURG PATHOL, V31, P598, DOI 10.1097/01.pas.0000213392.49698.8c; MacGlashan D, 2005, ANN NY ACAD SCI, V1050, P73, DOI 10.1196/annals.1313.009; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Muller S, 2006, INFLAMM BOWEL DIS, V12, P588; Nakamura M, 1999, INT J ONCOL, V15, P143; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; Reischl IG, 2000, CLIN EXP ALLERGY, V30, P1033; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rhodes JM, 2008, BIOCHEM SOC T, V36, P1482, DOI 10.1042/BST0361482; ROGNUM TO, 1989, INT ARCH ALLER A IMM, V89, P256, DOI 10.1159/000234956; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; Tu YH, 2006, AM J PHYSIOL-GASTR L, V291, pG532, DOI 10.1152/ajpgi.00524.2005; Untersmayr E, 2003, J ALLERGY CLIN IMMUN, V112, P616, DOI [10.1016/S0091-6749(03)01719-6, 10.1016/mai.2003.1681]; Untersmayr E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009023; Vasudev M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032556; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; WANG B, 1992, J EXP MED, V175, P1353, DOI 10.1084/jem.175.5.1353; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yen EH, 2010, J PEDIATR GASTR NUTR, V51, P584, DOI 10.1097/MPG.0b013e3181de7685; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470	39	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42066	10.1371/journal.pone.0042066	http://dx.doi.org/10.1371/journal.pone.0042066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848703	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200153
J	Huang, Q; Jin, HX; Liu, Q; Wu, Q; Kang, H; Cao, ZW; Zhu, RX				Huang, Qi; Jin, Haixiao; Liu, Qi; Wu, Qiong; Kang, Hong; Cao, Zhiwei; Zhu, Ruixin			Proteochemometric Modeling of the Bioactivity Spectra of HIV-1 Protease Inhibitors by Introducing Protein-Ligand Interaction Fingerprint	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; MULTITARGET QSAR; DRUG-RESISTANCE; DESIGN; DOCKING; SET; MUTATIONS; SELECTION; DARUNAVIR	HIV-1 protease is one of the main therapeutic targets in HIV. However, a major problem in treatment of HIV is the rapid emergence of drug-resistant strains. It should be particularly helpful to clinical therapy of AIDS if one method can be used to predict antivirus capability of compounds for different variants. In our study, proteochemometric (PCM) models were created to study the bioactivity spectra of 92 chemical compounds with 47 unique HIV-1 protease variants. In contrast to other PCM models, which used Multiplication of Ligands and Proteins Descriptors (MLPD) as cross-term, one new cross-term, i.e. Protein-Ligand Interaction Fingerprint (PLIF) was introduced in our modeling. With different combinations of ligand descriptors, protein descriptors and cross-terms, nine PCM models were obtained, and six of them achieved good predictive abilities (Q(test)(2)> 0.7). These results showed that the performance of PCM models could be improved when ligand and protein descriptors were complemented by the newly introduced cross-term PLIF. Compared with the conventional cross-term MLPD, the newly introduced PLIF had a better predictive ability. Furthermore, our best model (GD & P & PLIF: Q(test)(2) = 0.8271) could select out those inhibitors which have a broad antiviral activity. As a conclusion, our study indicates that proteochemometric modeling with PLIF as cross-term is a potential useful way to solve the HIV-1 drug-resistant problem.	[Huang, Qi; Liu, Qi; Kang, Hong; Cao, Zhiwei; Zhu, Ruixin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Jin, Haixiao] Ningbo Univ, Key Lab Appl Marine Biotechnol, Minist Educ, Ningbo 315211, Zhejiang, Peoples R China; [Wu, Qiong; Zhu, Ruixin] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian, Liaoning, Peoples R China; [Zhu, Ruixin] Tongji Univ, Inst Adv Study Translat Med, Shanghai 200092, Peoples R China	Tongji University; Ningbo University; Liaoning University of Traditional Chinese Medicine; Tongji University	Huang, Q (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	zwcao@tongji.edu.cn; rxzhu@tongji.edu.cn	, 金石为开/AFU-9737-2022; Kang, Hong/H-1388-2017	Kang, Hong/0000-0002-1229-2560; Zhu, Ruixin/0000-0002-5070-6453; Jin, Haixiao/0000-0002-0087-4651	National Natural Science Foundation of China [20903058, 30976611]; Research Fund for the Doctoral Program of Higher Education of China [20100072120050]; Natural Science Foundation of Ningbo [2010A610025]; TCM modernization of Shanghai [09dZ1972800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Ningbo; TCM modernization of Shanghai	This study was supported in part by grants from National Natural Science Foundation of China (20903058, 30976611), Research Fund for the Doctoral Program of Higher Education of China (20100072120050), Natural Science Foundation of Ningbo (2010A610025) and TCM modernization of Shanghai (09dZ1972800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala PJ, 1998, BIOCHEMISTRY-US, V37, P15042, DOI 10.1021/bi980386e; [Anonymous], 2009, MOL OP ENV; Cai YF, 2010, J CHEM THEORY COMPUT, V6, P1358, DOI 10.1021/ct9004678; Cichero E, 2011, J MOL MODEL, V17, P1537, DOI 10.1007/s00894-010-0857-7; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Cohen J, 2011, SCIENCE, V334, P1338, DOI 10.1126/science.334.6061.1338; De Martino Gabriella, 2006, Antiviral Chemistry & Chemotherapy, V17, P59; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Doyon L, 2005, ANTIVIR RES, V68, P27, DOI 10.1016/j.antiviral.2005.07.003; Ghosh AK, 2007, BIOORGAN MED CHEM, V15, P7576, DOI 10.1016/j.bmc.2007.09.010; Gupta L., 2010, J CURRENT PHARM RES, V01, P19; Hu RJ, 2009, EUR J MED CHEM, V44, P2158, DOI 10.1016/j.ejmech.2008.10.021; Huang Q, 2011, ACTA CHIM SINICA, V69, P515; Isa Dino, 2009, Proceedings of the 2009 International Conference on Artificial Intelligence. ICAI 2009, P708; Jamloki A, 2006, BIOORG MED CHEM LETT, V16, P3847, DOI 10.1016/j.bmcl.2006.04.014; Jayatilleke PRN, 2000, J MED CHEM, V43, P4446, DOI 10.1021/jm9905357; Junaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014353; Kang H, 2012, J CHEM INF MODEL; Kar P, 2012, J COMPUT AID MOL DES, V26, P215, DOI 10.1007/s10822-012-9550-5; Kar P, 2012, J PHYS CHEM B, V116, P2605, DOI 10.1021/jp211768n; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Labute P, 2000, J MOL GRAPH MODEL, V18, P464, DOI 10.1016/S1093-3263(00)00068-1; Lapins M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-339; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Liu Q, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-294; Liu Q, 2010, CHINESE J CHEM, V28, P1587, DOI 10.1002/cjoc.201090269; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; Muller KR, 2005, J CHEM INF MODEL, V45, P249, DOI 10.1021/ci049737o; Muzammil S, 2003, BIOCHEMISTRY-US, V42, P631, DOI 10.1021/bi027019u; Namba AM, 2009, CURT BIOACT COMPD, V5, P128; Perez-Nueno VI, 2009, J CHEM INF MODEL, V49, P1245, DOI 10.1021/ci900043r; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; Ragno R, 2005, J MED CHEM, V48, P200, DOI 10.1021/jm0493921; Ragno R, 2004, J MED CHEM, V47, P928, DOI 10.1021/jm0309856; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Sotriffer CA, 2005, J MED CHEM, V48, P3122, DOI 10.1021/jm050075j; Stahura FL, 2004, COMB CHEM HIGH T SCR, V7, P259; Stroembergsson H, 2008, J CHEM INF MODEL, V48, P2278, DOI 10.1021/ci800200e; Strombergsson H, 2006, PROTEINS, V65, P568, DOI 10.1002/prot.21163; Strombergsson H, 2010, MOL INFORM, V29, P499, DOI 10.1002/minf.201000052; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Vays VK, 2011, MED CHEM RES, V20, P355, DOI 10.1007/s00044-010-9333-2; Wang RR, 2011, MOLECULES, V16, P4264, DOI 10.3390/molecules16054264; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; Witten IH, 2011, MOR KAUF D, pXXI; Xu J, 2000, J CHEM INF COMP SCI, V40, P1177, DOI 10.1021/ci000026+; Yao XJ, 2004, J CHEM INF COMP SCI, V44, P1257, DOI 10.1021/ci049965i; Yoshimura K, 2002, J VIROL, V76, P1349, DOI 10.1128/JVI.76.3.1349-1358.2002; Zhang LP, 2006, IEEE T GEOSCI REMOTE, V44, P2950, DOI 10.1109/TGRS.2006.876704; Zhu RX, 2011, ACTA CHIM SINICA, V69, P1731	58	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41698	10.1371/journal.pone.0041698	http://dx.doi.org/10.1371/journal.pone.0041698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848570	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200089
J	Mmbaga, EJ; Leonard, F; Leyna, GH				Mmbaga, Elia John; Leonard, Frida; Leyna, Germana Henry			Incidence and Predictors of Adolescent's Early Sexual Debut after Three Decades of HIV Interventions in Tanzania: A Time to Debut Analysis	PLOS ONE			English	Article							SOUTH-AFRICA; RISK; COMMUNICATION; BEHAVIOR; TEACHERS; HIV/AIDS; WOMEN; AGE	Purpose: To determine the incidence and predictors of adolescent's early sexual debut after three decades of HIV interventions in Tanzania. Methods: In a cross-section study of adolescents aged 16-19 residing in Morogoro Municipality, information on socio-demographic, parental-and-peer communication, and sexual behaviors were collected. Cox-regression analysis was used to examine predictors of time to sexual debut. Results: A total of 316 adolescents with mean age of 17.5 +/- 0.9 were recruited. Half (48.7%) of adolescent were sexually active with mean age at sexual debut of 14.6 +/- 2.3. Of these, 57.8% had sex before their 15th birthday with incidence of early sexual debut of 17.4/1000 person-years at risk. Adolescent family characteristics, peer pressure, alcohol use, parental and peer communication were key predictors of early sexual debut. Conclusion: Parental and peer communication strategies works calling for efforts to increase its scope to reach all adolescents alongside promoting family stability and reducing adolescent alcohol consumption.	[Mmbaga, Elia John; Leyna, Germana Henry] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Leonard, Frida] Pact Tanzania, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Mmbaga, EJ (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.	eliajelia@yahoo.co.uk	Leyna, Germana Henry/I-2565-2019	Leyna, Germana Henry/0000-0001-7016-544X				Abma J, 1998, FAM PLANN PERSPECT, V30, P12, DOI 10.2307/2991518; [Anonymous], 2005, SEXUALLY TRANSMITTED; Bastien S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-25; Brown BB, 2002, PAPERS MATTER PEER P; DiClemente RJ, 2001, J PEDIATR-US, V139, P407, DOI 10.1067/mpd.2001.117075; Doyle AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024866; Ferguson A., 2007, SITUATION ANAL SEXUA; GREENBERG J, 1992, SEX TRANSM DIS, V19, P331, DOI 10.1097/00007435-199211000-00006; Hendershot CS, 2007, PSYCHOL ADDICT BEHAV, V21, P365, DOI 10.1037/0893-164X.21.3.365; Hutchison K, 2008, FAM RELAT, V47, P185; Ismayilova L, 2012, J ADOLESCENT HEALTH, V50, P228, DOI 10.1016/j.jadohealth.2011.06.008; Masatu MC, 2009, AIDS BEHAV, V13, P94, DOI 10.1007/s10461-007-9292-x; Maswanya E S, 2011, East Afr J Public Health, V8, P69; Mathews C, 2012, TROP MED INT HLTH; Mavedzenge SMN, 2011, J ADOLESCENT HEALTH, V49, P568, DOI 10.1016/j.jadohealth.2011.02.007; Mkumbo K, 2009, SCAND J PUBLIC HEALT, V37, P28, DOI 10.1177/1403494808091345; Namisi FS, 2009, SCAND J PUBLIC HEALT, V37, P65, DOI 10.1177/1403494808086986; NBS, 2004, TANZ HIV AIDS IND SU; NBS, 2002, NAT POP CENS; NBS, 2010, DEM HLTH SURV 2010; Nyamukapa CA, 2008, AM J PUBLIC HEALTH, V98, P133, DOI 10.2105/AJPH.2007.116038; Odimegwu OC, 2002, AFR J REPROD HLTH, V6, P95; Peltzer K, 2010, ACTA PAEDIATR, V16, P1651; Pettifor A, 2009, INT PERSPECT SEX R H, V35, P82, DOI [10.1363/3508209, 10.1363/ifpp.35.082.09]; Renju J, 2010, HEALTH EDUC RES, V25, P903, DOI 10.1093/her/cyq041; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; UNAIDS, 2004, HIV YOUNG PEOPL THRE; UNAIDS, 2010, AIDS EP UPD; UNFPA, 2008, GEN CHANG YOUNG PEOP; Whitaker DJ, 1999, FAM PLANN PERSPECT, V31, P117, DOI 10.2307/2991693; WHO, 2008, REPR HLTH SCH LOW IN; World Health Organization (WHO), 2004, WHO PUBL; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674	34	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41700	10.1371/journal.pone.0041700	http://dx.doi.org/10.1371/journal.pone.0041700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848571	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200090
J	Parra-Guillen, ZP; Fioravanti, J; Medina-Echeverz, J; Gomar, C; Ardaiz, N; Troconiz, IF; Berraondo, P				Patricia Parra-Guillen, Zinnia; Fioravanti, Jessica; Medina-Echeverz, Jose; Gomar, Celia; Ardaiz, Nuria; Troconiz, Inaki F.; Berraondo, Pedro			Kinetic and Dynamic Computational Model-Based Characterization of New Proteins in Mice: Application to Interferon Alpha Linked to Apolipoprotein A-I	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CENTRAL-NERVOUS-SYSTEM; INITIAL TREATMENT; PLUS RIBAVIRIN; GENE-THERAPY; PLASMID DNA; SR-BI; BRAIN; LIPOPROTEIN; DELIVERY	Interferon alpha linked to apolipoprotein A-I has been recently proposed as an improved interferon-based therapy. In the present study, we aimed to develop a computational model to gain further insight into the in vivo behaviour of this new fusion protein. In order to facilitate in vivo evaluation of interferon and the fusion protein without altering their biological properties, green fluorescent protein was incorporated into their structures. Kinetic and dynamic behaviour of both compounds was successfully described after plasmid hydrodynamic administration and in situ synthesis of the studied proteins. Results from the modelling exercise showed that apolipoprotein A-I conferred a modified kinetic behaviour, varying molecule distribution and prolonging half-life without altering liver dynamic performance. However, differences in the gene expression activity were observed at brain level between both compounds. Those differences could be explained by modifications in the dynamic, but also in the biodistribution properties, which would be worth evaluating in future experiments. Therefore, the modelling approach provided a global comprehension of a complex system and allowed us to compare the in vivo behaviour of both compounds and to identify critical aspects that might be important to understand the system better and suggests a need for new model-based experiments.	[Patricia Parra-Guillen, Zinnia; Troconiz, Inaki F.] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Navarra, Spain; [Fioravanti, Jessica; Medina-Echeverz, Jose; Gomar, Celia; Ardaiz, Nuria; Berraondo, Pedro] Ctr Appl Med Res CIMA, Div Hepatol & Gene Therapy, Pamplona, Navarra, Spain	University of Navarra; University of Navarra	Parra-Guillen, ZP (corresponding author), Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Navarra, Spain.	pberraondol@unav.es	Berraondo, Pedro/J-3154-2012; Troconiz, Inaki F/I-1740-2017; Troconiz, Iñaki/ABA-2543-2020; Fioravanti, Jessica/AAS-1245-2020; Parra-Guillen, Zinnia P./L-2862-2017	Berraondo, Pedro/0000-0001-7410-1865; Troconiz, Inaki F/0000-0003-3700-8658; Troconiz, Iñaki/0000-0003-3700-8658; Fioravanti, Jessica/0000-0001-6263-4306; Parra-Guillen, Zinnia P./0000-0003-1503-2710	FIMA; UTE project CIMA; Red de Inmunoterapia [INMUNONET-SOE1/P1/E014]; Fundacion Mutua Madrilena; Fondo de Investigacion Sanitaria [FIS PI10/00264]; predoctoral fellowship of "La Caixa", Asociacion de Amigos de la Universidad de Navarra; Spanish Ministerio de Educacion, Cultura y Deporte; fellowship of Spanish Fondo de Investigacion Sanitaria; Miguel Servet contract from Spanish Fondo de Investigacion Sanitaria	FIMA; UTE project CIMA; Red de Inmunoterapia; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); predoctoral fellowship of "La Caixa", Asociacion de Amigos de la Universidad de Navarra; Spanish Ministerio de Educacion, Cultura y Deporte(Spanish Government); fellowship of Spanish Fondo de Investigacion Sanitaria; Miguel Servet contract from Spanish Fondo de Investigacion Sanitaria	This work was supported by the agreement between FIMA and the "UTE project CIMA", Red de Inmunoterapia INMUNONET-SOE1/P1/E014, Fundacion Mutua Madrilena and Fondo de Investigacion Sanitaria (FIS PI10/00264). Z.P.P-G was supported by predoctoral fellowship of "La Caixa", Asociacion de Amigos de la Universidad de Navarra and of Spanish Ministerio de Educacion, Cultura y Deporte. J.F. and J.M-E. were supported by a fellowship of Spanish Fondo de Investigacion Sanitaria. P.B. was supported by a Miguel Servet contract from Spanish Fondo de Investigacion Sanitaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aghemo A, 2010, NAT REV GASTRO HEPAT, V7, P485, DOI 10.1038/nrgastro.2010.101; Agur Z, 2012, MOL THER, V20, P1, DOI 10.1038/mt.2011.272; Banerjee D, 1997, EXP CELL RES, V235, P334, DOI 10.1006/excr.1997.3687; Beal S, 1989, NONMEM USERS GUIDE; Berraondo P, 2009, EUR J PHARM SCI, V37, P418, DOI 10.1016/j.ejps.2009.03.013; Bonamassa B, 2011, PHARM RES-DORDR, V28, P694, DOI 10.1007/s11095-010-0338-9; Carney DS, 2006, HEPATITIS C VIRUSES; Dass CR, 2000, J PHARM PHARMACOL, V52, P731, DOI 10.1211/0022357001774606; de Beer MC, 2005, J LIPID RES, V46, P2143, DOI 10.1194/jlr.M500068-JLR200; Deutsch M, 2008, J VIRAL HEPATITIS, V15, P2, DOI 10.1111/j.1365-2893.2007.00887.x; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; DIANZANI F, 1990, J HEPATOL, V11, pS5, DOI 10.1016/0168-8278(90)90156-L; Feng MQ, 2008, J DRUG TARGET, V16, P502, DOI [10.1080/10611860802200938, 10.1080/10611860802200938 ]; Fioravanti J, 2011, HEPATOLOGY, V53, P1864, DOI 10.1002/hep.24306; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kim SI, 2009, J HEPATOL, V50, P479, DOI 10.1016/j.jhep.2008.10.029; Kreuter J, 2007, J CONTROL RELEASE, V118, P54, DOI 10.1016/j.jconrel.2006.12.012; Kuwahara H, 2011, MOL THER, V19, P2213, DOI 10.1038/mt.2011.186; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; LUDDEN TM, 1994, J PHARMACOKINET BIOP, V22, P431, DOI 10.1007/BF02353864; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Mok W, 2009, CLIN CANCER RES, V15, P2352, DOI 10.1158/1078-0432.CCR-08-2082; Nomura T, 1997, CANCER RES, V57, P2681; Pan WH, 1999, ADV DRUG DELIVER REV, V36, P291, DOI 10.1016/S0169-409X(98)00086-6; Parra-Guillen ZP, 2010, PHARM RES-DORDR, V27, P1487, DOI 10.1007/s11095-010-0136-4; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Rajman I, 2008, DRUG DISCOV TODAY, V13, P341, DOI 10.1016/j.drudis.2008.01.003; Rodriguez-Sureda V, 2002, ANAL BIOCHEM, V303, P73, DOI 10.1006/abio.2001.5546; Russo MW, 2003, GASTROENTEROLOGY, V124, P1711, DOI 10.1016/S0016-5085(03)00394-9; Sockalingam S, 2011, J VIRAL HEPATITIS, V18, P153, DOI 10.1111/j.1365-2893.2010.01393.x; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Van Gool AR, 2003, PHARM WORLD SCI, V25, P11, DOI 10.1023/A:1022449613907; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Wang J, 2008, MOL PSYCHIATR, V13, P293, DOI 10.1038/sj.mp.4002013; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yumada Y, 2005, INT J PHARMACEUT, V299, P34, DOI 10.1016/j.ijpharm.2005.04.003	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42100	10.1371/journal.pone.0042100	http://dx.doi.org/10.1371/journal.pone.0042100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848716	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200164
J	van Heeswijk, RB; Pilloud, Y; Flogel, U; Schwitter, J; Stuber, M				van Heeswijk, Ruud B.; Pilloud, Yves; Floegel, Ulrich; Schwitter, Juerg; Stuber, Matthias			Fluorine-19 Magnetic Resonance Angiography of the Mouse	PLOS ONE			English	Article							IN-VIVO; COMPUTED-TOMOGRAPHY; CONTRAST AGENTS; MR-ANGIOGRAPHY	Purpose: To implement and characterize a fluorine-19 (F-19) magnetic resonance imaging (MRI) technique and to test the hypothesis that the F-19 MRI signal in steady state after intravenous injection of a perfluoro-15-crown-5 ether (PCE) emulsion may be exploited for angiography in a pre-clinical in vivo animal study. Materials and Methods: In vitro at 9.4T, the detection limit of the PCE emulsion at a scan time of 10 min/slice was determined, after which the T-1 and T-2 of PCE in venous blood were measured. Permission from the local animal use committee was obtained for all animal experiments. 12 mu l/g of PCE emulsion was intravenously injected in 11 mice. Gradient echo H-1 and F-19 images were obtained at identical anatomical levels. Signal-to-noise (SNR) and contrast-to-noise (CNR) ratios were determined for 33 vessels in both the F-19 and H-1 images, which was followed by vessel tracking to determine the vessel conspicuity for both modalities. Results: In vitro, the detection limit was similar to 400 mu M, while the F-19 T-1 and T-2 were 1350 +/- 40 and 25 +/- 2 ms. The F-19 MR angiograms selectively visualized the vasculature ( and the liver parenchyma over time) while precisely coregistering with the H-1 images. Due to the lower SNR of F-19 compared to H-1 (17 +/- 8 vs. 83 +/- 49, p<0.001), the F-19 CNR was also lower at 15 +/- 8 vs. 52 +/- 35 (p<0.001). Vessel tracking demonstrated a significantly higher vessel sharpness in the F-19 images (66 +/- 11 vs. 56 +/- 12, p=0.002). Conclusion: F-19 magnetic resonance angiography of intravenously administered perfluorocarbon emulsions is feasible for a selective and exclusive visualization of the vasculature in vivo.	[van Heeswijk, Ruud B.; Stuber, Matthias] CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland; [van Heeswijk, Ruud B.; Stuber, Matthias] Univ Lausanne, Lausanne, Switzerland; [van Heeswijk, Ruud B.; Pilloud, Yves; Stuber, Matthias] Ctr Biomed Imaging CIBM, Lausanne, Switzerland; [Pilloud, Yves] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging LIFMET, Lausanne, Switzerland; [Floegel, Ulrich] Univ Dusseldorf, Dept Cardiovasc Physiol, D-40225 Dusseldorf, Germany; [Schwitter, Juerg] CHU Vaudois, Serv Cardiol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Heinrich Heine University Dusseldorf; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	van Heeswijk, RB (corresponding author), CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland.	ruud.mri@gmail.com	Stuber, Matthias/B-2949-2010; van Heeswijk, Ruud B/F-9711-2010	Stuber, Matthias/0000-0001-9843-2028; van Heeswijk, Ruud B/0000-0001-5028-4521	Department of Radiology, University (UNIL); University Hospital (CHUV) of Lausanne, Switzerland	Department of Radiology, University (UNIL); University Hospital (CHUV) of Lausanne, Switzerland	Funding source: Department of Radiology, University (UNIL) and University Hospital (CHUV) of Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluemke DA, 2008, CIRCULATION, V118, P586, DOI 10.1161/CIRCULATIONAHA.108.189695; DAmbra MN, 1995, AM J SURG, V170, pS49, DOI 10.1016/S0002-9610(99)80059-2; Eger EI, 2005, ANESTH ANALG, V100, P1020, DOI 10.1213/01.ANE.0000146961.70058.A1; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Gerretsen SC, 2010, RADIOLOGY, V255, P988, DOI 10.1148/radiol.10090357; Giraudeau C, 2010, MAGN RESON MED, V63, P1119, DOI 10.1002/mrm.22269; HOLLAND GN, 1977, J MAGN RESON, V28, P133, DOI 10.1016/0022-2364(77)90263-3; Hu L, 2012, EVALUATING ENDOTHELI, V2012; JOSEPH PM, 1985, J COMPUT ASSIST TOMO, V9, P1012, DOI 10.1097/00004728-198511000-00003; KEIPERT PE, 1995, ARTIF CELL BLOOD SUB, V23, P381, DOI 10.3109/10731199509117954; Korosoglou G, 2008, RADIOLOGY, V249, P501, DOI 10.1148/radiol.2491071706; Lewis M, 2012, J MED IMAG RADIAT ON, V56, P187, DOI 10.1111/j.1754-9485.2012.02347.x; MATTREY RF, 1982, RADIOLOGY, V145, P755, DOI 10.1148/radiology.145.3.7146408; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Neubauer AM, 2007, J CARDIOVASC MAGN R, V9, P565, DOI 10.1080/10976640600945481; Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824; Spees WM, 2005, CLIN CANCER RES, V11, P1454, DOI 10.1158/1078-0432.CCR-04-1439; Watts R, 2002, MAGNET RESON MED, V48, P550, DOI 10.1002/mrm.10220	19	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42236	10.1371/journal.pone.0042236	http://dx.doi.org/10.1371/journal.pone.0042236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848749	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200186
J	Zhu, Y; Bergland, AO; Gonzalez, J; Petrov, DA				Zhu, Yuan; Bergland, Alan O.; Gonzalez, Josefa; Petrov, Dmitri A.			Empirical Validation of Pooled Whole Genome Population Re-Sequencing in Drosophila melanogaster	PLOS ONE			English	Article							NEXT-GENERATION; ALLELE FREQUENCIES; DNA SAMPLES; VARIANTS; DISCOVERY; FRAMEWORK; MUTATION; SNPS	The sequencing of pooled non-barcoded individuals is an inexpensive and efficient means of assessing genome-wide population allele frequencies, yet its accuracy has not been thoroughly tested. We assessed the accuracy of this approach on whole, complex eukaryotic genomes by resequencing pools of largely isogenic, individually sequenced Drosophila melanogaster strains. We called SNPs in the pooled data and estimated false positive and false negative rates using the SNPs called in individual strain as a reference. We also estimated allele frequency of the SNPs using "pooled" data and compared them with "true" frequencies taken from the estimates in the individual strains. We demonstrate that pooled sequencing provides a faithful estimate of population allele frequency with the error well approximated by binomial sampling, and is a reliable means of novel SNP discovery with low false positive rates. However, a sufficient number of strains should be used in the pooling because variation in the amount of DNA derived from individual strains is a substantial source of noise when the number of pooled strains is low. Our results and analysis confirm that pooled sequencing is a very powerful and cost-effective technique for assessing of patterns of sequence variation in populations on genome-wide scales, and is applicable to any dataset where sequencing individuals or individual cells is impossible, difficult, time consuming, or expensive.	[Zhu, Yuan] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Bergland, Alan O.; Gonzalez, Josefa; Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Gonzalez, Josefa] Pompeu Fabra Univ, Inst Evolutionary Biol, Spanish Natl Res Council, Barcelona, Spain	Stanford University; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University	Zhu, Y (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	yuanzhu@stanford.edu		/0000-0001-9824-027X; Petrov, Dmitri/0000-0002-3664-9130; Zhu, Yuan/0000-0001-9419-6291	A*STAR National Science Scholarship PhD; NIH NRSA fellowship [F32 GM097837-01]; Spanish Ministry of Science and Innovation [RYC-2010-07306]; European Commission Marie Curie CIG Grant [PCIG09-GA-2011-293860]; NIH [1R01GM089926, P50HG002568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089926, R01GM100366, F32GM097837] Funding Source: NIH RePORTER	A*STAR National Science Scholarship PhD(Agency for Science Technology & Research (A*STAR)); NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission Marie Curie CIG Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	YZ was supported by the A*STAR National Science Scholarship PhD. AOB was supported by the NIH NRSA fellowship (F32 GM097837-01). JG was supported by a Spanish Ministry of Science and Innovation (RYC-2010-07306) and a European Commission Marie Curie CIG Grant (PCIG09-GA-2011-293860). DAP was supported by NIH grants 1R01GM089926 and P50HG002568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Bansal V, 2010, GENOME RES, V20, P537, DOI 10.1101/gr.100040.109; Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; CLARK AG, 1992, MOL BIOL EVOL, V9, P744; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Hajirasouliha I, 2008, BIOINFORMATICS, V24, pI32, DOI 10.1093/bioinformatics/btn173; Haubold B, 2010, MOL ECOL, V19, P277, DOI 10.1111/j.1365-294X.2009.04482.x; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Huang Audrey M, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5198; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2010, GENOME RES, V20, P101, DOI 10.1101/gr.097543.109; Lynch M, 2009, GENETICS, V182, P295, DOI 10.1534/genetics.109.100479; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Margraf Rebecca L, 2011, J Biomol Tech, V22, P74; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shaw SH, 1998, GENOME RES, V8, P111, DOI 10.1101/gr.8.2.111; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502; Wang W, 2011, J NEUROSCI, V31, P9746, DOI 10.1523/JNEUROSCI.0852-11.2011; Wen XQ, 2010, ANN APPL STAT, V4, P1158, DOI 10.1214/10-AOAS338	39	61	61	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41901	10.1371/journal.pone.0041901	http://dx.doi.org/10.1371/journal.pone.0041901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848651	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600056
J	Nakamura, Y; Asakura, Y; Piras, BA; Hirai, H; Tastad, CT; Verma, M; Christ, AJ; Zhang, JY; Yamazaki, T; Yoshiyama, M; Asakura, A				Nakamura, Yasuhiro; Asakura, Yoko; Piras, Bryan A.; Hirai, Hiroyuki; Tastad, Christopher T.; Verma, Mayank; Christ, Amanda J.; Zhang, Jianyi; Yamazaki, Takanori; Yoshiyama, Minoru; Asakura, Atsushi			Increased Angiogenesis and Improved Left Ventricular Function after Transplantation of Myoblasts Lacking the MyoD Gene into Infarcted Myocardium	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; MESENCHYMAL STEM-CELLS; ISCHEMIC-HEART FAILURE; ADULT SKELETAL-MUSCLE; PROGENITOR CELLS; CARDIAC REPAIR; GROWTH-FACTOR; TISSUE REGENERATION; ENDOTHELIAL-CELLS; FOLLOW-UP	Skeletal myoblast transplantation has therapeutic potential for repairing damaged heart. However, the optimal conditions for this transplantation are still unclear. Recently, we demonstrated that satellite cell-derived myoblasts lacking the MyoD gene (MyoD(-/-)), a master transcription factor for skeletal muscle myogenesis, display increased survival and engraftment compared to wild-type controls following transplantation into murine skeletal muscle. In this study, we compare cell survival between wild-type and MyoD(-/-) myoblasts after transplantation into infarcted heart. We demonstrate that MyoD(-/-) myoblasts display greater resistance to hypoxia, engraft with higher efficacy, and show a larger improvement in ejection fraction than wild-type controls. Following transplantation, the majority of MyoD(-/-) and wild-type myoblasts form skeletal muscle fibers while cardiomyocytes do not. Importantly, the transplantation of MyoD(-/-) myoblasts induces a high degree of angiogenesis in the area of injury. DNA microarray data demonstrate that paracrine angiogenic factors, such as stromal cell-derived factor-1 (SDF-1) and placental growth factor (PlGF), are up-regulated in MyoD(-/-) myoblasts. In addition, overexpression and gene knockdown experiments demonstrate that MyoD negatively regulates gene expression of these angiogenic factors. These results indicate that MyoD(-/-) myoblasts impart beneficial effects after transplantation into an infarcted heart, potentially due to the secretion of paracrine angiogenic factors and enhanced angiogenesis in the area of injury. Therefore, our data provide evidence that a genetically engineered myoblast cell type with suppressed MyoD function is useful for therapeutic stem cell transplantation.	[Nakamura, Yasuhiro; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Nakamura, Yasuhiro; Yamazaki, Takanori; Yoshiyama, Minoru] Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Osaka 545, Japan; [Asakura, Yoko; Piras, Bryan A.; Hirai, Hiroyuki; Tastad, Christopher T.; Verma, Mayank; Christ, Amanda J.; Asakura, Atsushi] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Asakura, Yoko; Piras, Bryan A.; Hirai, Hiroyuki; Tastad, Christopher T.; Verma, Mayank; Christ, Amanda J.; Asakura, Atsushi] Univ Minnesota, Sch Med, Paul & Sheila Wellstone Muscular Dystrophy Ctr, Minneapolis, MN 55455 USA; [Asakura, Yoko; Piras, Bryan A.; Hirai, Hiroyuki; Tastad, Christopher T.; Verma, Mayank; Christ, Amanda J.; Asakura, Atsushi] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Osaka Metropolitan University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nakamura, Y (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	asakura@umn.edu	Asakura, Atsushi/H-2745-2019; Yamazaki, Takanori/G-9752-2011; Verma, Mayank/E-6074-2011; Zhang, Jianyi/N-1949-2018; Hirai, Hiroyuki/A-6866-2019	Asakura, Atsushi/0000-0001-8078-1027; Yamazaki, Takanori/0000-0003-3542-3559; Verma, Mayank/0000-0003-0167-0842; Zhang, Jianyi/0000-0002-3955-6554; Hirai, Hiroyuki/0000-0001-7302-7587; Piras, Bryan/0000-0002-8352-2300	Muscular Dystrophy Association [MDA69856]; NIH [RO1 67828]; Lillehei Heart Institute; Nash Avery Search for Hope Research Fund; Minnesota Medical Foundation of the University of Minnesota; Muscular Dystrophy Association (MDA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067828, U01HL100407] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lillehei Heart Institute; Nash Avery Search for Hope Research Fund; Minnesota Medical Foundation of the University of Minnesota; Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by Muscular Dystrophy Association (Grant Number:MDA69856) (www.mdause.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Doris A. Taylor and Jesse L. Mull for critical reading of the manuscript, and Dr. Genya Gekker for her assistance in the flow cytometry facility of the Stem Cell Institute. This work was supported by grants to J.Z. from NIH RO1 67828, and to A. A. from the Lillehei Heart Institute Scholarship, the Nash Avery Search for Hope Research Fund, the Minnesota Medical Foundation of the University of Minnesota, and the Muscular Dystrophy Association (MDA).	Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Becker C, 2006, INT J CARDIOL, V113, P348, DOI 10.1016/j.ijcard.2005.11.060; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chedrawy EG, 2002, J THORAC CARDIOV SUR, V124, P584, DOI 10.1067/mtc.2002.122544; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Cizkova D, 2009, CELLS TISSUES ORGANS, V189, P338, DOI 10.1159/000142161; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Elmadbouh I, 2007, J MOL CELL CARDIOL, V42, P792, DOI 10.1016/j.yjmcc.2007.02.001; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Formigli L, 2010, CURR PHARM DESIGN, V16, P915, DOI 10.2174/138161210790883390; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; Fujita J, 2007, STEM CELLS, V25, P2750, DOI 10.1634/stemcells.2007-0275; Galvez BG, 2008, CELL DEATH DIFFER, V15, P1417, DOI 10.1038/cdd.2008.75; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Hagege AA, 2003, LANCET, V361, P491, DOI 10.1016/S0140-6736(03)12458-0; Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521; Haider HK, 2004, MOL THER, V9, P14, DOI 10.1016/j.ymthe.2003.10.009; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Jain M, 2001, CIRCULATION, V103, P1920; Keller UAD, 2004, EUR J CELL BIOL, V83, P607; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Nakamura Y, 2002, CIRC J, V66, P192, DOI 10.1253/circj.66.192; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Ohnishi S, 2007, J MOL CELL CARDIOL, V42, P88, DOI 10.1016/j.yjmcc.2006.10.003; Okada M, 2008, J AM COLL CARDIOL, V52, P1869, DOI 10.1016/j.jacc.2008.07.064; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Payne TR, 2007, J AM COLL CARDIOL, V50, P1677, DOI 10.1016/j.jacc.2007.04.100; Pelacho B, 2007, J TISSUE ENG REGEN M, V1, P51, DOI 10.1002/term.7; Pelacho B, 2008, CURR STEM CELL RES T, V3, P265, DOI 10.2174/157488808786734015; Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pyo JO, 2008, J BIOL CHEM, V283, P30707, DOI 10.1074/jbc.M804209200; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reinecke H, 2004, CIRC RES, V94, pE56, DOI 10.1161/01.RES.0000125294.04612.81; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Ricort JM, 2004, GROWTH HORM IGF RES, V14, P277, DOI 10.1016/j.ghir.2004.02.002; Roncal C, 2008, J PATHOL, V216, P236, DOI 10.1002/path.2408; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Shintani Y, 2009, J MOL CELL CARDIOL, V47, P288, DOI 10.1016/j.yjmcc.2009.05.009; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Sondergaard CS, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-24; Stievano L, 2004, CRIT REV IMMUNOL, V24, P205, DOI 10.1615/CritRevImmunol.v24.i3.40; Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje; TAPSCOTT SJ, 1989, SCIENCE, V245, P532, DOI 10.1126/science.2547249; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Tonlorenzi Rossana, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02b01s3; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Verma M, 2010, HUM MOL GENET, V19, P4145, DOI 10.1093/hmg/ddq334; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Xiang G, 2011, MOL THER; Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JCI200522326; Zaglia T, 2009, J MOL CELL CARDIOL, V46, P653, DOI 10.1016/j.yjmcc.2008.12.010	80	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41736	10.1371/journal.pone.0041736	http://dx.doi.org/10.1371/journal.pone.0041736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848585	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600111
J	Van der Laan, LN; De Ridder, DTD; Viergever, MA; Smeets, PAM				Van der Laan, Laura N.; De Ridder, Denise T. D.; Viergever, Max A.; Smeets, Paul A. M.			Appearance Matters: Neural Correlates of Food Choice and Packaging Aesthetics	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION; CONSUMERS; VALUATION; SIGNALS; ATTENTION; FMRI; ACTIVATIONS; HEALTHINESS; VARIABILITY	Neuro-imaging holds great potential for predicting choice behavior from brain responses. In this study we used both traditional mass-univariate and state-of-the-art multivariate pattern analysis to establish which brain regions respond to preferred packages and to what extent neural activation patterns can predict realistic low-involvement consumer choices. More specifically, this was assessed in the context of package-induced binary food choices. Mass-univariate analyses showed that several regions, among which the bilateral striatum, were more strongly activated in response to preferred food packages. Food choices could be predicted with an accuracy of up to 61.2% by activation patterns in brain regions previously found to be involved in healthy food choices (superior frontal gyrus) and visual processing (middle occipital gyrus). In conclusion, this study shows that mass-univariate analysis can detect small package-induced differences in product preference and that MVPA can successfully predict realistic low-involvement consumer choices from functional MRI data.	[Van der Laan, Laura N.; Viergever, Max A.; Smeets, Paul A. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [De Ridder, Denise T. D.] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands; [Smeets, Paul A. M.] Univ Wageningen & Res Ctr, Div Human Nutr, Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Wageningen University & Research	Van der Laan, LN (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	nynke@isi.uu.nl	Smeets, Paul AM/B-7979-2010; Viergever, Max A/J-1215-2014	Smeets, Paul AM/0000-0002-8695-9612; van der Laan, Laura Nynke/0000-0003-4307-0888	governmental research grant of Agentschap NL [FND08009]	governmental research grant of Agentschap NL	This work was supported by a governmental research grant of Agentschap NL (FND08009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FM, 1973, J CROSS CULT PSYCHOL, V4, P135, DOI 10.1177/002202217300400201; Ares G, 2010, APPETITE, V55, P298, DOI 10.1016/j.appet.2010.06.016; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Borgmeier I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-184; Carrillo E, 2011, J SENS STUD, V26, P85, DOI 10.1111/j.1745-459X.2010.00325.x; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Cohen JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00047; Conway BR, 2009, NEUROSCIENTIST, V15, P274, DOI 10.1177/1073858408331369; DAWAR N, 1994, J MARKETING, V58, P81, DOI 10.2307/1252271; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Deco G, 2010, P NATL ACAD SCI USA, V107, P7545, DOI 10.1073/pnas.1002333107; Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009; Forsythe S, 1996, PERCEPT MOTOR SKILL, V83, P299, DOI 10.2466/pms.1996.83.1.299; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Gelici-Zeko MM, 2012, UNDERSTANDING UNPUB; Gelici-Zeko MM, 2012, STUDYING INFLUENCE P; Gerdes ABM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00175; Golay X, 2000, MAGNET RESON MED, V43, P779, DOI 10.1002/1522-2594(200006)43:6<779::AID-MRM1>3.0.CO;2-4; GRIEVE KW, 1991, PERCEPT MOTOR SKILL, V72, P1319, DOI 10.2466/pms.1991.72.3c.1319; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lee YS, 2012, J NEUROSCI, V32, P3942, DOI 10.1523/JNEUROSCI.3814-11.2012; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Linder NS, 2010, NEUROIMAGE, V53, P215, DOI 10.1016/j.neuroimage.2010.05.077; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Madden TJ, 2000, J INT MARKETING, V8, P90, DOI 10.1509/jimk.8.4.90.19795; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Neumann J, 2003, NEUROIMAGE, V19, P784, DOI 10.1016/S1053-8119(03)00177-0; Novemsky N, 2003, J CONSUM RES, V29, P507, DOI 10.1086/346246; Orth UR, 2010, J MARKET THEORY PRAC, V18, P23, DOI 10.2753/MTP1069-6679180102; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Provencher V, 2009, APPETITE, V52, P340, DOI 10.1016/j.appet.2008.11.005; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Reimann M, 2010, J CONSUM PSYCHOL, V20, P431, DOI 10.1016/j.jcps.2010.06.009; Sabbe S, 2009, APPETITE, V53, P84, DOI 10.1016/j.appet.2009.05.014; Shapley R, 2002, CURR OPIN NEUROBIOL, V12, P426, DOI 10.1016/S0959-4388(02)00349-5; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; Silayoi P., 2004, British Food Journal, V106, P607, DOI 10.1108/00070700410553602; Silayoi P, 2007, EUR J MARKETING, V41, P1495, DOI 10.1108/03090560710821279; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Westenhoefer J, 2005, FORUM NUTR, V57, P44, DOI 10.1159/000083753; Wiegersma S, 2011, PERCEPT MOTOR SKILL, V66, P308	55	65	67	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41738	10.1371/journal.pone.0041738	http://dx.doi.org/10.1371/journal.pone.0041738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979GX	22848586	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600112
J	Koba, S; Paulson, KG; Nagase, K; Tegeder, A; Thibodeau, R; Iyer, JG; Narisawa, Y; Nghiem, P				Koba, Shinichi; Paulson, Kelly G.; Nagase, Kotaro; Tegeder, Andrew; Thibodeau, Renee; Iyer, Jayasri G.; Narisawa, Yutaka; Nghiem, Paul			Diagnostic Biopsy Does Not Commonly Induce Intratumoral CD8 T Cell Infiltration in Merkel Cell Carcinoma	PLOS ONE			English	Article							COMPLETE SPONTANEOUS REGRESSION; NEUROENDOCRINE CARCINOMA; COLORECTAL-CANCER; OVARIAN-CANCER; HIV-INFECTION; IMMUNE CELLS; LUNG-CANCER; POLYOMAVIRUS; TUMOR; SURVIVAL	Background: Merkel cell carcinoma is a polyomavirus-associated cancer that is strongly linked with T lymphocyte immune suppression in epidemiologic studies. CD8+ T cell infiltration into MCC tumors (intratumoral) has recently been shown to be strongly predictive of improved survival. In contrast, the presence of CD8+ T cells at the border of the tumor (peritumoral) had no independent prognostic value. Spontaneous regression has been reported for MCC approximately one thousand times more often than would be expected given the frequency of this cancer. Many of these events began shortly after biopsy, and in some cases lymphocytic infiltration was described. Methodology/Principal Findings: To determine whether CD8+ lymphocyte infiltration in MCC tumors is commonly altered by biopsy. 33 MCC patients who had microscopic confirmation of MCC on both an initial biopsy and a re-excision specimen were included in this study. Intratumoral and peritumoral CD8 lymphocyte infiltration was quantitated using immunohistochemistry and compared using the paired t-test in biopsy versus re-excision samples. There was a trend toward increased CD8 infiltration after biopsy in a peritumoral ('stalled') pattern (p = 0.08), however, biopsy was not associated with a significant increase in CD8 T cells in the clinically more important intratumoral location (p = 0.58). Conclusions/Significance: The initial diagnostic biopsy for MCC does not commonly alter intratumoral CD8+ T cell infiltration, suggesting it does not directly induce immunologic recognition of this cancer. Because CD8 infiltration is typically stable after biopsy, this parameter may be useful to assess the efficacy of future immune therapies for this virus-associated, immunogenic, often-lethal cancer.	[Koba, Shinichi; Paulson, Kelly G.; Nagase, Kotaro; Tegeder, Andrew; Thibodeau, Renee; Iyer, Jayasri G.; Nghiem, Paul] Univ Washington, Seattle, WA 98195 USA; [Nghiem, Paul] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Nghiem, Paul] Seattle Canc Care Alliance, Seattle, WA USA; [Koba, Shinichi; Nagase, Kotaro; Narisawa, Yutaka] Saga Univ, Div Dermatol, Dept Internal Med, Fac Med, Saga 840, Japan	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; Saga University	Koba, S (corresponding author), Univ Washington, Seattle, WA 98195 USA.	pnghiem@uw.edu	Paulson, Kelly G/E-5761-2010; Paulson, Kelly/HHC-3903-2022; Nghiem, Paul T/A-9210-2011	Paulson, Kelly G/0000-0002-0033-3708; Nghiem, Paul T/0000-0003-2784-963X	American Cancer Society [RSG-08-115- 01-CCE]; NIH [RC2CA147820, K24 CA139052-0, T32 CA80416-10, F30ES017385, ULRR025014, TL1RR025016]; David & Rosalind Bloom Fund; Michael W. Piepkorn Endowment; MCC Patient Gift Fund at the University of Washington; NATIONAL CANCER INSTITUTE [K24CA139052, RC2CA147820, P30CA015704, T32CA080416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES017385] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David & Rosalind Bloom Fund; Michael W. Piepkorn Endowment; MCC Patient Gift Fund at the University of Washington(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by American Cancer Society grant RSG-08-115- 01-CCE, NIH RC2CA147820 and NIH K24 CA139052-0 to PN, and NIH T32 CA80416-10 and F30ES017385 to KP, ULRR025014 to UW CTSA, TL1RR025016 to AT, the David & Rosalind Bloom Fund, the Michael W. Piepkorn Endowment, and the MCC Patient Gift Fund at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAJETTA E, 1993, CANCER, V72, P3099, DOI 10.1002/1097-0142(19931115)72:10<3099::AID-CNCR2820721035>3.0.CO;2-4; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Bir AS, 2009, ANTICANCER RES, V29, P465; Burack J, 2003, J ROY SOC MED, V96, P238, DOI 10.1258/jrsm.96.5.238; Busam KJ, 2009, AM J SURG PATHOL, V33, P1378, DOI 10.1097/PAS.0b013e3181aa30a5; Ciudad C, 2010, DERMATOL SURG, V36, P687, DOI 10.1111/j.1524-4725.2010.01531.x; COLE WH, 1981, J SURG ONCOL, V17, P201, DOI 10.1002/jso.2930170302; Connelly TJ, 1997, DERMATOL SURG, V23, P588, DOI 10.1111/j.1524-4725.1997.tb00695.x; Connelly T, 2009, DERMATOL SURG, V35, P721, DOI 10.1111/j.1524-4725.2009.01122.x; DUNCAN WC, 1993, J AM ACAD DERMATOL, V29, P653, DOI 10.1016/S0190-9622(08)81877-4; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Val-Bernal JF, 2011, ADV ANAT PATHOL, V18, P174, DOI 10.1097/PAP.0b013e31820ce11f; Flanagan K, 2004, CELL IMMUNOL, V231, P75, DOI 10.1016/j.cellimm.2004.12.006; Friedlaender MM, 2002, TRANSPLANTATION, V73, P1849, DOI 10.1097/00007890-200206150-00028; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Harimoto N, 2011, SURG TODAY; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Isobe Midori, 2009, Cancer Immun, V9, P8; Iwatani T, 2011, J CLIN ONCOL, V29, pE113, DOI 10.1200/JCO.2010.31.2801; Iyer JG, 2011, CLIN CANCER RES, V17, P6671, DOI 10.1158/1078-0432.CCR-11-1513; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; KAYASHIMA K, 1991, ARCH DERMATOL, V127, P550, DOI 10.1001/archderm.127.4.550; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Lemos BD, 2010, J AM ACAD DERMATOL, V63, P751, DOI 10.1016/j.jaad.2010.02.056; Lim Rebecca, 2009, Cases J, V2, P7769, DOI 10.4076/1757-1626-2-7769; MA C, 2010, MERKEL CELL CARCINOM, P315; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Melichar B, 2009, ACTA ONCOL, V48, P925, DOI 10.1080/02841860902882451; Mizuno T, 2011, CHEST, V140, P527, DOI 10.1378/chest.10-2564; Mori Y, 2001, AM J DERMATOPATH, V23, P16, DOI 10.1097/00000372-200102000-00003; Muirhead R, 2007, CLIN ONCOL-UK, V19, P96, DOI 10.1016/j.clon.2006.10.001; Nagasawa M, 2005, INT J HEMATOL, V82, P456, DOI 10.1532/IJH97.05091; Naito Y, 1998, CANCER RES, V58, P3491; Nakajima H, 2009, J DERMATOL SCI, V56, P210, DOI 10.1016/j.jdermsci.2009.07.013; OROURKE MGE, 1986, J DERMATOL SURG ONC, V12, P994, DOI 10.1111/j.1524-4725.1986.tb02143.x; Oya M, 2009, PATHOL INT, V59, P664, DOI 10.1111/j.1440-1827.2009.02424.x; Paulson KG, 2010, J CLIN ONCOL; Penn I, 1999, TRANSPLANTATION, V68, P1717, DOI 10.1097/00007890-199912150-00015; Pique-Duran Enric, 2011, Dermatol Online J, V17, P4; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schrama D, 2011, J INVEST DERMATOL; Schumacher K, 2001, CANCER RES, V61, P3932; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Sihto H, 2012, CLIN CANCER RES, V18, P2872, DOI 10.1158/1078-0432.CCR-11-3020; Sihto H, 2011, CLIN CANCER RES, V17, P4806, DOI 10.1158/1078-0432.CCR-10-3363; Titu LV, 2002, CANCER IMMUNOL IMMUN, V51, P235, DOI 10.1007/s00262-002-0276-4; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; Uenishi T, 2000, SURG TODAY, V30, P82, DOI 10.1007/PL00010054; Vesely MJJ, 2008, J PLAST RECONSTR AES, V61, P165, DOI 10.1016/j.bjps.2006.10.020; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2003, CANCER RES, V63, P4225	55	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41465	10.1371/journal.pone.0041465	http://dx.doi.org/10.1371/journal.pone.0041465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859987	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600028
J	Lailson-Brito, J; Cruz, R; Dorneles, PR; Andrade, L; Azevedo, AD; Fragoso, AB; Vidal, LG; Costa, MB; Bisi, TL; Almeida, R; Carvalho, DP; Bastos, WR; Malm, O				Lailson-Brito, Jose; Cruz, Renato; Dorneles, Paulo Renato; Andrade, Leonardo; Azevedo, Alexandre de Freitas; Fragoso, Ana Bernadete; Vidal, Lara Gama; Costa, Marianna Badini; Bisi, Tatiana Lemos; Almeida, Ronaldo; Carvalho, Dario Pires; Bastos, Wanderley Rodrigues; Malm, Olaf			Mercury-Selenium Relationships in Liver of Guiana Dolphin: The Possible Role of Kupffer Cells in the Detoxification Process by Tiemannite Formation	PLOS ONE			English	Article							WHALES DELPHINAPTERUS-LEUCAS; HEAVY-METALS; MARINE MAMMALS; BRAZILIAN COAST; STENELLA-COERULEOALBA; METHYL-MERCURY; SOTALIA-GUIANENSIS; ORGANIC MERCURY; TRACE-ELEMENTS; RINGED SEALS	Top marine predators present high mercury concentrations in their tissues as consequence of biomagnification of the most toxic form of this metal, methylmercury (MeHg). The present study concerns mercury accumulation by Guiana dolphins (Sotalia guianensis), highlighting the selenium-mediated methylmercury detoxification process. Liver samples from 19 dolphins incidentally captured within Guanabara Bay (Rio de Janeiro State, Brazil) from 1994 to 2006 were analyzed for total mercury (THg), methylmercury (MeHg), total organic mercury (TOrgHg) and selenium (Se). X-ray microanalyses were also performed. The specimens, including from fetuses to 30-year-old dolphins, comprising 8 females and 11 males, presented high THg (0.53-132 mg/g wet wt.) and Se concentrations (0.17-74.8 mg/g wet wt.). Correlations between THg, MeHg, TOrgHg and Se were verified with age (p < 0.05), as well as a high and positive correlation was observed between molar concentrations of Hg and Se (p < 0.05). Negative correlations were observed between THg and the percentage of MeHg contribution to THg (p < 0.05), which represents a consequence of the selenium-mediated methylmercury detoxification process. Accumulation of Se-Hg amorphous crystals in Kupffer Cells was demonstrated through ultra-structural analysis, which shows that Guiana dolphin is capable of carrying out the demethylation process via mercury selenide formation.	[Lailson-Brito, Jose; Dorneles, Paulo Renato; Azevedo, Alexandre de Freitas; Fragoso, Ana Bernadete; Vidal, Lara Gama; Bisi, Tatiana Lemos] Univ Estado Rio De Janeiro, Fac Oceanog, Lab Mamiferos Aquat & Bioindicadores Profa Izabel, Rio De Janeiro, Brazil; [Lailson-Brito, Jose; Dorneles, Paulo Renato; Costa, Marianna Badini; Malm, Olaf] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Radioisotopos Eduardo Penna Franca, Rio de Janeiro, Brazil; [Cruz, Renato] UFF, Dept Biol Celular & Mol, Rio De Janeiro, Brazil; [Andrade, Leonardo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, Brazil; [Fragoso, Ana Bernadete] Univ Estado Rio Grande do Norte UERN, Inst Ciencias Exatas & Nat, Mossoro, RN, Brazil; [Almeida, Ronaldo; Carvalho, Dario Pires; Bastos, Wanderley Rodrigues] Univ Fed Rondonia UNIR, Lab Biogeoquim Ambiental, Porto Velho, Rondonia, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio Grande do Norte (UERN); Universidade Federal de Rondonia	Lailson-Brito, J (corresponding author), Univ Estado Rio De Janeiro, Fac Oceanog, Lab Mamiferos Aquat & Bioindicadores Profa Izabel, Rio De Janeiro, Brazil.	lailson@uerj.br	Almeida, ronaldo/AFN-6168-2022; Malm, Olaf/H-1724-2012; Bastos, Wanderley/AAQ-5875-2020; AZEVEDO, ALEXANDRE/HII-5648-2022; Bisi, Tatiana L/B-1330-2014; de Almeida, Ronaldo/K-7658-2012; Brito, Jose Lailson/B-3572-2013; Azevedo, Alexandre/B-9660-2013; Andrade, Leonardo/C-9554-2011; Dorneles, Paulo R/M-2049-2013; Bastos, Wanderley R/E-9856-2013	Almeida, ronaldo/0000-0001-5666-2909; Bisi, Tatiana L/0000-0003-3480-6697; Brito, Jose Lailson/0000-0001-8366-458X; Azevedo, Alexandre/0000-0002-3754-9035; Andrade, Leonardo/0000-0002-0004-5677; Malm, Olaf/0000-0002-4116-7160; Bastos, Wanderley/0000-0002-2105-9947; Dorneles, Paulo/0000-0003-0296-739X	Brazilian Research Council - CNPq [482938/2007-2]; Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio'' Program) [E-26/110.371/2007]; Ministry of Education of Brazil - CAPES (Ciencias do Mar) [09/2009]; Society for Marine Mammalogy; CAPES; FAPERJ/UERJ ("Prociencia'' Program); FAPERJ/UERJ (JCNE) [E- 26/103.247/2011]; CNPq [305303/2010-4, 304826/2008-1]; FAPERJ (JCNE) [101.449/2010]; FAPERJ (CNE)	Brazilian Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio'' Program)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Education of Brazil - CAPES (Ciencias do Mar); Society for Marine Mammalogy; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ/UERJ ("Prociencia'' Program); FAPERJ/UERJ (JCNE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (JCNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ (CNE)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by Brazilian Research Council - CNPq (Edital Universal - grant #482938/2007-2), by Rio de Janeiro State Government Research Agency - FAPERJ ("Pensa Rio'' Program, grant #E-26/110.371/2007), by the Ministry of Education of Brazil - CAPES (Ciencias do Mar no 09/2009) and by Society for Marine Mammalogy. LB-J had a scholarship from CAPES and has a research grant from FAPERJ/UERJ ("Prociencia'' Program and JCNE # E- 26/103.247/2011) and from CNPq (grant # 305303/2010-4). AFA has a research grant from CNPq (grant # 304826/2008-1) and from FAPERJ (JCNE # 101.449/2010). OM has a research grant from CNPq and from FAPERJ (CNE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE JM, 1990, MAR ENVIRON RES, V30, P43, DOI 10.1016/0141-1136(90)90010-L; [Anonymous], 2001, 1630 EPA; AUGIER H, 1993, CELL MOL BIOL, V39, P621; Azevedo A.F., 2004, J CETACEAN RES MANAG, V6, P265; Azevedo Alexandre F., 2009, Marine Biodiversity Records, V2, pe22, DOI 10.1017/S1755267208000262; Bennett PM, 2001, ENVIRON POLLUT, V112, P33, DOI 10.1016/S0269-7491(00)00105-6; Betti C, 1996, MAR POLLUT BULL, V32, P545, DOI 10.1016/0025-326X(96)84573-5; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; BORN EW, 1981, ARCTIC, V34, P255; Cardellicchio N, 2002, ENVIRON POLLUT, V116, P265, DOI 10.1016/S0269-7491(01)00127-0; Caurant F, 1996, SCI TOTAL ENVIRON, V186, P95, DOI 10.1016/0048-9697(96)05087-5; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; Das K, 2003, MAR ENVIRON RES, V56, P349, DOI 10.1016/S0141-1136(02)00308-2; Das K, 2003, N P TOX ENV, P135; DeGuise S, 1996, ENVIRON TOXICOL CHEM, V15, P1357, DOI 10.1002/etc.5620150815; DIETZ R, 1991, SARSIA, V76, P17, DOI 10.1080/00364827.1991.10413461; DIETZ R, 1990, SCI TOTAL ENVIRON, V95, P41, DOI 10.1016/0048-9697(90)90051-U; Dorneles PR, 2008, ENVIRON SCI TECHNOL, V42, P5368, DOI 10.1021/es800702k; Dorneles PR, 2010, ENVIRON INT, V36, P60, DOI 10.1016/j.envint.2009.10.001; Dorneles PR, 2008, ENVIRON POLLUT, V156, P1268, DOI 10.1016/j.envpol.2008.03.007; Dufresne MM, 2010, MAR POLLUT BULL, V60, P344, DOI 10.1016/j.marpolbul.2009.10.019; Flanagan PR, 1978, GASTROENTEROLOGY, P74; Flores PAC, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1188; Frouin H, 2012, AQUAT TOXICOL, V109, P185, DOI 10.1016/j.aquatox.2011.09.021; Habran S, 2011, ENVIRON POLLUT, V159, P2523, DOI 10.1016/j.envpol.2011.06.019; HONDA K, 1982, AGR BIOL CHEM TOKYO, V46, P3011, DOI 10.1080/00021369.1982.10865534; ITANO K, 1984, AGR BIOL CHEM TOKYO, V48, P1109, DOI 10.1080/00021369.1984.10866282; JICA, 1992, STUD REC GUAN BAY EC; JULSHAMN K, 1987, SCI TOTAL ENVIRON, V65, P53, DOI 10.1016/0048-9697(87)90160-4; Khan MAK, 2010, CHEM RES TOXICOL, V23, P1202, DOI 10.1021/tx100080s; KOEMAN J H, 1975, Science of the Total Environment, V3, P279, DOI 10.1016/0048-9697(75)90052-2; Koeman J. H., 1972, TNO-Nieuws, V27, P570; KOEMAN JH, 1973, NATURE, V245, P385, DOI 10.1038/245385a0; Kunito T, 2004, MAR POLLUT BULL, V49, P574, DOI 10.1016/j.marpolbul.2004.03.009; Lacerda L.D., 1983, TROPICAL ECOLOGY, V24, P162; Lacerda LD, 1994, BIBLIOGRAFIA CONTAMI; Lailson-Brito J, 2010, ENVIRON POLLUT, V158, P1800, DOI 10.1016/j.envpol.2009.11.002; Lemes M, 2011, ENVIRON TOXICOL CHEM, V30, P2732, DOI 10.1002/etc.684; LEONZIO C, 1992, SCI TOTAL ENVIRON, V119, P77, DOI 10.1016/0048-9697(92)90257-S; LIANG L, 1994, CLIN CHEM, V40, P602; Lockhart WL, 2005, SCI TOTAL ENVIRON, V351, P391, DOI 10.1016/j.scitotenv.2005.01.050; Marins RV, 2004, QUIM NOVA, V27, P763, DOI 10.1590/S0100-40422004000500016; MARTOJA R, 1977, CR ACAD SCI D NAT, V285, P109; Martoja R., 1980, VIE MILIEU LIFE ENV, V30, P7; Mason A. Z., 1995, METAL SPECIATION BIO, P479; Monteiro-Neto C, 2003, ENVIRON POLLUT, V123, P319, DOI 10.1016/S0269-7491(02)00371-8; Nigro M, 1996, MAR ECOL PROG SER, V135, P137, DOI 10.3354/meps135137; O'Shea Thomas J., 1999, P485; PALMISANO F, 1995, MAR ENVIRON RES, V40, P109, DOI 10.1016/0141-1136(94)00142-C; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Pfeiffer WC, 1987, HEAVY METALS POLLUTI; RAWSON AJ, 1993, ECOTOX ENVIRON SAFE, V25, P41, DOI 10.1006/eesa.1993.1005; RAWSON AJ, 1995, ECOTOX ENVIRON SAFE, V30, P309, DOI 10.1006/eesa.1995.1035; REBELLO A D L, 1988, Anais da Academia Brasileira de Ciencias, V60, P419; Renzoni A, 1998, ENVIRON RES, V77, P68, DOI 10.1006/enrs.1998.3832; RONALD K, 1977, Science of the Total Environment, V8, P1, DOI 10.1016/0048-9697(77)90057-2; Seixas TG, 2006, J BRAZILIAN SOC ECOT, V1, P21; Siebert U, 1999, MAR POLLUT BULL, V38, P285, DOI 10.1016/S0025-326X(98)00147-7; Taylor VF, 2011, ANAL METHODS-UK, V3, P1143, DOI 10.1039/c0ay00528b; UTHE JF, 1972, J ASSOC OFF ANA CHEM, V55, P583; VANDEVEN WSM, 1979, CHEMOSPHERE, V8, P539, DOI 10.1016/0045-6535(79)90101-2; Wagemann R, 2000, SCI TOTAL ENVIRON, V261, P21, DOI 10.1016/S0048-9697(00)00592-1; Wagemann R, 1998, SCI TOTAL ENVIRON, V218, P19, DOI 10.1016/S0048-9697(98)00192-2; Wagemann R, 1996, SCI TOTAL ENVIRON, V186, P41, DOI 10.1016/0048-9697(96)05085-1; WAGEMANN R, 1988, MAR MAMMAL SCI, V4, P339, DOI 10.1111/j.1748-7692.1988.tb00542.x; Wagemann R, 1997, ENVIRON TOXICOL CHEM, V16, P1859, DOI 10.1002/etc.5620160914; Wagemann R., 1984, CAN TECH REP FISH AQ, V1279, P1	67	74	76	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42162	10.1371/journal.pone.0042162	http://dx.doi.org/10.1371/journal.pone.0042162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860072	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600065
J	Laksanalamai, P; Joseph, LA; Silk, BJ; Burall, LS; Tarr, CL; Gerner-Smidt, P; Datta, AR				Laksanalamai, Pongpan; Joseph, Lavin A.; Silk, Benjamin J.; Burall, Laurel S.; Tarr, Cheryl L.; Gerner-Smidt, Peter; Datta, Atin R.			Genomic Characterization of Listeria monocytogenes Strains Involved in a Multistate Listeriosis Outbreak Associated with Cantaloupe in US	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; UNITED-STATES; ESCHERICHIA-COLI; PULSENET; MEAT; DIVERSITY; ENVIRONMENT; EVOLUTION; INFECTION; PROTOCOL	A multistate listeriosis outbreak associated with cantaloupe consumption was reported in the United States in September, 2011. The outbreak investigation recorded a total of 146 invasive illnesses, 30 deaths and one miscarriage. Subtyping of the outbreak associated clinical, food and environmental isolates revealed two serotypes (1/2a and 1/2b) and four pulsed-field gel electrophoresis two-enzyme pattern combinations I, II, III, and IV, including one rarely seen before this outbreak. A DNA-microarray, Listeria GeneChip (R), developed by FDA from 24 Listeria monocytogenes genome sequences, was used to further characterize a representative sample of the outbreak isolates. The microarray data ( in the form of present or absent calls of specific DNA sequences) separated the isolates into two distinct groups as per their serotypes. The gene content of the outbreak-associated isolates was distinct from that of the previously-reported outbreak strains belonging to the same serotypes. Although the 1/2b outbreak associated isolates are closely related to each other, the 1/2a isolates could be further divided into two distinct genomic groups, one represented by pattern combination I strains and the other represented by highly similar pattern combinations III and IV strains. Gene content analysis of these groups revealed unique genomic sequences associated with these two 1/2a genovars. This work underscores the utility of multiple approaches, such as serotyping, PFGE and DNA microarray analysis to characterize the composition of complex polyclonal listeriosis outbreaks.	[Laksanalamai, Pongpan; Burall, Laurel S.; Datta, Atin R.] FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Joseph, Lavin A.; Silk, Benjamin J.; Tarr, Cheryl L.; Gerner-Smidt, Peter] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Laksanalamai, P (corresponding author), FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA.	Atin.datta@fda.hhs.gov						Abu-Ali GS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-296; Affymetrix, 2005, AFF GENECHIP EXPR AN; Affymetrix, 2002, STAT ALG DESCR DOC; [Anonymous], 2011, INFORM RECALLED JENS; [Anonymous], 2011, LISTERIOSIS LISTERIA; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruno JC, 2011, FEMS MICROBIOL LETT, V323, P171, DOI 10.1111/j.1574-6968.2011.02373.x; Burall LS, 2011, J FOOD PROTECT, V74, P403, DOI 10.4315/0362-028X.JFP-10-355; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Cheng Ying, 2008, P337, DOI 10.1201/9781420051414.ch11; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Datta A. R., 2003, International handbook of foodborne pathogens, P105; FLEMING DW, 1985, NEW ENGL J MED, V312, P404, DOI 10.1056/NEJM198502143120704; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Graves LM, 2001, INT J FOOD MICROBIOL, V65, P55, DOI 10.1016/S0168-1605(00)00501-8; Halpin JL, 2010, FOODBORNE PATHOG DIS, V7, P293, DOI 10.1089/fpd.2009.0394; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iturriaga MH, 2002, J FOOD PROTECT, V65, P1745, DOI 10.4315/0362-028X-65.11.1745; Jackson SA, 2007, FORENSIC SCI INT, V168, P183, DOI 10.1016/j.forsciint.2006.06.079; Jackson SA, 2012, APPL ENVIRON MICROB, V78, P1601, DOI 10.1128/AEM.07464-11; Jackson SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-349; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Kathariou S, 2006, FOODBORNE PATHOG DIS, V3, P292, DOI 10.1089/fpd.2006.3.292; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032896; Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Mellin JR, 2012, RNA BIOL, V9, P372, DOI 10.4161/rna.19235; Norton D. M., 2007, LISTERIA LISTERIOSIS, P305; O'Connor L, 2010, LETT APPL MICROBIOL, V51, P490, DOI 10.1111/j.1472-765X.2010.02928.x; Ooi ST, 2005, CLIN INFECT DIS, V40, P1327, DOI 10.1086/429324; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Pan YW, 2009, APPL ENVIRON MICROB, V75, P5846, DOI 10.1128/AEM.00816-09; Reina LD, 2002, J FOOD PROTECT, V65, P1881, DOI 10.4315/0362-028X-65.12.1881; Revazishvili T, 2004, J CLIN MICROBIOL, V42, P276, DOI 10.1128/JCM.42.1.276-285.2004; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schuppler M, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/704321; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Verghese B, 2011, APPL ENVIRON MICROB, V77, P3279, DOI 10.1128/AEM.00546-11; Voidarou C, 2011, ANAEROBE, V17, P341, DOI 10.1016/j.anaerobe.2011.05.018; Wagner Martin, 2008, P3, DOI 10.1201/9781420051414.ch1	48	95	98	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42448	10.1371/journal.pone.0042448	http://dx.doi.org/10.1371/journal.pone.0042448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860127	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600101
J	Miralles, M; Segura, MM; Puig, M; Bosch, A; Chillon, M				Miralles, Marta; Mercedes Segura, Maria; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel			Efficient Amplification of Chimeric Adenovirus 5/40S Vectors Carrying the Short Fiber Protein of Ad40 in Suspension Cell Cultures	PLOS ONE			English	Article							GENE-TRANSFER; ENTERIC ADENOVIRUS-40; IN-VITRO; TYPE-40; TRANSDUCTION; RECEPTOR; POLYCATIONS; TROPISM; GROWTH; VIRUS	The human adenovirus 40 (Ad40) is a promising tool for gene therapy of intestinal diseases. Since the production of Ad40 in vitro is extremely inefficient, chimeric Adenovirus 5/40S vectors carrying the Ad40 short fiber on the Ad5 capsid have been developed. However, Ad5/40S productivity is low. We hypothesized that low productivity was a result of inefficient viral entry into producer cells during amplification. To this end, we have developed a production strategy based on using 211B cells (expressing Ad5 fiber) during amplification steps, while Ad5/40S infectivity is further improved by adding polybrene during infections. In addition, the optimal harvesting time was determined by evaluating the Ad5/40S viral cycle. The developed production strategy significantly reduces the number of amplification cycles and duration of the process. Finally, to further facilitate Ad5/40S production, 211B cells were adapted to suspension thus allowing to easily upscale the production process in bioreactors.	[Miralles, Marta; Mercedes Segura, Maria; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain; [Miralles, Marta; Mercedes Segura, Maria; Puig, Meritxell; Bosch, Assumpcio; Chillon, Miguel] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Chillon, Miguel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA	Miralles, M (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain.	miguel.chillon@uab.es	Bosch, Assumpcio/C-7593-2015; Chillon, Miguel/A-2466-2009	Bosch, Assumpcio/0000-0002-7205-2796; Chillon, Miguel/0000-0003-0840-2111	Association Francaise contre les Myopathies (AFM) [12277]; FPU fellowship from Ministerio de Educacion de Espana [AP2007-01563];  [ISCIII-PI081162];  [ISCIII-PI10-00561];  [SGR2009-1300]; ICREA Funding Source: Custom	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); FPU fellowship from Ministerio de Educacion de Espana; ; ; ; ICREA(ICREA)	This work was supported by ISCIII-PI081162 and ISCIII-PI10-00561, SGR2009-1300 and Association Francaise contre les Myopathies (AFM#12277). M. M. is a recipient of an FPU fellowship from the Ministerio de Educacion de Espana (AP2007-01563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2007, VIROLOGY, V367, P51, DOI 10.1016/j.virol.2007.05.014; Arcasoy SM, 1997, GENE THER, V4, P32, DOI 10.1038/sj.gt.3300349; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BROWN M, 1984, J CLIN MICROBIOL, V20, P334, DOI 10.1128/JCM.20.3.334-338.1984; BROWN M, 1992, J VIROL, V66, P3198, DOI 10.1128/JVI.66.5.3198-3205.1992; Chillon M, 2011, METHODS MOL BIOL, V737, P117, DOI 10.1007/978-1-61779-095-9_5; Clark PR, 1999, CANCER GENE THER, V6, P437, DOI 10.1038/sj.cgt.7700074; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; Doronin K, 2003, VIROLOGY, V305, P378, DOI 10.1006/viro.2002.1772; Gall J, 1996, J VIROL, V70, P2116, DOI 10.1128/JVI.70.4.2116-2123.1996; Geisse S, 2005, ANIMAL CELL TECHNOLOGY MEETS GENOMICS, P373; HASHIMOTO S, 1991, J VIROL, V65, P2429, DOI 10.1128/JVI.65.5.2429-2435.1991; Jacobsen F, 2006, J GENE MED, V8, P138, DOI 10.1002/jgm.843; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; Kaplan JM, 1998, HUM GENE THER, V9, P1469, DOI 10.1089/hum.1998.9.10-1469; Kesisoglou F, 2005, MOL PHARMACEUT, V2, P500, DOI 10.1021/mp0498897; KIDD AH, 1993, VIROLOGY, V192, P73, DOI 10.1006/viro.1993.1009; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Lu ZZ, 2009, J GENE MED, V11, P128, DOI 10.1002/jgm.1284; Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003; Nicol CG, 2004, MOL THER, V10, P344, DOI 10.1016/j.ymthe.2004.05.020; Rodriguez E, 2006, MOL THER, V13, pS5, DOI 10.1016/j.ymthe.2006.08.023; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Schoelm G, 2008, J VIROL, V82, P3192, DOI 10.1128/JVI.02393-07; Schoggins JW, 2005, J VIROL, V79, P11627, DOI 10.1128/JVI.79.18.11627-11637.2005; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Seiradake E, 2005, J VIROL, V79, P14088, DOI 10.1128/JVI.79.22.14088-14094.2005; Sherwood V, 2007, J GEN VIROL, V88, P71, DOI 10.1099/vir.0.82445-0; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; TIEMESSEN CT, 1995, J GEN VIROL, V76, P481, DOI 10.1099/0022-1317-76-3-481; TIEMESSEN CT, 1994, J VIROL, V68, P1239, DOI 10.1128/JVI.68.2.1239-1244.1994; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984; Von Seggern DJ, 1998, J GEN VIROL, V79, P1461, DOI 10.1099/0022-1317-79-6-1461; Von Seggern DJ, 2000, J VIROL, V74, P354, DOI 10.1128/JVI.74.1.354-362.2000; Wang C, 2008, EXPERT OPIN DRUG DEL, V5, P385, DOI 10.1517/17425247.5.4.385 ; Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; Zabner J, 1999, J VIROL, V73, P8689, DOI 10.1128/JVI.73.10.8689-8695.1999	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42073	10.1371/journal.pone.0042073	http://dx.doi.org/10.1371/journal.pone.0042073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860056	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600058
J	Wang, ZY; Shah, OJ; Hunter, T				Wang, Zhiyong; Shah, O. Jameel; Hunter, Tony			The Transcriptional Coactivators p/CIP and SRC-1 Control Insulin Resistance through IRS1 in Obesity Models	PLOS ONE			English	Article							PPAR-GAMMA; ADIPONECTIN RECEPTORS; ENERGY-BALANCE; MICE; GROWTH; CELL; SENSITIVITY; SUBSTRATE-1; DISRUPTION; EXPRESSION	Three p160 family members, p/CIP, SRC1, and TIF2, have been identified as transcriptional coactivators for nuclear hormone receptors and other transcription factors in vitro. In a previous study, we reported initial characterization of the obesity-resistant phenotypes of p/CIP and SRC-1 double knockout (DKO) mice, which exhibit increased energy expenditure, and suggested that nuclear hormone receptor target genes were involved in these phenotypes. In this study, we demonstrate that p/CIP and SRC1 control insulin signaling in a cell-autonomous manner both in vitro and in vivo. Genetic deletion of p/CIP and SRC-1 increases glucose uptake and enhances insulin sensitivity in both regular chow-and high fat diet-fed DKO mice despite increased food intake. Interestingly, we discover that loss of p/CIP and SRC-1 results in resistance to age-related obesity and glucose intolerance. We show that expression levels of a key insulin signaling component, insulin receptor substrate 1 (IRS1), are significantly increased in two cell lines representing fat and muscle lineages with p/CIP and SRC-1 deletions and in white adipose tissue and skeletal muscle of DKO mice; this may account for increased glucose metabolism and insulin sensitivity. This is the first evidence that the p160 coactivators control insulin signaling and glucose metabolism through IRS1. Therefore, our studies indicate that p/CIP and SRC-1 are potential therapeutic targets not only for obesity but also for diabetes.	[Wang, Zhiyong; Shah, O. Jameel; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Wang, ZY (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zwang@salk.edu; hunter@salk.edu			California Breast Cancer Research Program [7FB-0040]; United States Public Health Service grants from the National Cancer Institute [CA14195, CA82683]; NATIONAL CANCER INSTITUTE [R01CA082683, P30CA014195] Funding Source: NIH RePORTER	California Breast Cancer Research Program; United States Public Health Service grants from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Z.Y.W was supported by a fellowship from California Breast Cancer Research Program (7FB-0040). T.H. is a Frank and Else Schilling American Cancer Society Professor. These studies were supported by United States Public Health Service grants from the National Cancer Institute CA14195 and CA82683 to T. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	28	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e36961	10.1371/journal.pone.0036961	http://dx.doi.org/10.1371/journal.pone.0036961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859932	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600001
J	Cameron, TA; Roper, M; Zambryski, PC				Cameron, Todd A.; Roper, Marcus; Zambryski, Patricia C.			Quantitative Image Analysis and Modeling Indicate the Agrobacterium tumefaciens Type IV Secretion System Is Organized in a Periodic Pattern of Foci	PLOS ONE			English	Article							PROTEIN TRANSLOCATION; DNA TRANSFER; MEMBRANE; FILAMENTS; GROWTH; IDENTIFICATION; MORPHOGENESIS; LOCALIZATION; DIVERSITY; SEQUENCE	The Gram negative plant pathogen Agrobacterium tumefaciens is uniquely capable of genetically transforming eukaryotic host cells during the infection process. DNA and protein substrates are transferred into plant cells via a type IV secretion system (T4SS), which forms large cell-envelope spanning complexes at multiple sites around the bacterial circumference. To gain a detailed understanding of T4SS positioning, the spatial distribution of fluorescently labeled T4SS components was quantitatively assessed to distinguish between random and structured localization processes. Through deconvolution microscopy followed by Fourier analysis and modeling, T4SS foci were found to localize in a non-random periodic pattern. These results indicate that T4SS complexes are dependent on an underlying scaffold or assembly process to obtain an organized distribution suitable for effective delivery of substrates into host cells.	[Cameron, Todd A.; Zambryski, Patricia C.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Roper, Marcus] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Cameron, TA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	zambrysk@berkeley.edu		Roper, Marcus/0000-0001-8756-0112; Cameron, Todd/0000-0002-6608-6551	NSF [MCB-0343566]; Miller Institute for Basic Research in Sciences; Div Of Molecular and Cellular Bioscience [0923840] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Sciences; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	TC and PZ were supported by NSF (http://www.nsf.gov) grant MCB-0343566. MR was supported by a fellowship from the Miller Institute for Basic Research in Sciences (http://millerinstitute.berkeley.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AKIYOSHI DE, 1983, P NATL ACAD SCI-BIOL, V80, P407, DOI 10.1073/pnas.80.2.407; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Brown PJB, 2011, SEMIN CELL DEV BIOL, V22, P790, DOI 10.1016/j.semcdb.2011.06.006; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; Chandran V, 2009, NATURE; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Foulquier E, 2011, MOL MICROBIOL, V80, P309, DOI 10.1111/j.1365-2958.2011.07587.x; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Judd PK, 2005, P NATL ACAD SCI USA, V102, P11498, DOI 10.1073/pnas.0505290102; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Perez-Nunez D, 2011, MOL MICROBIOL, V79, P759, DOI 10.1111/j.1365-2958.2010.07483.x; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Rasband W., 2006, IMAGEJ; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; STACHEL SE, 1986, P NATL ACAD SCI USA, V83, P379, DOI 10.1073/pnas.83.2.379; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; Swulius MT, 2011, BIOCHEM BIOPH RES CO, V407, P650, DOI 10.1016/j.bbrc.2011.03.062; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; THOMASHOW MF, 1986, SCIENCE, V231, P616, DOI 10.1126/science.3511528; THOMPSON J, 1992, RES MICROBIOL, V143, P127, DOI 10.1016/0923-2508(92)90001-5; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; VERNADE D, 1988, J BACTERIOL, V170, P5822, DOI 10.1128/jb.170.12.5822-5829.1988; Wang S, 2012, P NATL ACAD SCI USA, V109, pE595, DOI 10.1073/pnas.1117132109; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; Zupan J, 2007, J BACTERIOL, V189, P6551, DOI 10.1128/JB.00480-07	50	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42219	10.1371/journal.pone.0042219	http://dx.doi.org/10.1371/journal.pone.0042219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860087	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900079
J	Johannesson, TG; Sogaard, OS; Tolstrup, M; Petersen, MS; Bernth-Jensen, JM; Ostergaard, L; Erikstrup, C				Johannesson, Thomas G.; Sogaard, Ole S.; Tolstrup, Martin; Petersen, Mikkel S.; Bernth-Jensen, Jens M.; Ostergaard, Lars; Erikstrup, Christian			The Impact of B-Cell Perturbations on Pneumococcal Conjugate Vaccine Response in HIV-Infected Adults	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; STREPTOCOCCUS-PNEUMONIAE; RISK-FACTORS; DISEASE; MEMORY; IMMUNODEFICIENCY; INDIVIDUALS; ANTIBODIES; COHORT; ASSAYS	Untreated HIV infection results in severe perturbations of the B-cell population and hyporesponsiveness to vaccination. We studied associations between circulating B-cell subsets and antibody response to pneumococcal conjugate vaccine in treated and untreated HIV patients. Ninety-five HIV-infected adults were grouped according to antiretroviral therapy (ART) and CD4+ cell count as follows: 20 ART-naive (no prior ART), 62 ART-responders (received ART, and CD4 count >500 cells/mu l), and 13 impaired responders (received ART for more than 3 years, and CD4 count <500 cells/mu l). All subjects were immunized twice with double-dose 7-valent pneumococcal conjugate vaccine with or without 1 mg CPG 7909 (toll-like receptor 9 agonist) at baseline and after three months. Pre-vaccination B-cell subpopulations were assessed by flow cytometry. Serum IgG concentrations for vaccine serotypes were quantified by ELISA at baseline and 3, 4, and 9 months post-vaccination. ART responders had more isotype-switched memory B cells and more marginal-zone (MZ)-like B cells compared with impaired responders. Furthermore, ART-naive patients had higher concentration of transitional B cells and plasmablasts compared with B cells of other patient groups. The concentration of MZ-like, isotype switched memory cells and plasmablasts correlated positively with post-vaccination IgG concentration at 3, 4, and 9 months. Low concentrations of isotype-switched memory B cells was the strongest independent predictor of poor pneumococcal conjugate vaccine responsiveness, emphasizing that B-cell subset disturbances are associated with poor vaccine response among HIV-infected patients	[Johannesson, Thomas G.; Sogaard, Ole S.; Tolstrup, Martin; Ostergaard, Lars] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Johannesson, Thomas G.; Petersen, Mikkel S.; Bernth-Jensen, Jens M.; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Johannesson, TG (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.	tgjohannesson@gmail.com	Ostergaard, Lars/AAA-3020-2020; Hjelholt, Thomas/AAL-2056-2021; Søgaard, Ole S/P-6058-2016; Hjelholt, Thomas Johannesson/AAQ-3614-2020; Bernth-Jensen, Jens Magnus/H-6694-2019; Søgaard, Ole Schmeltz/AEP-7968-2022	Ostergaard, Lars/0000-0003-2459-0511; Hjelholt, Thomas/0000-0003-0112-5801; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Tolstrup, Martin/0000-0001-7020-5173; Bernth Jensen, Jens Magnus/0000-0002-5004-7822; Erikstrup, Christian/0000-0001-6551-6647; Ostergaard, Lars/0000-0002-7619-605X	Aarhus University; Danish Council for Independent Research \ Medical Sciences; Scandinavian Society for Antimicrobial Chemotherapy; Aase and Ejnar Danielsen's Foundation	Aarhus University; Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF)); Scandinavian Society for Antimicrobial Chemotherapy; Aase and Ejnar Danielsen's Foundation	Grant support was provided by Aarhus University, The Danish Council for Independent Research vertical bar Medical Sciences, Scandinavian Society for Antimicrobial Chemotherapy, and Aase and Ejnar Danielsen's Foundation. Coley Pharmaceutical Group (now part of Pfizer) provided CPG 7909 for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry PM, 2006, AIDS, V20, P437, DOI 10.1097/01.aids.0000206507.54901.84; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Crum-Cianflone NF, 2010, J INFECT DIS, V202, P1114, DOI 10.1086/656147; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Falco V, 2006, VACCINE, V24, P2567, DOI 10.1016/j.vaccine.2005.12.021; Fournier AM, 2002, AIDS, V16, P1755, DOI 10.1097/00002030-200209060-00007; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; KONRADSEN HB, 1993, J IMMUNOL METHODS, V164, P13, DOI 10.1016/0022-1759(93)90270-H; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Madhi SA, 2009, J INFECT DIS, V199, P1168, DOI 10.1086/597388; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Martinez JE, 2006, CLIN VACCINE IMMUNOL, V13, P459, DOI 10.1128/CVI.13.4.459-466.2006; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Rabian C, 2010, CLIN INFECT DIS, V50, P1174, DOI 10.1086/651418; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Shen X, 2010, CURR HIV AIDS REP; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Sogaard OS, 2010, AIDS, V24, P1315, DOI 10.1097/QAD.0b013e328339fe0b; Subramaniam KS, 2003, J INFECT DIS, V187, P758, DOI 10.1086/368331; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346	32	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42307	10.1371/journal.pone.0042307	http://dx.doi.org/10.1371/journal.pone.0042307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860110	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900088
J	Zeng, XY; Wang, YP; Cantley, J; Iseli, TJ; Molero, JC; Hegarty, BD; Kraegen, EW; Ye, Y; Ye, JM				Zeng, Xiao-Yi; Wang, Yi-Ping; Cantley, James; Iseli, Tristan J.; Molero, Juan Carlos; Hegarty, Bronwyn D.; Kraegen, Edward W.; Ye, Yang; Ye, Ji-Ming			Oleanolic Acid Reduces Hyperglycemia beyond Treatment Period with Akt/FoxO1-Induced Suppression of Hepatic Gluconeogenesis in Type-2 Diabetic Mice	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; FAT-FED RATS; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; SMALL-MOLECULE; URSOLIC ACID; BETA-CELLS; OBESITY; DIET	The present study investigated the chronic efficacy of oleanolic acid (OA), a triterpenoid selected from our recent screening, on hyperglycemia in type-2 diabetic mice. C57BL/6J mice were fed a high-fat diet followed by low doses of streptozotocin to generate a type-2 diabetic model. OA (100 mg/kg/day) was administered orally for 2 weeks with its effects monitored for 6 weeks. High-fat feeding and streptozotocin generated a steady hyperglycemia (21.2 +/- 1.1 mM) but OA administration reversed the hyperglycemia by similar to 60%. Interestingly, after the cessation of OA administration, the reversed hyperglycemia was sustained for the entire post-treatment period of the study (4 weeks) despite the reoccurrence of dyslipidemia. Examination of insulin secretion and pancreas morphology did not indicate improved beta-cell function as a likely mechanism. Urine glucose loss was decreased with substantial improvement of diabetic nephropathy after the OA treatment. Pair-feeding the OA-treated mice to an untreated group ruled out food intake as a main factor attributable for this sustained reduction in hyperglycemia. Studies with the use of glucose tracers revealed no increase in glucose influx into muscle, adipose tissue or liver in the OA-treated mice. Finally, we analyzed key regulators of gluconeogenesis in the liver and found significant increases in the phosphorylation of both Akt and FoxO1 after treatment with OA. Importantly, these increases were significantly correlated with a down-regulation of glucose-6-phosphatase expression. Our findings suggest triterpenoids are a potential source of new efficacious drugs for sustained control of hyperglycemia. The liver appears to be a major site of action, possibly by the suppression of hepatic glucose production via the Akt/FoxO1 axis.	[Zeng, Xiao-Yi; Wang, Yi-Ping; Molero, Juan Carlos; Ye, Ji-Ming] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Zeng, Xiao-Yi; Wang, Yi-Ping; Molero, Juan Carlos; Ye, Ji-Ming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Cantley, James; Iseli, Tristan J.; Hegarty, Bronwyn D.; Kraegen, Edward W.; Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia; [Ye, Yang; Ye, Ji-Ming] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Garvan Institute of Medical Research; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zeng, XY (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.	jiming.ye@rmit.edu.au		Zeng, Xiaoyi/0000-0002-0102-0367; Cantley, James/0000-0003-2509-1271	National Health and Medical Research Council [NHMRC Project Grant] [535930]; International Scientific Linkage Program Grant of Australia [CH 080212]	National Health and Medical Research Council [NHMRC Project Grant]; International Scientific Linkage Program Grant of Australia	This work was supported by the National Health and Medical Research Council [NHMRC Project Grant 535930 to JMY and YY] and the International Scientific Linkage Program Grant [CH 080212 to YJM and EWK] of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Chalkley SM, 2002, AM J PHYSIOL-ENDOC M, V282, pE1231, DOI 10.1152/ajpendo.00173.2001; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Cleasby ME, 2004, DIABETES, V53, P3258, DOI 10.2337/diabetes.53.12.3258; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Huang THW, 2005, BRIT J PHARMACOL, V145, P767, DOI 10.1038/sj.bjp.0706245; Ji HY, 2009, ARCH PHARM RES, V32, P251, DOI 10.1007/s12272-009-1230-1; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nataraju A, 2009, TRANSPLANTATION, V88, P987, DOI 10.1097/TP.0b013e3181b9cbc4; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275; Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Teodoro T, 2008, FEBS LETT, V582, P1375, DOI 10.1016/j.febslet.2008.03.026; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Wang ZH, 2010, EUR J PHARMACOL, V628, P255, DOI 10.1016/j.ejphar.2009.11.019; World Health Organization, 2011, DIAB FACT SHEET; Ye JM, 2011, BRIT J PHARMACOL, V163, P556, DOI 10.1111/j.1476-5381.2011.01240.x; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002	43	50	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42115	10.1371/journal.pone.0042115	http://dx.doi.org/10.1371/journal.pone.0042115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860063	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900069
J	Zhang, H; Rokas, A; Slot, JC				Zhang, Han; Rokas, Antonis; Slot, Jason C.			Two Different Secondary Metabolism Gene Clusters Occupied the Same Ancestral Locus in Fungal Dermatophytes of the Arthrodermataceae	PLOS ONE			English	Article							HORIZONTAL TRANSFER; PEPTIDE SYNTHETASES; SIDEROPHORES; IDENTIFICATION; PATHOGENICITY; BIOSYNTHESIS; ORGANIZATION; ORIGIN	Background: Dermatophyte fungi of the family Arthrodermataceae (Eurotiomycetes) colonize keratinized tissue, such as skin, frequently causing superficial mycoses in humans and other mammals, reptiles, and birds. Competition with native microflora likely underlies the propensity of these dermatophytes to produce a diversity of antibiotics and compounds for scavenging iron, which is extremely scarce, as well as the presence of an unusually large number of putative secondary metabolism gene clusters, most of which contain non-ribosomal peptide synthetases (NRPS), in their genomes. To better understand the historical origins and diversification of NRPS-containing gene clusters we examined the evolution of a variable locus (VL) that exists in one of three alternative conformations among the genomes of seven dermatophyte species. Results: The first conformation of the VL (termed VLA) contains only 539 base pairs of sequence and lacks protein-coding genes, whereas the other two conformations (termed VLB and VLC) span 36 Kb and 27 Kb and contain 12 and 10 genes, respectively. Interestingly, both VLB and VLC appear to contain distinct secondary metabolism gene clusters; VLB contains a NRPS gene as well as four porphyrin metabolism genes never found to be physically linked in the genomes of 128 other fungal species, whereas VLC also contains a NRPS gene as well as several others typically found associated with secondary metabolism gene clusters. Phylogenetic evidence suggests that the VL locus was present in the ancestor of all seven species achieving its present distribution through subsequent differential losses or retentions of specific conformations. Conclusions: We propose that the existence of variable loci, similar to the one we studied, in fungal genomes could potentially explain the dramatic differences in secondary metabolic diversity between closely related species of filamentous fungi, and contribute to host adaptation and the generation of metabolic diversity.	[Zhang, Han; Rokas, Antonis; Slot, Jason C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Zhang, H (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008; Slot, Jason/L-5500-2018; Slot, Jason/E-4802-2011	Rokas, Antonis/0000-0002-7248-6551; 	Searle Scholars Program; National Science Foundation [DBI-0805625, DEB-0844968]	Searle Scholars Program; National Science Foundation(National Science Foundation (NSF))	This work was supported by funds provided by the Searle Scholars Program (A.R.) and the National Science Foundation (DBI-0805625 to J.C.S. and DEB-0844968 to A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Burmester A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r7; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Campbell MA, 2012, GENOME BIOL EVOL, V4, P289, DOI 10.1093/gbe/evs011; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Elias PM, 2007, SEMIN IMMUNOPATHOL, V29, P3, DOI 10.1007/s00281-007-0060-9; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Graser Y, 2008, MYCOPATHOLOGIA, V166, P239, DOI 10.1007/s11046-008-9099-y; Gupta L K, 2004, Indian J Dermatol Venereol Leprol, V70, P131; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Hittinger CT, 2010, NATURE, V464, P54, DOI 10.1038/nature08791; Jeanjean R, 2008, ENVIRON MICROBIOL, V10, P2574, DOI 10.1111/j.1462-2920.2008.01680.x; Johansson P, 1999, MICROBIOL-SGM, V145, P529, DOI 10.1099/13500872-145-3-529; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Khaldi Nora, 2011, Int J Evol Biol, V2011, P423821, DOI 10.4061/2011/423821; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MOR H, 1992, BIOMETALS, V5, P213, DOI 10.1007/BF01061220; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Rondon MR, 2004, MICROBIOL-SGM, V150, P3857, DOI 10.1099/mic.0.27319-0; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strnad P, 2011, J CELL SCI, V124, P4221, DOI 10.1242/jcs.089516; Sun YH, 2006, MICROBIOL-SGM, V152, P3507, DOI 10.1099/mic.0.29176-0; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Temporini ED, 2004, CURR GENET, V46, P29, DOI 10.1007/s00294-004-0506-8; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240, DOI 10.1128/CMR.8.2.240; Will JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000893; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; YOUSSEF N, 1979, J HYG-CAMBRIDGE, V82, P301, DOI 10.1017/S0022172400025717	40	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41903	10.1371/journal.pone.0041903	http://dx.doi.org/10.1371/journal.pone.0041903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860027	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900046
J	Jiao, Y; Feng, X; Zhan, YP; Wang, RF; Zheng, S; Liu, WG; Zeng, XL				Jiao, Yang; Feng, Xue; Zhan, Yinpeng; Wang, Ruifei; Zheng, Sheng; Liu, Wenguang; Zeng, Xianlu			Matrix metalloproteinase-2 Promotes alpha v beta 3 Integrin-Mediated Adhesion and Migration of Human Melanoma Cells by Cleaving Fibronectin	PLOS ONE			English	Article							CANCER-CELLS; TUMOR PROGRESSION; IN-VITRO; MMP-2; METASTASIS; EXPRESSION; INVASION; ALPHA(V)BETA(3); ANGIOGENESIS; REQUIREMENT	Background: Matrix metalloproteinase-2 (MMP-2) is a key regulator in the migration of tumor cells. alpha v beta 3 integrin has been reported to play a critical role in cell adhesion and regulate the migration of tumor cells by promoting MMP-2 activation. However, little is known about the effects of MMP-2 on alpha v beta 3 integrin activity and alpha v beta 3 integrin-mediated adhesion and migration of tumor cells. Methodology/Principal Findings: Human melanoma cells were seeded using an agarose drop model and/or subjected to in vitro analysis using immunofluorescence, adhesion, migration and invasion assays to investigate the relationship between active MMP-2 and alpha v beta 3 integrin during the adhesion and migration of the tumor cells. We found that MMP-2 was localized at the leading edge of spreading cells before alpha v beta 3 integrin. alpha v beta 3 integrin-mediated adhesion and migration of the tumor cells were inhibited by a MMP-2 inhibitor. MMP-2 cleaved fibronectin into small fragments, which promoted the adhesion and migration of the tumor cells. Conclusion/Significance: MMP-2 cleaves fibronectin into small fragments to enhance the adhesion and migration of human melanoma cells mediated by alpha v beta 3 integrin. These results indicate that MMP-2 may guide the direction of the tumor cell migration.	[Jiao, Yang; Feng, Xue; Zhan, Yinpeng; Wang, Ruifei; Zheng, Sheng; Liu, Wenguang; Zeng, Xianlu] NE Normal Univ, Inst Cytol & Genet, Changchun, Jilin, Peoples R China	Northeast Normal University - China	Jiao, Y (corresponding author), NE Normal Univ, Inst Cytol & Genet, Changchun, Jilin, Peoples R China.	liuwg788@nenu.edu.cn; zengx779@nenu.edu.cn			National Nature Science Foundation of China [81071726, 81172014]; specialized Research Fund for the Doctoral Program of Higher education [20100043110007]; Fundamental Research Funds for the Central Universities [10SSXT129]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); specialized Research Fund for the Doctoral Program of Higher education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Nature Science Foundation of China (81071726, 81172014), the specialized Research Fund for the Doctoral Program of Higher education (20100043110007), and the Fundamental Research Funds for the Central Universities (10SSXT129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Danen EHJ, 2005, CURR PHARM DESIGN, V11, P881, DOI 10.2174/1381612053381756; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2003, INT J CANCER, V104, P533, DOI 10.1002/ijc.10977; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; FELDINGHABERMANN B, 1992, J CLIN INVEST, V89, P2018, DOI 10.1172/JCI115811; FILARDO EJ, 1995, J CELL BIOL, V130, P441, DOI 10.1083/jcb.130.2.441; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; GALARDY RE, 1994, ANN NY ACAD SCI, V732, P315, DOI 10.1111/j.1749-6632.1994.tb24746.x; Godefroy E, 2005, J EXP MED, V202, P61, DOI 10.1084/jem.20042138; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hijova E, 2005, Bratisl Lek Listy, V106, P127; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hofmann UB, 2003, CANCER RES, V63, P8221; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kuphal S, 2005, CANCER METAST REV, V24, P195, DOI 10.1007/s10555-005-1572-1; Liabakk NB, 1996, CANCER RES, V56, P190; LIOTTA LA, 1991, CANCER RES, V51, pS5054; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Makela M, 1999, EXP CELL RES, V251, P67, DOI 10.1006/excr.1999.4564; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Milner R, 1999, J CELL SCI, V112, P4271; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002	47	29	33	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41591	10.1371/journal.pone.0041591	http://dx.doi.org/10.1371/journal.pone.0041591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848537	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200075
J	Kelman, D; Wright, AD				Kelman, Dovi; Wright, Anthony D.			The Importance of H-1-Nuclear Magnetic Resonance Spectroscopy for Reference Standard Validation in Analytical Sciences	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; POLYPHENOLS; CATECHINS	This paper highlights the importance of recording at least a 1 H nuclear magnetic resonance (NMR) spectrum to verify identity of standards used in analyses of organic materials irrespective of source. We show the importance of this approach with an example of a quantitative high-performance liquid chromatography (HPLC) study undertaken with green tea extracts that required the use of several polyphenols as standards. In the course of the study one of these standards [(-)-epigallocatechin, EGC], although having the physical appearance and appropriate HPLC chromatographic behavior of EGC, proved by H-1-NMR to be a completely different class of molecule. For us, this raised significant questions concerning validity of many published pieces of research that used quantitative HPLC methods without first performing rigorous validation of the employed standards prior to their use. This paper clearly illustrates the importance of validation	[Kelman, Dovi; Wright, Anthony D.] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo	Kelman, D (corresponding author), Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA.	adwright@hawaii.edu						Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Dalluge JJ, 1998, J CHROMATOGR A, V793, P265, DOI 10.1016/S0021-9673(97)00906-0; Davis AL, 1996, MAGN RESON CHEM, V34, P887, DOI 10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hostettmann K, 2001, PHARM BIOL, V39, P18, DOI [10.1076/phbi.39.7.18.5867, 10.1076/phbi.39.s1.18.0008]; Kazakevich, 2007, HPLC PHARM SCI; Kelman D, 2009, ENVIRON MICROBIOL, V11, P1897, DOI 10.1111/j.1462-2920.2009.01913.x; Scot RPW, 2007, QUANTITATIVE CHROMAT; Xu JZ, 2004, BRIT J NUTR, V91, P873, DOI 10.1079/BJN20041132	9	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42061	10.1371/journal.pone.0042061	http://dx.doi.org/10.1371/journal.pone.0042061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848701	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200151
J	Khoshnan, A; Patterson, PH				Khoshnan, Ali; Patterson, Paul H.			Elevated IKK alpha Accelerates the Differentiation of Human Neuronal Progenitor Cells and Induces MeCP2-Dependent BDNF Expression	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ADULT NEUROGENESIS; NEURITE OUTGROWTH; HUMAN FIBROBLASTS; RETT-SYNDROME; NEURAL STEM; MECP2; TRANSCRIPTION; PHOSPHORYLATION; MIR-124	The I kappa B kinase alpha (IKK alpha) is implicated in the differentiation of epithelial and immune cells. We examined whether IKK alpha also plays a role in the differentiation and maturation of embryonic human neuronal progenitor cells (NPCs). We find that expression of an extra copy of IKK alpha (IKK alpha+) blocks self-renewal and accelerates the differentiation of NPCs. This coincides with reduced expression of the Repressor Element Silencing Transcription Factor/Neuron-Restrictive Silencing Factor (REST/NRSF), which is a prominent inhibitor of neurogenesis, and subsequent induction of the pro-differentiation non-coding RNA, miR-124a. However, the effects of IKK alpha on REST/NRSF and miR-124a expression are likely to be indirect. IKK alpha+ neurons display extensive neurite outgrowth and accumulate protein markers of neuronal maturation such as SCG10/stathmin-2, postsynaptic density 95 (PSD95), syntaxin, and methyl-CpG binding protein 2 (MeCP2). Interestingly, IKK alpha associates with MeCP2 in the nuclei of human neurons and can phosphorylate MeCP2 in vitro. Using chromatin immunoprecipitation assays, we find that IKK alpha is recruited to the exon-IV brain-derived neurotrophic factor (BDNF) promoter, which is a well-characterized target of MeCP2 activity. Moreover, IKK alpha induces the transcription of BDNF and knockdown expression of MeCP2 interferes with this event. These studies highlight a role for IKK alpha in accelerating the differentiation of human NPCs and identify IKK alpha as a potential regulator of MeCP2 function and BDNF expression.	[Khoshnan, Ali; Patterson, Paul H.] CALTECH, Biol Div 216 76, Pasadena, CA 91125 USA	California Institute of Technology	Khoshnan, A (corresponding author), CALTECH, Biol Div 216 76, Pasadena, CA 91125 USA.	khoshnan@caltech.edu			International Rett Syndrome Foundation [2433]	International Rett Syndrome Foundation	This work was supported by a grant (# 2433) from The International Rett Syndrome Foundation. www.rettsyndrome.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Arenas E, 2008, CELL STEM CELL, V2, P110, DOI 10.1016/j.stem.2008.01.012; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Deleyrolle Loic P., 2009, V549, P91, DOI 10.1007/978-1-60327-931-4_7; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Fang H, 2003, J BIOL CHEM, V278, P26401, DOI 10.1074/jbc.M211539200; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Gupta SK, 2009, DIFFERENTIATION, V77, P19, DOI 10.1016/j.diff.2008.09.001; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Huang YWA, 2012, CELL, V148, P933, DOI 10.1016/j.cell.2012.01.036; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Khoshnan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005768; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Knoferle J, 2010, NEUROBIOL DIS, V38, P395, DOI 10.1016/j.nbd.2010.02.011; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li L, 2011, J EXP MED, V208, P787, DOI 10.1084/jem.20091346; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Lopez-Atalaya JP, 2011, EMBO J, V30, P4287, DOI 10.1038/emboj.2011.299; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Maiorano NA, 2010, RNA BIOL, V7, P528, DOI 10.4161/rna.7.5.12262; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Marinari B, 2008, P NATL ACAD SCI USA, V105, P17091, DOI 10.1073/pnas.0809288105; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; Mills DM, 2007, P NATL ACAD SCI USA, V104, P6359, DOI 10.1073/pnas.0700296104; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Papagiannakopoulos T, 2009, CELL STEM CELL, V4, P375, DOI 10.1016/j.stem.2009.04.007; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Ravache M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014311; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	61	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41794	10.1371/journal.pone.0041794	http://dx.doi.org/10.1371/journal.pone.0041794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848609	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200108
J	Kusakabe, TG; Sakai, T; Aoyama, M; Kitajima, Y; Miyamoto, Y; Takigawa, T; Daido, Y; Fujiwara, K; Terashima, Y; Sugiuchi, Y; Matassi, G; Yagisawa, H; Park, MK; Satake, H; Tsuda, M				Kusakabe, Takehiro G.; Sakai, Tsubasa; Aoyama, Masato; Kitajima, Yuka; Miyamoto, Yuki; Takigawa, Toru; Daido, Yutaka; Fujiwara, Kentaro; Terashima, Yasuko; Sugiuchi, Yoko; Matassi, Giorgio; Yagisawa, Hitoshi; Park, Min Kyun; Satake, Honoo; Tsuda, Motoyuki			A Conserved Non-Reproductive GnRH System in Chordates	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MULTIPLE SEQUENCE ALIGNMENT; CIONA-INTESTINALIS; COMMISSURAL INTERNEURONS; INHIBITORY INTERNEURONS; ASCIDIAN LARVAE; SPINAL-CORD; RECEPTOR; NEURONS; VERTEBRATE	Gonadotropin-releasing hormone (GnRH) is a neuroendocrine peptide that plays a central role in the vertebrate hypothalamo-pituitary axis. The roles of GnRH in the control of vertebrate reproductive functions have been established, while its non-reproductive function has been suggested but less well understood. Here we show that the tunicate Ciona intestinalis has in its non-reproductive larval stage a prominent GnRH system spanning the entire length of the nervous system. Tunicate GnRH receptors are phylogenetically closest to vertebrate GnRH receptors, yet functional analysis of the receptors revealed that these simple chordates have evolved a unique GnRH system with multiple ligands and receptor heterodimerization enabling complex regulation. One of the gnrh genes is conspicuously expressed in the motor ganglion and nerve cord, which are homologous structures to the hindbrain and spinal cord of vertebrates. Correspondingly, GnRH receptor genes were found to be expressed in the tail muscle and notochord of embryos, both of which are phylotypic axial structures along the nerve cord. Our findings suggest a novel non-reproductive role of GnRH in tunicates. Furthermore, we present evidence that GnRH-producing cells are present in the hindbrain and spinal cord of the medaka, Oryzias latipes, thereby suggesting the deep evolutionary origin of a non-reproductive GnRH system in chordates.	[Kusakabe, Takehiro G.; Miyamoto, Yuki; Takigawa, Toru; Daido, Yutaka; Fujiwara, Kentaro; Terashima, Yasuko; Sugiuchi, Yoko; Matassi, Giorgio] Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo, Japan; [Kusakabe, Takehiro G.; Kitajima, Yuka; Miyamoto, Yuki; Terashima, Yasuko; Yagisawa, Hitoshi; Tsuda, Motoyuki] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan; [Sakai, Tsubasa; Aoyama, Masato] Suntory Inst Bioorgan Res, Div Biomol Res, Osaka 618, Japan; [Matassi, Giorgio] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Park, Min Kyun] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Tsuda, Motoyuki] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa, Japan	Konan University; University of Hyogo; Suntory Holdings Ltd; University of Udine; University of Tokyo; Tokushima Bunri University	Kusakabe, TG (corresponding author), Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo, Japan.	tgk@center.konan-u.ac.jp; qskh45539@zeus.eonet.ne.jp	Kusakabe, Takehiro/H-7178-2012; Yagisawa, Hitoshi/C-9305-2012; Matassi, Giorgio/G-6301-2014	Kusakabe, Takehiro/0000-0002-8325-3665; Yagisawa, Hitoshi/0000-0002-5365-4513; Matassi, Giorgio/0000-0003-4923-226X	JSPS; MEXT; Hyogo Science and Technology Association [23I094];  [18370089];  [20657018];  [22310120];  [22657023];  [16370075];  [21570174]; Grants-in-Aid for Scientific Research [23570069, 22310120] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid for Scientific Research from JSPS and MEXT to TGK. (18370089, 20657018, 22310120, 22657023) and M.T (16370075, 21570174) and by research grants from Hyogo Science and Technology Association to TGK (23I094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Adams BA, 2003, ENDOCRINOLOGY, V144, P1907, DOI 10.1210/en.2002-0216; Albertson AJ, 2008, CEREBELLUM, V7, P379, DOI 10.1007/s12311-008-0038-8; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Buchanan JT, 1999, J NEUROPHYSIOL, V81, P2037, DOI 10.1152/jn.1999.81.5.2037; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Chen CC, 2006, J COMP NEUROL, V495, P314, DOI 10.1002/cne.20877; Chiba S, 2004, ZOOL SCI, V21, P285, DOI 10.2108/zsj.21.285; CLONEY RA, 1982, AM ZOOL, V22, P817; Corbo JC, 1997, DEVELOPMENT, V124, P589; DALE N, 1985, J PHYSIOL-LONDON, V363, P61, DOI 10.1113/jphysiol.1985.sp015695; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dolan S, 2003, NEUROSCI LETT, V346, P120, DOI 10.1016/S0304-3940(03)00594-9; Dong B, 2009, DEV BIOL, V330, P237, DOI 10.1016/j.ydbio.2009.03.015; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Eri R, 1999, DEVELOPMENT, V126, P5809; Fernald RD, 2009, ENDOCRINOLOGY, V150, P2507, DOI 10.1210/en.2009-0475; Flanagan CA, 2007, ENDOCRINOLOGY, V148, P5060, DOI 10.1210/en.2006-1400; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grillner S, 1998, ANN NY ACAD SCI, V860, P1, DOI 10.1111/j.1749-6632.1998.tb09035.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Horie T, 2008, J COMP NEUROL, V509, P88, DOI 10.1002/cne.21733; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai Kaoru S., 2002, Gene Expression Patterns, V2, P319, DOI 10.1016/S0925-4773(02)00383-0; Inada K, 2003, NEUROSCI LETT, V347, P167, DOI 10.1016/S0304-3940(03)00689-X; Kanaho YI, 2009, J NEUROSCI RES, V87, P2237, DOI 10.1002/jnr.22051; Kanda S, 2010, ENDOCRINOLOGY, V151, P695, DOI 10.1210/en.2009-0842; Kavanaugh SI, 2005, GEN COMP ENDOCR, V141, P76, DOI 10.1016/j.ygcen.2004.11.012; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kusakabe R, 1999, INT J DEV BIOL, V43, P541; Kusakabe T, 2000, FEBS LETT, V483, P143, DOI 10.1016/S0014-5793(00)02109-8; Kusakabe T, 2003, GENE, V322, P77, DOI 10.1016/j.gene.2003.08.013; Kusakabe T, 2007, PHOTOCHEM PHOTOBIOL, V83, P248, DOI 10.1562/2006-07-11-IR-965; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; Mackie GO, 2004, INVERTEBR BIOL, V123, P269; Mackie GO, 2000, CAN J ZOOL, V78, P1626, DOI 10.1139/cjz-78-9-1626; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Nakagawa M, 1999, PHOTOCHEM PHOTOBIOL, V70, P359, DOI 10.1562/0031-8655(1999)070<0359:ASFTPR>2.3.CO;2; Nakashima Y, 2003, J COMP NEUROL, V460, P180, DOI 10.1002/cne.10645; Nakayama-Ishimura A, 2009, DEV BIOL, V326, P357, DOI 10.1016/j.ydbio.2008.11.026; Nishino A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-6; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohkuma M, 2000, NEUROSCI LETT, V293, P5, DOI 10.1016/S0304-3940(00)01481-6; Oka Y, 2009, J NEUROENDOCRINOL, V21, P334, DOI 10.1111/j.1365-2826.2009.01850.x; Okada T, 1999, DEV GROWTH DIFFER, V41, P759; Okubo K, 2008, ACTA PHYSIOL, V193, P3, DOI 10.1111/j.1748-1716.2008.01832.x; Okubo K, 2000, BIOCHEM BIOPH RES CO, V276, P298, DOI 10.1006/bbrc.2000.3476; Okubo K, 2006, ENDOCRINOLOGY, V147, P1076, DOI 10.1210/en.2005-0468; Okubo K, 2003, GENE, V314, P121, DOI 10.1016/S0378-1119(03)00711-X; Okubo K, 2001, ENDOCRINOLOGY, V142, P4729, DOI 10.1210/en.142.11.4729; Powell JFF, 1996, P NATL ACAD SCI USA, V93, P10461, DOI 10.1073/pnas.93.19.10461; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Ramakrishnan S, 2010, GEN COMP ENDOCR, V168, P401, DOI 10.1016/j.ygcen.2010.05.009; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Sakai T, 2012, ENDOCRINOLOGY, V153, P1841, DOI 10.1210/en.2011-1668; Sakai T, 2010, MOL BIOL EVOL, V27, P1097, DOI 10.1093/molbev/msp319; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sherwood NM, 2005, GEN COMP ENDOCR, V142, P74, DOI 10.1016/j.ygcen.2005.02.007; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SOFFE SR, 1984, J NEUROPHYSIOL, V51, P1257, DOI 10.1152/jn.1984.51.6.1257; Soffe SR, 2009, J PHYSIOL-LONDON, V587, P4829, DOI 10.1113/jphysiol.2009.175208; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tello JA, 2005, ENDOCRINOLOGY, V146, P4061, DOI 10.1210/en.2004-1558; Tello JA, 2009, ENDOCRINOLOGY, V150, P2847, DOI 10.1210/en.2009-0028; Terakado K, 2001, GEN COMP ENDOCR, V124, P277, DOI 10.1006/gcen.2001.7728; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuda M, 2003, J EXP BIOL, V206, P1409, DOI 10.1242/jeb.00235; Tsutsui H, 1998, GEN COMP ENDOCR, V112, P426, DOI 10.1006/gcen.1998.7160; Vandenberghe AE, 2001, GENE DEV, V15, P294, DOI 10.1101/gad.865401; VANMIER P, 1989, J NEUROSCI, V9, P25; Whelan S, 2007, SYSTEMATIC BIOL, V56, P727, DOI 10.1080/10635150701611134; Wu S, 2006, MOL CELL ENDOCRINOL, V257-8, P47, DOI 10.1016/j.mce.2006.06.010; YAMAGAMI K, 1972, DEV BIOL, V29, P343, DOI 10.1016/0012-1606(72)90074-7; YAMAMOTO N, 1995, J COMP NEUROL, V355, P354, DOI 10.1002/cne.903550303; Yamamoto Naoyuki, 2003, Anatomical Science International, V78, P139, DOI 10.1046/j.0022-7722.2003.00051.x; Yoshida R, 2004, GENESIS, V39, P130, DOI 10.1002/gene.20032	88	25	25	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41955	10.1371/journal.pone.0041955	http://dx.doi.org/10.1371/journal.pone.0041955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848672	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200135
J	Lowe, MR; Wu, W; Peterson, MS; Brown-Peterson, NJ; Slack, WT; Schofield, PJ				Lowe, Michael R.; Wu, Wei; Peterson, Mark S.; Brown-Peterson, Nancy J.; Slack, William T.; Schofield, Pamela J.			Survival, Growth and Reproduction of Non-Native Nile Tilapia II: Fundamental Niche Projections and Invasion Potential in the Northern Gulf of Mexico	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS; CLIMATE-CHANGE; COASTAL MISSISSIPPI; BIOLOGICAL INVASIONS; LOGISTIC-REGRESSION; LAKE PONTCHARTRAIN; WATER; FISH; AQUACULTURE; MODEL	Understanding the fundamental niche of invasive species facilitates our ability to predict both dispersal patterns and invasion success and therefore provides the basis for better-informed conservation and management policies. Here we focus on Nile tilapia (Oreochromis niloticus Linnaeus, 1758), one of the most widely cultured fish worldwide and a species that has escaped local aquaculture facilities to become established in a coastal-draining river in Mississippi (northern Gulf of Mexico). Using empirical physiological data, logistic regression models were developed to predict the probabilities of Nile tilapia survival, growth, and reproduction at different combinations of temperature (14 and 30 degrees C) and salinity (0-60, by increments of 10). These predictive models were combined with kriged seasonal salinity data derived from multiple long-term data sets to project the species' fundamental niche in Mississippi coastal waters during normal salinity years (averaged across all years) and salinity patterns in extremely wet and dry years (which might emerge more frequently under scenarios of climate change). The derived fundamental niche projections showed that during the summer, Nile tilapia is capable of surviving throughout Mississippi's coastal waters but growth and reproduction were limited to river mouths (or upriver). Overwinter survival was also limited to river mouths. The areas where Nile tilapia could survive, grow, and reproduce increased during extremely wet years (2-368%) and decreased during extremely dry years (86-92%) in the summer with a similar pattern holding for overwinter survival. These results indicate that Nile tilapia is capable of 1) using saline waters to gain access to other watersheds throughout the region and 2) establishing populations in nearshore, low-salinity waters, particularly in the western portion of coastal Mississippi.	[Lowe, Michael R.; Wu, Wei; Peterson, Mark S.; Brown-Peterson, Nancy J.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA; [Slack, William T.] USA, Waterways Expt Stn, Engineer Res & Dev Ctr, Vicksburg, MS 39180 USA; [Schofield, Pamela J.] US Geol Survey, SE Ecol Sci Ctr, Gainesville, FL USA	University of Southern Mississippi; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Geospatial Research Laboratory (GRL); United States Department of the Interior; United States Geological Survey	Lowe, MR (corresponding author), Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA.	michael.lowe@eagles.usm.edu			United States Fish and Wildlife Service (Region 4); United States Geological Survey Invasive Species Program; departmental fellowship through the Department of Coastal Sciences at the University of Southern Mississippi	United States Fish and Wildlife Service (Region 4); United States Geological Survey Invasive Species Program(United States Geological Survey); departmental fellowship through the Department of Coastal Sciences at the University of Southern Mississippi	None of the work in this manuscript was funded directly. Funding for previous aspects of this study were provided by the United States Fish and Wildlife Service (Region 4) and the United States Geological Survey Invasive Species Program. MRL was funded through a departmental fellowship through the Department of Coastal Sciences at the University of Southern Mississippi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2007, MAR FRESHWATER RES, V58, P921, DOI 10.1071/MF07086; ALBERT A, 1984, BIOMETRIKA, V71, P1; Bianchi TS, 2010, SCI TOTAL ENVIRON, V408, P1471, DOI 10.1016/j.scitotenv.2009.11.047; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blanco JA, 2007, FISH RES, V88, P100, DOI 10.1016/j.fishres.2007.07.015; Brown J. Anne, 2007, V2, P401; Brummett RE, 2009, REV FISH SCI, V17, P70, DOI 10.1080/10641260802083174; Bull SB, 2007, STAT MED, V26, P903, DOI 10.1002/sim.2518; BURGER J, 1992, ESTUARIES, V15, P239, DOI 10.2307/1352698; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canonico-Hyde G, 2011, SUSTAINABLE FISHERIES: MULTI-LEVEL APPROACHES TO A GLOBAL PROBLEM, P113; Casal CMV, 2006, BIOL INVASIONS, V8, P3, DOI 10.1007/s10530-005-0231-3; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; COBLENTZ BE, 1990, CONSERV BIOL, V4, P261, DOI 10.1111/j.1523-1739.1990.tb00287.x; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; De Silva SS, 2009, CLIMATE CHANGE IMPLI; DeVaney SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005451; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Engle VD, 1999, ENVIRON MONIT ASSESS, V57, P1, DOI 10.1023/A:1005980410752; Feely RA, 2004, SCIENCE, V305, P363; Figueredo CC, 2005, FRESHWATER BIOL, V50, P1391, DOI 10.1111/j.1365-2427.2005.01407.x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Gagliano M, 2007, J ANIM ECOL, V76, P174, DOI 10.1111/j.1365-2656.2006.01187.x; Genovesi P., 2005, BIOL INVASIONS, DOI [10.1007/1-4020-3870-4_12., DOI 10.1007/s10530-004-9642-9]; Genovesi P, 2010, EARLY WARNING INFORM; Genovesi Piero, 2007, V193, P385; Georgiou IY, 2009, J COASTAL RES, P59, DOI 10.2112/SI54-008.1; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; Goldburg RJ, 2002, ENV IMPACTS POLICY O; Grammer GL, 2012, AQUAT INVAT IN PRESS, V7; Griffith D.A., 1999, CASEBOOK SPATIAL STA; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hanberry BB, 2012, ECOL MODEL, V227, P29, DOI 10.1016/j.ecolmodel.2011.12.001; Hastings A, 1996, BIOL CONSERV, V78, P143, DOI 10.1016/0006-3207(96)00023-7; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hobbs RJ, 1998, CONSERV BIOL, V12, P271, DOI 10.1046/j.1523-1739.1998.96233.x; Holway DA, 1998, OECOLOGIA, V115, P206, DOI 10.1007/s004420050509; HUBBS C, 1968, T AM FISH SOC, V97, P197, DOI 10.1577/1548-8659(1968)97[197:AOOTEO]2.0.CO;2; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ianni RC, 2011, THESIS NICHOLLS STAT; Idelberger Charles F., 2011, Gulf and Caribbean Research, V23, P13; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kurien J, 2005, RESPONSIBLE FISH TRA; Lane RR, 2001, ECOL ENG, V17, P411, DOI 10.1016/S0925-8574(00)00170-1; Leprieur F, 2009, FISH FISH, V10, P88, DOI 10.1111/j.1467-2979.2008.00314.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lopez JA, 2009, J COASTAL RES, P1, DOI 10.2112/SI54-021.1; Lorenz OT, 2011, SOUTHEAST NAT, V10, P673, DOI 10.1656/058.010.0407; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lovell S. J., 2006, Agricultural and Resource Economics Review, V35, P195; Lowe-McConnell RH, 2000, FISH FISHERIES SERIE, V25, P129; Martin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014395; McAndrew BJ, 2000, FISH FISHERIES SERIE, V25, P1; McCormick MI, 2006, ECOLOGY, V87, P1104, DOI 10.1890/0012-9658(2006)87[1104:MMCLTS]2.0.CO;2; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; Mulholland PJ, 1997, HYDROL PROCESS, V11, P949; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Peterson MS, 2006, ENVIRON BIOL FISH, V76, P283, DOI 10.1007/s10641-006-9033-4; Peterson MS, 2005, WETLANDS, V25, P112, DOI 10.1672/0277-5212(2005)025[0112:TOONNT]2.0.CO;2; Peterson MS, 2004, COPEIA, P842; R Core Team, 2018, R LANG ENV STAT COMP; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Rakocinski Chet F., 1997, Gulf of Mexico Science, V15, P2; REEVES SA, 1989, ECOL MODEL, V47, P217, DOI 10.1016/0304-3800(89)90002-1; Ricciardi A, 2008, DIVERS DISTRIB, V14, P374, DOI 10.1111/j.1472-4642.2007.00451.x; Ridha Mohammad T., 2008, European Journal of Scientific Research, V24, P373; Roberts ME, PARTING FRIENDS; Ross LG, 2000, FISH FISHERIES SERIE, V25, P89; Schofield PJ, 2011, MAR FRESHWATER RES, V62, P439, DOI 10.1071/MF10207; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Starling F, 2002, FRESHWATER BIOL, V47, P2443, DOI 10.1046/j.1365-2427.2002.01013.x; Subasinghe R, 2009, REV AQUACULT, V1, P2, DOI 10.1111/j.1753-5131.2008.01002.x; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thuiller Wilfried, 2007, V193, P197; Turner GF, 2000, FISH FISHERIES SERIE, V25, P33; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wester R, 2007, GEOSTATISTICS ENV SC; WHITFIELD A K, 1979, Environmental Biology of Fishes, V4, P77, DOI 10.1007/BF00005931; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; [No title captured]; [No title captured]	88	56	60	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41580	10.1371/journal.pone.0041580	http://dx.doi.org/10.1371/journal.pone.0041580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848533	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200072
J	Nicolau, I; Ling, D; Tian, LL; Lienhardt, C; Pai, M				Nicolau, Ioana; Ling, Daphne; Tian, Lulu; Lienhardt, Christian; Pai, Madhukar			Research Questions and Priorities for Tuberculosis: A Survey of Published Systematic Reviews and Meta-Analyses	PLOS ONE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; ACID-AMPLIFICATION TESTS; GAMMA RELEASE ASSAYS; DIRECTLY OBSERVED THERAPY; ANTIBODY DETECTION TESTS; SPUTUM SMEAR MICROSCOPY; MIDDLE-INCOME COUNTRIES; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; LATENT TUBERCULOSIS	Background: Systematic reviews are increasingly informing policies in tuberculosis ( TB) care and control. They may also be a source of questions for future research. As part of the process of developing the International Roadmap for TB Research, we did a systematic review of published systematic reviews on TB, to identify research priorities that are most frequently suggested in reviews. Methodology/Principal Findings: We searched EMBASE, MEDLINE, Web of Science, and the Cochrane Library for systematic reviews and meta-analyses on any aspect of TB published between 2005 and 2010. One reviewer extracted data and a second reviewer independently extracted data from a random subset of included studies. In total, 137 systematic reviews, with 141 research questions, were included in this review. We used the UK Health Research Classification System (HRCS) to help us classify the research questions and priorities. The three most common research topics were in the area of detection, screening and diagnosis of TB (32.6%), development and evaluation of treatments and therapeutic interventions (23.4%), and TB aetiology and risk factors (19.9%). The research priorities determined were mainly focused on the discovery and evaluation of bacteriological TB tests and drug-resistant TB tests and immunological tests. Other important topics of future research were genetic susceptibility linked to TB and disease determinants attributed to HIV/TB. Evaluation of drug treatments for TB, drug-resistant TB and HIV/TB were also frequently proposed research topics. Conclusions: Systematic reviews are a good source of key research priorities. Findings from our survey have informed the development of the International Roadmap for TB Research by the TB Research Movement.	[Nicolau, Ioana; Ling, Daphne; Pai, Madhukar] McGill Univ, Montreal, PQ, Canada; [Tian, Lulu] Emory Univ, Atlanta, GA 30322 USA; [Lienhardt, Christian] WHO, Stop TB Partnership, CH-1211 Geneva, Switzerland	McGill University; Emory University; World Health Organization	Nicolau, I (corresponding author), McGill Univ, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Lienhardt, Christian/AAU-4969-2021; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Lienhardt, Christian/0000-0003-0233-893X; Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Stop TB Partnership; World Health Organization; European-Developing Countries Clinical Trials Programme (EDCTP; TB-NEAT grant)	Stop TB Partnership; World Health Organization(World Health Organization); European-Developing Countries Clinical Trials Programme (EDCTP; TB-NEAT grant)	This work was supported in part by the Stop TB Partnership and World Health Organization. Dr Christian Lienhardt from the Stop TB Partnership and WHO provided input in study design and interpretation and revised the manuscript for intellectual content. Additional funding was provided by the European-Developing Countries Clinical Trials Programme (EDCTP; TB-NEAT grant). EDCTP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub2; Abubakar I, 2010, LANCET INFECT DIS, V10, P176, DOI 10.1016/S1473-3099(10)70028-1; Agarwal R, 2008, RESP MED, V102, P382, DOI 10.1016/j.rmed.2007.10.017; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Arshad S, 2010, EUR RESPIR J, V35, P1336, DOI 10.1183/09031936.00054709; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bliven EE, 2009, INT J TUBERC LUNG D, V13, P1054; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; Chaisson RE, 2009, INT J TUBERC LUNG D, V13, P558; Chang KC, 2009, HONG KONG J PAEDIATR, V14, P86; Chang KC, 2006, AM J RESP CRIT CARE, V174, P1153, DOI 10.1164/rccm.200605-637OC; Chang KC, 2010, J ANTIMICROB CHEMOTH, V65, P1551, DOI 10.1093/jac/dkq202; Chang KC, 2010, THORAX, V65, P271, DOI 10.1136/thx.2009.126771; Chang Kwok-Chiu, 2009, Expert Opin Med Diagn, V3, P99, DOI 10.1517/17530050802665694; Clark RC, 2007, J PUBLIC HEALTH-UK, V29, P420, DOI 10.1093/pubmed/fdm063; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Daley P, 2007, INT J TUBERC LUNG D, V11, P1166; Davies G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005159.pub2; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Ena J, 2005, CLIN INFECT DIS, V40, P670, DOI 10.1086/427802; Engel ME, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001876.pub2; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Fraser A, 2006, INT J TUBERC LUNG D, V10, P19; Fraser A Paul M Attamna A Leibovici L, 2006, COCHRANE DATABASE SY; Freeman RJ, 2010, J TRAVEL MED, V17, P233, DOI 10.1111/j.1708-8305.2010.00424.x; Freeman RJ, 2008, AM J TROP MED HYG, V79, P209; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Gao L, 2010, PLOS ONE, V5; Gao XF, 2006, INT J TUBERC LUNG D, V10, P1080; Gao XF, 2009, INT J TUBERC LUNG D, V13, P810; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Gray DM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006418.pub2; Greco S, 2009, J CLIN MICROBIOL, V47, P569, DOI 10.1128/JCM.02051-08; Greveson Kay, 2009, Br J Nurs, V18, P1248; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Han T, 2006, INT J EVIDENCE BASED, P101; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Holty JEC, 2009, LIVER TRANSPLANT, V15, P894, DOI 10.1002/lt.21709; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Houben RMGJ, 2009, INT J TUBERC LUNG D, V13, P275; Houben RMGJ, 2009, TROP MED INT HEALTH, V14, P892, DOI 10.1111/j.1365-3156.2009.02316.x; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Jutte PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004532.pub2; Kakisi OK, 2010, EUR J ORAL SCI, V118, P103, DOI 10.1111/j.1600-0722.2010.00725.x; Kalantri S, 2005, BMC INFECT DIS, P5; Kangovi S, 2009, J COMMUN HEALTH, V34, P506, DOI 10.1007/s10900-009-9174-4; Kettaneh A, 2006, INT J TUBERC LUNG D, V10, P717; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Klinkenberg E, 2009, EUR RESPIR J, V34, P1180, DOI 10.1183/09031936.00038009; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; Leone S, 2010, INT J INFECT DIS, V14, pE283, DOI 10.1016/j.ijid.2009.05.016; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Lewis SJ, 2005, INT J TUBERC LUNG D, V9, P1174; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Liang HY, 2009, INT J CANCER, V125, P2936, DOI 10.1002/ijc.24636; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Lienhardt C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001135; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin MY, 2010, INT J TUBERC LUNG D, V14, P806; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Liu Q, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-365; Liu Q, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub2; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lutge Elizabeth E, 2009, COCHRANE DATABASE SY; Martin A, 2008, J ANTIMICROB CHEMOTH, V62, P56, DOI 10.1093/jac/dkn139; Martin A, 2007, J ANTIMICROB CHEMOTH, V59, P175, DOI 10.1093/jac/dkl477; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Menon PR, 2010, INDIAN PEDIATR, V47, P67; Menzies D, 2009, PLOS MED, V6; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millership SE, 2009, PEDIATR INFECT DIS J, V28, P915, DOI 10.1097/INF.0b013e3181a3d289; Minion J, 2010, INT J TUBERC LUNG D, V14, P941; Morgan M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-62; Morisson Patrizio, 2008, J. bras. pneumol., V34, P217, DOI 10.1590/S1806-37132008000400006; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; Nicolau I, 2010, EPIDEMIOLOGY Q UNPUB; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Obihara CC, 2007, PEDIAT ALLERG IMM-UK, V18, P551, DOI 10.1111/j.1399-3038.2007.00569.x; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Pai M, 2005, J INFECTION, V51, P175, DOI 10.1016/j.jinf.2005.05.017; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Pasipanodya JG, 2010, ANTIMICROB AGENTS CH, V54, P2847, DOI 10.1128/AAC.01567-09; Payne B, 2007, CLIN EVIDENCE; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Pereira Susan M, 2007, Rev. Saúde Pública, V41, P59, DOI 10.1590/S0034-89102007000800009; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Placidi D, 2007, G Ital Med Lav Ergon, V29, P409; Prasad K, 2008, COCHRANE DATABASE SY; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rajagopala S, 2008, AM J MED, V121, P539, DOI 10.1016/j.amjmed.2008.01.026; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Riquelme A, 2006, J CLIN GASTROENTEROL, V40, P705, DOI 10.1097/00004836-200609000-00009; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Sanai FM, 2005, ALIMENT PHARM THER, V22, P685, DOI 10.1111/j.1365-2036.2005.02645.x; Setia MS, 2006, LANCET INFECT DIS, V6, P162, DOI 10.1016/S1473-3099(06)70412-1; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Slama K, 2010, INT J TUBERC LUNG D, V14, P6; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steingart KR, 2007, POSTGRAD MED J, V83, P705, DOI 10.1136/thx.2006.075754; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Stop TB Partnership & World Health Organization, 2011, INT ROADM TUB RES WO; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Sun F, 2008, INT J TUBERC LUNG D, V12, P994; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tuon FF, 2006, ACTA TROP, V99, P67, DOI 10.1016/j.actatropica.2006.07.004; Tuon FF, 2010, SCAND J INFECT DIS, V42, P198, DOI 10.3109/00365540903428158; UK Clinical Research Collaboration, 2011, HLTH RES CLASS SYST; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Vassall A, 2006, HEALTH POLICY, V79, P1, DOI 10.1016/j.healthpol.2005.11.005; Vlassov Vasiliy V, 2006, COCHRANE DATABASE SY; Volmink J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub2; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wisnivesky JP, 2005, J GEN INTERN MED, V20, P947, DOI 10.1111/j.1525-1497.2005.0185.x; Yang XY, 2010, J INFECTION, V60, P320, DOI 10.1016/j.jinf.2010.02.005; Ziakas PD, 2009, CLIN INFECT DIS, V49, P1883, DOI 10.1086/647944; Ziganshina LE, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004795.pub3, 10.1002/14651858.CD004795.pub2]; Ziganshina LE, 2009, CLIN EVIDENCE; Zodpey SP, 2007, INDIAN J DERMATOL VE, V73, P86, DOI 10.4103/0378-6323.31891	148	12	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42479	10.1371/journal.pone.0042479	http://dx.doi.org/10.1371/journal.pone.0042479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848764	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200201
J	Rogers, MAM; Greene, MT; Saint, S; Chenoweth, CE; Malani, PN; Trivedi, I; Aronoff, DM				Rogers, Mary A. M.; Greene, M. Todd; Saint, Sanjay; Chenoweth, Carol E.; Malani, Preeti N.; Trivedi, Itishree; Aronoff, David M.			Higher Rates of Clostridium difficile Infection among Smokers	PLOS ONE			English	Article							CIGARETTE-SMOKING; DIETARY; ADULTS; RISK	Objectives: Cigarette smoking has been shown to be related to inflammatory bowel disease. We investigated whether smoking affected the probability of developing Clostridium difficile infection (CDI). Methods: We conducted a longitudinal study of 16,781 older individuals from the nationally representative Health and Retirement Study. Data were linked to files from the Centers for Medicare and Medicaid Services. Results: Overall, the rate of CDI in older individuals was 220.6 per 100,000 person-years (95% CI 193.3, 248.0). Rates of CDI were 281.6/100,000 person-years in current smokers, 229.0/100,000 in former smokers and 189.1/100,000 person-years in never smokers. The odds of CDI were 33% greater in former smokers (95% CI: 8%, 65%) and 80% greater in current smokers (95% CI: 33%, 145%) when compared to never smokers. When the number of CDI-related visits was evaluated, current smokers had a 75% increased rate of CDI compared to never smokers (95% CI: 15%, 167%). Conclusions: Smoking is associated with developing a Clostridium difficile infection. Current smokers have the highest risk, followed by former smokers, when compared to rates of infection in never smokers.	[Rogers, Mary A. M.; Greene, M. Todd; Saint, Sanjay; Chenoweth, Carol E.; Malani, Preeti N.; Trivedi, Itishree; Aronoff, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Malani, Preeti N.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Rogers, MAM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	maryroge@umich.edu	Saint, Sanjay/AAF-5126-2019	Rogers, Mary/0000-0001-5519-3223; Aronoff, David/0000-0003-4587-6121; Trivedi, Itishree/0000-0002-5338-5528	National Institute of Allergy and Infectious Diseases [5U19AI090871-02]; National Institute on Aging [NIA U01AG009740]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by a grant from the National Institute of Allergy and Infectious Diseases (grant number 5U19AI090871-02). The Health and Retirement Study is sponsored by the National Institute on Aging (grant number NIA U01AG009740) and is conducted by the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSaif N, 1996, J MED MICROBIOL, V45, P133, DOI 10.1099/00222615-45-2-133; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; Blix HS, 2011, J ANTIMICROB CHEMOTH, V66, P2159, DOI 10.1093/jac/dkr273; CADE JE, 1991, J EPIDEMIOL COMMUN H, V45, P270, DOI 10.1136/jech.45.4.270; Centers for Medicare and Medicaid Services, 2010, MED ENR REP; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; EATON T, 1995, J CLIN MICROBIOL, V33, P2757, DOI 10.1128/JCM.33.10.2757-2758.1995; Janezic S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-48; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; MARGETTS BM, 1993, BMJ-BRIT MED J, V307, P1381, DOI 10.1136/bmj.307.6916.1381; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Rodriguez-Palacios A, 2007, EMERG INFECT DIS, V13, P485, DOI 10.3201/eid1303.060988; Roumie CL, 2005, J GEN INTERN MED, V20, P697, DOI 10.1111/j.1525-1497.2005.0148.x; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Saulnier DM, 2009, CURR PHARM DESIGN, V15, P1403, DOI 10.2174/138161209788168128; Scheurer DB, 2007, EPIDEMIOL INFECT, V135, P1010, DOI 10.1017/S0950268806007655; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Walk Seth T, 2008, Interdiscip Perspect Infect Dis, V2008, P125081, DOI 10.1155/2008/125081	23	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42091	10.1371/journal.pone.0042091	http://dx.doi.org/10.1371/journal.pone.0042091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848714	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200162
J	Silva, PC; Santos, U; Travenzoli, NM; Zanuncio, JC; Cioffi, MD; Dergam, JA				Silva, Priscilla C.; Santos, Udson; Travenzoli, Natalia M.; Zanuncio, Jose C.; Cioffi, Marcelo de B.; Dergam, Jorge A.			The Unique Karyotype of Henochilus wheatlandii, a Critically Endangered Fish Living in a Fast-Developing Region in Minas Gerais State, Brazil	PLOS ONE			English	Article							CYTOGENETIC CHARACTERIZATION; PHYLOGENETIC ANALYSIS; CHROMOSOME EVOLUTION; ORGANIZER REGIONS; CHARACIFORMES; BRYCON; CHARACIDAE; TELEOSTEI; ERYTHRINIDAE; PISCES	Henochilus wheatlandii, the only species of this genus, is critically endangered and was considered extinct for over a century. The rediscovery of this fish in 1996 made it possible to study its phylogenetic relationships with other species in the subfamily Bryconinae. The aim of this study was to characterise the karyotype of H. wheatlandii. Standard staining, C-positive heterochromatin and nucleolar organiser region (NOR) banding, chromomycin A(3) staining, and fluorescent in situ hybridisation (FISH) using 5S rDNA and 18S rDNA probes were conducted on nineteen specimens collected in the Santo Antonio River, a sub-basin of the Doce River in Ferros municipality, Minas Gerais State, Brazil. Henochilus wheatlandii shared the same diploid number and chromosome morphology as other species of Bryconinae. However, its heterochromatin distribution patterns, NOR localisation, and FISH patterns revealed a cytogenetic profile unique among Neotropical Bryconinae, emphasizing the evolutionary uniqueness of this threatened species.	[Silva, Priscilla C.; Santos, Udson; Travenzoli, Natalia M.; Zanuncio, Jose C.; Dergam, Jorge A.] Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Mol Beagle, Vicosa, MG, Brazil; [Cioffi, Marcelo de B.] Univ Fed Sao Carlos, Dept Genet & Evolucao, Lab Biodiversidade Mol & Citogenet, BR-13560 Sao Carlos, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal de Sao Carlos	Silva, PC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Mol Beagle, Vicosa, MG, Brazil.	pricarola@gmail.com	Cioffi, Marcelo/AAG-4675-2022; Cioffi, Marcelo/AFK-6402-2022; Dergam, Jorge/B-1522-2013	Cioffi, Marcelo/0000-0003-4340-1464; Cioffi, Marcelo/0000-0003-4340-1464; Dergam, Jorge/0000-0003-1395-1377	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (REUNI/CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; Bertollo LAC, 2004, HEREDITY, V93, P228, DOI 10.1038/sj.hdy.6800511; Botero-Botero A, 2011, REV MVZ CORDOBA, V16, P2349; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Castro RMC, 2004, COPEIA, P496, DOI 10.1643/CI-03-202R2; Cioffi MB, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-34; Daniel-Silva MFZ, 2005, CYTOGENET GENOME RES, V109, P497, DOI 10.1159/000084209; Lopez DD, 2008, REV BIOL TROP, V56, P1619; DERGAM JA, 1990, REV BRAS GENET, V13, P755; EIGENMANN CARL H., 1929, MEM MUS COMP ZOOL HARVARD COLL, V43, P429; Garman S, 1890, B ESSEX I, V22, P49; Gery J., 1977, CHARACOIDS WORLD; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Howes G., 1982, Bulletin of the British Museum (Natural History) Zoology, V43, P1; Inoue Luis Antônio Kioshi Aoki, 2003, Cienc. Rural, V33, P943, DOI 10.1590/S0103-84782003000500023; Jacobina UP, 2011, NEOTROP ICHTHYOL, V9, P325, DOI 10.1590/S1679-62252011005000023; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Kavalco KF, 2011, CYTOGENET GENOME RES, V134, P108, DOI 10.1159/000325539; Kavalco KF, 2009, GENETICA, V136, P135, DOI 10.1007/s10709-008-9325-z; Kavalco KF, 2005, HEREDITY, V94, P180, DOI 10.1038/sj.hdy.6800595; King M., 1993, SPECIES EVOLUTION; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lima F.C.T., 2003, CHECK LIST FRESHWATE, P174; Lundberg John G., 1998, P13; Malabarba Luiz R., 1998, P193; Margarido Vladimir P., 1996, Cytobios, V85, P219; Margarido VP, 1999, GENET MOL BIOL, V22, P357, DOI 10.1590/S1415-47571999000300012; Mariguela TC, 2010, COMP CYTOGENET, V4, P185, DOI 10.3897/compcytogen.v4i2.49; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Reis RE., 2003, CLOFFSCA CHECK LIST; Rosa Ricardo S., 1996, Revista Brasileira de Zoologia, V13, P647; Santos U, 2009, J FISH BIOL, V75, P2326, DOI 10.1111/j.1095-8649.2009.02489.x; Hilsdorf AWS, 2008, GENET MOL BIOL, V31, P366; SOLA L, 1992, CYTOGENET CELL GENET, V60, P229, DOI 10.1159/000133346; Souza IL, 2008, MICRON, V39, P1036, DOI 10.1016/j.micron.2007.09.007; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swerdlow J, 1998, NATL GEOGR, V193, P2; Vieira F, 2001, ENVIRON BIOL FISH, V62, P414, DOI 10.1023/A:1012233128362; Vieira Fabio, 2000, Ichthyological Exploration of Freshwaters, V11, P201; Wasko AP, 2000, GENET MOL BIOL, V23, P135, DOI 10.1590/S1415-47572000000100025; Wasko AP, 2001, GENOME, V44, P893, DOI 10.1139/gen-44-5-893; White M.J.D., 1978, MODES SPECIATION	48	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42278	10.1371/journal.pone.0042278	http://dx.doi.org/10.1371/journal.pone.0042278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848754	Green Published, gold			2022-12-27	WOS:000306950200191
J	Sriwanthana, B; Mori, M; Tanaka, M; Nishimura, S; Miura, T; Pathipvanich, P; Sawanpanyalert, P; Ariyoshi, K				Sriwanthana, Busarawan; Mori, Masahiko; Tanaka, Mari; Nishimura, Sei; Miura, Toshiyuki; Pathipvanich, Panita; Sawanpanyalert, Pathom; Ariyoshi, Koya			The Effect of HLA Polymorphisms on the Recognition of Gag Epitopes in HIV-1 CRF01_AE Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; CROSS-CLADE; CLASS-I; IMMUNE-RESPONSES; SURFACE EXPRESSION; RHESUS-MONKEYS; CTL EPITOPES; INDIVIDUALS; VACCINE	Introduction: The design of a globally effective vaccine rests on the identification of epitopes capable of eliciting effective cytotoxic T lymphocyte (CTL) responses across multiple HIV clades in different populations. This study aims to discern the effect of HLA polymorphisms and the cross-clade reactivity or clade-specificity of epitopes in Thailand where HIV-1 CRF01_AE is circulating. Materials and Methods: 14 peptides based on consensus HIV-1 CRF01_AE amino acid sequences were designed for use in IFN-gamma ELISpot assays and Cr-51 release assays among 66 HIV-1 CRF01_AE-infected Thai patients. For ELISpot responders carrying HLA alleles currently unknown to restrict CRF01_AE epitopes, in silico epitope-HLA prediction was performed. Results: 29/66 (43.9%) patients recognized at least one peptide. In total 79 responses were seen against all 14 peptides. 28/79 (35.4%) of the responses were in patients with HLA alleles previously reported to restrict CRF01_AE epitopes, 24/79 (30.4%) responses were in individuals with HLA alleles previously reported to restrict epitopes of HIV clades other than CRF01_AE, and the remaining 27/79 (34.2%) responses were not associated with HLA alleles previously known to restrict HIV epitopes. In silico epitope prediction detected 19 novel, epitope-HLA combinations, and 11/19 (57.9%) were associated with HLA-C alleles. We further confirmed a novel HLA restriction of a previously identified HIV-1 Gag epitope [p24(122-130): PPIPVGDIY (PY9)] by HLA-B*40:01 with a standard Cr-51 release assay. Discussion: CTL recognition sites in HIV-1 Gag were similar among different clades but the HLA restriction differed in Thai patients. This disparity in HLA restriction along different populations illustrated the importance of clade- and population-specific HLA analysis prior to CTL vaccine design.	[Sriwanthana, Busarawan; Sawanpanyalert, Pathom] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Mori, Masahiko; Tanaka, Mari; Nishimura, Sei; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Mori, Masahiko] Univ Oxford, Dept Paediat, Oxford, England; [Miura, Toshiyuki] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Minato Ku, Tokyo, Japan; [Pathipvanich, Panita] Lampang Hosp, Day Care Ctr, Lampang, Thailand	Ministry of Public Health - Thailand; Nagasaki University; University of Oxford; University of Tokyo	Sriwanthana, B (corresponding author), Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand.	kari@nagasaki-u.ac.jp			Japan foundation for AIDS prevention; Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science	Japan foundation for AIDS prevention; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Japan foundation for AIDS prevention, and the Ministry of Health, Labour and Welfare of Japan and the Grand-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Bansal A, 2006, AIDS, V20, P353, DOI 10.1097/01.aids.0000206501.16783.67; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Brumme Z, 2009, CLIN INFECT DIS, V49, P956, DOI 10.1086/605503; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Buranapraditkun S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023603; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Cao HY, 2000, J INFECT DIS, V182, P1350, DOI 10.1086/315868; Cao HY, 1997, J VIROL, V71, P8615, DOI 10.1128/JVI.71.11.8615-8623.1997; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Fukada K, 2002, AIDS, V16, P701, DOI 10.1097/00002030-200203290-00005; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Gesprasert G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011179; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Gudmundsdotter L, 2008, VACCINE, V26, P5182, DOI 10.1016/j.vaccine.2008.03.094; Kantakamalakul W, 2006, AIDS RES HUM RETROV, V22, P1271, DOI 10.1089/aid.2006.22.1271; Kawashima Y, 2005, HUM IMMUNOL, V66, P1155, DOI 10.1016/j.humimm.2005.10.015; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lau KA, 2007, AIDS REV, V9, P218; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Makadzange AT, 2010, EUR J IMMUNOL, V40, P1036, DOI 10.1002/eji.200939634; Malhotra U, 2007, VACCINE, V25, P381, DOI 10.1016/j.vaccine.2006.07.045; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola AM, 2004, J IMMUNOL, V173, P4607, DOI 10.4049/jimmunol.173.7.4607; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Mori M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022680; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Neisig A, 1998, J IMMUNOL, V160, P171; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saengwonloey O, 2003, JAIDS-J ACQ IMM DEF, V32, pS63, DOI 10.1097/00126334-200302011-00010; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; SNARY D, 1977, EUR J IMMUNOL, V7, P580, DOI 10.1002/eji.1830070816; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	52	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41696	10.1371/journal.pone.0041696	http://dx.doi.org/10.1371/journal.pone.0041696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848569	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200088
J	Corridoni, D; Pastorelli, L; Mattioli, B; Locovei, S; Ishikawa, D; Arseneau, KO; Chieppa, M; Cominelli, F; Pizarro, TT				Corridoni, Daniele; Pastorelli, Luca; Mattioli, Benedetta; Locovei, Silviu; Ishikawa, Dai; Arseneau, Kristen O.; Chieppa, Marcello; Cominelli, Fabio; Pizarro, Theresa T.			Probiotic Bacteria Regulate Intestinal Epithelial Permeability in Experimental Ileitis by a TNF-Dependent Mechanism	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; TIGHT JUNCTION; ULCERATIVE-COLITIS; BARRIER FUNCTION; FACTOR-ALPHA; SAMP1/YITFC MOUSE; SPONTANEOUS MODEL; INTERFERON-GAMMA	Background: We previously showed that the probiotic mixture, VSL#3, prevents the onset of ileitis in SAMP/YitFc (SAMP) mice, and this effect was associated with stimulation of epithelial-derived TNF. The aim of this study was to determine the mechanism(s) of VSL#3-mediated protection on epithelial barrier function and to further investigate the "paradoxical" effects of TNF in preventing SAMP ileitis. Methods: Permeability was evaluated in SAMP mice prior to the onset of inflammation and during established disease by measuring transepithelial electrical resistance (TEER) on ex vivo-cultured ilea following exposure to VSL#3 conditioned media (CM), TNF or VSL#3-CM + anti-TNF. Tight junction (TJ) proteins were assessed by qRT-PCR, Western blot, and confocal microscopy, and TNFRI/TNFRII expression measured in freshly isolated intestinal epithelial cells (IEC) from SAMP and control AKR mice. Results: Culture with either VSL#3-CM or TNF resulted in decreased ileal paracellular permeability in pre-inflamed SAMP, but not SAMP with established disease, while addition of anti-TNF abrogated these effects. Modulation of the TJ proteins, claudin-2 and occludin, occurred with a significant decrease in claudin-2 and increase in occludin following stimulation with VSL#3-CM or TNF. TNF protein levels increased in supernatants of SAMP ilea incubated with VSL#3-CM compared to vehicle, while IEC-derived TNFR mRNA expression decreased in young, and was elevated in inflamed, SAMP versus AKR mice. Conclusions: Our data demonstrate that the previously established efficacy of VSL#3 in preventing SAMP ileitis is due to direct innate and homeostatic effects of TNF on the gut epithelium, modulation of the TJ proteins, claudin-2 and occludin, and overall improvement of intestinal permeability.	[Corridoni, Daniele; Locovei, Silviu; Ishikawa, Dai; Arseneau, Kristen O.; Cominelli, Fabio] Case Western Reserve Univ, Sch Med, Dept Med, Div Gastroenterol & Liver Dis, Cleveland, OH 44106 USA; [Pastorelli, Luca; Mattioli, Benedetta; Locovei, Silviu; Pizarro, Theresa T.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chieppa, Marcello] Inst Ricovero & Cura Carattere Sci IRCCS De Belli, Lab Expt Immunopathol, Bari, Italy	Case Western Reserve University; Case Western Reserve University	Corridoni, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Div Gastroenterol & Liver Dis, Cleveland, OH 44106 USA.	theresa.pizarro@case.edu	Chieppa, Marcello/AAG-9835-2019; Chieppa, Marcello/I-8447-2018; Pastorelli, Luca/K-5513-2016; Corridoni, Daniele/I-5161-2014	Chieppa, Marcello/0000-0001-9819-0823; Chieppa, Marcello/0000-0001-9819-0823; Pastorelli, Luca/0000-0002-2810-9951; Corridoni, Daniele/0000-0003-0251-2248; MATTIOLI, Benedetta/0000-0003-4270-245X	National Institutes of Health [DK091222, DK055812, DK056762, DK042191]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [MFAG 10684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, R01DK055812, R37DK042191, R01DK056762, R56DK042191, R01DK042191, R29DK042191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health: DK091222 (TTP and FC), DK055812 (FC), DK056762 (TTP), and DK042191 (TTP and FC). Also by Associazione Italiana per la Ricerca sul Cancro (AIRC): Grant # MFAG 10684 to Marcello Chieppa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH M, 1989, SCAND J GASTROENTERO, V24, P993, DOI 10.3109/00365528909089246; Arseneau Kristen O, 2007, Curr Gastroenterol Rep, V9, P508, DOI 10.1007/s11894-007-0067-3; Baert F J, 2000, Curr Gastroenterol Rep, V2, P446, DOI 10.1007/s11894-000-0006-z; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Chapman TM, 2007, BIODRUGS, V21, P61, DOI 10.2165/00063030-200721010-00007; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Cominelli F, 2004, NEW ENGL J MED, V351, P2045, DOI 10.1056/NEJMp048253; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; Ebach DR, 2005, INFLAMM BOWEL DIS, V11, P533, DOI 10.1097/01.MIB.0000163698.34592.30; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gionchetti P, 2000, J GASTROEN HEPATOL, V15, P489, DOI 10.1046/j.1440-1746.2000.02162.x; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gunzel D, 2006, AM J PHYSIOL-REG I, V290, pR1496, DOI 10.1152/ajpregu.00470.2005; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Huynh HQ, 2009, INFLAMM BOWEL DIS, V15, P760, DOI 10.1002/ibd.20816; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; Madsen KL, 2001, CAN J GASTROENTEROL, V15, P817, DOI 10.1155/2001/690741; MARANO CW, 1993, J CELL PHYSIOL, V157, P519, DOI 10.1002/jcp.1041570311; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; McCarthy KM, 1996, J CELL SCI, V109, P2287; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Mizoguchi E, 2008, GASTROENTEROLOGY, V134, P470, DOI 10.1053/j.gastro.2007.11.055; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; PEETERS M, 1994, DIGEST DIS SCI, V39, P2170, DOI 10.1007/BF02090367; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Pizarro TT, 2011, INFLAMM BOWEL DIS, V17, P2566, DOI 10.1002/ibd.21638; Prisciandaro L, 2009, INFLAMM BOWEL DIS, V15, P1906, DOI 10.1002/ibd.20938; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reuter BK, 2009, ANN NY ACAD SCI, V1165, P301, DOI 10.1111/j.1749-6632.2009.04035.x; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Secondulfo M, 2001, DIGEST LIVER DIS, V33, P680, DOI 10.1016/S1590-8658(01)80045-1; SHORTER RG, 1972, AM J DIG DIS, V17, P1024, DOI 10.1007/BF02239143; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	60	77	79	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42067	10.1371/journal.pone.0042067	http://dx.doi.org/10.1371/journal.pone.0042067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848704	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600163
J	Genua, M; Xu, SQ; Buraschi, S; Peiper, SC; Gomella, LG; Belfiore, A; Iozzo, RV; Morrione, A				Genua, Marco; Xu, Shi-Qiong; Buraschi, Simone; Peiper, Stephen C.; Gomella, Leonard G.; Belfiore, Antonino; Iozzo, Renato V.; Morrione, Andrea			Proline-Rich Tyrosine Kinase 2 (Pyk2) Regulates IGF-I-Induced Cell Motility and Invasion of Urothelial Carcinoma Cells	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; BLADDER-CANCER CELLS; GROWTH-FACTOR; NUCLEAR TRANSLOCATION; ADHESION KINASE; ACTIVATION; DIFFERENTIATION; TRANSFORMATION; PROEPITHELIN; ERK1/2	The insulin-like growth factor receptor I (IGF-IR) plays an essential role in transformation by promoting cell growth and protecting cancer cells from apoptosis. We have recently demonstrated that the IGF-IR is overexpressed in invasive bladder cancer tissues and promotes motility and invasion of urothelial carcinoma cells. These effects require IGF-I-induced Akt- and MAPK-dependent activation of paxillin. The latter co-localizes with focal adhesion kinases (FAK) at dynamic focal adhesions and is critical for promoting motility of urothelial cancer cells. FAK and its homolog Proline-rich tyrosine kinase 2 (Pyk2) modulate paxillin activation; however, their role in regulating IGF-IR-dependent signaling and motility in bladder cancer has not been established. In this study we demonstrate that FAK was not required for IGF-IR-dependent signaling and motility of invasive urothelial carcinoma cells. On the contrary, Pyk2, which was strongly activated by IGF-I, was critical for IGF-IR-dependent motility and invasion and regulated IGF-I-dependent activation of the Akt and MAPK pathways. Using immunofluorescence and AQUA analysis we further discovered that Pyk2 was overexpressed in bladder cancer tissues as compared to normal tissue controls. Significantly, in urothelial carcinoma tissues there was increased Pyk2 localization in the nuclei as compared to normal tissue controls. These results provide the first evidence of a specific Pyk2 activity in regulating IGF-IR-dependent motility and invasion of bladder cancer cells suggesting that Pyk2 and the IGF-IR may play a critical role in the invasive phenotype in urothelial neoplasia. In addition, Pyk2 and the IGF-IR may serve as novel biomarkers with diagnostic and prognostic significance in bladder cancer.	[Genua, Marco; Xu, Shi-Qiong; Gomella, Leonard G.; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Urol, Endocrine Mech & Hormone Act Program, Philadelphia, PA 19107 USA; [Buraschi, Simone; Peiper, Stephen C.; Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Canc Cell Biol & Signaling Program, Philadelphia, PA USA; [Belfiore, Antonino] Univ Catanzaro, Dept Hlth, Catanzaro, Italy	Jefferson University; Jefferson University; Magna Graecia University of Catanzaro	Genua, M (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Urol, Endocrine Mech & Hormone Act Program, Philadelphia, PA 19107 USA.	Andrea.Morrione@jefferson.edu	Belfiore, Antonino/B-4652-2011; Genua, Marco/J-4159-2018; Iozzo, Renato/AAS-1980-2020	Belfiore, Antonino/0000-0002-6181-4193; Genua, Marco/0000-0002-0764-8163; Buraschi, Simone/0000-0002-4233-7627; Iozzo, Renato/0000-0002-5908-5112	Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; National Institutes of Health [RO1 DK068419, RO1 CA39481, RO1 CA047282]; AIRC [IG-10625/2011]; Fondazione Cassa di Risparmio di Calabria e Lucania; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA047282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by the Benjamin Perkins Bladder Cancer Fund, the Martin Greitzer Fund, AIRC grant IG-10625/2011, AIRC project Calabria 2011 and Fondazione Cassa di Risparmio di Calabria e Lucania (to A.B.) and National Institutes of Health Grants RO1 DK068419 (A.M.) and RO1 CA39481 and RO1 CA047282 (R.V.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoto H, 2002, CELL STRUCT FUNCT, V27, P47, DOI 10.1247/csf.27.47; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Baserga R, 1999, J CELL BIOCHEM, P68; Baserga R, 2000, ONCOGENE, V19, P5574, DOI 10.1038/sj.onc.1203854; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Dews M, 2000, ENDOCRINOLOGY, V141, P1289, DOI 10.1210/en.141.4.1289; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Farsshori PQ, 2003, J STEROID BIOCHEM, V85, P337, DOI 10.1016/S0960-0760(03)00226-7; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Knowles MA, 2008, INT J CLIN ONCOL, V13, P287, DOI 10.1007/s10147-008-0812-0; Lassak A, 2002, J BIOL CHEM, V277, P17231, DOI 10.1074/jbc.M110885200; Le Roith D, 2000, GROWTH HORM IGF RES, V10, pS12, DOI 10.1016/S1096-6374(00)90005-4; Le Roith D, 1999, ISR MED ASSOC J, V1, P25; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Migliaccio I, 2010, BREAST CANCER RES TR, V123, P651, DOI 10.1007/s10549-009-0632-6; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Morrione A, 2001, ONCOGENE, V20, P4842, DOI 10.1038/sj.onc.1204649; Morrione A, 2000, CANCER RES, V60, P2263; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Peruzzi F, 2001, J BIOL CHEM, V276, P25990, DOI 10.1074/jbc.M103188200; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Reiss K, 2012, J CELL PHYSIOL, V227, P2992, DOI 10.1002/jcp.24019; Rubin MA, 2004, AM J PATHOL, V164, P831, DOI 10.1016/S0002-9440(10)63171-9; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; SCHER CD, 1979, NATURE, V281, P390, DOI 10.1038/281390a0; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shen XC, 2010, CELL MOL LIFE SCI, V67, P3893, DOI 10.1007/s00018-010-0411-x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sun HZ, 2003, MOL ENDOCRINOL, V17, P472, DOI 10.1210/me.2002-0276; Surmacz E, 2003, ONCOGENE, V22, P6589, DOI 10.1038/sj.onc.1206772; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Wu A, 2003, J CELL PHYSIOL, V195, P453, DOI 10.1002/jcp.10261; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	50	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2012	7	6							e40148	10.1371/journal.pone.0040148	http://dx.doi.org/10.1371/journal.pone.0040148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GR	22859931	Green Published, Green Submitted, gold			2022-12-27	WOS:000305826400056
J	Bi, MJ; Tong, J; Chang, F; Wang, J; Wei, HX; Dai, YP; Chu, MX; Zhao, YF; Li, N				Bi, Mingjun; Tong, Jia; Chang, Fei; Wang, Jing; Wei, Hengxi; Dai, Yunping; Chu, Mingxing; Zhao, Yaofeng; Li, Ning			Pituitary-Specific Overexpression of Porcine Follicle-Stimulating Hormone Leads to Improvement of Female Fecundity in BAC Transgenic Mice	PLOS ONE			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; BETA-SUBUNIT GENE; TIME QUANTITATIVE PCR; COPY-NUMBER; ESCHERICHIA-COLI; EXPRESSION; DNA; GONADOTROPINS; CLONING; MODELS	Follicle-stimulating hormone (FSH) is a pituitary glycoprotein that, together with luteinizing hormone, plays a crucial role in ovarian folliculogenesis and female fertility. We previously found that FSH beta is a major gene controlling high prolificacy of Chinese Erhualian pigs. To directly study the biological effects on reproductive function of porcine FSH (pFSH) for polyovulatory species, we generated a novel gain-of-function mouse model using a bacterial artificial chromosome (BAC) system to jointly introduce 92 kb and 165 kb genomic fragments comprising the pFSH alpha- and beta-subunit genes. These directed the physiological expression of pFSH with the same temporal and spatial pattern as endogenous FSH in female transgenic (TG) mice. Serum levels of biologically active pFSH heterodimers in independent TG lines ranged from 6.36 to 19.83 IU/L. High basal pFSH activity led to a significant reduction of serum LH and testosterone levels in TG females compared to wild-type (WT) littermates, yet endogenous FSH and estradiol levels were significantly elevated. Interestingly, ovarian histology showed that the number of corpora lutea was significantly higher at 14 and 28 weeks of age in TG females and breeding curves revealed that mean litter sizes of TG females were obviously larger than for WT littermates before 52 weeks of age. These findings indicate that pituitary-specific overexpression of pFSH within physiological boundaries can increase ovulation rate and litter size, but it does not cause reproductive defects. Therefore, our TG mouse model provides exciting insights for investigating the actions of pFSH in vivo.	[Bi, Mingjun; Tong, Jia; Chang, Fei; Wang, Jing; Dai, Yunping; Zhao, Yaofeng; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wei, Hengxi] S China Agr Univ, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Chu, Mingxing] Chinese Acad Agr Sci, Key Lab Farm Anim Genet Resources & Germplasm Inn, Minist Agr, Inst Anim Sci, Beijing 100193, Peoples R China	China Agricultural University; South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Bi, MJ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	nlicau@hotmail.com			National Transgenic Breeding Program of China [2008ZX08006-005, 2011ZX08006-005, 2011ZX08010-006]	National Transgenic Breeding Program of China	This work was supported by National Transgenic Breeding Program of China (2008ZX08006-005, 2011ZX08006-005 and 2011ZX08010-006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CM, 2006, J ENDOCRINOL, V188, P549, DOI 10.1677/joe.1.06614; Allan CM, 2001, ENDOCRINOLOGY, V142, P2213, DOI 10.1210/en.142.6.2213; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Campbell BK, 2006, ENDOCRINOLOGY, V147, P1608, DOI 10.1210/en.2005-0604; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chrast R, 1999, TRANSGENIC RES, V8, P147, DOI 10.1023/A:1008858014473; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Du Li-Xin, 2002, Yi Chuan Xue Bao, V29, P977; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; He ZY, 2008, FREE RADICAL BIO MED, V45, P1135, DOI 10.1016/j.freeradbiomed.2008.07.019; HIRAI T, 1990, J MOL ENDOCRINOL, V5, P147, DOI 10.1677/jme.0.0050147; KATO Y, 1989, MOL CELL ENDOCRINOL, V62, P135, DOI 10.1016/0303-7207(89)90122-6; KATO Y, 1991, J MOL ENDOCRINOL, V7, P27, DOI 10.1677/jme.0.0070027; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; Kumar TR, 2007, MOL CELL ENDOCRINOL, V260, P249, DOI 10.1016/j.mce.2006.09.002; Kumar TR, 1999, MOL ENDOCRINOL, V13, P851, DOI 10.1210/me.13.6.851; KUMAR TR, 1992, MOL ENDOCRINOL, V6, P81, DOI 10.1210/me.6.1.81; Kumar TR, 2006, MOL CELL ENDOCRINOL, V247, P103, DOI 10.1016/j.mce.2005.12.006; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Kumar TR, 1998, ENDOCRINOLOGY, V139, P3289, DOI 10.1210/en.139.7.3289; KUMAR TR, 1995, NEUROENDOCRINOLOGY, V61, P628, DOI 10.1159/000126889; KUMAR TR, 1993, MOL ENDOCRINOL, V7, P898, DOI 10.1210/me.7.7.898; LAMB BT, 1995, CURR OPIN GENET DEV, V5, P342, DOI 10.1016/0959-437X(95)80049-2; Liu W, 2006, PROG NAT SCI-MATER, V16, P889; LIU YX, 1986, BIOL REPROD, V35, P27, DOI 10.1095/biolreprod35.1.27; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matzuk MM, 2003, BIOL REPROD, V69, P338, DOI 10.1095/biolreprod.102.013953; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McTavish KJ, 2007, ENDOCRINOLOGY, V148, P4432, DOI 10.1210/en.2007-0046; MONACO AP, 1994, TRENDS BIOTECHNOL, V12, P280, DOI 10.1016/0167-7799(94)90140-6; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Nielsen LB, 1997, J BIOL CHEM, V272, P29752, DOI 10.1074/jbc.272.47.29752; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Robker RL, 1998, BIOL REPROD, V59, P476, DOI 10.1095/biolreprod59.3.476; Rulli SB, 2005, REPRODUCTION, V130, P283, DOI 10.1530/rep.1.00661; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Stinnakre MG, 1999, BIOCHEM J, V339, P33, DOI 10.1042/0264-6021:3390033; Strong SJ, 1997, NUCLEIC ACIDS RES, V25, P3959, DOI 10.1093/nar/25.19.3959; Su P, 2005, BIOL REPROD, V73, P681, DOI 10.1095/biolreprod.104.039164; Tomic D, 2004, MOL ENDOCRINOL, V18, P2224, DOI 10.1210/me.2003-0414; Tomic D, 2007, REPROD TOXICOL, V23, P317, DOI 10.1016/j.reprotox.2006.08.004; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896; Zhao YF, 1998, SCI CHINA SER C, V41, P664, DOI 10.1007/BF02882910	49	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42335	10.1371/journal.pone.0042335	http://dx.doi.org/10.1371/journal.pone.0042335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860114	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600091
J	Furler, RL; Uittenbogaart, CH				Furler, Robert L.; Uittenbogaart, Christel H.			GLI2 Regulates TGF-beta 1 in Human CD4(+) T Cells: Implications in Cancer and HIV Pathogenesis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEUKEMIA-VIRUS TYPE-1; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTIONAL ACTIVATION; SIGNAL-TRANSDUCTION; CROSS-TALK; IN-VITRO; HEDGEHOG; PROTEIN	Elevated levels of the immunoregulatory cytokine TGF-beta 1 in cancer and HIV infection have been linked to the suppression of protective immune responses. The transcriptional regulation of TGF-beta 1 is complex and still not completely understood. We report here for the first time that the transcription factor GLI2 regulates the expression of TGF-beta 1 in human CD4(+) T cells. In silico screening revealed five novel putative GLI binding sites in the human TGF-beta 1 promoter. At least two of these sites within the human TGF-beta 1 promoter are regulated by the GLI2 activator as knockdown of GLI2 in regulatory CD4(+)CD25(hi) T cells, high producers of TGF-beta 1, significantly decreased TGF-beta 1 transcription. Additionally, naive CD4(+) T cells, low producers of TGF-beta 1, increased their basal level of TGF-beta 1 mRNA following lentiviral infection with GLI2. The transcriptional regulation of TGF-beta 1 by GLI2 is a new extension to Sonic Hedgehog (SHH) and TGF-beta 1 cross-regulation and may provide insight into the detrimental elevation of TGF-beta 1 leading to pathogenesis in cancer and HIV infection.	[Furler, Robert L.; Uittenbogaart, Christel H.] Univ Calif Los Angeles, David E Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Uittenbogaart, Christel H.] Univ Calif Los Angeles, Dept Pediat, David E Geffen Sch Med, Los Angeles, CA 90024 USA; [Furler, Robert L.; Uittenbogaart, Christel H.] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA USA; [Uittenbogaart, Christel H.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David E Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Furler, RL (corresponding author), Univ Calif Los Angeles, David E Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	uittenbo@ucla.edu		Furler O'Brien, Robert/0000-0001-5706-4871	National Institutes of Health [AI-081636, AI-028697]; Jonsson Comprehensive Cancer Center; Stein Oppenheimer Endowment Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081636, P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonsson Comprehensive Cancer Center; Stein Oppenheimer Endowment Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health AI-081636 and AI-028697 (University of California Los Angeles, Center for AIDS Research), a Jonsson Comprehensive Cancer Center Seed Grant, and a Stein Oppenheimer Endowment Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-57; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Benson RA, 2004, MOL IMMUNOL, V41, P715, DOI 10.1016/j.molimm.2004.04.017; BRADY HJM, 1995, J VIROL, V69, P7622, DOI 10.1128/JVI.69.12.7622-7629.1995; Browning CM, 2001, J VIROL, V75, P2314, DOI 10.1128/JVI.75.5.2314-2323.2001; Chan VSF, 2006, INT IMMUNOL, V18, P1627, DOI 10.1093/intimm/dxl096; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Dan S, 1999, J VIROL, V73, P3258, DOI 10.1128/JVI.73.4.3258-3263.1999; Daya-Grosjean L, 2005, CANCER LETT, V225, P181, DOI 10.1016/j.canlet.2004.10.003; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Eichenmuller M, 2007, INT J ONCOL, V31, P405; ELLIOTT LH, 1992, J NEURO-ONCOL, V14, P1; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Fernandez-Zapico ME, 2008, PANCREATOLOGY, V8, P227, DOI 10.1159/000134271; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hao CH, 2002, ACTA NEUROPATHOL, V103, P171; HISHII M, 1995, NEUROSURGERY, V37, P1160, DOI 10.1227/00006123-199512000-00016; Johnson M D, 2004, J NeuroAIDS, V2, P33, DOI 10.1300/J128v02n04_03; Kawai S, 2001, BONE, V29, P54, DOI 10.1016/S8756-3282(01)00470-7; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lin SL, 2006, GENE, V367, P56, DOI 10.1016/j.gene.2005.09.019; Liu F, 1998, NAT GENET, V20, P325, DOI 10.1038/3793; LOTZ M, 1994, J CELL BIOL, V124, P365, DOI 10.1083/jcb.124.3.365; Lowrey JA, 2002, J IMMUNOL, V169, P1869, DOI 10.4049/jimmunol.169.4.1869; Luo X, 2007, P NATL ACAD SCI USA, V104, P2821; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302; Parney IF, 2000, NEUROSURGERY, V46, P1169, DOI 10.1097/00006123-200005000-00030; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Prud'homme GJ, 2007, LAB INVEST; Rasty S, 1996, P NATL ACAD SCI USA, V93, P6073, DOI 10.1073/pnas.93.12.6073; Reinhold D, 1999, IMMUNOL TODAY, V20, P384, DOI 10.1016/S0167-5699(99)01497-8; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rowbotham NJ, 2007, BLOOD, V109, P3757, DOI 10.1182/blood-2006-07-037655; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Smith MJ, 2001, J VIROL, V75, P2301, DOI 10.1128/JVI.75.5.2301-2313.2001; Stewart GA, 2002, J IMMUNOL, V169, P5451, DOI 10.4049/jimmunol.169.10.5451; Sugiura T, 1999, BIOCHEM J, V338, P433, DOI 10.1042/0264-6021:3380433; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998; Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Wiercinska-Drapalo A, 2004, VIRAL IMMUNOL, V17, P109, DOI 10.1089/088282404322875502; ZAULI G, 1992, BLOOD, V80, P3036	57	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e40874	10.1371/journal.pone.0040874	http://dx.doi.org/10.1371/journal.pone.0040874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859956	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600009
J	Toussaint, EFA; Condamine, FL; Kergoat, GJ; Capdevielle-Dulac, C; Barbut, J; Silvain, JF; Le Ru, BP				Toussaint, Emmanuel F. A.; Condamine, Fabien L.; Kergoat, Gael J.; Capdevielle-Dulac, Claire; Barbut, Jerome; Silvain, Jean-Francois; Le Ru, Bruno P.			Palaeoenvironmental Shifts Drove the Adaptive Radiation of a Noctuid Stemborer Tribe (Lepidoptera, Noctuidae, Apameini) in the Miocene	PLOS ONE			English	Article							DIVERSIFICATION RATE; MOLECULAR PHYLOGENY; SPECIES-DIVERSITY; STEM BORERS; CLADE AGE; EVOLUTIONARY; DISPERSAL; CLIMATE; VICARIANCE; PATTERNS	Between the late Oligocene and the early Miocene, climatic changes have shattered the faunal and floral communities and drove the apparition of new ecological niches. Grassland biomes began to supplant forestlands, thus favouring a large-scale ecosystem turnover. The independent adaptive radiations of several mammal lineages through the evolution of key innovations are classic examples of these changes. However, little is known concerning the evolutionary history of other herbivorous groups in relation with this modified environment. It is especially the case in phytophagous insect communities, which have been rarely studied in this context despite their ecological importance. Here, we investigate the phylogenetic and evolutionary patterns of grass-specialist moths from the species-rich tribe Apameini (Lepidoptera, Noctuidae). The molecular dating analyses carried out over the corresponding phylogenetic framework reveal an origin around 29 million years ago for the Apameini. Ancestral state reconstructions indicate (i) a potential Palaearctic origin of the tribe Apameini associated with a major dispersal event in Afrotropics for the subtribe Sesamiina; (ii) a recent colonization from Palaearctic of the New World and Oriental regions by several independent lineages; and (iii) an ancestral association of the tribe Apameini over grasses (Poaceae). Diversification analyses indicate that diversification rates have not remained constant during the evolution of the group, as underlined by a significant shift in diversification rates during the early Miocene. Interestingly, this age estimate is congruent with the development of grasslands at this time. Rather than clade ages, variations in diversification rates among genera better explain the current differences in species diversity. Our results underpin a potential adaptive radiation of these phytophagous moths with the family Poaceae in relation with the major environmental shifts that have occurred in the Miocene.	[Toussaint, Emmanuel F. A.] Zool State Collect, Dept Entomol, Munich, Germany; [Condamine, Fabien L.] Ecole Polytech, Ctr Math Appl, CNRS, F-91128 Palaiseau, France; [Kergoat, Gael J.] Montpellier SupAgro, INRA, Unite Mixte Rech,Ctr Biol Gest Populat, Ctr Cooperat Int Rech Agron Dev,Inst Rech Dev, Montferrier Sur Lez, France; [Capdevielle-Dulac, Claire; Silvain, Jean-Francois] CNRS, Inst Rech Dev, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Capdevielle-Dulac, Claire; Silvain, Jean-Francois; Le Ru, Bruno P.] Univ Paris, Orsay, France; [Barbut, Jerome] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Le Ru, Bruno P.] Int Ctr Insect Physiol & Ecol, Inst Rech Dev, Nairobi, Kenya	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD); International Centre of Insect Physiology & Ecology (ICIPE)	Toussaint, EFA (corresponding author), Zool State Collect, Dept Entomol, Munich, Germany.	emmanuel.touss1@gmail.com	LE RU, BRUNO/C-5862-2011; Le Ru, bruno/K-3480-2016; Kergoat, Gael J./AAW-6505-2020	Le Ru, bruno/0000-0002-4208-3727; Kergoat, Gael J./0000-0002-8284-6215; BARBUT, Jerome/0000-0002-5022-2475	Genoscope project @-Speed-Id; INRA; IRD	Genoscope project @-Speed-Id; INRA; IRD	Sequencing was supported by a Genoscope project @-Speed-Id (Accurate SPEciEs Delimitation and IDentification of eukaryotic biodiversity using DNA markers) proposed by F-BoL, the French Barcode of life initiative, and was financially supported by proper funds of INRA and IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Bowden J., 1956, Bulletin of Entomological Research London, V47, P415, DOI 10.1017/S0007485300046769; Bredenkamp GJ, 2002, PLANT ECOL, V163, P209, DOI 10.1023/A:1020957807971; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Burk Angela, 2000, Journal of Mammalian Evolution, V7, P213, DOI 10.1023/A:1009488431055; Carson Hampton L., 1995, P14; Clague DA, 1996, ORIGIN EVOLUTION PAC; Clague DA, 2010, J BIOGEOGR, V37, P1022, DOI 10.1111/j.1365-2699.2009.02235.x; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; Dietrich CH, 1999, P 15 N AM PRAR C; Douglas S.D., 1991, THESIS U ALBERTA EDM; Douglas SD, 1996, CAN J ZOOL, V74, P1140, DOI 10.1139/z96-126; Drummond A., 2011, GENEIOUS V 5 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fibiger Michael, 2006, Nota Lepidopterologica, V29, P193; Giron D, 2007, BIOL LETTERS, V3, P340, DOI 10.1098/rsbl.2007.0051; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heads M, 2011, SYST BIOL, V60, P204, DOI 10.1093/sysbio/syq075; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Jacobs BF, 2004, PHILOS T R SOC B, V359, P1573, DOI 10.1098/rstb.2004.1533; JANIS CM, 1989, PALAEONTOLOGY, V32, P463; Janis CM, 2000, P NATL ACAD SCI USA, V97, P7899, DOI 10.1073/pnas.97.14.7899; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kergoat GJ, 2011, MOL PHYLOGENET EVOL, V59, P746, DOI 10.1016/j.ympev.2011.03.014; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Le Ru BP, 2006, B ENTOMOL RES, V96, P555, DOI [10.1079/BER2006457, 10.1017/BER2006457]; Le Ru BP, 2006, ANN SOC ENTOMOL FR, V42, P353, DOI 10.1080/00379271.2006.10697467; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MacPhee RDE, 1999, EXTINCTIONS NEAR TIM; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; McLeish MJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-3; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Metlevski J, 2005, P ENTOMOL SOC WASH, V107, P812; Mico E, 2009, J BIOGEOGR, V36, P546, DOI 10.1111/j.1365-2699.2008.02010.x; Morley R. J., 2007, P1, DOI 10.1007/978-3-540-48842-2_1; Moyal P, 2011, AFR ENTOMOL, V19, P23, DOI 10.4001/003.019.0114; Moyal P, 2010, B ENTOMOL RES, V100, P641, DOI 10.1017/S0007485309990721; Moyal P, 2006, ANN SOC ENTOMOL FR, V42, P293, DOI 10.1080/00379271.2006.10697461; Moyal P, 2006, ANN SOC ENTOMOL FR, V42, P285, DOI 10.1080/00379271.2006.10697460; Moyal P, 2011, BIOL J LINN SOC, V103, P904, DOI 10.1111/j.1095-8312.2011.01666.x; Mullen SP, 2011, P ROY SOC B-BIOL SCI, V278, P1777, DOI 10.1098/rspb.2010.2140; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Nyman T, 2012, ECOL LETT, V15, P889, DOI 10.1111/j.1461-0248.2012.01782.x; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price JP, 2002, P ROY SOC B-BIOL SCI, V269, P2429, DOI 10.1098/rspb.2002.2175; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; SCOTESE C. R., 2001, ATLAS EARTH HIST, V1; Stromberg CAE, 2002, PALAEOGEOGR PALAEOCL, V177, P59, DOI 10.1016/S0031-0182(01)00352-2; TAMS WHT, 1953, B ENTOMOL RES, V43, P645, DOI 10.1017/S0007485300026717; Toussaint EFA, 2011, THESIS U PARIS SUD 1; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Winkler IS, 2009, P NATL ACAD SCI USA, V106, P18103, DOI 10.1073/pnas.0904852106; Wolfe J.A., 1987, S GEO SURV B, V1597, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zilli A., 2009, TAXONOMIC ATLAS EURA, V3; Zilli A, 2005, NOCTUIDAE EUROPAEAE, V8	84	40	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41377	10.1371/journal.pone.0041377	http://dx.doi.org/10.1371/journal.pone.0041377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859979	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600024
J	Baumert, M; Starc, V; Porta, A				Baumert, Mathias; Starc, Vito; Porta, Alberto			Conventional QT Variability Measurement vs. Template Matching Techniques: Comparison of Performance Using Simulated and Real ECG	PLOS ONE			English	Article							TORSADES-DE-POINTES; VENTRICULAR REPOLARIZATION DURATION; SHORT-TERM VARIABILITY; HEAD-UP TILT; INTERVAL VARIABILITY; SYSTOLIC DYSFUNCTION; SOTALOL; DOGS; ELECTROCARDIOGRAM; CARDIOMYOPATHY	Increased beat-to-beat variability in the QT interval (QTV) of ECG has been associated with increased risk for sudden cardiac death, but its measurement is technically challenging and currently not standardized. The aim of this study was to investigate the performance of commonly used beat-to-beat QT interval measurement algorithms. Three different methods (conventional, template stretching and template time shifting) were subjected to simulated data featuring typical ECG recording issues (broadband noise, baseline wander, amplitude modulation) and real short-term ECG of patients before and after infusion of sotalol, a QT interval prolonging drug. Among the three algorithms, the conventional algorithm was most susceptible to noise whereas the template time shifting algorithm showed superior overall performance on simulated and real ECG. None of the algorithms was able to detect increased beat-to-beat QT interval variability after sotalol infusion despite marked prolongation of the average QT interval. The QTV estimates of all three algorithms were inversely correlated with the amplitude of the T wave. In conclusion, template matching algorithms, in particular the time shifting algorithm, are recommended for beat-to-beat variability measurement of QT interval in body surface ECG. Recording noise, T wave amplitude and the beat-rejection strategy are important factors of QTV measurement and require further investigation.	[Baumert, Mathias] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Baumert, Mathias] Univ Adelaide, Ctr Heart Rhythm Disorders, Adelaide, SA, Australia; [Starc, Vito] Univ Ljubljana, Sch Med, Ljubljana, Slovenia; [Porta, Alberto] Univ Milan, Galeazzi Orthoped Inst, Dept Technol Hlth, Milan, Italy	University of Adelaide; University of Adelaide; University of Ljubljana; IRCCS Istituto Ortopedico Galeazzi; University of Milan	Baumert, M (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	mathias.baumert@adelaide.edu.au	Porta, Alberto/K-4390-2016; Baumert, Mathias/A-8324-2008	Porta, Alberto/0000-0002-6720-9824; Baumert, Mathias/0000-0003-2984-2167	Australian Research Council; Australian Research Council [DP 110102049]; Telethon Grant [GGP09247]	Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council); Telethon Grant(Fondazione Telethon)	MB holds a fellowship from the Australian Research Council. This study was partly supported by a grant from the Australian Research Council (DP 110102049). AP was partially supported by the Telethon Grant GGP09247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONACCIO MJ, 1993, AM J CARDIOL, V72, pA27, DOI 10.1016/0002-9149(93)90022-5; Baumert M, 2008, AM J PHYSIOL-HEART C, V295, pH962, DOI 10.1152/ajpheart.00301.2008; Baumert M, 2008, SLEEP, V31, P959; Baumert M, 2011, AM J PHYSIOL-HEART C, V300, pH1412, DOI 10.1152/ajpheart.01184.2010; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Couderc JP, 2009, J CLIN PHARMACOL, V49, P6, DOI 10.1177/0091270008325927; Haigney MC, 2009, HEART RHYTHM, V6, P180, DOI 10.1016/j.hrthm.2008.10.045; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; Hasan MA, 2012, ANN NONINVAS ELECTRO, V17, P195, DOI 10.1111/j.1542-474X.2012.00508.x; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; Kaab S, 2003, EUR HEART J, V24, P649, DOI 10.1016/S0195-668X(02)00806-0; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; LOCATI EH, 1992, PACE, V15, P1374; Malik M, 2010, DRUG SAFETY, V33, P1, DOI 10.2165/11319160-000000000-00000; Malik M, 2009, ANN NONINVAS ELECTRO, V14, P242, DOI 10.1111/j.1542-474X.2009.00304.x; Moody GB, 2006, COMPUT CARDIOL, P313; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Piccirillo G, 2007, EUR HEART J, V28, P1344, DOI 10.1093/eurheartj/ehl367; Porta A, 1998, MED BIOL ENG COMPUT, V36, P27, DOI 10.1007/BF02522854; Porta A, 1998, MED BIOL ENG COMPUT, V36, P35, DOI 10.1007/BF02522855; Porta A, 2011, J ELECTROCARDIOL, V44, P662, DOI 10.1016/j.jelectrocard.2011.08.002; Porta A, 2010, AM J PHYSIOL-HEART C, V298, pH1406, DOI 10.1152/ajpheart.01206.2009; Potter SLP, 2010, J ELECTROCARDIOL, V43, P713, DOI 10.1016/j.jelectrocard.2010.08.010; Schlegel TT, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-28; Schneider J, 2005, EUR J PHARMACOL, V512, P53, DOI 10.1016/j.ejphar.2005.01.042; Solaimanzadeh I, 2008, AUTON NEUROSCI-BASIC, V144, P76, DOI 10.1016/j.autneu.2008.08.016; Starc V, 2006, J ELECTROCARDIOL, V39, P358, DOI 10.1016/j.jelectrocard.2006.03.004; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Vormberge Thomas, 2006, Journal of Pharmacological and Toxicological Methods, V54, P130, DOI 10.1016/j.vascn.2006.03.011	29	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41920	10.1371/journal.pone.0041920	http://dx.doi.org/10.1371/journal.pone.0041920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860030	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900049
J	Jimenez, ZNC; Pereira, BJ; Romao, JE; Makida, SCD; Abensur, H; Moyses, RMA; Elias, RM				Cabrera Jimenez, Zaida Noemy; Pereira, Benedito Jorge; Romao, Joao Egidio, Jr.; da Silva Makida, Sonia Cristina; Abensur, Hugo; Affonso Moyses, Rosa Maria; Elias, Rosilene Motta			Ankle-Brachial Index: A Simple Way to Predict Mortality among Patients on Hemodialysis - A Prospective Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE INDEX; PULSE-WAVE VELOCITY; RENAL DATA SYSTEM; CARDIOVASCULAR-DISEASE; DIALYSIS	Background: Ankle-brachial index (ABI) can access peripheral artery disease and predict mortality in prevalent patients on hemodialysis. However, ABI has not yet been tested in incident patients, who present significant mortality. Typically, ABI is measured by Doppler, which is not always available, limiting its use in most patients. We therefore hypothesized that ABI, evaluated by a simplified method, can predict mortality in an incident hemodialysis population. Methodology/Principal Findings: We studied 119 patients with ESRD who had started hemodialysis three times weekly. ABI was calculated by using two oscillometric blood pressure devices simultaneously. Patients were followed until death or the end of the study. ABI was categorized in two groups normal (0.9-1.3) or abnormal (<0.9 and >1.3). There were 33 deaths during a median follow-up of 12 months (from 3 to 24 months). Age (1 year) (hazard of ratio, 1.026; p = 0.014) and ABI abnormal (hazard ratio, 3.664; p = 0.001) were independently related to mortality in a multiple regression analysis. Conclusions: An easy and inexpensive technique to measure ABI was tested and showed to be significant in predicting mortality. Both low and high ABI were associated to mortality in incident patients on hemodialysis. This technique allows nephrologists to identify high-risk patients and gives the opportunity of early intervention that could alter the natural progression of this population.	[Cabrera Jimenez, Zaida Noemy; Pereira, Benedito Jorge; Romao, Joao Egidio, Jr.; da Silva Makida, Sonia Cristina; Abensur, Hugo; Affonso Moyses, Rosa Maria; Elias, Rosilene Motta] Univ Sao Paulo, Sch Med, Div Renal, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo	Jimenez, ZNC (corresponding author), Univ Sao Paulo, Sch Med, Div Renal, Hosp Clin, Sao Paulo, Brazil.	rosilenemotta@hotmail.com	Elias, Rosilene M/J-1099-2012; Moyses, Rosa M A/F-8268-2012	Elias, Rosilene M/0000-0003-2212-041X; Moyses, Rosa M A/0000-0002-7902-2127; ROMAO JUNIOR, JOAO EGIDO/0000-0001-5142-6771	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Zaida Noemy Cabrera Jimenez was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adragao T, 2012, NEPHROL DIAL TRANSPL, V27, P318, DOI 10.1093/ndt/gfr233; Jimenez ZNC, 2012, KIDNEY BLOOD PRESS R, V35, P242, DOI 10.1159/000332400; Chan KE, 2011, CLIN J AM SOC NEPHRO, V6, P2642, DOI 10.2215/CJN.03680411; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Sesso Ricardo Cintra, 2011, J Bras Nefrol, V33, P442; Tanaka M, 2011, ATHEROSCLEROSIS, V219, P643, DOI 10.1016/j.atherosclerosis.2011.09.037; Zoccali C, 2009, CLIN J AM SOC NEPHRO, V4, pS18, DOI 10.2215/CJN.05210709	14	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42290	10.1371/journal.pone.0042290	http://dx.doi.org/10.1371/journal.pone.0042290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860108	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900087
J	Minderman, J; Pendlebury, CJ; Pearce-Higgins, JW; Park, KJ				Minderman, Jeroen; Pendlebury, Chris J.; Pearce-Higgins, James W.; Park, Kirsty J.			Experimental Evidence for the Effect of Small Wind Turbine Proximity and Operation on Bird and Bat Activity	PLOS ONE			English	Article							ENERGY FACILITIES; BREEDING BIRDS; COLLISION RISK; MORTALITY; FATALITIES; IMPACTS; BEHAVIOR; ELEMENTS; FARMS	The development of renewable energy technologies such as wind turbines forms a vital part of strategies to reduce greenhouse gas emissions worldwide. Although large wind farms generate the majority of wind energy, the small wind turbine (SWT, units generating <50 kW) sector is growing rapidly. In spite of evidence of effects of large wind farms on birds and bats, effects of SWTs on wildlife have not been studied and are likely to be different due to their potential siting in a wider range of habitats. We present the first study to quantify the effects of SWTs on birds and bats. Using a field experiment, we show that bird activity is similar in two distance bands surrounding a sample of SWTs (between 6-18 m hub height) and is not affected by SWT operation at the fine scale studied. At shorter distances from operating turbines (0-5 m), bat activity (measured as the probability of a bat "pass'' per hour) decreases from 84% (71-91%) to 28% (11-54%) as wind speed increases from 0 to 14 m/s. This effect is weaker at greater distances (20-25 m) from operating turbines (activity decreases from 80% (65-89%) to 59% (32-81%)), and absent when they are braked. We conclude that bats avoid operating SWTs but that this effect diminishes within 20 m. Such displacement effects may have important consequences especially in landscapes where suitable habitat is limiting. Planning guidance for SWTs is currently lacking. Based on our results we recommend that they are sited at least 20 m away from potentially valuable bat habitat.	[Minderman, Jeroen; Pendlebury, Chris J.; Park, Kirsty J.] Univ Stirling, Stirling FK9 4LA, Scotland; [Pearce-Higgins, James W.] The Nunnery, British Trust Ornithol, The Nunnery, Thetford, England	University of Stirling; British Trust for Ornithology	Minderman, J (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Jeroen.Minderman@newcastle.ac.uk		Park, Kirsty/0000-0001-6080-7197; Minderman, Jeroen/0000-0002-8451-5540	Leverhulme Trust (a U.K. based independent charity) [F/00 241/L]	Leverhulme Trust (a U.K. based independent charity)(Leverhulme Trust)	This research was funded by a research grant from the Leverhulme Trust (a U.K. based independent charity) to Dr. Kirsty Park, grant no. F/00 241/L. This grant has now expired. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; AWEA, 2011, 2010 US SMALL WIND M; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Barclay RMR, 2007, CAN J ZOOL, V85, P381, DOI 10.1139/Z07-011; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bat Conservation Trust, 2010, MICR SCHEM RISKS EV; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Chamberlain DE, 2006, IBIS, V148, P198, DOI 10.1111/j.1474-919X.2006.00507.x; Corben C., 2006, ANALOOKW BAT CALL AN; de Lucas M, 2005, BIODIVERS CONSERV, V14, P3289, DOI 10.1007/s10531-004-0447-z; Department of Trade and Industry, 2004, EN ACT 2004; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Devereux CL, 2008, J APPL ECOL, V45, P1689, DOI 10.1111/j.1365-2664.2008.01560.x; Douglas DJT, 2011, BIRD STUDY, V58, P37, DOI 10.1080/00063657.2010.524914; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Faraway JJ., 2005, EXTENDING LINEAR MOD; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2012, ARM DATA ANAL USING; Guillemette M, 2002, ECOL APPL, V12, P868, DOI 10.1890/1051-0761(2002)012[0868:PETDAD]2.0.CO;2; Horn JW, 2008, J WILDLIFE MANAGE, V72, P123, DOI 10.2193/2006-465; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Larsen JK, 2007, J APPL ECOL, V44, P516, DOI 10.1111/j.1365-2664.2007.01303.x; Larsen JK, 2000, LANDSCAPE ECOL, V15, P755, DOI 10.1023/A:1008127702944; Larson DJ, 2000, ACTA CHIROPTEROL, V2, P209; Leddy KL, 1999, WILSON BULL, V111, P100; Long CV, 2010, J ACOUST SOC AM, V128, P2238, DOI 10.1121/1.3479540; Masden EA, 2009, ICES J MAR SCI, V66, P746, DOI 10.1093/icesjms/fsp031; PARISH T, 1994, J APPL ECOL, V31, P764, DOI 10.2307/2404166; Pearce-Higgins JW, 2009, J APPL ECOL, V46, P1323, DOI 10.1111/j.1365-2664.2009.01715.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RenewableUK, 2011, SMALL WIND SYST UK M; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Scottish Natural Heritage, 2010, MICR NAT CONS GUID H; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; Szewczak J., 2006, ULTRASOUND EMISSIONS; UK Meteorological Office, 2006, MIDAS LAND SURF STAT; Verboom B, 1997, LANDSCAPE ECOL, V12, P117, DOI 10.1007/BF02698211; Vestas, 2012, WORLD WIND EN REP 20; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Whittingham MJ, 2009, BIRD STUDY, V56, P43, DOI 10.1080/00063650802648150; WWEA, 2012, SMALL WIND REP 2012	44	24	27	4	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41177	10.1371/journal.pone.0041177	http://dx.doi.org/10.1371/journal.pone.0041177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859969	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900018
J	Xie, W; Feng, Q; Su, YH; Dong, B; Wu, J; Meng, L; Qu, LK; Shou, CC				Xie, Wei; Feng, Qin; Su, Yahui; Dong, Bin; Wu, Jian; Meng, Lin; Qu, Like; Shou, Chengchao			Transcriptional Regulation of PES1 Expression by c-Jun in Colon Cancer	PLOS ONE			English	Article							60S RIBOSOMAL-SUBUNIT; CELL-PROLIFERATION; NUCLEOLAR LOCALIZATION; PEBOW-COMPLEX; BRCT DOMAIN; PESCADILLO; BIOGENESIS; PROTEIN; GENE; BOP1	Pescadillo is a nucleolar protein that has been suggested to be involved in embryonic development and ribosome biogenesis. Deregulated expression of human pescadillo (PES1) was described in some tumors, but its precise roles in tumorigenesis remains unclear. In this study, we generated three monoclonal antibodies recognizing PES1 with high specificity and sensitivity, with which PES1 expression in human colon cancer was analyzed immunohistochemically. Out of 265 colon cancer tissues, 89 (33.6%) showed positive PES1 expression, which was significantly higher than in non-cancerous tissues (P<0.001). Silencing of PES1 in colon cancer cells resulted in decreased proliferation, reduced growth of xenografts, and cell cycle arrest in G1 phase, indicating PES1 functions as an oncogene. We then explored the mechanism by which PES1 expression is controlled in human colon cancers and demonstrated that c-Jun, but not JunB, JunD, c-Fos, or mutant c-Jun, positively regulated PES1 promoter transcription activity. In addition, we mapped -274/-264 region of PES1 promoter as the c-Jun binding sequence, which was validated by chromatin immunoprecipitation and electrophoretic mobility shift assays. Moreover, we demonstrated a positive correlation between c-Jun and PES1 expression in colon cancer cells and colon cancer tissues. Upstream of c-Jun, it was revealed that c-Jun NH2-terminal kinases (JNK) is essential for controlling PES1 expression. Our study, in the first place, uncovers the oncogenic role of PES1 in colon cancer and elucidates the molecular mechanism directing PES1 expression.	[Xie, Wei; Feng, Qin; Su, Yahui; Wu, Jian; Meng, Lin; Qu, Like; Shou, Chengchao] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Dong, Bin] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Xie, W (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	scc@bjcancer.org			National 973 Program of China [2009CB521805]; National Nature Science Foundation of China [81172367]	National 973 Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National 973 Program of China (2009CB521805) and the National Nature Science Foundation of China (81172367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Charpentier AH, 2000, CANCER RES, V60, P5977; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fuchs SY, 1996, ONCOGENE, V13, P1531; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Haque J, 2000, GENOMICS, V70, P201, DOI 10.1006/geno.2000.6375; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; Holzel M, 2007, NUCLEIC ACIDS RES, V35, P789, DOI 10.1093/nar/gkl1058; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Killian A, 2004, ONCOGENE, V23, P8597, DOI 10.1038/sj.onc.1207845; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kim B, 2003, CANCER RES, V63, P8248; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kondoh N, 2001, ANTICANCER RES, V21, P2429; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Maiorana A, 2004, ONCOGENE, V23, P7116, DOI 10.1038/sj.onc.1207916; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Oeffinger M, 2002, RNA, V8, P626, DOI 10.1017/S1355838202020022; Prisco M, 2004, MOL CELL BIOL, V24, P5421, DOI 10.1128/MCB.24.12.5421-5433.2004; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Sikorski EM, 2006, J BIOL CHEM, V281, P24423, DOI 10.1074/jbc.M602287200; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Szabo E, 1996, CANCER RES, V56, P305; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Weber A, 2007, HUM PATHOL, V38, P228, DOI 10.1016/j.humpath.2006.07.012; Zhang H, 2005, SCI CHINA SER C, V48, P270, DOI 10.1360/062004-86; Zhang JH, 2009, ACTA BIOCH BIOPH SIN, V41, P991, DOI 10.1093/abbs/gmp096	35	28	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42253	10.1371/journal.pone.0042253	http://dx.doi.org/10.1371/journal.pone.0042253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860098	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900083
J	Epple, LM; Griffiths, SG; Dechkovskaia, AM; Dusto, NL; White, J; Ouellette, RJ; Anchordoquy, TJ; Bemis, LT; Graner, MW				Epple, Laura M.; Griffiths, Steve G.; Dechkovskaia, Anjelika M.; Dusto, Nathaniel L.; White, Jason; Ouellette, Rodney J.; Anchordoquy, Thomas J.; Bemis, Lynne T.; Graner, Michael W.			Medulloblastoma Exosome Proteomics Yield Functional Roles for Extracellular Vesicles	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; OVARIAN-CARCINOMA CELLS; TUMOR-DERIVED EXOSOMES; ACYL-COA THIOESTERS; ACID MEDICA 16; BRAIN-TUMORS; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC BIOMARKERS; SURFACE EXPRESSION; MEMBRANE-VESICLES	Medulloblastomas are the most prevalent malignant pediatric brain tumors. Survival for these patients has remained largely the same for approximately 20 years, and our therapies for these cancers cause significant health, cognitive, behavioral and developmental sequelae for those who survive the tumor and their treatments. We obviously need a better understanding of the biology of these tumors, particularly with regard to their migratory/invasive behaviors, their proliferative propensity, and their abilities to deflect immune responses. Exosomes, virus-sized membrane vesicles released extracellularly from cells after formation in, and transit thru, the endosomal pathway, may play roles in medulloblastoma pathogenesis but are as yet unstudied in this disease. Here we characterized exosomes from a medulloblastoma cell line with biochemical and proteomic analyses, and included characterization of patient serum exosomes. Further scrutiny of the proteomic data suggested functional properties of the exosomes that are relevant to medulloblastoma tumor biology, including their roles as proliferation stimulants, their activities as attractants for tumor cell migration, and their immune modulatory impacts on lymphocytes. Aspects of this held true for exosomes from other medulloblastoma cell lines as well. Additionally, pathway analyses suggested a possible role for the transcription factor hepatocyte nuclear factor 4 alpha (HNF4A); however, inhibition of the protein's activity actually increased D283MED cell proliferation/clonogenecity, suggesting that HNF4A may act as a tumor suppressor in this cell line. Our work demonstrates that relevant functional properties of exosomes may be derived from appropriate proteomic analyses, which translate into mechanisms of tumor pathophysiology harbored in these extracellular vesicles.	[Epple, Laura M.; Dusto, Nathaniel L.; White, Jason; Graner, Michael W.] Univ Colorado Denver, Anschutz Med Ctr, Dept Neurosurg, Aurora, CO 80045 USA; [Epple, Laura M.] Colorado State Univ, Coll Vet Med & Biomed Sci, Cell & Mol Biol Program, Ft Collins, CO 80523 USA; [Griffiths, Steve G.; Ouellette, Rodney J.] Atlantic Canc Res Inst, Moncton, NB, Canada; [Dechkovskaia, Anjelika M.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Anchordoquy, Thomas J.] Univ Colorado Denver, Anschutz Med Ctr, Sch Pharm, Aurora, CO USA; [Bemis, Lynne T.] Univ Colorado Denver, Anschutz Med Ctr, Dept Med Oncol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Epple, LM (corresponding author), Univ Colorado Denver, Anschutz Med Ctr, Dept Neurosurg, Aurora, CO 80045 USA.	michael.graner@ucdenver.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022	Bemis, Lynne/0000-0001-9986-7154	University of Colorado Cancer Center, Cancer League of Colorado, Anschutz Foundation; Skippy Frank Fund Scholar for Translational Research; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	University of Colorado Cancer Center, Cancer League of Colorado, Anschutz Foundation; Skippy Frank Fund Scholar for Translational Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grants to MWG (University of Colorado Cancer Center, Cancer League of Colorado [www.cancerleague.org], Anschutz Foundation), and to LME (Skippy Frank Fund Scholar for Translational Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri SL, 2004, J IMMUNOTHER, V27, P282, DOI 10.1097/00002371-200407000-00004; Alvarez-Llamas G, 2008, EXPERT REV PROTEOMIC, V5, P679, DOI 10.1586/14789450.5.5.679; Andre F, 2002, VACCINE, V20, pA28, DOI 10.1016/S0264-410X(02)00384-5; Ayan I, 1997, INT J RADIAT ONCOL, V39, P461; Baran J, 2010, CANCER IMMUNOL IMMUN, V59, P841, DOI 10.1007/s00262-009-0808-2; BARTANA J, 1988, J LIPID RES, V29, P431; Boman KK, 2009, EUR J CANCER, V45, P2552, DOI 10.1016/j.ejca.2009.06.008; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Deighton RF, 2010, BRAIN PATHOL, V20, P691, DOI 10.1111/j.1750-3639.2010.00376.x; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Fiorilli P, 2008, LAB INVEST, V88, P1143, DOI 10.1038/labinvest.2008.89; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Goligorsky MS, 2007, J AM SOC NEPHROL, V18, P2233, DOI 10.1681/ASN.2006121399; Gopal U, 2010, PLOS ONE, V6; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Graner MW, 2005, NEURO-ONCOLOGY, V7, P260, DOI 10.1215/S1152851704001188; Graner MW, 2009, CANC SCI; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Hakulinen J, 2008, J CELL BIOCHEM, V105, P1211, DOI 10.1002/jcb.21923; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hertz R, 2001, BIOCHEM PHARMACOL, V61, P1057, DOI 10.1016/S0006-2952(01)00578-0; Huber V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-63; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Johnson R, 2009, CURR ONCOL REP, V11, P68, DOI 10.1007/s11912-009-0011-9; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Keles GE, 1995, ONCOL RES, V7, P493; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kempuraj D, 2004, INT J IMMUNOPATH PH, V17, P57, DOI 10.1177/039463200401700108; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; KIKUCHI K, 1983, J NEUROSURG, V59, P790, DOI 10.3171/jns.1983.59.5.0790; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Laguinge L, 2005, ANTICANCER RES, V25, P23; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Mayorek N, 1997, DIABETES, V46, P1958, DOI 10.2337/diabetes.46.12.1958; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Mueller S, 2009, NEUROTHERAPEUTICS, V6, P570, DOI 10.1016/j.nurt.2009.04.006; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Packer RJ, 2003, PEDIATR NEUROSURG, V39, P60, DOI 10.1159/000071316; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Parker Carol E., 2005, V301, P117; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pinaud R, 2008, EUR J NEUROSCI, V27, P1409, DOI 10.1111/j.1460-9568.2008.06102.x; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Qazi KR, 2010, THORAX, V65, P1016, DOI 10.1136/thx.2009.132027; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Ren YN, 2011, TRANSFUSION, V51, P1002, DOI 10.1111/j.1537-2995.2010.02909.x; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sakurai T, 2008, J NEUROSCI RES, V86, P2602, DOI 10.1002/jnr.21705; Salsman VS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020267; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Soderberg A, 2007, FREE RADICAL BIO MED, V43, P90, DOI 10.1016/j.freeradbiomed.2007.03.026; Solit DB, 2002, CLIN CANCER RES, V8, P986; Stravopodis DJ, 2007, CURR MED CHEM, V14, P3122, DOI 10.2174/092986707782793925; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; ten Hoopen R, 2000, CHROMOSOMA, V109, P482, DOI 10.1007/s004120000109; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; Vrijsen KR, 2010, J CELL MOL MED, V14, P1064, DOI 10.1111/j.1582-4934.2010.01081.x; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Weissglas-Volkov D, 2006, DIABETES, V55, P1970, DOI 10.2337/db06-0035; WIKSTRAND CJ, 1991, INVAS METAST, V11, P310; Xiao Z, 2009, J PROTEOMICS, V72, P34, DOI 10.1016/j.jprot.2008.11.011; Yang M, 2011, J NEUROONCOL; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200	90	94	97	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42064	10.1371/journal.pone.0042064	http://dx.doi.org/10.1371/journal.pone.0042064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848702	Green Published, gold			2022-12-27	WOS:000306950200152
J	Eshima, N; Tokumaru, O; Hara, S; Bacal, K; Korematsu, S; Karukaya, S; Uruma, K; Okabe, N; Matsuishi, T				Eshima, Nobuoki; Tokumaru, Osamu; Hara, Shohei; Bacal, Kira; Korematsu, Seigo; Karukaya, Shigeru; Uruma, Kiyo; Okabe, Nobuhiko; Matsuishi, Toyojiro			Age-Specific Sex-Related Differences in Infections: A Statistical Analysis of National Surveillance Data in Japan	PLOS ONE			English	Article							FEMALE-MALE MORTALITY; VACCINE-PREVENTABLE DISEASES; ROUTINE VACCINATIONS; TETANUS-PERTUSSIS; COMMUNITY COHORT; UNITED-STATES; RISK-FACTORS; CHILDREN; SUSCEPTIBILITY; EXPRESSION	Background: To prevent and control infectious diseases, it is important to understand how sex and age influence morbidity rates, but consistent clear descriptions of differences in the reported incidence of infectious diseases in terms of sex and age are sparse. Methods and Findings: Data from the Japanese surveillance system for infectious diseases from 2000 to 2009 were used in the analysis of seven viral and four bacterial infectious diseases with relatively large impact on the Japanese community. The male-to-female morbidity (MFM) ratios in different age groups were estimated to compare incidence rates of symptomatic reported infection between the sexes at different ages. MFM ratios were >1 for five viral infections out of seven in childhood, i.e. male children were more frequently reported as infected than females with pharyngoconjunctival fever, herpangina, hand-foot-and-mouth disease, mumps, and varicella. More males were also reported to be infected with erythema infectiosum and exanthema subitum, but only in children 1 year of age. By contrast, in adulthood the MFM ratios decreased to <1 for all of the viral infections above except varicella, i.e. adult women were more frequently reported to be infected than men. Sex- and age-related differences in reported morbidity were also documented for bacterial infections. Reported morbidity for enterohemorrhagic Escherichia coli infection was higher in adult females and females were reportedly more infected with mycoplasma pneumonia than males in all age groups up to 70 years. Conclusions: Sex-related differences in reported morbidity for viral and bacterial infections were documented among different age groups. Changes in MFM ratios with age may reflect differences between the sexes in underlying development processes, including those affecting the immune, endocrine, and reproductive systems, or differences in reporting rates.	[Eshima, Nobuoki; Uruma, Kiyo] Oita Univ, Fac Med, Dept Biostat, Oita 87011, Japan; [Tokumaru, Osamu] Oita Univ, Fac Med, Dept Neurophysiol, Oita 87011, Japan; [Hara, Shohei] Yomiuri Shimbun Osaka Newspaper, Editorial Bur, Osaka, Japan; [Bacal, Kira] Univ Auckland, Fac Med & Hlth Sci, Med Programme Directorate, Auckland 1, New Zealand; [Korematsu, Seigo] Oita Univ, Fac Med, Dept Pediat & Child Neurol, Oita 87011, Japan; [Karukaya, Shigeru; Matsuishi, Toyojiro] Kurume Univ, Sch Med, Dept Pediat & Child Hlth, Kurume, Fukuoka 830, Japan; [Okabe, Nobuhiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Oita University; Oita University; University of Auckland; Oita University; Kurume University; National Institute of Infectious Diseases (NIID)	Eshima, N (corresponding author), Oita Univ, Fac Med, Dept Biostat, Oita 87011, Japan.	ostokuma@oita-u.ac.jp	Tokumaru, Osamu/AAN-3055-2020		Japan Ministry of Education, Culture, Sports, Science and Technology [22500260]; Grants-in-Aid for Scientific Research [22500260] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) #22500260 to NE from the Japan Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aaby P, 2004, INT J EPIDEMIOL, V33, P367, DOI 10.1093/ije/dyh004; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Aaby P, 2006, VACCINE, V24, P4701, DOI 10.1016/j.vaccine.2006.03.038; Alt FB, 1982, ENCY STATISTICAL SCI, V1, P294, DOI DOI 10.1002/0471667196.ESS0163; [Anonymous], 2011, LANCET, V378, P1826, DOI 10.1016/S0140-6736(11)61795-9; [Anonymous], POL PERT QUOT SETT L; [Anonymous], 2011, ECDC RAP RISK ASS RE; Baba K, 2011, VACCINE, V29, P3089, DOI 10.1016/j.vaccine.2010.09.022; Barskey AE, 2009, VACCINE, V27, P6186, DOI 10.1016/j.vaccine.2009.06.109; Cheng CC, 2008, EUR J PEDIATR, V167, P633, DOI 10.1007/s00431-007-0562-4; Eshima N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019409; Eshima N, 2009, J CLIN VIROL, V45, P135, DOI 10.1016/j.jcv.2009.03.012; Flanagan KL, 2011, VACCINE, V29, P2349, DOI 10.1016/j.vaccine.2011.01.071; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Frydenberg Alexis, 2003, Aust Fam Physician, V32, P589; Gay N, 1996, STAT MED, V15, P1567, DOI 10.1002/(SICI)1097-0258(19960730)15:14<1567::AID-SIM289>3.0.CO;2-G; GREEN MS, 1992, INT J EPIDEMIOL, V21, P381, DOI 10.1093/ije/21.2.381; Gutierrez F, 2006, J INFECTION, V53; Heymann DL, 2008, CONTROL COMMUNICABLE; Hukic M, 2010, EURO SURVEILL; Kawado M, 2007, J EPIDEMIOL, V17, pS32, DOI 10.2188/jea.17.S32; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Klein SL, 2002, BRAIN BEHAV IMMUN, V16, P736, DOI 10.1016/S0889-1591(02)00026-0; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kliegman RM, 2007, NELSON TXB PEDIAT, P1053; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Pinzan CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010757; Reich NG, 2012, BIOMETRICS, V68, P598, DOI 10.1111/j.1541-0420.2011.01709.x; Reller ME, 2008, EPIDEMIOL INFECT, V136, P1109, DOI 10.1017/S0950268807009594; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Rettew JA, 2009, ENDOCRINOLOGY, V150, P3877, DOI 10.1210/en.2009-0098; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Rodrigues A, 2006, VACCINE, V24, P4737, DOI 10.1016/j.vaccine.2006.03.033; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; SCHLEGEL RJ, 1969, LANCET, V2, P826; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Valentiner-Branth P, 2007, VACCINE, V25, P2733, DOI 10.1016/j.vaccine.2006.01.035; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; WASHBURN TC, 1965, PEDIATRICS, V35, P57; World Health Organization, 2007, ADDR SEX GEND EP PRO; Wu PY, 2007, INT J DERMATOL, V46, P362, DOI 10.1111/j.1365-4632.2006.03050.x; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	46	35	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42261	10.1371/journal.pone.0042261	http://dx.doi.org/10.1371/journal.pone.0042261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848753	Green Published, gold			2022-12-27	WOS:000306950200190
J	Hardmeier, M; Schoonheim, MM; Geurts, JJG; Hillebrand, A; Polman, CH; Barkhof, F; Stam, CJ				Hardmeier, Martin; Schoonheim, Menno M.; Geurts, Jeroen J. G.; Hillebrand, Arjan; Polman, Chris H.; Barkhof, Frederik; Stam, Cornelis J.			Dysfunction in Early Multiple Sclerosis: Altered Centrality Derived from Resting-State Functional Connectivity Using Magneto-Encephalography	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; FALSE DISCOVERY RATE; COGNITIVE IMPAIRMENT; BRAIN NETWORKS; GENERALIZED SYNCHRONIZATION; ALZHEIMERS-DISEASE; MS PATIENTS; DATA SETS; CORTEX; MEMORY	Background: Cognitive dysfunction in multiple sclerosis (MS) is frequent. Insight into underlying mechanisms would help to develop therapeutic strategies. Objective: To explore the relationship of cognitive performance to patterns of nodal centrality derived from magneto-encephalography (MEG). Methods: 34 early relapsing-remitting MS patients (median EDSS 2.0) and 28 age- and gender-matched healthy controls (HC) had a MEG, a neuropsychological assessment and structural MRI. Resting-state functional connectivity was determined by the synchronization likelihood. Eigenvector Centrality (EC) was used to quantify for each sensor its connectivity and importance within the network. A cognition-score was calculated, and normalized grey and white matter volumes were determined. EC was compared per sensor and frequency band between groups using permutation testing, and related to cognition. Results: Patients had lower grey and white matter volumes than HC, male patients lower cognitive performance than female patients. In HC, EC distribution showed highest nodal centrality over bi-parietal sensors ("hubs"). In patients, nodal centrality was even higher bi-parietally (theta-band) but markedly lower left temporally (upper alpha- and beta-band). Lower cognitive performance correlated to decreased nodal centrality over left temporal (lower alpha- band) and right temporal (beta-band) sensors, and to increased nodal centrality over right parieto-temporal sensors (beta-band). Network changes were most pronounced in male patients. Conclusions: Partial functional disconnection of the temporal regions was associated with cognitive dysfunction in MS; increased centrality in parietal hubs may reflect a shift from temporal to possibly less efficient parietal processing. To better understand patterns and dynamics of these network changes, longitudinal studies are warranted, also addressing the influence of gender.	[Hardmeier, Martin; Hillebrand, Arjan; Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol & Magnetoencephalog Ctr, Amsterdam, Netherlands; [Hardmeier, Martin] Univ Basel Hosp, Dept Neurol, Div Clin Neurophysiol, CH-4031 Basel, Switzerland; [Schoonheim, Menno M.; Barkhof, Frederik] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Schoonheim, Menno M.; Geurts, Jeroen J. G.] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Sect Clin Neurosci, Amsterdam, Netherlands; [Polman, Chris H.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Basel; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Hardmeier, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Neurophysiol & Magnetoencephalog Ctr, Amsterdam, Netherlands.	mhardmeier@uhbs.ch	Schoonheim, Menno M/X-5398-2018; Barkhof, Frederik/AAJ-6226-2020; Schoonheim, Menno/AAI-6853-2021; Hardmeier, Martin/ABE-9351-2020	Schoonheim, Menno M/0000-0002-2504-6959; Barkhof, Frederik/0000-0003-3543-3706; Schoonheim, Menno/0000-0002-2504-6959; Hardmeier, Martin/0000-0003-1451-7337; Hillebrand, Arjan/0000-0002-8508-3532; Stam, Cornelis/0000-0001-9163-7274	Dutch Multiple Sclerosis Research Foundation [02-358b, 05-358c, 08-650]; Swiss National Science Foundation [SPUM-33CM30-124115]; Swiss Multiple Sclerosis Society	Dutch Multiple Sclerosis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Multiple Sclerosis Society	The study was sponsored by a grant of the Dutch Multiple Sclerosis Research Foundation (Contract grant numbers: 02-358b, 05-358c and 08-650). MH was sponsored by the Swiss National Science Foundation (SPUM-33CM30-124115) and the Swiss Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Amann M, 2011, HUM BRAIN MAPP, V32, P1704, DOI 10.1002/hbm.21142; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bosma I, 2008, NEURO-ONCOLOGY, V10, P734, DOI 10.1215/15228517-2008-034; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calabrese M, 2010, NEUROLOGY, V74, P321, DOI 10.1212/WNL.0b013e3181cbcd03; Charil A, 2003, NEUROIMAGE, V19, P532, DOI 10.1016/S1053-8119(03)00117-4; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cover KS, 2006, NEUROIMAGE, V29, P783, DOI 10.1016/j.neuroimage.2005.08.048; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Haan W, 2012, NEUROIMAGE, V59, P3085, DOI 10.1016/j.neuroimage.2011.11.055; Dominguez LG, 2007, INT J PHYS SCI, V2, P305; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leocani L, 2000, J NEUROL NEUROSUR PS, V69, P192, DOI 10.1136/jnnp.69.2.192; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Miller KJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00197; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Penner IK, 2003, J NEUROL, V250, P461, DOI 10.1007/s00415-003-1025-0; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rao S, 1990, MANUAL BRIEF REPEATA; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Rocca MA, 2009, HUM BRAIN MAPP, V30, P276, DOI 10.1002/hbm.20504; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Roosendaal SD, 2010, RADIOLOGY, V255, P595, DOI 10.1148/radiol.10091433; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Schoonheim MM, 2013, HUM BRAIN MAPP, V34, P52, DOI 10.1002/hbm.21424; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; Wang H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021924; Zuo XN, 2011, CEREB CORTEX, P12	66	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42087	10.1371/journal.pone.0042087	http://dx.doi.org/10.1371/journal.pone.0042087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848712	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200160
J	Jiang, Q; Zhao, L; Dai, JB; Wu, QY				Jiang, Qiao; Zhao, Li; Dai, Junbiao; Wu, Qingyu			Analysis of Autophagy Genes in Microalgae: Chlorella as a Potential Model to Study Mechanism of Autophagy	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; CVT PATHWAY; YEAST; PROTEIN; PROTOTHECOIDES; FERMENTATION; DEGRADATION; STARVATION; MACHINERY; PEXOPHAGY	Background: Microalgae, with the ability to mitigate CO2 emission and produce carbohydrates and lipids, are considered one of the most promising resources for producing bioenergy. Recently, we discovered that autophagy plays a critical role in the metabolism of photosynthetic system and lipids production. So far, more than 30-autophagy related (ATG) genes in all subtypes of autophagy have been identified. However, compared with yeast and mammals, in silico and experimental research of autophagy pathways in microalgae remained limited and fragmentary. Principal Findings: In this article, we performed a genome-wide analysis of ATG genes in 7 microalgae species and explored their distributions, domain structures and evolution. Eighteen "core autophagy machinery" proteins, four mammalian-specific ATG proteins and more than 30 additional proteins (including "receptor-adaptor" complexes) in all subtypes of autophagy were analyzed. Data revealed that receptor proteins in cytoplasm-to-vacuole targeting and mitophagy seem to be absent in microalgae. However, most of the "core autophagy machinery" and mammalian-specific proteins are conserved among microalgae, except for the ATG9-cycling system in Chlamydomonas reinhardtii and the second ubiquitin-like protein conjugation complex in several algal species. The catalytic and binding residues in ATG3, ATG5, ATG7, ATG8, ATG10 and ATG12 are also conserved and the phylogenetic tree of ATG8 coincides well with the phylogenies. Chlorella contains the entire set of the core autophagy machinery. In addition, RT-PCR analysis verified that all crucial ATG genes tested are expressed during autophagy in both Chlorella and Chlamydomonas reinhardtii. Finally, we discovered that addition of 3-Methyladenine (a PI3K specific inhibitor) could suppress the formation of autophagic vacuoles in Chlorella. Conclusions: Taken together, Chlorella may represent a potential model organism to investigate autophagy pathways in photosynthetic eukaryotes. The study will not only promote understanding of the general features of autophagic pathways, but also benefit the production of Chlorella-derived biofuel with future commercial applications.	[Jiang, Qiao] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Ctr Epigenet & Chromatin, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Jiang, Q (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	jbdai@biomed.tsinghua.edu.cn; qingyu@mail.tsinghua.edu.cn	Dai, Junbiao/AAB-8328-2021	Dai, Junbiao/0000-0002-5299-4700	Natural Science Foundation of China [30970224, 41030210]; MOST [2011BAD14B05, 2011CB808800]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST	This work was supported by the Natural Science Foundation of China project 30970224, 41030210, MOST project 2011BAD14B05 and 2011CB808800 ( http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenzeller MJ, 2009, AUTOPHAGY, V5, P854, DOI 10.4161/auto.8791; Affenzeller MJ, 2009, J EXP BOT, V60, P939, DOI 10.1093/jxb/ern348; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bassham DC, 2007, CURR OPIN PLANT BIOL, V10, P587, DOI 10.1016/j.pbi.2007.06.006; BEAULATION J, 1977, J MORPHOL, V154, P39, DOI 10.1002/jmor.1051540104; Cao Y, 2008, J CELL BIOL, V182, P703, DOI 10.1083/jcb.200801035; Guedes AC, 2011, BIOTECHNOL PROGR, V27, P597, DOI 10.1002/btpr.575; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Chiu SY, 2011, BIORESOURCE TECHNOL, V102, P9135, DOI 10.1016/j.biortech.2011.06.091; Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Godefroy N, 2009, AUTOPHAGY, V5, P805, DOI 10.4161/auto.8995; Goodsell DS, 2010, AUTOPHAGY, V6, P3, DOI 10.4161/auto.6.1.10812; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Jiang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-198; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Khalfan WA, 2002, CURR OPIN CELL BIOL, V14, P468, DOI 10.1016/S0955-0674(02)00343-5; Kiel JAKW, 2009, FUNGAL GENET BIOL, V46, pS62, DOI 10.1016/j.fgb.2008.07.009; Kikuma T, 2011, FEMS MICROBIOL LETT, V316, P61, DOI 10.1111/j.1574-6968.2010.02192.x; Kim Y, 2011, BIOTECHNOL BIOENG, V108, P2705, DOI 10.1002/bit.23223; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li XF, 2007, BIOTECHNOL BIOENG, V98, P764, DOI 10.1002/bit.21489; MacIntosh GC, 2011, AUTOPHAGY, V7, P662, DOI 10.4161/auto.7.6.15447; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Miao XL, 2004, J BIOTECHNOL, V110, P85, DOI 10.1016/j.jbiotec.2004.01.013; Mistry Jaina, 2007, V396, P43; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mussgnug JH, 2010, J BIOTECHNOL, V150, P51, DOI 10.1016/j.jbiotec.2010.07.030; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Reumann S, 2010, PROTOPLASMA, V247, P233, DOI 10.1007/s00709-010-0190-0; Rigden DJ, 2009, AUTOPHAGY, V5, P784, DOI 10.4161/auto.8838; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; SICKOGOAD L, 1989, ARCH ENVIRON CON TOX, V18, P638, DOI 10.1007/BF01225002; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Tong JJ, 2010, PROTEIN CELL, V1, P907, DOI 10.1007/s13238-010-0121-z; Werner R, 2002, CHRONOBIOL INT, V19, P325, DOI 10.1081/CBI-120002981; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong W, 2008, APPL MICROBIOL BIOT, V78, P29, DOI 10.1007/s00253-007-1285-1; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Xiong W, 2010, BIORESOURCE TECHNOL, V101, P2287, DOI 10.1016/j.biortech.2009.11.041; Yan Y, 2007, BIOCHEM SOC T, V35, P239, DOI 10.1042/BST0350239; Yen WL, 2007, AUTOPHAGY, V3, P254, DOI 10.4161/auto.3823; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	56	29	29	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41826	10.1371/journal.pone.0041826	http://dx.doi.org/10.1371/journal.pone.0041826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848622	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200111
J	Lagorce, A; Fourcans, A; Dutertre, M; Bouyssiere, B; Zivanovic, Y; Confalonieri, F				Lagorce, Arnaud; Fourcans, Aude; Dutertre, Murielle; Bouyssiere, Brice; Zivanovic, Yvan; Confalonieri, Fabrice			Genome-Wide Transcriptional Response of the Archaeon Thermococcus gammatolerans to Cadmium	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; HEAVY-METAL RESISTANCE; SEA HYDROTHERMAL VENT; HYPERTHERMOPHILIC ARCHAEON; PYROCOCCUS-FURIOSUS; GENE-EXPRESSION; ELEMENTAL SULFUR; STAPHYLOCOCCUS-AUREUS; HYDROGEN-PRODUCTION; PROTEIN	Thermococcus gammatolerans, the most radioresistant archaeon known to date, is an anaerobic and hyperthermophilic sulfur-reducing organism living in deep-sea hydrothermal vents. Knowledge of mechanisms underlying archaeal metal tolerance in such metal-rich ecosystem is still poorly documented. We showed that T. gammatolerans exhibits high resistance to cadmium (Cd), cobalt (Co) and zinc (Zn), a weaker tolerance to nickel (Ni), copper (Cu) and arsenate (AsO4) and that cells exposed to 1 mM Cd exhibit a cellular Cd concentration of 67 mM. A time-dependent transcriptomic analysis using microarrays was performed at a non-toxic (100 mu M) and a toxic (1 mM) Cd dose. The reliability of microarray data was strengthened by real time RT-PCR validations. Altogether, 114 Cd responsive genes were revealed and a substantial subset of genes is related to metal homeostasis, drug detoxification, re-oxidization of cofactors and ATP production. This first genome-wide expression profiling study of archaeal cells challenged with Cd showed that T. gammatolerans withstands induced stress through pathways observed in both prokaryotes and eukaryotes but also through new and original strategies. T. gammatolerans cells challenged with 1 mM Cd basically promote: 1) the induction of several transporter/permease encoding genes, probably to detoxify the cell; 2) the upregulation of Fe transporters encoding genes to likely compensate Cd damages in iron-containing proteins; 3) the induction of membrane-bound hydrogenase (Mbh) and membrane-bound hydrogenlyase (Mhy2) subunits encoding genes involved in recycling reduced cofactors and/or in proton translocation for energy production. By contrast to other organisms, redox homeostasis genes appear constitutively expressed and only a few genes encoding DNA repair proteins are regulated. We compared the expression of 27 Cd responsive genes in other stress conditions (Zn, Ni, heat shock, gamma-rays), and showed that the Cd transcriptional pattern is comparable to other metal stress transcriptional responses (Cd, Zn, Ni) but not to a general stress response.	[Lagorce, Arnaud; Fourcans, Aude; Dutertre, Murielle; Zivanovic, Yvan; Confalonieri, Fabrice] Univ Paris 11, CNRS, Lab Genom Archaea, Inst Genet & Microbiol,UMR 8621, F-91405 Orsay, France; [Bouyssiere, Brice] CNRS, UMR 5254, IPREM, Lab Chim Analyt BioInorgan & Environm, Pau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Lagorce, A (corresponding author), Univ Paris 11, CNRS, Lab Genom Archaea, Inst Genet & Microbiol,UMR 8621, F-91405 Orsay, France.	fabrice.confalonieri@igmors.u-psud.fr		BOUYSSIERE, Brice/0000-0001-5878-6067; LAGORCE, ARNAUD/0000-0002-7828-0300	Toxicologie Nucleaire Environnementale; CNRS (Centre National de la Recherche Scientifique)(France)	Toxicologie Nucleaire Environnementale; CNRS (Centre National de la Recherche Scientifique)(France)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the scientific project 'Toxicologie Nucleaire Environnementale' (2004-2007, http://www.toxnuc-e.org/). AF was the recipient of a Fellowship from the CNRS (Centre National de la Recherche Scientifique)(France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRING BK, 1985, CURR MICROBIOL, V12, P273, DOI 10.1007/BF01567977; BAIROCH A, 1993, NUCLEIC ACIDS RES, V21, P2515, DOI 10.1093/nar/21.10.2515; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bini Elisabetta, 2008, P27; Bouyssiere B, 2004, J ANAL ATOM SPECTROM, V19, P196, DOI 10.1039/b308607k; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Bruno-Barcena JM, 2010, APPL ENVIRON MICROB, V76, P2747, DOI 10.1128/AEM.02718-09; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Chou CJ, 2007, APPL ENVIRON MICROB, V73, P6842, DOI 10.1128/AEM.00597-07; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; De Rossi E, 1998, ANTIMICROB AGENTS CH, V42, P1931, DOI 10.1128/AAC.42.8.1931; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgcomb VP, 2004, APPL ENVIRON MICROB, V70, P2551, DOI 10.1128/AEM.70.4.2551-2555.2004; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; GADD GM, 1978, MICROBIAL ECOL, V4, P303, DOI 10.1007/BF02013274; Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171; Giaginis C, 2006, TOXICOL APPL PHARM, V213, P282, DOI 10.1016/j.taap.2006.03.008; Glasemacher J, 1997, EUR J BIOCHEM, V244, P561, DOI 10.1111/j.1432-1033.1997.00561.x; Grogan DW, 2004, CURR ISSUES MOL BIOL, V6, P137; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Joe MH, 2011, J MICROBIOL BIOTECHN, V21, P438, DOI 10.4014/jmb.1012.12021; Jolivet E, 2003, INT J SYST EVOL MICR, V53, P847, DOI 10.1099/ijs.0.02503-0; Kaur A, 2006, GENOME RES, V16, P841, DOI 10.1101/gr.5189606; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Koizumi S, 2003, J OCCUP HEALTH, V45, P331, DOI 10.1539/joh.45.331; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Lipscomb GL, 2009, MOL MICROBIOL, V71, P332, DOI 10.1111/j.1365-2958.2008.06525.x; Liu T, 2005, BIOCHEMISTRY-US, V44, P8673, DOI 10.1021/bi050450+; Llanos J, 2000, CURR MICROBIOL, V41, P201, DOI 10.1007/s002840010119; Louvel H, 2009, FEMS MICROBIOL LETT, V295, P117, DOI 10.1111/j.1574-6968.2009.01594.x; Marisa L, 2007, BIOINFORMATICS, V23, P2339, DOI 10.1093/bioinformatics/btm321; Metz S, 2000, GEOCHIM COSMOCHIM AC, V64, P2267, DOI 10.1016/S0016-7037(00)00354-9; MITRA RS, 1978, J BACTERIOL, V133, P75, DOI 10.1128/JB.133.1.75-80.1978; Momose Y, 2001, ENVIRON TOXICOL CHEM, V20, P2353; Moon YJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015420; Mounicou S, 2003, FOOD ADDIT CONTAM A, V20, P343, DOI 10.1080/0265203031000077888; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Okamura H, 2007, STRUCTURE, V15, P1325, DOI 10.1016/j.str.2007.07.018; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002; Peeters E, 2010, ARCHAEA, V2010, DOI 10.1155/2010/750457; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; Robb Frank T., 1995, P167; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Ronconi S, 2008, FEBS J, V275, P2754, DOI 10.1111/j.1742-4658.2008.06416.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sandigursky M, 2000, J BIOL CHEM, V275, P19146, DOI 10.1074/jbc.M001995200; Sani RK, 2001, APPL ENVIRON MICROB, V67, P4765, DOI 10.1128/AEM.67.10.4765-4772.2001; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Shockley KR, 2003, APPL ENVIRON MICROB, V69, P2365, DOI 10.1128/AEM.69.4.2365-2371.2003; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Sindhikara DJ, 2009, BIOCHEMISTRY-US, V48, P12024, DOI 10.1021/bi9013352; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Strand KR, 2010, ARCH MICROBIOL, V192, P447, DOI 10.1007/s00203-010-0570-z; Tapias A, 2009, EXTREMOPHILES, V13, P333, DOI 10.1007/s00792-008-0221-3; Vaughn JL, 2000, NAT STRUCT BIOL, V7, P1139; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Von Damm K.L., 1995, SEAFLOOR HYDROTHERMA, P222, DOI DOI 10.1029/GM091P0222; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Williams E, 2007, EXTREMOPHILES, V11, P19, DOI 10.1007/s00792-006-0002-9; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yang H, 2010, MOL MICROBIOL, V77, P1111, DOI 10.1111/j.1365-2958.2010.07275.x; Yokoyama K, 2007, STRUCTURE, V15, P1542, DOI 10.1016/j.str.2007.10.015; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	81	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41935	10.1371/journal.pone.0041935	http://dx.doi.org/10.1371/journal.pone.0041935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848664	Green Published, gold			2022-12-27	WOS:000306950200132
J	Lombardi, G; Lanteri, P; Graziani, R; Colombini, A; Banfi, G; Corsetti, R				Lombardi, Giovanni; Lanteri, Patrizia; Graziani, Rosa; Colombini, Alessandra; Banfi, Giuseppe; Corsetti, Roberto			Bone and Energy Metabolism Parameters in Professional Cyclists during the Giro d'Italia 3-Weeks Stage Race	PLOS ONE			English	Article							TURNOVER MARKERS; POWER OUTPUT; MINERAL DENSITY; HORMONE LEVELS; TOUR; EXERCISE; COMPETITION; FRANCE; EXPENDITURE; INTENSITY	Cycling is a not weight-bearing activity and is known to induce bone resorption. Stage races are really strenuous endurance performances affecting the energy homeostasis. The recently highlighted link, in the co-regulation of bone and energy metabolism, demonstrates a central role for the equilibrium between carboxylated and undercarboxylated forms of osteocalcin. Aim of this study was to understand the acute physiological responses to a cycling stage race in terms of bone turnover and energy metabolism and the possible co-regulative mechanisms underlying their relationship. We studied nine professional cyclists engaged in 2011 Giro d'Italia stage race. Pre-analytical and analytical phases tightly followed academic and anti-doping authority's recommendations. Bone and energy metabolism markers (bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, total and undercarboxylated osteocalcin, leptin and adiponectin) and related hormones (cortisol and testosterone) were measured, by Sandwich Enzyme Immunoassays, at days -1 (pre-race), 12 and 22 during the race. The power output and the energy expenditure (mean and accumulated) were derived and correlated with the biochemical indexes. During the race, bone metabolism showed that an unbalance in behalf of resorption, which is enhanced, occurred along with a relative increase in the concentration of the undercarboxylated form of osteocalcin that was indirectly related to the enhanced energy expenditure, through adipokines modifications, with leptin decrease (high energy consumption) and adiponectin increase (optimization of energy expenditure). The exertion due to heavy effort induced a decrease of cortisol, while testosterone levels resulted unchanged. In conclusion, during a 3-weeks stage race, bone metabolism is pushed towards resorption. A possible relationship between the bone and the energy metabolisms is suggested by the relative correlations among absolute and relative concentrations trends of undercarboxylated OC, adipokines concentrations, BMI, fat mass (%), power output and the derived energy expenditure.	[Lombardi, Giovanni; Lanteri, Patrizia; Colombini, Alessandra; Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Milan, Italy; [Graziani, Rosa] CEDAL Lab, Gallarate, Italy; [Banfi, Giuseppe] Univ Milan, Sch Med, Chair Clin Biochem, Milan, Italy; [Corsetti, Roberto] Med Board, Liquigas Cannondale Procycling Team, Sesto Al Reghena, Italy	IRCCS Istituto Ortopedico Galeazzi; University of Milan	Lombardi, G (corresponding author), IRCCS Ist Ortoped Galeazzi, Milan, Italy.	giovanni.lombardi@grupposandonato.it	Colombini, Alessandra/I-2441-2012; Lombardi, Giovanni/I-2414-2012; Lanteri, Patrizia/I-2420-2012; Banfi, Giuseppe/K-6585-2015	Colombini, Alessandra/0000-0002-1800-3424; Lombardi, Giovanni/0000-0002-8365-985X; Banfi, Giuseppe/0000-0001-9578-5338	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was funded by the Italian Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfi G, 2003, J SPORT MED PHYS FIT, V43, P223; Banfi G., 2002, USE ANTICOAGULANTS D; Banfi G, 2010, SPORTS MED, V40, P697, DOI 10.2165/11533090-000000000-00000; Bouassida A, 2010, BRIT J SPORT MED, V44, P620, DOI 10.1136/bjsm.2008.046151; Campion F, 2010, INT J SPORTS MED, V31, P511, DOI 10.1055/s-0029-1243616; Chicharro JL, 2001, HORM RES, V56, P159, DOI 10.1159/000048112; Chicharro JL, 2001, BRIT J SPORT MED, V35, P303, DOI 10.1136/bjsm.35.5.303; Colombini A, 2012, SCAND J CLIN LAB INV, V72, P114, DOI 10.3109/00365513.2011.642305; Confavreux CB, 2011, KIDNEY INT, V79, pS14, DOI 10.1038/ki.2011.25; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Corsetti R, 2012, CLIN CHEM LAB MED, V50, P949, DOI 10.1515/cclm-2011-0857; Penteado VSD, 2010, J CLIN DENSITOM, V13, P43, DOI 10.1016/j.jocd.2009.09.002; Dozio E, 2011, ADV CLIN CHEM, V55, P61, DOI 10.1016/B978-0-12-387042-1.00004-6; Duclos M, 1996, EUR J APPL PHYSIOL O, V73, P427, DOI 10.1007/BF00334419; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; Ebert TR, 2006, INT J SPORT PHYSIOL, V1, P324, DOI 10.1123/ijspp.1.4.324; Fernandez-Garcia B, 2000, MED SCI SPORT EXER, V32, P1002; Fernandez-Garcia B, 2002, INT J SPORTS MED, V23, P555, DOI 10.1055/s-2002-35532; Foster C, 2005, MED SCI SPORT EXER, V37, P670, DOI 10.1249/01.MSS.0000158183.64465.BF; Hinton PS, 2010, APPL PHYSIOL NUTR ME, V35, P344, DOI 10.1139/H10-025; Hoogeveen AR, 1996, INT J SPORTS MED, V17, P423; Ihle R, 2004, J BONE MINER RES, V19, P1231, DOI 10.1359/JBMR.040410; Jurimae J, 2006, EUR J APPL PHYSIOL, V97, P127, DOI 10.1007/s00421-006-0158-0; Lippi G, 2010, EUR J APPL PHYSIOL, V109, P1003, DOI 10.1007/s00421-010-1437-3; Lombardi G, 2011, EUR J APPL PHYSIOL, V111, P433, DOI 10.1007/s00421-010-1664-7; Lucia A, 2003, SCAND J MED SCI SPOR, V13, P275, DOI 10.1034/j.1600-0838.2003.00345.x; Lucia A, 2001, BRIT J SPORT MED, V35, P424, DOI 10.1136/bjsm.35.6.424; Maimoun L, 2004, INT J SPORTS MED, V25, P230, DOI 10.1055/s-2003-45257; McMurray RG, 2005, SPORTS MED, V35, P393, DOI 10.2165/00007256-200535050-00003; Meier C, 2008, ARCH INTERN MED, V168, P47, DOI 10.1001/archinternmed.2007.2; Mouzopoulos G, 2007, INT J SPORTS MED, V28, P576, DOI 10.1055/s-2007-964841; Nichols JF, 2003, OSTEOPOROSIS INT, V14, P644, DOI 10.1007/s00198-003-1418-z; Olmedillas H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024841; Padilla S, 2008, EUR J APPL PHYSIOL, V102, P431, DOI 10.1007/s00421-007-0602-9; Rector RS, 2008, METABOLISM, V57, P226, DOI 10.1016/j.metabol.2007.09.005; SARIS WHM, 1989, INT J SPORTS MED, V10, pS26, DOI 10.1055/s-2007-1024951; Smathers AM, 2009, MED SCI SPORT EXER, V41, P290, DOI 10.1249/MSS.0b013e318185493e; Vogt S, 2008, INT J SPORTS MED, V29, P244, DOI 10.1055/s-2007-965353; Vogt S, 2007, INT J SPORTS MED, V28, P756, DOI 10.1055/s-2007-964982; Vogt S, 2006, MED SCI SPORT EXER, V38, P147, DOI 10.1249/01.mss.0000183196.63081.6a; Wei JW, 2010, ARCH BIOCHEM BIOPHYS, V503, P35, DOI 10.1016/j.abb.2010.05.021; Wolf G, 2008, NUTR REV, V66, P229, DOI 10.1111/j.1753-4887.2008.00027.x; Zanker CL, 2000, EUR J APPL PHYSIOL, V83, P434, DOI 10.1007/s004210000293	43	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42077	10.1371/journal.pone.0042077	http://dx.doi.org/10.1371/journal.pone.0042077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848709	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200158
J	Michael, PJ; Yeoh, PB; Scott, JK				Michael, Pippa J.; Yeoh, Paul B.; Scott, John K.			Potential Distribution of the Australian Native Chloris truncata Based on Modelling Both the Successful and Failed Global Introductions	PLOS ONE			English	Article							NEW-SOUTH-WALES; LOW-INPUT PASTURES; PERENNIAL GRASSES; NORTHWEST SLOPES; WARM-SEASON; SURVIVAL; ESTABLISHMENT; PERFORMANCE; MANAGEMENT; RECORDS	Our aim was to model the current and future potential global distribution of Chloris truncata (windmill grass) based on the plant's biology, soil requirements and colonisation success. The growth response of C. truncata to constant temperatures and soil moisture levels were measured and estimated respectively, to develop parameters for a CLIMEX bioclimatic model of potential distribution. The native distribution in eastern Australia and naturalised distribution in Western Australia was also used to inform the model. Associations with soil types were assessed within the suitable bioclimatic region in Australia. The global projection of the model was tested against the distribution of soil types and the known successful and failed global introductions. The verified model was then projected to future conditions due to climate change. Optimal temperature for plant development was 28 degrees C and the plant required 970 degree-days above a threshold of 10 degrees C. Early collection records indicate that the species is native to Queensland, New South Wales and Victoria. The plant has been introduced elsewhere in Australia and throughout the world as a wool contaminant and as a potential pasture species, but some of the recorded establishments have failed to persist. The CLIMEX model projected to the world reflected effectively both the successful and failed distributions. The inclusion of soil associations improved the explanation of the observed distribution in Australia, but did not improve the ability to determine the potential distribution elsewhere, due to lack of similarity of soil types between continents. The addition of a climate change projection showed decreased suitability for this species in Australia, but increased suitability for other parts of the world, including regions where the plant previously failed to establish.	[Michael, Pippa J.] Curtin Univ Technol, Sch Sci, Dept Environm & Agr, Perth, WA, Australia; [Yeoh, Paul B.; Scott, John K.] CSIRO Ecosyst Sci, Climate Adaptat Flagship, Perth, WA, Australia	Curtin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Michael, PJ (corresponding author), Curtin Univ Technol, Sch Sci, Dept Environm & Agr, Perth, WA, Australia.	p.michael@curtin.edu.au	Michael, Pippa/A-1381-2008; Yeoh, Paul B/D-3011-2011; Scott, John K./C-1061-2009	Scott, John K./0000-0002-8303-9706; Yeoh, Paul/0000-0002-6233-5901; Michael, Pippa/0000-0002-0341-8766	Curtin University; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Climate Adaptation Flagship; Department of Agriculture, Fisheries and Forestry (DAFF); Rural Industries Research and Development Corporation (RIRDC)	Curtin University; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Climate Adaptation Flagship; Department of Agriculture, Fisheries and Forestry (DAFF)(Australian GovernmentDepartment of Agriculture and Water Resources); Rural Industries Research and Development Corporation (RIRDC)(Rural Industries R&D Corp)	This work was supported by Curtin University, Commonwealth Scientific and Industrial Research Organisation (CSIRO) Climate Adaptation Flagship, Department of Agriculture, Fisheries and Forestry (DAFF), and Rural Industries Research and Development Corporation (RIRDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D E, 1974, Brigham Young University Science Bulletin Biological Series, V19, P1; AVH, 2011, AUSTR VIRTUAL HERBAR; Bishop Museum, 2011, BISH MUS NAT SCI DAT; Bolibar SC, 2003, ESTUDIO PRELIMINAR P; Brummitt R. K., 2001, PLANT TAXONOMIC DATA, V2; Bureau of Rural Sciences, 2009, DIG ATL AUSTR SOILS; Curl SM, 1877, T P NZ I, V10, P345; DAISIE, 2011, DAISIE EUR INV AL SP; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Dvorak J., 1966, PRESLIA, V38, P327; EDGAR E, 1991, NEW ZEAL J BOT, V29, P117, DOI 10.1080/0028825X.1991.10416715; Everist SL, 1935, QD AGRIC J, V44, P18; FAO, 2007, DIG SOIL MAP WORLD V; Fasseaux W, 1952, B SOC ROY BOT BELG, V84, P239; Flora Europaea, 2011, ROYAL BOT GARD ED; Garden DL, 2005, RANGELAND J, V27, P41, DOI 10.1071/RJ05003; Germinshuizen G, 2003, PLANTS SO AFRICA ANN; Green PS, 1994, FLORA AUSTR, V49, P478; Groves RH, 2002, FLORA AUSTR, P157; Hartmann HT., 2002, PLANT PROPAGATION PR, V6; Hawkes JR, 2005, AUST J AGR RES, V56, P257, DOI 10.1071/AR04259; HEALY A. J., 1957, TRANS ROY SOC NEW ZEALAND, V84, P649; Herbst DR, 1999, 7 BISHOP MUS OCCAS P, V58, P12; Hill M. O., 2005, AUDIT NONNATIVE SPEC; Home RW, 2006, REGARDFULLY YOURS SE, V3, P1876; Huxtable CHA, 1999, AUST J BOT, V47, P221, DOI 10.1071/BT97119; IPCC, 2007, CONTRIBUTION WORKING; Johnston WH, 1996, NEW ZEAL J AGR RES, V39, P527, DOI 10.1080/00288233.1996.9513213; KLOOT P M, 1985, Journal of the Adelaide Botanic Gardens, V7, P145; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; LAZARIDES M, 1972, AUST J BOT, P1; Lazarides M, 2002, FLORA AUST, P213; LEIGH J. H., 1966, AUSTRALIAN J EXP AGR ANIM HUSB, V6, P468, DOI 10.1071/EA9660468; Lodge G. M., 1979, Australian Rangeland Journal, V1, P327, DOI 10.1071/RJ9790327; Lodge GM, 2003, AUST J EXP AGR, V43, P891, DOI 10.1071/EA02189; LODGE GM, 1981, AUST J BOT, V29, P121, DOI 10.1071/BT9810121; LODGE GM, 1981, AUST J BOT, V29, P111, DOI 10.1071/BT9810111; MAZE KM, 1993, AUST J BOT, V41, P79, DOI 10.1071/BT9930079; McDonald G, 1995, AUST J ZOOL, V43, P601, DOI 10.1071/ZO9950601; MCKENZIE N, 2000, CSIRO LAND WATER TEC, V11, P1; Merrill ED, 1915, PHILIPP J SCI, V10, P187; Merrill ED, 1906, PHILIP J SC BOT S5, V1, P307; Michael PJ, 2012, AUST J BOT, V60, P128, DOI 10.1071/BT11242; MICHALK DL, 1976, J RANGE MANAGE, V29, P380, DOI 10.2307/3897144; Mito Toshikazu, 2004, Global Environmental Research, V8, P171; Molina AM, 2004, CANDOLLEA, V59, P347; Morris DI, 1991, TASMANIAN HERBARIUM, V3, P1; Murata G, 1992, ACTA PHYTOTAXONOMICA, V43, P147; Nakicenovic N., 2000, SPECIAL REPORT EMISS; National Museum of Natural History, 2011, BOT COLL; Nightingale M.E., 2005, FLORA AUSTR, V44B, P269; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Osten V, 2011, CHLOR SPP BIOL MAN S; Probst R., 1949, WOLLADVENTIVFLORA MI; Pysek P, 2005, BIOL INVASIONS, V7, P567, DOI 10.1007/s10530-004-7566-z; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Riefner Richard E. Jr., 2007, Journal of the Botanical Research Institute of Texas, V1, P719; Robertson G., 1987, Australian Rangeland Journal, V9, P79; Ryves TB, 1996, ALIEN GRASSES BRIT I; SANBI, 2009, INT BIOD INF SYST; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; SHINNERS L H, 1973, SIDA Contributions to Botany, V5, P182; Smith AC, 1979, FLORA VITIENSIS NOVA, P494; South Carolina Department of Natural Resources, 2010, S CAR PLANT ATL; South Pacific Regional Herbarium, 2011, SO PAC REG HERB; Summerhayes VS, 1927, B MISCELLANEOUS INFO, V1, P18; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2007, CLIMEX V3 USERS GUID; Sykes WR, 1970, B NZ DEP SCI IND RES, V200, P9; Syme H, 2007, AUST J SOIL RES, V45, P635, DOI 10.1071/SR07159; The New Zealand National Herbarium Network, 2009, NZ VIRT HERB; TROPICOS, 2011, MISS BOT GARD VAST V; van Ooststroom SJ, 1962, GORTERIA, V1, P41; Verloove F., 2005, Lazaroa, V26, P141; Verloove F, 2006, SCRIPTA BOT BELGICA, V39, P3; Verloove Filip, 2008, Acta Botanica Malacitana, V33, P147; Waters CM, 2005, RANGELAND J, V27, P23, DOI 10.1071/RJ05001; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x	80	13	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42140	10.1371/journal.pone.0042140	http://dx.doi.org/10.1371/journal.pone.0042140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848733	Green Published, gold			2022-12-27	WOS:000306950200173
J	Nair, GR; Dash, C; Le Grice, SFJ; DeStefano, JJ				Nair, Gauri R.; Dash, Chandravanu; Le Grice, Stuart F. J.; DeStefano, Jeffrey J.			Viral Reverse Transcriptases Show Selective High Affinity Binding to DNA-DNA Primer-Templates that Resemble the Polypurine Tract	PLOS ONE			English	Article							SARCOMA-VIRUS; PLUS STRANDS; IN-VITRO; RNA; MUTATIONS; SEQUENCE; TY3; INHIBITORS; INITIATION; MECHANISM	Previous results using a SELEX (Systematic Evolution of Ligands by Exponential Enrichment)-based approach that selected DNA primer-template duplexes binding with high affinity to HIV reverse transcriptase (RT) showed that primers mimicking the 3' end, and in particular the six nt terminal G tract, of the RNA polypurine tract (PPT; HIV PPT: 5'-AAAAGAAAAGGGGGG-3') were preferentially selected. In this report, two viral (Moloney murine leukemia virus (MuLV) and avian myeloblastosis virus (AMV)) and one retrotransposon (Ty3) RTs were used for selection. Like HIV RT, both viral RTs selected duplexes with primer strands mimicking the G tract at the PPT 3' end (AMV PPT: 5'-AGGGAGGGGGA-3'; MuLV PPT: 5'-AGAAAAAGGGGGG-3'). In contrast, Ty3, whose PPT lacks a G tract (5'-GAGAGAGAGGAA-3') showed no selective binding to any duplex sequences. Experiments were also conducted with DNA duplexes (termed DNA PPTs) mimicking the RNA PPT-DNA duplex of each virus and a control duplex with a random DNA sequence. Retroviral RTs bound with high affinity to all viral DNA PPT constructs, with HIV and MuLV RTs showing comparable binding to the counterpart DNA PPT duplexes and reduced affinity to the AMV DNA PPT. AMV RT showed similar behavior with a modest preference for its own DNA PPT. Ty3 RT showed no preferential binding for its own or any other DNA PPT and viral RTs bound the Ty3 DNA PPT with relatively low affinity. In contrast, binding affinity of HIV RT to duplexes containing the HIV RNA PPT was less dependent on the G tract, which is known to be pivotal for efficient extension. We hypothesize that the G tract on the RNA PPT helps shift the binding orientation of RT to the 3' end of the PPT where extension can occur.	[Nair, Gauri R.; DeStefano, Jeffrey J.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Dash, Chandravanu; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nair, GR (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	jdestefa@umd.edu		Dash, Chandravanu/0000-0003-4466-8355	National Institutes of General Medicine [GM051140]; National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051140, R29GM051140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033892, R03DA030896, R00DA024558] Funding Source: NIH RePORTER	National Institutes of General Medicine; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by National Institutes of General Medicine Grant GM051140 awarded to JJD. SFJLeG was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Arhel NJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-38; Boeke J. D., 1997, P343; Brinson RG, 2009, BIOCHEMISTRY-US, V48, P6988, DOI 10.1021/bi900357j; Cote ML, 2003, J MOL BIOL, V330, P57, DOI 10.1016/S0022-2836(03)00554-0; Cristofaro JV, 2002, BIOCHEMISTRY-US, V41, P10968, DOI 10.1021/bi025871v; Dash C, 2006, J BIOL CHEM, V281, P2773, DOI 10.1074/jbc.M510369200; DeStefano JJ, 2008, OLIGONUCLEOTIDES, V18, P133, DOI 10.1089/oli.2008.0103; DESTEFANO JJ, 1993, BIOCHEMISTRY-US, V32, P6908, DOI 10.1021/bi00078a014; DeStefano JJ, 2006, NUCLEIC ACIDS RES, V34, P130, DOI 10.1093/nar/gkj426; DESTEFANO JJ, 1995, NUCLEIC ACIDS RES, V23, P3901, DOI 10.1093/nar/23.19.3901; DeStefano JJ, 2001, J BIOL CHEM, V276, P32515, DOI 10.1074/jbc.M103958200; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Gorshkova II, 2001, ANAL BIOCHEM, V291, P198, DOI 10.1006/abio.2001.5053; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Jacob DT, 2008, VIROLOGY, V378, P385, DOI 10.1016/j.virol.2008.06.002; Jones FD, 2007, VIROLOGY, V360, P341, DOI 10.1016/j.virol.2006.10.008; Julias JG, 2004, J VIROL, V78, P13315, DOI 10.1128/JVI.78.23.13315-13324.2004; Kelleher CD, 2000, J BIOL CHEM, V275, P13061, DOI 10.1074/jbc.275.17.13061; Klarmann GJ, 1997, J VIROL, V71, P9259, DOI 10.1128/JVI.71.12.9259-9269.1997; KUNG HJ, 1981, J VIROL, V37, P127, DOI 10.1128/JVI.37.1.127-138.1981; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; MCCLURE MA, 1991, MOL BIOL EVOL, V8, P835; Michalowski D, 2008, NUCLEIC ACIDS RES, V36, P7124, DOI 10.1093/nar/gkn891; MILLER MD, 1995, J VIROL, V69, P3938, DOI 10.1128/JVI.69.6.3938-3944.1995; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Oh J, 2006, J VIROL, V80, P10281, DOI 10.1128/JVI.00361-06; Palaniappan C, 1998, J BIOL CHEM, V273, P3808, DOI 10.1074/jbc.273.7.3808; Park F, 2001, MOL THER, V4, P164, DOI 10.1006/mthe.2001.0450; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Post K, 2009, NUCLEIC ACIDS RES, V37, P1755, DOI 10.1093/nar/gkn1045; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; PULLEN KA, 1993, J BIOL CHEM, V268, P6221; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rausch JW, 2000, J BIOL CHEM, V275, P13879, DOI 10.1074/jbc.275.18.13879; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Robson ND, 2000, J VIROL, V74, P10293, DOI 10.1128/JVI.74.22.10293-10303.2000; Sambrook J., 2001, MOL CLONING LAB MANU; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; SCHNEIDER DJ, 1995, BIOCHEMISTRY-US, V34, P9599, DOI 10.1021/bi00029a037; Schultz SJ, 1999, J BIOL CHEM, V274, P34547, DOI 10.1074/jbc.274.49.34547; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Telesnitsky A., 1997, P121; Telesnitsky A, 1993, REVERSE TRANSCRIPTAS; Turner KB, 2009, RNA, V15, P1605, DOI 10.1261/rna.1615409; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41712	10.1371/journal.pone.0041712	http://dx.doi.org/10.1371/journal.pone.0041712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848574	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200092
J	Rosseel, T; Scheuch, M; Hoper, D; De Regge, N; Caij, AB; Vandenbussche, F; Van Borm, S				Rosseel, Toon; Scheuch, Matthias; Hoeper, Dirk; De Regge, Nick; Caij, Ann Brigitte; Vandenbussche, Frank; Van Borm, Steven			DNase SISPA-Next Generation Sequencing Confirms Schmallenberg Virus in Belgian Field Samples and Identifies Genetic Variation in Europe	PLOS ONE			English	Article							MOLECULAR EVOLUTION; RNA VIRUSES; RATES; PARVOVIRUS; INFECTION	In 2011, a novel Orthobunyavirus was identified in cattle and sheep in Germany and the Netherlands. This virus was named Schmallenberg virus (SBV). Later, presence of the virus was confirmed using real time RT-PCR in cases of congenital malformations of bovines and ovines in several European countries, including Belgium. In the absence of specific sequencing protocols for this novel virus we confirmed its presence in RT-qPCR positive field samples using DNase SISPA-next generation sequencing (NGS), a virus discovery method based on random amplification and next generation sequencing. An in vitro transcribed RNA was used to construct a standard curve allowing the quantification of viral RNA in the field samples. Two field samples of aborted lambs containing 7.66 and 7.64 log(10) RNA copies per mu L total RNA allowed unambiguous identification of SBV. One sample yielded 192 SBV reads covering about 81% of the L segment, 56% of the M segment and 13% of the S segment. The other sample resulted in 8 reads distributed over the L and M segments. Three weak positive field samples (one from an aborted calf, two from aborted lambs) containing virus quantities equivalent to 4.27-4.89 log(10) RNA copies per mu L did not allow identification using DNase SISPA-NGS. This partial sequence information was compared to the whole genome sequence of SBV isolated from bovines in Germany, identifying several sequence differences. The applied viral discovery method allowed the confirmation of SBV in RT-qPCR positive brain samples. However, the failure to confirm SBV in weak PCR-positive samples illustrates the importance of the selection of properly targeted and fresh field samples in any virus discovery method. The partial sequences derived from the field samples showed several differences compared to the sequences from bovines in Germany, indicating sequence divergence within the epidemic.	[Rosseel, Toon; Vandenbussche, Frank; Van Borm, Steven] Vet & Agrochem Res Ctr, Operat Direct Viral Dis, Virol Platform Unit VIRPLAT, Brussels, Belgium; [Scheuch, Matthias; Hoeper, Dirk] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [De Regge, Nick; Caij, Ann Brigitte] Vet & Agrochem Res Ctr, Operat Direct Viral Dis, Unit Enzoot & Reemerging Viral Dis ENZOREM, Brussels, Belgium	Friedrich Loeffler Institute	Rosseel, T (corresponding author), Vet & Agrochem Res Ctr, Operat Direct Viral Dis, Virol Platform Unit VIRPLAT, Brussels, Belgium.	steven.vanborm@coda-cerva.be	Van Borm, Steven/P-3336-2014	Hoper, Dirk/0000-0001-8408-2274	RandSeq11 of the Veterinary and Agrochemical Research Center; European Union FP7 project RAPIDIA-FIELD [FP7-289364]; Network of Competence of Agricultural and Nutritional Research "PHENOMICS'' of the German Federal Ministry of Education and Research	RandSeq11 of the Veterinary and Agrochemical Research Center; European Union FP7 project RAPIDIA-FIELD; Network of Competence of Agricultural and Nutritional Research "PHENOMICS'' of the German Federal Ministry of Education and Research	This study was supported by internal research and development grant RandSeq11 of the Veterinary and Agrochemical Research Center, European Union FP7 project RAPIDIA-FIELD (FP7-289364), and by the Network of Competence of Agricultural and Nutritional Research "PHENOMICS'' of the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bilk S, 2012, VET MICROBIOL, DOI [http://dx.doi.org/10.1016/j.vetmic.2012.03.35, DOI 10.1016/J.VETMIC.2012.03.35]; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Muskens J, 2012, TIJDSCHR DIERGENEESK, V137, P112; ProMED-Mail, 2012, SCHMALL VIR EUR UPD; ProMED-mail, 2012, SCHMALL VIR EUR VECT; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Rosseel T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463; Van Borm S, 2012, ARCH VIROL IN PRESS; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106	17	43	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41967	10.1371/journal.pone.0041967	http://dx.doi.org/10.1371/journal.pone.0041967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848676	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200138
J	van Eijl, S; Zhu, ZY; Cupitt, J; Gierula, M; Gotz, C; Fritsche, E; Edwards, RJ				van Eijl, Sven; Zhu, Zheying; Cupitt, John; Gierula, Magdalena; Goetz, Christine; Fritsche, Ellen; Edwards, Robert J.			Elucidation of Xenobiotic Metabolism Pathways in Human Skin and Human Skin Models by Proteomic Profiling	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; EPIDERMAL-KERATINOCYTES; HUMAN-LIVER; EXPRESSION; CYTOCHROME-P450; ENZYMES; SPECIFICITY; PROTEINS; CULTURES; FORMS	Background: Human skin has the capacity to metabolise foreign chemicals (xenobiotics), but knowledge of the various enzymes involved is incomplete. A broad-based unbiased proteomics approach was used to describe the profile of xenobiotic metabolising enzymes present in human skin and hence indicate principal routes of metabolism of xenobiotic compounds. Several in vitro models of human skin have been developed for the purpose of safety assessment of chemicals. The suitability of these epidermal models for studies involving biotransformation was assessed by comparing their profiles of xenobiotic metabolising enzymes with those of human skin. Methodology/Principal Findings: Label-free proteomic analysis of whole human skin (10 donors) was applied and analysed using custom-built PROTSIFT software. The results showed the presence of enzymes with a capacity for the metabolism of alcohols through dehydrogenation, aldehydes through dehydrogenation and oxidation, amines through oxidation, carbonyls through reduction, epoxides and carboxylesters through hydrolysis and, of many compounds, by conjugation to glutathione. Whereas protein levels of these enzymes in skin were mostly just 4-10 fold lower than those in liver and sufficient to support metabolism, the levels of cytochrome P450 enzymes were at least 300-fold lower indicating they play no significant role. Four epidermal models of human skin had profiles very similar to one another and these overlapped substantially with that of whole skin. Conclusions/Significance: The proteomics profiling approach was successful in producing a comprehensive analysis of the biotransformation characteristics of whole human skin and various in vitro skin models. The results show that skin contains a range of defined enzymes capable of metabolising different classes of chemicals. The degree of similarity of the profiles of the in vitro models indicates their suitability for epidermal toxicity testing. Overall, these results provide a rational basis for explaining the fate of xenobiotics in skin and will aid chemical safety testing programmes.	[van Eijl, Sven; Zhu, Zheying; Cupitt, John; Gierula, Magdalena; Edwards, Robert J.] Univ London Imperial Coll Sci Technol & Med, Ctr Pharmacol & Therapeut, Div Expt Med, London, England; [Goetz, Christine; Fritsche, Ellen] Univ Dusseldorf, Leibniz Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany; [Fritsche, Ellen] Univ Clin RWTH, Dept Dermatol & Allergol, Aachen, Germany	Imperial College London; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); RWTH Aachen University; RWTH Aachen University Hospital	Edwards, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Pharmacol & Therapeut, Div Expt Med, London, England.	r.edwards@imperial.ac.uk		van Eijl, Sven/0000-0002-7605-473X	European Cosmetics Association (COLIPA), as part of their Alternative Approaches to Animal Testing research programme; Medical Research Council [G0801056B] Funding Source: researchfish	European Cosmetics Association (COLIPA), as part of their Alternative Approaches to Animal Testing research programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the European Cosmetics Association (COLIPA), as part of their Alternative Approaches to Animal Testing research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardema MJ, 2010, MUTAT RES-GEN TOX EN, V701, P123, DOI 10.1016/j.mrgentox.2010.05.017; Abdul-Salam VB, 2010, CIRCULATION, V122, P2058, DOI 10.1161/CIRCULATIONAHA.110.972745; ADEMOLA JI, 1995, CURR PROBL DERMATOL, V22, P201; Afaq F, 2009, J INVEST DERMATOL, V129, P2396, DOI 10.1038/jid.2009.85; Baron JM, 2001, J INVEST DERMATOL, V116, P541, DOI 10.1046/j.1523-1747.2001.01298.x; Boelsma E, 2000, ACTA DERM-VENEREOL, V80, P82; Bonifas J, 2010, TOXICOL IN VITRO, V24, P973, DOI 10.1016/j.tiv.2009.12.023; BOOBIS AR, 1980, BRIT J CLIN PHARMACO, V9, P11, DOI 10.1111/j.1365-2125.1980.tb04790.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Casarett L.J., 1996, CASARETT DOULLS TOXI; Chanda S, 2008, DRUG METAB DISPOS, V36, P670, DOI 10.1124/dmd.107.019240; Cheung C, 2003, J DERMATOL SCI, V31, P9, DOI 10.1016/S0923-1811(02)00139-1; Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014; EDWARDS RJ, 1991, METHOD ENZYMOL, V206, P220; Edwards RJ, 1998, BIOCHEM PHARMACOL, V56, P377, DOI 10.1016/S0006-2952(98)00033-1; Gibbs S, 2007, CURR DRUG METAB, V8, P758, DOI 10.2174/138920007782798225; Gotz C, 2012, EXP DERMATOL, V21, P358, DOI 10.1111/j.1600-0625.2012.01486.x; GRANT DM, 1991, MOL PHARMACOL, V39, P184; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Higashi Y, 2004, J INVEST DERMATOL, V122, P1207, DOI 10.1111/j.0022-202X.2004.22416.x; Hoofnagle AN, 2012, CLIN CHEM, V58, P777, DOI 10.1373/clinchem.2011.173856; Hu T, 2010, TOXICOL IN VITRO, V24, P1450, DOI 10.1016/j.tiv.2010.03.013; KAWAKUBO Y, 1990, Skin Pharmacology, V3, P180; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9; Luu-The V, 2009, J STEROID BIOCHEM, V116, P178, DOI 10.1016/j.jsbmb.2009.05.011; Oesch F, 2007, DRUG METAB REV, V39, P659, DOI 10.1080/03602530701690366; RAZA H, 1991, J INVEST DERMATOL, V96, P463, DOI 10.1111/1523-1747.ep12470150; Rolsted K, 2008, ARCH DERMATOL RES, V300, P10, DOI 10.1007/s00403-007-0811-4; Schallreuter KU, 1996, ARCH DERMATOL RES, V288, P14, DOI 10.1007/BF02505037; Seidegard J, 1997, ENVIRON HEALTH PERSP, V105, P791, DOI 10.2307/3433285; WARD A, 1995, BIOCHEM PHARMACOL, V49, P1759, DOI 10.1016/0006-2952(95)00087-G; Westlind-Johnsson A, 2003, DRUG METAB DISPOS, V31, P755, DOI 10.1124/dmd.31.6.755; Wiegand C, 2009, SKIN PHARMACOL PHYS, V22, P74, DOI 10.1159/000178866; WILKIN JK, 1987, J INVEST DERMATOL, V88, P452, DOI 10.1111/1523-1747.ep12469846; Zhu ZY, 2008, PROTEOMICS, V8, P1987, DOI 10.1002/pmic.200700901; Zhu ZY, 2002, BIOCHEM BIOPH RES CO, V297, P65, DOI 10.1016/S0006-291X(02)02134-4	37	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41721	10.1371/journal.pone.0041721	http://dx.doi.org/10.1371/journal.pone.0041721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848577	Green Published, Green Submitted, gold			2022-12-27	WOS:000309240600044
J	Nagel, C; Prange, F; Guth, S; Herb, J; Ehlken, N; Fischer, C; Reichenberger, F; Rosenkranz, S; Seyfarth, HJ; Mayer, E; Halank, M; Grunig, E				Nagel, Christian; Prange, Felix; Guth, Stefan; Herb, Jochen; Ehlken, Nicola; Fischer, Christine; Reichenberger, Frank; Rosenkranz, Stephan; Seyfarth, Hans-Juergen; Mayer, Eckhard; Halank, Michael; Gruenig, Ekkehard			Exercise Training Improves Exercise Capacity and Quality of Life in Patients with Inoperable or Residual Chronic Thromboembolic Pulmonary Hypertension	PLOS ONE			English	Article							INTERNATIONAL PROSPECTIVE REGISTRY; BOSENTAN THERAPY; ARTERIAL-HYPERTENSION; FOLLOW-UP; EMBOLISM	Background: Aim of this prospective study was to evaluate the effects of exercise training in patients with inoperable or residual chronic thromboembolic pulmonary hypertension (CTEPH). Methods: Thirty-five consecutive patients with invasively confirmed inoperable or residual CTEPH (16 women; 19 men; mean age 61 +/- 15 years, mean pulmonary artery pressure, 63 +/- 20 mmHg; primary inoperable n = 33, persisting pulmonary hypertension after pulmonary endarterectomy n = 2) on stable disease-targeted medication received exercise training in-hospital for 3 weeks and continued at home for 15 weeks. Medication remained unchanged during the study period. Efficacy parameters have been evaluated at baseline, after 3 and 15 weeks by blinded-observers. Survival rate has been evaluated in a follow-up period of median 36.4 months (interquartile range 26.6-46.6 months). Results: All patients tolerated exercise training without severe adverse events. Patients significantly improved the mean distance walked in 6 minutes compared to baseline by 61 +/- 54 meters after 3 weeks (p < 0.001) and by 71 +/- 70 meters after 15 weeks (p = 0.001), as well as scores of quality-of-life questionnaire, peak oxygen consumption and maximal workload. NT-proBNP improved significantly after 3 weeks of exercise training (p = 0.046). The 1-year survival rate was 97%, 2-year survival rate was 94% and the 3-year-survival 86% respectively. Conclusion: Training as add-on to medical therapy may be effective in patients with CTEPH to improve work capacity, quality of life and further prognostic relevant parameters and possibly improves the 1-, 2- and 3-year survival rate. Further multicentric randomized controlled studies are needed to confirm these promising results.	[Nagel, Christian; Prange, Felix; Herb, Jochen; Ehlken, Nicola; Gruenig, Ekkehard] Univ Heidelberg Hosp, Thoraxclin, Ctr Pulm Hypertens, Heidelberg, Germany; [Guth, Stefan; Mayer, Eckhard] Max Planck Inst Physiol & Clin Res, Kerckhoff Klin, Dept Thorac Surg, Bad Nauheim, Germany; [Fischer, Christine] Heidelberg Univ, Dept Human Genet, Heidelberg, Germany; [Reichenberger, Frank] Univ Giessen Marburg, Dept Pneumol, Giessen, Germany; [Rosenkranz, Stephan] Univ Cologne, Dept Cardiol, D-50931 Cologne, Germany; [Seyfarth, Hans-Juergen] Univ Leipzig, Dept Pneumol, Leipzig, Germany; [Halank, Michael] Univ Dresden, Dept Pneumol, Dresden, Germany	Ruprecht Karls University Heidelberg; Kerckhoff Clinic; Max Planck Society; Ruprecht Karls University Heidelberg; University of Cologne; Leipzig University; Technische Universitat Dresden	Nagel, C (corresponding author), Univ Heidelberg Hosp, Thoraxclin, Ctr Pulm Hypertens, Heidelberg, Germany.	ekkehard.gruenig@thoraxklinik-heidelberg.de	Benjamin, Nicola/AAJ-4360-2021; Reichenberger, Frank/AAJ-7232-2020	Reichenberger, Frank/0000-0003-1136-4769	German patient organization Pulmonale Hypertonie e.V., Rheinstetten, Germany	German patient organization Pulmonale Hypertonie e.V., Rheinstetten, Germany	The study was funded by a grant of the German patient organization Pulmonale Hypertonie e.V., Rheinstetten, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becattini C, 2006, CHEST, V130, P172, DOI 10.1378/chest.130.1.172; Bonderman D, 2005, CHEST, V128, P2599, DOI 10.1378/chest.128.4.2599; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; de Man FS, 2009, EUR RESPIR J, V34, P669, DOI 10.1183/09031936.00027909; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Ghofrani HA, 2010, EUR RESPIR J, V36, P792, DOI 10.1183/09031936.00182909; Grunig E, 2011, RESPIRATION, V81, P394, DOI 10.1159/000322475; Grunig E, 2012, EUR RESP J; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; Handoko ML, 2009, CIRCULATION, V120, P42, DOI 10.1161/CIRCULATIONAHA.108.829713; Hoeper MM, 2005, CHEST, V128, P2363, DOI 10.1378/chest.128.4.2363; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Hughes RJ, 2006, EUR RESPIR J, V28, P138, DOI 10.1183/09031936.06.00135905; Jais X, 2008, J AM COLL CARDIOL, V52, P2127, DOI 10.1016/j.jacc.2008.08.059; Jensen KW, 2009, CIRCULATION, V120, P1248, DOI 10.1161/CIRCULATIONAHA.109.865881; Korkmaz A, 2012, CLIN APPL THROMB HEM; Lang IM, 2009, EUR RESPIR REV, V18, P24, DOI 10.1183/09059180.00011110; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Saouti N, 2009, RESP MED, V103, P1013, DOI 10.1016/j.rmed.2009.01.017; Scholzel BE, 2011, LUNG; Suntharalingam J, 2007, RESP MED, V101, P2254, DOI 10.1016/j.rmed.2007.06.027; Ulrich S, 2007, SWISS MED WKLY, V137, P573; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilkens H, 2011, INT J CARDIOL, V154, pS54, DOI 10.1016/S0167-5273(11)70493-4	32	79	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41603	10.1371/journal.pone.0041603	http://dx.doi.org/10.1371/journal.pone.0041603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848542	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600093
J	Eng, D; Ma, HY; Xu, J; Shih, HP; Gross, MK; Kiouss, C				Eng, Diana; Ma, Hsiao-Yen; Xu, Jun; Shih, Hung-Ping; Gross, Michael K.; Kiouss, Chrissa			Loss of Abdominal Muscle in Pitx2 Mutants Associated with Altered Axial Specification of Lateral Plate Mesoderm	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HOX GENES; RIEGER-SYNDROME; TRANSCRIPTIONAL NETWORK; REGULATORY NETWORKS; EXPRESSION ANALYSIS; MOUSE DEVELOPMENT; VERTEBRATE BODY; SKELETAL-MUSCLE; RETINOIC ACID	Sequence specific transcription factors (SSTFs) combinatorially define cell types during development by forming recursively linked network kernels. Pitx2 expression begins during gastrulation, together with Hox genes, and becomes localized to the abdominal lateral plate mesoderm (LPM) before the onset of myogenesis in somites. The somatopleure of Pitx2 null embryos begins to grow abnormally outward before muscle regulatory factors (MRFs) or Pitx2 begin expression in the dermomyotome/myotome. Abdominal somites become deformed and stunted as they elongate into the mutant body wall, but maintain normal MRF expression domains. Subsequent loss of abdominal muscles is therefore not due to defects in specification, determination, or commitment of the myogenic lineage. Microarray analysis was used to identify SSTF families whose expression levels change in E10.5 interlimb body wall biopsies. All Hox9-11 paralogs had lower RNA levels in mutants, whereas genes expressed selectively in the hypaxial dermomyotome/myotome and sclerotome had higher RNA levels in mutants. In situ hybridization analyses indicate that Hox gene expression was reduced in parts of the LPM and intermediate mesoderm of mutants. Chromatin occupancy studies conducted on E10.5 interlimb body wall biopsies showed that Pitx2 protein occupied chromatin sites containing conserved bicoid core motifs in the vicinity of Hox 9-11 and MRF genes. Taken together, the data indicate that Pitx2 protein in LPM cells acts, presumably in combination with other SSTFs, to repress gene expression, that are normally expressed in physically adjoining cell types. Pitx2 thereby prevents cells in the interlimb LPM from adopting the stable network kernels that define sclerotomal, dermomyotomal, or myotomal mesenchymal cell types. This mechanism may be viewed either as lineage restriction or specification.	[Eng, Diana; Ma, Hsiao-Yen; Xu, Jun; Gross, Michael K.; Kiouss, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Shih, Hung-Ping] Univ Calif San Diego, Dept Pediat, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Oregon State University; University of California System; University of California San Diego	Eng, D (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	michael.gross@oregonstate.edu; chrissa.kioussi@oregonstate.edu	Xu, Jun/K-1233-2016	Xu, Jun/0000-0003-4221-5563	NIH-NIAMS [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER	NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by NIH-NIAMS grant AR054406 to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2002, MECH DEVELOP, V110, P187, DOI 10.1016/S0925-4773(01)00560-3; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Alvares LE, 2003, DEV CELL, V5, P379, DOI 10.1016/S1534-5807(03)00263-6; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; BOBER E, 1994, DEVELOPMENT, V120, P3073; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Borycki AG, 1999, DEVELOPMENT, V126, P1665; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Burke AC, 2003, DEV CELL, V4, P159, DOI 10.1016/S1534-5807(03)00033-9; Campbell AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035822; Campione M, 1999, DEVELOPMENT, V126, P1225; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; CHRIST B, 1983, ANAT EMBRYOL, V166, P87, DOI 10.1007/BF00317946; Christ B, 1998, ANAT EMBRYOL, V197, P1; COATES MI, 1995, CURR BIOL, V5, P844, DOI 10.1016/S0960-9822(95)00169-2; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; Daston G, 1996, DEVELOPMENT, V122, P1017; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deries M, 2010, DEV DYNAM, V239, P2898, DOI 10.1002/dvdy.22425; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Eng D, 2010, GENE, V469, P1, DOI 10.1016/j.gene.2010.08.008; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Gage PJ, 1999, DEVELOPMENT, V126, P4643; GOULDING M, 1994, DEVELOPMENT, V120, P957; GRAHAM A, 1991, DEVELOPMENT, V112, P255; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Henderson DJ, 1999, DEV BIOL, V209, P143, DOI 10.1006/dbio.1999.9215; Hilton T, 2010, J BIOL CHEM, V285, P11129, DOI 10.1074/jbc.M109.087429; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kitamura K, 1999, DEVELOPMENT, V126, P5749; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Misra K, 2010, DEV BIOL, V337, P74, DOI 10.1016/j.ydbio.2009.10.015; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; Schubert M, 2004, P NATL ACAD SCI USA, V101, P10320, DOI 10.1073/pnas.0403216101; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Sporle R, 1996, DEVELOPMENT, V122, P79; SUEMORI H, 1995, MECH DEVELOP, V51, P265, DOI 10.1016/0925-4773(95)00371-1; Summerbell D, 2002, MECH DEVELOP, V117, P331, DOI 10.1016/S0925-4773(02)00208-3; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	68	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42228	10.1371/journal.pone.0042228	http://dx.doi.org/10.1371/journal.pone.0042228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860089	gold, Green Published			2022-12-27	WOS:000307045600076
J	Franzen, CA; Todorovic, V; Desai, BV; Mirzoeva, S; Yang, XMJ; Green, KJ; Pelling, JC				Franzen, Carrie A.; Todorovic, Viktor; Desai, Bhushan V.; Mirzoeva, Salida; Yang, Ximing J.; Green, Kathleen J.; Pelling, Jill C.			The Desmosomal Armadillo Protein Plakoglobin Regulates Prostate Cancer Cell Adhesion and Motility through Vitronectin-Dependent Src Signaling	PLOS ONE			English	Article							GAMMA-CATENIN; BETA-CATENIN; E-CADHERIN; N-CADHERIN; P-CADHERIN; MESENCHYMAL TRANSITION; ALPHA-CATENIN; LNCAP MODEL; EXPRESSION; PATHWAY	Plakoglobin (PG) is an armadillo protein that associates with both classic and desmosomal cadherins, but is primarily concentrated in mature desmosomes in epithelia. While reduced levels of PG have been reported in localized and hormone refractory prostate tumors, the functional significance of these changes is unknown. Here we report that PG expression is reduced in samples of a prostate tumor tissue array and inversely correlated with advancing tumor potential in 7 PCa cell lines. Ectopically expressed PG enhanced intercellular adhesive strength, and attenuated the motility and invasion of aggressive cell lines, whereas silencing PG in less tumorigenic cells had the opposite effect. PG also regulated cell-substrate adhesion and motility through extracellular matrix (ECM)-dependent inhibition of Src kinase, suggesting that PG's effects were not due solely to increased intercellular adhesion. PG silencing resulted in elevated levels of the ECM protein vitronectin (VN), and exposing PG-expressing cells to VN induced Src activity. Furthermore, increased VN levels and Src activation correlated with diminished expression of PG in patient tissues. Thus, PG may inhibit Src by keeping VN low. Our results suggest that loss of intercellular adhesion due to reduced PG expression might be exacerbated by activation of Src through a PG-dependent mechanism. Furthermore, PG down-regulation during PCa progression could contribute to the known VN-dependent promotion of PCa invasion and metastasis, demonstrating a novel functional interaction between desmosomal cell-cell adhesion and cell-substrate adhesion signaling axes in prostate cancer.	[Franzen, Carrie A.; Todorovic, Viktor; Desai, Bhushan V.; Mirzoeva, Salida; Yang, Ximing J.; Green, Kathleen J.; Pelling, Jill C.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	Northwestern University	Franzen, CA (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	j-pelling@northwestern.edu		Todorovic, Viktor/0000-0002-1428-6973; Franzen, Carrie/0000-0002-1127-8599	National Cancer Institute (NCI) Prostate SPORE grant, Zell Foundation [P50 CA90386]; Rosenberg Seed Grant; J. L. Mayberry endowment; National Institutes of Health (NIH) training grants [T32 CA070085, F32 AR055444]; American Cancer Society (ACS) postdoctoral grant [PF-10-235-01-CSM];  [R01s CA122151];  [AR041836]; NATIONAL CANCER INSTITUTE [T32CA070085, P50CA090386, R01CA122151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041836, F32AR055444] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Prostate SPORE grant, Zell Foundation; Rosenberg Seed Grant; J. L. Mayberry endowment; National Institutes of Health (NIH) training grants; American Cancer Society (ACS) postdoctoral grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Cancer Institute (NCI) Prostate SPORE grant P50 CA90386, Zell Foundation, support from Rosenberg Seed Grant (to J.C.P.), R01s CA122151, AR041836 and the J. L. Mayberry endowment (to K.J.G.), National Institutes of Health (NIH) training grants T32 CA070085 (to C.A.F. and V.T.) and F32 AR055444 (to V.T.) and an American Cancer Society (ACS) postdoctoral grant PF-10-235-01-CSM (C.A.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; Arenas MI, 2000, HISTOCHEM J, V32, P659, DOI 10.1023/A:1004111331752; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Breuninger S, 2010, AM J PATHOL, V176, P2509, DOI 10.2353/ajpath.2010.090737; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; COWIN P, 1994, P NATL ACAD SCI USA, V91, P10759, DOI 10.1073/pnas.91.23.10759; Denk C, 1997, CANCER LETT, V120, P185, DOI 10.1016/S0304-3835(97)00308-X; Dusek RL, 2007, J INVEST DERMATOL, V127, P792, DOI 10.1038/sj.jid.5700615; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Franzen CA, 2009, CANCER PREV RES, V2, P830, DOI 10.1158/1940-6207.CAPR-09-0066; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Giroldi LA, 1999, INT J CANCER, V82, P70, DOI 10.1002/(SICI)1097-0215(19990702)82:1<70::AID-IJC13>3.0.CO;2-#; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzfeld M, 2006, BIOCHIM BIOPHYS ACTA, V1773, P69; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hudson TY, 2004, METHOD CELL BIOL, V78, P757; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; Jarrard DF, 1997, CLIN CANCER RES, V3, P2121; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Levenberg S, 1998, J CELL SCI, V111, P347; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; MonierGavelle F, 1997, J CELL BIOL, V137, P1663, DOI 10.1083/jcb.137.7.1663; Morrissey C, 2007, J CELL BIOCHEM, V101, P873, DOI 10.1002/jcb.21214; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Ojakian GK, 2001, J CELL SCI, V114, P941; Palka HL, 1997, J CELL SCI, V110, P2359; Park SI, 2007, EXPERT OPIN THER TAR, V11, P1207, DOI 10.1517/14728222.11.9.1207; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Paul R, 1997, BRIT J UROL, V79, P37, DOI 10.1111/j.1464-410X.1997.tb00799.x; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Pontes-Junior Jose, 2009, J Carcinog, V8, P3; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Saad F, 2009, BJU INT, V103, P434, DOI 10.1111/j.1464-410X.2008.08249.x; Seiffert D, 1996, J BIOL CHEM, V271, P5474, DOI 10.1074/jbc.271.10.5474; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Sobin L, 2009, TNM CLASSIFICATION M; Society AC, 2010, CANC FACTS FIG 2010; Soler AP, 1997, AM J PATHOL, V151, P471; SOMMERS CL, 1994, CANCER RES, V54, P3544; Stewart D, 2004, NATION, V279, P2; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; THALMANN GN, 1994, CANCER RES, V54, P2577; Todorovic V, 2010, J CELL SCI; Todorovic V, 2010, MOL CELL PROTEOMICS, V9, P351, DOI 10.1074/mcp.M900358-MCP200; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; You XK, 2003, EXP CELL RES, V288, P246, DOI 10.1016/S0014-4827(03)00204-0; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	85	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42132	10.1371/journal.pone.0042132	http://dx.doi.org/10.1371/journal.pone.0042132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860065	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900071
J	Carrera, O; Adan, RAH; Gutierrez, E; Danner, UN; Hoek, HW; van Elburg, AA; Kas, MJH				Carrera, Olaia; Adan, Roger A. H.; Gutierrez, Emilio; Danner, Unna N.; Hoek, Hans W.; van Elburg, Annemarie A.; Kas, Martien J. H.			Hyperactivity in Anorexia Nervosa: Warming Up Not Just Burning-Off Calories	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AMBIENT-TEMPERATURE; DISORDER PATIENTS; EATING-DISORDERS; CONTROLLED-TRIAL; LEPTIN; EXERCISE; DIFFERENCE; MORTALITY; WEIGHT	Excessive physical activity is a common feature in Anorexia Nervosa (AN) that interferes with the recovery process. Animal models have demonstrated that ambient temperature modulates physical activity in semi-starved animals. The aim of the present study was to assess the effect of ambient temperature on physical activity in AN patients in the acute phase of the illness. Thirty-seven patients with AN wore an accelerometer to measure physical activity within the first week of contacting a specialized eating disorder center. Standardized measures of anxiety, depression and eating disorder psychopathology were assessed. Corresponding daily values for ambient temperature were obtained from local meteorological stations. Ambient temperature was negatively correlated with physical activity (p = -.405) and was the only variable that accounted for a significant portion of the variance in physical activity (p =.034). Consistent with recent research with an analogous animal model of the disorder, our findings suggest that ambient temperature is a critical factor contributing to the expression of excessive physical activity levels in AN. Keeping patients warm may prove to be a beneficial treatment option for this symptom.	[Carrera, Olaia; Adan, Roger A. H.; Hoek, Hans W.; Kas, Martien J. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Carrera, Olaia; Adan, Roger A. H.; Danner, Unna N.; van Elburg, Annemarie A.] Altrecht Mental Hlth Inst, Zeist, Netherlands; [Carrera, Olaia; Gutierrez, Emilio] Univ Santiago de Compostela, Fac Psicol, Dept Psicol Clin & Psicobiol, Santiago De Compostela, Spain; [Carrera, Olaia; Gutierrez, Emilio] Univ Santiago de Compostela, Fac Psicol, Unidad Venres Clin, Santiago De Compostela, Spain; [Carrera, Olaia] Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain; [Carrera, Olaia; Adan, Roger A. H.; Danner, Unna N.; Hoek, Hans W.; van Elburg, Annemarie A.; Kas, Martien J. H.] Utrecht Res Grp Eating Disorders, Utrecht, Netherlands; [Hoek, Hans W.] Parnassia Bavo Psychiat Inst, The Hague, Netherlands; [Hoek, Hans W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Hoek, Hans W.] Columbia Univ, Dept Epidemiol, New York, NY USA	Utrecht University; Utrecht University Medical Center; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Parnassia Psychiatric Institute; University of Groningen; Columbia University	Carrera, O (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Zamora, Cristina Cuesta/E-2864-2016; Gutierrez, Emilio/C-6227-2011; Gutierrez, Emilio/AAH-9986-2021; Kas, Martien J./G-8269-2018	Zamora, Cristina Cuesta/0000-0003-1121-9561; Gutierrez, Emilio/0000-0001-5808-353X; Gutierrez, Emilio/0000-0001-5808-353X; Kas, Martien J./0000-0002-4471-8618; Hoek, Hans/0000-0001-6353-5465	Netherlands Organization of Health Research and Development (ZONMW) [945-05-017]; Unidad Venres Clinicos	Netherlands Organization of Health Research and Development (ZONMW)(Netherlands Organization for Health Research and Development); Unidad Venres Clinicos	This project was funded by the Netherlands Organization of Health Research and Development (ZONMW # 945-05-017). Financial assistance was provided by Unidad Venres Clinicos (O.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bergh C, 1996, NAT MED, V2, P21, DOI 10.1038/nm0196-21; Bergh C, 2002, P NATL ACAD SCI USA, V99, P9486, DOI 10.1073/pnas.142284799; BEUMONT PJV, 1994, INT J EAT DISORDER, V15, P21, DOI 10.1002/1098-108X(199401)15:1&lt;21::AID-EAT2260150104&gt;3.0.CO;2-K; Birmingham CL, 2004, INT J EAT DISORDER, V35, P234, DOI 10.1002/eat.10246; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P88, DOI 10.1002/eat.20753; BREWERTON TD, 1995, INT J EAT DISORDER, V17, P413, DOI 10.1002/1098-108X(199505)17:4<413::AID-EAT2260170414>3.0.CO;2-0; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; BRUCH H, 1965, J NERV MENT DIS, V141, P555, DOI 10.1097/00005053-196511000-00008; Casper RC, 1998, INT J EAT DISORDER, V24, P381, DOI 10.1002/(SICI)1098-108X(199812)24:4<381::AID-EAT5>3.0.CO;2-Q; Casper RC, 2006, J AFFECT DISORDERS, V92, P99, DOI 10.1016/j.jad.2005.12.039; Cerrato M, 2012, INT J EAT DISORDER, V45, P26, DOI 10.1002/eat.20884; COOPER Z, 1987, INT J EAT DISORDER, V6, P1, DOI 10.1002/1098-108X(198701)6:1<1::AID-EAT2260060102>3.0.CO;2-9; Davis C, 2005, PSYCHOL MED, V35, P377, DOI 10.1017/S0033291704003447; Davis C, 1997, CAN J PSYCHIAT, V42, P168, DOI 10.1177/070674379704200207; Epling WF, 1991, SOLVING ANOREXIA PUZ; Exner C, 2000, MOL PSYCHIATR, V5, P476, DOI 10.1038/sj.mp.4000771; Favaro A, 2009, FERTIL STERIL, V91, P1395, DOI 10.1016/j.fertnstert.2008.04.055; GARNER DM, 1991, EATING DISORDERS INV; Gelegen C, 2008, GENES BRAIN BEHAV, V7, P552, DOI 10.1111/j.1601-183X.2008.00394.x; Gelegen C, 2007, EUR NEUROPSYCHOPHARM, V17, P199, DOI 10.1016/j.euroneuro.2006.04.007; Gull W., 1874, CLIN SOC T, V7, P22; Gutierrez E, 2009, PSYCHONEUROENDOCRINO, V34, P420, DOI 10.1016/j.psyneuen.2008.10.003; Gutierrez E, 2001, Eat Weight Disord, V6, P49; Gutierrez E, 2002, PSYCHON B REV, V9, P239, DOI 10.3758/BF03196278; Hebebrand J, 2003, PHYSIOL BEHAV, V6957, P1; Hechler T, 2008, ADAPT PHYS ACT Q, V25, P159, DOI 10.1123/apaq.25.2.159; Hillebrand JJG, 2005, BIOL PSYCHIAT, V58, P165, DOI 10.1016/j.biopsych.2005.03.011; Hillebrand JJG, 2005, PHYSIOL BEHAV, V85, P151, DOI 10.1016/j.physbeh.2005.03.017; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Holtkamp K, 2004, INT J EAT DISORDER, V36, P163, DOI 10.1002/eat.20035; Holtkamp K, 2003, J CLIN ENDOCR METAB, V88, P5169, DOI 10.1210/jc.2003-030569; Kas MJH, 2003, MOL PSYCHIATR, V8, P235, DOI 10.1038/sj.mp.4001206; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; KRON L, 1978, COMPR PSYCHIAT, V19, P433, DOI 10.1016/0010-440X(78)90072-X; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Papadopoulos FC, 2009, BRIT J PSYCHIAT, V194, P10, DOI 10.1192/bjp.bp.108.054742; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Penas-Lledo E, 2002, INT J EAT DISORDER, V31, P370, DOI 10.1002/eat.10042; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Elburg AA, 2007, J NEURAL TRANSM, V114, P1233, DOI 10.1007/s00702-007-0740-6; Vansteelandt K, 2007, BEHAV RES THER, V45, P1717, DOI 10.1016/j.brat.2006.12.005; Vazquez R, 2006, EAT WEIGHT DISORD-ST, V11, P1, DOI DOI 10.1007/BF03327745	49	46	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41851	10.1371/journal.pone.0041851	http://dx.doi.org/10.1371/journal.pone.0041851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848634	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200113
J	Massudi, H; Grant, R; Braidy, N; Guest, J; Farnsworth, B; Guillemin, GJ				Massudi, Hassina; Grant, Ross; Braidy, Nady; Guest, Jade; Farnsworth, Bruce; Guillemin, Gilles J.			Age-Associated Changes In Oxidative Stress and NAD(+) Metabolism In Human Tissue	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; DNA-DAMAGE; CALORIC RESTRICTION; CELL-DEATH; MITOCHONDRIAL-FUNCTION; QUINOLINIC ACID; SIRT1; NUCLEAR; PARP-1; P53	Nicotinamide adenine dinucleotide (NAD(+)) is an essential electron transporter in mitochondrial respiration and oxidative phosphorylation. In genomic DNA, NAD(+) also represents the sole substrate for the nuclear repair enzyme, poly(ADP-ribose) polymerase (PARP) and the sirtuin family of NAD-dependent histone deacetylases. Age associated increases in oxidative nuclear damage have been associated with PARP-mediated NAD(+) depletion and loss of SIRT1 activity in rodents. In this study, we further investigated whether these same associations were present in aging human tissue. Human pelvic skin samples were obtained from consenting patients aged between 15-77 and newborn babies (0-1 year old) (n = 49) previously scheduled for an unrelated surgical procedure. DNA damage correlated strongly with age in both males (p = 0.029; r = 0.490) and females (p = 0.003; r = 0.600) whereas lipid oxidation (MDA) levels increased with age in males (p = 0.004; r = 0.623) but not females (p = 0.3734; r = 0.200). PARP activity significantly increased with age in males (p<0.0001; r = 0.768) and inversely correlated with tissue NAD(+) levels (p = 0.0003; r = -0.639). These associations were less evident in females. A strong negative correlation was observed between NAD(+) levels and age in both males (p = 0.001; r = -0.706) and females (p = 0.01; r = -0.537). SIRT1 activity also negatively correlated with age in males (p = 0.007; r = -0.612) but not in females. Strong positive correlations were also observed between lipid peroxidation and DNA damage (p<0.0001; r = 0.4962), and PARP activity and NAD(+) levels (p = 0.0213; r = 0.5241) in post pubescent males. This study provides quantitative evidence in support of the hypothesis that hyperactivation of PARP due to an accumulation of oxidative damage to DNA during aging may be responsible for increased NAD(+) catabolism in human tissue. The resulting NAD(+) depletion may play a major role in the aging process, by limiting energy production, DNA repair and genomic signalling.	[Massudi, Hassina; Grant, Ross; Braidy, Nady; Guest, Jade; Guillemin, Gilles J.] Univ New S Wales, Fac Med, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia; [Massudi, Hassina; Grant, Ross; Guest, Jade; Farnsworth, Bruce] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia; [Braidy, Nady] Univ New S Wales, Sch Psychiat, Fac Med, Sydney, NSW, Australia; [Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia	University of New South Wales Sydney; Sydney Adventist Hospital; University of New South Wales Sydney	Massudi, H (corresponding author), Univ New S Wales, Fac Med, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia.	r.grant@unsw.edu.au	Grant, Ross/H-1805-2015; Guillemin, Gilles J/C-3878-2015; Braidy, Nady/G-4928-2012	Guillemin, Gilles J/0000-0001-8105-4470; Braidy, Nady/0000-0002-0497-5572	Australasian Research Institute; University of NSW; Alzheimer's Australia Viertel Foundation Postdoctoral Research Fellowship at the University of New South Wales	Australasian Research Institute; University of NSW; Alzheimer's Australia Viertel Foundation Postdoctoral Research Fellowship at the University of New South Wales	This study was funded by internal funds from the Australasian Research Institute and student allocated funding from the University of NSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the surgeons at the Sydney Adventist hospital that provided the skin tissues samples used in this study. Nady Braidy is a recipient of an Alzheimer's Australia Viertel Foundation Postdoctoral Research Fellowship at the University of New South Wales.	AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS58, DOI 10.1038/sj.ejcn.1602300; B N, 2008, CURR PHARM DESIGN, V15, P110; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Beneke S, 2004, INT J CANCER, V111, P813, DOI 10.1002/ijc.20342; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bradford MM, 1976, ANAL BIOCHEM, V53, P452, DOI DOI 10.1006/ABIO.1976; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Braidy N, 2009, NEUROTOX RES, V16, P77, DOI 10.1007/s12640-009-9051-z; Brandes RP, 1997, LIFE SCI, V60, P391, DOI 10.1016/S0024-3205(96)00663-7; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Burkle A, 2004, EXP GERONTOL, V39, P1599, DOI 10.1016/j.exger.2004.07.010; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Erdelyi K, 2005, CELL MOL LIFE SCI, V62, P751, DOI 10.1007/s00018-004-4506-0; Fiege J, 2008, CURR OPIN CELL BIOL, V20; Grant RS, 1998, J NEUROCHEM, V70, P1759; Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; HALLIWELL B, 1999, FREE RADICALS BIOL D; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hininger I, 2004, MUTAT RES, V558, P5; Huang X, 2006, INT J ONCOL, V29, P495; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kruszewski M, 2005, DNA REPAIR, V4, P1306, DOI 10.1016/j.dnarep.2005.06.013; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mecocci P, 1998, FREE RADIC BIOL MED, V25, P561; MESSRIPOUR M, 1994, J NEUROCHEM, V62, P502; Meyer R, 2006, POLYADP RIBOSYLATION; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Powers RW, 2002, METABOLISM, V51, P1433, DOI 10.1053/meta.2002.35587; Putt KS, 2005, CHEMBIOCHEM, V6, P53, DOI 10.1002/cbic.200400330; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Retz W, 1998, J NEURAL TRANSM-SUPP, P221; Rizvi SI, 2007, ANN NY ACAD SCI, V1100, P373, DOI 10.1196/annals.1395.041; Ryberg H, 2004, NEUROCHEM INT, V45, P57, DOI 10.1016/j.neuint.2003.12.012; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Smith BC, 2006, STRUCTURE, V14, P1207, DOI 10.1016/j.str.2006.07.004; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Xia WL, 2009, CURR PHARM DESIGN, V15, P12, DOI 10.2174/138161209787185832; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317; Ziegler M, 2006, POLYADP RIBOSYLATION	64	328	341	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42357	10.1371/journal.pone.0042357	http://dx.doi.org/10.1371/journal.pone.0042357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848760	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200197
J	Nishiguchi, KM; Rivolta, C				Nishiguchi, Koji M.; Rivolta, Carlo			Genes Associated with Retinitis Pigmentosa and Allied Diseases Are Frequently Mutated in the General Population	PLOS ONE			English	Article							CHILDHOOD BLINDNESS; GENOME; PREVALENCE	Background: Retinitis pigmentosa and other hereditary retinal degenerations (HRD) are rare genetic diseases leading to progressive blindness. Recessive HRD are caused by mutations in more than 100 different genes. Laws of population genetics predict that, on a purely theoretical ground, such a high number of genes should translate into an extremely elevated frequency of unaffected carriers of mutations. In this study we estimate the proportion of these individuals within the general population, via the analyses of data from whole-genome sequencing. Methodology/Principal Findings: We screened complete and high-quality genome sequences from 46 control individuals from various world populations for HRD mutations, using bioinformatic tools developed in-house. All mutations detected in silico were validated by Sanger sequencing. We identified clear-cut, null recessive HRD mutations in 10 out of the 46 unaffected individuals analyzed (similar to 22%). Conclusions/Significance: Based on our data, approximately one in 4-5 individuals from the general population may be a carrier of null mutations that are responsible for HRD. This would be the highest mutation carrier frequency so far measured for a class of Mendelian disorders, especially considering that missenses and other forms of pathogenic changes were not included in our assessment. Among other things, our results indicate that the risk for a consanguineous couple of generating a child with a blinding disease is particularly high, compared to other genetic conditions.	[Nishiguchi, Koji M.; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland	University of Lausanne	Nishiguchi, KM (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	carlo.rivolta@unil.ch		Rivolta, Carlo/0000-0002-0733-9950	Swiss National Science Foundation [310030_138346]; Gebert Ruf Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruf Foundation	This work was supported by the Swiss National Science Foundation (Grant Number 310030_138346) and the Gebert Ruf Foundation (Rare Diseases - New Technologies grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BAGHDASSARIAN SA, 1975, AM J OPHTHALMOL, V79, P827, DOI 10.1016/0002-9394(75)90744-8; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; ELDER MJ, 1993, EYE, V7, P580, DOI 10.1038/eye.1993.126; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Razavi H, 2010, OPHTHAL EPIDEMIOL, V17, P95, DOI 10.3109/09286581003624954; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; TABBARA KF, 1985, BRIT J OPHTHALMOL, V69, P312, DOI 10.1136/bjo.69.4.312; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	15	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41902	10.1371/journal.pone.0041902	http://dx.doi.org/10.1371/journal.pone.0041902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848652	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000306950200125
J	Xu, XF; Wang, QJ; Deng, BP; Wang, HY; Dong, ZG; Qu, X; Kong, BH				Xu, Xiaofei; Wang, Qingjie; Deng, Biping; Wang, Huayang; Dong, Zhaogang; Qu, Xun; Kong, Beihua			Monocyte Chemoattractant Protein-1 Secreted by Decidual Stromal Cells Inhibits NK Cells Cytotoxicity by Up-Regulating Expression of SOCS3	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MESENCHYMAL STEM-CELLS; NATURAL-KILLER-CELLS; T-CELLS; CHEMOTACTIC PROTEIN-1; CHEMOKINE PRODUCTION; EPITHELIAL-CELLS; PREGNANCY; INDUCTION; APOPTOSIS	Background: Decidual stromal cells (DSCs) are of particular importance due to their pleiotropic functions during pregnancy. Although previous research has demonstrated that DSCs participated in the regulation of immune cells during pregnancy, the crosstalk between DSCs and NK cells has not been fully elucidated. To address this issue, we investigated the effect of DSCs on perforin expression in CD56(+) NK cells and explored the underlying mechanism. Methodology/Principal Findings: Flow cytometry analysis showed perforin production in NK cells was attenuated by DSC media, and it was further suppressed by media from DSCs pretreated with lipopolysaccharide (LPS). However, the expression of granzyme A and apoptosis of NK cells were not influenced by DSC media. ELISA assays to detect cytokine production indicated that monocyte chemoattractant protein-1 (MCP-1) in the supernatant of DSCs conditioned culture significantly increased after LPS stimulation. The inhibitory effect of DSC media on perforin was abolished by the administration of anti-MCP-1 neutralizing antibody. Notably, reduced perforin expression attenuated the cytotoxic potential of CD56(+) NK cells to K562 cells. Moreover, Suppressor of cytokine signaling 3 (SOCS3) expression in NK cells was enhanced by treatment with MCP-1, as measured by RT-PCR and western blot. Interestingly, MCP-1-induced perforin expression was partly abolished by the siRNA induced SOCS3 knockdown. Western blot analysis suggested that both NF-kappa B and ERK/MAPKs pathway were involved in the LPS-induced upregulation of MCP-1 in DSCs. Conclusions/Significance: Our results demonstrate that LPS induces upregulation of MCP-1 in DSCs, which may play a critical role in inhibiting the cytotoxicity of NK cells partly by promoting SOCS3 expression. These findings suggest that the crosstalk between DSCs and NK cells may be crucial to maintain pregnancy homeostasis.	[Xu, Xiaofei; Kong, Beihua] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Wang, Qingjie; Deng, Biping; Wang, Huayang; Qu, Xun] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250100, Shandong, Peoples R China; [Dong, Zhaogang] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Xu, XF (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China.	kongbeihua@yahoo.com.cn		Wang, Qing-jie/0000-0002-4845-3696	National Natural Science Foundation of China [30872321, 81072406, 31100650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 30872321, No. 81072406 and No. 31100650) from the National Natural Science Foundation of China. URL:http://www.nsfc.gov.cn/Portal0/default106.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096; Adams KM, 2007, PLACENTA, V28, P477, DOI 10.1016/j.placenta.2006.08.004; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALLAVENA P, 1994, EUR J IMMUNOL, V24, P3233, DOI 10.1002/eji.1830241249; Blanco O, 2009, PLACENTA, V30, P677, DOI 10.1016/j.placenta.2009.05.011; Braunschweig A, 2011, AM J REPROD IMMUNOL, V66, P329, DOI 10.1111/j.1600-0897.2011.00989.x; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Dosiou C, 2005, ENDOCR REV, V26, P44, DOI 10.1210/er.2003-0021; Dudley DJ, 1997, J REPROD IMMUNOL, V36, P93, DOI 10.1016/S0165-0378(97)00065-X; DUDLEY DJ, 1993, J CLIN ENDOCR METAB, V76, P404, DOI 10.1210/jc.76.2.404; Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x; Fukushima A, 2010, J ENDODONT, V36, P1004, DOI 10.1016/j.joen.2010.02.027; Fushimi S, 2009, CLIN IMMUNOL, V133, P437, DOI 10.1016/j.clim.2009.08.015; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1997, J LEUKOCYTE BIOL, V62, P577, DOI 10.1002/jlb.62.5.577; He YY, 2007, HUM REPROD, V22, P2733, DOI 10.1093/humrep/dem208; Higuma-Myojo S, 2005, AM J REPROD IMMUNOL, V54, P21, DOI 10.1111/j.1600-0897.2005.00279.x; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Karpus WJ, 1998, J EXP MED, V187, P733, DOI 10.1084/jem.187.5.733; Kayisli UA, 2003, J IMMUNOL, V171, P2305, DOI 10.4049/jimmunol.171.5.2305; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847; Kumazaki K, 2004, HUM PATHOL, V35, P47, DOI 10.1016/j.humpath.2003.08.027; Liu JJ, 2005, CANCER CHEMOTH PHARM, V56, P400, DOI 10.1007/s00280-005-1029-9; Lockwood CJ, 2006, AM J PATHOL, V168, P445, DOI 10.2353/ajpath.2006.050082; Mor G, 2008, ANN NY ACAD SCI, V1127, P121, DOI 10.1196/annals.1434.006; Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308; Nokihara H, 2000, CANCER RES, V60, P7002; Olivares EG, 1997, BIOL REPROD, V57, P609, DOI 10.1095/biolreprod57.3.609; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; RIDDICK DH, 1977, AM J OBSTET GYNECOL, V127, P187, DOI 10.1016/S0002-9378(16)33248-3; Rindsjo E, 2007, HUM PATHOL, V38, P468, DOI 10.1016/j.humpath.2006.09.009; Ruiz C, 1997, J REPROD IMMUNOL, V33, P15, DOI 10.1016/S0165-0378(96)01009-1; Saito S, 2007, SEMIN IMMUNOPATHOL, V29, P115, DOI 10.1007/s00281-007-0067-2; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Wang L, 2011, CELL BIOL INT; Yu CR, 1999, J IMMUNOL, V162, P2785; Yu XW, 2009, INT J MOL SCI, V10, P2010, DOI 10.3390/ijms10052010; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297	48	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41869	10.1371/journal.pone.0041869	http://dx.doi.org/10.1371/journal.pone.0041869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848642	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200118
J	Griffiths, LA; Doig, J; Churchhouse, AMD; Davies, FCJ; Squires, CE; Newbery, HJ; Abbott, CM				Griffiths, Lowri A.; Doig, Jennifer; Churchhouse, Antonia M. D.; Davies, Faith C. J.; Squires, Charlotte E.; Newbery, Helen J.; Abbott, Catherine M.			Haploinsufficiency for Translation Elongation Factor eEF1A2 in Aged Mouse Muscle and Neurons Is Compatible with Normal Function	PLOS ONE			English	Article							MICE; ZPR1; FACTOR-1-ALPHA; EXPRESSION; PROTEIN; EXERCISE; MUTATION; MUTANT; MODEL	Translation elongation factor isoform eEF1A2 is expressed in muscle and neurons. Deletion of eEF1A2 in mice gives rise to the neurodegenerative phenotype "wasted" (wst). Mice homozygous for the wasted mutation die of muscle wasting and neurodegeneration at four weeks post-natal. Although the mutation is said to be recessive, aged heterozygous mice have never been examined in detail; a number of other mouse models of motor neuron degeneration have recently been shown to have similar, albeit less severe, phenotypic abnormalities in the heterozygous state. We therefore examined the effects of ageing on a cohort of heterozygous +/wst mice and control mice, in order to establish whether a presumed 50% reduction in eEF1A2 expression was compatible with normal function. We evaluated the grip strength assay as a way of distinguishing between wasted and wild-type mice at 3-4 weeks, and then performed the same assay in older +/wst and wild-type mice. We also used rotarod performance and immunohistochemistry of spinal cord sections to evaluate the phenotype of aged heterozygous mice. Heterozygous mutant mice showed no deficit in neuromuscular function or signs of spinal cord pathology, in spite of the low levels of eEF1A2.	[Griffiths, Lowri A.; Doig, Jennifer; Churchhouse, Antonia M. D.; Davies, Faith C. J.; Squires, Charlotte E.; Newbery, Helen J.; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	Griffiths, LA (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh, Midlothian, Scotland.	C.Abbott@ed.ac.uk	Abbott, Catherine M/C-7306-2013	Davies, Faith/0000-0003-0664-3237; Abbott, Catherine/0000-0001-8794-7173; Churchhouse, Antonia/0000-0002-2321-2140	Wellcome Trust; Medical Research Council [1137734] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANN DK, 1992, J BIOL CHEM, V267, P699; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Doran B, 2006, P NATL ACAD SCI USA, V103, P7471, DOI 10.1073/pnas.0602057103; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; LUTSEP HL, 1989, J NEUROPATH EXP NEUR, V48, P519, DOI 10.1097/00005072-198909000-00003; Mishra AK, 2007, P NATL ACAD SCI USA, V104, P13930, DOI 10.1073/pnas.0704915104; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295; SHULTZ LD, 1982, NATURE, V297, P402, DOI 10.1038/297402a0; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41917	10.1371/journal.pone.0041917	http://dx.doi.org/10.1371/journal.pone.0041917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848658	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600143
J	Wen, ZS; Liu, ZP; Yan, YQ; Piao, GY; Liu, ZR; Wu, JR; Chen, LN				Wen, Zhenshu; Liu, Zhi-Ping; Yan, Yiqing; Piao, Guanying; Liu, Zhengrong; Wu, Jiarui; Chen, Luonan			Identifying Responsive Modules by Mathematical Programming: An Application to Budding Yeast Cell Cycle	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; DNA-REPLICATION; FUNCTIONAL MODULES; MICROARRAY DATA; GENE-ONTOLOGY; COMPLEX; NETWORK; CLASSIFICATION; PHASE; RESOURCE	High-throughput biological data offer an unprecedented opportunity to fully characterize biological processes. However, how to extract meaningful biological information from these datasets is a significant challenge. Recently, pathway-based analysis has gained much progress in identifying biomarkers for some phenotypes. Nevertheless, these so-called pathway-based methods are mainly individual-gene-based or molecule-complex-based analyses. In this paper, we developed a novel module-based method to reveal causal or dependent relations between network modules and biological phenotypes by integrating both gene expression data and protein-protein interaction network. Specifically, we first formulated the identification problem of the responsive modules underlying biological phenotypes as a mathematical programming model by exploiting phenotype difference, which can also be viewed as a multi-classification problem. Then, we applied it to study cell-cycle process of budding yeast from microarray data based on our biological experiments, and identified important phenotype-and transition-based responsive modules for different stages of cell-cycle process. The resulting responsive modules provide new insight into the regulation mechanisms of cell-cycle process from a network viewpoint. Moreover, the identification of transition modules provides a new way to study dynamical processes at a functional module level. In particular, we found that the dysfunction of a well-known module and two new modules may directly result in cell cycle arresting at S phase. In addition to our biological experiments, the identified responsive modules were also validated by two independent datasets on budding yeast cell cycle.	[Wen, Zhenshu; Liu, Zhi-Ping; Wu, Jiarui; Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Key Lab Syst Biol, Shanghai, Peoples R China; [Wen, Zhenshu; Liu, Zhengrong] S China Univ Technol, Dept Math Sci, Guangzhou, Guangdong, Peoples R China; [Yan, Yiqing; Piao, Guanying; Wu, Jiarui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Yan, Yiqing; Piao, Guanying; Wu, Jiarui] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk; South China University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wen, ZS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Key Lab Syst Biol, Shanghai, Peoples R China.	wujr@sibs.ac.cn; lnchen@sibs.ac.cn	Liu, Zhi-Ping/C-9846-2010	Liu, Zhi-Ping/0000-0001-7742-9161	NSFC [10631070, 91029301, 60873205, 61134013, 30821065, 31100949]; Ministry of Science and Technology [2010CB912102, 2011CB910200]; CAS [KSCX1-YW-02]; Chief Scientist Program of SIBS of CAS [2009CSP002]; ShanghaiNSF [11ZR1443100]	NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); CAS(Chinese Academy of Sciences); Chief Scientist Program of SIBS of CAS; ShanghaiNSF	This work was supported by NSFC under Grant Nos. 10631070, 91029301, 60873205, 61134013, 30821065 and 31100949; Ministry of Science and Technology under Grant Nos. 2010CB912102 and 2011CB910200; CAS under Grant No. KSCX1-YW-02; the Chief Scientist Program of SIBS of CAS under Grant No. 2009CSP002; the ShanghaiNSF under Grant No. 11ZR1443100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amberg D, 2006, YEAST RNA ISOLATION; [Anonymous], 2003, METH MOL B; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Ben-Aroya S, 2003, P NATL ACAD SCI USA, V100, P9906, DOI 10.1073/pnas.1633757100; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cavalieri D, 2005, DRUG DISCOV TODAY, V10, P727, DOI 10.1016/S1359-6446(05)03433-1; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chen L, 2010, MODELING BIOMOLECULAR NETWORKS IN CELLS: STRUCTURES AND DYNAMICS, P1, DOI 10.1007/978-1-84996-214-8; Chen L, 2009, BIOMOLECULAR NETWORK; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cid VJ, 2001, MOL BIOL CELL, V12, P1645, DOI 10.1091/mbc.12.6.1645; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Haase SB, 2003, CELL CYCLE ANAL BUDD; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; He D, 2012, J MOL CELL BIOL; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Murray A, 1993, CELL CYCLE INTRO; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Pereira-Leal JB, 2006, PHILOS T R SOC B, V361, P507, DOI 10.1098/rstb.2005.1807; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Piao G, 2011, PHENOTYPE DIFFERENCE, P111; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Sentandreu M, 1997, YEAST, V13, P1375, DOI 10.1002/(SICI)1097-0061(199711)13:14<1375::AID-YEA179>3.3.CO;2-9; Sherman F, 1986, LAB COURSE MANUAL ME; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussman A, 2004, EUKARYOT CELL, V3, P932, DOI 10.1128/EC.3.4.932-943.2004; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Winand NJ, 1998, GENOMICS, V53, P69, DOI 10.1006/geno.1998.5447; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Xing E P, 2001, Bioinformatics, V17 Suppl 1, pS306; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	72	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41854	10.1371/journal.pone.0041854	http://dx.doi.org/10.1371/journal.pone.0041854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848637	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600135
J	Costa, MC; Arroyo, LG; Allen-Vercoe, E; Stampfli, HR; Kim, PT; Sturgeon, A; Weese, JS				Costa, Marcio C.; Arroyo, Luis G.; Allen-Vercoe, Emma; Staempfli, Henry R.; Kim, Peter T.; Sturgeon, Amy; Weese, J. Scott			Comparison of the Fecal Microbiota of Healthy Horses and Horses with Colitis by High Throughput Sequencing of the V3-V5 Region of the 16S rRNA Gene	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; PHYLOGENETIC CHARACTERIZATION; ACID PRODUCTION; COMMUNITIES; PREVENTION; DIVERSITY; PERFRINGENS; PREVALENCE; BACTERIA; DIARRHEA	The intestinal tract houses one of the richest and most complex microbial populations on the planet, and plays a critical role in health and a wide range of diseases. Limited studies using new sequencing technologies in horses are available. The objective of this study was to characterize the fecal microbiome of healthy horses and to compare the fecal microbiome of healthy horses to that of horses with undifferentiated colitis. A total of 195,748 sequences obtained from 6 healthy horses and 10 horses affected by undifferentiated colitis were analyzed. Firmicutes predominated (68%) among healthy horses followed by Bacteroidetes (14%) and Proteobacteria (10%). In contrast, Bacteroidetes (40%) was the most abundant phylum among horses with colitis, followed by Firmicutes (30%) and Proteobacteria (18%). Healthy horses had a significantly higher relative abundance of Actinobacteria and Spirochaetes while horses with colitis had significantly more Fusobacteria. Members of the Clostridia class were more abundant in healthy horses. Members of the Lachnospiraceae family were the most frequently shared among healthy individuals. The species richness reported here indicates the complexity of the equine intestinal microbiome. The predominance of Clostridia demonstrates the importance of this group of bacteria in healthy horses. The marked differences in the microbiome between healthy horses and horses with colitis indicate that colitis may be a disease of gut dysbiosis, rather than one that occurs simply through overgrowth of an individual pathogen.	[Costa, Marcio C.; Sturgeon, Amy; Weese, J. Scott] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Arroyo, Luis G.; Staempfli, Henry R.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Allen-Vercoe, Emma] Univ Guelph, Coll Biol Sci, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Kim, Peter T.] Univ Guelph, Dept Math & Stat, Coll Phys & Engn Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph; University of Guelph; University of Guelph	Costa, MC (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	costamc@gmail.com		Costa, Marcio/0000-0001-5067-7501	Equine Guelph	Equine Guelph	This work was supported by Equine Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chapman AM, 2009, VET CLIN N AM-EQUINE, V25, P363, DOI 10.1016/j.cveq.2009.05.001; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Desrochers AM, 2005, JAVMA-J AM VET MED A, V227, P954, DOI 10.2460/javma.2005.227.954; Donaldson MT, 1999, J AM VET MED ASSOC, V215, P358; Durso LM, 2011, FOODBORNE PATHOG DIS, V8, P647, DOI 10.1089/fpd.2010.0774; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frederick J, 2009, J VET INTERN MED, V23, P1254, DOI 10.1111/j.1939-1676.2009.0383.x; Giguere S, 2008, LARGE ANIMAL INTERNA, P500; GLINSKY MJ, 1976, J ANIM SCI, V42, P1465, DOI 10.2527/jas1976.4261465x; Guarino A, 2009, CURR OPIN GASTROEN, V25, P18, DOI 10.1097/MOG.0b013e32831b4455; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Jami E, 2012, ANAEROBE; Kassam Z, 2012, ARCH INTERN MED, V172, P191, DOI 10.1001/archinte.172.2.191; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Medina-Torres CE, 2011, VET MICROBIOL, V152, P212, DOI 10.1016/j.vetmic.2011.04.012; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Parraga ME, 1997, J VET INTERN MED, V11, P36, DOI 10.1111/j.1939-1676.1997.tb00071.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rea MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Weese JS, 2005, JAVMA-J AM VET MED A, V226, P2031, DOI 10.2460/javma.2005.226.2031; Weese JS, 2001, EQUINE VET J, V33, P403, DOI 10.2746/042516401776249534; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	43	221	231	5	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41484	10.1371/journal.pone.0041484	http://dx.doi.org/10.1371/journal.pone.0041484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859989	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600029
J	Frimodt-Moller, M; Kamper, AL; Strandgaard, S; Kreiner, S; Nielsen, AH				Frimodt-Moller, Marie; Kamper, Anne-Lise; Strandgaard, Svend; Kreiner, Svend; Nielsen, Arne Hoj			Beneficial Effects on Arterial Stiffness and Pulse-Wave Reflection of Combined Enalapril and Candesartan in Chronic Kidney Disease - A Randomized Trial	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITOR; CENTRAL AORTIC PRESSURE; CENTRAL BLOOD-PRESSURE; STAGE RENAL-DISEASE; CARDIOVASCULAR EVENTS; RECEPTOR BLOCKADE; HIGH-RISK; VELOCITY; REDUCTION; OUTCOMES	Background: Cardiovascular disease (CVD) is highly prevalent in patients with chronic kidney disease (CKD). Inhibition of the renin-angiotensinsystem (RAS) in hypertension causes differential effects on central and brachial blood pressure (BP), which has been translated into improved outcome. The objective was to examine if a more complete inhibition of RAS by combining an angiotensin converting enzyme inhibitor (ACEI) and an angiotensin receptor antagonist (ARB) compared to monotherapy has an additive effect on central BP and pulse-wave velocity (PWV), which are known markers of CVD. Methods: Sixty-seven CKD patients (mean GFR 30, range 13-59 ml/min/1.73 m(2)) participated in an open randomized study of 16 weeks of monotherapy with either enalapril or candesartan followed by 8 weeks of dual blockade aiming at a total dose of 16 mg candesartan and 20 mg enalapril o.d. Pulse-wave measurements were performed at week 0, 8, 16 and 24 by the SphygmoCor device. Results: Significant additive BP independent reductions were found after dual blockade in aortic PWV (20.3 m/s, P<0.05) and in augmentation index (22%, P<0.01) compared to monotherapy. Furthermore pulse pressure amplification was improved (P<0.05) and central systolic BP reduced (26 mmHg, P<0.01). Conclusions: Dual blockade of the RAS resulted in an additive BP independent reduction in pulse-wave reflection and arterial stiffness compared to monotherapy in CKD patients.	[Frimodt-Moller, Marie; Kamper, Anne-Lise] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Strandgaard, Svend; Nielsen, Arne Hoj] Herlev Hosp, Copenhagen, Denmark; [Kreiner, Svend] Univ Copenhagen, Dept Biostat, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Frimodt-Moller, M (corresponding author), Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark.	mariefm@dadlnet.dk	Frimodt-Moller, Marie/AAS-6945-2021	Frimodt-Moller, Marie/0000-0002-8486-1515; Kamper, Anne-Lise/0000-0001-7523-6569	Danish Kidney Association (Nyreforeningen); Danish Society of Nephrology; Danish Heart Association; Research Council of Herlev Hospital; Foundation of Augustinus; Foundation of Horslev; Foundation of Aase; Foundation of Ejnar Danielsen; Aase Bay, Denmark	Danish Kidney Association (Nyreforeningen); Danish Society of Nephrology; Danish Heart Association; Research Council of Herlev Hospital; Foundation of Augustinus; Foundation of Horslev; Foundation of Aase; Foundation of Ejnar Danielsen; Aase Bay, Denmark	This work is funded by the Danish Kidney Association (Nyreforeningen), the Danish Society of Nephrology, The Danish Heart Association, the Research Council of Herlev Hospital, the Foundations of Augustinus, Horslev, Aase and Ejnar Danielsen and Aase Bay, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Anan F, 2005, EUR J CLIN PHARMACOL, V61, P353, DOI 10.1007/s00228-005-0931-8; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290; BROCHNERMORTENSEN J, 1981, SCAND J CLIN LAB INV, V41, P91, DOI 10.3109/00365518109092020; Chan KE, 2011, KIDNEY INT, V80, P978, DOI 10.1038/ki.2011.228; Covic A, 2005, J NEPHROL, V18, P388; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dhakam Z, 2006, AM J HYPERTENS, V19, P214, DOI 10.1016/j.amjhyper.2005.08.007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Frimodt-Moller M, 2006, SCAND J CLIN LAB INV, V66, P385, DOI 10.1080/00365510600731332; FRIMODTMOLLER MHN, 2009, NEPHROL DIAL TRANSPL; Gallagher D, 2004, AM J HYPERTENS, V17, P1059, DOI 10.1016/j.amjhyper.2004.05.027; Hirata K, 2005, J HYPERTENS, V23, P551, DOI 10.1097/01.hjh.0000160211.56103.48; KAMPER AL, 1990, SCAND J UROL NEPHROL, V24, P69, DOI 10.3109/00365599009180363; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lemogoum D, 2004, J HYPERTENS, V22, P511, DOI 10.1097/00004872-200403000-00013; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; LONDON GM, 1994, CIRCULATION, V90, P2786, DOI 10.1161/01.CIR.90.6.2786; Mahmud A, 2000, J HUM HYPERTENS, V14, P541, DOI 10.1038/sj.jhh.1001053; Mahmud A, 2002, AM J HYPERTENS, V15, P321, DOI 10.1016/S0895-7061(01)02313-5; Nichols WW, 2008, J CLIN HYPERTENS, V10, P295, DOI 10.1111/j.1751-7176.2008.04746.x; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Protogerou AD, 2009, CURR PHARM DESIGN, V15, P267, DOI 10.2174/138161209787354267; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Sleight P, 2001, LANCET, V358, P2130, DOI 10.1016/S0140-6736(01)07186-0; Wang KL, 2009, J HYPERTENS, V27, P461, DOI 10.1097/HJH.0b013e3283220ea4; Weber T, 2009, J HYPERTENS, V27, P1624, DOI 10.1097/HJH.0b013e32832cb04e; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	39	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41757	10.1371/journal.pone.0041757	http://dx.doi.org/10.1371/journal.pone.0041757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860014	gold, Green Submitted, Green Published			2022-12-27	WOS:000307045600041
J	Khamduang, W; Gaudy-Graffin, C; Ngo-Giang-Huong, N; Jourdain, G; Moreau, A; Luekamlung, N; Halue, G; Buranawanitchakorn, Y; Kunkongkapan, S; Buranabanjasatean, S; Lallemant, M; Sirirungsi, W; Goudeau, A				Khamduang, Woottichai; Gaudy-Graffin, Catherine; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Moreau, Alain; Luekamlung, Nuananong; Halue, Guttiga; Buranawanitchakorn, Yuwadee; Kunkongkapan, Sura; Buranabanjasatean, Sudanee; Lallemant, Marc; Sirirungsi, Wasna; Goudeau, Alain		Program HIV Prevention Treatment	Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand	PLOS ONE			English	Article							PATIENTS RECEIVING LAMIVUDINE; HIV-1-INFECTED ADULTS; INDIVIDUALS; RESISTANT; EFFICACY; ADOLESCENTS; GUIDELINES; MORTALITY; IMPACT; COHORT	Background: Approximately 4 million of people are co-infected with HIV and Hepatitis B virus (HBV). In resource-limited settings, the majority of HIV-infected patients initiate first-line highly active antiretroviral therapy containing lamivudine (3TC-containing-HAART) and long-term virological response of HBV to lamivudine-containing HAART in co-infected patients is not well known. Methodology/Principal Finding: HIV-HBV co-infected patients enrolled in the PHPT cohort (ClinicalTrials. gov NCT00433030) and initiating a 3TC-containing-HAART regimen were included. HBV-DNA, HIV-RNA, CD4+ T-cell counts and alanine transaminase were measured at baseline, 3 months, 12 months and then every 6 months up to 5 years. Kaplan-Meier analysis was used to estimate the cumulative rates of patients who achieved and maintained HBV-DNA suppression. Of 30 co-infected patients, 19 were positive for HBe antigen (HBeAg). At initiation of 3TC-containing-HAART, median HBV DNA and HIV RNA levels were 7.35 log10 IU/mL and 4.47 log10 copies/mL, respectively. At 12 months, 67% of patients achieved HBV DNA suppression: 100% of HBeAg-negative patients and 47% of HBeAg-positive. Seventy-three percent of patients had HIV RNA below 50 copies/mL. The cumulative rates of maintained HBV-DNA suppression among the 23 patients who achieved HBV-DNA suppression were 91%, 87%, and 80% at 1, 2, and 4 years respectively. Of 17 patients who maintained HBV-DNA suppression while still on 3TC, 4 (24%) lost HBsAg and 7 of 8 (88%) HBeAg-positive patients lost HBeAg at their last visit (median duration, 59 months). HBV breakthrough was observed only in HBeAg-positive patients and 6 of 7 patients presenting HBV breakthrough had the rtM204I/V mutations associated with 3TC resistance along with rtL180M and/or rtV173L. Conclusions: All HBeAg-negative patients and 63% of HBeAg-positive HIV-HBV co-infected patients achieved long-term HBV DNA suppression while on 3TC-containing-HAART. This study provides information useful for the management of co-infected patients in resource-limited countries where the vast majority of co-infected patients are currently receiving 3TC.	[Khamduang, Woottichai; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc; Sirirungsi, Wasna] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Khamduang, Woottichai; Gaudy-Graffin, Catherine; Moreau, Alain; Goudeau, Alain] Univ Tours, Fac Med, INSERM, U966,CHRU Tours, Tours, France; [Khamduang, Woottichai; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] IRD, UMI Programs HIV Prevent & Treatment PHPT 174, Chiang Mai, Thailand; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Luekamlung, Nuananong] Lamphun Hosp, Lamphun, Thailand; [Halue, Guttiga] Phayao Hosp, Phayao, Thailand; [Buranawanitchakorn, Yuwadee] Chiang Kham Hosp, Phayao, Thailand; [Kunkongkapan, Sura] Mae Sai Hosp, Chiangrai, Thailand; [Buranabanjasatean, Sudanee] Mae Chan Hosp, Chiangrai, Thailand	Chiang Mai University; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Institut de Recherche pour le Developpement (IRD); Harvard University; Harvard T.H. Chan School of Public Health	Khamduang, W (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand.	kwoottichai@gmail.com; goudeau@med.univ-tours.fr	Jourdain, Gonzague/F-9117-2017; Ngo-Giang-Huong, Nicole/G-2860-2017; Khamduang, Woottichai/AFG-2454-2022	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Khamduang, Woottichai/0000-0003-0196-5691	Agence Nationale de Recherches sur le Sida et les hepatites virales [ANRS 12-179]; Global Fund to fight AIDS, TB and Malaria; Institut de Recherche pour le Developpement (IRD), France; Thailand International Development Cooperation Agency (TICA), Thai Ministry of Foreign Affairs; IRD; Franco-Thai cooperation program in Higher Education and Research; Faculty of Associated Medical Sciences, Chiang Mai University; French Ministry of Foreign Affairs	Agence Nationale de Recherches sur le Sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Global Fund to fight AIDS, TB and Malaria(United States Agency for International Development (USAID)); Institut de Recherche pour le Developpement (IRD), France; Thailand International Development Cooperation Agency (TICA), Thai Ministry of Foreign Affairs; IRD; Franco-Thai cooperation program in Higher Education and Research; Faculty of Associated Medical Sciences, Chiang Mai University; French Ministry of Foreign Affairs	This work was supported by Agence Nationale de Recherches sur le Sida et les hepatites virales (grant number ANRS 12-179); the Global Fund to fight AIDS, TB and Malaria; the Institut de Recherche pour le Developpement (IRD), France; and Thailand International Development Cooperation Agency (TICA), Thai Ministry of Foreign Affairs. WK received scholarships from the IRD, the Franco-Thai cooperation program in Higher Education and Research, the Faculty of Associated Medical Sciences, Chiang Mai University, and the French Ministry of Foreign Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2011, GUID US ANT AG HIV 1, P111; Benhamou Y, 2006, HEPATOLOGY, V43, P548, DOI 10.1002/hep.21055; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; da Silva Luiz Caetano, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P189; de Vries-Sluijs TEMS, 2006, J CLIN VIROL, V36, P60, DOI 10.1016/j.jcv.2005.12.004; Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942; Ford N, 2008, S AFR J HIV MED, P8; Hoff J, 2001, CLIN INFECT DIS, V32, P963, DOI 10.1086/319368; Kiertiburanakul Sasisopin, 2007, Journal of the Medical Association of Thailand, V90, P237; Kim HN, 2011, J VIRAL HEPATITIS, V18, pE447, DOI 10.1111/j.1365-2893.2011.01466.x; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Nishizaki Y, 2006, TOKAI J EXP CLIN MED, V31, P111; Phanuphak P, 2004, AIDS, V18, pS33, DOI 10.1097/00002030-200406003-00007; Pillay D, 2000, AIDS, V14, P1111, DOI 10.1097/00002030-200006160-00007; Sheng WH, 2012, CLIN INFECT DIS, V54, P548, DOI 10.1093/cid/cir851; Snow-Lampart A, 2011, HEPATOLOGY, V53, P763, DOI 10.1002/hep.24078; Sungkanuparph Somnuek, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P863; Sungkanuparph S, 2010, ASIAN BIOMED, V4, P515, DOI 10.2478/abm-2010-0066; Sungkanuparph Somnuek, 2008, Journal of the Medical Association of Thailand, V91, P1925; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Villeneuve JP, 2003, J HEPATOL, V39, P1085, DOI 10.1016/j.jhep.2003.09.022; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2009, RAP ADV ANT THER HIV, V3, P11	31	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42184	10.1371/journal.pone.0042184	http://dx.doi.org/10.1371/journal.pone.0042184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860080	Green Published, gold			2022-12-27	WOS:000307045600071
J	Naylor, RJ; Livesey, L; Schumacher, J; Henke, N; Massey, C; Brock, KV; Fernandez-Fuente, M; Piercy, RJ				Naylor, Rosie J.; Livesey, Leanda; Schumacher, John; Henke, Nicole; Massey, Claire; Brock, Kenny V.; Fernandez-Fuente, Marta; Piercy, Richard J.			Allele Copy Number and Underlying Pathology Are Associated with Subclinical Severity in Equine Type 1 Polysaccharide Storage Myopathy (PSSM1)	PLOS ONE			English	Article							SKELETAL-MUSCLE; POMPE DISEASE; PHOSPHOFRUCTOKINASE DEFICIENCY; EXERTIONAL RHABDOMYOLYSIS; INSULIN SENSITIVITY; MCARDLES DISEASE; QUARTER HORSES; GYS1 MUTATION; EXERCISE; GLUCOSE	Equine type 1 polysaccharide storage myopathy (PSSM1), a common glycogenosis associated with an R309H founder mutation in the glycogen synthase 1 gene (GYS1), shares pathological features with several human myopathies. In common with related human disorders, the pathogenesis remains unclear in particular, the marked phenotypic variability between affected animals. Given that affected animals accumulate glycogen and alpha-crystalline polysaccharide within their muscles, it is possible that physical disruption associated with the presence of this material could exacerbate the phenotype. The aim of this study was to compare the histopathological changes in horses with PSSM1, and specifically, to investigate the hypothesis that the severity of underlying pathology, (e.g. vacuolation and inclusion formation) would (1) be higher in homozygotes than heterozygotes and (2) correlate with clinical severity. Resting and post-exercise plasma creatine kinase (CK) and aspartate aminotransferase (AST) enzyme activity measurements and muscle pathology were assessed in matched cohorts of PSSM1 homozygotes, heterozygotes or control horses. Median (interquartile range (IR)) resting CK activities were 364 (332-764) U/L for homozygotes, 301 (222-377) U/L for heterozygotes and 260 (216-320) U/L for controls, and mean (+/- SD) AST activity for homozygotes were 502 (+/116) U/L, for heterozygotes, 357 (+/-92) U/L and for controls, 311 (+/-64) U/L and were significantly different between groups (P = 0.04 and P = 0.01 respectively). Resting plasma AST activity was significantly associated with the severity of subsarcolemmal vacuolation (rho = 0.816; P = 0.01) and cytoplasmic inclusions (rho = 0.766; P = 0.01). There were fewer type 2x and more type 2a muscle fibres in PSSM1-affected horses. Our results indicate that PSSM1 has incomplete dominance. Furthermore, the association between plasma muscle enzyme activity and severity of underlying pathology suggests that physical disruption of myofibres may contribute to the myopathic phenotype. This work provides insight into PSSM1 pathogenesis and has implications for related human glycogenoses.	[Naylor, Rosie J.; Massey, Claire; Fernandez-Fuente, Marta; Piercy, Richard J.] Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England; [Livesey, Leanda; Schumacher, John; Henke, Nicole; Brock, Kenny V.] Auburn Univ, Auburn, AL 36849 USA	University of London; University of London Royal Veterinary College; Auburn University System; Auburn University	Naylor, RJ (corresponding author), Univ London Royal Vet Coll, Comparat Neuromuscular Dis Lab, London, England.	rpiercy@rvc.ac.uk	Fernandez-Fuente, Marta/A-1761-2014					Annandale EJ, 2005, AM J VET RES, V66, P839, DOI 10.2460/ajvr.2005.66.839; Annandale EJ, 2004, NEUROMUSCULAR DISORD, V14, P666, DOI 10.1016/j.nmd.2004.05.007; ARGOV Z, 1987, ANN NEUROL, V22, P46, DOI 10.1002/ana.410220112; Art T, 2006, Equine Vet J Suppl, P298; Brojer JT, 2006, AM J VET RES, V67, P1589, DOI 10.2460/ajvr.67.9.1589; Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6; Byrne E, 2000, COMP CONT EDUC PRACT, V22, P503; De La Corte FD, 2002, J VET INTERN MED, V16, P581, DOI 10.1892/0891-6640(2002)016&lt;0581:DOOPSM&gt;2.3.CO;2; DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103; DiMauro S, 2011, OFFICIAL J MEDITERRA, V30, P96; Dranchak PK, 2007, AM J VET RES, V68, P1079, DOI 10.2460/ajvr.68.10.1079; Dubowitz V, 2007, MUSCLE BIOPSY PRACTC; Duran J, 2012, EMBO MOL MED; Eto D, 2003, EQUINE VET J, V35, P676, DOI 10.2746/042516403775696276; Firshman AM, 2005, JAVMA-J AM VET MED A, V227, P1958, DOI 10.2460/javma.2005.227.1958; Firshman AM, 2003, AM J VET RES, V64, P1319, DOI 10.2460/ajvr.2003.64.1319; Firshman AM, 2008, AM J VET RES, V69, P818, DOI 10.2460/ajvr.69.6.818; HAYS AP, 1981, NEUROLOGY, V31, P1077, DOI 10.1212/WNL.31.9.1077; Hicks J, 2011, ULTRASTRUCT PATHOL, V35, P183, DOI 10.3109/01913123.2011.601404; JENSEN M, 1990, ACTA VET SCAND, V31, P129; LEWIS SF, 1985, J APPL PHYSIOL, V59, P1991, DOI 10.1152/jappl.1985.59.6.1991; LEWIS SF, 1986, J APPL PHYSIOL, V61, P391, DOI 10.1152/jappl.1986.61.2.391; McCue ME, 2008, J VET INTERN MED, V22, P1228, DOI 10.1111/j.1939-1676.2008.0167.x; McCue ME, 2009, VET PATHOL, V46, P1281, DOI 10.1354/vp.08-VP-0177-M-FL; Mccue ME, 2009, NEUROMUSCULAR DISORD, V19, P37, DOI 10.1016/j.nmd.2008.10.001; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815; Naylor RJ, 2012, J VET INTER IN PRESS; Papadimas GK, 2011, CLIN NEUROL NEUROSUR, V113, P303, DOI 10.1016/j.clineuro.2010.12.005; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rivero JLL, 1996, ANAT RECORD, V246, P185, DOI 10.1002/(SICI)1097-0185(199610)246:2<185::AID-AR5>3.0.CO;2-0; Schwarz B, 2011, VET REC, V169, P583, DOI 10.1136/vr.d5438; Serrano AL, 2000, J MUSCLE RES CELL M, V21, P235, DOI 10.1023/A:1005642632711; Shea L, 2009, INT J CLIN PHARM TH, V47, pS42; Stanley RL, 2009, EQUINE VET J, V41, P597, DOI 10.2746/042516409X407611; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; Valberg SJ, 1999, EQUINE VET J, V31, P43, DOI 10.1111/j.2042-3306.1999.tb03789.x; VALBERG SJ, 1992, NEUROMUSCULAR DISORD, V2, P351, DOI 10.1016/S0960-8966(06)80006-4; Valentine BA, 2006, VET PATHOL, V43, P270, DOI 10.1354/vp.43-3-270; Valentine BA, 2005, VET PATHOL, V42, P823, DOI 10.1354/vp.42-6-823; Valentine BA, 2000, VET PATHOL, V37, P193, DOI 10.1354/vp.37-2-193; Valentine BA, 2006, NEUROMUSCULAR DISORD, V16, P603, DOI 10.1016/j.nmd.2006.05.259; Vucic S, 2007, MUSCLE NERVE, V35, P536, DOI 10.1002/mus.20720; Xu S, 2010, J APPL PHYSIOL, V108, P1383, DOI 10.1152/japplphysiol.01253.2009; Yamano S, 2002, AM J VET RES, V63, P1408, DOI 10.2460/ajvr.2002.63.1408	45	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42317	10.1371/journal.pone.0042317	http://dx.doi.org/10.1371/journal.pone.0042317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860112	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600090
J	Xue, HP; Wang, YC; Lin, B; An, JF; Chen, L; Chen, JX; Fang, JY				Xue, Huiping; Wang, Ying-Chao; Lin, Bing; An, Jianfu; Chen, Lu; Chen, Jinxian; Fang, Jing-Yuan			A Meta-Analysis of Interleukin-10-592 Promoter Polymorphism Associated with Gastric Cancer Risk	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CYTOKINE GENE POLYMORPHISMS; GASTRODUODENAL DISEASES; COSTA-RICA; CARCINOMA; POPULATION; STOMACH; CARDIA; IL-10; ADENOCARCINOMA	We aimed to explore the role of IL-10 -592 A/C SNP in the susceptibility to gastric cancer through a systematic review and meta-analysis. Each initially included article was scored for quality appraisal. 17 studies were eligible for the meta-analysis. We adopted the most probably appropriate genetic model (recessive model). Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated. IL-10-592 AA genotype is associated with the reduced risk of developing gastric cancer among Asians and even apparently observed among Asians high quality subgroup, suggesting IL-10-592 AA genotype may seem to be more protective from overall gastric cancer in Asian populations. IL-10-592 AA genotype is also associated with the overall reduced gastric cancer susceptibility in persons with H. pylori infection compared with controls without H. pylori infection, suggesting IL-10-592 AA genotype may seem to be more protective from overall gastric cancer susceptibility in persons infected with H. pylori. IL-10-592 AA genotype is not associated with either pathologic subtypes (intestinal or diffuse) or anatomic subtypes (non-cardia or cardia) of gastric cancer susceptibility. Genotyping methods like direct sequencing should be highly advocated to be conducted in future well-designed high quality studies among different ethnicities or populations.	[Xue, Huiping; Wang, Ying-Chao; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Renji Hosp, Div Gastroenterol & Hepatol,Sch Med,Minist Hlth, Shanghai 200030, Peoples R China; [Xue, Huiping; Wang, Ying-Chao; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai 200030, Peoples R China; [Lin, Bing] Fudan Univ, Sch Med, Zhongshan Hosp, Div Nutr, Shanghai 200433, Peoples R China; [An, Jianfu] Shanghai Jiao Tong Univ, Sch Med, Bioinformat Dept, Shanghai 200030, Peoples R China; [Chen, Lu; Chen, Jinxian] Renji Hosp, Dept Gen Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Xue, HP (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Renji Hosp, Div Gastroenterol & Hepatol,Sch Med,Minist Hlth, Shanghai 200030, Peoples R China.	xue_huiping@126.com; fang_jingyuan@126.com	wang, yingying/GRS-3058-2022; Kim, Seongman/N-6910-2014		National Basic Research Program of China 973 program [2010CB5293]; National High Technology Research and Development Program of China (863 Program) [2006AA02A402]; Science and Technology Commission of Shanghai Municipality [09DZ1950101]	National Basic Research Program of China 973 program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by The National Basic Research Program of China 973 program (2010CB5293), the National High Technology Research and Development Program of China (863 Program) (2006AA02A402), and Science and Technology Commission of Shanghai Municipality (09DZ1950101) to FJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar-Alpizar W, 2005, CLIN EXP MED, V5, P169, DOI 10.1007/s10238-005-0082-3; Avradopoulos K, 1997, ANN SURG ONCOL, V4, P184, DOI 10.1007/BF02303803; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Con SA, 2009, WORLD J GASTROENTERO, V15, P211, DOI 10.3748/wjg.15.211; Crusius JBA, 2008, ANN ONCOL, V19, P1894, DOI 10.1093/annonc/mdn400; Cui Y, 2011, DNA CELL BIOL, V30, P937, DOI 10.1089/dna.2011.1257; Deng W, 2008, CHIN J GASTROENTEROL, V17, P212; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; HEIDL G, 1993, J CANCER RES CLIN, V120, P95, DOI 10.1007/BF01200731; Jooste V, 2011, EUR J CANCER PREV, V20, P375, DOI 10.1097/CEJ.0b013e3283465426; Kamangar F, 2006, CANCER CAUSE CONTROL, V17, P117, DOI 10.1007/s10552-005-0439-7; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kim MA, 2005, CANCER-AM CANCER SOC, V103, P1439, DOI 10.1002/cncr.20966; Ko KP, 2009, J NUTR, V139, P1008, DOI 10.3945/jn.108.101865; Lee JY, 2005, CANCER LETT, V225, P207, DOI 10.1016/j.canlet.2004.11.028; Liu J, 2011, WORLD J GASTROENTERO, V17, P1362, DOI 10.3748/wjg.v17.i10.1362; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Perrin GQ, 1999, BLOOD, V93, P208, DOI 10.1182/blood.V93.1.208.401k06_208_216; Saito H, 2006, WORLD J SURG, V30, P1864, DOI 10.1007/s00268-005-0582-z; Savage SA, 2004, CANCER EPIDEM BIOMAR, V13, P1547; Sicinschi LA, 2006, INT J CANCER, V118, P649, DOI 10.1002/ijc.21364; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Valenti V, 2011, J SURG ONCOL, V104, P124, DOI 10.1002/jso.21947; Wu KC, 2009, J GASTROEN HEPATOL, V24, P37, DOI 10.1111/j.1440-1746.2008.05753.x; Wu MS, 2003, INT J CANCER, V104, P617, DOI 10.1002/ijc.10987; Xiao Hui, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P423, DOI 10.3760/cma.j.issn.1003-9406.2009.04.013; Xue HP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-102; Xue HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028083; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhu Y, 2011, MED ONCOL, V28, P133, DOI 10.1007/s12032-010-9417-3; Zhuang W, 2010, DIGEST DIS SCI, V55, P1525, DOI 10.1007/s10620-009-0922-1	41	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e39868	10.1371/journal.pone.0039868	http://dx.doi.org/10.1371/journal.pone.0039868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859944	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600005
J	Baranello, C; Mariani, M; Andreoli, M; Fanelli, M; Martinelli, E; Ferrandina, G; Scambia, G; Shahabi, S; Ferlini, C				Baranello, Cinzia; Mariani, Marisa; Andreoli, Mirko; Fanelli, Mara; Martinelli, Enrica; Ferrandina, Gabriella; Scambia, Giovanni; Shahabi, Shohreh; Ferlini, Cristiano			Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo?	PLOS ONE			English	Article							EXPRESSION; RECEPTOR; GROWTH; HYPOXIA; PEPTIDE; BINDING; CELLS; GENE	Stromal elements within a tumor interact with cancer cells to create a microenvironment that supports tumor growth and survival. Adrenomedullin (ADM) is an autocrine/paracrine factor produced by both stromal cells and cancer cells to create such a microenvironment. During differentiation of macrophages, ADM is produced in response to pro-inflammatory stimuli and hypoxia. In this study we investigated the role of ADM as a growth factor for ovarian cancer cells and as a modulator of macrophages. We also analyzed ADM expression levels in a retrospective clinical study using nanofluidic technology and assessment of ADM at the gene level in 220 ovarian cancer patients. To study the effects of ADM, ovarian cancer cell lines A2780, OVCAR-3, and HEY and their drug-resistant counterparts were used for proliferation assays, while monocytes from healthy donors were differentiated in vitro. ADM was a weak growth factor, as revealed by proliferation assays and cell cycle analysis. After culturing cancer cells under stressing conditions, such as serum starvation and/or hypoxia, ADM was found to be a survival factor in HEY but not in other cell lines. In macrophages, ADM showed activity on proliferation/differentiation, primarily in type 2 macrophages (M2). Unexpectedly, the clinical study revealed that high expression of ADM was linked to positive outcome and to cancer with low Ca125. In conclusion, although in vitro ADM was a potential factor in biological aggressiveness, this possibility was not confirmed in patients. Therefore, use of an ADM antagonist would be inappropriate in managing ovarian cancer patients.	[Baranello, Cinzia; Fanelli, Mara; Martinelli, Enrica; Ferrandina, Gabriella; Scambia, Giovanni; Shahabi, Shohreh; Ferlini, Cristiano] Univ Cattolica Sacro Cuore, Dept Oncol, Campobasso, Italy; [Mariani, Marisa; Andreoli, Mirko; Ferlini, Cristiano] Danbury Hosp Res Inst, Danbury, CT USA	Catholic University of the Sacred Heart	Baranello, C (corresponding author), Univ Cattolica Sacro Cuore, Dept Oncol, Campobasso, Italy.	cristiano.ferlini@danhosp.org	Fanelli, Mara/J-8765-2016; Ferrandina, Gabriella/AAA-9083-2019; Ferlini, Cristiano/K-1339-2013; Fanelli, Mara/U-7495-2019	Fanelli, Mara/0000-0001-5240-6932; Ferlini, Cristiano/0000-0003-3886-9134; Baranello, Cinzia/0000-0001-9361-8763; FERRANDINA, Maria Gabriella/0000-0003-4672-4197	Associazione Oppo e le sue stanze ONLUS; Ruth C. Donovan Cancer Research Program	Associazione Oppo e le sue stanze ONLUS; Ruth C. Donovan Cancer Research Program	This work was partially supported by a Grant from Associazione Oppo e le sue stanze ONLUS (www.oppostanze.it), by the Ruth C. Donovan Cancer Research Program and by a generous donation from Mr. and Mrs. Ruggles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltowski J, 2004, POL J PHARMACOL, V56, P5; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chen P, 2012, ONCOL REP; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; CHOCHUNG YS, 1990, CANCER RES, V50, P7093; De Donato M, 2012, J CELL PHYSIOL, V227, P1034, DOI 10.1002/jcp.22813; Deville JL, 2009, INT J CANCER, V125, P2307, DOI 10.1002/ijc.24568; Ferlini C, 1996, CYTOMETRY, V24, P106; Giacalone PL, 2003, GYNECOL ONCOL, V91, P651, DOI 10.1016/S0090-8258(03)00279-8; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hata K, 2000, MOL HUM REPROD, V6, P867, DOI 10.1093/molehr/6.10.867; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Huynh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018054; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Michelsen J, 2006, CLIN SCI, V111, P61, DOI 10.1042/CS20060030; Miksa M, 2007, J IMMUNOL, V179, P6263, DOI 10.4049/jimmunol.179.9.6263; Milliken D, 2002, CLIN CANCER RES, V8, P1108; NEGUS RPM, 1995, J CLIN INVEST, V95, P2391, DOI 10.1172/JCI117933; Ouafik L, 2002, AM J PATHOL, V160, P1279, DOI 10.1016/S0002-9440(10)62555-2; Raspaglio G, 2008, GENE, V409, P100, DOI 10.1016/j.gene.2007.11.015; Smith DM, 2002, BIOCHEM SOC T, V30, P432, DOI 10.1042/bst0300432	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40678	10.1371/journal.pone.0040678	http://dx.doi.org/10.1371/journal.pone.0040678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859951	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900009
J	Chamratrithirong, A; Kaiser, P				Chamratrithirong, Aphichat; Kaiser, Paulina			The Dynamics of Condom Use with Regular and Casual Partners: Analysis of the 2006 National Sexual Behavior Survey of Thailand	PLOS ONE			English	Article							HIV; PREVENTION; AIDS; DETERMINANTS; PROGRAM; IMPACT; YOUTH	Objective: This study aims to determine factors associated with levels of condom use among heterosexual Thai males in sex with regular partners and in sex with casual partners. Methods: The data used in this study are from the national probability sample of the 2006 National Sexual Behavior Study, the third nationally representative cross-sectional survey in Thailand. A subtotal of 2,281 men were analyzed in the study, including young (18-24) and older (25-59) adults who were residents of rural areas of Thailand, non-Bangkok urban areas, and Bangkok. Two outcomes of interest for this analysis are reported condom use in the past 12 months by males in relationships with the most recent regular and casual partners who were not sex workers. Chi-square statistics, bivariate regressions and the proportional odds regression models are used in the analysis. Results: Condom use for men with their regular partner is revealed to be positively related to education, knowledge of condom effectiveness, and pro-condom strategy, and negatively related to non-professional employment, status of registered marriage, and short relationship duration. Condom use with casual partner is positively determined by education, condom knowledge, non-professional occupation, short relationship duration, and lack of history of paid sex. Conclusion: The national survey emphasized the importance of risk perceptions and condom motivations variables in explaining condom use among men in Thailand. These factors include not only education and knowledge of condom effectiveness and pro-condom strategy but also types of partners and their relationship context and characteristics. Program intervention to promote condom use in Thailand in this new era of predominant casual sex rather than sex with sex workers has to take into account more dynamic partner-based strategies than in the past history of the epidemics in Thailand.	[Chamratrithirong, Aphichat] Mahidol Univ, Inst Populat & Social Res, Phutthamonthon, Nakhon Pathom, Thailand; [Kaiser, Paulina] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Mahidol University; University of Michigan System; University of Michigan	Chamratrithirong, A (corresponding author), Mahidol Univ, Inst Populat & Social Res, Phutthamonthon, Nakhon Pathom, Thailand.	aphichat.cha@mahidol.ac.th			UNAIDS-Geneva; UN agencies in Thailand; UNAIDS	UNAIDS-Geneva; UN agencies in Thailand; UNAIDS	The financial support was provided to Institute for Population and Social Research (IPSR), Mahidol University to undertake The 2006 National Sexual Behavior Study during 2006-2008 by the UNAIDS-Geneva and other UN agencies in Thailand. AC was the principle investigator of this study which was finished with two reports published including the preliminary report (2007) and the collection of in-depth analysis by subtopics (2009). At the end of the grant, the survey data was made available for internal and international public use in IPSR website (where anyone can download freely from the website) since 2010. As for the current study on condom use dynamics with regular and casual partners, we started to work on it in 2010, using this data set, without continuing direct financial support. However, the study appreciated the past funding of UNAIDS, and acknowledges IPSR's institutional support in terms of the data availability, office space and staff time allocation and publication cost.	Bessinger R, 2004, EVAL PROGRAM PLANN, V27, P397, DOI 10.1016/j.evalprogplan.2004.07.003; BROWN T, 1994, AIDS, V8, pS131; Chamratrithirong A, 2007, MAHIDOL U PUBLICATIO; Eloundou-Enyegue PM, 2005, J BIOSOC SCI, V37, P257, DOI 10.1017/S0021932004007011; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Knodel J, 1996, INT FAM PLAN PERSPEC, V22, P97, DOI 10.2307/2950749; KU L, 1994, FAM PLANN PERSPECT, V26, P246, DOI 10.2307/2135889; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Meekers D, 2002, STUD FAMILY PLANN, V33, P335, DOI 10.1111/j.1728-4465.2002.00335.x; Meekers D, 2006, J BIOSOC SCI, V38, P365, DOI 10.1017/S0021932005007200; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Rhodes F, 2007, AIDS BEHAV, V11, P393, DOI 10.1007/s10461-007-9208-9; Robinson NF, 1996, 11 INT C AIDS VANC J; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Rugpao S, 2008, AIDS BEHAV, V12, P419, DOI 10.1007/s10461-007-9283-y; Sangkarat O, 1997, THESIS MAHIDOL U BAN; SAS Institute Inc, 2008, SAS 9 2 ENH LOGG FAC; Schaalma H, 2009, SCAND J PUBLIC HEALT, V37, P87, DOI 10.1177/1403494808090632; Stoebenau K, 2009, AM J PUBLIC HEALTH, V99, P811, DOI 10.2105/AJPH.2007.118422; Thato S, 2003, J NURS SCHOLARSHIP, V35, P157, DOI 10.1111/j.1547-5069.2003.00157.x; UNAIDS, 2000, EV 100 COND PROGR TH; van Loggerenberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030669; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; World Health Organization Regional Office for South-East Asia & Regional Office for the Western Pacific, 2003, FAM PLANN FACT SHEET; Wuttiprasit R, 1991, THESIS MAHIDOL U BAN	30	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42009	10.1371/journal.pone.0042009	http://dx.doi.org/10.1371/journal.pone.0042009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860047	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900061
J	Forget, MA; Huon, Y; Reuben, A; Grange, C; Liberman, M; Martin, J; Mes-Masson, AM; Arbour, N; Lapointe, R				Forget, Marie-Andree; Huon, Yannick; Reuben, Alexandre; Grange, Cecile; Liberman, Moishe; Martin, Jocelyne; Mes-Masson, Anne-Marie; Arbour, Nathalie; Lapointe, Rejean			Stimulation of Wnt/beta-Catenin Pathway in Human CD8(+) T Lymphocytes from Blood and Lung Tumors Leads to a Shared Young/Memory Phenotype	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; MEMORY; EXPRESSION; ACTIVATION; DIFFERENTIATION; THERAPY; IMPAIRS; TCF-1	Cancer can be treated by adoptive cell transfer (ACT) of T lymphocytes. However, how to optimally raise human T cells to a differentiation state allowing the best persistence in ACT is a challenge. It is possible to differentiate mouse CD8(+) T cells towards stem cell-like memory (T-SCM) phenotype upon TCR stimulation with Wnt/beta-catenin pathway activation. Here, we evaluated if T-SCM can be obtained from human mature CD8(+) T cells following TCR and Wnt/beta-catenin activation through treatment with the chemical agent 4,6-disubstituted pyrrolopyrimidine (TWS119), which inhibits the glycogen synthase kinase-3 beta (GSK-3 beta), key inhibitor of the Wnt pathway. Human CD8(+) T cells isolated from peripheral blood or tumor-infiltrating lymphocytes (TIL), and treated with TWS119 gave rise to CD62L(+) CD45RA(+) cells, indicative of early differentiated stage, also expressing CD127 which is normally found on memory cells, and CD133, an hematopoietic stem cell marker. T-SCM cells raised from either TIL or blood secreted numerous inflammatory mediators, but in lower amounts than those measured without TWS119. Finally, generated T-SCM CD8(+) T cells expressed elevated Bcl-2 and no detectable caspase-3 activity, suggesting increased persistence. Our data support a role for Wnt/beta-catenin pathway in promoting the T-SCM subset in human CD8(+) T cells from TIL and the periphery, which are relevant for ACT.	[Forget, Marie-Andree; Huon, Yannick; Reuben, Alexandre; Grange, Cecile; Mes-Masson, Anne-Marie; Arbour, Nathalie; Lapointe, Rejean] Univ Montreal, Res Ctr, Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada; [Forget, Marie-Andree; Huon, Yannick; Reuben, Alexandre; Grange, Cecile; Mes-Masson, Anne-Marie; Arbour, Nathalie; Lapointe, Rejean] Hop Notre Dame de Bon Secours, Inst Canc Montreal, Montreal, PQ H2L 4K8, Canada; [Liberman, Moishe; Martin, Jocelyne] Univ Montreal, Dept Surg, Div Thorac Surg, CHUM, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Forget, MA (corresponding author), Univ Montreal, Res Ctr, Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ, Canada.	rejean.lapointe@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X; Arbour, Nathalie/0000-0002-3718-1584	Canadian Institutes of Health Research [MOP-62709]; Reseau TheCell du Fonds de recherche du Quebec - Sante (FRQS); FRSQ; Canderel fellowship; Institut du Cancer de Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Reseau TheCell du Fonds de recherche du Quebec - Sante (FRQS); FRSQ(Fonds de la Recherche en Sante du Quebec); Canderel fellowship; Institut du Cancer de Montreal	This work was supported by the Canadian Institutes of Health Research (MOP-62709) and by Reseau TheCell du Fonds de recherche du Quebec - Sante (FRQS). RL and MAF were supported by fellowships from FRSQ, and MAF was also funded by a Canderel fellowship from the Institut du Cancer de Montreal. NA holds a Donald Paty Career Development Award from the Multiple Sclerosis Society of Canada and is a Research Scholar from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Denton AE, 2011, P NATL ACAD SCI US; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Driessens G, 2011, J IMMUNOL, V186, P784, DOI 10.4049/jimmunol.1001562; Driessens G, 2010, NAT MED, V16, P513, DOI 10.1038/nm0510-513; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Grange C, 2011, J IMMUNOL METHODS, V372, P119, DOI 10.1016/j.jim.2011.07.002; Hinrichs CS, 2009, BLOOD, P106; Hinrichs CS, 2010, BLOOD; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; Muralidharan S, 2011, J IMMUNOL, V187, P5221, DOI 10.4049/jimmunol.1101585; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Peant B, 2009, PROSTATE, V69, P706, DOI 10.1002/pros.20912; Pelletier S, 2009, CANCER IMMUNOL IMMUN, V58, P1207, DOI 10.1007/s00262-008-0630-2; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yannelli JR, 1996, INT J CANCER, V65, P413, DOI 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#; Zeng FY, 2010, BIOCHEM BIOPH RES CO, V391, P1049, DOI 10.1016/j.bbrc.2009.12.017; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199	38	24	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41074	10.1371/journal.pone.0041074	http://dx.doi.org/10.1371/journal.pone.0041074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859966	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900016
J	Haraguchi, R; Matsumaru, D; Nakagata, N; Miyagawa, S; Suzuki, K; Kitazawa, S; Yamada, G				Haraguchi, Ryuma; Matsumaru, Daisuke; Nakagata, Naomi; Miyagawa, Shinichi; Suzuki, Kentaro; Kitazawa, Sohei; Yamada, Gen			The Hedgehog Signal Induced Modulation of Bone Morphogenetic Protein Signaling: An Essential Signaling Relay for Urinary Tract Morphogenesis	PLOS ONE			English	Article							EXTERNAL GENITALIA FORMATION; TAMOXIFEN-INDUCIBLE FORM; SONIC-HEDGEHOG; CONGENITAL-ANOMALIES; VACTERL ASSOCIATION; MOLECULAR ANALYSIS; MOUSE MODEL; KIDNEY; EXPRESSION; GENE	Background: Congenital diseases of the urinary tract are frequently observed in infants. Such diseases present a number of developmental anomalies such as hydroureter and hydronephrosis. Although some genetically-modified mouse models of growth factor signaling genes reproduce urinary phenotypes, the pathogenic mechanisms remain obscure. Previous studies suggest that a portion of the cells in the external genitalia and bladder are derived from peri-cloacal mesenchymal cells that receive Hedgehog (Hh) signaling in the early developmental stages. We hypothesized that defects in such progenitor cells, which give rise to urinary tract tissues, may be a cause of such diseases. Methodology/Principal Findings: To elucidate the pathogenic mechanisms of upper urinary tract malformations, we analyzed a series of Sonic hedgehog (Shh) deficient mice. Shh(-/-) displayed hydroureter and hydronephrosis phenotypes and reduced expression of several developmental markers. In addition, we suggested that Shh modulation at an early embryonic stage is responsible for such phenotypes by analyzing the Shh conditional mutants. Tissue contribution assays of Hh-responsive cells revealed that peri-cloacal mesenchymal cells, which received Hh signal secreted from cloacal epithelium, could contribute to the ureteral mesenchyme. Gain- and loss-of-functional mutants for Hh signaling revealed a correlation between Hh signaling and Bone morphogenetic protein (Bmp) signaling. Finally, a conditional ablation of Bmp receptor type IA (BmprIA) gene was examined in Hh-responsive cell lineages. This system thus made it possible to analyze the primary functions of the growth factor signaling relay. The defective Hh-to-Bmp signaling relay resulted in severe urinary tract phenotypes with a decrease in the number of Hh-responsive cells. Conclusions/Significance: This study identified the essential embryonic stages for the pathogenesis of urinary tract phenotypes. These results suggested that Hh-responsive mesenchymal Bmp signaling maintains the population of peri-cloacal mesenchyme cells, which is essential for the development of the ureter and the upper urinary tract.	[Haraguchi, Ryuma; Matsumaru, Daisuke; Suzuki, Kentaro; Yamada, Gen] Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Wakayama, Japan; [Haraguchi, Ryuma; Matsumaru, Daisuke; Miyagawa, Shinichi; Suzuki, Kentaro; Yamada, Gen] Kumamoto Univ, Dept Organ Format, Inst Mol Embryol & Genet, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto, Japan; [Haraguchi, Ryuma; Kitazawa, Sohei] Ehime Univ, Dept Mol Pathol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto, Japan; [Miyagawa, Shinichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Aichi, Japan	Wakayama Medical University; Kumamoto University; Ehime University; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Haraguchi, R (corresponding author), Wakayama Med Univ, Dept Dev Genet, Inst Adv Med, Wakayama, Japan.	transg8@wakayama-med.ac.jp	Kitazawa, Sohei/E-5602-2010	Kitazawa, Sohei/0000-0002-7466-7356; Matsumaru, Daisuke/0000-0002-1832-624X; Nakagata, Naomi/0000-0002-5737-9993; Yamada, Gen/0000-0001-6160-2660	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23790228, 24790292, 22132006]; Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institutes of Health Grant [R01ES016597]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Grant-in-Aid for Young Scientists B (23790228 and 24790292), for Scientific Research on Innovative Areas: Molecular mechanisms for establishment of sex differences (22132006), and the Global COE program Cell Fate Regulation Research and Education Unit from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work is also supported by National Institutes of Health Grant R01ES016597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaga M, 2010, AM J MED GENET A, V152A, P781, DOI 10.1002/ajmg.a.33293; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Cain JE, 2006, J ANAT, V209, P745, DOI 10.1111/j.1469-7580.2006.00655.x; Cain JE, 2011, PEDIATR NEPHROL, V26, P1365, DOI 10.1007/s00467-010-1704-x; Cain JE, 2005, KIDNEY INT, V67, P420, DOI 10.1111/j.1523-1755.2005.67098.x; Chan KT, 2010, BIOCHEM BIOPH RES CO, V398, P153, DOI 10.1016/j.bbrc.2010.05.150; Chevalier RL, 1998, SEMIN NEPHROL, V18, P585; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DANEMAN A, 1991, RADIOL CLIN N AM, V29, P351; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Di Giovanni V, 2011, DEVELOPMENT, V138, P2717, DOI 10.1242/dev.059030; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Dudley AT, 1997, DEV DYNAM, V208, P349; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Godin RE, 1998, DEVELOPMENT, V125, P3473; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Haraguchi R, 2001, DEVELOPMENT, V128, P4241; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hensley MR, 2012, ZEBRAFISH, V9, P44, DOI 10.1089/zeb.2011.0730; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jenkins D, 2007, J ANAT, V211, P620, DOI 10.1111/j.1469-7580.2007.00808.x; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Kim JH, 2001, CLIN GENET, V59, P306, DOI 10.1034/j.1399-0004.2001.590503.x; Kim PCW, 2001, J PEDIATR SURG, V36, P381, DOI 10.1053/jpsu.2001.20722; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Li MM, 2008, AM J MED GENET A, V146A, P368, DOI 10.1002/ajmg.a.32116; Li MM, 2009, J PEDIATR-US, V155, P311, DOI 10.1016/j.jpeds.2009.04.001; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Martinez-Frias M, 2001, CLIN GENET, V60, P397, DOI 10.1034/j.1399-0004.2001.600515.x; Matsumaru D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016260; McGlinn E, 2006, CURR OPIN GENET DEV, V16, P426, DOI 10.1016/j.gde.2006.06.013; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Miyazaki Y, 2003, PEDIATR INT, V45, P598, DOI 10.1046/j.1442-200X.2003.01777.x; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Omori A, 2011, CONGENIT ANOM, V51, P102, DOI 10.1111/j.1741-4520.2011.00318.x; Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Seifert AW, 2009, DEVELOPMENT, V136, P3949, DOI 10.1242/dev.042291; Song RF, 2011, PEDIATR NEPHROL, V26, P353, DOI 10.1007/s00467-010-1629-4; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Tabatabaeifar M, 2009, PEDIATR NEPHROL, V24, P2361, DOI 10.1007/s00467-009-1287-6; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Tripathi P, 2010, DEV BIOL, V340, P518, DOI 10.1016/j.ydbio.2010.02.007; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Wang YQ, 2009, GENESIS, V47, P409, DOI 10.1002/dvg.20515; Wong EYM, 2011, DEV BIOL, V352, P382, DOI 10.1016/j.ydbio.2011.02.003; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yao Y, 2011, BJU INT, V107, P1002, DOI 10.1111/j.1464-410X.2010.09520.x; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	81	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42245	10.1371/journal.pone.0042245	http://dx.doi.org/10.1371/journal.pone.0042245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860096	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950900081
J	Hsu, WL; Pan, WH; Chien, YC; Yu, KJ; Cheng, YJ; Chen, JY; Liu, MY; Hsu, MM; Lou, PJ; Chen, IH; Yang, CS; Hildesheim, A; Chen, CJ				Hsu, Wan-Lun; Pan, Wen-Harn; Chien, Yin-Chu; Yu, Kelly J.; Cheng, Yu-Juen; Chen, Jen-Yang; Liu, Mei-Ying; Hsu, Mow-Ming; Lou, Pei-Jen; Chen, I-How; Yang, Czau-Siung; Hildesheim, Allan; Chen, Chien-Jen			Lowered Risk of Nasopharyngeal Carcinoma and Intake of Plant Vitamin, Fresh Fish, Green Tea and Coffee: A Case-Control Study in Taiwan	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PRESERVED FOODS; SALTED FISH; FATTY-ACIDS; GENETIC POLYMORPHISMS; CIGARETTE-SMOKING; NUTRIENT INTAKE; CHINESE DIET; CANCER; CONSUMPTION	Background: A case-control study was conducted to evaluate the role of adult diet on nasopharyngeal carcinoma (NPC) in Taiwan. Methods: A total of 375 incident NPC cases and 327 controls matched to the cases on sex, age, and residence were recruited between July 1991 and December 1994. A structured questionnaire inquiring complete dietary history, socio-demographic characteristics, and other potential confounding factors was used in the personal interview. Unconditional logistic regression analysis was used to estimate multivariate-adjusted odds ratio (ORadj) with 95% confidence interval (CI) after accounting for known risk factors. Results: Fresh fish (ORadj, 0.56; 95% CI, 0.38-0.83 for the highest vs. lowest tertile of intake), green tea (ORadj, 0.61; 95% CI, 0.40-0.91 for drinking >= 1 times/week vs. never) and coffee (ORadj, 0.56; 95% CI, 0.37-0.85 for drinking 0.5 times/week vs. never) were inversely associated with the NPC risk. No association with NPC risk was observed for the intake of meats, salted fish, fresh vegetables, fruits and milk. Intake of vitamin A from plant sources was associated with a decreased NPC risk (ORadj, 0.62; 95% CI, 0.41-0.94 for the highest vs. lowest tertile). Conclusion: The study findings suggest that certain adult dietary patterns might protect against the development of NPC.	[Hsu, Wan-Lun; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Pan, Wen-Harn] Natl Hlth Res Inst, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan; [Chien, Yin-Chu] China Med Univ Hosp, Mol & Genom Epidemiol Res Ctr, Taichung, Taiwan; [Yu, Kelly J.] NCI, Canc Prevent Div, NIH, DHHS, Bethesda, MD 20892 USA; [Cheng, Yu-Juen; Chen, Chien-Jen] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Chunan, Taiwan; [Chen, Jen-Yang; Yang, Czau-Siung] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Liu, Mei-Ying] Natl Taipei Univ Nursing & Hlth Sci, Ctr Gen Educ, Taipei, Taiwan; [Hsu, Mow-Ming; Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chen, I-How] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Chen, I-How] Chang Gung Univ, Tao Yuan, Taiwan; [Hildesheim, Allan] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Taiwan University; National Health Research Institutes - Taiwan; National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hsu, WL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	chencj@gate.sinica.edu.tw	Pan, Wen-Harn/F-9972-2010; Hildesheim, Allan/B-9760-2015; Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	Pan, Wen-Harn/0000-0001-9136-0658; Hildesheim, Allan/0000-0003-0257-2363; LOU, PEI-JEN/0000-0002-3383-8593	National Institutes of Health, USA; NATIONAL CANCER INSTITUTE [ZIACP010211] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported from the the intramural funds from the National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CANC REG ANN REP ROC; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Bei JX, 2009, NAT GENET       0527, V42, P599; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Chow KC, 1997, CANCER EPIDEM BIOMAR, V6, P363; Fang MZ, 2005, CLIN CANCER RES, V11, P7033, DOI 10.1158/1078-0432.CCR-05-0406; Fang MZ, 2003, CANCER RES, V63, P7563; Farrow DC, 1998, INT J CANCER, V78, P675, DOI 10.1002/(SICI)1097-0215(19981209)78:6&lt;675::AID-IJC2&gt;3.0.CO;2-J; Feng BJ, 2007, INT J CANCER, V121, P1550, DOI 10.1002/ijc.22813; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; Hildesheim A, 2002, J NATL CANCER I, V94, P1780, DOI 10.1093/jnci/94.23.1780; Hildesheim A, 1997, J NATL CANCER I, V89, P1207, DOI 10.1093/jnci/89.16.1207; Hildesheim A, 2001, CANCER EPIDEM BIOMAR, V10, P1145; Ho J H, 1972, Adv Cancer Res, V15, P57, DOI 10.1016/S0065-230X(08)60372-3; Hsu WL, 2009, CANCER EPIDEM BIOMAR, V18, P1218, DOI 10.1158/1055-9965.EPI-08-1175; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; LANIER A, 1980, CANCER-AM CANCER SOC, V46, P2100, DOI 10.1002/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO;2-G; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; LEE MMS, 1992, INT J EPIDEMIOL, V21, P922, DOI 10.1093/ije/21.5.922; Li Li-Li, 2011, Chin J Cancer, V30, P231; Liu MY, 1997, J MED VIROL, V52, P262, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;262::AID-JMV5&gt;3.0.CO;2-0; Milner JA, 2006, NUTR CANCER, V56, P216, DOI 10.1207/s15327914nc5602_13; NING JP, 1990, J NATL CANCER I, V82, P291, DOI 10.1093/jnci/82.4.291; PAN WH, 1992, INT J EPIDEMIOL, V21, P929, DOI 10.1093/ije/21.5.929; Parkin DM, 2002, IARC SCI PUBL, VVIII; Porta M, 2003, EUR J EPIDEMIOL, V18, P289, DOI 10.1023/A:1023700216945; Ruan HL, 2011, FRONT MED CHINA, V4, P448; Simons Malcolm J, 2011, Chin J Cancer, V30, P79; Terry PD, 2003, AM J CLIN NUTR, V77, P532, DOI 10.1093/ajcn/77.3.532; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Utsunomiya H, 2008, FOOD CHEM TOXICOL, V46, P1919, DOI 10.1016/j.fct.2008.01.031; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; WEST S, 1993, INT J CANCER, V55, P722, DOI 10.1002/ijc.2910550504; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1988, CANCER RES, V48, P1954; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P364, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;364::AID-IJC12&gt;3.0.CO;2-C; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; ZHENG YM, 1994, BRIT J CANCER, V69, P508, DOI 10.1038/bjc.1994.92	52	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41779	10.1371/journal.pone.0041779	http://dx.doi.org/10.1371/journal.pone.0041779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848600	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200104
J	Kim, BK; Kim, HS; Park, JY; Kim, DY; Ahn, SH; Chon, CY; Park, YN; Han, KH; Kim, SU				Kim, Beom Kyung; Kim, Hyon Suk; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Park, Young Nyun; Han, Kwang-Hyub; Kim, Seung Up			Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B	PLOS ONE			English	Article							C VIRUS-INFECTION; TRANSIENT ELASTOGRAPHY; BIOCHEMICAL MARKERS; CLINICAL-OUTCOMES; VIRAL-HEPATITIS; SERUM MARKERS; CIRRHOSIS; INDEX; ACCURACY; DISEASE	Background and Aims: Liver stiffness measurement (LSM) and FibroTest (FT) are frequently used as non-invasive alternatives for fibrosis staging to liver biopsy. However, to date, diagnostic performances of Enhanced Liver Fibrosis (ELF) test, which consists of hyaluronic acid, aminoterminal propeptide of procollagen type-III, and tissue inhibitor of matrix metalloproteinases-1, have not been compared to those of LSM and FT in Asian chronic hepatitis B (CHB) patients. Methods: Between June 2010 and November 2011, we prospectively enrolled 170 CHB patients who underwent liver biopsies along with LSM, FT, and ELF. The Batts system was used to assess fibrosis stages. Results: Areas under receiver operating characteristic curves (AUROCs) to predict significant fibrosis (F >= 2), advanced fibrosis (F >= 3), and cirrhosis (F = 4) were 0.901, 0.860, and 0.862 for ELF, respectively; 0.937, 0.956, and 0.963 for LSM; and 0.896, 0.921, and 0.881 for FT. AUROCs to predict F >= 2 were similar between each other, whereas LSM and FT had better AUROCs than ELF for predicting F >= 3 (both p < 0.05), and LSM predicted F4 more accurately than ELF (p < 0.05). Optimized cutoffs of ELF to maximize sum of sensitivity and specificity were 8.5, 9.4, and 10.1 for F >= 2, F >= 3, and F = 4, respectively. Using suggested ELF, LSM and FT cutoffs to diagnose F1, F2, F3, and F4, 91 (53.5%), 117 (68.8%), and 110 (64.7%) patients, respectively, were correctly classified according to histological results. Conclusions: ELF demonstrated considerable diagnostic value in fibrosis staging in Asian CHB patients, especially in predicting F >= 2. However, LSM consistently provided better performance for predicting F >= 3 and F4.	[Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub; Kim, Seung Up] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub; Kim, Seung Up] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Hyon Suk] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub; Kim, Seung Up] Yonsei Univ, Coll Med, Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, BK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ksukorea@yuhs.ac	Kim, Hyon-Suk/R-4113-2017; Park, Jun Yong/H-7127-2019	Kim, Hyon-Suk/0000-0001-5662-7740; Han, Kwang-Hyub/0000-0003-3960-6539; Kim, Beom Kyung/0000-0002-5363-2496; Park, Jun Yong/0000-0001-6324-2224; Kim, Seung Up/0000-0002-9658-8050; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Young Nyun/0000-0003-0357-7967	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R D project; Ministry of Health and Welfare, Republic of Korea [A102065]; Yonsei Liver Blood Bank (YLBB); sanofi-aventis Korea	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R D project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Yonsei Liver Blood Bank (YLBB); sanofi-aventis Korea(Sanofi-Aventis)	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. A102065), and by the Yonsei Liver Blood Bank (YLBB), in part by a grant from sanofi-aventis Korea. BioPredictive kindly provided the complimentary service for calculation of FT score. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Castera L, 2006, HEPATOLOGY, V43, P373, DOI 10.1002/hep.21019; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Chang PE, 2008, ALIMENT PHARM THER, V28, P51, DOI 10.1111/j.1365-2036.2008.03711.x; Cho Sung Won, 2007, Korean J Hepatol, V13, P129; Crespo G, J HEPATOL; Degertekin B, 2009, HEPATOLOGY, V49, pS129, DOI 10.1002/hep.22931; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Guechot J, 2012, CLIN CHEM LAB MED, V50, P693, DOI 10.1515/cclm-2011-0858; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Halfon P, 2008, GASTROEN CLIN BIOL, V32, P22, DOI 10.1016/S0399-8320(08)73991-5; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035825; Kim BK, 2010, LIVER INT, V30, P1073, DOI 10.1111/j.1478-3231.2010.02269.x; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2009, J CLIN GASTROENTEROL, V43, P267, DOI 10.1097/MCG.0b013e31816f212e; Lee MH, 2010, DIGEST DIS SCI, V55, P3552, DOI 10.1007/s10620-010-1219-0; Leroy V, 2012, LIVER INT, V32, P528, DOI 10.1111/j.1478-3231.2012.02768.x; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Parkes J, 2010, GUT, V59, P1245, DOI 10.1136/gut.2009.203166; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	38	54	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41964	10.1371/journal.pone.0041964	http://dx.doi.org/10.1371/journal.pone.0041964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848675	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200137
J	Liu, HQ; Fu, YP; Xie, JT; Cheng, JS; Ghabrial, SA; Li, GQ; Yi, XH; Jiang, DH				Liu, Huiquan; Fu, Yanping; Xie, Jiatao; Cheng, Jiasen; Ghabrial, Said A.; Li, Guoqing; Yi, Xianhong; Jiang, Daohong			Discovery of Novel dsRNA Viral Sequences by In Silico Cloning and Implications for Viral Diversity, Host Range and Evolution	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; FAMILY TOTIVIRIDAE; VIRUS; METAGENOMICS; GENOMES; PLANT	Genome sequence of viruses can contribute greatly to the study of viral evolution, diversity and the interaction between viruses and hosts. Traditional molecular cloning methods for obtaining RNA viral genomes are time-consuming and often difficult because many viruses occur in extremely low titers. DsRNA viruses in the families, Partitiviridae, Totiviridae, Endornaviridae, Chrysoviridae, and other related unclassified dsRNA viruses are generally associated with symptomless or persistent infections of their hosts. These characteristics indicate that samples or materials derived from eukaryotic organisms used to construct cDNA libraries and EST sequencing might carry these viruses, which were not easily detected by the researchers. Therefore, the EST databases may include numerous unknown viral sequences. In this study, we performed in silico cloning, a procedure for obtaining full or partial cDNA sequence of a gene by bioinformatics analysis, using known dsRNA viral sequences as queries to search against NCBI Expressed Sequence Tag (EST) database. From this analysis, we obtained 119 novel virus-like sequences related to members of the families, Endornaviridae, Chrysoviridae, Partitiviridae, and Totiviridae. Many of them were identified in cDNA libraries of eukaryotic lineages, which were not known to be hosts for these viruses. Furthermore, comprehensive phylogenetic analysis of these newly discovered virus-like sequences with known dsRNA viruses revealed that these dsRNA viruses may have co-evolved with respective host supergroups over a long evolutionary time while potential horizontal transmissions of viruses between different host supergroups also is possible. We also found that some of the plant partitiviruses may have originated from fungal viruses by horizontal transmissions. These findings extend our knowledge of the diversity and possible host range of dsRNA viruses and offer insight into the origin and evolution of relevant viruses with their hosts.	[Liu, Huiquan; Li, Guoqing; Jiang, Daohong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei Province, Peoples R China; [Liu, Huiquan; Fu, Yanping; Xie, Jiatao; Cheng, Jiasen; Li, Guoqing; Yi, Xianhong; Jiang, Daohong] Huazhong Agr Univ, Prov Key Lab Plant Pathol Hubei Prov, Coll Plant Sci & Technol, Wuhan, Hubei Province, Peoples R China; [Ghabrial, Said A.] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA	Huazhong Agricultural University; Huazhong Agricultural University; University of Kentucky	Liu, HQ (corresponding author), NW A&F Univ, Purdue NWAFU Joint Res Ctr, Yangling, Shaanxi Provinc, Peoples R China.	daohongjiang@mail.hzau.edu.cn	Abbas, Aqleem/M-9403-2016; Liu, Huiquan/M-1587-2013	Abbas, Aqleem/0000-0001-9174-9700; Liu, Huiquan/0000-0002-4723-845X	China National Funds for Distinguished Young Scientists [31125023]; Special Fund for Agro-scientific Research in the Public Interest [201103016]; earmarked fund for China Agriculture Research System [nycytx-00514]	China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System	This research was supported by China National Funds for Distinguished Young Scientists (31125023), the Special Fund for Agro-scientific Research in the Public Interest (201103016) and the earmarked fund for China Agriculture Research System (nycytx-00514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balijja A, 2008, J VIROL METHODS, V152, P32, DOI 10.1016/j.jviromet.2008.06.001; Blawid R, 2008, ENCY VIROLOGY, V1, P98; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; Cox S, 2000, EUR J PLANT PATHOL, V106, P353, DOI 10.1023/A:1008765405744; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Fukuhara T, 2008, ENCY VIROLOGY, P109; Ghabrial S. A, 2008, ENCY VIROLOGY, V1, P503; Ghabrial SA, 1998, VIRUS GENES, V16, P119, DOI 10.1023/A:1007966229595; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Herrero N, 2009, ARCH VIROL, V154, P327, DOI 10.1007/s00705-008-0293-5; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Lin YH, 2012, VIROLOGY, V426, P42, DOI 10.1016/j.virol.2012.01.013; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Martin RR, 2011, VIRUS RES, V155, P175, DOI 10.1016/j.virusres.2010.09.020; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Poulos BT, 2006, J GEN VIROL, V87, P987, DOI 10.1099/vir.0.81127-0; Sabanadzovic S, 2010, ARCH VIROL, V155, P1859, DOI 10.1007/s00705-010-0770-5; Sabanadzovic S, 2009, VIRUS RES, V140, P130, DOI 10.1016/j.virusres.2008.11.018; Salem NM, 2008, ARCH VIROL, V153, P455, DOI 10.1007/s00705-007-0008-3; Spear A, 2010, VIROLOGY, V404, P304, DOI 10.1016/j.virol.2010.05.015; Tavantzis S, 2008, ENCY VIROLOGY, P63; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Villarreal LP, 2005, VIRUSES EVOLUTION LI; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; [No title captured]	39	41	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42147	10.1371/journal.pone.0042147	http://dx.doi.org/10.1371/journal.pone.0042147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848734	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200174
J	Nagel, JM; Geiger, BM; Karagiannis, AKA; Gras-Miralles, B; Horst, D; Najarian, RM; Ziogas, DC; Chen, XH; Kokkotou, E				Nagel, Jutta M.; Geiger, Brenda M.; Karagiannis, Apostolos K. A.; Gras-Miralles, Beatriz; Horst, David; Najarian, Robert M.; Ziogas, Dimitrios C.; Chen, XinHua; Kokkotou, Efi			Reduced Intestinal Tumorigenesis in APCmin Mice Lacking Melanin-Concentrating Hormone	PLOS ONE			English	Article							GASTROINTESTINAL CANCERS; TRANSCRIPTIONAL ACTIVITY; APC(MIN/+) MICE; BETA-CATENIN; COLON-CANCER; GROWTH; EXPRESSION; NEOPLASIA; INFLAMMATION; ACTIVATION	Background: Melanin-concentrating hormone (MCH) is an evolutionary conserved hypothalamic neuropeptide that in mammals primarily regulates appetite and energy balance. We have recently identified a novel role for MCH in intestinal inflammation by demonstrating attenuated experimental colitis in MCH deficient mice or wild type mice treated with an anti-MCH antibody. Therefore, targeting MCH has been proposed for the treatment of inflammatory bowel disease. Given the link between chronic intestinal inflammation and colorectal cancer, in the present study we sought to investigate whether blocking MCH might have effects on intestinal tumorigenesis that are independent of inflammation. Methodology: Tumor development was evaluated in MCH-deficient mice crossed to the APCmin mice which develop spontaneously intestinal adenomas. A different cohort of MCH-/- and MCH+/+ mice in the APCmin background was treated with dextran sodium sulphate (DSS) to induce inflammation-dependent colorectal tumors. In Caco2 human colorectal adenocarcinoma cells, the role of MCH on cell survival, proliferation and apoptosis was investigated. Results: APCmin mice lacking MCH developed fewer, smaller and less dysplastic tumors in the intestine and colon which at the molecular level are characterized by attenuated activation of the wnt/ beta-catenin signaling pathway and increased apoptotic indices. Form a mechanistic point of view, MCH increased the survival of colonic adenocarcinoma Caco2 cells via inhibiting apoptosis, consistent with the mouse studies. Conclusion: In addition to modulating inflammation, MCH was found to promote intestinal tumorigenesis at least in part by inhibiting epithelial cell apoptosis. Thereby, blocking MCH as a therapeutic approach is expected to decrease the risk for colorectal cancer.	[Nagel, Jutta M.; Geiger, Brenda M.; Karagiannis, Apostolos K. A.; Gras-Miralles, Beatriz; Horst, David; Najarian, Robert M.; Ziogas, Dimitrios C.; Chen, XinHua; Kokkotou, Efi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nagel, JM (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA.	ekokkoto@bidmc.harvard.edu		Gras-Miralles, Beatriz/0000-0002-5943-7755; Ziogas, Dimitrios C./0000-0003-2620-4004	National Institutes of Health Grant [DK080058]; American Gastroenterological Association Foundation Bridging Grant; Broad Medical Research Program of The Broad Foundation [IBD-0165]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080058] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association Foundation Bridging Grant; Broad Medical Research Program of The Broad Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK080058, by an American Gastroenterological Association Foundation Bridging Grant and by IBD-0165 grant from the Broad Medical Research Program of The Broad Foundation (EK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2010, WORLD J GASTROENTERO, V16, P5779, DOI 10.3748/wjg.v16.i46.5779; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bradley RL, 2002, AM J PHYSIOL-ENDOC M, V283, pE584, DOI 10.1152/ajpendo.00161.2002; Burdyga G, 2006, NEUROSCIENCE, V137, P1405, DOI 10.1016/j.neuroscience.2005.10.057; Chung SJ, 2011, J MOL NEUROSCI, V43, P115, DOI 10.1007/s12031-010-9411-4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; GUO YS, 1992, GASTROENTEROLOGY, V102, P1101; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herrinton LJ, 2012, GASTROENTEROLOGY; Hervieu G, 1996, ENDOCRINOLOGY, V137, P561, DOI 10.1210/en.137.2.561; HERVIEU G, 1995, NEUROENDOCRINOLOGY, V61, P348, DOI 10.1159/000126857; Jeon JY, 2006, DIABETES, V55, P428, DOI 10.2337/diabetes.55.02.06.db05-0203; Koehler JA, 2008, CANCER RES, V68, P7897, DOI 10.1158/0008-5472.CAN-08-0029; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Kokkotou E, 2009, GUT, V58, P34, DOI 10.1136/gut.2008.155341; Kokkotou E, 2008, P NATL ACAD SCI USA, V105, P10613, DOI 10.1073/pnas.0804536105; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lakaye B, 2009, PEPTIDES, V30, P2076, DOI 10.1016/j.peptides.2009.05.004; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Orihara K, 2009, J ALLERGY CLIN IMMUN, V124, P612, DOI 10.1016/j.jaci.2009.04.039; Pissios P, 2003, ENDOCRINOLOGY, V144, P3514, DOI 10.1210/en.2002-0004; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Verlaet M, 2002, FEBS LETT, V527, P205, DOI 10.1016/S0014-5793(02)03232-5; Wasan HS, 1997, P NATL ACAD SCI USA, V94, P3308, DOI 10.1073/pnas.94.7.3308; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801	35	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41914	10.1371/journal.pone.0041914	http://dx.doi.org/10.1371/journal.pone.0041914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848656	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200127
J	Vengen, IT; Madsen, HO; Garred, P; Platou, C; Vatten, L; Videm, V				Vengen, Inga Thorsen; Madsen, Hans O.; Garred, Peter; Platou, Carl; Vatten, Lars; Videm, Vibeke			Mannose-Binding Lectin Deficiency Is Associated with Myocardial Infarction: The HUNT2 Study in Norway	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INFLAMMATORY RESPONSE; COMPLEMENT ACTIVATION; SERUM-LEVELS; ATHEROSCLEROSIS; POLYMORPHISMS; GENE; RISK; MARKERS; INTIMA	Objectives: Mannose-binding lectin (MBL) and ficolins activate the complement cascade, which is involved in atherogenesis. Based on a pilot study, we hypothesized that functional polymorphisms in the MBL gene (MBL2) leading to dysfunctional protein are related to development of myocardial infarction (MI). The aim of the present study was to study polymorphisms in MBL2 and ficolin genes in relation to the risk of MI. Methods and Results: Using the population-based HUNT Study in Norway, 57133 persons were followed up for a first-time MI from 1995-1997 until the end of 2008. The 370 youngest MI patients were matched by age (range 29-62 years) and gender to 370 controls. A younger population was selected because disease in this group might be less dependent on non-genetic risk factors. The study size was based on power calculation. Polymorphisms in MBL2 and in the genes of ficolin-1, ficolin-2 and ficolin-3 were genotyped by pyrosequencing and related to the risk of MI, estimated as odds ratios (OR). Functional haplotypes were analyzed and stringent alpha levels of significance were set by permutation testing. Variant MBL2 haplotypes causing MBL deficiency were associated with a two-fold higher risk of MI (OR 2.04, 95%CI 1.29-3.24). Adjustments for conventional cardiovascular risk factors did not substantially influence the association. The ficolins were not associated with MI risk. Conclusion: In a young to middle aged and relatively healthy Caucasian population, MBL2 variants related to functional MBL deficiency were associated with a doubling of the risk for MI, independent of conventional risk factors. This supports that MBL deficiency may lead to increased atherosclerosis or development of vulnerable plaques.	[Vengen, Inga Thorsen; Videm, Vibeke] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Madsen, Hans O.; Garred, Peter] Univ Copenhagen, Fac Hlth Sci, Dept Clin Immunol, Mol Med Lab, Copenhagen, Denmark; [Platou, Carl] Nord Trondelag Hlth Trust, Dept Internal Med, Levanger Hosp, Levanger, Norway; [Vatten, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Videm, Vibeke] Univ Trondheim Hosp, Dept Immunol & Transfus Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); University of Copenhagen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Vengen, IT (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway.	vibeke.videm@ntnu.no	Madsen, Hans O/Q-2035-2015; Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022	Madsen, Hans O/0000-0001-5551-4787; Garred, Peter/0000-0002-2876-8586	Norwegian Council on Cardiovascular Diseases; Novo Nordisk Research Foundation; Sven Andersen Research Foundation; Capital Region of Denmark	Norwegian Council on Cardiovascular Diseases; Novo Nordisk Research Foundation(Novo Nordisk Foundation); Sven Andersen Research Foundation; Capital Region of Denmark	This work was supported by a grant from The Norwegian Council on Cardiovascular Diseases, The Novo Nordisk Research Foundation, Sven Andersen Research Foundation and The Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour A, 2009, ATHEROSCLEROSIS, V206, P444, DOI 10.1016/j.atherosclerosis.2009.03.007; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Berg KK, 2009, SCAND J IMMUNOL, V69, P36, DOI 10.1111/j.1365-3083.2008.02187.x; Best LG, 2004, CIRCULATION, V109, P471, DOI 10.1161/01.CIR.0000109757.95461.10; Charakida M, 2010, ATHEROSCLEROSIS, V208, P217, DOI 10.1016/j.atherosclerosis.2009.07.055; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Fiane AE, 2003, CIRCULATION, V108, P849, DOI 10.1161/01.CIR.0000084550.16565.01; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; GARRED P, 1992, EUR J IMMUNOGENET, V19, P403, DOI 10.1111/j.1744-313X.1992.tb00083.x; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; Hegele RA, 2000, J INVEST MED, V48, P198; Hegele RA, 1999, CLIN CHEM, V45, P1283; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; International Diabetes Federation [IDF], 2005, IDF CONS WORLDW DEF; Karpe F, 1999, J INTERN MED, V246, P341, DOI 10.1046/j.1365-2796.1999.00548.x; Keller TT, 2006, ARTERIOSCL THROM VAS, V26, P2345, DOI 10.1161/01.ATV.0000240517.69201.77; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; Madsen HO, 1998, LANCET, V352, P959, DOI 10.1016/S0140-6736(05)61513-9; Matthijsen RA, 2009, CIRCULATION, V119, P2188, DOI 10.1161/CIRCULATIONAHA.108.830661; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Roos A, 2006, J IMMUNOL METHODS, V309, P108, DOI 10.1016/j.jim.2005.11.017; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rugonfalvi-Kiss S, 2002, CIRCULATION, V106, P1071, DOI 10.1161/01.CIR.0000027137.96791.6A; SEIFERT PS, 1989, LAB INVEST, V60, P747; Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x; Troelsen LN, 2010, J RHEUMATOL, V37, P1815, DOI 10.3899/jrheum.100158; Troelsen LN, 2010, MOL IMMUNOL, V47, P713, DOI 10.1016/j.molimm.2009.10.021; Videm V, 2007, INT J CARDIOL, V118, P81, DOI 10.1016/j.ijcard.2006.07.005; Videm V, 2012, HUM IMMUNOL, V73, P554, DOI 10.1016/j.humimm.2012.02.014; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541	33	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42113	10.1371/journal.pone.0042113	http://dx.doi.org/10.1371/journal.pone.0042113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848725	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200168
J	Wells, AJ; Vink, R; Blumbergs, PC; Brophy, BP; Helps, SC; Knox, SJ; Turner, RJ				Wells, Adam J.; Vink, Robert; Blumbergs, Peter C.; Brophy, Brian P.; Helps, Stephen C.; Knox, Steven J.; Turner, Renee J.			A Surgical Model of Permanent and Transient Middle Cerebral Artery Stroke in the Sheep	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRACRANIAL-PRESSURE GRADIENTS; DECOMPRESSIVE CRANIECTOMY; RETE-MIRABILE; BLOOD-FLOW; BRAIN; INFARCTION; MANAGEMENT; OCCLUSION; THROMBOLYSIS	Background: Animal models are essential to study the pathophysiological changes associated with focal occlusive stroke and to investigate novel therapies. Currently used rodent models have yielded little clinical success, however large animal models may provide a more suitable alternative to improve clinical translation. We sought to develop a model of acute proximal middle cerebral artery (MCA) ischemic stroke in sheep, including both permanent occlusion and transient occlusion with reperfusion. Materials and Methods: 18 adult male and female Merino sheep were randomly allocated to one of three groups (n = 6/gp): 1) sham surgery; 2) permanent proximal MCA occlusion (MCAO); or 3) temporary MCAO with aneurysm clip. All animals had invasive arterial blood pressure, intracranial pressure and brain tissue oxygen monitoring. At 4 h following vessel occlusion or sham surgery animals were killed by perfusion fixation. Brains were processed for histopathological examination and infarct area determination. 6 further animals were randomized to either permanent (n = 3) or temporary MCAO (n = 3) and then had magnetic resonance imaging (MRI) at 4 h after MCAO. Results: Evidence of ischemic injury in an MCA distribution was seen in all stroke animals. The ischemic lesion area was significantly larger after permanent (28.8%) compared with temporary MCAO (14.6%). Sham animals demonstrated no evidence of ischemic injury. There was a significant reduction in brain tissue oxygen partial pressure after permanent vessel occlusion between 30 and 210 mins after MCAO. MRI at 4 h demonstrated complete proximal MCA occlusion in the permanent MCAO animals with a diffusion deficit involving the whole right MCA territory, whereas temporary MCAO animals demonstrated MRA evidence of flow within the right MCA and smaller predominantly cortical diffusion deficits. Conclusions: Proximal MCAO can be achieved in an ovine model of stroke via a surgical approach. Permanent occlusion creates larger infarct volumes, however aneurysm clip application allows for reperfusion.	[Wells, Adam J.; Vink, Robert; Helps, Stephen C.; Turner, Renee J.] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia; [Blumbergs, Peter C.] S Australia Pathol, Tissue Pathol, Adelaide, SA, Australia; [Wells, Adam J.; Brophy, Brian P.] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; [Knox, Steven J.] Royal Adelaide Hosp, Dept Radiol, Adelaide, SA 5000, Australia	University of Adelaide; Royal Adelaide Hospital; Royal Adelaide Hospital	Wells, AJ (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	adam.wells@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Turner, Renee/0000-0003-4278-8302	Neurosurgical Research Foundation, Adelaide Australia; National Health and Medical Research Council, Australia; Dora Lush Biomedical Postgraduate Fellowship; Overseas Biomedical Post-doctoral Training Fellowship	Neurosurgical Research Foundation, Adelaide Australia; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Dora Lush Biomedical Postgraduate Fellowship; Overseas Biomedical Post-doctoral Training Fellowship	Supported by the Neurosurgical Research Foundation, Adelaide Australia, http://www.nrf.com.au. Research grants received from the National Health and Medical Research Council, Australia, including the Dora Lush Biomedical Postgraduate Fellowship (AJW) and Overseas Biomedical Post-doctoral Training Fellowship (RJT). http://www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Amiridze N, 2009, J STROKE CEREBROVASC, V18, P281, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.013; Bataille B, 2007, NEUROSURGERY, V60, P761, DOI 10.1227/01.NEU.0000255391.92785.ED; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Carhuapoma JR, 2002, J NEUROSURG ANESTH, V14, P299, DOI 10.1097/00008506-200210000-00005; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; D'Ambrosio AL, 2002, SURG NEUROL, V58, P295, DOI 10.1016/S0090-3019(02)00817-0; Dittrich R, 2008, J NEUROL, V255, P896, DOI 10.1007/s00415-008-0802-1; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Fischer U, 2011, J NEUROL NEUROSUR PS, V82, P885, DOI 10.1136/jnnp.2009.198648; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; GILLILAN LA, 1974, J COMP NEUROL, V153, P275, DOI 10.1002/cne.901530305; Goetzen B, 1999, Morphologie, V83, P29; Goetzen B, 1996, FOLIA NEUROPATHOL, V34, P143; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Heiss WD, 2001, CEREBROVASC DIS, V11, P73, DOI 10.1159/000047616; Hossmann KA, 1998, CARDIOVASC RES, V39, P106, DOI 10.1016/S0008-6363(98)00075-3; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Jahan R, 2008, STROKE, V39, P1613, DOI 10.1161/STROKEAHA.107.507376; Koizumi J, 1986, JPN J STROKE, V8, P108; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; MACDONALD JD, 1994, NEUROSURGERY, V34, P876, DOI 10.1227/00006123-199405000-00014; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; Mehra M, 2012, J NEUROINTERV SURG, V4, P307, DOI 10.1136/neurintsurg-2011-010101; Mickey B E, 1981, Clin Neurosurg, V28, P429; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Nemani VM, 2004, OPER TECH NEUROSURG, V7, P2; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Pendlebury ST, 2007, INT J STROKE, V2, P80, DOI 10.1111/j.1747-4949.2007.00126.x; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Qian Z, 1999, AM J NEURORADIOL, V20, P765; Rhoton AL, 2002, NEUROSURGERY, V51, pS53, DOI 10.1227/01.NEU.0000028484.12422.23; Santoreneos S, 1998, J NEUROSCI METH, V79, P195, DOI 10.1016/S0165-0270(97)00180-5; Segura T, 2008, EXPERT OPIN PHARMACO, V9, P1071, DOI [10.1517/14656566.9.7.1071, 10.1517/14656560802049322]; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Sztamska E, 1997, FOLIA NEUROPATHOL, V35, P60; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Treadwell SD, 2010, POSTGRAD MED J, V86, P235, DOI 10.1136/pgmj.2009.094292; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37; Wang David Z, 2011, Curr Treat Options Cardiovasc Med, V13, P225, DOI 10.1007/s11936-011-0121-1; Watanabe H, 2007, J NEUROSCI METH, V160, P109, DOI 10.1016/j.jneumeth.2006.08.016; ZIVIN JA, 1985, SCIENCE, V230, P1289, DOI 10.1126/science.3934754	47	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42157	10.1371/journal.pone.0042157	http://dx.doi.org/10.1371/journal.pone.0042157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848737	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000306950200176
J	Fu, XZ; Gong, XQ; Zhang, YX; Wang, Y; Liu, JH				Fu, Xing-Zheng; Gong, Xiao-Qing; Zhang, Yue-Xin; Wang, Yin; Liu, Ji-Hong			Different Transcriptional Response to Xanthomonas citri subsp citri between Kumquat and Sweet Orange with Contrasting Canker Tolerance	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; FALSE DISCOVERY RATE; PLANT-CELL WALLS; DISEASE RESISTANCE; GENE-EXPRESSION; PROTEINASE-INHIBITOR; PSEUDOMONAS-SYRINGAE; CYTOCHROME-P450 GENE; FUNCTIONAL GENOMICS; SIGNALING PATHWAYS	Citrus canker disease caused by Xanthomonas citri subsp. citri (Xcc) is one of the most devastating biotic stresses affecting the citrus industry. Meiwa kumquat (Fortunella crassifolia) is canker-resistant, while Newhall navel orange (Citrus sinensis Osbeck) is canker-sensitive. To understand the molecular mechanisms underlying the differences in responses to Xcc, transcriptomic profiles of these two genotypes following Xcc attack were compared by using the Affymetrix citrus genome GeneChip. A total of 794 and 1324 differentially expressed genes (DEGs) were identified as canker-responsive genes in Meiwa and Newhall, respectively. Of these, 230 genes were expressed in common between both genotypes, while 564 and 1094 genes were only significantly expressed in either Meiwa or Newhall. Gene ontology (GO) annotation and Singular Enrichment Analysis (SEA) of the DEGs showed that genes related to the cell wall and polysaccharide metabolism were induced for basic defense in both Meiwa and Newhall, such as chitinase, glucanase and thaumatin-like protein. Moreover, apart from inducing basic defense, Meiwa showed specially upregulated expression of several genes involved in the response to biotic stimulus, defense response, and cation binding as comparing with Newhall. And in Newhall, abundant photosynthesis-related genes were significantly down-regulated, which may be in order to ensure the basic defense. This study revealed different molecular responses to canker disease in Meiwa and Newhall, affording insight into the response to canker and providing valuable information for the identification of potential genes for engineering canker tolerance in the future.	[Fu, Xing-Zheng; Gong, Xiao-Qing; Zhang, Yue-Xin; Wang, Yin; Liu, Ji-Hong] Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol MOE, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Fu, Xing-Zheng] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences	Liu, JH (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Key Lab Hort Plant Biol MOE, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	liujihong@mail.hzau.edu.cn		Fu, Xing-Zheng/0000-0003-4088-6443	National Science Foundation of China [30921002]; Fok Ying Tong Education Foundation [114034]; Special Fund for Agro-scientific Research in the Public Interest [201003067]; National High Technology Research and Development Program (863 Program) of China [2011AA100205]; Hubei Provincial Natural Science Foundation [2009CDA080]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); Special Fund for Agro-scientific Research in the Public Interest; National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Hubei Provincial Natural Science Foundation	This work is financially supported by National Science Foundation of China (30921002), Fok Ying Tong Education Foundation (114034), Special Fund for Agro-scientific Research in the Public Interest (201003067), the National High Technology Research and Development Program (863 Program) of China (2011AA100205), and Hubei Provincial Natural Science Foundation (2009CDA080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Alignan M, 2006, NEW PHYTOL, V170, P523, DOI 10.1111/j.1469-8137.2006.01696.x; Balestrini R, 2005, PLANTA, V220, P889, DOI 10.1007/s00425-004-1431-2; Behlau F, 2008, CROP PROT, V27, P807, DOI 10.1016/j.cropro.2007.11.008; Behlau F, 2010, CROP PROT, V29, P300, DOI 10.1016/j.cropro.2009.12.010; Behlau F, 2012, EUR J PLANT PATHOL, V132, P259, DOI 10.1007/s10658-011-9870-7; Behlau F, 2011, APPL ENVIRON MICROB, V77, P4089, DOI 10.1128/AEM.03043-10; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2007, J EXP BOT, V58, P797, DOI 10.1093/jxb/erl208; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Botella MA, 1996, PLANT PHYSIOL, V112, P1201, DOI 10.1104/pp.112.3.1201; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cantu D, 2008, TRENDS PLANT SCI, V13, P610, DOI 10.1016/j.tplants.2008.09.002; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Cernadas RA, 2009, PLANT SCI, V177, P190, DOI 10.1016/j.plantsci.2009.05.006; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Deng Z, 2003, THEOR APPL GENET, V108, P53, DOI 10.1007/s00122-003-1410-1; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Enrique R, 2011, PLANT BIOTECHNOL J, V9, P394, DOI 10.1111/j.1467-7652.2010.00555.x; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fujiwara S, 2004, MOL PLANT MICROBE IN, V17, P986, DOI 10.1094/MPMI.2004.17.9.986; Gandia M, 2007, VIROLOGY, V367, P298, DOI 10.1016/j.virol.2007.05.025; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gottwald TR., 2000, COMPENDIUM CITRUS DI, P5; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; HEJGAARD J, 1991, FEBS LETT, V291, P127, DOI 10.1016/0014-5793(91)81119-S; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hiwasa K, 2003, PHYSIOL PLANTARUM, V117, P564, DOI 10.1034/j.1399-3054.2003.00064.x; Huang YM, 2007, PLANTA, V226, P73, DOI 10.1007/s00425-006-0469-8; Hwang IS, 2010, PLANTA, V232, P1409, DOI 10.1007/s00425-010-1266-y; Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012; JONGEDIJK E, 1995, EUPHYTICA, V85, P173, DOI 10.1007/BF00023946; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kim YC, 2006, BIOCHEM BIOPH RES CO, V345, P638, DOI 10.1016/j.bbrc.2006.04.124; Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Loopstra CA, 1998, PLANT PHYSIOL, V116, P959, DOI 10.1104/pp.116.3.959; Lopez C, 2005, PLANT MOL BIOL, V57, P393, DOI 10.1007/s11103-004-7819-3; Lusso M, 1996, PHYSIOL MOL PLANT P, V49, P267, DOI 10.1006/pmpp.1996.0054; Miao WG, 2010, J EXP BOT, V61, P4263, DOI 10.1093/jxb/erq227; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; PUNJA ZK, 1993, J NEMATOL, V25, P526; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Rakwal R, 2001, GENE, V263, P189, DOI 10.1016/S0378-1119(00)00573-4; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schubert TS, 2001, PLANT DIS, V85, P340, DOI 10.1094/PDIS.2001.85.4.340; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; STALL RE, 1986, PHYTOPATHOLOGY, V76, P240, DOI 10.1094/Phyto-76-240; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wan JR, 2008, PLANT SIGNAL BEHAV, V3, P831, DOI 10.4161/psb.3.10.5916; Wang Y, 2012, J PLANT PHYSL; Wang Y, 2011, SCI HORTIC-AMSTERDAM, V128, P115, DOI 10.1016/j.scienta.2011.01.010; Wright DP, 2005, NEW PHYTOL, V167, P579, DOI 10.1111/j.1469-8137.2005.01441.x; Xu JC, 2007, J EXP BOT, V58, P3789, DOI 10.1093/jxb/erm229; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zheng J, 2010, PLANT MOL BIOL, V72, P407, DOI 10.1007/s11103-009-9579-6; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	75	35	38	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41790	10.1371/journal.pone.0041790	http://dx.doi.org/10.1371/journal.pone.0041790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848606	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600048
J	Zhao, ZX; Li, SY; Liu, GJ; Yan, FF; Ma, XL; Huang, ZY; Tian, HM				Zhao, Zhuoxian; Li, Sheyu; Liu, Guanjian; Yan, Fangfang; Ma, Xuelei; Huang, Zeyu; Tian, Haoming			Body Iron Stores and Heme-Iron Intake in Relation to Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; SERUM FERRITIN; INSULIN-RESISTANCE; TRANSFERRIN SATURATION; METABOLIC SYNDROME; PROSPECTIVE COHORT; BLOOD-DONATIONS; NATIONAL-HEALTH; FREE-RADICALS; WOMEN	Background Emerging evidence from biological and epidemiological studies has suggested that body iron stores and heme-iron intake may be related to the risk of type 2 diabetes (T2D). We aimed to examine the association of body iron stores and heme-iron intake with T2D risk by conducting a systematic review and meta-analysis of previously published studies. Research Design and Methods: Systematic review and subsequent meta-analysis were conducted by searching MEDLINE database up to June 22, 2012 to identify studies that analyzed the association of body iron stores or dietary heme-iron intake with T2D risk. The meta-analysis was performed using the effect estimates and 95% confidence intervals (CIs) to calculate the pooled risk estimates, while the heterogeneity among studies was examined using the I-2 and Q statistic. Results: The meta-analysis included 16 high-quality studies: 12 studies analyzed ferritin levels (4,366 T2D patients and 41,091 controls) and 4 measured heme-iron intake (9,246 T2D patients and 179,689 controls). The combined relative risk (RR) comparing the highest and lowest category of ferritin levels was 1.66 (95% CI: 1.15-2.39) for prospective studies, 2.29 (95% CI: 1.48-3.54) for cross-sectional studies with heterogeneity (Q = 14.84, p = 0.01, I-2 = 66.3%; Q = 44.16, p < 0.001, I-2 = 88.7%). The combined RR comparing the highest and lowest category of heme-iron intake was 1.31 (95% CI: 1.21-1.43) with heterogeneity (Q = 1.39, p = 0.71, I-2 = 0%). No publication bias was found. Additional 15 studies that were of good quality, had significant results, and analyzed the association between body iron stores and T2D risk were qualitatively included in the systematic review. Conclusions: The meta-analysis and systematic review suggest that increased ferritin levels and heme-iron intake are both associated with higher risk of T2D.	[Zhao, Zhuoxian; Yan, Fangfang; Tian, Haoming] Sichuan Univ, W China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China; [Liu, Guanjian] Chinese Evidence Based Med Cochrane Ctr, Chengdu, Peoples R China; [Ma, Xuelei] Sichuan Univ, W China Hosp, W China Med Sch, Dept Oncol,State Key Lab Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China; [Huang, Zeyu] Sichuan Univ, W China Hosp, Dept Orthoped, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Tian, HM (corresponding author), Sichuan Univ, W China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China.	hmtian999@yahoo.com.cn	Li, Sheyu/O-3242-2016; Huang, ZeYu/G-1340-2015	Li, Sheyu/0000-0003-0060-0287; Huang, ZeYu/0000-0002-0456-8379				Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Ascherio A, 2001, CIRCULATION, V103, P52; Ashourpour M, 2010, INT J FOOD SCI NUTR, V61, P316, DOI 10.3109/09637480903555150; Aso Y, 2010, DIABETES RES CLIN PR, V90, P250, DOI 10.1016/j.diabres.2010.09.008; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Ellervik C, 2011, DIABETES CARE, V34, P2256, DOI 10.2337/dc11-0416; Ferrannini E, 2000, LANCET, V355, P2181, DOI 10.1016/S0140-6736(00)02397-7; Ford ES, 1999, DIABETES CARE, V22, P1978, DOI 10.2337/diacare.22.12.1978; Forouhi NG, 2007, DIABETOLOGIA, V50, P949, DOI 10.1007/s00125-007-0604-5; Freixenet N, 2011, DIABETES RES CLIN PR, V91, pE33, DOI 10.1016/j.diabres.2010.10.003; Fumeron F, 2006, DIABETES CARE, V29, P2090, DOI 10.2337/dc06-0093; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Green A, 2006, METABOLISM, V55, P1042, DOI 10.1016/j.metabol.2006.03.015; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hardikar PS, 2012, DIABETES CARE, V35, P797, DOI 10.2337/dc11-1321; Hernandez C, 2005, DIABETIC MED, V22, P97, DOI 10.1111/j.1464-5491.2004.01331.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jehn ML, 2007, AM J EPIDEMIOL, V165, P1047, DOI 10.1093/aje/kwk093; Jiang F, 2011, DIABETES RES CLIN PR, V93, P43, DOI 10.1016/j.diabres.2011.03.028; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Jiang R, 2004, AM J CLIN NUTR, V79, P70; Kim C, 2008, DIABETES CARE, V31, P1386, DOI 10.2337/dc07-2362; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kim NH, 2000, YONSEI MED J, V41, P387, DOI 10.3349/ymj.2000.41.3.387; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Le Tuan D, 2008, Rev Diabet Stud, V5, P245, DOI 10.1900/RDS.2008.5.245; Lee BK, 2011, METABOLISM, V60, P1416, DOI 10.1016/j.metabol.2011.02.008; Lee DH, 2004, DIABETOLOGIA, V47, P185, DOI 10.1007/s00125-003-1307-1; Luan DC, 2008, DIABETES CARE, V31, P285, DOI 10.2337/dc07-0921; Mainous AG, 2002, J FAM PRACTICE, V51, P933; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Rajpathak SN, 2009, DIABETES OBES METAB, V11, P472, DOI 10.1111/j.1463-1326.2008.00985.x; Rajpathak S, 2006, DIABETES CARE, V29, P1370, DOI 10.2337/dc06-0119; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; Ren Y, 2004, DIABETES CARE, V27, P622, DOI 10.2337/diacare.27.2.622; Rowe MW, 2012, DIABETES METAB RES R; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Salonen JT, 1998, BRIT MED J, V317, P727, DOI 10.1136/bmj.317.7160.727; Shi ZM, 2006, DIABETES CARE, V29, P1878, DOI 10.2337/dc06-0327; Song Y, 2004, DIABETES CARE, V27, P2108, DOI 10.2337/diacare.27.9.2108; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Swiglo BA, 2008, J CLIN ENDOCR METAB, V93, P666, DOI 10.1210/jc.2007-1907; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Wells G.A., NEWCASTLE OTTAWA SCA; Wilson JG, 2003, AM J MED SCI, V325, P332, DOI 10.1097/00000441-200306000-00004; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Wu HY, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000191	52	77	79	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41641	10.1371/journal.pone.0041641	http://dx.doi.org/10.1371/journal.pone.0041641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848554	gold, Green Published			2022-12-27	WOS:000309240600036
J	Mil-Homens, D; Fialho, AM				Mil-Homens, Dalila; Fialho, Arsenio M.			A BCAM0223 Mutant of Burkholderia cenocepacia Is Deficient in Hemagglutination, Serum Resistance, Adhesion to Epithelial Cells and Virulence	PLOS ONE			English	Article							TRIMERIC AUTOTRANSPORTER ADHESINS; PATHOGEN MORAXELLA-CATARRHALIS; CYSTIC-FIBROSIS; CEPACIA COMPLEX; YERSINIA-ENTEROCOLITICA; PSEUDOMONAS-CEPACIA; BIOFILM FORMATION; BINDING-PROTEIN; USPA2 PROTEIN; VITRONECTIN	Burkholderia cepacia complex (Bcc) bacteria are a problematic group of microorganisms causing severe infections in patients with Cystic Fibrosis. In early stages of infection, Bcc bacteria must be able to adhere to and colonize the respiratory epithelium. Although this is not fully understood, this primary stage of infection is believed to be in part mediated by a specific type of adhesins, named trimeric autotransporter adhesins (TAAs). These homotrimeric proteins exist on the surface of many Gram negative pathogens and often mediate a number of critical functions, including biofilm formation, serum resistance and adherence to an invasion of host cells. We have previously identified in the genome of the epidemic clinical isolate B. cenocepacia J2315, a novel cluster of genes putatively encoding three TAAs (BCAM0219, BCAM0223 and BCAM0224). In this study, the genomic organization of the TAA cluster has been determined. To further address the direct role of the putative TAA BCAM0223 in B. cenocepacia pathogenicity, an isogenic mutant was constructed via insertional inactivation. The BCAM0223::Tp mutant is deficient in hemagglutination, affected in adherence to vitronectin and in biofilm formation and showed attenuated virulence in the Galleria mellonella model of infection. Moreover, the BCAM0223:: Tp mutant also showed a significant reduction in its resistance to human serum as well as in adherence, but not in invasion of, cultured human bronchial epithelial cells. Altogether these results demonstrate that the BCAM0223 protein is a multifunctional virulence factor that may contribute to the pathogenicity of B. cenocepacia.	[Mil-Homens, Dalila; Fialho, Arsenio M.] Inst Super Tecn, IBB Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Lisbon, Portugal; [Fialho, Arsenio M.] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Mil-Homens, D (corresponding author), Inst Super Tecn, IBB Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Lisbon, Portugal.	afialho@ist.utl.pt	Fialho, Arsenio/A-6246-2008; Mil-Homens, Dalila/F-7900-2014; AM, Fialho/AAB-5715-2021	Fialho, Arsenio/0000-0002-8066-5787; Mil-Homens, Dalila/0000-0002-9727-3579; AM, Fialho/0000-0002-8066-5787	FEDER; Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/BIA-MIC/71453/2006, PTDC/EBB-BIO/100326/2008, PTDC/BIA-MIC/118386/2010]; Ph.D. fellowship	FEDER(European Commission); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Ph.D. fellowship	This work was supported by FEDER and Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (grants: PTDC/BIA-MIC/71453/2006, PTDC/EBB-BIO/100326/2008 and PTDC/BIA-MIC/118386/2010) and a Ph.D. fellowship to D. Mil-Homens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bernier SP, 2005, J BACTERIOL, V187, P5278, DOI 10.1128/JB.187.15.5278-5291.2005; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cole LE, 2002, INFECT IMMUN, V70, P6158, DOI 10.1128/IAI.70.11.6158-6165.2002; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dehio M, 1998, FEBS LETT, V424, P84, DOI 10.1016/S0014-5793(98)00144-6; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Edwards TE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012803; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Elkins C, 2000, INFECT IMMUN, V68, P1608, DOI 10.1128/IAI.68.3.1608-1619.2000; Estrela AB, 2009, CURR MED CHEM, V16, P1512, DOI 10.2174/092986709787909640; Forman S, 2008, INFECT IMMUN, V76, P578, DOI 10.1128/IAI.00219-07; Ganesan S, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00025; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Leo JC, 2011, STRUCTURE, V19, P1021, DOI 10.1016/j.str.2011.03.021; Li L, 2004, ORAL MICROBIOL IMMUN, V19, P16, DOI 10.1046/j.0902-0055.2003.00102.x; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; LIPUMA JJ, 1990, LANCET, V336, P1094, DOI 10.1016/0140-6736(90)92571-X; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Lyskowski A, 2011, ADV EXP MED BIOL, V715, P143, DOI 10.1007/978-94-007-0940-9_9; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2001, CLIN INFECT DIS, V33, P1469, DOI 10.1086/322684; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x; McClean S, 2009, J MED MICROBIOL, V58, P1, DOI 10.1099/jmm.0.47788-0; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Mil-Homens D, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00013; Mil-Homens D, 2010, MICROBIOL-SGM, V156, P1084, DOI 10.1099/mic.0.032623-0; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ortega X, 2005, J BACTERIOL, V187, P1324, DOI 10.1128/JB.187.4.1324-1333.2005; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Pinto SN, 2008, BIOPHYS J, V95, P2867, DOI 10.1529/biophysj.108.129858; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Raghunathan D, 2011, INFECT IMMUN, V79, P4342, DOI 10.1128/IAI.05592-11; Riesbeck K, 2006, ACTA BIOCHIM POL, V53, P445; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Sajjan U, 2002, MICROBIOL-SGM, V148, P3477, DOI 10.1099/00221287-148-11-3477; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Sajjan US, 2000, INFECT IMMUN, V68, P1787, DOI 10.1128/IAI.68.4.1787-1795.2000; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Sheets AJ, 2011, J BACTERIOL, V193, P329, DOI 10.1128/JB.00933-10; SHEN W, 1995, GUT, V36, P401, DOI 10.1136/gut.36.3.401; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09	66	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41747	10.1371/journal.pone.0041747	http://dx.doi.org/10.1371/journal.pone.0041747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848588	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600114
J	Rosales-Reyes, R; Aubert, DF; Tolman, JS; Amer, AO; Valvano, MA				Rosales-Reyes, Roberto; Aubert, Daniel F.; Tolman, Jennifer S.; Amer, Amal O.; Valvano, Miguel A.			Burkholderia cenocepacia Type VI Secretion System Mediates Escape of Type II Secreted Proteins into the Cytoplasm of Infected Macrophages	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; INFLAMMASOME ACTIVATION; CEPACIA COMPLEX; CYSTIC-FIBROSIS; INTRACELLULAR SURVIVAL; ACTIN CYTOSKELETON; LUNG INFLAMMATION; ESCHERICHIA-COLI; HOST; BACTERIA	Burkholderia cenocepacia is an opportunistic pathogen that survives intracellularly in macrophages and causes serious respiratory infections in patients with cystic fibrosis. We have previously shown that bacterial survival occurs in bacteria-containing membrane vacuoles (BcCVs) resembling arrested autophagosomes. Intracellular bacteria stimulate IL-1 beta secretion in a caspase-1-dependent manner and induce dramatic changes to the actin cytoskeleton and the assembly of the NADPH oxidase complex onto the BcCV membrane. A Type 6 secretion system (T6SS) is required for these phenotypes but surprisingly it is not required for the maturation arrest of the BcCV. Here, we show that macrophages infected with B. cenocepacia employ the NLRP3 inflammasome to induce IL-1 beta secretion and pyroptosis. Moreover, IL-1 beta secretion by B. cenocepacia-infected macrophages is suppressed in deletion mutants unable to produce functional Type VI, Type IV, and Type 2 secretion systems (SS). We provide evidence that the T6SS mediates the disruption of the BcCV membrane, which allows the escape of proteins secreted by the T2SS into the macrophage cytoplasm. This was demonstrated by the activity of fusion derivatives of the T2SS-secreted metalloproteases ZmpA and ZmpB with adenylcyclase. Supporting this notion, ZmpA and ZmpB are required for efficient IL-1 beta secretion in a T6SS dependent manner. ZmpA and ZmpB are also required for the maturation arrest of the BcCVs and bacterial intra-macrophage survival in a T6SS-independent fashion. Our results uncover a novel mechanism for inflammasome activation that involves cooperation between two bacterial secretory pathways, and an unanticipated role for T2SS-secreted proteins in intracellular bacterial survival.	[Rosales-Reyes, Roberto; Aubert, Daniel F.; Tolman, Jennifer S.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Ctr Human Immunol, London, ON, Canada; [Rosales-Reyes, Roberto] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Infectol Microbiol & Inmunol Clin, Mexico City 04510, DF, Mexico; [Amer, Amal O.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	Western University (University of Western Ontario); Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rosales-Reyes, R (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Ctr Human Immunol, London, ON, Canada.	mvalvano@uwo.ca	Rosales-Reyes, Roberto/CAG-2458-2022; Valvano, Miguel A/G-8759-2012; Amer, Amal/E-2643-2011	Valvano, Miguel A/0000-0001-8229-3641; Rosales-Reyes, Roberto/0000-0001-9519-8766	Cystic Fibrosis Canada; National Institute of Health [R01HL094586]; Natural Sciences and Engineering Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER	Cystic Fibrosis Canada; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grants from Cystic Fibrosis Canada (to MAV) and from the National Institute of Health, grant R01HL094586 to AOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank colleagues mentioned in the text and referenced in Table 1 for reagents and plasmids. J.S.T. was supported by scholarships from Cystic Fibrosis Canada and the Natural Sciences and Engineering Research Council. M. A. V. holds a Canada Research Chair in Infectious Diseases and Microbial Pathogenesis.	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bergsbaken T, 2011, J IMMUNOL, V187, P2748, DOI 10.4049/jimmunol.1100477; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Cianciotto NP, 2009, FUTURE MICROBIOL, V4, P797, DOI 10.2217/FMB.09.53; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Downey DG, 2007, PEDIATR PULM, V42, P216, DOI 10.1002/ppul.20553; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Flannagan RS, 2012, CELL MICROBIOL, V14, P239, DOI 10.1111/j.1462-5822.2011.01715.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Groves E, 2010, J BIOL CHEM, V285, P4087, DOI 10.1074/jbc.M109.071035; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Huynh KK, 2010, J INNATE IMMUN, V2, P522, DOI 10.1159/000319864; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Jones AM, 2001, EUR RESPIR J, V17, P295, DOI 10.1183/09031936.01.17202950; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Koizumi Y, 2012, CELL MICROBIOL, V14, P149, DOI 10.1111/j.1462-5822.2011.01707.x; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Kooi C, 2005, J BACTERIOL, V187, P4421, DOI 10.1128/JB.187.13.4421-4429.2005; Kooi C, 2009, MICROBIOL-SGM, V155, P2818, DOI 10.1099/mic.0.028969-0; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moura JA, 2008, MICROBES INFECT, V10, P52, DOI 10.1016/j.micinf.2007.10.002; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Sajjan SU, 2008, INFECT IMMUN, V76, P5447, DOI 10.1128/IAI.00451-08; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Saldias MS, 2009, MICROBIOL-SGM, V155, P2809, DOI 10.1099/mic.0.031344-0; Skeldon A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00015; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Ventura GMD, 2009, J IMMUNOL, V183, P670, DOI 10.4049/jimmunol.0801497; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang RF, 2009, MICROBIOL-SGM, V155, P4005, DOI 10.1099/mic.0.033043-0; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	58	33	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41726	10.1371/journal.pone.0041726	http://dx.doi.org/10.1371/journal.pone.0041726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848580	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600108
J	Spector, I; Zilberstein, Y; Lavy, A; Nagler, A; Genin, O; Pines, M				Spector, Itai; Zilberstein, Yael; Lavy, Adi; Nagler, Arnon; Genin, Olga; Pines, Mark			Involvement of Host Stroma Cells and Tissue Fibrosis in Pancreatic Tumor Development in Transgenic Mice	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; INDUCED LIVER FIBROSIS; COLLAGEN TYPE-I; STELLATE CELLS; EPITHELIAL-CELLS; PROSTATE-CANCER; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA	Introduction: Stroma cells and extracellular matrix (ECM) components provide the pivotal microenvironment for tumor development. The study aimed to evaluate the importance of the pancreatic stroma for tumor development. Methods: Pancreatic tumor cells were implanted subcutaneously into green fluorescent protein transgenic mice, and stroma cells invading the tumors were identified through immunohistochemistry. Inhibition of tumor invasion by stroma cells was achieved with halofuginone, an inhibitor of TGF beta/Smad3 signaling, alone or in combination with chemotherapy. The origin of tumor ECM was evaluated with species-specific collagen I antibodies and in situ hybridization of collagen alpha 1(I) gene. Pancreatic fibrosis was induced by cerulean injection and tumors by spleen injection of pancreatic tumor cells. Results: Inhibition of stroma cell infiltration and reduction of tumor ECM levels by halofuginone inhibited development of tumors derived from mouse and human pancreatic cancer cells. Halofuginone reduced the number only of stroma myofibroblasts expressing both contractile and collagen biosynthesis markers. Both stroma myofibroblasts and tumor cells generated ECM that contributes to tumor growth. Combination of treatments that inhibit stroma cell infiltration, cause apoptosis of myofibroblasts and inhibit Smad3 phosphorylation, with chemotherapy that increases tumor-cell apoptosis without affecting Smad3 phosphorylation was more efficacious than either treatment alone. More tumors developed in fibrotic than in normal pancreas, and prevention of tissue fibrosis greatly reduced tumor development. Conclusions: The utmost importance of tissue fibrosis and of stroma cells for tumor development presents potential new therapy targets, suggesting combination therapy against stroma and neoplastic cells as a treatment of choice.	[Spector, Itai; Lavy, Adi; Genin, Olga; Pines, Mark] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel; [Spector, Itai; Lavy, Adi] Hebrew Univ Jerusalem, Dept Anim Sci, IL-76100 Rehovot, Israel; [Zilberstein, Yael] Tel Aviv Univ, SCMIC, IL-69978 Tel Aviv, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Tel Aviv University; Chaim Sheba Medical Center	Spector, I (corresponding author), Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel.	pines@agri.huji.ac.il	Lavy, Adi/O-9988-2019	Lavy, Adi/0000-0002-7518-1913	Israel Science Foundation [ISF 1315/10]	Israel Science Foundation(Israel Science Foundation)	This study was supported in part by the Israel Science Foundation (ISF 1315/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abramovitch Rinat, 1999, Neoplasia (New York), V1, P321, DOI 10.1038/sj.neo.7900043; Adegboyega PA, 2010, HUM PATHOL, V41, P1128, DOI 10.1016/j.humpath.2009.12.014; Alphonso A, 2009, NEOPLASIA, V11, P1264, DOI 10.1593/neo.91302; Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Bruck R, 2001, HEPATOLOGY, V33, P379, DOI 10.1053/jhep.2001.21408; Cheng JC, 2011, CANCER LETT, V304, P107, DOI 10.1016/j.canlet.2011.02.008; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; De Wever O, 2002, BIOL CHEM, V383, P55; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Erkan M., 2010, Experimental Oncology, V32, P128; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476; Gavish Z, 2002, PROSTATE, V51, P73, DOI 10.1002/pros.10059; Genin O, 2008, NEOPLASIA, V10, P940, DOI 10.1593/neo.08456; Gnainsky Y, 2007, CELL TISSUE RES, V328, P153, DOI 10.1007/s00441-006-0330-1; Huebner KD, 2008, AM J PHYSIOL-HEART C, V294, pH1550, DOI 10.1152/ajpheart.01253.2007; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ikenaga N, 2010, GASTROENTEROLOGY, V139, P1041, DOI 10.1053/j.gastro.2010.05.084; Imamichi Y, 2007, CELLS TISSUES ORGANS, V185, P180, DOI 10.1159/000101319; Jacobetz MA, 2012, GUT; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Liu M, 2011, INT J CANCER, V129, P1795, DOI 10.1002/ijc.26116; Longerich T, 2011, PATHOL RES PRACT, V207, P8, DOI 10.1016/j.prp.2010.09.007; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; McGaha TL, 2002, J INVEST DERMATOL, V118, P461, DOI 10.1046/j.0022-202x.2001.01690.x; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Nagler A, 1999, TRANSPLANTATION, V68, P1806, DOI 10.1097/00007890-199912150-00027; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Pines M, 2001, BIOCHEM PHARMACOL, V62, P1221, DOI 10.1016/S0006-2952(01)00753-5; Pinthus JH, 2005, J UROLOGY, V174, P1527, DOI 10.1097/01.ju.0000179218.16587.d2; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Rosenthal E, 2004, MOL CARCINOGEN, V40, P116, DOI 10.1002/mc.20024; Sheffer Y, 2007, MOL CANCER THER, V6, P570, DOI 10.1158/1535-7163.MCT-06-0468; Shekhar MPV, 2003, BREAST CANCER RES, V5, P130, DOI 10.1186/bcr580; Shekhar MPV, 2001, CANCER RES, V61, P1320; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Spector I, 2010, PANCREAS, V39, P1008, DOI 10.1097/MPA.0b013e3181da8aa3; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Van Hoorde L, 2000, Prog Mol Subcell Biol, V25, P105; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wu SD, 2012, CANCER TREAT REV, V38, P218, DOI 10.1016/j.ctrv.2011.06.010; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Xia YH, 2010, J CANCER RES CLIN, V136, P309, DOI 10.1007/s00432-009-0666-5; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946; Zhou JF, 2001, CANCER RES, V61, P2328; Zidar N, 2002, ONCOLOGY-BASEL, V62, P381, DOI 10.1159/000065071; Zion O, 2009, PANCREAS, V38, P427, DOI 10.1097/MPA.0b013e3181967670	66	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41833	10.1371/journal.pone.0041833	http://dx.doi.org/10.1371/journal.pone.0041833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848627	gold, Green Published, Green Submitted			2022-12-27	WOS:000306806600131
J	Chang, WQ; Li, Y; Zhang, L; Cheng, AX; Lou, HX				Chang, Wenqiang; Li, Ying; Zhang, Li; Cheng, Aixia; Lou, Hongxiang			Retigeric Acid B Attenuates the Virulence of Candida albicans via Inhibiting Adenylyl Cyclase Activity Targeted by Enhanced Farnesol Production	PLOS ONE			English	Article							HYPHAL GROWTH; EXPRESSION; IDENTIFICATION; DIMORPHISM; MORPHOLOGY; INDUCTION; AGENTS	Candida albicans, the most prevalent fungal pathogen, undergoes yeast-to-hyphal switch which has long been identified as a key fungal virulence factor. We showed here that the lichen-derived small molecule retigeric acid B (RAB) acted as an inhibitor that significantly inhibited the filamentation of C. albicans, leading to the prolonged survival of nematodes infected by C. albicans. Quantitative real-time PCR analysis and intracellular cAMP measurement revealed RAB regulated the Ras1-cAMP-Efg1 pathway by reducing cAMP level to inhibit the hyphae formation. Confocal microscopic observation showed RAB induced the expression of Dpp3, synthesizing more farnesol, which was confirmed by gas chromatography-mass spectroscopy detection. An adenylyl cyclase activity assay demonstrated RAB could repress the activity of Cdc35 through stimulating farnesol synthesis, thus causing a decrease in cAMP synthesis, leading to retarded yeast-to-hyphal transition. Moreover, reduced levels of intracellular cAMP resulted in the inhibition of downstream adhesins. Together, these findings indicate that RAB stimulates farnesol production that directly inhibits the Cdc35 activity, reducing the synthesis of cAMP and thereby causing the disruption of the morphologic transition and attenuating the virulence of C. albicans. Our work illustrates the underlying mechanism of RAB-dependent inhibition of the yeast-to-hyphal switch and provides a potential application in treating the infection of C. albicans.	[Chang, Wenqiang; Li, Ying; Zhang, Li; Cheng, Aixia; Lou, Hongxiang] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China	Shandong University	Chang, WQ (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China.	louhongxiang@sdu.edu.cn			National Natural Science Foundation [30730109, 30925038]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation (No. 30730109, 30925038). http://www.nsfc.gov.cn/Portal0/default106.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; [Anonymous], 2002, M27A2 NAT COMM CLIN; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Boustie J, 2005, PLANT GENET RESOUR, V3, P273, DOI DOI 10.1079/PGR200572; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cao YY, 2005, ANTIMICROB AGENTS CH, V49, P584, DOI 10.1128/AAC.49.2.584-589.2005; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chang WQ, 2011, BBA-GEN SUBJECTS, V1810, P569, DOI 10.1016/j.bbagen.2011.02.001; Davis-Hanna A, 2008, MOL MICROBIOL, V67, P47, DOI 10.1111/j.1365-2958.2007.06013.x; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; Hall RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001193; Hornby JM, 2004, ANTIMICROB AGENTS CH, V48, P2305, DOI 10.1128/AAC.48.6.2305-2307.2004; Hornby JM, 2003, ANTIMICROB AGENTS CH, V47, P2366, DOI 10.1128/AAC.47.7.2366-2369.2003; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Jung WH, 2003, MICROBIOL-SGM, V149, P2961, DOI 10.1099/mic.0.26517-0; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Larsen B, 2006, YEAST, V23, P795, DOI 10.1002/yea.1394; Miao ZH, 2003, INT J CANCER, V106, P108, DOI 10.1002/ijc.11174; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Mosel DD, 2005, APPL ENVIRON MICROB, V71, P4938, DOI 10.1128/AEM.71.8.4938-4940.2005; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Otzen T, 2004, J MED CHEM, V47, P240, DOI 10.1021/jm030931w; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schmidt M, 2008, ENVIRON TOXICOL CHEM, V27, P2346, DOI 10.1897/08-060.1; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sun LM, 2010, J APPL MICROBIOL, V108, P341, DOI 10.1111/j.1365-2672.2009.04429.x; Sun LM, 2009, ANTIMICROB AGENTS CH, V53, P1586, DOI 10.1128/AAC.00940-08; Tampakakis E, 2008, NAT PROTOC, V3, P1925, DOI 10.1038/nprot.2008.193; Xi GM, 2010, BIOORGAN MED CHEM, V18, P6725, DOI 10.1016/j.bmc.2010.07.055; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhang X. H., 1994, Yaoxue Xuebao, V29, P246	43	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41624	10.1371/journal.pone.0041624	http://dx.doi.org/10.1371/journal.pone.0041624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22848547	gold, Green Published, Green Submitted			2022-12-27	WOS:000306687700128
J	Abreu, M; Sealy, L				Abreu, Maria; Sealy, Linda			Cells Expressing the C/EBPbeta Isoform, LIP, Engulf Their Neighbors	PLOS ONE			English	Article							TRANSCRIPTIONAL INHIBITORY PROTEIN; MAMMARY EPITHELIAL-CELLS; BINDING-PROTEIN; BREAST-CANCER; BETA; LIVER; GLAND; LAP; RNA; SUPPRESSION	Descriptions of various processes that lead to cell-in-cell structures have been reported for decades. The exact molecular mechanism(s) of their formation and the physiological significance of cell-in-cell structures remain poorly understood. We had previously shown that an isoform of the CCAAT/enhancer-binding protein beta (C/EBPbeta) transcription factor, liver-enriched inhibitory protein (LIP), induces cell death in human breast cancer cells and stimulates autophagy. Here we describe a non-apoptotic cell death process where LIP mediates the engulfment of neighboring cells. We provide evidence of LIP-mediated engulfment via DNA profiling, fluorescent imaging and cell sorting studies, as well as ultrastructure analysis of LIP-expressing MDA-MB-468 breast cancer cells. Our work illustrates that expression of a specific transcription factor, LIP, can mediate cell engulfment.	[Abreu, Maria; Sealy, Linda] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Sealy, Linda] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Abreu, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	linda.sealy@vanderbilt.edu			National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM089106]; Vanderbilt Ingram Cancer Center (VICC); Vanderbilt Institute for Clinical and Translational Research award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM089106] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center (VICC); Vanderbilt Institute for Clinical and Translational Research award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award GM089106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Freddie L. Pruitt and Allison A. Atwood for review of the manuscript and Rachel Jerrell for technical assistance. We would also like to thank Carol Ann Bonner, Sam Wells, and the rest of the Vanderbilt Imaging Shared Resource Core for their assistance with the fluorescent microscopy and setting up our time-lapse photographs presented in Movies S1 and S2. We appreciate Trenis D. Palmer and Andries Zijlstra for assisting in setting up our time-lapse photographs presented in Movies S3 and S4. We would also like to thank Kevin Branch and Alissa Weaver for their help with the confocal imaging. We are greatly indebted to Catherine E. Alford in the Veterans Affairs Medical Center Pathology and Laboratory Medicine Services Department for FACS and cell cycle analyses. Thanks to Mary Dawes and Matthew Stephenson for their help preparing the sections for ultrastructural analysis and using the electron microscope and Jay Jerome for his expert help interpreting the electron micrographs. We would like to acknowledge the Vanderbilt Microarry Shared Resource for performing the genomic profiling. We are grateful for the Vanderbilt Ingram Cancer Center (VICC) shared resources scholarship and the Vanderbilt Institute for Clinical and Translational Research award that funded some of this study.	Abreu MM, 2010, EXP CELL RES, V316, P3227, DOI 10.1016/j.yexcr.2010.07.021; Arnal-Estape A, 2010, CANCER RES, V70, P9927, DOI 10.1158/0008-5472.CAN-10-0869; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Burger P, 2012, BLOOD; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; HUMBLE JG, 1956, BRIT J HAEMATOL, V2, P283, DOI 10.1111/j.1365-2141.1956.tb06700.x; Li HL, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-100; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Nakajima S, 2011, FEBS LETT, V585, P2249, DOI 10.1016/j.febslet.2011.05.047; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Qiao L, 2003, MOL CELL BIOL, V23, P3052, DOI 10.1128/MCB.23.9.3052-3066.2003; Sharma N, 2011, DIAGN CYTOPATHOL, V39, P229, DOI 10.1002/dc.21402; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; Xia P, 2008, CELL RES, V18, P705, DOI 10.1038/cr.2008.64; Zarzynska J, 2008, J PHYSIOL PHARMACOL, V59, P275	21	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41807	10.1371/journal.pone.0041807	http://dx.doi.org/10.1371/journal.pone.0041807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860016	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600042
J	Gomez-Cabello, A; Vicente-Rodriguez, G; Albers, U; Mata, E; Rodriguez-Marroyo, JA; Olivares, PR; Gusi, N; Villa, G; Aznar, S; Gonzalez-Gross, M; Casajus, JA; Ara, I				Gomez-Cabello, Alba; Vicente-Rodriguez, German; Albers, Ulrike; Mata, Esmeralda; Rodriguez-Marroyo, Jose A.; Olivares, Pedro R.; Gusi, Narcis; Villa, Gerardo; Aznar, Susana; Gonzalez-Gross, Marcela; Casajus, Jose A.; Ara, Ignacio		EXERNET Study Grp	Harmonization Process and Reliability Assessment of Anthropometric Measurements in the Elderly EXERNET Multi-Centre Study	PLOS ONE			English	Article							NUTRITIONAL-STATUS; BODY-COMPOSITION; CHRONIC DISEASE; ADOLESCENTS; STATURE; OBESITY; HEIGHT; PEOPLE; RISK	Background: The elderly EXERNET multi-centre study aims to collect normative anthropometric data for old functionally independent adults living in Spain. Purpose: To describe the standardization process and reliability of the anthropometric measurements carried out in the pilot study and during the final workshop, examining both intra-and inter-rater errors for measurements. Materials and Methods: A total of 98 elderly from five different regions participated in the intra-rater error assessment, and 10 different seniors living in the city of Toledo (Spain) participated in the inter-rater assessment. We examined both intra- and inter-rater errors for heights and circumferences. Results: For height, intra-rater technical errors of measurement (TEMs) were smaller than 0.25 cm. For circumferences and knee height, TEMs were smaller than 1 cm, except for waist circumference in the city of Caceres. Reliability for heights and circumferences was greater than 98% in all cases. Inter-rater TEMs were 0.61 cm for height, 0.75 cm for knee-height and ranged between 2.70 and 3.09 cm for the circumferences measured. Inter-rater reliabilities for anthropometric measurements were always higher than 90%. Conclusion: The harmonization process, including the workshop and pilot study, guarantee the quality of the anthropometric measurements in the elderly EXERNET multi-centre study. High reliability and low TEM may be expected when assessing anthropometry in elderly population.	[Gomez-Cabello, Alba; Vicente-Rodriguez, German; Casajus, Jose A.; Ara, Ignacio] Univ Zaragoza, GENUD Growth Exercise NUtr & Dev Res Grp, Zaragoza, Spain; [Gomez-Cabello, Alba; Casajus, Jose A.] Univ Zaragoza, Dept Physiatry & Nursing, Fac Hlth & Sport Sci FCSD, Huesca, Spain; [Albers, Ulrike; Gonzalez-Gross, Marcela] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain; [Mata, Esmeralda; Ara, Ignacio] Univ Castilla La Mancha, GENUD Growth Exercise NUtr & Dev Toledo Res Grp, Toledo, Spain; [Rodriguez-Marroyo, Jose A.; Villa, Gerardo] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Olivares, Pedro R.; Gusi, Narcis] Univ Extremadura, Fac Sport Sci, Caceres, Spain; [Aznar, Susana] Univ Castilla La Mancha, PAFS Promoting Phys Act Hlth Res Grp, Toledo, Spain	University of Zaragoza; University of Zaragoza; Universidad Politecnica de Madrid; Universidad de Castilla-La Mancha; Universidad de Leon; Universidad de Extremadura; Universidad de Castilla-La Mancha	Gomez-Cabello, A (corresponding author), Univ Zaragoza, GENUD Growth Exercise NUtr & Dev Res Grp, Zaragoza, Spain.	Ignacio.ara@uclm.es	Rodríguez-Marroyo, Jose A./AAA-5609-2019; Vicente-Rodriguez, German/J-9846-2016; Gonzalez-Gross, Marcela/W-8000-2018; Olivares, Pedro R/C-6287-2008; Gómez-Cabello, Alba/H-5891-2015; Aznar, Susana/AAD-9999-2021; Gusi, Narcis/C-3870-2010	Rodríguez-Marroyo, Jose A./0000-0002-9157-1532; Vicente-Rodriguez, German/0000-0002-4303-4097; Olivares, Pedro R/0000-0001-7371-343X; Gusi, Narcis/0000-0002-1001-8883; Casajus Mallen, Jose Antonio/0000-0002-7215-6931; Ara Royo, Ignacio/0000-0002-2854-6684; Gonzalez-Gross, Marcela/0000-0001-7757-3235	Ministerio de Trabajo y Asuntos Sociales [104/07]; Universidad de Zaragoza [UZ 2008-BIO-01]; Ministerio de Sanidad, Servicios Sociales e Igualdad [147/2011]; Gobierno de Aragon [B059/09]	Ministerio de Trabajo y Asuntos Sociales; Universidad de Zaragoza; Ministerio de Sanidad, Servicios Sociales e Igualdad; Gobierno de Aragon(Gobierno de Aragon)	The elderly EXERNET multi-centre study has been supported by the Ministerio de Trabajo y Asuntos Sociales (104/07), Universidad de Zaragoza (UZ 2008-BIO-01) and Ministerio de Sanidad, Servicios Sociales e Igualdad (147/2011). A. Gomez-Cabello has received a PhD grant from the Gobierno de Aragon (B059/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero Cruz J, 2005, AMD, V22, P121; Alvero Cruz J, 2005, AMD, V21, P45; Batty GD, 2011, J EPIDEMIOL COMMUN H, V65, P461, DOI 10.1136/jech.2009.103986; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; Cruz J.R.A., 2004, AMD, V21, P535; Gomez-Cabello A, 2012, NUTR HOSP, V27, P22, DOI [10.1590/S0212-16112012000100004, 10.3305/nh.2012.27.1.5502]; Gomez-Cabello A, 2011, OBES REV, V42, P301; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Hirani V, 2011, J NUTR HEALTH AGING, V15, P469, DOI 10.1007/s12603-011-0051-3; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Moreno LA, 2003, NUTRITION, V19, P481, DOI 10.1016/S0899-9007(03)00040-6; Nagy E, 2008, INT J OBESITY, V32, pS58, DOI 10.1038/ijo.2008.184; Nejat EJ, 2010, MATURITAS, V65, P106, DOI 10.1016/j.maturitas.2009.09.006; Sanchez-Garcia S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-2; Shahar S, 2003, ASIA PAC J CLIN NUTR, V12, P80; Stomfai S, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.34; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Vicente-Rodriguez G, 2012, OBESITY, V20, P221, DOI 10.1038/oby.2011.272; Zyriax BC, 2011, OBESITY FACTS, V4, P358, DOI 10.1159/000333964	19	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41752	10.1371/journal.pone.0041752	http://dx.doi.org/10.1371/journal.pone.0041752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	982LS	22860013	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600040
J	Roessler, E; Hu, P; Hong, SK; Srivastava, K; Carrington, B; Sood, R; Petrykowska, H; Elnitski, L; Ribeiro, LA; Richieri-Costa, A; Feldman, B; Odenwald, WF; Muenke, M				Roessler, Erich; Hu, Ping; Hong, Sung-Kook; Srivastava, Kshitij; Carrington, Blake; Sood, Raman; Petrykowska, Hanna; Elnitski, Laura; Ribeiro, Lucilene A.; Richieri-Costa, Antonio; Feldman, Benjamin; Odenwald, Ward F.; Muenke, Maximilian			Unique Alterations of an Ultraconserved Non-Coding Element in the 3 ' UTR of ZIC2 in Holoprosencephaly	PLOS ONE			English	Article							FOREBRAIN; MUTATIONS; ENHANCER; CONSERVATION; GENETICS; TOOL	Coding region alterations of ZIC2 are the second most common type of mutation in holoprosencephaly (HPE). Here we use several complementary bioinformatic approaches to identify ultraconserved cis-regulatory sequences potentially driving the expression of human ZIC2. We demonstrate that an 804 bp element in the 3' untranslated region (3'UTR) is highly conserved across the evolutionary history of vertebrates from fish to humans. Furthermore, we show that while genetic variation of this element is unexpectedly common among holoprosencephaly subjects (6/528 or >1%), it is not present in control individuals. Two of six proband-unique variants are de novo, supporting their pathogenic involvement in HPE outcomes. These findings support a general recommendation that the identification and analysis of key ultraconserved elements should be incorporated into the genetic risk assessment of holoprosencephaly cases.	[Roessler, Erich; Hu, Ping; Hong, Sung-Kook; Srivastava, Kshitij; Feldman, Benjamin; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Carrington, Blake; Sood, Raman] NHGRI, Zebrafish Core Facil, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Petrykowska, Hanna; Elnitski, Laura] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Ribeiro, Lucilene A.; Richieri-Costa, Antonio] Univ Sao Paulo, Hosp Rehabil & Craniofacial Anomalies, Mol Genet Lab, Bauru, Brazil; [Ribeiro, Lucilene A.; Richieri-Costa, Antonio] Univ Sao Paulo, Hosp Rehabil & Craniofacial Anomalies, Clin Genet Serv, Bauru, Brazil; [Odenwald, Ward F.] NINDS, Neural Cell Fate Determinants Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Universidade de Sao Paulo; Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roessler, E (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	mamuenke@mail.nih.gov	Srivastava, Kshitij/AAB-4468-2021; Richieri-Costa, Antonio/B-2514-2013; Bicudo, Lucilene/ABA-5679-2020; Ribeiro-Bicudo, Lucilene/G-9528-2013; Elnitski, Laura/AAD-3595-2021	Srivastava, Kshitij/0000-0002-3658-0815; Muenke, Maximilian/0000-0002-7719-6545; Feldman, Benjamin/0000-0003-4838-8641; Elnitski, Laura/0000-0003-1065-019X	Division of Intramural Research, National Human Genome Research Institute (NHGRI); National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD008921, ZIAHD008922] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323, ZIAHG000209, ZIGHG200351, ZIEHG200354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS009413, ZIANS002820] Funding Source: NIH RePORTER	Division of Intramural Research, National Human Genome Research Institute (NHGRI); National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the subjects and their families who participated in our research and the Division of Intramural Research, National Human Genome Research Institute (NHGRI) and National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), in part, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Aruga J, 2006, GENOMICS, V87, P783, DOI 10.1016/j.ygeno.2006.02.011; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; BJORK B. C., 2010, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0011273); Brody T, 2012, DEV DYNAM, V241, P169, DOI 10.1002/dvdy.22728; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Krauss Robert S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000440; Kuzin A, 2011, MECH DEVELOP, V128, P165, DOI 10.1016/j.mod.2011.02.001; Mates L, 2006, NAT GENET       0527, V41, P753; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Monuki ES, 2007, J NEUROPATH EXP NEUR, V66, P566, DOI 10.1097/nen.0b013e3180986e1b; Nagai T, 2000, P NATL ACAD SCI USA, V97, P1618, DOI 10.1073/pnas.97.4.1618; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Pineda-Alvarez DE, 2012, HUM GENET, V131, P301, DOI 10.1007/s00439-011-1078-6; Pineda-Alvarez DE, 2010, AM J MED GENET C, V154C, P93, DOI 10.1002/ajmg.c.30253; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Roessler E, 2012, MOL GENET M IN PRESS; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Roessler E, 2009, HUM MUTAT, V30, pE541, DOI 10.1002/humu.20982; Thisse C, 1998, ZEBRAFISH SCI MONITO, V5, P8; Warr N, 2008, HUM MOL GENET, V17, P2986, DOI 10.1093/hmg/ddn197; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9	35	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e39026	10.1371/journal.pone.0039026	http://dx.doi.org/10.1371/journal.pone.0039026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859937	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600002
J	Kulpa, J; Chinnappareddy, N; Pyle, WG				Kulpa, Justyna; Chinnappareddy, Nirmala; Pyle, W. Glen			Rapid Changes in Cardiac Myofilament Function following the Acute Activation of Estrogen Receptor-Alpha	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FEMALE RATS; POSTMENOPAUSAL WOMEN; OVARIECTOMIZED RATS; PLUS PROGESTIN; CARDIOPROTECTION; BETA; 17-BETA-ESTRADIOL; CARDIOMYOCYTES; GONADECTOMY	Estrogens have well-recognized and complex cardiovascular effects, including altering myocardial contractility through changes in myofilament function. The presence of multiple estrogen receptor (ER) isoforms in the heart may explain some discrepant findings about the cardiac effects of estrogens. Most studies examining the impact of estrogens on the heart have focused on chronic changes in estrogen levels, and have not investigated rapid, non-genomic pathways. The first objective of this study was to determine how acute activation of ER alpha impacts cardiac myofilaments. Nongenomic myocardial estrogen signaling is associated with the activation of a variety of signaling pathways. p38 MAPK has been implicated in acute ER alpha signaling in the heart, and is known to affect myofilament function. Thus, the second objective of this study was to determine if acute ER alpha activation mediates its myofilament effects through p38 MAPK recruitment. Hearts from female C57Bl/6 mice were perfused with the ER alpha agonist PPT and myofilaments isolated. Activation of ER alpha depressed actomyosin MgATPase activity and decreased myofilament calcium sensitivity. Inhibition of p38 MAPK attenuated the myofilament effects of ER alpha activation. ER alpha stimulation did not affect global myofilament protein phosphorylation, but troponin I phosphorylation at the putative PKA phosphorylation sites was decreased. Changes in myofilament activation did not translate into alterations in whole heart function. The present study provides evidence supporting rapid, non-genomic changes in cardiac myofilament function following acute ER alpha stimulation mediated by the p38 MAPK pathway.	[Kulpa, Justyna; Chinnappareddy, Nirmala; Pyle, W. Glen] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Cardiovasc Res Grp, Guelph, ON N1G 2W1, Canada; [Pyle, W. Glen] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Kulpa, J (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Cardiovasc Res Grp, Guelph, ON N1G 2W1, Canada.	gpyle@uoguelph.ca		Pyle, Glen/0000-0003-0980-4729; Kulpa, Justyna/0000-0001-9823-235X	Canadian Institutes of Health Research [FRN 84505]; Premier's Research Excellence Award (Government of Ontario); Maureen Andrews Award (Heart and Stroke Foundation of Ontario); Canadian Foundation for Innovation and the Ontario Innovation Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Premier's Research Excellence Award (Government of Ontario); Maureen Andrews Award (Heart and Stroke Foundation of Ontario); Canadian Foundation for Innovation and the Ontario Innovation Trust	This study was supported with an operating grant from the Canadian Institutes of Health Research (FRN 84505) (W. G. Pyle). W. G. Pyle is a New Investigator of the Heart and Stroke Foundation of Canada, a recipient of a Premier's Research Excellence Award (Government of Ontario) and the Maureen Andrews Award (Heart and Stroke Foundation of Ontario). Infrastructure support was provided with grants from the Canadian Foundation for Innovation and the Ontario Innovation Trust (W. G. Pyle). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bell JR, 2011, ENDOCRINOLOGY, V152, P4937, DOI 10.1210/en.2011-1212; Booth EA, 2005, AM J PHYSIOL-HEART C, V289, pH2039, DOI 10.1152/ajpheart.00479.2005; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Dubey RK, 2005, CARDIOVASC RES, V66, P295, DOI 10.1016/j.cardiores.2004.12.012; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Filice E, 2011, CELL PHYSIOL BIOCHEM, V28, P41, DOI 10.1159/000331712; Gardner JD, 2008, AM J PHYSIOL-HEART C, V294, pH198, DOI 10.1152/ajpheart.00281.2007; Grohe C, 1998, J ENDOCRINOL, V156, pR1, DOI 10.1677/joe.0.156R001; Hsu JT, 2007, AM J PHYSIOL-HEART C, V292, pH2982, DOI 10.1152/ajpheart.01303.2006; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JIANG C, 1992, BRIT J PHARMACOL, V106, P739, DOI 10.1111/j.1476-5381.1992.tb14403.x; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Novotny JL, 2009, ENDOCRINOLOGY, V150, P889, DOI 10.1210/en.2008-0708; Nuedling S, 1999, FEBS LETT, V454, P271, DOI 10.1016/S0014-5793(99)00816-9; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Pyle WG, 2000, AM J PHYSIOL-HEART C, V279, pH1941, DOI 10.1152/ajpheart.2000.279.4.H1941; Pyle WG, 2003, AM J PHYSIOL-HEART C, V285, pH1220, DOI 10.1152/ajpheart.00076.2003; Ropero AB, 2006, J MOL CELL CARDIOL, V41, P496, DOI 10.1016/j.yjmcc.2006.05.022; SCHAIBLE TF, 1984, CIRC RES, V54, P38, DOI 10.1161/01.RES.54.1.38; SCHEUER J, 1987, CIRC RES, V61, P12, DOI 10.1161/01.RES.61.1.12; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Ullrich ND, 2008, AM J PHYSIOL-HEART C, V294, pH2421, DOI 10.1152/ajpheart.01225.2007; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wattanapermpool J, 1998, LIFE SCI, V63, P955, DOI 10.1016/S0024-3205(98)00353-1; Wattanapermpool J, 2000, LIFE SCI, V66, P533, DOI 10.1016/S0024-3205(99)00623-2; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]	32	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41076	10.1371/journal.pone.0041076	http://dx.doi.org/10.1371/journal.pone.0041076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859967	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950900017
J	Li, L; Wang, M; Zhao, QJ; Fogelson, N				Li, Ling; Wang, Meng; Zhao, Qian-Jing; Fogelson, Noa			Neural Mechanisms Underlying the Cost of Task Switching: An ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; EXECUTIVE CONTROL; SET; COMPONENTS; CONFLICT	Background: When switching from one task to a new one, reaction times are prolonged. This phenomenon is called switch cost (SC). Researchers have recently used several kinds of task-switching paradigms to uncover neural mechanisms underlying the SC. Task-set reconfiguration and passive dissipation of a previously relevant task-set have been reported to contribute to the cost of task switching. Methodology/Principal Findings: An unpredictable cued task-switching paradigm was used, during which subjects were instructed to switch between a color and an orientation discrimination task. Electroencephalography (EEG) and behavioral measures were recorded in 14 subjects. Response-stimulus interval (RSI) and cue-stimulus interval (CSI) were manipulated with short and long intervals, respectively. Switch trials delayed reaction times (RTs) and increased error rates compared with repeat trials. The SC of RTs was smaller in the long CSI condition. For cue-locked waveforms, switch trials generated a larger parietal positive event-related potential (ERP), and a larger slow parietal positivity compared with repeat trials in the short and long CSI condition. Neural SC of cue-related ERP positivity was smaller in the long RSI condition. For stimulus-locked waveforms, a larger switch-related central negative ERP component was observed, and the neural SC of the ERP negativity was smaller in the long CSI. Results of standardized low resolution electromagnetic tomography (sLORETA) for both ERP positivity and negativity showed that switch trials evoked larger activation than repeat trials in dorsolateral prefrontal cortex (DLPFC) and posterior parietal cortex (PPC). Conclusions/Significance: The results provide evidence that both RSI and CSI modulate the neural activities in the process of task-switching, but that these have a differential role during task-set reconfiguration and passive dissipation of a previously relevant task-set.	[Li, Ling; Wang, Meng; Zhao, Qian-Jing] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Fogelson, Noa] Univ A Coruna, Dept Psychol, La Coruna, Spain	University of Electronic Science & Technology of China; Universidade da Coruna	Li, L (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	liling@uestc.edu.cn	Li, Ling/F-3433-2015	Fogelson, Noa/0000-0003-2239-2212	Natural Science Foundation of China [30800242, 91120016]; Program for Changjiang Scholars and Innovative Research Team in University; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Natural Science Foundation of China (Grant Nos. 30800242 and 91120016), by the Program for Changjiang Scholars and Innovative Research Team in University, by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; De Baene W, 2012, HUM BRAIN MAPP, V33, P639, DOI 10.1002/hbm.21234; Demiralp T, 2001, BRAIN TOPOGR, V13, P251, DOI 10.1023/A:1011102628306; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Friedman D, 1997, EVOKED POTENTIAL, V104, P498, DOI 10.1016/S0168-5597(97)00036-1; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Goffaux P, 2006, BIOL PSYCHOL, V72, P278, DOI 10.1016/j.biopsycho.2005.11.009; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jamadar S, 2010, NEUROIMAGE, V51, P432, DOI 10.1016/j.neuroimage.2010.01.090; Jersild A. T., 1927, ARCH PSYCHOL, V89; JODO E, 1990, ELECTROEN CLIN NEURO, V76, P249, DOI 10.1016/0013-4694(90)90019-G; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mayr U, 2003, J EXP PSYCHOL LEARN, V29, P362, DOI 10.1037/0278-7393.29.3.362; Mayr U, 2000, J EXP PSYCHOL LEARN, V26, P1124, DOI 10.1037/0278-7393.26.5.1124; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nicholson R, 2005, PSYCHOPHYSIOLOGY, V42, P540, DOI 10.1111/j.1469-8986.2005.00350.x; Nicholson R, 2006, BRAIN RES, V1121, P160, DOI 10.1016/j.brainres.2006.08.101; Nicholson R, 2006, BRAIN RES, V1095, P107, DOI 10.1016/j.brainres.2006.04.016; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Poulsen C, 2005, COGNITIVE BRAIN RES, V24, P133, DOI 10.1016/j.cogbrainres.2005.01.008; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2002, J COGNITIVE NEUROSCI, V14, P1139, DOI 10.1162/089892902760807159; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stoet G, 2009, TRENDS COGN SCI, V13, P228, DOI 10.1016/j.tics.2009.02.002; Swainson R, 2006, BRAIN RES, V1105, P61, DOI 10.1016/j.brainres.2006.02.027; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; VERLEGER R, 1991, PSYCHOPHYSIOLOGY, V28, P468, DOI 10.1111/j.1469-8986.1991.tb00733.x; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	50	26	26	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42233	10.1371/journal.pone.0042233	http://dx.doi.org/10.1371/journal.pone.0042233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22860090	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900080
J	Rosetti, N; Remis, MI				Rosetti, Natalia; Isabel Remis, Maria			Spatial Genetic Structure and Mitochondrial DNA Phylogeography of Argentinean Populations of the Grasshopper Dichroplus elongatus	PLOS ONE			English	Article							VNTR CORE SEQUENCES; AUTOCORRELATION ANALYSIS; MIOSCIRTUS-WAGNERI; MAXIMUM-LIKELIHOOD; B-CHROMOSOMES; ORTHOPTERA; SOFTWARE; FLOW; CONNECTIVITY; DISPERSAL	Many grasshopper species are considered of agronomical importance because they cause damage to pastures and crops. Comprehension of pest population dynamics requires a clear understanding of the genetic diversity and spatial structure of populations. In this study we report on patterns of genetic variation in the South American grasshopper Dichroplus elongatus which is an agricultural pest of crops and forage grasses of great economic significance in Argentina. We use Direct Amplification of Minisatellite Regions (DAMD) and partial sequences of the cytochrome oxydase 1 (COI) mitochondrial gene to investigate intraspecific structure, demographic history and gene flow patterns in twenty Argentinean populations of this species belonging to different geographic and biogeographic regions. DAMD data suggest that, although genetic drift and migration occur within and between populations, measurable relatedness among neighbouring populations declines with distance and dispersal over distances greater than 200 km is not typical, whereas effective gene flow may occur for populations separated by less than 100 km. Landscape analysis was useful to detect genetic discontinuities associated with environmental heterogeneity reflecting the changing agroecosystem. The COI results indicate the existence of strong genetic differentiation between two groups of populations located at both margins of the Parana River which became separated during climate oscillations of the Middle Pleistocene, suggesting a significant restriction in effective dispersion mediated by females and large scale geographic differentiation. The number of migrants between populations estimated through mitochondrial and DAMD markers suggest that gene flow is low prompting a non-homogeneous spatial structure and justifying the variation through space. Moreover, the genetic analysis of both markers allows us to conclude that males appear to disperse more than females, reducing the chance of the genetic loss associated with recent anthropogenic fragmentation of the D. elongatus studied range.	[Rosetti, Natalia; Isabel Remis, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina	University of Buenos Aires	Rosetti, N (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina.	mariar@ege.fcen.uba.ar			CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) PIP (Proyectos de Investigacion Plurianuales) [112-201001-00244]; Universidad de Buenos Aires [UBACYT 00412]	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) PIP (Proyectos de Investigacion Plurianuales); Universidad de Buenos Aires(University of Buenos Aires)	Funding provided by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas) PIP (Proyectos de Investigacion Plurianuales) 112-201001-00244 and Universidad de Buenos Aires UBACYT 00412, through grants to Dr. Maria Isabel Remis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENALEX V5 GENETIC A; Avise John C., 1994, pi; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Berggren A, 2002, CONSERV BIOL, V16, P1562, DOI 10.1046/j.1523-1739.2002.01203.x; Black IV, 1996, WC FORTRAN PROGRAMS; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; Cabrera AL, 1980, MONOGRAFIAS CIENTIFI, V3; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; Carlini A.A., 2004, Instituto Superior de Correlacion Geologica (INSUGEO) Miscelanea, V12, P83; CHAPCO W, 1992, HEREDITY, V69, P547, DOI 10.1038/hdy.1992.170; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Cigliano MM, 1998, ORTHOPTERA BIODIVERS, P67; COPR (Centre for Overseas Pest Research), 1982, LOC GRASSH AGR MAN; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; CRANDALL KA, 1993, GENETICS, V134, P959; Dawson MN, 2005, J BIOGEOGR, V32, P515, DOI 10.1111/j.1365-2699.2004.01193.x; Deussen O, 2000, COMPUT GRAPH FORUM, V19, pC41, DOI 10.1111/1467-8659.00396; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EPPERSON BK, 1990, GENETICS, V124, P757; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; HEATH DD, 1993, NUCLEIC ACIDS RES, V21, P5782, DOI 10.1093/nar/21.24.5782; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Holsinger KE, 2004, MOL ECOL, V13, P887, DOI 10.1111/j.1365-294X.2004.02052.x; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; IRIONDO M., 1984, QUAT S AM ANTARCTIC, V2, P51; Iriondo Martin, 2009, Rev. Asoc. Geol. Argent., V64, P109; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Li T, 2011, GENETICA, V139, P511, DOI 10.1007/s10709-011-9573-1; Lizenberger G, 2001, HEREDIY, V86, P54; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; MARCHANT AD, 1988, HEREDITY, V60, P39, DOI 10.1038/hdy.1988.7; Mariottini Y, 2011, NEOTROP ENTOMOL, V40, P190, DOI 10.1590/S1519-566X2011000200006; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Neaves LE, 2009, MOL ECOL, V18, P3363, DOI 10.1111/j.1365-294X.2009.04293.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nei M., 1987, MOL EVOLUTIONARY GEN; Ortego J, 2010, MOL ECOL, V19, P472, DOI 10.1111/j.1365-294X.2009.04512.x; Ortego J, 2009, BIOL J LINN SOC, V97, P623, DOI 10.1111/j.1095-8312.2009.01206.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V 1 4 8; Rosetti N, 2007, J EVOLUTION BIOL, V20, P249, DOI 10.1111/j.1420-9101.2006.01205.x; Rosetti N, 2011, THESIS BUENOS AIRES; Rosetti N, 2008, ANN ENTOMOL SOC AM, V101, P922, DOI 10.1603/0013-8746(2008)101[922:EOPABO]2.0.CO;2; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Saarinen K, 2005, BIOL CONSERV, V123, P403, DOI 10.1016/j.biocon.2004.12.012; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sequeira AS, 1995, EVOLUCION BIOL, V89, P281; Shannon C. E., 1949, MATH THEORY COMMUNIC; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; TAJIMA F, 1989, GENETICS, V123, P585; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Torrusio S, 2002, J BIOGEOGR, V29, P221, DOI 10.1046/j.1365-2699.2002.00663.x; Vekemans X, 2002, AFLPSURV VERSION 1 0; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x; Zhou Z, 1997, THEOR APPL GENET, V95, P942, DOI 10.1007/s001220050645	84	31	32	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e40807	10.1371/journal.pone.0040807	http://dx.doi.org/10.1371/journal.pone.0040807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859953	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900011
J	Braun, TP; Orwoll, B; Zhu, XX; Levasseur, PR; Szumowski, M; Nguyen, MLT; Bouxsein, ML; Klein, RF; Marks, DL				Braun, Theodore P.; Orwoll, Benjamin; Zhu, Xinxia; Levasseur, Peter R.; Szumowski, Marek; Nguyen, My Linh T.; Bouxsein, Mary L.; Klein, Robert F.; Marks, Daniel L.			Regulation of Lean Mass, Bone Mass, and Exercise Tolerance by the Central Melanocortin System	PLOS ONE			English	Article							UREMIA-ASSOCIATED CACHEXIA; MICE; OBESITY; DEFICIENCY; METABOLISM; MODULATION; RECEPTORS; PATHWAYS; BLOCKADE; LEPTIN	Signaling via the type 4-melanocortin receptor (MC4R) is an important determinant of body weight in mice and humans, where loss of function mutations lead to significant obesity. Humans with mutations in the MC4R experience an increase in lean mass. However, the simultaneous accrual of fat mass in such individuals may contribute to this effect via mechanical loading. We therefore examined the relationship of fat mass and lean mass in mice lacking the type-4 melanocortin receptor (MC4RKO). We demonstrate that MC4RKO mice display increased lean body mass. Further, this is not dependent on changes in adipose mass, as MC4RKO mice possess more lean body mass than diet-induced obese (DIO) wild type mice with equivalent fat mass. To examine potential sources of the increased lean mass in MC4RKO mice, bone mass and strength were examined in MC4RKO mice. Both parameters increase with age in MC4RKO mice, which likely contributes to increases in lean body mass. We functionally characterized the increased lean mass in MC4RKO mice by examining their capacity for treadmill running. MC4R deficiency results in a decrease in exercise performance. No changes in the ratio of oxidative to glycolytic fibers were seen, however MC4RKO mice demonstrate a significantly reduced heart rate, which may underlie their impaired exercise performance. The reduced exercise capacity we report in the MC4RKO mouse has potential clinical ramifications, as efforts to control body weight in humans with melanocortin deficiency may be ineffective due to poor tolerance for physical activity.	[Braun, Theodore P.; Zhu, Xinxia; Levasseur, Peter R.; Szumowski, Marek; Nguyen, My Linh T.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA; [Braun, Theodore P.] Oregon Hlth & Sci Univ, MD PhD Program, Portland, OR 97201 USA; [Klein, Robert F.] Oregon Hlth & Sci Univ, Div Endocrinol Diabet & Clin Nutr, Bone & Mineral Unit, Portland, OR 97201 USA; [Orwoll, Benjamin] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92350 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthoped Studies, Boston, MA 02215 USA; [Bouxsein, Mary L.] Harvard Univ, Sch Med, Boston, MA USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Loma Linda University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Braun, TP (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA.	marksd@ohsu.edu	Orwoll, Benjamin/AAK-2336-2021; Marks, Daniel/C-3712-2009	Orwoll, Benjamin/0000-0002-5023-3385; Braun, Theodore/0000-0002-6248-2143	NIH [DK 70333, DK 084646]; Canadian Institutes of Health Research [200948]; Portland ARCS Chapter; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084646, R01DK070333] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Portland ARCS Chapter; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NIH DK 70333, NIH DK 084646, Canadian Institutes of Health Research 200948 and Portland ARCS Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JD, 2006, ENDOCRINOLOGY, V147, P3196, DOI 10.1210/en.2006-0281; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Castle WE, 1942, P NATL ACAD SCI USA, V28, P69, DOI 10.1073/pnas.28.3.69; Cawley NX, 2010, AM J PHYSIOL-ENDOC M, V299, pE189, DOI 10.1152/ajpendo.00516.2009; Cheung W, 2005, J CLIN INVEST, V115, P1659, DOI 10.1172/JCI22521; Cheung WW, 2008, KIDNEY INT, V74, P180, DOI 10.1038/ki.2008.150; Cheung WW, 2007, J AM SOC NEPHROL, V18, P2517, DOI 10.1681/ASN.2006091024; Dumont LM, 2005, PEPTIDES, V26, P1929, DOI 10.1016/j.peptides.2004.12.034; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Joppa MA, 2007, PEPTIDES, V28, P636, DOI 10.1016/j.peptides.2006.11.021; Li SJ, 1996, J NEUROSCI, V16, P5182; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; Marks DL, 2001, CANCER RES, V61, P1432; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Scarlett JM, 2010, J ENDOCRINOL, V206, P121, DOI 10.1677/JOE-09-0397; Skibicka KP, 2008, ENDOCRINOLOGY, V149, P3605, DOI 10.1210/en.2007-1754; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; Tallam LS, 2006, HYPERTENSION, V48, P58, DOI 10.1161/01.HYP.0000227966.36744.d9; Tanaka T, 2007, CELL METAB, V5, P395, DOI 10.1016/j.cmet.2007.04.004; Ustunel I, 1997, ACTA ANAT, V158, P279; Weyermann P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004774; Wisse BE, 2001, ENDOCRINOLOGY, V142, P3292, DOI 10.1210/en.142.8.3292; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zhong Q, 2005, BONE, V36, P820, DOI 10.1016/j.bone.2005.01.020	29	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42183	10.1371/journal.pone.0042183	http://dx.doi.org/10.1371/journal.pone.0042183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848742	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200180
J	Wu, TJ; Hao, SG; Sun, OJ; Kang, L				Wu, Tingjuan; Hao, Shuguang; Sun, Osbert Jianxin; Kang, Le			Specificity Responses of Grasshoppers in Temperate Grasslands to Diel Asymmetric Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES ORTHOPTERA; PHENOLOGICAL RESPONSE; CHORTHIPPUS-BRUNNEUS; ACRIDIDAE; BUTTERFLIES; EMBRYOGENESIS; ECOSYSTEMS; MAXIMUM; ODONATA	Background: Global warming is characterized by not only an increase in the daily mean temperature, but also a diel asymmetric pattern. However, most of the current studies on climate change have only concerned with the mean values of the warming trend. Although many studies have been conducted concerning the responses of insects to climate change, studies that address the issue of diel asymmetric warming under field conditions are not found in the literature. Methodology/Principal Findings: We conducted a field climate manipulative experiment and investigated developmental and demographic responses to diel asymmetric warming in three grasshopper species (an early-season species Dasyhippus barbipes, a mid-season species Oedaleus asiaticus, and a late-season species Chorthippus fallax). It was found that warming generally advanced the development of eggs and nymphs, but had no apparent impacts on the hatching rate of eggs, the emergence rate of nymphs and the survival and fecundity of adults in all the three species. Nighttime warming was more effective in advancing egg development than the daytime warming. The emergence time of adults was differentially advanced by warming in the three species; it was advanced by 5.64 days in C. fallax, 3.55 days in O. asiaticus, and 1.96 days in D. barbipes. This phenological advancement was associated with increases in the effective GDDs accumulation. Conclusions/Significance: Results in this study indicate that the responses of the three grasshopper species to warming are influenced by several factors, including species traits, developmental stage, and the thermal sensitivity of the species. Moreover, species with diapausing eggs are less responsive to changes in temperature regimes, suggesting that development of diapausing eggs is a protective mechanism in early-season grasshopper for avoiding the risk of pre-winter hatching. Our results highlight the need to consider the complex relationships between climate change and specificity responses of invertebrates.	[Wu, Tingjuan; Hao, Shuguang; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Insect Pests, Beijing, Peoples R China; [Sun, Osbert Jianxin] Beijing Forestry Univ, Inst Forestry & Climate Change Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Forestry University	Wu, TJ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Insect Pests, Beijing, Peoples R China.	lkang@ioz.ac.cn	Kang, Le/ABD-1116-2022	Kang, Le/0000-0003-4262-2329; Sun, Osbert/0000-0002-8815-5984	Public Welfare Fund for Agriculture [201003079]; Chinese Academy of Sciences [KSCX2-YW-Z-1021, 2010-Biols-CAS-0102]; National High-tech Research & Development Program of China [2006AA10Z236]; Institute of Botany; Chinese Academy of Sciences	Public Welfare Fund for Agriculture; Chinese Academy of Sciences(Chinese Academy of Sciences); National High-tech Research & Development Program of China(National High Technology Research and Development Program of China); Institute of Botany; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the research grants of Public Welfare Fund for Agriculture (Project No: 201003079) and The Chinese Academy of Sciences (Project No: KSCX2-YW-Z-1021 and 2010-Biols-CAS-0102) and National High-tech Research & Development Program of China (2006AA10Z236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was conducted as part of a comprehensive research project (Global Change Multifactor Experiment-Duolun) sponsored by the Institute of Botany, Chinese Academy of Sciences. We are grateful to anonymous reviewers for valuable comments and suggestions on earlier versions of this manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Ahas R, 2006, INT J BIOMETEOROL, V51, P17, DOI 10.1007/s00484-006-0041-z; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; AYER J, 1970, CALIF LAW REV, V58, P1273, DOI 10.2307/3479700; Bai WM, 2012, BIOGEOSCIENCES, V9, P375, DOI 10.5194/bg-9-375-2012; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Chapin F.S.I.I.I., 2002, PRINCIPLES TERRESTRI; CHERRILL A, 1991, HOLARCTIC ECOL, V14, P225; Dingemanse NJ, 2008, ECOL ENTOMOL, V33, P394, DOI 10.1111/j.1365-2311.2007.00982.x; Doi H, 2008, BIOL LETTERS, V4, P388, DOI 10.1098/rsbl.2008.0234; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fielding DJ, 2010, ENVIRON ENTOMOL, V39, P1643, DOI 10.1603/EN09356; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Guo K, 2009, GLOBAL CHANGE BIOL, V15, P2539, DOI 10.1111/j.1365-2486.2009.01861.x; Hao SG, 2004, ENVIRON ENTOMOL, V33, P1528, DOI 10.1603/0046-225X-33.6.1528; Hao SG, 2004, J APPL ENTOMOL, V128, P95, DOI 10.1046/j.1439-0418.2003.00810.x; Harrington R, 2007, GLOBAL CHANGE BIOL, V13, P1550, DOI 10.1111/j.1365-2486.2007.01394.x; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; HONEK A, 1990, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V117, P401; Kang L, 1994, INSECT SCI, V1, P264, DOI DOI 10.1111/J.1744-7917.1994.TB00253.X; Kang L, 2007, PHILOS T R SOC B, V362, P997, DOI 10.1098/rstb.2007.2029; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Lockwood DR, 2008, ECOL SOC, V13; Nufio CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012977; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Saldamando CI, 2005, J EVOLUTION BIOL, V18, P703, DOI 10.1111/j.1420-9101.2004.00838.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; VANHORN SN, 1966, J MORPHOL, V120, P83, DOI 10.1002/jmor.1051200105; VANWINGERDEN WKRE, 1991, OECOLOGIA, V87, P417, DOI 10.1007/BF00634600; Volder A, 2007, GLOBAL CHANGE BIOL, V13, P1040, DOI 10.1111/j.1365-2486.2007.01321.x; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; WHITMAN DW, 1986, ANN ENTOMOL SOC AM, V79, P711, DOI 10.1093/aesa/79.4.711; Xia JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032088; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Xia JY, 2009, BIOGEOSCI DISCUSS, V6, P4385; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x; Zhang NL, 2011, SOIL BIOL BIOCHEM, V43, P2053, DOI 10.1016/j.soilbio.2011.06.001; Zhao YX, 2005, ZOOL STUD, V44, P536; Zhou LM, 2007, P NATL ACAD SCI USA, V104, P17937, DOI 10.1073/pnas.0700290104	50	11	14	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41764	10.1371/journal.pone.0041764	http://dx.doi.org/10.1371/journal.pone.0041764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848593	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200102
J	Yang, D; Xie, P; Liu, ZH				Yang, Dan; Xie, Ping; Liu, Zhihua			Ischemia/Reperfusion-Induced MKP-3 Impairs Endothelial NO Formation via Inactivation of ERK1/2 Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MESSENGER-RNA LEVELS; SALVIANOLIC ACID; KINASE PHOSPHATASES; EXPRESSION; DYSFUNCTION; ACTIVATION; INHIBITION; INDUCTION; APOPTOSIS	Mitogen-activated protein kinase phosphatases (MKPs) are a family of dual-specificity phosphatases. Endothelial cells express multiple MKP family members, such as MKP-3. However, the effects of MKP-3 on endothelial biological processes have not yet been fully elucidated. Here, we address the association between MKP-3 and endothelial Nitric oxide (NO) formation under ischemia/reperfusion (IS/RP) condition. Human umbilical vein endothelial cells (HUVECs) were subjected to IS/RP treatment. The MKP-3 expression and NO formation were examined. IS/RP induced endothelial MKP-3 expression and inhibited eNOS expression and NO formation, accompanied by an increase of endothelial apoptosis. The siRNA experiments showed that MKP-3 was an important mediator in impairing eNOS expression and NO production in endothelial cells. Transfection of HUVECs with constitutively active ERK plasmids suggested that the above mentioned effect of MKP-3 was via inactivation of ERK1/2 pathway. Furthermore, impairment of eNOS expression was restored by treatment of histone deacetylase (HDAC) inhibitor and related to histone deacetylation and recruitment of HDAC1 to the eNOS promoter. Finally, Salvianolic acid A (SalA) markedly attenuated induction of MKP-3 and inhibition of eNOS expression and NO formation under endothelial IS/RP condition. Overall, these results for the first time demonstrated that IS/RP inhibited eNOS expression by inactivation of ERK1/2 and recruitment of HDAC1 to the gene promoter, leading to decreased NO formation through a MKP-3-dependent mechanism in endothelial cells, and SalA has therapeutic significance in protecting endothelial cells from impaired NO formation in response to IS/RP.	[Yang, Dan] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, D (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	zhliu.liulab@foxmail.com			National Natural Science Foundation of China [81102746]; Beijing Natural Science Foundation [5113033]; Scientific Research Foundation of the State Human Resource Ministry; Education Ministry for Returned Chinese Scholars, New Star Project of Peking Union Medical College, Youth Foundation of Peking Union Medical College, the Research Fund for the Doctoral Program of Higher Education [20111106120028]; "Major Drug Discovery" major science and technology research "12nd Five-Year Plan" [2012ZX09301-002-001]; China Medical Board of New York [A2009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Scientific Research Foundation of the State Human Resource Ministry; Education Ministry for Returned Chinese Scholars, New Star Project of Peking Union Medical College, Youth Foundation of Peking Union Medical College, the Research Fund for the Doctoral Program of Higher Education; "Major Drug Discovery" major science and technology research "12nd Five-Year Plan"; China Medical Board of New York	This work was supported by National Natural Science Foundation of China (81102746), Beijing Natural Science Foundation (5113033), Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry for Returned Chinese Scholars, New Star Project of Peking Union Medical College, Youth Foundation of Peking Union Medical College, the Research Fund for the Doctoral Program of Higher Education (20111106120028), "Major Drug Discovery" major science and technology research "12nd Five-Year Plan" (2012ZX09301-002-001), and China Medical Board of New York (A2009001) granted to Zhihua Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Csonka C, 1999, CIRCULATION, V100, P2260, DOI 10.1161/01.CIR.100.22.2260; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Fan HY, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/508938; Fan YN, 2008, FEBS LETT, V582, P4008, DOI 10.1016/j.febslet.2008.11.009; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Gan YH, 2006, BIOCHEM BIOPH RES CO, V340, P29, DOI 10.1016/j.bbrc.2005.11.151; Gan YH, 2005, J BIOL CHEM, V280, P16467, DOI 10.1074/jbc.M412960200; Haagenson KK, 2010, CANCER BIOL THER, V9, P337, DOI 10.4161/cbt.9.5.11217; HEMPEL SL, 1990, AM J PHYSIOL, V259, pC738, DOI 10.1152/ajpcell.1990.259.5.C738; Ho JHC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-30; Jiang M, 2011, AM J CHINESE MED, V39, P111, DOI 10.1142/S0192415X11008683; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Koga S, 2012, BRAIN RES, V1436, P137, DOI 10.1016/j.brainres.2011.12.004; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; Liu ZH, 2012, J ETHNOPHARMACOL, V141, P242, DOI 10.1016/j.jep.2012.01.057; Liu ZH, 2012, GENE, V499, P76, DOI 10.1016/j.gene.2012.02.016; Liu ZH, 2010, BIOCHEM BIOPH RES CO, V400, P34, DOI 10.1016/j.bbrc.2010.07.132; Medhora M, 2008, AM J PHYSIOL-LUNG C, V294, pL676, DOI 10.1152/ajplung.00496.2007; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONCADA S, 1991, SEMIN PERINATOL, V15, P16; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Nunes-Xavier C, 2011, ANTI-CANCER AGENT ME, V11, P109, DOI 10.2174/187152011794941190; Oh KS, 2011, INT IMMUNOPHARMACOL, V11, P1901, DOI 10.1016/j.intimp.2011.07.022; Pan HJ, 2011, J CARDIOVASC PHARM, V58, P535, DOI 10.1097/FJC.0b013e31822de355; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Reher Vanessa G S, 2007, J Oral Sci, V49, P271, DOI 10.2334/josnusd.49.271; Rossig L, 2000, J BIOL CHEM, V275, P25502, DOI 10.1074/jbc.M002283200; Rossig L, 2002, BASIC RES CARDIOL, V97, P1, DOI 10.1007/s395-002-8381-2; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Whetzel AM, 2009, AM J PHYSIOL-CELL PH, V296, pC339, DOI 10.1152/ajpcell.00293.2008; Xia R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/767930; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Yang D, 2009, FEBS LETT, V583, P2500, DOI 10.1016/j.febslet.2009.07.006; Yang XY, 2011, J ASIAN NAT PROD RES, V13, P884, DOI 10.1080/10286020.2011.598457; Yuan ZR, 2012, MOL BIOL REP, V39, P6625, DOI 10.1007/s11033-012-1467-5; Zeng X, 2012, MOL BIOL REP, V39, P5737, DOI 10.1007/s11033-011-1383-0; Zhang YQ, 2010, J ASIAN NAT PROD RES, V12, P899, DOI 10.1080/10286020.2010.510115; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003	51	27	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42076	10.1371/journal.pone.0042076	http://dx.doi.org/10.1371/journal.pone.0042076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848708	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200157
J	Cocco, E; Meloni, A; Murru, MR; Corongiu, D; Tranquilli, S; Fadda, E; Murru, R; Schirru, L; Secci, MA; Costa, G; Asunis, I; Cuccu, S; Fenu, G; Lorefice, L; Carboni, N; Mura, G; Rosatelli, MC; Marrosu, MG				Cocco, Eleonora; Meloni, Alessandra; Murru, Maria Rita; Corongiu, Daniela; Tranquilli, Stefania; Fadda, Elisabetta; Murru, Raffaele; Schirru, Lucia; Secci, Maria Antonietta; Costa, Gianna; Asunis, Isadora; Cuccu, Stefania; Fenu, Giuseppe; Lorefice, Lorena; Carboni, Nicola; Mura, Gioia; Rosatelli, Maria Cristina; Marrosu, Maria Giovanna			Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles	PLOS ONE			English	Article							D-RECEPTOR; SERUM 25-HYDROXYVITAMIN-D; NEGATIVE SELECTION; RISK; POPULATION; GENES; BIRTH; PREDISPOSITION; IDENTIFICATION; RADIATION	Vitamin D response elements (VDREs) have been found in the promoter region of the MS-associated allele HLA-DRB1*15:01, suggesting that with low vitamin D availability VDREs are incapable of inducing *15:01 expression allowing in early life autoreactive T-cells to escape central thymic deletion. The Italian island of Sardinia exhibits a very high frequency of MS and high solar radiation exposure. We test the contribution of VDREs analysing the promoter region of the MS-associated DRB1 *04:05, *03:01, *13:01 and *15:01 and non-MS-associated *16:01, *01, *11, *07:01 alleles in a cohort of Sardinians (44 MS patients and 112 healthy subjects). Sequencing of the DRB1 promoter region revealed a homozygous canonical VDRE in all *15:01, *16:01, *11 and in 45/73 *03:01 and in heterozygous state in 28/73* 03:01 and all *01 alleles. A new mutated homozygous VDRE was found in all *13:03, *04:05 and *07:01 alleles. Functionality of mutated and canonical VDREs was assessed for its potential to modulate levels of DRB1 gene expression using an in vitro transactivation assay after stimulation with active vitamin D metabolite. Vitamin D failed to increase promoter activity of the *04:05 and *03:01 alleles carrying the new mutated VDRE, while the *16:01 and *03:01 alleles carrying the canonical VDRE sequence showed significantly increased transcriptional activity. The ability of VDR to bind the mutant VDRE in the DRB1 promoter was evaluated by EMSA. Efficient binding of VDR to the VDRE sequence found in the *16:01 and in the *15:01 allele reduced electrophoretic mobility when either an anti-VDR or an anti-RXR monoclonal antibody was added. Conversely, the Sardinian mutated VDRE sample showed very low affinity for the RXR/VDR heterodimer. These data seem to exclude a role of VDREs in the promoter region of the DRB1 gene in susceptibility to MS carried by DRB1* alleles in Sardinian patients.	[Cocco, Eleonora; Murru, Maria Rita; Corongiu, Daniela; Tranquilli, Stefania; Fadda, Elisabetta; Murru, Raffaele; Schirru, Lucia; Secci, Maria Antonietta; Costa, Gianna; Cuccu, Stefania; Fenu, Giuseppe; Lorefice, Lorena; Carboni, Nicola; Marrosu, Maria Giovanna] Univ Cagliari, Dipartimento Sanita Pubbl Med Clin & Mol, Ctr Sclerosi Multipla, Cagliari, Italy; [Meloni, Alessandra; Asunis, Isadora] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Mura, Gioia] Azienda Osped Univ, Ctr Psichiatria & Psicosomat, Cagliari, Italy	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari	Cocco, E (corresponding author), Univ Cagliari, Dipartimento Sanita Pubbl Med Clin & Mol, Ctr Sclerosi Multipla, Cagliari, Italy.	gmarrosu@unica.it	Cocco, Eleonora/G-5064-2012	Cocco, Eleonora/0000-0002-3878-8820; Lorefice, Lorena/0000-0003-2050-2908; MURRU, RAFFAELE/0000-0001-8830-5084; asunis, isadora/0000-0002-4389-2470; ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190; MURA, GIOIA/0000-0002-7354-3116; Fenu, Giuseppe/0000-0003-0198-0488; Marrosu, Maria Giovanna/0000-0003-2334-2081	Merk Serono; Italian Ministry of Health [RFPS-2007-1-637045]	Merk Serono; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by a unrestricted grant from Merk Serono and by Italian Ministry of Health (RFPS-2007-1-637045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Casu A, 2004, DIABETES CARE, V27, P1623, DOI 10.2337/diacare.27.7.1623; Cocco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033972; Cocco E, 2011, MULT SCLER J, V17, P1282, DOI 10.1177/1352458511408754; COLNOT S, 1995, MOL CELL ENDOCRINOL, V113, P89, DOI 10.1016/0303-7207(95)03618-H; Compston A, 2006, MCALPINES MULTIPLE S, V4th; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Cossu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018482; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; EBERS GC, 1993, NEUROEPIDEMIOLOGY, V12, P1, DOI 10.1159/000110293; Ebers G, 2010, EUR NEUROL, V63, P41, DOI 10.1159/000268164; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Im HJ, 2002, ONCOGENE, V21, P3706, DOI 10.1038/sj.onc.1205450; Israni N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008023; Koszewski NJ, 2000, J STEROID BIOCHEM, V72, P125, DOI 10.1016/S0960-0760(00)00022-4; Lampis R, 2000, TISSUE ANTIGENS, V56, P515, DOI 10.1034/j.1399-0039.2000.560605.x; Lampis R, 2000, HUM MOL GENET, V9, P2959, DOI 10.1093/hmg/9.20.2959; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Maestro B, 2003, J STEROID BIOCHEM, V84, P223, DOI 10.1016/S0960-0760(03)00032-3; Marrosu MG, 2002, NEUROLOGY, V58, P283, DOI 10.1212/WNL.58.2.283; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Matilainen M, 2005, NUCLEIC ACIDS RES, V33, P5521, DOI 10.1093/nar/gki872; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; Ramagopalan SV, 2008, LANCET, V371, P283, DOI 10.1016/S0140-6736(08)60145-2; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Soilu-Hanninen M, 2008, J NEUROL NEUROSUR PS, V79, P152, DOI 10.1136/jnnp.2006.105320; Staples J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1640; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TEMPLER DI, 1992, ACTA NEUROL SCAND, V85, P107, DOI 10.1111/j.1600-0404.1992.tb04007.x; Vieth R, 1999, AM J CLIN NUTR, V69, P842; White P, 2000, TRENDS ENDOCRIN MET, V11, P320, DOI 10.1016/S1043-2760(00)00317-9; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63	51	27	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41678	10.1371/journal.pone.0041678	http://dx.doi.org/10.1371/journal.pone.0041678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848563	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600102
J	Plones, T; Krohn, A; Burger, M; Veelken, H; Passlick, B; Muller-Quernheim, J; Zissel, G				Ploenes, Till; Krohn, Alexander; Burger, Meike; Veelken, Hendrik; Passlick, Bernward; Mueller-Quernheim, Joachim; Zissel, Gernot			Serum Level of CC-Chemokine Ligand 18 Is Increased in Patients with Non-Small-Cell Lung Cancer and Correlates with Survival Time in Adenocarcinomas	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; PERIPHERAL-BLOOD; EXPRESSION; ACTIVATION; PULMONARY; LYMPHOCYTES; PROGRESSION; DISEASE; CXCR4	CC-chemokine ligand 18(CCL18) is mainly expressed by alternatively activated macrophages and DCs and plays an important role in lung fibrosis, arthritis and other diseases. Here CCL18 was measured in sera of 31 healthy volunteers and 170 patients with lung cancer and correlated these data with histology, tumor stage and clinical parameters. Mean CCL18 serum level of the patients with non-small-cell lung cancer was 150(857) ng/ml vs. 32(61) ng/ml in the healthy control group. Patient groups differ significantly according their histology (adenocarcinoma 143(528) ng/ml vs squamous cell carcinoma 187(857) ng/ml, p<0.02). In addition, we found a significant difference between patients with lower versus higher T-stage (p<0.003). Receiver operating characteristic (ROC) analyses revealed a cut off point of 83 ng/ml (area under the curve (AUC):0.968; p<0.0001) to discriminate between healthy controls and non-small-cell lung cancer patients. ROC analyses to discriminate between patients, who died because of cancer related death and those who died for other reasons did not lead to a valid AUC. To stratify the tumor patients, a criterion value plot was performed leading to a point of equal sensitivity and specificity (54%) of 162 ng/ml. Patients with a CCL18 serum level higher than 160 ng/ml had a mean survival time of 623 days. In contrast, those in patients with a baseline level between 83 ng/ml and 160 ng/ml the mean survival time was 984 days (p<0.005). Survival-analysis revealed in adenocarcinoma a mean survival of 1152 days in the group below 83 ng/ml. In the median group the mean survival time was 788 days and in the group with the highest levels the mean survival time was 388 days (p<0.001). In contrast, we found no correlation between the FEV1 and the CCL18 baseline level. In conclusion, in patients suffering from adenocarcinoma increased serum CCL18 levels predict a diminished survival time.	[Ploenes, Till; Passlick, Bernward] Univ Med Ctr Freiburg, Dept Thorac Surg, Freiburg, Germany; [Krohn, Alexander; Burger, Meike] Univ Med Ctr Freiburg, Dept Haematol & Oncol, Freiburg, Germany; [Mueller-Quernheim, Joachim; Zissel, Gernot] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Haematol, Leiden, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Plones, T (corresponding author), Univ Med Ctr Freiburg, Dept Thorac Surg, Freiburg, Germany.	gernot.zissel@uniklinik-freiburg.de	Zissel, Gernot/B-1208-2010; Plönes, Till/AAK-8208-2021	Zissel, Gernot/0000-0001-8021-9798; Plönes, Till/0000-0003-4839-2130; Veelken, Hendrik/0000-0002-9108-3125				Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bates GJ, 2008, BREAST CANCER RES TR, V111, P453, DOI 10.1007/s10549-007-9812-4; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Boot RG, 2004, BLOOD, V103, P33, DOI 10.1182/blood-2003-05-1612; Chang Y, 2010, FASEB J, V24, P5063, DOI 10.1096/fj.10-162560; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Goeckenjan G, PNEUMOLOGIE S2, V64, pe1; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Hieshima K, 1997, J IMMUNOL, V159, P1140; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Na IK, 2008, HUM PATHOL, V39, P1751, DOI 10.1016/j.humpath.2008.04.017; Ohri CM, BMC CANC, V10, P172; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Sasada T, 2003, CANCER-AM CANCER SOC, V98, P1089, DOI 10.1002/cncr.11618; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schaefer C, 2005, BRIT J CANCER, V92, P913, DOI 10.1038/sj.bjc.6602407; Schneider T, 2011, J THORAC ONCOL, V6, P432, DOI 10.1097/JTO.0b013e31820b80ca; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Sin DD, 2011, AM J RESP CRIT CARE, V183, P1187, DOI 10.1164/rccm.201008-1220OC; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; Struyf S, 2003, AM J PATHOL, V163, P2065, DOI 10.1016/S0002-9440(10)63564-X; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Wagner PL, 2009, J THORAC CARDIOV SUR, V137, P615, DOI 10.1016/j.jtcvs.2008.07.039; Wang Q, 2011, INT J BIOL MARKERS; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Zhang B, 2010, MED ONCOL	39	30	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41746	10.1371/journal.pone.0041746	http://dx.doi.org/10.1371/journal.pone.0041746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848587	Green Published, gold			2022-12-27	WOS:000306806600113
J	Scheller, E; Buchel, C; Gamer, M				Scheller, Elisa; Buechel, Christian; Gamer, Matthias			Diagnostic Features of Emotional Expressions Are Processed Preferentially	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; FACIAL EXPRESSIONS; HUMAN AMYGDALA; VISUAL-ATTENTION; SOCIAL PHOBIA; FACE RECOGNITION; INFORMATION; GAZE; EYES; INVERSION	Diagnostic features of emotional expressions are differentially distributed across the face. The current study examined whether these diagnostic features are preferentially attended to even when they are irrelevant for the task at hand or when faces appear at different locations in the visual field. To this aim, fearful, happy and neutral faces were presented to healthy individuals in two experiments while measuring eye movements. In Experiment 1, participants had to accomplish an emotion classification, a gender discrimination or a passive viewing task. To differentiate fast, potentially reflexive, eye movements from a more elaborate scanning of faces, stimuli were either presented for 150 or 2000 ms. In Experiment 2, similar faces were presented at different spatial positions to rule out the possibility that eye movements only reflect a general bias for certain visual field locations. In both experiments, participants fixated the eye region much longer than any other region in the face. Furthermore, the eye region was attended to more pronouncedly when fearful or neutral faces were shown whereas more attention was directed toward the mouth of happy facial expressions. Since these results were similar across the other experimental manipulations, they indicate that diagnostic features of emotional expressions are preferentially processed irrespective of task demands and spatial locations. Saliency analyses revealed that a computational model of bottom-up visual attention could not explain these results. Furthermore, as these gaze preferences were evident very early after stimulus onset and occurred even when saccades did not allow for extracting further information from these stimuli, they may reflect a preattentive mechanism that automatically detects relevant facial features in the visual field and facilitates the orientation of attention towards them. This mechanism might crucially depend on amygdala functioning and it is potentially impaired in a number of clinical conditions such as autism or social anxiety disorders.	[Scheller, Elisa] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Buechel, Christian; Gamer, Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Scheller, E (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany.	m.gamer@uke.uni-hamburg.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038	Bundesministerium fur Bildung und Forschung (BMBF, Network "Social Cognition''); German Research Foundation (DFG) [SFB TRR 58]	Bundesministerium fur Bildung und Forschung (BMBF, Network "Social Cognition''); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF, Network "Social Cognition''). C. B. is additionally funded by the German Research Foundation (DFG) SFB TRR 58, project B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Arnold DH, 2011, PERCEPTION, V40, P989, DOI 10.1068/p6955; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S., 1995, JOINT ATTENTION ITS, P41, DOI DOI 10.1111/J.2044-835X.1997.TB00726.X; Benuzzi F, 2007, BRAIN RES BULL, V74, P344, DOI 10.1016/j.brainresbull.2007.07.010; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; De Martino B, 2009, CEREB CORTEX, V19, P127, DOI 10.1093/cercor/bhn062; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Gamer M, 2010, P NATL ACAD SCI USA, V107, P9400, DOI 10.1073/pnas.1000985107; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Genetti M, 2009, BRAIN COGNITION, V69, P296, DOI 10.1016/j.bandc.2008.08.008; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Hanawalt NG, 1944, J GEN PSYCHOL, V31, P23, DOI 10.1080/00221309.1944.10545217; Hernandez N, 2009, NEUROPSYCHOLOGIA, V47, P1004, DOI 10.1016/j.neuropsychologia.2008.10.023; Hills PJ, 2011, J EXP PSYCHOL HUMAN, V37, P1396, DOI 10.1037/a0024247; Horley K, 2004, PSYCHIAT RES, V127, P43, DOI 10.1016/j.psychres.2004.02.016; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Joyce CA, 2006, VISION RES, V46, P800, DOI 10.1016/j.visres.2005.09.016; Kliemann D, 2010, J NEUROSCI, V30, P12281, DOI 10.1523/JNEUROSCI.0688-10.2010; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Levine MW, 2005, VISION RES, V45, P2820, DOI 10.1016/j.visres.2005.04.001; Lipp OV, 2009, EMOTION, V9, P248, DOI 10.1037/a0014715; Lundqvist D., 1998, KAROLINSKA DIRECTED; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pflugshaupt T, 2009, VISION RES, V49, P237, DOI 10.1016/j.visres.2008.10.021; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Pizzagalli D, 1999, NEUROREPORT, V10, P2691, DOI 10.1097/00001756-199909090-00001; PREVIC FH, 1993, VISION RES, V33, P2697, DOI 10.1016/0042-6989(93)90229-P; Rutherford MD, 2008, J AUTISM DEV DISORD, V38, P1371, DOI 10.1007/s10803-007-0525-7; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Spezio ML, 2007, J NEUROSCI, V27, P3994, DOI 10.1523/JNEUROSCI.3789-06.2007; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Straube T, 2005, NEUROPSYCHOBIOLOGY, V52, P163, DOI 10.1159/000087987; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Vinette C, 2004, COGNITIVE SCI, V28, P289, DOI 10.1016/j.cogsci.2004.01.002; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; WHITE M, 1995, COGNITION EMOTION, V9, P439, DOI 10.1080/02699939508408975	50	72	73	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41792	10.1371/journal.pone.0041792	http://dx.doi.org/10.1371/journal.pone.0041792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848607	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600120
J	Zheng, L; Yao, HS				Zheng, Lian; Yao, Haishan			Stimulus-Entrained Oscillatory Activity Propagates as Waves from Area 18 to 17 in Cat Visual Cortex	PLOS ONE			English	Article							LATERAL GENICULATE NUCLEUS; RECEPTIVE-FIELD PROPERTIES; EVOKED CORTICAL WAVES; STRIATE CORTEX; CORTICOCORTICAL CONNECTIONS; RETINOTOPIC ORGANIZATION; SENSORY RESPONSES; SPATIAL SUMMATION; TRAVELING-WAVES; OLFACTORY-BULB	Previous studies in cat visual cortex reported that area 18 can actively drive neurons in area 17 through cortico-cortical projections. However, the dynamics of such cortico-cortical interaction remains unclear. Here we used multielectrode arrays to examine the spatiotemporal pattern of neuronal activity in cat visual cortex across the 17/18 border. We found that full-field contrast reversal gratings evoked oscillatory wave activity propagating from area 18 to 17. The wave direction was independent of the grating orientation, and could not be accounted for by the spatial distribution of receptive field latencies, suggesting that the waves are largely mediated by intrinsic connections in the cortex. Different from the evoked waves, spontaneous waves propagated along both directions across the 17/18 border. Together, our results suggest that visual stimulation may enhance the flow of information from area 18 to 17.	[Zheng, Lian; Yao, Haishan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Zheng, Lian; Yao, Haishan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai, Peoples R China; [Zheng, Lian] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Zheng, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.	haishanyao@ion.ac.cn		Yao, Haishan/0000-0003-4974-9197	973 program [2011CBA00405]	973 program(National Basic Research Program of China)	This work was supported by 973 program (2011CBA00405). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; BULLIER J, 1988, EXP BRAIN RES, V70, P90; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; DREHER B, 1980, J NEUROPHYSIOL, V44, P804, DOI 10.1152/jn.1980.44.4.804; DREHER B, 1992, VISUAL NEUROSCI, V9, P65, DOI 10.1017/S0952523800006374; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLEET DJ, 1990, INT J COMPUT VISION, V5, P77, DOI 10.1007/BF00056772; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; HOFFMANN KP, 1972, J NEUROPHYSIOL, V35, P518, DOI 10.1152/jn.1972.35.4.518; Hung CP, 2007, NAT NEUROSCI, V10, P1185, DOI 10.1038/nn1948; Hung CP, 2001, VISION RES, V41, P1389, DOI 10.1016/S0042-6989(01)00075-X; Jin JZ, 2011, J NEUROSCI, V31, P17471, DOI 10.1523/JNEUROSCI.2456-11.2011; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Jin WJ, 2002, J NEUROSCI METH, V115, P13, DOI 10.1016/S0165-0270(01)00511-8; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; KOPELL N, 1986, COMMUN PUR APPL MATH, V39, P623, DOI 10.1002/cpa.3160390504; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Malone BJ, 2007, J NEUROPHYSIOL, V97, P407, DOI 10.1152/jn.00830.2006; Martinez-Conde S, 1999, J NEUROPHYSIOL, V82, P2667, DOI 10.1152/jn.1999.82.5.2667; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; Onat S, 2011, NEUROIMAGE, V55, P1763, DOI 10.1016/j.neuroimage.2011.01.004; ORBACH HS, 1983, J NEUROSCI, V3, P2251; Payne BR, 2002, CAT PRIMARY VISUAL C, P1, DOI [10.1016/b978-012552104-8/50002-x, DOI 10.1016/B978-012552104-8/50002-X]; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Salin PA, 1995, CAN J PHYSIOL PHARM, V73, P1339, DOI 10.1139/y95-188; Senseman D M, 1999, J Neurosci, V19, pRC3; Senseman DM, 2002, J NEUROPHYSIOL, V87, P1499, DOI 10.1152/jn.00475.2001; Song WJ, 2006, CEREB CORTEX, V16, P718, DOI 10.1093/cercor/bhj018; SYMONDS LL, 1984, J COMP NEUROL, V229, P39, DOI 10.1002/cne.902290104; SYMONDS LL, 1984, J COMP NEUROL, V229, P1, DOI 10.1002/cne.902290103; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Takagaki K, 2011, J NEUROSCI METH, V200, P207, DOI 10.1016/j.jneumeth.2011.05.023; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; Wang C, 2011, CEREB CORTEX, V21, P964, DOI 10.1093/cercor/bhq176; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Yeh CI, 2009, J NEUROSCI, V29, P11753, DOI 10.1523/JNEUROSCI.1991-09.2009; Zhou YX, 1996, J NEUROPHYSIOL, V75, P1038, DOI 10.1152/jn.1996.75.3.1038	61	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41960	10.1371/journal.pone.0041960	http://dx.doi.org/10.1371/journal.pone.0041960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848673	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600150
J	Chung, E; Heimiller, J; Leinwand, LA				Chung, Eunhee; Heimiller, Joseph; Leinwand, Leslie A.			Distinct Cardiac Transcriptional Profiles Defining Pregnancy and Exercise	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-FAILURE; CYTOCHROME-P450 ENZYMES; NATRIURETIC PEPTIDE; PRESSURE-OVERLOAD; HYPERTROPHY; SKELETAL; APOPTOSIS; PROTECTS; MICE	Background: Although the hypertrophic responses of the heart to pregnancy and exercise are both considered to be physiological processes, they occur in quite different hormonal and temporal settings. In this study, we have compared the global transcriptional profiles of left ventricular tissues at various time points during the progression of hypertrophy in exercise and pregnancy. Methodology/Principal Findings: The following groups of female mice were analyzed: non-pregnant diestrus cycle sedentary control, mid-pregnant, late-pregnant, and immediate-postpartum, and animals subjected to 7 and 21 days of voluntary wheel running. Hierarchical clustering analysis shows that while mid-pregnancy and both exercise groups share the closest relationship and similar gene ontology categories, late pregnancy and immediate post-partum are quite different with high representation of secreted/extracellular matrix-related genes. Moreover, pathway-oriented ontological analysis shows that metabolism regulated by cytochrome P450 and chemokine pathways are the most significant signaling pathways regulated in late pregnancy and immediate-postpartum, respectively. Finally, increases in expression of components of the proteasome observed in both mid-pregnancy and immediate-postpartum also result in enhanced proteasome activity. Interestingly, the gene expression profiles did not correlate with the degree of cardiac hypertrophy observed in the animal groups, suggesting that distinct pathways are employed to achieve similar amounts of cardiac hypertrophy. Conclusions/Significance: Our results demonstrate that cardiac adaptation to the later stages of pregnancy is quite distinct from both mid-pregnancy and exercise. Furthermore, it is very dynamic since, by 12 hours post-partum, the heart has already initiated regression of cardiac growth, and 50 genes have changed expression significantly in the immediate-postpartum compared to late-pregnancy. Thus, pregnancy-induced cardiac hypertrophy is a more complex process than exercise-induced cardiac hypertrophy and our data suggest that the mechanisms underlying the two types of hypertrophy have limited overlap.	[Chung, Eunhee; Heimiller, Joseph; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Chung, Eunhee; Leinwand, Leslie A.] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chung, E (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	Leslie.Leinwand@colorado.edu	Chung, Eunhee/A-4941-2012; Chung, Eunhee/AAX-6863-2020	Chung, Eunhee/0000-0002-4501-9333; Chung, Eunhee/0000-0002-4501-9333; Heimiller, Joseph/0000-0002-7770-3746; LEINWAND, LESLIE/0000-0003-1470-4810	American Heart Association [0920040G]; National Institutes of Health [R01HL050560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050560] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by an American Heart Association Post-Doctoral fellowship (0920040G) to E. Chung and R01HL050560 from the National Institutes of Health to L.A. Leinwand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2008, ANN THORAC SURG, V86, P109, DOI 10.1016/j.athoracsur.2008.03.057; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bisping E, 2012, J BIOL CHEM, V287, P9827, DOI 10.1074/jbc.M111.338749; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Chaudhary KR, 2009, IUBMB LIFE, V61, P954, DOI 10.1002/iub.241; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Chung E, 2012, J APPL PHYSIOL, V112, P1564, DOI 10.1152/japplphysiol.00027.2012; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Dubey RK, 2005, J CLIN ENDOCR METAB, V90, P247, DOI 10.1210/jc.2003-032154; Dubey RK, 1998, HYPERTENSION, V31, P522, DOI 10.1161/01.HYP.31.1.522; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Elbekai RH, 2006, PHARMACOL THERAPEUT, V112, P564, DOI 10.1016/j.pharmthera.2005.05.011; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Graham HK, 2008, ACTA PHYSIOL, V194, P3, DOI 10.1111/j.1748-1716.2008.01881.x; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hedhli N, 2010, CARDIOVASC RES, V85, P321, DOI 10.1093/cvr/cvp226; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Kang PM, 2000, CIRC RES, V86, P1107; Kang PM, 2004, AM J PHYSIOL-HEART C, V287, pH72, DOI 10.1152/ajpheart.00556.2003; Kang YJ, 1999, P SOC EXP BIOL MED, V222, P263, DOI 10.1046/j.1525-1373.1999.d01-143.x; Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009; Kilic A, 2009, J MOL CELL CARDIOL, V46, P360, DOI 10.1016/j.yjmcc.2008.11.018; Knowles JW, 2001, J CLIN INVEST, V107, P975, DOI 10.1172/JCI11273; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Konhilas JP, 2006, CIRC RES, V98, P540, DOI 10.1161/01.RES.0000205766.97556.00; Lezoualc'h F, 2008, J MOL CELL CARDIOL, V44, P623, DOI 10.1016/j.yjmcc.2008.01.011; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Luckey SW, 2009, J MOL CELL CARDIOL, V46, P739, DOI 10.1016/j.yjmcc.2009.02.010; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Morano M, 1996, J CLIN INVEST, V98, P467, DOI 10.1172/JCI118813; Mori S, 2006, J CARD FAIL, V12, P314, DOI 10.1016/j.cardfail.2006.01.009; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Raisanen SR, 1999, FASEB J, V13, P513, DOI 10.1096/fasebj.13.3.513; Razeghi P, 2003, CIRCULATION, V108, P2536, DOI 10.1161/01.CIR.0000096481.45105.13; Reid MB, 2005, AM J PHYSIOL-REG I, V288, pR1423, DOI 10.1152/ajpregu.00545.2004; Sanbe A, 2000, AM J PHYSIOL-HEART C, V279, pH1355, DOI 10.1152/ajpheart.2000.279.3.H1355; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Simoncini T, 2000, CIRC RES, V87, P19, DOI 10.1161/01.RES.87.1.19; Siu PM, 2005, J APPL PHYSIOL, V99, P204, DOI 10.1152/japplphysiol.00084.2005; Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Tanous D, 2010, J AM COLL CARDIOL, V56, P1247, DOI 10.1016/j.jacc.2010.02.076; Thum T, 2002, FASEB J, V16, P1537, DOI 10.1096/fj.02-0138com; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Vanhoutte D, 2010, J MOL CELL CARDIOL, V48, P445, DOI 10.1016/j.yjmcc.2009.09.013; Vardhanabhuti S, 2006, OMICS, V10, P555, DOI 10.1089/omi.2006.10.555; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Weinberg EO, 2003, PHYSIOL GENOMICS, V12, P113, DOI 10.1152/physiolgenomics.00046.2002; Wu Z., 2004, DEP BIOSTATISTICS WO; Ye G, 2003, DIABETES, V52, P777, DOI 10.2337/diabetes.52.3.777; Zordoky BNM, 2008, DRUG METAB DISPOS, V36, P2277, DOI 10.1124/dmd.108.023077; Zordoky BNM, 2010, TOXICOL APPL PHARM, V242, P38, DOI 10.1016/j.taap.2009.09.012	72	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42297	10.1371/journal.pone.0042297	http://dx.doi.org/10.1371/journal.pone.0042297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860109	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600088
J	Mak, GWY; Lai, WL; Zhou, Y; Li, MT; Ng, IOL; Ching, YP				Mak, Grace Wing-Yan; Lai, Wai-Lung; Zhou, Yuan; Li, Mingtao; Ng, Irene Oi-Lin; Ching, Yick-Pang			CDK5RAP3 Is a Novel Repressor of p14(ARF) in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							ACTIVATOR-BINDING-PROTEIN; TUMOR-SUPPRESSOR; EXPRESSION; INVASION; KINASE; LZAP; C53; P53	CDK5 regulatory subunit associated protein 3 (CDK5RAP3) is a novel activator of PAK4 and processes important prometastatic function in hepatocarcinogenesis. However, it remains unclear if there are other mechanisms by which CDK5RAP3 promotes HCC metastasis. Here, we showed that in CDK5RAP3 stable knockdown SMMC-7721 HCC cells, p14(ARF) tumor suppressor was upregulated at protein and mRNA levels, and ectopic expression of CDK5RAP3 was found to repress the transcription of p14(ARF). Using chromatin immunoprecipitation assay, we demonstrated that CDK5RAP3 bound to p14(ARF) promoter in vivo. Furthermore, knockdown of p14(ARF) in CDK5RAP3 stable knockdown HCC cells reversed the suppression of HCC cell invasiveness mediated by knockdown of CDK5RAP3. Taken together, our findings provide the new evidence that overexpression of CDK5RAP3 promotes HCC metastasis via downregulation of p14(ARF).	[Mak, Grace Wing-Yan; Lai, Wai-Lung; Zhou, Yuan; Ching, Yick-Pang] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, Irene Oi-Lin; Ching, Yick-Pang] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Mingtao] Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510275, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University	Mak, GWY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	ypching@hku.hk		CHING, Yick Pang/0000-0002-6461-8358; Ng, Irene Oi-lin/0000-0001-7532-2029; Mak, Grace Wing-Yan/0000-0003-2861-6221	The Hong Kong Research Grant Council [N_HKU715/08, 7/CRF/09]	The Hong Kong Research Grant Council(Hong Kong Research Grants Council)	Our research is financially supported by The Hong Kong Research Grant Council (N_HKU715/08 and 7/CRF/09) (webpage: http://www.ugc.edu.hk/eng/rgc/about/about.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agesen TH, 2005, J NEUROPATH EXP NEUR, V64, P74, DOI 10.1093/jnen/64.1.74; Anzola M, 2004, EUR J GASTROEN HEPAT, V16, P19, DOI 10.1097/00042737-200401000-00004; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Mak GWY, 2011, CANCER RES, V71, P2949, DOI 10.1158/0008-5472.CAN-10-4046; Moll UM, 2003, MOL CANCER RES, V1, P1001; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Yin XL, 2005, INT J MOL MED, V16, P251; Zhou DP, 1996, BIOCHEM J, V320, P623, DOI 10.1042/bj3200623	20	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42210	10.1371/journal.pone.0042210	http://dx.doi.org/10.1371/journal.pone.0042210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860085	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600074
J	Samanta, S; Ghoshal, A; Bhattacharya, K; Saha, B; Walden, P; Mandal, C				Samanta, Sajal; Ghoshal, Angana; Bhattacharya, Kaushik; Saha, Bibhuti; Walden, Peter; Mandal, Chitra			Sialoglycosylation of RBC in Visceral Leishmaniasis Leads to Enhanced Oxidative Stress, Calpain-Induced Fragmentation of Spectrin and Hemolysis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACETYLATED SIALIC ACIDS; TRAUMATIC BRAIN-INJURY; ERYTHROCYTE-MEMBRANE; BINDING LECTIN; PHOSPHATIDYLSERINE EXTERNALIZATION; 9-O-ACETYLATED SIALOGLYCOPROTEINS; DIFFERENTIAL EXPRESSION; DONOVANI PROMASTIGOTES; MEDIATED HEMOLYSIS	Visceral leishmaniasis (VL) caused by the intracellular parasite Leishmania donovani accounts for an estimated 12 million cases of human infection. It is almost always associated with anemia, which severely complicates the disease course. However, the pathological processes leading to anemia in VL have thus far not been adequately characterized to date. In studying the glycosylation patterns of peripheral blood cells we found that the red blood cells (RBC) of VL patients (RBCVL) express eight 9-O-acetylated sialoglycoproteins (9-O-AcSGPs) that are not detected in the RBC of healthy individuals (RBCN). At the same time, the patients had high titers of anti-9-O-AcSGP IgG antibodies in their sera. These two conditions appear to be linked and related to the anemic state of the patients, as exposure of RBCVL but not RBCN to anti-9-O-AcSGPs antibodies purified from patient sera triggered a series of responses. These included calcium influx via the P/Q-type but not L-type channels, activation of calpain I, proteolysis of spectrin, enhanced oxidative stress, lipid peroxidation, externalization of phosphatidyl serine with enhanced erythrophagocytosis, enhanced membrane fragility and, finally, hemolysis. Taken together, this study suggests that the enhanced hemolysis is linked to an impairment of membrane integrity in RBCVL which is mediated by ligand-specific interaction of surface 9-O-AcSGPs. This affords a potential explanation for the structural and functional features of RBCVL which are involved in the hemolysis related to the anemia which develops in VL patients.	[Samanta, Sajal; Ghoshal, Angana; Bhattacharya, Kaushik; Mandal, Chitra] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India; [Saha, Bibhuti] Sch Trop Med, Dept Trop Med, Kolkata, India; [Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, Berlin, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Calcutta School of Tropical Medicine (CSTM); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Samanta, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India.	chitra_mandal@yahoo.com			CSIR-IICB; Department of Biotechnology [GAP235]; Indian Council of Medical Research, New Delhi [GAP266]; J.C. Bose Fellowship; Department of Science and Technology, Govt. of India [P90807]	CSIR-IICB; Department of Biotechnology; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); J.C. Bose Fellowship(Department of Science & Technology (India)); Department of Science and Technology, Govt. of India(Department of Science & Technology (India))	This work received financial support from the CSIR-IICB, Department of Biotechnology (GAP235) (http://dbtindia.nic.in/index.asp), Indian Council of Medical Research (GAP266) (http://www.icmr.nic.in/), New Delhi, J.C. Bose Fellowship, Department of Science and Technology (P90807) (http://www.dst.gov.in/), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED H, 1989, J BIOL CHEM, V264, P18673; Ansar W, 2009, GLYCOCONJUGATE J, V26, P1151, DOI 10.1007/s10719-009-9236-y; Bandyopadhyay S, 2004, GLYCOCONJUGATE J, V20, P531; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BLUMENFELD N, 1991, BLOOD, V77, P849; BORENSTAINBENYASHAR V, 1993, AM J HEMATOL, V44, P63; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chatterjee M, 1998, GLYCOCONJUGATE J, V15, P1141, DOI 10.1023/A:1006963806318; Chava AK, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P71; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; Chava AK, 2002, J IMMUNOL METHODS, V270, P1, DOI 10.1016/S0022-1759(02)00216-8; CROALL DE, 1986, BIOCHIM BIOPHYS ACTA, V882, P287, DOI 10.1016/0304-4165(86)90250-3; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; de Jong K, 2001, BLOOD, V98, P860, DOI 10.1182/blood.V98.3.860; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Ghosh S, 2005, ANN HEMATOL, V84, P76, DOI 10.1007/s00277-004-0933-0; Ghosh S, 2007, GLYCOCONJUGATE J, V24, P17, DOI 10.1007/s10719-006-9007-y; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Ghoshal A, 2011, GLYCOCONJ J, V26, P675; Ghoshal A, 2008, MINI-REV MED CHEM, V8, P358, DOI 10.2174/138955708783955980; Ghoshal A, 2009, CLIN VACCINE IMMUNOL, V16, P889, DOI 10.1128/CVI.00453-08; GLASER T, 1994, P NATL ACAD SCI USA, V91, P7879, DOI 10.1073/pnas.91.17.7879; HU RJ, 1991, J BIOL CHEM, V266, P18200; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Lee JC, 2006, NEUROCHEM RES, V31, P989, DOI 10.1007/s11064-006-9104-0; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lijnen P, 1998, AM J HYPERTENS, V11, P81, DOI 10.1016/S0895-7061(97)00368-3; Mahajan V, 2007, J TROP PEDIATRICS, V53, P284, DOI 10.1093/tropej/fmm018; Malorni W, 2000, FEBS LETT, V468, P125, DOI 10.1016/S0014-5793(00)01187-X; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Mandal D, 2002, FEBS LETT, V513, P184, DOI 10.1016/S0014-5793(02)02294-9; MORTENSEN AM, 1991, TOXICOL APPL PHARM, V110, P435, DOI 10.1016/0041-008X(91)90045-G; Mukherjee K, 2007, BIOCHEM BIOPH RES CO, V362, P651, DOI 10.1016/j.bbrc.2007.08.048; Pal S, 2000, GLYCOBIOLOGY, V10, P539, DOI 10.1093/glycob/10.6.539; Pal S, 2004, GLYCOBIOLOGY, V14, P859, DOI 10.1093/glycob/cwh111; Pal S, 2004, INT J CANCER, V111, P270, DOI 10.1002/ijc.20246; PANT HC, 1983, BIOCHEM BIOPH RES CO, V117, P372, DOI 10.1016/0006-291X(83)91210-X; PRADHAN D, 1994, MOL MEMBR BIOL, V11, P181, DOI 10.3109/09687689409162237; Resmi H, 2001, CLIN EXP MED, V1, P187, DOI 10.1007/s102380100002; Samanta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028169; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Sen G, 2001, ANN HEMATOL, V80, P32, DOI 10.1007/s002770000240; SEN GT, 1995, CARBOHYD RES, V268, P115, DOI 10.1016/0008-6215(94)00311-3; Sharma V, 1998, AM J TROP MED HYG, V58, P551, DOI 10.4269/ajtmh.1998.58.551; Sharma V, 2000, GLYCOCONJUGATE J, V17, P887, DOI 10.1023/A:1010925414222; Shukla M, 2006, NEUROCHEM INT, V48, P108, DOI 10.1016/j.neuint.2005.09.001; Siebert HC, 1996, GLYCOBIOLOGY, V6, P561, DOI 10.1093/glycob/6.6.561-b; Sinha D, 2000, TRENDS GLYCOSCI GLYC, V12, P17, DOI 10.4052/tigg.12.17; Starodubtseva MN, 2008, B EXP BIOL MED+, V145, P99, DOI 10.1007/s10517-008-0036-3; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WILSON MJ, 1993, BIOCHEMISTRY-US, V32, P11302, DOI 10.1021/bi00093a006; WOODRUFF AW, 1972, BRIT J HAEMATOL, V22, P319, DOI 10.1111/j.1365-2141.1972.tb05678.x; World Health Organization, 2010, TECH REP SER, V949, P186; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	61	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42361	10.1371/journal.pone.0042361	http://dx.doi.org/10.1371/journal.pone.0042361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860118	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600094
J	Shtrichman, R; Germanguz, I; Mandel, R; Ziskind, A; Nahor, I; Safran, M; Osenberg, S; Sherf, O; Rechavi, G; Itskovitz-Eldor, J				Shtrichman, Ronit; Germanguz, Igal; Mandel, Rachel; Ziskind, Anna; Nahor, Irit; Safran, Michal; Osenberg, Sivan; Sherf, Ofra; Rechavi, Gideon; Itskovitz-Eldor, Joseph			Altered A-to-I RNA Editing in Human Embryogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PRE-MESSENGER-RNA; ADENOSINE-DEAMINASE; HUMAN TRANSCRIPTOME; NUCLEAR RETENTION; BINDING DOMAINS; INOSINE RNA; EXPRESSION; ADAR1; GENE	Post-transcriptional events play an important role in human development. The question arises as to whether Adenosine to Inosine RNA editing, catalyzed by the ADAR (Adenosine Deaminase acting on RNA) enzymes, differs in human embryogenesis and in adulthood. We tested the editing of various target genes in coding (FLNA, BLCAP, CYFIP2) and non-coding sequences at their Alu elements (BRCA1, CARD11, RBBP9, MDM4, FNACC), as well as the transcriptional levels of the ADAR1 enzymes. This analysis was performed on five fetal and adult human tissues: brain, heart, liver, kidney, and spleen, as well as on human embryonic stem cells (hESCs), which represent the blastocyst stage in early human development. Our results show substantially greater editing activity for most adult tissue samples relative to fetal ones, in six of the eight genes tested. To test the effect of reduced A-to-I RNA editing activity in early human development we used human embryonic stem cells (hESCs) as a model and tried to generate hESC clones that overexpress the ADAR1-p110 isoform. We were unable to achieve overexpression of ADAR1-p110 by either transfection or lentiviral infection, though we easily generated hESC clones that expressed the GFP transgene and overexpressed ADAR1-p110 in 293T cells and in primary human foreskin fibroblast (HFF) cells. Moreover, in contrast to the expected overexpression of ADAR1-p110 protein following its introduction into hESCs, the expression levels of this protein decreased dramatically 24-48 hr post infection. Similar results were obtained when we tried to overexpress ADAR1-p110 in pluripotent embryonal carcinoma cells. This suggests that ADAR1 protein is substantially regulated in undifferentiated pluripotent hESCs. Overall, our data suggest that A-to-I RNA editing plays a critical role during early human development.	[Shtrichman, Ronit; Germanguz, Igal; Ziskind, Anna; Nahor, Irit; Itskovitz-Eldor, Joseph] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Mandel, Rachel; Itskovitz-Eldor, Joseph] Rambam Hlth Care Campus, Dept Obstet & Gynecol, Haifa, Israel; [Safran, Michal; Osenberg, Sivan; Sherf, Ofra; Rechavi, Gideon] Tel Aviv Univ, Tel Hashomer & Sackler Sch Med, Chaim Sheba Med Ctr, Canc Res Ctr, IL-69978 Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shtrichman, R (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	itksovitz@rambam.health.gov.il	Germanguz, Igal/F-2038-2017		Technion Research and Development Foundation Ltd.; Bio-Med Morasha ISF; Israel Ministry for Science and Technology (Scientific Infrastructure Program)	Technion Research and Development Foundation Ltd.; Bio-Med Morasha ISF; Israel Ministry for Science and Technology (Scientific Infrastructure Program)	This study was supported by Technion Research and Development Foundation Ltd., which is fully own by the Technion - Israel Institute of Technology a non-for-profit organization. This work was also supported in part by grants from Bio-Med Morasha ISF and The Israel Ministry for Science and Technology (Scientific Infrastructure Program). The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Andrews PW, 1998, APMIS, V106, P158, DOI 10.1111/j.1699-0463.1998.tb01331.x; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cassie S, 2006, CARCINOGENESIS, V27, P465, DOI 10.1093/carcin/bgi261; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Dufner A, 2006, CELL CYCLE, V5, P797, DOI 10.4161/cc.5.8.2635; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Hang PNT, 2008, NEUROSCI RES, V61, P398, DOI 10.1016/j.neures.2008.04.007; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Jacobs MM, 2009, DEV NEUROSCI-BASEL, V31, P223, DOI 10.1159/000210185; James CR, 2007, ONCOLOGIST, V12, P142, DOI 10.1634/theoncologist.12-2-142; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2004, DEV BRAIN RES, V148, P151, DOI 10.1016/j.devbrainres.2003.11.008; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Koren-Michowitz M, 2008, LEUKEMIA RES, V32, P421, DOI 10.1016/j.leukres.2007.07.003; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Saller E, 1999, EMBO J, V18, P4424, DOI 10.1093/emboj/18.16.4424; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; XuFeng R, 2009, P NATL ACAD SCI USA, V106, P17763, DOI 10.1073/pnas.0903324106; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang Zuo, 2004, Methods Mol Biol, V257, P75, DOI 10.1385/1-59259-750-5:075; Zilberman DE, 2011, UROL ONCOL-SEMIN ORI, V29, P21, DOI 10.1016/j.urolonc.2008.11.006	52	38	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41576	10.1371/journal.pone.0041576	http://dx.doi.org/10.1371/journal.pone.0041576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859999	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600034
J	Xu, XM; Wang, J; Aron, A; Lei, W; Westmaas, JL; Weng, XC				Xu, Xiaomeng; Wang, Jin; Aron, Arthur; Lei, Wei; Westmaas, J. Lee; Weng, Xuchu			Intense Passionate Love Attenuates Cigarette Cue-Reactivity in Nicotine-Deprived Smokers: An fMRI Study	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; SMOKING CUES; SELF-EXPANSION; WITHDRAWAL SYMPTOMS; DOPAMINE RELEASE; NEURAL BASIS; DRUG REWARD; ABSTINENCE; MINDFULNESS; ACTIVATION	Self-expanding experiences like falling in love or engaging in novel, exciting and interesting activities activate the same brain reward mechanism (mesolimbic dopamine pathway) that reinforces drug use and abuse, including tobacco smoking. This suggests the possibility that reward from smoking is substitutable by self-expansion (through competition with the same neural system), potentially aiding cessation efforts. Using a model of self-expansion in the context of romantic love, the present fMRI experiment examined whether, among nicotine-deprived smokers, relationship self-expansion is associated with deactivation of cigarette cue-reactivity regions. Results indicated that among participants who were experiencing moderate levels of craving, cigarette cue-reactivity regions (e.g., cuneus and posterior cingulate cortex) showed significantly less activation during self-expansion conditions compared with control conditions. These results provide evidence that rewards from one domain (self-expansion) can act as a substitute for reward from another domain (nicotine) to attenuate cigarette cue reactivity.	[Xu, Xiaomeng; Aron, Arthur] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Wang, Jin; Lei, Wei; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Lab Higher Brain Funct, Beijing 100101, Peoples R China; [Wang, Jin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Xu, Xiaomeng] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Miriam Hosp,Weight Control & Diabet Res Ctr, Providence, RI 02912 USA; [Lei, Wei] Sichuan Univ, W China Hosp, Mental Hlth Ctr, Chengdu 610064, Peoples R China; [Westmaas, J. Lee] Amer Canc Soc, Behav Res Ctr, Atlanta, GA 30329 USA; [Weng, Xuchu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Sichuan University; American Cancer Society; Hangzhou Normal University	Xu, XM (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	Xiaomeng_Xu@Brown.edu	Xu, Xiaomeng/H-3308-2019	Xu, Xiaomeng/0000-0003-3695-4845	National Institute on Drug Abuse [F31DA024941-01A2]; National Science Foundation [BCS-0937559]; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024941] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study came from award F31DA024941-01A2 from the National Institute on Drug Abuse to XX and award BCS-0937559 from the National Science Foundation to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and do not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.	Acevedo B, 2011, SOC COG AFFECT NEURO; Alter RJ, 2006, J DRUG EDUC, V36, P335, DOI 10.2190/2780-G96W-J17N-R3H1; Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Aron A, 2000, J PERS SOC PSYCHOL, V78, P273, DOI 10.1037/0022-3514.78.2.273; Aron A., 2001, BLACKWELL HDB SOCIAL, P478, DOI DOI 10.1002/9780470998557.CH19; Aron AP, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P27; Baker TB, 2011, ANN BEHAV MED, V41, P192, DOI 10.1007/s12160-010-9252-y; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bowen S, 2009, PSYCHOL ADDICT BEHAV, V23, P666, DOI 10.1037/a0017127; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brewer JA, 2011, DRUG ALCOHOL DEPEN, V119, P72, DOI 10.1016/j.drugalcdep.2011.05.027; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Carr KD, 2007, PHYSIOL BEHAV, V91, P459, DOI 10.1016/j.physbeh.2006.09.021; Carson JW, 2007, J MARITAL FAM THER, V33, P517, DOI 10.1111/j.1752-0606.2007.00035.x; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Cunningham WA, 2012, CURR DIR PSYCHOL SCI, V21, P54, DOI 10.1177/0963721411430832; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; David V, 2004, PSYCHOPHARMACOLOGY, V174, P367, DOI 10.1007/s00213-003-1767-5; DiNardo J, 2001, J HEALTH ECON, V20, P991, DOI 10.1016/S0167-6296(01)00102-3; DONOVAN DM, 1988, ASSESSMENT ADDICTIVE, P3; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Fiore MC, 2008, TREATING TOBACCO USE; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; Forget B, 2010, BIOL PSYCHIAT, V68, P265, DOI 10.1016/j.biopsych.2010.01.029; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Haylett SA, 2004, ADDICT BEHAV, V29, P61, DOI 10.1016/S0306-4603(03)00083-2; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Jarvik ME, 2000, PHARMACOL BIOCHEM BE, V66, P553, DOI 10.1016/S0091-3057(00)00261-6; Kalivas PW, 1998, J NEUROCHEM, V70, P1497; Kellogg SH, 2005, INT J DRUG POLICY, V16, P369, DOI 10.1016/j.drugpo.2005.08.001; Lambert C, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen074; Lee JH, 2005, APPL PSYCHOPHYS BIOF, V30, P195, DOI 10.1007/s10484-005-6377-z; Lim HK, 2005, J PSYCHIATR RES, V39, P333, DOI 10.1016/j.jpsychires.2004.08.004; Liu Y, 2011, J NEUROSCI, V31, P7960, DOI 10.1523/JNEUROSCI.1006-11.2011; MARKS I, 1990, BRIT J ADDICT, V85, P1389; McBride D, 2006, NEUROPSYCHOPHARMACOL, V31, P2728, DOI 10.1038/sj.npp.1301075; McClernon FJ, 2009, PSYCHOPHARMACOLOGY, V204, P25, DOI 10.1007/s00213-008-1436-9; McClernon FJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1940, DOI 10.1038/sj.npp.1300780; McClernon FJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2148, DOI 10.1038/sj.npp.1301618; Meeusen Romain, 2005, Ann Transplant, V10, P49; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Ortigue S, 2010, J SEX MED, V7, P3541, DOI 10.1111/j.1743-6109.2010.01999.x; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Qian J., 2010, B WORLD HEALTH ORGAN, P717; REISSMAN C, 1993, J SOC PERS RELAT, V10, P243, DOI 10.1177/026540759301000205; ROSE JE, 1985, CLIN PHARMACOL THER, V38, P450, DOI 10.1038/clpt.1985.203; Salvy SJ, 2009, ANN BEHAV MED, V38, P205, DOI 10.1007/s12160-009-9145-0; Shiffman S, 2006, PSYCHOPHARMACOLOGY, V184, P608, DOI 10.1007/s00213-005-0175-4; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Strong G., 2006, SELF RELATIONSHIPS C, P342; Sziraki I, 2002, NEUROCHEM RES, V27, P253, DOI 10.1023/A:1014844823534; Taylor AH, 2007, ADDICTION, V102, P534, DOI 10.1111/j.1360-0443.2006.01739.x; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Vaillant G.E., 1995, WISDOM EGO; Vidrine JI, 2009, SUBST ABUS, V30, P318, DOI 10.1080/08897070903252973; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Wilson SJ, 2005, NICOTINE TOB RES, V7, P637, DOI 10.1080/14622200500185520; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; WOOLVERTON WL, 1984, J PHARMACOL EXP THER, V230, P678; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Xu XM, 2010, ADDICT BEHAV, V35, P295, DOI 10.1016/j.addbeh.2009.10.019; Yan XD, 2009, ADDICT BIOL, V14, P478, DOI 10.1111/j.1369-1600.2009.00172.x; Younger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013309; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	74	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42235	10.1371/journal.pone.0042235	http://dx.doi.org/10.1371/journal.pone.0042235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860092	Green Published, gold			2022-12-27	WOS:000307045600078
J	Sibbritt, D; Adams, J; Lui, CW; Broom, A; Wardle, J				Sibbritt, David; Adams, Jon; Lui, Chi-Wai; Broom, Alex; Wardle, Jonathan			Who Uses Glucosamine and Why? A Study of 266,848 Australians Aged 45 Years and Older	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; DIETARY-SUPPLEMENTS; KNEE OSTEOARTHRITIS; CHONDROITIN SULFATE; COMPLEMENTARY; PRACTITIONERS; PROGRESSION; WELLNESS; REMEDIES; WOMEN	Objectives: There has been a dramatic increase in the use of complementary medicines over recent decades. Glucosamine is one of the most commonly used complementary medicines in Western societies. An understanding of glucosamine consumption is of significance for public health and future health promotion. This paper, drawing upon the largest dataset to date with regards to glucosamine use (n = 266,844), examines the use and users of glucosamine amongst a sample of older Australians. Design: Analysis of the self-reported data on use of glucosamine, demographics and health status as extracted from the dataset of the 45 and Up Study, which is the largest study of healthy ageing ever undertaken in the Southern Hemisphere involving over 265,000 participants aged 45 and over. Results: Analysis reveals that 58,630 (22.0%) participants reported using glucosamine in the 4 weeks prior to the survey. Use was higher for those who were female, non-smokers, residing in inner/outer regional areas, with higher income and private health insurance. Of all the health conditions examined only osteoarthritis was positively associated with use of glucosamine, while cancer, heart attack or angina and other heart disease were all negatively associated with glucosamine use. Conclusions: This study suggests that a considerable proportion of the Australia population aged 45 and over consume glucosamine. There is a need for health care practitioners to enquire with their patients about their use of glucosamine and for further attention to be directed to providing good quality information for patients and providers with regards to glucosamine products.	[Sibbritt, David] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Adams, Jon; Wardle, Jonathan] Univ Technol Sydney, Fac Nursing Midwifery & Hlth, Sydney, NSW 2007, Australia; [Lui, Chi-Wai] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Broom, Alex] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia	University of Newcastle; University of Technology Sydney; University of Queensland; University of Queensland	Sibbritt, D (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.	David.Sibbritt@newcastle.edu.au	Wardle, Jon/J-7357-2019; Lui, Chi-Wai/A-5050-2010; Sibbritt, David W/F-8070-2017	Wardle, Jon/0000-0001-8813-3542; Lui, Chi-Wai/0000-0003-4482-0396; Sibbritt, David W/0000-0003-3561-9447; Adams, Jon/0000-0002-9901-5717; Broom, Alexander/0000-0003-1258-1140				Adams J, 2003, MED J AUSTRALIA, V179, P297, DOI 10.5694/j.1326-5377.2003.tb05551.x; Aghazadeh-Habashi A, 2011, J PHARM PHARM SCI, V14, P264, DOI 10.18433/J3XG6F; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Barnes P. M., 2008, COMPLEMENTARY ALTERN; Bates ER, 2003, EUR HEART J, V24, P1707, DOI 10.1016/S0195-668X(03)00470-6; Bin YS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/632829; Bishop FL, 2010, EVID-BASED COMPL ALT, V7, P11, DOI 10.1093/ecam/nen023; Black C, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI [10.3310/htal3520, 10.3310/hta13520]; Block JA, 2010, OSTEOARTHR CARTILAGE, V18, P5, DOI 10.1016/j.joca.2009.07.005; Braun LA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-38; Brown J, 2008, COMPLEMENTARY MED IN; Bruyere O, 2007, DRUG AGING, V24, P573, DOI 10.2165/00002512-200724070-00005; Campbell P, 2001, AUST PRESCR, V24, P86; Chard J, 2001, BMJ-BRIT MED J, V322, P1439, DOI 10.1136/bmj.322.7300.1439; Conboy L, 2005, J ALTERN COMPLEM MED, V11, P977, DOI 10.1089/acm.2005.11.977; Dahmer S, 2008, AM FAM PHYSICIAN, V78, P471; Gregory PJ, 2008, AM FAM PHYSICIAN, V77, P177; Hale WA, 2007, UNDERSTANDING GLOBAL, P208; Herman Carla J, 2004, Prev Chronic Dis, V1, pA12; Hopman WM, 2006, OSTEOARTHR CARTILAGE, V14, P1288, DOI 10.1016/j.joca.2006.06.003; Kickbusch I, 2003, HEALTH PROMOT INT, V18, P275, DOI 10.1093/heapro/dag418; Knudsen JE, 2008, PHARMACOTHERAPY, V28, P540, DOI 10.1592/phco.28.4.540; Leipert BD, 2006, CAN J RURAL MED, V11, P296; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Messerer M, 2001, J INTERN MED, V250, P160, DOI 10.1046/j.1365-2796.2001.00872.x; Morgan TK, 2012, MED J AUSTRALIA, V196, P50, DOI 10.5694/mja11.10698; Myers SP, 2002, AUST PRESCR, V25, P54; Nichter M, 2006, CULT MED PSYCHIAT, V30, P175, DOI 10.1007/s11013-006-9016-0; Nilsson M, 2001, J INTERN MED, V250, P225, DOI 10.1046/j.1365-2796.2001.00882.x; Pirotta M, 2010, AUST FAM PHYSICIAN, V39, P946; Poolsup N, 2005, ANN PHARMACOTHER, V39, P1080, DOI 10.1345/aph.1E576; Richy F, 2003, ARCH INTERN MED, V163, P1514, DOI 10.1001/archinte.163.13.1514; Robinson A, 2004, COMPLEMENT THER MED, V12, P90, DOI 10.1016/j.ctim.2004.09.006; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Simon RR, 2011, DIABETES-METAB RES, V27, P14, DOI 10.1002/dmrr.1150; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Vangsness CT, 2009, ARTHROSCOPY, V25, P86, DOI 10.1016/j.arthro.2008.07.020; Vlad SC, 2007, ARTHRITIS RHEUM-US, V56, P2267, DOI 10.1002/art.22728; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wang Yuanyuan, 2004, Altern Med Rev, V9, P275; Wardle J, 2012, J RURAL HEALTH, V28, P101, DOI 10.1111/j.1748-0361.2010.00348.x; Watson RR, 2009, COMPLEMENTARY AND ALTERNATIVE THERAPIES IN THE AGING POPULATION: AN EVIDENCE-BASED APPROACH, P1; Wilkinson Jenny M, 2009, Complement Ther Clin Pract, V15, P80, DOI 10.1016/j.ctcp.2008.12.005; Willison Kevin D, 2007, Complement Ther Clin Pract, V13, P232, DOI 10.1016/j.ctcp.2007.06.002; Yue Q-Y, 2006, CONCOMITANT USE GLUC	47	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41540	10.1371/journal.pone.0041540	http://dx.doi.org/10.1371/journal.pone.0041540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22859995	Green Published, gold			2022-12-27	WOS:000306950900027
J	Canessa, N; Alemanno, F; Riva, F; Zani, A; Proverbio, AM; Mannara, N; Perani, D; Cappa, SF				Canessa, Nicola; Alemanno, Federica; Riva, Federica; Zani, Alberto; Proverbio, Alice Mado; Mannara, Nicola; Perani, Daniela; Cappa, Stefano F.			The Neural Bases of Social Intention Understanding: The Role of Interaction Goals	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; THEORY-OF-MIND; GENDER-DIFFERENCES; SEX-DIFFERENCES; ASPERGER SYNDROME; NONVERBAL TASK; TIME-SERIES; BRAIN; MIRROR; FMRI	Decoding others' intentions is a crucial aspect of social cognition. Neuroimaging studies suggest that inferring immediate goals engages the neural system for action understanding (i.e. mirror system), while the decoding of long-term intentions requires the system subserving the attribution of mental states (i.e. mentalizing). A controversial issue, stimulated by recent inconsistent results, concerns whether the two systems are concurrently vs. exclusively involved in intention understanding. This issue is particularly relevant in the case of social interactions, whose processing has been mostly, but not uncontroversially, associated with the mentalizing system. We tested the alternative hypothesis that the relative contribution of the two systems in intention understanding may also depend on the shared goal of interacting agents. To this purpose, 27 participants observed social interactions differing in their cooperative vs. affective shared goal during functional-Magnetic-Resonance-Imaging. The processing of both types of interactions activated the right temporo-parietal junction involved in mentalizing on action goals. Additionally, whole-brain and regions-of-interest analyses showed that the action understanding system (inferior prefrontal-parietal cortex) was more strongly activated by cooperative interactions, while the mentalizing-proper system (medial prefrontal cortex) was more strongly engaged by affective interactions. These differences were modulated by individual differences in empathizing. Both systems can thus be involved in understanding social intentions, with a relative weighting depending on the specific shared goal of the interaction.	[Canessa, Nicola; Alemanno, Federica; Mannara, Nicola; Perani, Daniela; Cappa, Stefano F.] Univ Vita Salute San Raffaele, Ctr Cognit Neurosci, Milan, Italy; [Canessa, Nicola; Perani, Daniela; Cappa, Stefano F.] Univ Vita Salute San Raffaele, CERMAC, Milan, Italy; [Canessa, Nicola; Perani, Daniela; Cappa, Stefano F.] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Riva, Federica; Proverbio, Alice Mado] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Zani, Alberto] CNR, Inst Mol Bioimaging & Physiol, Milan, Italy; [Perani, Daniela] Ist Sci San Raffaele, Nucl Med Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Canessa, N (corresponding author), Univ Vita Salute San Raffaele, Ctr Cognit Neurosci, Milan, Italy.	canessa.nicola@hsr.it	Cappa, Stefano/B-1874-2014; Perani, Daniela/AAN-3221-2020; Zani, Alberto/ABI-3498-2020; Zani, Alberto/ABG-8894-2020; Canessa, Nicola/K-3223-2016; Alemanno, Federica/K-4248-2018	Cappa, Stefano/0000-0003-1003-3925; Zani, Alberto/0000-0002-3906-7988; Canessa, Nicola/0000-0002-0179-6384; Alemanno, Federica/0000-0003-0893-2614; Proverbio, Alice Mado/0000-0002-5138-1523	Cariplo Foundation "Formazione universitaria d'eccellenza" grant	Cariplo Foundation "Formazione universitaria d'eccellenza" grant	This project was partially supported by a Cariplo Foundation "Formazione universitaria d'eccellenza" grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Centelles L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015749; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Dohnel K, 2012, NEUROIMAGE, V60, P1652, DOI 10.1016/j.neuroimage.2012.01.073; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fogassi L, 1998, SOC NEUR ABSTR, V24; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hassin RR, 2005, J EXP SOC PSYCHOL, V41, P129, DOI 10.1016/j.jesp.2004.06.008; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kourtis D, 2010, BIOL LETTERS, V6, P758, DOI 10.1098/rsbl.2010.0478; Krach S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-9; MEHRABIAN A, 1972, J PERSONALITY, V40; Meneghini AM, 2006, RICERCHE PSICOLOGIA, V29, P123; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pavlova M, 2010, CEREB CORTEX, V20, P2361, DOI 10.1093/cercor/bhp304; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Proverbio AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022026; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Scholz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004869; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Talairach I., 1988, COPLANAR STEREOTACTI; Tantam D, 2009, BRIT MED BULL, V89, P41, DOI 10.1093/bmb/ldp006; Tremoulet PD, 2006, PERCEPT PSYCHOPHYS, V68, P1047, DOI 10.3758/BF03193364; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	63	45	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42347	10.1371/journal.pone.0042347	http://dx.doi.org/10.1371/journal.pone.0042347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981ER	22848759	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200196
J	Darekar, S; Georgiou, K; Yurchenko, M; Yenamandra, SP; Chachami, G; Simos, G; Klein, G; Kashuba, E				Darekar, Suhas; Georgiou, Konstantinos; Yurchenko, Mariya; Yenamandra, Surya Pavan; Chachami, Georgia; Simos, George; Klein, George; Kashuba, Elena			Epstein-Barr Virus Immortalization of Human B-Cells Leads to Stabilization of Hypoxia-Induced Factor 1 Alpha, Congruent with the Warburg Effect	PLOS ONE			English	Article							INDUCIBLE FACTOR-1-ALPHA; GLUCOSE-METABOLISM; EBNA-3 BINDS; HIF-ALPHA; PATHWAY; COMPLEX; HIF-1-ALPHA; EXPRESSION; INDUCTION; RECEPTOR	Background: Epstein-Barr virus (EBV) encodes six nuclear transformation-associated proteins that induce extensive changes in cellular gene expression and signaling and induce B-cell transformation. The role of HIF1A in EBV-induced B-cell immortalization has not been previously studied. Methods and Findings: Using Western blotting and Q-PCR, we found that HIF1A protein is stabilized in EBV-transformed lymphoblastoid cells. Western blotting, GST pulldown assays, and immunoprecipitation showed that EBV-encoded nuclear antigens EBNA-5 and EBNA-3 bind to prolylhydroxylases 1 and 2, respectively, thus inhibiting HIF1A hydroxylation and degradation. Immunostaining and Q-PCR showed that the stabilized HIF1A translocates to the nucleus, forms a heterodimer with ARNT, and transactivates several genes involved in aerobic glycolysis. Using biochemical assays and Q-PCR, we also found that lymphoblastoid cells produce high levels of lactate, lactate dehydrogenase and pyruvate. Conclusions: Our data suggest that activation of the aerobic glycolytic pathway, corresponding to the Warburg effect, occurs in EBV-transformed lymphoblastoid cells, in contrast to mitogen-activated B-cells.	[Darekar, Suhas; Georgiou, Konstantinos; Yenamandra, Surya Pavan; Klein, George; Kashuba, Elena] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Yurchenko, Mariya; Kashuba, Elena] NASU, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine; [Chachami, Georgia; Simos, George] Univ Thessaly, Sch Med, Larisa, Greece; [Chachami, Georgia; Simos, George] Inst Biomed Res & Technol BIOMED, Larisa, Greece	Karolinska Institutet; National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; University of Thessaly	Darekar, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	Elena.Kashuba@ki.se	Kashuba, Elena/Q-4739-2019; Kashuba, Elena/O-5389-2015; Simos, George/AAH-2596-2021	Kashuba, Elena/0000-0001-7001-4035; Kashuba, Elena/0000-0001-7001-4035; Darekar, Suhas/0000-0003-4895-3313; Simos, George/0000-0001-5453-3185; Chachami, Georgia/0000-0002-4771-4196; Yurchenko, Maria/0000-0002-0516-4747	Swedish Cancer Society; Concern Foundation (Los Angeles); Cancer Research Institute (New York); Swedish Institute; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Concern Foundation (Los Angeles); Cancer Research Institute (New York); Swedish Institute; Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Society, by matching grants from the Concern Foundation (Los Angeles) and the Cancer Research Institute (New York), by the Swedish Institute, and by Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso T, 2000, BIOCHEM BIOPH RES CO, V276, P355, DOI 10.1006/bbrc.2000.3451; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; Chachami G, 2005, BIOCHEM BIOPH RES CO, V331, P464, DOI 10.1016/j.bbrc.2005.03.193; Chachami G, 2004, AM J RESP CELL MOL, V31, P544, DOI 10.1165/rcmb.2003-0426OC; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Graham JP, 2010, IMMUNOL REV, V237, P226, DOI 10.1111/j.1600-065X.2010.00932.x; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kashuba E, 1999, J HUMAN VIROL, V2, P33; Kashuba E, 2000, ONCOGENE, V19, P1801, DOI 10.1038/sj.onc.1203501; Kashuba E, 2011, INT J CANCER, V128, P817, DOI 10.1002/ijc.25414; Kashuba EV, 2006, J BIOL CHEM, V281, P1215, DOI 10.1074/jbc.M509036200; Kieff E, 2007, FIELDS VIROLOGY, P2603; Klein G, 2010, BIOCHEM BIOPH RES CO, V396, P67, DOI 10.1016/j.bbrc.2010.02.146; Kondo S, 2006, CANCER RES, V66, P9870, DOI 10.1158/0008-5472.CAN-06-1679; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Larbi A, 2010, J LEUKOCYTE BIOL, V87, P265, DOI 10.1189/jlb.0509304; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Lazar V, 1999, J CLIN ENDOCR METAB, V84, P3228, DOI 10.1210/jc.84.9.3228; MAGNANI M, 1992, BIOCHEM J, V285, P193, DOI 10.1042/bj2850193; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yenamandra SP, 2010, CELL MOL LIFE SCI, V67, P4249, DOI 10.1007/s00018-010-0441-4; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yurchenko M., 2011, Experimental Oncology, V33, P9	30	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42072	10.1371/journal.pone.0042072	http://dx.doi.org/10.1371/journal.pone.0042072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848707	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200156
J	Kim, S; Shin, EJ; Hahm, JH; Park, PJ; Hwang, JE; Paik, YK				Kim, Sunhee; Shin, E-Jin; Hahm, Jeong-Hoon; Park, Pil-Jong; Hwang, Ji-Eun; Paik, Young-Ki			PDHK-2 Deficiency Is Associated with Attenuation of Lipase-Mediated Fat Consumption for the Increased Survival of Caenorhabditis elegans Dauers	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE-4; LIVED DAF-2 MUTANTS; GENE-EXPRESSION; C-ELEGANS; LIFE-SPAN; SKELETAL-MUSCLE; METABOLISM; LONGEVITY; LONG; RESTRICTION	In Caenorhabditis elegans, slow fat consumption has been suggested to contribute to the extension of the survival rate during nutritionally adverse conditions. Here, we investigated the potential role of pyruvate dehydrogenase kinase (PDHK)-2, the C. elegans homolog of mammalian PDK, effects on fat metabolism under nutritional conditions. PDHK-2 was expressed at low levels under well-fed conditions but was highly induced during long-term starvation and in the dauer state. This increase in pdhk-2 expression was regulated by both DAF-16 and NHR-49. Dauer-specific induction of PDHK-2 was abolished upon entry into the post-dauer stage. Interestingly, in the long-term dauer state, stored fat levels were higher in daf-2(e1370); pdhk-2 double mutants than in daf-2(e1370), suggesting a positive relationship between PDHK-2 activity and fat consumption. PDHK-2 deficiency has been shown to lead to greater preservation of residual fats, which would be predicted to contribute to survival during the dauer state. A test of this prediction showed that the survival rates of daf-2(e1370); pdhk-2(tm3075) and daf-2(e1370); pdhk-2(tm3086) double mutants were higher than that of daf-2(e1370), suggesting that loss of either the ATP-binding domain (tm3075) or branched chain keto-acid dehydrogenase kinase domain (tm3086) of PDHK-2 leads to reduced fat consumption and thus favors increased dauer survival. This attenuated fat consumption in the long-term dauer state of C. elegans daf-2 (e1370); pdhk-2 mutants was associated with concomitant down-regulation of the lipases ATGL (adipose triglyceride lipase), HSL (hormone-sensitive lipase), and C07E3.9 (phospholipase). In contrast, PDHK-2 overexpression in wild-type starved worms induced lipase expression and promoted abnormal dauer formation. Thus, we propose that PDHK-2 serves as a molecular bridge, connecting fat metabolism and survival under nutritionally adverse conditions in C. elegans.	[Kim, Sunhee; Shin, E-Jin; Hahm, Jeong-Hoon; Park, Pil-Jong; Hwang, Ji-Eun; Paik, Young-Ki] Yonsei Univ, Dept Biochem & Integrated Om Biomed Sci, World Class Univ Program, Coll Life Sci & Biotechnol,Yonsei Proteome Res Ct, Seoul 120749, South Korea	Yonsei University	Kim, S (corresponding author), Yonsei Univ, Dept Biochem & Integrated Om Biomed Sci, World Class Univ Program, Coll Life Sci & Biotechnol,Yonsei Proteome Res Ct, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr			National Research Foundation of Korea (NRF) [2011-0028112]; WCU Program [R31-2008-000-10086-0]; Korean government (MEST); National Project for Personalized Genomic Medicine [A111218-11-CP01]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); WCU Program; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Project for Personalized Genomic Medicine	This study was supported by the National Research Foundation of Korea (NRF) grant (No. 2011-0028112 to YKP) and WCU Program (R31-2008-000-10086-0) funded by the Korean government (MEST), and the National Project for Personalized Genomic Medicine (A111218-11-CP01 to YKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2008, IUBMB LIFE, V60, P315, DOI 10.1002/iub.66; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Braeckman, 2009, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.146.1; Braeckman BP, 2001, MECH AGEING DEV, V122, P673, DOI 10.1016/S0047-6374(01)00222-6; BRENNER S, 1974, GENETICS, V77, P71; Burnell AM, 2005, EXP GERONTOL, V40, P850, DOI 10.1016/j.exger.2005.09.006; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Holt SJ, 2003, MECH AGEING DEV, V124, P779, DOI 10.1016/S0047-6374(03)00132-5; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Kell A, 2007, FREE RADICAL BIO MED, V43, P1560, DOI 10.1016/j.freeradbiomed.2007.08.025; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kondo Noriaki, 2004, Rinsho Byori, V52, P259; Kwon HS, 2004, ADV ENZYME REGUL, V44, P109, DOI 10.1016/j.advenzreg.2003.11.020; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Lee J, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.022665; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; ORIORDAN VB, 1989, COMP BIOCHEM PHYS B, V92, P233, DOI 10.1016/0305-0491(89)90271-X; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Riddle DL, 1997, C ELEGANS, P739; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Xu JX, 2006, BIOCHEM BIOPH RES CO, V344, P827, DOI 10.1016/j.bbrc.2006.03.211	41	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41755	10.1371/journal.pone.0041755	http://dx.doi.org/10.1371/journal.pone.0041755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848591	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200100
J	Luke-Glaser, S; Luke, B				Luke-Glaser, Sarah; Luke, Brian			The Mph1 Helicase Can Promote Telomere Uncapping and Premature Senescence in Budding Yeast	PLOS ONE			English	Article							BREAK-INDUCED REPLICATION; DNA-REPAIR; MAINTENANCE; PATHWAY; FANCM; GENE; CORE; ELONGATION; PROTECTION; RESISTANCE	Double strand breaks (DSBs) can be repaired via either Non-Homologous End Joining (NHEJ) or Homology directed Repair (HR). Telomeres, which resemble DSBs, are refractory to repair events in order to prevent chromosome end fusions and genomic instability. In some rare instances telomeres engage in Break-Induced Replication (BIR), a type of HR, in order to maintain telomere length in the absence of the enzyme telomerase. Here we have investigated how the yeast helicase, Mph1, affects DNA repair at both DSBs and telomeres. We have found that overexpressed Mph1 strongly inhibits BIR at internal DSBs however allows it to proceed at telomeres. Furthermore, while overexpressed Mph1 potently inhibits NHEJ at telomeres it has no effect on NHEJ at DSBs within the chromosome. At telomeres Mph1 is able to promote telomere uncapping and the accumulation of ssDNA, which results in premature senescence in the absence of telomerase. We propose that Mph1 is able to direct repair towards HR (thereby inhibiting NHEJ) at telomeres by remodeling them into a nuclease-sensitive structure, which promotes the accumulation of a recombinogenic ssDNA intermediate. We thus put forward that Mph1 is a double-edge sword at the telomere, it prevents NHEJ, but promotes senescence in cells with dysfunctional telomeres by increasing the levels of ssDNA.	[Luke-Glaser, Sarah; Luke, Brian] DKFZ ZMBH Allianz, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Luke-Glaser, S (corresponding author), DKFZ ZMBH Allianz, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany.	b.luke@zmbh.uni-heidelberg.de; s.luke-glaser@zmbh.uni-heidelberg.de		Luke, Brian/0000-0002-1648-5511	EMBO fellowship; Netzwerk Alterns-Forschung; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg	EMBO fellowship(European Molecular Biology Organization (EMBO)); Netzwerk Alterns-Forschung; Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg	S.L.-G. is supported by a long term EMBO fellowship. This work was supported by the Netzwerk Alterns-Forschung, which is funded from the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Banerjee S, 2008, J CELL BIOL, V181, P1083, DOI 10.1083/jcb.200711146; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Deshpande AM, 2011, MOL CELL BIOL, V31, P1637, DOI 10.1128/MCB.00144-10; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Gari K, 2008, P NATL ACAD SCI USA, V105, P16107, DOI 10.1073/pnas.0804777105; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Kang YH, 2009, J BIOL CHEM, V284, P10376, DOI 10.1074/jbc.M808894200; Kao WH, 2011, J INVEST DERMATOL, V131, P2139, DOI 10.1038/jid.2011.181; Kee Y, 2009, GENE DEV, V23, P555, DOI 10.1101/gad.1761309; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Luke-Glaser S, 2010, EMBO J, V29, P795, DOI 10.1038/emboj.2009.371; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Lydeard JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000973; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pobiega S, 2010, GENE DEV, V24, P720, DOI 10.1101/gad.571510; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Scheller J, 2000, GENETICS, V155, P1069; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; Wu X, 2012, TRANSGENIC RES; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	41	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42028	10.1371/journal.pone.0042028	http://dx.doi.org/10.1371/journal.pone.0042028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848695	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200148
J	Marchetti, A; Del Grammastro, M; Filice, G; Felicioni, L; Rossi, G; Graziano, P; Sartori, G; Leone, A; Malatesta, S; Iacono, M; Guetti, L; Viola, P; Mucilli, F; Cuccurullo, F; Buttitta, F				Marchetti, Antonio; Del Grammastro, Maela; Filice, Giampaolo; Felicioni, Lara; Rossi, Giulio; Graziano, Paolo; Sartori, Giuliana; Leone, Alvaro; Malatesta, Sara; Iacono, Michele; Guetti, Luigi; Viola, Patrizia; Mucilli, Felice; Cuccurullo, Franco; Buttitta, Fiamma			Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR-RECEPTOR; GEFITINIB; CHEMOTHERAPY; ANTIBODIES; INHIBITORS; ERLOTINIB; FEATURES; IMPACT	Microdeletions at exon 19 are the most frequent genetic alterations affecting the Epidermal Growth Factor Receptor (EGFR) gene in non-small cell lung cancer (NSCLC) and they are strongly associated with response to treatment with tyrosine kinase inhibitors. A series of 116 NSCLC DNA samples investigated by Sanger Sequencing (SS), including 106 samples carrying exon 19 EGFR deletions and 10 without deletions (control samples), were subjected to deep next generation sequencing (NGS). All samples with deletions at SS showed deletions with NGS. No deletions were seen in control cases. In 93 (88%) cases, deletions detected by NGS were exactly corresponding to those identified by SS. In 13 cases (12%) NGS resolved deletions not accurately characterized by SS. In 21 (20%) cases the NGS showed presence of complex (double/multiple) frameshift deletions producing a net in-frame change. In 5 of these cases the SS could not define the exact sequence of mutant alleles, in the other 16 cases the results obtained by SS were conventionally considered as deletions plus insertions. Different interpretative hypotheses for complex mutations are discussed. In 46 (43%) tumors deep NGS showed, for the first time to our knowledge, subpopulations of DNA molecules carrying EGFR deletions different from the main one. Each of these subpopulations accounted for 0.1% to 17% of the genomic DNA in the different tumors investigated. Our findings suggest that a region in exon 19 is highly unstable in a large proportion of patients carrying EGFR deletions. As a corollary to this study, NGS data were compared with those obtained by immunohistochemistry using the 6B6 anti-mutant EGFR antibody. The immunoreaction was E746-A750del specific. In conclusion, NGS analysis of EGFR exon 19 in NSCLCs allowed us to formulate a new interpretative hypothesis for complex mutations and revealed the presence of subpopulations of deletions with potential pathogenetic and clinical impact.	[Marchetti, Antonio; Del Grammastro, Maela; Filice, Giampaolo; Felicioni, Lara; Malatesta, Sara; Viola, Patrizia; Cuccurullo, Franco; Buttitta, Fiamma] Univ Fdn, Ctr Excellence Aging, Ctr Predict Mol Med, Chieti, Italy; [Rossi, Giulio; Sartori, Giuliana] Azienda Osped Univ Policlin Modena, Anat Pathol Unit, Modena, Italy; [Graziano, Paolo; Leone, Alvaro] San Camillo Forlanini Hosp, Anat Pathol Unit, Rome, Italy; [Iacono, Michele] Appl Sci Roche Diagnost, Monza, Italy; [Guetti, Luigi; Mucilli, Felice] Univ G dAnnunzio, Dept Surg, Chieti, Italy; [Buttitta, Fiamma] Univ Fdn, Oncol & Cardiovasc Mol Med Unit, Chieti, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Azienda Ospedaliera San Camillo-Forlanini; G d'Annunzio University of Chieti-Pescara	Marchetti, A (corresponding author), Univ Fdn, Ctr Excellence Aging, Ctr Predict Mol Med, Chieti, Italy.	amarchetti@unich.it; fbuttitta@unich.it	leone, alvaro/AAQ-7051-2020; Graziano, Paolo/AAC-9802-2022; Sartori, Giuliana/AAB-2226-2021; Rossi, Giulio/K-6217-2016; Leone, Alvaro/K-6410-2016; Rossi, Antonio/K-7054-2016	Graziano, Paolo/0000-0001-7066-7896; Sartori, Giuliana/0000-0002-2726-1978; Rossi, Giulio/0000-0001-8855-1218; Leone, Alvaro/0000-0003-3815-9052; viola, patrizia/0000-0002-2869-3908; Rossi, Antonio/0000-0003-3295-0345	Italian Ministry of University and Research (MIUR); Ministry of Health	Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health	This work was supported in part by the Italian Ministry of University and Research (MIUR) and Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; De Grassi A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000275; Gu D, 2007, HUM MUTAT, V28, P760, DOI 10.1002/humu.20512; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Lee DH, 2010, CLIN CANCER RES, V16, P1307, DOI 10.1158/1078-0432.CCR-09-1903; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marchetti A, 2006, NEW ENGL J MED, V354, P526; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Penzel R, 2011, VIRCHOWS ARCH, V458, P95, DOI 10.1007/s00428-010-1000-y; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Rosell R, 2007, NEW ENGL J MED, V361, P958; Sakurada A, 2006, CLIN LUNG CANCER, V7, pS138, DOI 10.3816/CLC.2006.s.005; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Simonetti S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-135; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Yamamoto H, 2009, LUNG CANCER, V63, P315, DOI 10.1016/j.lungcan.2008.06.021; Yokoyama T, 2006, CANCER SCI, V97, P753, DOI 10.1111/j.1349-7006.2006.00233.x; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739	32	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42164	10.1371/journal.pone.0042164	http://dx.doi.org/10.1371/journal.pone.0042164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848739	Green Submitted, Green Published, gold			2022-12-27	WOS:000306950200177
J	Niederstatter, H; Rampl, G; Erhart, D; Pitterl, F; Oberacher, H; Neuhuber, F; Hausner, I; Gassner, C; Schennach, H; Berger, B; Parson, W				Niederstaetter, Harald; Rampl, Gerhard; Erhart, Daniel; Pitterl, Florian; Oberacher, Herbert; Neuhuber, Franz; Hausner, Isolde; Gassner, Christoph; Schennach, Harald; Berger, Burkhard; Parson, Walther			Pasture Names with Romance and Slavic Roots Facilitate Dissection of Y Chromosome Variation in an Exclusively German-Speaking Alpine Region	PLOS ONE			English	Article							MULTIPLEX PCR; REFERENCE DATABASE; HAPLOGROUP R1B; GENETIC LEGACY; POPULATION; DIFFERENTIATION; RESOLUTION; DIVERSITY; SNPS; PHYLOGEOGRAPHY	The small alpine district of East Tyrol (Austria) has an exceptional demographic history. It was contemporaneously inhabited by members of the Romance, the Slavic and the Germanic language groups for centuries. Since the Late Middle Ages, however, the population of the principally agrarian-oriented area is solely Germanic speaking. Historic facts about East Tyrol's colonization are rare, but spatial density-distribution analysis based on the etymology of place-names has facilitated accurate spatial mapping of the various language groups' former settlement regions. To test for present-day Y chromosome population substructure, molecular genetic data were compared to the information attained by the linguistic analysis of pasture names. The linguistic data were used for subdividing East Tyrol into two regions of former Romance (A) and Slavic (B) settlement. Samples from 270 East Tyrolean men were genotyped for 17 Y-chromosomal microsatellites (Y-STRs) and 27 single nucleotide polymorphisms (Y-SNPs). Analysis of the probands' surnames revealed no evidence for spatial genetic structuring. Also, spatial autocorrelation analysis did not indicate significant correlation between genetic (Y-STR haplotypes) and geographic distance. Haplogroup R-M17 chromosomes, however, were absent in region A, but constituted one of the most frequent haplogroups in region B. The R-M343 (R1b) clade showed a marked and complementary frequency distribution pattern in these two regions. To further test East Tyrol's modern Y-chromosomal landscape for geographic patterning attributable to the early history of settlement in this alpine area, principal coordinates analysis was performed. The Y-STR haplotypes from region A clearly clustered with those of Romance reference populations and the samples from region B matched best with Germanic speaking reference populations. The combined use of onomastic and molecular genetic data revealed and mapped the marked structuring of the distribution of Y chromosomes in an alpine region that has been culturally homogeneous for centuries.	[Niederstaetter, Harald; Erhart, Daniel; Pitterl, Florian; Oberacher, Herbert; Berger, Burkhard; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria; [Rampl, Gerhard; Hausner, Isolde] Austrian Acad Sci, Inst Lexicog Austrian Dialects & Names, A-1010 Vienna, Austria; [Neuhuber, Franz] Salzburg Univ, Inst Legal Med, A-5020 Salzburg, Austria; [Gassner, Christoph; Schennach, Harald] Cent Inst Blood Transfus, Innsbruck, Austria; [Gassner, Christoph; Schennach, Harald] Dept Immunol, Innsbruck, Austria; [Gassner, Christoph] SRC, Blood Transfus Serv Zurich, Schlieren, Switzerland	Medical University of Innsbruck; Austrian Academy of Sciences; Salzburg University	Niederstatter, H (corresponding author), Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria.	burkhard.berger@i-med.ac.at	Parson, Walther/AAD-6845-2020; Gassner, Christoph/B-2171-2012	Parson, Walther/0000-0002-5692-2392; Oberacher, Herbert/0000-0002-0963-8268	Austrian Academy of Sciences; Leopold Franzens University of Innsbruck	Austrian Academy of Sciences; Leopold Franzens University of Innsbruck	This work was financially supported by the grants "ALPKULTUR - cultural historical documentation of toponyms in the alpine area" and "High-Resolution Analysis of Y-chromosome Variability in Selected Regions of the Tyrolean Alps (Austria): Influences of Topology and Demographic History on the Genetic Differentiation" within the "Alpine Research Programme" of the Austrian Academy of Sciences. DE received a scholarship from the Leopold Franzens University of Innsbruck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel O, 1986, GESCH LANGOBARDEN; Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anreiter P., 2009, GEMEINDENAMEN TIROLS, V17; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Benjamini Y, 2001, ANN STAT, V29, P1165; Berger B, 2002, J CHROMATOGR B, V782, P89, DOI 10.1016/S1570-0232(02)00694-3; Berger B, 2005, INT J LEGAL MED, V119, P241, DOI 10.1007/s00414-005-0546-8; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Brandstatter A, 2004, INT J LEGAL MED, V118, P47, DOI 10.1007/s00414-003-0418-z; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Brion M, 2005, ELECTROPHORESIS, V26, P4411, DOI 10.1002/elps.200500293; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; de Knijff P, 2000, AM J HUM GENET, V67, P1055; De Smith M.J., 2007, GEOSPATIAL ANAL COMP; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferri G, 2009, FORENSIC SCI INT-GEN, V3, pE31, DOI 10.1016/j.fsigen.2008.05.004; FINSTERWALDER Karl, 1990, TIROLER FAMILIENNAME; Gaibar M, 2010, ANN HUM BIOL, V37, P254, DOI 10.3109/03014460903341851; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; Gonzalez-Neira A, 2000, FORENSIC SCI INT, V110, P117, DOI 10.1016/S0379-0738(00)00156-0; Grskovic B, 2011, MOL BIOL REP, V38, P2203, DOI 10.1007/s11033-010-0349-y; Gusmao L, 2005, HUM MUTAT, V26, P520, DOI 10.1002/humu.20254; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Helczmanovszki H, 1979, EUROPEAN DEMOGRAPHY, P77; Hornung M, 1964, MUNDARTKUNDE OSTTIRO; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; Kittler R, 2003, EUR J HUM GENET, V11, P304, DOI 10.1038/sj.ejhg.5200960; Larmuseau MHD, 2012, EUR J HUM GENET, V20, P434, DOI 10.1038/ejhg.2011.218; Larmuseau MHD, 2011, FORENSIC SCI INT-GEN, V5, P95, DOI 10.1016/j.fsigen.2010.08.020; Mantl E, 1997, SOZIAL WIRTSCHAFTSHI, V23; Martinez-Cruz Begona, 2011, Investig Genet, V2, P13, DOI 10.1186/2041-2223-2-13; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Myres NM, 2007, CROAT MED J, V50, P239; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Niederstatter H, 2004, INT J LEGAL MED, V120, P255; Niederstatter H, 2008, FORENS SCI INT-GEN S, V1, P226, DOI 10.1016/j.fsigss.2007.10.158; Oberacher H, 2005, ANAL CHEM, V77, P4999, DOI 10.1021/ac050399f; Oberacher H, 2006, ANAL CHEM, V78, P7816, DOI 10.1021/ac061210i; Onofri V, 2006, FORENSIC SCI INT, V157, P23, DOI 10.1016/j.forsciint.2005.03.014; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pizzinini M, 1974, OSTTIROL BEZIRK LIEN; Popa LO, 2005, J GENET, V84, P303, DOI 10.1007/BF02715800; Rampl G, 2007, ONF, V35, P111; Roewer L, 2001, FORENSIC SCI INT, V118, P106, DOI 10.1016/S0379-0738(00)00478-3; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Rozen S, 2000, Methods Mol Biol, V132, P365; Sachs L, 2002, ANGEW STAT, P183; Sanchez JJ, 2003, FORENSIC SCI INT, V137, P74, DOI 10.1016/S0379-0738(03)00299-8; Sanchez JJ, 2006, NAT PROTOC, V1, P1370, DOI 10.1038/nprot.2006.247; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sims Lynn M, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9469; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vallone PM, 2004, J FORENSIC SCI, V49, P723; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Videsott P, 2001, VOX ROMANICA, V2001, P25; Walde E, 2005, SPURENSUCHE3 SCHNABE, P63; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017; Wolanska-Nowak P, 2009, FORENSIC SCI INT-GEN, V4, pE43, DOI 10.1016/j.fsigen.2009.04.009; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	82	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41885	10.1371/journal.pone.0041885	http://dx.doi.org/10.1371/journal.pone.0041885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848647	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200122
J	Yamada, T; Hara, K; Kadowaki, T				Yamada, Tomohide; Hara, Kazuo; Kadowaki, Takashi			Association of Adenovirus 36 Infection with Obesity and Metabolic Markers in Humans: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							WEIGHT-GAIN; ADIPOSITY; SEROPOSITIVITY; LIVER	Background: Several studies have shown that Adenovirus 36 (Ad36) influences the risk of obesity in humans. Clarifying the relationship between Ad36 infection and obesity could lead to more effective approaches for the management of obesity. The objective of this study was to conduct a meta-analysis to confirm the influence of Ad36 infection on obesity and metabolic markers. Methodology/Principal Findings: We searched MEDLINE and the Cochrane Library for pertinent articles (including their references) published between 1951 and April 22, 2012. Only English language reports of original observational studies were included in this meta-analysis. Data extraction was performed independently by two reviewers. Weighted mean differences (WMDs) and pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated using the random effects model. Of 237 potentially relevant studies, 10 cross-sectional studies (n = 2,870) conformed to the selection criteria. Pooled analysis showed that the WMD for BMI of Ad36 infection compared with non-infection was 3.19 (95% CI 1.44-4.93; P<0.001). Sensitivity analysis restricted to studies of adults yielded a similar result of 3.18 (95% CI 0.78-5.57; P = 0.009). The increased risk of obesity associated with Ad36 infection was also significant (OR: 1.9; 95% CI: 1.01-3.56; P = 0.047). No significant differences were found in relation to total cholesterol (P = 0.83), triglycerides (P = 0.64), HDL (P = 0.69), blood glucose (P = 0.08), waist circumstance (P = 0.09), and systolic blood pressure (P = 0.25). Conclusion/Significance: Ad36 infection was associated with the risk of obesity and weight gain, but was not associated with abnormal metabolic markers including waist circumstance. It suggests that Ad36 infection is more associated with accumulation of subcutaneous fat than that of visceral fat. The relationship between Ad36 and obesity should be assessed by further studies, including well-designed prospective studies, to gain a better understanding of whether Ad36 plays a role in the etiology of human obesity.	[Yamada, Tomohide; Hara, Kazuo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138654, Japan	University of Tokyo	Yamada, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138654, Japan.	thara-tky@umin.ac.jp						Atkinson RL, 2010, INT J PEDIATR OBES, V5, P157, DOI 10.3109/17477160903111789; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Broderick MP, 2010, INT J OBESITY, V34, P302, DOI 10.1038/ijo.2009.224; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Dhurandhar NV, 2001, INT J OBESITY, V25, P990, DOI 10.1038/sj.ijo.0801668; Dhurandhar NV, 2002, J NUTR, V132, P3155, DOI 10.1093/jn/131.10.3155; Dhurandhar NV, 2000, INT J OBESITY, V24, P989, DOI 10.1038/sj.ijo.0801319; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; FERNSTROM MH, 1989, ANN NY ACAD SCI, V575, P31; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; Goossens VJ, 2011, OBESITY, V19, P220, DOI 10.1038/oby.2009.452; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOWLETT TA, 1985, CLIN ENDOCRINOL META, V14, P911, DOI 10.1016/S0300-595X(85)80083-9; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Na HN, 2012, INT J OBESITY, V36, P281, DOI 10.1038/ijo.2011.102; Na HN, 2010, INT J OBESITY, V34, P89, DOI 10.1038/ijo.2009.207; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pasarica M, 2008, STEM CELLS, V26, P969, DOI 10.1634/stemcells.2007-0868; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Rathod MA, 2009, OBESITY, V17, P657, DOI 10.1038/oby.2008.630; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Trovato GM, 2012, DIGEST DIS SCI, V57, P535, DOI 10.1007/s10620-011-1903-8; Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x; Vangipuram SD, 2007, INT J OBESITY, V31, P87, DOI 10.1038/sj.ijo.0803366; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WHO, FACT SHEET OV OB	31	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e42031	10.1371/journal.pone.0042031	http://dx.doi.org/10.1371/journal.pone.0042031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848697	Green Published, gold, Green Submitted			2022-12-27	WOS:000306806600162
J	Carafoli, F; Hussain, SA; Hohenester, E				Carafoli, Federico; Hussain, Sadaf-Ahmahni; Hohenester, Erhard			Crystal Structures of the Network-Forming Short-Arm Tips of the Laminin beta 1 and gamma 1 Chains	PLOS ONE			English	Article							N-TERMINAL DOMAINS; CONGENITAL NEPHROSIS; MESANGIAL SCLEROSIS; MUSCULAR-DYSTROPHY; LE MODULES; BINDING; MUTATION; ANATOMY; COMPLEX; SYSTEM	The heterotrimeric laminins are a defining component of basement membranes and essential for tissue formation and function in all animals. The three short arms of the cross-shaped laminin molecule are composed of one chain each and their tips mediate the formation of a polymeric network. The structural basis for laminin polymerisation is unknown. We have determined crystal structures of the short-arm tips of the mouse laminin beta 1 and gamma 1 chains, which are grossly similar to the previously determined structure of the corresponding alpha 5 chain region. The short-arm tips consist of a laminin N-terminal (LN) domain that is attached like the head of a flower to a rod-like stem formed by tandem laminin-type epidermal growth factor-like (LE) domains. The LN domain is a beta-sandwich with elaborate loop regions that differ between chains. The gamma 1 LN domain uniquely contains a calcium binding site. The LE domains have little regular structure and are stabilised by cysteines that are disulphide-linked 1-3, 2-4, 5-6 and 7-8 in all chains. The LN surface is not conserved across the alpha, beta and gamma chains, but within each chain subfamily there is a striking concentration of conserved residues on one face of the beta-sandwich, while the opposite face invariably is shielded by glycans. We propose that the extensive conserved patches on the beta and gamma LN domains mediate the binding of these two chains to each other, and that the alpha chain LN domain subsequently binds to the composite beta-gamma surface. Mutations in the laminin beta 2 LN domain causing Pierson syndrome are likely to impair the folding of the beta 2 chain or its ability to form network interactions.	[Carafoli, Federico; Hussain, Sadaf-Ahmahni; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London	Carafoli, F (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	e.hohenester@imperial.ac.uk			Wellcome Trust Senior Research Fellowship in Basic Biomedical Science [083942/Z/07/Z]; BBSRC [BB/D524840/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524840/1] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship in Basic Biomedical Science(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science awarded to EH (083942/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YM, 2011, J AM SOC NEPHROL, V22, P849, DOI 10.1681/ASN.2010060632; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Ettner N, 1998, FEBS LETT, V430, P217, DOI 10.1016/S0014-5793(98)00601-2; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Kalkhof S, 2010, BIOCHEMISTRY-US, V49, P8359, DOI 10.1021/bi101187f; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Odenthal U, 2004, J BIOL CHEM, V279, P44504, DOI 10.1074/jbc.M402455200; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Patton BL, 2008, J CELL SCI, V121, P1593, DOI 10.1242/jcs.015354; PAULSSON M, 1988, J BIOL CHEM, V263, P5425; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SCHITTNY JC, 1990, J CELL BIOL, V110, P825, DOI 10.1083/jcb.110.3.825; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suh JH, 2011, P NATL ACAD SCI USA, V108, P15348, DOI 10.1073/pnas.1108269108; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zenker M, 2004, AM J MED GENET A, V130A, P138, DOI 10.1002/ajmg.a.30310	44	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42473	10.1371/journal.pone.0042473	http://dx.doi.org/10.1371/journal.pone.0042473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860131	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600105
J	Ciganda, M; Prohaska, K; Hellman, K; Williams, N				Ciganda, Martin; Prohaska, Kimberly; Hellman, Kristina; Williams, Noreen			A Novel Association between Two Trypanosome-Specific Factors and the Conserved L5-5S rRNA Complex	PLOS ONE			English	Article							C-TERMINAL REGION; PROTEIN L5; BINDING-PROTEINS; RIBONUCLEOPROTEIN COMPLEX; AMINO-ACIDS; BRUCEI; LOCALIZATION; L1; BIOGENESIS; OOGENESIS	P34 and P37 are two previously identified RNA binding proteins in the flagellate protozoan Trypanosoma brucei. RNA interference studies have determined that the proteins are involved in and essential for ribosome biogenesis. The proteins interact with the 5S rRNA with nearly identical binding characteristics. We have shown that this interaction is achieved mainly through the LoopA region of the RNA, but P34 and P37 also protect the L5 binding site located on LoopC. We now provide evidence to show that these factors form a novel pre-ribosomal particle through interactions with both 5S rRNA and the L5 ribosomal protein. Further in silico and in vitro analysis of T. brucei L5 indicates a lower affinity for 5S rRNA than expected, based on other eukaryotic L5 proteins. We hypothesize that P34 and P37 complement L5 and bridge the interaction with 5S rRNA, stabilizing it and aiding in the early steps of ribosome biogenesis.	[Ciganda, Martin] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ciganda, M (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	nw1@buffalo.edu			National Institutes of Health [GM092719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM092719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LA, 1991, DEV BIOL, V144, P129, DOI 10.1016/0012-1606(91)90485-L; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030029; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Claussen M, 1999, J BIOL CHEM, V274, P33951, DOI 10.1074/jbc.274.48.33951; DESHMUKH M, 1993, MOL CELL BIOL, V13, P2835, DOI 10.1128/MCB.13.5.2835; DESHMUKH M, 1995, J BIOL CHEM, V270, P30148; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; DiNitto JP, 2001, BIOCHEMISTRY-US, V40, P12645, DOI 10.1021/bi011439m; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Hellman KM, 2006, CHARACTERIZATION PRO; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Hellman KM, 2007, EUKARYOT CELL, V6, P1766, DOI 10.1128/EC.00119-07; Korepanov AP, 2007, J MOL BIOL, V366, P1199, DOI 10.1016/j.jmb.2006.11.097; Lin EL, 2001, NUCLEIC ACIDS RES, V29, P2510, DOI 10.1093/nar/29.12.2510; LUEHRSEN KR, 1981, P NATL ACAD SCI-BIOL, V78, P2150, DOI 10.1073/pnas.78.4.2150; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; MICHAELI S, 1990, MOL BIOCHEM PARASIT, V41, P7, DOI 10.1016/0166-6851(90)90091-Y; Moradi H, 2008, MOL GENET GENOMICS, V280, P337, DOI 10.1007/s00438-008-0369-7; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PICARD B, 1980, EUR J BIOCHEM, V109, P359, DOI 10.1111/j.1432-1033.1980.tb04802.x; Pittman RH, 1999, J BIOL CHEM, V274, P33198, DOI 10.1074/jbc.274.47.33198; Pitula J, 2002, BIOCHEM BIOPH RES CO, V290, P569, DOI 10.1006/bbrc.2001.6226; Pitula JS, 2002, MOL BIOCHEM PARASIT, V122, P81, DOI 10.1016/S0166-6851(02)00076-2; Prohaska K, 2009, EUKARYOT CELL, V8, P77; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Rout MP, 2001, J BIOL CHEM, V276, P38261; Scripture JB, 2011, BIOCHEMISTRY-US, V50, P3827, DOI 10.1021/bi200286e; SCRIPTURE JB, 1995, J BIOL CHEM, V270, P27358, DOI 10.1074/jbc.270.45.27358; STEITZ JA, 1988, J CELL BIOL, V106, P545, DOI 10.1083/jcb.106.3.545; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wong L, 1993, P NATL ACAD SCI USA, V90, P5428; WORMINGTON WM, 1983, DEV BIOL, V99, P248, DOI 10.1016/0012-1606(83)90273-7; YAGUCHI M, 1984, EUR J BIOCHEM, V139, P451, DOI 10.1111/j.1432-1033.1984.tb08026.x; YEH LCC, 1995, J MOL BIOL, V246, P295, DOI 10.1006/jmbi.1994.0085; Zhang J, 1998, MOL BIOCHEM PARASIT, V92, P79, DOI 10.1016/S0166-6851(97)00228-4; Zhang J, 1997, MOL BIOCHEM PARASIT, V87, P145, DOI 10.1016/S0166-6851(97)00060-1; ZIMMERN D, 1977, CELL, V11, P455, DOI 10.1016/0092-8674(77)90064-2	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41398	10.1371/journal.pone.0041398	http://dx.doi.org/10.1371/journal.pone.0041398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859981	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600025
J	Griffin, PE; Roddam, LF; Belessis, YC; Strachan, R; Beggs, S; Jaffe, A; Cooley, MA				Griffin, Phoebe E.; Roddam, Louise F.; Belessis, Yvonne C.; Strachan, Roxanne; Beggs, Sean; Jaffe, Adam; Cooley, Margaret A.			Expression of PPAR gamma and Paraoxonase 2 Correlated with Pseudomonas aeruginosa Infection in Cystic Fibrosis	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; SIGNAL N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; MESSENGER-RNA EXPRESSION; LUNG INFLAMMATION; IMMUNE-RESPONSE; YOUNG-CHILDREN; CELLS; MODEL; IDENTIFICATION; MACROPHAGES	The Pseudomonas aeruginosa quorum sensing signal molecule N-3-oxododecanoyl-L-homoserine lactone (3OC(12)HSL) can inhibit function of the mammalian anti-inflammatory transcription factor peroxisome proliferator activated receptor (PPAR)gamma, and can be degraded by human paraoxonase (PON)2. Because 3OC(12)HSL is detected in lungs of cystic fibrosis (CF) patients infected with P. aeruginosa, we investigated the relationship between P. aeruginosa infection and gene expression of PPAR gamma and PON2 in bronchoalveolar lavage fluid (BALF) of children with CF. Total RNA was extracted from cell pellets of BALF from 43 children aged 6 months-5 years and analyzed by reverse transcription-quantitative real time PCR for gene expression of PPAR gamma, PON2, and P. aeruginosa lasI, the 3OC12HSL synthase. Patients with culture-confirmed P. aeruginosa infection had significantly lower gene expression of PPAR gamma and PON2 than patients without P. aeruginosa infection. All samples that were culture-positive for P. aeruginosa were also positive for lasI expression. There was no significant difference in PPAR gamma or PON2 expression between patients without culture-detectable infection and those with non-Pseudomonal bacterial infection, so reduced expression was specifically associated with P. aeruginosa infection. Expression of both PPAR gamma and PON2 was inversely correlated with neutrophil counts in BALF, but showed no correlation with other variables evaluated. Thus, lower PPAR gamma and PON2 gene expression in the BALF of children with CF is associated specifically with P. aeruginosa infection and neutrophilia. We cannot differentiate whether this is a cause or the effect of P. aeruginosa infection, but propose that the level of expression of these genes may be a marker for susceptibility to early acquisition of P. aeruginosa in children with CF.	[Griffin, Phoebe E.] Menzies Res Inst, Hobart, Tas, Australia; [Griffin, Phoebe E.; Roddam, Louise F.; Beggs, Sean; Cooley, Margaret A.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Belessis, Yvonne C.; Strachan, Roxanne; Jaffe, Adam] Sydney Childrens Hosp, Dept Resp Med, Randwick, NSW, Australia; [Beggs, Sean] Royal Hobart Hosp, Dept Pediat, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; Royal Hobart Hospital	Griffin, PE (corresponding author), Menzies Res Inst, Hobart, Tas, Australia.	Margaret.Cooley@utas.edu.au	Beggs, Sean/J-5621-2013; Roddam, Louise/J-7348-2014; Roddam, Louise F/C-2408-2019	Roddam, Louise F/0000-0002-4152-0681; Griffin, Phoebe/0000-0001-8208-5818; Jaffe, Adam/0000-0002-1963-5415	Australian Cystic Fibrosis Research Trust; Royal Hobart Hospital Research Foundation	Australian Cystic Fibrosis Research Trust; Royal Hobart Hospital Research Foundation	This study was funded by grants from the Australian Cystic Fibrosis Research Trust (www.cysticfibrosis.org.au) and the Royal Hobart Hospital Research Foundation (www.rhhresearchfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson C, 2008, J CYST FIBROS, V7, P68, DOI 10.1016/j.jcf.2007.05.004; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Becker J, 2006, FUND CLIN PHARMACOL, V20, P429, DOI 10.1111/j.1472-8206.2006.00425.x; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Chambers CE, 2005, FEMS MICROBIOL LETT, V244, P297, DOI 10.1016/j.femsle.2005.01.055; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Greene M. E., 1995, Gene Expression, V4, P281; Hall GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023932; Hameed S, 2011, PEDIATR PULM, V46, P747, DOI 10.1002/ppul.21495; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Hotta K, 1999, J GERONTOL A-BIOL, V54, pB183, DOI 10.1093/gerona/54.5.B183; Jackson AD, 2011, THORAX, V66, P674, DOI 10.1136/thoraxjnl-2011-200038; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Jarad N A, 2005, Chron Respir Dis, V2, P133, DOI 10.1191/1479972305cd065oa; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mackness B, 2005, J INTERN MED, V258, P363, DOI 10.1111/j.1365-2796.2005.01554.x; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Mayer ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016246; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Pascual G, 2007, NOVART FDN SYMP, V286, P196; Pascual Gabriel, 2007, Novartis Found Symp, V286, P183; Perez A, 2008, AM J PHYSIOL-LUNG C, V295, pL303, DOI 10.1152/ajplung.90276.2008; Reddy RC, 2008, BLOOD, V112, P4250, DOI 10.1182/blood-2007-12-128967; Ritchie AJ, 2007, IMMUNOL CELL BIOL, V85, P596, DOI 10.1038/sj.icb.7100090; Saadane A, 2006, J ALLERGY CLIN IMMUN, V117, P1163, DOI 10.1016/j.jaci.2006.01.052; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Standiford Theodore J, 2005, Proc Am Thorac Soc, V2, P226, DOI 10.1513/pats.200501-010AC; STOLTZ DA, 2006, AM J PHYSL LUNG CELL; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Takamura T, 2001, EUR J PHARMACOL, V422, P23, DOI 10.1016/S0014-2999(01)01053-6; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Wargo MJ, 2007, FEMS MICROBIOL LETT, V273, P38, DOI 10.1111/j.1574-6968.2007.00773.x; Wilder CN, 2009, INFECT IMMUN, V77, P5631, DOI 10.1128/IAI.00755-09	52	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42241	10.1371/journal.pone.0042241	http://dx.doi.org/10.1371/journal.pone.0042241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860094	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600080
J	Hurt, RA; Brown, SD; Podar, M; Palumbo, AV; Elias, DA				Hurt, Richard A., Jr.; Brown, Steven D.; Podar, Mircea; Palumbo, Anthony V.; Elias, Dwayne A.			Sequencing Intractable DNA to Close Microbial Genomes	PLOS ONE			English	Article							PCR; AMPLIFICATION; METHYLATION; POLYMERASE; PROJECT; PLACE; DGTP; ERA	Advancement in high throughput DNA sequencing technologies has supported a rapid proliferation of microbial genome sequencing projects, providing the genetic blueprint for in-depth studies. Oftentimes, difficult to sequence regions in microbial genomes are ruled "intractable" resulting in a growing number of genomes with sequence gaps deposited in databases. A procedure was developed to sequence such problematic regions in the "non-contiguous finished" Desulfovibrio desulfuricans ND132 genome (6 intractable gaps) and the Desulfovibrio africanus genome (1 intractable gap). The polynucleotides surrounding each gap formed GC rich secondary structures making the regions refractory to amplification and sequencing. Strand-displacing DNA polymerases used in concert with a novel ramped PCR extension cycle supported amplification and closure of all gap regions in both genomes. The developed procedures support accurate gene annotation, and provide a step-wise method that reduces the effort required for genome finishing.	[Hurt, Richard A., Jr.; Brown, Steven D.; Podar, Mircea; Palumbo, Anthony V.; Elias, Dwayne A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Hurt, RA (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.	eliasda@ornl.gov	Elias, Dwayne A/B-5190-2011; Palumbo, Anthony V/A-4764-2011; Elias, Dwayne/GZL-8202-2022; Podar, Mircea/B-7299-2012; Brown, Steven D/A-6792-2011	Elias, Dwayne A/0000-0002-4469-6391; Palumbo, Anthony V/0000-0002-1102-3975; Podar, Mircea/0000-0003-2776-0205; Brown, Steven D/0000-0002-9281-3898	United States Department of Energy under the Subsurface Biogeochemical Research Program (SBR), Office of Biological and Environmental Research, Office of Science. Oak Ridge National Laboratory [DE-AC05-00OR22725]	United States Department of Energy under the Subsurface Biogeochemical Research Program (SBR), Office of Biological and Environmental Research, Office of Science. Oak Ridge National Laboratory	This research was conducted as part of the Oak Ridge National Laboratory Mercury Science Focus Area and was supported by The United States Department of Energy under the Subsurface Biogeochemical Research Program (SBR), Office of Biological and Environmental Research, Office of Science. Oak Ridge National Laboratory is managed by University of Tennessee UT-Battelle LLC for the Department of Energy under Contract No. DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andre P, 1997, GENOME RES, V7, P843, DOI 10.1101/gr.7.8.843; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Brown SD, 2011, J BACTERIOL, V193, P4037, DOI 10.1128/JB.05223-11; Brown SD, 2011, J BACTERIOL, V193, P2078, DOI 10.1128/JB.00170-11; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; DIERICK H, 1993, NUCLEIC ACIDS RES, V21, P4427, DOI 10.1093/nar/21.18.4427; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Gilmour CC, 2011, APPL ENVIRON MICROB, V77, P3938, DOI 10.1128/AEM.02993-10; Hurt RA, 2001, APPL ENVIRON MICROB, V67, P4495, DOI 10.1128/AEM.67.10.4495-4503.2001; Keith JM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh022; Kieleczawa Jan, 2006, J Biomol Tech, V17, P207; Kieleczawa Jan, 2010, J Biomol Tech, V21, P97; Kieleczawa Jan, 2008, J Biomol Tech, V19, P335; Koren S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-457; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Loudig O, 2011, HUM PATHOL; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; MIZUSAWA S, 1986, NUCLEIC ACIDS RES, V14, P1319, DOI 10.1093/nar/14.3.1319; Mount DW, 2007, CSH PROTOC; Musso M, 2006, J MOL DIAGN, V8, P544, DOI 10.2353/jmoldx.2006.060058; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; SEELA F, 1989, NUCLEIC ACIDS RES, V17, P901, DOI 10.1093/nar/17.3.901; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Viswanathan VK, 1999, BIOTECHNIQUES, V27, P508, DOI 10.2144/99273st04; Zane GM, 2010, APPL ENVIRON MICROB, V76, P5500, DOI 10.1128/AEM.00691-10; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	33	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41295	10.1371/journal.pone.0041295	http://dx.doi.org/10.1371/journal.pone.0041295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859974	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600019
J	Ovesna, J; Kucera, L; Vaculova, K; Strymplova, K; Svobodova, I; Milella, L				Ovesna, Jaroslava; Kucera, Ladislav; Vaculova, Katerina; Strymplova, Kamila; Svobodova, Ilona; Milella, Luigi			Validation of the beta-amy1 Transcription Profiling Assay and Selection of Reference Genes Suited for a RT-qPCR Assay in Developing Barley Caryopsis	PLOS ONE			English	Article							INTERNAL CONTROL GENES; REAL-TIME; MESSENGER-RNA; HOUSEKEEPING GENES; BETA-AMYLASE; PCR NORMALIZATION; QUANTITATIVE PCR; QUALITY-CONTROL; EXPRESSION; IDENTIFICATION	Reverse transcription coupled with real-time quantitative PCR (RT-qPCR) is a frequently used method for gene expression profiling. Reference genes (RGs) are commonly employed to normalize gene expression data. A limited information exist on the gene expression and profiling in developing barley caryopsis. Expression stability was assessed by measuring the cycle threshold (Ct) range and applying both the GeNorm (pair-wise comparison of geometric means) and Normfinder (model-based approach) principles for the calculation. Here, we have identified a set of four RGs suitable for studying gene expression in the developing barley caryopsis. These encode the proteins GAPDH, HSP90, HSP70 and ubiquitin. We found a correlation between the frequency of occurrence of a transcript in silico and its suitability as an RG. This set of RGs was tested by comparing the normalized level of beta-amylase (beta-amy1) transcript with directly measured quantities of the BMY1 gene product in the developing barley caryopsis. This panel of genes could be used for other gene expression studies, as well as to optimize beta-amy1 analysis for study of the impact of beta-amy1 expression upon barley end-use quality.	[Ovesna, Jaroslava; Kucera, Ladislav; Vaculova, Katerina; Strymplova, Kamila] Crop Res Inst, Dept Mol Biol, Prague, Czech Republic; [Svobodova, Ilona] Agrotest Fyto Ltd, Kromeriz, Czech Republic; [Milella, Luigi] Univ Basilicata, Dept Biol, I-85100 Potenza, Italy	Czech Crop Research Institute (CRI); Agricultural Research Institute Kromeriz, Ltd; Agrotest Fyto; University of Basilicata	Ovesna, J (corresponding author), Crop Res Inst, Dept Mol Biol, Prague, Czech Republic.	ovesna@vurv.cz	Vaculova, Katerina/C-8366-2012; Milella, Luigi/AAA-4431-2021	Vaculova, Katerina/0000-0001-9533-6890; Milella, Luigi/0000-0002-5874-1237	Czech Science Foundation [521/07/1028]; Ministry of Agriculture [CZ0002700604]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This research was financially supported by the Czech Science Foundation under project no. 521/07/1028 and Ministry of Agriculture CZ0002700604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2004, FEMS MICROBIOL LETT, V240, P105, DOI 10.1016/j.femsle.2004.09.027; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bumann D, 2007, NAT PROTOC, V2, P770, DOI 10.1038/nprot.2007.78; Bustin S. A., 2008, EUR PHARM REV, V4, P18; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Casadei R, 2011, GENE EXPR PATTERNS, V11, P271, DOI 10.1016/j.gep.2011.01.003; Christensen U, 2012, J CEREAL SCI, V55, P69, DOI 10.1016/j.jcs.2011.10.005; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Duke SH, 2009, J AM SOC BREW CHEM, V67, P206, DOI 10.1094/ASBCJ-2009-0629-01; DuPont FM, 1998, PHYSIOL PLANTARUM, V103, P70, DOI 10.1034/j.1399-3054.1998.1030109.x; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Erkkila MJ, 1998, PLANT PHYSIOL, V117, P679, DOI 10.1104/pp.117.2.679; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gur-Dedeoglu B, 2009, ONCOL RES, V17, P353, DOI 10.3727/096504009788428460; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Lapitan NLV, 2009, THEOR APPL GENET, V118, P937, DOI 10.1007/s00122-008-0951-8; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Li ZW, 2005, BIOTECHNIQUES, V38, P872, DOI 10.2144/05386BM05; Ling J, 2011, PLOS ONE, V6; MATHEWSON PR, 1983, J AGR FOOD CHEM, V31, P1322, DOI 10.1021/jf00120a043; Meitao D, 2012, CURR GENET, V1, P13, DOI [10.1007/s00294-011-0361-3, DOI 10.1007/S00294-011-0361-3]; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ovesna J, 2010, BIOLOGIA, V65, P75, DOI 10.2478/s11756-009-0218-0; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Suwabe K, 2008, PLANT BIOTECHNOL-NAR, V25, P413, DOI 10.5511/plantbiotechnology.25.413; Tai HH, 2005, PLANT MOL BIOL, V59, P909, DOI 10.1007/s11103-005-2081-x; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Vandesompele J, 2009, APPL FUNCTIONAL GENO; Vinje MA, 2011, PLANTA, V233, P1001, DOI 10.1007/s00425-011-1348-5; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Yanagawa Y, 2005, JARQ-JPN AGR RES Q, V39, P1; Zel J, 2008, FOOD ANAL METHOD, V1, P61, DOI 10.1007/s12161-008-9016-5	55	26	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41886	10.1371/journal.pone.0041886	http://dx.doi.org/10.1371/journal.pone.0041886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860024	Green Submitted, gold, Green Published			2022-12-27	WOS:000307045600044
J	Spulber, S; Edoff, K; Hong, L; Morisawa, S; Shirahata, S; Ceccatelli, S				Spulber, Stefan; Edoff, Karin; Hong, Lie; Morisawa, Shinkatsu; Shirahata, Sanetaka; Ceccatelli, Sandra			Molecular Hydrogen Reduces LPS-Induced Neuroinflammation and Promotes Recovery from Sickness Behaviour in Mice	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED SICKNESS; DIFFERENT BRAIN-REGIONS; RICH SALINE PROTECTS; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MICROGLIAL CELLS; ALPHA-TOCOPHEROL; INTESTINAL ISCHEMIA/REPERFUSION	Molecular hydrogen has been shown to have neuroprotective effects in mouse models of acute neurodegeneration. The effect was suggested to be mediated by its free-radical scavenger properties. However, it has been shown recently that molecular hydrogen alters gene expression and protein phosphorylation. The aim of this study was to test whether chronic ad libitum consumption of molecular hydrogen-enriched electrochemically reduced water (H-ERW) improves the outcome of lipopolysaccharide (LPS)-induced neuroinflammation. Seven days after the initiation of H-ERW treatment, C57Bl/6 mice received a single injection of LPS (0.33 mg/kg i.p.) or an equivalent volume of vehicle. The LPS-induced sickness behaviour was assessed 2 h after the injection, and recovery was assessed by monitoring the spontaneous locomotor activity in the homecage for 72 h after the administration of LPS. The mice were killed in the acute or recovery phase, and the expression of pro-and antiinflammatory cytokines in the hippocampus was assessed by real-time PCR. We found that molecular hydrogen reduces the LPS-induced sickness behaviour and promotes recovery. These effects are associated with a shift towards anti-inflammatory gene expression profile at baseline (downregulation of TNF-alpha and upregulation of IL-10). In addition, molecular hydrogen increases the amplitude, but shortens the duration and promotes the extinction of neuroinflammation. Consistently, molecular hydrogen modulates the activation and gene expression in a similar fashion in immortalized murine microglia (BV-2 cell line), suggesting that the effects observed in vivo may involve the modulation of microglial activation. Taken together, our data point to the regulation of cytokine expression being an additional critical mechanism underlying the beneficial effects of molecular hydrogen.	[Spulber, Stefan; Edoff, Karin; Hong, Lie; Ceccatelli, Sandra] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Morisawa, Shinkatsu] Nihon Trim Co Ltd, Osaka, Japan; [Shirahata, Sanetaka] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Kyushu, Japan	Karolinska Institutet; Kyushu University	Spulber, S (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	stefan.spulber@ki.se	Spulber, Stefan/J-2989-2012	Spulber, Stefan/0000-0001-8122-6738; Ceccatelli, Sandra/0000-0002-9367-8480	Nihon-Trim CO., Ltd.	Nihon-Trim CO., Ltd.	This work was funded by a research grant provided by Nihon-Trim CO., Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal-Price A, 2001, J NEUROSCI, V21, P6480; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; Berg BM, 2005, J NUTR, V135, P1157, DOI 10.1093/jn/135.5.1157; Berg BM, 2004, BRAIN BEHAV IMMUN, V18, P149, DOI 10.1016/S0889-1591(03)00113-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bonow RH, 2009, PHARMACOGENOMICS J, V9, P116, DOI 10.1038/tpj.2008.15; Cardinal JS, 2010, KIDNEY INT, V77, P101, DOI 10.1038/ki.2009.421; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DISANTO E, 1995, NEUROIMMUNOMODULAT, V2, P149, DOI 10.1159/000096885; Fishkin RJ, 1997, PSYCHOPHARMACOLOGY, V132, P335, DOI 10.1007/s002130050353; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Godbout JP, 2005, J NEUROIMMUNOL, V169, P97, DOI 10.1016/j.jneuroim.2005.08.003; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hennigan A, 2007, BRAIN RES, V1130, P158, DOI 10.1016/j.brainres.2006.10.066; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Innamorato NG, 2009, CURR OPIN NEUROL, V22, P308, DOI 10.1097/WCO.0b013e32832a3225; Itoh T, 2011, BIOCHEM BIOPH RES CO, V411, P143, DOI 10.1016/j.bbrc.2011.06.116; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024; Kerschensteiner M, 2009, NEUROSCIENCE, V158, P1122, DOI 10.1016/j.neuroscience.2008.09.009; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kremlev SG, 2004, J NEUROIMMUNOL, V149, P1, DOI 10.1016/j.jneuroim.2003.11.012; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Laurenzi MA, 2001, NEUROCHEM RES, V26, P1209, DOI 10.1023/A:1013911205494; Li J, 2010, BRAIN RES, V1328, P152, DOI 10.1016/j.brainres.2010.02.046; Lisak RP, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-30; Liu Q, 2010, LIVER INT, V30, P958, DOI 10.1111/j.1478-3231.2010.02254.x; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Lundkvist GB, 2002, NEUROBIOL DIS, V11, P20, DOI 10.1006/nbdi.2002.0536; Mao YF, 2009, BIOCHEM BIOPH RES CO, V381, P602, DOI 10.1016/j.bbrc.2009.02.105; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Nakao A, 2010, J HEART LUNG TRANSPL, V29, P544, DOI 10.1016/j.healun.2009.10.011; Neeley EW, 2011, NEUROSCIENCE, V187, P24, DOI 10.1016/j.neuroscience.2011.03.065; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2011, BIOCH BIOPHYS ACTA; Onishchenko N, 2011, NEUROTOX RES, V19, P452, DOI 10.1007/s12640-010-9200-4; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Ren LQ, 1999, MOL BRAIN RES, V65, P198, DOI 10.1016/S0169-328X(99)00016-9; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Richwine AF, 2008, PSYCHONEUROENDOCRINO, V33, P1369, DOI 10.1016/j.psyneuen.2008.08.003; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shirahata S, 2011, TRENDS FOOD SCI TECH; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sun HM, 2010, CURR NEUROVASC RES, V7, P268, DOI 10.2174/156720210793180819; Thibeault I, 2001, J COMP NEUROL, V434, P461, DOI 10.1002/cne.1187; Tsai CF, 2009, FOOD CHEM TOXICOL, V47, P2031, DOI 10.1016/j.fct.2009.05.021; Veroni C, 2010, MOL CELL NEUROSCI, V45, P234, DOI 10.1016/j.mcn.2010.06.014; Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109; Wolff S, 2009, INTENS CARE MED, V35, P730, DOI 10.1007/s00134-009-1394-7; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu TY, 2011, AAPS J, V13, P1, DOI 10.1208/s12248-010-9239-4; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603	69	50	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42078	10.1371/journal.pone.0042078	http://dx.doi.org/10.1371/journal.pone.0042078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860058	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600059
J	Theis, L; Hosseini, R; Bethge, M				Theis, Lucas; Hosseini, Reshad; Bethge, Matthias			Mixtures of Conditional Gaussian Scale Mixtures Applied to Multiscale Image Representations	PLOS ONE			English	Article							NATURAL IMAGES; STATISTICS	We present a probabilistic model for natural images that is based on mixtures of Gaussian scale mixtures and a simple multiscale representation. We show that it is able to generate images with interesting higher-order correlations when trained on natural images or samples from an occlusion-based model. More importantly, our multiscale model allows for a principled evaluation. While it is easy to generate visually appealing images, we demonstrate that our model also yields the best performance reported to date when evaluated with respect to the cross-entropy rate, a measure tightly linked to the average log-likelihood. The ability to quantitatively evaluate our model differentiates it from other multiscale models, for which evaluation of these kinds of measures is usually intractable.	[Theis, Lucas; Bethge, Matthias] Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Theis, Lucas; Hosseini, Reshad; Bethge, Matthias] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Bethge, Matthias] Bernstein Ctr Computat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Theis, L (corresponding author), Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany.	lucas@tuebingen.mpg.de	Bethge, Matthias/B-1554-2008; Hosseini, Reshad/AAD-8561-2021	Hosseini, Reshad/0000-0002-3669-760X	German Ministry of Education, Science, Research and Technology through the Bernstein award (BMBF) [FKZ: 01GQ0601]; German Research Foundation (DFG) [1527, BE 3848/2-1]	German Ministry of Education, Science, Research and Technology through the Bernstein award (BMBF); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financially supported by the German Ministry of Education, Science, Research and Technology through the Bernstein award (BMBF; FKZ: 01GQ0601) and the German Research Foundation (DFG; priority program 1527, Sachbeihilfe BE 3848/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethge M, 2007, Patent, Patent No. [WO/2009/146933, 2009146933]; Cover T, 2006, ELEMENTS INFORM THEO, P74; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Domke J, 2008, IEEE COMP SOC C COMP, DOI [10.1109/CVPR.2008.4587817, DOI 10.1109/CVPR.2008.4587817]; Gallant JL, 2008, SENSES COMPREHENSIVE, V1, P383; Guerrero-Colon JA, 2008, P 15 IEEE INT C IM P; Gupta AK, 1997, J STAT PLAN INFER, V60, P241, DOI 10.1016/S0378-3758(96)00129-2; Hosseini R, 2010, VISION RES, V50, P2213, DOI 10.1016/j.visres.2010.07.025; Lee AB, 1999, P IEEE WORKSH STAT C; Lyu S, 2007, ADV NEURAL INFORM PR; Moghaddam B, 2007, IEEE I CONF COMP VIS, P2073, DOI 10.1109/cvpr.2007.383092; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; PEREZ A, 1977, KYBERNETIKA, V13, P439; Ranzato M., 2010, ADV NEURAL INFORM PR, V23; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sinz F, 2009, ADV NEURAL INFORM PR; van Hateren JH, 1998, P ROYAL SOC B, V265; Wainwright MJ, 2000, ADV NEUR IN, V12, P855; Wu YN, 2008, Q APPL MATH, V66, P81	21	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e39857	10.1371/journal.pone.0039857	http://dx.doi.org/10.1371/journal.pone.0039857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859943	Green Published, gold, Green Submitted			2022-12-27	WOS:000307045600004
J	Ong, SP; Lee, LM; Leong, YFI; Ng, ML; Chu, JJH				Ong, Siew Pei; Lee, Ling Min; Leong, Yew Fai Ivan; Ng, Mah Lee; Chu, Justin Jang Hann			Dengue Virus Infection Mediates HMGB1 Release from Monocytes Involving PCAF Acetylase Complex and Induces Vascular Leakage in Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROUP BOX PROTEIN-1; HEMORRHAGIC-FEVER; DISEASE SEVERITY; ETHYL PYRUVATE; IMMUNE ACTIVATION; ANTIBODY-RESPONSE; NITRIC-OXIDE; T-CELLS; INFLAMMATION	High mobility group box 1 (HMGB1) protein is released from cells as a pro-inflammatory cytokine in response to an injury or infection. During dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS), a number of pro-inflammatory cytokines are released, contributing to disease pathogenesis. In this study, the release of HMGB1 from human myelogenous leukemia cell line K562 and primary peripheral blood monocytes (PBM) cells was examined during dengue virus (DV)-infection. HMGB1 was shown to translocate from cell nuclei to the cytoplasm in both K562- and PBM-infected cells. The translocation of HMGB1 from the nucleus to the cytoplasm was shown to be mediated by the host cell p300/CBP-associated factor (PCAF) acetylase complex in K562 cells. In addition, DV capsid protein was observed to be the putative viral protein in actuating HMGB1 migration from the nucleus to cytoplasm through the involvement of PCAF acetylase. HMGB1 was released from DV-infected K562 cells into the extracellular milieu in a multiplicity of infection (M.O.I.)-independent manner and its release can be inhibited by the addition of 1-5 mM of ethyl pyruvate (EP) in a dose-dependent manner. Application of DV-infected K562 cell culture supernatants to primary endothelial cells induced vascular permeability. In contrast, supernatants from DV-infected K562 cells treated with EP or HMGB1 neutralizing antibody were observed to maintain the structural integrity of the vascular barrier.	[Ong, Siew Pei; Lee, Ling Min; Leong, Yew Fai Ivan; Ng, Mah Lee; Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol RNA Virol & Antiviral Strategies, Singapore 117595, Singapore	National University of Singapore	Ong, SP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol RNA Virol & Antiviral Strategies, Singapore 117595, Singapore.	miccjh@nus.edu.sg	Chu, Justin Jang Hann/ABA-8297-2021; Ng, Mei Li/Q-3704-2016	Ng, Mei Li/0000-0001-9917-4534; Chu, Justin Jang Hann/0000-0002-1673-6819	Academic Research Grant [R182-000-165-133,, R182-000-165-733]; National Medical Research Council Grant/New Investigator Grant [0012/2007]	Academic Research Grant; National Medical Research Council Grant/New Investigator Grant	This work was supported by Academic Research Grant (R182-000-165-133, R182-000-165-733) and National Medical Research Council Grant/New Investigator Grant 0012/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 1997, IMMUNITY, V6, P519, DOI 10.1016/S1074-7613(00)80340-4; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145; BURKEGAFFNEY A, 1993, IMMUNOPHARMACOLOGY, V25, P1, DOI 10.1016/0162-3109(93)90025-L; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-165; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0; Cirino G, 1998, BIOCHEM PHARMACOL, V55, P105, DOI 10.1016/S0006-2952(97)00215-3; Das UN, 2006, MED SCI MONITOR, V12, pRA79; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; GE H, 1994, J BIOL CHEM, V269, P17136; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hober D, 1998, J MED VIROL, V54, P210, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;210::AID-JMV12&gt;3.0.CO;2-L; Johansson AS, 2008, BRIT J PHARMACOL, V154, P1318, DOI 10.1038/bjp.2008.201; Kalariya NM, 2011, INVEST OPHTH VIS SCI, V52, P5144, DOI 10.1167/iovs.10-7047; Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Lim SC, 2007, INT J MOL MED, V20, P187; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luan ZG, 2010, IMMUNOBIOLOGY, V215, P956, DOI 10.1016/j.imbio.2009.11.001; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Pacsa AS, 2000, FEMS IMMUNOL MED MIC, V28, P151, DOI 10.1111/j.1574-695X.2000.tb01470.x; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Wolfson RK, 2010, MICROVASC RES; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	59	58	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41932	10.1371/journal.pone.0041932	http://dx.doi.org/10.1371/journal.pone.0041932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860034	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950900052
J	Altmann, CF; Getzmann, S; Lewald, J				Altmann, Christian F.; Getzmann, Stephan; Lewald, Joerg			Allocentric or Craniocentric Representation of Acoustic Space: An Electrotomography Study Using Mismatch Negativity	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; HUMAN AUDITORY-CORTEX; SPATIAL LOCATION; ELECTROMAGNETIC TOMOGRAPHY; SOUND LOCATION; HEAD POSITION; ENCODE LOCATIONS; AREA LIP; BRAIN; MEMORY	The world around us appears stable in spite of our constantly moving head, eyes, and body. How this is achieved by our brain is hardly understood and even less so in the auditory domain. Using electroencephalography and the so-called mismatch negativity, we investigated whether auditory space is encoded in an allocentric (referenced to the environment) or craniocentric representation (referenced to the head). Fourteen subjects were presented with noise bursts from loudspeakers in an anechoic environment. Occasionally, subjects were cued to rotate their heads and a deviant sound burst occurred, that deviated from the preceding standard stimulus either in terms of an allocentric or craniocentric frame of reference. We observed a significant mismatch negativity, i.e., a more negative response to deviants with reference to standard stimuli from about 136 to 188 ms after stimulus onset in the craniocentric deviant condition only. Distributed source modeling with sLORETA revealed an involvement of lateral superior temporal gyrus and inferior parietal lobule in the underlying neural processes. These findings suggested a craniocentric, rather than allocentric, representation of auditory space at the level of the mismatch negativity.	[Altmann, Christian F.] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Altmann, Christian F.] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Getzmann, Stephan; Lewald, Joerg] Ruhr Univ Bochum, Fac Psychol, Dept Cognit Psychol, Bochum, Germany; [Getzmann, Stephan; Lewald, Joerg] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Kyoto University; Kyoto University; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Altmann, CF (corresponding author), Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	altmann@cp.kyoto-u.ac.jp	Lewald, Jörg/D-3034-2009	Lewald, Jörg/0000-0001-9351-0170; Getzmann, Stephan/0000-0002-6382-0183; Altmann, Christian/0000-0003-0958-1238	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science [23730701]; Deutsche Forschungsgemeinschaft [Ge1920/2-2]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partly supported by the Special Coordination Fund for Promoting Science and Technology to CFA from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and a Grant-in-Aid for Young Scientists (B) 23730701 to CFA from the Japan Society for the Promotion of Science and by a grant of the Deutsche Forschungsgemeinschaft (Ge1920/2-2) to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2007, NEUROIMAGE, V35, P1192, DOI 10.1016/j.neuroimage.2007.01.007; Altmann CF, 2009, J NEUROSCI, V29, P13074, DOI 10.1523/JNEUROSCI.1708-09.2009; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Andersen RA, 1999, ANN NY ACAD SCI, V871, P282, DOI 10.1111/j.1749-6632.1999.tb09192.x; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Arnott SR, 2011, NEUROSCI BIOBEHAV R, V35, P2162, DOI 10.1016/j.neubiorev.2011.04.005; Blauert J., 1997, SPATIAL HEARING PSYC; Brotchie PR, 2003, NEUROIMAGE, V18, P178, DOI 10.1006/nimg.2002.1294; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Cohen YE, 2004, CROSSMODAL SPACE CRO, P99; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; Deouell LY, 2006, EUR J NEUROSCI, V24, P1488, DOI 10.1111/j.1460-9568.2006.05025.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Getzmann S, 2010, HEARING RES, V259, P44, DOI 10.1016/j.heares.2009.09.021; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kaiser J, 2000, J NEUROSCI, V20, P6631, DOI 10.1523/JNEUROSCI.20-17-06631.2000; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Laufer I, 2009, NEUROIMAGE, V44, P546, DOI 10.1016/j.neuroimage.2008.09.010; Lewald J, 2004, NEUROPSYCHOLOGIA, V42, P1598, DOI 10.1016/j.neuropsychologia.2004.04.012; Lewald J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0005.2002; Lewald J, 2000, BEHAV BRAIN RES, V108, P105, DOI 10.1016/S0166-4328(99)00141-2; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Lewald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025146; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Maess B, 2007, NEUROIMAGE, V37, P561, DOI 10.1016/j.neuroimage.2007.05.040; Maris E, 2004, PSYCHOPHYSIOLOGY, V41, P142, DOI 10.1111/j.1469-8986.2003.00139.x; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Mullette-Gillman OA, 2009, CEREB CORTEX, V19, P1761, DOI 10.1093/cercor/bhn207; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R., 2018, ATTENTION BRAIN FUNC; PAAVILAINEN P, 1989, ELECTROEN CLIN NEURO, V73, P129, DOI 10.1016/0013-4694(89)90192-2; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schroger E, 2007, J PSYCHOPHYSIOL, V21, P138, DOI 10.1027/0269-8803.21.34.138; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Stein BE., 1993, MERGING SENSES; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Warren JD, 2003, J NEUROSCI, V23, P5799; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zimmer U, 2006, NEUROPSYCHOLOGIA, V44, P454, DOI 10.1016/j.neuropsychologia.2005.05.021	61	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41872	10.1371/journal.pone.0041872	http://dx.doi.org/10.1371/journal.pone.0041872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848643	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200119
J	Ban, KC; Kozar, RA				Ban, Kechen; Kozar, Rosemary A.			Protective Role of p70S6K in Intestinal Ischemia/Reperfusion Injury in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MAMMALIAN TARGET; EPITHELIAL-CELLS; SMALL-BOWEL; PPAR-GAMMA; S6 KINASE; IMMUNOSUPPRESSIVE DRUGS; MESENTERIC ISCHEMIA; ORGAN FAILURE; TISSUE-INJURY	The mTOR signaling pathway plays a crucial role in the regulation of cell growth, proliferation, survival and in directing immune responses. As the intestinal epithelium displays rapid cell growth and differentiation and is an important immune regulatory organ, we hypothesized that mTOR may play an important role in the protection against intestinal ischemia reperfusion (I/R)-induced injury. To better understand the molecular mechanisms by which the mTOR pathway is altered by intestinal I/R, p70S6K, the major effector of the mTOR pathway, was investigated along with the effects of rapamycin, a specific inhibitor of mTOR and an immunosuppressant agent used clinically in transplant patients. In vitro experiments using an intestinal epithelial cell line and hypoxia/reoxygenation demonstrated that overexpression of p70S6K promoted cell growth and migration, and decreased cell apoptosis. Inhibition of p70S6K by rapamycin reversed these protective effects. In a mouse model of gut I/R, an increase of p70S6K activity was found by 5 min and remained elevated after 6 h of reperfusion. Inhibition of p70S6K by rapamycin worsened gut injury, promoted inflammation, and enhanced intestinal permeability. Importantly, rapamycin treated animals had a significantly increased mortality. These novel results demonstrate a key role of p70S6K in protection against I/R injury in the intestine and suggest a potential danger in using mTOR inhibitors in patients at risk for gut hypoperfusion.	[Ban, Kechen; Kozar, Rosemary A.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Ban, KC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77225 USA.	Kechen.Ban@uth.tmc.edu			National Institutes of Health [R01 GM077282]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health Grant R01 GM077282, National Institutes of Health website: http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANTONSSON JB, 1991, ACTA CHIR-EUR J SURG, V157, P3; Arias-Diaz J, 2009, LAB INVEST, V89, P433, DOI 10.1038/labinvest.2009.3; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Ban K, 2001, MOL CELL BIOCHEM, V347, P191; Ban K, 2008, J LEUKOCYTE BIOL, V84, P595, DOI 10.1189/jlb.1107764; Baue AE, 2006, SHOCK, V26, P438, DOI 10.1097/01.shk.0000228172.32587.7a; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Bin C, 2012, MOL BIOL REP, V39, P185, DOI 10.1007/s11033-011-0724-3; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Esposito C, 2011, AM J NEPHROL, V33, P239, DOI 10.1159/000324577; Farrelly AM, 2011, APOPTOSIS, V16, P1128, DOI 10.1007/s10495-011-0641-x; Feitoza CQ, 2007, TRANSPL P, V39, P424, DOI 10.1016/j.transproceed.2007.01.035; Finn AV, 2009, CIRC RES, V105, P1003, DOI 10.1161/CIRCRESAHA.109.200519; Fujishiro J, 2010, AM J TRANSPLANT, V10, P1545, DOI 10.1111/j.1600-6143.2010.03117.x; Fukatsu K, 2011, SURG CLIN N AM, V91, P755, DOI 10.1016/j.suc.2011.04.007; Goncalves GM, 2007, TRANSPL P, V39, P417, DOI 10.1016/j.transproceed.2007.01.027; Gonzalez-Rodriguez A, 2009, HEPATOLOGY, V50, P216, DOI 10.1002/hep.22915; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Hassoun HT, 2002, AM J PHYSIOL-GASTR L, V282, pG1059, DOI 10.1152/ajpgi.00073.2001; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inman SR, 2003, UROLOGY, V62, P750, DOI 10.1016/S0090-4295(03)00475-8; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Khan SA, 2006, J MOL CELL CARDIOL, V41, P256, DOI 10.1016/j.yjmcc.2006.04.014; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Mills RE, 2009, CELL CYCLE, V8, P545, DOI 10.4161/cc.8.4.7625; Minami T, 1996, AM J PHYSIOL-GASTR L, V271, pG664, DOI 10.1152/ajpgi.1996.271.4.G664; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Paddenberg R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-15; PARK PO, 1990, SURGERY, V107, P574; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Pierro Agostino, 2004, Semin Pediatr Surg, V13, P11, DOI 10.1053/j.sempedsurg.2003.09.003; Puglisi RN, 1996, J SURG RES, V65, P115, DOI 10.1006/jsre.1996.0352; Qian J, 2009, CIRC RES, V105, P1223, DOI 10.1161/CIRCRESAHA.109.200378; Quaedackers JSLT, 2000, TRANSPLANT P, V32, P1307, DOI 10.1016/S0041-1345(00)01238-0; Rhoads JM, 2008, J NUTR, V138, P1652, DOI 10.1093/jn/138.9.1652; Rocourt DV, 2007, J SURG RES, V139, P269, DOI 10.1016/j.jss.2006.10.047; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato N, 2006, AM J PHYSIOL-GASTR L, V290, pG616, DOI 10.1152/ajpgi.00248.2005; Sato N, 2005, J TRAUMA, V58, P455, DOI 10.1097/01.TA.0000153937.04932.59; Sato N, 2005, SHOCK, V24, P462, DOI 10.1097/01.shk.0000183483.76972.ae; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shao JY, 2004, CANCER RES, V64, P229, DOI 10.1158/0008-5472.CAN-03-1859; Suer S, 2009, CELL TISSUE RES, V336, P213, DOI 10.1007/s00441-009-0776-z; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Takagi H, 1998, DIABETES, V47, P1480, DOI 10.2337/diabetes.47.9.1480; Tawadrous ZS, 2002, SHOCK, V17, P473, DOI 10.1097/00024382-200206000-00006; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Turnage RH, 1996, SURGERY, V119, P151, DOI 10.1016/S0039-6060(96)80163-2; Velagapudi C, 2011, J AM SOC NEPHROL, V22, P262, DOI 10.1681/ASN.2010040352; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Wattanasirichaigoon S, 1999, SHOCK, V11, P269, DOI 10.1097/00024382-199904000-00008; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang B, 2006, TRANSPLANTATION, V81, P1442, DOI 10.1097/01.tp.0000209412.77312.69; Yao C, 2011, HEPATO-GASTROENTEROL, V58, P1075; Zhao XF, 2009, EXPERT OPIN THER TAR, V13, P1085, DOI 10.1517/14728220903103833	64	21	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41584	10.1371/journal.pone.0041584	http://dx.doi.org/10.1371/journal.pone.0041584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848534	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200073
J	Hindinger, C; Bergmann, CC; Hinton, DR; Phares, TW; Parra, GI; Hussain, S; Savarin, C; Atkinson, RD; Stohlman, SA				Hindinger, Claudia; Bergmann, Cornelia C.; Hinton, David R.; Phares, Timothy W.; Parra, Gabriel I.; Hussain, Shabbir; Savarin, Carine; Atkinson, Roscoe D.; Stohlman, Stephen A.			IFN-gamma Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; T-CELL RESPONSES; INTERFERON-GAMMA; MULTIPLE-SCLEROSIS; REACTIVE ASTROCYTES; TRANSGENIC MICE; EFFECTOR PHASE	Demyelination and axonal degeneration are determinants of progressive neurological disability in patients with multiple sclerosis (MS). Cells resident within the central nervous system (CNS) are active participants in development, progression and subsequent control of autoimmune disease; however, their individual contributions are not well understood. Astrocytes, the most abundant CNS cell type, are highly sensitive to environmental cues and are implicated in both detrimental and protective outcomes during autoimmune demyelination. Experimental autoimmune encephalomyelitis (EAE) was induced in transgenic mice expressing signaling defective dominant-negative interferon gamma (IFN-gamma) receptors on astrocytes to determine the influence of inflammation on astrocyte activity. Inhibition of IFN-gamma signaling to astrocytes did not influence disease incidence, onset, initial progression of symptoms, blood brain barrier (BBB) integrity or the composition of the acute CNS inflammatory response. Nevertheless, increased demyelination at peak acute disease in the absence of IFN-gamma signaling to astrocytes correlated with sustained clinical symptoms. Following peak disease, diminished clinical remission, increased mortality and sustained astrocyte activation within the gray matter demonstrate a critical role of IFN-gamma signaling to astrocytes in neuroprotection. Diminished disease remission was associated with escalating demyelination, axonal degeneration and sustained inflammation. The CNS infiltrating leukocyte composition was not altered; however, decreased IL-10 and IL-27 correlated with sustained disease. These data indicate that astrocytes play a critical role in limiting CNS autoimmune disease dependent upon a neuroprotective signaling pathway mediated by engagement of IFN-gamma receptors.	[Hindinger, Claudia; Bergmann, Cornelia C.; Phares, Timothy W.; Parra, Gabriel I.; Hussain, Shabbir; Savarin, Carine; Stohlman, Stephen A.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Hinton, David R.; Atkinson, Roscoe D.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Cleveland Clinic Foundation; University of Southern California	Hindinger, C (corresponding author), Tech Univ Dresden, Dept Neurol, Univ Hosp Carl Gustav Carus, Dresden, Germany.	stohlms2@ccf.org	Parra, Gabriel I./H-4339-2019	Parra, Gabriel I./0000-0002-1102-4740; Bergmann, Cornelia/0000-0003-1319-402X	National Multiple Sclerosis Society, USA	National Multiple Sclerosis Society, USA(National Multiple Sclerosis Society)	This work was supported by a grant from the National Multiple Sclerosis Society, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 1997, J IMMUNOL, V159, P1604; Ambrosini E, 2004, NEUROCHEM RES, V29, P1017, DOI 10.1023/B:NERE.0000021246.96864.89; Arico E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-67; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Balasingam V, 1996, J NEUROSCI, V16, P2945; Bar-Or A, 2008, SEMIN NEUROL, V28, P29, DOI 10.1055/s-2007-1019124; BECK J, 1988, ACTA NEUROL SCAND, V78, P318, DOI 10.1111/j.1600-0404.1988.tb03663.x; Bettelli E, 1998, J IMMUNOL, V161, P3299; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cannella B, 2004, ANN NEUROL, V55, P46, DOI 10.1002/ana.10764; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferber IA, 1996, J IMMUNOL, V156, P5; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Gonzalez JM, 2006, AM J PATHOL, V168, P796, DOI 10.2353/ajpath.2006.050496; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gran B, 2004, J NEUROIMMUNOL, V156, P123, DOI 10.1016/j.jneuroim.2004.07.019; Hamo L, 2007, GLIA, V55, P1169, DOI 10.1002/glia.20538; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hindinger C, 2005, J NEUROSCI RES, V82, P20, DOI 10.1002/jnr.20616; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Liedtke W, 1998, AM J PATHOL, V152, P251; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Miljkovic D, 2011, FEBS LETT, V585, P3781, DOI 10.1016/j.febslet.2011.03.047; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Veldhoen M, 2010, NAT MED, V16, P166, DOI 10.1038/nm0210-166; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546	48	53	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42088	10.1371/journal.pone.0042088	http://dx.doi.org/10.1371/journal.pone.0042088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848713	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200161
J	Kunz, A; von Wurmb-Schwark, N; Sewangi, J; Ziske, J; Lau, I; Mbezi, P; Theuring, S; Hauser, A; Dugange, F; Katerna, A; Harms, G				Kunz, Andrea; von Wurmb-Schwark, Nicole; Sewangi, Julius; Ziske, Judith; Lau, Inga; Mbezi, Paulina; Theuring, Stefanie; Hauser, Andrea; Dugange, Festo; Katerna, Angela; Harms, Gundel			Zidovudine Exposure in HIV-1 Infected Tanzanian Women Increases Mitochondrial DNA Levels in Placenta and Umbilical Cords	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; REVERSE-TRANSCRIPTASE INHIBITORS; UNINFECTED INFANTS; IN-UTERO; ANTIRETROVIRAL THERAPY; PERIPHERAL NEUROPATHY; NUCLEOSIDE ANALOGS; OXIDATIVE STRESS; TOXICITY; EXPRESSION	Background: Zidovudine (AZT) constitutes part of the recommended regimens for prevention and treatment of HIV-1 infection. At the same time, AZT as well as HIV-1 infection itself may induce mitochondrial damage. In this study, we analyzed the impact of prenatal AZT-exposure on mitochondrial alterations in HIV-infected women and their infants. Methods: Mitochondrial DNA (mtDNA) levels in placentas of HIV-1 infected Tanzanian women with and without prenatal AZT exposure, and in the umbilical cords of their AZT-exposed/unexposed infants were quantified using real-time PCR. Furthermore, we checked for the most common mitochondrial deletion in humans, the 4977 base pair deletion (dmtDNA4977) as a marker for mitochondrial stress. Results: 83 women fulfilled the inclusion criteria. 30 women had been treated with AZT (median duration 56 days; IQR 43-70 days) while 53 women had not taken AZT during pregnancy. Baseline maternal characteristics in the two groups were similar. The median mtDNA levels in placentas and umbilical cords of women (311 copies/cell) and infants (190 copies/cell) exposed to AZT were significantly higher than in AZT-unexposed women (187 copies/cell; p = 0.021) and infants (127 copies/cell; p = 0.037). The dmtDNA4977 was found in placentas of one woman of each group and in 3 umbilical cords of AZT-unexposed infants but not in umbilical cords of AZT-exposed infants. Conclusions: Antenatal AZT intake did not increase the risk for the common mitochondrial deletion dmtDNA4977. Our data suggests that AZT exposure elevates mtDNA levels in placentas and umbilical cords possibly by positively influencing the course of maternal HIV-1 infection.	[Kunz, Andrea; Ziske, Judith; Lau, Inga; Theuring, Stefanie; Hauser, Andrea; Harms, Gundel] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [von Wurmb-Schwark, Nicole; Katerna, Angela] Univ Kiel, Inst Legal Med, Kiel, Germany; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya Reg, Mbeya, Tanzania; [Mbezi, Paulina] Minist Hlth & Social Welf, PMTCT Program Mbeya Reg, Mbeya, Tanzania; [Hauser, Andrea] Robert Koch Inst, Ctr HIV & Retrovirol, Berlin, Germany; [Dugange, Festo] Kyela Dist Hosp, Minist Hlth & Social Welf, Kyela Dist, Tanzania	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Robert Koch Institute	Kunz, A (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	stefanie.theuring@charite.de			German Ministry for Economic Cooperation and Development [01.2029.5]; H.W. & J. Hector Stiftung Foundation, Germany	German Ministry for Economic Cooperation and Development; H.W. & J. Hector Stiftung Foundation, Germany	This work was supported by the German Ministry for Economic Cooperation and Development through project 01.2029.5 (Prevention of Mother-to-Child Transmission of HIV) and by a grant of the H.W. & J. Hector Stiftung Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrovandi GM, 2009, PEDIATRICS, V124, pE1189, DOI 10.1542/peds.2008-2771; ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; Arnoult D, 2004, MITOCHONDRION, V4, P255, DOI 10.1016/j.mito.2004.06.010; Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08; Banas B, 2004, EUR J MED RES, V9, P371; Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Bulterys M, 2000, J ACQ IMMUN DEF SYND, V25, P261, DOI 10.1097/00126334-200011010-00009; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Canter JA, 2008, PHARMACOGENOMICS J, V8, P71, DOI 10.1038/sj.tpj.6500470; Casula M, 2005, J INFECT DIS, V192, P1794, DOI 10.1086/497140; Casula M, 2005, J INFECT DIS, V191, P1468, DOI 10.1086/429412; CHEN CH, 1991, MOL PHARMACOL, V39, P625; Christensen ER, 2004, CLIN INFECT DIS, V39, P1371, DOI 10.1086/424881; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Cote HCF, 2005, ANTIVIR THER, V10, pM3; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Divi RL, 2007, TOXICOL SCI, V99, P203, DOI 10.1093/toxsci/kfm143; Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P201, DOI 10.1002/em.20201; Divi RL, 2010, TOXICOL SCI, V118, P191, DOI 10.1093/toxsci/kfq235; Divi RL, 2004, AIDS, V18, P1013, DOI 10.1097/00002030-200404300-00009; Fahn HJ, 1998, AM J RESP CELL MOL, V19, P901, DOI 10.1165/ajrcmb.19.6.3130; FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1; FURUI T, 1994, OBSTET GYNECOL, V84, P283; Gerschenson M, 2004, AIDS RES HUM RETROV, V20, P91, DOI 10.1089/088922204322749530; Gerschenson M, 2000, ANN NY ACAD SCI, V918, P269; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; Hauser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032055; Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6; Hoschele D, 2006, TOXICOL IN VITRO, V20, P535, DOI 10.1016/j.tiv.2005.11.007; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Hulgan T, 2011, AIDS, V25, P37, DOI 10.1097/QAD.0b013e32833f9d02; Iwai K, 2006, MUTAT RES-FUND MOL M, V595, P191, DOI 10.1016/j.mrfmmm.2005.10.001; Kamemoto LE, 2004, MITOCHONDRION, V4, P153, DOI 10.1016/j.mito.2004.05.011; Kim J, 2010, OSTEOARTHR CARTILAGE, V18, P424, DOI 10.1016/j.joca.2009.09.008; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; KURAUCHI O, 1995, PLACENTA, V16, P461, DOI 10.1016/0143-4004(95)90104-3; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; Lewis W, 2001, LAB INVEST, V81, P777, DOI 10.1038/labinvest.3780288; Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200; Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268; Lund KC, 2008, TOXICOL APPL PHARM, V226, P94, DOI 10.1016/j.taap.2007.08.015; Maagaard A, 2006, ANTIVIR THER, V11, P601; McComsey GA, 2008, HIV CLIN TRIALS, V9, P126, DOI 10.1310/hct0902-126; Meissner C, 1998, BIOTECHNIQUES, V25, P652, DOI 10.2144/98254dt03; Miro O, 2004, CLIN INFECT DIS, V39, P710, DOI 10.1086/423176; Nadasi EA, 2003, ACTA BIOL HUNG, V54, P253, DOI 10.1556/ABiol.54.2003.3-4.4; Newell ML, 2003, JAIDS-J ACQ IMM DEF, V32, P380, DOI 10.1097/00126334-200304010-00006; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Pinti M, 2006, BBA-BIOENERGETICS, V1757, P700, DOI 10.1016/j.bbabio.2006.05.001; Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010; Pornprasert S, 2006, PLACENTA, V27, P989, DOI 10.1016/j.placenta.2005.10.010; Saitoh A, 2007, ANTIMICROB AGENTS CH, V51, P4236, DOI 10.1128/AAC.00893-07; Samuels DC, 2006, IUBMB LIFE, V58, P403, DOI 10.1080/15216540600791571; Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943; Shearer WT, 1997, ACTA PAEDIATR, V86, P33; Shiramizu B, 2003, JAIDS-J ACQ IMM DEF, V32, P370, DOI 10.1097/00126334-200304010-00004; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; The United Republic of Tanzania Ministry of Health and Social Welfare, 2007, PREV MOTH TO CHILD T; Torres SM, 2009, ENVIRON MOL MUTAGEN, V50, P10, DOI 10.1002/em.20433; von Wurmb-Schwark N, 2008, MUTAT RES-FUND MOL M, V637, P73, DOI 10.1016/j.mrfmmm.2007.07.003; von Wurmb-Schwark N, 2002, FORENSIC SCI INT, V126, P34, DOI 10.1016/S0379-0738(02)00026-9; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Williams PL, 2010, PEDIATRICS, V125, pE250, DOI 10.1542/peds.2009-1112; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129; World Health Organization, 2006, ANT DRUG TREAT PREG; World Health Organization, 2021, ANT DRUGS TREAT PREG; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Zhang Y, 2007, BIOSENS BIOELECTRON, V23, P438, DOI 10.1016/j.bios.2007.06.010	71	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41637	10.1371/journal.pone.0041637	http://dx.doi.org/10.1371/journal.pone.0041637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848552	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200080
J	Seidah, NG; Poirier, S; Denis, M; Parker, R; Miao, BM; Mapelli, C; Prat, A; Wassef, H; Davignon, J; Hajjar, KA; Mayer, G				Seidah, Nabil G.; Poirier, Steve; Denis, Maxime; Parker, Rex; Miao, Bowman; Mapelli, Claudio; Prat, Annik; Wassef, Hanny; Davignon, Jean; Hajjar, Katherine A.; Mayer, Gaetan			Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; CONVERTASE SUBTILISIN/KEXIN TYPE-9; CELL-SURFACE; IN-VIVO; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; PROPROTEIN CONVERTASES; MONOCLONAL-ANTIBODY; LIVER-REGENERATION	Proprotein convertase subtilisin/kexin-9 (PCSK9) enhances the degradation of hepatic low-density lipoprotein receptor (LDLR). Deletion of PCSK9, and loss-of-function mutants in humans result in lower levels of circulating LDL-cholesterol and a strong protection against coronary heart disease. Accordingly, the quest for PCSK9 inhibitors has major clinical implications. We have previously identified annexin A2 (AnxA2) as an endogenous binding partner and functional inhibitor of PCSK9. Herein, we studied the relevance of AnxA2 in PCSK9 inhibition and lipid metabolism in vivo. Plasma analyses of AnxA2(-/-) mice revealed: i) similar to 1.4-fold increase in LDL-cholesterol without significant changes in VLDLs or HDLs, and ii) similar to 2-fold increase in circulating PCSK9 levels. Western blotting and immunohistochemistry of AnxA2(-/-) tissues revealed that the LDLR was decreased by similar to 50% in extrahepatic tissues, such as adrenals and colon. We also show that AnxA2-derived synthetic peptides block the PCSK9=LDLR interaction in vitro, and adenoviral overexpression of AnxA2 in mouse liver increases LDLR protein levels in vivo. These results suggest that AnxA2 acts as an endogenous regulator of LDLR degradation, mostly in extrahepatic tissues. Finally, we identified an AnxA2 coding polymorphism, V98L, that correlates with lower circulating levels of PCSK9 thereby extending our results on the physiological role of AnxA2 in humans.	[Seidah, Nabil G.; Poirier, Steve; Denis, Maxime; Prat, Annik] Univ Montreal, Biochem Neuroendocrinol Lab, Clin Res Inst Montreal, Montreal, PQ, Canada; [Mayer, Gaetan] Univ Montreal, Dept Med, Montreal Heart Inst, Mol Cell Biol Lab, Montreal, PQ H3C 3J7, Canada; [Mayer, Gaetan] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Parker, Rex; Miao, Bowman; Mapelli, Claudio] Bristol Myers Squibb Pharmaceut R&D, Princeton, NJ USA; [Hajjar, Katherine A.] Cornell Univ, Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal; Bristol-Myers Squibb; Cornell University	Seidah, NG (corresponding author), Univ Montreal, Biochem Neuroendocrinol Lab, Clin Res Inst Montreal, Montreal, PQ, Canada.	gaetan.mayer@icm-mhi.org	Prat, Annik/S-6757-2018; Seidah, Nabil/I-3596-2013	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342	Canada Research Chair [216684]; Canadian Institutes of Health Research (CIHR) [CTP 82946, MOP 102741]; CIHR Institute of nutrition, metabolism and diabetes; Heart and Stroke Foundation of Canada and Quebec; Fonds de la Recherche en Sante du Quebec	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Institute of nutrition, metabolism and diabetes(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada and Quebec(Heart & Stroke Foundation of Canada); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	S.P. was supported by a F. Banting and C. Best doctoral scholarship. N.G.S. is a Canada Research Chair holder (# 216684) and is funded by the Canadian Institutes of Health Research (CIHR; grants # CTP 82946 and MOP 102741). G.M. is funded by the CIHR Institute of nutrition, metabolism and diabetes, the Heart and Stroke Foundation of Canada and Quebec, and the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd TT, 2011, EXPERT OPIN DRUG SAF, V10, P373, DOI 10.1517/14740338.2011.540568; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Akram ON, 2010, ARTERIOSCL THROM VAS, V30, P1279, DOI 10.1161/ATVBAHA.110.209007; Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CARR BR, 1981, ENDOCR REV, V2, P306, DOI 10.1210/edrv-2-3-306; Cenarro A, 2011, CLIN GENET, V79, P475, DOI 10.1111/j.1399-0004.2010.01485.x; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crunkhorn S, 2011, NAT REV DRUG DISCOV, V10, DOI 10.1038/nrd3587; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dias C, 2012, J AM COLL CARDIOL, V59, pE1379, DOI 10.1016/S0735-1097(12)61380-1; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Flood EC, 2011, VASC PHARMACOL, V54, P59, DOI 10.1016/j.vph.2011.03.003; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Graham MJ, 2007, J LIPID RES, V48, P763, DOI 10.1194/jlr.C600025-JLR200; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Lucki NC, 2012, MOL CELL ENDOCRINOL, V348, P165, DOI 10.1016/j.mce.2011.08.003; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; Marques-Pinheiro A, 2010, EUR J HUM GENET, V18, P1236, DOI 10.1038/ejhg.2010.94; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2004, CELL TISSUE RES, V316, P55, DOI 10.1007/s00441-004-0866-x; Mayer G, 2004, J HISTOCHEM CYTOCHEM, V52, P567, DOI 10.1177/002215540405200502; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Patchell BJ, 2007, AM J PHYSIOL-LUNG C, V293, pL354, DOI 10.1152/ajplung.00412.2006; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Rousselet E, 2011, J LIPID RES, V52, P1383, DOI 10.1194/jlr.M014118; SARIS CJM, 1987, J BIOL CHEM, V262, P10663; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 2012, NAT REV DRUG DISCOV; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; Thompson JF, 2009, CIRC-CARDIOVASC GENE, V2, P173, DOI 10.1161/CIRCGENETICS.108.818062; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Varret M, 2008, CLIN GENET, V73, P1, DOI 10.1111/j.1399-0004.2007.00915.x; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	82	76	86	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41865	10.1371/journal.pone.0041865	http://dx.doi.org/10.1371/journal.pone.0041865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848640	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200117
J	Toki, W; Tanahashi, M; Togashi, K; Fukatsu, T				Toki, Wataru; Tanahashi, Masahiko; Togashi, Katsumi; Fukatsu, Takema			Fungal Farming in a Non-Social Beetle	PLOS ONE			English	Article							COLEOPTERA EROTYLIDAE LANGURIINAE; LEAF-ROLLING WEEVIL; HIGH-MOISTURE WHEAT; PICHIA-ANOMALA; AIRTIGHT CONDITIONS; EVOLUTION; BIOCONTROL; MUTUALISM; GUILLIERMONDII; ENDOSYMBIONTS	Culturing of microbes for food production, called cultivation mutualism, has been well-documented from eusocial and subsocial insects such as ants, termites and ambrosia beetles, but poorly described from solitary, non-social insects. Here we report a fungal farming in a non-social lizard beetle Doubledaya bucculenta (Coleoptera: Erotylidae: Languriinae), which entails development of a special female structure for fungal storage/inoculation, so-called mycangium, and also obligate dependence of the insect on the fungal associate. Adult females of D. bucculenta bore a hole on a recently-dead bamboo culm with their specialized mandibles, lay an egg into the internode cavity, and plug the hole with bamboo fibres. We found that the inner wall of the bamboo internode harboring a larva is always covered with a white fungal layer. A specific Saccharomycetes yeast, Wickerhamomyces anomalus ( = Pichia anomala), was consistently isolated from the inner wall of the bamboo internodes and also from the body surface of the larvae. Histological examination of the ovipositor of adult females revealed an exoskeletal pocket on the eighth abdominal segment. The putative mycangium contained yeast cells, and W. anomalus was repeatedly detected from the symbiotic organ. When first instar larvae were placed on culture media inoculated with W. anomalus, they grew and developed normally to adulthood. By contrast, first instar larvae placed on either sterile culture media or autoclaved strips of bamboo inner wall exhibited arrested growth at the second instar, and addition of W. anomalus to the media resumed growth and development of the larvae. These results strongly suggest a mutualistic nature of the D. bucculenta-W. anomalus association with morphological specialization and physiological dependence. Based on these results, we compare the fungal farming of D. bucculenta with those of social and subsocial insects, and discuss ecological factors relevant to the evolution of fungal farming in a non-social insect.	[Toki, Wataru; Togashi, Katsumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Forest Sci, Bunkyo Ku, Tokyo, Japan; [Tanahashi, Masahiko; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Toki, W (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Forest Sci, Bunkyo Ku, Tokyo, Japan.	watarutoki@08.alumni.u-tokyo.ac.jp			Japan Society for the Promotion of Science for Young Scientists [20-6541]	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	WT was supported by a Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists (20-6541). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATRA LEKH R., 1963, TRANS KANAS ACAD SCI, V66, P213, DOI 10.2307/3626562; Batra LR, 1979, INSECT FUNGUS SYMBIO; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; BORKENT A, 1985, Symbiosis, V1, P185; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Francke-Grosmann H., 1967, P141; Fredlund E, 2002, FEMS YEAST RES, V2, P395, DOI 10.1111/j.1567-1364.2002.tb00109.x; Grebennikov VV, 2010, ENTOMOL SCI, V13, P81, DOI 10.1111/j.1479-8298.2009.00351.x; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; HAUSNER G, 1993, CAN J BOT, V71, P52, DOI 10.1139/b93-007; Hayashi N., 1974, NAT INSECT, V9, P17; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kobayashi C, 2008, EVOL ECOL, V22, P711, DOI 10.1007/s10682-007-9196-2; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Leschen R. A. B., 2003, FAUNA NZ; Leschen Richard A. B., 1998, Annales Zoologici (Warsaw), V48, P221; Leschen RAB, 2007, SYST BIOL, V56, P97, DOI 10.1080/10635150701211844; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Li XQ, 2012, J INSECT PHYSIOL, V58, P867, DOI 10.1016/j.jinsphys.2012.03.011; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; MORGAN FD, 1968, ANNU REV ENTOMOL, V13, P239, DOI 10.1146/annurev.en.13.010168.001323; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Norris D.M., 1979, P53; Olstorpe M, 2010, ANIM FEED SCI TECH, V156, P47, DOI 10.1016/j.anifeedsci.2009.12.008; PETERSSON S, 1995, APPL ENVIRON MICROB, V61, P1027, DOI 10.1128/AEM.61.3.1027-1032.1995; Petersson S, 1998, CAN J MICROBIOL, V44, P471, DOI 10.1139/cjm-44-5-471; POLONELLI L, 1986, J CLIN MICROBIOL, V24, P866, DOI 10.1128/JCM.24.5.866-869.1986; QUINLAN RJ, 1978, INSECT SOC, V25, P237, DOI 10.1007/BF02224744; Robertson JA, 2004, SYST ENTOMOL, V29, P173, DOI 10.1111/j.0307-6970.2004.00242.x; Rohfritsch O, 2008, ENTOMOL EXP APPL, V128, P208, DOI 10.1111/j.1570-7458.2008.00726.x; Sasaki T, 1996, J INSECT PHYSIOL, V42, P125, DOI 10.1016/0022-1910(95)00086-0; Sawada Y, 1986, SCI B FAC AGR KYUSHU, V49, P197; Schultz Ted R., 2005, P149; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Suh SO, 2004, FEMS YEAST RES, V5, P87, DOI 10.1016/j.femsyr.2004.06.001; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanahashi M, 2010, NATURWISSENSCHAFTEN, V97, P311, DOI 10.1007/s00114-009-0643-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toki Wataru, 2011, Elytra, V1, P253; Toki W, 2011, ZOOL SCI, V28, P348, DOI 10.2108/zsj.28.348; Toki Wataru, 2009, Biogeography, V11, P109; Van Zandt PA, 2003, COLEOPTS BULL, V57, P281, DOI 10.1649/553; Vega F. E., 2005, INSECT FUNGAL ASS EC; Wegrzynowicz Piotr, 2002, Genus (Wroclaw), V13, P435	49	38	42	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41893	10.1371/journal.pone.0041893	http://dx.doi.org/10.1371/journal.pone.0041893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848648	Green Published, gold, Green Submitted			2022-12-27	WOS:000306950200123
J	Zhang, K; Lu, YL; Yang, P; Li, C; Sun, HQ; Tao, DC; Liu, YQ; Zhang, SZ; Ma, YX				Zhang, Kun; Lu, Yilu; Yang, Ping; Li, Chao; Sun, Huaqin; Tao, Dachang; Liu, Yunqiang; Zhang, Sizhong; Ma, Yongxin			HILI Inhibits TGF-beta Signaling by Interacting with Hsp90 and Promoting T beta R Degradation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GERMLINE STEM-CELLS; SMAD PROTEINS; CRYSTAL-STRUCTURE; PIWI; TRANSDUCTION; ACTIVATION; KINASE; CHAPERONE; PATHWAY	PIWIL2, called HILI in humans, is a member of the PIWI subfamily. This subfamily has highly conserved PAZ and Piwi domains and is implicated in several critical functions, including embryonic development, stem-cell self-renewal, RNA silencing, and translational control. However, the underlying molecular mechanism remains largely unknown. Transforming growth factor-beta (TGF-beta) is a secreted multifunctional protein that controls several developmental processes and the pathogenesis of many diseases. TGF-beta signaling is activated by phosphorylation of transmembrane serine/threonine kinase receptors, TGF-beta type II (TbRII), and type I (TbRI), which are stabilized by Hsp90 via specific interactions with this molecular chaperone. Here, we present evidence that HILI suppresses TGF-beta signaling by physically associating with Hsp90 in human embryonic kidney cells (HEK-293). Our research shows that HILI mediates the loss of TGF-beta-induced Smad2/3 phosphorylation. We also demonstrate that HILI interacts with Hsp90 to prevent formation of Hsp90-T beta R heteromeric complexes, and improves ubiquitination and degradation of T beta Rs dependent on the ubiquitin E3 ligase Smurf2. This work reveals a critical negative regulation level of TGF-beta signaling mediated by HILI (human PIWIL2) by its ability to interact with Hsp90 and promote T beta R degradation.	[Zhang, Kun; Lu, Yilu; Yang, Ping; Li, Chao; Tao, Dachang; Liu, Yunqiang; Zhang, Sizhong; Ma, Yongxin] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Dept Med Genet, Chengdu 610064, Peoples R China; [Sun, Huaqin] Sichuan Univ, W China Univ Hosp 2, W China Inst Women & Childrens Hlth, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu 610064, Peoples R China	Sichuan University; Chinese University of Hong Kong; Sichuan University	Zhang, K (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Dept Med Genet, Chengdu 610064, Peoples R China.	mayongxin@gmail.com			National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China [90919006, 31070676]; Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China [NCET-07-0580]; Spring Sunshine Programme by the Ministry of Education of China [Z2009-1-61003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China; Spring Sunshine Programme by the Ministry of Education of China	This work is supported by National Basic Research Program of China (973 Program, grant no. 2012CB947600), National Natural Science Foundation of China (grant no. 90919006 and 31070676), Trans-Century Training Programme Foundation for the Talents by the Ministry of Education of China (grant no. NCET-07-0580) and Spring Sunshine Programme by the Ministry of Education of China (grant no. Z2009-1-61003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gonzalez-Santiago AE, 2011, J CLIN LAB ANAL, V25, P238, DOI 10.1002/jcla.20465; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; He G, 2010, AM J TRANSL RES, V2, P156; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Houwing S, 2008, EMBO J, V27, P2702, DOI 10.1038/emboj.2008.204; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Lu YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030999; Lu YL, 2010, BMB REP, V43, P635, DOI 10.3858/BMBRep.2010.43.9.635; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Moustakas A, 2001, J CELL SCI, V114, P4359; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Naoe T, 2001, CANCER CHEMOTH PHARM, V48, pS27, DOI 10.1007/s002800100301; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Sato N, 2003, BIOCHEM BIOPH RES CO, V300, P847, DOI 10.1016/S0006-291X(02)02941-8; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Seoane J, 2004, CANCER BIOL THER, V3, P226, DOI 10.4161/cbt.3.2.717; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Sun HQ, 2010, J BIOL CHEM, V285, P4243, DOI 10.1074/jbc.M109.079533; Tan Cheong-Huat, 2002, Gene Expression Patterns, V2, P257, DOI 10.1016/S1567-133X(02)00052-2; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Wrightont KH, 2008, P NATL ACAD SCI USA, V105, P9244, DOI 10.1073/pnas.0800163105; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yun TJ, 2011, J IMMUNOL, V186, P563, DOI 10.4049/jimmunol.1000222; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9	62	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41973	10.1371/journal.pone.0041973	http://dx.doi.org/10.1371/journal.pone.0041973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848678	Green Submitted, gold, Green Published			2022-12-27	WOS:000306950200139
J	de Lima, CDM; Calegari-Silva, TC; Pereira, RMS; Santos, SADL; Lopes, UG; Plotkowski, MCM; Saliba, AM				Mallet de Lima, Carolina Diettrich; Calegari-Silva, Teresa Cristina; Santos Pereira, Renata Meirelles; de Oliveira Lima Santos, Sabrina Alves; Lopes, Ulisses Gazos; Plotkowski, Maria-Cristina Maciel; Saliba, Alessandra Mattos			ExoU Activates NF-kappa B and Increases IL-8/KC Secretion during Pseudomonas aeruginosa Infection	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; OXIDATIVE STRESS; INTERLEUKIN-8 PRODUCTION; HISTONE ACETYLATION; CYTOTOXIN EXOU; TOXIN EXOU; EXPRESSION; PNEUMONIA; GENE; TRANSCRIPTION	ExoU, a Pseudomonas aeruginosa cytotoxin injected into host cytosol by type III secretion system, exhibits a potent proinflammatory activity that leads to a marked recruitment of neutrophils to infected tissues. To evaluate the mechanisms that account for neutrophil infiltration, we investigated the effect of ExoU on IL-8 secretion and NF-kappa B activation. We demonstrate that ExoU increases IL-8 mRNA and protein levels in P. aeruginosa-infected epithelial and endothelial cell lines. Also, ExoU induces the nuclear translocation of p65/p50 NF-kappa B transactivator heterodimer as well as NF-kappa B-dependent transcriptional activity. ChIP assays clearly revealed that ExoU promotes p65 binding to NF-kappa B site in IL-8 promoter and the treatment of cultures with the NF-kappa B inhibitor Bay 11-7082 led to a significant reduction in IL-8 mRNA levels and protein secretion induced by ExoU. These results were corroborated in a murine model of pneumonia that revealed a significant reduction in KC secretion and neutrophil infiltration in bronchoalveolar lavage when mice were treated with Bay 11-7082 before infection with an ExoU-producing strain. In conclusion, our data demonstrate that ExoU activates NF-kappa B, stimulating IL-8 expression and secretion during P. aeruginosa infection, and unveils a new mechanism triggered by this important virulence factor to interfere in host signaling pathways.	[Mallet de Lima, Carolina Diettrich; de Oliveira Lima Santos, Sabrina Alves; Plotkowski, Maria-Cristina Maciel; Saliba, Alessandra Mattos] Univ Estado Rio de Janeiro, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil; [Calegari-Silva, Teresa Cristina; Santos Pereira, Renata Meirelles; Lopes, Ulisses Gazos] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Parasitol Mol, BR-21941 Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Saliba, AM (corresponding author), Univ Estado Rio de Janeiro, Dept Microbiol Imunol & Parasitol, BR-20550011 Rio De Janeiro, Brazil.	alessandrasaliba@hotmail.com	Lopes, Ulisses Gazos/T-6634-2019; Lopes, Ulisses/N-4416-2013; Pereira, Renata/V-6194-2019; Saliba, Alessandra/AAL-5174-2021	Saliba, Alessandra/0000-0001-7378-8562; Alves, Sabrina/0000-0002-4664-0981; Calegari Silva, Teresa Cristina/0000-0002-1656-3460	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [101.447/2010]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (101.447/2010). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) supported Carolina Diettrich Mallet de Lima and Sabrina Alves de Oliveira Lima Santos, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Cuzick A, 2006, INFECT IMMUN, V74, P4104, DOI 10.1128/IAI.02045-05; Diaz MH, 2008, INFECT IMMUN, V76, P4414, DOI 10.1128/IAI.00012-08; Diaz MH, 2010, INFECT IMMUN, V78, P1447, DOI 10.1128/IAI.01134-09; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hou Y, 2009, INT IMMUNOPHARMACOL, V9, P120, DOI 10.1016/j.intimp.2008.10.020; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Lins RX, 2010, MICROBES INFECT, V12, P154, DOI 10.1016/j.micinf.2009.11.005; Machado GB, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-104; Maybin JA, 2011, AM J PATHOL, V178, P1245, DOI 10.1016/j.ajpath.2010.11.070; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Plotkowski MC, 2008, MICROB PATHOGENESIS, V45, P30, DOI 10.1016/j.micpath.2008.01.008; Rabin SDP, 2005, INFECT IMMUN, V73, P573, DOI 10.1128/IAI.73.1.573-582.2005; Rahman I, 2002, MOL CELL BIOCHEM, V234, P239, DOI 10.1023/A:1015905010086; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; Saliba AM, 2006, MICROBES INFECT, V8, P450, DOI 10.1016/j.micinf.2005.07.011; Saliba AM, 2005, CELL MICROBIOL, V7, P1811, DOI 10.1111/j.1462-5822.2005.00635.x; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Schulert GS, 2003, J INFECT DIS, V188, P1695, DOI 10.1086/379372; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Sun L, 2009, AM J RESP CELL MOL, V41, P76, DOI 10.1165/rcmb.2008-0202OC; Wareham DW, 2007, INT J MED MICROBIOL, V297, P227, DOI 10.1016/j.ijmm.2007.02.004; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wu WX, 2006, VIROLOGY, V355, P18, DOI 10.1016/j.virol.2006.07.001; Ye SF, 2009, BIOCHEM BIOPH RES CO, V379, P643, DOI 10.1016/j.bbrc.2008.12.137; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171	34	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41772	10.1371/journal.pone.0041772	http://dx.doi.org/10.1371/journal.pone.0041772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848596	Green Submitted, Green Published, gold			2022-12-27	WOS:000309240600046
J	Ding, JX; Jin, W; Chen, CM; Shao, ZM; Wu, J				Ding, Jingxian; Jin, Wei; Chen, Canming; Shao, Zhiming; Wu, Jiong			Tumor Associated Macrophage X Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer	PLOS ONE			English	Article							MARROW-DERIVED CELLS; ALTERNATIVE ACTIVATION; FUSION; IDENTIFICATION; EXPLANATION; PROGRESSION; METASTASIS; RECURRENCE; MECHANISMS; ANTIBODY	Breast cancer is one of the most frequently diagnosed cancers among women, and metastasis makes it lethal. Tumor-associated macrophages (TAMs) that acquire an alternatively activated macrophage (M2) phenotype may promote metastasis. However, the underlying mechanisms are still elusive. Here, we examined how TAMs interact with breast cancer cells to promote metastasis. Immunohistochemistry was used to examine the expression of the M2-specific antigen CD163 in paraffin-embedded mammary carcinoma blocks to explore fusion events in breast cancer patients. U937 cells were used as a substitute for human monocytes, and these cells differentiated into M2 macrophages following phorbol 12-myristate 13-acetate (PMA) and M-CSF stimulation. M2 macrophages and the breast cancer cell lines MCF-7 and MDA-MB-231 fused in the presence of 50% polyethylene glycol. Hybrids were isolated by fluorescence-activated cell sorting, and the relevant cell biological properties were compared with their parental counterparts. Breast cancer stem cell (BCSC)-related markers were quantified by immunofluorescence staining, RT-PCR, quantitative RT-PCR and/or western blotting. The tumor-initiating and metastatic capacities of the hybrids and their parental counterparts were assessed in NOD/SCID mice. We found that the CD163 expression rate in breast cancer tissues varied significantly and correlated with estrogen receptor status (p<0.05). The fusion efficiency of either breast cancer cell line with M2 macrophages ranged from 1.81 to 6.47% in the presence of PEG, and no significant difference was observed between the breast cancer cell lines used (p>0.05). Characterization of the fusion hybrids revealed a more aggressive phenotype, including increased migration, invasion and tumorigenicity, but reduced proliferative ability, compared with the parental lines. The hybrids also gained a CD44(+)CD24(-/low) phenotype and over-expressed epithelial-mesenchymal transition-associated genes. These results indicate that TAMs may promote breast cancer metastasis through cell fusion, and the hybrids may gain a BCSC phenotype.	[Ding, Jingxian; Jin, Wei; Chen, Canming; Shao, Zhiming; Wu, Jiong] Fudan Univ, Shanghai Canc Ctr, Breast Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China; [Ding, Jingxian; Jin, Wei; Chen, Canming; Shao, Zhiming; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Ding, Jingxian] Fudan Univ, Inst Canc, Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Ding, JX (corresponding author), Fudan Univ, Shanghai Canc Ctr, Breast Canc Inst, Dept Breast Surg, Shanghai 200433, Peoples R China.	wujiong1122@vip.sina.com	ding, jingxian/HDW-3150-2022	ding, jingxian/0000-0002-8242-1081	National Basic Research Program of China (973 Program) [2009CB521803]; National Natural Science Foundation of China [30971448]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program no. 2009CB521803. http://www.973.gov.cn/AreaAppl.aspx) and National Natural Science Foundation of China (no. 30971448 http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Bu Yiwen, 2012, Front Biosci (Schol Ed), V4, P819; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dittmar T, 2011, ADV EXP MED BIOL, V714, P1, DOI 10.1007/978-94-007-0782-5_1; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gottesman A, 2010, BIOTECHNIQUES, V49, P747, DOI 10.2144/000113515; Gottfried Eva, 2002, Cancer Immun, V2, P15; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Ikezumi Y, 2011, HISTOPATHOLOGY, V58, P198, DOI 10.1111/j.1365-2559.2011.03742.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lluis F, 2010, STEM CELLS, V28, P1940, DOI 10.1002/stem.515; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P80; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek J, 2006, CONTRIB MICROBIOL, V13, P138, DOI 10.1159/000092970; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, FUTURE ONCOL, V4, P449, DOI 10.2217/14796694.4.4.449; Piggott L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2945; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Serhal K, 2007, INT J ONCOL, V31, P1357; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Sumer H, 2010, CHROMOSOMA, V119, P167, DOI 10.1007/s00412-009-0245-1; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Yang XP, 2002, BIOTECHNIQUES, V32, P678, DOI 10.2144/02323dd05; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yu KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011035	46	77	83	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41942	10.1371/journal.pone.0041942	http://dx.doi.org/10.1371/journal.pone.0041942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848668	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600147
J	Meehan, TD; Werling, BP; Landis, DA; Gratton, C				Meehan, Timothy D.; Werling, Ben P.; Landis, Douglas A.; Gratton, Claudio			Pest-Suppression Potential of Midwestern Landscapes under Contrasting Bioenergy Scenarios	PLOS ONE			English	Article							ECOSYSTEM SERVICES; NATURAL ENEMIES; BIOFUELS; LAND; CROPS; DIVERSITY; CONSERVATION; BIODIVERSITY; ARTHROPODS; SYSTEMS	Biomass crops grown on marginal soils are expected to fuel an emerging bioenergy industry in the United States. Bioenergy crop choice and position in the landscape could have important impacts on a range of ecosystem services, including natural pest-suppression (biocontrol services) provided by predatory arthropods. In this study we use predation rates of three sentinel crop pests to develop a biocontrol index (BCI) summarizing pest-suppression potential in corn and perennial grass-based bioenergy crops in southern Wisconsin, lower Michigan, and northern Illinois. We show that BCI is higher in perennial grasslands than in corn, and increases with the amount of perennial grassland in the surrounding landscape. We develop an empirical model for predicting BCI from information on energy crop and landscape characteristics, and use the model in a qualitative assessment of changes in biocontrol services for annual croplands on prime agricultural soils under two contrasting bioenergy scenarios. Our analysis suggests that the expansion of annual energy crops onto 1.2 million ha of existing perennial grasslands on marginal soils could reduce BCI between -10 and -64% for nearly half of the annual cropland in the region. In contrast, replacement of the 1.1 million ha of existing annual crops on marginal land with perennial energy crops could increase BCI by 13 to 205% on over half of the annual cropland in the region. Through comparisons with other independent studies, we find that our biocontrol index is negatively related to insecticide use across the Midwest, suggesting that strategically positioned, perennial bioenergy crops could reduce insect damage and insecticide use on neighboring food and forage crops. We suggest that properly validated environmental indices can be used in decision support systems to facilitate integrated assessments of the environmental and economic impacts of different bioenergy policies.	[Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Meehan, Timothy D.; Gratton, Claudio] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Werling, Ben P.; Landis, Douglas A.] Michigan State Univ, E Lansing, MI 48824 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Michigan State University	Meehan, TD (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	tmeehan@wisc.edu	Landis, Douglas A./L-7991-2019	Gratton, Claudio/0000-0001-6262-9670	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was funded in part by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) and DOE OBP Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Costello C, 2009, ENVIRON SCI TECHNOL, V43, P7985, DOI 10.1021/es9011433; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Egbendewe-Mondzozo A, 2011, BIOMASS BIOENERG, V35, P4636, DOI 10.1016/j.biombioe.2011.09.010; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foster R, 1995, VEGETABLE INSECT MAN; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Gopalakrishnan G, 2012, GCB BIOENERGY, V4, P739, DOI 10.1111/j.1757-1707.2011.01145.x; Gopalakrishnan G, 2011, J ENVIRON QUAL, V40, P1593, DOI 10.2134/jeq2010.0539; Gopalakrishnan G, 2009, ENVIRON SCI TECHNOL, V43, P6094, DOI 10.1021/es900801u; HOERNER JL, 1948, J ECON ENTOMOL, V41, P631, DOI 10.1093/jee/41.4.631; James LK, 2010, AGRON J, V102, P675, DOI 10.2134/agronj2009.0289; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Landis DA, 2010, INSECT SCI, V17, P220, DOI 10.1111/j.1744-7917.2009.01310.x; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; National Academy of Sciences, 2009, LIQU TRANSP FUELS CO; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; NRCS, 2010, NAT SOIL SURV HD 622; NRCS Soil survey staff natural resources conservation service United States department of agriculture, 2010, SOIL SURVEY PAGE COU; Perlack R. D., 2011, ORNLTM2011224; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; RISCH SJ, 1983, ENVIRON ENTOMOL, V12, P625, DOI 10.1093/ee/12.3.625; Robertson BA, 2012, BIOENERG RES, V5, P179, DOI 10.1007/s12155-011-9161-3; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; USDA ERS, 2011, FEED GRAINS DAT YB T; USDA National Agricultural Statistics Service Cropland Data Layer, 2010, CROPL DAT LAYER; Werling BP, 2011, BIOL CONTROL, V59, P304, DOI 10.1016/j.biocontrol.2011.06.014; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; Zhang W, 2012, J ENVIRON MANAGE, V96, P7, DOI 10.1016/j.jenvman.2011.10.008; Zuur Alain F., 2009, P1	45	45	45	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41728	10.1371/journal.pone.0041728	http://dx.doi.org/10.1371/journal.pone.0041728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848582	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600109
J	Choi, JY; Roh, JY; Wang, Y; Zhen, Z; Tao, XY; Lee, JH; Liu, Q; Kim, JS; Shin, SW; Je, YH				Choi, Jae Young; Roh, Jong Yul; Wang, Yong; Zhen, Zou; Tao, Xue Ying; Lee, Joo Hyun; Liu, Qin; Kim, Jae Su; Shin, Sang Woon; Je, Yeon Ho			Analysis of Genes Expression of Spodoptera exigua Larvae upon AcMNPV Infection	PLOS ONE			English	Article							AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; HORMONE-BINDING-PROTEIN; GLYCOPROTEIN E2; MESSENGER-RNA; VIRUS; HEMOLYMPH; GLOVERIN; CELLS; BACULOVIRUSES; TRANSCRIPTION	Background: The impact of Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV) infection on host gene expression in Spodoptera exigua 4th instar larvae was investigated through the use of 454 sequencing-based RNA-seq of cDNA libraries developed from insects challenged with active AcMNPV or heat-inactivated AcMNPV. Methodology/Principal Findings: By comparing the two cDNA libraries, we show that 201 host genes are significantly up-regulated and 234 genes are significantly down-regulated by active AcMNPV infection. Down-regulated host genes included genes encoding antimicrobial peptides, namely three gloverin isoforms and an attacin, indicating that the viral infection actively repressed the expression of a portion of the host immune gene repertoire. Another interesting group of down-regulated host genes included genes encoding two juvenile hormone binding proteins and a hexamerin, all of which are involved in juvenile hormone regulation. The expression of these genes was enhanced by the topical application of Juvenile Hormone III (JHIII) in the insects challenged with heat-inactivated AcMNPV. However, infection with the active virus strongly suppresses the expression of these three genes, regardless of the absence or presence of JHIII. Conclusions/Significance: Using RNA-seq, we have identified groups of immune-regulated and juvenile hormone-regulated genes that are suppressed by infection with active AcMNPV. This information and further studies on the regulation of host gene expression by AcMNPV will provide the tools needed to enhance the utility of the virus as an effective protein expression system and as an insecticide.	[Choi, Jae Young; Tao, Xue Ying; Lee, Joo Hyun; Liu, Qin; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea; [Roh, Jong Yul] Korea Natl Inst Hlth, Div Med Entomol, Chungbuk, South Korea; [Wang, Yong] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Zhen, Zou] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Kim, Jae Su] Chonbuk Natl Univ, Coll Agr Life Sci, Dept Agr Biol, Jeonju, South Korea; [Shin, Sang Woon] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Shin, Sang Woon] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Je, Yeon Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Lanzhou University; Chinese Academy of Sciences; Institute of Zoology, CAS; Jeonbuk National University; University of California System; University of California Riverside; University of California System; University of California Riverside; Seoul National University (SNU)	Choi, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea.	shinwoongg@gmail.com; btrus@snu.ac.kr	zou, zhen/C-6134-2016; Tao, XueYing/ABG-6993-2021; Kim, Jae Su/L-2194-2013; Choi, Jae Young/G-1731-2010	zou, zhen/0000-0003-3550-7656; Tao, XueYing/0000-0002-6539-4659; 	Next-Generation BioGreen 21 Program [PJ008036]; Rural Development Administration, Republic of Korea; 2nd stage of the Brain Korea 21 project	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); 2nd stage of the Brain Korea 21 project	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008036), Rural Development Administration, Republic of Korea. HJS, YW, XYT, and QL were supported by the 2nd stage of the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Bangels Eva, 2008, Commun Agric Appl Biol Sci, V73, P655; Bouma A, 1999, VET MICROBIOL, V66, P101, DOI 10.1016/S0378-1135(99)00003-6; Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756; Choudary P V, 1995, Methods Mol Biol, V39, P243; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; FRASER JRE, 1986, CLIN RHEUM DIS, V12, P369; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; GUARINO LA, 1992, J VIROL, V66, P7113, DOI 10.1128/JVI.66.12.7113-7120.1992; Guo TQ, 2005, VIROLOGY, V341, P231, DOI 10.1016/j.virol.2005.06.045; HaasKogan DA, 1996, INT J RADIAT ONCOL, V36, P95, DOI 10.1016/S0360-3016(96)00244-1; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Katsuma S, 2007, J VIROL, V81, P13700, DOI 10.1128/JVI.01683-07; Kawaoka S, 2008, ARCH INSECT BIOCHEM, V67, P87, DOI 10.1002/arch.20223; KRAMER KJ, 1974, P NATL ACAD SCI USA, V71, P493, DOI 10.1073/pnas.71.2.493; Landais I, 2003, BIOINFORMATICS, V19, P2343, DOI 10.1093/bioinformatics/btg324; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; OREILLY DR, 1990, J VIROL, V64, P1321, DOI 10.1128/JVI.64.3.1321-1328.1990; OREILLY DR, 1989, SCIENCE, V245, P1110, DOI 10.1126/science.2505387; Pearson MN, 2001, VIROLOGY, V291, P22, DOI 10.1006/viro.2001.1191; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Sparks WO, 2011, VIROLOGY, V409, P69, DOI 10.1016/j.virol.2010.09.027; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Sun XL, 2002, J INVERTEBR PATHOL, V81, P63, DOI 10.1016/S0022-2011(02)00144-1; Tawfik AI, 2006, J INSECT PHYSIOL, V52, P255, DOI 10.1016/j.jinsphys.2005.11.005; van Oers MM, 1999, J GEN VIROL, V80, P2253, DOI 10.1099/0022-1317-80-8-2253; van Oers MM, 2001, INSECT MOL BIOL, V10, P255, DOI 10.1046/j.1365-2583.2001.00263.x; van Rijn PA, 1999, VACCINE, V17, P433, DOI 10.1016/S0264-410X(98)00215-1; Vanarsdall AL, 2007, VIROLOGY, V364, P475, DOI 10.1016/j.virol.2007.03.024; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019; YOUNG KKY, 1993, J CLIN MICROBIOL, V31, P882, DOI 10.1128/JCM.31.4.882-886.1993; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	46	24	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42462	10.1371/journal.pone.0042462	http://dx.doi.org/10.1371/journal.pone.0042462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860129	Green Submitted, Green Published, gold			2022-12-27	WOS:000307045600103
J	Joseph, S; Deneke, VE; Dahl, KDC				Joseph, Stancy; Deneke, Victoria E.; Dahl, Karen D. Cowden			ARID3B Induces Tumor Necrosis Factor Alpha Mediated Apoptosis While a Novel ARID3B Splice Form Does Not Induce Cell Death	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DNA-BINDING PROTEINS; EPITHELIAL OVARIAN-CARCINOMA; CANCER-THERAPY; EXPRESSION; FAMILY; PHOSPHORYLATION; DIFFERENTIATION; INHIBITION; ACTIVATION	Alternative splicing is a common occurrence in many cancers. Alternative splicing is linked with decreased apoptosis and chemoresistance in cancer cells. We previously demonstrated that ARID3B, a member of the AT-rich interactive domain (ARID) family of DNA binding proteins, is overexpressed in ovarian cancer. Therefore we wanted to assess the effect of ARID3B splice forms on cell viability. We identified a novel splice form of the ARID3B gene (designated as ARID3B Sh), which lacks the C-terminal exons 5-9 present in the full-length isoform (ARID3B Fl). ARID3B Fl is expressed in a variety of cancer cell lines. Expression of ARID3B Sh varied by cell type, but was highly expressed in most ovarian cancer lines. ARID3B is modestly transcriptionally activated by epidermal growth factor receptor (EGFR) signaling through the PEA3 transcription factor. We further found that ARID3B Fl is predominantly nuclear but is also present at the plasma membrane and in the cytosol. Endogenous ARID3B Sh is present in nuclear fractions, yet, when overexpressed ARID3B Sh accumulates in the cytosol and membrane fractions. The differential localization of these isoforms suggests they have different functions. Importantly, ARID3B Fl overexpression results in upregulation of pro-apoptotic BIM and induces Tumor Necrosis Factor alpha (TNF alpha) and TNF-related apoptosis inducing ligand (TRAIL) induced cell death. The ARID3B Fl-induced genes include TNF alpha, TRAIL, TRADD, TNF-R2, Caspase 10 and Caspase 7. Interestingly, ARID3B Sh does not induce apoptosis or expression of these genes. ARID3B Fl induces death receptor mediated apoptosis while the novel splice form ARID3B Sh does not induce cell death. Therefore alternative splice forms of ARID3B may play different roles in ovarian cancer progression.	[Joseph, Stancy; Dahl, Karen D. Cowden] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN USA; [Dahl, Karen D. Cowden] Notre Dame Univ, Dept Chem & Biochem, Notre Dame, IN USA; [Dahl, Karen D. Cowden] Notre Dame Univ, Eck Inst Global Hlth, Notre Dame, IN USA; [Dahl, Karen D. Cowden] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Deneke, Victoria E.] Univ Notre Dame, Dept Engn, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University-Purdue University Indianapolis; University of Notre Dame	Joseph, S (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN USA.	kcowdend@iupui.edu		Deneke, Victoria/0000-0002-4404-8706	National Institutes of Health (NIH) [R00CA133190]; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R00CA133190] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institutes of Health (NIH) R00CA133190. This research was supported in part by a grant from the Marsha Rivkin Center for Ovarian Cancer Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American CancerSociety, 2010, GLOB CANC FACTS FIG; BERKOWITZ R, 1983, AM J OBSTET GYNECOL, V146, P607, DOI 10.1016/0002-9378(83)90999-7; Bevis KS, 2010, GYNECOL ONCOL, V119, P157, DOI 10.1016/j.ygyno.2010.05.034; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cretney E, 2006, IMMUNOL CELL BIOL, V84, P87, DOI 10.1111/j.1440-1711.2005.01413.x; Dahl KDC, 2007, MOL CANCER RES, V5, P413, DOI 10.1158/1541-7786.MCR-07-0019; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Ellerbroek SM, 1998, INT J CANCER, V78, P331, DOI 10.1002/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO;2-9; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Kovalenko A, 2006, MOL CELL, V22, P433, DOI 10.1016/j.molcel.2006.05.002; MOSER TL, 1994, INT J CANCER, V56, P552, DOI 10.1002/ijc.2910560415; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Numata S, 1999, CANCER RES, V59, P3741; Sayers TJ, 2006, CANCER IMMUNOL IMMUN, V55, P76, DOI 10.1007/s00262-005-0676-3; SCAMBIA G, 1992, J CLIN ONCOL, V10, P529, DOI 10.1200/JCO.1992.10.4.529; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; STEWART CJR, 1992, INT J GYNECOL PATHOL, V11, P266, DOI 10.1097/00004347-199210000-00004; Syed V, 2007, J CELL BIOCHEM, V102, P442, DOI 10.1002/jcb.21304; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Tanaka Y, 2011, CANCER BIOL THER, V11, P50, DOI 10.4161/cbt.11.1.13877; Tidwell JA, 2011, MOL IMMUNOL, V49, P260, DOI 10.1016/j.molimm.2011.08.025; Tomek S, 2004, GYNECOL ONCOL, V94, P107, DOI 10.1016/j.ygyno.2004.04.012; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; Webb CF, 1998, J IMMUNOL, V160, P4747; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95	40	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42159	10.1371/journal.pone.0042159	http://dx.doi.org/10.1371/journal.pone.0042159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860069	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600062
J	Matias, I; Gatta-Cherifi, B; Tabarin, A; Clark, S; Leste-Lasserre, T; Marsicano, G; Piazza, PV; Cota, D				Matias, Isabelle; Gatta-Cherifi, Blandine; Tabarin, Antoine; Clark, Samantha; Leste-Lasserre, Thierry; Marsicano, Giovanni; Piazza, Pier Vincenzo; Cota, Daniela			Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity	PLOS ONE			English	Article							ENERGY-BALANCE; LIFE-STYLE; CB1 RECEPTOR; FOOD-INTAKE; ANANDAMIDE; SYSTEM; ACTIVATION; PLASMA; ACYLETHANOLAMIDES; INHIBITION	Background: The discovery of the endocannabinoid system and of its role in the regulation of energy balance has significantly advanced our understanding of the physiopathological mechanisms leading to obesity and type 2 diabetes. New knowledge on the role of this system in humans has been acquired by measuring blood endocannabinoids. Here we explored endocannabinoids and related N-acylethanolamines in saliva and verified their changes in relation to body weight status and in response to a meal or to body weight loss. Methodology/Principal Findings: Fasting plasma and salivary endocannabinoids and N-acylethanolamines were measured through liquid mass spectrometry in 12 normal weight and 12 obese, insulin-resistant subjects. Salivary endocannabinoids and N-acylethanolamines were evaluated in the same cohort before and after the consumption of a meal. Changes in salivary endocannabinoids and N-acylethanolamines after body weight loss were investigated in a second group of 12 obese subjects following a 12-weeks lifestyle intervention program. The levels of mRNAs coding for enzymes regulating the metabolism of endocannabinoids, N-acylethanolamines and of cannabinoid type 1 (CB1) receptor, alongside endocannabinoids and N-acylethanolamines content, were assessed in human salivary glands. The endocannabinoids 2-arachidonoylglycerol (2-AG), N-arachidonoylethanolamide (anandamide, AEA), and the N-acylethanolamines (oleoylethanolamide, OEA and palmitoylethanolamide, PEA) were quantifiable in saliva and their levels were significantly higher in obese than in normal weight subjects. Fasting salivary AEA and OEA directly correlated with BMI, waist circumference and fasting insulin. Salivary endocannabinoids and N-acylethanolamines did not change in response to a meal. CB1 receptors, ligands and enzymes were expressed in the salivary glands. Finally, a body weight loss of 5.3% obtained after a 12-weeks lifestyle program significantly decreased salivary AEA levels. Conclusions/Significance: Endocannabinoids and N-acylethanolamines are quantifiable in saliva and their levels correlate with obesity but not with feeding status. Body weight loss significantly decreases salivary AEA, which might represent a useful biomarker in obesity.	[Matias, Isabelle; Marsicano, Giovanni] INSERM, Grp Endocannabinoids & Neuroadaptat, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France; [Gatta-Cherifi, Blandine; Tabarin, Antoine; Clark, Samantha; Cota, Daniela] INSERM, Grp Energy Balance & Obes, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France; [Leste-Lasserre, Thierry; Piazza, Pier Vincenzo] INSERM, Grp Physiopathol Addict, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France; [Matias, Isabelle; Gatta-Cherifi, Blandine; Tabarin, Antoine; Clark, Samantha; Leste-Lasserre, Thierry; Marsicano, Giovanni; Piazza, Pier Vincenzo; Cota, Daniela] Univ Bordeaux, Neuroctr Magendie Physiopathol Plasticite Neurona, Bordeaux, France; [Gatta-Cherifi, Blandine; Tabarin, Antoine] Haut Leveque Hosp, Dept Endocrinol, Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Matias, I (corresponding author), INSERM, Grp Endocannabinoids & Neuroadaptat, Neuroctr Magendie Physiophatol Plasticite Neurona, Bordeaux, France.	daniela.cota@inserm.fr	Marsicano, Giovanni/I-9603-2016	Cota, Daniela/0000-0002-6909-2156; Marsicano, Giovanni/0000-0003-3804-1951; Cherifi, Blandine/0000-0002-7399-1330	INSERM/AVENIR; INSERM/ interface; Aquitaine Region; French Society of Endocrinology; Fondation Recherche Medicale; EU-FP7 [HEALTH-F2-2008-223713]; EU-FP7 ENDOFOOD [ERC-2010-StG]	INSERM/AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); INSERM/ interface; Aquitaine Region(Region Nouvelle-Aquitaine); French Society of Endocrinology; Fondation Recherche Medicale; EU-FP7(European Commission); EU-FP7 ENDOFOOD	This work was supported by INSERM/AVENIR (DC and GM), INSERM/ interface (DC), Aquitaine Region (DC and GM), French Society of Endocrinology (BGC), Fondation Recherche Medicale, EU-FP7 HEALTH-F2-2008-223713 and EU-FP7 ENDOFOOD ERC-2010-StG (GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026137; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Benedix F, 2011, OBES SURG, V21, P616, DOI 10.1007/s11695-011-0374-5; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Dall'Aglio C, 2010, VET RES COMMUN, V34, pS9, DOI 10.1007/s11259-010-9379-0; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Epstein LH, 1996, PSYCHOSOM MED, V58, P160, DOI 10.1097/00006842-199603000-00011; Fanelli F, 2012, J LIPID RES, V53, P481, DOI 10.1194/jlr.M021378; Fernandez-Solari J, 2010, ARCH ORAL BIOL, V55, P583, DOI 10.1016/j.archoralbio.2010.05.006; Fezza F, 2003, BBA-MOL CELL BIOL L, V1633, P61, DOI 10.1016/S1388-1981(03)00087-8; Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Joosten MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-49; Jumpertz R, 2010, EXP CLIN ENDOCR DIAB, V118, P591, DOI 10.1055/s-0030-1253344; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Lam PMW, 2010, ANAL BIOANAL CHEM, V398, P2089, DOI 10.1007/s00216-010-4103-z; Lawrence Herenia P, 2002, J Can Dent Assoc, V68, P170; Li BB, 2011, ARCH ORAL BIOL, V56, P389, DOI 10.1016/j.archoralbio.2010.10.014; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Marczylo TH, 2009, ANAL BIOCHEM, V384, P106, DOI 10.1016/j.ab.2008.08.040; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; Matias I, 2006, INT J OBESITY, V30, pS7, DOI 10.1038/sj.ijo.0803271; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Modeer T, 2010, OBESITY, V18, P2367, DOI 10.1038/oby.2010.63; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Prestifilippo JP, 2009, ALCOHOL ALCOHOLISM, V44, P443, DOI 10.1093/alcalc/agp040; POWERS PS, 1982, INT J OBESITY, V6, P267; Prestifilippo JP, 2006, EXP BIOL MED, V231, P1421, DOI 10.1177/153537020623100816; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schwartz GJ, 2011, PHYSIOL BEHAV, V104, P621, DOI 10.1016/j.physbeh.2011.05.003; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Spielmann N, 2011, ORAL DIS, V17, P345, DOI 10.1111/j.1601-0825.2010.01773.x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Unick JL, 2011, DIABETES CARE, V34, P2152, DOI 10.2337/dc11-0874; Ware MA, 2003, PAIN, V102, P211, DOI 10.1016/S0304-3959(02)00400-1; WOOLEY OW, 1976, PHYSIOL BEHAV, V17, P187, DOI 10.1016/0031-9384(76)90062-7; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107	44	84	88	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42399	10.1371/journal.pone.0042399	http://dx.doi.org/10.1371/journal.pone.0042399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860123	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600099
J	Song, ZB; Guo, QL; Zhang, J; Li, MY; Liu, C; Zou, WY				Song, Zongbin; Guo, Qulian; Zhang, Jie; Li, Maoyu; Liu, Chang; Zou, Wangyuan			Proteomic Analysis of PKC gamma-Related Proteins in the Spinal Cord of Morphine-Tolerant Rats	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; KINASE-C-GAMMA; NEUROTROPHIC FACTOR; GLIAL-CELLS; DOPAMINERGIC-NEURONS; ANALGESIC TOLERANCE; ACTIN CYTOSKELETON; RNA INTERFERENCE; NEUROPATHIC PAIN; EXPRESSION	Background: Morphine tolerance is a common drawback of chronic morphine exposure, hindering use of this drug. Studies have shown that PKCa may play a key role in the development of morphine tolerance, although the mechanisms are not fully known. Methodology/Principal Findings: In a rat model of morphine tolerance, PKCa knockdown in the spinal cord was successfully carried out using RNA interference (RNAi) with lentiviral vector-mediated short hairpin RNA of PKCa (LV-shPKCa). Spinal cords (L4-L5) were obtained surgically from morphine-tolerant (MT) rats with and without PKCa knockdown, for comparative proteomic analysis. Total proteins from the spinal cords (L4-L5) were extracted and separated using two-dimensional gel electrophoresis (2DGE); 2D gel images were analyzed with PDQuest software. Seven differential gel-spots were observed with increased spot volume, and 18 spots observed with decreased spot volume. Among these, 13 differentially expressed proteins (DEPs) were identified with matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), comparing between MT rats with and without PKCa knockdown. The DEPs identified have roles in the cytoskeleton, as neurotrophic factors, in oxidative stress, in ion metabolism, in cell signaling, and as chaperones. Three DEPs (GFAP, FSCN and GDNF) were validated with Western blot analysis, confirming the DEP data. Furthermore, using immunohistochemical analysis, we reveal for the first time that FSCN is involved in the development of morphine tolerance. Conclusions/Significance: These data cast light on the proteins associated with the PKCa activity during morphine tolerance, and hence may contribute to clarification of the mechanisms by which PKCa influences MT.	[Song, Zongbin; Guo, Qulian; Liu, Chang; Zou, Wangyuan] Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Zhang, Jie] Maternal & Child Hlth Hosp Hunan Prov, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Li, Maoyu] Cent S Univ, Xiangya Hosp, Minist Hlth, Key Lab Canc Prote Chinese, Changsha, Hunan, Peoples R China	Central South University; Central South University	Song, ZB (corresponding author), Cent S Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	zwyfeng@yahoo.com.cn	Song, Zongbin/GYD-5863-2022	Song, Zongbin/0000-0002-0447-8648	National Natural Science Foundation of China [30801074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 30801074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Zaher AO, 2010, NEUROCHEM RES, V35, P1557, DOI 10.1007/s11064-010-0215-2; Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Airavaara M, 2006, SYNAPSE, V59, P321, DOI 10.1002/syn.20245; Bailey CP, 2006, TRENDS PHARMACOL SCI, V27, P558, DOI 10.1016/j.tips.2006.09.006; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Bodzon-Kulakowska A, 2009, J SEP SCI, V32, P1200, DOI 10.1002/jssc.200800464; Brodie C, 1998, MOL BRAIN RES, V56, P108, DOI 10.1016/S0169-328X(98)00035-7; Brown JA, 2009, DEV NEUROBIOL, V69, P633, DOI 10.1002/dneu.20732; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chakrabarti S, 2005, MOL BRAIN RES, V138, P94, DOI 10.1016/j.molbrainres.2005.04.004; Chen SR, 2007, NEUROSCIENCE, V145, P676, DOI 10.1016/j.neuroscience.2006.12.016; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Contet C, 2008, NEUROPHARMACOLOGY, V54, P475, DOI 10.1016/j.neuropharm.2007.10.015; Dacher M, 2011, NEUROPHARMACOLOGY, V61, P1088, DOI 10.1016/j.neuropharm.2011.01.028; Darcq E, 2012, NEUROPSYCHOPHARMACOL, V37, P1288, DOI 10.1038/npp.2011.316; Doussau F, 2000, J BIOL CHEM, V275, P7764, DOI 10.1074/jbc.275.11.7764; Gintzler AR, 2008, J PHARMACOL EXP THER, V325, P709, DOI 10.1124/jpet.107.135533; Gomez-Flores R, 1999, J INTERF CYTOK RES, V19, P625, DOI 10.1089/107999099313767; Granados-Soto V, 2000, PAIN, V85, P395, DOI 10.1016/S0304-3959(99)00281-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Huang YN, 2012, BEHAV BRAIN RES, V229, P401, DOI 10.1016/j.bbr.2012.01.044; Kim SY, 2005, MOL BRAIN RES, V133, P58, DOI 10.1016/j.molbrainres.2004.09.018; KOIKE T, 1992, J BIOCHEM-TOKYO, V112, P624, DOI 10.1093/oxfordjournals.jbchem.a123950; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Li M, 2007, J BIOCHEM MOL BIOL, V40, P72; Lim GW, 2005, J NEUROSCI, V25, P11145, DOI 10.1523/JNEUROSCI.3768-05.2005; Lin HY, 2012, J PHARMACOL EXP THER, V341, P115, DOI 10.1124/jpet.111.188235; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindsey JC, 2007, BRIT J CANCER, V97, P267, DOI 10.1038/sj.bjc.6603852; Ma J, 2010, INFECT IMMUN, V78, P830, DOI 10.1128/IAI.00914-09; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mameli M, 2011, NEUROPHARMACOLOGY, V61, P1052, DOI 10.1016/j.neuropharm.2011.01.036; Martin WJ, 2001, J NEUROSCI, V21, P5321, DOI 10.1523/JNEUROSCI.21-14-05321.2001; Matsushita Y, 2007, NEUROSCIENCE, V148, P541, DOI 10.1016/j.neuroscience.2007.06.019; Moretto G, 1996, CELL TISSUE RES, V286, P257, DOI 10.1007/s004410050695; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Muscoli C, 2007, J CLIN INVEST, V117, P3530, DOI 10.1172/JCI32420; Narita M, 2004, EUR J NEUROSCI, V19, P479, DOI 10.1111/j.0953-816X.2003.03119.x; Niwa M, 2007, J PHARMACOL SCI, V104, P116, DOI 10.1254/jphs.CP0070017; Niwa M, 2007, BEHAV BRAIN RES, V179, P167, DOI 10.1016/j.bbr.2007.01.026; Ono S, 1997, J BIOL CHEM, V272, P2527; Pappas SS, 2011, NEUROPHARMACOLOGY, V61, P614, DOI 10.1016/j.neuropharm.2011.05.002; Parsons M, 2008, J CELL SCI, V121, P2805, DOI 10.1242/jcs.022509; Pushparaj PN, 2008, J DENT RES, V87, P992, DOI 10.1177/154405910808701109; Rohl T, 2006, J NEUROCHEM, V99, P371, DOI 10.1111/j.1471-4159.2006.04082.x; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Saeed U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002459; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sharma HS, 2011, CURR NEUROPHARMACOL, V9, P223, DOI 10.2174/157015911795017100; Shui HA, 2007, PROTEOMICS, V7, P796, DOI 10.1002/pmic.200600699; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Song ZB, 2010, J GENE MED, V12, P873, DOI 10.1002/jgm.1514; Suder P, 2009, J PROTEOME RES, V8, P4633, DOI 10.1021/pr900443r; Sun Y, 2007, FEBS LETT, V581, P131, DOI 10.1016/j.febslet.2006.12.008; Sweitzer SM, 2004, PAIN, V110, P281, DOI 10.1016/j.pain.2004.04.004; Walwyn WM, 2006, NEUROSCIENCE, V142, P493, DOI 10.1016/j.neuroscience.2006.06.021; Wen ZH, 2008, ACTA ANAESTH SCAND, V52, P499, DOI 10.1111/j.1399-6576.2008.01605.x; Zeitz KP, 2001, PAIN, V94, P245, DOI 10.1016/S0304-3959(01)00353-0; Zhang FR, 2008, J HISTOCHEM CYTOCHEM, V56, P193, DOI 10.1369/jhc.7A7353.2007; [邹望远 ZOU Wang-yuan], 2010, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V30, P44; Zou WY, 2012, BRAIN RES, V1440, P34, DOI 10.1016/j.brainres.2011.12.046; Zou WY, 2011, HUM GENE THER, V22, P465, DOI 10.1089/hum.2010.207	66	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42068	10.1371/journal.pone.0042068	http://dx.doi.org/10.1371/journal.pone.0042068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22860055	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600057
J	Sypsa, V; Psichogiou, M; Bouzala, GA; Hadjihannas, L; Hatzakis, A; Daikos, GL				Sypsa, Vana; Psichogiou, Mina; Bouzala, Georgia-Aikaterina; Hadjihannas, Linos; Hatzakis, Angelos; Daikos, Georgios L.			Transmission Dynamics of Carbapenemase-Producing Klebsiella Pneumoniae and Anticipated Impact of Infection Control Strategies in a Surgical Unit	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INTENSIVE-CARE-UNIT; MATHEMATICAL-MODEL; HAND HYGIENE; RISK-FACTORS; HOSPITALS; EPIDEMIC; COLONIZATION; ACQUISITION; BACTERIA	Background: Carbapenemase-producing Klebsiella pneumoniae (CPKP) has been established as important nosocomial pathogen in many geographic regions. Transmission from patient to patient via the hands of healthcare workers is the main route of spread in the acute-care setting. Methodology/Principal Findings: Epidemiological and infection control data were recorded during a prospective observational study conducted in a surgical unit of a tertiary-care hospital in Greece. Surveillance culture for CPKP were obtained from all patients upon admission and weekly thereafter. The Ross-Macdonald model for vector-borne diseases was applied to obtain estimates for the basic reproduction number R-0 (average number of secondary cases per primary case in the absence of infection control) and assess the impact of infection control measures on CPKP containment in endemic and hyperendemic settings. Eighteen of 850 patients were colonized with CPKP on admission and 51 acquired CPKP during hospilazation. R-0 reached 2 and exceeded unity for long periods of time under the observed hand hygiene compliance (21%). The minimum hand hygiene compliance level necessary to control transmission was 50%. Reduction of 60% to 90% in colonized patients on admission, through active surveillance culture, contact precautions and isolation/cohorting, in combination with 60% compliance in hand hygiene would result in rapid decline in CPKP prevalence within 8-12 weeks. Antibiotics restrictions did not have a substantial benefit when an aggressive control strategy was implemented. Conclusions/Significance: Surveillance culture on admission and isolation/cohorting of colonized patients coupled with moderate hand hygiene compliance and contact precautions may lead to rapid control of CPKP in endemic and hyperendemic healthcare settings.	[Sypsa, Vana; Hatzakis, Angelos] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Psichogiou, Mina; Bouzala, Georgia-Aikaterina; Hadjihannas, Linos; Daikos, Georgios L.] Univ Athens, Laikon Gen Hosp, Dept Internal Med Propaedeut 1, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Laiko General Hospital; National & Kapodistrian University of Athens	Sypsa, V (corresponding author), Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece.	vsipsa@med.uoa.gr	Daikos, George L./ABD-8378-2021	SYPSA, VANA/0000-0002-9430-7614	Hellenic Centre for Infectious Diseases control and prevention [20732/28/12/2009]	Hellenic Centre for Infectious Diseases control and prevention	Funding was provided by Hellenic Centre for Infectious Diseases control and prevention, Principal Investigator, G. L. Daikos, no: 20732/28/12/2009. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; D'Agata EMC, 2002, J INFECT DIS, V185, P766, DOI 10.1086/339293; Daikos GL, 2010, J ANTIMICROB CHEMOTH, V65, P784, DOI 10.1093/jac/dkq005; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Forrester M, 2005, INFECT CONT HOSP EP, V26, P598, DOI 10.1086/502588; Giakkoupi P, 2011, J ANTIMICROB CHEMOTH, V66, P1510, DOI 10.1093/jac/dkr166; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Grundmann H, 2010, EURO SURVEILL, V15; Kaki R, 2011, J ANTIMICROB CHEMOTH, V66, P1223, DOI 10.1093/jac/dkr137; Kassis-Chikhani N, 2010, EURO SURVEILL, V15; LARSON EL, 1980, J CLIN MICROBIOL, V12, P355, DOI 10.1128/JCM.12.3.355-360.1980; Lemmen SW, 2004, J HOSP INFECT, V56, P191, DOI 10.1016/j.jhin.2003.12.004; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Patel N, 2011, J ANTIMICROB CHEMOTH, V66, P1600, DOI 10.1093/jac/dkr156; Psichogiou M, 2008, J ANTIMICROB CHEMOTH, V61, P59, DOI 10.1093/jac/dkm443; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Schwaber MJ, 2008, JAMA-J AM MED ASSOC, V300, P2911, DOI 10.1001/jama.2008.896; Tsakris A, 2009, J CLIN MICROBIOL, V47, P3420, DOI 10.1128/JCM.01314-09; VATOPOULOS A, 2008, EURO SURVEILL, V13; Wang X, 2012, J THEOR BIOL, V293, P161, DOI 10.1016/j.jtbi.2011.10.009; Wernli D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001022	38	37	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e41068	10.1371/journal.pone.0041068	http://dx.doi.org/10.1371/journal.pone.0041068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	22859965	gold, Green Published, Green Submitted			2022-12-27	WOS:000307045600016
J	Ellertsdottir, E; Berthold, PR; Bouzaffour, M; Dufourcq, P; Trayer, V; Gauron, C; Vriz, S; Affolter, M; Rampon, C				Ellertsdottir, Elin; Berthold, Peter R.; Bouzaffour, Mohamed; Dufourcq, Pascale; Trayer, Vincent; Gauron, Carole; Vriz, Sophie; Affolter, Markus; Rampon, Christine			Developmental Role of Zebrafish Protease-Activated Receptor 1 (PAR1) in the Cardio-Vascular System	PLOS ONE			English	Article							THROMBIN-RECEPTOR; VASCULAR DEVELOPMENT; DESENSITIZATION; HEMATOPOIESIS; INHIBITION; KINASE	Thrombin receptor, F2R or PAR1 is a G-protein coupled receptor, located in the membrane of endothelial cells. It has been initially found to transduce signals in hemostasis, but recently also known to act in cancer and in vascular development. Mouse embryos lacking PAR1 function die from hemorrhages with varying frequency at midgestation. We have performed a survey of potential PAR1 homologs in the zebrafish genome and identified a teleost ortholog of mammalian PAR1. Knockdown of par1 function in zebrafish embryos demonstrates a requirement for Par1 in cardio-vascular development. Furthermore, we show that function of Par1 requires the presence of a phylogenetically conserved proteolytic cleavage site and a second intracellular domain. Altogether our results demonstrate a high degree of conservation of PAR1 proteins in the vertebrate lineage in respect to amino acid sequence as well as protein function.	[Ellertsdottir, Elin; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland; [Berthold, Peter R.; Bouzaffour, Mohamed; Dufourcq, Pascale; Trayer, Vincent; Vriz, Sophie; Rampon, Christine] Univ Paris Diderot, Paris, France; [Gauron, Carole; Vriz, Sophie; Rampon, Christine] Coll France, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Gauron, Carole; Vriz, Sophie; Rampon, Christine] CNRS, UMR 7241, Paris, France; [Gauron, Carole; Vriz, Sophie; Rampon, Christine] INSERM, Paris, France	University of Basel; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Ellertsdottir, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	christine.rampon@college-de-france.fr		Affolter, Markus/0000-0002-5171-0016; /0000-0002-9058-9378; rampon, christine/0000-0002-1444-3166; /0000-0003-2029-5750	Swiss National Science Foundation; Network of Excellence grant "Cells into Organs" from the FP6 of the European Community; ANR Proteophane; Canton Basel-Stadt; Canton Basel-Land	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Network of Excellence grant "Cells into Organs" from the FP6 of the European Community; ANR Proteophane(French National Research Agency (ANR)); Canton Basel-Stadt; Canton Basel-Land	This work has been supported by the Cantons Basel-Stadt and Basel-Land, the Swiss National Science Foundation, and by a Network of Excellence grant "Cells into Organs" from the FP6 of the European Community. Carole Gauron is supported by ANR Proteophane 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Hirano Katsuya, 2003, J Atheroscler Thromb, V10, P211; Iida A, 2010, CURR BIOL, V20, P1110, DOI 10.1016/j.cub.2010.04.052; ISHII K, 1994, J BIOL CHEM, V269, P1125; Jiang TR, 1998, J MOL CELL CARDIOL, V30, P2193, DOI 10.1006/jmcc.1998.0779; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Kwan TT, 2006, EXP HEMATOL, V34, P27, DOI 10.1016/j.exphem.2005.09.017; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McKinney MC, 2008, METHOD ENZYMOL, V444, P65, DOI 10.1016/S0076-6879(08)02804-8; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Song M, 2007, BIOCHEM BIOPH RES CO, V357, P924, DOI 10.1016/j.bbrc.2007.04.033; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wang YX, 2005, FEBS LETT, V579, P4843, DOI 10.1016/j.febslet.2005.07.068; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xu H, 2011, DEV DYNAM, V240, P278, DOI 10.1002/dvdy.22517; Yasutake M, 1996, CIRC RES, V79, P705, DOI 10.1161/01.RES.79.4.705; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025	38	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e42131	10.1371/journal.pone.0042131	http://dx.doi.org/10.1371/journal.pone.0042131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981EY	22860064	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950900070
J	Howe, PD; Incledon, NC; Little, DR				Howe, Piers D.; Incledon, Natalie C.; Little, Daniel R.			Can Attention Be Confined to Just Part of a Moving Object? Revisiting Target-Distractor Merging in Multiple Object Tracking	PLOS ONE			English	Article							VISUAL-DISPLAYS; SPATIAL EXTENT; MODEL; SELECTION; BINDING	While it was initially thought that attention was space-based, more recent work has shown that attention can also be object-based, in that observers find it easier to attend to different parts of the same object than to different parts of different objects. Such studies have shown that attention more easily spreads throughout an object than between objects. However, it is not known to what extent attention can be confined to just part of an object and to what extent attending to part of an object necessarily causes the entire object to be attended. We have investigated this question in the context of the multiple object tracking paradigm in which subjects are shown a scene containing a number of identical moving objects and asked to mentally track a subset of them, the targets, while not tracking the remainder, the distractors. Previous work has shown that joining each target to a distractor by a solid connector so that each target-distractor pair forms a single physical object, a technique known as target-distractor merging, makes it hard to track the targets, suggesting that attention cannot be restricted to just parts of objects. However, in that study the target-distractor pairs continuously changed length, which in itself would have made tracking difficult. Here we show that it remains difficult to track the targets even when the target-distractor pairs do not change length and even when the targets can be differentiated from the connectors that join them to the distractors. Our experiments suggest that it is hard to confine attention to just parts of objects, at least in the case of moving objects.	[Howe, Piers D.; Incledon, Natalie C.; Little, Daniel R.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Howe, PD (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia.	pdhowe@unimelb.edu.au	Little, Daniel/J-5034-2019	Little, Daniel/0000-0003-3607-5525; Howe, Piers/0000-0001-6171-1381				Atchley P, 2001, VIS COGN, V8, P1, DOI 10.1080/13506280042000009; Behrmann M, 1998, J EXP PSYCHOL HUMAN, V24, P1011, DOI 10.1037/0096-1523.24.4.1011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; ERIKSEN CW, 1973, PERCEPT PSYCHOPHYS, V14, P155, DOI 10.3758/BF03198630; ERIKSEN CW, 1972, PERCEPT PSYCHOPHYS, V12, P201, DOI 10.3758/BF03212870; Kazanovich Y, 2006, NEURAL COMPUT, V18, P1413, DOI 10.1162/neco.2006.18.6.1413; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; Lavie N, 1996, PERCEPT PSYCHOPHYS, V58, P1238, DOI 10.3758/BF03207556; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Richard AM, 2008, J EXP PSYCHOL HUMAN, V34, P842, DOI 10.1037/0096-1523.34.4.842; Scholl BJ, 2001, COGNITION, V80, P159, DOI 10.1016/S0010-0277(00)00157-8; Shomstein S, 2002, PERCEPT PSYCHOPHYS, V64, P41, DOI 10.3758/BF03194556; Tripathy S. P., 2011, ATTENTION PHILOS PSY, P117; Tsotsos JK, 1997, CONSCIOUS COGN, V6, P429, DOI 10.1006/ccog.1997.0302; vanMarle K, 2003, PSYCHOL SCI, V14, P498, DOI 10.1111/1467-9280.03451; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	24	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2012	7	7							e41491	10.1371/journal.pone.0041491	http://dx.doi.org/10.1371/journal.pone.0041491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	981EY	22859990	Green Published, gold			2022-12-27	WOS:000306950900025
J	Chen, L; Zhu, SS; Lu, XH; Pang, ZL; Cai, M; Liu, XL				Chen, Lei; Zhu, Shusheng; Lu, Xiaohong; Pang, Zhili; Cai, Meng; Liu, Xili			Assessing the Risk That Phytophthora melonis Can Develop a Point Mutation (V1109L) in CesA3 Conferring Resistance to Carboxylic Acid Amide Fungicides	PLOS ONE			English	Article							BASE-LINE SENSITIVITY; PSEUDOPERONOSPORA-CUBENSIS; PLASMOPARA-VITICOLA; CAA FUNGICIDES; PLANT PATHOGEN; DOWNY MILDEW; IN-VITRO; INFESTANS; CAPSICI; POPULATIONS	The risk that the plant pathogen Phytophthora melonis develops resistance to carboxylic acid amide (CAA) fungicides was determined by measuring baseline sensitivities of field isolates, generating resistant mutants, and measuring the fitness of the resistant mutants. The baseline sensitivities of 80 isolates to flumorph, dimethomorph and iprovalicarb were described by unimodal curves, with mean EC50 values of 0.986 (+/- 0.245), 0.284 (+/- 0.060) and 0.327 (+/- 0.068) mu g/ml, respectively. Seven isolates with different genetic background (as indicated by RAPD markers) were selected to generate CAA-resistance. Fifty-five resistant mutants were obtained from three out of seven isolates by spontaneous selection and UV-mutagenesis with frequencies of 1 x 10(-7) and 1 x 10(-6), respectively. CAA-resistance was stable for all mutants. The resistance factors of these mutants ranged from 7 to 601. The compound fitness index (CFI = mycelial growth x zoospore production x pathogenicity) was often lower for the CAA-resistant isolates than for wild-type isolates, suggesting that the risk of P. melonis developing resistance to CAA fungicides is low to moderate. Among the CAA-resistant isolates, a negative correlation between EC50 values was found for iprovalicarb vs. flumorph and for iprovalicarb vs. dimethomorph. Comparison of the full-length cellulose synthase 3 (CesA3) between wild-type and CAA-resistant isolates revealed only one point mutation at codon position 1109: a valine residue (codon GTG in wild-type isolates) was converted to leucine (codon CTG in resistant mutants). This represents a novel point mutation with respect to mutations in CesA3 conferring resistance to CAA fungicides. Based on this mutation, an efficient allelic-specific PCR (AS-PCR) method was developed for rapid detection of CAA-resistance in P. melonis populations.	[Chen, Lei; Lu, Xiaohong; Pang, Zhili; Cai, Meng; Liu, Xili] China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China; [Zhu, Shusheng] Yunnan Agr Univ, Educ Minist China, Key Lab Agrobiodivers & Pest Management, Kunming, Yunnan, Peoples R China	China Agricultural University; Yunnan Agricultural University	Chen, L (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China.	seedling@cau.edu.cn	Chen, Lei/A-2487-2015	Chen, Lei/0000-0001-5331-9574; Pang, Zhili/0000-0001-8047-1272	China National Science Foundation [30671390, 30800731]	China National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was funded by the China National Science Foundation (NO. 30671390 and 30800731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation manuscript.	Aoki Y, 2011, PEST MANAG SCI, V67, P1557, DOI 10.1002/ps.2214; Bagirova S. F., 2001, Journal of Russian Phytopathological Society, V2, P19; Bi Y, 2011, PHYTOPATHOLOGY, V101, P1104, DOI 10.1094/PHYTO-01-11-0010; Blum M, 2011, PEST MANAG SCI, V67, P1211, DOI 10.1002/ps.2238; Blum M, 2010, FUNGAL GENET BIOL, V47, P499, DOI 10.1016/j.fgb.2010.02.009; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Cohen Y, 2007, PLANT PATHOL, V56, P836, DOI 10.1111/j.1365-3059.2007.01625.x; Cohen Y, 2008, EUR J PLANT PATHOL, V122, P169, DOI 10.1007/s10658-008-9327-9; Cohen Y, 2007, PHYTOPATHOLOGY, V97, P1274, DOI 10.1094/PHYTO-97-10-1274; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Dutzmann S., 1999, Pflanzenschutz-Nachrichten Bayer, V52, P15; GEORGOPOULOS SG, 1981, PLANT DIS, V65, P729, DOI 10.1094/PD-65-729; Gisi U, 2007, PLANT PATHOL, V56, P199, DOI 10.1111/j.1365-3059.2006.01512.x; GISI U, 2007, MODERN CROP PROTECTI, P651; Guharoy S, 2006, J PHYTOPATHOL, V154, P612, DOI 10.1111/j.1439-0434.2006.01155.x; Hayashi K, 2004, THEOR APPL GENET, V108, P1212, DOI 10.1007/s00122-003-1553-0; Ho HH, 2007, MYCOTAXON, V102, P339; HO HH, 1986, MYCOLOGIA, V78, P907, DOI 10.2307/3807429; LI G, 1989, CHINESE SCI BULL, V34, P253; Linde C, 2001, PLANT PATHOL, V50, P97, DOI 10.1046/j.1365-3059.2001.00530.x; Lu XH, 2010, PHYTOPATHOLOGY, V100, P1162, DOI 10.1094/PHYTO-12-09-0351; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Mahuku G, 2000, PLANT PATHOL, V49, P252, DOI 10.1046/j.1365-3059.2000.00450.x; Meng QX, 2011, PLANT PATHOL, V60, P957, DOI 10.1111/j.1365-3059.2011.02454.x; Mirabolfathy M, 2001, MYCOL RES, V105, P1166, DOI 10.1016/S0953-7562(08)61987-5; Mohaghegh P, 2011, PLANT DIS, V95, P455, DOI 10.1094/PDIS-05-10-0379; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Reuveni M, 2003, EUR J PLANT PATHOL, V109, P243, DOI 10.1023/A:1022836105688; Ristaino JB, 1998, APPL ENVIRON MICROB, V64, P948; Shaofeng L, 2007, ZHONGGUO NONG XUE TO, V23, P301; Shattock RC, 2002, PEST MANAG SCI, V58, P944, DOI 10.1002/ps.527; Silvar C, 2006, PLANT DIS, V90, P1135, DOI 10.1094/PD-90-1135; Sun HY, 2010, J PHYTOPATHOL, V158, P244, DOI 10.1111/j.1439-0434.2009.01606.x; Tan G., 2005, NUCLEIC ACIDS RES, V33, P1; Wang HC, 2009, PLANT PATHOL, V58, P571, DOI 10.1111/j.1365-3059.2008.01990.x; Wang R, 2000, ZHI WU BAO HU, V26, P9; Wang Y, 2007, CAN J PLANT PATHOL, V29, P172, DOI 10.1080/07060660709507454; Wu Yongguan, 2011, Weishengwu Xuebao, V51, P1078; Yin YN, 2010, PESTIC BIOCHEM PHYS, V97, P36, DOI 10.1016/j.pestbp.2009.12.002; Young DH, 2001, PEST MANAG SCI, V57, P1081, DOI 10.1002/ps.399; Yuan SK, 2006, PLANT PATHOL, V55, P258, DOI 10.1111/j.1365-3059.2006.01338.x; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06; Zhu SS, 2007, PLANT PATHOL, V56, P967, DOI 10.1111/j.1365-3059.2007.01649.x; Zhu Shu-sheng, 2010, Nongyaoxue Xuebao, V12, P168, DOI 10.3969/j.issn.1008-7303.2010.02.09	44	8	9	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e42069	10.1371/journal.pone.0042069	http://dx.doi.org/10.1371/journal.pone.0042069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848705	gold, Green Submitted, Green Published			2022-12-27	WOS:000306950200154
J	Kim, PY; Zhong, M; Kim, YS; Sanborn, BM; Allen, KGD				Kim, Paul Y.; Zhong, Miao; Kim, Yoon-Sun; Sanborn, Barbara M.; Allen, Kenneth G. D.			Long Chain Polyunsaturated Fatty Acids Alter Oxytocin Signaling and Receptor Density in Cultured Pregnant Human Myometrial Smooth Muscle Cells	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CAVEOLIN-1 ENRICHED DOMAINS; RAT VENTRICULAR MYOCYTES; FISH-OIL SUPPLEMENTATION; 3RD INTRACELLULAR DOMAIN; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; PRETERM BIRTH; INDEPENDENT MECHANISM; HUMAN PARTURITION	Epidemiological studies and interventional clinical trials indicate that consumption of long chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) such as docosahexaenoic acid (DHA) lengthen gestational duration. Although the mechanisms are not well understood, prostaglandins (PG) of the 2-series are known to play a role in the initiation and progress of labor. In animal studies, modest DHA provision has been shown to reduce placental and uterine PGE(2) and PGF(2 alpha), matrix metalloproteinase (MMP)-2 and MMP-9 expression, and placental collagenase activity. However, modulation of PG biosynthesis may not account for all the effects of LC n-3 PUFAs in labor. We investigated one potential PG-independent mechanism of LC PUFA action using cultured pregnant human myometrial smooth muscle cells. Our goal was to characterize the effect of LC PUFA treatment on oxytocin signaling, a potent uterotonic hormone involved in labor. The addition of 10 mu M-100 mu M DHA or arachidonic acid (AA) to the culture media for 48 h resulted in dose dependent enrichment of these fatty acids in membrane lipid. DHA and AA significantly inhibited phosphatidylinositol turnover and [Ca2+](i) mobilization with oxytocin stimulation compared to bovine serum albumin control and equimolar oleic acid. DHA and AA significantly reduced oxytocin receptor membrane concentration without altering binding affinity or rate of receptor internalization. These findings demonstrate a role for LC n-3 PUFAs in regulation of oxytocin signaling and provide new insight into additional mechanisms pertaining to reports of dietary fish and fish oil consumption prolonging gestation.	[Kim, Paul Y.; Allen, Kenneth G. D.] Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA; [Zhong, Miao; Kim, Yoon-Sun; Sanborn, Barbara M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Allen, KGD (corresponding author), Colorado State Univ, Dept Food Sci & Human Nutr, Ft Collins, CO 80523 USA.	kenneth.allen@colostate.edu	Kim, Paul/GYV-3258-2022	Kim, Paul/0000-0003-0943-4924	Colorado Agriculture Experiment Station Grant [NC 116]; NIH [HD09618]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009618, R01HD009618] Funding Source: NIH RePORTER	Colorado Agriculture Experiment Station Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Colorado Agriculture Experiment Station Grant NC 1167 and NIH HD09618. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al MDM, 2000, AM J CLIN NUTR, V71, p285S, DOI 10.1093/ajcn/71.1.285s; Allen KGD, 2001, EXP BIOL MED, V226, P498, DOI 10.1177/153537020122600602; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Barhoumi R, 2006, TOXICOL LETT, V165, P133, DOI 10.1016/j.toxlet.2006.02.005; Behrman R.E, 2006, PRETERM BIRTH CAUSES; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Burghardt RC, 1996, BIOL REPROD, V55, P433, DOI 10.1095/biolreprod55.2.433; Bygdeman M, 1967, PROSTAGLANDINS, P93; CALDER PC, 1992, IMMUNOLOGY, V75, P108; Chen WQ, 2007, INVEST OPHTH VIS SCI, V48, P18, DOI 10.1167/iovs.06-0619; Ciarmela P, 2008, ENDOCRINOLOGY, V149, P2506, DOI 10.1210/en.2007-0692; Conti F, 2009, AM J PHYSIOL-ENDOC M, V296, pE532, DOI 10.1152/ajpendo.90590.2008; COREY EJ, 1983, P NATL ACAD SCI-BIOL, V80, P3581, DOI 10.1073/pnas.80.12.3581; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; deJonge HW, 1996, J MOL CELL CARDIOL, V28, P1097, DOI 10.1006/jmcc.1996.0101; Dunstan JA, 2004, EUR J CLIN NUTR, V58, P429, DOI 10.1038/sj.ejcn.1601825; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; Gimpl G, 2000, EUR J BIOCHEM, V267, P2483, DOI 10.1046/j.1432-1327.2000.01280.x; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gordon MJ, 1997, PROSTAGLANDIN LEUKOT, V57, P232; GRYNBERG A, 1995, J MOL CELL CARDIOL, V27, P2507, DOI 10.1006/jmcc.1995.0238; Guzzi F, 2002, ONCOGENE, V21, P1658, DOI 10.1038/sj.onc.1205219; HALLAQ H, 1990, P NATL ACAD SCI USA, V87, P7834, DOI 10.1073/pnas.87.20.7834; Hamilton BE, 2011, NATL VITAL STAT REP, V60, P1; Hauner H, 2012, AM J CLIN NUTR, V95, P383, DOI 10.3945/ajcn.111.022590; Huang MC, 1996, J NUTR, V126, P2199, DOI 10.1093/jn/126.9.2199; KARIM SMM, 1971, J OBSTET GYN BR COMM, V78, P172; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Ku CY, 2006, J SOC GYNECOL INVEST, V13, P217, DOI 10.1016/j.jsgi.2005.12.007; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McLaren J, 2000, MOL HUM REPROD, V6, P1033, DOI 10.1093/molehr/6.11.1033; MELCHERT HU, 1987, ATHEROSCLEROSIS, V65, P159, DOI 10.1016/0021-9150(87)90017-7; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Monga M, 1996, BIOL REPROD, V55, P427, DOI 10.1095/biolreprod55.2.427; MORRISON WR, 1964, J LIPID RES, V5, P600; Ng Y, 2005, CARCINOGENESIS, V26, P1914, DOI 10.1093/carcin/bgi163; OBRIEN WF, 1986, AM J OBSTET GYNECOL, V155, P1037, DOI 10.1016/0002-9378(86)90341-8; Olsen SF, 2007, EUR J CLIN NUTR, V61, P976, DOI 10.1038/sj.ejcn.1602609; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; OLSEN SF, 1986, LANCET, V2, P367; OLSEN SF, 1991, AM J OBSTET GYNECOL, V164, P1203, DOI 10.1016/0002-9378(91)90683-I; Olsen SF, 2002, BMJ-BRIT MED J, V324, P447, DOI 10.1136/bmj.324.7335.447; OLSON DM, 1995, SEMIN PERINATOL, V19, P52, DOI 10.1016/S0146-0005(95)80047-6; Paneth N, 1990, REPRODUCTIVE PERINAT, P371; Perez MA, 2006, J NUTR BIOCHEM, V17, P446, DOI 10.1016/j.jnutbio.2005.10.003; Phaneuf S, 1998, HUM REPROD UPDATE, V4, P625, DOI 10.1093/humupd/4.5.625; Phaneuf S, 2000, J REPROD FERTIL, V120, P91, DOI 10.1530/reprod/120.1.91; Reece MS, 1996, PROSTAG LEUKOTR ESS, V55, P303, DOI 10.1016/S0952-3278(96)90035-6; Reece MS, 1997, AM J OBSTET GYNECOL, V176, P907, DOI 10.1016/S0002-9378(97)70620-3; Rett BS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-36; Rimoldi V, 2003, ONCOGENE, V22, P6054, DOI 10.1038/sj.onc.1206612; ROMERO R, 1987, AM J OBSTET GYNECOL, V157, P1461, DOI 10.1016/S0002-9378(87)80245-4; Sadovsky Y, 2000, AM J OBSTET GYNECOL, V182, P370, DOI 10.1016/S0002-9378(00)70226-2; Salvig JD, 2011, ACTA OBSTET GYN SCAN, V90, P825, DOI 10.1111/j.1600-0412.2011.01171.x; Sanborn BA, 2007, SEMIN CELL DEV BIOL, V18, P305, DOI 10.1016/j.semcdb.2007.05.007; SANDERS TAB, 1978, AM J CLIN NUTR, V31, P805, DOI 10.1093/ajcn/31.5.805; SANTOLI D, 1989, J IMMUNOL, V143, P1303; Smuts CM, 2003, OBSTET GYNECOL, V101, P469, DOI 10.1016/S0029-7844(02)02585-1; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; TAKAHASHI K, 1980, AM J OBSTET GYNECOL, V136, P774, DOI 10.1016/0002-9378(80)90455-X; ULMSTEN U, 1979, ACTA OBSTET GYN SCAN, P5; Ulug U, 2001, MOL HUM REPROD, V7, P1187, DOI 10.1093/molehr/7.12.1187; VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Whittington K, 2007, PROSTATE, V67, P1132, DOI 10.1002/pros.20612; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000; Yang M, 2002, MOL ENDOCRINOL, V16, P814, DOI 10.1210/me.16.4.814; Yang M, 2002, BIOL REPROD, V67, P988, DOI 10.1095/biolreprod.102.004119; Zeyda M, 2002, J BIOL CHEM, V277, P28418, DOI 10.1074/jbc.M203343200; Zhong M, 2004, BIOCHEMISTRY-US, V43, P3490, DOI 10.1021/bi035899m; Zhong M, 2007, AM J PHYSIOL-ENDOC M, V292, pE977, DOI 10.1152/ajpendo.00531.2005	79	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2012	7	7							e41708	10.1371/journal.pone.0041708	http://dx.doi.org/10.1371/journal.pone.0041708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012MO	22848573	Green Published, gold, Green Submitted			2022-12-27	WOS:000309240600043
J	Downey, CM; Singla, AK; Villemaire, ML; Buie, HR; Boyd, SK; Jirik, FR				Downey, Charlene M.; Singla, Arvind K.; Villemaire, Michelle L.; Buie, Helen R.; Boyd, Steven K.; Jirik, Frank R.			Quantitative Ex-Vivo Micro-Computed Tomographic Imaging of Blood Vessels and Necrotic Regions within Tumors	PLOS ONE			English	Article							BREAST-CANCER CELLS; LUNG-CANCER; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; MOUSE MODEL; ANGIOGENESIS; BONE; ULTRASOUND; ANTIBODIES; INHIBITOR; CARCINOMA	Techniques for visualizing and quantifying the microvasculature of tumors are essential not only for studying angiogenic processes but also for monitoring the effects of anti-angiogenic treatments. Given the relatively limited information that can be gleaned from conventional 2-D histological analyses, there has been considerable interest in methods that enable the 3-D assessment of the vasculature. To this end, we employed a polymerizing intravascular contrast medium (Microfil) and micro-computed tomography (micro-CT) in combination with a maximal spheres direct 3-D analysis method to visualize and quantify ex-vivo vessel structural features, and to define regions of hypoperfusion within tumors that would be indicative of necrosis. Employing these techniques we quantified the effects of a vascular disrupting agent on the tumor vasculature. The methods described herein for quantifying whole tumor vascularity represent a significant advance in the 3-D study of tumor angiogenesis and evaluation of novel therapeutics, and will also find potential application in other fields where quantification of blood vessel structure and necrosis are important outcome parameters.	[Downey, Charlene M.; Singla, Arvind K.; Villemaire, Michelle L.; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Buie, Helen R.; Boyd, Steven K.] Univ Calgary, Dept Mech & Mfg Engn, Calgary, AB, Canada; [Downey, Charlene M.; Singla, Arvind K.; Villemaire, Michelle L.; Buie, Helen R.; Boyd, Steven K.; Jirik, Frank R.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Downey, CM (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jirik@ucalgary.ca	Boyd, Steven K/E-9595-2010	Boyd, Steven K/0000-0002-2930-5997	Alberta Cancer Foundation Breast Cancer Translational Group; Canadian Institute for Health Research; Alberta Heritage Foundation for Medical Research; Canada Research Chair award	Alberta Cancer Foundation Breast Cancer Translational Group; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This study was supported by an Alberta Cancer Foundation Breast Cancer Translational Group Grant. C. M. D. was supported by doctoral studentships from Canadian Institute for Health Research and the Alberta Heritage Foundation for Medical Research. F.R.J. was the recipient of a Canada Research Chair award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood RC, 2010, MICROCIRCULATION, V17, P59, DOI 10.1111/j.1549-8719.2009.00009.x; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cheung AMY, 2007, ULTRASOUND MED BIOL, V33, P1259, DOI 10.1016/j.ultrasmedbio.2007.01.015; Chugh BP, 2009, NEUROIMAGE, V47, P1312, DOI 10.1016/j.neuroimage.2009.03.083; Folarin AA, 2010, MICROVASC RES, V80, P89, DOI 10.1016/j.mvr.2010.03.007; Gandhi D, 2003, J COMPUT ASSIST TOMO, V27, P687, DOI 10.1097/00004728-200309000-00005; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Hadjiiski L, 2010, AM J NEURORADIOL, V31, P1744, DOI 10.3174/ajnr.A2177; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Jamniczky HA, 2011, EVOL DEV, V13, P28, DOI 10.1111/j.1525-142X.2010.00453.x; Jassar AS, 2005, CANCER RES, V65, P11752, DOI 10.1158/0008-5472.CAN-05-1658; Kodama T, 2011, CANCER RES, V71, P6957, DOI 10.1158/0008-5472.CAN-11-2389; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Mondy WL, 2009, TISSUE ENG PART C-ME, V15, P729, DOI [10.1089/ten.tec.2008.0583, 10.1089/ten.TEC.2008.0583]; Nyangoga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017336; O'Connor JPB, 2009, CLIN CANCER RES, V15, P6674, DOI 10.1158/1078-0432.CCR-09-0731; Olson P, 2011, P NATL ACAD SCI USA, V108, pE1275, DOI 10.1073/pnas.1111079108; Qi XL, 2012, J ONCOL, V2012, DOI 10.1155/2012/362096; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Seshadri M, 2009, TRANSL ONCOL, V2, P121, DOI 10.1593/tlo.09103; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Ungersma SE, 2010, MAGN RESON MED, V63, P1637, DOI 10.1002/mrm.22442; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yang J, 2010, AM J PHYSIOL-HEART C, V298, pH1249, DOI 10.1152/ajpheart.00363.2009; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Young S, 2008, TISSUE ENG PART B-RE, V14, P295, DOI 10.1089/ten.teb.2008.0153; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	36	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41685	10.1371/journal.pone.0041685	http://dx.doi.org/10.1371/journal.pone.0041685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848565	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600104
J	Kocer, ZA; Krauss, S; Stallknecht, DE; Rehg, JE; Webster, RG				Kocer, Zeynep A.; Krauss, Scott; Stallknecht, David E.; Rehg, Jerold E.; Webster, Robert G.			The Potential of Avian H1N1 Influenza A Viruses to Replicate and Cause Disease in Mammalian Models	PLOS ONE			English	Article							HEMAGGLUTININ GENE; SWINE INFLUENZA; ORIGIN; MOUSE; FERRETS; EVOLUTION; INFECTION; MICE	H1N1 viruses in which all gene segments are of avian origin are the most frequent cause of influenza pandemics in humans; therefore, we examined the disease-causing potential of 31 avian H1N1 isolates of American lineage in DBA/2J mice. Thirty of 31 isolates were very virulent, causing respiratory tract infection; 22 of 31 resulted in fecal shedding; and 10 of 31 were as pathogenic as the pandemic 2009 H1N1 viruses. Preliminary studies in BALB/cJ mice and ferrets showed that 1 of 4 isolates tested was more pathogenic than the pandemic 2009 H1N1 viruses in BALB/cJ mice, and 1 of 2 strains transmitted both by direct and respiratory-droplet contact in ferrets. Preliminary studies of other avian subtypes (H2, H3, H4, H6, H10, H12) in DBA/2J mice showed lower pathogenicity than the avian H1N1 viruses. These findings suggest that avian H1N1 influenza viruses are unique among influenza A viruses in their potential to infect mammals.	[Kocer, Zeynep A.; Krauss, Scott; Webster, Robert G.] St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA; [Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, SE Cooperat Wildlife Dis Study, Athens, GA USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University System of Georgia; University of Georgia; St Jude Children's Research Hospital	Kocer, ZA (corresponding author), St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org	Kocer, Zeynep A./P-8983-2019; Rehg, Jerold E/N-8111-2018	Kocer, Zeynep A./0000-0001-9178-0142; 	National Institute of Allergy and Infectious Diseases; National Institutes of Health; Department of Health and Human Services [HHSN266200700005C, HHSN266200700007C]; American Lebanese Syrian Associated Charities (ALSAC)	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, Department of Health and Human Services (Contract No. HHSN266200700005C and HHSN266200700007C), and by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; DREIDING P, 1985, VIROLOGY, V140, P192, DOI 10.1016/0042-6822(85)90460-X; Englund L, 2000, VET MICROBIOL, V74, P101, DOI 10.1016/S0378-1135(00)00170-X; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; KANEGAE Y, 1994, ARCH VIROL, V134, P17, DOI 10.1007/BF01379103; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Shope RE, 1931, SCIENCE, V73, P214, DOI 10.1126/science.73.1886.214; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Smith JH, 2011, J VIROL, V85, P7572, DOI 10.1128/JVI.00512-11; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Stoner TD, 2010, J VIROL, V84, P9800, DOI 10.1128/JVI.00296-10; SUGITA S, 1991, J MOL EVOL, V32, P16, DOI 10.1007/BF02099924; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108	26	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41609	10.1371/journal.pone.0041609	http://dx.doi.org/10.1371/journal.pone.0041609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848544	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600095
J	Lilleri, D; Gerna, G; Zelini, P; Chiesa, A; Rognoni, V; Mastronuzzi, A; Giorgiani, G; Zecca, M; Locatelli, F				Lilleri, Daniele; Gerna, Giuseppe; Zelini, Paola; Chiesa, Antonella; Rognoni, Vanina; Mastronuzzi, Angela; Giorgiani, Giovanna; Zecca, Marco; Locatelli, Franco			Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANT; IDENTIFY PATIENTS; SIMULTANEOUS QUANTIFICATION; GANCICLOVIR PROPHYLAXIS; MONOCLONAL-ANTIBODIES; PERIPHERAL-BLOOD; PP65 ANTIGENEMIA; CMV INFECTION; RECIPIENTS; CD8(+)	In allogeneic hematopoietic stem-cell transplantation (HSCT) recipients, outcome of human cytomegalovirus (HCMV) infection results from balance between viral load/replication and pathogen-specific T-cell response. Using a cut-off of 30,000 HCMV DNA copies/ml blood for pre-emptive therapy and cut-offs of 1 and 3 virus-specific CD4(+) and CD8(+) T cells/mu l blood for T-cell protection, we conducted in 131 young patients a prospective 3-year study aimed at verifying whether achievement of such immunological cut-offs protects from HCMV disease. In the first three months after transplantation, 55/89 (62%) HCMV-seropositive patients had infection and 36/55 (65%) were treated pre-emptively, whereas only 7/42 (17%) HCMV-seronegative patients developed infection and 3/7 (43%) were treated. After 12 months, 76 HCMV-seropositive and 9 HCMV-seronegative patients (cumulative incidence: 90% and 21%, respectively) displayed protective HCMV-specific immunity. Eighty of these 85 (95%) patients showed spontaneous control of HCMV infection without additional treatment. Five patients after reaching protective T-cell levels needed pre-emptive therapy, because they developed graft-versus-host disease (GvHD). HSCT recipients reconstituting protective levels of HCMV-specific T-cells in the absence of GvHD are no longer at risk for HCMV disease, at least within 3 years after transplantation. The decision to treat HCMV infection in young HSCT recipients may be taken by combining virological and immunological findings.	[Lilleri, Daniele; Gerna, Giuseppe] Fdn IRCCS Policlin San Matteo, Area Trapiantol, Lab Sperimentali Ric, Pavia, Italy; [Mastronuzzi, Angela; Locatelli, Franco] IRCCS Osped Pediat Bambino Gesu, Dipartimento Oncoematol Pediat, Rome, Italy; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Bambino Gesu; University of Pavia	Lilleri, D (corresponding author), Fdn IRCCS Policlin San Matteo, Area Trapiantol, Lab Sperimentali Ric, Pavia, Italy.	g.gerna@smatteo.pv.it	MASTRONUZZI, ANGELA/K-7875-2016; Zecca, Marco/K-3309-2018; Zelini, Paola/Z-2975-2019; Giovanna, Giorgiani/AAC-9935-2019; Lilleri, Daniele/K-7776-2016	MASTRONUZZI, ANGELA/0000-0002-4408-2373; Zecca, Marco/0000-0002-8818-1744; Zelini, Paola/0000-0002-4913-0012; Giovanna, Giorgiani/0000-0001-8538-6157; Lilleri, Daniele/0000-0001-7747-7622; Gerna, Giuseppe/0000-0001-5956-2786	Ministero della Salute, Ricerca Corrente [80425, 80541]; Fondazione Carlo Denegri, Torino, Italy; AIRC (Associazione Italiana Ricerca sul Cancro)	Ministero della Salute, Ricerca Corrente; Fondazione Carlo Denegri, Torino, Italy; AIRC (Associazione Italiana Ricerca sul Cancro)	This work was supported by Ministero della Salute, Ricerca Corrente (grants no. 80425 and 80541, to GG), and Fondazione Carlo Denegri, Torino, Italy (to GG), and by the special grant 5x1000 from AIRC (Associazione Italiana Ricerca sul Cancro, to FL). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avetisyan G, 2007, BONE MARROW TRANSPL, V40, P865, DOI 10.1038/sj.bmt.1705825; Barron MA, 2009, CLIN INFECT DIS, V49, P1777, DOI 10.1086/648423; Boeckh M, 1996, BLOOD, V88, P4063, DOI 10.1182/blood.V88.10.4063.bloodjournal88104063; Boeckh M, 1998, TRANSPLANT INFECT; Boeckh M, 2009, BLOOD, V113, P5711, DOI 10.1182/blood-2008-10-143560; Cortez KJ, 2003, J INFECT DIS, V188, P967, DOI 10.1086/378413; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Fornara C, 2011, J CLIN IMMUNOL, V31, P1054, DOI 10.1007/s10875-011-9577-8; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; GERNA G, 1990, J CLIN MICROBIOL, V28, P2681, DOI 10.1128/JCM.28.12.2681-2688.1990; Gerna G, 2006, J MED VIROL, V78, P408, DOI 10.1002/jmv.20555; GERNA G, 1992, J CLIN MICROBIOL, V30, P1232, DOI 10.1128/JCM.30.5.1232-1237.1992; GOODRICH JM, 1993, ANN INTERN MED, V118, P173, DOI 10.7326/0003-4819-118-3-199302010-00003; Gratama JW, 2008, CYTOM PART B-CLIN CY, V74B, P211, DOI 10.1002/cyto.b.20420; Gratama JW, 2001, BLOOD, V98, P1358, DOI 10.1182/blood.V98.5.1358; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Hebart H, 2002, BLOOD, V99, P3830, DOI 10.1182/blood.V99.10.3830; Knight A, 2010, BLOOD, V116, P2164, DOI 10.1182/blood-2010-01-255166; Krol L, 2011, BONE MARROW TRANSPL, V46, P1089, DOI 10.1038/bmt.2010.261; Kuijpers TW, 2008, BLOOD, V112, P914, DOI 10.1182/blood-2008-05-157354; Lacey SF, 2002, TRANSPLANTATION, V74, P722, DOI 10.1097/00007890-200209150-00023; Lafarge X, 2001, J INFECT DIS, V184, P533, DOI 10.1086/322843; LI CR, 1994, BLOOD, V83, P1971, DOI 10.1182/blood.V83.7.1971.1971; Lilleri D, 2008, J INFECT DIS, V198, P536, DOI 10.1086/590118; Lilleri D, 2008, HAEMATOLOGICA, V93, P248, DOI 10.3324/haematol.11912; Lilleri D, 2007, BLOOD, V110, P2757, DOI 10.1182/blood-2007-03-080820; Lilleri D, 2006, BLOOD, V108, P1406, DOI 10.1182/blood-2005-11-012864; Lilleri D, 2009, J INFECT DIS, V199, P829, DOI 10.1086/597123; Ljungman P, 2003, BLOOD, V102, P4255, DOI 10.1182/blood-2002-10-3263; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lozza L, 2005, EUR J IMMUNOL, V35, P1795, DOI 10.1002/eji.200526023; Ozdemir E, 2002, BLOOD, V100, P3690, DOI 10.1182/blood-2002-05-1387; Pang XL, 2009, AM J TRANSPLANT, V9, P258, DOI 10.1111/j.1600-6143.2008.02513.x; Pastore D, 2011, BIOL BLOOD MARROW TR, V17, P550, DOI 10.1016/j.bbmt.2010.04.011; QUINNAN GV, 1982, NEW ENGL J MED, V307, P7, DOI 10.1056/NEJM198207013070102; Salvaneschi L, 2001, TRANSFUSION, V41, P1299, DOI 10.1046/j.1537-2995.2001.41101299.x; VANDERBIJ W, 1988, J MED VIROL, V25, P179, DOI 10.1002/jmv.1890250208	38	51	52	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41648	10.1371/journal.pone.0041648	http://dx.doi.org/10.1371/journal.pone.0041648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848556	Green Published, Green Submitted, gold			2022-12-27	WOS:000306806600099
J	Martignetti, L; Laud-Duval, K; Tirode, F; Pierron, G; Reynaud, S; Barillot, E; Delattre, O; Zinovyev, A				Martignetti, Loredana; Laud-Duval, Karine; Tirode, Franck; Pierron, Gaelle; Reynaud, Stephanie; Barillot, Emmanuel; Delattre, Olivier; Zinovyev, Andrei			Antagonism Pattern Detection between MicroRNA and Target Expression in Ewing's Sarcoma	PLOS ONE			English	Article							FEEDFORWARD REGULATORY CIRCUITS; BIOLOGICAL FUNCTIONS; MAMMALIAN MICRORNAS; GENE-EXPRESSION; IMPACT; DATABASE; NETWORK; TOOL; IDENTIFICATION; ACTIVATION	MicroRNAs (miRNAs) have emerged as fundamental regulators that silence gene expression at the post-transcriptional and translational levels. The identification of their targets is a major challenge to elucidate the regulated biological processes. The overall effect of miRNA is reflected on target mRNA expression, suggesting the design of new investigative methods based on high-throughput experimental data such as miRNA and transcriptome profiles. We propose a novel statistical measure of non-linear dependence between miRNA and mRNA expression, in order to infer miRNA-target interactions. This approach, which we name antagonism pattern detection, is based on the statistical recognition of a triangular-shaped pattern in miRNA-target expression profiles. This pattern is observed in miRNA-target expression measurements since their simultaneously elevated expression is statistically under-represented in the case of miRNA silencing effect. The proposed method enables miRNA target prediction to strongly rely on cellular context and physiological conditions reflected by expression data. The procedure has been assessed on synthetic datasets and tested on a set of real positive controls. Then it has been applied to analyze expression data from Ewing's sarcoma patients. The antagonism relationship is evaluated as a good indicator of real miRNA-target biological interaction. The predicted targets are consistently enriched for miRNA binding site motifs in their 3'UTR. Moreover, we reveal sets of predicted targets for each miRNA sharing important biological function. The procedure allows us to infer crucial miRNA regulators and their potential targets in Ewing's sarcoma disease. It can be considered as a valid statistical approach to discover new insights in the miRNA regulatory mechanisms.	[Martignetti, Loredana; Laud-Duval, Karine; Tirode, Franck; Barillot, Emmanuel; Delattre, Olivier; Zinovyev, Andrei] Inst Curie, Paris, France; [Martignetti, Loredana; Barillot, Emmanuel; Zinovyev, Andrei] INSERM U900, Paris, France; [Martignetti, Loredana; Barillot, Emmanuel; Zinovyev, Andrei] Mines ParisTech, Fontainebleau, France; [Laud-Duval, Karine; Tirode, Franck; Delattre, Olivier] INSERM U830, Paris, France; [Pierron, Gaelle; Reynaud, Stephanie] Inst Curie Hosp, Dept Tumor Biol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Martignetti, L (corresponding author), Inst Curie, Paris, France.	loredana.martignetti@curie.fr	TIRODE, Franck/HHS-7070-2022; Zinovyev, Andrei/B-4715-2010; Zinovyev, Andrey/P-8212-2019; Tirode, Franck/B-4586-2009	Zinovyev, Andrei/0000-0002-9517-7284; Martignetti, Loredana/0000-0003-1535-7515; BARILLOT, Emmanuel/0000-0003-2724-2002; delattre, olivier/0000-0002-8730-2276; Tirode, Franck/0000-0003-4731-7817	European Union [259348]; Institut National du Cancer; Carte d'Identite des Tumeurs/Program of the Ligue Nationale Contre le Cancer	European Union(European Commission); Institut National du Cancer(Institut National du Cancer (INCA) France); Carte d'Identite des Tumeurs/Program of the Ligue Nationale Contre le Cancer	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n.259348. This work was supported by the Institut National du Cancer (SybEwing project) and by the Carte d'Identite des Tumeurs/Program of the Ligue Nationale Contre le Cancer. LM, AZ and EB are members of the team "Computational Systems Biology of Cancer,'' Equipe labellisee by the Ligue Nationale Contre le Cancer. KL, FT and OD are members of the team "Genetics and biology of childhood cancers and of sporadic breast cancers,'' Equipe labellisee by the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; CHO SJ, 2010, NUCL ACIDS RES; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Elkan-Miller T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018195; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee SK, 2011, DISCOV MED, V11, P245; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	75	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41770	10.1371/journal.pone.0041770	http://dx.doi.org/10.1371/journal.pone.0041770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848594	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600115
J	Shameem, M; Patel, AB				Shameem, Mohammad; Patel, Anant Bahadur			Glutamatergic and GABAergic Metabolism in Mouse Brain under Chronic Nicotine Exposure: Implications for Addiction	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CEREBRAL GLUCOSE-UTILIZATION; RESTING TOBACCO SMOKERS; VENTRAL TEGMENTAL AREA; VIVO C-13 NMR; IN-VIVO; RAT-BRAIN; ENERGY-METABOLISM; REWARD AREAS; BLOOD-FLOW	Background and Purpose: The effects of nicotine on cerebral metabolism and its influence on smoking behavior is poorly understood. An understanding of the chronic effects of nicotine on excitatory and inhibitory metabolic demand, and corresponding neurotransmission may provide clues for designing strategies for the optimal smoking cessation intervention. The objective of the current study was to investigate neuronal and astroglial metabolism in mice exposed to nicotine (0.5 and 2.0 mg/kg, sc) three times in a day for 4 weeks. Experimental Approach/Principal Findings: Metabolic measurements were carried out by co-infusing [U-C-13(6)]glucose and [2-C-13]acetate, and monitoring C-13 labeling of amino acids in brain tissue extract using H-1-[C-13] and C-13-[H-1]-NMR spectroscopy. Concentration of C-13-labeled glutamate-C4 was increased significantly from glucose and acetate with chronic nicotine treatment indicating an increase in glucose oxidation by glutamatergic neurons in all brain regions and glutamate-glutamine neurotransmitter cycle in cortical and subcortical regions. However, chronic nicotine treatment led to increased labeling of GABA-C2 from glucose only in the cortical region. Further, increased labeling of glutamine-C4 from [2-C-13] acetate is suggestive of increased astroglial activity in subcortical and cerebellum regions of brain with chronic nicotine treatment. Conclusions and Significance: Chronic nicotine exposure enhanced excitatory activity in the majority of brain regions while inhibitory and astroglial functions were enhanced only in selected brain regions.	[Shameem, Mohammad; Patel, Anant Bahadur] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Shameem, M (corresponding author), Cent Drug Res Inst, Div Pharmacol, MG Marg, Lucknow 226001, Uttar Pradesh, India.	abpatel@ccmb.res.in	Shameem, Mohammad/K-1632-2019	Shameem, Mohammad/0000-0003-0578-2622	Council of Scientific and Industrial Research, Government of India - Centre for Cellular and Molecular Biology, Hyderabad, India	Council of Scientific and Industrial Research, Government of India - Centre for Cellular and Molecular Biology, Hyderabad, India	This study was supported by funding from Council of Scientific and Industrial Research, Government of India - Centre for Cellular and Molecular Biology, Hyderabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BADARGOFFER RS, 1990, BIOCHEM J, V266, P133, DOI 10.1042/bj2660133; Bagga P, 2012, NEUROCHEM INT, V60, P177, DOI 10.1016/j.neuint.2011.10.016; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Chowdhury GMI, 2012, BIOL PSYCHIAT, V71, P1022, DOI 10.1016/j.biopsych.2011.11.006; de Graaf RA, 2004, P NATL ACAD SCI USA, V101, P12700, DOI 10.1073/pnas.0405065101; de Graaf RA, 2003, MAGNET RESON MED, V49, P37, DOI 10.1002/mrm.10348; Domino EF, 2000, NEUROSCIENCE, V101, P277, DOI 10.1016/S0306-4522(00)00357-2; Domino EF, 2000, SYNAPSE, V38, P313, DOI 10.1002/1098-2396(20001201)38:3<313::AID-SYN10>3.0.CO;2-6; Fagen ZM, 2003, ANN NY ACAD SCI, V1003, P185, DOI 10.1196/annals.1300.011; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Grabus SD, 2005, PSYCHOPHARMACOLOGY, V178, P183, DOI 10.1007/s00213-004-2007-3; GREENAMYRE JT, 1993, CEREBROVAS BRAIN MET, V5, P61; GRUETTER R, 1994, J NEUROCHEM, V63, P1377; Gruetter R, 2001, AM J PHYSIOL-ENDOC M, V281, pE100, DOI 10.1152/ajpendo.2001.281.1.E100; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Hyder F, 2000, J CEREBR BLOOD F MET, V20, P485, DOI 10.1097/00004647-200003000-00007; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Jackson KJ, 2009, NEUROPHARMACOLOGY, V57, P347, DOI 10.1016/j.neuropharm.2009.07.020; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; LONDON ED, 1988, J NEUROSCI, V8, P3920; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mao DY, 2010, J MOL NEUROSCI, V40, P154, DOI 10.1007/s12031-009-9230-7; Marchi M, 2002, J NEUROCHEM, V80, P1071, DOI 10.1046/j.0022-3042.2002.00805.x; Marenco T, 2000, BRIT J PHARMACOL, V129, P147, DOI 10.1038/sj.bjp.0703005; Marks MJ, 2010, BIOCHEM PHARMACOL, V80, P1238, DOI 10.1016/j.bcp.2010.06.040; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Meisingset TW, 2010, GLIA, V58, P1228, DOI 10.1002/glia.21003; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; Ortells MO, 2010, MED HYPOTHESES, V74, P884, DOI 10.1016/j.mehy.2009.11.004; Ottersen O P, 1986, Adv Exp Med Biol, V203, P263; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Patel AB, 2004, J CEREBR BLOOD F MET, V24, P972, DOI 10.1097/01.WCB.0000126234.16188.71; Patel AB, 2001, BRAIN RES, V919, P207, DOI 10.1016/S0006-8993(01)03015-3; Patel AB, 2010, P INT SOC MAGN RESON, V18, P3356; Patel AB, 2010, J CEREBR BLOOD F MET, V30, P1200, DOI 10.1038/jcbfm.2010.2; Paterson NE, 2003, PSYCHOPHARMACOLOGY, V167, P257, DOI 10.1007/s00213-003-1432-z; Pearl PL, 2004, CURR OPIN NEUROL, V17, P107, DOI 10.1097/00019052-200404000-00005; Rahman S, 2004, NEUROSCIENCE, V129, P415, DOI 10.1016/j.neuroscience.2004.08.010; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Sanacora G, 2003, ANN NY ACAD SCI, V1003, P292, DOI 10.1196/annals.1300.018; Schilstrom B, 2000, SYNAPSE, V38, P375, DOI 10.1002/1098-2396(20001215)38:4<375::AID-SYN2>3.0.CO;2-Y; Schmidt W J, 1992, J Neural Transm Suppl, V38, P65; Sharma G, 2008, J NEUROSCI, V28, P2563, DOI 10.1523/JNEUROSCI.5407-07.2008; Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Tiwari V, 2012, J ALZHEIMERS DIS, V28, P765, DOI 10.3233/JAD-2011-111502; Turegano L, 2001, J NEUROSCI RES, V64, P626, DOI 10.1002/jnr.1116; Wang J, 2010, J NEUROCHEM, V113, P1447, DOI 10.1111/j.1471-4159.2010.06684.x; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Zhang TA, 2010, J NEUROSCI, V30, P6443, DOI 10.1523/JNEUROSCI.0458-10.2010; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P906, DOI 10.1016/S0006-3223(00)01070-2; Zwingmann C, 2003, J CEREBR BLOOD F MET, V23, P756, DOI 10.1097/01.WCB.0000056062.25434.4D	63	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2012	7	7							e41824	10.1371/journal.pone.0041824	http://dx.doi.org/10.1371/journal.pone.0041824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979GX	22848621	Green Submitted, Green Published, gold			2022-12-27	WOS:000306806600128
J	Rowe, GC; El-Khoury, R; Patten, IS; Rustin, P; Arany, Z				Rowe, Glenn C.; El-Khoury, Riyad; Patten, Ian S.; Rustin, Pierre; Arany, Zolt			PGC-1 alpha is Dispensable for Exercise-Induced Mitochondrial Biogenesis in Skeletal Muscle	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ACTIVATED PROTEIN-KINASE; NUCLEAR RESPIRATORY FACTORS; MESSENGER-RNA EXPRESSION; ENDURANCE EXERCISE; INSULIN SENSITIVITY; GENE-EXPRESSION; PGC-1 FAMILY; GLUCOSE-HOMEOSTASIS; RECEPTOR ACTIVATION	Exercise confers numerous health benefits, many of which are thought to stem from exercise-induced mitochondrial biogenesis (EIMB) in skeletal muscle. The transcriptional coactivator PGC-1 alpha, a potent regulator of metabolism in numerous tissues, is widely believed to be required for EIMB. We show here that this is not the case. Mice engineered to lack PGC-1 alpha specifically in skeletal muscle (Myo-PGC-1 alpha KO mice) retained intact EIMB. The exercise capacity of these mice was comparable to littermate controls. Induction of metabolic genes after 2 weeks of in-cage voluntary wheel running was intact. Electron microscopy revealed no gross abnormalities in mitochondria, and the mitochondrial biogenic response to endurance exercise was as robust in Myo-PGC-1 alpha KO mice as in wildtype mice. The induction of enzymatic activity of the electron transport chain by exercise was likewise unperturbed in Myo-PGC-1 alpha KO mice. These data demonstrate that PGC-1 alpha is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle, in sharp contrast to the prevalent assumption in the field.	[Rowe, Glenn C.; Patten, Ian S.; Arany, Zolt] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA; [El-Khoury, Riyad; Rustin, Pierre] Hop Robert Debre, F-75019 Paris, France; [El-Khoury, Riyad; Rustin, Pierre] Univ Paris, Fac Med Denis Diderot, F-75252 Paris, France	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rowe, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Cardiovasc Inst, Boston, MA 02215 USA.	zarany@bidmc.harvard.edu	Rowe, Glenn/N-5314-2019	Patten, Ian/0000-0003-1888-656X; Rowe, Glenn/0000-0002-8195-9605	NIH [5T32HL007374-31]; UNCF-Merck Science Initiative (post-doctoral fellowship); Ellison Foundation; NHLBI [5R01HL094499-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374, R01HL094499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck Science Initiative (post-doctoral fellowship); Ellison Foundation(Lawrence Ellison Foundation); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	GCR has received support from NIH (5T32HL007374-31) and UNCF-Merck Science Initiative (post-doctoral fellowship) (umsi.uncf.org), and ZA is supported by the Ellison Foundation (www.ellisonfoundation.org) and the NHLBI (5R01HL094499-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Altenburg TM, 2007, J APPL PHYSIOL, V103, P1752, DOI 10.1152/japplphysiol.00496.2007; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Arany ZP, 2008, CURR PROTOC HUM GENE, DOI DOI 10.1002/0471142905.HG1110S58; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Freyssenet D, 1996, ARCH PHYSIOL BIOCHEM, V104, P129, DOI 10.1076/apab.104.2.129.12878; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Little JP, 2011, APPL PHYSIOL NUTR ME, V36, P598, DOI [10.1139/H11-076, 10.1139/h11-076]; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; MIURA S, 2008, ENDOCRINOLOGY; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mortensen OH, 2007, J APPL PHYSIOL, V103, P1536, DOI 10.1152/japplphysiol.00575.2007; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Ostergard T, 2006, AM J PHYSIOL-ENDOC M, V290, pE998, DOI 10.1152/ajpendo.00012.2005; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rowe GC, 2011, AM J PHYSIOL-ENDOC M, V301, pE155, DOI 10.1152/ajpendo.00681.2010; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Steiner JL, 2011, J APPL PHYSL; Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a; Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Uguccioni G, 2011, AM J PHYSIOL-ENDOC M, V300, pE361, DOI 10.1152/ajpendo.00292.2010; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yan Z, 2007, EXERC SPORT SCI REV, V35, P97, DOI 10.1097/JES.0b013e3180a03169; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	73	85	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41817	10.1371/journal.pone.0041817	http://dx.doi.org/10.1371/journal.pone.0041817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	22848618	Green Submitted, gold, Green Published			2022-12-27	WOS:000306751300076
J	Zhang, JT; Liu, H; Sun, J; Li, B; Zhu, Q; Chen, SL; Zhang, HX				Zhang, Jiantao; Liu, Hua; Sun, Jian; Li, Bei; Zhu, Qiang; Chen, Shaoliang; Zhang, Hongxia			Arabidopsis Fatty Acid Desaturase FAD2 Is Required for Salt Tolerance during Seed Germination and Early Seedling Growth	PLOS ONE			English	Article							CHLOROPLAST OMEGA-3-FATTY-ACID DESATURASE; STRESS TOLERANCE; LOW-TEMPERATURE; CALCIUM SENSOR; SACCHAROMYCES-CEREVISIAE; COLD TOLERANCE; PROTEIN-KINASE; GENE; EXPRESSION; PLANTS	Fatty acid desaturases play important role in plant responses to abiotic stresses. However, their exact function in plant resistance to salt stress is unknown. In this work, we provide the evidence that FAD2, an endoplasmic reticulum localized omega-desaturase, is required for salt tolerance in Arabidopsis. Using vacuolar and plasma membrane vesicles prepared from the leaves of wild-type (Col-0) and the loss-of-function Arabidopsis mutant, fad2, which lacks the functional FAD2, we examined the fatty acid composition and Na+-dependent H+ movements of the isolated vesicles. We observed that, when compared to Col-0, the level of vacuolar and plasma membrane polyunsaturation was lower, and the Na+/H+ exchange activity was reduced in vacuolar and plasma membrane vesicles isolated from fad2 mutant. Consistent with the reduced Na+/H+ exchange activity, fad2 accumulated more Na+ in the cytoplasm of root cells, and was more sensitive to salt stress during seed germination and early seedling growth, as indicated by CoroNa-Green staining, net NaNa+ efflux and salt tolerance analyses. Our results suggest that FAD2 mediated high-level vacuolar and plasma membrane fatty acid desaturation is essential for the proper function of membrane attached Na+/H+ exchangers, and thereby to maintain a low cytosolic NaNa+ concentration for salt tolerance during seed germination and early seedling growth in Arabidopsis.	[Zhang, Jiantao; Liu, Hua; Li, Bei; Zhu, Qiang; Zhang, Hongxia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Sun, Jian; Chen, Shaoliang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Beijing Forestry University	Zhang, JT (corresponding author), Texas A&M Univ Syst, Texas AgriLife Res Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA.	hxzhang@sippe.ac.cn	Zhang, Jiantao/I-5116-2014; LIU, HUA/M-7659-2019; Wang, Zhibo/GSD-3371-2022	Chen, Shaoliang/0000-0001-7511-3067; Zhang, Jiantao/0000-0002-2875-9743; Sun, Jian/0000-0002-1434-4029	National Natural Science Foundation of China [30872044, 30800880, 3100012, 31000288, 31171169, 31101154]; National Basic Research Program of China [2010CB126600]; National mega project of GMO crops [2008ZX08001-003, 2008ZX08004-002, 2008ZX08010-004]; Shanghai Science & Technology Development Fund [0853Z111C1, 08DZ2270800]; Fundamental Research Funds for the Central Universities [JC2011-2, BLYJ200903]; Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing [YB20081002201]; Beijing Natural Science Foundation [6112017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National mega project of GMO crops; Shanghai Science & Technology Development Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (30872044; 30800880; 3100012; 31000288; 31171169; 31101154); the National Basic Research Program of China (2010CB126600); the National mega project of GMO crops (2008ZX08001-003; 2008ZX08004-002; 2008ZX08010-004); Shanghai Science & Technology Development Fund (0853Z111C1; 08DZ2270800); the Fundamental Research Funds for the Central Universities (JC2011-2; BLYJ200903); Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing (YB20081002201); and Beijing Natural Science Foundation (6112017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Apse MP, 2002, CURR OPIN BIOTECH, V13, P146, DOI 10.1016/S0958-1669(02)00298-7; BLUMWALD E, 1987, PHYSIOL PLANTARUM, V69, P731, DOI 10.1111/j.1399-3054.1987.tb01993.x; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COOKE DT, 1990, PHYSIOL PLANTARUM, V78, P153, DOI 10.1111/j.1399-3054.1990.tb08730.x; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Craig W, 2008, TRANSGENIC RES, V17, P769, DOI 10.1007/s11248-008-9164-9; DEUTICKE B, 1987, ANNU REV PHYSIOL, V49, P221; Fiehn O, 2000, ANAL CHEM, V72, P3573, DOI 10.1021/ac991142i; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; GRAHAM D, 1982, ANNU REV PLANT PHYS, V33, P347, DOI 10.1146/annurev.pp.33.060182.002023; Im YJ, 2002, MOL CELLS, V13, P264; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; Liu W, 2003, PLANT J, V36, P189, DOI 10.1046/j.1365-313X.2003.01866.x; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; MIQUEL MF, 1994, PLANT PHYSIOL, V106, P421, DOI 10.1104/pp.106.2.421; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Verslues PE, 2007, PLANT MOL BIOL, V64, P205, DOI 10.1007/s11103-007-9145-z; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang B, 2006, J EXP BOT, V57, P1161, DOI 10.1093/jxb/erj116; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	51	147	171	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30355	10.1371/journal.pone.0030355	http://dx.doi.org/10.1371/journal.pone.0030355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22848559	Green Published, gold, Green Submitted			2022-12-27	WOS:000299771900063
J	Xie, T; d' Ario, G; Lamb, JR; Martin, E; Wang, K; Tejpar, S; Delorenzi, M; Bosman, FT; Roth, AD; Yan, P; Bougel, S; Di Narzo, AF; Popovici, V; Budinska, E; Mao, M; Weinrich, SL; Rejto, PA; Hodgson, JG				Xie, Tao; d' Ario, Giovanni; Lamb, John R.; Martin, Eric; Wang, Kai; Tejpar, Sabine; Delorenzi, Mauro; Bosman, Fred T.; Roth, Arnaud D.; Yan, Pu; Bougel, Stephanie; Di Narzo, Antonio Fabio; Popovici, Vlad; Budinska, Eva; Mao, Mao; Weinrich, Scott L.; Rejto, Paul A.; Hodgson, J. Graeme			A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations	PLOS ONE			English	Article							ELONGATION-FACTOR EEF1A2; COLON-CANCER; OVARIAN-CANCER; BREAST-CANCER; CELL-LINES; DNA; GENES; HYBRIDIZATION; PROTEIN; TUMORS	To develop a comprehensive overview of copy number aberrations (CNAs) in stage-II/III colorectal cancer (CRC), we characterized 302 tumors from the PETACC-3 clinical trial. Microsatellite-stable (MSS) samples (n = 269) had 66 minimal common CNA regions, with frequent gains on 20 q (72.5%), 7 (41.8%), 8 q (33.1%) and 13 q (51.0%) and losses on 18 (58.6%), 4 q (26%) and 21 q (21.6%). MSS tumors have significantly more CNAs than microsatellite-instable (MSI) tumors: within the MSI tumors a novel deletion of the tumor suppressor WWOX at 16 q23.1 was identified (p<0.01). Focal aberrations identified by the GISTIC method confirmed amplifications of oncogenes including EGFR, ERBB2, CCND1, MET, and MYC, and deletions of tumor suppressors including TP53, APC, and SMAD4, and gene expression was highly concordant with copy number aberration for these genes. Novel amplicons included putative oncogenes such as WNK1 and HNF4A, which also showed high concordance between copy number and expression. Survival analysis associated a specific patient segment featured by chromosome 20 q gains to an improved overall survival, which might be due to higher expression of genes such as EEF1B2 and PTK6. The CNA clustering also grouped tumors characterized by a poor prognosis BRAF-mutant-like signature derived from mRNA data from this cohort. We further revealed non-random correlation between CNAs among unlinked loci, including positive correlation between 20 q gain and 8 q gain, and 20 q gain and chromosome 18 loss, consistent with co-selection of these CNAs. These results reinforce the non-random nature of somatic CNAs in stage-II/III CRC and highlight loci and genes that may play an important role in driving the development and outcome of this disease.	[Xie, Tao; Lamb, John R.; Martin, Eric; Wang, Kai; Mao, Mao; Weinrich, Scott L.; Rejto, Paul A.; Hodgson, J. Graeme] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA; [d' Ario, Giovanni; Delorenzi, Mauro; Di Narzo, Antonio Fabio; Popovici, Vlad; Budinska, Eva] Swiss Inst Bioinformat, Lausanne, Switzerland; [Tejpar, Sabine] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium; [Delorenzi, Mauro; Bosman, Fred T.; Yan, Pu; Bougel, Stephanie] Univ Lausanne, Med Ctr, Lausanne, Switzerland; [Roth, Arnaud D.] Univ Hosp Geneva, Geneva, Switzerland	Pfizer; Swiss Institute of Bioinformatics; KU Leuven; University Hospital Leuven; University of Lausanne; University of Geneva	Xie, T (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA.	tao.xie@pfizer.com; hodgson.graeme@gmail.com	Whitehall, Vicki L/B-6262-2013; Budinska, Eva/F-2698-2011; Leggett, Barbara A/D-3579-2011; Young, Joanne P/H-7774-2014; Pandeya, Nirmala/F-8054-2010; Young, Joanne P/B-9981-2011; Whitehall, Vicki/E-5414-2019; Rejto, Paul/M-4782-2019; Popovici, Vlad C./C-2039-2008	Whitehall, Vicki L/0000-0002-8285-2391; Budinska, Eva/0000-0002-9004-9187; Pandeya, Nirmala/0000-0003-1462-4968; Popovici, Vlad C./0000-0002-1311-9188; Wang, Kai/0000-0003-0567-3004; /0000-0003-3281-8643	Swiss National Science Foundation [SNF 320030_135421]; Foundation Medic; Krebsforschung Schweiz [KFS 02697-08-2010]; Belgian Federation Against Cancer; Belgian National Cancer Plan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Medic; Krebsforschung Schweiz; Belgian Federation Against Cancer; Belgian National Cancer Plan	This work was supported in part by a grant from the Swiss National Science Foundation (SNF 320030_135421) and Foundation Medic and a grant of the Krebsforschung Schweiz (KFS 02697-08-2010) to AR and MD. ST is a senior clinical investigator of the Fund for Scientific Research Flanders and has received research grants from the Belgian Federation Against Cancer and from the Belgian National Cancer Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Andersen CL, 2010, INT J CANC; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Aust DE, 2004, SCAND J GASTROENTERO, V39, P766, DOI 10.1080/00365520410003191; Bartos JD, 2007, MUTAT RES-FUND MOL M, V615, P1, DOI 10.1016/j.mrfmmm.2006.09.006; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji HL, 2006, CANCER RES, V66, P7910, DOI 10.1158/0008-5472.CAN-06-0595; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Sayagues JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013752; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Nakao M, 2009, CANCER GENET CYTOGEN, V188, P70, DOI 10.1016/j.cancergencyto.2008.09.013; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Platzer P, 2002, CANCER RES, V62, P1134; Popovici V, 2012, J CONTRACEPT FERTIL; Postma C, 2009, ANN ONCOL, V20, P1048, DOI 10.1093/annonc/mdn738; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Venkatachalam R, 2008, CYTOGENET GENOME RES, V123, P188, DOI 10.1159/000184708; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wierzbicki PM, 2009, J PHYSIOL PHARMACOL, V60, P63; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie T, 2010, OMICS, V14, P91, DOI 10.1089/omi.2009.0114	46	83	87	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42001	10.1371/journal.pone.0042001	http://dx.doi.org/10.1371/journal.pone.0042001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	23094064	Green Published, Green Submitted, gold			2022-12-27	WOS:000307045600049
J	Zhang, J; Wang, SX; Li, HH; Hu, BB; Yang, XF; Wang, ZB				Zhang, Jing; Wang, Shuxia; Li, Houhun; Hu, Bingbing; Yang, Xiaofei; Wang, Zhibo			Diffuse Coevolution between Two Epicephala Species (Gracillariidae) and Two Breynia Species (Phyllanthaceae)	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; PLASTID MATK; YUCCA MOTHS; GLOCHIDION; PHYLOGENETICS; SPECIFICITY; ASSOCIATION; FIGS	The diffuse coevolution between two moth species (Epicephala lativalvaris and E. mirivalvata) and two plant species (Breynia fruticosa and B. rostrata) is reported based on field observations and indoor experiments conducted in Hainan and Fujian, China. Study results showed that the two Epicephala species jointly pollinated the two Breynia species, which led to a unique obligate pollination mutualism of two-to-two species specificity. A single Epicephala larva exclusively fed on seeds of host plants and developed to maturity by consuming all six seeds of each fruit, whereas a fraction of intact fruits were left to ensure the reproduction of plants within the whole population. Larvae of the two Epicephala species are competitive for resources; the population of E. mirivalvata is much smaller than that of E. lativalvaris, which has resulted from the differences in the female ovipositor structures and oviposition mode. The life history of Epicephala species highly coincides with the phenology of Breynia plants, and different phenology of B. fruticosa resulted in the different life history of the two Epicephala species in Hainan and Fujian. The natural hybridization of two host plants, possibly induced by the alternate pollination of two Epicephala species, is briefly discussed.	[Zhang, Jing; Wang, Shuxia; Li, Houhun; Hu, Bingbing; Yang, Xiaofei; Wang, Zhibo] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Zhang, J (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	lihouhun@nankai.edu.cn	Zhang, Jiantao/I-5116-2014; LIU, HUA/M-7659-2019; Wang, Zhibo/GSD-3371-2022	Chen, Shaoliang/0000-0001-7511-3067; Zhang, Jiantao/0000-0002-2875-9743; Sun, Jian/0000-0002-1434-4029	National Natural Science Foundation of China [30930014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 30930014). Funder's website: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; CORLETT RT, 1993, J TROP ECOL, V9, P501, DOI 10.1017/S0266467400007574; Doyle J. J., 1987, PHYTOCHEM B, P11; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; JANZEN DH, 1979, BIOTROPICA, V11, P48, DOI 10.2307/2388172; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kathriarachchi H, 2006, AM J BOT, V93, P637, DOI 10.3732/ajb.93.4.637; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, AM J BOT, V91, P1319, DOI 10.3732/ajb.91.9.1319; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kawakita A, 2006, MOL ECOL, V15, P3567, DOI 10.1111/j.1365-294X.2006.03037.x; Kawakita A, 2010, PLANT SPEC BIOL, V25, P3, DOI 10.1111/j.1442-1984.2009.00266.x; Li B.T., 2008, FLORA CHINA, V11, P216; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Okamoto T, 2007, J CHEM ECOL, V33, P1065, DOI 10.1007/s10886-007-9287-0; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Samuel R, 2005, AM J BOT, V92, P132, DOI 10.3732/ajb.92.1.132; Svensson GP, 2010, NEW PHYTOL, V186, P995, DOI 10.1111/j.1469-8137.2010.03227.x; Swofford DL, 2005, PAUP PHYLOGENETIC AN; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Zhang J, 2012, ZOOTAXA, P43, DOI 10.11646/zootaxa.3275.1.4	25	147	171	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41657	10.1371/journal.pone.0041657	http://dx.doi.org/10.1371/journal.pone.0041657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848559	gold, Green Published, Green Submitted			2022-12-27	WOS:000306950200085
